data_2khz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2khz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' ALA . 32.1 Cg_exo -57.62 -150.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.804 1.669 . . . . 0.0 111.213 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -111.03 -175.39 2.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 36.0 m -121.44 152.43 39.1 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.0 136.09 58.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' CG ' ' A' ' 69' ' ' ASP . 8.1 t80 -113.17 99.26 7.69 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -89.49 116.75 27.89 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.46 -0.896 . . . . 0.0 108.883 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.55 146.76 23.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.443 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.62 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -168.58 75.13 0.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.62 ' C ' ' O ' ' A' ' 16' ' ' GLY . 15.7 m -16.2 127.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.936 -0.743 . . . . 0.0 110.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.301 -1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 110.034 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.704 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.855 0.836 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -59.76 -42.95 94.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.7 m-20 -52.06 -34.76 45.01 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -64.09 -44.61 91.82 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.92 60.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.285 -0.885 . . . . 0.0 109.227 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -58.75 -32.45 69.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 16.0 m-30 -67.86 -46.03 72.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.343 -0.848 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.71 78.27 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.995 -1.065 . . . . 0.0 108.997 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -70.8 -57.22 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.077 . . . . 0.0 108.579 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 31' ' ' ILE . 26.5 mt -51.7 -42.57 31.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 49.1 t -61.72 -31.32 50.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.0 t -67.12 -39.24 86.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 110.026 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.554 ' NH2' ' HH ' ' A' ' 38' ' ' TYR . 53.0 ttt85 -69.56 -48.61 59.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.699 -1.251 . . . . 0.0 109.415 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -60.71 -38.54 85.37 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -63.17 -24.99 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -78.05 -36.66 48.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.056 -1.027 . . . . 0.0 109.419 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HH ' ' NH2' ' A' ' 34' ' ' ARG . 1.9 m-85 -69.8 -47.05 64.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.426 -0.796 . . . . 0.0 110.416 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.75 2.56 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -99.36 135.68 40.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.85 117.61 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 44' ' ' GLU . 19.3 mt -80.94 -35.81 31.8 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -68.27 37.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.561 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 42' ' ' LEU . 44.3 tp10 -50.27 -34.49 23.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -52.85 28.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 48' ' ' ASP . 21.8 t -58.83 163.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.716 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 62.55 -59.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 46' ' ' VAL . 24.0 t70 -65.85 24.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.716 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -103.63 -10.83 18.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.73 -39.78 95.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.802 ' CD1' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.07 161.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.527 -0.733 . . . . 0.0 109.773 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 51' ' ' LEU . 12.8 mt-10 55.97 158.61 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.287 -0.883 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -63.04 131.8 34.13 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.446 2.097 . . . . 0.0 111.593 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.7 mm? -93.91 171.16 9.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 141.27 37.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 58' ' ' ALA . 50.0 mt-10 47.11 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.482 -1.01 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 55' ' ' GLY . 97.1 mt-10 -47.47 -20.6 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' A' ' 56' ' ' GLU . . . -48.66 151.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.91 136.89 6.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.89 -62.57 0.17 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.78 80.6 1.13 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 18.8 p-10 -52.17 -45.22 65.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -1.091 . . . . 0.0 108.307 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 88.4 mt-30 -63.49 -48.59 77.02 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -61.64 -36.0 79.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.094 -1.004 . . . . 0.0 109.015 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 mt -62.71 -52.22 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.727 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -67.56 -50.54 58.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.588 0.709 . . . . 0.0 109.423 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.727 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 45.7 tp10 -43.09 -58.14 2.59 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -63.9 -39.42 94.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.656 ' CG ' ' OH ' ' A' ' 13' ' ' TYR . 8.5 t0 -58.42 -48.0 82.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.408 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -64.51 -45.14 88.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' NE2' ' A' ' 75' ' ' GLN . 10.1 t-20 -65.44 -52.11 55.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' GLN . 0.5 OUTLIER -63.12 -45.69 90.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 108.976 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 42.1 tp -50.35 -37.22 35.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.7 -28.1 61.55 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.435 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.49 ' NE2' ' OD1' ' A' ' 71' ' ' ASN . 41.2 mt-30 -88.1 -0.5 57.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 109.646 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.81 44.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.091 -1.005 . . . . 0.0 112.277 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 11' ' ' SER . 61.5 m-20 -85.61 -31.67 22.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.47 143.96 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.2 t -138.88 130.81 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.687 -1.258 . . . . 0.0 111.748 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 84.0 t -136.65 130.66 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.23 137.21 52.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.663 -1.273 . . . . 0.0 110.291 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD2' ' A' ' 27' ' ' LEU . 55.1 tt0 -84.71 139.18 32.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.6 -0.687 . . . . 0.0 109.282 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -143.62 147.71 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.272 -0.893 . . . . 0.0 109.793 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 14.5 m -173.87 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' ' OD2' ' A' ' 24' ' ' ASP . 24.6 pt20 -97.93 153.61 38.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -37.37 143.71 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.146 1.897 . . . . 0.0 111.676 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.432 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 3.5 m -163.5 123.9 2.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 110.104 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' B' ' 287' ' ' SER . 4.0 mt -76.62 -45.19 31.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.316 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.564 ' N ' ' OG ' ' A' ' 17' ' ' SER . . . -60.78 -42.17 99.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.547 ' N ' ' OG ' ' A' ' 17' ' ' SER . 40.7 t -64.62 -45.21 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.194 -1.18 . . . . 0.0 109.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.79 -46.7 93.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -66.25 -47.94 72.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -1.081 . . . . 0.0 109.501 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' SD ' ' B' ' 319' ' ' MET . 10.8 mm-40 -59.76 -37.27 78.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.6 mt -75.22 -41.53 57.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.051 -1.031 . . . . 0.0 109.242 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.04 -50.02 59.65 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -40.05 82.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.392 -1.064 . . . . 0.0 108.612 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' A' ' 101' ' ' GLY . . . -68.33 -37.06 80.18 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.633 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.73 -45.14 48.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.892 -1.13 . . . . 0.0 108.276 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -89.59 -53.04 4.7 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.089 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.506 ' CD1' ' C ' ' A' ' 100' ' ' LEU . 1.8 tm? -90.06 -29.85 18.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.089 -1.007 . . . . 0.0 109.643 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 97' ' ' ALA . . . -74.19 166.68 54.74 Favored Glycine 0 C--N 1.283 -2.392 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 4.8 mtmm -124.55 -71.09 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 82.9 Cg_endo -79.48 111.43 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.978 1.786 . . . . 0.0 109.293 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.59 116.03 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.782 -1.199 . . . . 0.0 111.995 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 132' ' ' TRP . 57.3 tp -110.5 126.26 54.18 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 145.66 39.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.928 -1.108 . . . . 0.0 108.771 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.3 mt -122.47 135.49 54.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.911 . . . . 0.0 111.625 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -133.5 138.01 45.91 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.577 ' NH2' ' NE2' ' A' ' 111' ' ' GLN . 4.4 mtm180 -98.98 134.66 21.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 120.703 -1.248 . . . . 0.0 111.338 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.43 -26.1 4.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.553 2.169 . . . . 0.0 111.267 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.577 ' NE2' ' NH2' ' A' ' 109' ' ' ARG . 20.3 pt20 -46.63 -38.66 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' GLY . 31.0 t -102.13 -15.8 16.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.82 51.37 2.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 115' ' ' VAL . 58.8 mtp85 -80.87 18.08 1.07 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.998 -1.295 . . . . 0.0 109.062 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 114' ' ' ARG . 48.7 t 46.99 100.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.671 0.748 . . . . 0.0 110.141 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.1 tp -47.95 145.77 2.82 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -45.8 143.13 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.63 -30.31 69.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.458 -0.776 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.408 ' SD ' ' CD ' ' B' ' 293' ' ' GLU . 0.8 OUTLIER -70.76 -51.57 26.28 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.878 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 120' ' ' ILE . 35.8 mm -62.66 -42.51 96.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -65.17 -48.84 72.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.544 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.603 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -62.35 -31.25 78.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 125' ' ' ASP . . . -62.6 -15.66 52.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.038 -1.272 . . . . 0.0 108.199 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.45 96.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 65.3 m-20 -105.29 -22.52 13.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.893 . . . . 0.0 108.693 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.42 30.37 77.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 89.6 p -134.89 59.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.7 mtt180 98.61 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -97.49 120.03 37.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -145.91 142.02 28.34 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.852 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.83 100.59 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.43 ' CD2' HD12 ' A' ' 105' ' ' LEU . 21.6 m0 -95.43 152.68 18.19 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.237 -0.914 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -97.38 155.54 16.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.094 -1.004 . . . . 0.0 108.877 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 6.3 p90 -170.19 -178.68 2.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.724 -1.235 . . . . 0.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.94 149.72 27.57 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.9 mt-10 -42.47 -29.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.704 -1.247 . . . . 0.0 110.154 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.51 -6.06 88.05 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.56 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.08 11.32 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.587 -1.537 . . . . 0.0 110.581 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.0 p -54.34 -45.35 68.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.924 -1.11 . . . . 0.0 108.448 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.504 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 49.9 mt-10 -57.76 -32.67 67.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.451 -0.781 . . . . 0.0 109.262 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.8 m -68.18 -45.52 73.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.568 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.97 -50.91 60.33 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.55 -34.1 77.15 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.89 -41.53 95.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.413 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -68.87 -48.7 62.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.867 -1.146 . . . . 0.0 108.331 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.39 -48.17 82.9 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 16.7 m-85 -69.74 -32.9 71.7 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.942 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 150' ' ' TYR . 27.1 mm-40 -62.24 -32.42 73.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.14 10.87 5.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.2 t80 -134.6 -105.09 0.23 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.24 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD1' ' CD1' ' A' ' 147' ' ' PHE . 14.9 mt -34.4 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.8 -0.563 . . . . 0.0 111.208 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 150' ' ' TYR . 87.1 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 C-N-CA 123.168 2.578 . . . . 0.0 111.142 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.09 -150.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.961 1.774 . . . . 0.0 111.279 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 28.2 p -111.25 -175.65 2.76 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 33.6 m -121.13 152.81 38.29 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 10.5 t -131.25 136.17 58.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.659 ' OH ' ' CG ' ' B' ' 269' ' ' ASP . 8.1 t80 -113.29 99.29 7.69 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' B' ' 214' ' ' PHE . 0.0 OUTLIER -89.67 116.52 27.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.975 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.1 m -92.34 146.75 23.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.625 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -168.29 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.625 ' C ' ' O ' ' B' ' 216' ' ' GLY . 14.6 m -15.94 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.883 -0.775 . . . . 0.0 110.78 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.303 -1.433 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.894 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.891 0.853 . . . . 0.0 111.825 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.92 -42.38 93.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.613 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.8 m-20 -52.68 -34.6 52.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -64.16 -44.44 92.09 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.02 59.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.32 -0.862 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.432 ' CD2' ' OE2' ' B' ' 282' ' ' GLU . 0.6 OUTLIER -58.67 -32.92 69.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 15.9 m-30 -67.49 -45.79 74.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.835 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.66 78.85 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.905 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -70.84 -57.15 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.901 -1.125 . . . . 0.0 108.619 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.76 -42.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 49.6 t -62.05 -31.23 50.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 10.5 t -67.07 -39.2 86.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . 0.542 ' NH2' ' OH ' ' B' ' 238' ' ' TYR . 53.8 ttt85 -69.56 -48.71 59.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.644 -1.285 . . . . 0.0 109.323 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.51 -38.66 85.06 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -63.18 -25.0 68.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.101 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -77.94 -36.43 49.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.026 -1.046 . . . . 0.0 109.402 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.558 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 1.9 m-85 -69.99 -47.1 63.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.505 -0.747 . . . . 0.0 110.469 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.92 2.6 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -99.3 135.75 40.25 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.363 -1.081 . . . . 0.0 109.346 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.86 117.55 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' B' ' 244' ' ' GLU . 19.4 mt -80.93 -35.82 31.85 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.318 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' B' ' 243' ' ' THR . 0.9 OUTLIER -68.34 36.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.597 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' B' ' 242' ' ' LEU . 45.1 tp10 -49.98 -34.03 19.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -52.22 34.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.11 -0.994 . . . . 0.0 109.047 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' B' ' 248' ' ' ASP . 21.9 t -59.62 163.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 108.899 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.729 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 62.57 -59.89 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' B' ' 246' ' ' VAL . 24.4 t70 -65.76 24.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.729 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -103.16 -10.68 18.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.627 -0.671 . . . . 0.0 109.194 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -63.68 -39.85 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.805 ' CD1' ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -55.05 161.69 1.59 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.451 -0.78 . . . . 0.0 109.754 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' B' ' 251' ' ' LEU . 12.3 mt-10 56.14 158.68 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.07 131.64 33.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 111.618 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' B' ' 254' ' ' LEU . 3.7 mm? -94.0 170.26 9.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.294 -0.879 . . . . 0.0 109.827 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 142.28 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' B' ' 258' ' ' ALA . 50.4 mt-10 46.9 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 255' ' ' GLY . 96.8 mt-10 -47.21 -21.23 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.171 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -47.92 151.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -46.35 136.23 7.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.57 -62.81 0.16 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.07 80.7 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 18.6 p-10 -52.34 -44.96 65.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -1.125 . . . . 0.0 108.254 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . 0.476 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.1 mt-30 -63.71 -48.78 75.71 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -61.6 -35.5 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 109.08 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 1.9 mt -63.21 -52.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.73 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 0.1 OUTLIER -67.42 -50.09 60.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.493 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.73 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 44.4 tp10 -43.74 -58.19 2.83 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 110.032 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -39.16 93.54 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.0 109.382 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.659 ' CG ' ' OH ' ' B' ' 213' ' ' TYR . 9.0 t0 -58.55 -48.14 81.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -0.867 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -64.5 -45.3 87.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 109.797 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.475 ' OD1' ' NE2' ' B' ' 275' ' ' GLN . 10.0 t-20 -65.34 -51.92 57.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 109.678 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' B' ' 275' ' ' GLN . 0.5 OUTLIER -63.18 -45.7 90.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.938 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.407 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 42.3 tp -50.37 -37.23 36.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -73.74 -28.06 61.5 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.423 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.475 ' NE2' ' OD1' ' B' ' 271' ' ' ASN . 41.1 mt-30 -87.93 -0.58 57.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.999 -1.063 . . . . 0.0 109.707 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.99 131.62 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.205 -0.934 . . . . 0.0 112.4 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' B' ' 211' ' ' SER . 64.0 m-20 -85.65 -31.63 22.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 97.1 t -134.51 143.8 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.76 130.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.69 -1.256 . . . . 0.0 111.849 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 91.4 t -136.47 130.54 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.26 136.84 52.65 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.669 -1.269 . . . . 0.0 110.268 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.432 ' OE2' ' CD2' ' B' ' 227' ' ' LEU . 52.7 tt0 -84.32 139.59 32.19 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.589 -0.694 . . . . 0.0 109.273 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -144.13 147.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 15.2 m -173.47 -68.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.46 ' NE2' ' OD2' ' B' ' 224' ' ' ASP . 24.7 pt20 -98.38 153.86 37.84 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.12 144.04 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.131 1.888 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.445 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 3.5 m -163.72 123.7 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 87' ' ' SER . 4.0 mt -76.8 -45.16 29.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 217' ' ' SER . . . -60.43 -42.75 99.1 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.536 ' N ' ' OG ' ' B' ' 217' ' ' SER . 41.2 t -64.07 -45.57 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -1.201 . . . . 0.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.03 93.11 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -66.17 -47.97 72.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 109.557 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.408 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 11.6 mm-40 -59.87 -37.12 78.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.25 -41.65 56.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.033 -1.042 . . . . 0.0 109.212 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.93 60.2 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -39.66 82.4 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.395 -1.062 . . . . 0.0 108.596 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.426 ' O ' ' CA ' ' B' ' 301' ' ' GLY . . . -68.45 -37.22 80.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.921 -1.111 . . . . 0.0 108.626 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.446 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -52.66 -45.51 48.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.889 -1.132 . . . . 0.0 108.226 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -89.27 -52.76 4.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.236 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.51 ' C ' ' CD1' ' B' ' 300' ' ' LEU . 1.7 tm? -90.46 -29.84 17.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.026 -1.047 . . . . 0.0 109.593 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' B' ' 297' ' ' ALA . . . -73.51 166.4 54.63 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 108.308 -1.917 . . . . 0.0 108.308 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.508 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 4.8 mtmm -124.54 -71.25 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 84.7 Cg_endo -79.4 110.86 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.884 1.723 . . . . 0.0 109.398 176.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 16.6 mt -128.98 116.35 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.699 -1.25 . . . . 0.0 112.103 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' B' ' 332' ' ' TRP . 57.8 tp -110.88 126.06 54.29 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 145.92 38.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.97 -1.081 . . . . 0.0 108.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.562 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 8.1 mt -122.98 135.6 54.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.229 -0.919 . . . . 0.0 111.643 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -133.45 138.35 46.15 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 311' ' ' GLN . 4.3 mtm180 -99.36 134.82 20.96 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 0.0 111.307 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.33 -26.27 4.23 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.531 2.154 . . . . 0.0 111.31 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 309' ' ' ARG . 20.2 pt20 -46.37 -38.76 9.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 28.7 t -102.04 -15.77 16.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.89 51.14 2.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.3 mtp85 -80.63 17.33 1.15 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.978 -1.307 . . . . 0.0 109.048 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.0 t 47.67 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.688 0.756 . . . . 0.0 110.128 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . . . . . . . . . 47.8 tp -47.44 145.6 2.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.569 -0.707 . . . . 0.0 109.519 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.4 m -45.7 142.98 2.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.892 . . . . 0.0 110.195 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.37 69.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -0.759 . . . . 0.0 109.607 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.443 ' SD ' ' CD ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -70.33 -52.03 25.7 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.911 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.453 HG23 HD13 ' B' ' 320' ' ' ILE . 35.9 mm -62.43 -42.28 95.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.61 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 18.0 tpt85 -65.33 -48.94 71.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.143 -0.973 . . . . 0.0 109.484 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.644 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.41 -31.36 79.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' B' ' 325' ' ' ASP . . . -62.19 -15.76 48.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.036 -1.273 . . . . 0.0 108.111 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -44.24 96.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.508 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 66.7 m-20 -105.17 -22.41 13.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 108.696 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 65.51 30.14 76.81 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.2 p -134.7 59.57 1.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' B' ' 327' ' ' SER . 95.1 mtt180 98.89 -31.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -97.37 119.73 36.44 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -145.71 142.11 28.68 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.901 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 30.4 t -107.85 100.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.427 ' CD2' HD12 ' B' ' 305' ' ' LEU . 21.4 m0 -95.34 152.62 18.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.248 -0.908 . . . . 0.0 109.578 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -97.23 155.65 16.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 108.822 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 6.2 p90 -170.28 -179.12 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.761 -1.212 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.59 149.61 27.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 335' ' ' ALA . 49.5 mt-10 -42.56 -29.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.707 -1.245 . . . . 0.0 110.18 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.33 -6.02 87.75 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.624 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -145.02 11.33 1.36 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.504 . . . . 0.0 110.6 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 5.0 p -54.3 -45.25 68.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.896 -1.128 . . . . 0.0 108.55 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 49.4 mt-10 -57.77 -32.76 67.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.498 -0.751 . . . . 0.0 109.203 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.7 m -68.33 -45.42 72.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.88 -51.21 58.44 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.12 -34.37 77.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.816 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.92 -41.43 95.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -68.75 -48.87 62.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.778 -1.201 . . . . 0.0 108.265 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.27 -48.1 83.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.856 . . . . 0.0 110.139 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.7 m-85 -69.85 -32.87 71.49 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.952 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' B' ' 350' ' ' TYR . 26.4 mm-40 -62.27 -32.67 73.42 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -81.9 10.82 5.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.3 t80 -134.4 -105.14 0.23 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.236 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' B' ' 350' ' ' TYR . 15.0 mt -34.22 92.17 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 111.182 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' B' ' 350' ' ' TYR . 88.6 Cg_endo . . . . . 0 C--N 1.312 -1.351 0 C-N-CA 123.103 2.536 . . . . 0.0 111.074 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.8 Cg_exo -55.38 -154.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.386 2.057 . . . . 0.0 111.424 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 32.0 p -111.91 172.74 6.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HG ' ' HG ' ' A' ' 42' ' ' LEU . 18.4 t -114.86 155.44 26.81 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 108.704 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 2.7 t -130.45 126.92 61.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.522 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 32.9 t80 -93.99 127.46 39.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' A' ' 32' ' ' VAL . 17.8 t80 -100.81 130.7 46.87 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.787 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' GLU . 5.5 t -134.0 128.79 35.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.99 -178.96 33.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -76.02 118.7 19.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -1.192 . . . . 0.0 108.634 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.65 ' H ' ' CB ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.883 0.849 . . . . 0.0 111.235 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 49.4 mp0 -60.62 -53.28 59.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 108.934 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -55.31 -29.36 58.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.65 ' CB ' ' H ' ' A' ' 22' ' ' ARG . 35.6 tp60 -64.34 -43.06 95.78 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -49.08 68.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 -34.22 67.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 19.2 m-30 -69.17 -41.32 77.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.983 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -62.67 -37.0 84.69 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 109.11 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.56 -56.78 5.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.841 -1.162 . . . . 0.0 108.613 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -54.08 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 45.5 t -65.27 -28.73 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 18.8 m -67.08 -40.47 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.593 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 -69.59 -47.26 64.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.806 -1.183 . . . . 0.0 109.113 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.71 -40.62 92.97 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -62.57 -25.29 68.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.688 -0.632 . . . . 0.0 109.42 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -78.03 -37.58 46.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.0 m-85 -67.83 -45.73 73.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 110.534 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -152.63 -152.48 5.98 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -90.08 120.39 31.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -1.167 . . . . 0.0 109.388 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -89.61 115.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 15.9 mt -79.44 172.35 13.92 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.498 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 45' ' ' HIS . 4.7 m 54.23 41.86 31.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.257 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.32 -12.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 108.778 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' ALA . 47.4 t-80 -52.98 -45.57 67.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.387 -0.821 . . . . 0.0 109.614 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' ALA . 69.2 t -39.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -50.05 -42.53 49.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 108.903 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 26.2 t70 -81.14 24.49 0.52 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -105.95 33.41 3.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.62 -21.33 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.701 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.08 163.62 20.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.499 -0.751 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 51' ' ' LEU . 14.6 mt-10 54.58 157.85 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' LEU . 23.2 Cg_endo -62.98 71.07 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.425 2.083 . . . . 0.0 111.475 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -54.97 -169.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 116.69 129.96 4.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 63.6 mt-10 -50.24 -33.69 20.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.248 . . . . 0.0 108.629 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -69.58 -24.07 63.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -62.09 150.02 39.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.88 11.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.908 . . . . 0.0 109.404 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -52.97 -30.88 38.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.56 76.8 1.18 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 56' ' ' GLU . 3.1 m-20 -52.96 -44.83 67.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.359 -1.083 . . . . 0.0 108.539 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -62.31 -45.5 92.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -55.45 -36.61 66.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 108.612 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 3.2 mt -67.61 -35.62 73.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.454 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.0 t-80 -79.4 -62.91 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 66' ' ' HIS . 72.2 mt-10 -43.58 -48.02 7.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.899 -1.126 . . . . 0.0 109.71 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -69.25 -42.75 75.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.115 -0.99 . . . . 0.0 109.371 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.522 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 1.2 m-20 -59.56 -47.06 87.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 110.307 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 1.5 mm? -65.21 -46.58 80.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.322 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 33.0 t-20 -61.86 -54.52 41.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.18 -34.78 75.61 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.208 -0.933 . . . . 0.0 109.236 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 39.5 tp -57.09 -41.56 79.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.122 -0.986 . . . . 0.0 108.754 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -76.9 -22.83 52.79 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.36 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 47.7 mt-30 -84.27 -9.09 58.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.108 . . . . 0.0 108.829 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 132.36 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.354 -0.841 . . . . 0.0 112.082 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 11' ' ' SER . 12.4 m-20 -86.95 -27.66 23.17 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 74.7 t -139.23 137.4 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.91 141.49 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.739 -1.226 . . . . 0.0 111.085 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 t -138.86 122.37 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.549 0.69 . . . . 0.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.61 128.76 53.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 110.044 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -87.71 125.91 34.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 108.549 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.602 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -115.74 27.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.428 -0.795 . . . . 0.0 109.747 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.5 ' C ' ' CZ ' ' A' ' 114' ' ' ARG . 4.3 m -78.39 23.97 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.903 . . . . 0.0 108.851 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.567 ' N ' ' CZ ' ' A' ' 114' ' ' ARG . 5.0 tp-100 -166.32 118.91 0.82 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.978 . . . . 0.0 109.373 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.649 ' N ' HH21 ' A' ' 114' ' ' ARG . 76.8 Cg_exo -45.44 108.75 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.061 1.841 . . . . 0.0 111.946 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 m -142.36 131.03 22.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.839 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.66 -39.07 80.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.46 ' CA ' ' OG ' ' B' ' 317' ' ' SER . . . -62.38 -45.03 96.78 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.81 -48.61 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -1.034 . . . . 0.0 108.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.73 98.03 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.78 -49.15 71.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.457 -1.025 . . . . 0.0 109.756 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 6.2 tp10 -59.65 -32.02 70.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.7 mt -70.78 -43.77 68.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.684 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -45.55 80.74 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -44.69 96.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.967 . . . . 0.0 108.748 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.39 -36.16 82.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.136 -0.978 . . . . 0.0 108.522 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -54.41 -44.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.877 -1.139 . . . . 0.0 108.071 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -86.67 -52.89 5.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.699 -0.626 . . . . 0.0 111.908 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.476 ' C ' ' CD1' ' A' ' 100' ' ' LEU . 2.2 tm? -92.34 -31.85 15.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.048 -1.033 . . . . 0.0 109.948 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -69.74 174.65 35.62 Favored Glycine 0 C--N 1.281 -2.507 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' A' ' 103' ' ' PRO . 22.1 mttt -136.55 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 102' ' ' LYS . 59.3 Cg_endo -98.84 109.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 123.748 2.965 . . . . 0.0 109.684 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.8 mt -127.21 124.35 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.839 -1.163 . . . . 0.0 112.027 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.2 tp -123.52 116.08 22.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 1.5 m -105.94 147.2 29.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.867 -1.145 . . . . 0.0 108.894 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.1 mt -120.26 139.12 53.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.193 -0.942 . . . . 0.0 111.068 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -146.02 122.96 11.35 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 16.8 mtt180 -88.07 140.0 30.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.719 -1.238 . . . . 0.0 110.481 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.66 -29.03 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.415 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.31 -32.9 5.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -99.17 -26.36 14.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.496 -0.752 . . . . 0.0 109.114 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.49 49.49 32.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.649 HH21 ' N ' ' A' ' 86' ' ' PRO . 10.4 mtp-105 -75.11 -11.41 60.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.035 -1.274 . . . . 0.0 111.205 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 114' ' ' ARG . 38.8 t 59.46 119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 116' ' ' LEU . 2.4 mt -77.34 158.64 30.03 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.84 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.454 ' OG ' ' CA ' ' B' ' 289' ' ' GLY . 0.3 OUTLIER -54.13 145.15 17.79 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.768 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.63 -19.09 5.37 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 108.696 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.496 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 1.0 OUTLIER -77.9 -45.18 24.86 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.399 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 120' ' ' ILE . 42.5 mm -66.71 -48.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.2 -0.938 . . . . 0.0 108.575 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.4 -44.68 74.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.247 -0.908 . . . . 0.0 108.81 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -64.15 -28.23 72.61 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -40.68 -64.65 0.5 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.553 -0.969 . . . . 0.0 110.273 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -150.94 -95.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.204 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 15.0 p-10 111.54 5.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.53 70.77 0.02 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.861 ' C ' ' H ' ' A' ' 129' ' ' PHE . 37.5 p -164.15 66.34 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 66.43 -20.3 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.861 ' H ' ' C ' ' A' ' 127' ' ' SER . 9.3 t80 -117.77 118.76 32.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.569 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 31.3 tt0 -137.19 134.28 36.11 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.205 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 69.5 t -91.85 105.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.569 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 13.7 m0 -102.14 142.35 33.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.171 -0.955 . . . . 0.0 109.724 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 54.0 m-20 -97.79 157.17 16.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.062 -1.024 . . . . 0.0 108.947 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' OH ' ' NE ' ' A' ' 109' ' ' ARG . 10.0 p90 -165.29 -172.72 2.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.591 -1.318 . . . . 0.0 111.936 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -159.27 148.37 18.34 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.4 mt-10 -42.93 -37.12 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.76 -1.213 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.92 2.86 53.71 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.207 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.97 7.14 0.52 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.58 -1.541 . . . . 0.0 110.601 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.8 p -53.99 -45.36 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.97 -1.081 . . . . 0.0 108.53 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 44.6 mt-10 -57.07 -33.67 67.5 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 83.9 m -68.19 -45.07 74.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.707 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.437 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.4 tpp -51.63 -48.13 63.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.76 -35.06 74.61 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 77.8 m-20 -65.59 -39.66 91.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 110.315 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -69.65 -50.29 45.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.818 -1.176 . . . . 0.0 108.315 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.92 -46.98 87.61 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.958 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 12.2 m-85 -68.96 -34.05 74.71 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.136 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.03 -23.9 66.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.34 59.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.675 -0.641 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -156.04 -48.86 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.221 -1.55 . . . . 0.0 112.715 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.616 ' N ' ' CG ' ' A' ' 150' ' ' TYR . 4.1 mt -38.32 -57.93 1.67 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.916 -1.115 . . . . 0.0 111.562 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 12.0 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 121.763 1.642 . . . . 0.0 111.741 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ALA . 31.7 Cg_exo -55.52 -154.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.276 1.984 . . . . 0.0 111.377 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.6 p -112.21 172.75 6.72 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 19.4 t -114.97 155.35 27.08 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.756 -1.215 . . . . 0.0 108.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 2.6 t -130.49 127.1 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.535 ' OH ' ' CB ' ' B' ' 269' ' ' ASP . 33.5 t80 -93.8 127.6 39.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' B' ' 232' ' ' VAL . 17.9 t80 -100.86 130.7 46.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.81 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' B' ' 293' ' ' GLU . 5.7 t -134.04 129.08 35.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.532 -0.73 . . . . 0.0 109.415 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -159.36 -178.85 33.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.7 p -76.11 118.06 18.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 0.0 108.757 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.274 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.645 ' H ' ' CB ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.902 0.858 . . . . 0.0 111.319 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' B' ' 223' ' ' GLU . 49.0 mp0 -60.5 -53.14 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 108.983 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.48 -29.01 57.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.645 ' CB ' ' H ' ' B' ' 222' ' ' ARG . 36.1 tp60 -64.68 -43.15 94.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.44 -0.787 . . . . 0.0 109.21 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -34.09 67.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.459 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 19.4 m-30 -69.28 -41.32 76.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.182 -0.949 . . . . 0.0 110.037 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -62.65 -37.26 85.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.59 -1.319 . . . . 0.0 109.161 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -70.37 -56.67 6.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.834 -1.166 . . . . 0.0 108.654 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 83.0 mt -54.09 -41.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 44.7 t -65.16 -28.63 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.761 . . . . 0.0 109.103 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 19.1 m -67.31 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.526 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -69.7 -47.87 61.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.891 -1.131 . . . . 0.0 109.078 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.1 -40.77 90.79 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -62.29 -25.45 67.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.695 -0.628 . . . . 0.0 109.458 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -78.0 -37.69 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.975 . . . . 0.0 109.535 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.0 m-85 -67.71 -45.51 74.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.591 -0.693 . . . . 0.0 110.541 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.86 -152.53 6.02 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -90.24 120.63 31.56 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.365 -1.079 . . . . 0.0 109.389 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.81 116.21 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.45 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 15.7 mt -79.81 172.15 14.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.082 -1.012 . . . . 0.0 109.491 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.501 ' C ' ' H ' ' B' ' 245' ' ' HIS . 4.5 m 54.38 41.92 31.7 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.36 -0.837 . . . . 0.0 109.322 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -50.64 -12.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 108.766 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' B' ' 243' ' ' THR . 46.7 t-80 -53.59 -45.14 69.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.5 -0.75 . . . . 0.0 109.426 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 249' ' ' ALA . 68.9 t -39.87 -79.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.622 -0.674 . . . . 0.0 109.992 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -49.69 -42.6 46.12 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.237 -0.915 . . . . 0.0 108.908 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' B' ' 251' ' ' LEU . 24.3 t70 -80.82 24.22 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 246' ' ' VAL . . . -105.73 33.61 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' B' ' 247' ' ' ALA . 0.1 OUTLIER -123.5 -22.12 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.726 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -82.62 163.09 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.459 -0.776 . . . . 0.0 109.564 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' B' ' 251' ' ' LEU . 14.9 mt-10 54.82 157.75 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 109.88 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 254' ' ' LEU . 22.6 Cg_endo -62.74 71.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.441 2.094 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -55.66 -169.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.902 . . . . 0.0 109.454 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 117.5 129.97 4.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' B' ' 262' ' ' ASP . 61.6 mt-10 -50.1 -33.8 19.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.088 -1.242 . . . . 0.0 108.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -69.52 -24.55 63.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -61.56 150.04 37.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.488 -0.758 . . . . 0.0 109.351 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.73 11.1 0.15 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -52.68 -31.26 37.29 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.68 77.27 1.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' B' ' 256' ' ' GLU . 2.7 m-20 -52.89 -44.94 67.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -1.111 . . . . 0.0 108.589 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -62.04 -46.0 91.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.26 -37.12 66.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.961 . . . . 0.0 108.557 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.485 ' O ' ' OD1' ' B' ' 269' ' ' ASP . 3.3 mt -67.26 -35.25 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.444 ' O ' HD23 ' B' ' 270' ' ' LEU . 4.1 t-80 -79.69 -63.35 1.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 109.859 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' B' ' 266' ' ' HIS . 72.7 mt-10 -42.94 -48.44 5.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.67 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -69.03 -42.57 76.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.472 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.535 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 1.2 m-20 -59.85 -46.89 87.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 1.6 mm? -65.17 -46.83 79.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 110.424 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 32.9 t-20 -61.77 -54.52 41.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.138 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.45 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -61.15 -34.99 75.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.151 -0.968 . . . . 0.0 109.077 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 38.2 tp -56.89 -41.08 77.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.0 108.822 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -77.48 -22.53 51.15 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 47.7 mt-30 -84.55 -8.78 58.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.14 . . . . 0.0 108.884 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.88 132.39 45.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.402 -0.811 . . . . 0.0 112.131 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' B' ' 211' ' ' SER . 9.7 m-20 -86.63 -27.88 23.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 63.6 t -139.33 137.94 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 64.8 t -127.14 141.54 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.852 -1.155 . . . . 0.0 111.131 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 18.3 t -138.71 121.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.514 -0.741 . . . . 0.0 109.306 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -120.02 128.98 54.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.005 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.08 125.52 34.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 108.502 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.59 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -115.28 27.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 109.658 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.492 ' C ' ' CZ ' ' B' ' 314' ' ' ARG . 4.1 m -78.42 24.51 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 108.91 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.574 ' N ' ' CZ ' ' B' ' 314' ' ' ARG . 4.9 tp-100 -166.65 118.5 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.638 ' N ' HH21 ' B' ' 314' ' ' ARG . 74.4 Cg_exo -45.31 109.13 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.011 1.807 . . . . 0.0 111.898 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 29.4 m -142.34 131.23 22.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 70.7 mt -69.21 -38.31 78.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . 0.454 ' CA ' ' OG ' ' A' ' 117' ' ' SER . . . -63.08 -44.98 96.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.74 -48.7 83.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -1.036 . . . . 0.0 108.703 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -62.02 -39.57 97.76 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.08 -49.13 71.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -1.036 . . . . 0.0 109.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.525 ' CB ' ' SG ' ' B' ' 215' ' ' CYS . 6.8 tp10 -59.55 -32.08 70.0 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.72 -43.86 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 108.691 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.27 81.48 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -43.96 97.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.597 -0.943 . . . . 0.0 108.8 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -67.16 -36.14 81.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.137 -0.977 . . . . 0.0 108.429 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.408 HG13 ' N ' ' B' ' 299' ' ' ALA . 0.7 OUTLIER -54.31 -44.53 66.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -86.76 -52.95 5.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.914 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.469 ' C ' ' CD1' ' B' ' 300' ' ' LEU . 2.2 tm? -92.13 -31.84 15.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 109.93 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -69.75 174.55 35.85 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.646 ' H ' ' CD ' ' B' ' 303' ' ' PRO . 22.6 mttt -136.59 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.646 ' CD ' ' H ' ' B' ' 302' ' ' LYS . 58.7 Cg_endo -98.83 109.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 123.703 2.935 . . . . 0.0 109.704 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.53 124.39 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.8 -1.188 . . . . 0.0 112.087 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 25.3 tp -123.73 115.97 22.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.466 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 1.5 m -105.4 147.36 28.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 108.88 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.476 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.1 mt -120.47 138.97 53.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.088 -1.008 . . . . 0.0 110.997 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' B' ' 333' ' ' ASP . 0.6 OUTLIER -145.89 122.99 11.45 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.572 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 15.7 mtt180 -88.25 140.3 30.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.726 -1.234 . . . . 0.0 110.378 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.78 -28.79 6.05 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.631 2.221 . . . . 0.0 111.623 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -47.56 -32.69 5.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 20.6 t -99.31 -26.28 14.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.064 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 49.33 49.62 31.26 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.638 HH21 ' N ' ' B' ' 286' ' ' PRO . 10.3 mtp-105 -75.1 -11.36 60.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.303 . . . . 0.0 111.218 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' B' ' 314' ' ' ARG . 38.4 t 59.6 119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.481 ' N ' HD22 ' B' ' 316' ' ' LEU . 2.4 mt -77.36 158.29 30.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.646 -1.221 . . . . 0.0 108.822 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.46 ' OG ' ' CA ' ' A' ' 89' ' ' GLY . 0.4 OUTLIER -53.78 145.27 16.2 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.712 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.74 -19.04 5.46 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.269 -0.895 . . . . 0.0 108.729 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.492 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -77.99 -45.41 23.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.337 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.408 HD11 HG22 ' B' ' 320' ' ' ILE . 40.1 mm -66.26 -48.61 80.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.615 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -44.19 75.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.935 . . . . 0.0 108.748 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -64.11 -29.0 73.69 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -40.14 -65.21 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.555 -0.968 . . . . 0.0 110.314 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -150.78 -95.18 0.06 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.233 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 15.0 p-10 111.47 4.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 161.46 70.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.83 ' C ' ' H ' ' B' ' 329' ' ' PHE . 32.8 p -164.31 66.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 66.33 -20.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.83 ' H ' ' C ' ' B' ' 327' ' ' SER . 8.8 t80 -117.53 118.9 33.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.553 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 31.7 tt0 -137.22 134.1 35.87 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.209 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.67 106.01 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.553 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 13.7 m0 -102.14 142.31 33.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.115 -0.991 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' B' ' 308' ' ' PHE . 53.9 m-20 -97.77 157.27 16.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.937 -1.102 . . . . 0.0 108.921 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.572 ' OH ' ' NE ' ' B' ' 309' ' ' ARG . 10.2 p90 -165.0 -171.88 2.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.629 -1.294 . . . . 0.0 111.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.461 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -159.97 148.31 17.11 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.4 mt-10 -42.85 -37.13 1.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.724 -1.235 . . . . 0.0 110.234 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.13 3.35 52.6 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -151.62 7.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.537 -1.566 . . . . 0.0 110.559 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 6.2 p -53.97 -45.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 108.556 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.496 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 42.5 mt-10 -57.14 -34.14 68.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.3 m -67.45 -45.51 75.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.147 -0.971 . . . . 0.0 109.658 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.423 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.4 tpp -51.42 -48.06 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 46.6 mt -69.65 -35.02 74.81 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.72 -39.43 91.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.927 -1.108 . . . . 0.0 110.294 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -70.05 -50.1 44.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.937 -1.102 . . . . 0.0 108.243 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.94 -47.3 86.35 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.017 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.477 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 12.5 m-85 -68.76 -33.83 74.57 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.149 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.59 -9.92 58.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.785 -0.572 . . . . 0.0 111.428 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -156.31 -48.88 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.161 -1.587 . . . . 0.0 112.643 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.617 ' N ' ' CG ' ' B' ' 350' ' ' TYR . 4.0 mt -38.62 -57.85 1.81 Allowed Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.961 -1.087 . . . . 0.0 111.526 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 12.1 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 121.826 1.684 . . . . 0.0 111.703 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.52 -152.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.318 2.012 . . . . 0.0 111.444 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.6 p -109.97 -179.69 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 20.5 p -120.03 158.24 27.22 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.67 137.1 47.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.849 0.833 . . . . 0.0 109.565 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 6.8 t80 -123.14 101.28 7.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.539 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -94.49 127.71 40.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.341 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.0 m -85.36 149.75 25.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 108.915 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -156.44 165.17 32.82 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.499 ' CB ' ' OG ' ' A' ' 87' ' ' SER . 6.1 t -91.8 130.05 37.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.444 0.64 . . . . 0.0 109.326 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -53.83 -39.8 65.89 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.6 m-20 -64.91 -27.02 68.57 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.686 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 8.9 tp60 -64.88 -41.88 95.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.08 63.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -26.98 68.45 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 108.765 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 12.6 m-30 -68.49 -46.75 68.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.01 74.75 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.357 -1.337 . . . . 0.0 107.924 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 33' ' ' SER . 57.4 ttt180 -71.97 -58.39 3.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.93 -1.106 . . . . 0.0 108.671 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 28' ' ' TYR . 6.0 tt -52.37 -40.3 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 44.5 t -64.31 -29.54 47.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 19.4 p -67.78 -39.85 84.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.743 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -71.7 -49.29 40.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.702 -1.249 . . . . 0.0 108.591 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.63 -39.46 73.7 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -65.8 -23.63 66.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -76.39 -36.77 57.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.988 -1.07 . . . . 0.0 108.988 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.565 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -70.3 -48.53 56.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.5 -140.19 3.02 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -101.02 136.45 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.3 t -101.88 122.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 10.6 mt -84.2 -42.85 15.52 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.511 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 43' ' ' THR . 13.7 t -67.54 60.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 109.771 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 42' ' ' LEU . 83.7 mt-10 -82.83 -25.34 32.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.059 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.65 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 4.7 p80 -53.19 -45.78 68.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.686 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -55.64 -60.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.428 ' H ' HG11 ' A' ' 46' ' ' VAL . . . -59.41 -31.93 69.72 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.826 -1.171 . . . . 0.0 108.973 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.461 ' C ' ' CD2' ' A' ' 51' ' ' LEU . 22.0 t70 -87.92 48.25 1.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.466 -0.771 . . . . 0.0 109.104 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.24 -16.03 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.43 -11.83 59.89 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.028 -1.045 . . . . 0.0 109.165 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.747 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.7 -43.95 72.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.172 -0.955 . . . . 0.0 108.686 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 3.3 tt0 -176.9 -48.47 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.538 -0.727 . . . . 0.0 109.422 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 15.4 Cg_exo -69.9 106.5 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.662 2.241 . . . . 0.0 111.56 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.06 110.51 4.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.352 -0.843 . . . . 0.0 109.369 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 130.26 42.05 0.22 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 61.0 mt-10 53.58 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -1.038 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.0 tt0 -42.59 -33.11 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 108.915 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' PRO . . . -106.49 65.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.01 -40.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.66 54.6 0.77 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.41 76.56 1.14 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -51.25 -43.76 61.58 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.2 -44.66 83.85 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -58.34 -34.76 70.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -68.17 -32.42 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -78.19 -64.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 68' ' ' GLN . 19.2 pt-20 -50.12 -44.56 52.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 109.572 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 51.5 tt0 -66.48 -48.23 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.39 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.519 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 84.0 m-20 -70.85 -54.38 11.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.982 . . . . 0.0 110.985 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 tp -56.58 -39.11 72.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 85.7 m-20 -63.68 -52.78 59.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.396 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.503 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.29 -41.21 83.9 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.468 -0.893 . . . . 0.0 108.731 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.508 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 11.8 tp -50.32 -41.38 51.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.41 -27.23 63.16 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.447 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 35.1 mt-30 -88.98 0.13 56.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.958 -1.089 . . . . 0.0 109.352 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.09 130.89 44.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.897 . . . . 0.0 111.862 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 11' ' ' SER . 38.8 t0 -80.6 -32.97 36.27 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.16 144.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 103' ' ' PRO . 82.8 t -136.08 124.81 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 111.501 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.0 t -117.98 176.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -164.15 116.03 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.574 -1.329 . . . . 0.0 110.033 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -79.22 142.94 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -147.66 148.38 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.785 -179.416 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.621 ' HG1' ' NE ' ' A' ' 109' ' ' ARG . 2.7 m -171.82 -42.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -129.47 152.56 79.82 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -36.36 147.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.604 2.202 . . . . 0.0 112.731 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.56 ' H ' ' CD2' ' B' ' 288' ' ' LEU . 12.9 t -175.34 123.0 0.22 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 110.484 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.55 ' CD2' ' H ' ' B' ' 287' ' ' SER . 2.2 mm? -71.32 -44.72 64.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.03 -36.69 75.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -75.75 -49.09 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -1.032 . . . . 0.0 109.495 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.97 89.87 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.846 -1.169 . . . . 0.0 110.257 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -69.45 -52.19 29.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -1.186 . . . . 0.0 109.867 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' OE2' ' SD ' ' B' ' 319' ' ' MET . 95.1 mt-10 -63.22 -30.86 71.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.514 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 mt -69.79 -47.46 62.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.971 . . . . 0.0 109.249 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.15 -36.77 93.44 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -62.24 -41.76 98.7 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.556 -0.967 . . . . 0.0 109.366 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.2 -38.52 78.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.897 -1.127 . . . . 0.0 108.956 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.36 -40.65 32.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.448 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -82.21 -53.01 6.4 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.71 -9.23 2.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -0.999 . . . . 0.0 110.206 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 102' ' ' LYS . . . 54.5 94.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.979 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.507 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 41.8 mttm -164.66 150.81 9.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 79' ' ' VAL . 82.4 Cg_exo -38.83 104.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.707 1.605 . . . . 0.0 111.332 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.507 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.2 mt -107.09 95.45 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.771 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.63 118.29 35.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 143.09 49.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 0.5 OUTLIER -132.1 144.11 50.49 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.063 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.79 147.42 50.79 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.621 ' NE ' ' HG1' ' A' ' 84' ' ' THR . 12.3 mtt180 -99.31 142.32 24.4 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.237 . . . . 0.0 111.472 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' GLY . 89.1 Cg_endo -80.82 -31.24 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.855 2.37 . . . . 0.0 110.944 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -45.62 -38.57 6.76 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 21.8 p -95.69 -20.52 18.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.86 43.43 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' VAL . 61.0 mtt180 -79.37 13.03 2.09 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -1.114 . . . . 0.0 109.387 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 114' ' ' ARG . 75.8 t 49.57 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.408 -0.807 . . . . 0.0 110.157 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' VAL . 24.2 tp -45.15 158.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.88 142.99 22.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 111.089 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.515 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -56.99 -50.68 71.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.73 -0.606 . . . . 0.0 110.339 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.51 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 19.5 mtp -65.89 -38.37 88.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.927 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.34 -44.92 90.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.064 -1.023 . . . . 0.0 109.565 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -74.46 -44.41 51.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.025 -1.047 . . . . 0.0 109.055 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.48 -22.33 61.26 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.77 -60.91 1.96 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.477 -1.013 . . . . 0.0 109.937 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.593 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -156.7 -88.18 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.147 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER 97.24 -1.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -179.92 85.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.794 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 162.08 74.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.475 -1.015 . . . . 0.0 109.595 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 67.04 -23.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.794 ' H ' ' C ' ' A' ' 127' ' ' SER . 12.8 t80 -123.28 118.89 28.6 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -135.23 138.3 43.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 111.214 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.448 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 84.7 t -101.95 99.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 21.0 m0 -93.76 148.68 21.9 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -93.75 147.71 22.79 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.501 ' HH ' ' HE ' ' A' ' 109' ' ' ARG . 4.5 p90 -168.02 174.31 7.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.363 -1.461 . . . . 0.0 112.133 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -140.6 147.28 39.14 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 135' ' ' ALA . 50.0 mt-10 -41.99 -30.3 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.932 -1.105 . . . . 0.0 110.581 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.25 1.46 88.78 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.999 -1.063 . . . . 0.0 110.752 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -135.82 -2.76 2.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.958 -1.319 . . . . 0.0 109.975 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 1.4 p -52.15 -45.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.013 -1.054 . . . . 0.0 108.161 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 27.6 mt-10 -52.67 -36.62 57.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -40.8 90.06 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.461 -0.775 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 11.4 mmt -55.67 -54.87 38.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 37.2 mt -59.71 -27.03 66.1 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.46 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 16.5 t70 -69.47 -46.86 65.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 0.0 111.111 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -73.81 -44.08 56.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.477 -1.389 . . . . 0.0 109.805 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.436 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 42.3 t80 -60.41 -46.53 89.69 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.487 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 11.4 m-85 -74.77 -34.4 62.45 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.349 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -68.93 -23.31 64.15 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.238 -1.538 . . . . 0.0 107.425 178.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.46 -10.46 55.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.623 -0.673 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.607 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -154.91 -47.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.419 -1.426 . . . . 0.0 112.16 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.607 ' N ' ' CG ' ' A' ' 150' ' ' TYR . 2.3 mt -41.52 -54.34 6.5 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.97 -1.081 . . . . 0.0 111.076 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 121.986 1.791 . . . . 0.0 112.141 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.27 -152.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 111.571 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 15.0 p -110.06 -179.75 3.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 17.2 p -120.1 157.73 28.36 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 137.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.782 0.801 . . . . 0.0 109.57 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 6.8 t80 -123.04 101.54 7.47 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.2 OUTLIER -94.82 127.41 40.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 109.163 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 12.4 m -85.13 148.82 25.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.002 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' B' ' 228' ' ' TYR . . . -155.19 164.95 32.14 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.781 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.503 ' CB ' ' OG ' ' B' ' 287' ' ' SER . 6.2 t -92.12 129.52 38.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.644 -0.915 . . . . 0.0 109.388 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -53.58 -39.84 65.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 75.4 m-20 -64.89 -27.15 68.66 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.7 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 9.2 tp60 -64.84 -41.34 95.79 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.99 63.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.97 -26.89 68.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 108.72 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 12.7 m-30 -68.6 -46.72 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.667 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.97 -32.83 74.51 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.368 -1.333 . . . . 0.0 107.939 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.455 ' O ' ' OG ' ' B' ' 233' ' ' SER . 57.6 ttt180 -72.09 -58.5 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.851 -1.155 . . . . 0.0 108.715 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.448 HG21 ' O ' ' B' ' 228' ' ' TYR . 5.9 tt -52.15 -40.48 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 44.6 t -64.28 -29.43 47.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' B' ' 230' ' ' ARG . 20.1 p -67.76 -39.81 84.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -71.86 -49.13 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.786 -1.196 . . . . 0.0 108.601 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.94 -39.37 74.4 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -65.64 -23.7 66.86 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -76.54 -37.17 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.948 -1.095 . . . . 0.0 108.932 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.579 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 1.9 m-30 -69.87 -48.43 58.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.554 -0.716 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -153.32 -140.5 3.08 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -101.08 136.53 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -1.104 . . . . 0.0 109.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.9 122.8 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.501 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 10.7 mt -84.08 -42.66 15.86 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.478 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' B' ' 243' ' ' THR . 13.8 t -67.36 60.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.845 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' B' ' 242' ' ' LEU . 82.7 mt-10 -82.58 -25.98 32.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.119 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.648 ' CG ' ' N ' ' B' ' 246' ' ' VAL . 4.8 p80 -52.48 -45.69 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.7 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 0.2 OUTLIER -55.97 -60.15 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 109.546 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.427 ' H ' HG11 ' B' ' 246' ' ' VAL . . . -59.28 -31.63 69.28 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.91 -1.119 . . . . 0.0 108.915 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.467 ' C ' ' CD2' ' B' ' 251' ' ' LEU . 22.4 t70 -88.26 48.01 1.58 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.721 0.772 . . . . 0.0 109.244 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -134.89 -16.19 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.4 -11.8 59.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.105 -0.997 . . . . 0.0 109.276 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.759 ' H ' ' CD2' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -54.79 -43.13 72.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 108.651 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 3.3 tt0 -177.83 -48.28 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.326 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 16.0 Cg_exo -69.83 106.27 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.617 2.211 . . . . 0.0 111.661 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.99 110.41 4.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.87 . . . . 0.0 109.494 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 130.34 41.85 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 64.8 mt-10 53.87 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.474 -1.015 . . . . 0.0 109.812 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.2 tt0 -43.14 -32.29 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 108.942 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' B' ' 253' ' ' PRO . . . -106.96 65.55 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -148.57 -40.51 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.098 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 105.46 53.95 0.76 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.96 76.46 1.11 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -51.02 -43.54 60.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.44 -44.37 84.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.55 -35.35 72.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.412 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.4 OUTLIER -67.57 -32.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -78.06 -65.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 0.0 110.398 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' B' ' 268' ' ' GLN . 19.1 pt-20 -49.58 -44.34 46.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.995 -1.066 . . . . 0.0 109.689 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . 0.507 ' N ' ' CG ' ' B' ' 267' ' ' GLU . 51.7 tt0 -66.7 -48.59 68.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.502 ' CG ' ' CD2' ' B' ' 245' ' ' HIS . 85.3 m-20 -70.51 -54.16 13.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.75 -39.28 73.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.982 . . . . 0.0 109.726 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' B' ' 267' ' ' GLU . 84.0 m-20 -63.45 -52.69 60.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.501 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -58.67 -41.14 85.44 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 108.728 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 11.7 tp -50.39 -41.24 51.72 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -71.42 -27.34 63.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.307 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 35.3 mt-30 -89.16 0.56 56.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.913 -1.117 . . . . 0.0 109.32 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.67 130.31 42.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.279 -0.888 . . . . 0.0 111.891 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' B' ' 211' ' ' SER . 40.6 t0 -80.23 -32.74 38.39 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.38 144.0 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 303' ' ' PRO . 80.8 t -135.92 124.92 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.98 -1.075 . . . . 0.0 111.353 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 25.5 t -118.02 176.82 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -164.01 115.69 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.576 -1.328 . . . . 0.0 110.089 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.93 143.22 36.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 108.67 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -147.88 148.23 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.098 -1.001 . . . . 0.0 109.772 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.603 ' HG1' ' NE ' ' B' ' 309' ' ' ARG . 2.8 m -171.72 -42.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -130.19 151.92 79.23 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -35.87 146.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.675 2.25 . . . . 0.0 112.682 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.55 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 14.8 t -175.46 122.46 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 0.0 110.525 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.56 ' CD2' ' H ' ' A' ' 87' ' ' SER . 2.2 mm? -70.99 -43.94 66.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.333 -0.854 . . . . 0.0 109.655 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.42 -36.56 77.45 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.1 -49.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -1.076 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -67.41 -37.98 90.69 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -69.77 -52.11 28.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -1.187 . . . . 0.0 109.926 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.51 ' OE2' ' SD ' ' A' ' 119' ' ' MET . 95.9 mt-10 -63.2 -31.15 72.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.222 -0.923 . . . . 0.0 109.495 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.65 -47.35 63.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.73 93.33 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -62.42 -41.58 98.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.546 -0.973 . . . . 0.0 109.299 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.64 79.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.956 -1.09 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -52.24 -40.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.448 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -81.88 -53.13 6.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.079 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.86 -9.16 2.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.104 -0.997 . . . . 0.0 110.206 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' B' ' 302' ' ' LYS . . . 54.41 94.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.94 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 41.4 mttm -165.04 150.54 8.51 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' B' ' 279' ' ' VAL . 82.8 Cg_exo -38.63 104.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.75 1.634 . . . . 0.0 111.296 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.2 mt -106.82 95.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.654 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.73 118.53 36.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 142.29 50.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 0.4 OUTLIER -131.3 143.62 50.67 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.298 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -128.11 147.49 50.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.603 ' NE ' ' HG1' ' B' ' 284' ' ' THR . 13.0 mtt180 -99.19 141.82 23.53 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.732 -1.23 . . . . 0.0 111.516 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 313' ' ' GLY . 92.7 Cg_endo -80.27 -31.63 1.61 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.807 2.338 . . . . 0.0 110.954 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 310' ' ' PRO . 20.2 pt20 -45.47 -38.65 6.38 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.0 p -95.66 -20.02 19.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.46 43.09 1.47 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.0 mtt180 -78.98 13.0 1.91 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.346 -1.091 . . . . 0.0 109.424 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 314' ' ' ARG . 79.6 t 49.42 101.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.366 -0.834 . . . . 0.0 110.255 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' B' ' 315' ' ' VAL . 24.0 tp -45.19 158.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.64 142.75 22.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 111.05 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . 0.479 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.93 -50.66 71.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.367 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.514 ' SD ' ' OE2' ' A' ' 93' ' ' GLU . 19.3 mtp -65.65 -38.65 89.94 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.964 -1.085 . . . . 0.0 109.859 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.24 -44.86 91.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.541 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -74.26 -44.47 52.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.952 -1.093 . . . . 0.0 108.97 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -61.55 -22.33 61.43 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -45.49 -61.04 1.85 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.576 -0.956 . . . . 0.0 110.047 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.581 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -156.64 -87.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.967 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 0.7 OUTLIER 96.99 -1.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -177.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -179.59 84.95 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.81 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.1 p 162.37 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.406 -1.055 . . . . 0.0 109.737 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 67.11 -23.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.81 ' H ' ' C ' ' B' ' 327' ' ' SER . 11.9 t80 -123.65 118.97 28.48 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -135.21 138.68 43.85 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.212 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 83.9 t -102.3 100.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 21.1 m0 -94.04 148.58 22.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.85 148.13 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.514 ' HH ' ' HE ' ' B' ' 309' ' ' ARG . 4.6 p90 -168.53 174.37 6.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.114 -1.434 . . . . 0.0 112.057 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -140.69 147.28 39.0 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.5 mt-10 -41.86 -30.37 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.605 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.19 1.31 88.93 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.766 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -135.53 -2.72 2.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.95 -1.324 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 1.4 p -52.31 -45.81 44.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 26.5 mt-10 -52.93 -36.34 59.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 24.4 m -66.37 -41.03 90.04 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 11.6 mmt -55.34 -54.99 36.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 39.6 mt -59.61 -27.17 66.07 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' B' ' 348' ' ' GLU . 15.9 t70 -69.33 -46.79 66.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -0.966 . . . . 0.0 111.184 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -73.64 -44.36 57.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.333 -1.48 . . . . 0.0 109.846 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . 0.432 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 42.2 t80 -60.18 -46.49 89.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.738 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.482 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 11.5 m-85 -74.88 -34.23 62.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.437 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 348' ' ' GLU . 0.7 OUTLIER -69.07 -23.38 64.02 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 117.846 -1.542 . . . . 0.0 107.485 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.4 -10.23 53.75 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.612 -0.68 . . . . 0.0 110.468 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -155.11 -47.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.46 -1.4 . . . . 0.0 112.15 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.604 ' N ' ' CG ' ' B' ' 350' ' ' TYR . 2.2 mt -41.53 -54.33 6.53 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 110.998 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 C--N 1.308 -1.574 0 C-N-CA 122.008 1.805 . . . . 0.0 112.231 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 -155.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.402 2.068 . . . . 0.0 110.965 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 26.4 p -99.67 178.02 4.97 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 3.0 t -116.08 152.95 32.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.81 132.63 56.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.431 -0.793 . . . . 0.0 109.348 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' CZ ' ' OE2' ' A' ' 44' ' ' GLU . 39.2 t80 -96.34 147.1 24.15 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 24.6 t80 -110.45 133.21 53.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.029 . . . . 0.0 111.517 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 102.53 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.29 177.58 19.48 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.418 ' H ' ' HG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -73.24 122.86 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -1.061 . . . . 0.0 109.73 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 108.654 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' H ' ' HB2' ' A' ' 25' ' ' GLN . 12.5 ptm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.901 0.858 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -55.96 -39.27 71.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 86.9 m-20 -60.03 -33.34 71.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB2' ' H ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -63.24 -46.83 85.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -50.19 69.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.62 -35.49 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.516 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 18.5 m-30 -67.44 -47.7 69.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.93 75.8 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.681 -1.262 . . . . 0.0 108.803 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 -68.69 -57.15 6.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 108.609 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -50.88 -45.2 28.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 94.5 t -59.65 -30.63 45.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -66.02 -40.13 90.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.115 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -63.45 -41.99 98.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.78 -1.2 . . . . 0.0 108.045 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.24 -43.1 99.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -56.66 -26.1 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -85.49 -29.42 24.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.161 -0.962 . . . . 0.0 110.046 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.5 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.2 m-85 -84.39 -58.8 2.6 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.182 -0.949 . . . . 0.0 110.511 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 10' ' ' CYS . . . -132.61 -164.61 10.99 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -89.61 124.2 34.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.223 -1.163 . . . . 0.0 109.036 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.62 104.05 8.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 43' ' ' THR . 80.9 mt -52.03 142.43 15.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.764 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' CE3' ' A' ' 72' ' ' TRP . 17.4 p -37.75 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.512 0.672 . . . . 0.0 110.161 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 13' ' ' TYR . 19.5 mm-40 -122.91 110.41 15.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.664 ' O ' ' N ' ' A' ' 49' ' ' ALA . 4.7 p80 -56.44 -15.35 4.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.341 -0.85 . . . . 0.0 109.624 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 60.8 t -41.7 -78.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.335 -0.853 . . . . 0.0 110.651 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.25 10.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.883 -1.136 . . . . 0.0 109.09 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 45' ' ' HIS . 20.7 t70 -96.54 22.71 7.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -109.2 35.88 3.11 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -129.57 -20.32 3.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.721 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -62.67 -102.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -57.02 164.1 2.55 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.4 36.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.552 2.168 . . . . 0.0 112.996 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 52' ' ' GLU . 6.6 mp 51.3 -155.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.93 -1.106 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . -127.83 -36.58 0.47 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 36.4 mp0 -46.58 -20.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -1.061 . . . . 0.0 109.108 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' GLY . 24.5 pt-20 -132.47 3.51 3.9 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.59 -173.79 4.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.05 152.45 21.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.18 -9.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.64 74.93 1.22 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -53.62 -37.0 62.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.348 -1.09 . . . . 0.0 108.336 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.545 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 16.4 mp0 -62.23 -47.15 85.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -53.58 -36.27 61.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 0.0 109.184 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -67.3 -53.1 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.475 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 4.8 t-80 -63.65 -45.77 88.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 110.785 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -54.43 -54.73 36.8 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.632 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 72' ' ' TRP . 99.5 mt-30 -72.42 -40.34 67.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 110.169 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.514 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 23.8 m-20 -64.93 -52.97 53.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.972 . . . . 0.0 111.014 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.93 78.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 111.148 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -65.41 -54.01 34.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.785 -1.197 . . . . 0.0 110.049 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.578 ' CE3' ' OG1' ' A' ' 43' ' ' THR . 0.0 OUTLIER -62.45 -42.74 99.68 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.814 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 2.0 tt -53.15 -36.87 61.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -75.18 -26.2 58.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.527 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.496 ' CD ' ' CD1' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -97.86 5.7 48.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.797 -1.189 . . . . 0.0 109.064 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.08 129.4 39.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.697 0.76 . . . . 0.0 112.536 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 11' ' ' SER . 64.0 t0 -74.94 -36.17 62.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.437 ' CG2' ' OH ' ' A' ' 150' ' ' TYR . 46.0 t -134.25 168.01 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.8 t -150.21 140.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.104 -0.998 . . . . 0.0 111.074 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -132.07 143.23 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -152.74 156.14 38.55 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 110.51 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' OH ' ' A' ' 134' ' ' TYR . 47.1 tt0 -123.25 124.77 43.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -120.22 23.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 109.523 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 83' ' ' VAL . 89.4 m -45.76 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.148 -0.97 . . . . 0.0 108.564 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' PRO . 34.3 tt0 -68.15 133.74 91.59 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLN . 86.2 Cg_exo -37.34 112.71 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.99 1.793 . . . . 0.0 111.769 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' A' ' 87' ' ' SER . 2.4 p -117.06 130.56 56.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.218 -0.926 . . . . 0.0 110.201 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' B' ' 287' ' ' SER . 0.4 OUTLIER -80.88 -56.36 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 317' ' ' SER . . . -57.87 -40.21 92.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.65 -36.62 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.164 . . . . 0.0 109.437 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.16 95.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -66.89 -47.53 71.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.679 -0.895 . . . . 0.0 109.709 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.37 -34.77 75.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.493 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.32 -42.46 75.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 108.478 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.07 -36.44 80.7 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' NH1' ' CG1' ' B' ' 298' ' ' VAL . 20.0 tpt180 -64.97 -45.46 85.61 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -68.8 -37.8 79.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.482 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' NH1' ' B' ' 296' ' ' ARG . 0.8 OUTLIER -51.46 -43.36 30.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.99 72.72 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.09 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.587 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -129.19 -38.88 1.57 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.096 -1.002 . . . . 0.0 110.386 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -70.65 97.46 0.63 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.39 -69.65 0.55 Allowed Pre-proline 0 C--N 1.288 -2.08 0 O-C-N 121.762 -0.846 . . . . 0.0 111.446 -176.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 24.0 Cg_endo -63.41 111.36 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.88 1.72 . . . . 0.0 111.348 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 97' ' ' ALA . 46.5 mt -135.88 101.94 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.157 -0.965 . . . . 0.0 111.088 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.24 118.21 30.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -111.42 138.24 48.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.991 -1.068 . . . . 0.0 108.352 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mt -118.15 146.28 44.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.15 -0.969 . . . . 0.0 110.926 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -149.95 142.06 24.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.091 -1.005 . . . . 0.0 108.827 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.638 HH11 ' NE2' ' A' ' 111' ' ' GLN . 10.7 mtm180 -119.59 150.34 49.87 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.291 -0.88 . . . . 0.0 110.924 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 -15.64 36.96 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.643 2.229 . . . . 0.0 112.4 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.638 ' NE2' HH11 ' A' ' 109' ' ' ARG . 4.7 pt20 -67.09 -37.24 83.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -0.971 . . . . 0.0 110.151 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.475 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 31.0 m -142.51 -6.03 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 109' ' ' ARG . . . -111.19 99.69 1.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 106.74 -2.544 . . . . 0.0 106.74 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -98.26 -59.38 1.76 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.664 -0.903 . . . . 0.0 108.608 -177.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.1 t -132.07 109.38 15.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.812 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -54.49 146.55 15.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' B' ' 289' ' ' GLY . 0.6 OUTLIER -43.3 146.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 0.0 109.398 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.0 81.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 77.6 mmm -64.8 -37.59 88.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.438 HG21 HD12 ' A' ' 120' ' ' ILE . 48.4 mm -65.25 -47.12 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.992 . . . . 0.0 109.31 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -40.8 98.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.04 -37.48 95.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.84 -47.38 71.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -0.3 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.415 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 128' ' ' ARG . 54.9 t0 -76.74 -35.24 57.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 108.58 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.8 -22.29 6.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -101.26 -46.26 5.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.066 -1.256 . . . . 0.0 109.869 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 125' ' ' ASP . 34.2 ptt-85 -121.11 -43.3 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.492 -0.755 . . . . 0.0 109.32 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 129' ' ' PHE . 7.0 t80 -97.29 130.03 44.52 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.671 ' NE2' ' HE1' ' A' ' 132' ' ' TRP . 3.6 tt0 -155.67 161.68 40.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.712 -1.242 . . . . 0.0 111.376 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.79 105.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.671 ' HE1' ' NE2' ' A' ' 130' ' ' GLN . 15.9 m0 -101.79 143.14 32.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 134' ' ' TYR . 61.0 t0 -93.34 155.32 17.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.101 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.596 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 6.3 p90 -169.88 -166.54 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.091 -1.006 . . . . 0.0 110.342 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.709 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -169.91 160.51 8.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.46 28.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.709 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.09 -2.07 3.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -156.13 12.25 0.29 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.013 -1.286 . . . . 0.0 110.102 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 7.5 p -52.03 -42.93 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 108.631 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 36.7 mt-10 -57.47 -37.09 72.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.107 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.4 m -66.67 -44.28 82.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.9 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.4 tpp -52.44 -49.51 64.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 89.8 mt -71.36 -29.31 64.81 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.428 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 36.4 t0 -67.25 -38.97 86.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 109.881 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -73.35 -50.2 23.29 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.84 -1.163 . . . . 0.0 108.801 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.67 -47.12 80.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.339 -0.851 . . . . 0.0 110.235 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CD1' HD11 ' A' ' 151' ' ' LEU . 12.7 m-85 -78.41 -30.57 47.81 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.512 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 44.8 mt-10 -58.53 -25.47 62.48 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.7 62.08 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.768 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -177.85 105.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 0.0 111.114 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.56 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.6 OUTLIER 175.82 -54.78 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.326 -0.858 . . . . 0.0 109.642 177.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 20.1 Cg_endo . . . . . 0 C--N 1.309 -1.543 0 C-N-CA 122.093 1.862 . . . . 0.0 111.513 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.4 -155.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.487 2.124 . . . . 0.0 110.893 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.46 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 27.9 p -99.52 178.04 4.98 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 3.0 t -116.22 152.83 32.99 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.41 132.64 57.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.562 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CZ ' ' OE2' ' B' ' 244' ' ' GLU . 39.3 t80 -96.35 146.43 24.75 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.444 ' O ' ' OE1' ' B' ' 244' ' ' GLU . 24.0 t80 -109.89 132.6 54.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.07 -1.019 . . . . 0.0 111.614 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.29 102.51 5.38 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -136.22 177.67 19.39 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' B' ' 217' ' ' SER . 1.0 OUTLIER -73.39 123.22 23.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.834 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.52 ' H ' ' HB2' ' B' ' 225' ' ' GLN . 12.4 ptm180 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.932 0.873 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -55.82 -39.1 70.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 88.2 m-20 -60.45 -33.39 72.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.52 ' HB2' ' H ' ' B' ' 222' ' ' ARG . 0.8 OUTLIER -63.03 -46.93 85.22 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.07 -50.27 69.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.45 -35.58 70.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.756 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.536 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 18.5 m-30 -67.44 -47.42 70.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.326 -0.859 . . . . 0.0 109.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.28 -37.84 75.82 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.593 -1.317 . . . . 0.0 108.886 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -68.83 -57.03 6.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.849 -1.157 . . . . 0.0 108.648 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.3 mt -50.94 -45.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 87.1 t -59.92 -30.33 45.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 7.2 t -66.15 -40.16 90.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.075 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -63.45 -41.87 98.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.822 -1.174 . . . . 0.0 107.929 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.23 -42.92 99.44 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -56.95 -26.08 59.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -85.37 -29.55 24.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.969 . . . . 0.0 110.079 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.496 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.2 m-85 -84.34 -58.7 2.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.215 -0.928 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 210' ' ' CYS . . . -132.94 -164.87 11.02 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -89.58 124.14 34.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.191 -1.181 . . . . 0.0 109.015 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.49 104.22 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.461 ' O ' ' C ' ' B' ' 243' ' ' THR . 80.7 mt -52.22 141.98 17.75 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.833 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.568 ' OG1' ' CE3' ' B' ' 272' ' ' TRP . 17.3 p -37.38 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.502 0.668 . . . . 0.0 110.234 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.544 ' OE2' ' CZ ' ' B' ' 213' ' ' TYR . 19.1 mm-40 -122.99 110.68 15.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' B' ' 249' ' ' ALA . 4.9 p80 -56.59 -15.58 4.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' B' ' 249' ' ' ALA . 62.5 t -41.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.239 -0.913 . . . . 0.0 110.695 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -48.72 -33.29 9.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.934 -1.104 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' B' ' 245' ' ' HIS . 20.5 t70 -96.53 22.96 7.32 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' B' ' 245' ' ' HIS . . . -109.47 35.68 3.22 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -129.27 -20.09 3.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.714 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -62.72 -103.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' B' ' 254' ' ' LEU . 0.0 OUTLIER -56.1 164.39 1.85 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.85 36.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.525 2.15 . . . . 0.0 112.895 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' B' ' 252' ' ' GLU . 6.6 mp 51.28 -155.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.018 -1.051 . . . . 0.0 109.548 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . -127.35 -36.53 0.49 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' B' ' 256' ' ' GLU . 36.5 mp0 -46.44 -20.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -1.033 . . . . 0.0 109.211 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 255' ' ' GLY . 24.4 pt-20 -133.2 4.39 3.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 108.925 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -145.97 -173.49 4.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -90.95 151.5 21.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.15 -9.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.45 74.62 1.21 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -36.91 62.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.36 -1.082 . . . . 0.0 108.321 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . 0.556 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 17.0 mp0 -62.5 -47.18 85.1 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -53.6 -36.03 61.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 0.6 OUTLIER -67.55 -52.87 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.47 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 4.6 t-80 -64.03 -46.26 85.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.454 -0.779 . . . . 0.0 110.654 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -53.74 -55.08 29.4 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.84 -1.162 . . . . 0.0 109.676 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' B' ' 272' ' ' TRP . 99.5 mt-30 -72.21 -40.36 67.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.51 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 25.5 m-20 -64.79 -52.95 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.03 -1.044 . . . . 0.0 111.174 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.87 78.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 111.138 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.5 -54.01 34.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.671 -1.268 . . . . 0.0 110.147 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.568 ' CE3' ' OG1' ' B' ' 243' ' ' THR . 0.0 OUTLIER -62.42 -42.38 99.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.037 -1.039 . . . . 0.0 108.935 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.457 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 1.9 tt -53.62 -36.49 62.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -75.34 -26.25 58.43 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.372 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.492 ' CD ' ' CD1' ' B' ' 272' ' ' TRP . 0.0 OUTLIER -98.02 5.82 48.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.175 . . . . 0.0 109.095 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.17 129.47 39.84 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.759 0.79 . . . . 0.0 112.555 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.443 ' HB3' ' H ' ' B' ' 211' ' ' SER . 64.1 t0 -75.14 -35.86 61.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.432 ' CG2' ' OH ' ' B' ' 350' ' ' TYR . 46.6 t -134.4 167.94 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 61.8 t -150.37 140.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.026 . . . . 0.0 111.06 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.06 143.6 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.08 156.16 38.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.046 -1.034 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' B' ' 334' ' ' TYR . 47.4 tt0 -123.15 125.04 44.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' B' ' 284' ' ' THR . 0.1 OUTLIER -120.5 22.69 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.519 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.415 ' O ' ' O ' ' B' ' 283' ' ' VAL . 87.5 m -45.25 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.184 -0.948 . . . . 0.0 108.54 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' B' ' 286' ' ' PRO . 33.4 tt0 -68.0 133.92 91.88 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 285' ' ' GLN . 87.9 Cg_exo -37.36 112.57 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.084 1.856 . . . . 0.0 111.842 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.473 ' H ' ' HG ' ' B' ' 287' ' ' SER . 2.6 p -116.91 130.52 56.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.74 -56.14 4.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . 0.556 ' N ' ' OG ' ' A' ' 117' ' ' SER . . . -58.0 -40.27 93.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.61 -36.67 78.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.322 -1.104 . . . . 0.0 109.497 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.2 95.48 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.05 -47.25 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.623 -0.928 . . . . 0.0 109.84 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.91 -34.77 76.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.29 -42.44 75.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.965 . . . . 0.0 108.578 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.24 -36.09 78.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . 0.418 ' NH1' ' CG1' ' A' ' 98' ' ' VAL . 20.0 tpt180 -64.93 -45.59 85.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.272 -1.134 . . . . 0.0 109.517 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -68.67 -37.89 79.95 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.466 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.405 ' CG1' ' NH1' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -51.61 -43.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.1 72.87 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.177 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.596 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -129.35 -38.21 1.58 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.135 -0.978 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -71.18 97.26 0.66 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.596 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -65.26 -69.77 0.54 Allowed Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.826 -0.808 . . . . 0.0 111.43 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 24.0 Cg_endo -63.44 111.02 1.35 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.878 1.719 . . . . 0.0 111.534 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.444 HD12 ' C ' ' B' ' 297' ' ' ALA . 45.5 mt -135.61 101.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 111.174 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.16 118.54 30.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -111.53 137.95 48.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 108.445 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . . . . . . . . . 9.7 mt -118.05 146.09 44.33 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -0.973 . . . . 0.0 110.862 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -149.77 142.19 24.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 108.764 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.64 HH11 ' NE2' ' B' ' 311' ' ' GLN . 10.5 mtm180 -119.47 150.53 49.98 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 110.867 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.18 -15.31 35.49 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.64 ' NE2' HH11 ' B' ' 309' ' ' ARG . 4.6 pt20 -67.34 -37.61 83.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.229 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' B' ' 311' ' ' GLN . 23.2 m -142.16 -5.82 0.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' B' ' 309' ' ' ARG . . . -111.2 100.04 1.18 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.629 ' CD ' ' N ' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -98.41 -59.55 1.73 Allowed 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.695 -0.885 . . . . 0.0 108.614 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . . . . . . . . . 77.8 t -131.94 109.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.765 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' B' ' 317' ' ' SER . 0.1 OUTLIER -54.55 146.27 16.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 89' ' ' GLY . 0.6 OUTLIER -43.08 146.17 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.98 -1.075 . . . . 0.0 109.431 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.24 80.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 0.0 110.534 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.63 -37.69 88.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.407 HD12 HG21 ' B' ' 320' ' ' ILE . 47.5 mm -64.94 -47.23 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.303 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -40.6 98.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -63.08 -37.47 94.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.594 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.89 -47.83 70.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.594 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 0.32 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.521 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.533 ' OD2' ' NH1' ' B' ' 328' ' ' ARG . 53.7 t0 -76.34 -35.25 58.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.889 -1.132 . . . . 0.0 108.565 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 82.81 -22.26 6.86 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 30.0 t -101.36 -45.92 5.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.984 -1.303 . . . . 0.0 109.874 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.533 ' NH1' ' OD2' ' B' ' 325' ' ' ASP . 34.2 ptt-85 -121.45 -43.44 2.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.529 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 6.9 t80 -97.15 130.1 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.664 ' NE2' ' HE1' ' B' ' 332' ' ' TRP . 3.6 tt0 -155.67 161.71 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.513 -1.275 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.75 105.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.664 ' HE1' ' NE2' ' B' ' 330' ' ' GLN . 15.7 m0 -101.72 143.1 32.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' B' ' 334' ' ' TYR . 59.7 t0 -93.18 155.36 17.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 109.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.582 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 6.3 p90 -169.7 -166.31 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -170.26 160.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -59.39 28.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -134.97 -2.44 3.08 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -155.87 12.1 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -1.196 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 8.1 p -51.9 -42.9 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 108.548 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.478 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 40.0 mt-10 -57.64 -36.97 72.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.558 -0.714 . . . . 0.0 109.123 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 57.0 m -66.69 -44.16 82.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.867 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -52.74 -49.54 65.23 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 88.8 mt -71.2 -29.34 65.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.491 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 37.6 t0 -67.2 -39.05 86.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.067 -1.02 . . . . 0.0 109.937 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -73.11 -50.36 23.24 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.89 -1.131 . . . . 0.0 108.834 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.36 -47.31 79.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.42 ' CD1' HD11 ' B' ' 351' ' ' LEU . 12.7 m-85 -78.05 -30.76 50.0 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.591 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 45.3 mt-10 -58.5 -25.71 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.62 -17.11 62.29 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.772 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -177.69 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.073 -1.017 . . . . 0.0 111.162 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.543 ' N ' ' HD2' ' B' ' 352' ' ' PRO . 0.7 OUTLIER 176.14 -55.28 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 20.1 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 121.861 1.708 . . . . 0.0 111.579 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.13 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.617 2.211 . . . . 0.0 111.772 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 89.8 m -100.31 177.14 5.14 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -119.93 121.21 38.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.026 -1.046 . . . . 0.0 108.581 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 5.3 t -94.06 130.94 42.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 69' ' ' ASP . 33.2 t80 -99.85 133.39 44.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.491 ' O ' ' CE1' ' A' ' 13' ' ' TYR . 26.6 t80 -86.88 116.34 24.89 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.365 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HG ' ' CB ' ' A' ' 93' ' ' GLU . 6.5 t -107.0 108.99 20.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.771 0.796 . . . . 0.0 109.287 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.85 174.3 46.62 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 6.7 p -113.44 160.13 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -1.074 . . . . 0.0 108.461 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG22 ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.605 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.631 ' HE ' ' CD1' ' A' ' 54' ' ' LEU . 38.3 mmt-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.118 0.485 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -56.99 -38.86 73.63 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -63.67 -26.68 68.78 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.555 HE21 ' C ' ' A' ' 46' ' ' VAL . 20.2 tp60 -64.77 -42.68 94.92 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.71 84.37 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.96 -37.88 77.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.543 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 21.1 m-30 -65.94 -41.81 90.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -63.14 -39.31 94.3 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 120.851 -1.156 . . . . 0.0 109.041 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.49 -55.02 9.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.951 -1.093 . . . . 0.0 108.321 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 20.9 mt -53.89 -45.07 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 49.3 t -60.15 -29.37 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.6 m -67.31 -38.56 85.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.082 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -68.51 -50.19 54.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.127 . . . . 0.0 109.043 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.1 mt -56.77 -40.82 76.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -61.6 -27.05 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.845 -0.535 . . . . 0.0 109.598 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -75.94 -36.81 59.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.959 -1.088 . . . . 0.0 109.542 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.519 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.8 m-85 -71.69 -48.76 45.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.52 -0.737 . . . . 0.0 110.598 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -149.35 -148.83 4.84 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -95.66 125.13 40.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.413 -1.051 . . . . 0.0 109.825 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.4 101.17 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.1 149.67 0.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.31 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 m -44.61 140.08 2.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 109.301 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 46' ' ' VAL . 11.0 pt-20 -161.57 134.27 6.06 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.86 25.0 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.241 -0.912 . . . . 0.0 109.188 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.555 ' C ' HE21 ' A' ' 25' ' ' GLN . 27.6 t -83.97 -85.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' C ' ' N ' ' A' ' 49' ' ' ALA . . . -68.08 178.87 1.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 t70 48.57 20.09 0.29 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.188 . . . . 0.0 108.193 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' N ' ' C ' ' A' ' 47' ' ' ALA . . . -115.01 -9.51 12.37 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -62.85 -32.96 74.3 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 108.798 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.844 ' CD1' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.63 157.1 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.604 -0.685 . . . . 0.0 109.961 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 51' ' ' LEU . 17.9 mt-10 55.02 155.46 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 55.6 Cg_endo -72.19 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.493 2.129 . . . . 0.0 111.938 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD1' ' HE ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -55.55 165.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.895 -1.128 . . . . 0.0 109.628 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 150.46 32.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 59.15 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.926 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.7 tt0 -52.46 -28.77 21.55 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 53' ' ' PRO . . . -68.07 149.18 49.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.78 142.9 5.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.67 -58.53 0.23 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.75 80.63 0.48 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -53.47 -41.11 65.85 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.33 -1.1 . . . . 0.0 108.494 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.96 -48.89 67.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -60.08 -38.15 82.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -63.36 -40.22 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.46 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 1.4 t-80 -78.84 -51.03 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 110.55 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 64.8 mm-40 -50.68 -47.93 58.72 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.869 -1.144 . . . . 0.0 110.012 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.82 -49.04 27.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 0.0 110.421 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 68.6 m-20 -62.75 -51.92 65.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 0.0 110.776 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.405 HD12 ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -68.22 -41.28 81.51 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 0.0 111.274 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.87 -54.03 47.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.597 -1.314 . . . . 0.0 109.314 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -38.02 75.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.0 tp -52.6 -45.76 66.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' A' ' 96' ' ' ARG . 20.2 mt-30 -67.03 -30.32 70.37 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.483 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -91.24 3.53 54.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.54 -1.35 . . . . 0.0 109.349 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.59 58.72 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.987 0.899 . . . . 0.0 112.612 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 103' ' ' PRO . 65.1 t0 -98.48 -20.51 17.05 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 18.4 t -144.55 144.63 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.01 137.96 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.717 -1.239 . . . . 0.0 112.382 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.13 125.41 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.54 144.6 41.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.34 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.6 121.71 45.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.71 . . . . 0.0 109.169 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 107' ' ' LEU . 1.7 m -146.77 113.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 m -130.04 -13.42 4.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -142.92 156.18 62.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -39.13 108.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.047 1.831 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.608 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 45.1 m -126.29 134.39 51.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.142 -0.974 . . . . 0.0 111.165 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.608 ' HB2' ' H ' ' B' ' 287' ' ' SER . 14.7 tp -105.68 153.11 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.59 -29.99 3.19 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 88' ' ' LEU . 47.4 t -86.01 -49.92 14.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.35 62.45 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -70.86 -58.14 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.541 ' CB ' ' HG ' ' A' ' 15' ' ' CYS . 85.9 mt-10 -52.16 -32.95 38.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.29 -41.15 49.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.0 -48.76 81.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 74' ' ' GLN . 45.4 ttm-85 -62.61 -38.26 89.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.341 -1.093 . . . . 0.0 108.89 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.56 -39.93 88.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -54.92 -44.31 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.791 -1.193 . . . . 0.0 108.136 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -76.01 -48.93 19.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.469 ' O ' ' CD ' ' A' ' 102' ' ' LYS . 2.8 pp -116.66 -23.08 8.33 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.831 -1.168 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -53.26 170.3 0.78 Allowed Glycine 0 C--N 1.286 -2.196 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.538 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -131.63 -75.71 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 79.8 Cg_endo -81.79 109.12 1.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.811 1.674 . . . . 0.0 109.552 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.08 126.7 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.691 -1.256 . . . . 0.0 111.579 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 tp -123.0 119.39 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.73 153.05 21.12 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.71 -1.244 . . . . 0.0 108.561 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.562 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 14.7 mt -127.9 132.69 49.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.962 -1.086 . . . . 0.0 111.838 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -138.93 122.35 17.2 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 65.4 mtm180 -86.55 135.66 35.92 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 111.388 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.7 Cg_endo -79.32 -23.87 7.06 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.434 2.089 . . . . 0.0 110.58 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' SER . 14.6 pt20 -48.06 -38.2 16.84 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 10.7 t -95.3 -18.59 20.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.1 52.77 4.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 115' ' ' VAL . 3.6 mtp180 -87.57 6.26 35.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.289 . . . . 0.0 109.993 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 114' ' ' ARG . 21.1 t 58.08 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 117' ' ' SER . 30.6 tp -74.08 150.83 40.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -40.49 140.03 0.71 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.311 -0.868 . . . . 0.0 110.609 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.67 98.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 81.0 mmm -63.89 -44.06 94.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.17 -0.956 . . . . 0.0 109.176 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.74 -41.79 91.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.243 -0.91 . . . . 0.0 108.768 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.81 -45.15 95.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.425 -0.797 . . . . 0.0 109.585 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -66.98 -39.11 93.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.645 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -48.41 -55.91 9.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -1.215 . . . . 0.0 108.217 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -9.87 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.432 0.634 . . . . 0.0 111.148 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -130.89 -28.16 2.01 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 80.24 -5.45 63.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.663 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 p -79.17 39.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 127' ' ' SER . 86.1 mtt-85 106.12 -25.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.903 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -89.71 114.67 26.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -137.66 137.76 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.762 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.85 103.98 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 15.0 m0 -104.59 143.09 33.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.074 -1.016 . . . . 0.0 109.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.474 ' O ' ' SD ' ' A' ' 142' ' ' MET . 98.7 m-20 -96.96 159.83 14.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.86 -1.15 . . . . 0.0 108.792 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 8.0 p90 -165.5 -167.06 1.06 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.652 -1.28 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -166.71 146.63 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 135' ' ' ALA . 42.6 mt-10 -41.48 -37.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.127 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.59 4.13 37.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.447 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 135' ' ' ALA . 20.4 pt-20 -155.75 8.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.463 -1.61 . . . . 0.0 110.797 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.3 p -53.63 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.913 -1.117 . . . . 0.0 108.539 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 20.8 pt-20 -58.86 -31.94 69.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.483 -0.761 . . . . 0.0 109.09 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.1 m -68.51 -46.01 70.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.0 tpp -51.06 -45.8 61.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.63 -34.97 70.25 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.493 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.54 -40.53 95.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 110.279 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -71.64 -50.54 29.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.894 -1.129 . . . . 0.0 108.629 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -59.61 -46.44 88.97 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 151' ' ' LEU . 13.6 m-85 -70.16 -32.95 71.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.88 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.505 -1.372 . . . . 0.0 107.551 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.14 -18.05 62.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.571 -0.705 . . . . 0.0 110.661 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -152.84 3.37 0.33 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.385 -1.447 . . . . 0.0 111.598 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 147' ' ' PHE . 6.1 mt -116.25 83.84 13.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.677 -1.264 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.594 2.196 . . . . 0.0 111.688 179.275 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.39 -156.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.62 2.213 . . . . 0.0 111.719 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.506 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 92.0 m -100.09 177.08 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 2.4 m -119.97 120.86 37.58 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 5.8 t -93.86 130.95 42.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' B' ' 269' ' ' ASP . 32.7 t80 -100.01 133.32 44.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.499 ' O ' ' CE1' ' B' ' 213' ' ' TYR . 26.9 t80 -86.7 116.82 25.05 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.273 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.538 ' HG ' ' CB ' ' B' ' 293' ' ' GLU . 5.6 t -107.76 109.03 20.5 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.728 0.775 . . . . 0.0 109.267 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -174.75 174.54 46.69 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' B' ' 290' ' ' VAL . 6.5 p -113.46 160.09 18.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -1.059 . . . . 0.0 108.362 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.414 HG22 ' NE2' ' B' ' 225' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.516 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.622 ' HE ' ' CD1' ' B' ' 254' ' ' LEU . 39.2 mmt-85 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -56.75 -38.87 73.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.68 -26.82 68.83 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.532 HE21 ' C ' ' B' ' 246' ' ' VAL . 19.9 tp60 -64.58 -42.69 95.46 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.61 84.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 tp -59.21 -38.03 78.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.551 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 21.2 m-30 -65.86 -41.53 91.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -63.34 -39.44 94.55 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.828 -1.17 . . . . 0.0 108.992 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.22 -55.13 10.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.078 . . . . 0.0 108.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -53.78 -45.4 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 49.8 t -59.91 -29.14 42.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 5.9 m -67.43 -38.33 84.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.81 -50.13 52.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.893 -1.129 . . . . 0.0 108.932 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 24.9 mt -56.71 -40.75 76.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -61.6 -27.02 68.35 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -76.07 -36.57 58.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.882 -1.136 . . . . 0.0 109.473 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.525 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.8 m-85 -72.14 -48.79 41.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.536 -0.727 . . . . 0.0 110.646 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -149.15 -149.1 4.89 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.7 125.33 40.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 109.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.22 101.27 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.3 mt -47.28 149.59 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.256 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 3.5 m -44.59 140.08 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 109.303 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' B' ' 246' ' ' VAL . 11.2 pt-20 -161.54 134.6 6.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.339 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -74.86 24.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.935 . . . . 0.0 109.222 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' B' ' 244' ' ' GLU . 27.7 t -83.42 -85.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' B' ' 249' ' ' ALA . . . -67.97 178.86 1.64 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.89 19.5 0.27 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.75 -1.218 . . . . 0.0 108.226 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' B' ' 247' ' ' ALA . . . -114.27 -9.89 12.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -62.2 -33.23 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.863 ' CD1' ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -57.75 157.37 7.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.525 -0.734 . . . . 0.0 109.915 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' B' ' 251' ' ' LEU . 18.3 mt-10 54.7 155.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.619 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' B' ' 258' ' ' ALA . 55.9 Cg_endo -72.09 68.12 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.506 2.138 . . . . 0.0 111.937 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.622 ' CD1' ' HE ' ' B' ' 222' ' ' ARG . 0.2 OUTLIER -55.35 165.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.992 . . . . 0.0 109.643 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 149.83 32.78 0.05 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 58.9 -74.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.501 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.9 tt0 -52.51 -27.94 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' B' ' 253' ' ' PRO . . . -68.88 149.17 49.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.356 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -48.68 141.96 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 167.43 -58.24 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.44 80.64 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -53.49 -40.85 65.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -1.108 . . . . 0.0 108.525 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.22 -48.96 66.28 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 108.775 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.95 -38.34 82.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.415 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.9 OUTLIER -63.29 -39.94 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.458 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 1.3 t-80 -79.16 -51.37 9.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.572 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.458 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 65.4 mm-40 -50.21 -47.9 54.56 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.87 -1.144 . . . . 0.0 109.879 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -74.11 -48.42 29.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.547 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 69.1 m-20 -63.27 -51.45 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.71 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.408 HD12 ' NE ' ' B' ' 296' ' ' ARG . 0.6 OUTLIER -68.76 -40.96 79.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.887 -1.133 . . . . 0.0 111.277 -178.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.4 t-20 -62.19 -53.77 50.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.654 -1.279 . . . . 0.0 109.305 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -38.18 75.77 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.088 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.441 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.1 tp -52.63 -45.65 66.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . 0.554 ' OE1' ' NH1' ' B' ' 296' ' ' ARG . 20.5 mt-30 -67.12 -30.37 70.36 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 5.3 mt-30 -91.28 3.54 54.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.625 -1.297 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.79 141.07 58.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.0 112.527 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' B' ' 303' ' ' PRO . 65.3 t0 -97.84 -20.43 17.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 18.7 t -144.65 144.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 22.6 t -143.5 137.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.544 -1.347 . . . . 0.0 112.527 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.86 125.88 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.97 144.98 41.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.195 -0.94 . . . . 0.0 110.274 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -108.83 121.65 45.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.535 -0.728 . . . . 0.0 109.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 1.7 m -146.74 113.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 18.9 m -130.22 -13.6 3.94 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -142.79 156.26 62.7 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -39.07 108.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.259 1.973 . . . . 0.0 111.691 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.608 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 45.6 m -125.9 134.35 51.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.099 -1.001 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.608 ' HB2' ' H ' ' A' ' 87' ' ' SER . 15.0 tp -105.32 153.51 21.53 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 81.97 -29.74 3.03 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.599 ' H ' ' C ' ' B' ' 288' ' ' LEU . 46.6 t -86.39 -49.54 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.67 -28.55 62.93 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 106.946 -2.461 . . . . 0.0 106.946 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.99 -57.95 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.936 -0.743 . . . . 0.0 109.088 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.538 ' CB ' ' HG ' ' B' ' 215' ' ' CYS . 86.5 mt-10 -52.2 -33.2 39.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.26 -41.13 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.74 -48.63 82.95 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . 0.554 ' NH1' ' OE1' ' B' ' 274' ' ' GLN . 45.4 ttm-85 -62.97 -38.16 90.0 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.371 -1.076 . . . . 0.0 108.987 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.6 -39.68 88.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.468 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -54.92 -44.32 72.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 120.82 -1.175 . . . . 0.0 108.216 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.98 -49.28 18.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.46 ' O ' ' CD ' ' B' ' 302' ' ' LYS . 2.8 pp -116.36 -23.56 8.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.949 -1.094 . . . . 0.0 110.403 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -52.92 170.38 0.64 Allowed Glycine 0 C--N 1.288 -2.128 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.543 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 0.4 OUTLIER -131.46 -75.67 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 66.5 Cg_endo -81.73 109.49 2.02 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.819 1.679 . . . . 0.0 109.623 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 55.4 mt -130.47 126.79 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.688 -1.258 . . . . 0.0 111.514 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -123.06 119.29 29.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.45 153.08 20.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.642 -1.286 . . . . 0.0 108.511 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.584 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 14.7 mt -127.69 132.5 49.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.996 -1.065 . . . . 0.0 111.865 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -138.79 122.51 17.54 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 68.3 mtm180 -86.93 135.61 35.12 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.985 -1.072 . . . . 0.0 111.421 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' B' ' 313' ' ' GLY . 72.8 Cg_endo -79.36 -24.29 6.64 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.508 2.139 . . . . 0.0 110.425 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' B' ' 312' ' ' SER . 14.6 pt20 -47.9 -38.28 16.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 9.9 t -95.23 -18.78 20.58 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 40.8 53.1 3.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' B' ' 315' ' ' VAL . 3.6 mtp180 -87.73 6.44 34.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.923 -1.339 . . . . 0.0 109.98 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' B' ' 314' ' ' ARG . 24.1 t 58.25 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.841 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' B' ' 317' ' ' SER . 30.0 tp -74.19 151.21 40.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.41 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.59 139.84 0.75 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 110.596 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.61 97.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.468 -0.77 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 81.0 mmm -64.31 -43.9 93.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.444 HG23 HD13 ' B' ' 320' ' ' ILE . 45.7 mm -61.57 -41.6 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.102 -0.999 . . . . 0.0 108.756 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.09 -45.03 95.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.435 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.431 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -67.01 -39.0 93.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.636 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -48.45 -55.96 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.065 -1.256 . . . . 0.0 108.288 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.636 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -9.99 118.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.344 0.592 . . . . 0.0 111.16 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -131.43 -27.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 79.95 -5.18 63.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 54.7 p -79.34 39.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' B' ' 327' ' ' SER . 84.8 mtt-85 106.22 -25.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.969 -1.469 . . . . 0.0 107.831 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -89.66 114.3 25.9 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.415 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 81.0 mt-30 -137.14 137.85 39.65 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.748 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.94 104.15 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 14.7 m0 -104.88 142.81 34.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.189 -0.945 . . . . 0.0 109.824 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.476 ' O ' ' SD ' ' B' ' 342' ' ' MET . 97.9 m-20 -97.06 159.97 14.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.828 -1.17 . . . . 0.0 108.807 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 8.1 p90 -165.4 -167.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.705 -1.247 . . . . 0.0 111.64 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.467 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -166.39 146.51 6.08 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.7 mt-10 -41.33 -37.24 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.801 -1.187 . . . . 0.0 110.058 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -74.75 4.89 34.01 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.389 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 335' ' ' ALA . 20.3 pt-20 -156.21 8.79 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.461 -1.611 . . . . 0.0 110.899 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.3 p -53.51 -44.75 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.92 -1.113 . . . . 0.0 108.468 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 20.2 pt-20 -58.64 -31.88 68.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.428 -0.795 . . . . 0.0 109.202 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 62.2 m -68.76 -45.91 70.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.0 tpp -51.38 -45.67 62.53 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.6 mt -71.53 -35.19 70.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.2 -40.57 96.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -72.02 -50.1 31.38 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.933 -1.104 . . . . 0.0 108.717 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -59.99 -46.39 89.6 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.1 -1.0 . . . . 0.0 110.153 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' B' ' 351' ' ' LEU . 13.6 m-85 -70.03 -33.03 71.46 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.903 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -67.08 -22.9 65.82 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.493 -1.379 . . . . 0.0 107.589 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.05 -17.82 62.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.512 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.9 OUTLIER -153.02 3.11 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.494 -1.379 . . . . 0.0 111.689 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' B' ' 347' ' ' PHE . 6.2 mt -116.05 83.87 12.89 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.662 -1.274 . . . . 0.0 109.69 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 C--N 1.309 -1.547 0 C-N-CA 122.651 2.234 . . . . 0.0 111.75 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.71 -154.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 111.406 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.464 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 30.3 p -102.41 -178.19 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 2.7 p -119.88 150.62 40.18 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.8 t -125.41 131.96 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 26.5 t80 -99.09 94.88 6.75 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.751 ' H ' ' HG1' ' A' ' 43' ' ' THR . 63.2 t80 -88.01 128.77 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 111.213 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 m -118.39 157.8 26.49 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.248 -0.907 . . . . 0.0 109.765 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' C ' ' CG2' ' A' ' 90' ' ' VAL . . . -168.93 173.8 43.47 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' NE2' ' A' ' 85' ' ' GLN . 19.2 t -81.6 132.25 35.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -1.124 . . . . 0.0 109.689 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.153 -0.967 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 65.9 mtt180 . . . . . 0 N--CA 1.503 2.197 0 CA-C-O 121.716 0.769 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -52.55 -26.87 14.47 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 66.1 m-20 -69.71 -36.05 75.59 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -59.8 -43.59 94.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.93 72.49 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.4 -28.95 68.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 12.7 m-30 -69.43 -49.39 55.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.552 -0.717 . . . . 0.0 110.088 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.25 77.12 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.544 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.478 ' O ' ' OG ' ' A' ' 33' ' ' SER . 63.1 ttt180 -71.74 -55.45 7.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.864 -1.147 . . . . 0.0 108.393 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.409 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 5.5 mt -54.04 -47.36 65.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.434 ' CG2' ' CD2' ' A' ' 14' ' ' PHE . 40.4 t -60.85 -28.77 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.72 -0.613 . . . . 0.0 109.363 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 26.7 p -69.31 -37.2 77.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.553 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -70.46 -47.41 60.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.831 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.26 -41.54 97.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -61.02 -26.12 67.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -78.66 -35.15 45.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -74.68 -51.77 13.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.47 -0.769 . . . . 0.0 109.809 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -142.54 -152.85 5.76 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -98.07 130.9 44.85 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.218 -1.166 . . . . 0.0 109.018 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.46 111.22 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.1 mt -79.8 -29.09 40.22 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.569 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.751 ' HG1' ' H ' ' A' ' 14' ' ' PHE . 12.5 p -82.96 23.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . 85.9 tt0 -44.08 -31.47 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -54.91 -35.96 64.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.875 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 45' ' ' HIS . 56.1 t -50.43 -66.75 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.916 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -62.94 -38.97 93.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -61.58 -0.58 0.44 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -60.57 -40.16 90.67 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.246 -0.909 . . . . 0.0 108.678 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.06 -23.73 1.3 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -66.3 123.15 19.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 109.403 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 51' ' ' LEU . 3.6 mt-10 54.02 162.79 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.798 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ALA . 84.2 Cg_exo -42.71 136.51 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.816 1.677 . . . . 0.0 111.065 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.725 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.3 mp -81.9 -103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 108.694 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.725 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 38.52 112.98 0.0 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' GLY . 15.8 mm-40 -37.74 -48.91 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -1.217 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -74.95 -31.58 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 0.0 108.858 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -83.39 46.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.03 -165.0 1.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.12 69.21 0.21 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 75.36 1.08 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 30.3 p-10 -52.44 -38.76 59.98 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 6.6 tt0 -63.26 -48.57 77.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -57.15 -36.73 71.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.17 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -64.1 -38.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.723 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -77.27 -58.25 3.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 110.45 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.723 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 96.2 mt-10 -45.13 -46.14 11.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.894 -1.129 . . . . 0.0 109.853 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.06 -42.47 76.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 109.716 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 86.0 m-20 -66.59 -36.06 81.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.607 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.54 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.3 mm? -69.77 -52.05 28.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -57.21 -40.57 77.74 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -67.22 -44.74 78.77 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 14.2 tp -51.97 -35.74 47.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.1 -33.2 67.67 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.858 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -84.04 -1.23 54.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.188 -0.945 . . . . 0.0 109.216 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.05 136.65 50.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.062 0.934 . . . . 0.0 112.486 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 11' ' ' SER . 47.6 m-20 -99.71 -30.44 12.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 58.1 t -137.1 144.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.6 t -132.99 140.14 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.787 -1.196 . . . . 0.0 111.205 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.63 121.64 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.34 121.91 45.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.814 -1.178 . . . . 0.0 110.28 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 54.8 tt0 -86.1 112.95 21.76 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -86.65 -99.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 110.383 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.5 m 59.48 -96.87 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.203 -1.561 . . . . 0.0 109.032 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.602 HE22 ' CZ ' ' A' ' 22' ' ' ARG . 28.7 tt0 -61.39 133.34 93.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.914 -1.116 . . . . 0.0 108.589 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD3' ' HE ' ' A' ' 114' ' ' ARG . 32.3 Cg_endo -66.62 115.59 3.64 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.975 1.784 . . . . 0.0 111.869 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.634 ' HG ' ' H ' ' A' ' 90' ' ' VAL . 12.8 t -138.45 129.73 27.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.849 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.05 -40.25 78.66 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 108.932 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.19 95.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.634 ' H ' ' HG ' ' A' ' 87' ' ' SER . 44.6 t -66.13 -47.29 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.451 -1.029 . . . . 0.0 108.832 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.96 74.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -68.89 -47.61 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.507 -0.996 . . . . 0.0 109.698 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.48 -35.22 78.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.551 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.09 -46.73 67.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 108.616 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.4 -33.95 87.97 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -43.99 93.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.49 -1.006 . . . . 0.0 109.706 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -71.14 -29.1 64.8 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.602 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -53.61 -50.42 50.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.305 -1.497 . . . . 0.0 106.994 178.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.514 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -85.43 -55.64 3.91 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.452 0.644 . . . . 0.0 110.681 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 100' ' ' LEU . 1.2 tt -61.97 -16.81 54.11 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.503 1.144 . . . . 0.0 108.004 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 102' ' ' LYS . . . 75.81 -163.17 53.35 Favored Glycine 0 C--N 1.281 -2.511 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 7.6 mmtm 96.85 136.24 0.03 OUTLIER Pre-proline 0 C--N 1.285 -2.215 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -36.41 111.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.218 1.945 . . . . 0.0 111.429 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' PHE . 3.5 mt -105.36 87.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.248 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.7 tp -91.42 116.7 29.06 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.571 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -108.0 139.81 42.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 108.536 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.5 mt -123.31 138.6 54.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -140.4 138.9 35.12 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -92.06 135.27 27.36 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 0.0 110.906 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.04 -32.86 2.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.514 2.143 . . . . 0.0 111.094 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.02 -33.52 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 113' ' ' GLY . 36.4 p -97.11 -21.41 17.36 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 39.74 44.84 2.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HE ' ' HD3' ' A' ' 86' ' ' PRO . 14.8 mtp85 -70.62 8.43 0.85 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.202 -1.175 . . . . 0.0 109.323 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 113' ' ' GLY . 94.5 t 53.92 102.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.428 -0.795 . . . . 0.0 110.419 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.4 tp -57.05 139.52 52.03 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.1 144.63 1.22 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.476 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.11 78.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.484 -0.76 . . . . 0.0 109.913 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 119' ' ' MET . 26.7 mmm -68.58 -45.69 71.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.315 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.427 HG22 HD13 ' A' ' 120' ' ' ILE . 45.3 mm -64.5 -47.37 89.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.79 -44.21 77.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.401 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.27 -26.53 69.48 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -56.44 -51.96 66.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.261 . . . . 0.0 107.743 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 8.97 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.6 t0 -67.86 -35.4 78.49 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.692 -1.255 . . . . 0.0 107.921 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.859 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.77 176.54 45.73 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 56.05 -26.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.488 1.137 . . . . 0.0 108.79 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.859 ' H ' ' C ' ' A' ' 126' ' ' GLY . 7.2 tpp85 -149.95 -3.63 0.38 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.415 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.571 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 6.3 t80 -152.73 112.31 3.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.868 -1.145 . . . . 0.0 108.013 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.515 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 86.8 mt-30 -138.62 132.27 30.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -86.7 103.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.515 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 14.2 m0 -98.11 139.73 33.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.288 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' O ' ' CE ' ' A' ' 142' ' ' MET . 74.2 m-20 -94.18 141.92 28.0 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.954 -1.091 . . . . 0.0 109.046 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.6 p90 -157.51 -173.63 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.035 -1.04 . . . . 0.0 111.034 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -158.87 157.75 32.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.5 30.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.447 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.78 -1.33 3.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.666 ' O ' ' SD ' ' A' ' 142' ' ' MET . 23.2 pt-20 -154.26 10.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.122 -1.222 . . . . 0.0 110.027 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.557 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.7 p -50.86 -41.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.045 -1.034 . . . . 0.0 108.865 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.447 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.0 tt0 -61.66 -29.18 69.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 108.771 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' GLU . 16.9 m -71.31 -48.36 51.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 110.367 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -55.76 -47.16 77.49 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.42 -29.83 70.79 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.128 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.479 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 43.2 t0 -69.09 -39.08 79.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 110.0 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -70.54 -51.76 26.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.69 -1.256 . . . . 0.0 108.814 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -57.92 -47.33 83.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.08 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 12.0 m-85 -74.34 -32.82 62.94 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.123 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 12.2 mm-40 -58.54 -26.48 63.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.21 -22.15 62.95 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.82 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -172.75 101.48 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' A' ' 152' ' ' PRO . 0.7 OUTLIER 175.23 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 151' ' ' LEU . 86.9 Cg_endo . . . . . 0 C--N 1.31 -1.492 0 C-N-CA 122.913 2.409 . . . . 0.0 111.456 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.69 -154.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.065 2.51 . . . . 0.0 111.459 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.471 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 30.3 p -102.65 -178.16 3.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 2.8 p -119.77 151.12 39.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 3.6 t -125.86 131.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 26.0 t80 -98.98 94.46 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.717 ' H ' ' HG1' ' B' ' 243' ' ' THR . 62.4 t80 -87.84 129.3 35.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 0.0 111.117 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -119.24 157.99 26.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.402 -0.812 . . . . 0.0 109.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CG2' ' B' ' 290' ' ' VAL . . . -169.12 174.29 43.6 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.52 ' OG ' ' NE2' ' B' ' 285' ' ' GLN . 17.7 t -81.73 132.12 35.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -1.115 . . . . 0.0 109.8 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.452 ' N ' ' NH1' ' B' ' 222' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.201 -0.937 . . . . 0.0 110.101 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.596 ' CZ ' HE22 ' B' ' 285' ' ' GLN . 65.9 mtt180 . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 121.666 0.746 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -52.75 -26.28 13.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 63.7 m-20 -70.58 -35.79 73.24 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 222' ' ' ARG . 0.4 OUTLIER -59.9 -43.34 94.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.03 71.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.34 -28.81 68.46 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' B' ' 224' ' ' ASP . 12.8 m-30 -69.55 -49.18 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 110.167 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.28 77.36 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.477 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.479 ' O ' ' OG ' ' B' ' 233' ' ' SER . 64.3 ttt180 -71.4 -55.41 8.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.138 . . . . 0.0 108.356 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.43 ' CD1' ' OE1' ' B' ' 282' ' ' GLU . 5.8 mt -54.24 -47.51 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.433 ' CG2' ' CD2' ' B' ' 214' ' ' PHE . 40.1 t -60.73 -28.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 230' ' ' ARG . 28.4 p -69.44 -37.31 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.541 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -70.08 -47.61 61.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.131 . . . . 0.0 108.919 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.24 -41.61 97.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.8 -26.27 67.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -78.51 -35.47 46.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.045 -1.034 . . . . 0.0 109.371 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.558 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -74.3 -51.65 14.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -142.45 -152.51 5.7 Favored Glycine 0 N--CA 1.478 1.443 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -98.18 130.97 44.92 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.253 -1.145 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 110.79 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 16.9 mt -79.37 -29.2 42.05 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.673 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.717 ' HG1' ' H ' ' B' ' 214' ' ' PHE . 13.6 p -83.0 24.19 0.78 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.521 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 243' ' ' THR . 85.9 tt0 -44.36 -31.19 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.539 ' CD2' ' OD2' ' B' ' 269' ' ' ASP . 0.1 OUTLIER -54.96 -36.05 64.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.845 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' B' ' 245' ' ' HIS . 55.8 t -50.32 -66.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -63.11 -39.16 93.89 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -61.41 -0.31 0.37 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.566 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -60.58 -40.15 90.68 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.167 -0.958 . . . . 0.0 108.735 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -49.29 -23.1 1.25 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.494 -0.754 . . . . 0.0 109.782 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' B' ' 251' ' ' LEU . 0.7 OUTLIER -66.78 123.25 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 251' ' ' LEU . 3.3 mt-10 54.06 163.25 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 108.88 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' B' ' 258' ' ' ALA . 84.5 Cg_exo -43.09 135.84 5.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.781 1.654 . . . . 0.0 111.038 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.735 ' O ' ' O ' ' B' ' 255' ' ' GLY . 4.6 mp -81.14 -103.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 108.842 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 38.18 113.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' B' ' 255' ' ' GLY . 14.7 mm-40 -37.86 -48.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.12 -1.223 . . . . 0.0 109.204 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -74.8 -31.91 61.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 108.846 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -83.22 46.97 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -139.89 -164.71 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.24 68.62 0.22 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.03 75.66 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 30.5 p-10 -52.57 -38.4 59.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 6.7 tt0 -63.49 -48.9 75.74 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -56.66 -36.9 70.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.099 -1.001 . . . . 0.0 109.145 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.5 OUTLIER -64.05 -38.07 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.719 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 0.5 OUTLIER -77.31 -58.13 3.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.716 . . . . 0.0 110.478 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.719 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 95.9 mt-10 -45.23 -46.26 12.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.778 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.82 -42.61 77.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.746 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' B' ' 245' ' ' HIS . 87.5 m-20 -66.47 -36.37 82.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.969 . . . . 0.0 110.695 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.54 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 1.3 mm? -69.56 -52.23 28.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.92 -1.113 . . . . 0.0 109.636 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -57.01 -40.58 76.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 1.0 OUTLIER -67.21 -44.64 79.05 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.275 -0.89 . . . . 0.0 109.608 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.546 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.9 tp -52.22 -35.31 49.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -72.34 -33.45 67.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.79 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -83.81 -1.33 54.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.37 51.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 112.401 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' B' ' 211' ' ' SER . 53.1 m-20 -100.58 -30.43 11.78 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 57.4 t -137.03 144.31 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.33 139.78 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.782 -1.199 . . . . 0.0 111.16 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 43.5 t -142.54 121.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -113.38 122.18 46.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.799 -1.188 . . . . 0.0 110.188 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.43 ' OE1' ' CD1' ' B' ' 231' ' ' ILE . 53.7 tt0 -86.03 112.91 21.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.45 -99.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' B' ' 285' ' ' GLN . 6.2 m 59.9 -96.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.217 -1.552 . . . . 0.0 109.036 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.596 HE22 ' CZ ' ' B' ' 222' ' ' ARG . 28.9 tt0 -61.64 133.43 93.45 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.871 -1.143 . . . . 0.0 108.582 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.416 ' HD3' ' HE ' ' B' ' 314' ' ' ARG . 33.1 Cg_endo -66.77 115.27 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.938 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.624 ' HG ' ' H ' ' B' ' 290' ' ' VAL . 13.1 t -138.22 130.22 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.812 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 8.4 mt -69.39 -40.8 77.17 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.79 94.19 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.624 ' H ' ' HG ' ' B' ' 287' ' ' SER . 43.5 t -65.57 -47.53 86.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.462 -1.023 . . . . 0.0 108.827 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.26 73.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -68.85 -47.49 65.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.59 -0.947 . . . . 0.0 109.773 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.76 -35.08 78.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 0.0 109.635 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.02 -46.82 66.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 108.596 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.38 -34.19 88.65 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -43.89 94.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.458 -1.025 . . . . 0.0 109.685 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -71.39 -28.65 64.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.619 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.518 HG11 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -53.91 -50.15 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.518 ' N ' HG11 ' B' ' 298' ' ' VAL . . . -85.61 -55.75 3.84 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.419 0.628 . . . . 0.0 110.564 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' B' ' 300' ' ' LEU . 1.1 tt -61.81 -17.07 54.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' B' ' 302' ' ' LYS . . . 75.78 -162.75 53.16 Favored Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' B' ' 301' ' ' GLY . 7.5 mmtm 96.63 136.4 0.03 OUTLIER Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 302' ' ' LYS . 80.7 Cg_exo -36.41 110.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.2 1.933 . . . . 0.0 111.591 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' B' ' 329' ' ' PHE . 3.4 mt -104.65 87.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.91 0.862 . . . . 0.0 111.256 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.16 116.94 29.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.4 OUTLIER -108.28 140.29 41.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 0.0 108.585 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.0 mt -123.7 138.77 54.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.0 111.059 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -140.34 138.89 35.23 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -91.69 135.17 27.99 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.29 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.518 2.145 . . . . 0.0 110.934 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -49.78 -33.49 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.452 ' O ' ' C ' ' B' ' 313' ' ' GLY . 38.7 p -97.27 -21.06 17.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 39.6 44.74 2.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.416 ' HE ' ' HD3' ' B' ' 286' ' ' PRO . 14.5 mtp85 -70.31 8.38 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -1.203 . . . . 0.0 109.397 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' B' ' 313' ' ' GLY . 97.3 t 53.85 102.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.297 -0.877 . . . . 0.0 110.356 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.39 139.6 52.63 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.13 144.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.469 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.95 77.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' B' ' 319' ' ' MET . 25.3 mmm -69.0 -45.35 70.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.83 -46.59 91.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -68.44 -44.54 74.71 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.116 -0.99 . . . . 0.0 109.326 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.8 -26.6 68.89 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -56.47 -52.45 64.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.015 -1.285 . . . . 0.0 107.863 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 9.25 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' B' ' 323' ' ' ALA . 23.5 t0 -67.75 -35.48 78.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 107.945 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.879 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.78 176.49 45.68 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 21.1 m 56.25 -26.05 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.463 1.125 . . . . 0.0 108.824 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.879 ' H ' ' C ' ' B' ' 326' ' ' GLY . 7.2 tpp85 -150.34 -3.32 0.36 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.37 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.568 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 6.1 t80 -153.0 112.55 3.87 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.51 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 86.8 mt-30 -138.77 132.85 31.34 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.572 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 43.5 t -87.16 103.69 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.51 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 14.2 m0 -98.4 139.71 33.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -0.932 . . . . 0.0 109.306 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.477 ' O ' ' CE ' ' B' ' 342' ' ' MET . 73.9 m-20 -94.32 142.11 27.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.891 -1.13 . . . . 0.0 109.052 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -157.71 -173.28 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 111.078 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -159.22 157.61 31.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.6 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -135.77 -1.14 3.08 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.648 ' O ' ' SD ' ' B' ' 342' ' ' MET . 23.0 pt-20 -154.29 10.37 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.235 . . . . 0.0 109.995 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.547 ' O ' ' HG2' ' B' ' 342' ' ' MET . 1.9 p -51.03 -41.82 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.023 -1.048 . . . . 0.0 108.856 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 81.2 tt0 -61.37 -28.78 69.48 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.027 -1.045 . . . . 0.0 108.833 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.1 m -71.96 -48.12 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.665 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.76 -47.0 77.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 75.3 mt -62.62 -30.13 71.13 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.07 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 43.4 t0 -68.32 -39.55 81.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -70.47 -51.61 27.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.173 . . . . 0.0 108.955 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.88 -47.06 83.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.507 -0.746 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 11.7 m-85 -74.83 -32.46 61.96 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.185 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 12.3 mm-40 -58.94 -26.28 64.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.67 62.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.821 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -173.23 101.56 0.12 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.465 ' N ' ' HD3' ' B' ' 352' ' ' PRO . 0.7 OUTLIER 175.17 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' B' ' 351' ' ' LEU . 90.7 Cg_endo . . . . . 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 111.513 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' CYS . 61.2 Cg_endo -75.09 155.27 42.48 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.389 2.059 . . . . 0.0 112.141 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 12.2 p -54.01 -175.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.112 -0.992 . . . . 0.0 108.508 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 69.4 m -111.17 152.63 26.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.109 -0.995 . . . . 0.0 108.739 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 9.0 t -140.09 136.94 38.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 122.086 0.946 . . . . 0.0 109.273 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 69' ' ' ASP . 7.3 t80 -115.58 111.03 20.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -98.14 124.47 42.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 0.0 109.087 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.42 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 13.3 m -99.81 143.2 30.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.194 -0.941 . . . . 0.0 109.034 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.68 157.09 27.15 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.556 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 5.3 m -81.0 119.82 24.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.773 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.9 . . . . 0.0 108.732 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.196 0.522 . . . . 0.0 109.635 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -53.03 -39.16 62.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.65 -28.99 68.91 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.91 -41.62 97.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.89 -50.46 70.79 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.23 -32.91 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.556 ' OH ' ' N ' ' A' ' 17' ' ' SER . 20.5 m-30 -69.41 -46.86 65.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.951 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.89 84.47 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.739 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.663 HH22 HH21 ' A' ' 34' ' ' ARG . 65.9 ttt-85 -69.46 -56.4 7.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.506 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.47 -48.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 55.7 t -58.1 -32.27 43.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 34' ' ' ARG . 17.7 p -63.32 -43.32 98.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 109.7 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.663 HH21 HH22 ' A' ' 30' ' ' ARG . 82.3 mtt-85 -64.4 -40.3 95.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.154 . . . . 0.0 108.06 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 38' ' ' TYR . 85.4 mt -62.9 -43.08 99.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.83 -28.49 61.64 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.81 -59.88 2.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.709 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -125.49 152.38 45.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 176.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.8 64.29 1.62 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' C ' ' O ' ' A' ' 39' ' ' GLY . 10.4 ttpt -34.42 121.79 0.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -1.037 . . . . 0.0 108.657 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.38 108.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.811 -1.181 . . . . 0.0 109.16 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.17 -36.82 69.38 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.775 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.412 ' OG1' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -91.24 93.16 8.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.024 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.23 -23.74 19.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.51 -37.85 85.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 55.9 t -47.32 -73.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.098 -1.001 . . . . 0.0 109.68 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.18 -47.6 71.86 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.039 -1.038 . . . . 0.0 109.14 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.35 45.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -122.79 -16.34 7.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -8.28 17.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.738 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.11 130.08 34.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.224 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 51' ' ' LEU . 5.7 mt-10 55.81 157.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' HH22 ' A' ' 22' ' ' ARG . 8.9 Cg_endo -52.77 112.03 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.286 1.991 . . . . 0.0 111.493 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.409 ' N ' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -92.66 -3.79 54.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ALA . . . -46.09 150.37 1.58 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 43.9 mt-10 -53.56 -35.49 60.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.062 -1.258 . . . . 0.0 109.117 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -66.31 -11.21 49.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . -57.17 176.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -47.03 164.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.26 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -43.31 150.96 0.46 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 154.87 -17.44 0.55 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.85 -44.03 90.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.0 109.219 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.39 -55.45 7.04 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -56.42 -29.31 61.42 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -69.85 -49.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -64.73 -55.34 20.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.629 -0.669 . . . . 0.0 110.012 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 91.1 mt-10 -49.1 -54.91 13.98 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.967 -1.083 . . . . 0.0 110.206 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 68' ' ' GLN . 4.2 mp0 -71.77 -50.61 28.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.924 -1.11 . . . . 0.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.482 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.4 m-20 -61.43 -54.61 41.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 111.493 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.37 -39.15 68.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.709 -1.244 . . . . 0.0 111.202 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 63.8 t-20 -58.48 -50.26 74.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.011 -1.68 . . . . 0.0 108.217 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -38.77 81.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.2 tp -49.84 -39.79 40.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.54 -31.3 65.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.614 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -85.06 0.31 51.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.919 -1.113 . . . . 0.0 109.344 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.98 121.86 18.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 112.057 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 11' ' ' SER . 76.2 m-20 -68.47 -37.63 80.33 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 79.6 t -131.49 151.23 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.0 t -135.77 143.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 0.0 112.356 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 t -135.08 156.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -162.99 123.38 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.364 -1.46 . . . . 0.0 110.749 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.09 116.46 22.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.39 30.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.55 HG23 ' N ' ' A' ' 113' ' ' GLY . 25.9 m -62.13 -108.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.817 -0.552 . . . . 0.0 110.125 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 84' ' ' THR . 1.2 tm0? -41.02 126.57 2.03 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.502 -0.749 . . . . 0.0 110.221 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 78.2 Cg_exo -45.76 113.44 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.881 1.721 . . . . 0.0 111.645 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.464 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 8.0 t -142.16 131.88 24.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.0 110.219 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HG ' ' H ' ' B' ' 287' ' ' SER . 8.3 mt -79.71 -42.46 24.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.76 -37.29 89.78 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 t -74.37 -42.56 50.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -1.22 . . . . 0.0 108.817 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.02 -25.18 67.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.467 ' HH ' ' CB ' ' B' ' 323' ' ' ALA . 65.2 t80 -70.82 -56.51 6.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.79 -0.829 . . . . 0.0 109.308 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 96.1 mt-10 -60.18 -33.76 72.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 94' ' ' LEU . 3.2 tm? -70.75 -49.95 41.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.17 57.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -56.16 -36.28 68.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -1.076 . . . . 0.0 108.334 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.69 -38.58 87.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -54.4 -43.47 62.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.876 -1.14 . . . . 0.0 108.531 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -74.71 -48.36 26.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.411 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.8 pp -119.5 -28.02 5.42 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.912 -1.117 . . . . 0.0 110.585 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -40.74 162.35 0.01 OUTLIER Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 2.5 mmtp -98.38 -161.57 0.04 OUTLIER Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 71.8 Cg_exo -41.71 115.03 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.354 1.519 . . . . 0.0 110.376 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 104' ' ' ILE . 3.3 mt -106.62 138.97 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.088 0.947 . . . . 0.0 112.188 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 132' ' ' TRP . 50.8 tp -126.5 118.1 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER -102.63 157.27 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.924 -1.11 . . . . 0.0 109.411 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 5.7 mt -143.12 127.75 18.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -138.78 145.05 39.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.208 -0.933 . . . . 0.0 108.966 178.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.522 ' NH1' ' OH ' ' A' ' 134' ' ' TYR . 24.2 ptt-85 -128.67 148.12 67.14 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.52 29.46 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.58 2.186 . . . . 0.0 112.507 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 50.6 mt-30 -104.79 -44.01 4.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -129.69 -22.62 2.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 108.676 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 114' ' ' ARG . . . -87.03 -52.03 3.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.705 ' O ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 39.59 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 114' ' ' ARG . 96.6 t 61.78 93.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.682 ' H ' ' CD2' ' A' ' 116' ' ' LEU . 1.5 pt? -70.03 -43.56 71.05 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.788 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER 163.05 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.877 -1.139 . . . . 0.0 110.303 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.493 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -63.91 -46.12 86.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.818 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 80.4 mmm -62.22 -46.53 88.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.8 mm -61.1 -41.86 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -44.57 95.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.921 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.21 -33.96 88.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.476 ' CB ' ' HH ' ' B' ' 292' ' ' TYR . . . -56.3 -22.16 28.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.274 -1.133 . . . . 0.0 108.659 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -36.45 109.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.276 0.56 . . . . 0.0 110.084 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' OD2' ' OG ' ' A' ' 127' ' ' SER . 55.0 t0 -105.73 -29.41 10.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.38 77.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 128' ' ' ARG . 80.0 p -122.24 -78.97 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -1.066 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.448 ' H ' ' HG ' ' A' ' 127' ' ' SER . 46.6 ttp180 -97.92 -5.08 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 108.885 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.27 125.34 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.502 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 57.0 mt-30 -138.35 149.94 46.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.051 -1.03 . . . . 0.0 111.215 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.25 107.22 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.465 ' CD2' HD12 ' A' ' 105' ' ' LEU . 20.3 m0 -106.14 145.23 31.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.128 -0.983 . . . . 0.0 109.984 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.531 ' O ' ' CE ' ' A' ' 142' ' ' MET . 57.7 p-10 -100.97 161.07 13.85 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.649 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 8.0 p90 -172.67 -167.88 0.47 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.807 -1.183 . . . . 0.0 110.7 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.963 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -131.34 149.95 52.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.714 ' C ' ' O ' ' A' ' 135' ' ' ALA . 72.2 mt-10 -32.29 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.963 ' O ' ' O ' ' A' ' 135' ' ' ALA . . . -95.54 -176.45 37.14 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.92 -13.11 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.057 -1.261 . . . . 0.0 108.864 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.743 ' H ' ' C ' ' A' ' 137' ' ' GLY . 1.3 p -59.19 -46.88 91.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.541 ' OE1' ' NH2' ' A' ' 34' ' ' ARG . 23.3 pt-20 -53.37 -33.58 54.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.7 m -68.31 -40.84 81.56 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.395 -0.816 . . . . 0.0 108.884 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 8.2 mmt -52.49 -48.04 66.2 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.0 -38.59 91.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.44 -40.46 95.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 110.731 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -70.05 -49.87 46.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.488 -1.382 . . . . 0.0 108.796 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.84 -48.72 80.55 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.489 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 19.4 m-85 -70.45 -32.95 70.72 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.236 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 150' ' ' TYR . 24.5 mm-40 -61.19 -31.14 70.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.13 12.21 5.44 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -138.1 -104.29 0.18 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.323 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 ' CD1' ' CD1' ' A' ' 147' ' ' PHE . 12.1 mt -33.5 90.69 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.844 -0.535 . . . . 0.0 110.841 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' N ' ' O ' ' A' ' 150' ' ' TYR . 83.6 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 C-N-CA 123.217 2.612 . . . . 0.0 111.477 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' B' ' 210' ' ' CYS . 61.1 Cg_endo -75.09 155.01 42.46 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.46 2.107 . . . . 0.0 112.18 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' B' ' 209' ' ' PRO . 10.2 p -53.85 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.173 -0.955 . . . . 0.0 108.467 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 62.9 m -111.17 152.82 26.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.157 -0.965 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 8.9 t -140.33 136.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 122.04 0.924 . . . . 0.0 109.21 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 269' ' ' ASP . 7.2 t80 -115.51 110.95 19.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.466 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.0 OUTLIER -98.04 124.2 42.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.036 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.425 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 12.2 m -99.73 142.62 30.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.046 -1.034 . . . . 0.0 109.071 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -144.18 157.17 27.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.552 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 5.7 m -80.78 119.96 24.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -1.037 . . . . 0.0 109.795 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.258 0.551 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.09 -39.14 63.14 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 79.4 m-20 -66.7 -29.01 68.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -63.93 -41.81 97.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.16 72.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.28 -33.17 69.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.552 ' OH ' ' N ' ' B' ' 217' ' ' SER . 20.5 m-30 -69.26 -46.47 67.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 0.0 110.074 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.87 85.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.766 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.693 HH22 HH21 ' B' ' 234' ' ' ARG . 65.8 ttt-85 -69.37 -56.19 8.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 108.535 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.2 mt -52.86 -48.18 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' B' ' 214' ' ' PHE . 56.1 t -58.2 -32.22 43.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' B' ' 234' ' ' ARG . 18.1 p -63.29 -43.58 97.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 109.597 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . 0.693 HH21 HH22 ' B' ' 230' ' ' ARG . 83.6 mtt-85 -64.23 -40.5 96.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.867 -1.145 . . . . 0.0 108.008 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.712 ' O ' ' O ' ' B' ' 238' ' ' TYR . 87.0 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -56.93 -28.3 61.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 108.75 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.04 -59.87 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.712 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.9 OUTLIER -125.32 152.32 44.87 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 176.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 84.03 64.16 1.62 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' B' ' 239' ' ' GLY . 10.6 ttpt -34.2 121.9 0.48 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -1.085 . . . . 0.0 108.584 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.67 109.53 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.793 -1.192 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.6 -37.64 68.07 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.677 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.415 ' OG1' ' CG2' ' B' ' 246' ' ' VAL . 0.1 OUTLIER -90.47 92.86 9.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.957 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -91.89 -23.7 19.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 109.158 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -61.94 -37.77 85.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 110.128 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.59 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 55.8 t -46.86 -73.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.658 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -53.83 -48.08 70.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -72.26 45.48 0.13 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -122.82 -16.57 7.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -8.32 15.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.737 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -84.3 130.41 34.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.088 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' B' ' 251' ' ' LEU . 6.0 mt-10 55.55 157.97 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.039 -1.038 . . . . 0.0 108.861 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.426 ' HA ' HH22 ' B' ' 222' ' ' ARG . 8.6 Cg_endo -52.7 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.224 1.95 . . . . 0.0 111.437 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.407 ' H ' HD11 ' B' ' 254' ' ' LEU . 0.3 OUTLIER -92.87 -3.97 53.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 258' ' ' ALA . . . -45.84 150.2 1.48 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 44.2 mt-10 -53.43 -35.89 60.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -1.205 . . . . 0.0 108.983 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.99 -11.14 45.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.0 108.843 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 255' ' ' GLY . . . -57.51 175.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' B' ' 260' ' ' GLY . . . -46.97 165.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.326 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' B' ' 259' ' ' ALA . . . -43.36 151.5 0.42 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 154.25 -17.53 0.61 Allowed Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.07 -44.24 91.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.116 -1.226 . . . . 0.0 109.265 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -72.32 -55.26 7.42 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 0.9 OUTLIER -56.39 -29.27 61.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' B' ' 261' ' ' GLY . 8.5 mt -69.87 -49.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -65.27 -55.15 19.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.662 -0.649 . . . . 0.0 110.001 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 90.9 mt-10 -49.01 -54.55 15.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 110.224 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 4.8 mp0 -72.06 -50.8 25.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.923 -1.111 . . . . 0.0 111.038 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.469 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 1.6 m-20 -61.2 -54.79 39.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.457 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -38.79 68.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.766 -1.209 . . . . 0.0 111.323 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 64.7 t-20 -58.74 -50.02 75.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 119.955 -1.715 . . . . 0.0 108.155 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -38.9 83.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.428 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.4 tp -49.64 -39.47 36.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . 0.402 ' OE1' ' NH2' ' B' ' 296' ' ' ARG . 15.2 mt-30 -72.84 -31.22 64.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.533 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -85.24 0.2 52.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.97 121.95 18.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.318 -0.864 . . . . 0.0 112.091 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.56 -37.65 80.09 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 77.7 t -131.34 151.45 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 86.9 t -136.16 143.6 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 122.564 1.173 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 27.8 t -135.11 156.35 39.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -163.06 122.72 2.2 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.434 -1.416 . . . . 0.0 110.81 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.29 116.23 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 1.9 m -101.24 29.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 108.778 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.553 HG23 ' N ' ' B' ' 313' ' ' GLY . 25.3 m -61.86 -109.37 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.728 -0.607 . . . . 0.0 110.169 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' B' ' 286' ' ' PRO . 1.2 tm0? -40.63 126.76 1.87 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.407 -0.808 . . . . 0.0 110.181 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.41 ' O ' ' NE2' ' B' ' 285' ' ' GLN . 76.6 Cg_exo -45.61 113.7 0.61 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.933 1.755 . . . . 0.0 111.595 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.468 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 8.1 t -142.64 131.66 23.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.121 -0.987 . . . . 0.0 110.251 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 87' ' ' SER . 8.3 mt -79.68 -42.6 24.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 109.304 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -58.57 -37.52 89.07 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 8.2 t -74.2 -42.28 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 108.809 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -63.49 -24.98 68.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.476 ' HH ' ' CB ' ' A' ' 123' ' ' ALA . 65.1 t80 -70.81 -56.42 6.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.707 -0.878 . . . . 0.0 109.248 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.425 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 95.7 mt-10 -60.19 -33.68 72.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' B' ' 294' ' ' LEU . 3.3 tm? -70.77 -49.73 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.99 -51.5 54.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . 0.402 ' NH2' ' OE1' ' B' ' 274' ' ' GLN . 56.1 ttt85 -55.96 -36.4 67.76 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 108.394 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.55 -38.78 87.85 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.474 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.4 OUTLIER -54.19 -43.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 120.862 -1.149 . . . . 0.0 108.565 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -74.55 -48.8 24.71 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 112.387 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.7 pp -119.06 -27.95 5.61 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.974 -1.079 . . . . 0.0 110.747 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' B' ' 300' ' ' LEU . . . -40.8 162.19 0.01 OUTLIER Glycine 0 C--N 1.289 -2.044 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.49 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 2.8 mmtp -98.23 -161.54 0.04 OUTLIER Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 75.9 Cg_exo -41.89 115.41 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 121.458 1.557 . . . . 0.0 110.329 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.85 138.96 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.195 0.998 . . . . 0.0 112.147 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . 0.463 HD12 ' CD2' ' B' ' 332' ' ' TRP . 50.9 tp -126.47 118.25 24.55 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 330' ' ' GLN . 0.5 OUTLIER -102.8 157.41 16.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.899 -1.126 . . . . 0.0 109.457 -179.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 5.9 mt -143.02 128.0 18.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -139.33 144.7 38.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.139 -0.976 . . . . 0.0 108.865 178.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' B' ' 334' ' ' TYR . 24.9 ptt-85 -128.65 148.09 66.96 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.464 -0.772 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.42 29.46 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.208 . . . . 0.0 112.566 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.544 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 51.3 mt-30 -104.62 -43.77 5.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 22.6 m -129.73 -23.24 2.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 108.6 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.707 ' O ' ' O ' ' B' ' 314' ' ' ARG . . . -86.44 -51.87 3.37 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.707 ' O ' ' O ' ' B' ' 313' ' ' GLY . 0.1 OUTLIER 39.47 101.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' B' ' 314' ' ' ARG . 96.6 t 61.97 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.69 ' CD2' ' H ' ' B' ' 316' ' ' LEU . 1.5 pt? -70.45 -43.84 69.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.739 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.3 OUTLIER 163.35 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.96 -1.088 . . . . 0.0 110.176 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . 0.495 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -64.1 -45.57 88.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.442 -0.786 . . . . 0.0 109.798 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 80.2 mmm -62.52 -46.9 86.3 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.36 -0.838 . . . . 0.0 109.371 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 3.8 mm -60.69 -41.88 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -44.39 96.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.748 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -63.66 -33.58 87.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.467 ' CB ' ' HH ' ' A' ' 92' ' ' TYR . . . -56.7 -22.11 32.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -1.15 . . . . 0.0 108.605 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -36.44 109.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.21 0.529 . . . . 0.0 110.043 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -105.94 -29.46 9.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.12 3.7 76.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.492 ' HG ' ' H ' ' B' ' 328' ' ' ARG . 68.1 p -121.49 -79.08 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.472 -1.017 . . . . 0.0 109.1 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.492 ' H ' ' HG ' ' B' ' 327' ' ' SER . 46.2 ttp180 -97.89 -4.93 35.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.855 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.37 125.24 22.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' B' ' 306' ' ' CYS . 55.4 mt-30 -138.13 149.77 46.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.0 111.12 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.04 106.93 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.463 ' CD2' HD12 ' B' ' 305' ' ' LEU . 20.4 m0 -106.21 145.11 31.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.111 -0.993 . . . . 0.0 110.103 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.54 ' O ' ' CE ' ' B' ' 342' ' ' MET . 57.1 p-10 -100.68 160.83 14.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 8.0 p90 -172.41 -167.89 0.49 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.735 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.962 ' O ' ' O ' ' B' ' 337' ' ' GLY . . . -131.47 149.49 52.51 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.76 ' C ' ' O ' ' B' ' 335' ' ' ALA . 71.1 mt-10 -31.94 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.962 ' O ' ' O ' ' B' ' 335' ' ' ALA . . . -95.36 -176.71 37.42 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -13.06 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.93 -1.335 . . . . 0.0 108.908 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.746 ' H ' ' C ' ' B' ' 337' ' ' GLY . 1.3 p -59.12 -46.97 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.55 ' OE1' ' NH2' ' B' ' 234' ' ' ARG . 22.7 pt-20 -53.21 -33.78 54.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 17.9 m -68.16 -40.7 82.27 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.955 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.54 ' CE ' ' O ' ' B' ' 333' ' ' ASP . 7.9 mmt -52.86 -47.91 67.47 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 49.3 mt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.824 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -64.44 -40.36 95.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.42 -0.8 . . . . 0.0 110.73 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -70.11 -49.71 48.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.422 -1.423 . . . . 0.0 108.756 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.25 -48.65 80.83 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 109.961 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.49 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 19.7 m-85 -70.41 -32.51 70.17 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.144 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' B' ' 350' ' ' TYR . 24.3 mm-40 -61.59 -30.95 71.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.24 12.25 5.53 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.5 t80 -138.04 -104.44 0.18 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.283 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.49 ' CD1' ' CD1' ' B' ' 347' ' ' PHE . 12.0 mt -33.53 90.77 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.915 -0.491 . . . . 0.0 110.815 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' B' ' 350' ' ' TYR . 78.8 Cg_endo . . . . . 0 C--N 1.315 -1.225 0 C-N-CA 123.27 2.647 . . . . 0.0 111.339 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -155.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.533 2.155 . . . . 0.0 111.459 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -102.07 -175.61 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 11.2 p -120.35 154.39 35.12 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.58 135.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 0.0 109.006 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 8.1 t80 -118.15 95.39 4.87 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.825 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -83.2 104.73 13.6 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.03 170.43 9.42 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 111.417 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.3 93.05 0.72 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' CE2' ' A' ' 28' ' ' TYR . 2.7 p -168.39 -177.29 3.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.014 -1.286 . . . . 0.0 109.746 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.592 -0.693 . . . . 0.0 109.922 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.3 mmt85 . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.08 -35.22 61.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 28' ' ' TYR . 4.6 t0 -65.99 -27.75 68.37 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.746 ' NE2' ' N ' ' A' ' 50' ' ' GLU . 35.3 tt0 -57.9 -45.55 86.29 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.46 94.15 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.65 -30.22 71.35 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 17' ' ' SER . 22.7 m-30 -70.77 -49.77 43.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.48 -0.762 . . . . 0.0 110.089 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.32 72.68 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.426 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -71.43 -58.15 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.918 -1.113 . . . . 0.0 108.291 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.85 -44.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 55.4 t -61.07 -28.84 44.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -70.82 -35.09 72.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.404 ' HA ' HH11 ' A' ' 37' ' ' ARG . 68.1 mtp85 -73.89 -50.28 20.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 108.694 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.64 -40.09 86.51 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.95 -23.0 67.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.404 HH11 ' HA ' ' A' ' 34' ' ' ARG . 26.0 mtt85 -77.88 -34.6 51.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.026 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.584 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -73.32 -51.09 18.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 110.082 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.11 -144.99 4.22 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -98.95 135.59 40.15 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.178 -1.189 . . . . 0.0 108.669 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 t -100.11 122.19 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 12.2 mt -87.36 -17.05 33.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.295 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -86.22 43.23 1.04 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.402 -0.811 . . . . 0.0 109.513 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -66.34 -38.67 88.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.493 ' ND1' ' C ' ' A' ' 45' ' ' HIS . 6.5 t-80 -53.94 -46.97 71.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.877 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -48.34 -49.31 13.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.315 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -74.3 -40.74 62.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 108.54 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t0 -75.07 50.89 0.49 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.678 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -126.21 -30.69 2.89 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.746 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -55.08 -5.33 0.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.678 ' H ' ' C ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -49.49 -55.99 11.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 1.8 tm-20 -179.67 -44.73 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.418 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 13.2 Cg_exo -69.31 92.22 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.686 2.257 . . . . 0.0 112.467 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' HE22 ' A' ' 25' ' ' GLN . 4.0 mm? -125.21 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.809 . . . . 0.0 109.549 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 68.19 35.73 83.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' ALA . 69.3 mm-40 47.46 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.531 -0.982 . . . . 0.0 109.197 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 47.92 13.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.04 -1.037 . . . . 0.0 108.65 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' GLU . . . -139.64 96.64 3.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.48 -0.763 . . . . 0.0 109.016 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.72 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.233 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.16 17.12 21.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 62' ' ' ASP . . . 152.23 76.83 0.02 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 23.8 p-10 -48.69 -44.29 37.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 89.6 mt-30 -57.42 -45.13 84.95 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.63 -41.58 95.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -39.06 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.455 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.8 t-80 -76.14 -51.02 13.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.63 -0.669 . . . . 0.0 110.38 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 97.0 mt-10 -46.68 -53.69 11.17 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.071 -1.018 . . . . 0.0 109.825 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.85 -42.63 66.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 110.91 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.71 -57.44 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.965 -1.084 . . . . 0.0 111.143 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.097 -1.002 . . . . 0.0 110.792 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -60.97 -52.94 62.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.591 -1.318 . . . . 0.0 108.958 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.489 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.69 -40.84 89.21 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 108.703 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 7.6 tp -50.07 -37.7 34.85 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.536 ' O ' ' NZ ' ' A' ' 102' ' ' LYS . 51.4 mt-30 -74.44 -29.43 61.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.715 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 18.0 mt-30 -90.2 3.87 52.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.83 -1.169 . . . . 0.0 109.284 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.01 130.08 40.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.899 . . . . 0.0 112.27 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 11' ' ' SER . 85.1 m-20 -78.09 -34.9 49.91 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.25 144.24 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 103' ' ' PRO . 91.9 t -136.08 129.06 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.917 -1.115 . . . . 0.0 111.205 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 70.1 t -129.03 124.85 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.39 156.13 33.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.307 -1.496 . . . . 0.0 110.24 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -99.82 122.66 43.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.32 33.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 4.2 m -88.87 -73.54 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.741 -0.6 . . . . 0.0 109.756 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.77 120.48 81.5 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.798 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.41 141.84 89.28 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.236 1.957 . . . . 0.0 112.202 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.422 ' OG ' ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -179.49 141.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 110.019 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 92' ' ' TYR . 19.7 mt -62.45 -43.21 99.36 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.458 -0.776 . . . . 0.0 109.044 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -54.48 -38.52 63.13 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.422 ' CG2' ' OG ' ' A' ' 87' ' ' SER . 44.6 t -68.07 -53.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.512 -0.993 . . . . 0.0 108.676 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.37 -28.41 73.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 88' ' ' LEU . 51.3 t80 -70.72 -55.09 9.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -1.092 . . . . 0.0 109.633 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' SD ' ' B' ' 319' ' ' MET . 77.4 mt-10 -62.15 -34.15 75.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.253 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.22 -48.55 56.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.253 -0.905 . . . . 0.0 109.195 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.24 96.07 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -61.92 -40.47 95.59 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.519 -0.989 . . . . 0.0 109.299 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.21 76.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.09 -1.006 . . . . 0.0 108.982 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -39.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -77.64 -51.14 11.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.68 -6.18 10.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.973 -1.079 . . . . 0.0 108.722 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.6 26.0 30.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 74' ' ' GLN . 43.9 mttp -84.38 147.54 50.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.906 -1.35 . . . . 0.0 107.644 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -38.53 116.52 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.756 1.637 . . . . 0.0 110.896 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -115.95 98.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.271 -0.893 . . . . 0.0 111.602 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.69 120.64 35.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.28 131.22 55.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.885 -1.134 . . . . 0.0 108.838 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.469 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 3.5 mt -123.15 130.19 52.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 0.0 111.502 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -131.12 151.07 51.82 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' NH1' ' CG ' ' A' ' 136' ' ' GLU . 49.9 mtm180 -114.23 136.02 22.22 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.115 -0.99 . . . . 0.0 110.219 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -29.97 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.355 2.037 . . . . 0.0 111.286 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' ' 112' ' ' SER . 12.2 pt20 -59.7 -46.36 89.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.354 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 17.2 t -75.85 -22.18 56.49 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' O ' ' NE ' ' A' ' 114' ' ' ARG . . . 55.93 111.0 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.601 ' O ' ' C ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -144.6 -7.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -1.017 . . . . 0.0 110.259 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' A' ' 114' ' ' ARG . 94.7 t 32.85 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.863 ' H ' ' CD2' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -61.13 172.31 1.07 Allowed 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.81 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' B' ' 289' ' ' GLY . 29.3 t -64.95 141.36 58.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 111.721 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.18 63.76 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.529 ' SD ' ' CG ' ' B' ' 293' ' ' GLU . 1.7 mtp -63.94 -43.51 95.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.542 -0.724 . . . . 0.0 109.317 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.1 mm -61.87 -45.48 98.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.497 -0.752 . . . . 0.0 109.418 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -64.43 -44.8 90.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.482 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -58.55 -32.1 68.27 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -51.7 -57.33 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 108.265 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 10.38 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 123' ' ' ALA . 2.2 m-20 -68.97 -35.36 76.64 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.747 -1.221 . . . . 0.0 107.757 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.793 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.41 174.04 40.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.4 t 60.56 -30.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.668 1.223 . . . . 0.0 108.573 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.793 ' H ' ' C ' ' A' ' 126' ' ' GLY . 8.7 mtm180 -147.33 0.95 0.71 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.539 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' GLY . 11.3 t80 -156.94 112.9 2.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.49 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 90.5 mt-30 -139.29 142.8 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.398 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.51 98.86 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.49 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 18.1 m0 -94.66 147.29 23.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.345 -0.847 . . . . 0.0 109.521 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.27 150.64 22.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 7.8 p90 -170.95 177.58 3.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.642 -1.286 . . . . 0.0 111.548 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -141.99 146.83 36.03 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.0 mt-10 -39.41 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.748 -1.22 . . . . 0.0 110.474 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -86.32 -2.37 85.42 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.109 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -135.93 0.19 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.813 -1.404 . . . . 0.0 110.231 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -55.21 -47.04 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.851 -1.156 . . . . 0.0 108.476 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 29.6 mt-10 -53.16 -33.17 51.41 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.7 m -69.56 -40.91 76.52 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 109.25 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 12.9 mmt -53.16 -51.78 60.9 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 48.8 mt -62.05 -32.48 73.0 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.72 -43.91 87.62 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 -71.98 -47.74 49.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.534 -1.354 . . . . 0.0 109.149 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -60.44 -48.96 79.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 21.3 m-85 -71.37 -28.86 64.34 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.159 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.05 -31.14 71.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.07 9.57 10.03 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -134.85 -104.49 0.23 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.237 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 150' ' ' TYR . 22.6 mt -32.42 90.84 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.91 -0.494 . . . . 0.0 110.925 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . 71.5 Cg_endo . . . . . 0 C--N 1.313 -1.335 0 C-N-CA 123.067 2.511 . . . . 0.0 111.248 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.62 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 111.34 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 32.1 p -102.21 -175.61 2.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.9 p -120.36 154.0 35.68 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 6.8 t -133.41 135.37 56.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.7 0.762 . . . . 0.0 109.034 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 7.9 t80 -118.01 95.76 5.05 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.833 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -83.36 104.94 13.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.28 170.23 9.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.078 0.942 . . . . 0.0 111.49 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 84.37 93.51 0.71 Allowed Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.574 ' CB ' ' CE2' ' B' ' 228' ' ' TYR . 2.6 p -168.52 -176.85 2.94 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 0.0 109.888 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' B' ' 225' ' ' GLN . 9.4 mmt85 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.05 -34.9 61.25 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' B' ' 228' ' ' TYR . 4.5 t0 -66.26 -27.61 68.08 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' NE2' ' N ' ' B' ' 250' ' ' GLU . 35.5 tt0 -58.15 -45.21 87.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.64 -43.28 94.18 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.9 tp -64.07 -29.68 70.8 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.574 ' CE2' ' CB ' ' B' ' 217' ' ' SER . 22.7 m-30 -71.11 -49.62 42.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.39 -0.818 . . . . 0.0 109.98 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.04 72.67 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.478 -1.289 . . . . 0.0 108.44 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -71.71 -57.9 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.882 -1.136 . . . . 0.0 108.283 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.5 mt -53.09 -44.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 55.7 t -60.99 -28.74 44.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' B' ' 237' ' ' ARG . 7.1 t -70.94 -34.91 71.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.394 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.88 -50.5 19.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 108.752 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 14.1 mt -59.22 -40.42 85.78 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -64.78 -23.16 67.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' B' ' 233' ' ' SER . 24.1 mtt85 -77.66 -34.98 52.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 108.922 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.574 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 1.9 m-30 -73.23 -50.86 20.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 110.041 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -145.22 -145.29 4.26 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -98.59 135.34 40.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.293 -1.122 . . . . 0.0 108.704 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.07 122.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.489 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 11.4 mt -87.35 -16.34 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.309 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.84 43.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.4 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -66.55 -38.22 86.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.89 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.488 ' ND1' ' C ' ' B' ' 245' ' ' HIS . 6.6 t-80 -54.43 -46.92 73.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.971 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 t -48.5 -48.38 14.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -75.1 -40.97 59.61 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' B' ' 251' ' ' LEU . 2.7 t0 -74.86 50.68 0.46 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -126.32 -30.08 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.736 ' N ' ' NE2' ' B' ' 225' ' ' GLN . 0.4 OUTLIER -55.71 -4.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.671 ' H ' ' C ' ' B' ' 249' ' ' ALA . 0.4 OUTLIER -50.12 -55.3 15.52 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 1.8 tm-20 179.99 -45.28 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.426 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 13.0 Cg_exo -69.14 92.35 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.47 ' CD2' HE22 ' B' ' 225' ' ' GLN . 4.0 mm? -125.44 178.39 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 68.26 35.93 83.77 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' B' ' 258' ' ' ALA . 69.0 mm-40 47.05 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -1.02 . . . . 0.0 109.277 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 48.15 13.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.583 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -139.29 96.35 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -172.38 -30.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.64 16.39 22.24 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' B' ' 262' ' ' ASP . . . 152.74 76.56 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 23.8 p-10 -48.42 -44.14 34.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.9 mt-30 -57.49 -45.41 84.92 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -60.13 -42.05 93.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -38.7 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.482 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.8 t-80 -76.35 -51.21 12.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.246 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 97.1 mt-10 -46.67 -53.42 11.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.794 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.97 -42.79 66.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.68 -57.35 9.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.0 -1.062 . . . . 0.0 111.143 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -39.64 83.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.091 -1.005 . . . . 0.0 110.81 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.6 t-20 -60.95 -52.74 63.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.684 -1.26 . . . . 0.0 108.965 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.489 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -60.0 -40.75 90.28 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.738 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 8.1 tp -50.06 -37.81 35.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . 0.532 ' O ' ' NZ ' ' B' ' 302' ' ' LYS . 52.2 mt-30 -74.25 -29.55 61.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.773 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 17.7 mt-30 -90.11 3.97 51.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.838 -1.164 . . . . 0.0 109.204 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.07 129.95 39.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 112.311 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' B' ' 211' ' ' SER . 85.1 m-20 -77.96 -34.74 50.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.66 144.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' B' ' 303' ' ' PRO . 87.3 t -136.12 129.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.921 -1.112 . . . . 0.0 111.296 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . 0.833 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 69.4 t -128.96 125.15 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -121.87 156.72 32.7 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.296 -1.503 . . . . 0.0 110.3 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -100.19 123.03 43.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.82 33.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' B' ' 314' ' ' ARG . 4.0 m -88.45 -73.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.766 -0.583 . . . . 0.0 109.804 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.43 120.75 82.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.47 141.7 89.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.255 1.97 . . . . 0.0 112.229 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' B' ' 290' ' ' VAL . 0.1 OUTLIER -179.34 140.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.102 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' B' ' 292' ' ' TYR . 20.1 mt -62.24 -42.83 99.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 117' ' ' SER . . . -54.88 -38.6 65.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.434 ' CG2' ' OG ' ' B' ' 287' ' ' SER . 44.3 t -68.03 -52.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.933 . . . . 0.0 108.696 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.45 -27.94 73.42 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' B' ' 288' ' ' LEU . 50.5 t80 -71.1 -55.28 8.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.368 -1.078 . . . . 0.0 109.592 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.529 ' CG ' ' SD ' ' A' ' 119' ' ' MET . 76.7 mt-10 -62.09 -34.05 75.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.137 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 21.7 mt -70.24 -48.6 56.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.86 95.87 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 16.8 tpt85 -62.27 -40.42 96.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.544 -0.974 . . . . 0.0 109.244 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.48 76.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 108.937 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.41 -39.64 22.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -77.53 -51.38 10.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.924 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.49 -6.11 9.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.949 -1.094 . . . . 0.0 108.834 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 299' ' ' ALA . . . 53.44 26.0 28.97 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' B' ' 274' ' ' GLN . 43.7 mttp -84.29 147.32 49.96 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.849 -1.383 . . . . 0.0 107.667 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 302' ' ' LYS . 83.6 Cg_exo -38.26 116.15 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.805 1.67 . . . . 0.0 110.856 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.6 mt -115.76 98.54 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 0.0 111.467 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 58.0 tp -94.45 120.85 35.31 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 131.6 54.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.77 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.483 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 3.3 mt -123.48 130.62 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 111.429 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -131.36 151.4 51.56 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -114.7 135.88 22.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.026 -1.046 . . . . 0.0 110.185 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.06 -29.37 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 111.381 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' B' ' 312' ' ' SER . 12.1 pt20 -60.32 -45.92 91.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.526 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 16.6 t -76.44 -21.84 55.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.559 ' O ' ' NE ' ' B' ' 314' ' ' ARG . . . 55.82 110.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' B' ' 315' ' ' VAL . 0.0 OUTLIER -144.57 -7.72 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.434 -1.039 . . . . 0.0 110.244 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.568 ' C ' ' O ' ' B' ' 314' ' ' ARG . 86.5 t 33.09 90.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.856 ' H ' ' CD2' ' B' ' 316' ' ' LEU . 0.2 OUTLIER -60.89 172.23 1.02 Allowed 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.77 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.443 ' H ' HD13 ' A' ' 88' ' ' LEU . 28.8 t -65.02 141.28 58.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.039 -1.038 . . . . 0.0 111.736 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.38 -32.99 63.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.493 ' SD ' ' CG ' ' A' ' 93' ' ' GLU . 1.8 mtp -64.21 -43.67 94.28 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.597 -0.689 . . . . 0.0 109.319 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 4.3 mm -61.49 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.328 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . 0.404 HH21 HD21 ' B' ' 316' ' ' LEU . 41.1 mtt180 -64.82 -44.36 90.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.19 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -58.51 -32.06 68.04 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -52.08 -57.43 9.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -1.178 . . . . 0.0 108.326 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.583 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 10.36 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' B' ' 323' ' ' ALA . 2.0 m-20 -69.12 -35.07 76.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.793 -1.192 . . . . 0.0 107.855 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.856 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.32 174.02 40.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 7.1 t 60.58 -30.92 0.06 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.637 1.208 . . . . 0.0 108.718 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.856 ' H ' ' C ' ' B' ' 326' ' ' GLY . 8.5 mtm180 -147.22 1.04 0.73 Allowed 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.518 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' GLY . 12.1 t80 -157.0 112.83 2.91 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.478 ' OE1' ' NE1' ' B' ' 332' ' ' TRP . 91.0 mt-30 -139.23 142.42 37.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.423 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.12 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.478 ' NE1' ' OE1' ' B' ' 330' ' ' GLN . 18.3 m0 -94.4 147.24 23.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.28 151.09 21.88 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 7.9 p90 -171.36 177.65 3.48 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.659 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -142.13 147.13 36.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 335' ' ' ALA . 41.3 mt-10 -39.27 -25.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.575 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -86.19 -2.36 85.73 Favored Glycine 0 N--CA 1.495 2.599 0 O-C-N 120.999 -1.063 . . . . 0.0 111.208 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -136.27 0.46 2.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.843 -1.386 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 0.9 OUTLIER -55.59 -47.19 79.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.821 -1.174 . . . . 0.0 108.413 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 30.1 mt-10 -52.67 -33.53 47.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.3 m -69.21 -41.01 77.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 12.7 mmt -53.16 -51.64 61.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 47.4 mt -62.07 -32.61 73.17 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.81 -43.84 87.44 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.326 -0.859 . . . . 0.0 110.587 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -71.81 -48.0 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.527 -1.358 . . . . 0.0 109.216 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.15 -49.02 79.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 110.454 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 20.9 m-85 -71.46 -29.0 64.35 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.219 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' B' ' 350' ' ' TYR . 65.0 mt-10 -65.98 -31.13 71.86 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.09 9.17 10.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.6 t80 -134.47 -104.21 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.201 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.468 ' H ' ' HB3' ' B' ' 350' ' ' TYR . 21.6 mt -32.91 91.08 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.891 -0.506 . . . . 0.0 110.955 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' TYR . 72.2 Cg_endo . . . . . 0 C--N 1.312 -1.348 0 C-N-CA 123.239 2.626 . . . . 0.0 111.301 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.4 Cg_exo -56.3 -158.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.967 1.778 . . . . 0.0 110.987 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.427 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 31.1 p -111.72 174.55 5.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.609 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 m -113.45 157.02 22.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.15 134.03 47.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 9.5 t80 -111.84 95.5 5.52 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -83.05 118.29 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.78 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -125.21 -130.0 3.43 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t 156.57 111.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.405 -1.056 . . . . 0.0 109.42 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 108.883 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLN . 2.0 tpp85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -52.03 -37.06 52.24 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 25' ' ' GLN . 35.4 p-10 -68.24 -31.55 71.12 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.699 HE21 ' N ' ' A' ' 50' ' ' GLU . 31.5 tt0 -60.9 -42.73 98.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.6 68.22 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.01 -27.85 65.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -70.93 -53.59 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.43 72.08 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.425 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.434 ' O ' ' OG ' ' A' ' 33' ' ' SER . 31.5 ttm180 -69.66 -58.49 3.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.07 . . . . 0.0 108.673 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.4 mt -51.59 -42.78 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 47.2 t -62.45 -30.03 48.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.618 ' HG ' ' N ' ' A' ' 34' ' ' ARG . 26.5 p -69.17 -40.69 77.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.174 -0.954 . . . . 0.0 109.71 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.618 ' N ' ' HG ' ' A' ' 33' ' ' SER . 95.2 mtt180 -70.29 -49.17 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 108.895 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.05 -39.71 82.88 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -63.1 -24.5 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -76.23 -37.84 57.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.958 -1.089 . . . . 0.0 109.247 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.4 m-85 -68.45 -47.91 65.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.515 -0.74 . . . . 0.0 110.674 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -151.82 -150.31 5.32 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.32 115.48 26.83 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.115 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 2.7 t -78.29 103.06 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 2.0 mt -47.14 126.33 9.03 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.001 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' LEU . 43.1 m -38.57 138.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.815 0.817 . . . . 0.0 111.131 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' VAL . 26.5 mt-10 -149.46 101.93 3.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 49' ' ' ALA . 18.6 t-80 -43.19 -19.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.738 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 44' ' ' GLU . 87.5 t -46.03 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.05 -39.54 66.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.861 -1.15 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -75.72 21.07 0.16 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.678 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -86.69 -19.41 29.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 108.859 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.699 ' N ' HE21 ' A' ' 25' ' ' GLN . 57.1 mt-10 -62.11 7.33 0.06 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.693 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -88.86 134.87 33.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 51' ' ' LEU . 7.3 mm-40 54.9 159.61 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -38.56 153.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.562 2.175 . . . . 0.0 112.258 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.7 154.69 25.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.379 -0.826 . . . . 0.0 109.726 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 137.48 41.81 0.1 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 49.16 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -1.062 . . . . 0.0 109.256 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 55' ' ' GLY . 50.5 tp10 -48.53 -26.17 2.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.61 44.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.18 179.67 5.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.755 . . . . 0.0 109.474 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.18 62.75 0.51 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.87 79.14 0.87 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -49.31 -38.16 26.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.13 -1.217 . . . . 0.0 107.803 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 9.5 mp0 -59.86 -41.16 90.87 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -54.4 -38.86 66.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.642 -1.286 . . . . 0.0 108.835 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -46.57 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.74 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -71.91 -61.97 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 110.44 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.74 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 79.1 mm-40 -43.71 -52.17 6.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.09 -41.95 99.5 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.024 -1.048 . . . . 0.0 109.628 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.458 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 77.9 m-20 -66.52 -40.92 89.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 111.605 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -68.01 -51.85 42.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -178.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -60.14 -46.55 89.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.632 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -64.79 -45.78 84.82 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.027 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 59.0 tp -52.44 -34.17 47.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.975 -1.078 . . . . 0.0 108.45 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -78.04 -32.01 50.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.508 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.632 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 29.3 mt-30 -87.66 -0.68 57.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.875 -1.141 . . . . 0.0 109.23 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.83 125.71 24.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 112.122 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' HB2' ' H ' ' A' ' 11' ' ' SER . 82.7 m-20 -76.09 -35.44 59.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.91 155.29 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.18 139.33 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.812 -1.18 . . . . 0.0 111.931 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.62 158.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.53 148.85 27.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.495 -1.378 . . . . 0.0 110.309 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -113.08 124.29 52.25 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -122.6 26.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 110.136 -179.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 83' ' ' VAL . 62.8 m -43.49 -69.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.992 -1.067 . . . . 0.0 109.043 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.52 149.05 38.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 108.689 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.72 91.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.168 1.912 . . . . 0.0 111.313 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.45 ' OG ' ' CB ' ' A' ' 17' ' ' SER . 32.8 t -99.36 135.4 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 110.632 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -40.24 50.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 109.07 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.92 93.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.33 -39.29 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.29 . . . . 0.0 109.914 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -47.86 87.77 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -67.81 -44.73 76.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.642 -0.916 . . . . 0.0 109.603 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.94 -30.59 71.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.253 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -73.04 -39.5 65.9 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 108.668 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.24 99.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.26 -42.14 99.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.417 -1.049 . . . . 0.0 109.156 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -68.1 -38.53 82.39 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.161 -0.962 . . . . 0.0 108.814 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -55.76 -42.73 71.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.773 -1.205 . . . . 0.0 108.518 179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.489 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -75.02 -50.12 17.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 112.509 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.2 pp -118.34 -24.97 6.69 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.122 -0.986 . . . . 0.0 110.566 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -47.33 166.17 0.12 Allowed Glycine 0 C--N 1.29 -1.972 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 1.5 mptm? -117.68 -85.86 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 51.5 Cg_endo -85.22 102.3 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 121.387 1.531 . . . . 0.0 109.431 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 mt -102.05 98.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.805 -1.184 . . . . 0.0 111.187 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 tp -94.27 118.9 32.27 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.7 OUTLIER -106.73 154.06 21.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.022 -1.049 . . . . 0.0 108.895 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.504 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 17.4 mt -125.3 137.46 54.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 110.263 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -137.41 117.84 13.77 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 0.1 OUTLIER -75.02 123.34 88.86 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 0.0 110.562 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.7 -31.41 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.326 2.017 . . . . 0.0 110.663 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 13.7 pt20 -49.75 -35.06 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.479 ' HG ' ' NH2' ' A' ' 109' ' ' ARG . 53.1 m -97.82 -14.65 20.64 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.39 51.57 4.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 115' ' ' VAL . 42.2 mtp85 -83.58 13.3 4.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.049 -1.265 . . . . 0.0 110.279 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' ARG . 54.1 t 54.31 107.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 0.0 110.138 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' SER . 19.4 tp -46.34 -71.96 0.06 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 164.47 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.21 82.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.981 -1.074 . . . . 0.0 109.789 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' A' ' 119' ' ' MET . 17.9 mmm -66.38 -50.58 63.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.461 HD13 HG22 ' A' ' 120' ' ' ILE . 35.5 mm -63.68 -41.16 91.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 108.93 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 117' ' ' SER . 18.5 mmt85 -62.42 -44.02 97.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 109.604 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -64.68 -36.12 92.75 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.221 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.75 -23.06 10.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.061 -1.258 . . . . 0.0 107.98 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -32.48 101.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.234 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 93.1 m-20 -101.33 -30.01 11.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 108.709 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.66 -0.12 57.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.4 p -112.49 -69.39 0.87 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.58 -0.953 . . . . 0.0 108.582 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.16 -39.55 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 32.1 t80 -98.37 129.18 45.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.523 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 42.1 tt0 -154.06 163.79 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.05 -1.031 . . . . 0.0 110.435 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.72 112.33 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.523 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 20.6 m0 -105.02 145.0 31.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 108.944 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 43.4 p30 -89.78 154.23 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.802 -1.186 . . . . 0.0 109.16 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.4 p90 -163.85 -174.49 3.66 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.898 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -152.86 148.11 26.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 135' ' ' ALA . 47.7 mt-10 -36.71 -37.8 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.928 -1.107 . . . . 0.0 110.259 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.46 19.04 38.36 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.446 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.644 ' N ' ' O ' ' A' ' 135' ' ' ALA . 94.5 mt-10 -142.69 -10.39 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.067 -1.255 . . . . 0.0 110.397 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.522 ' CG1' ' NH1' ' A' ' 34' ' ' ARG . 8.0 p -50.89 -45.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.921 -1.112 . . . . 0.0 108.655 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.48 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.2 pt-20 -60.38 -36.41 77.98 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.282 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -65.68 -46.26 79.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.486 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -47.85 64.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 38.7 mt -68.51 -31.99 71.65 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.479 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 76.9 m-20 -66.17 -42.74 88.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.536 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -69.86 -50.75 39.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.67 -1.269 . . . . 0.0 108.264 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.681 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 38' ' ' TYR . 13.2 m-85 -71.74 -33.16 68.45 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.764 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.56 28.45 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.01 -78.0 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.836 -1.146 . . . . 0.0 113.065 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 8.3 mt -61.42 -40.2 69.45 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.139 -0.975 . . . . 0.0 112.402 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 47.6 Cg_exo . . . . . 0 C--N 1.302 -1.899 0 C-N-CA 121.91 1.74 . . . . 0.0 111.733 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.48 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.072 1.848 . . . . 0.0 110.947 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.424 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.2 p -111.7 174.5 5.84 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 11.2 m -113.63 156.73 23.17 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.84 133.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.474 ' OH ' ' CB ' ' B' ' 269' ' ' ASP . 9.7 t80 -111.6 95.57 5.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' B' ' 214' ' ' PHE . 0.0 OUTLIER -83.23 118.28 23.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -87.32 123.48 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 109.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' B' ' 217' ' ' SER . . . -126.37 -130.22 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' B' ' 216' ' ' GLY . 1.4 t 156.98 111.86 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -1.045 . . . . 0.0 109.369 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.603 ' H ' ' CD1' ' B' ' 218' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.721 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.44 -36.63 55.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 225' ' ' GLN . 35.3 p-10 -68.52 -31.52 70.81 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.722 HE21 ' N ' ' B' ' 250' ' ' GLU . 30.8 tt0 -60.93 -42.62 98.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.05 -48.45 68.27 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.95 -28.11 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 17.3 m-30 -70.49 -53.6 15.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.53 -35.28 72.04 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.607 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.439 ' O ' ' OG ' ' B' ' 233' ' ' SER . 31.5 ttm180 -69.68 -58.69 3.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.923 -1.11 . . . . 0.0 108.548 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.54 -42.92 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.543 ' CG2' ' CE2' ' B' ' 214' ' ' PHE . 46.7 t -62.37 -29.82 47.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' B' ' 234' ' ' ARG . 26.3 p -69.34 -40.77 77.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' B' ' 233' ' ' SER . 95.4 mtt180 -70.15 -49.47 50.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.798 -1.189 . . . . 0.0 108.903 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.69 -39.99 82.3 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -63.02 -24.69 68.03 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -75.96 -38.06 57.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.931 -1.106 . . . . 0.0 109.329 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.4 m-85 -68.29 -48.03 66.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.559 -0.713 . . . . 0.0 110.766 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -151.56 -150.4 5.33 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -89.31 115.44 26.79 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.19 -1.183 . . . . 0.0 109.058 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' B' ' 242' ' ' LEU . 2.7 t -78.18 103.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.447 ' HB3' ' CD1' ' B' ' 272' ' ' TRP . 2.2 mt -47.55 126.8 10.44 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.929 -1.109 . . . . 0.0 108.97 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 242' ' ' LEU . 42.1 m -39.16 137.99 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 111.133 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 246' ' ' VAL . 26.8 mt-10 -148.81 101.84 3.23 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 249' ' ' ALA . 18.3 t-80 -43.1 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 109.864 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 244' ' ' GLU . 82.6 t -46.11 -84.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -54.16 -40.01 67.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.823 -1.173 . . . . 0.0 108.927 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -75.38 20.91 0.14 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.716 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -86.22 -19.88 29.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.818 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.722 ' N ' HE21 ' B' ' 225' ' ' GLN . 59.1 mt-10 -61.77 7.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.716 ' H ' ' C ' ' B' ' 249' ' ' ALA . 0.6 OUTLIER -88.87 134.48 33.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' B' ' 251' ' ' LEU . 7.0 mm-40 54.75 159.19 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.204 -0.935 . . . . 0.0 109.409 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -37.93 152.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.67 2.247 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.68 154.1 26.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.652 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 138.28 41.34 0.1 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 49.83 -82.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -1.045 . . . . 0.0 109.104 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' B' ' 255' ' ' GLY . 50.8 tp10 -48.87 -26.72 2.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 108.504 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.13 45.02 0.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -129.18 -179.32 5.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.461 -0.774 . . . . 0.0 109.298 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.56 63.14 0.54 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 113.61 78.75 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -49.22 -37.94 24.69 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' B' ' 263' ' ' GLN . 10.2 mp0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -54.48 -38.67 66.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.718 -1.239 . . . . 0.0 108.876 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -46.84 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.752 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 0.9 OUTLIER -71.97 -62.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.752 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 79.4 mm-40 -43.17 -52.39 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -62.97 -41.71 99.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.474 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 80.9 m-20 -66.67 -40.92 88.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 111.522 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.583 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 0.2 OUTLIER -68.13 -51.68 43.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.021 -1.05 . . . . 0.0 110.2 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -60.4 -46.4 90.11 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.133 -0.979 . . . . 0.0 109.576 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.633 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.1 OUTLIER -64.85 -46.25 82.68 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.466 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 59.8 tp -52.06 -34.03 41.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.42 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.34 -32.16 48.96 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.633 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 29.2 mt-30 -87.25 -0.81 57.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.891 -1.131 . . . . 0.0 109.286 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.79 125.73 24.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.24 -0.913 . . . . 0.0 112.159 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.612 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.9 m-20 -76.04 -35.75 59.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.65 155.08 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.96 139.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 111.832 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 24.4 t -137.93 158.25 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.599 -1.313 . . . . 0.0 110.322 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -113.84 123.58 50.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' B' ' 284' ' ' THR . 0.0 OUTLIER -122.1 26.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.041 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.442 ' C ' ' O ' ' B' ' 283' ' ' VAL . 66.5 m -43.21 -69.7 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.01 -1.056 . . . . 0.0 109.019 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -91.51 149.22 39.05 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 108.756 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.38 91.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.027 1.818 . . . . 0.0 111.262 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' B' ' 217' ' ' SER . 34.3 t -99.92 135.31 41.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.25 -39.67 53.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.533 -0.73 . . . . 0.0 109.206 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.3 -40.3 91.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.11 -39.41 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.053 -1.263 . . . . 0.0 109.961 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.76 -47.53 89.7 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -68.02 -45.24 74.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 0.0 109.649 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.4 -30.88 70.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.56 -39.76 67.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 108.732 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -63.58 -41.78 99.03 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.463 -1.022 . . . . 0.0 109.175 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -68.23 -38.67 82.11 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.143 -0.973 . . . . 0.0 108.792 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.42 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -55.87 -42.42 70.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.732 -1.23 . . . . 0.0 108.481 179.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.489 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.25 -50.0 17.53 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.2 pp -118.67 -24.93 6.54 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 0.0 110.422 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -47.16 166.45 0.1 Allowed Glycine 0 C--N 1.289 -2.079 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 1.5 mptm? -117.96 -85.87 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 49.6 Cg_endo -85.23 102.32 0.76 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 121.42 1.543 . . . . 0.0 109.378 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.15 98.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.237 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 35.4 tp -93.98 118.4 31.44 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' B' ' 330' ' ' GLN . 0.8 OUTLIER -106.42 153.79 21.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.009 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.515 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 17.0 mt -124.92 138.02 54.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.26 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -137.85 117.85 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.578 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 0.1 OUTLIER -74.92 123.39 88.93 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.494 -0.754 . . . . 0.0 110.536 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.82 -31.7 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.381 2.054 . . . . 0.0 110.763 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.578 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 13.3 pt20 -49.65 -34.88 19.54 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.444 ' OG ' ' NH2' ' B' ' 309' ' ' ARG . 49.8 m -97.86 -14.66 20.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 41.35 51.55 4.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' B' ' 315' ' ' VAL . 42.2 mtp85 -83.49 13.32 4.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.988 -1.301 . . . . 0.0 110.221 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.4 t 54.51 106.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 110.054 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' B' ' 317' ' ' SER . 19.0 tp -46.36 -72.12 0.06 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.64 -0.662 . . . . 0.0 109.305 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 1.0 OUTLIER 164.75 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.08 -43.85 81.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 109.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' B' ' 319' ' ' MET . 17.7 mmm -66.07 -50.79 62.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.278 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.456 HD13 HG22 ' B' ' 320' ' ' ILE . 34.9 mm -63.4 -41.26 92.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 108.905 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' B' ' 317' ' ' SER . 18.8 mmt85 -62.46 -43.62 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.947 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -64.64 -36.67 93.42 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.34 -23.38 9.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.061 -1.258 . . . . 0.0 108.066 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -32.33 101.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.248 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 92.3 m-20 -101.84 -30.04 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 108.705 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.62 0.09 57.69 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 12.9 p -112.99 -69.95 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.981 . . . . 0.0 108.462 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -107.24 -39.77 5.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 31.2 t80 -98.57 128.92 45.07 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.543 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 43.2 tt0 -153.49 164.29 38.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.11 112.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.543 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 20.5 m0 -105.15 144.97 31.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.903 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 42.0 p30 -90.03 154.35 19.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 0.0 109.202 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 5.6 p90 -163.73 -174.28 3.61 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.64 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -152.95 148.05 26.66 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.8 mt-10 -36.79 -37.49 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.11 . . . . 0.0 110.198 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -88.68 19.56 36.4 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.473 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 335' ' ' ALA . 94.3 mt-10 -143.25 -10.71 0.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.073 -1.251 . . . . 0.0 110.491 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' NH1' ' B' ' 234' ' ' ARG . 7.1 p -50.95 -45.19 28.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.003 -1.061 . . . . 0.0 108.548 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.478 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 22.7 pt-20 -60.3 -36.62 78.32 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.226 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.5 m -65.57 -46.25 80.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.173 -0.954 . . . . 0.0 109.498 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.21 -47.69 65.49 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 37.4 mt -68.52 -32.29 72.14 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.86 -42.74 90.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.005 -1.059 . . . . 0.0 110.457 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -70.01 -50.94 36.53 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.684 -1.26 . . . . 0.0 108.27 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.42 -47.03 79.88 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.462 -0.774 . . . . 0.0 109.755 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' B' ' 238' ' ' TYR . 13.7 m-85 -71.59 -33.01 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.844 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.75 -26.19 65.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -101.4 27.84 5.94 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.8 -78.16 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.78 -1.168 . . . . 0.0 113.101 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 8.3 mt -60.81 -40.76 77.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 112.334 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 48.5 Cg_exo . . . . . 0 C--N 1.302 -1.881 0 C-N-CA 122.014 1.809 . . . . 0.0 111.726 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 10' ' ' CYS . 50.1 Cg_endo -71.01 155.54 61.62 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.357 2.038 . . . . 0.0 111.228 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' PRO . 22.6 p -52.61 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.037 -1.04 . . . . 0.0 109.16 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 77' ' ' ASP . 5.0 p -109.19 149.3 29.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 13.0 t -139.86 131.52 33.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.495 ' OH ' ' OD2' ' A' ' 69' ' ' ASP . 14.2 t80 -100.65 124.91 46.89 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -96.21 122.73 39.38 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.539 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.6 t -133.87 154.97 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 -159.53 21.71 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -96.66 139.09 33.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -1.187 . . . . 0.0 108.724 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.104 . . . . 0.0 110.822 -179.258 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' NH2' ' NE2' ' A' ' 85' ' ' GLN . 50.1 mtp85 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 122.001 0.905 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.71 -24.29 14.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 80.0 m-20 -69.84 -32.25 70.55 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.611 ' NE2' ' O ' ' A' ' 49' ' ' ALA . 5.9 mt-30 -64.78 -40.2 94.87 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.07 -52.47 34.9 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.31 -29.83 64.25 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 9.9 m-30 -69.18 -44.46 72.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 110.295 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.11 83.34 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.488 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.587 ' NE ' HH22 ' A' ' 34' ' ' ARG . 60.0 ttt180 -71.26 -56.69 5.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.928 -1.108 . . . . 0.0 108.146 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.525 ' HA ' HH11 ' A' ' 34' ' ' ARG . 12.1 mt -52.85 -45.33 50.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 42.1 t -60.66 -27.58 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 15.5 p -68.87 -36.68 78.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.389 -0.819 . . . . 0.0 109.367 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.587 HH22 ' NE ' ' A' ' 30' ' ' ARG . 77.4 mtt85 -68.6 -47.96 65.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.597 -1.314 . . . . 0.0 107.849 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.1 mt -62.3 -28.91 70.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.608 ' NH2' ' H ' ' A' ' 41' ' ' VAL . 2.0 tpm_? -64.98 -29.14 70.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -70.8 -62.08 1.53 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -123.74 157.01 34.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.576 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 81.59 69.86 1.37 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.8 mtmt -36.37 131.81 0.62 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.333 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.608 ' H ' ' NH2' ' A' ' 36' ' ' ARG . 23.2 t -96.05 107.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.828 -1.17 . . . . 0.0 108.854 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 24.6 mt -78.79 152.94 31.11 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.204 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 45' ' ' HIS . 19.7 m 51.36 53.22 13.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -54.4 -7.22 0.14 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 43' ' ' THR . 8.5 t-80 -45.34 -31.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.6 -53.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.093 -1.004 . . . . 0.0 109.881 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -65.92 -43.47 88.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 108.714 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.64 37.01 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.611 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -108.97 9.48 26.49 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.25 3.3 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.588 -0.695 . . . . 0.0 109.719 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.67 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.0 163.16 15.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.242 -0.911 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.5 mt-10 54.46 156.69 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.499 -0.751 . . . . 0.0 109.238 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.67 122.42 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.068 1.846 . . . . 0.0 111.878 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -90.77 -164.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 90.64 130.82 4.63 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 28.3 mm-40 -49.43 -30.9 8.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.997 -1.296 . . . . 0.0 109.132 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.12 -0.68 8.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.054 -1.029 . . . . 0.0 108.993 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -65.16 149.12 50.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.494 -0.753 . . . . 0.0 109.114 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.31 0.37 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.7 -31.26 7.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.2 76.43 1.03 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 56' ' ' GLU . 91.8 m-20 -52.18 -38.14 56.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -67.22 -52.01 46.31 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -58.64 -32.64 69.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.64 -52.26 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.502 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 2.6 t-80 -66.23 -53.67 34.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.589 -0.695 . . . . 0.0 109.985 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 9.4 tt0 -47.68 -57.34 5.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.991 -1.068 . . . . 0.0 109.667 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.91 -37.5 81.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' OD2' ' OH ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -68.19 -56.69 7.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 110.763 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 tp -58.84 -40.61 84.73 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.47 -0.769 . . . . 0.0 110.313 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 90.8 m-20 -65.33 -58.84 4.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.007 -1.058 . . . . 0.0 109.253 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -57.2 -40.78 78.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -50.72 -41.05 55.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -72.54 -26.18 61.65 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.807 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 19.3 mt-30 -90.76 1.26 57.04 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.965 -1.084 . . . . 0.0 108.826 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.03 122.72 23.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.381 -0.825 . . . . 0.0 111.748 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.417 ' N ' ' OG ' ' A' ' 11' ' ' SER . 89.7 m-20 -69.95 -35.74 74.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 t -135.16 141.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.65 120.13 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.825 -1.172 . . . . 0.0 111.805 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -116.0 120.16 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.693 0.758 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.28 158.37 35.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.444 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 30.0 tt0 -97.07 128.27 43.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.64 28.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.756 . . . . 0.0 110.135 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -79.67 -77.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.446 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.585 ' NE2' ' NH2' ' A' ' 22' ' ' ARG . 6.3 mm100 -64.33 136.39 96.73 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' B' ' 286' ' ' PRO . 72.9 Cg_endo -77.43 88.09 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 111.716 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.77 139.58 53.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.16 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' TYR . 16.1 mt -59.45 -42.1 91.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.182 -0.949 . . . . 0.0 108.677 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.6 -30.9 56.99 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.7 t -75.44 -57.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.63 -0.924 . . . . 0.0 108.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.29 -36.31 89.34 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' LEU . 75.5 t80 -65.56 -52.54 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.088 . . . . 0.0 109.129 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' OE2' ' OD1' ' A' ' 69' ' ' ASP . 1.8 tp10 -58.75 -34.82 71.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.338 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.2 mt -74.63 -41.08 61.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.99 . . . . 0.0 108.742 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -34.52 89.47 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.628 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.79 -43.17 80.36 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.626 -0.926 . . . . 0.0 109.176 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.663 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -69.86 -42.0 74.09 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.521 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -37.92 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.85 -49.76 35.41 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.361 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -126.53 -34.71 2.43 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.145 -0.972 . . . . 0.0 109.885 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -73.82 102.61 1.34 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.615 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.72 -69.78 0.31 Allowed Pre-proline 0 C--N 1.288 -2.092 0 O-C-N 121.595 -0.944 . . . . 0.0 110.871 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 31.5 Cg_endo -65.64 109.01 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.573 1.515 . . . . 0.0 110.841 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.63 119.38 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 110.777 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.0 tp -105.26 119.45 39.1 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -107.46 139.48 41.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.012 . . . . 0.0 108.566 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 11.6 mt -126.82 124.19 39.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -124.0 154.5 39.76 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' OE2' ' A' ' 136' ' ' GLU . 50.2 mtm180 -109.82 141.23 23.29 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.835 -1.166 . . . . 0.0 110.95 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.43 -29.32 3.08 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.812 2.341 . . . . 0.0 111.384 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 112' ' ' SER . 19.3 pt20 -46.5 -40.46 12.55 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 2.7 m -98.41 -23.1 15.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 50.07 40.57 36.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 7.6 mmt180 -51.0 -8.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.862 -1.375 . . . . 0.0 109.364 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 113' ' ' GLY . 23.4 t 64.1 99.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.963 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 108' ' ' PHE . 4.1 mm? -37.97 128.25 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 t -51.3 147.75 5.45 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.104 -0.998 . . . . 0.0 109.094 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.68 78.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.982 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 0.1 OUTLIER -67.03 -42.31 85.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 109.359 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 120' ' ' ILE . 35.8 mm -66.58 -46.38 86.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.054 -1.029 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.417 ' CG ' HH11 ' A' ' 121' ' ' ARG . 0.3 OUTLIER -62.04 -47.77 83.24 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.56 -36.68 86.23 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 124' ' ' ALA . . . -50.42 -61.85 1.94 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 129' ' ' PHE . . . 155.34 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.306 1.05 . . . . 0.0 112.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.664 ' HA ' ' H ' ' A' ' 131' ' ' VAL . 55.7 p30 -126.27 26.69 6.39 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -178.08 149.88 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.762 ' C ' ' H ' ' A' ' 129' ' ' PHE . 4.2 t 96.88 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 117.935 0.868 . . . . 0.0 109.044 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 61.68 -19.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.762 ' H ' ' C ' ' A' ' 127' ' ' SER . 82.0 t80 -120.39 121.9 39.57 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -139.68 132.35 28.92 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.122 -1.431 . . . . 0.0 111.656 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.664 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 73.3 t -105.32 101.62 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 146' ' ' TYR . 22.8 m0 -98.37 155.66 17.12 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 110.771 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -107.51 147.74 30.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 6.6 p90 -164.14 -175.73 4.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.848 -1.158 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.703 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -155.27 158.09 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.538 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 15.3 mt-10 -58.1 23.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.438 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.703 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -119.16 -11.46 7.49 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.684 ' O ' ' SD ' ' A' ' 142' ' ' MET . 5.7 pt-20 -153.96 16.2 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.997 -1.296 . . . . 0.0 110.202 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.556 ' O ' ' HG2' ' A' ' 142' ' ' MET . 3.5 p -51.05 -41.97 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.189 -0.944 . . . . 0.0 109.117 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 81.2 tt0 -61.63 -27.89 68.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.003 -1.061 . . . . 0.0 109.125 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.3 m -73.96 -48.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 110.444 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.684 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -54.41 -48.62 71.4 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.8 mt -57.69 -38.66 75.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 45.2 t0 -63.08 -37.97 89.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -70.61 -53.38 16.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.62 -1.3 . . . . 0.0 108.773 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.427 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 67.3 t80 -58.16 -48.23 80.91 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 17.9 m-85 -70.48 -31.13 68.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.998 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 38.7 mt-10 -59.69 -29.89 68.4 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 17.62 10.19 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.48 -21.44 0.33 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.833 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 85.2 mt -120.34 39.84 0.37 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.527 -1.358 . . . . 0.0 111.776 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 92.4 Cg_endo . . . . . 0 C--N 1.309 -1.539 0 C-N-CA 122.223 1.949 . . . . 0.0 110.526 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' B' ' 210' ' ' CYS . 45.7 Cg_endo -70.56 155.9 62.35 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.389 2.059 . . . . 0.0 111.185 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' B' ' 209' ' ' PRO . 23.9 p -52.82 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.028 -1.045 . . . . 0.0 109.15 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' B' ' 277' ' ' ASP . 7.3 p -109.21 148.85 30.27 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 12.9 t -139.63 131.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' B' ' 269' ' ' ASP . 13.8 t80 -100.8 124.36 46.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.343 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -95.48 122.89 38.68 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.553 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 21.7 t -133.95 155.02 50.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.252 -0.905 . . . . 0.0 110.082 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -175.73 -159.83 22.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 25.1 p -96.32 138.9 33.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.222 -1.163 . . . . 0.0 108.888 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.928 -1.108 . . . . 0.0 110.797 -179.204 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.589 ' NH2' ' NE2' ' B' ' 285' ' ' GLN . 51.5 mtp85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.991 0.901 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.31 -24.95 13.11 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.5 m-20 -69.48 -32.06 70.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.591 ' NE2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-30 -65.02 -39.92 94.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.42 -52.42 32.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.13 -30.0 64.04 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 10.0 m-30 -69.09 -44.56 72.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.681 -0.637 . . . . 0.0 110.295 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.07 83.13 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.507 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.573 ' NE ' HH22 ' B' ' 234' ' ' ARG . 60.3 ttt180 -71.32 -56.81 5.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.082 . . . . 0.0 108.115 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.514 ' HA ' HH11 ' B' ' 234' ' ' ARG . 12.1 mt -52.77 -45.35 49.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 41.8 t -60.48 -27.72 40.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 230' ' ' ARG . 15.2 p -68.79 -36.84 78.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.431 -0.793 . . . . 0.0 109.405 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . 0.573 HH22 ' NE ' ' B' ' 230' ' ' ARG . 77.5 mtt85 -68.38 -47.91 66.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.287 . . . . 0.0 107.831 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.558 ' O ' ' O ' ' B' ' 238' ' ' TYR . 3.0 mt -62.33 -29.08 70.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.634 HH21 ' H ' ' B' ' 241' ' ' VAL . 2.1 tpm_? -64.89 -29.34 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -70.57 -61.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.8 OUTLIER -123.81 156.92 35.25 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 81.73 69.84 1.37 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' B' ' 239' ' ' GLY . 50.6 mtmt -36.58 131.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.347 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . 0.634 ' H ' HH21 ' B' ' 236' ' ' ARG . 24.1 t -96.23 107.71 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.859 -1.15 . . . . 0.0 108.835 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.445 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 24.4 mt -78.67 153.71 30.76 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.508 ' C ' ' H ' ' B' ' 245' ' ' HIS . 22.5 m 50.62 53.25 13.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.71 -7.08 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.078 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.508 ' H ' ' C ' ' B' ' 243' ' ' THR . 8.1 t-80 -45.59 -30.97 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.34 -52.91 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.74 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -66.14 -43.56 86.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 108.847 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.58 37.08 0.09 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.591 ' O ' ' NE2' ' B' ' 225' ' ' GLN . . . -109.16 9.84 26.01 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.411 ' H ' HD13 ' B' ' 251' ' ' LEU . 2.3 mt-10 -104.44 3.11 31.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.668 ' CD1' ' N ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -112.69 163.31 14.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.269 -0.894 . . . . 0.0 109.643 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 47.6 mt-10 54.57 156.78 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.467 -0.771 . . . . 0.0 109.339 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -40.91 121.96 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.034 1.822 . . . . 0.0 111.795 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 249' ' ' ALA . 1.0 OUTLIER -90.4 -164.19 1.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 90.38 130.49 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' B' ' 262' ' ' ASP . 28.4 mm-40 -49.34 -31.47 9.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.066 -1.256 . . . . 0.0 109.275 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.36 -1.15 7.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 0.0 108.782 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -64.38 148.85 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.166 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.52 4.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -47.23 -30.85 5.88 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.0 76.05 1.01 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' B' ' 256' ' ' GLU . 94.7 m-20 -52.01 -38.2 56.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -67.25 -51.85 48.09 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -58.91 -32.53 69.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.64 -51.86 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.507 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 2.5 t-80 -66.71 -53.61 31.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.507 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 9.8 tt0 -47.59 -57.37 5.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.647 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -67.77 -37.86 82.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.505 ' OD2' ' OH ' ' B' ' 213' ' ' TYR . 0.4 OUTLIER -68.0 -56.83 7.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.08 -1.012 . . . . 0.0 110.785 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.5 tp -58.76 -40.36 83.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 88.8 m-20 -65.43 -58.74 5.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.074 -1.016 . . . . 0.0 109.158 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.445 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.12 -41.17 78.53 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 13.0 tp -50.36 -41.31 51.42 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -72.43 -26.18 61.74 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 18.6 mt-30 -90.68 1.03 57.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.012 -1.055 . . . . 0.0 108.725 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.56 122.82 22.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.497 -0.752 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.436 ' N ' ' OG ' ' B' ' 211' ' ' SER . 89.2 m-20 -70.14 -35.76 74.28 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 51.1 t -135.37 141.4 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.61 120.25 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.69 -1.256 . . . . 0.0 111.61 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.79 120.12 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.594 -0.692 . . . . 0.0 109.514 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -126.12 159.2 33.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 109.881 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.448 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 30.5 tt0 -97.87 128.76 44.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.95 27.86 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.307 -0.87 . . . . 0.0 110.095 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 5.4 m -79.17 -76.99 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.589 ' NE2' ' NH2' ' B' ' 222' ' ' ARG . 6.5 mm100 -64.53 136.26 96.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.494 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' PRO . 73.1 Cg_endo -77.33 87.58 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.341 2.027 . . . . 0.0 111.839 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.4 139.84 52.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' B' ' 292' ' ' TYR . 15.0 mt -59.31 -41.82 89.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.115 -0.991 . . . . 0.0 108.777 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.19 -30.92 58.68 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 89.9 t -75.15 -57.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.545 -0.974 . . . . 0.0 108.8 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.12 90.62 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' B' ' 288' ' ' LEU . 74.9 t80 -66.15 -52.76 45.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -1.131 . . . . 0.0 109.222 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.476 ' OE1' ' SD ' ' A' ' 119' ' ' MET . 1.7 tp10 -58.37 -34.91 71.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 18.1 mt -74.44 -41.4 60.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 108.796 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.3 -34.44 89.25 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' B' ' 296' ' ' ARG . 0.4 OUTLIER -67.96 -42.68 80.54 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.625 -0.926 . . . . 0.0 109.186 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.659 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -70.24 -41.88 72.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.493 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -37.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -72.13 -49.88 32.42 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.603 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -126.21 -34.51 2.51 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -74.03 102.44 1.34 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.603 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -72.57 -69.86 0.31 Allowed Pre-proline 0 C--N 1.288 -2.087 0 O-C-N 121.651 -0.911 . . . . 0.0 110.841 -177.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 31.7 Cg_endo -65.64 109.07 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.508 1.472 . . . . 0.0 110.849 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 119.11 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.087 -1.008 . . . . 0.0 110.754 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 47.6 tp -105.22 119.4 38.98 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -107.5 140.8 39.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.007 . . . . 0.0 108.622 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 11.8 mt -127.91 124.34 37.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -124.13 154.58 39.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.542 ' NH1' ' OE2' ' B' ' 336' ' ' GLU . 52.1 mtm180 -109.78 140.82 22.59 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 111.006 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.29 -29.62 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.643 2.229 . . . . 0.0 111.428 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.446 ' CG ' ' N ' ' B' ' 312' ' ' SER . 19.4 pt20 -45.96 -40.66 10.62 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 2.6 m -98.12 -23.34 15.77 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 50.5 40.73 39.98 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.426 ' O ' ' HB ' ' B' ' 315' ' ' VAL . 7.7 mmt180 -51.36 -8.33 0.05 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.965 -1.315 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' B' ' 313' ' ' GLY . 22.6 t 64.11 99.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.537 -0.727 . . . . 0.0 110.039 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' B' ' 308' ' ' PHE . 4.1 mm? -38.33 128.46 1.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.1 t -51.51 148.18 5.44 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.059 -1.026 . . . . 0.0 109.215 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.74 78.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 109.88 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -67.21 -42.76 83.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.09 -46.11 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.899 -1.125 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' B' ' 321' ' ' ARG . 0.3 OUTLIER -62.42 -47.82 82.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -58.09 -36.64 82.69 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' B' ' 324' ' ' ALA . . . -50.68 -62.18 1.75 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CD2' ' B' ' 329' ' ' PHE . . . 155.72 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.284 1.04 . . . . 0.0 112.157 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.64 ' HA ' ' H ' ' B' ' 331' ' ' VAL . 56.5 p30 -126.33 27.04 6.29 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -178.3 150.06 9.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.77 ' C ' ' H ' ' B' ' 329' ' ' PHE . 4.1 t 96.51 71.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.632 -0.923 . . . . 0.0 109.089 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 61.71 -19.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.77 ' H ' ' C ' ' B' ' 327' ' ' SER . 81.2 t80 -120.02 121.33 38.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -139.3 132.69 30.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.051 -1.46 . . . . 0.0 111.577 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . 0.64 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 67.4 t -105.31 101.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 346' ' ' TYR . 23.3 m0 -98.61 155.8 17.12 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.198 -0.939 . . . . 0.0 110.728 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 50.6 p-10 -107.67 147.72 30.33 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' B' ' 309' ' ' ARG . 6.5 p90 -164.24 -175.57 4.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.903 -1.123 . . . . 0.0 111.07 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.699 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -155.18 158.37 38.82 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' B' ' 309' ' ' ARG . 17.0 mt-10 -58.42 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -118.99 -11.07 7.82 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.675 ' O ' ' SD ' ' B' ' 342' ' ' MET . 5.9 pt-20 -154.63 16.6 0.45 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.929 -1.336 . . . . 0.0 110.168 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' B' ' 342' ' ' MET . 3.6 p -51.32 -42.05 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 0.0 108.975 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 82.3 tt0 -61.44 -27.89 68.87 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.125 -0.984 . . . . 0.0 109.139 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.9 m -74.09 -48.4 29.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.395 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.675 ' SD ' ' O ' ' B' ' 338' ' ' GLU . 0.0 OUTLIER -54.64 -48.61 72.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.73 -38.39 75.21 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 45.3 t0 -63.38 -37.94 89.22 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.543 -0.723 . . . . 0.0 110.169 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -70.43 -53.28 17.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.669 -1.269 . . . . 0.0 108.784 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . 0.44 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 67.2 t80 -58.31 -47.95 82.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 18.6 m-85 -70.89 -31.11 67.66 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.999 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 38.2 mt-10 -59.48 -29.76 68.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -93.09 17.98 10.02 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -148.91 -21.39 0.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.686 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 85.5 mt -120.48 40.02 0.38 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 111.741 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 93.6 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.191 1.927 . . . . 0.0 110.408 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' ALA . 45.2 Cg_exo -53.0 -155.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.641 2.227 . . . . 0.0 111.699 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.9 p -108.05 178.07 4.62 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -120.87 131.67 54.53 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.842 -1.161 . . . . 0.0 108.814 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 4.6 t -102.95 126.18 57.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.543 ' CE2' ' OG1' ' A' ' 43' ' ' THR . 40.8 t80 -93.19 118.99 31.88 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 32' ' ' VAL . 24.0 t80 -85.58 123.98 31.62 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.434 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 2.7 t -117.34 113.65 22.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -162.07 75.98 0.18 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 16' ' ' GLY . 30.4 t -31.8 106.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.932 . . . . 0.0 110.48 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.596 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.721 ' NH2' ' H ' ' A' ' 55' ' ' GLY . 33.6 mmt180 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.185 0.517 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -55.15 -46.8 75.73 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 17.2 m-20 -62.74 -20.5 65.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.788 HE22 ' N ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -67.25 -47.06 71.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.18 85.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.18 -37.15 74.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 14.4 m-30 -67.33 -41.49 85.18 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.405 -0.809 . . . . 0.0 109.69 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -60.82 -36.54 79.34 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.419 -1.425 . . . . 0.0 108.463 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 140' ' ' GLU . 70.7 ttt-85 -72.56 -57.38 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.1 -40.74 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 52.3 t -64.62 -29.35 47.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 10.2 m -67.8 -37.15 81.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.39 -0.819 . . . . 0.0 109.646 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.41 -52.11 24.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.671 -1.268 . . . . 0.0 108.755 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.48 -40.21 78.08 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -61.36 -25.32 67.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.73 -31.05 32.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 0.0 109.745 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.556 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -75.18 -52.67 10.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.242 -0.911 . . . . 0.0 110.946 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.34 -147.05 4.46 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -89.81 129.04 36.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.4 -1.059 . . . . 0.0 109.006 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.77 106.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.886 -1.134 . . . . 0.0 107.974 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 20.5 mt -72.38 -176.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.543 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 1.7 m 55.82 39.67 30.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.783 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 52.3 mp0 -46.3 -25.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -49.06 -38.41 24.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.093 -1.004 . . . . 0.0 108.996 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' ASP . 59.2 t -61.27 170.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.788 ' N ' HE22 ' A' ' 25' ' ' GLN . . . 61.82 -71.96 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' VAL . 21.0 t70 -67.82 28.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.723 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -106.62 12.91 28.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' H ' HD13 ' A' ' 51' ' ' LEU . 28.7 mt-10 -108.47 11.4 26.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.336 -0.852 . . . . 0.0 109.744 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.81 ' CD2' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -86.08 -93.76 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.01 . . . . 0.0 110.232 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' LEU . 2.0 mp0 -42.67 158.73 0.21 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 0.0 110.268 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.0 -22.16 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.647 2.232 . . . . 0.0 112.24 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 1.6 mm? 59.69 -172.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 109.73 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' H ' ' NH2' ' A' ' 22' ' ' ARG . . . 99.04 25.67 9.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 62' ' ' ASP . 73.4 mm-40 53.52 -74.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.781 -0.834 . . . . 0.0 109.664 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.679 ' N ' ' O ' ' A' ' 55' ' ' GLY . 86.6 tt0 -44.5 -26.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.87 166.28 15.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.105 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.84 133.67 31.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.242 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.39 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.37 80.88 0.37 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 56' ' ' GLU . 3.0 m-20 -52.5 -44.13 65.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -1.144 . . . . 0.0 108.255 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -62.61 -49.26 75.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -60.48 -34.79 74.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 109.049 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.03 -53.95 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.46 ' ND1' ' C ' ' A' ' 66' ' ' HIS . 1.6 t-80 -65.6 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.623 -0.673 . . . . 0.0 109.666 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.1 -64.0 1.03 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -71.55 -38.95 70.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 110.138 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.447 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 10.1 m-20 -62.69 -59.25 5.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.093 -1.004 . . . . 0.0 110.351 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -36.86 80.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.845 -1.159 . . . . 0.0 109.785 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -66.57 -52.36 46.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.565 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.468 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -43.52 87.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.133 -0.979 . . . . 0.0 108.998 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CE2' ' A' ' 13' ' ' TYR . 4.1 tt -53.47 -43.65 68.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.474 ' CG ' HH21 ' A' ' 96' ' ' ARG . 28.2 mt-30 -65.78 -29.87 70.43 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.68 -0.638 . . . . 0.0 111.258 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -103.49 11.51 36.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.626 -1.296 . . . . 0.0 109.274 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.05 138.83 48.14 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.337 -0.852 . . . . 0.0 111.694 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -88.16 -25.74 22.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 69.7 t -144.99 136.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.9 t -133.14 125.17 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.864 -1.147 . . . . 0.0 111.91 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.19 124.69 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.24 146.54 45.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.072 0.939 . . . . 0.0 111.231 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.414 ' CD ' ' OH ' ' A' ' 28' ' ' TYR . 1.3 pp20? -100.23 147.23 25.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.06 -89.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 109.915 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 64.29 -141.12 0.28 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.063 -1.648 . . . . 0.0 109.748 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 84' ' ' THR . 2.0 pt20 -43.29 148.63 0.62 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.754 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -45.24 128.0 9.45 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.131 1.888 . . . . 0.0 111.615 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.614 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 15.7 t -102.41 -121.1 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.602 ' HB2' ' H ' ' B' ' 287' ' ' SER . 9.9 tp 160.02 -58.66 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.06 58.72 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.4 -45.25 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.48 -35.4 66.25 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.32 -56.09 9.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.46 -1.024 . . . . 0.0 109.675 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.521 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 87.0 mt-10 -57.25 -36.64 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.518 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.41 ' CD2' ' SG ' ' A' ' 106' ' ' CYS . 63.2 mt -60.35 -49.09 78.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.83 65.39 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 74' ' ' GLN . 17.1 mmm180 -71.94 -47.26 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -1.179 . . . . 0.0 110.102 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -70.35 -34.49 72.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.376 -1.453 . . . . 0.0 107.766 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.72 -40.93 78.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.425 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -78.49 -55.87 4.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.682 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 ' CB ' ' HZ2' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -82.44 0.88 40.17 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.242 -0.911 . . . . 0.0 108.606 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . 72.99 -156.93 52.1 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 18.6 mtmm 95.68 132.75 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.191 0 C-N-CA 123.887 0.875 . . . . 0.0 108.768 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.89 112.96 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.05 1.833 . . . . 0.0 111.196 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 102' ' ' LYS . 1.1 mt -112.32 104.46 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.224 -0.922 . . . . 0.0 110.961 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.6 tp -99.89 121.21 40.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.41 ' SG ' ' CD2' ' A' ' 94' ' ' LEU . 75.0 m -109.9 124.72 51.85 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 1.1 mt -121.76 131.19 53.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.508 ' HE2' ' O ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -125.63 153.37 43.87 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 60.7 mtm180 -105.82 145.75 31.51 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.732 -1.23 . . . . 0.0 111.805 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' GLY . 92.7 Cg_endo -83.49 -23.29 3.46 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 123.019 2.48 . . . . 0.0 111.6 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.456 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 18.7 pt20 -45.66 -42.44 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 m -90.38 -14.33 33.22 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . 46.74 45.65 18.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.508 ' O ' ' HE2' ' A' ' 108' ' ' PHE . 32.5 mtp85 -85.32 177.26 7.88 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.998 -1.295 . . . . 0.0 107.588 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 116' ' ' LEU . 87.5 t -114.05 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.8 -1.188 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 115' ' ' VAL . 9.9 tp -41.59 137.41 1.6 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.3 m -46.52 145.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.032 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.25 64.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.584 -0.697 . . . . 0.0 109.69 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.405 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 3.3 tpt -72.23 -52.39 16.65 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 120' ' ' ILE . 39.7 mm -62.26 -43.27 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 108.788 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -59.62 -47.57 85.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.478 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -56.89 -33.32 63.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -59.54 -47.17 86.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.232 . . . . 0.0 107.949 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -20.95 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 123' ' ' ALA . 65.9 m-20 -110.24 -16.54 13.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 108.794 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.84 40.53 97.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.644 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 86.1 p -144.64 63.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.1 mtt-85 95.38 -31.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -102.32 121.83 43.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -145.25 145.3 31.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.049 -1.032 . . . . 0.0 110.426 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.29 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 132' ' ' TRP . 16.0 m0 -97.66 147.76 24.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.522 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 37.8 p-10 -99.44 144.89 28.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.9 p90 -167.18 178.62 5.53 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.379 -1.328 . . . . 0.0 111.505 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -150.93 155.94 40.16 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 38.6 mt-10 -58.03 27.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.416 -0.802 . . . . 0.0 110.396 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -126.44 -12.63 3.36 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.596 ' O ' ' SD ' ' A' ' 142' ' ' MET . 3.3 pt-20 -145.4 10.04 1.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.145 -1.209 . . . . 0.0 109.554 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 3.7 p -48.98 -43.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 30' ' ' ARG . 93.9 mt-10 -56.1 -33.2 64.88 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 138' ' ' GLU . 15.6 m -65.62 -41.1 93.08 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 108.858 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -55.07 -50.95 67.85 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 84.7 mt -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 38.5 m-20 -70.37 -43.86 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.262 -0.899 . . . . 0.0 110.806 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.484 ' NH1' ' CG2' ' A' ' 141' ' ' THR . 52.7 mtt85 -70.49 -47.74 59.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.392 . . . . 0.0 108.951 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -60.1 -46.51 89.35 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.662 -0.649 . . . . 0.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.506 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 14.6 m-85 -80.1 -27.84 39.14 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.842 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 60.5 mt-10 -61.98 -29.27 70.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.19 64.43 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.785 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -174.65 101.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 111.098 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.538 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 1.0 OUTLIER 170.7 -47.63 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.587 -0.696 . . . . 0.0 109.232 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 69.7 Cg_exo . . . . . 0 C--N 1.309 -1.521 0 C-N-CA 122.338 2.025 . . . . 0.0 112.021 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' B' ' 208' ' ' ALA . 43.6 Cg_exo -53.0 -155.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 111.817 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.84 177.82 4.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 3.9 m -120.86 131.33 54.35 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.983 -1.073 . . . . 0.0 108.776 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 4.9 t -102.52 126.29 56.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' B' ' 243' ' ' THR . 41.0 t80 -93.22 119.05 31.97 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' B' ' 232' ' ' VAL . 24.3 t80 -85.53 123.47 30.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.532 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.511 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 2.8 t -116.84 113.42 22.47 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.678 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -161.79 75.91 0.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.522 ' C ' ' O ' ' B' ' 216' ' ' GLY . 28.4 t -31.66 106.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.646 -0.914 . . . . 0.0 110.588 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.607 ' H ' ' CD1' ' B' ' 218' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 108.778 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.735 ' NH2' ' H ' ' B' ' 255' ' ' GLY . 33.6 mmt180 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.238 0.542 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -55.25 -46.08 76.08 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 16.4 m-20 -63.33 -20.49 65.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.794 HE22 ' N ' ' B' ' 247' ' ' ALA . 0.7 OUTLIER -67.32 -46.73 72.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.23 86.43 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.1 -37.14 73.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.559 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 14.4 m-30 -67.5 -41.18 84.91 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.703 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.445 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -61.15 -36.37 79.6 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.43 -1.419 . . . . 0.0 108.52 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 340' ' ' GLU . 71.3 ttt-85 -72.76 -57.4 4.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 108.6 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.89 -40.87 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 51.3 t -64.71 -29.23 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 12.2 m -67.88 -37.01 81.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.38 -0.825 . . . . 0.0 109.493 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.35 -52.29 23.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.719 -1.238 . . . . 0.0 108.757 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.53 -39.94 77.71 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -61.49 -25.39 67.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.78 -31.33 31.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.141 -0.975 . . . . 0.0 109.777 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.558 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -75.01 -52.6 10.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.21 -0.931 . . . . 0.0 110.926 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -147.21 -147.58 4.57 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -89.42 129.08 35.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 108.961 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.54 106.78 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.477 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 20.4 mt -72.88 -176.78 2.14 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.865 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 1.9 m 56.25 39.2 30.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.001 -1.062 . . . . 0.0 108.786 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' B' ' 244' ' ' GLU . 52.6 mp0 -45.99 -25.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.731 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -48.95 -38.1 21.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' B' ' 248' ' ' ASP . 62.0 t -61.23 170.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.794 ' N ' HE22 ' B' ' 225' ' ' GLN . . . 61.74 -71.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' B' ' 246' ' ' VAL . 20.0 t70 -67.59 28.65 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.717 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -106.76 13.46 27.94 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.447 ' H ' HD13 ' B' ' 251' ' ' LEU . 29.0 mt-10 -108.64 10.52 26.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.775 ' CD2' ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -85.59 -94.06 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.106 -0.996 . . . . 0.0 110.256 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 254' ' ' LEU . 1.9 mp0 -42.43 158.68 0.21 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.28 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -41.09 -22.11 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.212 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' B' ' 249' ' ' ALA . 1.6 mm? 59.52 -172.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.829 . . . . 0.0 109.933 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.735 ' H ' ' NH2' ' B' ' 222' ' ' ARG . . . 98.51 25.23 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.441 ' OE1' ' OD1' ' B' ' 262' ' ' ASP . 73.5 mm-40 53.73 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.913 -0.757 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.673 ' N ' ' O ' ' B' ' 255' ' ' GLY . 86.8 tt0 -44.59 -25.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -69.6 165.11 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.113 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -50.39 134.02 23.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.351 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.82 -81.6 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 126.26 81.34 0.39 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.441 ' OD1' ' OE1' ' B' ' 256' ' ' GLU . 3.1 m-20 -52.87 -43.99 66.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.63 -49.33 75.61 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -60.52 -35.02 74.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.4 OUTLIER -62.51 -54.07 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.478 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -65.51 -33.78 76.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.577 -0.702 . . . . 0.0 109.64 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -55.79 -64.18 0.94 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 109.551 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -71.62 -38.71 70.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 110.217 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.444 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 10.4 m-20 -62.87 -59.22 5.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 110.296 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.12 -36.86 80.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.118 . . . . 0.0 109.734 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -66.35 -52.53 46.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -0.949 . . . . 0.0 109.638 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.477 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.91 -43.79 86.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.495 ' N ' ' CE2' ' B' ' 213' ' ' TYR . 3.9 tt -53.21 -43.82 67.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . 0.467 ' CG ' HH21 ' B' ' 296' ' ' ARG . 28.9 mt-30 -65.41 -30.15 70.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.683 -0.636 . . . . 0.0 111.136 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.54 11.72 35.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.124 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.87 48.04 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.845 . . . . 0.0 111.514 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -88.45 -25.72 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 69.9 t -144.82 136.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 91.4 t -133.09 125.27 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.89 -1.132 . . . . 0.0 111.914 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.3 124.65 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -120.39 146.04 46.58 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.1 0.953 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -99.8 147.07 25.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.96 -90.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.927 -1.108 . . . . 0.0 109.986 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.36 -140.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 119.902 -1.749 . . . . 0.0 109.776 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.408 ' HA ' ' NE ' ' B' ' 314' ' ' ARG . 2.0 pt20 -43.47 148.56 0.66 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.24 128.12 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.185 1.923 . . . . 0.0 111.622 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.602 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 15.4 t -102.43 -120.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' A' ' 87' ' ' SER . 9.7 tp 159.74 -58.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.51 58.8 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.89 -45.09 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -56.47 -35.5 66.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -68.35 -56.03 9.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.602 -0.94 . . . . 0.0 109.701 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.511 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 82.9 mt-10 -57.21 -36.62 71.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . 0.406 ' CD2' ' SG ' ' B' ' 306' ' ' CYS . 63.4 mt -60.44 -48.96 79.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.67 -23.67 65.42 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' B' ' 274' ' ' GLN . 17.2 mmm180 -71.92 -47.22 54.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -1.158 . . . . 0.0 110.096 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -70.43 -34.43 72.47 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.36 -1.462 . . . . 0.0 107.879 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.82 -40.64 76.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.425 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -78.75 -56.37 4.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.594 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.491 ' CB ' ' HZ2' ' B' ' 302' ' ' LYS . 0.8 OUTLIER -82.1 0.65 39.71 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.929 0.871 . . . . 0.0 108.675 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' B' ' 302' ' ' LYS . . . 72.82 -156.81 52.11 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' B' ' 301' ' ' GLY . 18.2 mtmm 95.5 132.6 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 302' ' ' LYS . 87.7 Cg_exo -38.49 113.42 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.941 1.761 . . . . 0.0 111.209 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.504 HG12 ' O ' ' B' ' 302' ' ' LYS . 1.1 mt -112.83 104.62 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.334 -0.854 . . . . 0.0 110.871 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.03 121.48 41.45 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' B' ' 294' ' ' LEU . 73.5 m -110.28 124.42 51.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 1.1 mt -121.31 131.17 54.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.988 -1.07 . . . . 0.0 112.321 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -125.63 153.36 43.9 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 60.9 mtm180 -105.92 145.38 30.79 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.713 -1.242 . . . . 0.0 111.663 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' B' ' 313' ' ' GLY . 94.4 Cg_endo -83.39 -22.83 3.72 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.965 2.443 . . . . 0.0 111.68 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.481 ' NE2' ' CZ ' ' B' ' 309' ' ' ARG . 18.3 pt20 -46.1 -42.45 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 39.7 m -89.96 -14.72 33.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 310' ' ' PRO . . . 46.8 45.62 18.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.501 ' O ' ' HE2' ' B' ' 308' ' ' PHE . 32.5 mtp85 -85.44 177.28 7.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.97 -1.312 . . . . 0.0 107.563 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 316' ' ' LEU . 83.5 t -114.25 107.96 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' B' ' 315' ' ' VAL . 9.7 tp -41.63 137.41 1.62 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 59.1 m -46.57 145.61 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 110.034 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.87 -22.77 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.45 -53.03 13.3 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 109.69 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.41 HG23 HD13 ' B' ' 320' ' ' ILE . 39.7 mm -61.64 -42.86 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.016 -1.052 . . . . 0.0 108.833 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -60.36 -47.56 85.55 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.953 -1.092 . . . . 0.0 108.34 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -56.85 -33.2 63.04 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -59.75 -47.58 85.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.111 -1.229 . . . . 0.0 107.982 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -20.42 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.962 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' B' ' 323' ' ' ALA . 65.5 m-20 -110.67 -16.41 13.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 108.814 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 64.76 39.85 96.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.7 p -143.89 62.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' B' ' 327' ' ' SER . 93.6 mtt-85 95.72 -31.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -102.4 121.53 42.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -145.08 145.0 31.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.452 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.23 101.46 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' B' ' 332' ' ' TRP . 16.1 m0 -97.84 147.75 24.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 0.0 110.473 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 38.7 p-10 -99.49 144.79 28.18 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.524 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.0 p90 -166.91 178.81 5.6 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.464 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -151.12 156.14 40.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -58.2 27.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.424 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -126.83 -12.13 3.37 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.586 ' O ' ' SD ' ' B' ' 342' ' ' MET . 3.4 pt-20 -145.93 10.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.133 -1.216 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 3.6 p -48.95 -43.42 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 230' ' ' ARG . 93.1 mt-10 -56.33 -33.26 65.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 341' ' ' THR . . . . . 0.488 ' N ' ' O ' ' B' ' 338' ' ' GLU . 14.0 m -65.41 -41.11 93.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.872 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.01 -51.3 66.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 82.4 mt -60.17 -30.77 69.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.849 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 39.1 m-20 -70.6 -43.62 68.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 110.666 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . 0.472 ' NH1' ' CG2' ' B' ' 341' ' ' THR . 53.0 mtt85 -70.8 -47.41 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.411 -1.431 . . . . 0.0 108.955 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -60.18 -46.75 88.64 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.69 -0.631 . . . . 0.0 110.506 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.496 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 14.9 m-85 -79.99 -27.87 39.55 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.84 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 61.5 mt-10 -61.95 -29.1 70.01 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.96 -18.76 64.12 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.787 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -174.94 102.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.53 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 1.0 OUTLIER 170.21 -48.03 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.536 -0.727 . . . . 0.0 109.328 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 75.0 Cg_exo . . . . . 0 C--N 1.309 -1.533 0 C-N-CA 122.395 2.064 . . . . 0.0 112.061 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' CYS . 55.3 Cg_endo -72.12 158.69 51.68 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.637 2.225 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' PRO . 32.1 p -52.49 -179.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.132 -0.98 . . . . 0.0 108.734 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HG ' ' H ' ' A' ' 77' ' ' ASP . 10.3 p -112.54 146.36 38.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.096 -1.003 . . . . 0.0 108.522 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 7.8 t -127.38 127.12 68.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CE2' ' OG1' ' A' ' 43' ' ' THR . 29.2 t80 -100.85 144.17 30.13 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -104.27 128.17 52.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 110.279 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 104.34 10.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.95 162.64 22.45 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 87' ' ' SER . 2.5 m -67.39 -55.32 14.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -1.067 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.981 179.56 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.591 0.71 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.07 -39.41 92.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 71.5 m-20 -58.54 -30.21 66.93 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -68.86 -49.06 61.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.03 81.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.3 -34.7 70.84 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.556 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 20.1 m-30 -68.54 -43.88 75.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.56 80.22 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.398 -1.439 . . . . 0.0 108.815 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.641 ' NE ' HH22 ' A' ' 34' ' ' ARG . 61.7 ttt180 -71.58 -59.0 2.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.915 -1.116 . . . . 0.0 108.533 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -51.55 -40.97 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.556 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 68.8 t -66.57 -27.78 41.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 17.4 p -65.53 -41.34 93.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.187 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.641 HH22 ' NE ' ' A' ' 30' ' ' ARG . 73.2 mtt85 -65.57 -41.72 92.59 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' TYR . 86.0 mt -59.59 -42.94 93.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -58.88 -24.49 62.31 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 88.5 mtt-85 -70.18 -62.43 1.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.2 p90 -129.15 154.1 47.06 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 87.45 72.27 1.29 Allowed Glycine 0 N--CA 1.477 1.421 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 39' ' ' GLY . 2.6 ttmt -35.76 126.65 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.052 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -84.18 90.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.552 -1.343 . . . . 0.0 107.964 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -52.42 -57.41 9.95 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.229 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -86.69 91.22 8.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.14 -24.15 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.264 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -65.47 -29.54 70.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.764 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.456 ' O ' ' OE1' ' A' ' 25' ' ' GLN . 25.2 t -52.75 -20.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.591 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.614 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -106.64 -65.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.513 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.854 ' O ' ' N ' ' A' ' 50' ' ' GLU . 56.5 m-20 -44.81 -24.22 0.19 Allowed 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 47' ' ' ALA . . . -23.01 -30.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.525 0.678 . . . . 0.0 110.318 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 48' ' ' ASP . 26.9 mt-10 -62.42 -19.55 63.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.94 -1.1 . . . . 0.0 109.352 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -57.85 135.39 56.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.89 -1.131 . . . . 0.0 108.545 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 56.42 152.63 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 109.336 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' A' ' 54' ' ' LEU . 39.5 Cg_endo -69.28 92.47 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.167 1.912 . . . . 0.0 110.836 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 53' ' ' PRO . 20.6 mt -53.77 -155.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.803 0.811 . . . . 0.0 110.696 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . 96.54 26.47 10.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 26.1 mt-10 63.18 -23.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.974 -0.721 . . . . 0.0 109.353 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.698 ' H ' ' C ' ' A' ' 55' ' ' GLY . 60.8 tt0 -75.02 -17.73 60.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 108.849 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 60' ' ' GLY . . . -58.88 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.191 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 58' ' ' ALA . . . -36.67 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.631 -0.668 . . . . 0.0 109.612 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 58' ' ' ALA . . . 91.31 -162.72 28.47 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.718 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 92.88 42.54 4.38 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' GLY . 66.5 m-20 -48.08 -45.41 32.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -59.64 -43.49 93.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -61.01 -48.06 83.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.625 -0.672 . . . . 0.0 109.847 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 tt -71.34 -33.88 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 1.008 ' HD1' ' CA ' ' B' ' 319' ' ' MET . 21.8 t60 -78.58 -31.22 47.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 46.1 mm-40 -68.79 -51.93 35.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 108.702 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.17 -39.7 89.96 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.393 -0.817 . . . . 0.0 109.217 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 74.6 m-20 -69.78 -53.22 19.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.37 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.42 -38.5 81.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.11 -0.994 . . . . 0.0 110.697 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 49.0 t-20 -64.36 -53.13 53.43 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.167 -0.958 . . . . 0.0 109.402 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.555 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -60.23 -41.64 93.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 108.659 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 4.3 tt -52.69 -37.33 58.76 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -74.91 -29.28 60.92 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.751 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.555 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 32.1 mt-30 -92.56 5.14 51.98 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.42 131.13 35.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.317 -0.865 . . . . 0.0 111.722 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' ' HG ' ' A' ' 11' ' ' SER . 81.1 m-20 -74.49 -31.3 62.16 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 61.5 t -139.36 140.11 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.0 128.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.905 -1.122 . . . . 0.0 111.942 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.82 123.87 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.75 47.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 109.326 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' OE2' ' CZ ' ' A' ' 134' ' ' TYR . 18.5 tp10 -84.44 114.4 21.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.481 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -119.82 148.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.512 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.57 ' HG1' ' C ' ' A' ' 83' ' ' VAL . 57.8 m -167.44 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -143.69 150.65 51.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 87' ' ' SER . 85.1 Cg_exo -35.6 131.69 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.755 2.303 . . . . 0.0 112.425 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 86' ' ' PRO . 15.6 m -166.87 116.22 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' TYR . 3.1 mt -68.15 -41.18 81.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.988 -1.07 . . . . 0.0 109.647 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.18 70.62 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.05 -49.49 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -1.017 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.96 -39.95 89.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.461 ' CD1' ' CD1' ' B' ' 320' ' ' ILE . 66.4 t80 -61.5 -44.56 96.85 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.234 -1.156 . . . . 0.0 109.434 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.86 -31.72 71.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.403 -0.811 . . . . 0.0 109.194 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.27 -43.56 81.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.75 97.66 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -41.02 90.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -1.062 . . . . 0.0 108.887 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.09 -39.94 75.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.75 -37.77 26.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.25 -50.26 16.69 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.129 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.95 -4.83 18.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.061 -1.025 . . . . 0.0 108.877 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.04 29.02 6.22 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 25.0 mtmm -95.72 152.12 38.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.976 -1.308 . . . . 0.0 107.786 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 90.8 Cg_exo -34.21 118.67 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.148 1.899 . . . . 0.0 111.775 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -119.63 104.88 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 0.0 110.98 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.69 115.64 29.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.618 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -107.69 139.58 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 83' ' ' VAL . 11.7 mt -123.84 144.73 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.105 -0.997 . . . . 0.0 112.046 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.644 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.88 140.24 29.66 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 27.8 mtt180 -97.39 140.54 22.08 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.592 -1.318 . . . . 0.0 111.518 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.6 Cg_endo -78.29 -34.14 1.67 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 122.652 2.235 . . . . 0.0 110.789 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.473 ' CG ' ' N ' ' A' ' 112' ' ' SER . 18.2 pt20 -47.83 -38.96 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 113' ' ' GLY . 8.1 p -90.95 -21.04 21.53 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 37.91 39.38 0.64 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' VAL . 45.7 mtt-85 -74.79 13.73 0.6 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.389 -1.065 . . . . 0.0 109.711 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 114' ' ' ARG . 56.0 t 49.43 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.313 -0.867 . . . . 0.0 110.066 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 117' ' ' SER . 36.1 tp -48.28 143.55 4.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -40.42 141.62 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 111.053 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.465 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -54.98 -55.03 35.38 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.44 0.638 . . . . 0.0 110.854 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 1.028 ' CA ' ' HD1' ' B' ' 266' ' ' HIS . 14.8 mtp -60.37 -39.78 88.45 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.18 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' B' ' 292' ' ' TYR . 45.2 mm -62.67 -41.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.712 -1.242 . . . . 0.0 109.59 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -72.86 -45.69 56.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 109.969 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.22 -18.98 65.73 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 -57.54 8.96 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.039 -1.271 . . . . 0.0 109.616 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.616 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -153.69 -89.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.687 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 22.9 t0 94.26 -0.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . 177.4 82.59 0.06 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.827 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 165.44 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.445 -1.033 . . . . 0.0 109.79 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.38 -25.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.827 ' H ' ' C ' ' A' ' 127' ' ' SER . 8.9 t80 -116.95 115.5 25.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.53 132.71 41.26 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.175 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.04 102.75 13.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.29 145.22 26.31 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.169 -0.957 . . . . 0.0 110.378 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' SD ' ' A' ' 142' ' ' MET . 63.7 m-20 -96.54 152.21 18.85 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CZ ' ' OE2' ' A' ' 82' ' ' GLU . 5.5 p90 -170.35 173.86 5.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.606 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -147.79 150.95 35.18 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.5 mt-10 -40.5 -27.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.826 -1.171 . . . . 0.0 110.316 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -85.79 -4.75 84.72 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 120.976 -1.077 . . . . 0.0 111.2 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -135.36 4.37 3.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.784 -1.421 . . . . 0.0 110.112 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.0 p -57.82 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.979 -1.076 . . . . 0.0 108.759 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.524 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.9 pt-20 -55.01 -33.65 62.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 m -66.13 -39.45 89.89 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.069 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 14.3 mmt -55.06 -53.19 59.04 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 30.6 mt -63.34 -31.59 72.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.549 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 28.7 t0 -69.05 -46.05 68.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 111.001 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -70.64 -50.36 37.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.404 -1.435 . . . . 0.0 109.818 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 29.4 t80 -57.12 -50.07 73.94 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 151' ' ' LEU . 27.0 m-85 -75.79 -30.83 59.23 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.586 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 5.5 mm-40 -55.12 -35.3 64.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.98 18.72 3.38 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 147' ' ' PHE . 2.0 t80 -147.27 -34.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 111.723 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.607 HD13 ' CD1' ' A' ' 147' ' ' PHE . 18.4 mt -117.87 40.99 0.34 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 61.3 Cg_endo . . . . . 0 C--N 1.311 -1.427 0 C-N-CA 121.922 1.748 . . . . 0.0 111.169 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 210' ' ' CYS . 55.3 Cg_endo -72.3 159.13 50.28 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.595 2.197 . . . . 0.0 111.786 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' B' ' 209' ' ' PRO . 31.0 p -52.77 -179.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.09 -1.007 . . . . 0.0 108.766 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' B' ' 277' ' ' ASP . 10.1 p -112.71 146.26 39.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 7.2 t -127.35 127.41 69.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.472 ' CE2' ' OG1' ' B' ' 243' ' ' THR . 29.7 t80 -101.04 144.32 30.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -104.57 127.8 52.39 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 110.392 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 104.78 11.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.5 22.44 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.441 ' OG ' ' OG ' ' B' ' 287' ' ' SER . 2.7 m -66.83 -55.98 12.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 109.205 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.473 -0.767 . . . . 0.0 109.883 179.675 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.615 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.14 -39.66 93.33 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 70.8 m-20 -58.29 -30.07 66.34 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.563 ' NE2' ' O ' ' B' ' 247' ' ' ALA . 0.0 OUTLIER -69.13 -48.7 61.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.95 81.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.8 tp -58.76 -34.35 71.32 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.552 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 20.3 m-30 -68.61 -43.96 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.55 80.14 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.519 -1.363 . . . . 0.0 108.823 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.633 ' NE ' HH22 ' B' ' 234' ' ' ARG . 57.8 ttt180 -71.5 -58.94 3.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.806 -1.183 . . . . 0.0 108.505 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.46 -41.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 70.8 t -66.33 -28.07 42.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 14.5 p -65.44 -41.17 93.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . 0.633 HH22 ' NE ' ' B' ' 230' ' ' ARG . 73.5 mtt85 -65.61 -41.67 92.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' B' ' 238' ' ' TYR . 84.9 mt -59.92 -42.86 94.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -58.7 -24.58 61.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' B' ' 234' ' ' ARG . 87.6 mtt-85 -70.26 -62.94 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.1 p90 -128.49 154.49 46.05 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 86.98 72.39 1.29 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' B' ' 239' ' ' GLY . 2.7 ttmt -35.75 126.53 0.68 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.575 -0.956 . . . . 0.0 109.112 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.99 90.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.543 -1.348 . . . . 0.0 108.088 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.22 -57.43 9.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.223 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.472 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 0.2 OUTLIER -86.85 91.37 8.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.742 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.2 -24.47 51.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.23 -29.64 70.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' B' ' 225' ' ' GLN . 25.3 t -52.65 -20.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.579 ' C ' ' N ' ' B' ' 249' ' ' ALA . . . -106.56 -65.28 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.858 ' O ' ' N ' ' B' ' 250' ' ' GLU . 55.8 m-20 -44.98 -24.13 0.2 Allowed 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.579 ' N ' ' C ' ' B' ' 247' ' ' ALA . . . -23.18 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.858 ' N ' ' O ' ' B' ' 248' ' ' ASP . 27.0 mt-10 -63.08 -19.31 64.29 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.901 -1.124 . . . . 0.0 109.35 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -57.78 135.33 56.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.961 -1.087 . . . . 0.0 108.58 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 0.8 OUTLIER 56.38 152.37 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' B' ' 254' ' ' LEU . 39.1 Cg_endo -69.08 92.43 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.194 1.929 . . . . 0.0 110.895 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' B' ' 253' ' ' PRO . 20.1 mt -53.99 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.848 0.833 . . . . 0.0 110.69 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' B' ' 257' ' ' GLU . . . 96.25 26.94 10.5 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.465 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 26.9 mt-10 62.99 -23.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.931 -0.747 . . . . 0.0 109.401 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.696 ' H ' ' C ' ' B' ' 255' ' ' GLY . 61.0 tt0 -74.5 -17.66 60.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 108.928 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' B' ' 260' ' ' GLY . . . -58.7 -161.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.417 -0.802 . . . . 0.0 109.356 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 258' ' ' ALA . . . -36.68 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.431 0.634 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' B' ' 258' ' ' ALA . . . 91.48 -162.81 28.3 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 120.16 -1.019 . . . . 0.0 110.737 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' B' ' 264' ' ' PHE . . . 93.37 42.44 4.26 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 261' ' ' GLY . 68.4 m-20 -47.98 -45.29 31.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.85 -43.58 94.56 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' B' ' 261' ' ' GLY . 0.7 OUTLIER -60.87 -48.35 82.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.541 -0.724 . . . . 0.0 109.937 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 3.8 tt -71.23 -33.59 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.475 -0.765 . . . . 0.0 109.996 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 1.028 ' HD1' ' CA ' ' A' ' 119' ' ' MET . 22.5 t60 -78.65 -31.14 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 46.0 mm-40 -68.78 -52.71 27.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 108.63 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -65.3 -40.24 93.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.117 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.459 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 67.1 m-20 -69.12 -53.65 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.83 . . . . 0.0 110.564 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.2 tp -68.46 -38.39 81.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.029 -1.044 . . . . 0.0 110.644 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 50.6 t-20 -64.14 -53.49 48.66 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.353 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -59.92 -41.77 92.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 108.642 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.438 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 4.1 tt -52.78 -36.92 58.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -75.39 -28.99 59.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.726 . . . . 0.0 109.769 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.561 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 32.4 mt-30 -92.45 4.76 52.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.971 -1.08 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.26 131.49 35.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.458 -0.776 . . . . 0.0 111.829 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.459 ' H ' ' HG ' ' B' ' 211' ' ' SER . 83.2 m-20 -74.91 -31.48 61.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 61.8 t -139.27 140.25 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.0 129.6 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.939 -1.1 . . . . 0.0 111.995 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.27 123.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.16 46.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.539 ' OE2' ' CZ ' ' B' ' 334' ' ' TYR . 18.4 tp10 -83.81 114.21 21.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.605 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -119.34 149.02 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 0.0 109.562 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.576 ' HG1' ' C ' ' B' ' 283' ' ' VAL . 57.6 m -167.7 -31.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.45 150.59 51.83 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.442 ' O ' ' OG ' ' B' ' 287' ' ' SER . 92.8 Cg_exo -35.62 131.12 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.718 2.279 . . . . 0.0 112.514 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 286' ' ' PRO . 15.4 m -166.29 116.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.11 -0.994 . . . . 0.0 109.622 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 292' ' ' TYR . 3.5 mt -68.27 -41.23 81.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.102 -0.999 . . . . 0.0 109.568 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.73 -36.32 71.52 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.83 -49.75 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -1.016 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 88' ' ' LEU . . . -67.67 -40.29 90.3 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.472 ' CD1' ' CD1' ' A' ' 120' ' ' ILE . 67.0 t80 -60.97 -44.67 97.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.233 -1.157 . . . . 0.0 109.419 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.67 -32.04 72.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 20.0 mt -67.17 -43.43 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.64 -39.74 97.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -40.87 90.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.267 -1.137 . . . . 0.0 108.739 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.83 74.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.409 ' CG2' ' OH ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -52.96 -37.71 26.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -75.23 -50.3 16.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.57 -5.05 17.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.126 -0.984 . . . . 0.0 108.848 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 48.07 29.01 6.27 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.46 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 25.3 mtmm -95.75 152.29 38.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.953 -1.322 . . . . 0.0 107.748 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' B' ' 302' ' ' LYS . 84.0 Cg_exo -34.08 119.01 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.24 1.96 . . . . 0.0 111.788 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.5 mt -120.07 105.01 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.359 -0.838 . . . . 0.0 111.032 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 60.5 tp -99.85 115.94 30.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -107.8 139.7 42.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.067 -1.021 . . . . 0.0 108.251 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' B' ' 283' ' ' VAL . 11.8 mt -124.0 144.67 49.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.028 -1.045 . . . . 0.0 112.093 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.651 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -143.94 140.14 29.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.48 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 27.7 mtt180 -97.35 140.28 21.94 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 111.557 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.04 -33.66 2.0 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.607 2.205 . . . . 0.0 110.796 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' B' ' 312' ' ' SER . 18.2 pt20 -48.33 -38.96 20.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.481 ' O ' ' C ' ' B' ' 313' ' ' GLY . 7.5 p -91.31 -20.31 22.02 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 37.17 39.62 0.48 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' B' ' 315' ' ' VAL . 45.5 mtt-85 -74.78 13.72 0.6 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.311 -1.111 . . . . 0.0 109.724 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' B' ' 314' ' ' ARG . 55.3 t 49.58 100.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 110.119 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' B' ' 317' ' ' SER . 36.6 tp -48.34 143.85 4.42 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.53 141.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.02 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . 0.464 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -54.87 -55.12 33.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.693 -0.63 . . . . 0.0 110.79 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 1.008 ' CA ' ' HD1' ' A' ' 66' ' ' HIS . 14.2 mtp -60.13 -40.22 89.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.029 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 45.1 mm -62.53 -41.86 93.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.82 -1.175 . . . . 0.0 109.477 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . 0.516 ' NH2' ' OD2' ' B' ' 325' ' ' ASP . 0.9 OUTLIER -72.77 -45.91 56.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 109.893 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -65.36 -18.78 65.79 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -51.32 -57.6 8.45 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.124 -1.221 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -153.96 -89.03 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.85 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 23.2 t0 94.12 -0.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . 177.76 82.5 0.06 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.824 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.0 OUTLIER 165.81 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.433 -1.039 . . . . 0.0 109.811 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.42 -25.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.824 ' H ' ' C ' ' B' ' 327' ' ' SER . 9.0 t80 -117.25 115.67 25.75 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.67 132.98 41.33 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.173 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 73.0 t -92.41 102.55 13.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.09 145.15 26.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.08 -1.012 . . . . 0.0 110.441 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.487 ' O ' ' SD ' ' B' ' 342' ' ' MET . 65.7 m-20 -96.41 152.11 18.91 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.539 ' CZ ' ' OE2' ' B' ' 282' ' ' GLU . 5.6 p90 -170.28 174.08 5.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.51 -1.368 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -148.09 150.9 34.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.0 mt-10 -40.43 -27.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.0 110.308 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -85.5 -5.27 84.93 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.015 -1.053 . . . . 0.0 111.226 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -135.43 4.62 3.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.92 -1.341 . . . . 0.0 110.082 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.1 p -57.97 -48.64 83.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.888 -1.132 . . . . 0.0 108.763 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 24.0 pt-20 -55.23 -33.78 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.0 m -65.77 -39.75 91.35 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 14.0 mmt -54.88 -53.96 48.65 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 32.1 mt -62.39 -31.66 72.36 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.891 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 30.0 t0 -68.95 -46.09 69.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.18 -0.95 . . . . 0.0 111.063 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -70.93 -50.61 32.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.473 -1.392 . . . . 0.0 109.759 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' B' ' 346' ' ' TYR . 29.6 t80 -56.58 -50.1 72.93 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.436 -0.79 . . . . 0.0 109.994 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' B' ' 351' ' ' LEU . 25.2 m-85 -75.85 -30.76 59.04 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.561 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 5.3 mm-40 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -87.41 19.56 3.23 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' B' ' 347' ' ' PHE . 2.0 t80 -148.0 -34.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.571 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' B' ' 347' ' ' PHE . 18.7 mt -117.72 40.77 0.33 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.864 -1.147 . . . . 0.0 111.277 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 63.9 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 121.963 1.775 . . . . 0.0 111.164 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.99 155.51 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.059 1.84 . . . . 0.0 111.344 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.3 p -58.84 175.66 0.25 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.024 -1.047 . . . . 0.0 108.583 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -119.0 153.05 35.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.315 -0.866 . . . . 0.0 109.525 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -123.84 126.74 73.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.588 ' CE2' ' OG1' ' A' ' 43' ' ' THR . 37.1 t80 -88.83 129.66 35.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 14' ' ' PHE . 16.4 t80 -97.15 131.91 43.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.613 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.588 ' HG ' ' CB ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -142.14 100.61 3.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.383 -0.823 . . . . 0.0 109.332 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.31 -176.18 14.33 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.533 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 4.5 m -87.53 120.27 28.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -1.125 . . . . 0.0 110.186 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' NE ' ' A' ' 22' ' ' ARG . 3.6 mt . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.556 ' NE ' ' O ' ' A' ' 18' ' ' ILE . 72.0 mtt-85 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 122.726 1.251 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.29 -17.4 28.66 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 40.9 m-20 -63.7 -38.93 92.98 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.601 HE22 ' N ' ' A' ' 47' ' ' ALA . 20.1 mm100 -68.22 -42.74 79.35 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.89 -51.43 69.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.084 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 -35.42 75.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 19.3 m-30 -68.89 -42.12 77.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.19 90.2 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 108.951 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.461 ' O ' ' OG ' ' A' ' 33' ' ' SER . 44.2 ttt180 -71.41 -55.51 7.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.754 -1.217 . . . . 0.0 108.292 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.68 -44.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 55.7 t -63.5 -27.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.716 ' HG ' HH12 ' A' ' 37' ' ' ARG . 21.5 p -67.4 -39.53 85.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.621 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.497 ' NE ' ' CD ' ' A' ' 140' ' ' GLU . 84.8 mtt-85 -69.15 -47.38 65.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.833 -1.167 . . . . 0.0 108.757 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 38' ' ' TYR . 4.7 mt -62.25 -33.86 75.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -64.91 -28.38 69.5 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.716 HH12 ' HG ' ' A' ' 33' ' ' SER . 80.7 mtt85 -71.28 -59.88 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.4 p90 -121.57 151.36 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.89 77.84 1.12 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 39' ' ' GLY . 43.2 mtmt -40.9 118.64 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.451 -1.029 . . . . 0.0 108.57 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.9 t -82.4 128.04 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 110.118 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.2 mt -105.86 172.43 6.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 32.4 m 51.81 47.28 25.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 108.887 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' HIS . 75.3 tt0 -50.05 -21.17 1.15 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.635 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -38.42 -47.49 1.26 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.374 -0.829 . . . . 0.0 110.157 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.707 ' O ' ' N ' ' A' ' 48' ' ' ASP . 3.4 p -57.47 162.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.941 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.739 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 60.85 -58.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.055 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -62.2 16.73 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.739 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -82.07 -39.56 23.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.15 -0.969 . . . . 0.0 108.475 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 58.3 mt-10 -45.92 -15.39 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.246 -0.909 . . . . 0.0 108.656 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' ALA . 3.0 mp -54.64 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 110.042 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -155.55 -44.77 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.661 -0.649 . . . . 0.0 109.991 -178.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.644 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -84.06 80.37 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.916 2.411 . . . . 0.0 110.526 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 5.1 mp -95.52 157.42 15.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.323 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 42.96 -167.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' C ' ' N ' ' A' ' 58' ' ' ALA . 43.5 mp0 -72.83 -30.86 64.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.579 -0.953 . . . . 0.0 109.696 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' GLU . 72.9 tt0 -47.53 -20.8 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -56.69 91.24 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.48 -3.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.933 . . . . 0.0 109.858 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -49.05 -46.12 33.16 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.65 79.36 0.03 OUTLIER Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -48.23 -46.96 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -60.16 -44.51 94.96 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.43 -47.02 87.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 109.143 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.465 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -54.32 -39.66 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.645 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 2.2 t-80 -75.14 -48.46 23.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.84 -57.44 9.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 110.022 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -63.13 -40.36 97.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 109.354 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 65.2 m-20 -60.5 -40.77 92.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.932 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.645 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -74.66 -39.02 62.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.635 -1.291 . . . . 0.0 109.84 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -56.3 -45.77 80.1 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -70.49 -40.13 73.78 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.5 tp -58.32 -33.34 69.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.29 -28.07 38.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.558 -0.714 . . . . 0.0 110.34 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.6 5.9 47.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.07 . . . . 0.0 108.989 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.27 132.74 46.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 111.756 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -85.22 -30.96 23.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 22.3 t -143.32 138.18 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' HA ' ' H ' ' A' ' 13' ' ' TYR . 99.5 t -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.219 -0.925 . . . . 0.0 111.641 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.15 114.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.588 ' CB ' ' HG ' ' A' ' 15' ' ' CYS . . . -115.17 131.83 56.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.149 -0.969 . . . . 0.0 110.386 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -91.16 114.72 27.32 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.97 -99.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.947 -1.095 . . . . 0.0 109.977 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 m 64.66 -122.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.674 -1.266 . . . . 0.0 109.047 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -48.72 147.3 4.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.064 -1.023 . . . . 0.0 109.128 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.46 124.38 11.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.362 2.041 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.6 t -140.61 130.18 24.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.37 -41.39 73.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.55 97.38 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.9 -47.19 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.356 -1.085 . . . . 0.0 109.078 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.87 -46.8 93.48 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 19.9 t80 -62.28 -45.05 94.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.748 -0.854 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -60.79 -33.54 73.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.221 -0.925 . . . . 0.0 109.098 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.42 -41.56 63.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.31 -48.7 62.11 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -59.24 -42.42 91.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.31 -1.112 . . . . 0.0 108.871 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.72 -39.48 88.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.048 . . . . 0.0 108.905 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -51.72 -40.8 27.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.468 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -71.85 -47.74 50.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.896 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 102' ' ' LYS . 2.8 pp -124.7 -33.19 3.0 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.932 -1.105 . . . . 0.0 111.298 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' C ' ' A' ' 102' ' ' LYS . . . -74.25 10.51 7.88 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 7.85 -74.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.342 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' GLY . 30.9 Cg_endo -65.33 108.43 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.349 1.16 . . . . 0.0 111.261 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 mt -134.55 150.16 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.132 0.968 . . . . 0.0 111.486 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 132' ' ' TRP . 47.9 tp -128.02 113.74 16.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.765 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -114.17 150.79 33.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.815 -1.178 . . . . 0.0 109.19 -179.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 2.9 mp -132.46 137.08 47.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 0.0 111.585 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -128.81 140.01 51.9 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -88.93 133.05 36.33 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.001 -1.062 . . . . 0.0 110.992 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 113' ' ' GLY . 87.8 Cg_endo -78.76 -38.81 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.537 2.158 . . . . 0.0 111.277 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.27 -31.52 6.04 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 113' ' ' GLY . 22.0 p -95.23 -20.55 19.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 38.42 42.49 1.33 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.411 HH11 ' HB2' ' A' ' 112' ' ' SER . 1.7 mtt85 -67.48 7.19 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.376 -1.073 . . . . 0.0 109.494 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 113' ' ' GLY . 77.3 t 57.57 99.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.448 -0.783 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.4 tp -54.76 151.12 8.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.439 ' HG ' ' CG1' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -58.05 142.07 47.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.116 -0.99 . . . . 0.0 110.9 -178.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.68 82.4 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 41.8 mmm -62.25 -45.7 92.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.724 0.773 . . . . 0.0 109.361 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' ALA . 28.0 mm -61.1 -43.19 95.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.122 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' GLY . 0.3 OUTLIER -55.61 -45.46 77.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.587 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -51.05 -40.07 42.74 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 103.973 -3.651 . . . . 0.0 103.973 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.612 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -76.07 89.56 3.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.14 40.42 0.07 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.918 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 127' ' ' SER . 97.7 m-20 -54.7 -20.08 7.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 110.059 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 68.8 -14.62 0.74 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 125' ' ' ASP . 22.5 t -102.49 -74.62 0.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.236 . . . . 0.0 108.805 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.77 -49.15 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.765 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 4.5 t80 -103.55 129.05 50.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.713 HE21 ' HE1' ' A' ' 132' ' ' TRP . 2.6 mt-30 -140.47 135.65 32.19 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.581 -1.324 . . . . 0.0 111.895 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.2 112.19 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.713 ' HE1' HE21 ' A' ' 130' ' ' GLN . 14.2 m0 -108.09 138.76 43.81 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.979 -1.076 . . . . 0.0 109.946 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' SD ' ' A' ' 142' ' ' MET . 80.9 m-20 -90.04 155.37 19.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.6 -1.313 . . . . 0.0 107.771 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.8 p90 -172.15 -177.28 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.697 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -150.89 148.33 28.3 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' ALA . 62.3 mt-10 -41.7 -34.62 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.745 -1.222 . . . . 0.0 110.438 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.81 6.18 75.49 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.885 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -137.89 -3.61 1.81 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.961 -1.317 . . . . 0.0 109.795 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.2 p -55.7 -46.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 54.5 mt-10 -52.64 -34.56 52.0 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -70.07 -38.78 75.84 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.375 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 13.0 mmt -53.5 -53.38 52.29 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 79.0 mt -60.69 -39.11 87.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.029 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.53 -45.22 93.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 110.941 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -68.64 -51.55 41.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.545 -1.347 . . . . 0.0 108.873 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.45 -45.27 80.9 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.611 -0.68 . . . . 0.0 109.971 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 15.5 m-85 -73.4 -33.15 64.84 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -58.09 -29.9 65.82 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.18 26.86 4.45 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.99 -82.4 0.21 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.693 -1.203 . . . . 0.0 113.472 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.508 ' CD1' ' CD1' ' A' ' 147' ' ' PHE . 4.8 mt -55.11 -59.21 11.49 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.131 -0.98 . . . . 0.0 112.195 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 2.6 Cg_endo . . . . . 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 0.0 111.878 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -56.41 155.89 23.68 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.986 1.791 . . . . 0.0 111.279 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 18.6 p -58.92 175.55 0.27 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.047 -1.033 . . . . 0.0 108.506 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 14.6 m -119.09 153.18 35.2 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 0.0 OUTLIER -123.92 126.97 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.579 ' CE2' ' OG1' ' B' ' 243' ' ' THR . 36.4 t80 -89.04 129.42 35.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' B' ' 214' ' ' PHE . 15.9 t80 -96.99 132.34 42.89 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.593 ' HG ' ' CB ' ' B' ' 281' ' ' ALA . 0.2 OUTLIER -142.57 101.15 3.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -0.807 . . . . 0.0 109.234 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.62 -176.39 14.41 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.515 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 4.4 m -87.19 120.62 28.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 110.108 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.559 ' O ' ' NE ' ' B' ' 222' ' ' ARG . 3.9 mt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' B' ' 218' ' ' ILE . 73.7 mtt-85 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 122.692 1.234 . . . . 0.0 112.734 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.18 -17.34 26.6 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 44.2 m-20 -64.0 -38.9 92.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.611 HE22 ' N ' ' B' ' 247' ' ' ALA . 20.3 mm100 -68.13 -42.94 79.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.73 -51.28 70.46 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.989 -1.084 . . . . 0.0 108.173 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.52 -35.98 77.28 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 19.5 m-30 -68.29 -42.74 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.536 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.25 90.32 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.846 -1.159 . . . . 0.0 109.091 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.472 ' O ' ' OG ' ' B' ' 233' ' ' SER . 43.8 ttt180 -71.38 -55.41 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.877 -1.14 . . . . 0.0 108.249 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 45.6 mt -53.74 -44.64 59.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 55.9 t -63.35 -28.18 44.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.719 ' HG ' HH12 ' B' ' 237' ' ' ARG . 23.9 p -67.21 -39.52 86.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . 0.498 ' NE ' ' CD ' ' B' ' 340' ' ' GLU . 85.4 mtt-85 -69.31 -47.33 64.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.912 -1.117 . . . . 0.0 108.815 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 238' ' ' TYR . 4.7 mt -62.26 -33.72 75.16 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -65.1 -28.55 69.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . 0.719 HH12 ' HG ' ' B' ' 233' ' ' SER . 80.6 mtt85 -71.19 -59.87 2.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.4 p90 -121.42 151.7 39.89 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 83.33 77.92 1.09 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' B' ' 239' ' ' GLY . 42.9 mtmt -40.87 118.71 1.02 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.385 -1.068 . . . . 0.0 108.657 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 30.3 t -82.35 127.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.192 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.422 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 17.1 mt -105.52 172.45 6.79 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.579 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 35.7 m 51.69 48.01 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 108.881 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 245' ' ' HIS . 75.1 tt0 -50.77 -20.83 1.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' B' ' 244' ' ' GLU . 0.1 OUTLIER -38.48 -47.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.255 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.697 ' O ' ' N ' ' B' ' 248' ' ' ASP . 3.4 p -57.58 163.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 108.976 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.724 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 60.42 -58.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.473 -0.767 . . . . 0.0 109.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' B' ' 246' ' ' VAL . 0.1 OUTLIER -62.15 16.76 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.724 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -81.91 -39.31 23.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 108.594 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -46.45 -14.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.61 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 249' ' ' ALA . 2.9 mp -55.26 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' B' ' 253' ' ' PRO . 1.0 OUTLIER -155.47 -44.81 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.62 -0.675 . . . . 0.0 109.886 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -84.06 80.52 2.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.994 2.462 . . . . 0.0 110.668 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' B' ' 254' ' ' LEU . 5.0 mp -95.84 157.62 15.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.345 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 43.11 -167.76 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.484 ' C ' ' N ' ' B' ' 258' ' ' ALA . 41.2 mp0 -73.08 -30.29 63.58 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.523 -0.986 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' B' ' 256' ' ' GLU . 71.2 tt0 -48.21 -20.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -57.22 91.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -55.54 -4.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -48.39 -46.57 28.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 152.7 79.51 0.03 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -48.24 -46.96 36.14 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -60.2 -44.4 95.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.58 -47.01 87.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.7 OUTLIER -54.24 -39.92 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.645 ' CE1' ' HG ' ' B' ' 270' ' ' LEU . 2.2 t-80 -74.72 -48.43 25.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.07 -57.38 9.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.962 . . . . 0.0 110.091 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.08 -40.28 97.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.5 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 62.0 m-20 -60.76 -40.68 93.4 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.645 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -74.82 -39.28 61.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.599 -1.313 . . . . 0.0 109.79 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -56.01 -45.69 79.01 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.971 -1.081 . . . . 0.0 108.15 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.422 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -70.43 -40.62 73.69 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.463 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.3 tp -58.06 -33.03 68.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 108.471 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.49 -28.15 37.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.47 6.11 47.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.992 -1.068 . . . . 0.0 108.949 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.74 132.88 46.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.33 -0.856 . . . . 0.0 111.765 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -85.36 -31.01 23.2 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 24.4 t -143.1 138.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . 0.426 ' HA ' ' H ' ' B' ' 213' ' ' TYR . 99.0 t -120.95 148.17 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.134 -0.979 . . . . 0.0 111.614 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.24 114.68 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.384 0.612 . . . . 0.0 109.388 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . 0.593 ' CB ' ' HG ' ' B' ' 215' ' ' CYS . . . -115.74 131.54 56.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.49 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.402 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 71.7 tt0 -90.95 114.63 27.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' B' ' 284' ' ' THR . 1.7 t -85.55 -98.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.965 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.431 ' H ' ' HB ' ' B' ' 283' ' ' VAL . 5.0 m 64.26 -122.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.549 -1.345 . . . . 0.0 109.111 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -49.69 147.23 6.43 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.042 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.24 124.73 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.395 2.064 . . . . 0.0 111.785 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 28.9 t -141.28 130.37 23.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.143 -0.973 . . . . 0.0 109.383 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.59 -41.74 71.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.51 -40.7 96.58 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 19.5 t -69.93 -47.39 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -1.082 . . . . 0.0 109.169 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.72 93.59 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 18.2 t80 -62.47 -44.85 95.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.958 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.6 -33.54 72.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.04 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 76.7 mt -73.77 -41.01 63.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.69 -48.67 60.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.17 -42.54 91.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.333 -1.099 . . . . 0.0 108.779 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.7 -39.63 88.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.405 HG13 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -51.63 -40.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.468 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -71.98 -47.94 48.52 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.92 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . 0.507 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 2.8 pp -124.37 -33.15 3.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.986 -1.071 . . . . 0.0 111.226 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' B' ' 302' ' ' LYS . . . -74.16 10.08 8.47 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' B' ' 301' ' ' GLY . 0.0 OUTLIER 7.93 -74.11 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' B' ' 301' ' ' GLY . 29.0 Cg_endo -65.17 107.89 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.456 1.199 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.7 mt -134.08 149.87 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.189 0.995 . . . . 0.0 111.534 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 49.1 tp -127.72 114.02 16.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.773 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -114.46 150.53 34.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 109.211 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 2.9 mp -132.15 137.0 47.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 111.463 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -128.68 140.0 51.96 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -88.85 133.12 36.34 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.924 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 313' ' ' GLY . 77.0 Cg_endo -78.83 -38.94 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.544 2.163 . . . . 0.0 111.069 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.24 -31.72 6.25 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.463 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.3 p -95.01 -20.34 19.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 38.5 42.41 1.34 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -67.55 7.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.29 -1.124 . . . . 0.0 109.588 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' B' ' 313' ' ' GLY . 79.4 t 57.21 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.496 -0.753 . . . . 0.0 110.648 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . . . . . . . . . 19.4 tp -54.8 151.17 8.78 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.467 ' HG ' ' CG1' ' B' ' 320' ' ' ILE . 0.0 OUTLIER -57.86 141.77 48.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.926 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.3 -43.22 83.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 42.6 mmm -61.76 -45.5 93.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.626 0.727 . . . . 0.0 109.286 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' B' ' 323' ' ' ALA . 28.4 mm -61.19 -43.21 95.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . 0.472 ' O ' ' C ' ' B' ' 322' ' ' GLY . 0.3 OUTLIER -55.62 -45.09 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.825 -1.172 . . . . 0.0 107.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.619 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -51.33 -40.03 44.77 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 103.997 -3.641 . . . . 0.0 103.997 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' B' ' 329' ' ' PHE . . . -76.02 89.5 2.99 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -165.07 40.47 0.07 Allowed 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.812 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' B' ' 327' ' ' SER . 98.4 m-20 -54.61 -20.35 7.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.825 . . . . 0.0 110.029 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 69.06 -14.93 0.76 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 327' ' ' SER . . . . . 0.498 ' H ' ' C ' ' B' ' 325' ' ' ASP . 19.8 t -102.55 -74.68 0.62 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -1.231 . . . . 0.0 108.819 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -83.67 -49.41 9.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.773 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 4.4 t80 -103.39 129.06 50.4 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.729 HE21 ' HE1' ' B' ' 332' ' ' TRP . 2.7 mt-30 -140.34 135.66 32.39 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.661 -1.274 . . . . 0.0 111.853 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.34 111.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.729 ' HE1' HE21 ' B' ' 330' ' ' GLN . 14.1 m0 -107.78 138.87 43.26 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.0 110.108 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.469 ' O ' ' SD ' ' B' ' 342' ' ' MET . 81.4 m-20 -90.38 154.72 19.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.62 -1.3 . . . . 0.0 107.802 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -171.59 -177.16 1.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.782 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -150.75 148.31 28.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' B' ' 335' ' ' ALA . 62.1 mt-10 -41.6 -34.34 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.767 -1.208 . . . . 0.0 110.51 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.87 5.75 77.66 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.844 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' B' ' 335' ' ' ALA . 60.7 mm-40 -137.62 -3.6 1.87 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.001 -1.293 . . . . 0.0 109.821 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.0 p -55.88 -47.0 80.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 108.597 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 55.7 mt-10 -52.84 -34.07 52.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.1 m -70.61 -38.24 73.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.31 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 12.5 mmt -54.07 -52.97 59.23 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 76.8 mt -60.81 -39.16 87.93 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.044 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.4 -45.18 94.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 110.942 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -68.68 -51.79 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.516 -1.365 . . . . 0.0 108.808 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -56.13 -45.98 79.36 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.819 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.519 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.8 m-85 -72.82 -33.11 65.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.401 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.1 -29.62 65.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -97.38 26.77 4.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.4 ' HB3' ' H ' ' B' ' 351' ' ' LEU . 2.5 t80 -142.05 -82.39 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.434 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.519 ' CD1' ' CD1' ' B' ' 347' ' ' PHE . 4.7 mt -54.9 -59.23 11.22 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.179 -0.951 . . . . 0.0 112.181 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 2.3 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.362 2.041 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.26 -156.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.35 2.033 . . . . 0.0 111.283 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 25.9 p -108.99 172.77 6.65 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 61.4 m -115.07 158.9 21.49 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.849 -1.157 . . . . 0.0 108.99 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.41 134.14 46.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.163 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 8.3 t80 -115.53 97.29 6.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.48 126.79 38.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.526 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.67 130.1 47.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.955 . . . . 0.0 108.92 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -126.05 -124.01 2.73 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 58.1 m -155.69 138.08 14.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 109.105 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 120.913 -1.117 . . . . 0.0 109.441 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 122.073 0.94 . . . . 0.0 111.522 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.18 -40.83 96.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 74.8 m-20 -55.53 -33.32 63.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 1.8 mm100 -68.78 -39.18 80.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -52.04 66.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 108.702 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -34.6 76.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 24' ' ' ASP . 14.3 m-85 -69.2 -47.85 63.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.085 -1.01 . . . . 0.0 110.251 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.32 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.256 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.7 ttt85 -69.67 -57.22 5.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 108.494 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.5 mt -50.82 -43.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 68.4 t -61.16 -30.58 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 4.6 m -66.84 -41.18 87.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -67.92 -48.88 64.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.901 -1.125 . . . . 0.0 109.197 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.9 -40.27 79.94 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -62.1 -26.07 68.08 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -74.9 -36.97 62.22 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.94 -1.1 . . . . 0.0 108.873 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.477 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.6 m-85 -70.4 -48.36 56.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.947 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -153.1 -145.38 4.13 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.98 131.38 46.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.968 -1.313 . . . . 0.0 108.658 178.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.424 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 18.1 t -90.73 127.47 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 44' ' ' GLU . 11.9 mt -87.05 -38.63 16.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.198 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 t -70.77 37.67 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.269 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 42' ' ' LEU . 57.7 mt-10 -54.28 -28.57 42.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.81 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.482 ' NE2' ' CG1' ' A' ' 65' ' ' ILE . 18.4 t-80 -52.09 -44.9 64.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.183 -0.948 . . . . 0.0 109.865 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.496 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 41.3 t -50.12 -69.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.32 61.02 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 14.6 t70 -85.34 43.08 0.99 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -118.54 -32.3 4.64 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' HE21 ' A' ' 25' ' ' GLN . 12.2 pt-20 -86.1 60.28 6.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.498 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -168.88 22.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER 162.19 160.7 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -37.28 99.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.268 1.979 . . . . 0.0 111.67 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 54' ' ' LEU . 6.8 mp -49.36 -79.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . -175.33 -36.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -46.97 -101.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.582 -0.952 . . . . 0.0 110.554 -179.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.53 ' H ' ' CG ' ' A' ' 56' ' ' GLU . 80.8 mm-40 -64.18 -8.9 13.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.025 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 158.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.63 66.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.19 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.01 -171.99 36.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 103.02 -29.86 11.61 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 20.5 p-10 -56.15 -43.16 78.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.2 mt-30 -70.39 -53.2 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -28.84 56.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' GLY . 1.8 mt -70.37 -39.71 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.71 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 1.3 t-80 -76.45 -60.59 2.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.489 0.661 . . . . 0.0 109.367 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.71 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 8.4 tp10 -43.04 -54.52 4.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -64.68 -44.6 89.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.945 . . . . 0.0 110.044 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.462 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 73.9 m-20 -60.91 -44.14 97.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.0 111.265 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.455 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.1 mm? -65.4 -50.25 66.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.024 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.18 -50.48 71.67 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.489 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.29 -42.46 99.08 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.3 tp -52.03 -37.33 53.16 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.36 -28.08 59.41 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.603 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -83.52 -5.96 59.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.869 -1.145 . . . . 0.0 109.258 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.84 125.33 25.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 112.153 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 11' ' ' SER . 39.0 m-20 -77.81 -33.15 52.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.21 148.18 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.26 138.7 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.966 -1.084 . . . . 0.0 111.002 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 20.5 t -138.45 164.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.46 130.42 5.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.579 -1.326 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CG ' ' OH ' ' A' ' 134' ' ' TYR . 53.1 tt0 -93.65 126.03 38.6 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -155.71 114.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.08 -1.012 . . . . 0.0 110.353 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.644 ' HG1' ' H ' ' A' ' 109' ' ' ARG . 39.5 m -105.76 -18.54 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.679 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 6.6 tt0 163.81 -37.31 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.383 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 7.0 Cg_exo -71.14 104.1 1.49 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.327 2.018 . . . . 0.0 112.009 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.429 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -159.51 173.49 16.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 108.574 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.762 ' C ' ' H ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER 167.77 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.48 ' O ' ' SD ' ' B' ' 319' ' ' MET . . . 73.33 -23.21 0.96 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.762 ' H ' ' C ' ' A' ' 88' ' ' LEU . 2.1 t -85.14 -46.35 17.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.85 -30.48 56.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 1.3 t80 -68.58 -41.86 79.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.66 -34.59 65.14 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.2 -37.83 66.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.71 95.87 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.034 -2.027 . . . . 0.0 108.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -66.14 -40.0 90.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.489 -1.006 . . . . 0.0 108.711 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.32 -40.99 77.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.064 . . . . 0.0 108.549 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -39.86 48.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.44 56.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.007 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.3 mt -71.16 -7.22 45.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.135 -0.978 . . . . 0.0 108.786 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.12 24.86 9.75 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.838 -0.539 . . . . 0.0 112.09 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -79.7 154.45 75.93 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 120.603 -1.528 . . . . 0.0 108.141 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.37 118.58 1.79 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.933 1.755 . . . . 0.0 111.167 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.8 mt -121.13 135.3 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.988 . . . . 0.0 111.223 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.4 m -110.44 156.06 21.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.911 -1.118 . . . . 0.0 108.228 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 83' ' ' VAL . 3.5 mp -136.61 152.63 50.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 111.63 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.87 130.72 15.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.644 ' H ' ' HG1' ' A' ' 84' ' ' THR . 0.0 OUTLIER -52.89 140.03 41.34 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.052 -1.03 . . . . 0.0 110.522 -177.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 134' ' ' TYR . 31.8 Cg_endo -67.15 -50.25 1.09 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.147 1.898 . . . . 0.0 109.252 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' N ' ' A' ' 113' ' ' GLY . 13.3 pt20 -67.11 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.56 -72.25 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.989 -1.07 . . . . 0.0 109.753 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 111' ' ' GLN . . . 68.34 42.74 81.62 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' VAL . 4.5 mtt180 -85.63 18.42 2.84 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 114' ' ' ARG . 15.7 t 49.77 99.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.881 0.848 . . . . 0.0 109.448 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 117' ' ' SER . 8.9 tp -45.22 -61.24 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 162.86 144.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.288 -0.883 . . . . 0.0 110.002 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.52 86.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.555 -0.716 . . . . 0.0 110.399 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' B' ' 289' ' ' GLY . 1.7 mtp -74.81 -36.38 62.46 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.388 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 120' ' ' ILE . 45.4 mm -72.42 -46.07 57.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 109.37 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -77.54 -34.74 53.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 108.807 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.8 -27.49 73.82 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -43.56 -59.31 2.22 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -133.65 -111.5 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 112.178 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 1.9 m-20 160.23 -2.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.436 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.1 38.93 0.36 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.468 -1.349 . . . . 0.0 111.604 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 p -116.1 -86.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.727 -1.455 . . . . 0.0 108.838 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.501 ' O ' ' NE2' ' A' ' 130' ' ' GLN . 20.0 tpt180 -94.4 -30.05 14.67 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -117.69 126.0 51.7 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 128' ' ' ARG . 6.9 mp0 -131.91 135.92 47.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.55 -1.344 . . . . 0.0 112.726 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.42 106.89 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.482 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 20.8 m0 -104.63 143.02 33.64 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.006 -1.059 . . . . 0.0 110.986 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' O ' ' SD ' ' A' ' 142' ' ' MET . 68.0 m-20 -85.84 154.86 21.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.651 -1.281 . . . . 0.0 108.002 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.458 ' OH ' ' CG ' ' A' ' 82' ' ' GLU . 3.6 p90 -168.7 172.54 7.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 0.0 111.488 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -141.65 146.67 36.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 40.0 mt-10 -39.26 -37.03 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.746 -1.221 . . . . 0.0 110.335 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.17 15.52 33.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 135' ' ' ALA . 74.8 mt-10 -146.29 -4.88 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.258 . . . . 0.0 110.407 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.6 p -54.04 -46.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 120.865 -1.147 . . . . 0.0 108.616 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 22.8 pt-20 -56.54 -34.63 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.8 m -65.67 -39.41 91.3 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.165 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 11.3 mmt -55.82 -51.6 66.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.91 -30.3 71.4 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.347 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 48.6 m-20 -69.27 -44.14 72.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 0.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -71.67 -43.61 65.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.677 -1.264 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -62.97 -48.6 78.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.446 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.49 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 19.6 m-85 -73.64 -31.08 63.32 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.393 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -68.25 -27.16 66.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.47 65.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.689 -0.632 . . . . 0.0 109.621 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.813 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -145.88 -63.69 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.042 -1.036 . . . . 0.0 110.653 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.813 ' N ' ' CG ' ' A' ' 150' ' ' TYR . 1.4 mt -31.01 92.89 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 0.0 110.643 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 150' ' ' TYR . 72.4 Cg_endo . . . . . 0 C--N 1.311 -1.419 0 C-N-CA 123.166 2.577 . . . . 0.0 111.048 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.67 -156.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.217 1.945 . . . . 0.0 111.24 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.503 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 26.6 p -109.12 172.98 6.53 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 69.8 m -115.38 159.08 21.55 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.895 -1.128 . . . . 0.0 108.909 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.63 133.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.449 ' OH ' ' CB ' ' B' ' 269' ' ' ASP . 8.1 t80 -115.31 97.59 6.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -93.74 126.83 39.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.455 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.49 129.4 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.18 -0.95 . . . . 0.0 108.93 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.437 ' O ' ' CG2' ' B' ' 290' ' ' VAL . . . -125.42 -124.3 2.79 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' SER . . . . . 0.553 ' O ' ' NH1' ' B' ' 222' ' ' ARG . 58.7 m -155.58 137.8 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.055 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.894 -1.129 . . . . 0.0 109.581 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.553 ' NH1' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.171 0.986 . . . . 0.0 111.418 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.03 -40.64 96.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' B' ' 228' ' ' TYR . 74.7 m-20 -55.31 -33.77 63.58 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 1.9 mm100 -68.45 -38.84 81.48 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.19 66.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 108.646 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -34.31 76.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.482 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 14.0 m-85 -69.14 -48.42 62.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.059 -1.025 . . . . 0.0 110.217 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.407 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -60.02 -35.61 75.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.483 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' B' ' 233' ' ' SER . 32.0 ttt85 -69.62 -57.31 5.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.089 . . . . 0.0 108.452 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -50.61 -43.39 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 67.9 t -61.03 -30.73 48.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 230' ' ' ARG . 4.4 m -66.65 -41.36 88.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.776 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.91 -48.57 65.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.745 -1.222 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.2 -40.37 81.4 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -61.99 -25.98 67.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -74.93 -37.2 62.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.913 -1.117 . . . . 0.0 108.92 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . 0.477 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 2.5 m-85 -70.09 -48.55 57.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.614 -0.679 . . . . 0.0 110.072 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.73 -145.53 4.16 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.428 ' H ' ' HD3' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -100.88 131.48 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -1.216 . . . . 0.0 108.575 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . 0.417 ' O ' ' CG ' ' B' ' 244' ' ' GLU . 19.4 t -90.67 127.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' B' ' 244' ' ' GLU . 12.0 mt -87.08 -38.44 16.49 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.181 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 8.1 t -71.18 37.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 109.257 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' B' ' 242' ' ' LEU . 59.3 mt-10 -54.29 -28.84 44.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.818 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.498 ' NE2' ' CG1' ' B' ' 265' ' ' ILE . 17.7 t-80 -52.08 -45.24 64.71 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.494 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 41.2 t -49.85 -69.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.295 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -51.87 -41.36 61.82 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 248' ' ' ASP . 14.5 t70 -85.2 43.44 1.01 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' B' ' 246' ' ' VAL . . . -119.0 -32.05 4.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . 0.44 ' HG2' HE21 ' B' ' 225' ' ' GLN . 11.7 pt-20 -86.4 60.55 6.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.269 -0.894 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.625 ' CD2' ' N ' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -169.28 22.56 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.514 -0.741 . . . . 0.0 109.945 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER 161.87 160.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -37.03 99.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.382 2.055 . . . . 0.0 111.702 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.441 ' CD1' ' H ' ' B' ' 254' ' ' LEU . 6.7 mp -49.17 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.05 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . -175.71 -37.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.539 ' CG ' ' H ' ' B' ' 257' ' ' GLU . 0.2 OUTLIER -46.68 -101.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.568 -0.96 . . . . 0.0 110.578 -178.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' B' ' 256' ' ' GLU . 80.7 mm-40 -63.94 -8.21 10.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.875 . . . . 0.0 110.058 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -56.84 159.04 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.37 66.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 109.16 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -171.42 -172.33 37.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 103.14 -29.95 11.39 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 20.0 p-10 -56.17 -43.02 77.97 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . 0.467 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 1.2 mt-30 -70.59 -53.25 16.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.29 -28.51 54.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' B' ' 261' ' ' GLY . 1.9 mt -71.08 -39.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.703 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 1.2 t-80 -76.32 -60.73 2.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . 0.703 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 9.4 tp10 -43.02 -54.86 4.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.723 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -64.63 -43.8 92.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.449 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 75.3 m-20 -61.84 -44.1 97.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.2 -0.937 . . . . 0.0 111.2 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 1.1 mm? -65.32 -50.05 67.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.975 -1.078 . . . . 0.0 110.02 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -62.22 -50.76 70.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.537 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.03 -42.76 99.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.362 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.435 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.4 tp -51.76 -37.3 50.74 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.4 -28.1 59.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.42 -5.94 59.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.191 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.91 125.74 26.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -0.851 . . . . 0.0 112.034 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 211' ' ' SER . 41.9 m-20 -78.25 -33.14 49.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.91 147.7 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 79.3 t -133.93 138.38 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.883 -1.136 . . . . 0.0 111.015 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 20.0 t -137.83 164.76 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -159.95 130.16 5.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.614 -1.304 . . . . 0.0 110.143 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.453 ' CG ' ' OH ' ' B' ' 334' ' ' TYR . 52.0 tt0 -93.56 125.75 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 0.5 OUTLIER -155.3 115.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.987 -1.07 . . . . 0.0 110.349 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' B' ' 309' ' ' ARG . 38.0 m -106.06 -19.0 13.86 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.68 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 6.6 tt0 164.09 -37.18 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.244 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 7.5 Cg_exo -70.9 103.82 1.41 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.389 2.06 . . . . 0.0 111.937 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.421 ' O ' HD21 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -159.81 173.25 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.747 ' C ' ' H ' ' B' ' 290' ' ' VAL . 0.1 OUTLIER 167.9 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 119' ' ' MET . . . 73.26 -22.81 0.97 Allowed Glycine 0 N--CA 1.481 1.662 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -176.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . 0.747 ' H ' ' C ' ' B' ' 288' ' ' LEU . 2.1 t -85.43 -46.41 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -55.65 -30.51 56.34 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 1.3 t80 -68.62 -41.98 78.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.8 -34.55 65.41 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 54.4 mt -73.15 -37.97 66.4 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.9 -37.79 94.34 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.8 -39.88 87.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.451 -1.029 . . . . 0.0 108.649 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -69.55 -41.08 76.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.96 -1.088 . . . . 0.0 108.524 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -39.79 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.11 57.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.007 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -71.63 -6.97 44.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 108.832 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . 51.05 25.01 9.49 Favored Glycine 0 N--CA 1.494 2.557 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.052 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.403 ' O ' HG13 ' B' ' 304' ' ' ILE . 24.6 mttp -79.76 154.61 75.83 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 120.631 -1.511 . . . . 0.0 108.254 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.39 118.35 1.71 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.806 1.67 . . . . 0.0 111.098 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.403 HG13 ' O ' ' B' ' 302' ' ' LYS . 11.9 mt -120.82 134.77 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.149 -0.969 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.25 114.78 18.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 85.9 m -110.57 156.18 21.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.76 -1.213 . . . . 0.0 108.105 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' B' ' 283' ' ' VAL . 3.5 mp -136.59 152.43 50.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.0 -1.062 . . . . 0.0 111.626 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -148.68 130.62 15.25 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.63 ' H ' ' HG1' ' B' ' 284' ' ' THR . 0.0 OUTLIER -52.87 139.8 41.6 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.045 -1.034 . . . . 0.0 110.496 -177.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' B' ' 311' ' ' GLN . 33.3 Cg_endo -67.08 -50.06 1.17 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.067 1.845 . . . . 0.0 109.352 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.788 ' O ' ' N ' ' B' ' 313' ' ' GLY . 13.2 pt20 -67.09 -143.21 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.31 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 109.687 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.788 ' N ' ' O ' ' B' ' 311' ' ' GLN . . . 68.39 42.76 81.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' B' ' 315' ' ' VAL . 4.4 mtt180 -85.43 17.57 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' B' ' 314' ' ' ARG . 17.9 t 50.41 99.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.969 0.89 . . . . 0.0 109.4 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 317' ' ' SER . 8.5 tp -45.33 -61.42 1.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 317' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.9 OUTLIER 162.97 143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.49 86.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.437 -0.79 . . . . 0.0 110.316 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 89' ' ' GLY . 1.6 mtp -74.3 -36.78 63.76 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.038 -1.039 . . . . 0.0 109.407 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.445 HD12 HG21 ' B' ' 320' ' ' ILE . 45.2 mm -72.32 -45.93 58.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 109.439 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -77.46 -34.77 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 108.841 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -69.09 -27.27 74.0 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -43.43 -59.56 2.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -1.122 . . . . 0.0 110.013 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 325' ' ' ASP . . . -133.07 -111.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 112.068 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' B' ' 324' ' ' ALA . 2.0 m-20 160.01 -2.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.336 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 128.27 38.97 0.35 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 119.611 -1.281 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 57.0 p -115.97 -86.97 0.61 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.773 -1.427 . . . . 0.0 108.678 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.506 ' O ' ' NE2' ' B' ' 330' ' ' GLN . 20.1 tpt180 -94.29 -29.91 14.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 0.7 OUTLIER -117.86 126.25 52.04 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 328' ' ' ARG . 6.9 mp0 -132.23 136.37 46.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.471 -1.393 . . . . 0.0 112.65 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.72 107.11 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 20.7 m0 -104.48 142.92 33.77 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.071 -1.018 . . . . 0.0 110.939 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.542 ' O ' ' SD ' ' B' ' 342' ' ' MET . 67.0 m-20 -86.05 155.18 20.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.626 -1.296 . . . . 0.0 107.855 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.453 ' OH ' ' CG ' ' B' ' 282' ' ' GLU . 3.9 p90 -168.74 172.63 7.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.388 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -141.74 146.81 36.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' B' ' 335' ' ' ALA . 36.7 mt-10 -39.35 -37.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.83 -1.169 . . . . 0.0 110.286 -178.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.93 15.67 31.14 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 335' ' ' ALA . 74.1 mt-10 -146.59 -5.15 0.56 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.119 -1.224 . . . . 0.0 110.47 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.8 p -53.8 -46.85 63.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.804 -1.185 . . . . 0.0 108.606 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 23.1 pt-20 -56.29 -34.39 66.42 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 32.2 m -65.78 -39.46 91.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.542 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 11.8 mmt -55.79 -51.56 67.0 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.79 -30.48 71.57 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.39 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -69.26 -44.09 72.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.991 -1.068 . . . . 0.0 110.69 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -71.86 -43.35 65.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.532 -1.355 . . . . 0.0 109.38 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -63.02 -48.86 76.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.358 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 19.9 m-85 -73.36 -31.0 63.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.413 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -68.15 -27.48 66.47 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -59.25 -27.56 65.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.766 -0.584 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.822 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.1 OUTLIER -145.73 -63.63 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.0 -1.063 . . . . 0.0 110.591 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.822 ' N ' ' CG ' ' B' ' 350' ' ' TYR . 1.4 mt -31.13 92.99 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.633 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . 0.53 ' N ' ' O ' ' B' ' 350' ' ' TYR . 77.2 Cg_endo . . . . . 0 C--N 1.311 -1.442 0 C-N-CA 123.105 2.536 . . . . 0.0 110.914 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.51 -161.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.457 2.105 . . . . 0.0 111.704 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 29.1 p -99.8 -173.25 2.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 1.2 m -118.68 143.52 46.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.01 136.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CZ ' ' OE1' ' A' ' 44' ' ' GLU . 5.9 t80 -113.41 109.17 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CE1' ' OE2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -98.23 129.95 44.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.636 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 3.2 m -102.12 151.19 22.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.342 -0.849 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.84 162.66 36.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -86.35 132.94 33.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.226 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 mm . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 51.3 mp0 -51.5 -46.2 63.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 5.7 m-20 -65.01 -22.62 67.02 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 18.3 tp60 -63.35 -39.15 93.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.87 -47.88 67.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.86 -32.22 67.44 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 19.5 m-30 -67.44 -46.99 71.48 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.48 80.62 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.644 -1.285 . . . . 0.0 109.046 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -70.79 -56.79 5.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.756 -1.215 . . . . 0.0 108.515 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mt -52.9 -43.99 47.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 61.6 t -59.44 -29.09 41.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.3 m -71.68 -34.41 69.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -69.46 -53.29 19.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 108.615 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 mt -56.95 -39.51 74.67 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.96 -22.92 67.15 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -72.89 -44.54 61.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 109.412 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.95 -50.09 9.55 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.564 -0.71 . . . . 0.0 111.784 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.554 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . -142.46 132.48 5.15 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -35.79 145.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -1.052 . . . . 0.0 109.129 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 43' ' ' THR . 50.2 t -79.4 100.56 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.625 HD11 ' CD1' ' A' ' 72' ' ' TRP . 0.1 OUTLIER -49.88 94.56 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.952 -177.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 41' ' ' VAL . 6.6 m 28.21 100.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.363 0.602 . . . . 0.0 111.371 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' A' ' 46' ' ' VAL . 16.3 tp10 -142.9 65.88 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' VAL . 25.0 p80 -50.16 -5.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 44' ' ' GLU . 39.0 t -40.18 -58.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.686 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -66.93 -40.76 87.7 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 108.641 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.454 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 7.4 t70 -70.67 25.05 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.686 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -101.98 -16.18 16.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.01 -43.96 70.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 109.027 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.87 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.73 136.99 20.94 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 0.0 109.353 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 51' ' ' LEU . 20.8 mm-40 53.98 153.55 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.997 . . . . 0.0 109.082 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.47 88.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.195 1.93 . . . . 0.0 111.736 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.15 -163.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.155 -0.966 . . . . 0.0 109.806 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 91.09 151.85 27.22 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 58' ' ' ALA . 44.4 mt-10 -50.55 178.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -1.176 . . . . 0.0 109.003 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 64.91 -24.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.166 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.681 ' H ' ' C ' ' A' ' 56' ' ' GLU . . . -80.37 141.41 35.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 109.162 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.58 133.38 36.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.154 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.38 -77.08 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.05 83.61 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -52.44 -45.79 66.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -1.043 . . . . 0.0 108.562 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -62.14 -46.36 89.37 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 35.3 t80 -62.56 -41.62 99.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 11.9 mt -56.02 -46.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.71 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.7 t-80 -76.46 -27.11 56.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.7 -0.625 . . . . 0.0 109.852 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -61.86 -56.8 15.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.314 -0.867 . . . . 0.0 109.592 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 23.5 mp0 -76.37 -41.78 46.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.627 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 63.6 m-20 -60.11 -52.82 63.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.149 -0.97 . . . . 0.0 109.797 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.495 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 1.2 tp -67.98 -44.71 76.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.591 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -59.33 -49.27 78.46 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.592 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.63 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -76.73 -19.71 57.36 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.084 -1.447 . . . . 0.0 109.485 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.8 tp -64.67 -35.14 80.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -86.66 -19.0 29.89 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.398 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.63 ' NE2' ' CD1' ' A' ' 72' ' ' TRP . 4.0 tt0 -99.26 2.74 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.879 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 129.26 39.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.194 -0.941 . . . . 0.0 111.381 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -63.5 -35.23 79.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 11' ' ' SER . 42.9 t -138.41 149.78 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 82.0 t -137.39 142.0 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.499 1.142 . . . . 0.0 112.106 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.2 165.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -158.04 137.13 11.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.632 -1.293 . . . . 0.0 109.227 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' OE2' ' CE1' ' A' ' 14' ' ' PHE . 28.4 mt-10 -93.61 126.1 38.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -126.68 130.72 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 20.0 m -170.5 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.843 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 31.5 tt0 -100.05 -24.64 0.22 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.706 . . . . 0.0 109.843 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 96.2 Cg_exo -43.3 -142.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.731 2.287 . . . . 0.0 112.163 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.664 ' OG ' ' N ' ' A' ' 88' ' ' LEU . 2.4 t 172.53 -153.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.677 -1.264 . . . . 0.0 109.669 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.664 ' N ' ' OG ' ' A' ' 87' ' ' SER . 20.9 mt -30.59 136.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 110.091 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.37 -38.07 3.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.85 -41.86 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.969 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.66 -33.39 71.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' CD2' ' SD ' ' B' ' 319' ' ' MET . 65.4 t80 -66.65 -52.89 39.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -1.143 . . . . 0.0 109.745 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.562 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 59.0 mt-10 -64.82 -31.27 72.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.314 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.1 mt -66.9 -44.42 80.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.88 -33.06 86.24 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.569 HH11 ' CG1' ' B' ' 298' ' ' VAL . 17.2 mmm180 -65.27 -44.46 87.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -1.03 . . . . 0.0 109.846 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 -36.71 73.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 108.67 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.551 ' CG1' HH11 ' B' ' 296' ' ' ARG . 0.5 OUTLIER -53.52 -44.52 56.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.457 ' N ' HG11 ' A' ' 98' ' ' VAL . . . -74.8 -50.85 15.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.647 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.98 -6.45 12.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.53 17.54 66.79 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.905 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 104' ' ' ILE . 64.4 mmtt -83.47 135.43 43.75 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 120.708 -1.466 . . . . 0.0 107.973 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.15 121.73 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.642 1.561 . . . . 0.0 110.966 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 102' ' ' LYS . 1.7 mp -108.8 100.13 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.961 -1.087 . . . . 0.0 111.45 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.75 114.37 26.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.713 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -110.95 154.53 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 109.383 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.8 mt -122.92 149.5 44.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.7 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -145.03 119.63 9.76 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' NH1' ' NE2' ' A' ' 111' ' ' GLN . 7.2 mtm180 -79.25 124.61 84.27 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.797 -1.189 . . . . 0.0 111.109 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 113' ' ' GLY . 95.3 Cg_endo -83.42 -30.74 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.594 2.196 . . . . 0.0 110.758 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.469 ' NE2' ' NH1' ' A' ' 109' ' ' ARG . 9.4 pt20 -51.25 -35.24 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 39.6 m -98.7 -11.9 21.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 39.98 48.07 3.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 5.12 2.43 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -1.15 . . . . 0.0 109.386 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.0 t 53.92 109.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.822 0.82 . . . . 0.0 110.135 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' O ' ' OE2' ' B' ' 256' ' ' GLU . 8.7 tp -56.19 149.32 16.31 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.94 150.07 14.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.16 86.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 108.643 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.602 ' SD ' ' CD2' ' B' ' 292' ' ' TYR . 0.0 OUTLIER -60.28 -50.58 73.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' ALA . 32.6 mm -63.94 -36.32 76.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.104 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -53.58 -43.37 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.709 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -54.63 -43.92 79.04 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.715 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -78.01 90.17 4.18 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -174.28 46.5 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.591 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.37 -12.39 61.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 67.62 2.61 22.75 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.4 m -105.58 -78.85 0.57 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.993 -1.298 . . . . 0.0 108.87 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -93.19 -31.77 14.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.713 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 8.5 t80 -110.74 130.19 55.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.6 125.74 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.864 -1.148 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.68 106.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 12.3 m0 -102.06 138.02 39.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.0 -1.063 . . . . 0.0 109.558 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' O ' ' CE ' ' A' ' 142' ' ' MET . 91.8 m-20 -91.79 152.67 20.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.705 -1.247 . . . . 0.0 109.012 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.8 p90 -164.29 -179.33 6.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.475 -1.29 . . . . 0.0 111.917 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.53 147.36 25.33 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 135' ' ' ALA . 52.0 mt-10 -42.06 -36.17 1.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.926 -1.109 . . . . 0.0 110.298 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.36 4.44 41.53 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.496 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.96 7.15 0.33 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.552 -1.558 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.8 p -51.25 -43.29 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 108.464 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.7 mt-10 -57.93 -36.34 72.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 m -64.99 -45.53 85.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.455 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 3.9 tpp -51.56 -46.32 63.37 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.84 -33.18 68.26 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.702 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 55.3 m-20 -65.43 -40.42 93.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.95 -1.093 . . . . 0.0 109.837 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -69.91 -49.06 55.8 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.634 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.28 -48.73 80.06 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 109.979 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' LEU . 8.9 m-85 -66.95 -32.43 73.67 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.904 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.71 -25.14 64.62 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.588 -1.32 . . . . 0.0 107.785 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.39 62.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.53 -0.732 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -146.05 -0.13 0.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.456 -1.402 . . . . 0.0 111.649 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 147' ' ' PHE . 16.6 mt -115.69 82.75 10.58 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.672 -1.267 . . . . 0.0 109.267 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--N 1.31 -1.454 0 C-N-CA 122.646 2.231 . . . . 0.0 112.095 179.77 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.61 -161.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.625 2.217 . . . . 0.0 111.587 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' CYS . . . . . 0.456 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 29.7 p -100.07 -173.19 2.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' B' ' 278' ' ' VAL . 1.2 m -118.62 143.76 46.6 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 60.1 t -126.14 136.63 60.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' TYR . . . . . 0.53 ' CZ ' ' OE1' ' B' ' 244' ' ' GLU . 6.0 t80 -113.35 109.12 18.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.46 ' CE1' ' OE2' ' B' ' 282' ' ' GLU . 0.0 OUTLIER -98.13 130.09 44.91 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.658 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 3.2 m -102.28 151.33 22.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -165.95 162.75 36.23 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 15.9 m -86.48 133.0 33.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.168 -1.195 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 1.3 mm . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.229 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 50.3 mp0 -51.34 -46.08 62.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 6.0 m-20 -65.56 -22.53 66.7 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 17.9 tp60 -63.44 -39.07 93.49 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.29 68.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.95 -32.53 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' TYR . . . . . 0.578 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 19.5 m-30 -67.27 -47.02 71.94 Favored 'General case' 0 C--O 1.198 -1.631 0 O-C-N 121.527 -0.733 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.38 -37.4 80.64 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.723 -1.236 . . . . 0.0 109.044 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -70.65 -56.86 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.773 -1.204 . . . . 0.0 108.505 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 4.9 mt -52.83 -43.93 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' VAL . . . . . 0.578 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 60.6 t -59.66 -28.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.0 m -71.93 -34.19 68.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.0 109.383 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.47 -53.54 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.871 -1.143 . . . . 0.0 108.626 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.64 -39.61 73.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -62.97 -22.97 67.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -72.91 -44.62 61.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 109.491 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.81 -49.9 9.85 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.513 -0.742 . . . . 0.0 111.873 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . -142.67 132.75 5.24 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' B' ' 239' ' ' GLY . 0.0 OUTLIER -35.96 145.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -1.003 . . . . 0.0 109.027 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' B' ' 243' ' ' THR . 44.7 t -79.31 100.63 4.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' LEU . . . . . 0.621 HD11 ' CD1' ' B' ' 272' ' ' TRP . 0.1 OUTLIER -49.84 94.88 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.938 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' THR . . . . . 0.524 ' N ' ' O ' ' B' ' 241' ' ' VAL . 6.6 m 27.81 100.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.421 0.629 . . . . 0.0 111.387 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' B' ' 246' ' ' VAL . 15.7 tp10 -143.2 66.52 1.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' B' ' 246' ' ' VAL . 25.0 p80 -50.64 -5.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.562 -0.711 . . . . 0.0 110.147 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' B' ' 244' ' ' GLU . 39.3 t -40.36 -58.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.675 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -67.2 -40.54 86.51 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 108.616 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' ASP . . . . . 0.443 ' O ' ' CD1' ' B' ' 251' ' ' LEU . 7.0 t70 -71.0 25.58 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.67 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -102.47 -15.97 16.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -54.16 -43.89 70.98 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' LEU . . . . . 0.863 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -50.83 136.79 21.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' GLU . . . . . 0.606 ' O ' ' O ' ' B' ' 251' ' ' LEU . 20.6 mm-40 54.17 153.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.98 . . . . 0.0 109.175 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.69 89.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.181 1.921 . . . . 0.0 111.542 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' LEU . . . . . 0.432 ' C ' ' CD1' ' B' ' 254' ' ' LEU . 0.3 OUTLIER -61.88 -163.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.75 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 91.37 151.58 27.03 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' GLU . . . . . 0.679 ' C ' ' H ' ' B' ' 258' ' ' ALA . 46.7 mt-10 -50.29 178.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -1.214 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 64.82 -25.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 109.055 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' ALA . . . . . 0.679 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -80.08 141.73 35.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.29 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.21 132.12 38.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 168.57 -77.5 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 138.81 83.21 0.1 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -52.08 -45.88 64.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -1.072 . . . . 0.0 108.387 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -62.09 -46.52 88.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 36.0 t80 -62.72 -41.3 99.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.31 -0.869 . . . . 0.0 108.994 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 12.0 mt -56.28 -45.86 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' HIS . . . . . 0.709 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -76.68 -27.33 55.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.926 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.66 -56.66 17.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.348 -0.845 . . . . 0.0 109.688 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 23.1 mp0 -76.65 -41.54 45.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 62.1 m-20 -60.01 -52.3 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' B' ' 274' ' ' GLN . 1.2 tp -68.57 -44.49 74.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.23 -49.37 78.09 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.621 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' TRP . . . . . 0.624 ' CD1' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -76.6 -19.63 57.64 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.121 -1.432 . . . . 0.0 109.588 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 273' ' ' LEU . . . . . 0.418 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.7 tp -64.81 -34.91 79.49 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 274' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.2 OUTLIER -86.96 -19.1 29.24 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.442 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 275' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' B' ' 272' ' ' TRP . 4.1 tt0 -99.11 2.39 45.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.822 -1.174 . . . . 0.0 108.817 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.02 129.3 39.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.108 -0.995 . . . . 0.0 111.405 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.37 -35.38 80.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' B' ' 211' ' ' SER . 42.6 t -138.28 149.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 83.2 t -137.48 142.22 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.534 1.159 . . . . 0.0 112.194 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 280' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 97.2 t -138.34 165.45 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -157.72 137.04 11.85 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.548 -1.345 . . . . 0.0 109.283 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 282' ' ' GLU . . . . . 0.46 ' OE2' ' CE1' ' B' ' 214' ' ' PHE . 28.7 mt-10 -93.32 126.29 38.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 283' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -126.81 130.88 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 284' ' ' THR . . . . . 0.465 HG23 ' N ' ' B' ' 285' ' ' GLN . 20.2 m -170.77 -92.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 285' ' ' GLN . . . . . 0.841 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 31.8 tt0 -100.11 -24.75 0.22 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.452 -0.78 . . . . 0.0 109.838 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 286' ' ' PRO . . . . . 0.841 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 97.6 Cg_exo -43.31 -142.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.688 2.259 . . . . 0.0 112.125 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 287' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' B' ' 288' ' ' LEU . 2.1 t 172.53 -153.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.569 -1.332 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 288' ' ' LEU . . . . . 0.679 ' N ' ' OG ' ' B' ' 287' ' ' SER . 20.2 mt -30.49 136.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 114.97 -37.64 3.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.17 -42.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.583 -0.951 . . . . 0.0 108.588 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.06 71.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 292' ' ' TYR . . . . . 0.602 ' CD2' ' SD ' ' A' ' 119' ' ' MET . 65.7 t80 -66.97 -52.24 45.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -1.161 . . . . 0.0 109.9 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 293' ' ' GLU . . . . . 0.552 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 59.5 mt-10 -65.25 -31.3 72.39 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 24.6 mt -66.98 -44.46 80.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.11 -32.75 85.06 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 296' ' ' ARG . . . . . 0.551 HH11 ' CG1' ' A' ' 98' ' ' VAL . 16.9 mmm180 -65.33 -44.52 87.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.051 . . . . 0.0 109.82 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.84 -36.82 73.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.993 . . . . 0.0 108.647 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 298' ' ' VAL . . . . . 0.569 ' CG1' HH11 ' A' ' 96' ' ' ARG . 0.5 OUTLIER -53.26 -44.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 299' ' ' ALA . . . . . 0.454 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.02 -50.68 15.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.736 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.45 -6.18 13.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 109.475 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.41 17.57 66.56 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.817 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 302' ' ' LYS . . . . . 0.424 ' O ' HG13 ' B' ' 304' ' ' ILE . 65.1 mmtt -83.42 135.69 43.62 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 120.667 -1.49 . . . . 0.0 107.931 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.23 122.16 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.75 1.634 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 304' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 302' ' ' LYS . 1.7 mp -109.37 99.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.987 . . . . 0.0 111.283 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 24.9 tp -91.55 114.37 26.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 306' ' ' CYS . . . . . 0.71 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.3 OUTLIER -110.97 154.34 24.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.901 -1.124 . . . . 0.0 109.566 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 307' ' ' LEU . . . . . 0.538 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 9.2 mt -122.86 149.76 43.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.245 -0.909 . . . . 0.0 111.249 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 308' ' ' PHE . . . . . 0.709 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.4 OUTLIER -145.72 119.69 9.37 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 309' ' ' ARG . . . . . 0.461 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 7.7 mtm180 -79.07 125.21 84.1 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.0 111.131 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 310' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.5 Cg_endo -83.55 -29.98 0.94 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.579 2.186 . . . . 0.0 110.669 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 311' ' ' GLN . . . . . 0.461 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 9.4 pt20 -51.95 -35.16 45.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 312' ' ' SER . . . . . 0.448 ' O ' ' C ' ' B' ' 313' ' ' GLY . 31.1 m -98.8 -11.68 21.59 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 39.84 47.93 3.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 314' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' B' ' 315' ' ' VAL . 0.5 OUTLIER -71.14 4.39 2.8 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.168 -1.195 . . . . 0.0 109.373 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' B' ' 314' ' ' ARG . 2.9 t 54.6 109.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.82 0.819 . . . . 0.0 110.101 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 316' ' ' LEU . . . . . 0.55 ' O ' ' OE2' ' A' ' 56' ' ' GLU . 8.7 tp -56.58 149.83 16.71 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 150.03 16.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.629 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.66 85.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 108.606 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 319' ' ' MET . . . . . 0.612 ' SD ' ' CD2' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -60.78 -50.48 73.28 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 108.836 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 320' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' B' ' 323' ' ' ALA . 32.2 mm -64.02 -36.34 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.981 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 321' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' B' ' 322' ' ' GLY . 19.2 mmt85 -53.54 -43.61 68.55 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 322' ' ' GLY . . . . . 0.71 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -54.58 -43.82 78.55 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 104.632 -3.387 . . . . 0.0 104.632 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 323' ' ' ALA . . . . . 0.71 ' O ' ' O ' ' B' ' 320' ' ' ILE . . . -77.92 90.14 4.12 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -174.14 46.32 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.622 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.08 -12.29 61.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.413 -0.805 . . . . 0.0 111.212 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 326' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 67.36 2.15 18.62 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.666 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 73.6 m -105.27 -78.91 0.56 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.991 -1.299 . . . . 0.0 108.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -93.16 -32.11 14.53 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.71 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 9.1 t80 -110.23 130.13 55.6 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.52 125.43 13.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.796 -1.19 . . . . 0.0 111.25 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 35.9 t -85.46 106.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 332' ' ' TRP . . . . . 0.479 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 11.9 m0 -102.02 137.79 39.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.04 -1.038 . . . . 0.0 109.44 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 333' ' ' ASP . . . . . 0.458 ' O ' ' SD ' ' B' ' 342' ' ' MET . 91.8 m-20 -91.54 152.57 20.26 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.801 -1.187 . . . . 0.0 109.084 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 334' ' ' TYR . . . . . 0.538 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.7 p90 -164.15 -179.22 6.01 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.856 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.91 147.59 25.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 336' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.4 mt-10 -42.21 -36.07 1.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.802 -1.186 . . . . 0.0 110.281 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -75.26 3.79 44.79 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.507 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.52 7.09 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.486 -1.597 . . . . 0.0 110.866 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.9 p -51.11 -43.49 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.908 -1.12 . . . . 0.0 108.467 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 340' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 83.1 mt-10 -57.88 -36.24 72.1 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 72.1 m -64.88 -45.67 85.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 342' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.9 tpp -51.42 -46.81 63.06 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.23 -33.6 70.02 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.789 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 344' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' B' ' 340' ' ' GLU . 55.4 m-20 -65.4 -40.33 93.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.972 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.92 -49.17 54.66 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.923 -1.111 . . . . 0.0 108.462 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.15 -48.61 80.8 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.215 -0.928 . . . . 0.0 110.017 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 347' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' B' ' 351' ' ' LEU . 9.1 m-85 -66.96 -32.18 73.25 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.934 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -68.98 -25.04 64.33 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.54 -1.35 . . . . 0.0 107.83 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.26 62.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 350' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.5 OUTLIER -146.26 -0.34 0.78 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.611 -1.306 . . . . 0.0 111.512 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 351' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' B' ' 347' ' ' PHE . 16.7 mt -115.53 82.58 10.0 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 120.576 -1.328 . . . . 0.0 109.189 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--N 1.312 -1.391 0 C-N-CA 122.752 2.301 . . . . 0.0 112.136 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.99 146.9 40.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.8 154.52 36.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 6' ' ' GLU . 17.7 m -57.98 158.4 6.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.78 38.46 0.5 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 4' ' ' SER . 95.3 mt-10 -114.88 156.94 24.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.496 -1.002 . . . . 0.0 109.207 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.43 176.58 8.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -89.76 135.54 30.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.314 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' ALA . 32.1 Cg_exo -57.62 -150.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.804 1.669 . . . . 0.0 111.213 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -111.03 -175.39 2.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 36.0 m -121.44 152.43 39.1 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.0 136.09 58.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' CG ' ' A' ' 69' ' ' ASP . 8.1 t80 -113.17 99.26 7.69 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -89.49 116.75 27.89 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.46 -0.896 . . . . 0.0 108.883 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.55 146.76 23.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.443 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.62 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -168.58 75.13 0.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.62 ' C ' ' O ' ' A' ' 16' ' ' GLY . 15.7 m -16.2 127.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.936 -0.743 . . . . 0.0 110.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 19' ' ' ARG . 2.4 mt -94.43 -75.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 110.034 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' NE ' ' OE2' ' A' ' 56' ' ' GLU . 39.7 mmm-85 48.42 72.08 0.31 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.41 -116.71 4.45 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.39 95.57 0.11 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.704 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -129.09 -144.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 111.859 -175.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -59.76 -42.95 94.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.7 m-20 -52.06 -34.76 45.01 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -64.09 -44.61 91.82 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.92 60.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.285 -0.885 . . . . 0.0 109.227 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -58.75 -32.45 69.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 16.0 m-30 -67.86 -46.03 72.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.343 -0.848 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.71 78.27 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.995 -1.065 . . . . 0.0 108.997 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -70.8 -57.22 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.077 . . . . 0.0 108.579 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.45 HG23 HD11 ' A' ' 31' ' ' ILE . 26.5 mt -51.7 -42.57 31.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 49.1 t -61.72 -31.32 50.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.0 t -67.12 -39.24 86.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 110.026 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.554 ' NH2' ' HH ' ' A' ' 38' ' ' TYR . 53.0 ttt85 -69.56 -48.61 59.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.699 -1.251 . . . . 0.0 109.415 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.3 mt -60.71 -38.54 85.37 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -63.17 -24.99 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -78.05 -36.66 48.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.056 -1.027 . . . . 0.0 109.419 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.554 ' HH ' ' NH2' ' A' ' 34' ' ' ARG . 1.9 m-85 -69.8 -47.05 64.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.426 -0.796 . . . . 0.0 110.416 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.75 2.56 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -99.36 135.68 40.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.85 117.61 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 44' ' ' GLU . 19.3 mt -80.94 -35.81 31.8 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -68.27 37.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.561 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 42' ' ' LEU . 44.3 tp10 -50.27 -34.49 23.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -52.85 28.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 48' ' ' ASP . 21.8 t -58.83 163.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.716 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 62.55 -59.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.624 ' N ' ' O ' ' A' ' 46' ' ' VAL . 24.0 t70 -65.85 24.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.716 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -103.63 -10.83 18.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.73 -39.78 95.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.802 ' CD1' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.07 161.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.527 -0.733 . . . . 0.0 109.773 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 51' ' ' LEU . 12.8 mt-10 55.97 158.61 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.287 -0.883 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -63.04 131.8 34.13 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.446 2.097 . . . . 0.0 111.593 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 54' ' ' LEU . 3.7 mm? -93.91 171.16 9.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 141.27 37.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' OE2' ' NE ' ' A' ' 19' ' ' ARG . 50.0 mt-10 47.11 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.482 -1.01 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 55' ' ' GLY . 97.1 mt-10 -47.47 -20.6 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' A' ' 56' ' ' GLU . . . -48.66 151.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.91 136.89 6.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.89 -62.57 0.17 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.78 80.6 1.13 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 18.8 p-10 -52.17 -45.22 65.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -1.091 . . . . 0.0 108.307 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.468 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 88.4 mt-30 -63.49 -48.59 77.02 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -61.64 -36.0 79.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.094 -1.004 . . . . 0.0 109.015 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 mt -62.71 -52.22 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.727 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -67.56 -50.54 58.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.588 0.709 . . . . 0.0 109.423 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.727 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 45.7 tp10 -43.09 -58.14 2.59 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -63.9 -39.42 94.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.656 ' CG ' ' OH ' ' A' ' 13' ' ' TYR . 8.5 t0 -58.42 -48.0 82.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.408 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -64.51 -45.14 88.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' NE2' ' A' ' 75' ' ' GLN . 10.1 t-20 -65.44 -52.11 55.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 75' ' ' GLN . 0.5 OUTLIER -63.12 -45.69 90.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 108.976 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 42.1 tp -50.35 -37.22 35.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -73.7 -28.1 61.55 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.435 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.49 ' NE2' ' OD1' ' A' ' 71' ' ' ASN . 41.2 mt-30 -88.1 -0.5 57.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 109.646 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.81 44.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.091 -1.005 . . . . 0.0 112.277 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 11' ' ' SER . 61.5 m-20 -85.61 -31.67 22.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.47 143.96 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.2 t -138.88 130.81 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.687 -1.258 . . . . 0.0 111.748 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 84.0 t -136.65 130.66 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.23 137.21 52.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.663 -1.273 . . . . 0.0 110.291 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD2' ' A' ' 27' ' ' LEU . 55.1 tt0 -84.71 139.18 32.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.6 -0.687 . . . . 0.0 109.282 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -143.62 147.71 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.272 -0.893 . . . . 0.0 109.793 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 14.5 m -173.87 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' ' OD2' ' A' ' 24' ' ' ASP . 24.6 pt20 -97.93 153.61 38.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -37.37 143.71 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.146 1.897 . . . . 0.0 111.676 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.432 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 3.5 m -163.5 123.9 2.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 110.104 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' B' ' 287' ' ' SER . 4.0 mt -76.62 -45.19 31.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.316 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.564 ' N ' ' OG ' ' A' ' 17' ' ' SER . . . -60.78 -42.17 99.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.547 ' N ' ' OG ' ' A' ' 17' ' ' SER . 40.7 t -64.62 -45.21 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.194 -1.18 . . . . 0.0 109.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.79 -46.7 93.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -66.25 -47.94 72.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -1.081 . . . . 0.0 109.501 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' SD ' ' B' ' 319' ' ' MET . 10.8 mm-40 -59.76 -37.27 78.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.6 mt -75.22 -41.53 57.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.051 -1.031 . . . . 0.0 109.242 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.04 -50.02 59.65 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -40.05 82.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.392 -1.064 . . . . 0.0 108.612 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.42 ' O ' ' CA ' ' A' ' 101' ' ' GLY . . . -68.33 -37.06 80.18 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.633 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.73 -45.14 48.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.892 -1.13 . . . . 0.0 108.276 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -89.59 -53.04 4.7 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.089 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.506 ' CD1' ' C ' ' A' ' 100' ' ' LEU . 1.8 tm? -90.06 -29.85 18.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.089 -1.007 . . . . 0.0 109.643 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 97' ' ' ALA . . . -74.19 166.68 54.74 Favored Glycine 0 C--N 1.283 -2.392 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 4.8 mtmm -124.55 -71.09 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 82.9 Cg_endo -79.48 111.43 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.978 1.786 . . . . 0.0 109.293 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.59 116.03 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.782 -1.199 . . . . 0.0 111.995 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 132' ' ' TRP . 57.3 tp -110.5 126.26 54.18 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 145.66 39.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.928 -1.108 . . . . 0.0 108.771 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.3 mt -122.47 135.49 54.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.911 . . . . 0.0 111.625 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -133.5 138.01 45.91 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.577 ' NH2' ' NE2' ' A' ' 111' ' ' GLN . 4.4 mtm180 -98.98 134.66 21.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 120.703 -1.248 . . . . 0.0 111.338 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.43 -26.1 4.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.553 2.169 . . . . 0.0 111.267 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.577 ' NE2' ' NH2' ' A' ' 109' ' ' ARG . 20.3 pt20 -46.63 -38.66 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' GLY . 31.0 t -102.13 -15.8 16.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.82 51.37 2.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 115' ' ' VAL . 58.8 mtp85 -80.87 18.08 1.07 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.998 -1.295 . . . . 0.0 109.062 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 114' ' ' ARG . 48.7 t 46.99 100.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.671 0.748 . . . . 0.0 110.141 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.1 tp -47.95 145.77 2.82 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -45.8 143.13 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.63 -30.31 69.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.458 -0.776 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.408 ' SD ' ' CD ' ' B' ' 293' ' ' GLU . 0.8 OUTLIER -70.76 -51.57 26.28 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.878 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.451 HG23 HD13 ' A' ' 120' ' ' ILE . 35.8 mm -62.66 -42.51 96.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -65.17 -48.84 72.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.544 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.603 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -62.35 -31.25 78.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 125' ' ' ASP . . . -62.6 -15.66 52.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.038 -1.272 . . . . 0.0 108.199 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.45 96.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 65.3 m-20 -105.29 -22.52 13.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.893 . . . . 0.0 108.693 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.42 30.37 77.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 89.6 p -134.89 59.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.629 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.7 mtt180 98.61 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -97.49 120.03 37.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -145.91 142.02 28.34 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.852 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.83 100.59 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.43 ' CD2' HD12 ' A' ' 105' ' ' LEU . 21.6 m0 -95.43 152.68 18.19 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.237 -0.914 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -97.38 155.54 16.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.094 -1.004 . . . . 0.0 108.877 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 6.3 p90 -170.19 -178.68 2.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.724 -1.235 . . . . 0.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.94 149.72 27.57 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.9 mt-10 -42.47 -29.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.704 -1.247 . . . . 0.0 110.154 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.51 -6.06 88.05 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.56 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.08 11.32 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.587 -1.537 . . . . 0.0 110.581 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.0 p -54.34 -45.35 68.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.924 -1.11 . . . . 0.0 108.448 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.504 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 49.9 mt-10 -57.76 -32.67 67.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.451 -0.781 . . . . 0.0 109.262 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.8 m -68.18 -45.52 73.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.568 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.97 -50.91 60.33 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.55 -34.1 77.15 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.89 -41.53 95.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.413 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -68.87 -48.7 62.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.867 -1.146 . . . . 0.0 108.331 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.39 -48.17 82.9 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 16.7 m-85 -69.74 -32.9 71.7 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.942 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 150' ' ' TYR . 27.1 mm-40 -62.24 -32.42 73.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.14 10.87 5.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.2 t80 -134.6 -105.09 0.23 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.24 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD1' ' CD1' ' A' ' 147' ' ' PHE . 14.9 mt -34.4 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.8 -0.563 . . . . 0.0 111.208 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 150' ' ' TYR . 87.1 Cg_endo -94.8 -61.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.168 2.578 . . . . 0.0 111.142 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.44 ' H ' ' CG ' ' A' ' 152' ' ' PRO . 92.6 mm-40 -107.54 -23.48 12.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -57.19 -30.25 64.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 108.949 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 156' ' ' ALA . 12.0 t -57.1 -44.94 83.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.457 ' N ' ' CG2' ' A' ' 155' ' ' THR . . . -168.48 148.86 4.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -150.56 118.8 6.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.54 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 m -74.02 -31.09 62.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.7 p -96.33 151.28 19.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.517 ' ND1' ' N ' ' A' ' 160' ' ' HIS . 6.4 p-80 -139.04 76.46 33.21 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.855 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 152.6 12.76 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.707 2.272 . . . . 0.0 112.02 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.5 m -55.14 153.18 7.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.372 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.438 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.14 146.64 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.525 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -64.52 154.23 36.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' SER . . . . . 0.544 ' C ' ' H ' ' B' ' 206' ' ' GLU . 18.2 m -57.87 158.34 6.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -70.68 38.01 0.48 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' B' ' 204' ' ' SER . 95.4 mt-10 -114.23 155.61 25.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.522 -0.987 . . . . 0.0 109.181 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.51 176.42 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 109.43 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.56 136.1 30.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.249 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.09 -150.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.961 1.774 . . . . 0.0 111.279 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 28.2 p -111.25 -175.65 2.76 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 33.6 m -121.13 152.81 38.29 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 10.5 t -131.25 136.17 58.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.659 ' OH ' ' CG ' ' B' ' 269' ' ' ASP . 8.1 t80 -113.29 99.29 7.69 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' B' ' 214' ' ' PHE . 0.0 OUTLIER -89.67 116.52 27.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.975 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.1 m -92.34 146.75 23.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.625 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -168.29 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.625 ' C ' ' O ' ' B' ' 216' ' ' GLY . 14.6 m -15.94 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.883 -0.775 . . . . 0.0 110.78 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.97 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.448 ' NE ' ' OE2' ' B' ' 256' ' ' GLU . 39.8 mmm-85 49.02 71.63 0.36 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.84 -116.65 4.36 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 159.23 95.82 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 106.51 -2.636 . . . . 0.0 106.51 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER -129.21 -144.27 0.27 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -1.138 . . . . 0.0 111.825 -175.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.92 -42.38 93.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.613 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.8 m-20 -52.68 -34.6 52.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -64.16 -44.44 92.09 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.02 59.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.32 -0.862 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.432 ' CD2' ' OE2' ' B' ' 282' ' ' GLU . 0.6 OUTLIER -58.67 -32.92 69.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 15.9 m-30 -67.49 -45.79 74.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.835 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.66 78.85 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.905 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -70.84 -57.15 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.901 -1.125 . . . . 0.0 108.619 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.76 -42.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 49.6 t -62.05 -31.23 50.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 10.5 t -67.07 -39.2 86.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . 0.542 ' NH2' ' OH ' ' B' ' 238' ' ' TYR . 53.8 ttt85 -69.56 -48.71 59.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.644 -1.285 . . . . 0.0 109.323 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.51 -38.66 85.06 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -63.18 -25.0 68.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.101 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -77.94 -36.43 49.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.026 -1.046 . . . . 0.0 109.402 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.558 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 1.9 m-85 -69.99 -47.1 63.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.505 -0.747 . . . . 0.0 110.469 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.92 2.6 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -99.3 135.75 40.25 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.363 -1.081 . . . . 0.0 109.346 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.86 117.55 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' B' ' 244' ' ' GLU . 19.4 mt -80.93 -35.82 31.85 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.318 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' B' ' 243' ' ' THR . 0.9 OUTLIER -68.34 36.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.597 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' B' ' 242' ' ' LEU . 45.1 tp10 -49.98 -34.03 19.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -49.87 -52.22 34.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.11 -0.994 . . . . 0.0 109.047 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' B' ' 248' ' ' ASP . 21.9 t -59.62 163.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 108.899 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.729 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 62.57 -59.89 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.626 ' N ' ' O ' ' B' ' 246' ' ' VAL . 24.4 t70 -65.76 24.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.729 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -103.16 -10.68 18.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.627 -0.671 . . . . 0.0 109.194 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -63.68 -39.85 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.805 ' CD1' ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -55.05 161.69 1.59 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.451 -0.78 . . . . 0.0 109.754 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' B' ' 251' ' ' LEU . 12.3 mt-10 56.14 158.68 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.07 131.64 33.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 111.618 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' B' ' 254' ' ' LEU . 3.7 mm? -94.0 170.26 9.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.294 -0.879 . . . . 0.0 109.827 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 142.28 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.448 ' OE2' ' NE ' ' B' ' 219' ' ' ARG . 50.4 mt-10 46.9 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 255' ' ' GLY . 96.8 mt-10 -47.21 -21.23 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.171 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -47.92 151.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -46.35 136.23 7.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.57 -62.81 0.16 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.07 80.7 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 18.6 p-10 -52.34 -44.96 65.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -1.125 . . . . 0.0 108.254 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . 0.476 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.1 mt-30 -63.71 -48.78 75.71 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -61.6 -35.5 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 109.08 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 1.9 mt -63.21 -52.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.73 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 0.1 OUTLIER -67.42 -50.09 60.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.493 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.73 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 44.4 tp10 -43.74 -58.19 2.83 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 110.032 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -39.16 93.54 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.0 109.382 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.659 ' CG ' ' OH ' ' B' ' 213' ' ' TYR . 9.0 t0 -58.55 -48.14 81.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -0.867 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -64.5 -45.3 87.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 109.797 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.475 ' OD1' ' NE2' ' B' ' 275' ' ' GLN . 10.0 t-20 -65.34 -51.92 57.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 109.678 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' B' ' 275' ' ' GLN . 0.5 OUTLIER -63.18 -45.7 90.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.938 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.407 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 42.3 tp -50.37 -37.23 36.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -73.74 -28.06 61.5 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.423 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.475 ' NE2' ' OD1' ' B' ' 271' ' ' ASN . 41.1 mt-30 -87.93 -0.58 57.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.999 -1.063 . . . . 0.0 109.707 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.99 131.62 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.205 -0.934 . . . . 0.0 112.4 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' B' ' 211' ' ' SER . 64.0 m-20 -85.65 -31.63 22.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 97.1 t -134.51 143.8 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 88.9 t -138.76 130.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.69 -1.256 . . . . 0.0 111.849 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 91.4 t -136.47 130.54 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -116.26 136.84 52.65 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.669 -1.269 . . . . 0.0 110.268 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.432 ' OE2' ' CD2' ' B' ' 227' ' ' LEU . 52.7 tt0 -84.32 139.59 32.19 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.589 -0.694 . . . . 0.0 109.273 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -144.13 147.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 15.2 m -173.47 -68.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.46 ' NE2' ' OD2' ' B' ' 224' ' ' ASP . 24.7 pt20 -98.38 153.86 37.84 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.12 144.04 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.131 1.888 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.445 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 3.5 m -163.72 123.7 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 87' ' ' SER . 4.0 mt -76.8 -45.16 29.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 217' ' ' SER . . . -60.43 -42.75 99.1 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.536 ' N ' ' OG ' ' B' ' 217' ' ' SER . 41.2 t -64.07 -45.57 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -1.201 . . . . 0.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.03 93.11 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -66.17 -47.97 72.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 109.557 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.408 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 11.6 mm-40 -59.87 -37.12 78.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.25 -41.65 56.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.033 -1.042 . . . . 0.0 109.212 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.93 60.2 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -39.66 82.4 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.395 -1.062 . . . . 0.0 108.596 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.426 ' O ' ' CA ' ' B' ' 301' ' ' GLY . . . -68.45 -37.22 80.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.921 -1.111 . . . . 0.0 108.626 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.446 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -52.66 -45.51 48.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.889 -1.132 . . . . 0.0 108.226 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -89.27 -52.76 4.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.236 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.51 ' C ' ' CD1' ' B' ' 300' ' ' LEU . 1.7 tm? -90.46 -29.84 17.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.026 -1.047 . . . . 0.0 109.593 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' B' ' 297' ' ' ALA . . . -73.51 166.4 54.63 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 108.308 -1.917 . . . . 0.0 108.308 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.508 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 4.8 mtmm -124.54 -71.25 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 84.7 Cg_endo -79.4 110.86 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.884 1.723 . . . . 0.0 109.398 176.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 16.6 mt -128.98 116.35 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.699 -1.25 . . . . 0.0 112.103 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . 0.427 HD12 ' CD2' ' B' ' 332' ' ' TRP . 57.8 tp -110.88 126.06 54.29 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 145.92 38.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.97 -1.081 . . . . 0.0 108.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.562 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 8.1 mt -122.98 135.6 54.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.229 -0.919 . . . . 0.0 111.643 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -133.45 138.35 46.15 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 311' ' ' GLN . 4.3 mtm180 -99.36 134.82 20.96 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 0.0 111.307 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.33 -26.27 4.23 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.531 2.154 . . . . 0.0 111.31 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 309' ' ' ARG . 20.2 pt20 -46.37 -38.76 9.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 28.7 t -102.04 -15.77 16.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.89 51.14 2.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.3 mtp85 -80.63 17.33 1.15 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.978 -1.307 . . . . 0.0 109.048 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.0 t 47.67 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.688 0.756 . . . . 0.0 110.128 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . . . . . . . . . 47.8 tp -47.44 145.6 2.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.569 -0.707 . . . . 0.0 109.519 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.4 m -45.7 142.98 2.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.892 . . . . 0.0 110.195 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.37 69.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -0.759 . . . . 0.0 109.607 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.443 ' SD ' ' CD ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -70.33 -52.03 25.7 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.911 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.453 HG23 HD13 ' B' ' 320' ' ' ILE . 35.9 mm -62.43 -42.28 95.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.61 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 18.0 tpt85 -65.33 -48.94 71.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.143 -0.973 . . . . 0.0 109.484 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.644 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.41 -31.36 79.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.408 ' O ' ' OD1' ' B' ' 325' ' ' ASP . . . -62.19 -15.76 48.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.036 -1.273 . . . . 0.0 108.111 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -44.24 96.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.508 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 66.7 m-20 -105.17 -22.41 13.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 108.696 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 65.51 30.14 76.81 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.2 p -134.7 59.57 1.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' B' ' 327' ' ' SER . 95.1 mtt180 98.89 -31.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -97.37 119.73 36.44 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -145.71 142.11 28.68 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.901 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 30.4 t -107.85 100.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.427 ' CD2' HD12 ' B' ' 305' ' ' LEU . 21.4 m0 -95.34 152.62 18.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.248 -0.908 . . . . 0.0 109.578 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -97.23 155.65 16.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 108.822 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 6.2 p90 -170.28 -179.12 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.761 -1.212 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.59 149.61 27.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 335' ' ' ALA . 49.5 mt-10 -42.56 -29.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.707 -1.245 . . . . 0.0 110.18 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.33 -6.02 87.75 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.624 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -145.02 11.33 1.36 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.504 . . . . 0.0 110.6 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 5.0 p -54.3 -45.25 68.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.896 -1.128 . . . . 0.0 108.55 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 49.4 mt-10 -57.77 -32.76 67.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.498 -0.751 . . . . 0.0 109.203 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.7 m -68.33 -45.42 72.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.88 -51.21 58.44 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.12 -34.37 77.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.816 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.92 -41.43 95.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -68.75 -48.87 62.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.778 -1.201 . . . . 0.0 108.265 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.27 -48.1 83.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.856 . . . . 0.0 110.139 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.7 m-85 -69.85 -32.87 71.49 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.952 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' B' ' 350' ' ' TYR . 26.4 mm-40 -62.27 -32.67 73.42 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -81.9 10.82 5.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.3 t80 -134.4 -105.14 0.23 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.236 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.48 ' H ' ' HB3' ' B' ' 350' ' ' TYR . 15.0 mt -34.22 92.17 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 111.182 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' B' ' 350' ' ' TYR . 88.6 Cg_endo -94.9 -61.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 123.103 2.536 . . . . 0.0 111.074 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . 0.441 ' H ' ' CG ' ' B' ' 352' ' ' PRO . 92.4 mm-40 -107.19 -24.01 12.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -56.66 -30.51 63.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 108.952 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' B' ' 356' ' ' ALA . 12.0 t -57.01 -45.36 83.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . 0.455 ' N ' ' CG2' ' B' ' 355' ' ' THR . . . -168.1 148.32 4.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 23.5 t -150.39 118.37 6.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.417 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 50.5 m -73.58 -31.48 63.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 84.7 p -95.66 151.23 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.526 ' ND1' ' N ' ' B' ' 360' ' ' HIS . 5.9 p-80 -138.79 76.76 34.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.897 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.69 152.71 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.554 2.169 . . . . 0.0 111.917 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 20.4 m -55.45 148.64 14.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.543 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.295 0.569 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 141.33 39.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 5' ' ' GLY . . . -66.12 -31.26 72.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.605 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 m 49.54 17.57 0.24 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 3' ' ' ALA . . . -52.89 -39.1 55.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -60.81 135.37 57.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -1.086 . . . . 0.0 109.354 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.0 -55.84 11.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -137.81 153.78 74.12 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.683 . . . . 0.0 109.263 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.8 Cg_exo -55.38 -154.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.386 2.057 . . . . 0.0 111.424 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 32.0 p -111.91 172.74 6.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HG ' ' HG ' ' A' ' 42' ' ' LEU . 18.4 t -114.86 155.44 26.81 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 108.704 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 2.7 t -130.45 126.92 61.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.522 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 32.9 t80 -93.99 127.46 39.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' A' ' 32' ' ' VAL . 17.8 t80 -100.81 130.7 46.87 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.787 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' GLU . 5.5 t -134.0 128.79 35.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.99 -178.96 33.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -76.02 118.7 19.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -1.192 . . . . 0.0 108.634 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.7 97.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -88.57 -87.99 0.15 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.29 36.38 2.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.07 137.33 6.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.65 ' H ' ' CB ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -172.21 -164.08 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.83 -1.394 . . . . 0.0 111.235 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 49.4 mp0 -60.62 -53.28 59.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 108.934 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -55.31 -29.36 58.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.65 ' CB ' ' H ' ' A' ' 22' ' ' ARG . 35.6 tp60 -64.34 -43.06 95.78 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -49.08 68.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 -34.22 67.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 19.2 m-30 -69.17 -41.32 77.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.983 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -62.67 -37.0 84.69 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 109.11 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.56 -56.78 5.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.841 -1.162 . . . . 0.0 108.613 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -54.08 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 45.5 t -65.27 -28.73 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 18.8 m -67.08 -40.47 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.593 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 -69.59 -47.26 64.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.806 -1.183 . . . . 0.0 109.113 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.71 -40.62 92.97 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -62.57 -25.29 68.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.688 -0.632 . . . . 0.0 109.42 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -78.03 -37.58 46.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.0 m-85 -67.83 -45.73 73.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 110.534 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -152.63 -152.48 5.98 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -90.08 120.39 31.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -1.167 . . . . 0.0 109.388 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -89.61 115.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 15.9 mt -79.44 172.35 13.92 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.498 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 45' ' ' HIS . 4.7 m 54.23 41.86 31.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.257 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.32 -12.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 108.778 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' ALA . 47.4 t-80 -52.98 -45.57 67.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.387 -0.821 . . . . 0.0 109.614 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' ALA . 69.2 t -39.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -50.05 -42.53 49.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 108.903 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 26.2 t70 -81.14 24.49 0.52 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -105.95 33.41 3.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.62 -21.33 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.701 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.08 163.62 20.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.499 -0.751 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 51' ' ' LEU . 14.6 mt-10 54.58 157.85 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' LEU . 23.2 Cg_endo -62.98 71.07 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.425 2.083 . . . . 0.0 111.475 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -54.97 -169.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 116.69 129.96 4.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 63.6 mt-10 -50.24 -33.69 20.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.248 . . . . 0.0 108.629 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -69.58 -24.07 63.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -62.09 150.02 39.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.88 11.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.908 . . . . 0.0 109.404 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -52.97 -30.88 38.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.56 76.8 1.18 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 56' ' ' GLU . 3.1 m-20 -52.96 -44.83 67.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.359 -1.083 . . . . 0.0 108.539 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -62.31 -45.5 92.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -55.45 -36.61 66.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 108.612 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 3.2 mt -67.61 -35.62 73.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.454 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.0 t-80 -79.4 -62.91 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 66' ' ' HIS . 72.2 mt-10 -43.58 -48.02 7.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.899 -1.126 . . . . 0.0 109.71 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -69.25 -42.75 75.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.115 -0.99 . . . . 0.0 109.371 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.522 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 1.2 m-20 -59.56 -47.06 87.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 110.307 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 1.5 mm? -65.21 -46.58 80.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.322 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 33.0 t-20 -61.86 -54.52 41.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.18 -34.78 75.61 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.208 -0.933 . . . . 0.0 109.236 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 39.5 tp -57.09 -41.56 79.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.122 -0.986 . . . . 0.0 108.754 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -76.9 -22.83 52.79 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.36 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 47.7 mt-30 -84.27 -9.09 58.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.108 . . . . 0.0 108.829 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 132.36 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.354 -0.841 . . . . 0.0 112.082 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 11' ' ' SER . 12.4 m-20 -86.95 -27.66 23.17 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 74.7 t -139.23 137.4 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 63.5 t -126.91 141.49 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.739 -1.226 . . . . 0.0 111.085 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 t -138.86 122.37 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.549 0.69 . . . . 0.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.61 128.76 53.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 110.044 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -87.71 125.91 34.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 108.549 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.602 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -115.74 27.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.428 -0.795 . . . . 0.0 109.747 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.5 ' C ' ' CZ ' ' A' ' 114' ' ' ARG . 4.3 m -78.39 23.97 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.903 . . . . 0.0 108.851 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.567 ' N ' ' CZ ' ' A' ' 114' ' ' ARG . 5.0 tp-100 -166.32 118.91 0.82 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.978 . . . . 0.0 109.373 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.649 ' N ' HH21 ' A' ' 114' ' ' ARG . 76.8 Cg_exo -45.44 108.75 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.061 1.841 . . . . 0.0 111.946 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 m -142.36 131.03 22.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.839 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.66 -39.07 80.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.46 ' CA ' ' OG ' ' B' ' 317' ' ' SER . . . -62.38 -45.03 96.78 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.4 t -64.81 -48.61 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -1.034 . . . . 0.0 108.787 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.73 98.03 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.78 -49.15 71.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.457 -1.025 . . . . 0.0 109.756 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 6.2 tp10 -59.65 -32.02 70.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.7 mt -70.78 -43.77 68.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.684 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -45.55 80.74 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -44.69 96.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.967 . . . . 0.0 108.748 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.39 -36.16 82.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.136 -0.978 . . . . 0.0 108.522 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -54.41 -44.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.877 -1.139 . . . . 0.0 108.071 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -86.67 -52.89 5.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.699 -0.626 . . . . 0.0 111.908 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.476 ' C ' ' CD1' ' A' ' 100' ' ' LEU . 2.2 tm? -92.34 -31.85 15.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.048 -1.033 . . . . 0.0 109.948 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -69.74 174.65 35.62 Favored Glycine 0 C--N 1.281 -2.507 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' A' ' 103' ' ' PRO . 22.1 mttt -136.55 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.638 ' CD ' ' H ' ' A' ' 102' ' ' LYS . 59.3 Cg_endo -98.84 109.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 123.748 2.965 . . . . 0.0 109.684 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.8 mt -127.21 124.35 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.839 -1.163 . . . . 0.0 112.027 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.2 tp -123.52 116.08 22.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 1.5 m -105.94 147.2 29.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.867 -1.145 . . . . 0.0 108.894 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.478 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.1 mt -120.26 139.12 53.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.193 -0.942 . . . . 0.0 111.068 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -146.02 122.96 11.35 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 16.8 mtt180 -88.07 140.0 30.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.719 -1.238 . . . . 0.0 110.481 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.66 -29.03 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.415 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.31 -32.9 5.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -99.17 -26.36 14.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.496 -0.752 . . . . 0.0 109.114 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.49 49.49 32.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.649 HH21 ' N ' ' A' ' 86' ' ' PRO . 10.4 mtp-105 -75.11 -11.41 60.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.035 -1.274 . . . . 0.0 111.205 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 114' ' ' ARG . 38.8 t 59.46 119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.466 ' N ' HD22 ' A' ' 116' ' ' LEU . 2.4 mt -77.34 158.64 30.03 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.84 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.454 ' OG ' ' CA ' ' B' ' 289' ' ' GLY . 0.3 OUTLIER -54.13 145.15 17.79 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.768 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.63 -19.09 5.37 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 108.696 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.496 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 1.0 OUTLIER -77.9 -45.18 24.86 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.399 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 120' ' ' ILE . 42.5 mm -66.71 -48.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.2 -0.938 . . . . 0.0 108.575 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.4 -44.68 74.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.247 -0.908 . . . . 0.0 108.81 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -64.15 -28.23 72.61 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -40.68 -64.65 0.5 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.553 -0.969 . . . . 0.0 110.273 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -150.94 -95.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.204 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 15.0 p-10 111.54 5.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.53 70.77 0.02 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.861 ' C ' ' H ' ' A' ' 129' ' ' PHE . 37.5 p -164.15 66.34 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 66.43 -20.3 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.861 ' H ' ' C ' ' A' ' 127' ' ' SER . 9.3 t80 -117.77 118.76 32.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.569 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 31.3 tt0 -137.19 134.28 36.11 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.205 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 69.5 t -91.85 105.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.569 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 13.7 m0 -102.14 142.35 33.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.171 -0.955 . . . . 0.0 109.724 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 54.0 m-20 -97.79 157.17 16.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.062 -1.024 . . . . 0.0 108.947 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' OH ' ' NE ' ' A' ' 109' ' ' ARG . 10.0 p90 -165.29 -172.72 2.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.591 -1.318 . . . . 0.0 111.936 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -159.27 148.37 18.34 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.4 mt-10 -42.93 -37.12 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.76 -1.213 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.92 2.86 53.71 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.207 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.97 7.14 0.52 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.58 -1.541 . . . . 0.0 110.601 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.8 p -53.99 -45.36 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.97 -1.081 . . . . 0.0 108.53 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 44.6 mt-10 -57.07 -33.67 67.5 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 83.9 m -68.19 -45.07 74.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.707 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.437 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.4 tpp -51.63 -48.13 63.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.76 -35.06 74.61 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 77.8 m-20 -65.59 -39.66 91.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 110.315 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -69.65 -50.29 45.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.818 -1.176 . . . . 0.0 108.315 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.92 -46.98 87.61 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.958 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 12.2 m-85 -68.96 -34.05 74.71 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.136 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.03 -23.9 66.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.34 59.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.675 -0.641 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -156.04 -48.86 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.221 -1.55 . . . . 0.0 112.715 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.616 ' N ' ' CG ' ' A' ' 150' ' ' TYR . 4.1 mt -38.32 -57.93 1.67 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.916 -1.115 . . . . 0.0 111.562 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 12.0 Cg_endo -59.67 -26.25 81.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.763 1.642 . . . . 0.0 111.741 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -81.75 -15.01 55.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.252 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -56.1 -31.79 63.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.1 t -65.24 -36.41 84.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.48 72.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.2 m -57.52 152.46 14.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.344 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.0 t -153.58 160.03 42.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.7 m -64.45 150.82 45.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.324 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -67.75 150.98 97.56 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.37 -22.96 51.84 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.55 2.167 . . . . 0.0 111.912 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.5 t -97.71 146.8 25.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.331 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.595 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.244 0.545 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.96 141.11 39.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.899 . . . . 0.0 109.393 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' B' ' 205' ' ' GLY . . . -66.07 -30.63 71.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 32.8 m 48.77 17.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 203' ' ' ALA . . . -52.85 -39.0 55.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -60.54 135.51 57.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -1.113 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -68.05 -55.7 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . -137.93 153.88 73.98 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ALA . 31.7 Cg_exo -55.52 -154.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.276 1.984 . . . . 0.0 111.377 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.6 p -112.21 172.75 6.72 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 19.4 t -114.97 155.35 27.08 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.756 -1.215 . . . . 0.0 108.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 2.6 t -130.49 127.1 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.535 ' OH ' ' CB ' ' B' ' 269' ' ' ASP . 33.5 t80 -93.8 127.6 39.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' B' ' 232' ' ' VAL . 17.9 t80 -100.86 130.7 46.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.81 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' B' ' 293' ' ' GLU . 5.7 t -134.04 129.08 35.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.532 -0.73 . . . . 0.0 109.415 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -159.36 -178.85 33.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.7 p -76.11 118.06 18.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 0.0 108.757 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.23 98.05 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.274 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -88.52 -87.85 0.16 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -128.6 36.37 2.46 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.12 136.87 5.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.645 ' H ' ' CB ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -171.96 -164.22 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.813 -1.404 . . . . 0.0 111.319 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' B' ' 223' ' ' GLU . 49.0 mp0 -60.5 -53.14 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 108.983 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.48 -29.01 57.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.645 ' CB ' ' H ' ' B' ' 222' ' ' ARG . 36.1 tp60 -64.68 -43.15 94.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.44 -0.787 . . . . 0.0 109.21 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -34.09 67.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.459 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 19.4 m-30 -69.28 -41.32 76.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.182 -0.949 . . . . 0.0 110.037 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -62.65 -37.26 85.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.59 -1.319 . . . . 0.0 109.161 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -70.37 -56.67 6.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.834 -1.166 . . . . 0.0 108.654 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 83.0 mt -54.09 -41.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 44.7 t -65.16 -28.63 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.761 . . . . 0.0 109.103 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 19.1 m -67.31 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.526 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -69.7 -47.87 61.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.891 -1.131 . . . . 0.0 109.078 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 13.1 mt -60.1 -40.77 90.79 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.7 ttt-85 -62.29 -25.45 67.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.695 -0.628 . . . . 0.0 109.458 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -78.0 -37.69 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.975 . . . . 0.0 109.535 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.0 m-85 -67.71 -45.51 74.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.591 -0.693 . . . . 0.0 110.541 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.86 -152.53 6.02 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -90.24 120.63 31.56 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.365 -1.079 . . . . 0.0 109.389 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.81 116.21 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.45 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 15.7 mt -79.81 172.15 14.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.082 -1.012 . . . . 0.0 109.491 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.501 ' C ' ' H ' ' B' ' 245' ' ' HIS . 4.5 m 54.38 41.92 31.7 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.36 -0.837 . . . . 0.0 109.322 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -50.64 -12.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 108.766 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' B' ' 243' ' ' THR . 46.7 t-80 -53.59 -45.14 69.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.5 -0.75 . . . . 0.0 109.426 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 249' ' ' ALA . 68.9 t -39.87 -79.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.622 -0.674 . . . . 0.0 109.992 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -49.69 -42.6 46.12 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.237 -0.915 . . . . 0.0 108.908 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.443 ' O ' ' CD2' ' B' ' 251' ' ' LEU . 24.3 t70 -80.82 24.22 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 246' ' ' VAL . . . -105.73 33.61 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' B' ' 247' ' ' ALA . 0.1 OUTLIER -123.5 -22.12 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.726 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -82.62 163.09 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.459 -0.776 . . . . 0.0 109.564 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' B' ' 251' ' ' LEU . 14.9 mt-10 54.82 157.75 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 109.88 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 254' ' ' LEU . 22.6 Cg_endo -62.74 71.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.441 2.094 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -55.66 -169.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.902 . . . . 0.0 109.454 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 117.5 129.97 4.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' B' ' 262' ' ' ASP . 61.6 mt-10 -50.1 -33.8 19.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.088 -1.242 . . . . 0.0 108.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -69.52 -24.55 63.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -61.56 150.04 37.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.488 -0.758 . . . . 0.0 109.351 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.73 11.1 0.15 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -52.68 -31.26 37.29 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.68 77.27 1.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' B' ' 256' ' ' GLU . 2.7 m-20 -52.89 -44.94 67.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -1.111 . . . . 0.0 108.589 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -62.04 -46.0 91.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.26 -37.12 66.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.961 . . . . 0.0 108.557 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.485 ' O ' ' OD1' ' B' ' 269' ' ' ASP . 3.3 mt -67.26 -35.25 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.444 ' O ' HD23 ' B' ' 270' ' ' LEU . 4.1 t-80 -79.69 -63.35 1.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 109.859 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' B' ' 266' ' ' HIS . 72.7 mt-10 -42.94 -48.44 5.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.67 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -69.03 -42.57 76.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.472 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.535 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 1.2 m-20 -59.85 -46.89 87.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 1.6 mm? -65.17 -46.83 79.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 110.424 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 32.9 t-20 -61.77 -54.52 41.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.138 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.45 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -61.15 -34.99 75.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.151 -0.968 . . . . 0.0 109.077 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 38.2 tp -56.89 -41.08 77.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.0 108.822 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -77.48 -22.53 51.15 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 47.7 mt-30 -84.55 -8.78 58.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.14 . . . . 0.0 108.884 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.88 132.39 45.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.402 -0.811 . . . . 0.0 112.131 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' B' ' 211' ' ' SER . 9.7 m-20 -86.63 -27.88 23.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 63.6 t -139.33 137.94 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 64.8 t -127.14 141.54 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.852 -1.155 . . . . 0.0 111.131 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 18.3 t -138.71 121.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.514 -0.741 . . . . 0.0 109.306 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -120.02 128.98 54.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.005 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.08 125.52 34.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 108.502 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.59 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -115.28 27.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 109.658 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.492 ' C ' ' CZ ' ' B' ' 314' ' ' ARG . 4.1 m -78.42 24.51 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 108.91 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.574 ' N ' ' CZ ' ' B' ' 314' ' ' ARG . 4.9 tp-100 -166.65 118.5 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.638 ' N ' HH21 ' B' ' 314' ' ' ARG . 74.4 Cg_exo -45.31 109.13 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.011 1.807 . . . . 0.0 111.898 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 29.4 m -142.34 131.23 22.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 70.7 mt -69.21 -38.31 78.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . 0.454 ' CA ' ' OG ' ' A' ' 117' ' ' SER . . . -63.08 -44.98 96.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.74 -48.7 83.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -1.036 . . . . 0.0 108.703 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -62.02 -39.57 97.76 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.08 -49.13 71.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -1.036 . . . . 0.0 109.728 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.525 ' CB ' ' SG ' ' B' ' 215' ' ' CYS . 6.8 tp10 -59.55 -32.08 70.0 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 61.0 mt -70.72 -43.86 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 108.691 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.27 81.48 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -43.96 97.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.597 -0.943 . . . . 0.0 108.8 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -67.16 -36.14 81.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.137 -0.977 . . . . 0.0 108.429 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.408 HG13 ' N ' ' B' ' 299' ' ' ALA . 0.7 OUTLIER -54.31 -44.53 66.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -86.76 -52.95 5.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.914 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.469 ' C ' ' CD1' ' B' ' 300' ' ' LEU . 2.2 tm? -92.13 -31.84 15.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 109.93 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -69.75 174.55 35.85 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.646 ' H ' ' CD ' ' B' ' 303' ' ' PRO . 22.6 mttt -136.59 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.646 ' CD ' ' H ' ' B' ' 302' ' ' LYS . 58.7 Cg_endo -98.83 109.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 123.703 2.935 . . . . 0.0 109.704 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 37.7 mt -127.53 124.39 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.8 -1.188 . . . . 0.0 112.087 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 25.3 tp -123.73 115.97 22.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.466 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 1.5 m -105.4 147.36 28.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 108.88 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.476 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.1 mt -120.47 138.97 53.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.088 -1.008 . . . . 0.0 110.997 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' B' ' 333' ' ' ASP . 0.6 OUTLIER -145.89 122.99 11.45 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.572 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 15.7 mtt180 -88.25 140.3 30.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.726 -1.234 . . . . 0.0 110.378 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.78 -28.79 6.05 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.631 2.221 . . . . 0.0 111.623 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -47.56 -32.69 5.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 20.6 t -99.31 -26.28 14.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.064 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 49.33 49.62 31.26 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.638 HH21 ' N ' ' B' ' 286' ' ' PRO . 10.3 mtp-105 -75.1 -11.36 60.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.303 . . . . 0.0 111.218 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' B' ' 314' ' ' ARG . 38.4 t 59.6 119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.481 ' N ' HD22 ' B' ' 316' ' ' LEU . 2.4 mt -77.36 158.29 30.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.646 -1.221 . . . . 0.0 108.822 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.46 ' OG ' ' CA ' ' A' ' 89' ' ' GLY . 0.4 OUTLIER -53.78 145.27 16.2 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.712 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.74 -19.04 5.46 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.269 -0.895 . . . . 0.0 108.729 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.492 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -77.99 -45.41 23.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.337 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.408 HD11 HG22 ' B' ' 320' ' ' ILE . 40.1 mm -66.26 -48.61 80.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.615 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -44.19 75.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.935 . . . . 0.0 108.748 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -64.11 -29.0 73.69 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -40.14 -65.21 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.555 -0.968 . . . . 0.0 110.314 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -150.78 -95.18 0.06 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.233 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 15.0 p-10 111.47 4.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 161.46 70.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.83 ' C ' ' H ' ' B' ' 329' ' ' PHE . 32.8 p -164.31 66.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 66.33 -20.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.83 ' H ' ' C ' ' B' ' 327' ' ' SER . 8.8 t80 -117.53 118.9 33.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.553 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 31.7 tt0 -137.22 134.1 35.87 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.209 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.67 106.01 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.553 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 13.7 m0 -102.14 142.31 33.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.115 -0.991 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' B' ' 308' ' ' PHE . 53.9 m-20 -97.77 157.27 16.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.937 -1.102 . . . . 0.0 108.921 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.572 ' OH ' ' NE ' ' B' ' 309' ' ' ARG . 10.2 p90 -165.0 -171.88 2.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.629 -1.294 . . . . 0.0 111.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.461 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -159.97 148.31 17.11 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.4 mt-10 -42.85 -37.13 1.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.724 -1.235 . . . . 0.0 110.234 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.13 3.35 52.6 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -151.62 7.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.537 -1.566 . . . . 0.0 110.559 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 6.2 p -53.97 -45.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 108.556 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.496 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 42.5 mt-10 -57.14 -34.14 68.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.3 m -67.45 -45.51 75.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.147 -0.971 . . . . 0.0 109.658 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.423 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.4 tpp -51.42 -48.06 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 46.6 mt -69.65 -35.02 74.81 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.72 -39.43 91.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.927 -1.108 . . . . 0.0 110.294 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -70.05 -50.1 44.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.937 -1.102 . . . . 0.0 108.243 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.94 -47.3 86.35 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.017 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.477 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 12.5 m-85 -68.76 -33.83 74.57 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.149 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.59 -9.92 58.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.785 -0.572 . . . . 0.0 111.428 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -156.31 -48.88 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.161 -1.587 . . . . 0.0 112.643 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.617 ' N ' ' CG ' ' B' ' 350' ' ' TYR . 4.0 mt -38.62 -57.85 1.81 Allowed Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.961 -1.087 . . . . 0.0 111.526 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 12.1 Cg_endo -59.77 -25.8 80.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.826 1.684 . . . . 0.0 111.703 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -82.21 -14.95 54.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.344 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -56.17 -31.79 63.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.439 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 8.1 t -65.02 -36.02 83.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.86 73.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 46.8 m -57.36 152.33 14.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 8.6 t -153.37 160.05 42.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 109.513 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 43.0 m -64.18 151.18 44.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.223 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -68.51 150.76 97.57 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.95 . . . . 0.0 109.387 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.09 -22.04 55.17 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.56 2.173 . . . . 0.0 111.84 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 8.8 t -99.31 152.17 20.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.404 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.7 157.16 36.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.82 154.29 39.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m -55.18 -34.64 64.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.82 51.69 28.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -81.07 140.75 34.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.8 -56.65 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.567 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.52 151.86 91.71 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.52 -152.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.318 2.012 . . . . 0.0 111.444 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.6 p -109.97 -179.69 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 20.5 p -120.03 158.24 27.22 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.67 137.1 47.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.849 0.833 . . . . 0.0 109.565 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 6.8 t80 -123.14 101.28 7.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.539 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -94.49 127.71 40.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.341 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.0 m -85.36 149.75 25.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 108.915 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -156.44 165.17 32.82 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.499 ' CB ' ' OG ' ' A' ' 87' ' ' SER . 6.1 t -91.8 130.05 37.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.38 -1.21 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.588 ' NH1' ' H ' ' A' ' 56' ' ' GLU . 26.8 mmt180 -119.97 15.64 12.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.354 -0.841 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.22 2.73 6.25 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.28 -179.52 40.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -130.32 -23.07 2.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.44 -1.036 . . . . 0.0 109.326 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -53.83 -39.8 65.89 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.6 m-20 -64.91 -27.02 68.57 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.686 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 8.9 tp60 -64.88 -41.88 95.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.08 63.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -26.98 68.45 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 108.765 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 12.6 m-30 -68.49 -46.75 68.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.01 74.75 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.357 -1.337 . . . . 0.0 107.924 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 33' ' ' SER . 57.4 ttt180 -71.97 -58.39 3.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.93 -1.106 . . . . 0.0 108.671 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 28' ' ' TYR . 6.0 tt -52.37 -40.3 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 44.5 t -64.31 -29.54 47.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 19.4 p -67.78 -39.85 84.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.743 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -71.7 -49.29 40.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.702 -1.249 . . . . 0.0 108.591 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.4 mt -56.63 -39.46 73.7 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -65.8 -23.63 66.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -76.39 -36.77 57.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.988 -1.07 . . . . 0.0 108.988 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.565 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -70.3 -48.53 56.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.5 -140.19 3.02 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -101.02 136.45 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 68.3 t -101.88 122.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 10.6 mt -84.2 -42.85 15.52 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.511 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 43' ' ' THR . 13.7 t -67.54 60.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 109.771 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 42' ' ' LEU . 83.7 mt-10 -82.83 -25.34 32.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.059 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.65 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 4.7 p80 -53.19 -45.78 68.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.686 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -55.64 -60.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.428 ' H ' HG11 ' A' ' 46' ' ' VAL . . . -59.41 -31.93 69.72 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.826 -1.171 . . . . 0.0 108.973 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.461 ' C ' ' CD2' ' A' ' 51' ' ' LEU . 22.0 t70 -87.92 48.25 1.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.466 -0.771 . . . . 0.0 109.104 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.24 -16.03 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.43 -11.83 59.89 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.028 -1.045 . . . . 0.0 109.165 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.747 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.7 -43.95 72.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.172 -0.955 . . . . 0.0 108.686 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 3.3 tt0 -176.9 -48.47 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.538 -0.727 . . . . 0.0 109.422 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 15.4 Cg_exo -69.9 106.5 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.662 2.241 . . . . 0.0 111.56 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.06 110.51 4.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.352 -0.843 . . . . 0.0 109.369 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 130.26 42.05 0.22 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' H ' ' NH1' ' A' ' 19' ' ' ARG . 61.0 mt-10 53.58 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -1.038 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.0 tt0 -42.59 -33.11 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 108.915 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' PRO . . . -106.49 65.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.01 -40.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.66 54.6 0.77 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.41 76.56 1.14 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -51.25 -43.76 61.58 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.2 -44.66 83.85 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -58.34 -34.76 70.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -68.17 -32.42 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -78.19 -64.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 68' ' ' GLN . 19.2 pt-20 -50.12 -44.56 52.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 109.572 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 51.5 tt0 -66.48 -48.23 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.39 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.519 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 84.0 m-20 -70.85 -54.38 11.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.982 . . . . 0.0 110.985 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 tp -56.58 -39.11 72.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 85.7 m-20 -63.68 -52.78 59.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.396 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.503 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.29 -41.21 83.9 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.468 -0.893 . . . . 0.0 108.731 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.508 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 11.8 tp -50.32 -41.38 51.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.41 -27.23 63.16 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.447 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 35.1 mt-30 -88.98 0.13 56.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.958 -1.089 . . . . 0.0 109.352 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.09 130.89 44.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.897 . . . . 0.0 111.862 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 11' ' ' SER . 38.8 t0 -80.6 -32.97 36.27 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.16 144.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 103' ' ' PRO . 82.8 t -136.08 124.81 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 111.501 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.0 t -117.98 176.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -164.15 116.03 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.574 -1.329 . . . . 0.0 110.033 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -79.22 142.94 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -147.66 148.38 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.785 -179.416 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.621 ' HG1' ' NE ' ' A' ' 109' ' ' ARG . 2.7 m -171.82 -42.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -129.47 152.56 79.82 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -36.36 147.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.604 2.202 . . . . 0.0 112.731 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.56 ' H ' ' CD2' ' B' ' 288' ' ' LEU . 12.9 t -175.34 123.0 0.22 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 110.484 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.55 ' CD2' ' H ' ' B' ' 287' ' ' SER . 2.2 mm? -71.32 -44.72 64.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.03 -36.69 75.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.8 t -75.75 -49.09 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -1.032 . . . . 0.0 109.495 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.6 -37.97 89.87 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.846 -1.169 . . . . 0.0 110.257 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -69.45 -52.19 29.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -1.186 . . . . 0.0 109.867 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' OE2' ' SD ' ' B' ' 319' ' ' MET . 95.1 mt-10 -63.22 -30.86 71.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.514 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 mt -69.79 -47.46 62.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.971 . . . . 0.0 109.249 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.15 -36.77 93.44 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -62.24 -41.76 98.7 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.556 -0.967 . . . . 0.0 109.366 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.2 -38.52 78.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.897 -1.127 . . . . 0.0 108.956 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.36 -40.65 32.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.448 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -82.21 -53.01 6.4 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.71 -9.23 2.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -0.999 . . . . 0.0 110.206 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 102' ' ' LYS . . . 54.5 94.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.979 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.507 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 41.8 mttm -164.66 150.81 9.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 79' ' ' VAL . 82.4 Cg_exo -38.83 104.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.707 1.605 . . . . 0.0 111.332 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.507 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.2 mt -107.09 95.45 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.771 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.63 118.29 35.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 143.09 49.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 0.5 OUTLIER -132.1 144.11 50.49 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.063 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.79 147.42 50.79 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.621 ' NE ' ' HG1' ' A' ' 84' ' ' THR . 12.3 mtt180 -99.31 142.32 24.4 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.237 . . . . 0.0 111.472 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' GLY . 89.1 Cg_endo -80.82 -31.24 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.855 2.37 . . . . 0.0 110.944 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -45.62 -38.57 6.76 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 21.8 p -95.69 -20.52 18.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.86 43.43 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' VAL . 61.0 mtt180 -79.37 13.03 2.09 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -1.114 . . . . 0.0 109.387 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 114' ' ' ARG . 75.8 t 49.57 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.408 -0.807 . . . . 0.0 110.157 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' VAL . 24.2 tp -45.15 158.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.88 142.99 22.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 111.089 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.515 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -56.99 -50.68 71.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.73 -0.606 . . . . 0.0 110.339 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.51 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 19.5 mtp -65.89 -38.37 88.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.927 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.34 -44.92 90.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.064 -1.023 . . . . 0.0 109.565 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -74.46 -44.41 51.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.025 -1.047 . . . . 0.0 109.055 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.48 -22.33 61.26 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -45.77 -60.91 1.96 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.477 -1.013 . . . . 0.0 109.937 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.593 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -156.7 -88.18 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.147 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER 97.24 -1.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -179.92 85.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.794 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 162.08 74.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.475 -1.015 . . . . 0.0 109.595 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 67.04 -23.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.794 ' H ' ' C ' ' A' ' 127' ' ' SER . 12.8 t80 -123.28 118.89 28.6 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -135.23 138.3 43.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 111.214 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.448 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 84.7 t -101.95 99.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 21.0 m0 -93.76 148.68 21.9 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -93.75 147.71 22.79 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.501 ' HH ' ' HE ' ' A' ' 109' ' ' ARG . 4.5 p90 -168.02 174.31 7.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.363 -1.461 . . . . 0.0 112.133 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -140.6 147.28 39.14 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 135' ' ' ALA . 50.0 mt-10 -41.99 -30.3 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.932 -1.105 . . . . 0.0 110.581 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.25 1.46 88.78 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.999 -1.063 . . . . 0.0 110.752 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -135.82 -2.76 2.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.958 -1.319 . . . . 0.0 109.975 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 1.4 p -52.15 -45.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.013 -1.054 . . . . 0.0 108.161 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 27.6 mt-10 -52.67 -36.62 57.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -40.8 90.06 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.461 -0.775 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 11.4 mmt -55.67 -54.87 38.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 37.2 mt -59.71 -27.03 66.1 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.46 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 16.5 t70 -69.47 -46.86 65.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 0.0 111.111 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -73.81 -44.08 56.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.477 -1.389 . . . . 0.0 109.805 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.436 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 42.3 t80 -60.41 -46.53 89.69 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.487 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 11.4 m-85 -74.77 -34.4 62.45 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.349 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -68.93 -23.31 64.15 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.238 -1.538 . . . . 0.0 107.425 178.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.46 -10.46 55.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.623 -0.673 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.607 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -154.91 -47.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.419 -1.426 . . . . 0.0 112.16 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.607 ' N ' ' CG ' ' A' ' 150' ' ' TYR . 2.3 mt -41.52 -54.34 6.5 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.97 -1.081 . . . . 0.0 111.076 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -44.57 -12.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.986 1.791 . . . . 0.0 112.141 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 151' ' ' LEU . 50.5 tt0 -65.95 -63.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.41 ' HZ3' HD22 ' A' ' 151' ' ' LEU . 14.7 pttm -84.06 -18.0 38.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.149 -0.969 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 86.8 m -87.89 149.15 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.396 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 62.49 44.69 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 96.3 p -137.39 170.56 15.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 12.8 t -69.49 131.9 45.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.6 p -80.67 154.38 27.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.472 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.403 ' CD2' ' O ' ' A' ' 158' ' ' SER . 20.3 m-70 -131.03 74.33 79.93 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.96 153.77 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.86 2.373 . . . . 0.0 112.192 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.6 t -87.55 153.22 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.16 -0.962 . . . . 0.0 109.467 179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.396 0.617 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.79 157.48 36.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.557 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.09 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 15.3 m -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.7 51.58 29.58 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -80.42 141.79 34.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -1.112 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -63.56 -57.41 10.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.91 151.82 93.02 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.444 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.27 -152.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 111.571 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 15.0 p -110.06 -179.75 3.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.432 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 17.2 p -120.1 157.73 28.36 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.18 137.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.782 0.801 . . . . 0.0 109.57 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 6.8 t80 -123.04 101.54 7.47 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.2 OUTLIER -94.82 127.41 40.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 109.163 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 12.4 m -85.13 148.82 25.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.002 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' B' ' 228' ' ' TYR . . . -155.19 164.95 32.14 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.781 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.503 ' CB ' ' OG ' ' B' ' 287' ' ' SER . 6.2 t -92.12 129.52 38.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.644 -0.915 . . . . 0.0 109.388 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.16 -0.53 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.591 ' NH1' ' H ' ' B' ' 256' ' ' GLU . 27.3 mmt180 -120.47 15.52 12.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -129.39 2.83 6.19 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 166.55 -179.97 40.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -130.52 -23.33 2.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.488 -1.007 . . . . 0.0 109.22 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -53.58 -39.84 65.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 75.4 m-20 -64.89 -27.15 68.66 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.7 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 9.2 tp60 -64.84 -41.34 95.79 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.99 63.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.97 -26.89 68.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 108.72 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 12.7 m-30 -68.6 -46.72 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.667 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.97 -32.83 74.51 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.368 -1.333 . . . . 0.0 107.939 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.455 ' O ' ' OG ' ' B' ' 233' ' ' SER . 57.6 ttt180 -72.09 -58.5 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.851 -1.155 . . . . 0.0 108.715 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.448 HG21 ' O ' ' B' ' 228' ' ' TYR . 5.9 tt -52.15 -40.48 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 44.6 t -64.28 -29.43 47.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' B' ' 230' ' ' ARG . 20.1 p -67.76 -39.81 84.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -71.86 -49.13 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.786 -1.196 . . . . 0.0 108.601 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.94 -39.37 74.4 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -65.64 -23.7 66.86 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -76.54 -37.17 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.948 -1.095 . . . . 0.0 108.932 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.579 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 1.9 m-30 -69.87 -48.43 58.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.554 -0.716 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -153.32 -140.5 3.08 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -101.08 136.53 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -1.104 . . . . 0.0 109.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.9 122.8 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.501 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 10.7 mt -84.08 -42.66 15.86 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.478 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.5 ' O ' ' CG2' ' B' ' 243' ' ' THR . 13.8 t -67.36 60.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.845 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' B' ' 242' ' ' LEU . 82.7 mt-10 -82.58 -25.98 32.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.119 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.648 ' CG ' ' N ' ' B' ' 246' ' ' VAL . 4.8 p80 -52.48 -45.69 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.7 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 0.2 OUTLIER -55.97 -60.15 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 109.546 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.427 ' H ' HG11 ' B' ' 246' ' ' VAL . . . -59.28 -31.63 69.28 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.91 -1.119 . . . . 0.0 108.915 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.467 ' C ' ' CD2' ' B' ' 251' ' ' LEU . 22.4 t70 -88.26 48.01 1.58 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.721 0.772 . . . . 0.0 109.244 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -134.89 -16.19 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.4 -11.8 59.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.105 -0.997 . . . . 0.0 109.276 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.759 ' H ' ' CD2' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -54.79 -43.13 72.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 108.651 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 3.3 tt0 -177.83 -48.28 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.326 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 16.0 Cg_exo -69.83 106.27 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.617 2.211 . . . . 0.0 111.661 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.99 110.41 4.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.87 . . . . 0.0 109.494 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 130.34 41.85 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.591 ' H ' ' NH1' ' B' ' 219' ' ' ARG . 64.8 mt-10 53.87 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.474 -1.015 . . . . 0.0 109.812 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.2 tt0 -43.14 -32.29 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 108.942 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' B' ' 253' ' ' PRO . . . -106.96 65.55 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -148.57 -40.51 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.098 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 105.46 53.95 0.76 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.96 76.46 1.11 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -51.02 -43.54 60.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.44 -44.37 84.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.55 -35.35 72.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.412 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.4 OUTLIER -67.57 -32.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -78.06 -65.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 0.0 110.398 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' B' ' 268' ' ' GLN . 19.1 pt-20 -49.58 -44.34 46.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.995 -1.066 . . . . 0.0 109.689 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . 0.507 ' N ' ' CG ' ' B' ' 267' ' ' GLU . 51.7 tt0 -66.7 -48.59 68.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.502 ' CG ' ' CD2' ' B' ' 245' ' ' HIS . 85.3 m-20 -70.51 -54.16 13.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.75 -39.28 73.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.982 . . . . 0.0 109.726 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' B' ' 267' ' ' GLU . 84.0 m-20 -63.45 -52.69 60.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.501 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -58.67 -41.14 85.44 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 108.728 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 11.7 tp -50.39 -41.24 51.72 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -71.42 -27.34 63.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.307 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 35.3 mt-30 -89.16 0.56 56.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.913 -1.117 . . . . 0.0 109.32 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.67 130.31 42.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.279 -0.888 . . . . 0.0 111.891 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.432 ' HB3' ' H ' ' B' ' 211' ' ' SER . 40.6 t0 -80.23 -32.74 38.39 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.38 144.0 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 303' ' ' PRO . 80.8 t -135.92 124.92 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.98 -1.075 . . . . 0.0 111.353 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 25.5 t -118.02 176.82 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -164.01 115.69 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.576 -1.328 . . . . 0.0 110.089 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.93 143.22 36.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 108.67 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -147.88 148.23 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.098 -1.001 . . . . 0.0 109.772 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.603 ' HG1' ' NE ' ' B' ' 309' ' ' ARG . 2.8 m -171.72 -42.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -130.19 151.92 79.23 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -35.87 146.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.675 2.25 . . . . 0.0 112.682 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.55 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 14.8 t -175.46 122.46 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 0.0 110.525 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.56 ' CD2' ' H ' ' A' ' 87' ' ' SER . 2.2 mm? -70.99 -43.94 66.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.333 -0.854 . . . . 0.0 109.655 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.42 -36.56 77.45 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.1 -49.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -1.076 . . . . 0.0 109.338 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -67.41 -37.98 90.69 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -69.77 -52.11 28.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -1.187 . . . . 0.0 109.926 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.51 ' OE2' ' SD ' ' A' ' 119' ' ' MET . 95.9 mt-10 -63.2 -31.15 72.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.222 -0.923 . . . . 0.0 109.495 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 17.4 mt -69.65 -47.35 63.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.73 93.33 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -62.42 -41.58 98.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.546 -0.973 . . . . 0.0 109.299 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.64 79.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.956 -1.09 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -52.24 -40.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.448 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -81.88 -53.13 6.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.079 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.86 -9.16 2.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.104 -0.997 . . . . 0.0 110.206 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' B' ' 302' ' ' LYS . . . 54.41 94.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.94 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 41.4 mttm -165.04 150.54 8.51 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' B' ' 279' ' ' VAL . 82.8 Cg_exo -38.63 104.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.75 1.634 . . . . 0.0 111.296 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.2 mt -106.82 95.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.654 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.73 118.53 36.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 142.29 50.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 0.4 OUTLIER -131.3 143.62 50.67 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.298 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -128.11 147.49 50.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.603 ' NE ' ' HG1' ' B' ' 284' ' ' THR . 13.0 mtt180 -99.19 141.82 23.53 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.732 -1.23 . . . . 0.0 111.516 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 313' ' ' GLY . 92.7 Cg_endo -80.27 -31.63 1.61 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.807 2.338 . . . . 0.0 110.954 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 310' ' ' PRO . 20.2 pt20 -45.47 -38.65 6.38 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.0 p -95.66 -20.02 19.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.46 43.09 1.47 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.0 mtt180 -78.98 13.0 1.91 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.346 -1.091 . . . . 0.0 109.424 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 314' ' ' ARG . 79.6 t 49.42 101.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.366 -0.834 . . . . 0.0 110.255 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' B' ' 315' ' ' VAL . 24.0 tp -45.19 158.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.64 142.75 22.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 111.05 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . 0.479 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.93 -50.66 71.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.367 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.514 ' SD ' ' OE2' ' A' ' 93' ' ' GLU . 19.3 mtp -65.65 -38.65 89.94 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.964 -1.085 . . . . 0.0 109.859 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 5.1 mm -66.24 -44.86 91.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.541 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -74.26 -44.47 52.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.952 -1.093 . . . . 0.0 108.97 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -61.55 -22.33 61.43 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -45.49 -61.04 1.85 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.576 -0.956 . . . . 0.0 110.047 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.581 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -156.64 -87.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.967 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 0.7 OUTLIER 96.99 -1.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -177.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -179.59 84.95 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.81 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.1 p 162.37 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.406 -1.055 . . . . 0.0 109.737 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 67.11 -23.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.81 ' H ' ' C ' ' B' ' 327' ' ' SER . 11.9 t80 -123.65 118.97 28.48 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -135.21 138.68 43.85 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.212 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 83.9 t -102.3 100.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 21.1 m0 -94.04 148.58 22.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.85 148.13 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.514 ' HH ' ' HE ' ' B' ' 309' ' ' ARG . 4.6 p90 -168.53 174.37 6.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.114 -1.434 . . . . 0.0 112.057 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -140.69 147.28 39.0 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.5 mt-10 -41.86 -30.37 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.605 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.19 1.31 88.93 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.766 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -135.53 -2.72 2.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.95 -1.324 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 1.4 p -52.31 -45.81 44.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 26.5 mt-10 -52.93 -36.34 59.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 24.4 m -66.37 -41.03 90.04 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 11.6 mmt -55.34 -54.99 36.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 39.6 mt -59.61 -27.17 66.07 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' B' ' 348' ' ' GLU . 15.9 t70 -69.33 -46.79 66.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -0.966 . . . . 0.0 111.184 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -73.64 -44.36 57.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.333 -1.48 . . . . 0.0 109.846 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . 0.432 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 42.2 t80 -60.18 -46.49 89.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.738 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.482 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 11.5 m-85 -74.88 -34.23 62.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.437 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 348' ' ' GLU . 0.7 OUTLIER -69.07 -23.38 64.02 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 117.846 -1.542 . . . . 0.0 107.485 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.4 -10.23 53.75 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.612 -0.68 . . . . 0.0 110.468 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -155.11 -47.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.46 -1.4 . . . . 0.0 112.15 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.604 ' N ' ' CG ' ' B' ' 350' ' ' TYR . 2.2 mt -41.53 -54.33 6.53 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 110.998 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -44.46 -13.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.008 1.805 . . . . 0.0 112.231 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 351' ' ' LEU . 50.5 tt0 -65.85 -63.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.956 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -84.25 -17.93 38.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.051 -1.031 . . . . 0.0 109.753 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 87.1 m -88.02 149.82 23.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . 62.17 44.16 8.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.87 . . . . 0.0 109.383 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 89.6 p -136.99 171.4 14.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.392 -0.818 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 10.8 t -70.25 132.65 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 61.6 p -81.38 155.22 26.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -131.77 73.99 78.15 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.756 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.21 151.88 18.15 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.829 2.352 . . . . 0.0 112.25 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 33.0 t -84.2 144.42 28.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.431 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 tpp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.63 149.26 45.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.33 156.53 7.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.482 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 p -54.52 172.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.64 -176.38 42.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -137.06 157.51 46.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -1.155 . . . . 0.0 109.563 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -133.19 -177.22 4.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.413 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.98 148.59 49.38 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.457 -0.777 . . . . 0.0 109.121 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 -155.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.402 2.068 . . . . 0.0 110.965 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 26.4 p -99.67 178.02 4.97 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 3.0 t -116.08 152.95 32.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.81 132.63 56.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.431 -0.793 . . . . 0.0 109.348 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' CZ ' ' OE2' ' A' ' 44' ' ' GLU . 39.2 t80 -96.34 147.1 24.15 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.446 ' O ' ' OE1' ' A' ' 44' ' ' GLU . 24.6 t80 -110.45 133.21 53.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.029 . . . . 0.0 111.517 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 102.53 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.29 177.58 19.48 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.418 ' H ' ' HG ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -73.24 122.86 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -1.061 . . . . 0.0 109.73 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.02 95.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 108.654 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -129.75 4.58 5.01 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 110.331 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 145.58 99.23 0.25 Allowed Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.502 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 20' ' ' GLY . . . 19.57 115.59 0.0 OUTLIER Glycine 0 N--CA 1.506 3.317 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' H ' ' HB2' ' A' ' 25' ' ' GLN . 12.5 ptm180 -150.52 163.97 37.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.853 -1.381 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -55.96 -39.27 71.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 86.9 m-20 -60.03 -33.34 71.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB2' ' H ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -63.24 -46.83 85.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -50.19 69.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.62 -35.49 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.516 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 18.5 m-30 -67.44 -47.7 69.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.93 75.8 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.681 -1.262 . . . . 0.0 108.803 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 -68.69 -57.15 6.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 108.609 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -50.88 -45.2 28.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 94.5 t -59.65 -30.63 45.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -66.02 -40.13 90.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.115 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -63.45 -41.99 98.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.78 -1.2 . . . . 0.0 108.045 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.24 -43.1 99.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -56.66 -26.1 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -85.49 -29.42 24.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.161 -0.962 . . . . 0.0 110.046 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.5 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.2 m-85 -84.39 -58.8 2.6 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.182 -0.949 . . . . 0.0 110.511 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 10' ' ' CYS . . . -132.61 -164.61 10.99 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -89.61 124.2 34.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.223 -1.163 . . . . 0.0 109.036 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.62 104.05 8.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 43' ' ' THR . 80.9 mt -52.03 142.43 15.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.764 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' CE3' ' A' ' 72' ' ' TRP . 17.4 p -37.75 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.512 0.672 . . . . 0.0 110.161 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 13' ' ' TYR . 19.5 mm-40 -122.91 110.41 15.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.664 ' O ' ' N ' ' A' ' 49' ' ' ALA . 4.7 p80 -56.44 -15.35 4.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.341 -0.85 . . . . 0.0 109.624 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 60.8 t -41.7 -78.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.335 -0.853 . . . . 0.0 110.651 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.25 10.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.883 -1.136 . . . . 0.0 109.09 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 45' ' ' HIS . 20.7 t70 -96.54 22.71 7.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -109.2 35.88 3.11 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -129.57 -20.32 3.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.721 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -62.67 -102.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -57.02 164.1 2.55 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.4 36.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.552 2.168 . . . . 0.0 112.996 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.561 ' CD1' ' H ' ' A' ' 21' ' ' GLY . 6.6 mp 51.3 -155.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.93 -1.106 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . -127.83 -36.58 0.47 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 36.4 mp0 -46.58 -20.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -1.061 . . . . 0.0 109.108 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' GLY . 24.5 pt-20 -132.47 3.51 3.9 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -145.59 -173.79 4.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.05 152.45 21.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.18 -9.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.64 74.93 1.22 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -53.62 -37.0 62.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.348 -1.09 . . . . 0.0 108.336 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.545 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 16.4 mp0 -62.23 -47.15 85.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -53.58 -36.27 61.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 0.0 109.184 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -67.3 -53.1 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.475 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 4.8 t-80 -63.65 -45.77 88.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 110.785 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -54.43 -54.73 36.8 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.632 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 72' ' ' TRP . 99.5 mt-30 -72.42 -40.34 67.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 110.169 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 23.8 m-20 -64.93 -52.97 53.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.972 . . . . 0.0 111.014 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.93 78.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 111.148 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -65.41 -54.01 34.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.785 -1.197 . . . . 0.0 110.049 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.578 ' CE3' ' OG1' ' A' ' 43' ' ' THR . 0.0 OUTLIER -62.45 -42.74 99.68 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.814 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 2.0 tt -53.15 -36.87 61.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -75.18 -26.2 58.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.527 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.496 ' CD ' ' CD1' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -97.86 5.7 48.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.797 -1.189 . . . . 0.0 109.064 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.08 129.4 39.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.697 0.76 . . . . 0.0 112.536 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 11' ' ' SER . 64.0 t0 -74.94 -36.17 62.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.437 ' CG2' ' OH ' ' A' ' 150' ' ' TYR . 46.0 t -134.25 168.01 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.8 t -150.21 140.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.104 -0.998 . . . . 0.0 111.074 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -132.07 143.23 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -152.74 156.14 38.55 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 110.51 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' OH ' ' A' ' 134' ' ' TYR . 47.1 tt0 -123.25 124.77 43.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -120.22 23.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 109.523 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.417 ' C ' ' O ' ' A' ' 83' ' ' VAL . 89.4 m -45.76 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.148 -0.97 . . . . 0.0 108.564 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' PRO . 34.3 tt0 -68.15 133.74 91.59 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLN . 86.2 Cg_exo -37.34 112.71 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.99 1.793 . . . . 0.0 111.769 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' A' ' 87' ' ' SER . 2.4 p -117.06 130.56 56.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.218 -0.926 . . . . 0.0 110.201 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' B' ' 287' ' ' SER . 0.4 OUTLIER -80.88 -56.36 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 317' ' ' SER . . . -57.87 -40.21 92.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.65 -36.62 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.164 . . . . 0.0 109.437 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.16 95.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -66.89 -47.53 71.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.679 -0.895 . . . . 0.0 109.709 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.37 -34.77 75.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.493 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.32 -42.46 75.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 108.478 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.07 -36.44 80.7 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' NH1' ' CG1' ' B' ' 298' ' ' VAL . 20.0 tpt180 -64.97 -45.46 85.61 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -68.8 -37.8 79.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.482 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG1' ' NH1' ' B' ' 296' ' ' ARG . 0.8 OUTLIER -51.46 -43.36 30.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.99 72.72 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.09 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.587 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -129.19 -38.88 1.57 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.096 -1.002 . . . . 0.0 110.386 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -70.65 97.46 0.63 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.39 -69.65 0.55 Allowed Pre-proline 0 C--N 1.288 -2.08 0 O-C-N 121.762 -0.846 . . . . 0.0 111.446 -176.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 24.0 Cg_endo -63.41 111.36 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.88 1.72 . . . . 0.0 111.348 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 97' ' ' ALA . 46.5 mt -135.88 101.94 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.157 -0.965 . . . . 0.0 111.088 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.24 118.21 30.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -111.42 138.24 48.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.991 -1.068 . . . . 0.0 108.352 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mt -118.15 146.28 44.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.15 -0.969 . . . . 0.0 110.926 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -149.95 142.06 24.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.091 -1.005 . . . . 0.0 108.827 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.638 HH11 ' NE2' ' A' ' 111' ' ' GLN . 10.7 mtm180 -119.59 150.34 49.87 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.291 -0.88 . . . . 0.0 110.924 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.82 -15.64 36.96 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.643 2.229 . . . . 0.0 112.4 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.638 ' NE2' HH11 ' A' ' 109' ' ' ARG . 4.7 pt20 -67.09 -37.24 83.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -0.971 . . . . 0.0 110.151 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.475 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 31.0 m -142.51 -6.03 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 109' ' ' ARG . . . -111.19 99.69 1.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 106.74 -2.544 . . . . 0.0 106.74 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -98.26 -59.38 1.76 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.664 -0.903 . . . . 0.0 108.608 -177.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.1 t -132.07 109.38 15.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.812 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -54.49 146.55 15.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' B' ' 289' ' ' GLY . 0.6 OUTLIER -43.3 146.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 0.0 109.398 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.0 81.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 77.6 mmm -64.8 -37.59 88.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.438 HG21 HD12 ' A' ' 120' ' ' ILE . 48.4 mm -65.25 -47.12 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.992 . . . . 0.0 109.31 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -40.8 98.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.04 -37.48 95.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.84 -47.38 71.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -0.3 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.415 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 128' ' ' ARG . 54.9 t0 -76.74 -35.24 57.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 108.58 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.8 -22.29 6.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -101.26 -46.26 5.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.066 -1.256 . . . . 0.0 109.869 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 125' ' ' ASP . 34.2 ptt-85 -121.11 -43.3 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.492 -0.755 . . . . 0.0 109.32 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 129' ' ' PHE . 7.0 t80 -97.29 130.03 44.52 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.671 ' NE2' ' HE1' ' A' ' 132' ' ' TRP . 3.6 tt0 -155.67 161.68 40.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.712 -1.242 . . . . 0.0 111.376 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.79 105.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.671 ' HE1' ' NE2' ' A' ' 130' ' ' GLN . 15.9 m0 -101.79 143.14 32.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 134' ' ' TYR . 61.0 t0 -93.34 155.32 17.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.101 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.596 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 6.3 p90 -169.88 -166.54 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.091 -1.006 . . . . 0.0 110.342 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.709 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -169.91 160.51 8.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.46 28.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.709 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.09 -2.07 3.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -156.13 12.25 0.29 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.013 -1.286 . . . . 0.0 110.102 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 7.5 p -52.03 -42.93 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 108.631 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 36.7 mt-10 -57.47 -37.09 72.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.107 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.4 m -66.67 -44.28 82.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.9 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.4 tpp -52.44 -49.51 64.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 89.8 mt -71.36 -29.31 64.81 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.428 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 36.4 t0 -67.25 -38.97 86.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 109.881 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -73.35 -50.2 23.29 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.84 -1.163 . . . . 0.0 108.801 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -56.67 -47.12 80.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.339 -0.851 . . . . 0.0 110.235 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.413 ' CD1' HD11 ' A' ' 151' ' ' LEU . 12.7 m-85 -78.41 -30.57 47.81 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.512 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 44.8 mt-10 -58.53 -25.47 62.48 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.99 -16.7 62.08 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.768 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -177.85 105.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 0.0 111.114 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.6 OUTLIER 175.82 -54.78 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.326 -0.858 . . . . 0.0 109.642 177.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 20.1 Cg_endo -62.78 -14.06 38.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.093 1.862 . . . . 0.0 111.513 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -69.17 -45.69 69.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 109.806 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.419 ' O ' ' OG ' ' A' ' 157' ' ' SER . 23.1 mtmm -60.45 -36.26 77.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 31.2 p -61.61 -40.73 95.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.05 60.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 154' ' ' LYS . 83.0 p -72.97 159.27 33.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 85.0 p -144.63 160.61 40.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 109.398 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -63.28 -32.6 74.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -130.16 79.26 73.14 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.399 -0.813 . . . . 0.0 109.506 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.66 -21.11 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.82 2.347 . . . . 0.0 112.189 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.8 m 47.0 -161.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.513 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.59 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 31.3 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.22 149.84 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -57.86 156.6 8.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 52.0 p -54.35 172.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.324 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 89.59 -176.06 42.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.41 158.34 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.89 -177.21 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.04 148.52 48.94 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.162 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.4 -155.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.487 2.124 . . . . 0.0 110.893 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.46 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 27.9 p -99.52 178.04 4.98 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 3.0 t -116.22 152.83 32.99 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.41 132.64 57.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.562 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CZ ' ' OE2' ' B' ' 244' ' ' GLU . 39.3 t80 -96.35 146.43 24.75 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.444 ' O ' ' OE1' ' B' ' 244' ' ' GLU . 24.0 t80 -109.89 132.6 54.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.07 -1.019 . . . . 0.0 111.614 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.29 102.51 5.38 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -136.22 177.67 19.39 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' B' ' 217' ' ' SER . 1.0 OUTLIER -73.39 123.22 23.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.834 -179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.48 95.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -130.36 4.47 4.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.317 -0.864 . . . . 0.0 110.19 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . 0.733 ' O ' ' O ' ' B' ' 221' ' ' GLY . . . 145.7 99.22 0.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.603 -1.285 . . . . 0.0 110.554 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.733 ' O ' ' O ' ' B' ' 220' ' ' GLY . . . 19.54 115.33 0.0 OUTLIER Glycine 0 N--CA 1.504 3.181 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.52 ' H ' ' HB2' ' B' ' 225' ' ' GLN . 12.4 ptm180 -150.28 163.83 37.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.395 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -55.82 -39.1 70.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 88.2 m-20 -60.45 -33.39 72.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.52 ' HB2' ' H ' ' B' ' 222' ' ' ARG . 0.8 OUTLIER -63.03 -46.93 85.22 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.07 -50.27 69.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.45 -35.58 70.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.756 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.536 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 18.5 m-30 -67.44 -47.42 70.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.326 -0.859 . . . . 0.0 109.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.28 -37.84 75.82 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.593 -1.317 . . . . 0.0 108.886 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 39.2 ttt85 -68.83 -57.03 6.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.849 -1.157 . . . . 0.0 108.648 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.3 mt -50.94 -45.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 87.1 t -59.92 -30.33 45.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 7.2 t -66.15 -40.16 90.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.075 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 81.4 mtt-85 -63.45 -41.87 98.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.822 -1.174 . . . . 0.0 107.929 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.23 -42.92 99.44 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -56.95 -26.08 59.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -85.37 -29.55 24.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.969 . . . . 0.0 110.079 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.496 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.2 m-85 -84.34 -58.7 2.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.215 -0.928 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 210' ' ' CYS . . . -132.94 -164.87 11.02 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -89.58 124.14 34.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.191 -1.181 . . . . 0.0 109.015 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.49 104.22 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.461 ' O ' ' C ' ' B' ' 243' ' ' THR . 80.7 mt -52.22 141.98 17.75 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.833 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.568 ' OG1' ' CE3' ' B' ' 272' ' ' TRP . 17.3 p -37.38 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.502 0.668 . . . . 0.0 110.234 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.544 ' OE2' ' CZ ' ' B' ' 213' ' ' TYR . 19.1 mm-40 -122.99 110.68 15.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' B' ' 249' ' ' ALA . 4.9 p80 -56.59 -15.58 4.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' B' ' 249' ' ' ALA . 62.5 t -41.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.239 -0.913 . . . . 0.0 110.695 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -48.72 -33.29 9.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.934 -1.104 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' B' ' 245' ' ' HIS . 20.5 t70 -96.53 22.96 7.32 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' B' ' 245' ' ' HIS . . . -109.47 35.68 3.22 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -129.27 -20.09 3.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.714 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -62.72 -103.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' B' ' 254' ' ' LEU . 0.0 OUTLIER -56.1 164.39 1.85 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.85 36.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.525 2.15 . . . . 0.0 112.895 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.592 ' N ' ' O ' ' B' ' 252' ' ' GLU . 6.6 mp 51.28 -155.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.018 -1.051 . . . . 0.0 109.548 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . -127.35 -36.53 0.49 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' B' ' 256' ' ' GLU . 36.5 mp0 -46.44 -20.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -1.033 . . . . 0.0 109.211 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 255' ' ' GLY . 24.4 pt-20 -133.2 4.39 3.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 108.925 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -145.97 -173.49 4.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -90.95 151.5 21.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.15 -9.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.45 74.62 1.21 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -36.91 62.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.36 -1.082 . . . . 0.0 108.321 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . 0.556 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 17.0 mp0 -62.5 -47.18 85.1 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -53.6 -36.03 61.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 0.6 OUTLIER -67.55 -52.87 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.47 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 4.6 t-80 -64.03 -46.26 85.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.454 -0.779 . . . . 0.0 110.654 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -53.74 -55.08 29.4 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.84 -1.162 . . . . 0.0 109.676 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' B' ' 272' ' ' TRP . 99.5 mt-30 -72.21 -40.36 67.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.51 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 25.5 m-20 -64.79 -52.95 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.03 -1.044 . . . . 0.0 111.174 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.87 78.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 111.138 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.5 -54.01 34.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.671 -1.268 . . . . 0.0 110.147 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.568 ' CE3' ' OG1' ' B' ' 243' ' ' THR . 0.0 OUTLIER -62.42 -42.38 99.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.037 -1.039 . . . . 0.0 108.935 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.457 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 1.9 tt -53.62 -36.49 62.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -75.34 -26.25 58.43 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.372 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.492 ' CD ' ' CD1' ' B' ' 272' ' ' TRP . 0.0 OUTLIER -98.02 5.82 48.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.175 . . . . 0.0 109.095 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.17 129.47 39.84 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.759 0.79 . . . . 0.0 112.555 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.443 ' HB3' ' H ' ' B' ' 211' ' ' SER . 64.1 t0 -75.14 -35.86 61.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.432 ' CG2' ' OH ' ' B' ' 350' ' ' TYR . 46.6 t -134.4 167.94 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 61.8 t -150.37 140.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.026 . . . . 0.0 111.06 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.06 143.6 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.08 156.16 38.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.046 -1.034 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' B' ' 334' ' ' TYR . 47.4 tt0 -123.15 125.04 44.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' B' ' 284' ' ' THR . 0.1 OUTLIER -120.5 22.69 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.519 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.415 ' O ' ' O ' ' B' ' 283' ' ' VAL . 87.5 m -45.25 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.184 -0.948 . . . . 0.0 108.54 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' B' ' 286' ' ' PRO . 33.4 tt0 -68.0 133.92 91.88 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 285' ' ' GLN . 87.9 Cg_exo -37.36 112.57 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.084 1.856 . . . . 0.0 111.842 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.473 ' H ' ' HG ' ' B' ' 287' ' ' SER . 2.6 p -116.91 130.52 56.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.74 -56.14 4.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . 0.556 ' N ' ' OG ' ' A' ' 117' ' ' SER . . . -58.0 -40.27 93.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.61 -36.67 78.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.322 -1.104 . . . . 0.0 109.497 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.2 95.48 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -67.05 -47.25 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.623 -0.928 . . . . 0.0 109.84 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.91 -34.77 76.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 72.5 mt -69.29 -42.44 75.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.965 . . . . 0.0 108.578 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.24 -36.09 78.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . 0.418 ' NH1' ' CG1' ' A' ' 98' ' ' VAL . 20.0 tpt180 -64.93 -45.59 85.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.272 -1.134 . . . . 0.0 109.517 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -68.67 -37.89 79.95 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.466 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.405 ' CG1' ' NH1' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -51.61 -43.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.6 -45.1 72.87 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.177 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.596 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -129.35 -38.21 1.58 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.135 -0.978 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -71.18 97.26 0.66 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.596 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -65.26 -69.77 0.54 Allowed Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.826 -0.808 . . . . 0.0 111.43 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 24.0 Cg_endo -63.44 111.02 1.35 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.878 1.719 . . . . 0.0 111.534 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.444 HD12 ' C ' ' B' ' 297' ' ' ALA . 45.5 mt -135.61 101.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 111.174 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.16 118.54 30.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -111.53 137.95 48.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 108.445 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . . . . . . . . . 9.7 mt -118.05 146.09 44.33 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -0.973 . . . . 0.0 110.862 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -149.77 142.19 24.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 108.764 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.64 HH11 ' NE2' ' B' ' 311' ' ' GLN . 10.5 mtm180 -119.47 150.53 49.98 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 110.867 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.18 -15.31 35.49 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.64 ' NE2' HH11 ' B' ' 309' ' ' ARG . 4.6 pt20 -67.34 -37.61 83.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.229 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' B' ' 311' ' ' GLN . 23.2 m -142.16 -5.82 0.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' B' ' 309' ' ' ARG . . . -111.2 100.04 1.18 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.629 ' CD ' ' N ' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -98.41 -59.55 1.73 Allowed 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.695 -0.885 . . . . 0.0 108.614 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . . . . . . . . . 77.8 t -131.94 109.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.765 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' B' ' 317' ' ' SER . 0.1 OUTLIER -54.55 146.27 16.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 89' ' ' GLY . 0.6 OUTLIER -43.08 146.17 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.98 -1.075 . . . . 0.0 109.431 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.24 80.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 0.0 110.534 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.63 -37.69 88.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.407 HD12 HG21 ' B' ' 320' ' ' ILE . 47.5 mm -64.94 -47.23 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.303 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -40.6 98.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -63.08 -37.47 94.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.594 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.89 -47.83 70.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.594 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 0.32 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.521 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.533 ' OD2' ' NH1' ' B' ' 328' ' ' ARG . 53.7 t0 -76.34 -35.25 58.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.889 -1.132 . . . . 0.0 108.565 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 82.81 -22.26 6.86 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 30.0 t -101.36 -45.92 5.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.984 -1.303 . . . . 0.0 109.874 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.533 ' NH1' ' OD2' ' B' ' 325' ' ' ASP . 34.2 ptt-85 -121.45 -43.44 2.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.529 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 6.9 t80 -97.15 130.1 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.664 ' NE2' ' HE1' ' B' ' 332' ' ' TRP . 3.6 tt0 -155.67 161.71 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.513 -1.275 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.75 105.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.664 ' HE1' ' NE2' ' B' ' 330' ' ' GLN . 15.7 m0 -101.72 143.1 32.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' B' ' 334' ' ' TYR . 59.7 t0 -93.18 155.36 17.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 109.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.582 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 6.3 p90 -169.7 -166.31 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -170.26 160.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -59.39 28.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -134.97 -2.44 3.08 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -155.87 12.1 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -1.196 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 8.1 p -51.9 -42.9 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 108.548 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.478 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 40.0 mt-10 -57.64 -36.97 72.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.558 -0.714 . . . . 0.0 109.123 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 57.0 m -66.69 -44.16 82.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.867 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -52.74 -49.54 65.23 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 88.8 mt -71.2 -29.34 65.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.491 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 37.6 t0 -67.2 -39.05 86.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.067 -1.02 . . . . 0.0 109.937 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -73.11 -50.36 23.24 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.89 -1.131 . . . . 0.0 108.834 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -56.36 -47.31 79.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.42 ' CD1' HD11 ' B' ' 351' ' ' LEU . 12.7 m-85 -78.05 -30.76 50.0 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.591 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 45.3 mt-10 -58.5 -25.71 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.62 -17.11 62.29 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.772 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -177.69 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.073 -1.017 . . . . 0.0 111.162 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.543 ' N ' ' HD2' ' B' ' 352' ' ' PRO . 0.7 OUTLIER 176.14 -55.28 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 20.1 Cg_endo -62.2 -14.21 36.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.861 1.708 . . . . 0.0 111.579 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -68.84 -45.09 72.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.768 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . 0.419 ' O ' ' OG ' ' B' ' 357' ' ' SER . 23.0 mtmm -61.13 -36.08 78.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.121 -0.987 . . . . 0.0 109.619 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 30.4 p -61.76 -40.2 94.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.14 -22.96 60.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.712 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 354' ' ' LYS . 84.8 p -73.09 159.09 34.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.71 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 85.0 p -144.51 160.84 40.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.377 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 17.0 m -63.63 -31.51 72.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -131.24 79.41 70.5 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.363 -0.836 . . . . 0.0 109.438 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.92 -22.83 4.96 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.784 2.323 . . . . 0.0 112.311 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 68.7 m 47.55 -167.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.524 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.45 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptt? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.4 29.03 4.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.2 158.64 43.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 109.655 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.5 p -147.91 170.23 18.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' GLU . . . 84.81 -99.56 2.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLY . 91.7 mt-10 47.78 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -1.186 . . . . 0.0 109.349 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.84 178.5 6.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.88 153.8 80.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.564 -0.71 . . . . 0.0 109.143 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.13 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.617 2.211 . . . . 0.0 111.772 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.502 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 89.8 m -100.31 177.14 5.14 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 m -119.93 121.21 38.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.026 -1.046 . . . . 0.0 108.581 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 5.3 t -94.06 130.94 42.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 69' ' ' ASP . 33.2 t80 -99.85 133.39 44.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.491 ' O ' ' CE1' ' A' ' 13' ' ' TYR . 26.6 t80 -86.88 116.34 24.89 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.365 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' HG ' ' CB ' ' A' ' 93' ' ' GLU . 6.5 t -107.0 108.99 20.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.771 0.796 . . . . 0.0 109.287 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.85 174.3 46.62 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 90' ' ' VAL . 6.7 p -113.44 160.13 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -1.074 . . . . 0.0 108.461 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 ' O ' ' O ' ' A' ' 19' ' ' ARG . 0.6 OUTLIER -84.66 -13.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.605 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 21' ' ' GLY . 17.7 mmm180 -50.18 -85.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 40.87 -82.1 0.0 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.758 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 162.94 36.4 0.02 OUTLIER Glycine 0 N--CA 1.488 2.153 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.631 ' HE ' ' CD1' ' A' ' 54' ' ' LEU . 38.3 mmt-85 55.88 -46.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.314 -0.521 . . . . 0.0 109.817 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 21' ' ' GLY . 76.9 mm-40 -56.99 -38.86 73.63 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -63.67 -26.68 68.78 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.555 HE21 ' C ' ' A' ' 46' ' ' VAL . 20.2 tp60 -64.77 -42.68 94.92 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.71 84.37 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.96 -37.88 77.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.543 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 21.1 m-30 -65.94 -41.81 90.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -63.14 -39.31 94.3 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 120.851 -1.156 . . . . 0.0 109.041 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.49 -55.02 9.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.951 -1.093 . . . . 0.0 108.321 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 20.9 mt -53.89 -45.07 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 49.3 t -60.15 -29.37 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.6 m -67.31 -38.56 85.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.082 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -68.51 -50.19 54.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.127 . . . . 0.0 109.043 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.1 mt -56.77 -40.82 76.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -61.6 -27.05 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.845 -0.535 . . . . 0.0 109.598 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -75.94 -36.81 59.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.959 -1.088 . . . . 0.0 109.542 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.519 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.8 m-85 -71.69 -48.76 45.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.52 -0.737 . . . . 0.0 110.598 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -149.35 -148.83 4.84 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -95.66 125.13 40.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.413 -1.051 . . . . 0.0 109.825 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.4 101.17 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.8 mt -47.1 149.67 0.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.31 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 m -44.61 140.08 2.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 109.301 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 46' ' ' VAL . 11.0 pt-20 -161.57 134.27 6.06 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -74.86 25.0 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.241 -0.912 . . . . 0.0 109.188 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.555 ' C ' HE21 ' A' ' 25' ' ' GLN . 27.6 t -83.97 -85.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' C ' ' N ' ' A' ' 49' ' ' ALA . . . -68.08 178.87 1.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 t70 48.57 20.09 0.29 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.188 . . . . 0.0 108.193 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' N ' ' C ' ' A' ' 47' ' ' ALA . . . -115.01 -9.51 12.37 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -62.85 -32.96 74.3 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 108.798 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.844 ' CD1' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.63 157.1 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.604 -0.685 . . . . 0.0 109.961 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 51' ' ' LEU . 17.9 mt-10 55.02 155.46 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 55.6 Cg_endo -72.19 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.493 2.129 . . . . 0.0 111.938 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.631 ' CD1' ' HE ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -55.55 165.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.895 -1.128 . . . . 0.0 109.628 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 150.46 32.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 59.15 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.926 . . . . 0.0 109.447 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.7 tt0 -52.46 -28.77 21.55 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 53' ' ' PRO . . . -68.07 149.18 49.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.78 142.9 5.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.67 -58.53 0.23 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.75 80.63 0.48 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -53.47 -41.11 65.85 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.33 -1.1 . . . . 0.0 108.494 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.96 -48.89 67.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -60.08 -38.15 82.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -63.36 -40.22 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.46 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 1.4 t-80 -78.84 -51.03 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 110.55 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.46 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 64.8 mm-40 -50.68 -47.93 58.72 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.869 -1.144 . . . . 0.0 110.012 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.82 -49.04 27.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 0.0 110.421 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 68.6 m-20 -62.75 -51.92 65.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 0.0 110.776 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.405 HD12 ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -68.22 -41.28 81.51 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 0.0 111.274 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -61.87 -54.03 47.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.597 -1.314 . . . . 0.0 109.314 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -38.02 75.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.0 tp -52.6 -45.76 66.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' A' ' 96' ' ' ARG . 20.2 mt-30 -67.03 -30.32 70.37 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.483 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -91.24 3.53 54.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.54 -1.35 . . . . 0.0 109.349 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 141.59 58.72 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.987 0.899 . . . . 0.0 112.612 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 103' ' ' PRO . 65.1 t0 -98.48 -20.51 17.05 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 18.4 t -144.55 144.63 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.01 137.96 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.717 -1.239 . . . . 0.0 112.382 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.13 125.41 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.54 144.6 41.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.34 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.6 121.71 45.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.71 . . . . 0.0 109.169 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 107' ' ' LEU . 1.7 m -146.77 113.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 m -130.04 -13.42 4.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -142.92 156.18 62.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -39.13 108.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.047 1.831 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.608 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 45.1 m -126.29 134.39 51.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.142 -0.974 . . . . 0.0 111.165 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.608 ' HB2' ' H ' ' B' ' 287' ' ' SER . 14.7 tp -105.68 153.11 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.59 -29.99 3.19 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.591 ' H ' ' C ' ' A' ' 88' ' ' LEU . 47.4 t -86.01 -49.92 14.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.35 62.45 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -70.86 -58.14 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.541 ' CB ' ' HG ' ' A' ' 15' ' ' CYS . 85.9 mt-10 -52.16 -32.95 38.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.29 -41.15 49.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.0 -48.76 81.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 74' ' ' GLN . 45.4 ttm-85 -62.61 -38.26 89.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.341 -1.093 . . . . 0.0 108.89 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.56 -39.93 88.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -54.92 -44.31 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.791 -1.193 . . . . 0.0 108.136 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -76.01 -48.93 19.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.469 ' O ' ' CD ' ' A' ' 102' ' ' LYS . 2.8 pp -116.66 -23.08 8.33 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.831 -1.168 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -53.26 170.3 0.78 Allowed Glycine 0 C--N 1.286 -2.196 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.538 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -131.63 -75.71 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 79.8 Cg_endo -81.79 109.12 1.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.811 1.674 . . . . 0.0 109.552 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.08 126.7 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.691 -1.256 . . . . 0.0 111.579 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 tp -123.0 119.39 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.73 153.05 21.12 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.71 -1.244 . . . . 0.0 108.561 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.562 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 14.7 mt -127.9 132.69 49.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.962 -1.086 . . . . 0.0 111.838 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -138.93 122.35 17.2 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 65.4 mtm180 -86.55 135.66 35.92 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 111.388 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.7 Cg_endo -79.32 -23.87 7.06 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.434 2.089 . . . . 0.0 110.58 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' SER . 14.6 pt20 -48.06 -38.2 16.84 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 10.7 t -95.3 -18.59 20.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.1 52.77 4.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 115' ' ' VAL . 3.6 mtp180 -87.57 6.26 35.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.289 . . . . 0.0 109.993 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 114' ' ' ARG . 21.1 t 58.08 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 117' ' ' SER . 30.6 tp -74.08 150.83 40.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -40.49 140.03 0.71 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.311 -0.868 . . . . 0.0 110.609 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.67 98.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 81.0 mmm -63.89 -44.06 94.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.17 -0.956 . . . . 0.0 109.176 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.74 -41.79 91.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.243 -0.91 . . . . 0.0 108.768 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.81 -45.15 95.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.425 -0.797 . . . . 0.0 109.585 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -66.98 -39.11 93.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.645 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -48.41 -55.91 9.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -1.215 . . . . 0.0 108.217 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -9.87 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.432 0.634 . . . . 0.0 111.148 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -130.89 -28.16 2.01 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 80.24 -5.45 63.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.663 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 p -79.17 39.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' A' ' 127' ' ' SER . 86.1 mtt-85 106.12 -25.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.903 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -89.71 114.67 26.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -137.66 137.76 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.762 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.85 103.98 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 15.0 m0 -104.59 143.09 33.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.074 -1.016 . . . . 0.0 109.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.474 ' O ' ' SD ' ' A' ' 142' ' ' MET . 98.7 m-20 -96.96 159.83 14.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.86 -1.15 . . . . 0.0 108.792 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 8.0 p90 -165.5 -167.06 1.06 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.652 -1.28 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -166.71 146.63 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 135' ' ' ALA . 42.6 mt-10 -41.48 -37.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.127 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.59 4.13 37.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.447 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 135' ' ' ALA . 20.4 pt-20 -155.75 8.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.463 -1.61 . . . . 0.0 110.797 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.3 p -53.63 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.913 -1.117 . . . . 0.0 108.539 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 20.8 pt-20 -58.86 -31.94 69.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.483 -0.761 . . . . 0.0 109.09 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.1 m -68.51 -46.01 70.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.0 tpp -51.06 -45.8 61.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.63 -34.97 70.25 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.493 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.54 -40.53 95.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 110.279 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -71.64 -50.54 29.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.894 -1.129 . . . . 0.0 108.629 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -59.61 -46.44 88.97 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 151' ' ' LEU . 13.6 m-85 -70.16 -32.95 71.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.88 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.505 -1.372 . . . . 0.0 107.551 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.14 -18.05 62.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.571 -0.705 . . . . 0.0 110.661 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -152.84 3.37 0.33 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.385 -1.447 . . . . 0.0 111.598 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 147' ' ' PHE . 6.1 mt -116.25 83.84 13.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.677 -1.264 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.11 -100.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.594 2.196 . . . . 0.0 111.688 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -72.89 -35.32 67.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -54.49 -22.42 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.294 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 151' ' ' LEU . 58.9 m -47.46 -39.41 15.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.48 143.17 22.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 109.549 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.3 m -139.16 160.42 39.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.862 ' HG ' ' NE2' ' A' ' 160' ' ' HIS . 18.4 t -139.22 157.26 46.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.426 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 m -57.36 -41.76 80.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.862 ' NE2' ' HG ' ' A' ' 158' ' ' SER . 3.7 p-80 -85.56 152.2 56.99 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.79 147.75 85.84 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.508 2.138 . . . . 0.0 112.025 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 81.1 p -58.95 -13.05 5.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.313 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.686 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 51.98 29.11 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.29 158.98 43.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.603 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 53.1 p -148.24 170.36 18.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 206' ' ' GLU . . . 84.82 -99.16 2.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' B' ' 205' ' ' GLY . 90.7 mt-10 47.34 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -1.163 . . . . 0.0 109.372 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.41 178.24 6.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -129.57 154.25 80.83 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.39 -156.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.62 2.213 . . . . 0.0 111.719 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.506 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 92.0 m -100.09 177.08 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 2.4 m -119.97 120.86 37.58 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 5.8 t -93.86 130.95 42.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' B' ' 269' ' ' ASP . 32.7 t80 -100.01 133.32 44.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.499 ' O ' ' CE1' ' B' ' 213' ' ' TYR . 26.9 t80 -86.7 116.82 25.05 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.273 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.538 ' HG ' ' CB ' ' B' ' 293' ' ' GLU . 5.6 t -107.76 109.03 20.5 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.728 0.775 . . . . 0.0 109.267 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -174.75 174.54 46.69 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' B' ' 290' ' ' VAL . 6.5 p -113.46 160.09 18.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -1.059 . . . . 0.0 108.362 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.414 HG22 ' NE2' ' B' ' 225' ' ' GLN . 0.7 OUTLIER -84.91 -13.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.516 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.69 ' O ' ' N ' ' B' ' 221' ' ' GLY . 17.5 mmm180 -50.15 -85.81 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 219' ' ' ARG . . . 40.61 -82.07 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.755 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 163.19 36.26 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.622 ' HE ' ' CD1' ' B' ' 254' ' ' LEU . 39.2 mmt-85 56.07 -47.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 122.242 -0.563 . . . . 0.0 109.77 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' B' ' 221' ' ' GLY . 75.8 mm-40 -56.75 -38.87 73.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.68 -26.82 68.83 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.532 HE21 ' C ' ' B' ' 246' ' ' VAL . 19.9 tp60 -64.58 -42.69 95.46 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.61 84.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 tp -59.21 -38.03 78.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.551 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 21.2 m-30 -65.86 -41.53 91.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -63.34 -39.44 94.55 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.828 -1.17 . . . . 0.0 108.992 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.22 -55.13 10.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.078 . . . . 0.0 108.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -53.78 -45.4 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 49.8 t -59.91 -29.14 42.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 5.9 m -67.43 -38.33 84.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.81 -50.13 52.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.893 -1.129 . . . . 0.0 108.932 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 24.9 mt -56.71 -40.75 76.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -61.6 -27.02 68.35 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -76.07 -36.57 58.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.882 -1.136 . . . . 0.0 109.473 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.525 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.8 m-85 -72.14 -48.79 41.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.536 -0.727 . . . . 0.0 110.646 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -149.15 -149.1 4.89 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.7 125.33 40.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 109.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.2 t -83.22 101.27 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 94.3 mt -47.28 149.59 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.256 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 3.5 m -44.59 140.08 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 109.303 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' B' ' 246' ' ' VAL . 11.2 pt-20 -161.54 134.6 6.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.339 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -74.86 24.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.935 . . . . 0.0 109.222 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' B' ' 244' ' ' GLU . 27.7 t -83.42 -85.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' B' ' 249' ' ' ALA . . . -67.97 178.86 1.64 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.89 19.5 0.27 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.75 -1.218 . . . . 0.0 108.226 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' B' ' 247' ' ' ALA . . . -114.27 -9.89 12.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -62.2 -33.23 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.863 ' CD1' ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -57.75 157.37 7.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.525 -0.734 . . . . 0.0 109.915 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' B' ' 251' ' ' LEU . 18.3 mt-10 54.7 155.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.619 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' B' ' 258' ' ' ALA . 55.9 Cg_endo -72.09 68.12 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.506 2.138 . . . . 0.0 111.937 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.622 ' CD1' ' HE ' ' B' ' 222' ' ' ARG . 0.2 OUTLIER -55.35 165.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.992 . . . . 0.0 109.643 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 149.83 32.78 0.05 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 58.9 -74.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.501 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.9 tt0 -52.51 -27.94 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' B' ' 253' ' ' PRO . . . -68.88 149.17 49.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.356 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -48.68 141.96 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 167.43 -58.24 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.44 80.64 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -53.49 -40.85 65.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -1.108 . . . . 0.0 108.525 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.22 -48.96 66.28 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 108.775 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.95 -38.34 82.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.415 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.9 OUTLIER -63.29 -39.94 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.458 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 1.3 t-80 -79.16 -51.37 9.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.572 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.458 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 65.4 mm-40 -50.21 -47.9 54.56 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.87 -1.144 . . . . 0.0 109.879 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -74.11 -48.42 29.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.547 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 69.1 m-20 -63.27 -51.45 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.71 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.408 HD12 ' NE ' ' B' ' 296' ' ' ARG . 0.6 OUTLIER -68.76 -40.96 79.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.887 -1.133 . . . . 0.0 111.277 -178.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.4 t-20 -62.19 -53.77 50.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.654 -1.279 . . . . 0.0 109.305 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -38.18 75.77 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.088 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.441 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.1 tp -52.63 -45.65 66.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.554 ' OE1' ' NH1' ' B' ' 296' ' ' ARG . 20.5 mt-30 -67.12 -30.37 70.36 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 5.3 mt-30 -91.28 3.54 54.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.625 -1.297 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.79 141.07 58.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.0 112.527 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' B' ' 303' ' ' PRO . 65.3 t0 -97.84 -20.43 17.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 18.7 t -144.65 144.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 22.6 t -143.5 137.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.544 -1.347 . . . . 0.0 112.527 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.86 125.88 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -112.97 144.98 41.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.195 -0.94 . . . . 0.0 110.274 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -108.83 121.65 45.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.535 -0.728 . . . . 0.0 109.179 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 1.7 m -146.74 113.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 18.9 m -130.22 -13.6 3.94 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -142.79 156.26 62.7 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -39.07 108.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.259 1.973 . . . . 0.0 111.691 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.608 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 45.6 m -125.9 134.35 51.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.099 -1.001 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.608 ' HB2' ' H ' ' A' ' 87' ' ' SER . 15.0 tp -105.32 153.51 21.53 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 81.97 -29.74 3.03 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.599 ' H ' ' C ' ' B' ' 288' ' ' LEU . 46.6 t -86.39 -49.54 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.67 -28.55 62.93 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 106.946 -2.461 . . . . 0.0 106.946 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.99 -57.95 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.936 -0.743 . . . . 0.0 109.088 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.538 ' CB ' ' HG ' ' B' ' 215' ' ' CYS . 86.5 mt-10 -52.2 -33.2 39.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.26 -41.13 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.74 -48.63 82.95 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . 0.554 ' NH1' ' OE1' ' B' ' 274' ' ' GLN . 45.4 ttm-85 -62.97 -38.16 90.0 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.371 -1.076 . . . . 0.0 108.987 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.6 -39.68 88.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.468 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -54.92 -44.32 72.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 120.82 -1.175 . . . . 0.0 108.216 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.98 -49.28 18.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.46 ' O ' ' CD ' ' B' ' 302' ' ' LYS . 2.8 pp -116.36 -23.56 8.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.949 -1.094 . . . . 0.0 110.403 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -52.92 170.38 0.64 Allowed Glycine 0 C--N 1.288 -2.128 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.543 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 0.4 OUTLIER -131.46 -75.67 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 66.5 Cg_endo -81.73 109.49 2.02 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.819 1.679 . . . . 0.0 109.623 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 55.4 mt -130.47 126.79 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.688 -1.258 . . . . 0.0 111.514 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 24.1 tp -123.06 119.29 29.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.45 153.08 20.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.642 -1.286 . . . . 0.0 108.511 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.584 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 14.7 mt -127.69 132.5 49.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.996 -1.065 . . . . 0.0 111.865 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -138.79 122.51 17.54 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 68.3 mtm180 -86.93 135.61 35.12 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.985 -1.072 . . . . 0.0 111.421 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' B' ' 313' ' ' GLY . 72.8 Cg_endo -79.36 -24.29 6.64 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.508 2.139 . . . . 0.0 110.425 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' B' ' 312' ' ' SER . 14.6 pt20 -47.9 -38.28 16.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 9.9 t -95.23 -18.78 20.58 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 40.8 53.1 3.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' B' ' 315' ' ' VAL . 3.6 mtp180 -87.73 6.44 34.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.923 -1.339 . . . . 0.0 109.98 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' B' ' 314' ' ' ARG . 24.1 t 58.25 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.841 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' B' ' 317' ' ' SER . 30.0 tp -74.19 151.21 40.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.41 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.59 139.84 0.75 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 110.596 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.61 97.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.468 -0.77 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 81.0 mmm -64.31 -43.9 93.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.444 HG23 HD13 ' B' ' 320' ' ' ILE . 45.7 mm -61.57 -41.6 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.102 -0.999 . . . . 0.0 108.756 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.09 -45.03 95.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.435 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.431 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -67.01 -39.0 93.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.636 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -48.45 -55.96 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.065 -1.256 . . . . 0.0 108.288 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.636 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -9.99 118.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.344 0.592 . . . . 0.0 111.16 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -131.43 -27.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.614 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 79.95 -5.18 63.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 54.7 p -79.34 39.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' B' ' 327' ' ' SER . 84.8 mtt-85 106.22 -25.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.969 -1.469 . . . . 0.0 107.831 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -89.66 114.3 25.9 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.415 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 81.0 mt-30 -137.14 137.85 39.65 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.748 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.94 104.15 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.476 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 14.7 m0 -104.88 142.81 34.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.189 -0.945 . . . . 0.0 109.824 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.476 ' O ' ' SD ' ' B' ' 342' ' ' MET . 97.9 m-20 -97.06 159.97 14.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.828 -1.17 . . . . 0.0 108.807 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 8.1 p90 -165.4 -167.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.705 -1.247 . . . . 0.0 111.64 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.467 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -166.39 146.51 6.08 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.7 mt-10 -41.33 -37.24 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.801 -1.187 . . . . 0.0 110.058 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -74.75 4.89 34.01 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.389 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' B' ' 335' ' ' ALA . 20.3 pt-20 -156.21 8.79 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.461 -1.611 . . . . 0.0 110.899 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.3 p -53.51 -44.75 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.92 -1.113 . . . . 0.0 108.468 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 20.2 pt-20 -58.64 -31.88 68.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.428 -0.795 . . . . 0.0 109.202 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 62.2 m -68.76 -45.91 70.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.0 tpp -51.38 -45.67 62.53 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.6 mt -71.53 -35.19 70.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.2 -40.57 96.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -72.02 -50.1 31.38 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.933 -1.104 . . . . 0.0 108.717 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -59.99 -46.39 89.6 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.1 -1.0 . . . . 0.0 110.153 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.566 ' O ' ' N ' ' B' ' 351' ' ' LEU . 13.6 m-85 -70.03 -33.03 71.46 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.903 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -67.08 -22.9 65.82 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.493 -1.379 . . . . 0.0 107.589 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.05 -17.82 62.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.512 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.9 OUTLIER -153.02 3.11 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.494 -1.379 . . . . 0.0 111.689 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' B' ' 347' ' ' PHE . 6.2 mt -116.05 83.87 12.89 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.662 -1.274 . . . . 0.0 109.69 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.9 -100.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.651 2.234 . . . . 0.0 111.75 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -72.63 -35.78 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -53.82 -22.24 9.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 351' ' ' LEU . 57.9 m -47.71 -39.27 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.903 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -152.25 143.16 23.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 69.6 m -139.11 160.46 39.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.375 -0.828 . . . . 0.0 109.251 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' SER . . . . . 0.871 ' HG ' ' NE2' ' B' ' 360' ' ' HIS . 14.6 t -139.52 157.6 45.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 20.2 m -57.86 -41.47 82.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.871 ' NE2' ' HG ' ' B' ' 358' ' ' SER . 3.5 p-80 -86.0 152.11 55.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.43 147.99 87.59 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.517 2.145 . . . . 0.0 112.006 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 59.6 p -60.88 -21.36 63.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.361 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.375 -179.889 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.41 141.25 58.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.26 147.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.6 m -62.46 157.27 20.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.77 -169.01 54.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 7' ' ' GLN . 83.9 tt0 -90.39 128.22 36.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -1.159 . . . . 0.0 109.392 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' GLU . 89.7 mt-30 46.32 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.658 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.75 23.5 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.71 -154.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 111.406 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.464 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 30.3 p -102.41 -178.19 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 2.7 p -119.88 150.62 40.18 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.8 t -125.41 131.96 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 26.5 t80 -99.09 94.88 6.75 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.751 ' H ' ' HG1' ' A' ' 43' ' ' THR . 63.2 t80 -88.01 128.77 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 111.213 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 m -118.39 157.8 26.49 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.248 -0.907 . . . . 0.0 109.765 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' C ' ' CG2' ' A' ' 90' ' ' VAL . . . -168.93 173.8 43.47 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' NE2' ' A' ' 85' ' ' GLN . 19.2 t -81.6 132.25 35.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -1.124 . . . . 0.0 109.689 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -137.24 133.54 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.153 -0.967 . . . . 0.0 109.968 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 6.3 tpp180 -175.89 0.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.982 -1.074 . . . . 0.0 110.571 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.85 82.95 0.04 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.711 ' O ' ' CB ' ' A' ' 22' ' ' ARG . . . 56.88 -140.55 44.2 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.711 ' CB ' ' O ' ' A' ' 21' ' ' GLY . 65.9 mtt180 118.01 131.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 117.752 0.776 . . . . 0.0 110.93 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -52.55 -26.87 14.47 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 66.1 m-20 -69.71 -36.05 75.59 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -59.8 -43.59 94.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.93 72.49 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.4 -28.95 68.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 12.7 m-30 -69.43 -49.39 55.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.552 -0.717 . . . . 0.0 110.088 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.25 77.12 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.544 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.478 ' O ' ' OG ' ' A' ' 33' ' ' SER . 63.1 ttt180 -71.74 -55.45 7.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.864 -1.147 . . . . 0.0 108.393 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 5.5 mt -54.04 -47.36 65.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.434 ' CG2' ' CD2' ' A' ' 14' ' ' PHE . 40.4 t -60.85 -28.77 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.72 -0.613 . . . . 0.0 109.363 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 26.7 p -69.31 -37.2 77.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.553 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -70.46 -47.41 60.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.831 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.26 -41.54 97.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -61.02 -26.12 67.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -78.66 -35.15 45.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -74.68 -51.77 13.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.47 -0.769 . . . . 0.0 109.809 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -142.54 -152.85 5.76 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -98.07 130.9 44.85 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.218 -1.166 . . . . 0.0 109.018 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.46 111.22 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.1 mt -79.8 -29.09 40.22 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.569 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.751 ' HG1' ' H ' ' A' ' 14' ' ' PHE . 12.5 p -82.96 23.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . 85.9 tt0 -44.08 -31.47 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -54.91 -35.96 64.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.875 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 45' ' ' HIS . 56.1 t -50.43 -66.75 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.916 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -62.94 -38.97 93.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -61.58 -0.58 0.44 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -60.57 -40.16 90.67 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.246 -0.909 . . . . 0.0 108.678 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.06 -23.73 1.3 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -66.3 123.15 19.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 109.403 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 51' ' ' LEU . 3.6 mt-10 54.02 162.79 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.798 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ALA . 84.2 Cg_exo -42.71 136.51 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.816 1.677 . . . . 0.0 111.065 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.725 ' O ' ' O ' ' A' ' 55' ' ' GLY . 4.3 mp -81.9 -103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 108.694 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.725 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 38.52 112.98 0.0 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.511 ' C ' ' O ' ' A' ' 55' ' ' GLY . 15.8 mm-40 -37.74 -48.91 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -1.217 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -74.95 -31.58 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 0.0 108.858 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -83.39 46.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.03 -165.0 1.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.12 69.21 0.21 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 75.36 1.08 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 30.3 p-10 -52.44 -38.76 59.98 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 6.6 tt0 -63.26 -48.57 77.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -57.15 -36.73 71.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.17 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -64.1 -38.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.723 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -77.27 -58.25 3.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 110.45 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.723 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 96.2 mt-10 -45.13 -46.14 11.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.894 -1.129 . . . . 0.0 109.853 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.06 -42.47 76.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 109.716 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 86.0 m-20 -66.59 -36.06 81.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.607 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.54 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.3 mm? -69.77 -52.05 28.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -57.21 -40.57 77.74 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.517 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -67.22 -44.74 78.77 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 14.2 tp -51.97 -35.74 47.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.1 -33.2 67.67 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.858 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -84.04 -1.23 54.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.188 -0.945 . . . . 0.0 109.216 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.05 136.65 50.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.062 0.934 . . . . 0.0 112.486 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 11' ' ' SER . 47.6 m-20 -99.71 -30.44 12.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 58.1 t -137.1 144.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.6 t -132.99 140.14 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.787 -1.196 . . . . 0.0 111.205 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.63 121.64 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -113.34 121.91 45.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.814 -1.178 . . . . 0.0 110.28 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 54.8 tt0 -86.1 112.95 21.76 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -86.65 -99.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 110.383 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.5 m 59.48 -96.87 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.203 -1.561 . . . . 0.0 109.032 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.602 HE22 ' CZ ' ' A' ' 22' ' ' ARG . 28.7 tt0 -61.39 133.34 93.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.914 -1.116 . . . . 0.0 108.589 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD3' ' HE ' ' A' ' 114' ' ' ARG . 32.3 Cg_endo -66.62 115.59 3.64 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.975 1.784 . . . . 0.0 111.869 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.634 ' HG ' ' H ' ' A' ' 90' ' ' VAL . 12.8 t -138.45 129.73 27.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.849 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.05 -40.25 78.66 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 108.932 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.19 95.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.634 ' H ' ' HG ' ' A' ' 87' ' ' SER . 44.6 t -66.13 -47.29 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.451 -1.029 . . . . 0.0 108.832 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.96 74.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -68.89 -47.61 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.507 -0.996 . . . . 0.0 109.698 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.48 -35.22 78.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.551 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.3 mt -69.09 -46.73 67.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 108.616 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.4 -33.95 87.97 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -43.99 93.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.49 -1.006 . . . . 0.0 109.706 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -71.14 -29.1 64.8 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.602 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -53.61 -50.42 50.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.305 -1.497 . . . . 0.0 106.994 178.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.514 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -85.43 -55.64 3.91 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.452 0.644 . . . . 0.0 110.681 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 100' ' ' LEU . 1.2 tt -61.97 -16.81 54.11 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.503 1.144 . . . . 0.0 108.004 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 102' ' ' LYS . . . 75.81 -163.17 53.35 Favored Glycine 0 C--N 1.281 -2.511 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 7.6 mmtm 96.85 136.24 0.03 OUTLIER Pre-proline 0 C--N 1.285 -2.215 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -36.41 111.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.218 1.945 . . . . 0.0 111.429 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 129' ' ' PHE . 3.5 mt -105.36 87.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.248 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.7 tp -91.42 116.7 29.06 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.571 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -108.0 139.81 42.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 108.536 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.5 mt -123.31 138.6 54.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -140.4 138.9 35.12 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -92.06 135.27 27.36 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 0.0 110.906 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.04 -32.86 2.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.514 2.143 . . . . 0.0 111.094 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.02 -33.52 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 113' ' ' GLY . 36.4 p -97.11 -21.41 17.36 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 39.74 44.84 2.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.416 ' HE ' ' HD3' ' A' ' 86' ' ' PRO . 14.8 mtp85 -70.62 8.43 0.85 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.202 -1.175 . . . . 0.0 109.323 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 113' ' ' GLY . 94.5 t 53.92 102.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.428 -0.795 . . . . 0.0 110.419 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.4 tp -57.05 139.52 52.03 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.1 144.63 1.22 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.476 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.83 -37.11 78.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.484 -0.76 . . . . 0.0 109.913 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 119' ' ' MET . 26.7 mmm -68.58 -45.69 71.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.315 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.427 HG22 HD13 ' A' ' 120' ' ' ILE . 45.3 mm -64.5 -47.37 89.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.79 -44.21 77.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.401 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.528 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.27 -26.53 69.48 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -56.44 -51.96 66.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.261 . . . . 0.0 107.743 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 8.97 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.6 t0 -67.86 -35.4 78.49 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.692 -1.255 . . . . 0.0 107.921 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.859 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.77 176.54 45.73 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 56.05 -26.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.488 1.137 . . . . 0.0 108.79 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.859 ' H ' ' C ' ' A' ' 126' ' ' GLY . 7.2 tpp85 -149.95 -3.63 0.38 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.415 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.571 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 6.3 t80 -152.73 112.31 3.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.868 -1.145 . . . . 0.0 108.013 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.515 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 86.8 mt-30 -138.62 132.27 30.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -86.7 103.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.515 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 14.2 m0 -98.11 139.73 33.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.288 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' O ' ' CE ' ' A' ' 142' ' ' MET . 74.2 m-20 -94.18 141.92 28.0 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.954 -1.091 . . . . 0.0 109.046 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.6 p90 -157.51 -173.63 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.035 -1.04 . . . . 0.0 111.034 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -158.87 157.75 32.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.5 30.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.447 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.68 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.78 -1.33 3.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.666 ' O ' ' SD ' ' A' ' 142' ' ' MET . 23.2 pt-20 -154.26 10.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.122 -1.222 . . . . 0.0 110.027 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.557 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.7 p -50.86 -41.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.045 -1.034 . . . . 0.0 108.865 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.447 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.0 tt0 -61.66 -29.18 69.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 108.771 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' GLU . 16.9 m -71.31 -48.36 51.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 110.367 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -55.76 -47.16 77.49 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.42 -29.83 70.79 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.128 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.479 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 43.2 t0 -69.09 -39.08 79.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 110.0 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -70.54 -51.76 26.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.69 -1.256 . . . . 0.0 108.814 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -57.92 -47.33 83.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.08 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.457 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 12.0 m-85 -74.34 -32.82 62.94 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.123 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 12.2 mm-40 -58.54 -26.48 63.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.21 -22.15 62.95 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.82 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -172.75 101.48 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' A' ' 152' ' ' PRO . 0.7 OUTLIER 175.23 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 151' ' ' LEU . 86.9 Cg_endo -83.0 30.22 0.54 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.913 2.409 . . . . 0.0 111.456 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 65.76 32.82 8.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.073 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp 51.3 40.04 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -50.44 169.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.16 -29.85 65.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.832 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.3 t 49.31 -167.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.0 p -136.41 157.83 45.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.278 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 t -126.43 146.8 49.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' SER . 10.1 m-70 -78.63 152.05 77.65 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.045 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -38.76 -25.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.554 2.169 . . . . 0.0 112.22 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' HIS . 73.5 m -71.77 159.56 34.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.853 . . . . 0.0 109.448 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.503 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.11 141.41 58.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -64.23 147.18 52.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.6 m -62.47 156.43 22.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.26 -168.26 54.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' B' ' 207' ' ' GLN . 84.0 tt0 -90.78 127.95 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -1.183 . . . . 0.0 109.431 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' B' ' 206' ' ' GLU . 89.4 mt-30 46.4 -170.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.32 -0.863 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -155.18 163.69 23.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.69 -154.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.065 2.51 . . . . 0.0 111.459 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.471 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 30.3 p -102.65 -178.16 3.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.42 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 2.8 p -119.77 151.12 39.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 3.6 t -125.86 131.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 26.0 t80 -98.98 94.46 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.717 ' H ' ' HG1' ' B' ' 243' ' ' THR . 62.4 t80 -87.84 129.3 35.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 0.0 111.117 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -119.24 157.99 26.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.402 -0.812 . . . . 0.0 109.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CG2' ' B' ' 290' ' ' VAL . . . -169.12 174.29 43.6 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.52 ' OG ' ' NE2' ' B' ' 285' ' ' GLN . 17.7 t -81.73 132.12 35.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -1.115 . . . . 0.0 109.8 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.452 ' N ' ' NH1' ' B' ' 222' ' ' ARG . 1.0 OUTLIER -137.04 133.27 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.201 -0.937 . . . . 0.0 110.101 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 6.1 tpp180 -175.35 0.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.905 -1.122 . . . . 0.0 110.623 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.85 82.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' B' ' 222' ' ' ARG . . . 57.0 -140.91 44.02 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.709 ' CB ' ' O ' ' B' ' 221' ' ' GLY . 65.9 mtt180 118.38 131.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 117.768 0.784 . . . . 0.0 110.981 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -52.75 -26.28 13.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 63.7 m-20 -70.58 -35.79 73.24 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 222' ' ' ARG . 0.4 OUTLIER -59.9 -43.34 94.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.03 71.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.34 -28.81 68.46 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' B' ' 224' ' ' ASP . 12.8 m-30 -69.55 -49.18 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 110.167 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.28 77.36 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.477 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.479 ' O ' ' OG ' ' B' ' 233' ' ' SER . 64.3 ttt180 -71.4 -55.41 8.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.138 . . . . 0.0 108.356 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.43 ' CD1' ' OE1' ' B' ' 282' ' ' GLU . 5.8 mt -54.24 -47.51 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.433 ' CG2' ' CD2' ' B' ' 214' ' ' PHE . 40.1 t -60.73 -28.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' B' ' 230' ' ' ARG . 28.4 p -69.44 -37.31 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.541 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -70.08 -47.61 61.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.131 . . . . 0.0 108.919 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.24 -41.61 97.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.8 -26.27 67.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -78.51 -35.47 46.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.045 -1.034 . . . . 0.0 109.371 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.558 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -74.3 -51.65 14.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -142.45 -152.51 5.7 Favored Glycine 0 N--CA 1.478 1.443 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -98.18 130.97 44.92 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.253 -1.145 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 110.79 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 16.9 mt -79.37 -29.2 42.05 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.673 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.717 ' HG1' ' H ' ' B' ' 214' ' ' PHE . 13.6 p -83.0 24.19 0.78 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.521 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 243' ' ' THR . 85.9 tt0 -44.36 -31.19 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.539 ' CD2' ' OD2' ' B' ' 269' ' ' ASP . 0.1 OUTLIER -54.96 -36.05 64.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.845 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' B' ' 245' ' ' HIS . 55.8 t -50.32 -66.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -63.11 -39.16 93.89 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -61.41 -0.31 0.37 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.566 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -60.58 -40.15 90.68 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.167 -0.958 . . . . 0.0 108.735 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -49.29 -23.1 1.25 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.494 -0.754 . . . . 0.0 109.782 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' B' ' 251' ' ' LEU . 0.7 OUTLIER -66.78 123.25 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 251' ' ' LEU . 3.3 mt-10 54.06 163.25 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 108.88 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' B' ' 258' ' ' ALA . 84.5 Cg_exo -43.09 135.84 5.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.781 1.654 . . . . 0.0 111.038 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.735 ' O ' ' O ' ' B' ' 255' ' ' GLY . 4.6 mp -81.14 -103.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 108.842 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 38.18 113.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' B' ' 255' ' ' GLY . 14.7 mm-40 -37.86 -48.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.12 -1.223 . . . . 0.0 109.204 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -74.8 -31.91 61.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 108.846 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -83.22 46.97 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -139.89 -164.71 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.24 68.62 0.22 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.03 75.66 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 30.5 p-10 -52.57 -38.4 59.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 6.7 tt0 -63.49 -48.9 75.74 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -56.66 -36.9 70.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.099 -1.001 . . . . 0.0 109.145 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.5 OUTLIER -64.05 -38.07 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.719 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 0.5 OUTLIER -77.31 -58.13 3.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.716 . . . . 0.0 110.478 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.719 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 95.9 mt-10 -45.23 -46.26 12.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.778 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.82 -42.61 77.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.746 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' B' ' 245' ' ' HIS . 87.5 m-20 -66.47 -36.37 82.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.969 . . . . 0.0 110.695 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.54 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 1.3 mm? -69.56 -52.23 28.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.92 -1.113 . . . . 0.0 109.636 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -57.01 -40.58 76.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.509 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 1.0 OUTLIER -67.21 -44.64 79.05 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.275 -0.89 . . . . 0.0 109.608 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.546 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.9 tp -52.22 -35.31 49.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -72.34 -33.45 67.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.79 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -83.81 -1.33 54.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.37 51.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 112.401 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' B' ' 211' ' ' SER . 53.1 m-20 -100.58 -30.43 11.78 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 57.4 t -137.03 144.31 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.33 139.78 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.782 -1.199 . . . . 0.0 111.16 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 43.5 t -142.54 121.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -113.38 122.18 46.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.799 -1.188 . . . . 0.0 110.188 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.43 ' OE1' ' CD1' ' B' ' 231' ' ' ILE . 53.7 tt0 -86.03 112.91 21.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 1.9 t -86.45 -99.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' B' ' 285' ' ' GLN . 6.2 m 59.9 -96.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.217 -1.552 . . . . 0.0 109.036 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.596 HE22 ' CZ ' ' B' ' 222' ' ' ARG . 28.9 tt0 -61.64 133.43 93.45 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.871 -1.143 . . . . 0.0 108.582 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.416 ' HD3' ' HE ' ' B' ' 314' ' ' ARG . 33.1 Cg_endo -66.77 115.27 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.938 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.624 ' HG ' ' H ' ' B' ' 290' ' ' VAL . 13.1 t -138.22 130.22 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.812 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 8.4 mt -69.39 -40.8 77.17 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.79 94.19 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.624 ' H ' ' HG ' ' B' ' 287' ' ' SER . 43.5 t -65.57 -47.53 86.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.462 -1.023 . . . . 0.0 108.827 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.26 73.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -68.85 -47.49 65.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.59 -0.947 . . . . 0.0 109.773 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.76 -35.08 78.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 0.0 109.635 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.02 -46.82 66.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 108.596 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.38 -34.19 88.65 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -43.89 94.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.458 -1.025 . . . . 0.0 109.685 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -71.39 -28.65 64.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.619 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.518 HG11 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -53.91 -50.15 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.518 ' N ' HG11 ' B' ' 298' ' ' VAL . . . -85.61 -55.75 3.84 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.419 0.628 . . . . 0.0 110.564 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' B' ' 300' ' ' LEU . 1.1 tt -61.81 -17.07 54.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' B' ' 302' ' ' LYS . . . 75.78 -162.75 53.16 Favored Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' B' ' 301' ' ' GLY . 7.5 mmtm 96.63 136.4 0.03 OUTLIER Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 302' ' ' LYS . 80.7 Cg_exo -36.41 110.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.2 1.933 . . . . 0.0 111.591 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' B' ' 329' ' ' PHE . 3.4 mt -104.65 87.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.91 0.862 . . . . 0.0 111.256 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 32.9 tp -91.16 116.94 29.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.568 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.4 OUTLIER -108.28 140.29 41.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 0.0 108.585 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.418 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.0 mt -123.7 138.77 54.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.0 111.059 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -140.34 138.89 35.23 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -91.69 135.17 27.99 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.29 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.518 2.145 . . . . 0.0 110.934 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -49.78 -33.49 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.452 ' O ' ' C ' ' B' ' 313' ' ' GLY . 38.7 p -97.27 -21.06 17.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 39.6 44.74 2.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.416 ' HE ' ' HD3' ' B' ' 286' ' ' PRO . 14.5 mtp85 -70.31 8.38 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -1.203 . . . . 0.0 109.397 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' B' ' 313' ' ' GLY . 97.3 t 53.85 102.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.297 -0.877 . . . . 0.0 110.356 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.39 139.6 52.63 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.13 144.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.469 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.74 -36.95 77.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' B' ' 319' ' ' MET . 25.3 mmm -69.0 -45.35 70.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.83 -46.59 91.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -68.44 -44.54 74.71 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.116 -0.99 . . . . 0.0 109.326 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.8 -26.6 68.89 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -56.47 -52.45 64.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.015 -1.285 . . . . 0.0 107.863 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 9.25 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' B' ' 323' ' ' ALA . 23.5 t0 -67.75 -35.48 78.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 107.945 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.879 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.78 176.49 45.68 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 21.1 m 56.25 -26.05 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.463 1.125 . . . . 0.0 108.824 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.879 ' H ' ' C ' ' B' ' 326' ' ' GLY . 7.2 tpp85 -150.34 -3.32 0.36 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.37 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.568 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 6.1 t80 -153.0 112.55 3.87 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.51 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 86.8 mt-30 -138.77 132.85 31.34 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.572 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 43.5 t -87.16 103.69 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.51 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 14.2 m0 -98.4 139.71 33.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -0.932 . . . . 0.0 109.306 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.477 ' O ' ' CE ' ' B' ' 342' ' ' MET . 73.9 m-20 -94.32 142.11 27.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.891 -1.13 . . . . 0.0 109.052 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -157.71 -173.28 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 111.078 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.656 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -159.22 157.61 31.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.6 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -135.77 -1.14 3.08 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.648 ' O ' ' SD ' ' B' ' 342' ' ' MET . 23.0 pt-20 -154.29 10.37 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.235 . . . . 0.0 109.995 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.547 ' O ' ' HG2' ' B' ' 342' ' ' MET . 1.9 p -51.03 -41.82 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.023 -1.048 . . . . 0.0 108.856 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 81.2 tt0 -61.37 -28.78 69.48 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.027 -1.045 . . . . 0.0 108.833 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.1 m -71.96 -48.12 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.665 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.76 -47.0 77.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 75.3 mt -62.62 -30.13 71.13 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.07 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 43.4 t0 -68.32 -39.55 81.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -70.47 -51.61 27.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.173 . . . . 0.0 108.955 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.88 -47.06 83.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.507 -0.746 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 11.7 m-85 -74.83 -32.46 61.96 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.185 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 12.3 mm-40 -58.94 -26.28 64.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.67 62.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.821 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -173.23 101.56 0.12 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.465 ' N ' ' HD3' ' B' ' 352' ' ' PRO . 0.7 OUTLIER 175.17 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' B' ' 351' ' ' LEU . 90.7 Cg_endo -83.15 30.49 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 111.513 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 65.38 34.12 8.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.505 -0.747 . . . . 0.0 109.02 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp 50.02 40.74 22.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 9.7 t -51.14 169.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.07 65.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 46.8 t 49.4 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 82.9 p -136.8 158.61 44.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.838 . . . . 0.0 109.143 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 25.4 t -127.34 146.36 50.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' B' ' 362' ' ' SER . 10.1 m-70 -78.29 152.32 78.79 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -38.68 -25.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.41 2.073 . . . . 0.0 112.111 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 360' ' ' HIS . 73.1 m -72.5 160.42 32.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.449 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.23 153.63 39.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.55 147.4 30.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.4 t -140.22 145.6 37.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.365 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.32 176.6 37.76 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -103.29 140.75 36.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -1.107 . . . . 0.0 109.57 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -148.89 176.93 9.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 109.585 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -170.61 135.93 1.14 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.452 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' CYS . 61.2 Cg_endo -75.09 155.27 42.48 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.389 2.059 . . . . 0.0 112.141 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 12.2 p -54.01 -175.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.112 -0.992 . . . . 0.0 108.508 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 69.4 m -111.17 152.63 26.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.109 -0.995 . . . . 0.0 108.739 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 9.0 t -140.09 136.94 38.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 122.086 0.946 . . . . 0.0 109.273 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 69' ' ' ASP . 7.3 t80 -115.58 111.03 20.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -98.14 124.47 42.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 0.0 109.087 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.42 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 13.3 m -99.81 143.2 30.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.194 -0.941 . . . . 0.0 109.034 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.68 157.09 27.15 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.556 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 5.3 m -81.0 119.82 24.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.773 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -109.42 137.68 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.9 . . . . 0.0 108.732 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 47.2 ttt-85 83.12 10.88 0.52 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.56 -13.8 12.41 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.03 103.52 0.17 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.55 -25.67 27.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.063 -1.257 . . . . 0.0 109.635 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -53.03 -39.16 62.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.65 -28.99 68.91 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.91 -41.62 97.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.89 -50.46 70.79 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.23 -32.91 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.556 ' OH ' ' N ' ' A' ' 17' ' ' SER . 20.5 m-30 -69.41 -46.86 65.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.951 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.89 84.47 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.739 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.663 HH22 HH21 ' A' ' 34' ' ' ARG . 65.9 ttt-85 -69.46 -56.4 7.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.506 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.47 -48.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 55.7 t -58.1 -32.27 43.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 34' ' ' ARG . 17.7 p -63.32 -43.32 98.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 109.7 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.663 HH21 HH22 ' A' ' 30' ' ' ARG . 82.3 mtt-85 -64.4 -40.3 95.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.154 . . . . 0.0 108.06 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 38' ' ' TYR . 85.4 mt -62.9 -43.08 99.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.83 -28.49 61.64 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.81 -59.88 2.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.709 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -125.49 152.38 45.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 176.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.8 64.29 1.62 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' C ' ' O ' ' A' ' 39' ' ' GLY . 10.4 ttpt -34.42 121.79 0.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -1.037 . . . . 0.0 108.657 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.38 108.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.811 -1.181 . . . . 0.0 109.16 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.17 -36.82 69.38 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.775 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.412 ' OG1' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -91.24 93.16 8.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.024 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.23 -23.74 19.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.51 -37.85 85.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 55.9 t -47.32 -73.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.098 -1.001 . . . . 0.0 109.68 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.18 -47.6 71.86 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.039 -1.038 . . . . 0.0 109.14 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.35 45.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -122.79 -16.34 7.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -8.28 17.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.738 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.11 130.08 34.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.224 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 51' ' ' LEU . 5.7 mt-10 55.81 157.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HA ' HH22 ' A' ' 22' ' ' ARG . 8.9 Cg_endo -52.77 112.03 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.286 1.991 . . . . 0.0 111.493 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.409 ' N ' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -92.66 -3.79 54.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 58' ' ' ALA . . . -46.09 150.37 1.58 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 43.9 mt-10 -53.56 -35.49 60.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.062 -1.258 . . . . 0.0 109.117 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -66.31 -11.21 49.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . -57.17 176.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -47.03 164.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.26 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -43.31 150.96 0.46 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 154.87 -17.44 0.55 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.85 -44.03 90.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.0 109.219 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.39 -55.45 7.04 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -56.42 -29.31 61.42 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -69.85 -49.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -64.73 -55.34 20.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.629 -0.669 . . . . 0.0 110.012 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 91.1 mt-10 -49.1 -54.91 13.98 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.967 -1.083 . . . . 0.0 110.206 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 68' ' ' GLN . 4.2 mp0 -71.77 -50.61 28.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.924 -1.11 . . . . 0.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.482 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.4 m-20 -61.43 -54.61 41.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 111.493 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.37 -39.15 68.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.709 -1.244 . . . . 0.0 111.202 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 63.8 t-20 -58.48 -50.26 74.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.011 -1.68 . . . . 0.0 108.217 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -38.77 81.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.2 tp -49.84 -39.79 40.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.54 -31.3 65.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.614 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -85.06 0.31 51.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.919 -1.113 . . . . 0.0 109.344 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.98 121.86 18.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 112.057 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 11' ' ' SER . 76.2 m-20 -68.47 -37.63 80.33 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 79.6 t -131.49 151.23 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.0 t -135.77 143.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 0.0 112.356 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 t -135.08 156.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -162.99 123.38 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.364 -1.46 . . . . 0.0 110.749 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.09 116.46 22.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.39 30.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 108.778 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.55 HG23 ' N ' ' A' ' 113' ' ' GLY . 25.9 m -62.13 -108.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.817 -0.552 . . . . 0.0 110.125 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 84' ' ' THR . 1.2 tm0? -41.02 126.57 2.03 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.502 -0.749 . . . . 0.0 110.221 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 78.2 Cg_exo -45.76 113.44 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.881 1.721 . . . . 0.0 111.645 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.464 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 8.0 t -142.16 131.88 24.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.0 110.219 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HG ' ' H ' ' B' ' 287' ' ' SER . 8.3 mt -79.71 -42.46 24.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.76 -37.29 89.78 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 t -74.37 -42.56 50.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -1.22 . . . . 0.0 108.817 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.02 -25.18 67.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.467 ' HH ' ' CB ' ' B' ' 323' ' ' ALA . 65.2 t80 -70.82 -56.51 6.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.79 -0.829 . . . . 0.0 109.308 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 96.1 mt-10 -60.18 -33.76 72.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 94' ' ' LEU . 3.2 tm? -70.75 -49.95 41.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.17 57.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -56.16 -36.28 68.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -1.076 . . . . 0.0 108.334 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.69 -38.58 87.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -54.4 -43.47 62.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.876 -1.14 . . . . 0.0 108.531 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -74.71 -48.36 26.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.411 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.8 pp -119.5 -28.02 5.42 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.912 -1.117 . . . . 0.0 110.585 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -40.74 162.35 0.01 OUTLIER Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 2.5 mmtp -98.38 -161.57 0.04 OUTLIER Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 71.8 Cg_exo -41.71 115.03 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.354 1.519 . . . . 0.0 110.376 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.425 HD12 HG23 ' A' ' 104' ' ' ILE . 3.3 mt -106.62 138.97 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.088 0.947 . . . . 0.0 112.188 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 132' ' ' TRP . 50.8 tp -126.5 118.1 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER -102.63 157.27 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.924 -1.11 . . . . 0.0 109.411 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 5.7 mt -143.12 127.75 18.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -138.78 145.05 39.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.208 -0.933 . . . . 0.0 108.966 178.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.522 ' NH1' ' OH ' ' A' ' 134' ' ' TYR . 24.2 ptt-85 -128.67 148.12 67.14 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.52 29.46 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.58 2.186 . . . . 0.0 112.507 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 50.6 mt-30 -104.79 -44.01 4.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -129.69 -22.62 2.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 108.676 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 114' ' ' ARG . . . -87.03 -52.03 3.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.705 ' O ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 39.59 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 114' ' ' ARG . 96.6 t 61.78 93.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.682 ' H ' ' CD2' ' A' ' 116' ' ' LEU . 1.5 pt? -70.03 -43.56 71.05 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.788 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER 163.05 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.877 -1.139 . . . . 0.0 110.303 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.493 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -63.91 -46.12 86.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.818 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 80.4 mmm -62.22 -46.53 88.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.8 mm -61.1 -41.86 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -44.57 95.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.921 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.21 -33.96 88.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.476 ' CB ' ' HH ' ' B' ' 292' ' ' TYR . . . -56.3 -22.16 28.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.274 -1.133 . . . . 0.0 108.659 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -36.45 109.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.276 0.56 . . . . 0.0 110.084 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' OD2' ' OG ' ' A' ' 127' ' ' SER . 55.0 t0 -105.73 -29.41 10.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.38 77.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 128' ' ' ARG . 80.0 p -122.24 -78.97 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -1.066 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' H ' ' HG ' ' A' ' 127' ' ' SER . 46.6 ttp180 -97.92 -5.08 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 108.885 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.27 125.34 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.502 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 57.0 mt-30 -138.35 149.94 46.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.051 -1.03 . . . . 0.0 111.215 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.25 107.22 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.465 ' CD2' HD12 ' A' ' 105' ' ' LEU . 20.3 m0 -106.14 145.23 31.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.128 -0.983 . . . . 0.0 109.984 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.531 ' O ' ' CE ' ' A' ' 142' ' ' MET . 57.7 p-10 -100.97 161.07 13.85 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.649 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 8.0 p90 -172.67 -167.88 0.47 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.807 -1.183 . . . . 0.0 110.7 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.963 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -131.34 149.95 52.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.714 ' C ' ' O ' ' A' ' 135' ' ' ALA . 72.2 mt-10 -32.29 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.963 ' O ' ' O ' ' A' ' 135' ' ' ALA . . . -95.54 -176.45 37.14 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.92 -13.11 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.057 -1.261 . . . . 0.0 108.864 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.743 ' H ' ' C ' ' A' ' 137' ' ' GLY . 1.3 p -59.19 -46.88 91.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.541 ' OE1' ' NH2' ' A' ' 34' ' ' ARG . 23.3 pt-20 -53.37 -33.58 54.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.7 m -68.31 -40.84 81.56 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.395 -0.816 . . . . 0.0 108.884 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 8.2 mmt -52.49 -48.04 66.2 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.0 -38.59 91.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.44 -40.46 95.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 110.731 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -70.05 -49.87 46.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.488 -1.382 . . . . 0.0 108.796 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.84 -48.72 80.55 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.489 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 19.4 m-85 -70.45 -32.95 70.72 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.236 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.428 ' C ' ' H ' ' A' ' 150' ' ' TYR . 24.5 mm-40 -61.19 -31.14 70.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.13 12.21 5.44 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -138.1 -104.29 0.18 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.323 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' CD1' ' CD1' ' A' ' 147' ' ' PHE . 12.1 mt -33.5 90.69 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.844 -0.535 . . . . 0.0 110.841 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' N ' ' O ' ' A' ' 150' ' ' TYR . 83.6 Cg_endo -95.33 -83.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 123.217 2.612 . . . . 0.0 111.477 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -82.58 -22.93 34.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -53.04 -36.22 60.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 94.1 m -58.6 -40.74 84.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -84.7 -48.7 9.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.7 t -156.73 140.94 16.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.963 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.9 m -74.43 163.93 27.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.359 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -64.82 153.98 38.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 162' ' ' SER . 47.4 m80 -58.47 152.57 43.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -42.82 -19.81 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 160' ' ' HIS . 15.0 t -54.14 -30.94 50.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.615 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.2 37.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.97 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.09 30.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.8 t -139.07 145.24 39.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -70.61 176.49 35.5 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -103.41 140.81 36.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 0.0 109.394 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -149.11 176.86 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -170.7 135.93 1.11 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.49 -0.756 . . . . 0.0 109.498 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' B' ' 210' ' ' CYS . 61.1 Cg_endo -75.09 155.01 42.46 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.46 2.107 . . . . 0.0 112.18 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' B' ' 209' ' ' PRO . 10.2 p -53.85 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.173 -0.955 . . . . 0.0 108.467 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 62.9 m -111.17 152.82 26.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.157 -0.965 . . . . 0.0 108.714 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 8.9 t -140.33 136.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 122.04 0.924 . . . . 0.0 109.21 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 269' ' ' ASP . 7.2 t80 -115.51 110.95 19.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.466 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.0 OUTLIER -98.04 124.2 42.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.036 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.425 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 12.2 m -99.73 142.62 30.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.046 -1.034 . . . . 0.0 109.071 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -144.18 157.17 27.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.552 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 5.7 m -80.78 119.96 24.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -1.037 . . . . 0.0 109.795 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.509 ' O ' ' CB ' ' B' ' 219' ' ' ARG . 0.4 OUTLIER -109.41 138.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' B' ' 218' ' ' ILE . 47.3 ttt-85 82.85 10.66 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.661 -0.649 . . . . 0.0 109.487 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -111.87 -13.5 12.43 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 166.21 103.54 0.17 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' B' ' 222' ' ' ARG . 0.0 OUTLIER -54.65 -25.6 27.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -1.213 . . . . 0.0 109.538 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.09 -39.14 63.14 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 79.4 m-20 -66.7 -29.01 68.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -63.93 -41.81 97.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.16 72.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.28 -33.17 69.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.552 ' OH ' ' N ' ' B' ' 217' ' ' SER . 20.5 m-30 -69.26 -46.47 67.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 0.0 110.074 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.87 85.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.766 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.693 HH22 HH21 ' B' ' 234' ' ' ARG . 65.8 ttt-85 -69.37 -56.19 8.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 108.535 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.2 mt -52.86 -48.18 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.461 ' CG2' ' CE2' ' B' ' 214' ' ' PHE . 56.1 t -58.2 -32.22 43.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' B' ' 234' ' ' ARG . 18.1 p -63.29 -43.58 97.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 109.597 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . 0.693 HH21 HH22 ' B' ' 230' ' ' ARG . 83.6 mtt-85 -64.23 -40.5 96.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.867 -1.145 . . . . 0.0 108.008 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.712 ' O ' ' O ' ' B' ' 238' ' ' TYR . 87.0 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -56.93 -28.3 61.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 108.75 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.04 -59.87 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.712 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.9 OUTLIER -125.32 152.32 44.87 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 176.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 84.03 64.16 1.62 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' B' ' 239' ' ' GLY . 10.6 ttpt -34.2 121.9 0.48 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -1.085 . . . . 0.0 108.584 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.67 109.53 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.793 -1.192 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 78.1 mt -72.6 -37.64 68.07 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.677 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.415 ' OG1' ' CG2' ' B' ' 246' ' ' VAL . 0.1 OUTLIER -90.47 92.86 9.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.957 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -91.89 -23.7 19.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 109.158 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -61.94 -37.77 85.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 110.128 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.59 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 55.8 t -46.86 -73.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.658 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -53.83 -48.08 70.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -72.26 45.48 0.13 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -122.82 -16.57 7.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -8.32 15.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.737 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -84.3 130.41 34.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.088 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' B' ' 251' ' ' LEU . 6.0 mt-10 55.55 157.97 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.039 -1.038 . . . . 0.0 108.861 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.426 ' HA ' HH22 ' B' ' 222' ' ' ARG . 8.6 Cg_endo -52.7 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.224 1.95 . . . . 0.0 111.437 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.407 ' H ' HD11 ' B' ' 254' ' ' LEU . 0.3 OUTLIER -92.87 -3.97 53.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 258' ' ' ALA . . . -45.84 150.2 1.48 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 44.2 mt-10 -53.43 -35.89 60.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -1.205 . . . . 0.0 108.983 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.99 -11.14 45.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.0 108.843 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 255' ' ' GLY . . . -57.51 175.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' B' ' 260' ' ' GLY . . . -46.97 165.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.326 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' B' ' 259' ' ' ALA . . . -43.36 151.5 0.42 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 154.25 -17.53 0.61 Allowed Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.07 -44.24 91.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.116 -1.226 . . . . 0.0 109.265 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -72.32 -55.26 7.42 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 0.9 OUTLIER -56.39 -29.27 61.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.548 ' N ' ' O ' ' B' ' 261' ' ' GLY . 8.5 mt -69.87 -49.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -65.27 -55.15 19.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.662 -0.649 . . . . 0.0 110.001 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 90.9 mt-10 -49.01 -54.55 15.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 110.224 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 4.8 mp0 -72.06 -50.8 25.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.923 -1.111 . . . . 0.0 111.038 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.469 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 1.6 m-20 -61.2 -54.79 39.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.457 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -38.79 68.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.766 -1.209 . . . . 0.0 111.323 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 64.7 t-20 -58.74 -50.02 75.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 119.955 -1.715 . . . . 0.0 108.155 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -38.9 83.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.428 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.4 tp -49.64 -39.47 36.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.402 ' OE1' ' NH2' ' B' ' 296' ' ' ARG . 15.2 mt-30 -72.84 -31.22 64.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.533 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -85.24 0.2 52.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.97 121.95 18.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.318 -0.864 . . . . 0.0 112.091 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.56 -37.65 80.09 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 77.7 t -131.34 151.45 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 86.9 t -136.16 143.6 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 122.564 1.173 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 27.8 t -135.11 156.35 39.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -163.06 122.72 2.2 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.434 -1.416 . . . . 0.0 110.81 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.29 116.23 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 1.9 m -101.24 29.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 108.778 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.553 HG23 ' N ' ' B' ' 313' ' ' GLY . 25.3 m -61.86 -109.37 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.728 -0.607 . . . . 0.0 110.169 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' B' ' 286' ' ' PRO . 1.2 tm0? -40.63 126.76 1.87 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.407 -0.808 . . . . 0.0 110.181 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.41 ' O ' ' NE2' ' B' ' 285' ' ' GLN . 76.6 Cg_exo -45.61 113.7 0.61 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.933 1.755 . . . . 0.0 111.595 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.468 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 8.1 t -142.64 131.66 23.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.121 -0.987 . . . . 0.0 110.251 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 87' ' ' SER . 8.3 mt -79.68 -42.6 24.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 109.304 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -58.57 -37.52 89.07 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 8.2 t -74.2 -42.28 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 108.809 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -63.49 -24.98 68.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.476 ' HH ' ' CB ' ' A' ' 123' ' ' ALA . 65.1 t80 -70.81 -56.42 6.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.707 -0.878 . . . . 0.0 109.248 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.425 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 95.7 mt-10 -60.19 -33.68 72.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' B' ' 294' ' ' LEU . 3.3 tm? -70.77 -49.73 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.99 -51.5 54.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . 0.402 ' NH2' ' OE1' ' B' ' 274' ' ' GLN . 56.1 ttt85 -55.96 -36.4 67.76 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 108.394 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.55 -38.78 87.85 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.474 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.4 OUTLIER -54.19 -43.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 120.862 -1.149 . . . . 0.0 108.565 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -74.55 -48.8 24.71 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 112.387 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.7 pp -119.06 -27.95 5.61 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.974 -1.079 . . . . 0.0 110.747 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' B' ' 300' ' ' LEU . . . -40.8 162.19 0.01 OUTLIER Glycine 0 C--N 1.289 -2.044 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.49 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 2.8 mmtp -98.23 -161.54 0.04 OUTLIER Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 75.9 Cg_exo -41.89 115.41 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 121.458 1.557 . . . . 0.0 110.329 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.85 138.96 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.195 0.998 . . . . 0.0 112.147 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . 0.463 HD12 ' CD2' ' B' ' 332' ' ' TRP . 50.9 tp -126.47 118.25 24.55 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' B' ' 330' ' ' GLN . 0.5 OUTLIER -102.8 157.41 16.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.899 -1.126 . . . . 0.0 109.457 -179.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 5.9 mt -143.02 128.0 18.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -139.33 144.7 38.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.139 -0.976 . . . . 0.0 108.865 178.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' B' ' 334' ' ' TYR . 24.9 ptt-85 -128.65 148.09 66.96 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.464 -0.772 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.42 29.46 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.208 . . . . 0.0 112.566 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.544 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 51.3 mt-30 -104.62 -43.77 5.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 22.6 m -129.73 -23.24 2.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 108.6 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.707 ' O ' ' O ' ' B' ' 314' ' ' ARG . . . -86.44 -51.87 3.37 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.707 ' O ' ' O ' ' B' ' 313' ' ' GLY . 0.1 OUTLIER 39.47 101.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' B' ' 314' ' ' ARG . 96.6 t 61.97 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.69 ' CD2' ' H ' ' B' ' 316' ' ' LEU . 1.5 pt? -70.45 -43.84 69.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.739 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.3 OUTLIER 163.35 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.96 -1.088 . . . . 0.0 110.176 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . 0.495 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -64.1 -45.57 88.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.442 -0.786 . . . . 0.0 109.798 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 80.2 mmm -62.52 -46.9 86.3 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.36 -0.838 . . . . 0.0 109.371 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 3.8 mm -60.69 -41.88 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -44.39 96.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.748 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -63.66 -33.58 87.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.467 ' CB ' ' HH ' ' A' ' 92' ' ' TYR . . . -56.7 -22.11 32.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -1.15 . . . . 0.0 108.605 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -36.44 109.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.21 0.529 . . . . 0.0 110.043 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -105.94 -29.46 9.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.12 3.7 76.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.492 ' HG ' ' H ' ' B' ' 328' ' ' ARG . 68.1 p -121.49 -79.08 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.472 -1.017 . . . . 0.0 109.1 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.492 ' H ' ' HG ' ' B' ' 327' ' ' SER . 46.2 ttp180 -97.89 -4.93 35.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.855 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.37 125.24 22.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' B' ' 306' ' ' CYS . 55.4 mt-30 -138.13 149.77 46.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.0 111.12 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.04 106.93 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.463 ' CD2' HD12 ' B' ' 305' ' ' LEU . 20.4 m0 -106.21 145.11 31.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.111 -0.993 . . . . 0.0 110.103 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.54 ' O ' ' CE ' ' B' ' 342' ' ' MET . 57.1 p-10 -100.68 160.83 14.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 8.0 p90 -172.41 -167.89 0.49 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.735 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.962 ' O ' ' O ' ' B' ' 337' ' ' GLY . . . -131.47 149.49 52.51 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.76 ' C ' ' O ' ' B' ' 335' ' ' ALA . 71.1 mt-10 -31.94 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.962 ' O ' ' O ' ' B' ' 335' ' ' ALA . . . -95.36 -176.71 37.42 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -13.06 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.93 -1.335 . . . . 0.0 108.908 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.746 ' H ' ' C ' ' B' ' 337' ' ' GLY . 1.3 p -59.12 -46.97 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.55 ' OE1' ' NH2' ' B' ' 234' ' ' ARG . 22.7 pt-20 -53.21 -33.78 54.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 17.9 m -68.16 -40.7 82.27 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.955 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.54 ' CE ' ' O ' ' B' ' 333' ' ' ASP . 7.9 mmt -52.86 -47.91 67.47 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 49.3 mt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.824 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -64.44 -40.36 95.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.42 -0.8 . . . . 0.0 110.73 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -70.11 -49.71 48.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.422 -1.423 . . . . 0.0 108.756 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.25 -48.65 80.83 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 109.961 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.49 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 19.7 m-85 -70.41 -32.51 70.17 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.144 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' B' ' 350' ' ' TYR . 24.3 mm-40 -61.59 -30.95 71.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.24 12.25 5.53 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.5 t80 -138.04 -104.44 0.18 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.283 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.49 ' CD1' ' CD1' ' B' ' 347' ' ' PHE . 12.0 mt -33.53 90.77 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.915 -0.491 . . . . 0.0 110.815 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' B' ' 350' ' ' TYR . 78.8 Cg_endo -95.46 -83.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 123.27 2.647 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.33 -23.34 35.15 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -52.78 -36.33 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 93.9 m -58.34 -40.87 83.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.586 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -84.72 -48.88 8.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.923 . . . . 0.0 109.473 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 23.5 t -156.38 141.53 17.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 31.5 m -75.16 162.79 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 44.2 t -63.79 153.47 36.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.347 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' B' ' 362' ' ' SER . 49.0 m80 -57.91 152.86 36.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.62 -19.77 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.373 2.049 . . . . 0.0 112.089 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.445 ' N ' ' O ' ' B' ' 360' ' ' HIS . 12.5 t -53.86 -30.57 46.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.216 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.34 179.792 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.74 -35.06 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.49 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.58 -33.77 74.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 p -78.94 154.39 29.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.288 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.38 43.07 2.67 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -96.91 131.02 44.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 109.56 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -143.93 178.06 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.07 151.7 78.34 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.434 -0.791 . . . . 0.0 109.029 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -155.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.533 2.155 . . . . 0.0 111.459 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -102.07 -175.61 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 11.2 p -120.35 154.39 35.12 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.58 135.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 0.0 109.006 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.413 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 8.1 t80 -118.15 95.39 4.87 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.825 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -83.2 104.73 13.6 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.03 170.43 9.42 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 111.417 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.3 93.05 0.72 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' CE2' ' A' ' 28' ' ' TYR . 2.7 p -168.39 -177.29 3.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.014 -1.286 . . . . 0.0 109.746 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.77 ' C ' ' H ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER 37.2 -160.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.592 -0.693 . . . . 0.0 109.922 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? 62.43 -16.93 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.77 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . 166.03 108.97 0.21 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.76 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 159.94 -58.71 0.32 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.985 -1.303 . . . . 0.0 110.072 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.3 mmt85 49.43 -73.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.327 -1.102 . . . . 0.0 109.266 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.76 ' N ' ' O ' ' A' ' 21' ' ' GLY . 94.6 mt-10 -54.08 -35.22 61.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 28' ' ' TYR . 4.6 t0 -65.99 -27.75 68.37 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.746 ' NE2' ' N ' ' A' ' 50' ' ' GLU . 35.3 tt0 -57.9 -45.55 86.29 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.46 94.15 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.65 -30.22 71.35 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' CB ' ' A' ' 17' ' ' SER . 22.7 m-30 -70.77 -49.77 43.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.48 -0.762 . . . . 0.0 110.089 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.32 72.68 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.426 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -71.43 -58.15 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.918 -1.113 . . . . 0.0 108.291 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.85 -44.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 55.4 t -61.07 -28.84 44.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -70.82 -35.09 72.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.404 ' HA ' HH11 ' A' ' 37' ' ' ARG . 68.1 mtp85 -73.89 -50.28 20.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 108.694 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.64 -40.09 86.51 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.95 -23.0 67.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.404 HH11 ' HA ' ' A' ' 34' ' ' ARG . 26.0 mtt85 -77.88 -34.6 51.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.026 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.584 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-30 -73.32 -51.09 18.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 110.082 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.11 -144.99 4.22 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -98.95 135.59 40.15 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.178 -1.189 . . . . 0.0 108.669 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 t -100.11 122.19 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 12.2 mt -87.36 -17.05 33.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.295 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 43' ' ' THR . 0.2 OUTLIER -86.22 43.23 1.04 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.402 -0.811 . . . . 0.0 109.513 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -66.34 -38.67 88.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.493 ' ND1' ' C ' ' A' ' 45' ' ' HIS . 6.5 t-80 -53.94 -46.97 71.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.877 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.3 t -48.34 -49.31 13.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.315 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -74.3 -40.74 62.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 108.54 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 2.7 t0 -75.07 50.89 0.49 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.678 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -126.21 -30.69 2.89 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.746 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -55.08 -5.33 0.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.678 ' H ' ' C ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -49.49 -55.99 11.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 1.8 tm-20 -179.67 -44.73 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.418 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 13.2 Cg_exo -69.31 92.22 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.686 2.257 . . . . 0.0 112.467 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' HE22 ' A' ' 25' ' ' GLN . 4.0 mm? -125.21 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.809 . . . . 0.0 109.549 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 68.19 35.73 83.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' ALA . 69.3 mm-40 47.46 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.531 -0.982 . . . . 0.0 109.197 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 47.92 13.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.04 -1.037 . . . . 0.0 108.65 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' GLU . . . -139.64 96.64 3.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.48 -0.763 . . . . 0.0 109.016 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.72 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.233 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.16 17.12 21.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 62' ' ' ASP . . . 152.23 76.83 0.02 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 23.8 p-10 -48.69 -44.29 37.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 89.6 mt-30 -57.42 -45.13 84.95 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.63 -41.58 95.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -39.06 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.455 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.8 t-80 -76.14 -51.02 13.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.63 -0.669 . . . . 0.0 110.38 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 97.0 mt-10 -46.68 -53.69 11.17 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.071 -1.018 . . . . 0.0 109.825 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.85 -42.63 66.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 110.91 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.71 -57.44 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.965 -1.084 . . . . 0.0 111.143 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.097 -1.002 . . . . 0.0 110.792 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -60.97 -52.94 62.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.591 -1.318 . . . . 0.0 108.958 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.489 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.69 -40.84 89.21 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 108.703 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 7.6 tp -50.07 -37.7 34.85 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.536 ' O ' ' NZ ' ' A' ' 102' ' ' LYS . 51.4 mt-30 -74.44 -29.43 61.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.715 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 18.0 mt-30 -90.2 3.87 52.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.83 -1.169 . . . . 0.0 109.284 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.01 130.08 40.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.899 . . . . 0.0 112.27 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 11' ' ' SER . 85.1 m-20 -78.09 -34.9 49.91 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.25 144.24 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 103' ' ' PRO . 91.9 t -136.08 129.06 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.917 -1.115 . . . . 0.0 111.205 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.825 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 70.1 t -129.03 124.85 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.39 156.13 33.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.307 -1.496 . . . . 0.0 110.24 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -99.82 122.66 43.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.32 33.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 4.2 m -88.87 -73.54 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.741 -0.6 . . . . 0.0 109.756 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.77 120.48 81.5 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.798 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.41 141.84 89.28 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.236 1.957 . . . . 0.0 112.202 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.422 ' OG ' ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -179.49 141.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 110.019 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 92' ' ' TYR . 19.7 mt -62.45 -43.21 99.36 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.458 -0.776 . . . . 0.0 109.044 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.437 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -54.48 -38.52 63.13 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.422 ' CG2' ' OG ' ' A' ' 87' ' ' SER . 44.6 t -68.07 -53.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.512 -0.993 . . . . 0.0 108.676 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.37 -28.41 73.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 88' ' ' LEU . 51.3 t80 -70.72 -55.09 9.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -1.092 . . . . 0.0 109.633 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' SD ' ' B' ' 319' ' ' MET . 77.4 mt-10 -62.15 -34.15 75.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.253 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.22 -48.55 56.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.253 -0.905 . . . . 0.0 109.195 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.24 96.07 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -61.92 -40.47 95.59 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.519 -0.989 . . . . 0.0 109.299 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.53 -41.21 76.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.09 -1.006 . . . . 0.0 108.982 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -39.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -77.64 -51.14 11.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.68 -6.18 10.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.973 -1.079 . . . . 0.0 108.722 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.6 26.0 30.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 74' ' ' GLN . 43.9 mttp -84.38 147.54 50.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.906 -1.35 . . . . 0.0 107.644 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -38.53 116.52 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.756 1.637 . . . . 0.0 110.896 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -115.95 98.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.271 -0.893 . . . . 0.0 111.602 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.69 120.64 35.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.28 131.22 55.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.885 -1.134 . . . . 0.0 108.838 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.469 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 3.5 mt -123.15 130.19 52.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 0.0 111.502 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -131.12 151.07 51.82 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' NH1' ' CG ' ' A' ' 136' ' ' GLU . 49.9 mtm180 -114.23 136.02 22.22 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.115 -0.99 . . . . 0.0 110.219 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -29.97 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.355 2.037 . . . . 0.0 111.286 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' ' 112' ' ' SER . 12.2 pt20 -59.7 -46.36 89.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.354 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 17.2 t -75.85 -22.18 56.49 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' O ' ' NE ' ' A' ' 114' ' ' ARG . . . 55.93 111.0 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.601 ' O ' ' C ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -144.6 -7.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -1.017 . . . . 0.0 110.259 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' A' ' 114' ' ' ARG . 94.7 t 32.85 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.863 ' H ' ' CD2' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -61.13 172.31 1.07 Allowed 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.81 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.44 ' HB2' ' H ' ' B' ' 289' ' ' GLY . 29.3 t -64.95 141.36 58.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 111.721 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.18 63.76 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.529 ' SD ' ' CG ' ' B' ' 293' ' ' GLU . 1.7 mtp -63.94 -43.51 95.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.542 -0.724 . . . . 0.0 109.317 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.1 mm -61.87 -45.48 98.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.497 -0.752 . . . . 0.0 109.418 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -64.43 -44.8 90.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.482 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -58.55 -32.1 68.27 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -51.7 -57.33 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 108.265 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 10.38 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 123' ' ' ALA . 2.2 m-20 -68.97 -35.36 76.64 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.747 -1.221 . . . . 0.0 107.757 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.793 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.41 174.04 40.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.4 t 60.56 -30.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.668 1.223 . . . . 0.0 108.573 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.793 ' H ' ' C ' ' A' ' 126' ' ' GLY . 8.7 mtm180 -147.33 0.95 0.71 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.539 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' GLY . 11.3 t80 -156.94 112.9 2.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.49 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 90.5 mt-30 -139.29 142.8 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.398 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.51 98.86 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.49 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 18.1 m0 -94.66 147.29 23.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.345 -0.847 . . . . 0.0 109.521 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.27 150.64 22.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 7.8 p90 -170.95 177.58 3.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.642 -1.286 . . . . 0.0 111.548 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -141.99 146.83 36.03 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.0 mt-10 -39.41 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.748 -1.22 . . . . 0.0 110.474 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -86.32 -2.37 85.42 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.109 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -135.93 0.19 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.813 -1.404 . . . . 0.0 110.231 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -55.21 -47.04 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.851 -1.156 . . . . 0.0 108.476 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 29.6 mt-10 -53.16 -33.17 51.41 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.7 m -69.56 -40.91 76.52 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 109.25 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 12.9 mmt -53.16 -51.78 60.9 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 48.8 mt -62.05 -32.48 73.0 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.72 -43.91 87.62 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 -71.98 -47.74 49.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.534 -1.354 . . . . 0.0 109.149 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -60.44 -48.96 79.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 21.3 m-85 -71.37 -28.86 64.34 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.159 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.05 -31.14 71.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.07 9.57 10.03 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -134.85 -104.49 0.23 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.237 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 150' ' ' TYR . 22.6 mt -32.42 90.84 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.91 -0.494 . . . . 0.0 110.925 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . 71.5 Cg_endo -93.31 -72.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.067 2.511 . . . . 0.0 111.248 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.415 ' H ' ' CG ' ' A' ' 152' ' ' PRO . 85.1 mt-30 -96.94 -18.88 19.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.451 ' HZ3' ' CD2' ' A' ' 151' ' ' LEU . 8.3 mtpm? -59.95 -29.69 68.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.067 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' ALA . 55.2 m -64.52 157.85 25.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' THR . . . -42.85 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.447 ' C ' ' H ' ' A' ' 159' ' ' SER . 8.7 t -99.82 147.79 25.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 m 51.18 12.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 157' ' ' SER . 85.1 p -82.79 161.15 22.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.547 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -129.39 79.21 74.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 109.286 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.86 -23.66 60.34 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.687 2.258 . . . . 0.0 112.142 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 t -98.02 142.39 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.522 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.25 72.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -61.29 -33.94 74.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 7.4 p -78.64 154.12 30.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.13 43.24 2.69 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -96.97 131.38 43.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -1.147 . . . . 0.0 109.524 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -144.12 177.27 8.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -132.31 151.37 78.19 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.55 -0.719 . . . . 0.0 109.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.62 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 111.34 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 32.1 p -102.21 -175.61 2.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.9 p -120.36 154.0 35.68 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 6.8 t -133.41 135.37 56.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.7 0.762 . . . . 0.0 109.034 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 7.9 t80 -118.01 95.76 5.05 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.833 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -83.36 104.94 13.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.28 170.23 9.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.078 0.942 . . . . 0.0 111.49 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 84.37 93.51 0.71 Allowed Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.574 ' CB ' ' CE2' ' B' ' 228' ' ' TYR . 2.6 p -168.52 -176.85 2.94 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.785 ' C ' ' H ' ' B' ' 220' ' ' GLY . 0.0 OUTLIER 36.89 -160.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 0.0 109.888 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? 62.61 -17.08 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . 0.785 ' H ' ' C ' ' B' ' 218' ' ' ILE . . . 166.18 109.04 0.21 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.757 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 159.91 -59.0 0.32 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.1 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' B' ' 225' ' ' GLN . 9.4 mmt85 49.77 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.324 -1.104 . . . . 0.0 109.093 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.757 ' N ' ' O ' ' B' ' 221' ' ' GLY . 95.2 mt-10 -54.05 -34.9 61.25 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' B' ' 228' ' ' TYR . 4.5 t0 -66.26 -27.61 68.08 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' NE2' ' N ' ' B' ' 250' ' ' GLU . 35.5 tt0 -58.15 -45.21 87.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.64 -43.28 94.18 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.9 tp -64.07 -29.68 70.8 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.574 ' CE2' ' CB ' ' B' ' 217' ' ' SER . 22.7 m-30 -71.11 -49.62 42.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.39 -0.818 . . . . 0.0 109.98 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.04 72.67 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.478 -1.289 . . . . 0.0 108.44 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -71.71 -57.9 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.882 -1.136 . . . . 0.0 108.283 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.5 mt -53.09 -44.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 55.7 t -60.99 -28.74 44.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' B' ' 237' ' ' ARG . 7.1 t -70.94 -34.91 71.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.394 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -73.88 -50.5 19.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 108.752 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 14.1 mt -59.22 -40.42 85.78 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -64.78 -23.16 67.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' B' ' 233' ' ' SER . 24.1 mtt85 -77.66 -34.98 52.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 108.922 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.574 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -73.23 -50.86 20.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 110.041 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -145.22 -145.29 4.26 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -98.59 135.34 40.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.293 -1.122 . . . . 0.0 108.704 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.07 122.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.489 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 11.4 mt -87.35 -16.34 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.309 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.84 43.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.4 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -66.55 -38.22 86.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.89 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.488 ' ND1' ' C ' ' B' ' 245' ' ' HIS . 6.6 t-80 -54.43 -46.92 73.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.971 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 5.5 t -48.5 -48.38 14.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -75.1 -40.97 59.61 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' B' ' 251' ' ' LEU . 2.7 t0 -74.86 50.68 0.46 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.671 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -126.32 -30.08 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.736 ' N ' ' NE2' ' B' ' 225' ' ' GLN . 0.4 OUTLIER -55.71 -4.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.671 ' H ' ' C ' ' B' ' 249' ' ' ALA . 0.4 OUTLIER -50.12 -55.3 15.52 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 1.8 tm-20 179.99 -45.28 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.426 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 13.0 Cg_exo -69.14 92.35 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.47 ' CD2' HE22 ' B' ' 225' ' ' GLN . 4.0 mm? -125.44 178.39 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 68.26 35.93 83.77 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' B' ' 258' ' ' ALA . 69.0 mm-40 47.05 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -1.02 . . . . 0.0 109.277 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 48.15 13.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.583 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -139.29 96.35 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -172.38 -30.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.64 16.39 22.24 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' B' ' 262' ' ' ASP . . . 152.74 76.56 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 23.8 p-10 -48.42 -44.14 34.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.9 mt-30 -57.49 -45.41 84.92 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -60.13 -42.05 93.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -38.7 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.482 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.8 t-80 -76.35 -51.21 12.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.246 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 97.1 mt-10 -46.67 -53.42 11.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.794 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.97 -42.79 66.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.68 -57.35 9.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.0 -1.062 . . . . 0.0 111.143 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -39.64 83.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.091 -1.005 . . . . 0.0 110.81 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.6 t-20 -60.95 -52.74 63.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.684 -1.26 . . . . 0.0 108.965 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.489 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -60.0 -40.75 90.28 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.738 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 8.1 tp -50.06 -37.81 35.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.532 ' O ' ' NZ ' ' B' ' 302' ' ' LYS . 52.2 mt-30 -74.25 -29.55 61.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.773 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 17.7 mt-30 -90.11 3.97 51.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.838 -1.164 . . . . 0.0 109.204 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.07 129.95 39.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 112.311 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' B' ' 211' ' ' SER . 85.1 m-20 -77.96 -34.74 50.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.66 144.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' B' ' 303' ' ' PRO . 87.3 t -136.12 129.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.921 -1.112 . . . . 0.0 111.296 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . 0.833 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 69.4 t -128.96 125.15 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -121.87 156.72 32.7 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.296 -1.503 . . . . 0.0 110.3 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -100.19 123.03 43.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.82 33.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' B' ' 314' ' ' ARG . 4.0 m -88.45 -73.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.766 -0.583 . . . . 0.0 109.804 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.43 120.75 82.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.47 141.7 89.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.255 1.97 . . . . 0.0 112.229 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' B' ' 290' ' ' VAL . 0.1 OUTLIER -179.34 140.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.102 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' B' ' 292' ' ' TYR . 20.1 mt -62.24 -42.83 99.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 117' ' ' SER . . . -54.88 -38.6 65.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.434 ' CG2' ' OG ' ' B' ' 287' ' ' SER . 44.3 t -68.03 -52.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.933 . . . . 0.0 108.696 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.45 -27.94 73.42 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' B' ' 288' ' ' LEU . 50.5 t80 -71.1 -55.28 8.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.368 -1.078 . . . . 0.0 109.592 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.529 ' CG ' ' SD ' ' A' ' 119' ' ' MET . 76.7 mt-10 -62.09 -34.05 75.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.137 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 21.7 mt -70.24 -48.6 56.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.86 95.87 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 16.8 tpt85 -62.27 -40.42 96.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.544 -0.974 . . . . 0.0 109.244 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.46 -41.48 76.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 108.937 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.41 -39.64 22.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.442 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -77.53 -51.38 10.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.924 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.49 -6.11 9.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.949 -1.094 . . . . 0.0 108.834 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' B' ' 299' ' ' ALA . . . 53.44 26.0 28.97 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' B' ' 274' ' ' GLN . 43.7 mttp -84.29 147.32 49.96 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.849 -1.383 . . . . 0.0 107.667 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 302' ' ' LYS . 83.6 Cg_exo -38.26 116.15 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.805 1.67 . . . . 0.0 110.856 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.488 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.6 mt -115.76 98.54 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 0.0 111.467 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 58.0 tp -94.45 120.85 35.31 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 131.6 54.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.77 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.483 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 3.3 mt -123.48 130.62 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 111.429 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -131.36 151.4 51.56 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -114.7 135.88 22.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.026 -1.046 . . . . 0.0 110.185 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.06 -29.37 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 111.381 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' B' ' 312' ' ' SER . 12.1 pt20 -60.32 -45.92 91.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.526 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 16.6 t -76.44 -21.84 55.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.559 ' O ' ' NE ' ' B' ' 314' ' ' ARG . . . 55.82 110.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' B' ' 315' ' ' VAL . 0.0 OUTLIER -144.57 -7.72 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.434 -1.039 . . . . 0.0 110.244 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.568 ' C ' ' O ' ' B' ' 314' ' ' ARG . 86.5 t 33.09 90.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.856 ' CD2' ' H ' ' B' ' 316' ' ' LEU . 0.2 OUTLIER -60.89 172.23 1.02 Allowed 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.77 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.443 ' H ' HD13 ' A' ' 88' ' ' LEU . 28.8 t -65.02 141.28 58.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.039 -1.038 . . . . 0.0 111.736 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.38 -32.99 63.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.493 ' SD ' ' CG ' ' A' ' 93' ' ' GLU . 1.8 mtp -64.21 -43.67 94.28 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.597 -0.689 . . . . 0.0 109.319 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 4.3 mm -61.49 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.328 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . 0.404 HH21 HD21 ' B' ' 316' ' ' LEU . 41.1 mtt180 -64.82 -44.36 90.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.19 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.455 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -58.51 -32.06 68.04 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -52.08 -57.43 9.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -1.178 . . . . 0.0 108.326 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.583 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 10.36 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' B' ' 323' ' ' ALA . 2.0 m-20 -69.12 -35.07 76.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.793 -1.192 . . . . 0.0 107.855 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.856 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.32 174.02 40.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 7.1 t 60.58 -30.92 0.06 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.637 1.208 . . . . 0.0 108.718 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.856 ' H ' ' C ' ' B' ' 326' ' ' GLY . 8.5 mtm180 -147.22 1.04 0.73 Allowed 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.518 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' GLY . 12.1 t80 -157.0 112.83 2.91 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.478 ' OE1' ' NE1' ' B' ' 332' ' ' TRP . 91.0 mt-30 -139.23 142.42 37.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.423 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.12 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.478 ' NE1' ' OE1' ' B' ' 330' ' ' GLN . 18.3 m0 -94.4 147.24 23.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.28 151.09 21.88 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 7.9 p90 -171.36 177.65 3.48 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.659 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -142.13 147.13 36.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 335' ' ' ALA . 41.3 mt-10 -39.27 -25.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.575 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -86.19 -2.36 85.73 Favored Glycine 0 N--CA 1.495 2.599 0 O-C-N 120.999 -1.063 . . . . 0.0 111.208 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -136.27 0.46 2.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.843 -1.386 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 0.9 OUTLIER -55.59 -47.19 79.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.821 -1.174 . . . . 0.0 108.413 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 30.1 mt-10 -52.67 -33.53 47.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.3 m -69.21 -41.01 77.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 12.7 mmt -53.16 -51.64 61.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 47.4 mt -62.07 -32.61 73.17 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.81 -43.84 87.44 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.326 -0.859 . . . . 0.0 110.587 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -71.81 -48.0 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.527 -1.358 . . . . 0.0 109.216 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.15 -49.02 79.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 110.454 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 20.9 m-85 -71.46 -29.0 64.35 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.219 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' B' ' 350' ' ' TYR . 65.0 mt-10 -65.98 -31.13 71.86 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.09 9.17 10.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.6 t80 -134.47 -104.21 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.201 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.468 ' H ' ' HB3' ' B' ' 350' ' ' TYR . 21.6 mt -32.91 91.08 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.891 -0.506 . . . . 0.0 110.955 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' TYR . 72.2 Cg_endo -93.42 -72.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.239 2.626 . . . . 0.0 111.301 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' B' ' 352' ' ' PRO . 85.6 mt-30 -97.31 -19.85 18.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . 0.441 ' HZ3' ' CD2' ' B' ' 351' ' ' LEU . 8.3 mtpm? -59.38 -29.5 67.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.063 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' THR . . . . . 0.428 ' O ' ' C ' ' B' ' 356' ' ' ALA . 54.2 m -64.45 158.14 24.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.143 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' B' ' 355' ' ' THR . . . -43.16 102.84 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' SER . . . . . 0.458 ' C ' ' H ' ' B' ' 359' ' ' SER . 8.4 t -99.24 147.87 24.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.61 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 75.3 m 51.26 12.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' SER . . . . . 0.458 ' H ' ' C ' ' B' ' 357' ' ' SER . 82.7 p -82.74 160.8 22.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.634 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -129.14 79.34 74.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.419 -0.8 . . . . 0.0 109.263 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.62 -23.32 56.56 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.812 2.342 . . . . 0.0 112.151 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 36.8 t -99.39 144.85 28.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.507 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.428 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' SER . . . -151.03 158.66 44.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.505 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.21 16.62 0.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.415 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 2' ' ' ALA . 50.4 m -65.11 153.21 41.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.76 6.44 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -49.32 140.26 10.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.05 178.07 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.726 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -49.88 150.74 3.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.246 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.4 Cg_exo -56.3 -158.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.967 1.778 . . . . 0.0 110.987 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.427 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 31.1 p -111.72 174.55 5.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.609 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 m -113.45 157.02 22.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.15 134.03 47.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 9.5 t80 -111.84 95.5 5.52 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -83.05 118.29 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.78 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -125.21 -130.0 3.43 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t 156.57 111.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.405 -1.056 . . . . 0.0 109.42 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -54.01 -49.21 62.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 108.883 179.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -51.68 110.42 0.46 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.86 -39.7 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 23' ' ' GLU . . . 151.88 14.44 0.07 OUTLIER Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.849 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLN . 2.0 tpp85 66.84 -41.3 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.295 . . . . 0.0 109.393 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 21' ' ' GLY . 80.4 mm-40 -52.03 -37.06 52.24 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 25' ' ' GLN . 35.4 p-10 -68.24 -31.55 71.12 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.699 HE21 ' N ' ' A' ' 50' ' ' GLU . 31.5 tt0 -60.9 -42.73 98.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.6 68.22 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.01 -27.85 65.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -70.93 -53.59 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.43 -35.43 72.08 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.425 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' O ' ' OG ' ' A' ' 33' ' ' SER . 31.5 ttm180 -69.66 -58.49 3.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.07 . . . . 0.0 108.673 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.4 mt -51.59 -42.78 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 47.2 t -62.45 -30.03 48.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.618 ' HG ' ' N ' ' A' ' 34' ' ' ARG . 26.5 p -69.17 -40.69 77.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.174 -0.954 . . . . 0.0 109.71 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.618 ' N ' ' HG ' ' A' ' 33' ' ' SER . 95.2 mtt180 -70.29 -49.17 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 108.895 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.05 -39.71 82.88 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -63.1 -24.5 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -76.23 -37.84 57.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.958 -1.089 . . . . 0.0 109.247 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.4 m-85 -68.45 -47.91 65.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.515 -0.74 . . . . 0.0 110.674 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -151.82 -150.31 5.32 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.32 115.48 26.83 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.115 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 42' ' ' LEU . 2.7 t -78.29 103.06 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 2.0 mt -47.14 126.33 9.03 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.001 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' LEU . 43.1 m -38.57 138.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.815 0.817 . . . . 0.0 111.131 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' VAL . 26.5 mt-10 -149.46 101.93 3.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 49' ' ' ALA . 18.6 t-80 -43.19 -19.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.738 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 44' ' ' GLU . 87.5 t -46.03 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.566 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.05 -39.54 66.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.861 -1.15 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -75.72 21.07 0.16 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.678 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -86.69 -19.41 29.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 108.859 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.699 ' N ' HE21 ' A' ' 25' ' ' GLN . 57.1 mt-10 -62.11 7.33 0.06 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.693 ' CD1' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -88.86 134.87 33.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 51' ' ' LEU . 7.3 mm-40 54.9 159.61 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -38.56 153.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.562 2.175 . . . . 0.0 112.258 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.7 154.69 25.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.379 -0.826 . . . . 0.0 109.726 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 137.48 41.81 0.1 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 49.16 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -1.062 . . . . 0.0 109.256 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 55' ' ' GLY . 50.5 tp10 -48.53 -26.17 2.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.61 44.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.18 179.67 5.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.755 . . . . 0.0 109.474 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.18 62.75 0.51 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.87 79.14 0.87 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -49.31 -38.16 26.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.13 -1.217 . . . . 0.0 107.803 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 9.5 mp0 -59.86 -41.16 90.87 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -54.4 -38.86 66.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.642 -1.286 . . . . 0.0 108.835 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -46.57 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.74 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -71.91 -61.97 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 110.44 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.74 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 79.1 mm-40 -43.71 -52.17 6.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.09 -41.95 99.5 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.024 -1.048 . . . . 0.0 109.628 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.458 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 77.9 m-20 -66.52 -40.92 89.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 111.605 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -68.01 -51.85 42.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -178.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -60.14 -46.55 89.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.632 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -64.79 -45.78 84.82 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.027 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 59.0 tp -52.44 -34.17 47.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.975 -1.078 . . . . 0.0 108.45 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -78.04 -32.01 50.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.508 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.632 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 29.3 mt-30 -87.66 -0.68 57.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.875 -1.141 . . . . 0.0 109.23 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.83 125.71 24.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 112.122 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' HB2' ' H ' ' A' ' 11' ' ' SER . 82.7 m-20 -76.09 -35.44 59.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -132.91 155.29 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.8 t -142.18 139.33 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.812 -1.18 . . . . 0.0 111.931 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.62 158.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.53 148.85 27.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.495 -1.378 . . . . 0.0 110.309 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -113.08 124.29 52.25 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -122.6 26.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 110.136 -179.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 83' ' ' VAL . 62.8 m -43.49 -69.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.992 -1.067 . . . . 0.0 109.043 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.52 149.05 38.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 108.689 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.72 91.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.168 1.912 . . . . 0.0 111.313 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.45 ' OG ' ' CB ' ' A' ' 17' ' ' SER . 32.8 t -99.36 135.4 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 110.632 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -40.24 50.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 109.07 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.92 93.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.33 -39.29 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.29 . . . . 0.0 109.914 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -47.86 87.77 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -67.81 -44.73 76.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.642 -0.916 . . . . 0.0 109.603 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.94 -30.59 71.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.253 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -73.04 -39.5 65.9 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 108.668 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.24 99.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.26 -42.14 99.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.417 -1.049 . . . . 0.0 109.156 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -68.1 -38.53 82.39 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.161 -0.962 . . . . 0.0 108.814 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -55.76 -42.73 71.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.773 -1.205 . . . . 0.0 108.518 179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.489 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -75.02 -50.12 17.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 112.509 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.2 pp -118.34 -24.97 6.69 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.122 -0.986 . . . . 0.0 110.566 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -47.33 166.17 0.12 Allowed Glycine 0 C--N 1.29 -1.972 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 1.5 mptm? -117.68 -85.86 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 51.5 Cg_endo -85.22 102.3 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 121.387 1.531 . . . . 0.0 109.431 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 mt -102.05 98.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.805 -1.184 . . . . 0.0 111.187 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 tp -94.27 118.9 32.27 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.7 OUTLIER -106.73 154.06 21.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.022 -1.049 . . . . 0.0 108.895 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.504 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 17.4 mt -125.3 137.46 54.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 110.263 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -137.41 117.84 13.77 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 0.1 OUTLIER -75.02 123.34 88.86 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 0.0 110.562 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.7 -31.41 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.326 2.017 . . . . 0.0 110.663 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 13.7 pt20 -49.75 -35.06 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.479 ' HG ' ' NH2' ' A' ' 109' ' ' ARG . 53.1 m -97.82 -14.65 20.64 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.39 51.57 4.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 115' ' ' VAL . 42.2 mtp85 -83.58 13.3 4.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.049 -1.265 . . . . 0.0 110.279 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' ARG . 54.1 t 54.31 107.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 0.0 110.138 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 117' ' ' SER . 19.4 tp -46.34 -71.96 0.06 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 164.47 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.21 82.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.981 -1.074 . . . . 0.0 109.789 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' A' ' 119' ' ' MET . 17.9 mmm -66.38 -50.58 63.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.461 HD13 HG22 ' A' ' 120' ' ' ILE . 35.5 mm -63.68 -41.16 91.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 108.93 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 117' ' ' SER . 18.5 mmt85 -62.42 -44.02 97.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 109.604 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -64.68 -36.12 92.75 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.221 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.75 -23.06 10.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.061 -1.258 . . . . 0.0 107.98 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -32.48 101.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.234 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 93.1 m-20 -101.33 -30.01 11.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 108.709 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.66 -0.12 57.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.4 p -112.49 -69.39 0.87 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.58 -0.953 . . . . 0.0 108.582 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.16 -39.55 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 32.1 t80 -98.37 129.18 45.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.523 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 42.1 tt0 -154.06 163.79 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.05 -1.031 . . . . 0.0 110.435 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.72 112.33 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.523 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 20.6 m0 -105.02 145.0 31.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 108.944 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 43.4 p30 -89.78 154.23 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.802 -1.186 . . . . 0.0 109.16 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.4 p90 -163.85 -174.49 3.66 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.898 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -152.86 148.11 26.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 135' ' ' ALA . 47.7 mt-10 -36.71 -37.8 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.928 -1.107 . . . . 0.0 110.259 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.46 19.04 38.36 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.446 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.644 ' N ' ' O ' ' A' ' 135' ' ' ALA . 94.5 mt-10 -142.69 -10.39 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.067 -1.255 . . . . 0.0 110.397 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.522 ' CG1' ' NH1' ' A' ' 34' ' ' ARG . 8.0 p -50.89 -45.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.921 -1.112 . . . . 0.0 108.655 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.48 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.2 pt-20 -60.38 -36.41 77.98 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.282 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -65.68 -46.26 79.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.486 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -47.85 64.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 38.7 mt -68.51 -31.99 71.65 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.479 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 76.9 m-20 -66.17 -42.74 88.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.536 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -69.86 -50.75 39.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.67 -1.269 . . . . 0.0 108.264 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.681 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 38' ' ' TYR . 13.2 m-85 -71.74 -33.16 68.45 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.764 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.56 28.45 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.01 -78.0 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.836 -1.146 . . . . 0.0 113.065 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 8.3 mt -61.42 -40.2 69.45 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.139 -0.975 . . . . 0.0 112.402 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 47.6 Cg_exo -54.83 -27.34 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.91 1.74 . . . . 0.0 111.733 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.25 -21.4 13.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.278 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -58.98 -37.38 76.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.8 m -56.17 -40.14 73.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -91.08 120.95 32.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.418 ' OG ' ' CB ' ' A' ' 163' ' ' ALA . 9.4 t -176.36 -27.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.8 p -58.48 -28.89 65.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.306 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.8 p -70.71 -28.02 64.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.587 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.34 148.73 56.51 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.12 -24.02 45.18 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.513 2.142 . . . . 0.0 112.273 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.3 t -152.72 147.98 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.367 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.418 ' CB ' ' OG ' ' A' ' 157' ' ' SER . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.323 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.291 0.567 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 204' ' ' SER . . . -151.67 158.22 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . 51.34 16.97 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.84 . . . . 0.0 109.39 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' SER . . . . . 0.4 ' N ' ' C ' ' B' ' 202' ' ' ALA . 50.4 m -65.4 153.16 42.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.87 51.28 6.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -48.95 140.13 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -1.22 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -74.01 178.79 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.862 . . . . 0.0 109.681 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -50.75 151.18 4.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.185 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.48 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.072 1.848 . . . . 0.0 110.947 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.424 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.2 p -111.7 174.5 5.84 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 11.2 m -113.63 156.73 23.17 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.84 133.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.474 ' OH ' ' CB ' ' B' ' 269' ' ' ASP . 9.7 t80 -111.6 95.57 5.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.566 ' CG ' ' O ' ' B' ' 214' ' ' PHE . 0.0 OUTLIER -83.23 118.28 23.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -87.32 123.48 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 109.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' B' ' 217' ' ' SER . . . -126.37 -130.22 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' B' ' 216' ' ' GLY . 1.4 t 156.98 111.86 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -1.045 . . . . 0.0 109.369 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.603 ' H ' ' CD1' ' B' ' 218' ' ' ILE . 0.0 OUTLIER -54.59 -49.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.721 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -51.66 110.26 0.44 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 170.86 -39.7 0.18 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.546 ' C ' ' H ' ' B' ' 223' ' ' GLU . . . 152.03 14.47 0.07 OUTLIER Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.494 -1.004 . . . . 0.0 110.977 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 66.74 -41.19 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.928 -1.336 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' B' ' 221' ' ' GLY . 80.1 mm-40 -52.44 -36.63 55.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 225' ' ' GLN . 35.3 p-10 -68.52 -31.52 70.81 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.722 HE21 ' N ' ' B' ' 250' ' ' GLU . 30.8 tt0 -60.93 -42.62 98.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.05 -48.45 68.27 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.95 -28.11 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.401 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 17.3 m-30 -70.49 -53.6 15.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.53 -35.28 72.04 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.607 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.439 ' O ' ' OG ' ' B' ' 233' ' ' SER . 31.5 ttm180 -69.68 -58.69 3.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.923 -1.11 . . . . 0.0 108.548 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.54 -42.92 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.543 ' CG2' ' CE2' ' B' ' 214' ' ' PHE . 46.7 t -62.37 -29.82 47.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' B' ' 234' ' ' ARG . 26.3 p -69.34 -40.77 77.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . 0.6 ' N ' ' HG ' ' B' ' 233' ' ' SER . 95.4 mtt180 -70.15 -49.47 50.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.798 -1.189 . . . . 0.0 108.903 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.69 -39.99 82.3 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -63.02 -24.69 68.03 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -75.96 -38.06 57.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.931 -1.106 . . . . 0.0 109.329 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.4 m-85 -68.29 -48.03 66.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.559 -0.713 . . . . 0.0 110.766 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -151.56 -150.4 5.33 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -89.31 115.44 26.79 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.19 -1.183 . . . . 0.0 109.058 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' B' ' 242' ' ' LEU . 2.7 t -78.18 103.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.447 ' HB3' ' CD1' ' B' ' 272' ' ' TRP . 2.2 mt -47.55 126.8 10.44 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.929 -1.109 . . . . 0.0 108.97 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 242' ' ' LEU . 42.1 m -39.16 137.99 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 111.133 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 246' ' ' VAL . 26.8 mt-10 -148.81 101.84 3.23 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 249' ' ' ALA . 18.3 t-80 -43.1 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 109.864 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 244' ' ' GLU . 82.6 t -46.11 -84.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -54.16 -40.01 67.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.823 -1.173 . . . . 0.0 108.927 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -75.38 20.91 0.14 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.716 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -86.22 -19.88 29.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.818 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.722 ' N ' HE21 ' B' ' 225' ' ' GLN . 59.1 mt-10 -61.77 7.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.716 ' H ' ' C ' ' B' ' 249' ' ' ALA . 0.6 OUTLIER -88.87 134.48 33.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' B' ' 251' ' ' LEU . 7.0 mm-40 54.75 159.19 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.204 -0.935 . . . . 0.0 109.409 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -37.93 152.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.67 2.247 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.68 154.1 26.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.652 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 138.28 41.34 0.1 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 49.83 -82.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -1.045 . . . . 0.0 109.104 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' B' ' 255' ' ' GLY . 50.8 tp10 -48.87 -26.72 2.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 108.504 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -80.13 45.02 0.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -129.18 -179.32 5.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.461 -0.774 . . . . 0.0 109.298 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.56 63.14 0.54 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 113.61 78.75 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -49.22 -37.94 24.69 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . 0.42 ' CD ' ' H ' ' B' ' 263' ' ' GLN . 10.2 mp0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -54.48 -38.67 66.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.718 -1.239 . . . . 0.0 108.876 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.9 -46.84 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.752 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 0.9 OUTLIER -71.97 -62.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.752 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 79.4 mm-40 -43.17 -52.39 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -62.97 -41.71 99.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.474 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 80.9 m-20 -66.67 -40.92 88.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 111.522 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.583 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 0.2 OUTLIER -68.13 -51.68 43.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.021 -1.05 . . . . 0.0 110.2 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -60.4 -46.4 90.11 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.133 -0.979 . . . . 0.0 109.576 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.633 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.1 OUTLIER -64.85 -46.25 82.68 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.466 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 59.8 tp -52.06 -34.03 41.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.42 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.34 -32.16 48.96 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.633 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 29.2 mt-30 -87.25 -0.81 57.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.891 -1.131 . . . . 0.0 109.286 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.79 125.73 24.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.24 -0.913 . . . . 0.0 112.159 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.612 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.9 m-20 -76.04 -35.75 59.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 88.8 t -132.65 155.08 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.96 139.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 111.832 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 24.4 t -137.93 158.25 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.599 -1.313 . . . . 0.0 110.322 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -113.84 123.58 50.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' B' ' 284' ' ' THR . 0.0 OUTLIER -122.1 26.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.041 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.442 ' C ' ' O ' ' B' ' 283' ' ' VAL . 66.5 m -43.21 -69.7 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.01 -1.056 . . . . 0.0 109.019 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -91.51 149.22 39.05 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 108.756 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.38 91.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.027 1.818 . . . . 0.0 111.262 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.453 ' OG ' ' CB ' ' B' ' 217' ' ' SER . 34.3 t -99.92 135.31 41.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.25 -39.67 53.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.533 -0.73 . . . . 0.0 109.206 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.3 -40.3 91.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 4.5 t -71.11 -39.41 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.053 -1.263 . . . . 0.0 109.961 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.76 -47.53 89.7 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -68.02 -45.24 74.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 0.0 109.649 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.4 -30.88 70.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.56 -39.76 67.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 108.732 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -63.58 -41.78 99.03 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.463 -1.022 . . . . 0.0 109.175 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -68.23 -38.67 82.11 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.143 -0.973 . . . . 0.0 108.792 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.42 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -55.87 -42.42 70.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.732 -1.23 . . . . 0.0 108.481 179.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.489 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.25 -50.0 17.53 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.2 pp -118.67 -24.93 6.54 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 0.0 110.422 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -47.16 166.45 0.1 Allowed Glycine 0 C--N 1.289 -2.079 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 1.5 mptm? -117.96 -85.87 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 49.6 Cg_endo -85.23 102.32 0.76 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 121.42 1.543 . . . . 0.0 109.378 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 14.8 mt -102.15 98.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.237 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 35.4 tp -93.98 118.4 31.44 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' B' ' 330' ' ' GLN . 0.8 OUTLIER -106.42 153.79 21.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.009 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.515 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 17.0 mt -124.92 138.02 54.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.26 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -137.85 117.85 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.578 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 0.1 OUTLIER -74.92 123.39 88.93 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.494 -0.754 . . . . 0.0 110.536 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.82 -31.7 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.381 2.054 . . . . 0.0 110.763 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.578 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 13.3 pt20 -49.65 -34.88 19.54 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.444 ' OG ' ' NH2' ' B' ' 309' ' ' ARG . 49.8 m -97.86 -14.66 20.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 41.35 51.55 4.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' B' ' 315' ' ' VAL . 42.2 mtp85 -83.49 13.32 4.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.988 -1.301 . . . . 0.0 110.221 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.4 t 54.51 106.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 110.054 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' B' ' 317' ' ' SER . 19.0 tp -46.36 -72.12 0.06 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.64 -0.662 . . . . 0.0 109.305 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 1.0 OUTLIER 164.75 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.08 -43.85 81.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 109.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' B' ' 319' ' ' MET . 17.7 mmm -66.07 -50.79 62.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.278 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.456 HD13 HG22 ' B' ' 320' ' ' ILE . 34.9 mm -63.4 -41.26 92.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 108.905 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' B' ' 317' ' ' SER . 18.8 mmt85 -62.46 -43.62 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.947 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -64.64 -36.67 93.42 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.34 -23.38 9.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.061 -1.258 . . . . 0.0 108.066 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -32.33 101.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.248 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 92.3 m-20 -101.84 -30.04 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 108.705 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.62 0.09 57.69 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 12.9 p -112.99 -69.95 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.981 . . . . 0.0 108.462 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -107.24 -39.77 5.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.428 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 31.2 t80 -98.57 128.92 45.07 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.543 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 43.2 tt0 -153.49 164.29 38.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 25.5 t -126.11 112.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.543 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 20.5 m0 -105.15 144.97 31.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.903 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 42.0 p30 -90.03 154.35 19.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 0.0 109.202 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 5.6 p90 -163.73 -174.28 3.61 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.64 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -152.95 148.05 26.66 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.8 mt-10 -36.79 -37.49 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.11 . . . . 0.0 110.198 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -88.68 19.56 36.4 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.473 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 335' ' ' ALA . 94.3 mt-10 -143.25 -10.71 0.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.073 -1.251 . . . . 0.0 110.491 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' NH1' ' B' ' 234' ' ' ARG . 7.1 p -50.95 -45.19 28.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.003 -1.061 . . . . 0.0 108.548 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.478 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 22.7 pt-20 -60.3 -36.62 78.32 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.226 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.5 m -65.57 -46.25 80.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.173 -0.954 . . . . 0.0 109.498 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.21 -47.69 65.49 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 37.4 mt -68.52 -32.29 72.14 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.86 -42.74 90.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.005 -1.059 . . . . 0.0 110.457 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -70.01 -50.94 36.53 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.684 -1.26 . . . . 0.0 108.27 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.42 -47.03 79.88 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.462 -0.774 . . . . 0.0 109.755 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' B' ' 238' ' ' TYR . 13.7 m-85 -71.59 -33.01 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.844 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.75 -26.19 65.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -101.4 27.84 5.94 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.8 -78.16 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.78 -1.168 . . . . 0.0 113.101 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 8.3 mt -60.81 -40.76 77.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 112.334 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 48.5 Cg_exo -54.44 -27.42 49.26 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.014 1.809 . . . . 0.0 111.726 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -103.13 -22.22 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -58.21 -37.36 74.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 41.1 m -56.28 -40.04 73.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.16 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.865 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 11.4 t -176.45 -28.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 53.1 p -58.03 -29.74 65.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.339 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 -28.31 65.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.591 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.1 148.77 57.34 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.311 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.35 -24.32 43.4 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.552 2.168 . . . . 0.0 112.276 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 31.3 t -154.17 156.44 37.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 109.732 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.414 179.861 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.62 -172.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.97 -94.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.238 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m -113.85 142.28 46.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.833 . . . . 0.0 109.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.24 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.49 168.95 12.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.341 -1.093 . . . . 0.0 109.64 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -59.83 -54.47 45.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.97 144.68 0.08 OUTLIER Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.72 -0.613 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 10' ' ' CYS . 50.1 Cg_endo -71.01 155.54 61.62 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.357 2.038 . . . . 0.0 111.228 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' PRO . 22.6 p -52.61 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.037 -1.04 . . . . 0.0 109.16 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 77' ' ' ASP . 5.0 p -109.19 149.3 29.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 13.0 t -139.86 131.52 33.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.495 ' OH ' ' OD2' ' A' ' 69' ' ' ASP . 14.2 t80 -100.65 124.91 46.89 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -96.21 122.73 39.38 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.539 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.6 t -133.87 154.97 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 -159.53 21.71 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -96.66 139.09 33.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -1.187 . . . . 0.0 108.724 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.8 mt -136.89 4.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.104 . . . . 0.0 110.822 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.645 ' NH2' ' H ' ' A' ' 89' ' ' GLY . 47.3 mmt-85 -47.94 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.854 -1.154 . . . . 0.0 108.728 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . 75.22 172.86 31.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.05 129.36 26.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' NH2' ' NE2' ' A' ' 85' ' ' GLN . 50.1 mtp85 -135.12 149.89 50.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.289 . . . . 0.0 111.333 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.71 -24.29 14.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 80.0 m-20 -69.84 -32.25 70.55 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.611 ' NE2' ' O ' ' A' ' 49' ' ' ALA . 5.9 mt-30 -64.78 -40.2 94.87 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.07 -52.47 34.9 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.31 -29.83 64.25 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 9.9 m-30 -69.18 -44.46 72.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 110.295 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.11 83.34 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.488 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.587 ' NE ' HH22 ' A' ' 34' ' ' ARG . 60.0 ttt180 -71.26 -56.69 5.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.928 -1.108 . . . . 0.0 108.146 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.525 ' HA ' HH11 ' A' ' 34' ' ' ARG . 12.1 mt -52.85 -45.33 50.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 42.1 t -60.66 -27.58 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 15.5 p -68.87 -36.68 78.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.389 -0.819 . . . . 0.0 109.367 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.587 HH22 ' NE ' ' A' ' 30' ' ' ARG . 77.4 mtt85 -68.6 -47.96 65.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.597 -1.314 . . . . 0.0 107.849 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 38' ' ' TYR . 3.1 mt -62.3 -28.91 70.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.608 ' NH2' ' H ' ' A' ' 41' ' ' VAL . 2.0 tpm_? -64.98 -29.14 70.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -70.8 -62.08 1.53 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -123.74 157.01 34.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.274 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 81.59 69.86 1.37 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.8 mtmt -36.37 131.81 0.62 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.333 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.608 ' H ' ' NH2' ' A' ' 36' ' ' ARG . 23.2 t -96.05 107.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.828 -1.17 . . . . 0.0 108.854 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 24.6 mt -78.79 152.94 31.11 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.204 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 45' ' ' HIS . 19.7 m 51.36 53.22 13.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -54.4 -7.22 0.14 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 43' ' ' THR . 8.5 t-80 -45.34 -31.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.6 -53.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.093 -1.004 . . . . 0.0 109.881 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.599 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -65.92 -43.47 88.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 108.714 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.64 37.01 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.611 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -108.97 9.48 26.49 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -104.25 3.3 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.588 -0.695 . . . . 0.0 109.719 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.67 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.0 163.16 15.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.242 -0.911 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.5 mt-10 54.46 156.69 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.499 -0.751 . . . . 0.0 109.238 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.67 122.42 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.068 1.846 . . . . 0.0 111.878 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -90.77 -164.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 90.64 130.82 4.63 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 28.3 mm-40 -49.43 -30.9 8.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.997 -1.296 . . . . 0.0 109.132 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.12 -0.68 8.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.054 -1.029 . . . . 0.0 108.993 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -65.16 149.12 50.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.494 -0.753 . . . . 0.0 109.114 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.31 0.37 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.7 -31.26 7.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.2 76.43 1.03 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 56' ' ' GLU . 91.8 m-20 -52.18 -38.14 56.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -67.22 -52.01 46.31 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -58.64 -32.64 69.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 mt -65.64 -52.26 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.502 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 2.6 t-80 -66.23 -53.67 34.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.589 -0.695 . . . . 0.0 109.985 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 9.4 tt0 -47.68 -57.34 5.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.991 -1.068 . . . . 0.0 109.667 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.91 -37.5 81.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' OD2' ' OH ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -68.19 -56.69 7.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 110.763 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.5 tp -58.84 -40.61 84.73 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.47 -0.769 . . . . 0.0 110.313 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 90.8 m-20 -65.33 -58.84 4.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.007 -1.058 . . . . 0.0 109.253 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -57.2 -40.78 78.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -50.72 -41.05 55.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -72.54 -26.18 61.65 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.807 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 19.3 mt-30 -90.76 1.26 57.04 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.965 -1.084 . . . . 0.0 108.826 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.03 122.72 23.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.381 -0.825 . . . . 0.0 111.748 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.417 ' N ' ' OG ' ' A' ' 11' ' ' SER . 89.7 m-20 -69.95 -35.74 74.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.682 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 t -135.16 141.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.65 120.13 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.825 -1.172 . . . . 0.0 111.805 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -116.0 120.16 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.693 0.758 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.28 158.37 35.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 30.0 tt0 -97.07 128.27 43.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.64 28.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.756 . . . . 0.0 110.135 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -79.67 -77.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.446 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.585 ' NE2' ' NH2' ' A' ' 22' ' ' ARG . 6.3 mm100 -64.33 136.39 96.73 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' B' ' 286' ' ' PRO . 72.9 Cg_endo -77.43 88.09 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 111.716 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.418 ' OG ' ' CZ ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -121.77 139.58 53.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.16 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' TYR . 16.1 mt -59.45 -42.1 91.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.182 -0.949 . . . . 0.0 108.677 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.645 ' H ' ' NH2' ' A' ' 19' ' ' ARG . . . -55.6 -30.9 56.99 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.7 t -75.44 -57.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.63 -0.924 . . . . 0.0 108.904 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.29 -36.31 89.34 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 88' ' ' LEU . 75.5 t80 -65.56 -52.54 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.088 . . . . 0.0 109.129 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' OE2' ' OD1' ' A' ' 69' ' ' ASP . 1.8 tp10 -58.75 -34.82 71.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.338 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.2 mt -74.63 -41.08 61.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.99 . . . . 0.0 108.742 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -34.52 89.47 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.628 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.79 -43.17 80.36 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.626 -0.926 . . . . 0.0 109.176 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.663 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -69.86 -42.0 74.09 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.521 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -37.92 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.85 -49.76 35.41 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.361 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -126.53 -34.71 2.43 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.145 -0.972 . . . . 0.0 109.885 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -73.82 102.61 1.34 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.615 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.72 -69.78 0.31 Allowed Pre-proline 0 C--N 1.288 -2.092 0 O-C-N 121.595 -0.944 . . . . 0.0 110.871 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 31.5 Cg_endo -65.64 109.01 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.573 1.515 . . . . 0.0 110.841 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.63 119.38 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 110.777 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.0 tp -105.26 119.45 39.1 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -107.46 139.48 41.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.012 . . . . 0.0 108.566 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 11.6 mt -126.82 124.19 39.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -124.0 154.5 39.76 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' OE2' ' A' ' 136' ' ' GLU . 50.2 mtm180 -109.82 141.23 23.29 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.835 -1.166 . . . . 0.0 110.95 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.43 -29.32 3.08 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.812 2.341 . . . . 0.0 111.384 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 112' ' ' SER . 19.3 pt20 -46.5 -40.46 12.55 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.442 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 2.7 m -98.41 -23.1 15.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 50.07 40.57 36.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 7.6 mmt180 -51.0 -8.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.862 -1.375 . . . . 0.0 109.364 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.544 ' H ' ' C ' ' A' ' 113' ' ' GLY . 23.4 t 64.1 99.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.963 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 108' ' ' PHE . 4.1 mm? -37.97 128.25 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.409 ' HB2' HH21 ' B' ' 219' ' ' ARG . 2.3 t -51.3 147.75 5.45 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.104 -0.998 . . . . 0.0 109.094 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.68 78.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.982 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 0.1 OUTLIER -67.03 -42.31 85.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 109.359 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 120' ' ' ILE . 35.8 mm -66.58 -46.38 86.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.054 -1.029 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.417 ' CG ' HH11 ' A' ' 121' ' ' ARG . 0.3 OUTLIER -62.04 -47.77 83.24 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.56 -36.68 86.23 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.564 ' O ' ' CB ' ' A' ' 124' ' ' ALA . . . -50.42 -61.85 1.94 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 129' ' ' PHE . . . 155.34 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.306 1.05 . . . . 0.0 112.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.664 ' HA ' ' H ' ' A' ' 131' ' ' VAL . 55.7 p30 -126.27 26.69 6.39 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -178.08 149.88 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.762 ' C ' ' H ' ' A' ' 129' ' ' PHE . 4.2 t 96.88 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 117.935 0.868 . . . . 0.0 109.044 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 61.68 -19.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.762 ' H ' ' C ' ' A' ' 127' ' ' SER . 82.0 t80 -120.39 121.9 39.57 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -139.68 132.35 28.92 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.122 -1.431 . . . . 0.0 111.656 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.664 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 73.3 t -105.32 101.62 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 146' ' ' TYR . 22.8 m0 -98.37 155.66 17.12 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 110.771 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -107.51 147.74 30.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 6.6 p90 -164.14 -175.73 4.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.848 -1.158 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.703 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -155.27 158.09 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.538 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 15.3 mt-10 -58.1 23.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.438 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.703 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -119.16 -11.46 7.49 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.684 ' O ' ' SD ' ' A' ' 142' ' ' MET . 5.7 pt-20 -153.96 16.2 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.997 -1.296 . . . . 0.0 110.202 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.556 ' O ' ' HG2' ' A' ' 142' ' ' MET . 3.5 p -51.05 -41.97 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.189 -0.944 . . . . 0.0 109.117 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 81.2 tt0 -61.63 -27.89 68.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.003 -1.061 . . . . 0.0 109.125 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.3 m -73.96 -48.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 110.444 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.684 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -54.41 -48.62 71.4 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.8 mt -57.69 -38.66 75.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 45.2 t0 -63.08 -37.97 89.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -70.61 -53.38 16.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.62 -1.3 . . . . 0.0 108.773 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.427 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 67.3 t80 -58.16 -48.23 80.91 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 17.9 m-85 -70.48 -31.13 68.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.998 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 38.7 mt-10 -59.69 -29.89 68.4 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 17.62 10.19 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.48 -21.44 0.33 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.833 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 85.2 mt -120.34 39.84 0.37 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.527 -1.358 . . . . 0.0 111.776 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 92.4 Cg_endo -79.38 116.7 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.223 1.949 . . . . 0.0 110.526 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 157' ' ' SER . 61.4 mt-30 67.83 -37.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.0 109.039 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.574 ' H ' ' C ' ' A' ' 152' ' ' PRO . 76.4 tttt -59.57 -26.43 65.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.0 . . . . 0.0 108.788 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 m -53.66 -38.4 64.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 157' ' ' SER . . . -171.14 -12.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 0.0 109.568 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 153' ' ' GLN . 99.2 p 48.89 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.542 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.7 m -118.11 154.49 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.378 -0.826 . . . . 0.0 109.411 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.441 ' OG ' ' ND1' ' A' ' 160' ' ' HIS . 88.0 p -149.93 176.24 10.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.441 ' ND1' ' OG ' ' A' ' 159' ' ' SER . 47.1 m80 55.67 69.14 2.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.25 -23.49 9.99 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 0.0 112.153 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.44 ' O ' ' OXT' ' A' ' 163' ' ' ALA . 82.5 p -65.15 162.6 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.44 ' OXT' ' O ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.524 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 49.07 -172.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.583 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -161.29 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.163 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 67.7 m -114.88 141.58 47.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.71 -163.7 29.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -87.56 169.68 11.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.311 -1.111 . . . . 0.0 109.516 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . 0.405 ' O ' ' O ' ' B' ' 208' ' ' ALA . 45.4 mt-30 -60.92 -53.65 54.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' B' ' 207' ' ' GLN . . . 62.05 144.45 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.665 -0.647 . . . . 0.0 109.505 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' B' ' 210' ' ' CYS . 45.7 Cg_endo -70.56 155.9 62.35 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.389 2.059 . . . . 0.0 111.185 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' B' ' 209' ' ' PRO . 23.9 p -52.82 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.028 -1.045 . . . . 0.0 109.15 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' B' ' 277' ' ' ASP . 7.3 p -109.21 148.85 30.27 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 12.9 t -139.63 131.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' B' ' 269' ' ' ASP . 13.8 t80 -100.8 124.36 46.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.343 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -95.48 122.89 38.68 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.553 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 21.7 t -133.95 155.02 50.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.252 -0.905 . . . . 0.0 110.082 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -175.73 -159.83 22.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 25.1 p -96.32 138.9 33.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.222 -1.163 . . . . 0.0 108.888 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' B' ' 220' ' ' GLY . 2.7 mt -136.73 5.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.928 -1.108 . . . . 0.0 110.797 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.658 ' NH2' ' H ' ' B' ' 289' ' ' GLY . 49.4 mmt-85 -48.21 98.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.95 -1.094 . . . . 0.0 108.579 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 218' ' ' ILE . . . 74.88 173.17 31.14 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.23 129.16 25.85 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.191 -1.964 . . . . 0.0 108.191 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.589 ' NH2' ' NE2' ' B' ' 285' ' ' GLN . 51.5 mtp85 -135.05 149.95 50.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.236 . . . . 0.0 111.427 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.31 -24.95 13.11 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.5 m-20 -69.48 -32.06 70.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.591 ' NE2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-30 -65.02 -39.92 94.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.42 -52.42 32.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.13 -30.0 64.04 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 10.0 m-30 -69.09 -44.56 72.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.681 -0.637 . . . . 0.0 110.295 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.07 83.13 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.507 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.573 ' NE ' HH22 ' B' ' 234' ' ' ARG . 60.3 ttt180 -71.32 -56.81 5.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.082 . . . . 0.0 108.115 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.514 ' HA ' HH11 ' B' ' 234' ' ' ARG . 12.1 mt -52.77 -45.35 49.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 41.8 t -60.48 -27.72 40.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 230' ' ' ARG . 15.2 p -68.79 -36.84 78.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.431 -0.793 . . . . 0.0 109.405 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . 0.573 HH22 ' NE ' ' B' ' 230' ' ' ARG . 77.5 mtt85 -68.38 -47.91 66.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.287 . . . . 0.0 107.831 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.558 ' O ' ' O ' ' B' ' 238' ' ' TYR . 3.0 mt -62.33 -29.08 70.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.634 HH21 ' H ' ' B' ' 241' ' ' VAL . 2.1 tpm_? -64.89 -29.34 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -70.57 -61.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.8 OUTLIER -123.81 156.92 35.25 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 81.73 69.84 1.37 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' B' ' 239' ' ' GLY . 50.6 mtmt -36.58 131.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.347 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . 0.634 ' H ' HH21 ' B' ' 236' ' ' ARG . 24.1 t -96.23 107.71 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.859 -1.15 . . . . 0.0 108.835 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.445 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 24.4 mt -78.67 153.71 30.76 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.508 ' C ' ' H ' ' B' ' 245' ' ' HIS . 22.5 m 50.62 53.25 13.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.71 -7.08 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.078 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.508 ' H ' ' C ' ' B' ' 243' ' ' THR . 8.1 t-80 -45.59 -30.97 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.34 -52.91 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.74 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.584 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -66.14 -43.56 86.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 108.847 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.58 37.08 0.09 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.591 ' O ' ' NE2' ' B' ' 225' ' ' GLN . . . -109.16 9.84 26.01 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.411 ' H ' HD13 ' B' ' 251' ' ' LEU . 2.3 mt-10 -104.44 3.11 31.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.668 ' CD1' ' N ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -112.69 163.31 14.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.269 -0.894 . . . . 0.0 109.643 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 47.6 mt-10 54.57 156.78 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.467 -0.771 . . . . 0.0 109.339 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -40.91 121.96 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.034 1.822 . . . . 0.0 111.795 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 249' ' ' ALA . 1.0 OUTLIER -90.4 -164.19 1.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 90.38 130.49 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' B' ' 262' ' ' ASP . 28.4 mm-40 -49.34 -31.47 9.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.066 -1.256 . . . . 0.0 109.275 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.36 -1.15 7.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 0.0 108.782 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -64.38 148.85 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.166 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.52 4.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -47.23 -30.85 5.88 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.0 76.05 1.01 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' B' ' 256' ' ' GLU . 94.7 m-20 -52.01 -38.2 56.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -67.25 -51.85 48.09 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -58.91 -32.53 69.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.64 -51.86 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.507 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 2.5 t-80 -66.71 -53.61 31.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.507 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 9.8 tt0 -47.59 -57.37 5.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.647 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -67.77 -37.86 82.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.505 ' OD2' ' OH ' ' B' ' 213' ' ' TYR . 0.4 OUTLIER -68.0 -56.83 7.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.08 -1.012 . . . . 0.0 110.785 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.5 tp -58.76 -40.36 83.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 88.8 m-20 -65.43 -58.74 5.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.074 -1.016 . . . . 0.0 109.158 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.445 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.12 -41.17 78.53 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 13.0 tp -50.36 -41.31 51.42 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -72.43 -26.18 61.74 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 18.6 mt-30 -90.68 1.03 57.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.012 -1.055 . . . . 0.0 108.725 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.56 122.82 22.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.497 -0.752 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.436 ' N ' ' OG ' ' B' ' 211' ' ' SER . 89.2 m-20 -70.14 -35.76 74.28 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 51.1 t -135.37 141.4 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.61 120.25 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.69 -1.256 . . . . 0.0 111.61 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.79 120.12 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.594 -0.692 . . . . 0.0 109.514 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -126.12 159.2 33.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 109.881 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.448 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 30.5 tt0 -97.87 128.76 44.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.95 27.86 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.307 -0.87 . . . . 0.0 110.095 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 5.4 m -79.17 -76.99 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.589 ' NE2' ' NH2' ' B' ' 222' ' ' ARG . 6.5 mm100 -64.53 136.26 96.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.494 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' PRO . 73.1 Cg_endo -77.33 87.58 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.341 2.027 . . . . 0.0 111.839 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.428 ' OG ' ' CZ ' ' B' ' 219' ' ' ARG . 0.2 OUTLIER -121.4 139.84 52.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' B' ' 292' ' ' TYR . 15.0 mt -59.31 -41.82 89.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.115 -0.991 . . . . 0.0 108.777 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . 0.658 ' H ' ' NH2' ' B' ' 219' ' ' ARG . . . -56.19 -30.92 58.68 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 89.9 t -75.15 -57.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.545 -0.974 . . . . 0.0 108.8 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.12 90.62 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' B' ' 288' ' ' LEU . 74.9 t80 -66.15 -52.76 45.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -1.131 . . . . 0.0 109.222 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.476 ' OE1' ' SD ' ' A' ' 119' ' ' MET . 1.7 tp10 -58.37 -34.91 71.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 18.1 mt -74.44 -41.4 60.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 108.796 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.3 -34.44 89.25 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' B' ' 296' ' ' ARG . 0.4 OUTLIER -67.96 -42.68 80.54 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.625 -0.926 . . . . 0.0 109.186 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.659 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -70.24 -41.88 72.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.493 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -37.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -72.13 -49.88 32.42 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.354 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.603 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -126.21 -34.51 2.51 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -74.03 102.44 1.34 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.603 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -72.57 -69.86 0.31 Allowed Pre-proline 0 C--N 1.288 -2.087 0 O-C-N 121.651 -0.911 . . . . 0.0 110.841 -177.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 31.7 Cg_endo -65.64 109.07 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.508 1.472 . . . . 0.0 110.849 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.43 119.11 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.087 -1.008 . . . . 0.0 110.754 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 47.6 tp -105.22 119.4 38.98 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -107.5 140.8 39.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.007 . . . . 0.0 108.622 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 11.8 mt -127.91 124.34 37.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -124.13 154.58 39.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.542 ' NH1' ' OE2' ' B' ' 336' ' ' GLU . 52.1 mtm180 -109.78 140.82 22.59 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 111.006 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.29 -29.62 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.643 2.229 . . . . 0.0 111.428 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.446 ' CG ' ' N ' ' B' ' 312' ' ' SER . 19.4 pt20 -45.96 -40.66 10.62 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 2.6 m -98.12 -23.34 15.77 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 50.5 40.73 39.98 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.426 ' O ' ' HB ' ' B' ' 315' ' ' VAL . 7.7 mmt180 -51.36 -8.33 0.05 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.965 -1.315 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' B' ' 313' ' ' GLY . 22.6 t 64.11 99.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.537 -0.727 . . . . 0.0 110.039 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' B' ' 308' ' ' PHE . 4.1 mm? -38.33 128.46 1.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.1 t -51.51 148.18 5.44 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.059 -1.026 . . . . 0.0 109.215 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.74 78.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 109.88 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -67.21 -42.76 83.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 35.6 mm -66.09 -46.11 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.899 -1.125 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . 0.428 ' HG3' HH11 ' B' ' 321' ' ' ARG . 0.3 OUTLIER -62.42 -47.82 82.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -58.09 -36.64 82.69 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.579 ' O ' ' CB ' ' B' ' 324' ' ' ALA . . . -50.68 -62.18 1.75 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CD2' ' B' ' 329' ' ' PHE . . . 155.72 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.284 1.04 . . . . 0.0 112.157 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.64 ' HA ' ' H ' ' B' ' 331' ' ' VAL . 56.5 p30 -126.33 27.04 6.29 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -178.3 150.06 9.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.77 ' C ' ' H ' ' B' ' 329' ' ' PHE . 4.1 t 96.51 71.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.632 -0.923 . . . . 0.0 109.089 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 61.71 -19.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.77 ' H ' ' C ' ' B' ' 327' ' ' SER . 81.2 t80 -120.02 121.33 38.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -139.3 132.69 30.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.051 -1.46 . . . . 0.0 111.577 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . 0.64 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 67.4 t -105.31 101.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.44 ' CH2' ' HB2' ' B' ' 346' ' ' TYR . 23.3 m0 -98.61 155.8 17.12 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.198 -0.939 . . . . 0.0 110.728 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 50.6 p-10 -107.67 147.72 30.33 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' B' ' 309' ' ' ARG . 6.5 p90 -164.24 -175.57 4.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.903 -1.123 . . . . 0.0 111.07 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.699 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -155.18 158.37 38.82 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' B' ' 309' ' ' ARG . 17.0 mt-10 -58.42 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -118.99 -11.07 7.82 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.675 ' O ' ' SD ' ' B' ' 342' ' ' MET . 5.9 pt-20 -154.63 16.6 0.45 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.929 -1.336 . . . . 0.0 110.168 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.555 ' O ' ' HG2' ' B' ' 342' ' ' MET . 3.6 p -51.32 -42.05 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 0.0 108.975 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 82.3 tt0 -61.44 -27.89 68.87 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.125 -0.984 . . . . 0.0 109.139 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.9 m -74.09 -48.4 29.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.395 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.675 ' SD ' ' O ' ' B' ' 338' ' ' GLU . 0.0 OUTLIER -54.64 -48.61 72.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.73 -38.39 75.21 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 45.3 t0 -63.38 -37.94 89.22 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.543 -0.723 . . . . 0.0 110.169 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -70.43 -53.28 17.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.669 -1.269 . . . . 0.0 108.784 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . 0.44 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 67.2 t80 -58.31 -47.95 82.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 18.6 m-85 -70.89 -31.11 67.66 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.999 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 38.2 mt-10 -59.48 -29.76 68.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -93.09 17.98 10.02 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -148.91 -21.39 0.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.686 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 85.5 mt -120.48 40.02 0.38 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 111.741 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 93.6 Cg_endo -79.95 117.24 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.191 1.927 . . . . 0.0 110.408 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' B' ' 357' ' ' SER . 60.3 mt-30 67.62 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.869 . . . . 0.0 109.024 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' B' ' 352' ' ' PRO . 76.8 tttt -59.75 -25.7 65.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 108.798 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 9.0 m -54.52 -38.03 66.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.746 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' B' ' 357' ' ' SER . . . -171.5 -12.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 353' ' ' GLN . 95.7 p 48.28 -175.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.605 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 20.5 m -117.48 154.52 31.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' SER . . . . . 0.43 ' OG ' ' ND1' ' B' ' 360' ' ' HIS . 98.4 p -150.01 176.3 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.544 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.43 ' ND1' ' OG ' ' B' ' 359' ' ' SER . 45.6 m80 55.46 69.42 1.96 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.593 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.88 -23.16 8.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.688 2.259 . . . . 0.0 112.031 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 80.0 p -68.55 167.26 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.377 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.415 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.56 -44.29 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.966 . . . . 0.0 109.753 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.89 162.03 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.611 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 p -63.29 -23.44 67.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 109.371 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.67 -170.35 41.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -60.21 140.79 56.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -1.195 . . . . 0.0 109.225 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.21 -167.8 1.94 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -48.32 158.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' ALA . 45.2 Cg_exo -53.0 -155.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.641 2.227 . . . . 0.0 111.699 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.9 p -108.05 178.07 4.62 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -120.87 131.67 54.53 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.842 -1.161 . . . . 0.0 108.814 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 4.6 t -102.95 126.18 57.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.543 ' CE2' ' OG1' ' A' ' 43' ' ' THR . 40.8 t80 -93.19 118.99 31.88 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' CE2' HG21 ' A' ' 32' ' ' VAL . 24.0 t80 -85.58 123.98 31.62 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.434 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 2.7 t -117.34 113.65 22.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -162.07 75.98 0.18 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 16' ' ' GLY . 30.4 t -31.8 106.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.932 . . . . 0.0 110.48 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.596 ' H ' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.13 -170.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.672 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 60.3 ttt85 51.54 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.068 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.97 -22.73 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.964 -2.055 . . . . 0.0 107.964 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 23' ' ' GLU . . . 178.89 -29.9 0.06 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.721 ' NH2' ' H ' ' A' ' 55' ' ' GLY . 33.6 mmt180 73.91 -33.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.126 -0.632 . . . . 0.0 109.621 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 21' ' ' GLY . 78.5 tt0 -55.15 -46.8 75.73 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 17.2 m-20 -62.74 -20.5 65.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.788 HE22 ' N ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -67.25 -47.06 71.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.18 85.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.18 -37.15 74.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 14.4 m-30 -67.33 -41.49 85.18 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.405 -0.809 . . . . 0.0 109.69 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -60.82 -36.54 79.34 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.419 -1.425 . . . . 0.0 108.463 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 140' ' ' GLU . 70.7 ttt-85 -72.56 -57.38 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.1 -40.74 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 52.3 t -64.62 -29.35 47.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 10.2 m -67.8 -37.15 81.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.39 -0.819 . . . . 0.0 109.646 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.41 -52.11 24.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.671 -1.268 . . . . 0.0 108.755 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.48 -40.21 78.08 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -61.36 -25.32 67.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.73 -31.05 32.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 0.0 109.745 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.556 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -75.18 -52.67 10.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.242 -0.911 . . . . 0.0 110.946 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.34 -147.05 4.46 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -89.81 129.04 36.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.4 -1.059 . . . . 0.0 109.006 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.77 106.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.886 -1.134 . . . . 0.0 107.974 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 20.5 mt -72.38 -176.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.543 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 1.7 m 55.82 39.67 30.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.783 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 52.3 mp0 -46.3 -25.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -49.06 -38.41 24.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.093 -1.004 . . . . 0.0 108.996 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' ASP . 59.2 t -61.27 170.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.788 ' N ' HE22 ' A' ' 25' ' ' GLN . . . 61.82 -71.96 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' VAL . 21.0 t70 -67.82 28.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.723 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -106.62 12.91 28.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' H ' HD13 ' A' ' 51' ' ' LEU . 28.7 mt-10 -108.47 11.4 26.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.336 -0.852 . . . . 0.0 109.744 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.81 ' CD2' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -86.08 -93.76 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.01 . . . . 0.0 110.232 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' LEU . 2.0 mp0 -42.67 158.73 0.21 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 0.0 110.268 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.0 -22.16 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.647 2.232 . . . . 0.0 112.24 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 49' ' ' ALA . 1.6 mm? 59.69 -172.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 109.73 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' H ' ' NH2' ' A' ' 22' ' ' ARG . . . 99.04 25.67 9.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 62' ' ' ASP . 73.4 mm-40 53.52 -74.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.781 -0.834 . . . . 0.0 109.664 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.679 ' N ' ' O ' ' A' ' 55' ' ' GLY . 86.6 tt0 -44.5 -26.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.87 166.28 15.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.105 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.84 133.67 31.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.242 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.39 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.37 80.88 0.37 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 56' ' ' GLU . 3.0 m-20 -52.5 -44.13 65.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -1.144 . . . . 0.0 108.255 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -62.61 -49.26 75.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -60.48 -34.79 74.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 109.049 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -63.03 -53.95 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.46 ' ND1' ' C ' ' A' ' 66' ' ' HIS . 1.6 t-80 -65.6 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.623 -0.673 . . . . 0.0 109.666 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.1 -64.0 1.03 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -71.55 -38.95 70.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 110.138 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 10.1 m-20 -62.69 -59.25 5.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.093 -1.004 . . . . 0.0 110.351 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -36.86 80.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.845 -1.159 . . . . 0.0 109.785 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -66.57 -52.36 46.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.565 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.468 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -43.52 87.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.133 -0.979 . . . . 0.0 108.998 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CE2' ' A' ' 13' ' ' TYR . 4.1 tt -53.47 -43.65 68.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.474 ' CG ' HH21 ' A' ' 96' ' ' ARG . 28.2 mt-30 -65.78 -29.87 70.43 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.68 -0.638 . . . . 0.0 111.258 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -103.49 11.51 36.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.626 -1.296 . . . . 0.0 109.274 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.05 138.83 48.14 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.337 -0.852 . . . . 0.0 111.694 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -88.16 -25.74 22.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 69.7 t -144.99 136.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.9 t -133.14 125.17 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.864 -1.147 . . . . 0.0 111.91 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.19 124.69 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.24 146.54 45.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.072 0.939 . . . . 0.0 111.231 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.414 ' CD ' ' OH ' ' A' ' 28' ' ' TYR . 1.3 pp20? -100.23 147.23 25.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.06 -89.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 109.915 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 64.29 -141.12 0.28 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.063 -1.648 . . . . 0.0 109.748 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 84' ' ' THR . 2.0 pt20 -43.29 148.63 0.62 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.754 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -45.24 128.0 9.45 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.131 1.888 . . . . 0.0 111.615 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.614 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 15.7 t -102.41 -121.1 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.602 ' HB2' ' H ' ' B' ' 287' ' ' SER . 9.9 tp 160.02 -58.66 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.06 58.72 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.5 t -65.4 -45.25 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.48 -35.4 66.25 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.32 -56.09 9.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.46 -1.024 . . . . 0.0 109.675 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.521 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 87.0 mt-10 -57.25 -36.64 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.518 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.41 ' CD2' ' SG ' ' A' ' 106' ' ' CYS . 63.2 mt -60.35 -49.09 78.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.83 65.39 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 74' ' ' GLN . 17.1 mmm180 -71.94 -47.26 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -1.179 . . . . 0.0 110.102 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -70.35 -34.49 72.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.376 -1.453 . . . . 0.0 107.766 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.72 -40.93 78.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.425 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -78.49 -55.87 4.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.682 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 ' CB ' ' HZ2' ' A' ' 102' ' ' LYS . 0.8 OUTLIER -82.44 0.88 40.17 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.242 -0.911 . . . . 0.0 108.606 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . 72.99 -156.93 52.1 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 18.6 mtmm 95.68 132.75 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.191 0 C-N-CA 123.887 0.875 . . . . 0.0 108.768 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.89 112.96 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.05 1.833 . . . . 0.0 111.196 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 102' ' ' LYS . 1.1 mt -112.32 104.46 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.224 -0.922 . . . . 0.0 110.961 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.6 tp -99.89 121.21 40.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.41 ' SG ' ' CD2' ' A' ' 94' ' ' LEU . 75.0 m -109.9 124.72 51.85 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 1.1 mt -121.76 131.19 53.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.508 ' HE2' ' O ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -125.63 153.37 43.87 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 60.7 mtm180 -105.82 145.75 31.51 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.732 -1.23 . . . . 0.0 111.805 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' GLY . 92.7 Cg_endo -83.49 -23.29 3.46 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 123.019 2.48 . . . . 0.0 111.6 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.456 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 18.7 pt20 -45.66 -42.44 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 m -90.38 -14.33 33.22 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . 46.74 45.65 18.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.508 ' O ' ' HE2' ' A' ' 108' ' ' PHE . 32.5 mtp85 -85.32 177.26 7.88 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.998 -1.295 . . . . 0.0 107.588 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 116' ' ' LEU . 87.5 t -114.05 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.8 -1.188 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 115' ' ' VAL . 9.9 tp -41.59 137.41 1.6 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.3 m -46.52 145.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.032 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.25 64.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.584 -0.697 . . . . 0.0 109.69 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.405 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 3.3 tpt -72.23 -52.39 16.65 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 120' ' ' ILE . 39.7 mm -62.26 -43.27 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 108.788 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -59.62 -47.57 85.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.478 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -56.89 -33.32 63.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -59.54 -47.17 86.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.232 . . . . 0.0 107.949 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -20.95 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 123' ' ' ALA . 65.9 m-20 -110.24 -16.54 13.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 108.794 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.84 40.53 97.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.644 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 86.1 p -144.64 63.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.1 mtt-85 95.38 -31.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -102.32 121.83 43.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -145.25 145.3 31.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.049 -1.032 . . . . 0.0 110.426 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.29 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 132' ' ' TRP . 16.0 m0 -97.66 147.76 24.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.522 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 37.8 p-10 -99.44 144.89 28.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.524 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.9 p90 -167.18 178.62 5.53 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.379 -1.328 . . . . 0.0 111.505 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -150.93 155.94 40.16 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 38.6 mt-10 -58.03 27.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.416 -0.802 . . . . 0.0 110.396 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -126.44 -12.63 3.36 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.596 ' O ' ' SD ' ' A' ' 142' ' ' MET . 3.3 pt-20 -145.4 10.04 1.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.145 -1.209 . . . . 0.0 109.554 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 3.7 p -48.98 -43.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 30' ' ' ARG . 93.9 mt-10 -56.1 -33.2 64.88 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 138' ' ' GLU . 15.6 m -65.62 -41.1 93.08 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 108.858 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.673 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -55.07 -50.95 67.85 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 84.7 mt -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 38.5 m-20 -70.37 -43.86 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.262 -0.899 . . . . 0.0 110.806 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.484 ' NH1' ' CG2' ' A' ' 141' ' ' THR . 52.7 mtt85 -70.49 -47.74 59.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.392 . . . . 0.0 108.951 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -60.1 -46.51 89.35 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.662 -0.649 . . . . 0.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.506 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 14.6 m-85 -80.1 -27.84 39.14 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.842 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 60.5 mt-10 -61.98 -29.27 70.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.61 -19.19 64.43 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.785 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -174.65 101.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 111.098 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.538 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 1.0 OUTLIER 170.7 -47.63 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.587 -0.696 . . . . 0.0 109.232 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 69.7 Cg_exo -49.05 -39.6 41.01 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.338 2.025 . . . . 0.0 112.021 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 155' ' ' THR . 48.5 tt0 -67.57 -34.34 76.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 109.245 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 156' ' ' ALA . 46.0 tttp -66.61 2.92 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 153' ' ' GLN . 9.1 t -68.3 34.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 154' ' ' LYS . . . 61.16 39.26 16.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.2 t -72.89 145.9 46.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.341 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 20.5 m -66.62 151.09 48.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.174 -0.954 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -67.01 -13.5 61.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 158' ' ' SER . 93.1 m-70 52.17 68.17 3.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.744 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.31 -24.43 42.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.816 2.344 . . . . 0.0 112.057 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -73.22 155.88 39.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.872 . . . . 0.0 109.566 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.457 -179.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -73.83 162.23 29.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.698 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 59.7 p -63.4 -23.72 67.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.858 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.88 -169.74 40.68 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -60.73 141.17 57.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -90.37 -167.96 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.815 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . -48.48 158.17 0.64 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.843 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' B' ' 208' ' ' ALA . 43.6 Cg_exo -53.0 -155.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 111.817 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.84 177.82 4.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 3.9 m -120.86 131.33 54.35 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.983 -1.073 . . . . 0.0 108.776 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 4.9 t -102.52 126.29 56.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' B' ' 243' ' ' THR . 41.0 t80 -93.22 119.05 31.97 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' B' ' 232' ' ' VAL . 24.3 t80 -85.53 123.47 30.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.532 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.511 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 2.8 t -116.84 113.42 22.47 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.678 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -161.79 75.91 0.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.522 ' C ' ' O ' ' B' ' 216' ' ' GLY . 28.4 t -31.66 106.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.646 -0.914 . . . . 0.0 110.588 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.607 ' H ' ' CD1' ' B' ' 218' ' ' ILE . 0.0 OUTLIER -60.67 -171.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 108.778 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.686 ' H ' ' NH1' ' B' ' 222' ' ' ARG . 59.7 ttt85 51.8 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.97 . . . . 0.0 109.127 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 177.12 -22.87 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.016 -2.033 . . . . 0.0 108.016 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' B' ' 223' ' ' GLU . . . 179.29 -29.86 0.06 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.735 ' NH2' ' H ' ' B' ' 255' ' ' GLY . 33.6 mmt180 73.93 -33.57 0.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 122.16 -0.612 . . . . 0.0 109.764 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' B' ' 221' ' ' GLY . 78.0 tt0 -55.25 -46.08 76.08 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 16.4 m-20 -63.33 -20.49 65.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.794 HE22 ' N ' ' B' ' 247' ' ' ALA . 0.7 OUTLIER -67.32 -46.73 72.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.23 86.43 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.1 -37.14 73.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.559 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 14.4 m-30 -67.5 -41.18 84.91 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.703 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.445 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -61.15 -36.37 79.6 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.43 -1.419 . . . . 0.0 108.52 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 340' ' ' GLU . 71.3 ttt-85 -72.76 -57.4 4.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 108.6 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.89 -40.87 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 51.3 t -64.71 -29.23 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 12.2 m -67.88 -37.01 81.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.38 -0.825 . . . . 0.0 109.493 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.35 -52.29 23.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.719 -1.238 . . . . 0.0 108.757 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 15.8 mt -57.53 -39.94 77.71 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -61.49 -25.39 67.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.78 -31.33 31.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.141 -0.975 . . . . 0.0 109.777 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.558 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -75.01 -52.6 10.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.21 -0.931 . . . . 0.0 110.926 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -147.21 -147.58 4.57 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -89.42 129.08 35.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 108.961 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.54 106.78 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.477 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 20.4 mt -72.88 -176.78 2.14 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.865 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 1.9 m 56.25 39.2 30.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.001 -1.062 . . . . 0.0 108.786 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' B' ' 244' ' ' GLU . 52.6 mp0 -45.99 -25.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.731 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -48.95 -38.1 21.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' B' ' 248' ' ' ASP . 62.0 t -61.23 170.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.794 ' N ' HE22 ' B' ' 225' ' ' GLN . . . 61.74 -71.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' B' ' 246' ' ' VAL . 20.0 t70 -67.59 28.65 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.717 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -106.76 13.46 27.94 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.447 ' H ' HD13 ' B' ' 251' ' ' LEU . 29.0 mt-10 -108.64 10.52 26.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.775 ' CD2' ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -85.59 -94.06 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.106 -0.996 . . . . 0.0 110.256 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' B' ' 254' ' ' LEU . 1.9 mp0 -42.43 158.68 0.21 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.28 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -41.09 -22.11 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.212 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' B' ' 249' ' ' ALA . 1.6 mm? 59.52 -172.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.829 . . . . 0.0 109.933 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.735 ' H ' ' NH2' ' B' ' 222' ' ' ARG . . . 98.51 25.23 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.441 ' OE1' ' OD1' ' B' ' 262' ' ' ASP . 73.5 mm-40 53.73 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.913 -0.757 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.673 ' N ' ' O ' ' B' ' 255' ' ' GLY . 86.8 tt0 -44.59 -25.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -69.6 165.11 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.113 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -50.39 134.02 23.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.351 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.82 -81.6 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 126.26 81.34 0.39 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.441 ' OD1' ' OE1' ' B' ' 256' ' ' GLU . 3.1 m-20 -52.87 -43.99 66.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.63 -49.33 75.61 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -60.52 -35.02 74.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.4 OUTLIER -62.51 -54.07 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.478 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -65.51 -33.78 76.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.577 -0.702 . . . . 0.0 109.64 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -55.79 -64.18 0.94 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 109.551 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -71.62 -38.71 70.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 110.217 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.444 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 10.4 m-20 -62.87 -59.22 5.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 110.296 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.12 -36.86 80.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.118 . . . . 0.0 109.734 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -66.35 -52.53 46.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -0.949 . . . . 0.0 109.638 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.477 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.91 -43.79 86.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.495 ' N ' ' CE2' ' B' ' 213' ' ' TYR . 3.9 tt -53.21 -43.82 67.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.467 ' CG ' HH21 ' B' ' 296' ' ' ARG . 28.9 mt-30 -65.41 -30.15 70.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.683 -0.636 . . . . 0.0 111.136 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.54 11.72 35.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.124 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.87 48.04 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.845 . . . . 0.0 111.514 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -88.45 -25.72 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 69.9 t -144.82 136.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 91.4 t -133.09 125.27 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.89 -1.132 . . . . 0.0 111.914 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.3 124.65 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -120.39 146.04 46.58 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.1 0.953 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -99.8 147.07 25.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.96 -90.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.927 -1.108 . . . . 0.0 109.986 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.36 -140.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 119.902 -1.749 . . . . 0.0 109.776 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.408 ' HA ' ' NE ' ' B' ' 314' ' ' ARG . 2.0 pt20 -43.47 148.56 0.66 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.24 128.12 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.185 1.923 . . . . 0.0 111.622 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.602 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 15.4 t -102.43 -120.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' A' ' 87' ' ' SER . 9.7 tp 159.74 -58.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.51 58.8 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.89 -45.09 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -56.47 -35.5 66.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -68.35 -56.03 9.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.602 -0.94 . . . . 0.0 109.701 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.511 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 82.9 mt-10 -57.21 -36.62 71.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . 0.406 ' CD2' ' SG ' ' B' ' 306' ' ' CYS . 63.4 mt -60.44 -48.96 79.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.67 -23.67 65.42 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' B' ' 274' ' ' GLN . 17.2 mmm180 -71.92 -47.22 54.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -1.158 . . . . 0.0 110.096 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -70.43 -34.43 72.47 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.36 -1.462 . . . . 0.0 107.879 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 1.1 t -57.82 -40.64 76.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.425 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -78.75 -56.37 4.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.594 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.491 ' CB ' ' HZ2' ' B' ' 302' ' ' LYS . 0.8 OUTLIER -82.1 0.65 39.71 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.929 0.871 . . . . 0.0 108.675 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' B' ' 302' ' ' LYS . . . 72.82 -156.81 52.11 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.656 ' HB2' ' O ' ' B' ' 301' ' ' GLY . 18.2 mtmm 95.5 132.6 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 302' ' ' LYS . 87.7 Cg_exo -38.49 113.42 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.941 1.761 . . . . 0.0 111.209 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.504 HG12 ' O ' ' B' ' 302' ' ' LYS . 1.1 mt -112.83 104.62 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.334 -0.854 . . . . 0.0 110.871 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 47.1 tp -100.03 121.48 41.45 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' B' ' 294' ' ' LEU . 73.5 m -110.28 124.42 51.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 1.1 mt -121.31 131.17 54.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.988 -1.07 . . . . 0.0 112.321 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -125.63 153.36 43.9 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 60.9 mtm180 -105.92 145.38 30.79 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.713 -1.242 . . . . 0.0 111.663 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' B' ' 313' ' ' GLY . 94.4 Cg_endo -83.39 -22.83 3.72 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.965 2.443 . . . . 0.0 111.68 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.481 ' NE2' ' CZ ' ' B' ' 309' ' ' ARG . 18.3 pt20 -46.1 -42.45 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 39.7 m -89.96 -14.72 33.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 310' ' ' PRO . . . 46.8 45.62 18.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.501 ' O ' ' HE2' ' B' ' 308' ' ' PHE . 32.5 mtp85 -85.44 177.28 7.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.97 -1.312 . . . . 0.0 107.563 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 316' ' ' LEU . 83.5 t -114.25 107.96 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' B' ' 315' ' ' VAL . 9.7 tp -41.63 137.41 1.62 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 59.1 m -46.57 145.61 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 110.034 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.87 -22.77 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.45 -53.03 13.3 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 109.69 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.41 HG23 HD13 ' B' ' 320' ' ' ILE . 39.7 mm -61.64 -42.86 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.016 -1.052 . . . . 0.0 108.833 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -60.36 -47.56 85.55 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.953 -1.092 . . . . 0.0 108.34 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.453 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -56.85 -33.2 63.04 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -59.75 -47.58 85.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.111 -1.229 . . . . 0.0 107.982 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -20.42 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.962 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' B' ' 323' ' ' ALA . 65.5 m-20 -110.67 -16.41 13.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 108.814 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 64.76 39.85 96.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.7 p -143.89 62.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' B' ' 327' ' ' SER . 93.6 mtt-85 95.72 -31.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -102.4 121.53 42.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -145.08 145.0 31.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.452 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.23 101.46 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' B' ' 332' ' ' TRP . 16.1 m0 -97.84 147.75 24.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 0.0 110.473 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 38.7 p-10 -99.49 144.79 28.18 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.524 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.0 p90 -166.91 178.81 5.6 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.464 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -151.12 156.14 40.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -58.2 27.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.424 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -126.83 -12.13 3.37 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.586 ' O ' ' SD ' ' B' ' 342' ' ' MET . 3.4 pt-20 -145.93 10.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.133 -1.216 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 3.6 p -48.95 -43.42 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 230' ' ' ARG . 93.1 mt-10 -56.33 -33.26 65.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 341' ' ' THR . . . . . 0.488 ' N ' ' O ' ' B' ' 338' ' ' GLU . 14.0 m -65.41 -41.11 93.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.872 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.01 -51.3 66.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 82.4 mt -60.17 -30.77 69.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.849 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 39.1 m-20 -70.6 -43.62 68.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 110.666 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . 0.472 ' NH1' ' CG2' ' B' ' 341' ' ' THR . 53.0 mtt85 -70.8 -47.41 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.411 -1.431 . . . . 0.0 108.955 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -60.18 -46.75 88.64 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.69 -0.631 . . . . 0.0 110.506 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.496 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 14.9 m-85 -79.99 -27.87 39.55 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.84 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 61.5 mt-10 -61.95 -29.1 70.01 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.96 -18.76 64.12 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.787 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -174.94 102.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.53 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 1.0 OUTLIER 170.21 -48.03 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.536 -0.727 . . . . 0.0 109.328 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 75.0 Cg_exo -48.77 -39.83 38.88 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.395 2.064 . . . . 0.0 112.061 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . 0.476 ' C ' ' H ' ' B' ' 355' ' ' THR . 48.2 tt0 -67.52 -34.21 76.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . 0.584 ' C ' ' H ' ' B' ' 356' ' ' ALA . 46.3 tttp -66.39 2.85 1.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 355' ' ' THR . . . . . 0.476 ' H ' ' C ' ' B' ' 353' ' ' GLN . 8.9 t -68.45 34.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' B' ' 354' ' ' LYS . . . 60.84 38.57 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 38.6 t -72.31 146.19 47.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 358' ' ' SER . . . . . 0.483 ' O ' ' CD2' ' B' ' 360' ' ' HIS . 25.8 m -67.09 150.87 48.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.968 . . . . 0.0 109.589 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 64.0 m -66.56 -14.33 62.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.095 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' B' ' 358' ' ' SER . 93.0 m-70 52.67 68.11 3.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.727 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.42 -22.06 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.768 2.312 . . . . 0.0 112.239 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 26.9 t -77.32 153.85 33.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.377 179.702 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.311 0.576 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.5 -19.48 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.608 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.63 146.31 45.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.161 -0.962 . . . . 0.0 109.454 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.5 p -79.61 170.82 15.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -0.899 . . . . 0.0 109.679 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.93 170.72 35.41 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -74.63 152.02 39.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -1.161 . . . . 0.0 109.388 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' OE1' ' A' ' 7' ' ' GLN . 0.8 OUTLIER -63.74 -179.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.571 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.09 153.43 81.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' CYS . 55.3 Cg_endo -72.12 158.69 51.68 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.637 2.225 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' PRO . 32.1 p -52.49 -179.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.132 -0.98 . . . . 0.0 108.734 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HG ' ' H ' ' A' ' 77' ' ' ASP . 10.3 p -112.54 146.36 38.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.096 -1.003 . . . . 0.0 108.522 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 7.8 t -127.38 127.12 68.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CE2' ' OG1' ' A' ' 43' ' ' THR . 29.2 t80 -100.85 144.17 30.13 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -104.27 128.17 52.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 110.279 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 104.34 10.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.95 162.64 22.45 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 87' ' ' SER . 2.5 m -67.39 -55.32 14.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -1.067 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 mt 58.0 -123.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.981 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttp180 52.64 82.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.68 -34.35 5.17 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.67 113.91 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -142.34 -147.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.105 -1.232 . . . . 0.0 110.133 -178.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.07 -39.41 92.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 71.5 m-20 -58.54 -30.21 66.93 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -68.86 -49.06 61.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.03 81.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.3 -34.7 70.84 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.556 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 20.1 m-30 -68.54 -43.88 75.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.56 80.22 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.398 -1.439 . . . . 0.0 108.815 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.641 ' NE ' HH22 ' A' ' 34' ' ' ARG . 61.7 ttt180 -71.58 -59.0 2.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.915 -1.116 . . . . 0.0 108.533 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -51.55 -40.97 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.556 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 68.8 t -66.57 -27.78 41.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 17.4 p -65.53 -41.34 93.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.187 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.641 HH22 ' NE ' ' A' ' 30' ' ' ARG . 73.2 mtt85 -65.57 -41.72 92.59 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 38' ' ' TYR . 86.0 mt -59.59 -42.94 93.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -58.88 -24.49 62.31 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 88.5 mtt-85 -70.18 -62.43 1.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.2 p90 -129.15 154.1 47.06 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 87.45 72.27 1.29 Allowed Glycine 0 N--CA 1.477 1.421 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 39' ' ' GLY . 2.6 ttmt -35.76 126.65 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.052 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -84.18 90.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.552 -1.343 . . . . 0.0 107.964 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -52.42 -57.41 9.95 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.229 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -86.69 91.22 8.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.14 -24.15 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.264 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -65.47 -29.54 70.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.764 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' O ' ' OE1' ' A' ' 25' ' ' GLN . 25.2 t -52.75 -20.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.591 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.614 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -106.64 -65.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.513 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.854 ' O ' ' N ' ' A' ' 50' ' ' GLU . 56.5 m-20 -44.81 -24.22 0.19 Allowed 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 47' ' ' ALA . . . -23.01 -30.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.525 0.678 . . . . 0.0 110.318 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 48' ' ' ASP . 26.9 mt-10 -62.42 -19.55 63.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.94 -1.1 . . . . 0.0 109.352 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -57.85 135.39 56.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.89 -1.131 . . . . 0.0 108.545 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 56.42 152.63 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 109.336 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' A' ' 54' ' ' LEU . 39.5 Cg_endo -69.28 92.47 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.167 1.912 . . . . 0.0 110.836 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.55 ' O ' ' O ' ' A' ' 53' ' ' PRO . 20.6 mt -53.77 -155.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.803 0.811 . . . . 0.0 110.696 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.698 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . 96.54 26.47 10.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 26.1 mt-10 63.18 -23.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.974 -0.721 . . . . 0.0 109.353 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.698 ' H ' ' C ' ' A' ' 55' ' ' GLY . 60.8 tt0 -75.02 -17.73 60.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 108.849 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 60' ' ' GLY . . . -58.88 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.191 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 58' ' ' ALA . . . -36.67 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.631 -0.668 . . . . 0.0 109.612 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 58' ' ' ALA . . . 91.31 -162.72 28.47 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.718 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 92.88 42.54 4.38 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' GLY . 66.5 m-20 -48.08 -45.41 32.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -59.64 -43.49 93.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -61.01 -48.06 83.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.625 -0.672 . . . . 0.0 109.847 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 tt -71.34 -33.88 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 1.008 ' HD1' ' CA ' ' B' ' 319' ' ' MET . 21.8 t60 -78.58 -31.22 47.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 46.1 mm-40 -68.79 -51.93 35.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 108.702 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.17 -39.7 89.96 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.393 -0.817 . . . . 0.0 109.217 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 74.6 m-20 -69.78 -53.22 19.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.37 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tp -68.42 -38.5 81.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.11 -0.994 . . . . 0.0 110.697 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 49.0 t-20 -64.36 -53.13 53.43 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.167 -0.958 . . . . 0.0 109.402 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.555 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -60.23 -41.64 93.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 108.659 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 4.3 tt -52.69 -37.33 58.76 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -74.91 -29.28 60.92 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.751 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.555 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 32.1 mt-30 -92.56 5.14 51.98 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.42 131.13 35.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.317 -0.865 . . . . 0.0 111.722 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' ' HG ' ' A' ' 11' ' ' SER . 81.1 m-20 -74.49 -31.3 62.16 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 61.5 t -139.36 140.11 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.0 128.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.905 -1.122 . . . . 0.0 111.942 -178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.82 123.87 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.75 47.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 109.326 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' OE2' ' CZ ' ' A' ' 134' ' ' TYR . 18.5 tp10 -84.44 114.4 21.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.481 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -119.82 148.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.512 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.57 ' HG1' ' C ' ' A' ' 83' ' ' VAL . 57.8 m -167.44 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -143.69 150.65 51.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 87' ' ' SER . 85.1 Cg_exo -35.6 131.69 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.755 2.303 . . . . 0.0 112.425 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 86' ' ' PRO . 15.6 m -166.87 116.22 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 92' ' ' TYR . 3.1 mt -68.15 -41.18 81.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.988 -1.07 . . . . 0.0 109.647 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.18 70.62 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.05 -49.49 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -1.017 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.96 -39.95 89.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.461 ' CD1' ' CD1' ' B' ' 320' ' ' ILE . 66.4 t80 -61.5 -44.56 96.85 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.234 -1.156 . . . . 0.0 109.434 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.86 -31.72 71.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.403 -0.811 . . . . 0.0 109.194 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.27 -43.56 81.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.75 97.66 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -41.02 90.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -1.062 . . . . 0.0 108.887 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.09 -39.94 75.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.75 -37.77 26.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.25 -50.26 16.69 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.129 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.95 -4.83 18.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.061 -1.025 . . . . 0.0 108.877 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.04 29.02 6.22 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 25.0 mtmm -95.72 152.12 38.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.976 -1.308 . . . . 0.0 107.786 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 90.8 Cg_exo -34.21 118.67 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.148 1.899 . . . . 0.0 111.775 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -119.63 104.88 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 0.0 110.98 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.69 115.64 29.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.618 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -107.69 139.58 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 83' ' ' VAL . 11.7 mt -123.84 144.73 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.105 -0.997 . . . . 0.0 112.046 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.644 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.88 140.24 29.66 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 27.8 mtt180 -97.39 140.54 22.08 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.592 -1.318 . . . . 0.0 111.518 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.6 Cg_endo -78.29 -34.14 1.67 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 122.652 2.235 . . . . 0.0 110.789 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.473 ' CG ' ' N ' ' A' ' 112' ' ' SER . 18.2 pt20 -47.83 -38.96 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 113' ' ' GLY . 8.1 p -90.95 -21.04 21.53 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 37.91 39.38 0.64 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' VAL . 45.7 mtt-85 -74.79 13.73 0.6 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.389 -1.065 . . . . 0.0 109.711 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' B' ' 219' ' ' ARG . 56.0 t 49.43 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.313 -0.867 . . . . 0.0 110.066 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 117' ' ' SER . 36.1 tp -48.28 143.55 4.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -40.42 141.62 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 111.053 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.465 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -54.98 -55.03 35.38 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.44 0.638 . . . . 0.0 110.854 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 1.028 ' CA ' ' HD1' ' B' ' 266' ' ' HIS . 14.8 mtp -60.37 -39.78 88.45 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.18 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' B' ' 292' ' ' TYR . 45.2 mm -62.67 -41.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.712 -1.242 . . . . 0.0 109.59 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -72.86 -45.69 56.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 109.969 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.22 -18.98 65.73 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 -57.54 8.96 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.039 -1.271 . . . . 0.0 109.616 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.616 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -153.69 -89.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.687 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 22.9 t0 94.26 -0.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . 177.4 82.59 0.06 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.827 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 165.44 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.445 -1.033 . . . . 0.0 109.79 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.38 -25.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.827 ' H ' ' C ' ' A' ' 127' ' ' SER . 8.9 t80 -116.95 115.5 25.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.53 132.71 41.26 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.175 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.04 102.75 13.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.29 145.22 26.31 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.169 -0.957 . . . . 0.0 110.378 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' SD ' ' A' ' 142' ' ' MET . 63.7 m-20 -96.54 152.21 18.85 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CZ ' ' OE2' ' A' ' 82' ' ' GLU . 5.5 p90 -170.35 173.86 5.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.606 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -147.79 150.95 35.18 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.5 mt-10 -40.5 -27.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.826 -1.171 . . . . 0.0 110.316 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -85.79 -4.75 84.72 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 120.976 -1.077 . . . . 0.0 111.2 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -135.36 4.37 3.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.784 -1.421 . . . . 0.0 110.112 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.0 p -57.82 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.979 -1.076 . . . . 0.0 108.759 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.524 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.9 pt-20 -55.01 -33.65 62.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 m -66.13 -39.45 89.89 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.069 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 14.3 mmt -55.06 -53.19 59.04 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 30.6 mt -63.34 -31.59 72.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.549 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 28.7 t0 -69.05 -46.05 68.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 111.001 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -70.64 -50.36 37.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.404 -1.435 . . . . 0.0 109.818 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 29.4 t80 -57.12 -50.07 73.94 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 151' ' ' LEU . 27.0 m-85 -75.79 -30.83 59.23 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.586 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 5.5 mm-40 -55.12 -35.3 64.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.98 18.72 3.38 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 147' ' ' PHE . 2.0 t80 -147.27 -34.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 111.723 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.607 HD13 ' CD1' ' A' ' 147' ' ' PHE . 18.4 mt -117.87 40.99 0.34 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 61.3 Cg_endo -74.13 -32.84 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.922 1.748 . . . . 0.0 111.169 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.27 -26.93 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -58.31 -33.61 69.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.24 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 47.3 m -57.5 -37.59 73.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.93 139.79 30.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.441 ' O ' ' OG ' ' A' ' 158' ' ' SER . 95.9 p -148.49 162.91 38.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.856 . . . . 0.0 109.414 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 157' ' ' SER . 18.9 p 55.2 50.3 15.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.402 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 160' ' ' HIS . 96.8 p -61.62 -34.72 76.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 159' ' ' SER . 1.0 OUTLIER 56.22 150.68 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.521 -0.737 . . . . 0.0 109.705 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.43 148.37 79.12 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.547 2.164 . . . . 0.0 112.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.9 m -58.74 -31.08 67.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.487 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 55.9 mtt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.06 -18.46 65.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -61.31 145.82 50.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 84.4 p -79.29 169.46 18.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -157.46 170.11 34.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -73.89 151.65 40.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -1.207 . . . . 0.0 109.382 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' B' ' 207' ' ' GLN . 0.8 OUTLIER -63.48 -179.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.421 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.97 153.66 81.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.337 -0.852 . . . . 0.0 109.268 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 210' ' ' CYS . 55.3 Cg_endo -72.3 159.13 50.28 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.595 2.197 . . . . 0.0 111.786 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' B' ' 209' ' ' PRO . 31.0 p -52.77 -179.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.09 -1.007 . . . . 0.0 108.766 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' B' ' 277' ' ' ASP . 10.1 p -112.71 146.26 39.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 7.2 t -127.35 127.41 69.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.472 ' CE2' ' OG1' ' B' ' 243' ' ' THR . 29.7 t80 -101.04 144.32 30.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -104.57 127.8 52.39 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 110.392 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 104.78 11.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.5 22.44 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.441 ' OG ' ' OG ' ' B' ' 287' ' ' SER . 2.7 m -66.83 -55.98 12.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 109.205 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 mt 58.62 -123.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.473 -0.767 . . . . 0.0 109.883 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 13.5 ttp180 52.59 82.22 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.261 -0.899 . . . . 0.0 109.172 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 112.97 -34.12 5.25 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 71.63 113.76 0.05 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.615 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER -142.63 -147.81 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.176 -1.19 . . . . 0.0 110.169 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.14 -39.66 93.33 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 70.8 m-20 -58.29 -30.07 66.34 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.563 ' NE2' ' O ' ' B' ' 247' ' ' ALA . 0.0 OUTLIER -69.13 -48.7 61.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.08 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.95 81.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.8 tp -58.76 -34.35 71.32 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.552 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 20.3 m-30 -68.61 -43.96 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.55 80.14 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.519 -1.363 . . . . 0.0 108.823 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.633 ' NE ' HH22 ' B' ' 234' ' ' ARG . 57.8 ttt180 -71.5 -58.94 3.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.806 -1.183 . . . . 0.0 108.505 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.46 -41.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 70.8 t -66.33 -28.07 42.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 14.5 p -65.44 -41.17 93.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . 0.633 HH22 ' NE ' ' B' ' 230' ' ' ARG . 73.5 mtt85 -65.61 -41.67 92.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.585 ' O ' ' O ' ' B' ' 238' ' ' TYR . 84.9 mt -59.92 -42.86 94.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -58.7 -24.58 61.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' B' ' 234' ' ' ARG . 87.6 mtt-85 -70.26 -62.94 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.1 p90 -128.49 154.49 46.05 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 86.98 72.39 1.29 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' B' ' 239' ' ' GLY . 2.7 ttmt -35.75 126.53 0.68 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.575 -0.956 . . . . 0.0 109.112 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.99 90.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.543 -1.348 . . . . 0.0 108.088 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.22 -57.43 9.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.223 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.472 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 0.2 OUTLIER -86.85 91.37 8.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.742 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.2 -24.47 51.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -65.23 -29.64 70.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.464 ' O ' ' OE1' ' B' ' 225' ' ' GLN . 25.3 t -52.65 -20.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.579 ' C ' ' N ' ' B' ' 249' ' ' ALA . . . -106.56 -65.28 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.858 ' O ' ' N ' ' B' ' 250' ' ' GLU . 55.8 m-20 -44.98 -24.13 0.2 Allowed 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.579 ' N ' ' C ' ' B' ' 247' ' ' ALA . . . -23.18 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.858 ' N ' ' O ' ' B' ' 248' ' ' ASP . 27.0 mt-10 -63.08 -19.31 64.29 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.901 -1.124 . . . . 0.0 109.35 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -57.78 135.33 56.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.961 -1.087 . . . . 0.0 108.58 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 0.8 OUTLIER 56.38 152.37 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' B' ' 254' ' ' LEU . 39.1 Cg_endo -69.08 92.43 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.194 1.929 . . . . 0.0 110.895 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' B' ' 253' ' ' PRO . 20.1 mt -53.99 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.848 0.833 . . . . 0.0 110.69 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' B' ' 257' ' ' GLU . . . 96.25 26.94 10.5 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.465 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 26.9 mt-10 62.99 -23.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.931 -0.747 . . . . 0.0 109.401 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.696 ' H ' ' C ' ' B' ' 255' ' ' GLY . 61.0 tt0 -74.5 -17.66 60.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 108.928 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' B' ' 260' ' ' GLY . . . -58.7 -161.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.417 -0.802 . . . . 0.0 109.356 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 258' ' ' ALA . . . -36.68 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.431 0.634 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' B' ' 258' ' ' ALA . . . 91.48 -162.81 28.3 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 120.16 -1.019 . . . . 0.0 110.737 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' B' ' 264' ' ' PHE . . . 93.37 42.44 4.26 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 261' ' ' GLY . 68.4 m-20 -47.98 -45.29 31.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.85 -43.58 94.56 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' B' ' 261' ' ' GLY . 0.7 OUTLIER -60.87 -48.35 82.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.541 -0.724 . . . . 0.0 109.937 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 3.8 tt -71.23 -33.59 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.475 -0.765 . . . . 0.0 109.996 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 1.028 ' HD1' ' CA ' ' A' ' 119' ' ' MET . 22.5 t60 -78.65 -31.14 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 46.0 mm-40 -68.78 -52.71 27.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 108.63 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -65.3 -40.24 93.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.117 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.459 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 67.1 m-20 -69.12 -53.65 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.83 . . . . 0.0 110.564 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.2 tp -68.46 -38.39 81.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.029 -1.044 . . . . 0.0 110.644 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 50.6 t-20 -64.14 -53.49 48.66 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.353 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -59.92 -41.77 92.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 108.642 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.438 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 4.1 tt -52.78 -36.92 58.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -75.39 -28.99 59.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.726 . . . . 0.0 109.769 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.561 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 32.4 mt-30 -92.45 4.76 52.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.971 -1.08 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.26 131.49 35.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.458 -0.776 . . . . 0.0 111.829 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.459 ' H ' ' HG ' ' B' ' 211' ' ' SER . 83.2 m-20 -74.91 -31.48 61.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 61.8 t -139.27 140.25 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.0 129.6 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.939 -1.1 . . . . 0.0 111.995 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.27 123.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.16 46.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.539 ' OE2' ' CZ ' ' B' ' 334' ' ' TYR . 18.4 tp10 -83.81 114.21 21.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.605 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -119.34 149.02 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 0.0 109.562 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.576 ' HG1' ' C ' ' B' ' 283' ' ' VAL . 57.6 m -167.7 -31.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.45 150.59 51.83 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.442 ' O ' ' OG ' ' B' ' 287' ' ' SER . 92.8 Cg_exo -35.62 131.12 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.718 2.279 . . . . 0.0 112.514 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 286' ' ' PRO . 15.4 m -166.29 116.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.11 -0.994 . . . . 0.0 109.622 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' B' ' 292' ' ' TYR . 3.5 mt -68.27 -41.23 81.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.102 -0.999 . . . . 0.0 109.568 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.73 -36.32 71.52 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.83 -49.75 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -1.016 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 88' ' ' LEU . . . -67.67 -40.29 90.3 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.472 ' CD1' ' CD1' ' A' ' 120' ' ' ILE . 67.0 t80 -60.97 -44.67 97.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.233 -1.157 . . . . 0.0 109.419 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.67 -32.04 72.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 20.0 mt -67.17 -43.43 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.64 -39.74 97.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -40.87 90.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.267 -1.137 . . . . 0.0 108.739 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.25 -39.83 74.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.409 ' CG2' ' OH ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -52.96 -37.71 26.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -75.23 -50.3 16.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.57 -5.05 17.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.126 -0.984 . . . . 0.0 108.848 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 48.07 29.01 6.27 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.46 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 25.3 mtmm -95.75 152.29 38.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.953 -1.322 . . . . 0.0 107.748 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' B' ' 302' ' ' LYS . 84.0 Cg_exo -34.08 119.01 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.24 1.96 . . . . 0.0 111.788 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.5 mt -120.07 105.01 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.359 -0.838 . . . . 0.0 111.032 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 60.5 tp -99.85 115.94 30.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -107.8 139.7 42.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.067 -1.021 . . . . 0.0 108.251 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' B' ' 283' ' ' VAL . 11.8 mt -124.0 144.67 49.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.028 -1.045 . . . . 0.0 112.093 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.651 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -143.94 140.14 29.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.48 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 27.7 mtt180 -97.35 140.28 21.94 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 111.557 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.04 -33.66 2.0 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.607 2.205 . . . . 0.0 110.796 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' B' ' 312' ' ' SER . 18.2 pt20 -48.33 -38.96 20.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.481 ' O ' ' C ' ' B' ' 313' ' ' GLY . 7.5 p -91.31 -20.31 22.02 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 37.17 39.62 0.48 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' B' ' 315' ' ' VAL . 45.5 mtt-85 -74.78 13.72 0.6 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.311 -1.111 . . . . 0.0 109.724 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 55.3 t 49.58 100.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 110.119 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' B' ' 317' ' ' SER . 36.6 tp -48.34 143.85 4.42 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.53 141.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.02 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . 0.464 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -54.87 -55.12 33.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.693 -0.63 . . . . 0.0 110.79 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 1.008 ' CA ' ' HD1' ' A' ' 66' ' ' HIS . 14.2 mtp -60.13 -40.22 89.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.029 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 45.1 mm -62.53 -41.86 93.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.82 -1.175 . . . . 0.0 109.477 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . 0.516 ' NH2' ' OD2' ' B' ' 325' ' ' ASP . 0.9 OUTLIER -72.77 -45.91 56.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 109.893 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -65.36 -18.78 65.79 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -51.32 -57.6 8.45 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.124 -1.221 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.625 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -153.96 -89.03 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.85 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 23.2 t0 94.12 -0.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . 177.76 82.5 0.06 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.824 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.0 OUTLIER 165.81 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.433 -1.039 . . . . 0.0 109.811 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.42 -25.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.824 ' H ' ' C ' ' B' ' 327' ' ' SER . 9.0 t80 -117.25 115.67 25.75 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.67 132.98 41.33 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.173 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 73.0 t -92.41 102.55 13.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.09 145.15 26.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.08 -1.012 . . . . 0.0 110.441 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.487 ' O ' ' SD ' ' B' ' 342' ' ' MET . 65.7 m-20 -96.41 152.11 18.91 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.539 ' CZ ' ' OE2' ' B' ' 282' ' ' GLU . 5.6 p90 -170.28 174.08 5.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.51 -1.368 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -148.09 150.9 34.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.0 mt-10 -40.43 -27.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.0 110.308 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -85.5 -5.27 84.93 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.015 -1.053 . . . . 0.0 111.226 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -135.43 4.62 3.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.92 -1.341 . . . . 0.0 110.082 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.1 p -57.97 -48.64 83.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.888 -1.132 . . . . 0.0 108.763 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 24.0 pt-20 -55.23 -33.78 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.0 m -65.77 -39.75 91.35 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 14.0 mmt -54.88 -53.96 48.65 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 32.1 mt -62.39 -31.66 72.36 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.891 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 30.0 t0 -68.95 -46.09 69.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.18 -0.95 . . . . 0.0 111.063 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -70.93 -50.61 32.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.473 -1.392 . . . . 0.0 109.759 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' B' ' 346' ' ' TYR . 29.6 t80 -56.58 -50.1 72.93 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.436 -0.79 . . . . 0.0 109.994 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' B' ' 351' ' ' LEU . 25.2 m-85 -75.85 -30.76 59.04 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.561 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 5.3 mm-40 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -87.41 19.56 3.23 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' B' ' 347' ' ' PHE . 2.0 t80 -148.0 -34.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.571 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' B' ' 347' ' ' PHE . 18.7 mt -117.72 40.77 0.33 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.864 -1.147 . . . . 0.0 111.277 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 63.9 Cg_endo -74.26 -32.79 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.963 1.775 . . . . 0.0 111.164 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -129.24 -26.38 2.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -58.85 -33.72 70.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.188 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 47.5 m -57.59 -37.45 73.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -95.18 139.36 31.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 357' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' B' ' 358' ' ' SER . 95.4 p -147.94 162.42 39.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.38 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 358' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 357' ' ' SER . 17.9 p 55.55 50.59 14.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 359' ' ' SER . . . . . 0.524 ' O ' ' O ' ' B' ' 360' ' ' HIS . 88.6 p -61.94 -34.46 76.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' B' ' 359' ' ' SER . 0.9 OUTLIER 56.25 150.57 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.666 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 147.9 77.83 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.553 2.168 . . . . 0.0 112.074 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 15.1 m -59.54 -32.38 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.377 179.875 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' C ' ' H ' ' A' ' 3' ' ' ALA . 56.7 mtt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.64 10.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 1' ' ' MET . . . -59.67 -24.9 64.29 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.379 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p -56.53 -18.6 12.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.11 -158.26 32.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.65 144.89 2.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.383 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -90.76 -172.37 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.94 80.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.395 -0.815 . . . . 0.0 109.415 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.99 155.51 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.059 1.84 . . . . 0.0 111.344 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.3 p -58.84 175.66 0.25 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.024 -1.047 . . . . 0.0 108.583 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 m -119.0 153.05 35.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.315 -0.866 . . . . 0.0 109.525 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -123.84 126.74 73.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.588 ' CE2' ' OG1' ' A' ' 43' ' ' THR . 37.1 t80 -88.83 129.66 35.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 14' ' ' PHE . 16.4 t80 -97.15 131.91 43.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.613 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.588 ' HG ' ' CB ' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -142.14 100.61 3.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.383 -0.823 . . . . 0.0 109.332 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.31 -176.18 14.33 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.533 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 4.5 m -87.53 120.27 28.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -1.125 . . . . 0.0 110.186 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' NE ' ' A' ' 22' ' ' ARG . 3.6 mt -110.2 -108.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 0.2 OUTLIER 75.0 -10.34 1.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.14 -0.975 . . . . 0.0 110.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 173.66 177.47 42.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' GLN . . . -48.08 -86.34 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.556 ' NE ' ' O ' ' A' ' 18' ' ' ILE . 72.0 mtt-85 72.12 142.39 0.06 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.726 1.251 . . . . 0.0 112.605 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.29 -17.4 28.66 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 40.9 m-20 -63.7 -38.93 92.98 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.601 HE22 ' N ' ' A' ' 47' ' ' ALA . 20.1 mm100 -68.22 -42.74 79.35 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.89 -51.43 69.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.084 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 -35.42 75.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 19.3 m-30 -68.89 -42.12 77.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -38.19 90.2 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 108.951 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.461 ' O ' ' OG ' ' A' ' 33' ' ' SER . 44.2 ttt180 -71.41 -55.51 7.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.754 -1.217 . . . . 0.0 108.292 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.68 -44.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 55.7 t -63.5 -27.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.716 ' HG ' HH12 ' A' ' 37' ' ' ARG . 21.5 p -67.4 -39.53 85.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.621 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' NE ' ' CD ' ' A' ' 140' ' ' GLU . 84.8 mtt-85 -69.15 -47.38 65.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.833 -1.167 . . . . 0.0 108.757 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 38' ' ' TYR . 4.7 mt -62.25 -33.86 75.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -64.91 -28.38 69.5 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.716 HH12 ' HG ' ' A' ' 33' ' ' SER . 80.7 mtt85 -71.28 -59.88 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.4 p90 -121.57 151.36 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.89 77.84 1.12 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 39' ' ' GLY . 43.2 mtmt -40.9 118.64 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.451 -1.029 . . . . 0.0 108.57 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.9 t -82.4 128.04 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 110.118 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.2 mt -105.86 172.43 6.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.588 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 32.4 m 51.81 47.28 25.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 108.887 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' HIS . 75.3 tt0 -50.05 -21.17 1.15 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.635 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -38.42 -47.49 1.26 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.374 -0.829 . . . . 0.0 110.157 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.707 ' O ' ' N ' ' A' ' 48' ' ' ASP . 3.4 p -57.47 162.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.941 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.739 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 60.85 -58.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.055 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -62.2 16.73 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.739 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -82.07 -39.56 23.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.15 -0.969 . . . . 0.0 108.475 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 58.3 mt-10 -45.92 -15.39 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.246 -0.909 . . . . 0.0 108.656 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 49' ' ' ALA . 3.0 mp -54.64 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 110.042 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -155.55 -44.77 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.661 -0.649 . . . . 0.0 109.991 -178.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.644 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -84.06 80.37 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.916 2.411 . . . . 0.0 110.526 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 54' ' ' LEU . 5.1 mp -95.52 157.42 15.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.323 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 42.96 -167.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' C ' ' N ' ' A' ' 58' ' ' ALA . 43.5 mp0 -72.83 -30.86 64.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.579 -0.953 . . . . 0.0 109.696 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' GLU . 72.9 tt0 -47.53 -20.8 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -56.69 91.24 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.48 -3.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.933 . . . . 0.0 109.858 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -49.05 -46.12 33.16 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.65 79.36 0.03 OUTLIER Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -48.23 -46.96 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -60.16 -44.51 94.96 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -61.43 -47.02 87.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 109.143 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.465 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.7 OUTLIER -54.32 -39.66 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.645 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 2.2 t-80 -75.14 -48.46 23.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.84 -57.44 9.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 110.022 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -63.13 -40.36 97.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 109.354 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 65.2 m-20 -60.5 -40.77 92.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.932 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.645 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -74.66 -39.02 62.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.635 -1.291 . . . . 0.0 109.84 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -56.3 -45.77 80.1 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -70.49 -40.13 73.78 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.5 tp -58.32 -33.34 69.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -80.29 -28.07 38.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.558 -0.714 . . . . 0.0 110.34 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.6 5.9 47.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.07 . . . . 0.0 108.989 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.27 132.74 46.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 111.756 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -85.22 -30.96 23.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 22.3 t -143.32 138.18 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' HA ' ' H ' ' A' ' 13' ' ' TYR . 99.5 t -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.219 -0.925 . . . . 0.0 111.641 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.15 114.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.588 ' CB ' ' HG ' ' A' ' 15' ' ' CYS . . . -115.17 131.83 56.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.149 -0.969 . . . . 0.0 110.386 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -91.16 114.72 27.32 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.8 t -85.97 -99.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.947 -1.095 . . . . 0.0 109.977 -178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.1 m 64.66 -122.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.674 -1.266 . . . . 0.0 109.047 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -48.72 147.3 4.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.064 -1.023 . . . . 0.0 109.128 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.46 124.38 11.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.362 2.041 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.6 t -140.61 130.18 24.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.37 -41.39 73.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.55 97.38 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.9 -47.19 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.356 -1.085 . . . . 0.0 109.078 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.87 -46.8 93.48 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 19.9 t80 -62.28 -45.05 94.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.748 -0.854 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -60.79 -33.54 73.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.221 -0.925 . . . . 0.0 109.098 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.42 -41.56 63.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.31 -48.7 62.11 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -59.24 -42.42 91.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.31 -1.112 . . . . 0.0 108.871 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.72 -39.48 88.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.048 . . . . 0.0 108.905 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -51.72 -40.8 27.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.468 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -71.85 -47.74 50.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.896 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 102' ' ' LYS . 2.8 pp -124.7 -33.19 3.0 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.932 -1.105 . . . . 0.0 111.298 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' C ' ' A' ' 102' ' ' LYS . . . -74.25 10.51 7.88 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 7.85 -74.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.342 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' GLY . 30.9 Cg_endo -65.33 108.43 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.349 1.16 . . . . 0.0 111.261 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 mt -134.55 150.16 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.132 0.968 . . . . 0.0 111.486 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.411 HD11 ' CD2' ' A' ' 132' ' ' TRP . 47.9 tp -128.02 113.74 16.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.765 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -114.17 150.79 33.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.815 -1.178 . . . . 0.0 109.19 -179.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 2.9 mp -132.46 137.08 47.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 0.0 111.585 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -128.81 140.01 51.9 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -88.93 133.05 36.33 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.001 -1.062 . . . . 0.0 110.992 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 113' ' ' GLY . 87.8 Cg_endo -78.76 -38.81 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.537 2.158 . . . . 0.0 111.277 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.27 -31.52 6.04 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 113' ' ' GLY . 22.0 p -95.23 -20.55 19.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 38.42 42.49 1.33 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.411 HH11 ' HB2' ' A' ' 112' ' ' SER . 1.7 mtt85 -67.48 7.19 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.376 -1.073 . . . . 0.0 109.494 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 113' ' ' GLY . 77.3 t 57.57 99.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.448 -0.783 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.4 tp -54.76 151.12 8.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.439 ' HG ' ' CG1' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -58.05 142.07 47.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.116 -0.99 . . . . 0.0 110.9 -178.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.68 82.4 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 41.8 mmm -62.25 -45.7 92.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.724 0.773 . . . . 0.0 109.361 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' ALA . 28.0 mm -61.1 -43.19 95.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.122 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' GLY . 0.3 OUTLIER -55.61 -45.46 77.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.587 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -51.05 -40.07 42.74 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 103.973 -3.651 . . . . 0.0 103.973 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.612 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -76.07 89.56 3.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.14 40.42 0.07 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.918 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 127' ' ' SER . 97.7 m-20 -54.7 -20.08 7.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 110.059 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 68.8 -14.62 0.74 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 125' ' ' ASP . 22.5 t -102.49 -74.62 0.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.236 . . . . 0.0 108.805 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.77 -49.15 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.765 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 4.5 t80 -103.55 129.05 50.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.713 HE21 ' HE1' ' A' ' 132' ' ' TRP . 2.6 mt-30 -140.47 135.65 32.19 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.581 -1.324 . . . . 0.0 111.895 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.2 112.19 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.713 ' HE1' HE21 ' A' ' 130' ' ' GLN . 14.2 m0 -108.09 138.76 43.81 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.979 -1.076 . . . . 0.0 109.946 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' SD ' ' A' ' 142' ' ' MET . 80.9 m-20 -90.04 155.37 19.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.6 -1.313 . . . . 0.0 107.771 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.8 p90 -172.15 -177.28 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.697 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -150.89 148.33 28.3 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' ALA . 62.3 mt-10 -41.7 -34.62 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.745 -1.222 . . . . 0.0 110.438 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.81 6.18 75.49 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.885 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -137.89 -3.61 1.81 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.961 -1.317 . . . . 0.0 109.795 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.2 p -55.7 -46.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 54.5 mt-10 -52.64 -34.56 52.0 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -70.07 -38.78 75.84 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.375 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 13.0 mmt -53.5 -53.38 52.29 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 79.0 mt -60.69 -39.11 87.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.029 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.53 -45.22 93.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 110.941 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -68.64 -51.55 41.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.545 -1.347 . . . . 0.0 108.873 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.45 -45.27 80.9 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.611 -0.68 . . . . 0.0 109.971 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 15.5 m-85 -73.4 -33.15 64.84 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -58.09 -29.9 65.82 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.18 26.86 4.45 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.99 -82.4 0.21 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.693 -1.203 . . . . 0.0 113.472 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 153' ' ' GLN . 4.8 mt -55.11 -59.21 11.49 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.131 -0.98 . . . . 0.0 112.195 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 2.6 Cg_endo -41.1 -17.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 0.0 111.878 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 151' ' ' LEU . 6.8 tt0 -87.42 -61.76 1.65 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -4.83 14.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 19.1 m -49.31 -37.16 23.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -168.95 44.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 51.1 m -67.72 -33.2 74.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.2 p -68.91 162.91 25.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.428 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.5 t -88.85 152.08 21.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 160' ' ' HIS . 11.8 p80 -128.55 76.07 78.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 109.244 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 162' ' ' SER . 53.2 Cg_exo -49.59 -17.87 2.16 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.855 2.37 . . . . 0.0 112.33 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 161' ' ' PRO . 69.1 m 49.68 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.484 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . 0.51 ' C ' ' H ' ' B' ' 203' ' ' ALA . 55.7 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 50.13 10.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' B' ' 201' ' ' MET . . . -59.62 -24.84 64.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.331 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 97.3 p -56.82 -18.39 12.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.3 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.29 -158.77 33.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.69 144.69 3.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -1.15 . . . . 0.0 109.385 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.14 -172.05 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.41 153.31 79.02 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.547 -0.721 . . . . 0.0 109.328 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -56.41 155.89 23.68 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.986 1.791 . . . . 0.0 111.279 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 18.6 p -58.92 175.55 0.27 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.047 -1.033 . . . . 0.0 108.506 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 14.6 m -119.09 153.18 35.2 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.41 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 0.0 OUTLIER -123.92 126.97 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.579 ' CE2' ' OG1' ' B' ' 243' ' ' THR . 36.4 t80 -89.04 129.42 35.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' B' ' 214' ' ' PHE . 15.9 t80 -96.99 132.34 42.89 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.593 ' HG ' ' CB ' ' B' ' 281' ' ' ALA . 0.2 OUTLIER -142.57 101.15 3.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -0.807 . . . . 0.0 109.234 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.62 -176.39 14.41 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.515 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 4.4 m -87.19 120.62 28.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 110.108 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.559 ' O ' ' NE ' ' B' ' 222' ' ' ARG . 3.9 mt -110.63 -108.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER 74.97 -10.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 221' ' ' GLY . . . 173.43 177.37 42.61 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' B' ' 225' ' ' GLN . . . -47.89 -86.2 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' B' ' 218' ' ' ILE . 73.7 mtt-85 71.96 142.17 0.06 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.692 1.234 . . . . 0.0 112.734 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.18 -17.34 26.6 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 44.2 m-20 -64.0 -38.9 92.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.611 HE22 ' N ' ' B' ' 247' ' ' ALA . 20.3 mm100 -68.13 -42.94 79.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.73 -51.28 70.46 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.989 -1.084 . . . . 0.0 108.173 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.52 -35.98 77.28 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' B' ' 224' ' ' ASP . 19.5 m-30 -68.29 -42.74 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.536 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.25 90.32 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.846 -1.159 . . . . 0.0 109.091 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.472 ' O ' ' OG ' ' B' ' 233' ' ' SER . 43.8 ttt180 -71.38 -55.41 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.877 -1.14 . . . . 0.0 108.249 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 45.6 mt -53.74 -44.64 59.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 55.9 t -63.35 -28.18 44.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.719 ' HG ' HH12 ' B' ' 237' ' ' ARG . 23.9 p -67.21 -39.52 86.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . 0.498 ' NE ' ' CD ' ' B' ' 340' ' ' GLU . 85.4 mtt-85 -69.31 -47.33 64.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.912 -1.117 . . . . 0.0 108.815 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 238' ' ' TYR . 4.7 mt -62.26 -33.72 75.16 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -65.1 -28.55 69.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . 0.719 HH12 ' HG ' ' B' ' 233' ' ' SER . 80.6 mtt85 -71.19 -59.87 2.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.4 p90 -121.42 151.7 39.89 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 83.33 77.92 1.09 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' B' ' 239' ' ' GLY . 42.9 mtmt -40.87 118.71 1.02 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.385 -1.068 . . . . 0.0 108.657 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 30.3 t -82.35 127.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.192 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.422 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 17.1 mt -105.52 172.45 6.79 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.579 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 35.7 m 51.69 48.01 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 108.881 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 245' ' ' HIS . 75.1 tt0 -50.77 -20.83 1.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' B' ' 244' ' ' GLU . 0.1 OUTLIER -38.48 -47.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.255 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.697 ' O ' ' N ' ' B' ' 248' ' ' ASP . 3.4 p -57.58 163.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 108.976 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.724 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 60.42 -58.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.473 -0.767 . . . . 0.0 109.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' B' ' 246' ' ' VAL . 0.1 OUTLIER -62.15 16.76 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.724 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -81.91 -39.31 23.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 108.594 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -46.45 -14.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.61 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' B' ' 249' ' ' ALA . 2.9 mp -55.26 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.637 ' H ' ' CD ' ' B' ' 253' ' ' PRO . 1.0 OUTLIER -155.47 -44.81 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.62 -0.675 . . . . 0.0 109.886 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.637 ' CD ' ' H ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -84.06 80.52 2.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.994 2.462 . . . . 0.0 110.668 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' B' ' 254' ' ' LEU . 5.0 mp -95.84 157.62 15.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.345 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 43.11 -167.76 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.484 ' C ' ' N ' ' B' ' 258' ' ' ALA . 41.2 mp0 -73.08 -30.29 63.58 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.523 -0.986 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' B' ' 256' ' ' GLU . 71.2 tt0 -48.21 -20.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -57.22 91.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -55.54 -4.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -48.39 -46.57 28.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 152.7 79.51 0.03 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -48.24 -46.96 36.14 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -60.2 -44.4 95.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.58 -47.01 87.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.472 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.7 OUTLIER -54.24 -39.92 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.645 ' CE1' ' HG ' ' B' ' 270' ' ' LEU . 2.2 t-80 -74.72 -48.43 25.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.07 -57.38 9.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.962 . . . . 0.0 110.091 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.08 -40.28 97.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.5 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 62.0 m-20 -60.76 -40.68 93.4 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.645 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -74.82 -39.28 61.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.599 -1.313 . . . . 0.0 109.79 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -56.01 -45.69 79.01 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.971 -1.081 . . . . 0.0 108.15 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.422 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -70.43 -40.62 73.69 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.463 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.3 tp -58.06 -33.03 68.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 108.471 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.49 -28.15 37.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.47 6.11 47.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.992 -1.068 . . . . 0.0 108.949 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.74 132.88 46.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.33 -0.856 . . . . 0.0 111.765 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -85.36 -31.01 23.2 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 24.4 t -143.1 138.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . 0.426 ' HA ' ' H ' ' B' ' 213' ' ' TYR . 99.0 t -120.95 148.17 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.134 -0.979 . . . . 0.0 111.614 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.24 114.68 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.384 0.612 . . . . 0.0 109.388 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . 0.593 ' CB ' ' HG ' ' B' ' 215' ' ' CYS . . . -115.74 131.54 56.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.49 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.402 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 71.7 tt0 -90.95 114.63 27.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.431 ' HB ' ' H ' ' B' ' 284' ' ' THR . 1.7 t -85.55 -98.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.965 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.431 ' H ' ' HB ' ' B' ' 283' ' ' VAL . 5.0 m 64.26 -122.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.549 -1.345 . . . . 0.0 109.111 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -49.69 147.23 6.43 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.042 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.24 124.73 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.395 2.064 . . . . 0.0 111.785 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 28.9 t -141.28 130.37 23.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.143 -0.973 . . . . 0.0 109.383 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.59 -41.74 71.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.51 -40.7 96.58 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 19.5 t -69.93 -47.39 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -1.082 . . . . 0.0 109.169 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.72 93.59 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 18.2 t80 -62.47 -44.85 95.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.958 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.6 -33.54 72.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.04 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 76.7 mt -73.77 -41.01 63.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.69 -48.67 60.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.17 -42.54 91.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.333 -1.099 . . . . 0.0 108.779 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.7 -39.63 88.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.405 HG13 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -51.63 -40.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.468 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -71.98 -47.94 48.52 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.92 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . 0.507 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 2.8 pp -124.37 -33.15 3.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.986 -1.071 . . . . 0.0 111.226 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.555 ' O ' ' C ' ' B' ' 302' ' ' LYS . . . -74.16 10.08 8.47 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' B' ' 301' ' ' GLY . 0.0 OUTLIER 7.93 -74.11 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' B' ' 301' ' ' GLY . 29.0 Cg_endo -65.17 107.89 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.456 1.199 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.7 mt -134.08 149.87 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.189 0.995 . . . . 0.0 111.534 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 49.1 tp -127.72 114.02 16.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.773 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -114.46 150.53 34.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 109.211 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 2.9 mp -132.15 137.0 47.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 111.463 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -128.68 140.0 51.96 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -88.85 133.12 36.34 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.924 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 313' ' ' GLY . 77.0 Cg_endo -78.83 -38.94 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.544 2.163 . . . . 0.0 111.069 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.24 -31.72 6.25 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.463 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.3 p -95.01 -20.34 19.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 38.5 42.41 1.34 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -67.55 7.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.29 -1.124 . . . . 0.0 109.588 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.515 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.4 t 57.21 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.496 -0.753 . . . . 0.0 110.648 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . . . . . . . . . 19.4 tp -54.8 151.17 8.78 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.467 ' HG ' ' CG1' ' B' ' 320' ' ' ILE . 0.0 OUTLIER -57.86 141.77 48.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.926 -178.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.3 -43.22 83.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 42.6 mmm -61.76 -45.5 93.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.626 0.727 . . . . 0.0 109.286 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' B' ' 323' ' ' ALA . 28.4 mm -61.19 -43.21 95.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . 0.472 ' O ' ' C ' ' B' ' 322' ' ' GLY . 0.3 OUTLIER -55.62 -45.09 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.825 -1.172 . . . . 0.0 107.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.619 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -51.33 -40.03 44.77 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 103.997 -3.641 . . . . 0.0 103.997 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' B' ' 329' ' ' PHE . . . -76.02 89.5 2.99 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -165.07 40.47 0.07 Allowed 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.812 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' B' ' 327' ' ' SER . 98.4 m-20 -54.61 -20.35 7.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.825 . . . . 0.0 110.029 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 69.06 -14.93 0.76 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 327' ' ' SER . . . . . 0.498 ' H ' ' C ' ' B' ' 325' ' ' ASP . 19.8 t -102.55 -74.68 0.62 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -1.231 . . . . 0.0 108.819 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -83.67 -49.41 9.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.773 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 4.4 t80 -103.39 129.06 50.4 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.729 HE21 ' HE1' ' B' ' 332' ' ' TRP . 2.7 mt-30 -140.34 135.66 32.39 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.661 -1.274 . . . . 0.0 111.853 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.34 111.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.729 ' HE1' HE21 ' B' ' 330' ' ' GLN . 14.1 m0 -107.78 138.87 43.26 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.0 110.108 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.469 ' O ' ' SD ' ' B' ' 342' ' ' MET . 81.4 m-20 -90.38 154.72 19.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.62 -1.3 . . . . 0.0 107.802 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -171.59 -177.16 1.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.782 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -150.75 148.31 28.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' B' ' 335' ' ' ALA . 62.1 mt-10 -41.6 -34.34 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.767 -1.208 . . . . 0.0 110.51 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.87 5.75 77.66 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.844 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' B' ' 335' ' ' ALA . 60.7 mm-40 -137.62 -3.6 1.87 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.001 -1.293 . . . . 0.0 109.821 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.0 p -55.88 -47.0 80.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 108.597 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 55.7 mt-10 -52.84 -34.07 52.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.1 m -70.61 -38.24 73.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.31 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 12.5 mmt -54.07 -52.97 59.23 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 76.8 mt -60.81 -39.16 87.93 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.044 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.4 -45.18 94.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 110.942 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -68.68 -51.79 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.516 -1.365 . . . . 0.0 108.808 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -56.13 -45.98 79.36 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.819 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.519 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.8 m-85 -72.82 -33.11 65.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.401 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.1 -29.62 65.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -97.38 26.77 4.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.4 ' HB3' ' H ' ' B' ' 351' ' ' LEU . 2.5 t80 -142.05 -82.39 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.434 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' B' ' 353' ' ' GLN . 4.7 mt -54.9 -59.23 11.22 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.179 -0.951 . . . . 0.0 112.181 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 2.3 Cg_endo -41.14 -17.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.362 2.041 . . . . 0.0 112.064 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' B' ' 351' ' ' LEU . 6.7 tt0 -87.88 -62.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.993 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -4.95 11.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 109.77 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 19.0 m -49.29 -38.07 26.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.616 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -167.85 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 54.1 m -67.82 -34.12 76.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.548 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 80.1 p -68.37 163.38 23.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 24.0 t -88.9 151.99 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.928 . . . . 0.0 109.628 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.416 ' O ' ' CG ' ' B' ' 360' ' ' HIS . 12.2 p80 -128.64 76.53 78.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.462 -0.774 . . . . 0.0 109.118 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 362' ' ' SER . 50.0 Cg_exo -50.7 -16.64 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 0.0 112.253 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.431 ' O ' ' OXT' ' B' ' 363' ' ' ALA . 67.5 m 50.2 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.168 -0.958 . . . . 0.0 109.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . 0.431 ' OXT' ' O ' ' B' ' 362' ' ' SER . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.628 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.7 148.97 36.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.63 142.15 48.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.5 t -95.47 147.87 23.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.42 28.92 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -100.31 162.6 12.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.267 -1.137 . . . . 0.0 109.334 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -71.26 177.3 3.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -155.34 154.63 28.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.26 -156.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.35 2.033 . . . . 0.0 111.283 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 25.9 p -108.99 172.77 6.65 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.443 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 61.4 m -115.07 158.9 21.49 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.849 -1.157 . . . . 0.0 108.99 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.6 t -137.41 134.14 46.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.163 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 8.3 t80 -115.53 97.29 6.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.569 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.48 126.79 38.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.526 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.67 130.1 47.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.955 . . . . 0.0 108.92 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -126.05 -124.01 2.73 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 58.1 m -155.69 138.08 14.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 109.105 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.22 149.68 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.913 -1.117 . . . . 0.0 109.441 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' NH2' ' OE1' ' B' ' 285' ' ' GLN . 1.7 tpt180 -165.14 1.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.95 7.52 0.03 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' N ' ' CD2' ' A' ' 54' ' ' LEU . . . 68.79 94.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -127.79 -151.59 0.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -1.187 . . . . 0.0 111.522 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.18 -40.83 96.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 74.8 m-20 -55.53 -33.32 63.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 1.8 mm100 -68.78 -39.18 80.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -52.04 66.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 108.702 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -34.6 76.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 24' ' ' ASP . 14.3 m-85 -69.2 -47.85 63.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.085 -1.01 . . . . 0.0 110.251 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.32 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.256 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.7 ttt85 -69.67 -57.22 5.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 108.494 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.5 mt -50.82 -43.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 68.4 t -61.16 -30.58 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 4.6 m -66.84 -41.18 87.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -67.92 -48.88 64.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.901 -1.125 . . . . 0.0 109.197 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.9 -40.27 79.94 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -62.1 -26.07 68.08 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -74.9 -36.97 62.22 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.94 -1.1 . . . . 0.0 108.873 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.477 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.6 m-85 -70.4 -48.36 56.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.947 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -153.1 -145.38 4.13 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.98 131.38 46.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.968 -1.313 . . . . 0.0 108.658 178.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.424 ' O ' ' CG ' ' A' ' 44' ' ' GLU . 18.1 t -90.73 127.47 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 44' ' ' GLU . 11.9 mt -87.05 -38.63 16.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.198 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 t -70.77 37.67 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.269 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 42' ' ' LEU . 57.7 mt-10 -54.28 -28.57 42.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.81 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.482 ' NE2' ' CG1' ' A' ' 65' ' ' ILE . 18.4 t-80 -52.09 -44.9 64.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.183 -0.948 . . . . 0.0 109.865 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.496 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 41.3 t -50.12 -69.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.32 61.02 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 14.6 t70 -85.34 43.08 0.99 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 46' ' ' VAL . . . -118.54 -32.3 4.64 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG2' HE21 ' A' ' 25' ' ' GLN . 12.2 pt-20 -86.1 60.28 6.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.498 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -168.88 22.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER 162.19 160.7 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -37.28 99.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.268 1.979 . . . . 0.0 111.67 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' CD1' ' H ' ' A' ' 54' ' ' LEU . 6.8 mp -49.36 -79.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . -175.33 -36.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' CG ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -46.97 -101.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.582 -0.952 . . . . 0.0 110.554 -179.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.53 ' H ' ' CG ' ' A' ' 56' ' ' GLU . 80.8 mm-40 -64.18 -8.9 13.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.025 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 158.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.63 66.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.19 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.01 -171.99 36.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 103.02 -29.86 11.61 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 20.5 p-10 -56.15 -43.16 78.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.2 mt-30 -70.39 -53.2 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -28.84 56.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' GLY . 1.8 mt -70.37 -39.71 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.71 ' HD1' ' N ' ' A' ' 67' ' ' GLU . 1.3 t-80 -76.45 -60.59 2.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.489 0.661 . . . . 0.0 109.367 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' N ' ' HD1' ' A' ' 66' ' ' HIS . 8.4 tp10 -43.04 -54.52 4.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -64.68 -44.6 89.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.945 . . . . 0.0 110.044 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.462 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 73.9 m-20 -60.91 -44.14 97.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.0 111.265 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.455 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.1 mm? -65.4 -50.25 66.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.024 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.18 -50.48 71.67 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.489 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.526 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.29 -42.46 99.08 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.3 tp -52.03 -37.33 53.16 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.36 -28.08 59.41 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.603 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -83.52 -5.96 59.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.869 -1.145 . . . . 0.0 109.258 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.84 125.33 25.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 112.153 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 11' ' ' SER . 39.0 m-20 -77.81 -33.15 52.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.21 148.18 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.26 138.7 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.966 -1.084 . . . . 0.0 111.002 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 20.5 t -138.45 164.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -159.46 130.42 5.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.579 -1.326 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CG ' ' OH ' ' A' ' 134' ' ' TYR . 53.1 tt0 -93.65 126.03 38.6 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -155.71 114.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.08 -1.012 . . . . 0.0 110.353 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.644 ' HG1' ' H ' ' A' ' 109' ' ' ARG . 39.5 m -105.76 -18.54 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.679 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 6.6 tt0 163.81 -37.31 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.383 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 7.0 Cg_exo -71.14 104.1 1.49 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.327 2.018 . . . . 0.0 112.009 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.429 ' O ' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -159.51 173.49 16.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 108.574 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.762 ' C ' ' H ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER 167.77 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.48 ' O ' ' SD ' ' B' ' 319' ' ' MET . . . 73.33 -23.21 0.96 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.762 ' H ' ' C ' ' A' ' 88' ' ' LEU . 2.1 t -85.14 -46.35 17.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.85 -30.48 56.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 1.3 t80 -68.58 -41.86 79.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.66 -34.59 65.14 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.2 -37.83 66.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.71 95.87 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.034 -2.027 . . . . 0.0 108.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -66.14 -40.0 90.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.489 -1.006 . . . . 0.0 108.711 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.32 -40.99 77.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.064 . . . . 0.0 108.549 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -39.86 48.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.44 56.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.007 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.3 mt -71.16 -7.22 45.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.135 -0.978 . . . . 0.0 108.786 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.12 24.86 9.75 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.838 -0.539 . . . . 0.0 112.09 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -79.7 154.45 75.93 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 120.603 -1.528 . . . . 0.0 108.141 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.37 118.58 1.79 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.933 1.755 . . . . 0.0 111.167 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.8 mt -121.13 135.3 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.988 . . . . 0.0 111.223 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.4 m -110.44 156.06 21.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.911 -1.118 . . . . 0.0 108.228 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 83' ' ' VAL . 3.5 mp -136.61 152.63 50.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 111.63 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.87 130.72 15.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.644 ' H ' ' HG1' ' A' ' 84' ' ' THR . 0.0 OUTLIER -52.89 140.03 41.34 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.052 -1.03 . . . . 0.0 110.522 -177.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 134' ' ' TYR . 31.8 Cg_endo -67.15 -50.25 1.09 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.147 1.898 . . . . 0.0 109.252 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' N ' ' A' ' 113' ' ' GLY . 13.3 pt20 -67.11 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.56 -72.25 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.989 -1.07 . . . . 0.0 109.753 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 111' ' ' GLN . . . 68.34 42.74 81.62 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' VAL . 4.5 mtt180 -85.63 18.42 2.84 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.462 ' O ' ' NH2' ' B' ' 219' ' ' ARG . 15.7 t 49.77 99.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.881 0.848 . . . . 0.0 109.448 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 117' ' ' SER . 8.9 tp -45.22 -61.24 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 162.86 144.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.288 -0.883 . . . . 0.0 110.002 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.52 86.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.555 -0.716 . . . . 0.0 110.399 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' B' ' 289' ' ' GLY . 1.7 mtp -74.81 -36.38 62.46 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.388 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 120' ' ' ILE . 45.4 mm -72.42 -46.07 57.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 109.37 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -77.54 -34.74 53.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 108.807 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.8 -27.49 73.82 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -43.56 -59.31 2.22 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -133.65 -111.5 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 112.178 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 1.9 m-20 160.23 -2.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.436 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.1 38.93 0.36 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.468 -1.349 . . . . 0.0 111.604 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 p -116.1 -86.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.727 -1.455 . . . . 0.0 108.838 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.501 ' O ' ' NE2' ' A' ' 130' ' ' GLN . 20.0 tpt180 -94.4 -30.05 14.67 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -117.69 126.0 51.7 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 128' ' ' ARG . 6.9 mp0 -131.91 135.92 47.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.55 -1.344 . . . . 0.0 112.726 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.42 106.89 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.482 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 20.8 m0 -104.63 143.02 33.64 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.006 -1.059 . . . . 0.0 110.986 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' O ' ' SD ' ' A' ' 142' ' ' MET . 68.0 m-20 -85.84 154.86 21.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.651 -1.281 . . . . 0.0 108.002 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.458 ' OH ' ' CG ' ' A' ' 82' ' ' GLU . 3.6 p90 -168.7 172.54 7.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 0.0 111.488 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -141.65 146.67 36.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 40.0 mt-10 -39.26 -37.03 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.746 -1.221 . . . . 0.0 110.335 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.17 15.52 33.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 135' ' ' ALA . 74.8 mt-10 -146.29 -4.88 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.258 . . . . 0.0 110.407 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.6 p -54.04 -46.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 120.865 -1.147 . . . . 0.0 108.616 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 22.8 pt-20 -56.54 -34.63 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.8 m -65.67 -39.41 91.3 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.165 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 11.3 mmt -55.82 -51.6 66.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.91 -30.3 71.4 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.347 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 48.6 m-20 -69.27 -44.14 72.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 0.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -71.67 -43.61 65.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.677 -1.264 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -62.97 -48.6 78.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.446 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.49 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 19.6 m-85 -73.64 -31.08 63.32 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.393 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -68.25 -27.16 66.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.47 65.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.689 -0.632 . . . . 0.0 109.621 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.813 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -145.88 -63.69 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.042 -1.036 . . . . 0.0 110.653 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.813 ' N ' ' CG ' ' A' ' 150' ' ' TYR . 1.4 mt -31.01 92.89 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 0.0 110.643 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 150' ' ' TYR . 72.4 Cg_endo -92.92 50.95 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.166 2.577 . . . . 0.0 111.048 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 52.44 21.85 1.9 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptp 50.77 25.85 2.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.9 m -68.1 -24.31 65.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.611 -0.681 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.46 155.5 47.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.3 p -148.58 161.06 42.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -62.34 -30.33 71.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.7 p -69.31 168.05 15.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.345 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.411 ' N ' ' CD2' ' A' ' 160' ' ' HIS . 19.7 m170 54.13 72.43 1.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -54.03 -14.03 5.47 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.827 2.351 . . . . 0.0 112.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.0 t -53.85 -33.01 55.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.383 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -61.03 149.31 37.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -72.86 142.5 47.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.3 t -96.15 148.19 22.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.09 174.44 29.52 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.91 162.06 13.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -1.092 . . . . 0.0 109.428 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.47 177.65 3.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.492 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -155.77 154.94 28.85 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.67 -156.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.217 1.945 . . . . 0.0 111.24 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.503 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 26.6 p -109.12 172.98 6.53 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 69.8 m -115.38 159.08 21.55 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.895 -1.128 . . . . 0.0 108.909 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.63 133.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.449 ' OH ' ' CB ' ' B' ' 269' ' ' ASP . 8.1 t80 -115.31 97.59 6.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -93.74 126.83 39.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.455 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.49 129.4 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.18 -0.95 . . . . 0.0 108.93 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.437 ' O ' ' CG2' ' B' ' 290' ' ' VAL . . . -125.42 -124.3 2.79 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' SER . . . . . 0.553 ' O ' ' NH1' ' B' ' 222' ' ' ARG . 58.7 m -155.58 137.8 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.055 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.79 149.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.894 -1.129 . . . . 0.0 109.581 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.47 ' NH2' ' OE1' ' A' ' 85' ' ' GLN . 1.6 tpt180 -164.74 1.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.65 7.3 0.03 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.406 ' N ' ' CD2' ' B' ' 254' ' ' LEU . . . 68.83 94.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.553 ' NH1' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER -127.69 -151.99 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.272 -1.134 . . . . 0.0 111.418 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.03 -40.64 96.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' B' ' 228' ' ' TYR . 74.7 m-20 -55.31 -33.77 63.58 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 1.9 mm100 -68.45 -38.84 81.48 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.19 66.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 108.646 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -34.31 76.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.482 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 14.0 m-85 -69.14 -48.42 62.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.059 -1.025 . . . . 0.0 110.217 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.407 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -60.02 -35.61 75.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.483 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' B' ' 233' ' ' SER . 32.0 ttt85 -69.62 -57.31 5.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.089 . . . . 0.0 108.452 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -50.61 -43.39 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 67.9 t -61.03 -30.73 48.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 230' ' ' ARG . 4.4 m -66.65 -41.36 88.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.776 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.91 -48.57 65.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.745 -1.222 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 32.8 mt -58.2 -40.37 81.4 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -61.99 -25.98 67.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -74.93 -37.2 62.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.913 -1.117 . . . . 0.0 108.92 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . 0.477 ' N ' ' HD1' ' B' ' 238' ' ' TYR . 2.5 m-85 -70.09 -48.55 57.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.614 -0.679 . . . . 0.0 110.072 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.73 -145.53 4.16 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.428 ' H ' ' HD3' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -100.88 131.48 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -1.216 . . . . 0.0 108.575 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . 0.417 ' O ' ' CG ' ' B' ' 244' ' ' GLU . 19.4 t -90.67 127.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' B' ' 244' ' ' GLU . 12.0 mt -87.08 -38.44 16.49 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.181 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 8.1 t -71.18 37.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 109.257 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' B' ' 242' ' ' LEU . 59.3 mt-10 -54.29 -28.84 44.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.818 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.498 ' NE2' ' CG1' ' B' ' 265' ' ' ILE . 17.7 t-80 -52.08 -45.24 64.71 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.494 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 41.2 t -49.85 -69.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.295 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -51.87 -41.36 61.82 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 248' ' ' ASP . 14.5 t70 -85.2 43.44 1.01 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' B' ' 246' ' ' VAL . . . -119.0 -32.05 4.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . 0.44 ' HG2' HE21 ' B' ' 225' ' ' GLN . 11.7 pt-20 -86.4 60.55 6.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.269 -0.894 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.625 ' CD2' ' N ' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -169.28 22.56 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.514 -0.741 . . . . 0.0 109.945 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER 161.87 160.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -37.03 99.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.382 2.055 . . . . 0.0 111.702 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.441 ' CD1' ' H ' ' B' ' 254' ' ' LEU . 6.7 mp -49.17 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.05 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . -175.71 -37.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.539 ' CG ' ' H ' ' B' ' 257' ' ' GLU . 0.2 OUTLIER -46.68 -101.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.568 -0.96 . . . . 0.0 110.578 -178.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' B' ' 256' ' ' GLU . 80.7 mm-40 -63.94 -8.21 10.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.875 . . . . 0.0 110.058 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -56.84 159.04 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.37 66.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 109.16 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -171.42 -172.33 37.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 103.14 -29.95 11.39 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 20.0 p-10 -56.17 -43.02 77.97 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . 0.467 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 1.2 mt-30 -70.59 -53.25 16.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.29 -28.51 54.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' B' ' 261' ' ' GLY . 1.9 mt -71.08 -39.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.703 ' HD1' ' N ' ' B' ' 267' ' ' GLU . 1.2 t-80 -76.32 -60.73 2.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . 0.703 ' N ' ' HD1' ' B' ' 266' ' ' HIS . 9.4 tp10 -43.02 -54.86 4.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.723 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -64.63 -43.8 92.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.449 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 75.3 m-20 -61.84 -44.1 97.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.2 -0.937 . . . . 0.0 111.2 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.454 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 1.1 mm? -65.32 -50.05 67.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.975 -1.078 . . . . 0.0 110.02 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -62.22 -50.76 70.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.537 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.03 -42.76 99.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.362 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.435 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.4 tp -51.76 -37.3 50.74 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.4 -28.1 59.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.42 -5.94 59.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.191 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.91 125.74 26.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -0.851 . . . . 0.0 112.034 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 211' ' ' SER . 41.9 m-20 -78.25 -33.14 49.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.91 147.7 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 79.3 t -133.93 138.38 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.883 -1.136 . . . . 0.0 111.015 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 20.0 t -137.83 164.76 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -159.95 130.16 5.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.614 -1.304 . . . . 0.0 110.143 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.453 ' CG ' ' OH ' ' B' ' 334' ' ' TYR . 52.0 tt0 -93.56 125.75 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 0.5 OUTLIER -155.3 115.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.987 -1.07 . . . . 0.0 110.349 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.63 ' HG1' ' H ' ' B' ' 309' ' ' ARG . 38.0 m -106.06 -19.0 13.86 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.68 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 6.6 tt0 164.09 -37.18 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.244 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 7.5 Cg_exo -70.9 103.82 1.41 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.389 2.06 . . . . 0.0 111.937 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.421 ' O ' HD21 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -159.81 173.25 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.747 ' C ' ' H ' ' B' ' 290' ' ' VAL . 0.1 OUTLIER 167.9 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 119' ' ' MET . . . 73.26 -22.81 0.97 Allowed Glycine 0 N--CA 1.481 1.662 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -176.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . 0.747 ' H ' ' C ' ' B' ' 288' ' ' LEU . 2.1 t -85.43 -46.41 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -55.65 -30.51 56.34 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.446 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 1.3 t80 -68.62 -41.98 78.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.8 -34.55 65.41 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 54.4 mt -73.15 -37.97 66.4 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.9 -37.79 94.34 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.8 -39.88 87.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.451 -1.029 . . . . 0.0 108.649 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -69.55 -41.08 76.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.96 -1.088 . . . . 0.0 108.524 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -39.79 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.11 57.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.007 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -71.63 -6.97 44.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 108.832 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . 51.05 25.01 9.49 Favored Glycine 0 N--CA 1.494 2.557 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.052 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.403 ' O ' HG13 ' B' ' 304' ' ' ILE . 24.6 mttp -79.76 154.61 75.83 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 120.631 -1.511 . . . . 0.0 108.254 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.39 118.35 1.71 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.806 1.67 . . . . 0.0 111.098 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.403 HG13 ' O ' ' B' ' 302' ' ' LYS . 11.9 mt -120.82 134.77 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.149 -0.969 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.25 114.78 18.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 85.9 m -110.57 156.18 21.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.76 -1.213 . . . . 0.0 108.105 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' B' ' 283' ' ' VAL . 3.5 mp -136.59 152.43 50.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.0 -1.062 . . . . 0.0 111.626 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.489 ' O ' ' CD1' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -148.68 130.62 15.25 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.63 ' H ' ' HG1' ' B' ' 284' ' ' THR . 0.0 OUTLIER -52.87 139.8 41.6 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.045 -1.034 . . . . 0.0 110.496 -177.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' B' ' 311' ' ' GLN . 33.3 Cg_endo -67.08 -50.06 1.17 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.067 1.845 . . . . 0.0 109.352 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.788 ' O ' ' N ' ' B' ' 313' ' ' GLY . 13.2 pt20 -67.09 -143.21 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.31 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 109.687 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.788 ' N ' ' O ' ' B' ' 311' ' ' GLN . . . 68.39 42.76 81.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' B' ' 315' ' ' VAL . 4.4 mtt180 -85.43 17.57 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.471 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 17.9 t 50.41 99.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.969 0.89 . . . . 0.0 109.4 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 317' ' ' SER . 8.5 tp -45.33 -61.42 1.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 317' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.9 OUTLIER 162.97 143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.49 86.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.437 -0.79 . . . . 0.0 110.316 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 89' ' ' GLY . 1.6 mtp -74.3 -36.78 63.76 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.038 -1.039 . . . . 0.0 109.407 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.445 HD12 HG21 ' B' ' 320' ' ' ILE . 45.2 mm -72.32 -45.93 58.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 109.439 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -77.46 -34.77 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 108.841 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -69.09 -27.27 74.0 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -43.43 -59.56 2.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -1.122 . . . . 0.0 110.013 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 325' ' ' ASP . . . -133.07 -111.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 112.068 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' B' ' 324' ' ' ALA . 2.0 m-20 160.01 -2.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.336 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 128.27 38.97 0.35 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 119.611 -1.281 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 57.0 p -115.97 -86.97 0.61 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.773 -1.427 . . . . 0.0 108.678 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.506 ' O ' ' NE2' ' B' ' 330' ' ' GLN . 20.1 tpt180 -94.29 -29.91 14.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 0.7 OUTLIER -117.86 126.25 52.04 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 328' ' ' ARG . 6.9 mp0 -132.23 136.37 46.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.471 -1.393 . . . . 0.0 112.65 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.72 107.11 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.492 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 20.7 m0 -104.48 142.92 33.77 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.071 -1.018 . . . . 0.0 110.939 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.542 ' O ' ' SD ' ' B' ' 342' ' ' MET . 67.0 m-20 -86.05 155.18 20.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.626 -1.296 . . . . 0.0 107.855 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.453 ' OH ' ' CG ' ' B' ' 282' ' ' GLU . 3.9 p90 -168.74 172.63 7.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.388 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -141.74 146.81 36.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' B' ' 335' ' ' ALA . 36.7 mt-10 -39.35 -37.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.83 -1.169 . . . . 0.0 110.286 -178.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.93 15.67 31.14 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 335' ' ' ALA . 74.1 mt-10 -146.59 -5.15 0.56 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.119 -1.224 . . . . 0.0 110.47 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.8 p -53.8 -46.85 63.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.804 -1.185 . . . . 0.0 108.606 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 23.1 pt-20 -56.29 -34.39 66.42 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 32.2 m -65.78 -39.46 91.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.542 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 11.8 mmt -55.79 -51.56 67.0 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.0 mt -63.79 -30.48 71.57 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.39 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -69.26 -44.09 72.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.991 -1.068 . . . . 0.0 110.69 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -71.86 -43.35 65.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.532 -1.355 . . . . 0.0 109.38 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -63.02 -48.86 76.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.358 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.515 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 19.9 m-85 -73.36 -31.0 63.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.413 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -68.15 -27.48 66.47 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -59.25 -27.56 65.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.766 -0.584 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.822 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.1 OUTLIER -145.73 -63.63 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.0 -1.063 . . . . 0.0 110.591 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.822 ' N ' ' CG ' ' B' ' 350' ' ' TYR . 1.4 mt -31.13 92.99 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.633 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . 0.53 ' N ' ' O ' ' B' ' 350' ' ' TYR . 77.2 Cg_endo -92.99 51.2 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.105 2.536 . . . . 0.0 110.914 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 52.04 22.07 1.74 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 50.69 25.85 2.25 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 5.4 m -68.29 -24.18 64.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -131.52 155.02 48.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.853 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 87.5 p -148.18 161.13 42.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 19.2 m -62.21 -30.53 71.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.359 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 86.4 p -69.31 168.13 14.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . 0.425 ' CD2' ' N ' ' B' ' 360' ' ' HIS . 20.4 m170 54.07 71.91 1.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -53.58 -15.28 6.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.829 2.353 . . . . 0.0 112.184 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 9.5 t -51.3 -25.89 6.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.554 179.93 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.7 ttp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.78 -26.22 67.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.01 147.91 40.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.9 p -78.53 158.28 28.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.5 -178.44 21.02 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -106.63 140.32 39.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -1.044 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -87.26 177.1 7.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.78 149.36 35.87 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 0.0 109.37 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.51 -161.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.457 2.105 . . . . 0.0 111.704 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 29.1 p -99.8 -173.25 2.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 1.2 m -118.68 143.52 46.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.01 136.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CZ ' ' OE1' ' A' ' 44' ' ' GLU . 5.9 t80 -113.41 109.17 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CE1' ' OE2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -98.23 129.95 44.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.636 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 3.2 m -102.12 151.19 22.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.342 -0.849 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.84 162.66 36.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -86.35 132.94 33.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.226 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 mm -99.89 -27.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.716 ' NH1' ' H ' ' A' ' 56' ' ' GLU . 15.0 mmm180 -55.22 -69.85 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 18.81 56.87 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -67.61 -90.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 55.13 -93.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.389 -1.065 . . . . 0.0 108.591 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 51.3 mp0 -51.5 -46.2 63.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 5.7 m-20 -65.01 -22.62 67.02 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 18.3 tp60 -63.35 -39.15 93.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.87 -47.88 67.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.86 -32.22 67.44 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 19.5 m-30 -67.44 -46.99 71.48 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.48 80.62 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.644 -1.285 . . . . 0.0 109.046 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -70.79 -56.79 5.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.756 -1.215 . . . . 0.0 108.515 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 mt -52.9 -43.99 47.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 28' ' ' TYR . 61.6 t -59.44 -29.09 41.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.3 m -71.68 -34.41 69.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -69.46 -53.29 19.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 108.615 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 mt -56.95 -39.51 74.67 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.96 -22.92 67.15 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -72.89 -44.54 61.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 109.412 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.95 -50.09 9.55 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.564 -0.71 . . . . 0.0 111.784 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.554 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . -142.46 132.48 5.15 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -35.79 145.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -1.052 . . . . 0.0 109.129 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 43' ' ' THR . 50.2 t -79.4 100.56 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.625 HD11 ' CD1' ' A' ' 72' ' ' TRP . 0.1 OUTLIER -49.88 94.56 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.952 -177.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 41' ' ' VAL . 6.6 m 28.21 100.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.363 0.602 . . . . 0.0 111.371 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' A' ' 46' ' ' VAL . 16.3 tp10 -142.9 65.88 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' VAL . 25.0 p80 -50.16 -5.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 44' ' ' GLU . 39.0 t -40.18 -58.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.686 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -66.93 -40.76 87.7 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 108.641 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' O ' ' CD1' ' A' ' 51' ' ' LEU . 7.4 t70 -70.67 25.05 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.686 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -101.98 -16.18 16.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.01 -43.96 70.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 109.027 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.87 ' H ' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.73 136.99 20.94 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 0.0 109.353 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 51' ' ' LEU . 20.8 mm-40 53.98 153.55 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.997 . . . . 0.0 109.082 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.47 88.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.195 1.93 . . . . 0.0 111.736 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.15 -163.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.155 -0.966 . . . . 0.0 109.806 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 91.09 151.85 27.22 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' H ' ' NH1' ' A' ' 19' ' ' ARG . 44.4 mt-10 -50.55 178.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -1.176 . . . . 0.0 109.003 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 64.91 -24.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.166 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.681 ' H ' ' C ' ' A' ' 56' ' ' GLU . . . -80.37 141.41 35.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 109.162 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.58 133.38 36.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.154 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.38 -77.08 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.05 83.61 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -52.44 -45.79 66.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -1.043 . . . . 0.0 108.562 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -62.14 -46.36 89.37 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 35.3 t80 -62.56 -41.62 99.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 11.9 mt -56.02 -46.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.71 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.7 t-80 -76.46 -27.11 56.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.7 -0.625 . . . . 0.0 109.852 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -61.86 -56.8 15.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.314 -0.867 . . . . 0.0 109.592 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 23.5 mp0 -76.37 -41.78 46.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.627 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 63.6 m-20 -60.11 -52.82 63.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.149 -0.97 . . . . 0.0 109.797 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.495 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 1.2 tp -67.98 -44.71 76.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.591 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -59.33 -49.27 78.46 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.592 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.63 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -76.73 -19.71 57.36 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.084 -1.447 . . . . 0.0 109.485 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.8 tp -64.67 -35.14 80.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -86.66 -19.0 29.89 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.398 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.63 ' NE2' ' CD1' ' A' ' 72' ' ' TRP . 4.0 tt0 -99.26 2.74 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.879 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 129.26 39.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.194 -0.941 . . . . 0.0 111.381 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -63.5 -35.23 79.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 11' ' ' SER . 42.9 t -138.41 149.78 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 82.0 t -137.39 142.0 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.499 1.142 . . . . 0.0 112.106 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.7 t -138.2 165.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -158.04 137.13 11.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.632 -1.293 . . . . 0.0 109.227 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' OE2' ' CE1' ' A' ' 14' ' ' PHE . 28.4 mt-10 -93.61 126.1 38.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -126.68 130.72 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 20.0 m -170.5 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.843 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 31.5 tt0 -100.05 -24.64 0.22 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.706 . . . . 0.0 109.843 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 96.2 Cg_exo -43.3 -142.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.731 2.287 . . . . 0.0 112.163 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.664 ' OG ' ' N ' ' A' ' 88' ' ' LEU . 2.4 t 172.53 -153.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.677 -1.264 . . . . 0.0 109.669 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.664 ' N ' ' OG ' ' A' ' 87' ' ' SER . 20.9 mt -30.59 136.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 110.091 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.37 -38.07 3.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.1 t -88.85 -41.86 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.969 . . . . 0.0 108.589 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.66 -33.39 71.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' CD2' ' SD ' ' B' ' 319' ' ' MET . 65.4 t80 -66.65 -52.89 39.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -1.143 . . . . 0.0 109.745 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.562 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 59.0 mt-10 -64.82 -31.27 72.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.314 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.1 mt -66.9 -44.42 80.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.88 -33.06 86.24 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.569 HH11 ' CG1' ' B' ' 298' ' ' VAL . 17.2 mmm180 -65.27 -44.46 87.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -1.03 . . . . 0.0 109.846 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 -36.71 73.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 108.67 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.551 ' CG1' HH11 ' B' ' 296' ' ' ARG . 0.5 OUTLIER -53.52 -44.52 56.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.457 ' N ' HG11 ' A' ' 98' ' ' VAL . . . -74.8 -50.85 15.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.647 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.98 -6.45 12.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.53 17.54 66.79 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.905 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 104' ' ' ILE . 64.4 mmtt -83.47 135.43 43.75 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 120.708 -1.466 . . . . 0.0 107.973 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.15 121.73 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.642 1.561 . . . . 0.0 110.966 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 102' ' ' LYS . 1.7 mp -108.8 100.13 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.961 -1.087 . . . . 0.0 111.45 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.6 tp -91.75 114.37 26.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.713 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -110.95 154.53 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 109.383 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.8 mt -122.92 149.5 44.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.7 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -145.03 119.63 9.76 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' NH1' ' NE2' ' A' ' 111' ' ' GLN . 7.2 mtm180 -79.25 124.61 84.27 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.797 -1.189 . . . . 0.0 111.109 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 113' ' ' GLY . 95.3 Cg_endo -83.42 -30.74 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.594 2.196 . . . . 0.0 110.758 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.469 ' NE2' ' NH1' ' A' ' 109' ' ' ARG . 9.4 pt20 -51.25 -35.24 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 39.6 m -98.7 -11.9 21.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 39.98 48.07 3.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 5.12 2.43 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -1.15 . . . . 0.0 109.386 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.0 t 53.92 109.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.822 0.82 . . . . 0.0 110.135 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' O ' ' OE2' ' B' ' 256' ' ' GLU . 8.7 tp -56.19 149.32 16.31 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.94 150.07 14.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.16 86.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 108.643 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.602 ' SD ' ' CD2' ' B' ' 292' ' ' TYR . 0.0 OUTLIER -60.28 -50.58 73.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' ALA . 32.6 mm -63.94 -36.32 76.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.104 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -53.58 -43.37 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.709 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -54.63 -43.92 79.04 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.715 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -78.01 90.17 4.18 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -174.28 46.5 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.591 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.37 -12.39 61.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 67.62 2.61 22.75 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.4 m -105.58 -78.85 0.57 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.993 -1.298 . . . . 0.0 108.87 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -93.19 -31.77 14.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.713 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 8.5 t80 -110.74 130.19 55.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.6 125.74 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.864 -1.148 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.68 106.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.487 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 12.3 m0 -102.06 138.02 39.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.0 -1.063 . . . . 0.0 109.558 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' O ' ' CE ' ' A' ' 142' ' ' MET . 91.8 m-20 -91.79 152.67 20.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.705 -1.247 . . . . 0.0 109.012 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.8 p90 -164.29 -179.33 6.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.475 -1.29 . . . . 0.0 111.917 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.53 147.36 25.33 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 135' ' ' ALA . 52.0 mt-10 -42.06 -36.17 1.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.926 -1.109 . . . . 0.0 110.298 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.36 4.44 41.53 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.496 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.96 7.15 0.33 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.552 -1.558 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.8 p -51.25 -43.29 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 108.464 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.7 mt-10 -57.93 -36.34 72.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 m -64.99 -45.53 85.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.455 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 3.9 tpp -51.56 -46.32 63.37 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.84 -33.18 68.26 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.702 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 55.3 m-20 -65.43 -40.42 93.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.95 -1.093 . . . . 0.0 109.837 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -69.91 -49.06 55.8 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.634 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.28 -48.73 80.06 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 109.979 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 151' ' ' LEU . 8.9 m-85 -66.95 -32.43 73.67 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.904 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.71 -25.14 64.62 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.588 -1.32 . . . . 0.0 107.785 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.39 62.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.53 -0.732 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -146.05 -0.13 0.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.456 -1.402 . . . . 0.0 111.649 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 147' ' ' PHE . 16.6 mt -115.69 82.75 10.58 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.672 -1.267 . . . . 0.0 109.267 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.24 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.646 2.231 . . . . 0.0 112.095 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.93 -34.95 64.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -51.82 -27.17 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.147 -0.971 . . . . 0.0 109.299 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 151' ' ' LEU . 36.2 m -53.23 -35.84 60.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.78 114.41 4.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.089 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.1 t -56.67 -26.7 57.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t -64.11 150.9 44.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.42 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -59.93 146.08 43.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.76 150.54 86.42 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.224 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.84 157.9 53.92 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.529 2.153 . . . . 0.0 112.132 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -54.17 -37.62 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.516 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 37.2 ttp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.18 66.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -73.82 148.45 42.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 93.7 p -79.43 158.39 27.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -145.32 -178.88 21.21 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -106.24 139.74 40.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -1.124 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -86.65 176.52 7.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -99.4 149.53 35.93 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.432 -0.792 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.61 -161.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.625 2.217 . . . . 0.0 111.587 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' CYS . . . . . 0.456 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 29.7 p -100.07 -173.19 2.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' B' ' 278' ' ' VAL . 1.2 m -118.62 143.76 46.6 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 60.1 t -126.14 136.63 60.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' TYR . . . . . 0.53 ' CZ ' ' OE1' ' B' ' 244' ' ' GLU . 6.0 t80 -113.35 109.12 18.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.46 ' CE1' ' OE2' ' B' ' 282' ' ' GLU . 0.0 OUTLIER -98.13 130.09 44.91 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.658 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 3.2 m -102.28 151.33 22.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -165.95 162.75 36.23 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 15.9 m -86.48 133.0 33.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.168 -1.195 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 1.3 mm -99.95 -27.46 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.727 ' NH1' ' H ' ' B' ' 256' ' ' GLU . 14.9 mmm180 -54.96 -69.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 109.827 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -97.01 18.77 56.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . -67.67 -89.91 0.06 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER 54.98 -93.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -1.054 . . . . 0.0 108.53 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 50.3 mp0 -51.34 -46.08 62.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 6.0 m-20 -65.56 -22.53 66.7 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 17.9 tp60 -63.44 -39.07 93.49 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.29 68.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.95 -32.53 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' TYR . . . . . 0.578 ' O ' ' CG2' ' B' ' 232' ' ' VAL . 19.5 m-30 -67.27 -47.02 71.94 Favored 'General case' 0 C--O 1.198 -1.631 0 O-C-N 121.527 -0.733 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.38 -37.4 80.64 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.723 -1.236 . . . . 0.0 109.044 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -70.65 -56.86 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.773 -1.204 . . . . 0.0 108.505 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 4.9 mt -52.83 -43.93 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' VAL . . . . . 0.578 ' CG2' ' O ' ' B' ' 228' ' ' TYR . 60.6 t -59.66 -28.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.0 m -71.93 -34.19 68.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.0 109.383 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.47 -53.54 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.871 -1.143 . . . . 0.0 108.626 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 12.9 mt -56.64 -39.61 73.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -62.97 -22.97 67.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -72.91 -44.62 61.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 109.491 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.81 -49.9 9.85 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.513 -0.742 . . . . 0.0 111.873 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . -142.67 132.75 5.24 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' B' ' 239' ' ' GLY . 0.0 OUTLIER -35.96 145.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -1.003 . . . . 0.0 109.027 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' B' ' 243' ' ' THR . 44.7 t -79.31 100.63 4.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' LEU . . . . . 0.621 HD11 ' CD1' ' B' ' 272' ' ' TRP . 0.1 OUTLIER -49.84 94.88 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.938 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' THR . . . . . 0.524 ' N ' ' O ' ' B' ' 241' ' ' VAL . 6.6 m 27.81 100.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.421 0.629 . . . . 0.0 111.387 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' GLU . . . . . 0.587 ' C ' ' H ' ' B' ' 246' ' ' VAL . 15.7 tp10 -143.2 66.52 1.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' B' ' 246' ' ' VAL . 25.0 p80 -50.64 -5.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.562 -0.711 . . . . 0.0 110.147 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' B' ' 244' ' ' GLU . 39.3 t -40.36 -58.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.675 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -67.2 -40.54 86.51 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 108.616 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' ASP . . . . . 0.443 ' O ' ' CD1' ' B' ' 251' ' ' LEU . 7.0 t70 -71.0 25.58 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.67 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -102.47 -15.97 16.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -54.16 -43.89 70.98 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' LEU . . . . . 0.863 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -50.83 136.79 21.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLU . . . . . 0.606 ' O ' ' O ' ' B' ' 251' ' ' LEU . 20.6 mm-40 54.17 153.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.98 . . . . 0.0 109.175 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.69 89.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.181 1.921 . . . . 0.0 111.542 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . 0.432 ' C ' ' CD1' ' B' ' 254' ' ' LEU . 0.3 OUTLIER -61.88 -163.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.75 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 91.37 151.58 27.03 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . 0.727 ' H ' ' NH1' ' B' ' 219' ' ' ARG . 46.7 mt-10 -50.29 178.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -1.214 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 64.82 -25.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 109.055 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ALA . . . . . 0.679 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -80.08 141.73 35.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.29 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.21 132.12 38.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 168.57 -77.5 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 138.81 83.21 0.1 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -52.08 -45.88 64.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -1.072 . . . . 0.0 108.387 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -62.09 -46.52 88.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 36.0 t80 -62.72 -41.3 99.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.31 -0.869 . . . . 0.0 108.994 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 12.0 mt -56.28 -45.86 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' HIS . . . . . 0.709 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -76.68 -27.33 55.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.926 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.66 -56.66 17.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.348 -0.845 . . . . 0.0 109.688 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 23.1 mp0 -76.65 -41.54 45.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' ASP . . . . . 0.481 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 62.1 m-20 -60.01 -52.3 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' B' ' 274' ' ' GLN . 1.2 tp -68.57 -44.49 74.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.23 -49.37 78.09 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.621 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' TRP . . . . . 0.624 ' CD1' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -76.6 -19.63 57.64 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.121 -1.432 . . . . 0.0 109.588 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.418 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.7 tp -64.81 -34.91 79.49 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.2 OUTLIER -86.96 -19.1 29.24 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.442 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' B' ' 272' ' ' TRP . 4.1 tt0 -99.11 2.39 45.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.822 -1.174 . . . . 0.0 108.817 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.02 129.3 39.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.108 -0.995 . . . . 0.0 111.405 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.37 -35.38 80.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' B' ' 211' ' ' SER . 42.6 t -138.28 149.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 83.2 t -137.48 142.22 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.534 1.159 . . . . 0.0 112.194 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 97.2 t -138.34 165.45 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -157.72 137.04 11.85 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.548 -1.345 . . . . 0.0 109.283 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' GLU . . . . . 0.46 ' OE2' ' CE1' ' B' ' 214' ' ' PHE . 28.7 mt-10 -93.32 126.29 38.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -126.81 130.88 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' THR . . . . . 0.465 HG23 ' N ' ' B' ' 285' ' ' GLN . 20.2 m -170.77 -92.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' GLN . . . . . 0.841 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 31.8 tt0 -100.11 -24.75 0.22 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.452 -0.78 . . . . 0.0 109.838 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' PRO . . . . . 0.841 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 97.6 Cg_exo -43.31 -142.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.688 2.259 . . . . 0.0 112.125 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' B' ' 288' ' ' LEU . 2.1 t 172.53 -153.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.569 -1.332 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' LEU . . . . . 0.679 ' N ' ' OG ' ' B' ' 287' ' ' SER . 20.2 mt -30.49 136.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 114.97 -37.64 3.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 4.3 t -89.17 -42.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.583 -0.951 . . . . 0.0 108.588 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.06 71.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' TYR . . . . . 0.602 ' CD2' ' SD ' ' A' ' 119' ' ' MET . 65.7 t80 -66.97 -52.24 45.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -1.161 . . . . 0.0 109.9 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' GLU . . . . . 0.552 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 59.5 mt-10 -65.25 -31.3 72.39 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 24.6 mt -66.98 -44.46 80.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.11 -32.75 85.06 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 296' ' ' ARG . . . . . 0.551 HH11 ' CG1' ' A' ' 98' ' ' VAL . 16.9 mmm180 -65.33 -44.52 87.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.051 . . . . 0.0 109.82 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.84 -36.82 73.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.993 . . . . 0.0 108.647 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 298' ' ' VAL . . . . . 0.569 ' CG1' HH11 ' A' ' 96' ' ' ARG . 0.5 OUTLIER -53.26 -44.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' ALA . . . . . 0.454 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.02 -50.68 15.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.736 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.45 -6.18 13.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 109.475 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.41 17.57 66.56 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.817 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' LYS . . . . . 0.424 ' O ' HG13 ' B' ' 304' ' ' ILE . 65.1 mmtt -83.42 135.69 43.62 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 120.667 -1.49 . . . . 0.0 107.931 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.23 122.16 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.75 1.634 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' ILE . . . . . 0.424 HG13 ' O ' ' B' ' 302' ' ' LYS . 1.7 mp -109.37 99.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.987 . . . . 0.0 111.283 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 24.9 tp -91.55 114.37 26.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' CYS . . . . . 0.71 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.3 OUTLIER -110.97 154.34 24.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.901 -1.124 . . . . 0.0 109.566 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' LEU . . . . . 0.538 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 9.2 mt -122.86 149.76 43.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.245 -0.909 . . . . 0.0 111.249 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' PHE . . . . . 0.709 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.4 OUTLIER -145.72 119.69 9.37 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' ARG . . . . . 0.461 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 7.7 mtm180 -79.07 125.21 84.1 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.0 111.131 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.5 Cg_endo -83.55 -29.98 0.94 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.579 2.186 . . . . 0.0 110.669 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' GLN . . . . . 0.461 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 9.4 pt20 -51.95 -35.16 45.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' SER . . . . . 0.448 ' O ' ' C ' ' B' ' 313' ' ' GLY . 31.1 m -98.8 -11.68 21.59 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 39.84 47.93 3.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' B' ' 315' ' ' VAL . 0.5 OUTLIER -71.14 4.39 2.8 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.168 -1.195 . . . . 0.0 109.373 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' B' ' 314' ' ' ARG . 2.9 t 54.6 109.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.82 0.819 . . . . 0.0 110.101 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 316' ' ' LEU . . . . . 0.55 ' O ' ' OE2' ' A' ' 56' ' ' GLU . 8.7 tp -56.58 149.83 16.71 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 150.03 16.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.629 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.66 85.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 108.606 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.612 ' SD ' ' CD2' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -60.78 -50.48 73.28 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 108.836 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' B' ' 323' ' ' ALA . 32.2 mm -64.02 -36.34 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.981 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 321' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' B' ' 322' ' ' GLY . 19.2 mmt85 -53.54 -43.61 68.55 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 322' ' ' GLY . . . . . 0.71 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -54.58 -43.82 78.55 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 104.632 -3.387 . . . . 0.0 104.632 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 323' ' ' ALA . . . . . 0.71 ' O ' ' O ' ' B' ' 320' ' ' ILE . . . -77.92 90.14 4.12 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -174.14 46.32 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.622 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.08 -12.29 61.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.413 -0.805 . . . . 0.0 111.212 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 326' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 67.36 2.15 18.62 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.666 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 73.6 m -105.27 -78.91 0.56 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.991 -1.299 . . . . 0.0 108.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -93.16 -32.11 14.53 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.71 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 9.1 t80 -110.23 130.13 55.6 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.52 125.43 13.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.796 -1.19 . . . . 0.0 111.25 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 35.9 t -85.46 106.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 332' ' ' TRP . . . . . 0.479 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 11.9 m0 -102.02 137.79 39.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.04 -1.038 . . . . 0.0 109.44 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . 0.458 ' O ' ' SD ' ' B' ' 342' ' ' MET . 91.8 m-20 -91.54 152.57 20.26 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.801 -1.187 . . . . 0.0 109.084 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 334' ' ' TYR . . . . . 0.538 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.7 p90 -164.15 -179.22 6.01 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.856 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.91 147.59 25.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 336' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.4 mt-10 -42.21 -36.07 1.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.802 -1.186 . . . . 0.0 110.281 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -75.26 3.79 44.79 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.507 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.52 7.09 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.486 -1.597 . . . . 0.0 110.866 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.9 p -51.11 -43.49 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.908 -1.12 . . . . 0.0 108.467 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 340' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 83.1 mt-10 -57.88 -36.24 72.1 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 72.1 m -64.88 -45.67 85.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 342' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.9 tpp -51.42 -46.81 63.06 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.23 -33.6 70.02 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.789 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 344' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' B' ' 340' ' ' GLU . 55.4 m-20 -65.4 -40.33 93.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.972 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.92 -49.17 54.66 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.923 -1.111 . . . . 0.0 108.462 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.15 -48.61 80.8 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.215 -0.928 . . . . 0.0 110.017 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 347' ' ' PHE . . . . . 0.511 ' O ' ' N ' ' B' ' 351' ' ' LEU . 9.1 m-85 -66.96 -32.18 73.25 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.934 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -68.98 -25.04 64.33 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.54 -1.35 . . . . 0.0 107.83 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.26 62.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 350' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.5 OUTLIER -146.26 -0.34 0.78 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.611 -1.306 . . . . 0.0 111.512 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' B' ' 347' ' ' PHE . 16.7 mt -115.53 82.58 10.0 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 120.576 -1.328 . . . . 0.0 109.189 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.97 -96.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.752 2.301 . . . . 0.0 112.136 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -74.68 -34.37 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -52.31 -26.61 12.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 355' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' B' ' 351' ' ' LEU . 32.9 m -53.4 -36.54 61.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -151.37 114.38 4.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.366 -0.834 . . . . 0.0 109.244 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 30.5 t -56.52 -26.48 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 33.3 t -64.43 151.29 44.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.283 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 46.3 m -60.3 146.72 42.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -75.2 150.35 85.29 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 109.182 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.15 158.05 54.13 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.464 2.109 . . . . 0.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 47.8 m -52.81 -34.03 51.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.385 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.48 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' ALA . 32.1 Cg_exo -57.62 -150.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.804 1.669 . . . . 0.0 111.213 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -111.03 -175.39 2.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 36.0 m -121.44 152.43 39.1 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 35' ' ' LEU . 10.8 t -131.0 136.09 58.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' CG ' ' A' ' 69' ' ' ASP . 8.1 t80 -113.17 99.26 7.69 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -89.49 116.75 27.89 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.46 -0.896 . . . . 0.0 108.883 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.55 146.76 23.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.443 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.62 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -168.58 75.13 0.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.62 ' C ' ' O ' ' A' ' 16' ' ' GLY . 15.7 m -16.2 127.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.936 -0.743 . . . . 0.0 110.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.301 -1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 110.034 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.855 0.836 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -59.76 -42.95 94.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.7 m-20 -52.06 -34.76 45.01 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -64.09 -44.61 91.82 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.92 60.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.285 -0.885 . . . . 0.0 109.227 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -58.75 -32.45 69.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.0 m-30 -67.86 -46.03 72.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.343 -0.848 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.71 78.27 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.995 -1.065 . . . . 0.0 108.997 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -70.8 -57.22 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.077 . . . . 0.0 108.579 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.5 mt -51.7 -42.57 31.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.1 t -61.72 -31.32 50.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.0 t -67.12 -39.24 86.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 110.026 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 38' ' ' TYR . 53.0 ttt85 -69.56 -48.61 59.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.699 -1.251 . . . . 0.0 109.415 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 12' ' ' VAL . 15.3 mt -60.71 -38.54 85.37 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -63.17 -24.99 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -78.05 -36.66 48.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.056 -1.027 . . . . 0.0 109.419 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.553 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-85 -69.8 -47.05 64.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.426 -0.796 . . . . 0.0 110.416 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.75 2.56 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -99.36 135.68 40.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.85 117.61 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 44' ' ' GLU . 19.3 mt -80.94 -35.81 31.8 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -68.27 37.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.561 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 42' ' ' LEU . 44.3 tp10 -50.27 -34.49 23.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -49.77 -52.85 28.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 48' ' ' ASP . 21.8 t -58.83 163.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.719 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 62.55 -59.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.759 ' O ' HD11 ' A' ' 51' ' ' LEU . 24.0 t70 -65.85 24.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.719 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -103.63 -10.83 18.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.73 -39.78 95.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.028 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.07 161.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.527 -0.733 . . . . 0.0 109.773 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 51' ' ' LEU . 12.8 mt-10 55.97 158.61 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.287 -0.883 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' C ' HD22 ' A' ' 54' ' ' LEU . 23.6 Cg_endo -63.04 131.8 34.13 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.446 2.097 . . . . 0.0 111.593 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 49' ' ' ALA . 3.7 mm? -93.91 171.16 9.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 141.27 37.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 58' ' ' ALA . 50.0 mt-10 47.11 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.482 -1.01 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 55' ' ' GLY . 97.1 mt-10 -47.47 -20.6 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' A' ' 56' ' ' GLU . . . -48.66 151.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.91 136.89 6.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.89 -62.57 0.17 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.78 80.6 1.13 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 18.8 p-10 -52.17 -45.22 65.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -1.091 . . . . 0.0 108.307 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 88.4 mt-30 -63.49 -48.59 77.02 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -61.64 -36.0 79.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.094 -1.004 . . . . 0.0 109.015 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 45' ' ' HIS . 2.0 mt -62.71 -52.22 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.657 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 0.1 OUTLIER -67.56 -50.54 58.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.588 0.709 . . . . 0.0 109.423 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 45.7 tp10 -43.09 -58.14 2.59 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -63.9 -39.42 94.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.656 ' CG ' ' OH ' ' A' ' 13' ' ' TYR . 8.5 t0 -58.42 -48.0 82.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.408 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.516 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -64.51 -45.14 88.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' ND2' ' OE1' ' A' ' 75' ' ' GLN . 13.5 t30 -65.44 -52.11 55.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.447 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.12 -45.69 90.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 108.976 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 42.1 tp -50.35 -37.22 35.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HA ' HD11 ' A' ' 100' ' ' LEU . 32.1 mt-30 -73.7 -28.1 61.55 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.435 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.491 ' OE1' ' ND2' ' A' ' 71' ' ' ASN . 38.0 mt-30 -88.1 -0.5 57.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 109.646 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.81 44.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.091 -1.005 . . . . 0.0 112.277 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 11' ' ' SER . 61.5 m-20 -85.61 -31.67 22.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.47 143.96 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 13' ' ' TYR . 86.2 t -138.88 130.81 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.687 -1.258 . . . . 0.0 111.748 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 105' ' ' LEU . 84.0 t -136.65 130.66 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -116.23 137.21 52.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.663 -1.273 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD2' ' A' ' 27' ' ' LEU . 55.1 tt0 -84.71 139.18 32.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.6 -0.687 . . . . 0.0 109.282 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.613 HG13 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -143.62 147.71 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.272 -0.893 . . . . 0.0 109.793 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 14.5 m -173.87 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' ' OD2' ' A' ' 24' ' ' ASP . 24.6 pt20 -97.93 153.61 38.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -37.37 143.71 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.146 1.897 . . . . 0.0 111.676 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB3' HG23 ' A' ' 90' ' ' VAL . 3.5 m -163.5 123.9 2.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 110.104 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' B' ' 287' ' ' SER . 4.0 mt -76.62 -45.19 31.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.316 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.564 ' N ' ' OG ' ' A' ' 17' ' ' SER . . . -60.78 -42.17 99.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.613 HG11 HG13 ' A' ' 83' ' ' VAL . 40.7 t -64.62 -45.21 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.194 -1.18 . . . . 0.0 109.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.79 -46.7 93.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' B' ' 319' ' ' MET . 82.5 t80 -66.25 -47.94 72.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -1.081 . . . . 0.0 109.501 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' SD ' ' B' ' 319' ' ' MET . 10.8 mm-40 -59.76 -37.27 78.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.6 mt -75.22 -41.53 57.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.051 -1.031 . . . . 0.0 109.242 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.04 -50.02 59.65 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -40.05 82.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.392 -1.064 . . . . 0.0 108.612 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -68.33 -37.06 80.18 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.633 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.73 -45.14 48.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.892 -1.13 . . . . 0.0 108.276 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -89.59 -53.04 4.7 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.089 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 100' ' ' LEU . 1.8 tm? -90.06 -29.85 18.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.089 -1.007 . . . . 0.0 109.643 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 97' ' ' ALA . . . -74.19 166.68 54.74 Favored Glycine 0 C--N 1.283 -2.392 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 4.8 mtmm -124.55 -71.09 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 82.9 Cg_endo -79.48 111.43 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.978 1.786 . . . . 0.0 109.293 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 97' ' ' ALA . 16.0 mt -129.59 116.03 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.782 -1.199 . . . . 0.0 111.995 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 80' ' ' VAL . 57.3 tp -110.5 126.26 54.18 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 145.66 39.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.928 -1.108 . . . . 0.0 108.771 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.3 mt -122.47 135.49 54.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.911 . . . . 0.0 111.625 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -133.5 138.01 45.91 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NE ' ' NE2' ' A' ' 111' ' ' GLN . 4.4 mtm180 -98.98 134.66 21.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 120.703 -1.248 . . . . 0.0 111.338 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.43 -26.1 4.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.553 2.169 . . . . 0.0 111.267 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.447 ' NE2' ' NE ' ' A' ' 109' ' ' ARG . 7.5 pt20 -46.63 -38.66 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' GLY . 31.0 t -102.13 -15.8 16.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.82 51.37 2.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 115' ' ' VAL . 58.8 mtp85 -80.87 18.08 1.07 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.998 -1.295 . . . . 0.0 109.062 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 114' ' ' ARG . 48.7 t 46.99 100.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.671 0.748 . . . . 0.0 110.141 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 83' ' ' VAL . 49.1 tp -47.95 145.77 2.82 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 0.0 109.449 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -45.8 143.13 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.63 -30.31 69.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.458 -0.776 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.408 ' SD ' ' CD ' ' B' ' 293' ' ' GLU . 0.8 OUTLIER -70.76 -51.57 26.28 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.878 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.66 -42.51 96.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.675 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -65.17 -48.84 72.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.544 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.617 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -62.35 -31.25 78.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . . . -62.6 -15.66 52.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.038 -1.272 . . . . 0.0 108.199 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.45 96.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 65.3 m-20 -105.29 -22.52 13.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.893 . . . . 0.0 108.693 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.42 30.37 77.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 89.6 p -134.89 59.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.7 mtt180 98.61 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 123' ' ' ALA . 88.5 t80 -97.49 120.03 37.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.6 mt-30 -145.91 142.02 28.34 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.852 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.83 100.59 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.508 ' CG ' HD11 ' A' ' 105' ' ' LEU . 21.6 m0 -95.43 152.68 18.19 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.237 -0.914 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -97.38 155.54 16.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.094 -1.004 . . . . 0.0 108.877 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 6.3 p90 -170.19 -178.68 2.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.724 -1.235 . . . . 0.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.94 149.72 27.57 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.9 mt-10 -42.47 -29.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.704 -1.247 . . . . 0.0 110.154 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.51 -6.06 88.05 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.56 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.08 11.32 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.587 -1.537 . . . . 0.0 110.581 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.0 p -54.34 -45.35 68.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.924 -1.11 . . . . 0.0 108.448 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.504 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 49.9 mt-10 -57.76 -32.67 67.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.451 -0.781 . . . . 0.0 109.262 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.8 m -68.18 -45.52 73.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.568 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.97 -50.91 60.33 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.55 -34.1 77.15 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.89 -41.53 95.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.413 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -68.87 -48.7 62.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.867 -1.146 . . . . 0.0 108.331 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.39 -48.17 82.9 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 16.7 m-85 -69.74 -32.9 71.7 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.942 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 150' ' ' TYR . 27.1 mm-40 -62.24 -32.42 73.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.14 10.87 5.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.2 t80 -134.6 -105.09 0.23 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.24 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 14.9 mt -34.4 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.8 -0.563 . . . . 0.0 111.208 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 150' ' ' TYR . 87.1 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 C-N-CA 123.168 2.578 . . . . 0.0 111.142 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.09 -150.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.961 1.774 . . . . 0.0 111.279 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 28.2 p -111.25 -175.65 2.76 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 33.6 m -121.13 152.81 38.29 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.778 HG11 HD22 ' B' ' 235' ' ' LEU . 10.5 t -131.25 136.17 58.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.659 ' OH ' ' CG ' ' B' ' 269' ' ' ASP . 8.1 t80 -113.29 99.29 7.69 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -89.67 116.52 27.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.975 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.1 m -92.34 146.75 23.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.625 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -168.29 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.625 ' C ' ' O ' ' B' ' 216' ' ' GLY . 14.6 m -15.94 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.883 -0.775 . . . . 0.0 110.78 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.303 -1.433 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.894 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.891 0.853 . . . . 0.0 111.825 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.92 -42.38 93.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.613 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.8 m-20 -52.68 -34.6 52.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -64.16 -44.44 92.09 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.02 59.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.32 -0.862 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.432 ' CD2' ' OE2' ' B' ' 282' ' ' GLU . 0.6 OUTLIER -58.67 -32.92 69.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.699 ' O ' HG23 ' B' ' 232' ' ' VAL . 15.9 m-30 -67.49 -45.79 74.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.835 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.66 78.85 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.905 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -70.84 -57.15 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.901 -1.125 . . . . 0.0 108.619 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.76 -42.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.6 t -62.05 -31.23 50.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 10.5 t -67.07 -39.2 86.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.542 ' NH2' ' OH ' ' B' ' 238' ' ' TYR . 53.8 ttt85 -69.56 -48.71 59.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.644 -1.285 . . . . 0.0 109.323 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.778 HD22 HG11 ' B' ' 212' ' ' VAL . 14.7 mt -60.51 -38.66 85.06 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -63.18 -25.0 68.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.101 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -77.94 -36.43 49.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.026 -1.046 . . . . 0.0 109.402 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.568 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-85 -69.99 -47.1 63.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.505 -0.747 . . . . 0.0 110.469 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.92 2.6 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -99.3 135.75 40.25 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.363 -1.081 . . . . 0.0 109.346 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.86 117.55 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' B' ' 244' ' ' GLU . 19.4 mt -80.93 -35.82 31.85 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.318 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.42 ' H ' HG22 ' B' ' 243' ' ' THR . 0.9 OUTLIER -68.34 36.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.597 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' B' ' 242' ' ' LEU . 45.1 tp10 -49.98 -34.03 19.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.525 ' CD2' HG23 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -49.87 -52.22 34.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.11 -0.994 . . . . 0.0 109.047 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' B' ' 248' ' ' ASP . 21.9 t -59.62 163.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 108.899 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 62.57 -59.89 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.795 ' O ' HD11 ' B' ' 251' ' ' LEU . 24.4 t70 -65.76 24.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.697 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -103.16 -10.68 18.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.627 -0.671 . . . . 0.0 109.194 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -63.68 -39.85 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 1.025 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -55.05 161.69 1.59 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.451 -0.78 . . . . 0.0 109.754 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' B' ' 251' ' ' LEU . 12.3 mt-10 56.14 158.68 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.408 ' C ' HD22 ' B' ' 254' ' ' LEU . 21.8 Cg_endo -63.07 131.64 33.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 111.618 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.639 HD11 ' O ' ' B' ' 249' ' ' ALA . 3.7 mm? -94.0 170.26 9.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.294 -0.879 . . . . 0.0 109.827 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 142.28 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' B' ' 258' ' ' ALA . 50.4 mt-10 46.9 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 255' ' ' GLY . 96.8 mt-10 -47.21 -21.23 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.171 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -47.92 151.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -46.35 136.23 7.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.57 -62.81 0.16 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.07 80.7 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 18.6 p-10 -52.34 -44.96 65.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -1.125 . . . . 0.0 108.254 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 263' ' ' GLN . . . . . 0.476 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.1 mt-30 -63.71 -48.78 75.71 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -61.6 -35.5 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 109.08 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.525 HG23 ' CD2' ' B' ' 245' ' ' HIS . 1.9 mt -63.21 -52.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.617 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -67.42 -50.09 60.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.493 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.577 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 44.4 tp10 -43.74 -58.19 2.83 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 110.032 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -39.16 93.54 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.0 109.382 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.659 ' CG ' ' OH ' ' B' ' 213' ' ' TYR . 9.0 t0 -58.55 -48.14 81.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -0.867 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -64.5 -45.3 87.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 109.797 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.34 -51.92 57.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 109.678 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.444 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.18 -45.7 90.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.938 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 42.3 tp -50.37 -37.23 36.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.405 ' HA ' HD11 ' B' ' 300' ' ' LEU . 32.3 mt-30 -73.74 -28.06 61.5 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.423 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' B' ' 272' ' ' TRP . 38.1 mt-30 -87.93 -0.58 57.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.999 -1.063 . . . . 0.0 109.707 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.99 131.62 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.205 -0.934 . . . . 0.0 112.4 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' B' ' 211' ' ' SER . 64.0 m-20 -85.65 -31.63 22.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 97.1 t -134.51 143.8 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' B' ' 213' ' ' TYR . 88.9 t -138.76 130.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.69 -1.256 . . . . 0.0 111.849 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 280' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' B' ' 305' ' ' LEU . 91.4 t -136.47 130.54 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -116.26 136.84 52.65 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.669 -1.269 . . . . 0.0 110.268 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.432 ' OE2' ' CD2' ' B' ' 227' ' ' LEU . 52.7 tt0 -84.32 139.59 32.19 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.589 -0.694 . . . . 0.0 109.273 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.623 HG13 HG11 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -144.13 147.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 15.2 m -173.47 -68.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.46 ' NE2' ' OD2' ' B' ' 224' ' ' ASP . 24.7 pt20 -98.38 153.86 37.84 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.12 144.04 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.131 1.888 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.508 ' HB3' HG23 ' B' ' 290' ' ' VAL . 3.5 m -163.72 123.7 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.48 ' HG ' ' H ' ' A' ' 87' ' ' SER . 4.0 mt -76.8 -45.16 29.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 289' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 217' ' ' SER . . . -60.43 -42.75 99.1 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.623 HG11 HG13 ' B' ' 283' ' ' VAL . 41.2 t -64.07 -45.57 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -1.201 . . . . 0.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.03 93.11 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 119' ' ' MET . 81.7 t80 -66.17 -47.97 72.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 109.557 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.408 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 11.6 mm-40 -59.87 -37.12 78.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.5 mt -75.25 -41.65 56.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.033 -1.042 . . . . 0.0 109.212 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.93 60.2 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -39.66 82.4 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.395 -1.062 . . . . 0.0 108.596 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.484 ' O ' HD11 ' B' ' 304' ' ' ILE . . . -68.45 -37.22 80.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.921 -1.111 . . . . 0.0 108.626 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -52.66 -45.51 48.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.889 -1.132 . . . . 0.0 108.226 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -89.27 -52.76 4.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.236 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.774 ' C ' HD13 ' B' ' 300' ' ' LEU . 1.7 tm? -90.46 -29.84 17.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.026 -1.047 . . . . 0.0 109.593 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' B' ' 297' ' ' ALA . . . -73.51 166.4 54.63 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 108.308 -1.917 . . . . 0.0 108.308 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.508 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 4.8 mtmm -124.54 -71.25 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 84.7 Cg_endo -79.4 110.86 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.884 1.723 . . . . 0.0 109.398 176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.484 HD11 ' O ' ' B' ' 297' ' ' ALA . 16.6 mt -128.98 116.35 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.699 -1.25 . . . . 0.0 112.103 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.659 ' HB3' HG22 ' B' ' 280' ' ' VAL . 57.8 tp -110.88 126.06 54.29 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 145.92 38.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.97 -1.081 . . . . 0.0 108.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.585 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 8.1 mt -122.98 135.6 54.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.229 -0.919 . . . . 0.0 111.643 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -133.45 138.35 46.15 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.45 ' NE ' ' NE2' ' B' ' 311' ' ' GLN . 4.3 mtm180 -99.36 134.82 20.96 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 0.0 111.307 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.33 -26.27 4.23 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.531 2.154 . . . . 0.0 111.31 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.45 ' NE2' ' NE ' ' B' ' 309' ' ' ARG . 7.3 pt20 -46.37 -38.76 9.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 28.7 t -102.04 -15.77 16.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.89 51.14 2.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.3 mtp85 -80.63 17.33 1.15 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.978 -1.307 . . . . 0.0 109.048 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.0 t 47.67 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.688 0.756 . . . . 0.0 110.128 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.557 HD11 HG11 ' B' ' 283' ' ' VAL . 47.8 tp -47.44 145.6 2.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.569 -0.707 . . . . 0.0 109.519 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.4 m -45.7 142.98 2.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.892 . . . . 0.0 110.195 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.37 69.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -0.759 . . . . 0.0 109.607 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.443 ' SD ' ' CD ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -70.33 -52.03 25.7 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.911 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.401 ' CG2' HD21 ' B' ' 316' ' ' LEU . 35.9 mm -62.43 -42.28 95.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.61 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 18.0 tpt85 -65.33 -48.94 71.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.143 -0.973 . . . . 0.0 109.484 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.657 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.41 -31.36 79.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' B' ' 329' ' ' PHE . . . -62.19 -15.76 48.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.036 -1.273 . . . . 0.0 108.111 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -44.24 96.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 66.7 m-20 -105.17 -22.41 13.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 108.696 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 65.51 30.14 76.81 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.637 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.2 p -134.7 59.57 1.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' B' ' 327' ' ' SER . 95.1 mtt180 98.89 -31.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' B' ' 323' ' ' ALA . 88.5 t80 -97.37 119.73 36.44 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.406 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 82.0 mt-30 -145.71 142.11 28.68 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.901 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 30.4 t -107.85 100.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.502 ' CG ' HD11 ' B' ' 305' ' ' LEU . 21.4 m0 -95.34 152.62 18.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.248 -0.908 . . . . 0.0 109.578 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -97.23 155.65 16.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 108.822 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.585 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 6.2 p90 -170.28 -179.12 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.761 -1.212 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.59 149.61 27.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 335' ' ' ALA . 49.5 mt-10 -42.56 -29.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.707 -1.245 . . . . 0.0 110.18 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.33 -6.02 87.75 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.624 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -145.02 11.33 1.36 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.504 . . . . 0.0 110.6 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 5.0 p -54.3 -45.25 68.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.896 -1.128 . . . . 0.0 108.55 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 49.4 mt-10 -57.77 -32.76 67.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.498 -0.751 . . . . 0.0 109.203 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.7 m -68.33 -45.42 72.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.88 -51.21 58.44 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.12 -34.37 77.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.816 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.92 -41.43 95.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -68.75 -48.87 62.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.778 -1.201 . . . . 0.0 108.265 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.27 -48.1 83.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.856 . . . . 0.0 110.139 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.7 m-85 -69.85 -32.87 71.49 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.952 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 350' ' ' TYR . 26.4 mm-40 -62.27 -32.67 73.42 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -81.9 10.82 5.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.3 t80 -134.4 -105.14 0.23 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.236 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' B' ' 350' ' ' TYR . 15.0 mt -34.22 92.17 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 111.182 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' B' ' 350' ' ' TYR . 88.6 Cg_endo . . . . . 0 C--N 1.312 -1.351 0 C-N-CA 123.103 2.536 . . . . 0.0 111.074 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.8 Cg_exo -55.38 -154.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.386 2.057 . . . . 0.0 111.424 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 32.0 p -111.91 172.74 6.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 18.4 t -114.86 155.44 26.81 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 108.704 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 2.7 t -130.45 126.92 61.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.67 ' HB3' HG13 ' A' ' 79' ' ' VAL . 32.9 t80 -93.99 127.46 39.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 32' ' ' VAL . 17.8 t80 -100.81 130.7 46.87 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.787 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' GLU . 5.5 t -134.0 128.79 35.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.99 -178.96 33.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -76.02 118.7 19.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -1.192 . . . . 0.0 108.634 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.883 0.849 . . . . 0.0 111.235 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 49.4 mp0 -60.62 -53.28 59.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 108.934 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -55.31 -29.36 58.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 35.6 tp60 -64.34 -43.06 95.78 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -49.08 68.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 -34.22 67.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.2 m-30 -69.17 -41.32 77.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.983 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.0 84.69 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 109.11 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.56 -56.78 5.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.841 -1.162 . . . . 0.0 108.613 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -54.08 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 28' ' ' TYR . 45.5 t -65.27 -28.73 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.8 m -67.08 -40.47 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.593 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 -69.59 -47.26 64.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.806 -1.183 . . . . 0.0 109.113 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 12' ' ' VAL . 13.8 mt -60.71 -40.62 92.97 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.428 ' HA ' HG23 ' A' ' 41' ' ' VAL . 67.2 ttt-85 -62.57 -25.29 68.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.688 -0.632 . . . . 0.0 109.42 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -78.03 -37.58 46.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.576 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.0 m-85 -67.83 -45.73 73.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 110.534 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -152.63 -152.48 5.98 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -90.08 120.39 31.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -1.167 . . . . 0.0 109.388 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG11 HG13 ' A' ' 32' ' ' VAL . 3.7 t -89.61 115.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 15.9 mt -79.44 172.35 13.92 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.498 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 45' ' ' HIS . 4.7 m 54.23 41.86 31.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.257 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.32 -12.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 108.778 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 65' ' ' ILE . 47.4 t-80 -52.98 -45.57 67.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.387 -0.821 . . . . 0.0 109.614 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 69.2 t -39.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 50' ' ' GLU . . . -50.05 -42.53 49.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 108.903 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.859 ' O ' HD21 ' A' ' 51' ' ' LEU . 26.2 t70 -81.14 24.49 0.52 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -105.95 33.41 3.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.62 -21.33 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.938 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.08 163.62 20.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.499 -0.751 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 51' ' ' LEU . 14.6 mt-10 54.58 157.85 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' LEU . 23.2 Cg_endo -62.98 71.07 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.425 2.083 . . . . 0.0 111.475 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -54.97 -169.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 116.69 129.96 4.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 63.6 mt-10 -50.24 -33.69 20.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.248 . . . . 0.0 108.629 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -69.58 -24.07 63.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -62.09 150.02 39.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.88 11.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.908 . . . . 0.0 109.404 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -52.97 -30.88 38.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.56 76.8 1.18 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 56' ' ' GLU . 3.1 m-20 -52.96 -44.83 67.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.359 -1.083 . . . . 0.0 108.539 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -62.31 -45.5 92.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -55.45 -36.61 66.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 108.612 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.658 HD11 ' CE1' ' A' ' 45' ' ' HIS . 3.2 mt -67.61 -35.62 73.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.0 t-80 -79.4 -62.91 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 66' ' ' HIS . 72.2 mt-10 -43.58 -48.02 7.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.899 -1.126 . . . . 0.0 109.71 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -69.25 -42.75 75.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.115 -0.99 . . . . 0.0 109.371 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.522 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 1.2 m-20 -59.56 -47.06 87.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 110.307 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 1.5 mm? -65.21 -46.58 80.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.322 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 33.0 t-20 -61.86 -54.52 41.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.18 -34.78 75.61 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.208 -0.933 . . . . 0.0 109.236 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 39.5 tp -57.09 -41.56 79.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.122 -0.986 . . . . 0.0 108.754 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -76.9 -22.83 52.79 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.36 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 44.9 mt-30 -84.27 -9.09 58.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.108 . . . . 0.0 108.829 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 132.36 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.354 -0.841 . . . . 0.0 112.082 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 11' ' ' SER . 12.4 m-20 -86.95 -27.66 23.17 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 74.7 t -139.23 137.4 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.67 HG13 ' HB3' ' A' ' 13' ' ' TYR . 63.5 t -126.91 141.49 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.739 -1.226 . . . . 0.0 111.085 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 t -138.86 122.37 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.549 0.69 . . . . 0.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.61 128.76 53.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 110.044 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' HG11 ' A' ' 90' ' ' VAL . 46.5 mt-10 -87.71 125.91 34.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 108.549 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.602 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -115.74 27.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.428 -0.795 . . . . 0.0 109.747 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.5 ' C ' ' CZ ' ' A' ' 114' ' ' ARG . 4.3 m -78.39 23.97 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.903 . . . . 0.0 108.851 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.567 ' N ' ' CZ ' ' A' ' 114' ' ' ARG . 5.0 tp-100 -166.32 118.91 0.82 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.978 . . . . 0.0 109.373 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.67 ' N ' HH21 ' A' ' 114' ' ' ARG . 76.8 Cg_exo -45.44 108.75 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.061 1.841 . . . . 0.0 111.946 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 m -142.36 131.03 22.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.839 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD11 HH22 ' B' ' 314' ' ' ARG . 74.1 mt -68.66 -39.07 80.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -62.38 -45.03 96.78 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 82' ' ' GLU . 18.4 t -64.81 -48.61 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -1.034 . . . . 0.0 108.787 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.73 98.03 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.419 ' HB2' HD11 ' B' ' 320' ' ' ILE . 75.7 t80 -64.78 -49.15 71.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.457 -1.025 . . . . 0.0 109.756 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 6.2 tp10 -59.65 -32.02 70.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 81' ' ' ALA . 62.7 mt -70.78 -43.77 68.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.684 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -45.55 80.74 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -44.69 96.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.967 . . . . 0.0 108.748 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.39 -36.16 82.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.136 -0.978 . . . . 0.0 108.522 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -54.41 -44.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.877 -1.139 . . . . 0.0 108.071 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -86.67 -52.89 5.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.699 -0.626 . . . . 0.0 111.908 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.739 ' C ' HD13 ' A' ' 100' ' ' LEU . 2.2 tm? -92.34 -31.85 15.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.048 -1.033 . . . . 0.0 109.948 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -69.74 174.65 35.62 Favored Glycine 0 C--N 1.281 -2.507 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.754 ' H ' ' CD ' ' A' ' 103' ' ' PRO . 22.1 mttt -136.55 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 102' ' ' LYS . 59.3 Cg_endo -98.84 109.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 123.748 2.965 . . . . 0.0 109.684 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.425 HG21 ' CD2' ' A' ' 129' ' ' PHE . 37.8 mt -127.21 124.35 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.839 -1.163 . . . . 0.0 112.027 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.2 tp -123.52 116.08 22.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.448 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 1.5 m -105.94 147.2 29.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.867 -1.145 . . . . 0.0 108.894 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 mt -120.26 139.12 53.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.193 -0.942 . . . . 0.0 111.068 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -146.02 122.96 11.35 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 16.8 mtt180 -88.07 140.0 30.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.719 -1.238 . . . . 0.0 110.481 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.66 -29.03 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.415 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.31 -32.9 5.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -99.17 -26.36 14.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.496 -0.752 . . . . 0.0 109.114 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.49 49.49 32.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.67 HH21 ' N ' ' A' ' 86' ' ' PRO . 10.4 mtp-105 -75.11 -11.41 60.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.035 -1.274 . . . . 0.0 111.205 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 114' ' ' ARG . 38.8 t 59.46 119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 116' ' ' LEU . 2.4 mt -77.34 158.64 30.03 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.84 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.454 ' OG ' ' CA ' ' B' ' 289' ' ' GLY . 0.3 OUTLIER -54.13 145.15 17.79 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.768 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.63 -19.09 5.37 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 108.696 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.496 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 1.0 OUTLIER -77.9 -45.18 24.86 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.399 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' B' ' 292' ' ' TYR . 42.5 mm -66.71 -48.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.2 -0.938 . . . . 0.0 108.575 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.443 ' CZ ' HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -68.4 -44.68 74.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.247 -0.908 . . . . 0.0 108.81 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -64.15 -28.23 72.61 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -40.68 -64.65 0.5 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.553 -0.969 . . . . 0.0 110.273 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -150.94 -95.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.204 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 15.0 p-10 111.54 5.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.53 70.77 0.02 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.836 ' C ' ' H ' ' A' ' 129' ' ' PHE . 37.5 p -164.15 66.34 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 66.43 -20.3 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.836 ' H ' ' C ' ' A' ' 127' ' ' SER . 9.3 t80 -117.77 118.76 32.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.601 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 31.3 tt0 -137.19 134.28 36.11 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.205 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 121' ' ' ARG . 69.5 t -91.85 105.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.601 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 13.7 m0 -102.14 142.35 33.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.171 -0.955 . . . . 0.0 109.724 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 54.0 m-20 -97.79 157.17 16.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.062 -1.024 . . . . 0.0 108.947 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' OH ' ' NE ' ' A' ' 109' ' ' ARG . 10.0 p90 -165.29 -172.72 2.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.591 -1.318 . . . . 0.0 111.936 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -159.27 148.37 18.34 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.4 mt-10 -42.93 -37.12 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.76 -1.213 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.92 2.86 53.71 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.207 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.97 7.14 0.52 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.58 -1.541 . . . . 0.0 110.601 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.8 p -53.99 -45.36 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.97 -1.081 . . . . 0.0 108.53 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 44.6 mt-10 -57.07 -33.67 67.5 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 83.9 m -68.19 -45.07 74.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.707 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.437 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.4 tpp -51.63 -48.13 63.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.76 -35.06 74.61 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 77.8 m-20 -65.59 -39.66 91.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 110.315 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -69.65 -50.29 45.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.818 -1.176 . . . . 0.0 108.315 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.92 -46.98 87.61 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.958 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 151' ' ' LEU . 12.2 m-85 -68.96 -34.05 74.71 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.136 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.03 -23.9 66.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.34 59.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.675 -0.641 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -156.04 -48.86 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.221 -1.55 . . . . 0.0 112.715 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.721 HD12 ' CD1' ' A' ' 147' ' ' PHE . 4.1 mt -38.32 -57.93 1.67 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.916 -1.115 . . . . 0.0 111.562 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 12.0 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 121.763 1.642 . . . . 0.0 111.741 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ALA . 31.7 Cg_exo -55.52 -154.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.276 1.984 . . . . 0.0 111.377 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.6 p -112.21 172.75 6.72 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 19.4 t -114.97 155.35 27.08 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.756 -1.215 . . . . 0.0 108.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 2.6 t -130.49 127.1 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' B' ' 279' ' ' VAL . 33.5 t80 -93.8 127.6 39.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.632 ' CD2' HG22 ' B' ' 232' ' ' VAL . 17.9 t80 -100.86 130.7 46.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.81 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' B' ' 293' ' ' GLU . 5.7 t -134.04 129.08 35.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.532 -0.73 . . . . 0.0 109.415 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -159.36 -178.85 33.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.7 p -76.11 118.06 18.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 0.0 108.757 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.457 HG23 ' OE1' ' B' ' 225' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.274 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.902 0.858 . . . . 0.0 111.319 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 49.0 mp0 -60.5 -53.14 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 108.983 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.48 -29.01 57.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' B' ' 222' ' ' ARG . 36.1 tp60 -64.68 -43.15 94.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.44 -0.787 . . . . 0.0 109.21 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -34.09 67.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.635 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.4 m-30 -69.28 -41.32 76.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.182 -0.949 . . . . 0.0 110.037 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.26 85.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.59 -1.319 . . . . 0.0 109.161 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -70.37 -56.67 6.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.834 -1.166 . . . . 0.0 108.654 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 83.0 mt -54.09 -41.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.7 t -65.16 -28.63 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.761 . . . . 0.0 109.103 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.1 m -67.31 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -69.7 -47.87 61.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.891 -1.131 . . . . 0.0 109.078 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.56 HD22 HG11 ' B' ' 212' ' ' VAL . 13.1 mt -60.1 -40.77 90.79 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.431 ' HA ' HG23 ' B' ' 241' ' ' VAL . 64.7 ttt-85 -62.29 -25.45 67.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.695 -0.628 . . . . 0.0 109.458 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -78.0 -37.69 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.975 . . . . 0.0 109.535 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.573 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.0 m-85 -67.71 -45.51 74.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.591 -0.693 . . . . 0.0 110.541 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.86 -152.53 6.02 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -90.24 120.63 31.56 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.365 -1.079 . . . . 0.0 109.389 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.632 HG11 HG13 ' B' ' 232' ' ' VAL . 3.6 t -89.81 116.21 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.473 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 15.7 mt -79.81 172.15 14.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.082 -1.012 . . . . 0.0 109.491 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.495 ' C ' ' N ' ' B' ' 245' ' ' HIS . 4.5 m 54.38 41.92 31.7 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.36 -0.837 . . . . 0.0 109.322 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -50.64 -12.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 108.766 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.646 ' CE1' HD11 ' B' ' 265' ' ' ILE . 46.7 t-80 -53.59 -45.14 69.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.5 -0.75 . . . . 0.0 109.426 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 249' ' ' ALA . 68.9 t -39.87 -79.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.622 -0.674 . . . . 0.0 109.992 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' B' ' 250' ' ' GLU . . . -49.69 -42.6 46.12 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.237 -0.915 . . . . 0.0 108.908 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.86 ' O ' HD21 ' B' ' 251' ' ' LEU . 24.3 t70 -80.82 24.22 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 246' ' ' VAL . . . -105.73 33.61 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' B' ' 247' ' ' ALA . 0.1 OUTLIER -123.5 -22.12 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.932 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -82.62 163.09 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.459 -0.776 . . . . 0.0 109.564 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' B' ' 251' ' ' LEU . 14.9 mt-10 54.82 157.75 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 109.88 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 254' ' ' LEU . 22.6 Cg_endo -62.74 71.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.441 2.094 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.796 HD23 ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER -55.66 -169.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.902 . . . . 0.0 109.454 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 117.5 129.97 4.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' B' ' 262' ' ' ASP . 61.6 mt-10 -50.1 -33.8 19.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.088 -1.242 . . . . 0.0 108.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -69.52 -24.55 63.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -61.56 150.04 37.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.488 -0.758 . . . . 0.0 109.351 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.73 11.1 0.15 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -52.68 -31.26 37.29 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.68 77.27 1.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' B' ' 256' ' ' GLU . 2.7 m-20 -52.89 -44.94 67.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -1.111 . . . . 0.0 108.589 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -62.04 -46.0 91.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.26 -37.12 66.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.961 . . . . 0.0 108.557 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.646 HD11 ' CE1' ' B' ' 245' ' ' HIS . 3.3 mt -67.26 -35.25 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' B' ' 267' ' ' GLU . 4.1 t-80 -79.69 -63.35 1.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 109.859 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' B' ' 266' ' ' HIS . 72.7 mt-10 -42.94 -48.44 5.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.67 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -69.03 -42.57 76.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.472 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.535 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 1.2 m-20 -59.85 -46.89 87.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 1.6 mm? -65.17 -46.83 79.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 110.424 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 32.9 t-20 -61.77 -54.52 41.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.138 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.473 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -61.15 -34.99 75.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.151 -0.968 . . . . 0.0 109.077 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 38.2 tp -56.89 -41.08 77.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.0 108.822 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -77.48 -22.53 51.15 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 44.1 mt-30 -84.55 -8.78 58.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.14 . . . . 0.0 108.884 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.88 132.39 45.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.402 -0.811 . . . . 0.0 112.131 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' B' ' 211' ' ' SER . 9.7 m-20 -86.63 -27.88 23.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 63.6 t -139.33 137.94 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' B' ' 213' ' ' TYR . 64.8 t -127.14 141.54 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.852 -1.155 . . . . 0.0 111.131 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 18.3 t -138.71 121.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.514 -0.741 . . . . 0.0 109.306 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.02 128.98 54.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.005 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.508 ' O ' HG11 ' B' ' 290' ' ' VAL . 46.3 mt-10 -88.08 125.52 34.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.59 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -115.28 27.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 109.658 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.492 ' C ' ' CZ ' ' B' ' 314' ' ' ARG . 4.1 m -78.42 24.51 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 108.91 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.574 ' N ' ' CZ ' ' B' ' 314' ' ' ARG . 4.9 tp-100 -166.65 118.5 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.658 ' N ' HH21 ' B' ' 314' ' ' ARG . 74.4 Cg_exo -45.31 109.13 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.011 1.807 . . . . 0.0 111.898 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 29.4 m -142.34 131.23 22.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 70.7 mt -69.21 -38.31 78.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 289' ' ' GLY . . . . . 0.454 ' CA ' ' OG ' ' A' ' 117' ' ' SER . . . -63.08 -44.98 96.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.508 HG11 ' O ' ' B' ' 282' ' ' GLU . 17.4 t -64.74 -48.7 83.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -1.036 . . . . 0.0 108.703 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -62.02 -39.57 97.76 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.414 ' HB2' HD11 ' A' ' 120' ' ' ILE . 74.7 t80 -65.08 -49.13 71.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -1.036 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.525 ' CB ' ' SG ' ' B' ' 215' ' ' CYS . 6.8 tp10 -59.55 -32.08 70.0 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' B' ' 281' ' ' ALA . 61.0 mt -70.72 -43.86 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 108.691 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.27 81.48 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -43.96 97.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.597 -0.943 . . . . 0.0 108.8 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -67.16 -36.14 81.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.137 -0.977 . . . . 0.0 108.429 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.477 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.7 OUTLIER -54.31 -44.53 66.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -86.76 -52.95 5.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.914 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.747 ' C ' HD13 ' B' ' 300' ' ' LEU . 2.2 tm? -92.13 -31.84 15.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 109.93 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -69.75 174.55 35.85 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.758 ' H ' ' CD ' ' B' ' 303' ' ' PRO . 22.6 mttt -136.59 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.758 ' CD ' ' H ' ' B' ' 302' ' ' LYS . 58.7 Cg_endo -98.83 109.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 123.703 2.935 . . . . 0.0 109.704 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' B' ' 329' ' ' PHE . 37.7 mt -127.53 124.39 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.8 -1.188 . . . . 0.0 112.087 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 25.3 tp -123.73 115.97 22.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 306' ' ' CYS . . . . . 0.454 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 1.5 m -105.4 147.36 28.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 108.88 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.494 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.1 mt -120.47 138.97 53.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.088 -1.008 . . . . 0.0 110.997 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' B' ' 333' ' ' ASP . 0.6 OUTLIER -145.89 122.99 11.45 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.572 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 15.7 mtt180 -88.25 140.3 30.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.726 -1.234 . . . . 0.0 110.378 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.78 -28.79 6.05 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.631 2.221 . . . . 0.0 111.623 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -47.56 -32.69 5.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 20.6 t -99.31 -26.28 14.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.064 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 49.33 49.62 31.26 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.658 HH21 ' N ' ' B' ' 286' ' ' PRO . 10.3 mtp-105 -75.1 -11.36 60.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.303 . . . . 0.0 111.218 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' B' ' 314' ' ' ARG . 38.4 t 59.6 119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.54 HD23 ' N ' ' B' ' 316' ' ' LEU . 2.4 mt -77.36 158.29 30.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.646 -1.221 . . . . 0.0 108.822 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 0.4 OUTLIER -53.78 145.27 16.2 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.712 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.74 -19.04 5.46 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.269 -0.895 . . . . 0.0 108.729 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.492 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -77.99 -45.41 23.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.337 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 92' ' ' TYR . 40.1 mm -66.26 -48.61 80.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.615 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.446 ' CZ ' HG11 ' B' ' 331' ' ' VAL . 0.1 OUTLIER -68.55 -44.19 75.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.935 . . . . 0.0 108.748 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -64.11 -29.0 73.69 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -40.14 -65.21 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.555 -0.968 . . . . 0.0 110.314 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -150.78 -95.18 0.06 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.233 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 15.0 p-10 111.47 4.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 161.46 70.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.823 ' C ' ' H ' ' B' ' 329' ' ' PHE . 32.8 p -164.31 66.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 66.33 -20.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.823 ' H ' ' C ' ' B' ' 327' ' ' SER . 8.8 t80 -117.53 118.9 33.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 31.7 tt0 -137.22 134.1 35.87 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.209 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 331' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' B' ' 321' ' ' ARG . 72.8 t -91.67 106.01 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 13.7 m0 -102.14 142.31 33.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.115 -0.991 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' B' ' 308' ' ' PHE . 53.9 m-20 -97.77 157.27 16.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.937 -1.102 . . . . 0.0 108.921 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.572 ' OH ' ' NE ' ' B' ' 309' ' ' ARG . 10.2 p90 -165.0 -171.88 2.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.629 -1.294 . . . . 0.0 111.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.461 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -159.97 148.31 17.11 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.4 mt-10 -42.85 -37.13 1.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.724 -1.235 . . . . 0.0 110.234 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.13 3.35 52.6 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -151.62 7.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.537 -1.566 . . . . 0.0 110.559 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.52 HG13 ' N ' ' B' ' 340' ' ' GLU . 6.2 p -53.97 -45.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 108.556 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.52 ' N ' HG13 ' B' ' 339' ' ' VAL . 42.5 mt-10 -57.14 -34.14 68.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.3 m -67.45 -45.51 75.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.147 -0.971 . . . . 0.0 109.658 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.423 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.4 tpp -51.42 -48.06 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 46.6 mt -69.65 -35.02 74.81 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.72 -39.43 91.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.927 -1.108 . . . . 0.0 110.294 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -70.05 -50.1 44.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.937 -1.102 . . . . 0.0 108.243 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.94 -47.3 86.35 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.017 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.719 ' CD1' HD12 ' B' ' 351' ' ' LEU . 12.5 m-85 -68.76 -33.83 74.57 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.149 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.59 -9.92 58.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.785 -0.572 . . . . 0.0 111.428 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -156.31 -48.88 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.161 -1.587 . . . . 0.0 112.643 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.719 HD12 ' CD1' ' B' ' 347' ' ' PHE . 4.0 mt -38.62 -57.85 1.81 Allowed Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.961 -1.087 . . . . 0.0 111.526 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 12.1 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 121.826 1.684 . . . . 0.0 111.703 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.52 -152.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.318 2.012 . . . . 0.0 111.444 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.6 p -109.97 -179.69 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 20.5 p -120.03 158.24 27.22 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG11 HD22 ' A' ' 35' ' ' LEU . 2.2 t -136.67 137.1 47.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.849 0.833 . . . . 0.0 109.565 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 6.8 t80 -123.14 101.28 7.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.539 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -94.49 127.71 40.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.341 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 12.0 m -85.36 149.75 25.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -156.44 165.17 32.82 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.499 ' CB ' ' OG ' ' A' ' 87' ' ' SER . 6.1 t -91.8 130.05 37.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.444 0.64 . . . . 0.0 109.326 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -53.83 -39.8 65.89 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.6 m-20 -64.91 -27.02 68.57 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.686 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 8.9 tp60 -64.88 -41.88 95.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.08 63.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -26.98 68.45 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 108.765 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.661 ' O ' HG23 ' A' ' 32' ' ' VAL . 12.6 m-30 -68.49 -46.75 68.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.01 74.75 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.357 -1.337 . . . . 0.0 107.924 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 33' ' ' SER . 57.4 ttt180 -71.97 -58.39 3.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.93 -1.106 . . . . 0.0 108.671 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 32' ' ' VAL . 6.0 tt -52.37 -40.3 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 28' ' ' TYR . 44.5 t -64.31 -29.54 47.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 30' ' ' ARG . 19.4 p -67.78 -39.85 84.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.743 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -71.7 -49.29 40.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.702 -1.249 . . . . 0.0 108.591 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.735 HD22 HG11 ' A' ' 12' ' ' VAL . 10.4 mt -56.63 -39.46 73.7 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -65.8 -23.63 66.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -76.39 -36.77 57.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.988 -1.07 . . . . 0.0 108.988 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.574 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-30 -70.3 -48.53 56.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.5 -140.19 3.02 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -101.02 136.45 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG11 HG13 ' A' ' 32' ' ' VAL . 68.3 t -101.88 122.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 10.6 mt -84.2 -42.85 15.52 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.511 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.727 ' O ' HG23 ' A' ' 43' ' ' THR . 13.7 t -67.54 60.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 109.771 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' LEU . 83.7 mt-10 -82.83 -25.34 32.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.059 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.65 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 12.8 p-80 -53.19 -45.78 68.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.686 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -55.64 -60.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HG13 ' A' ' 46' ' ' VAL . . . -59.41 -31.93 69.72 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.826 -1.171 . . . . 0.0 108.973 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.639 ' C ' HD21 ' A' ' 51' ' ' LEU . 22.0 t70 -87.92 48.25 1.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.466 -0.771 . . . . 0.0 109.104 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB3' HE21 ' A' ' 25' ' ' GLN . . . -135.24 -16.03 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.43 -11.83 59.89 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.028 -1.045 . . . . 0.0 109.165 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.109 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.7 -43.95 72.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.172 -0.955 . . . . 0.0 108.686 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 3.3 tt0 -176.9 -48.47 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.538 -0.727 . . . . 0.0 109.422 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 15.4 Cg_exo -69.9 106.5 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.662 2.241 . . . . 0.0 111.56 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -148.06 110.51 4.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.352 -0.843 . . . . 0.0 109.369 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 130.26 42.05 0.22 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 61.0 mt-10 53.58 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -1.038 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.0 tt0 -42.59 -33.11 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 108.915 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' PRO . . . -106.49 65.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.01 -40.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.66 54.6 0.77 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.41 76.56 1.14 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -51.25 -43.76 61.58 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.2 -44.66 83.85 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -58.34 -34.76 70.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.547 HG12 ' CD2' ' A' ' 45' ' ' HIS . 0.4 OUTLIER -68.17 -32.42 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.421 ' CE1' HD22 ' A' ' 70' ' ' LEU . 23.3 t-80 -78.19 -64.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 68' ' ' GLN . 19.2 pt-20 -50.12 -44.56 52.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 109.572 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 51.5 tt0 -66.48 -48.23 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.39 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD2' ' CE1' ' A' ' 45' ' ' HIS . 84.0 m-20 -70.85 -54.38 11.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.982 . . . . 0.0 110.985 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 66' ' ' HIS . 5.1 tp -56.58 -39.11 72.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 85.7 m-20 -63.68 -52.78 59.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.396 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.29 -41.21 83.9 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.468 -0.893 . . . . 0.0 108.731 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 11.8 tp -50.32 -41.38 51.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.41 -27.23 63.16 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.447 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 34.7 mt-30 -88.98 0.13 56.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.958 -1.089 . . . . 0.0 109.352 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.09 130.89 44.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.897 . . . . 0.0 111.862 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 11' ' ' SER . 38.8 t0 -80.6 -32.97 36.27 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.16 144.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.8 t -136.08 124.81 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 111.501 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 81' ' ' ALA . 24.0 t -117.98 176.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.626 ' H ' HG12 ' A' ' 80' ' ' VAL . . . -164.15 116.03 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.574 -1.329 . . . . 0.0 110.033 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -79.22 142.94 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -147.66 148.38 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.785 -179.416 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 2.7 m -171.82 -42.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -129.47 152.56 79.82 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD23 ' B' ' 288' ' ' LEU . 76.4 Cg_exo -36.36 147.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.604 2.202 . . . . 0.0 112.731 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.584 ' H ' ' CD2' ' B' ' 288' ' ' LEU . 12.9 t -175.34 123.0 0.22 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 110.484 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.685 HD12 HG13 ' B' ' 320' ' ' ILE . 2.2 mm? -71.32 -44.72 64.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.03 -36.69 75.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' A' ' 87' ' ' SER . 11.8 t -75.75 -49.09 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -1.032 . . . . 0.0 109.495 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' CA ' HD13 ' B' ' 288' ' ' LEU . . . -67.6 -37.97 89.87 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.846 -1.169 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -69.45 -52.19 29.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -1.186 . . . . 0.0 109.867 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' OE2' ' SD ' ' B' ' 319' ' ' MET . 95.1 mt-10 -63.22 -30.86 71.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.514 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.8 mt -69.79 -47.46 62.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.971 . . . . 0.0 109.249 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.15 -36.77 93.44 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -62.24 -41.76 98.7 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.556 -0.967 . . . . 0.0 109.366 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.2 -38.52 78.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.897 -1.127 . . . . 0.0 108.956 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.36 -40.65 32.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -82.21 -53.01 6.4 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.71 -9.23 2.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -0.999 . . . . 0.0 110.206 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 102' ' ' LYS . . . 54.5 94.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.979 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 104' ' ' ILE . 41.8 mttm -164.66 150.81 9.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 79' ' ' VAL . 82.4 Cg_exo -38.83 104.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.707 1.605 . . . . 0.0 111.332 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.2 mt -107.09 95.45 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.771 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.63 118.29 35.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 143.09 49.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -132.1 144.11 50.49 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.063 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.79 147.42 50.79 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 134' ' ' TYR . 12.3 mtt180 -99.31 142.32 24.4 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.237 . . . . 0.0 111.472 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' GLY . 89.1 Cg_endo -80.82 -31.24 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.855 2.37 . . . . 0.0 110.944 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -45.62 -38.57 6.76 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 21.8 p -95.69 -20.52 18.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.86 43.43 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' VAL . 61.0 mtt180 -79.37 13.03 2.09 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -1.114 . . . . 0.0 109.387 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 114' ' ' ARG . 75.8 t 49.57 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.408 -0.807 . . . . 0.0 110.157 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.505 HD11 HG11 ' A' ' 83' ' ' VAL . 24.2 tp -45.15 158.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.88 142.99 22.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 111.089 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.515 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -56.99 -50.68 71.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.73 -0.606 . . . . 0.0 110.339 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.51 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 19.5 mtp -65.89 -38.37 88.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.927 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.662 HG13 HD12 ' B' ' 288' ' ' LEU . 5.1 mm -66.34 -44.92 90.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.064 -1.023 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -74.46 -44.41 51.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.025 -1.047 . . . . 0.0 109.055 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.48 -22.33 61.26 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -45.77 -60.91 1.96 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.477 -1.013 . . . . 0.0 109.937 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -156.7 -88.18 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.147 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER 97.24 -1.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -179.92 85.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.777 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 162.08 74.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.475 -1.015 . . . . 0.0 109.595 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 67.04 -23.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.777 ' H ' ' C ' ' A' ' 127' ' ' SER . 12.8 t80 -123.28 118.89 28.6 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.23 138.3 43.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 111.214 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 84.7 t -101.95 99.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 21.0 m0 -93.76 148.68 21.9 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -93.75 147.71 22.79 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.5 p90 -168.02 174.31 7.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.363 -1.461 . . . . 0.0 112.133 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -140.6 147.28 39.14 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 135' ' ' ALA . 50.0 mt-10 -41.99 -30.3 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.932 -1.105 . . . . 0.0 110.581 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.25 1.46 88.78 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.999 -1.063 . . . . 0.0 110.752 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -135.82 -2.76 2.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.958 -1.319 . . . . 0.0 109.975 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 1.4 p -52.15 -45.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.013 -1.054 . . . . 0.0 108.161 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 27.6 mt-10 -52.67 -36.62 57.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -40.8 90.06 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.461 -0.775 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 11.4 mmt -55.67 -54.87 38.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 37.2 mt -59.71 -27.03 66.1 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.46 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 16.5 t70 -69.47 -46.86 65.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 0.0 111.111 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -73.81 -44.08 56.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.477 -1.389 . . . . 0.0 109.805 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 42.3 t80 -60.41 -46.53 89.69 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.764 ' CD1' HD12 ' A' ' 151' ' ' LEU . 11.4 m-85 -74.77 -34.4 62.45 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.349 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -68.93 -23.31 64.15 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.238 -1.538 . . . . 0.0 107.425 178.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.46 -10.46 55.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.623 -0.673 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.607 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -154.91 -47.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.419 -1.426 . . . . 0.0 112.16 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 147' ' ' PHE . 2.3 mt -41.52 -54.34 6.5 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.97 -1.081 . . . . 0.0 111.076 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 121.986 1.791 . . . . 0.0 112.141 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.27 -152.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 111.571 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 15.0 p -110.06 -179.75 3.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 17.2 p -120.1 157.73 28.36 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.734 HG11 HD22 ' B' ' 235' ' ' LEU . 2.2 t -136.18 137.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.782 0.801 . . . . 0.0 109.57 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 6.8 t80 -123.04 101.54 7.47 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.2 OUTLIER -94.82 127.41 40.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 109.163 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.433 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 12.4 m -85.13 148.82 25.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.002 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' B' ' 228' ' ' TYR . . . -155.19 164.95 32.14 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.781 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.503 ' CB ' ' OG ' ' B' ' 287' ' ' SER . 6.2 t -92.12 129.52 38.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.644 -0.915 . . . . 0.0 109.388 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -53.58 -39.84 65.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 75.4 m-20 -64.89 -27.15 68.66 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.7 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 9.2 tp60 -64.84 -41.34 95.79 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.99 63.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.97 -26.89 68.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 108.72 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.648 ' O ' HG23 ' B' ' 232' ' ' VAL . 12.7 m-30 -68.6 -46.72 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.667 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.97 -32.83 74.51 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.368 -1.333 . . . . 0.0 107.939 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' B' ' 233' ' ' SER . 57.6 ttt180 -72.09 -58.5 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.851 -1.155 . . . . 0.0 108.715 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' B' ' 232' ' ' VAL . 5.9 tt -52.15 -40.48 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.6 t -64.28 -29.43 47.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 20.1 p -67.76 -39.81 84.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -71.86 -49.13 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.786 -1.196 . . . . 0.0 108.601 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.734 HD22 HG11 ' B' ' 212' ' ' VAL . 9.9 mt -56.94 -39.37 74.4 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -65.64 -23.7 66.86 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -76.54 -37.17 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.948 -1.095 . . . . 0.0 108.932 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.591 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -69.87 -48.43 58.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.554 -0.716 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -153.32 -140.5 3.08 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -101.08 136.53 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -1.104 . . . . 0.0 109.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.642 HG11 HG13 ' B' ' 232' ' ' VAL . 62.1 t -101.9 122.8 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 10.7 mt -84.08 -42.66 15.86 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.478 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.749 ' O ' HG23 ' B' ' 243' ' ' THR . 13.8 t -67.36 60.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.845 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' B' ' 242' ' ' LEU . 82.7 mt-10 -82.58 -25.98 32.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.119 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.648 ' CG ' ' N ' ' B' ' 246' ' ' VAL . 12.8 p-80 -52.48 -45.69 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.7 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 0.2 OUTLIER -55.97 -60.15 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 109.546 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.471 ' H ' HG13 ' B' ' 246' ' ' VAL . . . -59.28 -31.63 69.28 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.91 -1.119 . . . . 0.0 108.915 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.647 ' C ' HD21 ' B' ' 251' ' ' LEU . 22.4 t70 -88.26 48.01 1.58 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.721 0.772 . . . . 0.0 109.244 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.561 ' HB3' HE21 ' B' ' 225' ' ' GLN . . . -134.89 -16.19 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' B' ' 250' ' ' GLU . 1.0 OUTLIER -77.4 -11.8 59.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.105 -0.997 . . . . 0.0 109.276 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 1.06 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -54.79 -43.13 72.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 108.651 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 3.3 tt0 -177.83 -48.28 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.326 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 16.0 Cg_exo -69.83 106.27 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.617 2.211 . . . . 0.0 111.661 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.463 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.3 OUTLIER -147.99 110.41 4.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.87 . . . . 0.0 109.494 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 130.34 41.85 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 64.8 mt-10 53.87 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.474 -1.015 . . . . 0.0 109.812 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.2 tt0 -43.14 -32.29 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 108.942 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' B' ' 253' ' ' PRO . . . -106.96 65.55 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -148.57 -40.51 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.098 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 105.46 53.95 0.76 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.96 76.46 1.11 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -51.02 -43.54 60.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.44 -44.37 84.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.55 -35.35 72.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.539 HG12 ' CD2' ' B' ' 245' ' ' HIS . 0.4 OUTLIER -67.57 -32.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.409 ' CE1' HD22 ' B' ' 270' ' ' LEU . 23.3 t-80 -78.06 -65.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' B' ' 268' ' ' GLN . 19.1 pt-20 -49.58 -44.34 46.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.995 -1.066 . . . . 0.0 109.689 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 268' ' ' GLN . . . . . 0.507 ' N ' ' CG ' ' B' ' 267' ' ' GLU . 51.7 tt0 -66.7 -48.59 68.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' B' ' 245' ' ' HIS . 85.3 m-20 -70.51 -54.16 13.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' B' ' 266' ' ' HIS . 5.2 tp -56.75 -39.28 73.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.982 . . . . 0.0 109.726 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 84.0 m-20 -63.45 -52.69 60.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -58.67 -41.14 85.44 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 108.728 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.535 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 11.7 tp -50.39 -41.24 51.72 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -71.42 -27.34 63.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.307 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 34.7 mt-30 -89.16 0.56 56.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.913 -1.117 . . . . 0.0 109.32 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.67 130.31 42.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.279 -0.888 . . . . 0.0 111.891 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' B' ' 211' ' ' SER . 40.6 t0 -80.23 -32.74 38.39 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.38 144.0 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' B' ' 213' ' ' TYR . 80.8 t -135.92 124.92 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.98 -1.075 . . . . 0.0 111.353 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 280' ' ' VAL . . . . . 0.621 HG12 ' H ' ' B' ' 281' ' ' ALA . 25.5 t -118.02 176.82 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.621 ' H ' HG12 ' B' ' 280' ' ' VAL . . . -164.01 115.69 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.576 -1.328 . . . . 0.0 110.089 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.93 143.22 36.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 108.67 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -147.88 148.23 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.098 -1.001 . . . . 0.0 109.772 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 2.8 m -171.72 -42.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -130.19 151.92 79.23 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 88' ' ' LEU . 77.0 Cg_exo -35.87 146.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.675 2.25 . . . . 0.0 112.682 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.562 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 14.8 t -175.46 122.46 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 0.0 110.525 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.662 HD12 HG13 ' A' ' 120' ' ' ILE . 2.2 mm? -70.99 -43.94 66.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.333 -0.854 . . . . 0.0 109.655 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.42 -36.56 77.45 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' B' ' 287' ' ' SER . 11.7 t -76.1 -49.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -1.076 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 291' ' ' GLY . . . . . 0.482 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -67.41 -37.98 90.69 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -69.77 -52.11 28.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -1.187 . . . . 0.0 109.926 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.51 ' OE2' ' SD ' ' A' ' 119' ' ' MET . 95.9 mt-10 -63.2 -31.15 72.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.222 -0.923 . . . . 0.0 109.495 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.4 mt -69.65 -47.35 63.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.73 93.33 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -62.42 -41.58 98.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.546 -0.973 . . . . 0.0 109.299 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.64 79.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.956 -1.09 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.409 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.6 OUTLIER -52.24 -40.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -81.88 -53.13 6.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.079 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.86 -9.16 2.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.104 -0.997 . . . . 0.0 110.206 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' B' ' 302' ' ' LYS . . . 54.41 94.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.94 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 41.4 mttm -165.04 150.54 8.51 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' B' ' 279' ' ' VAL . 82.8 Cg_exo -38.63 104.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.75 1.634 . . . . 0.0 111.296 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.2 mt -106.82 95.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.654 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.73 118.53 36.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 142.29 50.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.602 HD12 ' N ' ' B' ' 307' ' ' LEU . 0.4 OUTLIER -131.3 143.62 50.67 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.298 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -128.11 147.49 50.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -99.19 141.82 23.53 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.732 -1.23 . . . . 0.0 111.516 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 313' ' ' GLY . 92.7 Cg_endo -80.27 -31.63 1.61 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.807 2.338 . . . . 0.0 110.954 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 310' ' ' PRO . 20.2 pt20 -45.47 -38.65 6.38 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.0 p -95.66 -20.02 19.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.46 43.09 1.47 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.0 mtt180 -78.98 13.0 1.91 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.346 -1.091 . . . . 0.0 109.424 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 314' ' ' ARG . 79.6 t 49.42 101.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.366 -0.834 . . . . 0.0 110.255 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.525 HD11 HG11 ' B' ' 283' ' ' VAL . 24.0 tp -45.19 158.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.64 142.75 22.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 111.05 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 318' ' ' ALA . . . . . 0.479 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.93 -50.66 71.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.367 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.514 ' SD ' ' OE2' ' A' ' 93' ' ' GLU . 19.3 mtp -65.65 -38.65 89.94 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.964 -1.085 . . . . 0.0 109.859 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.685 HG13 HD12 ' A' ' 88' ' ' LEU . 5.1 mm -66.24 -44.86 91.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -74.26 -44.47 52.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.952 -1.093 . . . . 0.0 108.97 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -61.55 -22.33 61.43 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 320' ' ' ILE . . . -45.49 -61.04 1.85 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.576 -0.956 . . . . 0.0 110.047 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -156.64 -87.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.967 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 0.7 OUTLIER 96.99 -1.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -177.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -179.59 84.95 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.783 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.1 p 162.37 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.406 -1.055 . . . . 0.0 109.737 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 67.11 -23.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.783 ' H ' ' C ' ' B' ' 327' ' ' SER . 11.9 t80 -123.65 118.97 28.48 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.21 138.68 43.85 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.212 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 331' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 83.9 t -102.3 100.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 21.1 m0 -94.04 148.58 22.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.85 148.13 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.6 p90 -168.53 174.37 6.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.114 -1.434 . . . . 0.0 112.057 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -140.69 147.28 39.0 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.5 mt-10 -41.86 -30.37 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.605 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.19 1.31 88.93 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.766 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -135.53 -2.72 2.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.95 -1.324 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 1.4 p -52.31 -45.81 44.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 26.5 mt-10 -52.93 -36.34 59.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 24.4 m -66.37 -41.03 90.04 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 11.6 mmt -55.34 -54.99 36.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 39.6 mt -59.61 -27.17 66.07 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' B' ' 348' ' ' GLU . 15.9 t70 -69.33 -46.79 66.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -0.966 . . . . 0.0 111.184 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -73.64 -44.36 57.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.333 -1.48 . . . . 0.0 109.846 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' TYR . . . . . 0.429 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 42.2 t80 -60.18 -46.49 89.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.738 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.765 ' CD1' HD12 ' B' ' 351' ' ' LEU . 11.5 m-85 -74.88 -34.23 62.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.437 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 348' ' ' GLU . 0.7 OUTLIER -69.07 -23.38 64.02 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 117.846 -1.542 . . . . 0.0 107.485 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.4 -10.23 53.75 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.612 -0.68 . . . . 0.0 110.468 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -155.11 -47.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.46 -1.4 . . . . 0.0 112.15 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' B' ' 347' ' ' PHE . 2.2 mt -41.53 -54.33 6.53 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 110.998 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 C--N 1.308 -1.574 0 C-N-CA 122.008 1.805 . . . . 0.0 112.231 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 -155.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.402 2.068 . . . . 0.0 110.965 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 26.4 p -99.67 178.02 4.97 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.576 ' OG ' HD21 ' A' ' 42' ' ' LEU . 3.0 t -116.08 152.95 32.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.81 132.63 56.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.431 -0.793 . . . . 0.0 109.348 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' CZ ' ' OE2' ' A' ' 44' ' ' GLU . 39.2 t80 -96.34 147.1 24.15 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.673 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.6 t80 -110.45 133.21 53.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.029 . . . . 0.0 111.517 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 102.53 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.29 177.58 19.48 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 122.86 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -1.061 . . . . 0.0 109.73 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.727 ' CD1' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 108.654 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.496 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 12.5 ptm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.901 0.858 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -55.96 -39.27 71.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 86.9 m-20 -60.03 -33.34 71.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.496 ' H ' ' HG3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -63.24 -46.83 85.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -50.19 69.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.62 -35.49 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 32' ' ' VAL . 18.5 m-30 -67.44 -47.7 69.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.93 75.8 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.681 -1.262 . . . . 0.0 108.803 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 -68.69 -57.15 6.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 108.609 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -50.88 -45.2 28.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 28' ' ' TYR . 94.5 t -59.65 -30.63 45.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -66.02 -40.13 90.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.115 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -63.45 -41.99 98.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.78 -1.2 . . . . 0.0 108.045 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 32' ' ' VAL . 52.9 mt -61.24 -43.1 99.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -56.66 -26.1 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -85.49 -29.42 24.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.161 -0.962 . . . . 0.0 110.046 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.508 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.2 m-85 -84.39 -58.8 2.6 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.182 -0.949 . . . . 0.0 110.511 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -132.61 -164.61 10.99 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 11' ' ' SER . 33.7 mtmt -89.61 124.2 34.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.223 -1.163 . . . . 0.0 109.036 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.45 HG11 ' CG1' ' A' ' 32' ' ' VAL . 39.8 t -80.62 104.05 8.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD21 ' OG ' ' A' ' 11' ' ' SER . 80.9 mt -52.03 142.43 15.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.764 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.561 ' OG1' ' CE3' ' A' ' 72' ' ' TRP . 17.4 p -37.75 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.512 0.672 . . . . 0.0 110.161 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 13' ' ' TYR . 19.5 mm-40 -122.91 110.41 15.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.664 ' O ' ' N ' ' A' ' 49' ' ' ALA . 4.7 p80 -56.44 -15.35 4.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.341 -0.85 . . . . 0.0 109.624 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CD1' ' A' ' 18' ' ' ILE . 60.8 t -41.7 -78.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.335 -0.853 . . . . 0.0 110.651 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.25 10.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.883 -1.136 . . . . 0.0 109.09 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.916 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.7 t70 -96.54 22.71 7.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -109.2 35.88 3.11 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HG3' HD13 ' A' ' 51' ' ' LEU . 1.9 pt-20 -129.57 -20.32 3.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.916 HD21 ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -62.67 -102.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -57.02 164.1 2.55 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.4 36.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.552 2.168 . . . . 0.0 112.996 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 54' ' ' LEU . 6.6 mp 51.3 -155.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.93 -1.106 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . -127.83 -36.58 0.47 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 36.4 mp0 -46.58 -20.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -1.061 . . . . 0.0 109.108 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' GLY . 24.5 pt-20 -132.47 3.51 3.9 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 54' ' ' LEU . . . -145.59 -173.79 4.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.05 152.45 21.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.18 -9.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.64 74.93 1.22 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -53.62 -37.0 62.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.348 -1.09 . . . . 0.0 108.336 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.628 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 3.4 mp0 -62.23 -47.15 85.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -53.58 -36.27 61.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 0.0 109.184 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -67.3 -53.1 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.132 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.491 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 4.8 t-80 -63.65 -45.77 88.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 110.785 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -54.43 -54.73 36.8 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.632 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' TRP . 99.5 mt-30 -72.42 -40.34 67.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 110.169 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 23.8 m-20 -64.93 -52.97 53.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.972 . . . . 0.0 111.014 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.93 78.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 111.148 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -65.41 -54.01 34.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.785 -1.197 . . . . 0.0 110.049 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.45 -42.74 99.68 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.814 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 2.0 tt -53.15 -36.87 61.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -75.18 -26.2 58.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.527 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.496 ' CD ' ' CD1' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -97.86 5.7 48.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.797 -1.189 . . . . 0.0 109.064 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -65.08 129.4 39.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.697 0.76 . . . . 0.0 112.536 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 11' ' ' SER . 64.0 t0 -74.94 -36.17 62.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 79' ' ' VAL . 46.0 t -134.25 168.01 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' N ' HG12 ' A' ' 78' ' ' VAL . 60.8 t -150.21 140.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.104 -0.998 . . . . 0.0 111.074 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -132.07 143.23 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -152.74 156.14 38.55 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 110.51 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' OH ' ' A' ' 134' ' ' TYR . 47.1 tt0 -123.25 124.77 43.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -120.22 23.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 109.523 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 109' ' ' ARG . 89.4 m -45.76 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.148 -0.97 . . . . 0.0 108.564 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' PRO . 34.3 tt0 -68.15 133.74 91.59 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLN . 86.2 Cg_exo -37.34 112.71 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.99 1.793 . . . . 0.0 111.769 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.462 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 2.4 p -117.06 130.56 56.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.218 -0.926 . . . . 0.0 110.201 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' B' ' 287' ' ' SER . 0.4 OUTLIER -80.88 -56.36 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 317' ' ' SER . . . -57.87 -40.21 92.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.65 -36.62 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.164 . . . . 0.0 109.437 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.16 95.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.489 ' HB2' HD11 ' B' ' 320' ' ' ILE . 67.5 t80 -66.89 -47.53 71.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.679 -0.895 . . . . 0.0 109.709 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.37 -34.77 75.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.493 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.32 -42.46 75.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 108.478 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.07 -36.44 80.7 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' NH1' ' CG1' ' B' ' 298' ' ' VAL . 20.0 tpt180 -64.97 -45.46 85.61 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -68.8 -37.8 79.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.482 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.8 OUTLIER -51.46 -43.36 30.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -68.72 -44.99 72.72 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.09 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.587 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -129.19 -38.88 1.57 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.096 -1.002 . . . . 0.0 110.386 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -70.65 97.46 0.63 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.39 -69.65 0.55 Allowed Pre-proline 0 C--N 1.288 -2.08 0 O-C-N 121.762 -0.846 . . . . 0.0 111.446 -176.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 24.0 Cg_endo -63.41 111.36 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.88 1.72 . . . . 0.0 111.348 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 101' ' ' GLY . 46.5 mt -135.88 101.94 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.157 -0.965 . . . . 0.0 111.088 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.24 118.21 30.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -111.42 138.24 48.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.991 -1.068 . . . . 0.0 108.352 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mt -118.15 146.28 44.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.15 -0.969 . . . . 0.0 110.926 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -149.95 142.06 24.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.091 -1.005 . . . . 0.0 108.827 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.605 ' O ' ' N ' ' A' ' 113' ' ' GLY . 10.7 mtm180 -119.59 150.34 49.87 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.291 -0.88 . . . . 0.0 110.924 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 113' ' ' GLY . 46.0 Cg_endo -69.82 -15.64 36.96 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.643 2.229 . . . . 0.0 112.4 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 112' ' ' SER . 1.8 pt20 -67.09 -37.24 83.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -0.971 . . . . 0.0 110.151 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.475 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 31.0 m -142.51 -6.03 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 109' ' ' ARG . . . -111.19 99.69 1.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 106.74 -2.544 . . . . 0.0 106.74 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -98.26 -59.38 1.76 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.664 -0.903 . . . . 0.0 108.608 -177.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG21 ' O ' ' B' ' 256' ' ' GLU . 78.1 t -132.07 109.38 15.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.812 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -54.49 146.55 15.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' B' ' 289' ' ' GLY . 0.6 OUTLIER -43.3 146.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 0.0 109.398 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.0 81.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 77.6 mmm -64.8 -37.59 88.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 292' ' ' TYR . 48.4 mm -65.25 -47.12 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.992 . . . . 0.0 109.31 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -62.99 -40.8 98.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.04 -37.48 95.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.84 -47.38 71.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -0.3 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.415 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 128' ' ' ARG . 54.9 t0 -76.74 -35.24 57.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 108.58 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.8 -22.29 6.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -101.26 -46.26 5.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.066 -1.256 . . . . 0.0 109.869 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 125' ' ' ASP . 34.2 ptt-85 -121.11 -43.3 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.492 -0.755 . . . . 0.0 109.32 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 129' ' ' PHE . 7.0 t80 -97.29 130.03 44.52 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.491 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 16.2 tt0 -155.67 161.68 40.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.712 -1.242 . . . . 0.0 111.376 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.79 105.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.491 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 15.9 m0 -101.79 143.14 32.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 134' ' ' TYR . 61.0 t0 -93.34 155.32 17.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.101 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.596 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 6.3 p90 -169.88 -166.54 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.091 -1.006 . . . . 0.0 110.342 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -169.91 160.51 8.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 136' ' ' GLU . 18.9 mt-10 -59.46 28.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.09 -2.07 3.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -156.13 12.25 0.29 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.013 -1.286 . . . . 0.0 110.102 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 140' ' ' GLU . 7.5 p -52.03 -42.93 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 108.631 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 139' ' ' VAL . 36.7 mt-10 -57.47 -37.09 72.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.107 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.4 m -66.67 -44.28 82.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.9 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.4 tpp -52.44 -49.51 64.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 89.8 mt -71.36 -29.31 64.81 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.428 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 36.4 t0 -67.25 -38.97 86.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 109.881 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -73.35 -50.2 23.29 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.84 -1.163 . . . . 0.0 108.801 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.5 t80 -56.67 -47.12 80.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.339 -0.851 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.7 m-85 -78.41 -30.57 47.81 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.512 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 44.8 mt-10 -58.53 -25.47 62.48 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -71.99 -16.7 62.08 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.768 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -177.85 105.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 0.0 111.114 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.6 OUTLIER 175.82 -54.78 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.326 -0.858 . . . . 0.0 109.642 177.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 20.1 Cg_endo . . . . . 0 C--N 1.309 -1.543 0 C-N-CA 122.093 1.862 . . . . 0.0 111.513 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.4 -155.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.487 2.124 . . . . 0.0 110.893 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.46 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 27.9 p -99.52 178.04 4.98 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.585 ' OG ' HD21 ' B' ' 242' ' ' LEU . 3.0 t -116.22 152.83 32.99 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.41 132.64 57.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.562 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CZ ' ' OE2' ' B' ' 244' ' ' GLU . 39.3 t80 -96.35 146.43 24.75 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.681 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.0 t80 -109.89 132.6 54.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.07 -1.019 . . . . 0.0 111.614 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.29 102.51 5.38 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -136.22 177.67 19.39 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.39 123.22 23.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.834 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' B' ' 246' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.501 ' HG3' ' H ' ' B' ' 225' ' ' GLN . 12.4 ptm180 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.932 0.873 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -55.82 -39.1 70.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 88.2 m-20 -60.45 -33.39 72.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.501 ' H ' ' HG3' ' B' ' 222' ' ' ARG . 0.8 OUTLIER -63.03 -46.93 85.22 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.07 -50.27 69.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.45 -35.58 70.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.756 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.902 ' O ' HG23 ' B' ' 232' ' ' VAL . 18.5 m-30 -67.44 -47.42 70.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.326 -0.859 . . . . 0.0 109.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.28 -37.84 75.82 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.593 -1.317 . . . . 0.0 108.886 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.403 ' HE ' ' NH2' ' B' ' 234' ' ' ARG . 39.2 ttt85 -68.83 -57.03 6.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.849 -1.157 . . . . 0.0 108.648 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.3 mt -50.94 -45.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.902 HG23 ' O ' ' B' ' 228' ' ' TYR . 87.1 t -59.92 -30.33 45.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 7.2 t -66.15 -40.16 90.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.075 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.403 ' NH2' ' HE ' ' B' ' 230' ' ' ARG . 81.4 mtt-85 -63.45 -41.87 98.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.822 -1.174 . . . . 0.0 107.929 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' B' ' 232' ' ' VAL . 52.9 mt -61.23 -42.92 99.44 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -56.95 -26.08 59.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -85.37 -29.55 24.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.969 . . . . 0.0 110.079 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.506 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.2 m-85 -84.34 -58.7 2.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.215 -0.928 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 210' ' ' CYS . . . -132.94 -164.87 11.02 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' B' ' 211' ' ' SER . 33.1 mtmt -89.58 124.14 34.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.191 -1.181 . . . . 0.0 109.015 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.443 HG11 ' CG1' ' B' ' 232' ' ' VAL . 38.6 t -80.49 104.22 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' B' ' 211' ' ' SER . 80.7 mt -52.22 141.98 17.75 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.833 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.568 ' OG1' ' CE3' ' B' ' 272' ' ' TRP . 17.3 p -37.38 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.502 0.668 . . . . 0.0 110.234 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.544 ' OE2' ' CZ ' ' B' ' 213' ' ' TYR . 19.1 mm-40 -122.99 110.68 15.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' B' ' 249' ' ' ALA . 4.9 p80 -56.59 -15.58 4.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' B' ' 218' ' ' ILE . 62.5 t -41.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.239 -0.913 . . . . 0.0 110.695 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -48.72 -33.29 9.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.934 -1.104 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.883 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.5 t70 -96.53 22.96 7.32 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' B' ' 245' ' ' HIS . . . -109.47 35.68 3.22 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.518 ' HG3' HD13 ' B' ' 251' ' ' LEU . 1.9 pt-20 -129.27 -20.09 3.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.89 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -62.72 -103.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' B' ' 254' ' ' LEU . 0.0 OUTLIER -56.1 164.39 1.85 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.387 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.85 36.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.525 2.15 . . . . 0.0 112.895 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.645 HD12 ' N ' ' B' ' 254' ' ' LEU . 6.6 mp 51.28 -155.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.018 -1.051 . . . . 0.0 109.548 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . -127.35 -36.53 0.49 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' B' ' 256' ' ' GLU . 36.5 mp0 -46.44 -20.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -1.033 . . . . 0.0 109.211 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 255' ' ' GLY . 24.4 pt-20 -133.2 4.39 3.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 108.925 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 254' ' ' LEU . . . -145.97 -173.49 4.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -90.95 151.5 21.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.15 -9.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.45 74.62 1.21 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -36.91 62.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.36 -1.082 . . . . 0.0 108.321 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' GLN . . . . . 0.636 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 3.4 mp0 -62.5 -47.18 85.1 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -53.6 -36.03 61.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -67.55 -52.87 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.486 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 4.6 t-80 -64.03 -46.26 85.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.454 -0.779 . . . . 0.0 110.654 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -53.74 -55.08 29.4 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.84 -1.162 . . . . 0.0 109.676 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' TRP . 99.5 mt-30 -72.21 -40.36 67.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.503 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 25.5 m-20 -64.79 -52.95 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.03 -1.044 . . . . 0.0 111.174 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.87 78.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 111.138 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.5 -54.01 34.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.671 -1.268 . . . . 0.0 110.147 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -62.42 -42.38 99.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.037 -1.039 . . . . 0.0 108.935 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.473 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 1.9 tt -53.62 -36.49 62.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -75.34 -26.25 58.43 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.372 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.492 ' CD ' ' CD1' ' B' ' 272' ' ' TRP . 0.0 OUTLIER -98.02 5.82 48.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.175 . . . . 0.0 109.095 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 276' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -65.17 129.47 39.84 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.759 0.79 . . . . 0.0 112.555 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' B' ' 211' ' ' SER . 64.1 t0 -75.14 -35.86 61.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.59 HG12 ' N ' ' B' ' 279' ' ' VAL . 46.6 t -134.4 167.94 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.59 ' N ' HG12 ' B' ' 278' ' ' VAL . 61.8 t -150.37 140.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.026 . . . . 0.0 111.06 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.06 143.6 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.08 156.16 38.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.046 -1.034 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' B' ' 334' ' ' TYR . 47.4 tt0 -123.15 125.04 44.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' B' ' 316' ' ' LEU . 0.1 OUTLIER -120.5 22.69 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.519 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.441 HG23 ' H ' ' B' ' 309' ' ' ARG . 87.5 m -45.25 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.184 -0.948 . . . . 0.0 108.54 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' B' ' 286' ' ' PRO . 33.4 tt0 -68.0 133.92 91.88 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 285' ' ' GLN . 87.9 Cg_exo -37.36 112.57 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.084 1.856 . . . . 0.0 111.842 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 2.6 p -116.91 130.52 56.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.74 -56.14 4.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 289' ' ' GLY . . . . . 0.556 ' N ' ' OG ' ' A' ' 117' ' ' SER . . . -58.0 -40.27 93.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.61 -36.67 78.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.322 -1.104 . . . . 0.0 109.497 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.2 95.48 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.502 ' HB2' HD11 ' A' ' 120' ' ' ILE . 67.8 t80 -67.05 -47.25 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.623 -0.928 . . . . 0.0 109.84 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.91 -34.77 76.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 294' ' ' LEU . 72.5 mt -69.29 -42.44 75.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.965 . . . . 0.0 108.578 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.24 -36.09 78.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.418 ' NH1' ' CG1' ' A' ' 98' ' ' VAL . 20.0 tpt180 -64.93 -45.59 85.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.272 -1.134 . . . . 0.0 109.517 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -68.67 -37.89 79.95 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.466 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.455 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.8 OUTLIER -51.61 -43.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -68.6 -45.1 72.87 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.177 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.596 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -129.35 -38.21 1.58 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.135 -0.978 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -71.18 97.26 0.66 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.596 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -65.26 -69.77 0.54 Allowed Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.826 -0.808 . . . . 0.0 111.43 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 24.0 Cg_endo -63.44 111.02 1.35 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.878 1.719 . . . . 0.0 111.534 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.439 HD11 ' O ' ' B' ' 301' ' ' GLY . 45.5 mt -135.61 101.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 111.174 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.16 118.54 30.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -111.53 137.95 48.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 108.445 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 307' ' ' LEU . . . . . . . . . . . . . 9.7 mt -118.05 146.09 44.33 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -0.973 . . . . 0.0 110.862 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -149.77 142.19 24.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 108.764 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.598 ' O ' ' N ' ' B' ' 313' ' ' GLY . 10.5 mtm180 -119.47 150.53 49.98 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 110.867 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.18 -15.31 35.49 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' B' ' 312' ' ' SER . 1.9 pt20 -67.34 -37.61 83.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.229 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' B' ' 311' ' ' GLN . 23.2 m -142.16 -5.82 0.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' B' ' 309' ' ' ARG . . . -111.2 100.04 1.18 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.629 ' CD ' ' N ' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -98.41 -59.55 1.73 Allowed 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.695 -0.885 . . . . 0.0 108.614 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 56' ' ' GLU . 77.8 t -131.94 109.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.765 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.632 HD11 ' HB ' ' B' ' 283' ' ' VAL . 0.1 OUTLIER -54.55 146.27 16.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 89' ' ' GLY . 0.6 OUTLIER -43.08 146.17 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.98 -1.075 . . . . 0.0 109.431 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.24 80.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 0.0 110.534 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.63 -37.69 88.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 92' ' ' TYR . 47.5 mm -64.94 -47.23 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.303 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 0.1 OUTLIER -63.13 -40.6 98.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -63.08 -37.47 94.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.594 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.89 -47.83 70.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.594 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 0.32 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.521 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.533 ' OD2' ' NH1' ' B' ' 328' ' ' ARG . 53.7 t0 -76.34 -35.25 58.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.889 -1.132 . . . . 0.0 108.565 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 82.81 -22.26 6.86 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 30.0 t -101.36 -45.92 5.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.984 -1.303 . . . . 0.0 109.874 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.533 ' NH1' ' OD2' ' B' ' 325' ' ' ASP . 34.2 ptt-85 -121.45 -43.44 2.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.529 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 6.9 t80 -97.15 130.1 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.485 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 16.4 tt0 -155.67 161.71 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.513 -1.275 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.75 105.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.485 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 15.7 m0 -101.72 143.1 32.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' B' ' 334' ' ' TYR . 59.7 t0 -93.18 155.36 17.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 109.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.582 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 6.3 p90 -169.7 -166.31 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -170.26 160.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -59.39 28.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -134.97 -2.44 3.08 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -155.87 12.1 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -1.196 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.51 HG13 ' N ' ' B' ' 340' ' ' GLU . 8.1 p -51.9 -42.9 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 108.548 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.51 ' N ' HG13 ' B' ' 339' ' ' VAL . 40.0 mt-10 -57.64 -36.97 72.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.558 -0.714 . . . . 0.0 109.123 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 57.0 m -66.69 -44.16 82.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.867 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -52.74 -49.54 65.23 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 88.8 mt -71.2 -29.34 65.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.491 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 37.6 t0 -67.2 -39.05 86.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.067 -1.02 . . . . 0.0 109.937 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -73.11 -50.36 23.24 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.89 -1.131 . . . . 0.0 108.834 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 346' ' ' TYR . . . . . 0.481 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.8 t80 -56.36 -47.31 79.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' B' ' 351' ' ' LEU . 12.7 m-85 -78.05 -30.76 50.0 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.591 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 45.3 mt-10 -58.5 -25.71 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 349' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -71.62 -17.11 62.29 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.772 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -177.69 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.073 -1.017 . . . . 0.0 111.162 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.7 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 176.14 -55.28 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 20.1 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 121.861 1.708 . . . . 0.0 111.579 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.13 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.617 2.211 . . . . 0.0 111.772 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 89.8 m -100.31 177.14 5.14 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 2.6 m -119.93 121.21 38.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.026 -1.046 . . . . 0.0 108.581 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 78' ' ' VAL . 5.3 t -94.06 130.94 42.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 69' ' ' ASP . 33.2 t80 -99.85 133.39 44.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 32' ' ' VAL . 26.6 t80 -86.88 116.34 24.89 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.365 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 6.5 t -107.0 108.99 20.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.771 0.796 . . . . 0.0 109.287 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.556 ' C ' HG22 ' A' ' 90' ' ' VAL . . . -174.85 174.3 46.62 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 90' ' ' VAL . 6.7 p -113.44 160.13 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -1.074 . . . . 0.0 108.461 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.408 HG23 ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.605 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HE ' ' CD1' ' A' ' 54' ' ' LEU . 38.3 mmt-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.118 0.485 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -56.99 -38.86 73.63 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -63.67 -26.68 68.78 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.59 HE21 ' C ' ' A' ' 46' ' ' VAL . 20.2 tp60 -64.77 -42.68 94.92 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.71 84.37 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.96 -37.88 77.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.741 ' O ' HG23 ' A' ' 32' ' ' VAL . 21.1 m-30 -65.94 -41.81 90.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -63.14 -39.31 94.3 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 120.851 -1.156 . . . . 0.0 109.041 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.49 -55.02 9.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.951 -1.093 . . . . 0.0 108.321 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.432 HG21 ' OE2' ' A' ' 82' ' ' GLU . 20.9 mt -53.89 -45.07 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.3 t -60.15 -29.37 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.6 m -67.31 -38.56 85.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.082 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -68.51 -50.19 54.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.127 . . . . 0.0 109.043 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.601 HD22 HG11 ' A' ' 12' ' ' VAL . 25.1 mt -56.77 -40.82 76.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -61.6 -27.05 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.845 -0.535 . . . . 0.0 109.598 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -75.94 -36.81 59.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.959 -1.088 . . . . 0.0 109.542 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.519 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.8 m-85 -71.69 -48.76 45.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.52 -0.737 . . . . 0.0 110.598 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -149.35 -148.83 4.84 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -95.66 125.13 40.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.413 -1.051 . . . . 0.0 109.825 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 32' ' ' VAL . 3.2 t -83.4 101.17 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' A' ' 76' ' ' ALA . 93.8 mt -47.1 149.67 0.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.31 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 m -44.61 140.08 2.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 109.301 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' VAL . 11.0 pt-20 -161.57 134.27 6.06 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.0 t-80 -74.86 25.0 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.241 -0.912 . . . . 0.0 109.188 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.681 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 27.6 t -83.97 -85.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' C ' ' N ' ' A' ' 49' ' ' ALA . . . -68.08 178.87 1.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.814 ' O ' HD11 ' A' ' 51' ' ' LEU . 14.7 t70 48.57 20.09 0.29 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.188 . . . . 0.0 108.193 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -115.01 -9.51 12.37 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -62.85 -32.96 74.3 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 108.798 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.991 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.63 157.1 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.604 -0.685 . . . . 0.0 109.961 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 51' ' ' LEU . 17.9 mt-10 55.02 155.46 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 55.6 Cg_endo -72.19 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.493 2.129 . . . . 0.0 111.938 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD1' ' HE ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -55.55 165.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.895 -1.128 . . . . 0.0 109.628 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 150.46 32.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 22.9 mm-40 59.15 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.926 . . . . 0.0 109.447 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.7 tt0 -52.46 -28.77 21.55 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 53' ' ' PRO . . . -68.07 149.18 49.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.78 142.9 5.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.67 -58.53 0.23 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.75 80.63 0.48 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -53.47 -41.11 65.85 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.33 -1.1 . . . . 0.0 108.494 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.96 -48.89 67.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -60.08 -38.15 82.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.36 -40.22 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.436 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.4 t-80 -78.84 -51.03 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 110.55 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -50.68 -47.93 58.72 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.869 -1.144 . . . . 0.0 110.012 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.82 -49.04 27.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 0.0 110.421 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 68.6 m-20 -62.75 -51.92 65.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 0.0 110.776 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -68.22 -41.28 81.51 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 0.0 111.274 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -61.87 -54.03 47.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.597 -1.314 . . . . 0.0 109.314 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.577 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.07 -38.02 75.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.163 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.0 tp -52.6 -45.76 66.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' A' ' 96' ' ' ARG . 20.2 mt-30 -67.03 -30.32 70.37 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.483 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 3.2 mt-30 -91.24 3.53 54.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.54 -1.35 . . . . 0.0 109.349 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -64.5 141.59 58.72 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.987 0.899 . . . . 0.0 112.612 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' PRO . 65.1 t0 -98.48 -20.51 17.05 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 12' ' ' VAL . 18.4 t -144.55 144.63 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.01 137.96 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.717 -1.239 . . . . 0.0 112.382 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.13 125.41 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -112.54 144.6 41.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.34 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.432 ' OE2' HG21 ' A' ' 31' ' ' ILE . 50.2 mt-10 -108.6 121.71 45.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.71 . . . . 0.0 109.169 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 107' ' ' LEU . 1.7 m -146.77 113.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 m -130.04 -13.42 4.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -142.92 156.18 62.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -39.13 108.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.047 1.831 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.64 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 45.1 m -126.29 134.39 51.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.142 -0.974 . . . . 0.0 111.165 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.635 ' HB2' ' H ' ' B' ' 287' ' ' SER . 14.7 tp -105.68 153.11 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.59 -29.99 3.19 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 16' ' ' GLY . 47.4 t -86.01 -49.92 14.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.35 62.45 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.431 ' HB2' HD11 ' B' ' 320' ' ' ILE . 85.8 t80 -70.86 -58.14 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 85.9 mt-10 -52.16 -32.95 38.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 81' ' ' ALA . 37.8 mt -76.29 -41.15 49.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.0 -48.76 81.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 74' ' ' GLN . 45.4 ttm-85 -62.61 -38.26 89.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.341 -1.093 . . . . 0.0 108.89 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.56 -39.93 88.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -54.92 -44.31 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.791 -1.193 . . . . 0.0 108.136 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -76.01 -48.93 19.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.469 ' O ' ' CD ' ' A' ' 102' ' ' LYS . 2.8 pp -116.66 -23.08 8.33 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.831 -1.168 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -53.26 170.3 0.78 Allowed Glycine 0 C--N 1.286 -2.196 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.538 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -131.63 -75.71 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 79.8 Cg_endo -81.79 109.12 1.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.811 1.674 . . . . 0.0 109.552 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.08 126.7 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.691 -1.256 . . . . 0.0 111.579 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 132' ' ' TRP . 24.4 tp -123.0 119.39 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.73 153.05 21.12 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.71 -1.244 . . . . 0.0 108.561 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 14.7 mt -127.9 132.69 49.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.962 -1.086 . . . . 0.0 111.838 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.482 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -138.93 122.35 17.2 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 65.4 mtm180 -86.55 135.66 35.92 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 111.388 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 72.7 Cg_endo -79.32 -23.87 7.06 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.434 2.089 . . . . 0.0 110.58 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' SER . 14.6 pt20 -48.06 -38.2 16.84 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 10.7 t -95.3 -18.59 20.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.1 52.77 4.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 115' ' ' VAL . 3.6 mtp180 -87.57 6.26 35.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.289 . . . . 0.0 109.993 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 114' ' ' ARG . 21.1 t 58.08 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 117' ' ' SER . 30.6 tp -74.08 150.83 40.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.587 ' H ' HD23 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -40.49 140.03 0.71 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.311 -0.868 . . . . 0.0 110.609 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.64 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -61.07 -43.67 98.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 81.0 mmm -63.89 -44.06 94.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.17 -0.956 . . . . 0.0 109.176 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' B' ' 292' ' ' TYR . 45.1 mm -61.74 -41.79 91.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.243 -0.91 . . . . 0.0 108.768 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.81 -45.15 95.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.425 -0.797 . . . . 0.0 109.585 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -66.98 -39.11 93.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.645 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -48.41 -55.91 9.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -1.215 . . . . 0.0 108.217 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -9.87 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.432 0.634 . . . . 0.0 111.148 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -130.89 -28.16 2.01 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 80.24 -5.45 63.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.668 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 p -79.17 39.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 127' ' ' SER . 86.1 mtt-85 106.12 -25.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.903 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -89.71 114.67 26.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.1 mt-30 -137.66 137.76 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.762 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.85 103.98 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.546 ' CD2' HD11 ' A' ' 105' ' ' LEU . 15.0 m0 -104.59 143.09 33.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.074 -1.016 . . . . 0.0 109.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.474 ' O ' ' SD ' ' A' ' 142' ' ' MET . 98.7 m-20 -96.96 159.83 14.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.86 -1.15 . . . . 0.0 108.792 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 8.0 p90 -165.5 -167.06 1.06 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.652 -1.28 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -166.71 146.63 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 135' ' ' ALA . 42.6 mt-10 -41.48 -37.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.127 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.59 4.13 37.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.447 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -155.75 8.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.463 -1.61 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.3 p -53.63 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.913 -1.117 . . . . 0.0 108.539 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 20.8 pt-20 -58.86 -31.94 69.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.483 -0.761 . . . . 0.0 109.09 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.1 m -68.51 -46.01 70.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.0 tpp -51.06 -45.8 61.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.63 -34.97 70.25 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.493 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.54 -40.53 95.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 110.279 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -71.64 -50.54 29.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.894 -1.129 . . . . 0.0 108.629 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -59.61 -46.44 88.97 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.966 ' CD1' HD12 ' A' ' 151' ' ' LEU . 13.6 m-85 -70.16 -32.95 71.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.88 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.505 -1.372 . . . . 0.0 107.551 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.14 -18.05 62.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.571 -0.705 . . . . 0.0 110.661 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -152.84 3.37 0.33 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.385 -1.447 . . . . 0.0 111.598 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 147' ' ' PHE . 6.1 mt -116.25 83.84 13.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.677 -1.264 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.594 2.196 . . . . 0.0 111.688 179.275 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.39 -156.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.62 2.213 . . . . 0.0 111.719 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.527 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 92.0 m -100.09 177.08 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 2.4 m -119.97 120.86 37.58 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.625 HG13 HG12 ' B' ' 278' ' ' VAL . 5.8 t -93.86 130.95 42.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' B' ' 269' ' ' ASP . 32.7 t80 -100.01 133.32 44.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.516 ' CD2' HG22 ' B' ' 232' ' ' VAL . 26.9 t80 -86.7 116.82 25.05 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.273 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' B' ' 281' ' ' ALA . 5.6 t -107.76 109.03 20.5 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.728 0.775 . . . . 0.0 109.267 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.553 ' C ' HG22 ' B' ' 290' ' ' VAL . . . -174.75 174.54 46.69 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 290' ' ' VAL . 6.5 p -113.46 160.09 18.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -1.059 . . . . 0.0 108.362 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.415 HG23 ' NE2' ' B' ' 225' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.516 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.655 ' HE ' ' CD1' ' B' ' 254' ' ' LEU . 39.2 mmt-85 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -56.75 -38.87 73.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.68 -26.82 68.83 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.568 HE21 ' C ' ' B' ' 246' ' ' VAL . 19.9 tp60 -64.58 -42.69 95.46 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.61 84.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 tp -59.21 -38.03 78.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.745 ' O ' HG23 ' B' ' 232' ' ' VAL . 21.2 m-30 -65.86 -41.53 91.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -63.34 -39.44 94.55 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.828 -1.17 . . . . 0.0 108.992 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.22 -55.13 10.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.078 . . . . 0.0 108.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.435 HG21 ' OE2' ' B' ' 282' ' ' GLU . 20.6 mt -53.78 -45.4 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.8 t -59.91 -29.14 42.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 5.9 m -67.43 -38.33 84.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.81 -50.13 52.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.893 -1.129 . . . . 0.0 108.932 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.605 HD22 HG11 ' B' ' 212' ' ' VAL . 24.9 mt -56.71 -40.75 76.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -61.6 -27.02 68.35 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -76.07 -36.57 58.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.882 -1.136 . . . . 0.0 109.473 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.525 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.8 m-85 -72.14 -48.79 41.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.536 -0.727 . . . . 0.0 110.646 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -149.15 -149.1 4.89 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.7 125.33 40.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 109.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.441 HG11 HG13 ' B' ' 232' ' ' VAL . 3.2 t -83.22 101.27 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' B' ' 276' ' ' ALA . 94.3 mt -47.28 149.59 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.256 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 3.5 m -44.59 140.08 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 109.303 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' B' ' 246' ' ' VAL . 11.2 pt-20 -161.54 134.6 6.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.339 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 34.4 t-80 -74.86 24.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.935 . . . . 0.0 109.222 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.67 ' O ' ' HB3' ' B' ' 249' ' ' ALA . 27.7 t -83.42 -85.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' B' ' 249' ' ' ALA . . . -67.97 178.86 1.64 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.833 ' O ' HD11 ' B' ' 251' ' ' LEU . 15.5 t70 48.89 19.5 0.27 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.75 -1.218 . . . . 0.0 108.226 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -114.27 -9.89 12.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -62.2 -33.23 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.98 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -57.75 157.37 7.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.525 -0.734 . . . . 0.0 109.915 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' B' ' 251' ' ' LEU . 18.3 mt-10 54.7 155.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.619 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' B' ' 258' ' ' ALA . 55.9 Cg_endo -72.09 68.12 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.506 2.138 . . . . 0.0 111.937 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.655 ' CD1' ' HE ' ' B' ' 222' ' ' ARG . 0.2 OUTLIER -55.35 165.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.992 . . . . 0.0 109.643 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 149.83 32.78 0.05 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.64 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 23.8 mm-40 58.9 -74.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.9 tt0 -52.51 -27.94 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' B' ' 253' ' ' PRO . . . -68.88 149.17 49.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.356 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -48.68 141.96 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 167.43 -58.24 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.44 80.64 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -53.49 -40.85 65.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -1.108 . . . . 0.0 108.525 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.22 -48.96 66.28 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 108.775 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.95 -38.34 82.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.29 -39.94 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.3 t-80 -79.16 -51.37 9.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.572 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -50.21 -47.9 54.56 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.87 -1.144 . . . . 0.0 109.879 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -74.11 -48.42 29.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.547 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 69.1 m-20 -63.27 -51.45 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.71 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.472 HD11 ' NE ' ' B' ' 296' ' ' ARG . 0.6 OUTLIER -68.76 -40.96 79.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.887 -1.133 . . . . 0.0 111.277 -178.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.4 t-20 -62.19 -53.77 50.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.654 -1.279 . . . . 0.0 109.305 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.567 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -58.04 -38.18 75.77 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.088 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.455 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.1 tp -52.63 -45.65 66.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.554 ' OE1' ' NH1' ' B' ' 296' ' ' ARG . 20.5 mt-30 -67.12 -30.37 70.36 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 3.2 mt-30 -91.28 3.54 54.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.625 -1.297 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 276' ' ' ALA . . . . . 0.582 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -64.79 141.07 58.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.0 112.527 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' B' ' 303' ' ' PRO . 65.3 t0 -97.84 -20.43 17.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.625 HG12 HG13 ' B' ' 212' ' ' VAL . 18.7 t -144.65 144.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 22.6 t -143.5 137.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.544 -1.347 . . . . 0.0 112.527 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.86 125.88 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.55 ' CB ' HD21 ' B' ' 294' ' ' LEU . . . -112.97 144.98 41.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.195 -0.94 . . . . 0.0 110.274 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.435 ' OE2' HG21 ' B' ' 231' ' ' ILE . 48.9 mt-10 -108.83 121.65 45.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.535 -0.728 . . . . 0.0 109.179 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 1.7 m -146.74 113.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 18.9 m -130.22 -13.6 3.94 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -142.79 156.26 62.7 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -39.07 108.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.259 1.973 . . . . 0.0 111.691 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.635 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 45.6 m -125.9 134.35 51.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.099 -1.001 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.64 ' HB2' ' H ' ' A' ' 87' ' ' SER . 15.0 tp -105.32 153.51 21.53 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 81.97 -29.74 3.03 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.569 ' H ' ' C ' ' B' ' 288' ' ' LEU . 46.6 t -86.39 -49.54 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.67 -28.55 62.93 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 106.946 -2.461 . . . . 0.0 106.946 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' A' ' 120' ' ' ILE . 86.1 t80 -70.99 -57.95 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.936 -0.743 . . . . 0.0 109.088 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.403 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . 86.5 mt-10 -52.2 -33.2 39.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' B' ' 281' ' ' ALA . 36.7 mt -76.26 -41.13 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.74 -48.63 82.95 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.554 ' NH1' ' OE1' ' B' ' 274' ' ' GLN . 45.4 ttm-85 -62.97 -38.16 90.0 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.371 -1.076 . . . . 0.0 108.987 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.6 -39.68 88.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.486 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -54.92 -44.32 72.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 120.82 -1.175 . . . . 0.0 108.216 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.98 -49.28 18.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.46 ' O ' ' CD ' ' B' ' 302' ' ' LYS . 2.8 pp -116.36 -23.56 8.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.949 -1.094 . . . . 0.0 110.403 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -52.92 170.38 0.64 Allowed Glycine 0 C--N 1.288 -2.128 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.543 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 0.4 OUTLIER -131.46 -75.67 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 66.5 Cg_endo -81.73 109.49 2.02 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.819 1.679 . . . . 0.0 109.623 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 55.4 mt -130.47 126.79 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.688 -1.258 . . . . 0.0 111.514 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 332' ' ' TRP . 24.1 tp -123.06 119.29 29.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.45 153.08 20.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.642 -1.286 . . . . 0.0 108.511 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 14.7 mt -127.69 132.5 49.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.996 -1.065 . . . . 0.0 111.865 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -138.79 122.51 17.54 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 68.3 mtm180 -86.93 135.61 35.12 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.985 -1.072 . . . . 0.0 111.421 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' B' ' 313' ' ' GLY . 72.8 Cg_endo -79.36 -24.29 6.64 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.508 2.139 . . . . 0.0 110.425 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' B' ' 312' ' ' SER . 14.6 pt20 -47.9 -38.28 16.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 9.9 t -95.23 -18.78 20.58 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 40.8 53.1 3.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' B' ' 315' ' ' VAL . 3.6 mtp180 -87.73 6.44 34.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.923 -1.339 . . . . 0.0 109.98 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' B' ' 314' ' ' ARG . 24.1 t 58.25 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.841 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 316' ' ' LEU . 30.0 tp -74.19 151.21 40.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.594 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -40.59 139.84 0.75 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 110.596 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 318' ' ' ALA . . . . . 0.612 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -60.81 -43.61 97.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.468 -0.77 . . . . 0.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 81.0 mmm -64.31 -43.9 93.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 92' ' ' TYR . 45.7 mm -61.57 -41.6 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.102 -0.999 . . . . 0.0 108.756 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.09 -45.03 95.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.435 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -67.01 -39.0 93.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.636 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -48.45 -55.96 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.065 -1.256 . . . . 0.0 108.288 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.636 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -9.99 118.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.344 0.592 . . . . 0.0 111.16 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -131.43 -27.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 79.95 -5.18 63.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 54.7 p -79.34 39.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.66 ' HB2' ' O ' ' B' ' 327' ' ' SER . 84.8 mtt-85 106.22 -25.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.969 -1.469 . . . . 0.0 107.831 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -89.66 114.3 25.9 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.473 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 81.0 mt-30 -137.14 137.85 39.65 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.748 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.94 104.15 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.551 ' CD2' HD11 ' B' ' 305' ' ' LEU . 14.7 m0 -104.88 142.81 34.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.189 -0.945 . . . . 0.0 109.824 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.476 ' O ' ' SD ' ' B' ' 342' ' ' MET . 97.9 m-20 -97.06 159.97 14.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.828 -1.17 . . . . 0.0 108.807 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 8.1 p90 -165.4 -167.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.705 -1.247 . . . . 0.0 111.64 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.467 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -166.39 146.51 6.08 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.7 mt-10 -41.33 -37.24 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.801 -1.187 . . . . 0.0 110.058 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -74.75 4.89 34.01 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.389 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.21 8.79 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.461 -1.611 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.3 p -53.51 -44.75 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.92 -1.113 . . . . 0.0 108.468 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 20.2 pt-20 -58.64 -31.88 68.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.428 -0.795 . . . . 0.0 109.202 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 62.2 m -68.76 -45.91 70.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.0 tpp -51.38 -45.67 62.53 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.6 mt -71.53 -35.19 70.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.2 -40.57 96.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -72.02 -50.1 31.38 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.933 -1.104 . . . . 0.0 108.717 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -59.99 -46.39 89.6 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.1 -1.0 . . . . 0.0 110.153 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' B' ' 351' ' ' LEU . 13.6 m-85 -70.03 -33.03 71.46 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.903 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -67.08 -22.9 65.82 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.493 -1.379 . . . . 0.0 107.589 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.05 -17.82 62.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.512 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.9 OUTLIER -153.02 3.11 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.494 -1.379 . . . . 0.0 111.689 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.977 HD12 ' CD1' ' B' ' 347' ' ' PHE . 6.2 mt -116.05 83.87 12.89 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.662 -1.274 . . . . 0.0 109.69 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 C--N 1.309 -1.547 0 C-N-CA 122.651 2.234 . . . . 0.0 111.75 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.539 ' HB1' ' HD2' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 89.5 Cg_endo -80.71 -154.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 111.406 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.489 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 30.3 p -102.41 -178.19 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 2.7 p -119.88 150.62 40.18 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.8 t -125.41 131.96 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CB ' HG22 ' A' ' 79' ' ' VAL . 26.5 t80 -99.09 94.88 6.75 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' N ' ' OG1' ' A' ' 43' ' ' THR . 63.2 t80 -88.01 128.77 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 111.213 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 m -118.39 157.8 26.49 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.248 -0.907 . . . . 0.0 109.765 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' C ' ' CG2' ' A' ' 90' ' ' VAL . . . -168.93 173.8 43.47 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 19.2 t -81.6 132.25 35.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -1.124 . . . . 0.0 109.689 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.153 -0.967 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 25' ' ' GLN . 65.9 mtt180 . . . . . 0 N--CA 1.503 2.197 0 CA-C-O 121.716 0.769 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -52.55 -26.87 14.47 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 66.1 m-20 -69.71 -36.05 75.59 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -59.8 -43.59 94.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.93 72.49 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.4 -28.95 68.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 12.7 m-30 -69.43 -49.39 55.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.552 -0.717 . . . . 0.0 110.088 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.25 77.12 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.544 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -71.74 -55.45 7.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.864 -1.147 . . . . 0.0 108.393 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.409 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 5.5 mt -54.04 -47.36 65.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.552 HG13 HG11 ' A' ' 41' ' ' VAL . 40.4 t -60.85 -28.77 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.72 -0.613 . . . . 0.0 109.363 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -69.31 -37.2 77.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.553 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -70.46 -47.41 60.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.831 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.26 -41.54 97.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -61.02 -26.12 67.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -78.66 -35.15 45.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.573 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -74.68 -51.77 13.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.47 -0.769 . . . . 0.0 109.809 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -142.54 -152.85 5.76 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -98.07 130.9 44.85 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.218 -1.166 . . . . 0.0 109.018 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG11 HG13 ' A' ' 32' ' ' VAL . 2.2 t -89.46 111.22 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.1 mt -79.8 -29.09 40.22 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.569 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 14' ' ' PHE . 12.5 p -82.96 23.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . 85.9 tt0 -44.08 -31.47 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -54.91 -35.96 64.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.875 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 45' ' ' HIS . 56.1 t -50.43 -66.75 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.916 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -62.94 -38.97 93.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -61.58 -0.58 0.44 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -60.57 -40.16 90.67 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.246 -0.909 . . . . 0.0 108.678 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.06 -23.73 1.3 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -66.3 123.15 19.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 109.403 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 51' ' ' LEU . 3.6 mt-10 54.02 162.79 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.798 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ALA . 84.2 Cg_exo -42.71 136.51 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.816 1.677 . . . . 0.0 111.065 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.806 ' N ' HD12 ' A' ' 54' ' ' LEU . 4.3 mp -81.9 -103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 108.694 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.725 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 38.52 112.98 0.0 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.791 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 15.8 mm-40 -37.74 -48.91 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -1.217 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -74.95 -31.58 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 0.0 108.858 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -83.39 46.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.03 -165.0 1.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.12 69.21 0.21 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 75.36 1.08 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 30.3 p-10 -52.44 -38.76 59.98 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.548 ' NE2' ' OE2' ' A' ' 67' ' ' GLU . 46.8 tt0 -63.26 -48.57 77.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -57.15 -36.73 71.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.17 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -64.1 -38.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -77.27 -58.25 3.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 110.45 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 96.2 mt-10 -45.13 -46.14 11.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.894 -1.129 . . . . 0.0 109.853 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.06 -42.47 76.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 109.716 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 86.0 m-20 -66.59 -36.06 81.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.607 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.3 mm? -69.77 -52.05 28.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -57.21 -40.57 77.74 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.539 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -67.22 -44.74 78.77 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.572 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 14.2 tp -51.97 -35.74 47.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.1 -33.2 67.67 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.858 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -84.04 -1.23 54.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.188 -0.945 . . . . 0.0 109.216 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.05 136.65 50.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.062 0.934 . . . . 0.0 112.486 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 47.6 m-20 -99.71 -30.44 12.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 58.1 t -137.1 144.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG22 ' CB ' ' A' ' 13' ' ' TYR . 80.6 t -132.99 140.14 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.787 -1.196 . . . . 0.0 111.205 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.63 121.64 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -113.34 121.91 45.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.814 -1.178 . . . . 0.0 110.28 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 54.8 tt0 -86.1 112.95 21.76 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.794 HG11 HD11 ' A' ' 116' ' ' LEU . 1.8 t -86.65 -99.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 110.383 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 85' ' ' GLN . 6.5 m 59.48 -96.87 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.203 -1.561 . . . . 0.0 109.032 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.444 ' H ' ' HB ' ' A' ' 84' ' ' THR . 25.3 tt0 -61.39 133.34 93.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.914 -1.116 . . . . 0.0 108.589 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.465 ' HD3' ' HE ' ' A' ' 114' ' ' ARG . 32.3 Cg_endo -66.62 115.59 3.64 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.975 1.784 . . . . 0.0 111.869 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.405 ' OG ' HG23 ' A' ' 90' ' ' VAL . 12.8 t -138.45 129.73 27.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.849 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' CG1' ' B' ' 283' ' ' VAL . 8.9 mt -69.05 -40.25 78.66 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 108.932 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.19 95.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 16' ' ' GLY . 44.6 t -66.13 -47.29 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.451 -1.029 . . . . 0.0 108.832 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.96 74.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -68.89 -47.61 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.507 -0.996 . . . . 0.0 109.698 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.48 -35.22 78.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.551 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.3 mt -69.09 -46.73 67.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 108.616 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.4 -33.95 87.97 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.496 HH21 ' HB2' ' B' ' 299' ' ' ALA . 0.3 OUTLIER -64.18 -43.99 93.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.49 -1.006 . . . . 0.0 109.706 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -71.14 -29.1 64.8 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.602 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -53.61 -50.42 50.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.305 -1.497 . . . . 0.0 106.994 178.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' N ' HG12 ' A' ' 98' ' ' VAL . . . -85.43 -55.64 3.91 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.452 0.644 . . . . 0.0 110.681 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 100' ' ' LEU . 1.2 tt -61.97 -16.81 54.11 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.503 1.144 . . . . 0.0 108.004 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 102' ' ' LYS . . . 75.81 -163.17 53.35 Favored Glycine 0 C--N 1.281 -2.511 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 7.6 mmtm 96.85 136.24 0.03 OUTLIER Pre-proline 0 C--N 1.285 -2.215 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -36.41 111.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.218 1.945 . . . . 0.0 111.429 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.5 mt -105.36 87.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.248 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.7 tp -91.42 116.7 29.06 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.514 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -108.0 139.81 42.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 108.536 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.5 mt -123.31 138.6 54.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -140.4 138.9 35.12 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -92.06 135.27 27.36 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 0.0 110.906 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.04 -32.86 2.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.514 2.143 . . . . 0.0 111.094 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.02 -33.52 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 113' ' ' GLY . 36.4 p -97.11 -21.41 17.36 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 39.74 44.84 2.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.465 ' HE ' ' HD3' ' A' ' 86' ' ' PRO . 14.8 mtp85 -70.62 8.43 0.85 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.202 -1.175 . . . . 0.0 109.323 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 113' ' ' GLY . 94.5 t 53.92 102.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.428 -0.795 . . . . 0.0 110.419 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.794 HD11 HG11 ' A' ' 83' ' ' VAL . 13.4 tp -57.05 139.52 52.03 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.1 144.63 1.22 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.476 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.798 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -59.83 -37.11 78.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.484 -0.76 . . . . 0.0 109.913 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 119' ' ' MET . 26.7 mmm -68.58 -45.69 71.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.315 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.5 -47.37 89.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.79 -44.21 77.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.401 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.27 -26.53 69.48 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -56.44 -51.96 66.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.261 . . . . 0.0 107.743 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 8.97 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.6 t0 -67.86 -35.4 78.49 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.692 -1.255 . . . . 0.0 107.921 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.887 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.77 176.54 45.73 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 56.05 -26.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.488 1.137 . . . . 0.0 108.79 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.887 ' H ' ' C ' ' A' ' 126' ' ' GLY . 7.2 tpp85 -149.95 -3.63 0.38 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.415 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 6.3 t80 -152.73 112.31 3.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.868 -1.145 . . . . 0.0 108.013 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.548 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 86.8 mt-30 -138.62 132.27 30.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -86.7 103.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.548 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 14.2 m0 -98.11 139.73 33.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.288 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' O ' ' CE ' ' A' ' 142' ' ' MET . 74.2 m-20 -94.18 141.92 28.0 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.954 -1.091 . . . . 0.0 109.046 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 139' ' ' VAL . 3.6 p90 -157.51 -173.63 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.035 -1.04 . . . . 0.0 111.034 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -158.87 157.75 32.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.5 30.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.447 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -135.78 -1.33 3.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.666 ' O ' ' SD ' ' A' ' 142' ' ' MET . 23.2 pt-20 -154.26 10.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.122 -1.222 . . . . 0.0 110.027 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.7 p -50.86 -41.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.045 -1.034 . . . . 0.0 108.865 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.447 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.0 tt0 -61.66 -29.18 69.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 108.771 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' GLU . 16.9 m -71.31 -48.36 51.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 110.367 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -55.76 -47.16 77.49 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.42 -29.83 70.79 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.128 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.479 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 43.2 t0 -69.09 -39.08 79.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 110.0 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -70.54 -51.76 26.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.69 -1.256 . . . . 0.0 108.814 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.7 t80 -57.92 -47.33 83.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.08 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.0 m-85 -74.34 -32.82 62.94 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.123 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 12.2 mm-40 -58.54 -26.48 63.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -70.21 -22.15 62.95 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.82 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -172.75 101.48 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.7 OUTLIER 175.23 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 151' ' ' LEU . 86.9 Cg_endo . . . . . 0 C--N 1.31 -1.492 0 C-N-CA 122.913 2.409 . . . . 0.0 111.456 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' B' ' 208' ' ' ALA . 90.1 Cg_endo -80.69 -154.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.065 2.51 . . . . 0.0 111.459 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.493 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 30.3 p -102.65 -178.16 3.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 2.8 p -119.77 151.12 39.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 3.6 t -125.86 131.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.667 ' CB ' HG22 ' B' ' 279' ' ' VAL . 26.0 t80 -98.98 94.46 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.506 ' O ' ' CB ' ' B' ' 243' ' ' THR . 62.4 t80 -87.84 129.3 35.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 0.0 111.117 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -119.24 157.99 26.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.402 -0.812 . . . . 0.0 109.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CG2' ' B' ' 290' ' ' VAL . . . -169.12 174.29 43.6 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.7 t -81.73 132.12 35.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -1.115 . . . . 0.0 109.8 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.452 ' N ' ' NH1' ' B' ' 222' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.201 -0.937 . . . . 0.0 110.101 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' B' ' 225' ' ' GLN . 65.9 mtt180 . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 121.666 0.746 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -52.75 -26.28 13.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 63.7 m-20 -70.58 -35.79 73.24 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 222' ' ' ARG . 0.4 OUTLIER -59.9 -43.34 94.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.03 71.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.34 -28.81 68.46 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' B' ' 224' ' ' ASP . 12.8 m-30 -69.55 -49.18 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 110.167 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.28 77.36 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.477 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -71.4 -55.41 8.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.138 . . . . 0.0 108.356 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.43 ' CD1' ' OE1' ' B' ' 282' ' ' GLU . 5.8 mt -54.24 -47.51 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.536 HG13 HG11 ' B' ' 241' ' ' VAL . 40.1 t -60.73 -28.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 28.4 p -69.44 -37.31 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.541 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -70.08 -47.61 61.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.131 . . . . 0.0 108.919 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.24 -41.61 97.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.8 -26.27 67.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -78.51 -35.47 46.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.045 -1.034 . . . . 0.0 109.371 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.566 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -74.3 -51.65 14.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -142.45 -152.51 5.7 Favored Glycine 0 N--CA 1.478 1.443 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -98.18 130.97 44.92 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.253 -1.145 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.536 HG11 HG13 ' B' ' 232' ' ' VAL . 2.2 t -89.67 110.79 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.526 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 16.9 mt -79.37 -29.2 42.05 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.673 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' B' ' 214' ' ' PHE . 13.6 p -83.0 24.19 0.78 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.521 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 243' ' ' THR . 85.9 tt0 -44.36 -31.19 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.539 ' CD2' ' OD2' ' B' ' 269' ' ' ASP . 0.1 OUTLIER -54.96 -36.05 64.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.845 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' B' ' 245' ' ' HIS . 55.8 t -50.32 -66.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -63.11 -39.16 93.89 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -61.41 -0.31 0.37 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -60.58 -40.15 90.68 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.167 -0.958 . . . . 0.0 108.735 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -49.29 -23.1 1.25 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.494 -0.754 . . . . 0.0 109.782 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' B' ' 251' ' ' LEU . 0.7 OUTLIER -66.78 123.25 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 251' ' ' LEU . 3.3 mt-10 54.06 163.25 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 108.88 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' B' ' 258' ' ' ALA . 84.5 Cg_exo -43.09 135.84 5.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.781 1.654 . . . . 0.0 111.038 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.798 HD12 ' N ' ' B' ' 254' ' ' LEU . 4.6 mp -81.14 -103.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 108.842 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 38.18 113.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.798 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 14.7 mm-40 -37.86 -48.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.12 -1.223 . . . . 0.0 109.204 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -74.8 -31.91 61.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 108.846 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -83.22 46.97 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -139.89 -164.71 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.24 68.62 0.22 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.03 75.66 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 30.5 p-10 -52.57 -38.4 59.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 263' ' ' GLN . . . . . 0.583 ' NE2' ' OE2' ' B' ' 267' ' ' GLU . 46.4 tt0 -63.49 -48.9 75.74 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -56.66 -36.9 70.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.099 -1.001 . . . . 0.0 109.145 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.5 OUTLIER -64.05 -38.07 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.595 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.5 OUTLIER -77.31 -58.13 3.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.716 . . . . 0.0 110.478 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.595 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 95.9 mt-10 -45.23 -46.26 12.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.778 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.82 -42.61 77.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.746 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' B' ' 245' ' ' HIS . 87.5 m-20 -66.47 -36.37 82.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.969 . . . . 0.0 110.695 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.554 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 1.3 mm? -69.56 -52.23 28.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.92 -1.113 . . . . 0.0 109.636 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -57.01 -40.58 76.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.526 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 1.0 OUTLIER -67.21 -44.64 79.05 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.275 -0.89 . . . . 0.0 109.608 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.573 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.9 tp -52.22 -35.31 49.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -72.34 -33.45 67.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.79 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.81 -1.33 54.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.37 51.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 112.401 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' B' ' 211' ' ' SER . 53.1 m-20 -100.58 -30.43 11.78 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 57.4 t -137.03 144.31 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.667 HG22 ' CB ' ' B' ' 213' ' ' TYR . 77.2 t -133.33 139.78 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.782 -1.199 . . . . 0.0 111.16 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 280' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 43.5 t -142.54 121.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -113.38 122.18 46.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.799 -1.188 . . . . 0.0 110.188 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.43 ' OE1' ' CD1' ' B' ' 231' ' ' ILE . 53.7 tt0 -86.03 112.91 21.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.836 HG11 HD11 ' B' ' 316' ' ' LEU . 1.9 t -86.45 -99.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 6.2 m 59.9 -96.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.217 -1.552 . . . . 0.0 109.036 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -61.64 133.43 93.45 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.871 -1.143 . . . . 0.0 108.582 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.472 ' HD3' ' HE ' ' B' ' 314' ' ' ARG . 33.1 Cg_endo -66.77 115.27 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.938 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.403 ' OG ' HG23 ' B' ' 290' ' ' VAL . 13.1 t -138.22 130.22 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.812 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.476 HD13 ' CG1' ' A' ' 83' ' ' VAL . 8.4 mt -69.39 -40.8 77.17 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.79 94.19 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' B' ' 216' ' ' GLY . 43.5 t -65.57 -47.53 86.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.462 -1.023 . . . . 0.0 108.827 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.26 73.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -68.85 -47.49 65.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.59 -0.947 . . . . 0.0 109.773 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.76 -35.08 78.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 0.0 109.635 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.5 mt -69.02 -46.82 66.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 108.596 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.38 -34.19 88.65 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.47 HH21 ' HB2' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -64.02 -43.89 94.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.458 -1.025 . . . . 0.0 109.685 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -71.39 -28.65 64.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.619 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.591 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -53.91 -50.15 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.591 ' N ' HG12 ' B' ' 298' ' ' VAL . . . -85.61 -55.75 3.84 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.419 0.628 . . . . 0.0 110.564 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.624 ' O ' HD23 ' B' ' 300' ' ' LEU . 1.1 tt -61.81 -17.07 54.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' B' ' 302' ' ' LYS . . . 75.78 -162.75 53.16 Favored Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' B' ' 301' ' ' GLY . 7.5 mmtm 96.63 136.4 0.03 OUTLIER Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 302' ' ' LYS . 80.7 Cg_exo -36.41 110.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.2 1.933 . . . . 0.0 111.591 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.503 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.4 mt -104.65 87.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.91 0.862 . . . . 0.0 111.256 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 305' ' ' LEU . 32.9 tp -91.16 116.94 29.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 306' ' ' CYS . . . . . 0.541 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.4 OUTLIER -108.28 140.29 41.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 0.0 108.585 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.0 mt -123.7 138.77 54.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.0 111.059 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -140.34 138.89 35.23 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -91.69 135.17 27.99 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.29 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.518 2.145 . . . . 0.0 110.934 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -49.78 -33.49 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.452 ' O ' ' C ' ' B' ' 313' ' ' GLY . 38.7 p -97.27 -21.06 17.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 39.6 44.74 2.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.472 ' HE ' ' HD3' ' B' ' 286' ' ' PRO . 14.5 mtp85 -70.31 8.38 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -1.203 . . . . 0.0 109.397 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' B' ' 313' ' ' GLY . 97.3 t 53.85 102.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.297 -0.877 . . . . 0.0 110.356 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 283' ' ' VAL . 13.3 tp -57.39 139.6 52.63 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.13 144.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.469 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 318' ' ' ALA . . . . . 0.791 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -59.74 -36.95 77.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' B' ' 319' ' ' MET . 25.3 mmm -69.0 -45.35 70.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.83 -46.59 91.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -68.44 -44.54 74.71 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.116 -0.99 . . . . 0.0 109.326 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.8 -26.6 68.89 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -56.47 -52.45 64.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.015 -1.285 . . . . 0.0 107.863 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 9.25 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' B' ' 323' ' ' ALA . 23.5 t0 -67.75 -35.48 78.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 107.945 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.878 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.78 176.49 45.68 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 21.1 m 56.25 -26.05 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.463 1.125 . . . . 0.0 108.824 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.878 ' H ' ' C ' ' B' ' 326' ' ' GLY . 7.2 tpp85 -150.34 -3.32 0.36 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.37 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.541 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 6.1 t80 -153.0 112.55 3.87 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.542 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 86.8 mt-30 -138.77 132.85 31.34 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.572 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 43.5 t -87.16 103.69 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.542 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 14.2 m0 -98.4 139.71 33.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -0.932 . . . . 0.0 109.306 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.477 ' O ' ' CE ' ' B' ' 342' ' ' MET . 73.9 m-20 -94.32 142.11 27.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.891 -1.13 . . . . 0.0 109.052 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.485 ' CD2' HG23 ' B' ' 339' ' ' VAL . 3.7 p90 -157.71 -173.28 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 111.078 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.651 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -159.22 157.61 31.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.6 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -135.77 -1.14 3.08 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.648 ' O ' ' SD ' ' B' ' 342' ' ' MET . 23.0 pt-20 -154.29 10.37 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.235 . . . . 0.0 109.995 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' B' ' 342' ' ' MET . 1.9 p -51.03 -41.82 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.023 -1.048 . . . . 0.0 108.856 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 81.2 tt0 -61.37 -28.78 69.48 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.027 -1.045 . . . . 0.0 108.833 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.1 m -71.96 -48.12 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.665 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.76 -47.0 77.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 75.3 mt -62.62 -30.13 71.13 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.07 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 43.4 t0 -68.32 -39.55 81.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -70.47 -51.61 27.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.173 . . . . 0.0 108.955 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 346' ' ' TYR . . . . . 0.63 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.3 t80 -57.88 -47.06 83.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.507 -0.746 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.818 ' CG ' HD12 ' B' ' 351' ' ' LEU . 11.7 m-85 -74.83 -32.46 61.96 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.185 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 12.3 mm-40 -58.94 -26.28 64.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 349' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -70.51 -21.67 62.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.821 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -173.23 101.56 0.12 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.818 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 175.17 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' B' ' 351' ' ' LEU . 90.7 Cg_endo . . . . . 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 111.513 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' CYS . 61.2 Cg_endo -75.09 155.27 42.48 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.389 2.059 . . . . 0.0 112.141 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 12.2 p -54.01 -175.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.112 -0.992 . . . . 0.0 108.508 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.47 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 69.4 m -111.17 152.63 26.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.109 -0.995 . . . . 0.0 108.739 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 35' ' ' LEU . 9.0 t -140.09 136.94 38.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 122.086 0.946 . . . . 0.0 109.273 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 69' ' ' ASP . 7.3 t80 -115.58 111.03 20.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.574 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.14 124.47 42.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 0.0 109.087 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 13.3 m -99.81 143.2 30.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.194 -0.941 . . . . 0.0 109.034 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.68 157.09 27.15 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.556 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 5.3 m -81.0 119.82 24.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.773 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.688 ' CG2' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.9 . . . . 0.0 108.732 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.196 0.522 . . . . 0.0 109.635 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -53.03 -39.16 62.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.65 -28.99 68.91 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.91 -41.62 97.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.89 -50.46 70.79 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.23 -32.91 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.5 m-30 -69.41 -46.86 65.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.951 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.89 84.47 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.739 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.692 HH22 HH21 ' A' ' 34' ' ' ARG . 65.9 ttt-85 -69.46 -56.4 7.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.506 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.47 -48.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -58.1 -32.27 43.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 p -63.32 -43.32 98.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 109.7 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.692 HH21 HH22 ' A' ' 30' ' ' ARG . 82.3 mtt-85 -64.4 -40.3 95.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.154 . . . . 0.0 108.06 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 38' ' ' TYR . 85.4 mt -62.9 -43.08 99.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.83 -28.49 61.64 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.81 -59.88 2.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.709 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -125.49 152.38 45.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 176.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.8 64.29 1.62 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' C ' ' O ' ' A' ' 39' ' ' GLY . 10.4 ttpt -34.42 121.79 0.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -1.037 . . . . 0.0 108.657 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.38 108.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.811 -1.181 . . . . 0.0 109.16 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 78.3 mt -72.17 -36.82 69.38 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.775 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.526 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -91.24 93.16 8.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.024 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.23 -23.74 19.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.51 -37.85 85.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 55.9 t -47.32 -73.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.098 -1.001 . . . . 0.0 109.68 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.18 -47.6 71.86 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.039 -1.038 . . . . 0.0 109.14 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.691 ' C ' HD11 ' A' ' 51' ' ' LEU . 26.3 t70 -72.35 45.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -122.79 -16.34 7.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -8.28 17.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.04 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.11 130.08 34.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.224 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 51' ' ' LEU . 5.7 mt-10 55.81 157.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' HH22 ' A' ' 22' ' ' ARG . 8.9 Cg_endo -52.77 112.03 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.286 1.991 . . . . 0.0 111.493 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.66 -3.79 54.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.617 ' N ' HD12 ' A' ' 54' ' ' LEU . . . -46.09 150.37 1.58 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' B' ' 318' ' ' ALA . 43.9 mt-10 -53.56 -35.49 60.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.062 -1.258 . . . . 0.0 109.117 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -66.31 -11.21 49.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . -57.17 176.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -47.03 164.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.26 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -43.31 150.96 0.46 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 154.87 -17.44 0.55 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.85 -44.03 90.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.0 109.219 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.39 -55.45 7.04 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -56.42 -29.31 61.42 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -69.85 -49.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.427 ' CE1' HD22 ' A' ' 70' ' ' LEU . 4.4 t-80 -64.73 -55.34 20.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.629 -0.669 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 91.1 mt-10 -49.1 -54.91 13.98 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.967 -1.083 . . . . 0.0 110.206 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 68' ' ' GLN . 4.2 mp0 -71.77 -50.61 28.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.924 -1.11 . . . . 0.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.482 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.4 m-20 -61.43 -54.61 41.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 111.493 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -72.37 -39.15 68.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.709 -1.244 . . . . 0.0 111.202 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 63.8 t-20 -58.48 -50.26 74.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.011 -1.68 . . . . 0.0 108.217 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.55 -38.77 81.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.2 tp -49.84 -39.79 40.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.54 -31.3 65.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.614 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -85.06 0.31 51.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.919 -1.113 . . . . 0.0 109.344 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.98 121.86 18.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 112.057 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' SER . 76.2 m-20 -68.47 -37.63 80.33 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 79.6 t -131.49 151.23 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.0 t -135.77 143.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 0.0 112.356 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 t -135.08 156.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 15' ' ' CYS . . . -162.99 123.38 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.364 -1.46 . . . . 0.0 110.749 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.09 116.46 22.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 116' ' ' LEU . 2.0 m -101.39 30.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 108.778 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 113' ' ' GLY . 25.9 m -62.13 -108.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.817 -0.552 . . . . 0.0 110.125 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 84' ' ' THR . 17.2 tm0? -41.02 126.57 2.03 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.502 -0.749 . . . . 0.0 110.221 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -45.76 113.44 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.881 1.721 . . . . 0.0 111.645 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.615 ' O ' HD23 ' B' ' 288' ' ' LEU . 8.0 t -142.16 131.88 24.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.0 110.219 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' O ' ' B' ' 287' ' ' SER . 8.3 mt -79.71 -42.46 24.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.76 -37.29 89.78 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 t -74.37 -42.56 50.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -1.22 . . . . 0.0 108.817 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.02 -25.18 67.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -70.82 -56.51 6.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.79 -0.829 . . . . 0.0 109.308 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 96.1 mt-10 -60.18 -33.76 72.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.693 ' C ' HD13 ' A' ' 94' ' ' LEU . 3.2 tm? -70.75 -49.95 41.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.17 57.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 HG11 ' B' ' 298' ' ' VAL . 56.0 ttt85 -56.16 -36.28 68.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -1.076 . . . . 0.0 108.334 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.69 -38.58 87.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -54.4 -43.47 62.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.876 -1.14 . . . . 0.0 108.531 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -74.71 -48.36 26.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.411 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.8 pp -119.5 -28.02 5.42 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.912 -1.117 . . . . 0.0 110.585 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -40.74 162.35 0.01 OUTLIER Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 2.5 mmtp -98.38 -161.57 0.04 OUTLIER Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 71.8 Cg_exo -41.71 115.03 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.354 1.519 . . . . 0.0 110.376 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.3 mt -106.62 138.97 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.088 0.947 . . . . 0.0 112.188 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 132' ' ' TRP . 50.8 tp -126.5 118.1 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER -102.63 157.27 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.924 -1.11 . . . . 0.0 109.411 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 134' ' ' TYR . 5.7 mt -143.12 127.75 18.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -138.78 145.05 39.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.208 -0.933 . . . . 0.0 108.966 178.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.522 ' NH1' ' OH ' ' A' ' 134' ' ' TYR . 24.2 ptt-85 -128.67 148.12 67.14 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.52 29.46 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.58 2.186 . . . . 0.0 112.507 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 50.6 mt-30 -104.79 -44.01 4.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -129.69 -22.62 2.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 108.676 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 114' ' ' ARG . . . -87.03 -52.03 3.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.705 ' O ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 39.59 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 114' ' ' ARG . 96.6 t 61.78 93.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.887 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.5 pt? -70.03 -43.56 71.05 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.788 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER 163.05 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.877 -1.139 . . . . 0.0 110.303 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' B' ' 256' ' ' GLU . . . -63.91 -46.12 86.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.818 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 80.4 mmm -62.22 -46.53 88.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 94' ' ' LEU . 3.8 mm -61.1 -41.86 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -44.57 95.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.921 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.21 -33.96 88.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -56.3 -22.16 28.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.274 -1.133 . . . . 0.0 108.659 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -36.45 109.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.276 0.56 . . . . 0.0 110.084 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' OD2' ' OG ' ' A' ' 127' ' ' SER . 55.0 t0 -105.73 -29.41 10.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.38 77.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 80.0 p -122.24 -78.97 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -1.066 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' N ' ' OG ' ' A' ' 127' ' ' SER . 46.6 ttp180 -97.92 -5.08 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 108.885 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.27 125.34 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.449 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 57.0 mt-30 -138.35 149.94 46.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.051 -1.03 . . . . 0.0 111.215 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.25 107.22 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.437 ' CD2' HD11 ' A' ' 105' ' ' LEU . 20.3 m0 -106.14 145.23 31.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.128 -0.983 . . . . 0.0 109.984 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.531 ' O ' ' CE ' ' A' ' 142' ' ' MET . 57.7 p-10 -100.97 161.07 13.85 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.649 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 8.0 p90 -172.67 -167.88 0.47 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.807 -1.183 . . . . 0.0 110.7 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.963 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -131.34 149.95 52.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.714 ' C ' ' O ' ' A' ' 135' ' ' ALA . 72.2 mt-10 -32.29 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.963 ' O ' ' O ' ' A' ' 135' ' ' ALA . . . -95.54 -176.45 37.14 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.92 -13.11 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.057 -1.261 . . . . 0.0 108.864 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.7 ' H ' ' C ' ' A' ' 137' ' ' GLY . 1.3 p -59.19 -46.88 91.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.541 ' OE1' ' NH2' ' A' ' 34' ' ' ARG . 23.3 pt-20 -53.37 -33.58 54.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.7 m -68.31 -40.84 81.56 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.395 -0.816 . . . . 0.0 108.884 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 8.2 mmt -52.49 -48.04 66.2 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.0 -38.59 91.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.44 -40.46 95.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 110.731 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -70.05 -49.87 46.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.488 -1.382 . . . . 0.0 108.796 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.84 -48.72 80.55 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 151' ' ' LEU . 19.4 m-85 -70.45 -32.95 70.72 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.236 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -61.19 -31.14 70.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.13 12.21 5.44 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -138.1 -104.29 0.18 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.323 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 12.1 mt -33.5 90.69 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.844 -0.535 . . . . 0.0 110.841 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' N ' ' O ' ' A' ' 150' ' ' TYR . 83.6 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 C-N-CA 123.217 2.612 . . . . 0.0 111.477 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' B' ' 210' ' ' CYS . 61.1 Cg_endo -75.09 155.01 42.46 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.46 2.107 . . . . 0.0 112.18 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' B' ' 209' ' ' PRO . 10.2 p -53.85 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.173 -0.955 . . . . 0.0 108.467 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' B' ' 277' ' ' ASP . 62.9 m -111.17 152.82 26.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.157 -0.965 . . . . 0.0 108.714 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.549 HG11 HD22 ' B' ' 235' ' ' LEU . 8.9 t -140.33 136.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 122.04 0.924 . . . . 0.0 109.21 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 269' ' ' ASP . 7.2 t80 -115.51 110.95 19.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.592 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.04 124.2 42.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.036 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.425 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 12.2 m -99.73 142.62 30.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.046 -1.034 . . . . 0.0 109.071 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -144.18 157.17 27.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.552 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 5.7 m -80.78 119.96 24.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -1.037 . . . . 0.0 109.795 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.686 ' CG2' HD22 ' B' ' 254' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.258 0.551 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.09 -39.14 63.14 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 79.4 m-20 -66.7 -29.01 68.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -63.93 -41.81 97.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.16 72.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.28 -33.17 69.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.654 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.5 m-30 -69.26 -46.47 67.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 0.0 110.074 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.87 85.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.766 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.725 HH22 HH21 ' B' ' 234' ' ' ARG . 65.8 ttt-85 -69.37 -56.19 8.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 108.535 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.2 mt -52.86 -48.18 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 228' ' ' TYR . 56.1 t -58.2 -32.22 43.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 18.1 p -63.29 -43.58 97.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 109.597 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.725 HH21 HH22 ' B' ' 230' ' ' ARG . 83.6 mtt-85 -64.23 -40.5 96.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.867 -1.145 . . . . 0.0 108.008 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.712 ' O ' ' O ' ' B' ' 238' ' ' TYR . 87.0 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -56.93 -28.3 61.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 108.75 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.04 -59.87 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.712 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.9 OUTLIER -125.32 152.32 44.87 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 176.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 84.03 64.16 1.62 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' B' ' 239' ' ' GLY . 10.6 ttpt -34.2 121.9 0.48 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -1.085 . . . . 0.0 108.584 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.67 109.53 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.793 -1.192 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 78.1 mt -72.6 -37.64 68.07 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.677 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.53 ' OG1' HG23 ' B' ' 246' ' ' VAL . 0.1 OUTLIER -90.47 92.86 9.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.957 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -91.89 -23.7 19.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 109.158 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -61.94 -37.77 85.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 110.128 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.59 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 55.8 t -46.86 -73.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.658 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -53.83 -48.08 70.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.684 ' C ' HD11 ' B' ' 251' ' ' LEU . 26.2 t70 -72.26 45.48 0.13 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -122.82 -16.57 7.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -8.32 15.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.984 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -84.3 130.41 34.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.088 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' B' ' 251' ' ' LEU . 6.0 mt-10 55.55 157.97 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.039 -1.038 . . . . 0.0 108.861 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.446 ' HA ' HH22 ' B' ' 222' ' ' ARG . 8.6 Cg_endo -52.7 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.224 1.95 . . . . 0.0 111.437 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.686 HD22 ' CG2' ' B' ' 218' ' ' ILE . 0.3 OUTLIER -92.87 -3.97 53.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.608 ' N ' HD12 ' B' ' 254' ' ' LEU . . . -45.84 150.2 1.48 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 44.2 mt-10 -53.43 -35.89 60.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -1.205 . . . . 0.0 108.983 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.99 -11.14 45.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.0 108.843 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 255' ' ' GLY . . . -57.51 175.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 259' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' B' ' 260' ' ' GLY . . . -46.97 165.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.326 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 260' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' B' ' 259' ' ' ALA . . . -43.36 151.5 0.42 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 261' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 154.25 -17.53 0.61 Allowed Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.07 -44.24 91.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.116 -1.226 . . . . 0.0 109.265 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -72.32 -55.26 7.42 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 264' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 0.9 OUTLIER -56.39 -29.27 61.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' B' ' 261' ' ' GLY . 8.5 mt -69.87 -49.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.429 ' CE1' HD22 ' B' ' 270' ' ' LEU . 3.9 t-80 -65.27 -55.15 19.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.662 -0.649 . . . . 0.0 110.001 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 90.9 mt-10 -49.01 -54.55 15.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 110.224 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 268' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 4.8 mp0 -72.06 -50.8 25.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.923 -1.111 . . . . 0.0 111.038 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.469 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 1.6 m-20 -61.2 -54.79 39.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.457 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.429 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.5 OUTLIER -72.43 -38.79 68.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.766 -1.209 . . . . 0.0 111.323 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 64.7 t-20 -58.74 -50.02 75.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 119.955 -1.715 . . . . 0.0 108.155 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -59.8 -38.9 83.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.4 tp -49.64 -39.47 36.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.402 ' OE1' ' NH2' ' B' ' 296' ' ' ARG . 15.2 mt-30 -72.84 -31.22 64.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.533 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.24 0.2 52.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.97 121.95 18.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.318 -0.864 . . . . 0.0 112.091 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.482 ' H ' ' HB2' ' B' ' 211' ' ' SER . 79.3 m-20 -68.56 -37.65 80.09 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 77.7 t -131.34 151.45 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 86.9 t -136.16 143.6 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 122.564 1.173 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 27.8 t -135.11 156.35 39.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -163.06 122.72 2.2 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.434 -1.416 . . . . 0.0 110.81 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.29 116.23 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.476 HG21 HD12 ' B' ' 316' ' ' LEU . 1.9 m -101.24 29.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 108.778 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.595 HG22 ' N ' ' B' ' 313' ' ' GLY . 25.3 m -61.86 -109.37 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.728 -0.607 . . . . 0.0 110.169 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.409 ' N ' HG22 ' B' ' 284' ' ' THR . 17.4 tm0? -40.63 126.76 1.87 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.407 -0.808 . . . . 0.0 110.181 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -45.61 113.7 0.61 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.933 1.755 . . . . 0.0 111.595 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.627 ' O ' HD23 ' A' ' 88' ' ' LEU . 8.1 t -142.64 131.66 23.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.121 -0.987 . . . . 0.0 110.251 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 87' ' ' SER . 8.3 mt -79.68 -42.6 24.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 109.304 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -58.57 -37.52 89.07 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 8.2 t -74.2 -42.28 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 108.809 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -63.49 -24.98 68.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -70.81 -56.42 6.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.707 -0.878 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.425 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 95.7 mt-10 -60.19 -33.68 72.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.677 ' C ' HD13 ' B' ' 294' ' ' LEU . 3.3 tm? -70.77 -49.73 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.99 -51.5 54.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.41 HH11 HG11 ' A' ' 98' ' ' VAL . 56.1 ttt85 -55.96 -36.4 67.76 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 108.394 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.55 -38.78 87.85 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.463 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.4 OUTLIER -54.19 -43.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 120.862 -1.149 . . . . 0.0 108.565 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -74.55 -48.8 24.71 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 112.387 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.7 pp -119.06 -27.95 5.61 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.974 -1.079 . . . . 0.0 110.747 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' B' ' 300' ' ' LEU . . . -40.8 162.19 0.01 OUTLIER Glycine 0 C--N 1.289 -2.044 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.49 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 2.8 mmtp -98.23 -161.54 0.04 OUTLIER Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 75.9 Cg_exo -41.89 115.41 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 121.458 1.557 . . . . 0.0 110.329 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.85 138.96 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.195 0.998 . . . . 0.0 112.147 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' B' ' 332' ' ' TRP . 50.9 tp -126.47 118.25 24.55 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.8 157.41 16.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.899 -1.126 . . . . 0.0 109.457 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' B' ' 334' ' ' TYR . 5.9 mt -143.02 128.0 18.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -139.33 144.7 38.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.139 -0.976 . . . . 0.0 108.865 178.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' B' ' 334' ' ' TYR . 24.9 ptt-85 -128.65 148.09 66.96 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.464 -0.772 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.42 29.46 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.208 . . . . 0.0 112.566 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.544 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 51.3 mt-30 -104.62 -43.77 5.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 22.6 m -129.73 -23.24 2.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 108.6 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.707 ' O ' ' O ' ' B' ' 314' ' ' ARG . . . -86.44 -51.87 3.37 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.707 ' O ' ' O ' ' B' ' 313' ' ' GLY . 0.1 OUTLIER 39.47 101.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 315' ' ' VAL . . . . . . . . . . . . . 96.6 t 61.97 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.897 HD23 ' H ' ' B' ' 316' ' ' LEU . 1.5 pt? -70.45 -43.84 69.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.739 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.3 OUTLIER 163.35 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.96 -1.088 . . . . 0.0 110.176 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 318' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . . . -64.1 -45.57 88.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.442 -0.786 . . . . 0.0 109.798 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 80.2 mmm -62.52 -46.9 86.3 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.36 -0.838 . . . . 0.0 109.371 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.411 ' CD1' HD12 ' B' ' 294' ' ' LEU . 3.8 mm -60.69 -41.88 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -44.39 96.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.748 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -63.66 -33.58 87.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -56.7 -22.11 32.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -1.15 . . . . 0.0 108.605 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -36.44 109.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.21 0.529 . . . . 0.0 110.043 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -105.94 -29.46 9.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.12 3.7 76.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 68.1 p -121.49 -79.08 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.472 -1.017 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -97.89 -4.93 35.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.855 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.404 ' HE1' HD11 ' B' ' 294' ' ' LEU . 85.6 t80 -137.37 125.24 22.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.13 149.77 46.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.0 111.12 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.04 106.93 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.436 ' CD2' HD11 ' B' ' 305' ' ' LEU . 20.4 m0 -106.21 145.11 31.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.111 -0.993 . . . . 0.0 110.103 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.54 ' O ' ' CE ' ' B' ' 342' ' ' MET . 57.1 p-10 -100.68 160.83 14.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 8.0 p90 -172.41 -167.89 0.49 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.735 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.962 ' O ' ' O ' ' B' ' 337' ' ' GLY . . . -131.47 149.49 52.51 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.76 ' C ' ' O ' ' B' ' 335' ' ' ALA . 71.1 mt-10 -31.94 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.962 ' O ' ' O ' ' B' ' 335' ' ' ALA . . . -95.36 -176.71 37.42 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -13.06 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.93 -1.335 . . . . 0.0 108.908 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.713 ' H ' ' C ' ' B' ' 337' ' ' GLY . 1.3 p -59.12 -46.97 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.55 ' OE1' ' NH2' ' B' ' 234' ' ' ARG . 22.7 pt-20 -53.21 -33.78 54.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 17.9 m -68.16 -40.7 82.27 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.955 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.54 ' CE ' ' O ' ' B' ' 333' ' ' ASP . 7.9 mmt -52.86 -47.91 67.47 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.824 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -64.44 -40.36 95.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.42 -0.8 . . . . 0.0 110.73 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -70.11 -49.71 48.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.422 -1.423 . . . . 0.0 108.756 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.25 -48.65 80.83 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 109.961 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.494 ' HB3' HD12 ' B' ' 351' ' ' LEU . 19.7 m-85 -70.41 -32.51 70.17 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.144 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.59 -30.95 71.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.24 12.25 5.53 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.5 t80 -138.04 -104.44 0.18 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.283 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' B' ' 347' ' ' PHE . 12.0 mt -33.53 90.77 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.915 -0.491 . . . . 0.0 110.815 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' B' ' 350' ' ' TYR . 78.8 Cg_endo . . . . . 0 C--N 1.315 -1.225 0 C-N-CA 123.27 2.647 . . . . 0.0 111.339 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -155.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.533 2.155 . . . . 0.0 111.459 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -102.07 -175.61 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.5 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 11.2 p -120.35 154.39 35.12 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.717 HG11 HD22 ' A' ' 35' ' ' LEU . 7.2 t -133.58 135.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 0.0 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.1 t80 -118.15 95.39 4.87 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -83.2 104.73 13.6 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -95.03 170.43 9.42 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 111.417 -176.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.678 ' HA2' HG22 ' A' ' 90' ' ' VAL . . . 84.3 93.05 0.72 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' CE2' ' A' ' 28' ' ' TYR . 2.7 p -168.39 -177.29 3.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.014 -1.286 . . . . 0.0 109.746 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.592 -0.693 . . . . 0.0 109.922 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.3 mmt85 . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.08 -35.22 61.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 28' ' ' TYR . 4.6 t0 -65.99 -27.75 68.37 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.607 ' OE1' ' N ' ' A' ' 50' ' ' GLU . 5.5 tt0 -57.9 -45.55 86.29 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.46 94.15 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.65 -30.22 71.35 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 32' ' ' VAL . 22.7 m-30 -70.77 -49.77 43.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.48 -0.762 . . . . 0.0 110.089 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.32 72.68 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.426 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -71.43 -58.15 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.918 -1.113 . . . . 0.0 108.291 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.85 -44.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.802 HG13 HG11 ' A' ' 41' ' ' VAL . 55.4 t -61.07 -28.84 44.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -70.82 -35.09 72.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.422 ' HA ' HH11 ' A' ' 37' ' ' ARG . 68.1 mtp85 -73.89 -50.28 20.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 108.694 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.717 HD22 HG11 ' A' ' 12' ' ' VAL . 13.4 mt -59.64 -40.09 86.51 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.95 -23.0 67.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.422 HH11 ' HA ' ' A' ' 34' ' ' ARG . 26.0 mtt85 -77.88 -34.6 51.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.026 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-30 -73.32 -51.09 18.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 110.082 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.11 -144.99 4.22 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -98.95 135.59 40.15 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.178 -1.189 . . . . 0.0 108.669 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.802 HG11 HG13 ' A' ' 32' ' ' VAL . 12.4 t -100.11 122.19 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 12.2 mt -87.36 -17.05 33.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.295 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.426 HG22 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -86.22 43.23 1.04 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.402 -0.811 . . . . 0.0 109.513 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -66.34 -38.67 88.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.493 ' ND1' ' C ' ' A' ' 45' ' ' HIS . 6.5 t-80 -53.94 -46.97 71.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.877 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG11 ' CZ ' ' A' ' 14' ' ' PHE . 5.3 t -48.34 -49.31 13.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.315 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.3 -40.74 62.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 108.54 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' HD22 ' A' ' 51' ' ' LEU . 2.7 t0 -75.07 50.89 0.49 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.635 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -126.21 -30.69 2.89 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.607 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -55.08 -5.33 0.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.197 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -49.49 -55.99 11.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 1.8 tm-20 -179.67 -44.73 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.418 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' O ' HD22 ' A' ' 54' ' ' LEU . 13.2 Cg_exo -69.31 92.22 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.686 2.257 . . . . 0.0 112.467 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 53' ' ' PRO . 4.0 mm? -125.21 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.809 . . . . 0.0 109.549 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 68.19 35.73 83.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' ALA . 69.3 mm-40 47.46 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.531 -0.982 . . . . 0.0 109.197 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 47.92 13.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.04 -1.037 . . . . 0.0 108.65 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' GLU . . . -139.64 96.64 3.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.48 -0.763 . . . . 0.0 109.016 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 65' ' ' ILE . . . -172.72 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.233 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.16 17.12 21.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 62' ' ' ASP . . . 152.23 76.83 0.02 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 23.8 p-10 -48.69 -44.29 37.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.497 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 89.6 mt-30 -57.42 -45.13 84.95 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.63 -41.58 95.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.506 HD12 ' CB ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -58.04 -39.06 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.463 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.8 t-80 -76.14 -51.02 13.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.63 -0.669 . . . . 0.0 110.38 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 97.0 mt-10 -46.68 -53.69 11.17 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.071 -1.018 . . . . 0.0 109.825 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.85 -42.63 66.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 110.91 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.71 -57.44 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.965 -1.084 . . . . 0.0 111.143 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.097 -1.002 . . . . 0.0 110.792 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -60.97 -52.94 62.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.591 -1.318 . . . . 0.0 108.958 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.69 -40.84 89.21 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 108.703 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 7.6 tp -50.07 -37.7 34.85 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' NZ ' ' A' ' 102' ' ' LYS . 51.4 mt-30 -74.44 -29.43 61.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.715 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 15.3 mt-30 -90.2 3.87 52.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.83 -1.169 . . . . 0.0 109.284 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.01 130.08 40.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.899 . . . . 0.0 112.27 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 11' ' ' SER . 85.1 m-20 -78.09 -34.9 49.91 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.25 144.24 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 13' ' ' TYR . 91.9 t -136.08 129.06 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.917 -1.115 . . . . 0.0 111.205 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 70.1 t -129.03 124.85 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.767 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -121.39 156.13 33.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.307 -1.496 . . . . 0.0 110.24 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -99.82 122.66 43.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.32 33.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 109' ' ' ARG . 4.2 m -88.87 -73.54 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.741 -0.6 . . . . 0.0 109.756 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -77.77 120.48 81.5 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.798 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.41 141.84 89.28 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.236 1.957 . . . . 0.0 112.202 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.92 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -179.49 141.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 110.019 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 92' ' ' TYR . 19.7 mt -62.45 -43.21 99.36 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.458 -0.776 . . . . 0.0 109.044 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -54.48 -38.52 63.13 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.92 HG23 ' OG ' ' A' ' 87' ' ' SER . 44.6 t -68.07 -53.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.512 -0.993 . . . . 0.0 108.676 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.37 -28.41 73.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.509 ' OH ' ' HB2' ' B' ' 323' ' ' ALA . 51.3 t80 -70.72 -55.09 9.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -1.092 . . . . 0.0 109.633 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' SD ' ' B' ' 319' ' ' MET . 77.4 mt-10 -62.15 -34.15 75.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.253 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 81' ' ' ALA . 21.1 mt -70.22 -48.55 56.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.253 -0.905 . . . . 0.0 109.195 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.24 96.07 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -61.92 -40.47 95.59 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.519 -0.989 . . . . 0.0 109.299 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.53 -41.21 76.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.09 -1.006 . . . . 0.0 108.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -39.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -77.64 -51.14 11.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.68 -6.18 10.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.973 -1.079 . . . . 0.0 108.722 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.6 26.0 30.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 104' ' ' ILE . 43.9 mttp -84.38 147.54 50.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.906 -1.35 . . . . 0.0 107.644 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -38.53 116.52 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.756 1.637 . . . . 0.0 110.896 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -115.95 98.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.271 -0.893 . . . . 0.0 111.602 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 80' ' ' VAL . 59.1 tp -94.69 120.64 35.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.28 131.22 55.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.885 -1.134 . . . . 0.0 108.838 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 3.5 mt -123.15 130.19 52.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 0.0 111.502 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -131.12 151.07 51.82 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.569 ' H ' HG23 ' A' ' 84' ' ' THR . 49.9 mtm180 -114.23 136.02 22.22 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.115 -0.99 . . . . 0.0 110.219 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -29.97 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.355 2.037 . . . . 0.0 111.286 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' ' 112' ' ' SER . 12.2 pt20 -59.7 -46.36 89.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.354 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 17.2 t -75.85 -22.18 56.49 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' O ' ' NE ' ' A' ' 114' ' ' ARG . . . 55.93 111.0 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.601 ' O ' ' C ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -144.6 -7.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -1.017 . . . . 0.0 110.259 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' A' ' 114' ' ' ARG . 94.7 t 32.85 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.978 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -61.13 172.31 1.07 Allowed 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.81 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 289' ' ' GLY . 29.3 t -64.95 141.36 58.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 111.721 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.18 63.76 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.529 ' SD ' ' CG ' ' B' ' 293' ' ' GLU . 1.7 mtp -63.94 -43.51 95.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.542 -0.724 . . . . 0.0 109.317 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' B' ' 292' ' ' TYR . 4.1 mm -61.87 -45.48 98.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.497 -0.752 . . . . 0.0 109.418 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -64.43 -44.8 90.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -58.55 -32.1 68.27 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -51.7 -57.33 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 108.265 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 10.38 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 123' ' ' ALA . 2.2 m-20 -68.97 -35.36 76.64 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.747 -1.221 . . . . 0.0 107.757 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.817 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.41 174.04 40.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.4 t 60.56 -30.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.668 1.223 . . . . 0.0 108.573 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.817 ' H ' ' C ' ' A' ' 126' ' ' GLY . 8.7 mtm180 -147.33 0.95 0.71 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.539 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' GLY . 11.3 t80 -156.94 112.9 2.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.521 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 90.5 mt-30 -139.29 142.8 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.398 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.51 98.86 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.521 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 18.1 m0 -94.66 147.29 23.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.345 -0.847 . . . . 0.0 109.521 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' O ' ' HE1' ' A' ' 142' ' ' MET . 67.6 m-20 -100.27 150.64 22.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 7.8 p90 -170.95 177.58 3.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.642 -1.286 . . . . 0.0 111.548 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -141.99 146.83 36.03 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.0 mt-10 -39.41 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.748 -1.22 . . . . 0.0 110.474 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -86.32 -2.37 85.42 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.109 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -135.93 0.19 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.813 -1.404 . . . . 0.0 110.231 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -55.21 -47.04 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.851 -1.156 . . . . 0.0 108.476 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 29.6 mt-10 -53.16 -33.17 51.41 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.7 m -69.56 -40.91 76.52 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 109.25 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.467 ' HE1' ' O ' ' A' ' 133' ' ' ASP . 12.9 mmt -53.16 -51.78 60.9 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 48.8 mt -62.05 -32.48 73.0 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.72 -43.91 87.62 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 -71.98 -47.74 49.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.534 -1.354 . . . . 0.0 109.149 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -60.44 -48.96 79.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 21.3 m-85 -71.37 -28.86 64.34 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.159 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.05 -31.14 71.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.07 9.57 10.03 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 2.5 t80 -134.85 -104.49 0.23 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.237 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.531 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 22.6 mt -32.42 90.84 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.91 -0.494 . . . . 0.0 110.925 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . 71.5 Cg_endo . . . . . 0 C--N 1.313 -1.335 0 C-N-CA 123.067 2.511 . . . . 0.0 111.248 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.62 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 111.34 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 32.1 p -102.21 -175.61 2.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.9 p -120.36 154.0 35.68 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.722 HG11 HD22 ' B' ' 235' ' ' LEU . 6.8 t -133.41 135.37 56.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.7 0.762 . . . . 0.0 109.034 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' B' ' 279' ' ' VAL . 7.9 t80 -118.01 95.76 5.05 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.868 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -83.36 104.94 13.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.1 OUTLIER -95.28 170.23 9.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.078 0.942 . . . . 0.0 111.49 -176.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' B' ' 290' ' ' VAL . . . 84.37 93.51 0.71 Allowed Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.574 ' CB ' ' CE2' ' B' ' 228' ' ' TYR . 2.6 p -168.52 -176.85 2.94 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 0.0 109.888 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' B' ' 225' ' ' GLN . 9.4 mmt85 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.05 -34.9 61.25 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' B' ' 228' ' ' TYR . 4.5 t0 -66.26 -27.61 68.08 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.595 ' OE1' ' N ' ' B' ' 250' ' ' GLU . 5.5 tt0 -58.15 -45.21 87.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.64 -43.28 94.18 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.9 tp -64.07 -29.68 70.8 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.677 ' O ' HG23 ' B' ' 232' ' ' VAL . 22.7 m-30 -71.11 -49.62 42.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.39 -0.818 . . . . 0.0 109.98 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.04 72.67 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.478 -1.289 . . . . 0.0 108.44 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -71.71 -57.9 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.882 -1.136 . . . . 0.0 108.283 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.5 mt -53.09 -44.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.822 HG13 HG11 ' B' ' 241' ' ' VAL . 55.7 t -60.99 -28.74 44.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' B' ' 237' ' ' ARG . 7.1 t -70.94 -34.91 71.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.394 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.412 ' HA ' HH11 ' B' ' 237' ' ' ARG . 67.8 mtp85 -73.88 -50.5 19.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 108.752 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.722 HD22 HG11 ' B' ' 212' ' ' VAL . 14.1 mt -59.22 -40.42 85.78 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -64.78 -23.16 67.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' B' ' 233' ' ' SER . 24.1 mtt85 -77.66 -34.98 52.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 108.922 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -73.23 -50.86 20.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 110.041 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -145.22 -145.29 4.26 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -98.59 135.34 40.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.293 -1.122 . . . . 0.0 108.704 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.822 HG11 HG13 ' B' ' 232' ' ' VAL . 12.8 t -100.07 122.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 11.4 mt -87.35 -16.34 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.309 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.419 HG22 ' CG2' ' B' ' 246' ' ' VAL . 0.2 OUTLIER -86.84 43.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.4 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -66.55 -38.22 86.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.89 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.488 ' ND1' ' C ' ' B' ' 245' ' ' HIS . 6.6 t-80 -54.43 -46.92 73.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.971 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.462 HG11 ' CZ ' ' B' ' 214' ' ' PHE . 5.5 t -48.5 -48.38 14.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.97 59.61 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.649 ' O ' HD22 ' B' ' 251' ' ' LEU . 2.7 t0 -74.86 50.68 0.46 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -126.32 -30.08 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.595 ' N ' ' OE1' ' B' ' 225' ' ' GLN . 0.4 OUTLIER -55.71 -4.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.66 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.4 OUTLIER -50.12 -55.3 15.52 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 1.8 tm-20 179.99 -45.28 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.426 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.644 ' O ' HD22 ' B' ' 254' ' ' LEU . 13.0 Cg_exo -69.14 92.35 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.644 HD22 ' O ' ' B' ' 253' ' ' PRO . 4.0 mm? -125.44 178.39 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 68.26 35.93 83.77 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' B' ' 258' ' ' ALA . 69.0 mm-40 47.05 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -1.02 . . . . 0.0 109.277 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 48.15 13.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.583 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -139.29 96.35 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 259' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' B' ' 265' ' ' ILE . . . -172.38 -30.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.64 16.39 22.24 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' B' ' 262' ' ' ASP . . . 152.74 76.56 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 23.8 p-10 -48.42 -44.14 34.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 263' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.9 mt-30 -57.49 -45.41 84.92 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -60.13 -42.05 93.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.505 HD12 ' CB ' ' B' ' 259' ' ' ALA . 0.1 OUTLIER -57.75 -38.7 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.49 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.8 t-80 -76.35 -51.21 12.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.246 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 97.1 mt-10 -46.67 -53.42 11.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.794 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.97 -42.79 66.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 269' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.68 -57.35 9.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.0 -1.062 . . . . 0.0 111.143 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -39.64 83.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.091 -1.005 . . . . 0.0 110.81 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.6 t-20 -60.95 -52.74 63.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.684 -1.26 . . . . 0.0 108.965 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.515 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -60.0 -40.75 90.28 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.738 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 8.1 tp -50.06 -37.81 35.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.49 ' O ' ' NZ ' ' B' ' 302' ' ' LYS . 52.2 mt-30 -74.25 -29.55 61.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.773 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 14.8 mt-30 -90.11 3.97 51.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.838 -1.164 . . . . 0.0 109.204 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.07 129.95 39.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 112.311 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.508 ' HB2' ' H ' ' B' ' 211' ' ' SER . 85.1 m-20 -77.96 -34.74 50.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.66 144.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' B' ' 213' ' ' TYR . 87.3 t -136.12 129.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.921 -1.112 . . . . 0.0 111.296 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 280' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 69.4 t -128.96 125.15 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.752 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -121.87 156.72 32.7 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.296 -1.503 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -100.19 123.03 43.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.82 33.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.556 HG23 ' H ' ' B' ' 309' ' ' ARG . 4.0 m -88.45 -73.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.766 -0.583 . . . . 0.0 109.804 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -77.43 120.75 82.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.47 141.7 89.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.255 1.97 . . . . 0.0 112.229 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.937 ' OG ' HG23 ' B' ' 290' ' ' VAL . 0.1 OUTLIER -179.34 140.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.102 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 292' ' ' TYR . 20.1 mt -62.24 -42.83 99.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 289' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 117' ' ' SER . . . -54.88 -38.6 65.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.937 HG23 ' OG ' ' B' ' 287' ' ' SER . 44.3 t -68.03 -52.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.933 . . . . 0.0 108.696 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.45 -27.94 73.42 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.515 ' OH ' ' HB2' ' A' ' 123' ' ' ALA . 50.5 t80 -71.1 -55.28 8.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.368 -1.078 . . . . 0.0 109.592 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.529 ' CG ' ' SD ' ' A' ' 119' ' ' MET . 76.7 mt-10 -62.09 -34.05 75.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.137 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' B' ' 281' ' ' ALA . 21.7 mt -70.24 -48.6 56.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.86 95.87 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 16.8 tpt85 -62.27 -40.42 96.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.544 -0.974 . . . . 0.0 109.244 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.499 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -69.46 -41.48 76.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 108.937 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.41 -39.64 22.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -77.53 -51.38 10.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.924 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.49 -6.11 9.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.949 -1.094 . . . . 0.0 108.834 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.44 26.0 28.97 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.518 ' O ' HG13 ' B' ' 304' ' ' ILE . 43.7 mttp -84.29 147.32 49.96 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.849 -1.383 . . . . 0.0 107.667 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 302' ' ' LYS . 83.6 Cg_exo -38.26 116.15 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.805 1.67 . . . . 0.0 110.856 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 302' ' ' LYS . 3.6 mt -115.76 98.54 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 0.0 111.467 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 280' ' ' VAL . 58.0 tp -94.45 120.85 35.31 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 131.6 54.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.77 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.5 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 3.3 mt -123.48 130.62 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 111.429 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -131.36 151.4 51.56 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.556 ' H ' HG23 ' B' ' 284' ' ' THR . 49.6 mtm180 -114.7 135.88 22.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.026 -1.046 . . . . 0.0 110.185 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.06 -29.37 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 111.381 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' B' ' 312' ' ' SER . 12.1 pt20 -60.32 -45.92 91.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.526 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 16.6 t -76.44 -21.84 55.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.559 ' O ' ' NE ' ' B' ' 314' ' ' ARG . . . 55.82 110.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' B' ' 315' ' ' VAL . 0.0 OUTLIER -144.57 -7.72 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.434 -1.039 . . . . 0.0 110.244 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.568 ' C ' ' O ' ' B' ' 314' ' ' ARG . 86.5 t 33.09 90.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.948 ' H ' HD23 ' B' ' 316' ' ' LEU . 0.2 OUTLIER -60.89 172.23 1.02 Allowed 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.77 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 28.8 t -65.02 141.28 58.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.039 -1.038 . . . . 0.0 111.736 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.38 -32.99 63.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.493 ' SD ' ' CG ' ' A' ' 93' ' ' GLU . 1.8 mtp -64.21 -43.67 94.28 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.597 -0.689 . . . . 0.0 109.319 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 92' ' ' TYR . 4.3 mm -61.49 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -64.82 -44.36 90.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.19 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -58.51 -32.06 68.04 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -52.08 -57.43 9.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -1.178 . . . . 0.0 108.326 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.583 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 10.36 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' B' ' 323' ' ' ALA . 2.0 m-20 -69.12 -35.07 76.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.793 -1.192 . . . . 0.0 107.855 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.803 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.32 174.02 40.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 7.1 t 60.58 -30.92 0.06 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.637 1.208 . . . . 0.0 108.718 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.803 ' H ' ' C ' ' B' ' 326' ' ' GLY . 8.5 mtm180 -147.22 1.04 0.73 Allowed 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.518 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' GLY . 12.1 t80 -157.0 112.83 2.91 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.509 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 91.0 mt-30 -139.23 142.42 37.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.423 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.12 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.509 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 18.3 m0 -94.4 147.24 23.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.28 151.09 21.88 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 7.9 p90 -171.36 177.65 3.48 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.659 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -142.13 147.13 36.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 335' ' ' ALA . 41.3 mt-10 -39.27 -25.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.575 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -86.19 -2.36 85.73 Favored Glycine 0 N--CA 1.495 2.599 0 O-C-N 120.999 -1.063 . . . . 0.0 111.208 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -136.27 0.46 2.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.843 -1.386 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 0.9 OUTLIER -55.59 -47.19 79.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.821 -1.174 . . . . 0.0 108.413 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 30.1 mt-10 -52.67 -33.53 47.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.3 m -69.21 -41.01 77.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 12.7 mmt -53.16 -51.64 61.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 47.4 mt -62.07 -32.61 73.17 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.81 -43.84 87.44 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.326 -0.859 . . . . 0.0 110.587 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -71.81 -48.0 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.527 -1.358 . . . . 0.0 109.216 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.15 -49.02 79.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 110.454 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 20.9 m-85 -71.46 -29.0 64.35 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.219 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -65.98 -31.13 71.86 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.09 9.17 10.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.6 t80 -134.47 -104.21 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.201 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' B' ' 350' ' ' TYR . 21.6 mt -32.91 91.08 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.891 -0.506 . . . . 0.0 110.955 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' TYR . 72.2 Cg_endo . . . . . 0 C--N 1.312 -1.348 0 C-N-CA 123.239 2.626 . . . . 0.0 111.301 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.4 Cg_exo -56.3 -158.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.967 1.778 . . . . 0.0 110.987 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 31.1 p -111.72 174.55 5.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.683 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 m -113.45 157.02 22.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.15 134.03 47.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.464 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 9.5 t80 -111.84 95.5 5.52 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.646 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.05 118.29 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.78 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -125.21 -130.0 3.43 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t 156.57 111.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.405 -1.056 . . . . 0.0 109.42 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.705 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 108.883 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLN . 2.0 tpp85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -52.03 -37.06 52.24 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 25' ' ' GLN . 35.4 p-10 -68.24 -31.55 71.12 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 5.1 tt0 -60.9 -42.73 98.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.6 68.22 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.01 -27.85 65.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' VAL . 17.3 m-30 -70.93 -53.59 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -58.43 -35.43 72.08 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.425 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.66 -58.49 3.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.07 . . . . 0.0 108.673 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.4 mt -51.59 -42.78 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.879 HG13 HG11 ' A' ' 41' ' ' VAL . 47.2 t -62.45 -30.03 48.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -69.17 -40.69 77.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.174 -0.954 . . . . 0.0 109.71 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' A' ' 139' ' ' VAL . 95.2 mtt180 -70.29 -49.17 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 108.895 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.05 -39.71 82.88 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 41' ' ' VAL . 48.5 ttt85 -63.1 -24.5 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -76.23 -37.84 57.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.958 -1.089 . . . . 0.0 109.247 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.4 m-85 -68.45 -47.91 65.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.515 -0.74 . . . . 0.0 110.674 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -151.82 -150.31 5.32 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.32 115.48 26.83 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.115 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.879 HG11 HG13 ' A' ' 32' ' ' VAL . 2.7 t -78.29 103.06 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 2.0 mt -47.14 126.33 9.03 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.001 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' LEU . 43.1 m -38.57 138.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.815 0.817 . . . . 0.0 111.131 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' VAL . 26.5 mt-10 -149.46 101.93 3.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 49' ' ' ALA . 18.6 t-80 -43.19 -19.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.738 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 44' ' ' GLU . 87.5 t -46.03 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.05 -39.54 66.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.861 -1.15 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.941 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.72 21.07 0.16 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -86.69 -19.41 29.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 108.859 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 57.1 mt-10 -62.11 7.33 0.06 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -88.86 134.87 33.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 51' ' ' LEU . 7.3 mm-40 54.9 159.61 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' C ' HD22 ' A' ' 54' ' ' LEU . 89.0 Cg_exo -38.56 153.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.562 2.175 . . . . 0.0 112.258 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 53' ' ' PRO . 3.9 mm? -112.7 154.69 25.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.379 -0.826 . . . . 0.0 109.726 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 137.48 41.81 0.1 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 49.16 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -1.062 . . . . 0.0 109.256 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 55' ' ' GLY . 50.5 tp10 -48.53 -26.17 2.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.61 44.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.18 179.67 5.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.755 . . . . 0.0 109.474 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.18 62.75 0.51 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.87 79.14 0.87 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -49.31 -38.16 26.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.13 -1.217 . . . . 0.0 107.803 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.512 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 2.8 mp0 -59.86 -41.16 90.87 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -54.4 -38.86 66.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.642 -1.286 . . . . 0.0 108.835 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -46.57 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -71.91 -61.97 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 110.44 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 79.1 mm-40 -43.71 -52.17 6.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.09 -41.95 99.5 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.024 -1.048 . . . . 0.0 109.628 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.458 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 77.9 m-20 -66.52 -40.92 89.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 111.605 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -68.01 -51.85 42.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -178.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -60.14 -46.55 89.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.632 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -64.79 -45.78 84.82 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.027 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 59.0 tp -52.44 -34.17 47.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.975 -1.078 . . . . 0.0 108.45 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -78.04 -32.01 50.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.508 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.632 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 29.3 mt-30 -87.66 -0.68 57.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.875 -1.141 . . . . 0.0 109.23 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -62.83 125.71 24.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 112.122 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 11' ' ' SER . 82.7 m-20 -76.09 -35.44 59.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 79' ' ' VAL . 90.4 t -132.91 155.29 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 78' ' ' VAL . 58.8 t -142.18 139.33 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.812 -1.18 . . . . 0.0 111.931 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.62 158.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -153.53 148.85 27.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.495 -1.378 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.636 ' O ' HG11 ' A' ' 90' ' ' VAL . 7.8 mt-10 -113.08 124.29 52.25 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.519 ' HB ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -122.6 26.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 110.136 -179.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 83' ' ' VAL . 62.8 m -43.49 -69.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.992 -1.067 . . . . 0.0 109.043 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.52 149.05 38.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 108.689 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HA ' HD23 ' B' ' 288' ' ' LEU . 6.3 Cg_endo -51.72 91.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.168 1.912 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.514 ' OG ' HG23 ' A' ' 90' ' ' VAL . 32.8 t -99.36 135.4 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 110.632 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 286' ' ' PRO . 0.2 OUTLIER -76.55 -40.24 50.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 109.07 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.92 93.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.7 t -71.33 -39.29 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.29 . . . . 0.0 109.914 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -47.86 87.77 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -67.81 -44.73 76.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.642 -0.916 . . . . 0.0 109.603 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.94 -30.59 71.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.253 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.2 mt -73.04 -39.5 65.9 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 108.668 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.24 99.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.26 -42.14 99.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.417 -1.049 . . . . 0.0 109.156 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.1 -38.53 82.39 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.161 -0.962 . . . . 0.0 108.814 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -55.76 -42.73 71.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.773 -1.205 . . . . 0.0 108.518 179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -75.02 -50.12 17.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 112.509 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.2 pp -118.34 -24.97 6.69 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.122 -0.986 . . . . 0.0 110.566 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -47.33 166.17 0.12 Allowed Glycine 0 C--N 1.29 -1.972 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 1.5 mptm? -117.68 -85.86 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 51.5 Cg_endo -85.22 102.3 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 121.387 1.531 . . . . 0.0 109.431 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 ' HB1' ' A' ' 97' ' ' ALA . 15.2 mt -102.05 98.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.805 -1.184 . . . . 0.0 111.187 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 tp -94.27 118.9 32.27 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.7 OUTLIER -106.73 154.06 21.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.022 -1.049 . . . . 0.0 108.895 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.519 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 17.4 mt -125.3 137.46 54.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 110.263 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -137.41 117.84 13.77 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.443 ' HB2' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -75.02 123.34 88.86 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 0.0 110.562 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 88.4 Cg_endo -82.7 -31.41 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.326 2.017 . . . . 0.0 110.663 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.461 HE22 ' HB1' ' A' ' 135' ' ' ALA . 2.4 pt20 -49.75 -35.06 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.446 ' HB3' HH11 ' A' ' 114' ' ' ARG . 53.1 m -97.82 -14.65 20.64 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.39 51.57 4.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 115' ' ' VAL . 42.2 mtp85 -83.58 13.3 4.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.049 -1.265 . . . . 0.0 110.279 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' ARG . 54.1 t 54.31 107.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 0.0 110.138 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 131' ' ' VAL . 19.4 tp -46.34 -71.96 0.06 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 164.47 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.21 82.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.981 -1.074 . . . . 0.0 109.789 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' A' ' 119' ' ' MET . 17.9 mmm -66.38 -50.58 63.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 116' ' ' LEU . 35.5 mm -63.68 -41.16 91.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 108.93 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HG2' HD23 ' A' ' 116' ' ' LEU . 18.5 mmt85 -62.42 -44.02 97.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 109.604 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -64.68 -36.12 92.75 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.221 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 129' ' ' PHE . . . -53.75 -23.06 10.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.061 -1.258 . . . . 0.0 107.98 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 121' ' ' ARG . . . -32.48 101.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.234 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 93.1 m-20 -101.33 -30.01 11.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 108.709 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.66 -0.12 57.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.4 p -112.49 -69.39 0.87 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.58 -0.953 . . . . 0.0 108.582 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.16 -39.55 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 123' ' ' ALA . 32.1 t80 -98.37 129.18 45.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.56 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 42.1 tt0 -154.06 163.79 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.05 -1.031 . . . . 0.0 110.435 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 116' ' ' LEU . 23.3 t -125.72 112.33 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.56 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 20.6 m0 -105.02 145.0 31.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 108.944 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 43.4 p30 -89.78 154.23 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.802 -1.186 . . . . 0.0 109.16 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.4 p90 -163.85 -174.49 3.66 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.898 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -152.86 148.11 26.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 135' ' ' ALA . 47.7 mt-10 -36.71 -37.8 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.928 -1.107 . . . . 0.0 110.259 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.46 19.04 38.36 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.446 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.644 ' N ' ' O ' ' A' ' 135' ' ' ALA . 94.5 mt-10 -142.69 -10.39 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.067 -1.255 . . . . 0.0 110.397 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 140' ' ' GLU . 8.0 p -50.89 -45.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.921 -1.112 . . . . 0.0 108.655 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' N ' HG13 ' A' ' 139' ' ' VAL . 23.2 pt-20 -60.38 -36.41 77.98 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.282 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -65.68 -46.26 79.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.486 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -47.85 64.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 38.7 mt -68.51 -31.99 71.65 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.479 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 76.9 m-20 -66.17 -42.74 88.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.536 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -69.86 -50.75 39.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.67 -1.269 . . . . 0.0 108.264 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.681 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 38' ' ' TYR . 13.2 m-85 -71.74 -33.16 68.45 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.764 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.56 28.45 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.01 -78.0 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.836 -1.146 . . . . 0.0 113.065 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 8.3 mt -61.42 -40.2 69.45 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.139 -0.975 . . . . 0.0 112.402 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 47.6 Cg_exo . . . . . 0 C--N 1.302 -1.899 0 C-N-CA 121.91 1.74 . . . . 0.0 111.733 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.48 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.072 1.848 . . . . 0.0 110.947 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.2 p -111.7 174.5 5.84 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 11.2 m -113.63 156.73 23.17 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.84 133.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 9.7 t80 -111.6 95.57 5.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -83.23 118.28 23.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -87.32 123.48 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 109.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' B' ' 217' ' ' SER . . . -126.37 -130.22 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' B' ' 216' ' ' GLY . 1.4 t 156.98 111.86 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -1.045 . . . . 0.0 109.369 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.702 ' H ' HD13 ' B' ' 218' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.721 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.44 -36.63 55.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 225' ' ' GLN . 35.3 p-10 -68.52 -31.52 70.81 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' B' ' 224' ' ' ASP . 5.0 tt0 -60.93 -42.62 98.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.05 -48.45 68.27 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.95 -28.11 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.605 ' O ' HG23 ' B' ' 232' ' ' VAL . 17.3 m-30 -70.49 -53.6 15.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.426 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -58.53 -35.28 72.04 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.68 -58.69 3.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.923 -1.11 . . . . 0.0 108.548 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.54 -42.92 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.874 HG13 HG11 ' B' ' 241' ' ' VAL . 46.7 t -62.37 -29.82 47.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.3 p -69.34 -40.77 77.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.518 ' NH1' ' CG1' ' B' ' 339' ' ' VAL . 95.4 mtt180 -70.15 -49.47 50.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.798 -1.189 . . . . 0.0 108.903 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.69 -39.99 82.3 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 241' ' ' VAL . 49.0 ttt85 -63.02 -24.69 68.03 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -75.96 -38.06 57.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.931 -1.106 . . . . 0.0 109.329 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.4 m-85 -68.29 -48.03 66.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.559 -0.713 . . . . 0.0 110.766 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -151.56 -150.4 5.33 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -89.31 115.44 26.79 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.19 -1.183 . . . . 0.0 109.058 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.874 HG11 HG13 ' B' ' 232' ' ' VAL . 2.7 t -78.18 103.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' B' ' 272' ' ' TRP . 2.2 mt -47.55 126.8 10.44 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.929 -1.109 . . . . 0.0 108.97 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 242' ' ' LEU . 42.1 m -39.16 137.99 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 111.133 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 246' ' ' VAL . 26.8 mt-10 -148.81 101.84 3.23 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 249' ' ' ALA . 18.3 t-80 -43.1 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 109.864 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 244' ' ' GLU . 82.6 t -46.11 -84.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -54.16 -40.01 67.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.823 -1.173 . . . . 0.0 108.927 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.927 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -75.38 20.91 0.14 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -86.22 -19.88 29.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.818 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' B' ' 225' ' ' GLN . 59.1 mt-10 -61.77 7.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 248' ' ' ASP . 0.6 OUTLIER -88.87 134.48 33.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' B' ' 251' ' ' LEU . 7.0 mm-40 54.75 159.19 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.204 -0.935 . . . . 0.0 109.409 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.499 ' C ' HD22 ' B' ' 254' ' ' LEU . 97.7 Cg_exo -37.93 152.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.67 2.247 . . . . 0.0 112.439 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.499 HD22 ' C ' ' B' ' 253' ' ' PRO . 3.9 mm? -112.68 154.1 26.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.652 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 138.28 41.34 0.1 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 49.83 -82.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -1.045 . . . . 0.0 109.104 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' B' ' 255' ' ' GLY . 50.8 tp10 -48.87 -26.72 2.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 108.504 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' B' ' 253' ' ' PRO . . . -80.13 45.02 0.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -129.18 -179.32 5.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.461 -0.774 . . . . 0.0 109.298 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.56 63.14 0.54 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 113.61 78.75 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -49.22 -37.94 24.69 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' GLN . . . . . 0.5 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 2.8 mp0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -54.48 -38.67 66.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.718 -1.239 . . . . 0.0 108.876 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.8 OUTLIER -65.9 -46.84 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.9 OUTLIER -71.97 -62.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.626 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 79.4 mm-40 -43.17 -52.39 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -62.97 -41.71 99.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.474 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 80.9 m-20 -66.67 -40.92 88.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 111.522 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.2 OUTLIER -68.13 -51.68 43.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.021 -1.05 . . . . 0.0 110.2 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -60.4 -46.4 90.11 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.133 -0.979 . . . . 0.0 109.576 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.479 ' CZ3' ' OE1' ' B' ' 275' ' ' GLN . 0.1 OUTLIER -64.85 -46.25 82.68 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.477 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 59.8 tp -52.06 -34.03 41.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.42 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.34 -32.16 48.96 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.479 ' OE1' ' CZ3' ' B' ' 272' ' ' TRP . 91.0 mt-30 -87.25 -0.81 57.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.891 -1.131 . . . . 0.0 109.286 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 276' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' B' ' 213' ' ' TYR . . . -62.79 125.73 24.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.24 -0.913 . . . . 0.0 112.159 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.688 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.9 m-20 -76.04 -35.75 59.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.407 HG12 ' N ' ' B' ' 279' ' ' VAL . 88.8 t -132.65 155.08 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.407 ' N ' HG12 ' B' ' 278' ' ' VAL . 60.1 t -141.96 139.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 111.832 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 24.4 t -137.93 158.25 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.486 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.599 -1.313 . . . . 0.0 110.322 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.639 ' O ' HG11 ' B' ' 290' ' ' VAL . 8.8 mt-10 -113.84 123.58 50.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' B' ' 316' ' ' LEU . 0.0 OUTLIER -122.1 26.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.041 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.445 HG23 ' HB2' ' B' ' 309' ' ' ARG . 66.5 m -43.21 -69.7 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.01 -1.056 . . . . 0.0 109.019 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -91.51 149.22 39.05 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 108.756 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.574 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.9 Cg_endo -52.38 91.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.027 1.818 . . . . 0.0 111.262 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.514 ' OG ' HG23 ' B' ' 290' ' ' VAL . 34.3 t -99.92 135.31 41.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -76.25 -39.67 53.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.533 -0.73 . . . . 0.0 109.206 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.3 -40.3 91.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.639 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.5 t -71.11 -39.41 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.053 -1.263 . . . . 0.0 109.961 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.76 -47.53 89.7 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -68.02 -45.24 74.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 0.0 109.649 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.4 -30.88 70.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.1 mt -72.56 -39.76 67.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 108.732 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -63.58 -41.78 99.03 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.463 -1.022 . . . . 0.0 109.175 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.517 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -68.23 -38.67 82.11 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.143 -0.973 . . . . 0.0 108.792 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -55.87 -42.42 70.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.732 -1.23 . . . . 0.0 108.481 179.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.25 -50.0 17.53 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.2 pp -118.67 -24.93 6.54 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 0.0 110.422 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -47.16 166.45 0.1 Allowed Glycine 0 C--N 1.289 -2.079 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 1.5 mptm? -117.96 -85.87 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 49.6 Cg_endo -85.23 102.32 0.76 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 121.42 1.543 . . . . 0.0 109.378 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.517 HG12 ' HB1' ' B' ' 297' ' ' ALA . 14.8 mt -102.15 98.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.237 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 35.4 tp -93.98 118.4 31.44 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.42 153.79 21.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.009 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 17.0 mt -124.92 138.02 54.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.26 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -137.85 117.85 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.445 ' HB2' HG23 ' B' ' 284' ' ' THR . 0.1 OUTLIER -74.92 123.39 88.93 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.494 -0.754 . . . . 0.0 110.536 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.6 Cg_endo -82.82 -31.7 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.381 2.054 . . . . 0.0 110.763 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.457 HE22 ' HB1' ' B' ' 335' ' ' ALA . 2.3 pt20 -49.65 -34.88 19.54 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.444 ' OG ' ' NH2' ' B' ' 309' ' ' ARG . 49.8 m -97.86 -14.66 20.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 41.35 51.55 4.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' B' ' 315' ' ' VAL . 42.2 mtp85 -83.49 13.32 4.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.988 -1.301 . . . . 0.0 110.221 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.4 t 54.51 106.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 110.054 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.857 HD22 HG11 ' B' ' 331' ' ' VAL . 19.0 tp -46.36 -72.12 0.06 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.64 -0.662 . . . . 0.0 109.305 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 1.0 OUTLIER 164.75 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.08 -43.85 81.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 109.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' B' ' 319' ' ' MET . 17.7 mmm -66.07 -50.79 62.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.278 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.784 HG22 HD21 ' B' ' 316' ' ' LEU . 34.9 mm -63.4 -41.26 92.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 108.905 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.68 ' HG2' HD23 ' B' ' 316' ' ' LEU . 18.8 mmt85 -62.46 -43.62 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.947 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -64.64 -36.67 93.42 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 329' ' ' PHE . . . -53.34 -23.38 9.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.061 -1.258 . . . . 0.0 108.066 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -32.33 101.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.248 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 92.3 m-20 -101.84 -30.04 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 108.705 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.62 0.09 57.69 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 12.9 p -112.99 -69.95 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.981 . . . . 0.0 108.462 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -107.24 -39.77 5.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 323' ' ' ALA . 31.2 t80 -98.57 128.92 45.07 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 43.2 tt0 -153.49 164.29 38.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 331' ' ' VAL . . . . . 0.857 HG11 HD22 ' B' ' 316' ' ' LEU . 25.5 t -126.11 112.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 20.5 m0 -105.15 144.97 31.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.903 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 42.0 p30 -90.03 154.35 19.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 0.0 109.202 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 5.6 p90 -163.73 -174.28 3.61 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.64 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -152.95 148.05 26.66 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.8 mt-10 -36.79 -37.49 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.11 . . . . 0.0 110.198 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -88.68 19.56 36.4 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.473 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 335' ' ' ALA . 94.3 mt-10 -143.25 -10.71 0.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.073 -1.251 . . . . 0.0 110.491 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 340' ' ' GLU . 7.1 p -50.95 -45.19 28.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.003 -1.061 . . . . 0.0 108.548 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.553 ' N ' HG13 ' B' ' 339' ' ' VAL . 22.7 pt-20 -60.3 -36.62 78.32 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.226 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.5 m -65.57 -46.25 80.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.173 -0.954 . . . . 0.0 109.498 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.21 -47.69 65.49 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 37.4 mt -68.52 -32.29 72.14 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.86 -42.74 90.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.005 -1.059 . . . . 0.0 110.457 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -70.01 -50.94 36.53 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.684 -1.26 . . . . 0.0 108.27 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.42 -47.03 79.88 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.462 -0.774 . . . . 0.0 109.755 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' B' ' 238' ' ' TYR . 13.7 m-85 -71.59 -33.01 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.844 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.75 -26.19 65.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -101.4 27.84 5.94 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.8 -78.16 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.78 -1.168 . . . . 0.0 113.101 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 8.3 mt -60.81 -40.76 77.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 112.334 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 48.5 Cg_exo . . . . . 0 C--N 1.302 -1.881 0 C-N-CA 122.014 1.809 . . . . 0.0 111.726 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 10' ' ' CYS . 50.1 Cg_endo -71.01 155.54 61.62 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.357 2.038 . . . . 0.0 111.228 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' PRO . 22.6 p -52.61 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.037 -1.04 . . . . 0.0 109.16 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 5.0 p -109.19 149.3 29.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 13.0 t -139.86 131.52 33.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 69' ' ' ASP . 14.2 t80 -100.65 124.91 46.89 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -96.21 122.73 39.38 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.539 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.6 t -133.87 154.97 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 -159.53 21.71 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -96.66 139.09 33.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -1.187 . . . . 0.0 108.724 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.104 . . . . 0.0 110.822 -179.258 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' NH2' ' NE2' ' A' ' 85' ' ' GLN . 50.1 mtp85 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 122.001 0.905 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.71 -24.29 14.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 80.0 m-20 -69.84 -32.25 70.55 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' ARG . 11.0 mt-30 -64.78 -40.2 94.87 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.07 -52.47 34.9 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.31 -29.83 64.25 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.614 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m-30 -69.18 -44.46 72.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 110.295 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.11 83.34 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.488 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.599 ' NE ' HH22 ' A' ' 34' ' ' ARG . 60.0 ttt180 -71.26 -56.69 5.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.928 -1.108 . . . . 0.0 108.146 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HH11 ' A' ' 34' ' ' ARG . 12.1 mt -52.85 -45.33 50.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 28' ' ' TYR . 42.1 t -60.66 -27.58 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -68.87 -36.68 78.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.389 -0.819 . . . . 0.0 109.367 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.599 HH22 ' NE ' ' A' ' 30' ' ' ARG . 77.4 mtt85 -68.6 -47.96 65.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.597 -1.314 . . . . 0.0 107.849 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.673 HD22 HG11 ' A' ' 12' ' ' VAL . 3.1 mt -62.3 -28.91 70.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 41' ' ' VAL . 2.0 tpm_? -64.98 -29.14 70.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -70.8 -62.08 1.53 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -123.74 157.01 34.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.274 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.576 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 81.59 69.86 1.37 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.8 mtmt -36.37 131.81 0.62 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.333 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.695 ' H ' HH21 ' A' ' 36' ' ' ARG . 23.2 t -96.05 107.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.828 -1.17 . . . . 0.0 108.854 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 24.6 mt -78.79 152.94 31.11 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.204 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 45' ' ' HIS . 19.7 m 51.36 53.22 13.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -54.4 -7.22 0.14 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 43' ' ' THR . 8.5 t-80 -45.34 -31.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.6 -53.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.093 -1.004 . . . . 0.0 109.881 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -65.92 -43.47 88.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 108.714 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.789 ' O ' HD21 ' A' ' 51' ' ' LEU . 38.1 t70 -73.64 37.01 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.823 ' O ' HD21 ' A' ' 54' ' ' LEU . . . -108.97 9.48 26.49 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' HD13 ' A' ' 51' ' ' LEU . 2.3 mt-10 -104.25 3.3 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.588 -0.695 . . . . 0.0 109.719 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.0 163.16 15.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.242 -0.911 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.5 mt-10 54.46 156.69 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.499 -0.751 . . . . 0.0 109.238 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.67 122.42 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.068 1.846 . . . . 0.0 111.878 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.823 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -90.77 -164.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 90.64 130.82 4.63 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 28.3 mm-40 -49.43 -30.9 8.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.997 -1.296 . . . . 0.0 109.132 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.12 -0.68 8.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.054 -1.029 . . . . 0.0 108.993 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -65.16 149.12 50.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.494 -0.753 . . . . 0.0 109.114 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.31 0.37 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.7 -31.26 7.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.2 76.43 1.03 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 56' ' ' GLU . 91.8 m-20 -52.18 -38.14 56.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -67.22 -52.01 46.31 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -58.64 -32.64 69.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 5.3 mt -65.64 -52.26 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' ND1' ' C ' ' A' ' 66' ' ' HIS . 2.6 t-80 -66.23 -53.67 34.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.589 -0.695 . . . . 0.0 109.985 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -47.68 -57.34 5.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.991 -1.068 . . . . 0.0 109.667 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.91 -37.5 81.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -68.19 -56.69 7.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 110.763 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 66' ' ' HIS . 6.5 tp -58.84 -40.61 84.73 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.47 -0.769 . . . . 0.0 110.313 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 90.8 m-20 -65.33 -58.84 4.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.007 -1.058 . . . . 0.0 109.253 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.463 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -57.2 -40.78 78.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -50.72 -41.05 55.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -72.54 -26.18 61.65 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.807 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 19.3 mt-30 -90.76 1.26 57.04 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.965 -1.084 . . . . 0.0 108.826 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.03 122.72 23.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.381 -0.825 . . . . 0.0 111.748 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 11' ' ' SER . 89.7 m-20 -69.95 -35.74 74.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 t -135.16 141.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.65 120.13 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.825 -1.172 . . . . 0.0 111.805 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -116.0 120.16 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.693 0.758 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.28 158.37 35.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.444 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 30.0 tt0 -97.07 128.27 43.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -107.64 28.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.756 . . . . 0.0 110.135 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 109' ' ' ARG . 5.2 m -79.67 -77.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.446 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.585 ' NE2' ' NH2' ' A' ' 22' ' ' ARG . 6.3 mm100 -64.33 136.39 96.73 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' B' ' 286' ' ' PRO . 72.9 Cg_endo -77.43 88.09 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 111.716 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -121.77 139.58 53.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.16 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' H ' ' B' ' 287' ' ' SER . 16.1 mt -59.45 -42.1 91.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.182 -0.949 . . . . 0.0 108.677 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.6 -30.9 56.99 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 87' ' ' SER . 80.7 t -75.44 -57.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.63 -0.924 . . . . 0.0 108.904 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.29 -36.31 89.34 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 88' ' ' LEU . 75.5 t80 -65.56 -52.54 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.088 . . . . 0.0 109.129 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' OE2' ' OD1' ' A' ' 69' ' ' ASP . 1.8 tp10 -58.75 -34.82 71.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.338 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 94' ' ' LEU . 18.2 mt -74.63 -41.08 61.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.99 . . . . 0.0 108.742 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -34.52 89.47 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.686 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.79 -43.17 80.36 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.626 -0.926 . . . . 0.0 109.176 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.663 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -69.86 -42.0 74.09 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.521 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -37.92 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -49.76 35.41 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -126.53 -34.71 2.43 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.145 -0.972 . . . . 0.0 109.885 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -73.82 102.61 1.34 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.615 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.72 -69.78 0.31 Allowed Pre-proline 0 C--N 1.288 -2.092 0 O-C-N 121.595 -0.944 . . . . 0.0 110.871 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 31.5 Cg_endo -65.64 109.01 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.573 1.515 . . . . 0.0 110.841 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' HD1' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.63 119.38 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 110.777 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 132' ' ' TRP . 46.0 tp -105.26 119.45 39.1 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -107.46 139.48 41.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.012 . . . . 0.0 108.566 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 11.6 mt -126.82 124.19 39.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -124.0 154.5 39.76 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' OE2' ' A' ' 136' ' ' GLU . 50.2 mtm180 -109.82 141.23 23.29 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.835 -1.166 . . . . 0.0 110.95 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.43 -29.32 3.08 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.812 2.341 . . . . 0.0 111.384 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 112' ' ' SER . 19.3 pt20 -46.5 -40.46 12.55 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.444 ' HB3' ' NE ' ' A' ' 114' ' ' ARG . 2.7 m -98.41 -23.1 15.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 50.07 40.57 36.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NE ' ' HB3' ' A' ' 112' ' ' SER . 7.6 mmt180 -51.0 -8.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.862 -1.375 . . . . 0.0 109.364 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 113' ' ' GLY . 23.4 t 64.1 99.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.963 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' HD22 ' A' ' 116' ' ' LEU . 4.1 mm? -37.97 128.25 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 t -51.3 147.75 5.45 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.104 -0.998 . . . . 0.0 109.094 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.68 78.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.982 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 0.1 OUTLIER -67.03 -42.31 85.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 109.359 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 35.8 mm -66.58 -46.38 86.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.054 -1.029 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 121' ' ' ARG . 0.3 OUTLIER -62.04 -47.77 83.24 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' B' ' 266' ' ' HIS . . . -58.56 -36.68 86.23 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 124' ' ' ALA . . . -50.42 -61.85 1.94 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 123' ' ' ALA . . . 155.34 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.306 1.05 . . . . 0.0 112.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.695 ' HA ' ' H ' ' A' ' 131' ' ' VAL . 55.7 p30 -126.27 26.69 6.39 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -178.08 149.88 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.77 ' C ' ' H ' ' A' ' 129' ' ' PHE . 4.2 t 96.88 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 117.935 0.868 . . . . 0.0 109.044 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 61.68 -19.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.77 ' H ' ' C ' ' A' ' 127' ' ' SER . 82.0 t80 -120.39 121.9 39.57 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.465 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 18.1 mt-30 -139.68 132.35 28.92 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.122 -1.431 . . . . 0.0 111.656 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.695 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 73.3 t -105.32 101.62 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 130' ' ' GLN . 22.8 m0 -98.37 155.66 17.12 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 110.771 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -107.51 147.74 30.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 139' ' ' VAL . 6.6 p90 -164.14 -175.73 4.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.848 -1.158 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.665 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -155.27 158.09 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.538 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 15.3 mt-10 -58.1 23.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.438 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -119.16 -11.46 7.49 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.684 ' O ' ' SD ' ' A' ' 142' ' ' MET . 5.7 pt-20 -153.96 16.2 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.997 -1.296 . . . . 0.0 110.202 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' MET . 3.5 p -51.05 -41.97 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.189 -0.944 . . . . 0.0 109.117 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 81.2 tt0 -61.63 -27.89 68.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.003 -1.061 . . . . 0.0 109.125 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.3 m -73.96 -48.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 110.444 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.684 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -54.41 -48.62 71.4 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 143' ' ' LEU . 92.8 mt -57.69 -38.66 75.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 45.2 t0 -63.08 -37.97 89.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -70.61 -53.38 16.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.62 -1.3 . . . . 0.0 108.773 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.422 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 67.3 t80 -58.16 -48.23 80.91 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 17.9 m-85 -70.48 -31.13 68.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.998 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 38.7 mt-10 -59.69 -29.89 68.4 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 17.62 10.19 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.48 -21.44 0.33 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.833 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 85.2 mt -120.34 39.84 0.37 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.527 -1.358 . . . . 0.0 111.776 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 92.4 Cg_endo . . . . . 0 C--N 1.309 -1.539 0 C-N-CA 122.223 1.949 . . . . 0.0 110.526 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' B' ' 210' ' ' CYS . 45.7 Cg_endo -70.56 155.9 62.35 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.389 2.059 . . . . 0.0 111.185 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' B' ' 209' ' ' PRO . 23.9 p -52.82 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.028 -1.045 . . . . 0.0 109.15 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.487 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 7.3 p -109.21 148.85 30.27 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 12.9 t -139.63 131.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' B' ' 269' ' ' ASP . 13.8 t80 -100.8 124.36 46.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.343 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -95.48 122.89 38.68 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.553 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 21.7 t -133.95 155.02 50.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.252 -0.905 . . . . 0.0 110.082 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -175.73 -159.83 22.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 25.1 p -96.32 138.9 33.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.222 -1.163 . . . . 0.0 108.888 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.928 -1.108 . . . . 0.0 110.797 -179.204 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.589 ' NH2' ' NE2' ' B' ' 285' ' ' GLN . 51.5 mtp85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.991 0.901 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.31 -24.95 13.11 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.5 m-20 -69.48 -32.06 70.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' B' ' 222' ' ' ARG . 9.7 mt-30 -65.02 -39.92 94.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.42 -52.42 32.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.13 -30.0 64.04 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.614 ' O ' HG23 ' B' ' 232' ' ' VAL . 10.0 m-30 -69.09 -44.56 72.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.681 -0.637 . . . . 0.0 110.295 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.07 83.13 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.507 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.585 ' NE ' HH22 ' B' ' 234' ' ' ARG . 60.3 ttt180 -71.32 -56.81 5.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.082 . . . . 0.0 108.115 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.525 ' HA ' HH11 ' B' ' 234' ' ' ARG . 12.1 mt -52.77 -45.35 49.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 228' ' ' TYR . 41.8 t -60.48 -27.72 40.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -68.79 -36.84 78.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.431 -0.793 . . . . 0.0 109.405 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.585 HH22 ' NE ' ' B' ' 230' ' ' ARG . 77.5 mtt85 -68.38 -47.91 66.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.287 . . . . 0.0 107.831 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.657 HD22 HG11 ' B' ' 212' ' ' VAL . 3.0 mt -62.33 -29.08 70.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.718 HH21 ' H ' ' B' ' 241' ' ' VAL . 2.1 tpm_? -64.89 -29.34 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -70.57 -61.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.8 OUTLIER -123.81 156.92 35.25 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 81.73 69.84 1.37 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' B' ' 239' ' ' GLY . 50.6 mtmt -36.58 131.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.347 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.718 ' H ' HH21 ' B' ' 236' ' ' ARG . 24.1 t -96.23 107.71 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.859 -1.15 . . . . 0.0 108.835 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.466 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 24.4 mt -78.67 153.71 30.76 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.494 ' C ' ' H ' ' B' ' 245' ' ' HIS . 22.5 m 50.62 53.25 13.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.71 -7.08 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.078 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' B' ' 245' ' ' HIS . 8.1 t-80 -45.59 -30.97 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.34 -52.91 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.74 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -66.14 -43.56 86.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 108.847 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.8 ' O ' HD21 ' B' ' 251' ' ' LEU . 36.0 t70 -73.58 37.08 0.09 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.816 ' O ' HD21 ' B' ' 254' ' ' LEU . . . -109.16 9.84 26.01 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.412 ' C ' HD13 ' B' ' 251' ' ' LEU . 2.3 mt-10 -104.44 3.11 31.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.946 ' N ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -112.69 163.31 14.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.269 -0.894 . . . . 0.0 109.643 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 47.6 mt-10 54.57 156.78 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.467 -0.771 . . . . 0.0 109.339 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -40.91 121.96 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.034 1.822 . . . . 0.0 111.795 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.816 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.0 OUTLIER -90.4 -164.19 1.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 90.38 130.49 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' B' ' 262' ' ' ASP . 28.4 mm-40 -49.34 -31.47 9.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.066 -1.256 . . . . 0.0 109.275 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.36 -1.15 7.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 0.0 108.782 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -64.38 148.85 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.166 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.52 4.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -47.23 -30.85 5.88 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.0 76.05 1.01 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' B' ' 256' ' ' GLU . 94.7 m-20 -52.01 -38.2 56.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -67.25 -51.85 48.09 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -58.91 -32.53 69.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' B' ' 269' ' ' ASP . 5.0 mt -65.64 -51.86 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.496 ' ND1' ' C ' ' B' ' 266' ' ' HIS . 2.5 t-80 -66.71 -53.61 31.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.59 -57.37 5.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.647 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -67.77 -37.86 82.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.505 ' OD2' ' OH ' ' B' ' 213' ' ' TYR . 0.4 OUTLIER -68.0 -56.83 7.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.08 -1.012 . . . . 0.0 110.785 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' B' ' 266' ' ' HIS . 6.5 tp -58.76 -40.36 83.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 88.8 m-20 -65.43 -58.74 5.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.074 -1.016 . . . . 0.0 109.158 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.12 -41.17 78.53 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 13.0 tp -50.36 -41.31 51.42 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -72.43 -26.18 61.74 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 18.6 mt-30 -90.68 1.03 57.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.012 -1.055 . . . . 0.0 108.725 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.56 122.82 22.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.497 -0.752 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' B' ' 211' ' ' SER . 89.2 m-20 -70.14 -35.76 74.28 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 51.1 t -135.37 141.4 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.61 120.25 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.69 -1.256 . . . . 0.0 111.61 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.79 120.12 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.594 -0.692 . . . . 0.0 109.514 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -126.12 159.2 33.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 109.881 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.448 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 30.5 tt0 -97.87 128.76 44.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.419 HG13 HD11 ' B' ' 294' ' ' LEU . 0.0 OUTLIER -107.95 27.86 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.307 -0.87 . . . . 0.0 110.095 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 309' ' ' ARG . 5.4 m -79.17 -76.99 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.589 ' NE2' ' NH2' ' B' ' 222' ' ' ARG . 6.5 mm100 -64.53 136.26 96.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.494 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' PRO . 73.1 Cg_endo -77.33 87.58 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.341 2.027 . . . . 0.0 111.839 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.619 ' HB3' HG23 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -121.4 139.84 52.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 87' ' ' SER . 15.0 mt -59.31 -41.82 89.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.115 -0.991 . . . . 0.0 108.777 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.19 -30.92 58.68 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' B' ' 287' ' ' SER . 89.9 t -75.15 -57.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.545 -0.974 . . . . 0.0 108.8 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.12 90.62 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' B' ' 288' ' ' LEU . 74.9 t80 -66.15 -52.76 45.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -1.131 . . . . 0.0 109.222 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.476 ' OE1' ' SD ' ' A' ' 119' ' ' MET . 1.7 tp10 -58.37 -34.91 71.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' B' ' 294' ' ' LEU . 18.1 mt -74.44 -41.4 60.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 108.796 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.3 -34.44 89.25 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.671 ' HE ' ' HA ' ' B' ' 296' ' ' ARG . 0.4 OUTLIER -67.96 -42.68 80.54 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.625 -0.926 . . . . 0.0 109.186 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.659 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -70.24 -41.88 72.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.493 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -37.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -72.13 -49.88 32.42 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.354 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.603 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -126.21 -34.51 2.51 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -74.03 102.44 1.34 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.603 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -72.57 -69.86 0.31 Allowed Pre-proline 0 C--N 1.288 -2.087 0 O-C-N 121.651 -0.911 . . . . 0.0 110.841 -177.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 31.7 Cg_endo -65.64 109.07 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.508 1.472 . . . . 0.0 110.849 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -135.43 119.11 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.087 -1.008 . . . . 0.0 110.754 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' B' ' 332' ' ' TRP . 47.6 tp -105.22 119.4 38.98 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -107.5 140.8 39.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.007 . . . . 0.0 108.622 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 11.8 mt -127.91 124.34 37.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -124.13 154.58 39.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.542 ' NH1' ' OE2' ' B' ' 336' ' ' GLU . 52.1 mtm180 -109.78 140.82 22.59 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 111.006 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.29 -29.62 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.643 2.229 . . . . 0.0 111.428 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.446 ' CG ' ' N ' ' B' ' 312' ' ' SER . 19.4 pt20 -45.96 -40.66 10.62 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 2.6 m -98.12 -23.34 15.77 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 50.5 40.73 39.98 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.445 ' NE ' ' HB3' ' B' ' 312' ' ' SER . 7.7 mmt180 -51.36 -8.33 0.05 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.965 -1.315 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 313' ' ' GLY . 22.6 t 64.11 99.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.537 -0.727 . . . . 0.0 110.039 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.599 ' H ' HD22 ' B' ' 316' ' ' LEU . 4.1 mm? -38.33 128.46 1.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.1 t -51.51 148.18 5.44 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.059 -1.026 . . . . 0.0 109.215 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.74 78.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 109.88 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -67.21 -42.76 83.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' B' ' 323' ' ' ALA . 35.6 mm -66.09 -46.11 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.899 -1.125 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' B' ' 321' ' ' ARG . 0.3 OUTLIER -62.42 -47.82 82.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -58.09 -36.64 82.69 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.771 ' O ' ' HB2' ' B' ' 324' ' ' ALA . . . -50.68 -62.18 1.75 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' B' ' 323' ' ' ALA . . . 155.72 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.284 1.04 . . . . 0.0 112.157 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.692 ' HA ' ' H ' ' B' ' 331' ' ' VAL . 56.5 p30 -126.33 27.04 6.29 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -178.3 150.06 9.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.749 ' C ' ' H ' ' B' ' 329' ' ' PHE . 4.1 t 96.51 71.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.632 -0.923 . . . . 0.0 109.089 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 61.71 -19.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.749 ' H ' ' C ' ' B' ' 327' ' ' SER . 81.2 t80 -120.02 121.33 38.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.452 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 16.8 mt-30 -139.3 132.69 30.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.051 -1.46 . . . . 0.0 111.577 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 331' ' ' VAL . . . . . 0.692 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 67.4 t -105.31 101.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.452 ' HE1' ' HB3' ' B' ' 330' ' ' GLN . 23.3 m0 -98.61 155.8 17.12 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.198 -0.939 . . . . 0.0 110.728 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 50.6 p-10 -107.67 147.72 30.33 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.544 ' CD2' HG23 ' B' ' 339' ' ' VAL . 6.5 p90 -164.24 -175.57 4.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.903 -1.123 . . . . 0.0 111.07 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -155.18 158.37 38.82 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' B' ' 309' ' ' ARG . 17.0 mt-10 -58.42 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -118.99 -11.07 7.82 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.675 ' O ' ' SD ' ' B' ' 342' ' ' MET . 5.9 pt-20 -154.63 16.6 0.45 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.929 -1.336 . . . . 0.0 110.168 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' B' ' 342' ' ' MET . 3.6 p -51.32 -42.05 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 0.0 108.975 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 82.3 tt0 -61.44 -27.89 68.87 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.125 -0.984 . . . . 0.0 109.139 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.9 m -74.09 -48.4 29.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.395 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.675 ' SD ' ' O ' ' B' ' 338' ' ' GLU . 0.0 OUTLIER -54.64 -48.61 72.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 343' ' ' LEU . 94.1 mt -57.73 -38.39 75.21 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 45.3 t0 -63.38 -37.94 89.22 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.543 -0.723 . . . . 0.0 110.169 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -70.43 -53.28 17.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.669 -1.269 . . . . 0.0 108.784 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 346' ' ' TYR . . . . . 0.432 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 67.2 t80 -58.31 -47.95 82.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 18.6 m-85 -70.89 -31.11 67.66 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.999 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 38.2 mt-10 -59.48 -29.76 68.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -93.09 17.98 10.02 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -148.91 -21.39 0.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.686 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 85.5 mt -120.48 40.02 0.38 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 111.741 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 93.6 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.191 1.927 . . . . 0.0 110.408 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' ALA . 45.2 Cg_exo -53.0 -155.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.641 2.227 . . . . 0.0 111.699 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.9 p -108.05 178.07 4.62 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.431 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 3.8 m -120.87 131.67 54.53 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.842 -1.161 . . . . 0.0 108.814 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.953 HG11 HD22 ' A' ' 35' ' ' LEU . 4.6 t -102.95 126.18 57.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 79' ' ' VAL . 40.8 t80 -93.19 118.99 31.88 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.582 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.0 t80 -85.58 123.98 31.62 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.434 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 2.7 t -117.34 113.65 22.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -162.07 75.98 0.18 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 16' ' ' GLY . 30.4 t -31.8 106.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.932 . . . . 0.0 110.48 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.798 ' NH2' ' H ' ' A' ' 55' ' ' GLY . 33.6 mmt180 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.185 0.517 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -55.15 -46.8 75.73 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 17.2 m-20 -62.74 -20.5 65.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.669 HE21 ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -67.25 -47.06 71.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.18 85.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.18 -37.15 74.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.4 m-30 -67.33 -41.49 85.18 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.405 -0.809 . . . . 0.0 109.69 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -60.82 -36.54 79.34 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.419 -1.425 . . . . 0.0 108.463 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 140' ' ' GLU . 70.7 ttt-85 -72.56 -57.38 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.1 -40.74 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' TYR . 52.3 t -64.62 -29.35 47.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 10.2 m -67.8 -37.15 81.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.39 -0.819 . . . . 0.0 109.646 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.41 -52.11 24.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.671 -1.268 . . . . 0.0 108.755 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 12' ' ' VAL . 16.6 mt -57.48 -40.21 78.08 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -61.36 -25.32 67.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.73 -31.05 32.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 0.0 109.745 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.564 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -75.18 -52.67 10.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.242 -0.911 . . . . 0.0 110.946 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.34 -147.05 4.46 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -89.81 129.04 36.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.4 -1.059 . . . . 0.0 109.006 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 32' ' ' VAL . 2.8 t -93.77 106.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.886 -1.134 . . . . 0.0 107.974 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 20.5 mt -72.38 -176.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.543 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 1.7 m 55.82 39.67 30.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.783 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 52.3 mp0 -46.3 -25.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -49.06 -38.41 24.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.093 -1.004 . . . . 0.0 108.996 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 47' ' ' ALA . 59.2 t -61.27 170.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 61.82 -71.96 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.86 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.0 t70 -67.82 28.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -106.62 12.91 28.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' CD ' HE21 ' A' ' 25' ' ' GLN . 28.7 mt-10 -108.47 11.4 26.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.336 -0.852 . . . . 0.0 109.744 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.015 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -86.08 -93.76 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.01 . . . . 0.0 110.232 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.477 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 mp0 -42.67 158.73 0.21 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 0.0 110.268 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.0 -22.16 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.647 2.232 . . . . 0.0 112.24 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.6 mm? 59.69 -172.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 109.73 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.798 ' H ' ' NH2' ' A' ' 22' ' ' ARG . . . 99.04 25.67 9.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 62' ' ' ASP . 73.4 mm-40 53.52 -74.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.781 -0.834 . . . . 0.0 109.664 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.679 ' N ' ' O ' ' A' ' 55' ' ' GLY . 86.6 tt0 -44.5 -26.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' LEU . . . -67.87 166.28 15.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.105 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.84 133.67 31.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.242 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.39 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.37 80.88 0.37 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 56' ' ' GLU . 3.0 m-20 -52.5 -44.13 65.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -1.144 . . . . 0.0 108.255 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -62.61 -49.26 75.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -60.48 -34.79 74.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 109.049 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -63.03 -53.95 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.511 ' N ' HG22 ' A' ' 65' ' ' ILE . 1.6 t-80 -65.6 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.623 -0.673 . . . . 0.0 109.666 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.1 -64.0 1.03 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -71.55 -38.95 70.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 110.138 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 10.1 m-20 -62.69 -59.25 5.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.093 -1.004 . . . . 0.0 110.351 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -61.05 -36.86 80.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.845 -1.159 . . . . 0.0 109.785 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -66.57 -52.36 46.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.565 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.484 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -43.52 87.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.133 -0.979 . . . . 0.0 108.998 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CE2' ' A' ' 13' ' ' TYR . 4.1 tt -53.47 -43.65 68.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.49 ' CG ' HH21 ' A' ' 96' ' ' ARG . 28.2 mt-30 -65.78 -29.87 70.43 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.68 -0.638 . . . . 0.0 111.258 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -103.49 11.51 36.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.626 -1.296 . . . . 0.0 109.274 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.05 138.83 48.14 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.337 -0.852 . . . . 0.0 111.694 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 11' ' ' SER . 86.4 m-20 -88.16 -25.74 22.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 69.7 t -144.99 136.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 13' ' ' TYR . 93.9 t -133.14 125.17 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.864 -1.147 . . . . 0.0 111.91 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.19 124.69 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.55 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.24 146.54 45.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.072 0.939 . . . . 0.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' HG11 ' A' ' 90' ' ' VAL . 1.3 pp20? -100.23 147.23 25.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.674 HG11 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.06 -89.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.525 HG21 ' HE ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER 64.29 -141.12 0.28 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.063 -1.648 . . . . 0.0 109.748 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 84' ' ' THR . 17.0 pt20 -43.29 148.63 0.62 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.754 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -45.24 128.0 9.45 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.131 1.888 . . . . 0.0 111.615 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.616 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 15.7 t -102.41 -121.1 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB2' ' H ' ' B' ' 287' ' ' SER . 9.9 tp 160.02 -58.66 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.06 58.72 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 82' ' ' GLU . 48.5 t -65.4 -45.25 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.48 -35.4 66.25 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.504 ' OH ' HG21 ' B' ' 298' ' ' VAL . 64.4 t80 -68.32 -56.09 9.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.46 -1.024 . . . . 0.0 109.675 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.521 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 87.0 mt-10 -57.25 -36.64 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.518 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.736 HD22 ' SG ' ' A' ' 106' ' ' CYS . 63.2 mt -60.35 -49.09 78.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.83 65.39 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' A' ' 74' ' ' GLN . 17.1 mmm180 -71.94 -47.26 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -1.179 . . . . 0.0 110.102 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -70.35 -34.49 72.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.376 -1.453 . . . . 0.0 107.766 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.53 HG21 ' OH ' ' B' ' 292' ' ' TYR . 1.1 t -57.72 -40.93 78.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -78.49 -55.87 4.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.682 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 0.88 40.17 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.242 -0.911 . . . . 0.0 108.606 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . 72.99 -156.93 52.1 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 18.6 mtmm 95.68 132.75 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.191 0 C-N-CA 123.887 0.875 . . . . 0.0 108.768 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.89 112.96 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.05 1.833 . . . . 0.0 111.196 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 102' ' ' LYS . 1.1 mt -112.32 104.46 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.224 -0.922 . . . . 0.0 110.961 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 132' ' ' TRP . 45.6 tp -99.89 121.21 40.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.736 ' SG ' HD22 ' A' ' 94' ' ' LEU . 75.0 m -109.9 124.72 51.85 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 1.1 mt -121.76 131.19 53.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.512 ' HE2' ' O ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -125.63 153.37 43.87 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.087 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HE ' HG21 ' A' ' 84' ' ' THR . 60.7 mtm180 -105.82 145.75 31.51 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.732 -1.23 . . . . 0.0 111.805 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' GLY . 92.7 Cg_endo -83.49 -23.29 3.46 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 123.019 2.48 . . . . 0.0 111.6 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 110' ' ' PRO . 6.9 pt20 -45.66 -42.44 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 m -90.38 -14.33 33.22 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . 46.74 45.65 18.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' O ' ' HE2' ' A' ' 108' ' ' PHE . 32.5 mtp85 -85.32 177.26 7.88 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.998 -1.295 . . . . 0.0 107.588 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 116' ' ' LEU . 87.5 t -114.05 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.8 -1.188 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.674 HD11 HG11 ' A' ' 83' ' ' VAL . 9.9 tp -41.59 137.41 1.6 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.3 m -46.52 145.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.032 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.25 64.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.584 -0.697 . . . . 0.0 109.69 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.405 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 3.3 tpt -72.23 -52.39 16.65 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.26 -43.27 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 108.788 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -59.62 -47.57 85.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -56.89 -33.32 63.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -59.54 -47.17 86.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.232 . . . . 0.0 107.949 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -20.95 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 123' ' ' ALA . 65.9 m-20 -110.24 -16.54 13.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 108.794 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.84 40.53 97.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 86.1 p -144.64 63.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.642 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.1 mtt-85 95.38 -31.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -102.32 121.83 43.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.404 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 20.2 mt-30 -145.25 145.3 31.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.049 -1.032 . . . . 0.0 110.426 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.29 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 132' ' ' TRP . 16.0 m0 -97.66 147.76 24.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.522 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 37.8 p-10 -99.44 144.89 28.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.9 p90 -167.18 178.62 5.53 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.379 -1.328 . . . . 0.0 111.505 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.681 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -150.93 155.94 40.16 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 38.6 mt-10 -58.03 27.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.416 -0.802 . . . . 0.0 110.396 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -126.44 -12.63 3.36 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.596 ' O ' ' SD ' ' A' ' 142' ' ' MET . 3.3 pt-20 -145.4 10.04 1.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.145 -1.209 . . . . 0.0 109.554 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 3.7 p -48.98 -43.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 30' ' ' ARG . 93.9 mt-10 -56.1 -33.2 64.88 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.532 HG22 HH11 ' A' ' 145' ' ' ARG . 15.6 m -65.62 -41.1 93.08 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 108.858 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -55.07 -50.95 67.85 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 84.7 mt -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 38.5 m-20 -70.37 -43.86 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.262 -0.899 . . . . 0.0 110.806 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.532 HH11 HG22 ' A' ' 141' ' ' THR . 52.7 mtt85 -70.49 -47.74 59.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.392 . . . . 0.0 108.951 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 36.1 t80 -60.1 -46.51 89.35 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.662 -0.649 . . . . 0.0 110.572 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.837 ' CG ' HD12 ' A' ' 151' ' ' LEU . 14.6 m-85 -80.1 -27.84 39.14 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.842 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 60.5 mt-10 -61.98 -29.27 70.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -68.61 -19.19 64.43 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.785 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -174.65 101.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 111.098 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.837 HD12 ' CG ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER 170.7 -47.63 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.587 -0.696 . . . . 0.0 109.232 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 69.7 Cg_exo . . . . . 0 C--N 1.309 -1.521 0 C-N-CA 122.338 2.025 . . . . 0.0 112.021 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 208' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' B' ' 208' ' ' ALA . 43.6 Cg_exo -53.0 -155.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 111.817 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.84 177.82 4.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 3.9 m -120.86 131.33 54.35 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.983 -1.073 . . . . 0.0 108.776 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.997 HG11 HD22 ' B' ' 235' ' ' LEU . 4.9 t -102.52 126.29 56.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.677 ' HB3' HG22 ' B' ' 279' ' ' VAL . 41.0 t80 -93.22 119.05 31.97 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.587 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.3 t80 -85.53 123.47 30.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.532 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.511 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 2.8 t -116.84 113.42 22.47 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.678 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -161.79 75.91 0.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.522 ' C ' ' O ' ' B' ' 216' ' ' GLY . 28.4 t -31.66 106.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.646 -0.914 . . . . 0.0 110.588 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.737 HD13 ' N ' ' B' ' 218' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 108.778 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.806 ' NH2' ' H ' ' B' ' 255' ' ' GLY . 33.6 mmt180 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.238 0.542 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -55.25 -46.08 76.08 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 16.4 m-20 -63.33 -20.49 65.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.674 HE21 ' CD ' ' B' ' 250' ' ' GLU . 0.0 OUTLIER -67.32 -46.73 72.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.23 86.43 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.1 -37.14 73.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.743 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.4 m-30 -67.5 -41.18 84.91 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.703 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.15 -36.37 79.6 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.43 -1.419 . . . . 0.0 108.52 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 340' ' ' GLU . 71.3 ttt-85 -72.76 -57.4 4.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 108.6 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.89 -40.87 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.743 HG23 ' O ' ' B' ' 228' ' ' TYR . 51.3 t -64.71 -29.23 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' SER . . . . . 0.401 ' N ' ' O ' ' B' ' 230' ' ' ARG . 12.2 m -67.88 -37.01 81.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.38 -0.825 . . . . 0.0 109.493 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.35 -52.29 23.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.719 -1.238 . . . . 0.0 108.757 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.997 HD22 HG11 ' B' ' 212' ' ' VAL . 15.8 mt -57.53 -39.94 77.71 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -61.49 -25.39 67.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.78 -31.33 31.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.141 -0.975 . . . . 0.0 109.777 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.567 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -75.01 -52.6 10.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.21 -0.931 . . . . 0.0 110.926 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -147.21 -147.58 4.57 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -89.42 129.08 35.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 108.961 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.689 HG11 HG13 ' B' ' 232' ' ' VAL . 2.8 t -93.54 106.78 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.494 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 20.4 mt -72.88 -176.78 2.14 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.865 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.563 HG22 HG23 ' B' ' 246' ' ' VAL . 1.9 m 56.25 39.2 30.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.001 -1.062 . . . . 0.0 108.786 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' B' ' 244' ' ' GLU . 52.6 mp0 -45.99 -25.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.731 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -48.95 -38.1 21.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 247' ' ' ALA . 62.0 t -61.23 170.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.687 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 61.74 -71.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.854 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.0 t70 -67.59 28.65 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -106.76 13.46 27.94 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.674 ' CD ' HE21 ' B' ' 225' ' ' GLN . 29.0 mt-10 -108.64 10.52 26.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 1.08 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -85.59 -94.06 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.106 -0.996 . . . . 0.0 110.256 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.481 ' O ' HD23 ' B' ' 254' ' ' LEU . 1.9 mp0 -42.43 158.68 0.21 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.28 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -41.09 -22.11 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.212 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.572 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.6 mm? 59.52 -172.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.829 . . . . 0.0 109.933 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.806 ' H ' ' NH2' ' B' ' 222' ' ' ARG . . . 98.51 25.23 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.441 ' OE1' ' OD1' ' B' ' 262' ' ' ASP . 73.5 mm-40 53.73 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.913 -0.757 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.673 ' N ' ' O ' ' B' ' 255' ' ' GLY . 86.8 tt0 -44.59 -25.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 254' ' ' LEU . . . -69.6 165.11 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.113 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -50.39 134.02 23.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.351 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.82 -81.6 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 126.26 81.34 0.39 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.441 ' OD1' ' OE1' ' B' ' 256' ' ' GLU . 3.1 m-20 -52.87 -43.99 66.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.63 -49.33 75.61 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -60.52 -35.02 74.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.503 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.4 OUTLIER -62.51 -54.07 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.018 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.503 ' N ' HG22 ' B' ' 265' ' ' ILE . 1.7 t-80 -65.51 -33.78 76.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.577 -0.702 . . . . 0.0 109.64 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -55.79 -64.18 0.94 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 109.551 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -71.62 -38.71 70.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 110.217 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.444 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 10.4 m-20 -62.87 -59.22 5.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 110.296 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.479 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.9 OUTLIER -61.12 -36.86 80.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.118 . . . . 0.0 109.734 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -66.35 -52.53 46.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -0.949 . . . . 0.0 109.638 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.494 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.91 -43.79 86.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.497 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 3.9 tt -53.21 -43.82 67.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.481 ' CG ' HH21 ' B' ' 296' ' ' ARG . 28.9 mt-30 -65.41 -30.15 70.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.683 -0.636 . . . . 0.0 111.136 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.54 11.72 35.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.124 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.87 48.04 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.845 . . . . 0.0 111.514 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' B' ' 211' ' ' SER . 87.4 m-20 -88.45 -25.72 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 69.9 t -144.82 136.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' B' ' 213' ' ' TYR . 91.4 t -133.09 125.27 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.89 -1.132 . . . . 0.0 111.914 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.3 124.65 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.39 146.04 46.58 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.1 0.953 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.535 ' O ' HG11 ' B' ' 290' ' ' VAL . 1.2 pp20? -99.8 147.07 25.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.686 HG11 HD11 ' B' ' 316' ' ' LEU . 0.4 OUTLIER -122.96 -90.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.927 -1.108 . . . . 0.0 109.986 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.539 HG21 ' HE ' ' B' ' 309' ' ' ARG . 0.2 OUTLIER 64.36 -140.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 119.902 -1.749 . . . . 0.0 109.776 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.416 ' HA ' ' NE ' ' B' ' 314' ' ' ARG . 17.0 pt20 -43.47 148.56 0.66 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.24 128.12 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.185 1.923 . . . . 0.0 111.622 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.598 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 15.4 t -102.43 -120.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.616 ' HB2' ' H ' ' A' ' 87' ' ' SER . 9.7 tp 159.74 -58.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.51 58.8 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.535 HG11 ' O ' ' B' ' 282' ' ' GLU . 48.9 t -65.89 -45.09 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -56.47 -35.5 66.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.53 ' OH ' HG21 ' A' ' 98' ' ' VAL . 64.7 t80 -68.35 -56.03 9.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.602 -0.94 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.511 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 82.9 mt-10 -57.21 -36.62 71.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' B' ' 306' ' ' CYS . 63.4 mt -60.44 -48.96 79.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.67 -23.67 65.42 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.481 HH21 ' CG ' ' B' ' 274' ' ' GLN . 17.2 mmm180 -71.92 -47.22 54.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -1.158 . . . . 0.0 110.096 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -70.43 -34.43 72.47 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.36 -1.462 . . . . 0.0 107.879 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.504 HG21 ' OH ' ' A' ' 92' ' ' TYR . 1.1 t -57.82 -40.64 76.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -78.75 -56.37 4.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.594 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.1 0.65 39.71 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.929 0.871 . . . . 0.0 108.675 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' B' ' 302' ' ' LYS . . . 72.82 -156.81 52.11 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' B' ' 301' ' ' GLY . 18.2 mtmm 95.5 132.6 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 302' ' ' LYS . 87.7 Cg_exo -38.49 113.42 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.941 1.761 . . . . 0.0 111.209 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 302' ' ' LYS . 1.1 mt -112.83 104.62 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.334 -0.854 . . . . 0.0 110.871 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' B' ' 332' ' ' TRP . 47.1 tp -100.03 121.48 41.45 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 306' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' B' ' 294' ' ' LEU . 73.5 m -110.28 124.42 51.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 1.1 mt -121.31 131.17 54.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.988 -1.07 . . . . 0.0 112.321 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -125.63 153.36 43.9 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.539 ' HE ' HG21 ' B' ' 284' ' ' THR . 60.9 mtm180 -105.92 145.38 30.79 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.713 -1.242 . . . . 0.0 111.663 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' B' ' 313' ' ' GLY . 94.4 Cg_endo -83.39 -22.83 3.72 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.965 2.443 . . . . 0.0 111.68 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 310' ' ' PRO . 6.7 pt20 -46.1 -42.45 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 39.7 m -89.96 -14.72 33.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 310' ' ' PRO . . . 46.8 45.62 18.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.505 ' O ' ' HE2' ' B' ' 308' ' ' PHE . 32.5 mtp85 -85.44 177.28 7.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.97 -1.312 . . . . 0.0 107.563 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 316' ' ' LEU . 83.5 t -114.25 107.96 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.686 HD11 HG11 ' B' ' 283' ' ' VAL . 9.7 tp -41.63 137.41 1.62 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 59.1 m -46.57 145.61 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 110.034 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.87 -22.77 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.45 -53.03 13.3 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 109.69 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 39.7 mm -61.64 -42.86 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.016 -1.052 . . . . 0.0 108.833 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -60.36 -47.56 85.55 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.953 -1.092 . . . . 0.0 108.34 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -56.85 -33.2 63.04 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -59.75 -47.58 85.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.111 -1.229 . . . . 0.0 107.982 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -20.42 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.962 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' B' ' 323' ' ' ALA . 65.5 m-20 -110.67 -16.41 13.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 108.814 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 64.76 39.85 96.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.7 p -143.89 62.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' B' ' 327' ' ' SER . 93.6 mtt-85 95.72 -31.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -102.4 121.53 42.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.403 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 19.5 mt-30 -145.08 145.0 31.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.452 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.23 101.46 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.434 ' CG ' HD11 ' B' ' 305' ' ' LEU . 16.1 m0 -97.84 147.75 24.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 0.0 110.473 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 38.7 p-10 -99.49 144.79 28.18 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.0 p90 -166.91 178.81 5.6 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.464 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.671 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -151.12 156.14 40.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -58.2 27.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.424 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -126.83 -12.13 3.37 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.586 ' O ' ' SD ' ' B' ' 342' ' ' MET . 3.4 pt-20 -145.93 10.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.133 -1.216 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 3.6 p -48.95 -43.42 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 230' ' ' ARG . 93.1 mt-10 -56.33 -33.26 65.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 341' ' ' THR . . . . . 0.526 HG22 HH11 ' B' ' 345' ' ' ARG . 14.0 m -65.41 -41.11 93.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.872 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.01 -51.3 66.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.142 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 82.4 mt -60.17 -30.77 69.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.849 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 39.1 m-20 -70.6 -43.62 68.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 110.666 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 345' ' ' ARG . . . . . 0.526 HH11 HG22 ' B' ' 341' ' ' THR . 53.0 mtt85 -70.8 -47.41 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.411 -1.431 . . . . 0.0 108.955 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 346' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 35.8 t80 -60.18 -46.75 88.64 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.69 -0.631 . . . . 0.0 110.506 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.824 ' CG ' HD12 ' B' ' 351' ' ' LEU . 14.9 m-85 -79.99 -27.87 39.55 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.84 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 61.5 mt-10 -61.95 -29.1 70.01 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 349' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -68.96 -18.76 64.12 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.787 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -174.94 102.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.824 HD12 ' CG ' ' B' ' 347' ' ' PHE . 1.0 OUTLIER 170.21 -48.03 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.536 -0.727 . . . . 0.0 109.328 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 75.0 Cg_exo . . . . . 0 C--N 1.309 -1.533 0 C-N-CA 122.395 2.064 . . . . 0.0 112.061 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' CYS . 55.3 Cg_endo -72.12 158.69 51.68 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.637 2.225 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' PRO . 32.1 p -52.49 -179.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.132 -0.98 . . . . 0.0 108.734 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 p -112.54 146.36 38.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.096 -1.003 . . . . 0.0 108.522 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.981 HG11 HD22 ' A' ' 35' ' ' LEU . 7.8 t -127.38 127.12 68.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB3' HG13 ' A' ' 79' ' ' VAL . 29.2 t80 -100.85 144.17 30.13 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 32' ' ' VAL . 3.7 t80 -104.27 128.17 52.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 110.279 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 104.34 10.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.95 162.64 22.45 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.41 ' OG ' ' CB ' ' A' ' 87' ' ' SER . 2.5 m -67.39 -55.32 14.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -1.067 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 18' ' ' ILE . 9.5 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.981 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.591 0.71 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.07 -39.41 92.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 71.5 m-20 -58.54 -30.21 66.93 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.81 ' OE1' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.86 -49.06 61.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.023 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.03 81.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.3 -34.7 70.84 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.1 m-30 -68.54 -43.88 75.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.56 80.22 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.398 -1.439 . . . . 0.0 108.815 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.653 ' NE ' HH22 ' A' ' 34' ' ' ARG . 61.7 ttt180 -71.58 -59.0 2.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.915 -1.116 . . . . 0.0 108.533 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -51.55 -40.97 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.8 t -66.57 -27.78 41.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 17.4 p -65.53 -41.34 93.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.187 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.653 HH22 ' NE ' ' A' ' 30' ' ' ARG . 73.2 mtt85 -65.57 -41.72 92.59 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.981 HD22 HG11 ' A' ' 12' ' ' VAL . 86.0 mt -59.59 -42.94 93.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -58.88 -24.49 62.31 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 88.5 mtt-85 -70.18 -62.43 1.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.2 p90 -129.15 154.1 47.06 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 87.45 72.27 1.29 Allowed Glycine 0 N--CA 1.477 1.421 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 39' ' ' GLY . 2.6 ttmt -35.76 126.65 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.052 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -84.18 90.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.552 -1.343 . . . . 0.0 107.964 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -52.42 -57.41 9.95 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.229 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -86.69 91.22 8.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.14 -24.15 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.264 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 30.4 t-80 -65.47 -29.54 70.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.764 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.606 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 25.2 t -52.75 -20.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.591 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.614 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -106.64 -65.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.513 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.854 ' O ' ' N ' ' A' ' 50' ' ' GLU . 56.5 m-20 -44.81 -24.22 0.19 Allowed 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.81 ' HB3' ' OE1' ' A' ' 25' ' ' GLN . . . -23.01 -30.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.525 0.678 . . . . 0.0 110.318 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 48' ' ' ASP . 26.9 mt-10 -62.42 -19.55 63.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.94 -1.1 . . . . 0.0 109.352 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -57.85 135.39 56.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.89 -1.131 . . . . 0.0 108.545 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 56.42 152.63 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 109.336 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' A' ' 54' ' ' LEU . 39.5 Cg_endo -69.28 92.47 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.167 1.912 . . . . 0.0 110.836 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.762 HD11 ' O ' ' A' ' 49' ' ' ALA . 20.6 mt -53.77 -155.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.803 0.811 . . . . 0.0 110.696 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . 96.54 26.47 10.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 26.1 mt-10 63.18 -23.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.974 -0.721 . . . . 0.0 109.353 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 55' ' ' GLY . 60.8 tt0 -75.02 -17.73 60.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 108.849 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 60' ' ' GLY . . . -58.88 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.191 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 58' ' ' ALA . . . -36.67 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.631 -0.668 . . . . 0.0 109.612 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 58' ' ' ALA . . . 91.31 -162.72 28.47 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.718 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 92.88 42.54 4.38 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' GLY . 66.5 m-20 -48.08 -45.41 32.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -59.64 -43.49 93.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -61.01 -48.06 83.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.625 -0.672 . . . . 0.0 109.847 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 tt -71.34 -33.88 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.771 ' ND1' ' O ' ' B' ' 319' ' ' MET . 21.8 t60 -78.58 -31.22 47.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 46.1 mm-40 -68.79 -51.93 35.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 108.702 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.17 -39.7 89.96 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.393 -0.817 . . . . 0.0 109.217 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 74.6 m-20 -69.78 -53.22 19.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.37 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 66' ' ' HIS . 6.3 tp -68.42 -38.5 81.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.11 -0.994 . . . . 0.0 110.697 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 49.0 t-20 -64.36 -53.13 53.43 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.167 -0.958 . . . . 0.0 109.402 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.555 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -60.23 -41.64 93.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 108.659 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 4.3 tt -52.69 -37.33 58.76 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -74.91 -29.28 60.92 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.751 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.555 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 32.1 mt-30 -92.56 5.14 51.98 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.42 131.13 35.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.317 -0.865 . . . . 0.0 111.722 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 11' ' ' SER . 81.1 m-20 -74.49 -31.3 62.16 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 61.5 t -139.36 140.11 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 13' ' ' TYR . 61.7 t -134.0 128.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.905 -1.122 . . . . 0.0 111.942 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.82 123.87 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.75 47.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 109.326 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' OE2' ' CZ ' ' A' ' 134' ' ' TYR . 18.5 tp10 -84.44 114.4 21.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.481 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -119.82 148.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.512 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 114' ' ' ARG . 57.8 m -167.44 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -143.69 150.65 51.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.434 ' O ' ' OG ' ' A' ' 87' ' ' SER . 85.1 Cg_exo -35.6 131.69 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.755 2.303 . . . . 0.0 112.425 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.773 ' O ' HD23 ' B' ' 288' ' ' LEU . 15.6 m -166.87 116.22 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.768 HD23 ' O ' ' B' ' 287' ' ' SER . 3.1 mt -68.15 -41.18 81.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.988 -1.07 . . . . 0.0 109.647 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.18 70.62 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.05 -49.49 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -1.017 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.96 -39.95 89.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.796 ' OH ' HG21 ' B' ' 298' ' ' VAL . 66.4 t80 -61.5 -44.56 96.85 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.234 -1.156 . . . . 0.0 109.434 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.86 -31.72 71.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.403 -0.811 . . . . 0.0 109.194 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.27 -43.56 81.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.75 97.66 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -41.02 90.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -1.062 . . . . 0.0 108.887 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -70.09 -39.94 75.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.77 HG21 ' OH ' ' B' ' 292' ' ' TYR . 0.5 OUTLIER -52.75 -37.77 26.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.25 -50.26 16.69 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.129 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.95 -4.83 18.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.061 -1.025 . . . . 0.0 108.877 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.04 29.02 6.22 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 25.0 mtmm -95.72 152.12 38.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.976 -1.308 . . . . 0.0 107.786 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 90.8 Cg_exo -34.21 118.67 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.148 1.899 . . . . 0.0 111.775 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.582 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.6 mt -119.63 104.88 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 0.0 110.98 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.69 115.64 29.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.57 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -107.69 139.58 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 83' ' ' VAL . 11.7 mt -123.84 144.73 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.105 -0.997 . . . . 0.0 112.046 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.88 140.24 29.66 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 27.8 mtt180 -97.39 140.54 22.08 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.592 -1.318 . . . . 0.0 111.518 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.6 Cg_endo -78.29 -34.14 1.67 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 122.652 2.235 . . . . 0.0 110.789 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.473 ' CG ' ' N ' ' A' ' 112' ' ' SER . 18.2 pt20 -47.83 -38.96 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 113' ' ' GLY . 8.1 p -90.95 -21.04 21.53 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 37.91 39.38 0.64 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' VAL . 45.7 mtt-85 -74.79 13.73 0.6 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.389 -1.065 . . . . 0.0 109.711 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 114' ' ' ARG . 56.0 t 49.43 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.313 -0.867 . . . . 0.0 110.066 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 120' ' ' ILE . 36.1 tp -48.28 143.55 4.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -40.42 141.62 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 111.053 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.465 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -54.98 -55.03 35.38 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.44 0.638 . . . . 0.0 110.854 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.745 ' O ' ' ND1' ' B' ' 266' ' ' HIS . 14.8 mtp -60.37 -39.78 88.45 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.18 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' B' ' 292' ' ' TYR . 45.2 mm -62.67 -41.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.712 -1.242 . . . . 0.0 109.59 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.533 HH12 ' CG ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -72.86 -45.69 56.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 109.969 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.22 -18.98 65.73 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 -57.54 8.96 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.039 -1.271 . . . . 0.0 109.616 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.777 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -153.69 -89.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.687 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 22.9 t0 94.26 -0.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . 177.4 82.59 0.06 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.807 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 165.44 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.445 -1.033 . . . . 0.0 109.79 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.38 -25.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.807 ' H ' ' C ' ' A' ' 127' ' ' SER . 8.9 t80 -116.95 115.5 25.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.53 132.71 41.26 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.175 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.04 102.75 13.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.29 145.22 26.31 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.169 -0.957 . . . . 0.0 110.378 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' SD ' ' A' ' 142' ' ' MET . 63.7 m-20 -96.54 152.21 18.85 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CZ ' ' OE2' ' A' ' 82' ' ' GLU . 5.5 p90 -170.35 173.86 5.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.606 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -147.79 150.95 35.18 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.5 mt-10 -40.5 -27.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.826 -1.171 . . . . 0.0 110.316 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -85.79 -4.75 84.72 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 120.976 -1.077 . . . . 0.0 111.2 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -135.36 4.37 3.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.784 -1.421 . . . . 0.0 110.112 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.0 p -57.82 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.979 -1.076 . . . . 0.0 108.759 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.524 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.9 pt-20 -55.01 -33.65 62.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 m -66.13 -39.45 89.89 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.069 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 14.3 mmt -55.06 -53.19 59.04 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 30.6 mt -63.34 -31.59 72.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.549 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 28.7 t0 -69.05 -46.05 68.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 111.001 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -70.64 -50.36 37.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.404 -1.435 . . . . 0.0 109.818 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 29.4 t80 -57.12 -50.07 73.94 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 151' ' ' LEU . 27.0 m-85 -75.79 -30.83 59.23 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.586 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 5.5 mm-40 -55.12 -35.3 64.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.98 18.72 3.38 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 147' ' ' PHE . 2.0 t80 -147.27 -34.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 111.723 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.557 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 18.4 mt -117.87 40.99 0.34 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 61.3 Cg_endo . . . . . 0 C--N 1.311 -1.427 0 C-N-CA 121.922 1.748 . . . . 0.0 111.169 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 210' ' ' CYS . 55.3 Cg_endo -72.3 159.13 50.28 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.595 2.197 . . . . 0.0 111.786 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' B' ' 209' ' ' PRO . 31.0 p -52.77 -179.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.09 -1.007 . . . . 0.0 108.766 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.1 p -112.71 146.26 39.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 1.005 HG11 HD22 ' B' ' 235' ' ' LEU . 7.2 t -127.35 127.41 69.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.579 ' HB3' HG13 ' B' ' 279' ' ' VAL . 29.7 t80 -101.04 144.32 30.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' B' ' 232' ' ' VAL . 3.7 t80 -104.57 127.8 52.39 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 110.392 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 104.78 11.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.5 22.44 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.416 ' HG ' ' CB ' ' B' ' 287' ' ' SER . 2.7 m -66.83 -55.98 12.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 109.205 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.473 -0.767 . . . . 0.0 109.883 179.675 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.615 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.14 -39.66 93.33 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 70.8 m-20 -58.29 -30.07 66.34 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.798 ' OE1' ' HB3' ' B' ' 249' ' ' ALA . 0.0 OUTLIER -69.13 -48.7 61.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.08 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.95 81.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.8 tp -58.76 -34.35 71.32 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.751 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.3 m-30 -68.61 -43.96 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.55 80.14 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.519 -1.363 . . . . 0.0 108.823 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.647 ' NE ' HH22 ' B' ' 234' ' ' ARG . 57.8 ttt180 -71.5 -58.94 3.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.806 -1.183 . . . . 0.0 108.505 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.46 -41.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.751 HG23 ' O ' ' B' ' 228' ' ' TYR . 70.8 t -66.33 -28.07 42.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 14.5 p -65.44 -41.17 93.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.647 HH22 ' NE ' ' B' ' 230' ' ' ARG . 73.5 mtt85 -65.61 -41.67 92.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 1.005 HD22 HG11 ' B' ' 212' ' ' VAL . 84.9 mt -59.92 -42.86 94.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -58.7 -24.58 61.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 234' ' ' ARG . 87.6 mtt-85 -70.26 -62.94 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.1 p90 -128.49 154.49 46.05 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 86.98 72.39 1.29 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' B' ' 239' ' ' GLY . 2.7 ttmt -35.75 126.53 0.68 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.575 -0.956 . . . . 0.0 109.112 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.99 90.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.543 -1.348 . . . . 0.0 108.088 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 1.1 mt -52.22 -57.43 9.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.223 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.472 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 0.2 OUTLIER -86.85 91.37 8.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.742 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.2 -24.47 51.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.529 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 31.8 t-80 -65.23 -29.64 70.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.614 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 25.3 t -52.65 -20.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.579 ' C ' ' N ' ' B' ' 249' ' ' ALA . . . -106.56 -65.28 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.858 ' O ' ' N ' ' B' ' 250' ' ' GLU . 55.8 m-20 -44.98 -24.13 0.2 Allowed 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.798 ' HB3' ' OE1' ' B' ' 225' ' ' GLN . . . -23.18 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.858 ' N ' ' O ' ' B' ' 248' ' ' ASP . 27.0 mt-10 -63.08 -19.31 64.29 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.901 -1.124 . . . . 0.0 109.35 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -57.78 135.33 56.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.961 -1.087 . . . . 0.0 108.58 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 0.8 OUTLIER 56.38 152.37 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' B' ' 254' ' ' LEU . 39.1 Cg_endo -69.08 92.43 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.194 1.929 . . . . 0.0 110.895 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.772 HD11 ' O ' ' B' ' 249' ' ' ALA . 20.1 mt -53.99 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.848 0.833 . . . . 0.0 110.69 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' B' ' 257' ' ' GLU . . . 96.25 26.94 10.5 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.465 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 26.9 mt-10 62.99 -23.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.931 -0.747 . . . . 0.0 109.401 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.666 ' H ' ' C ' ' B' ' 255' ' ' GLY . 61.0 tt0 -74.5 -17.66 60.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 108.928 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' B' ' 260' ' ' GLY . . . -58.7 -161.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.417 -0.802 . . . . 0.0 109.356 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 259' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 258' ' ' ALA . . . -36.68 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.431 0.634 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 260' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' B' ' 258' ' ' ALA . . . 91.48 -162.81 28.3 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 120.16 -1.019 . . . . 0.0 110.737 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 261' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' B' ' 264' ' ' PHE . . . 93.37 42.44 4.26 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 261' ' ' GLY . 68.4 m-20 -47.98 -45.29 31.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.85 -43.58 94.56 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 264' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' B' ' 261' ' ' GLY . 0.7 OUTLIER -60.87 -48.35 82.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.541 -0.724 . . . . 0.0 109.937 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 3.8 tt -71.23 -33.59 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.475 -0.765 . . . . 0.0 109.996 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.745 ' ND1' ' O ' ' A' ' 119' ' ' MET . 22.5 t60 -78.65 -31.14 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 46.0 mm-40 -68.78 -52.71 27.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 108.63 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -65.3 -40.24 93.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.117 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.459 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 67.1 m-20 -69.12 -53.65 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.83 . . . . 0.0 110.564 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' B' ' 266' ' ' HIS . 6.2 tp -68.46 -38.39 81.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.029 -1.044 . . . . 0.0 110.644 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 271' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 50.6 t-20 -64.14 -53.49 48.66 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.353 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -59.92 -41.77 92.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 108.642 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.442 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 4.1 tt -52.78 -36.92 58.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -75.39 -28.99 59.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.726 . . . . 0.0 109.769 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.561 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 32.4 mt-30 -92.45 4.76 52.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.971 -1.08 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.26 131.49 35.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.458 -0.776 . . . . 0.0 111.829 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.2 m-20 -74.91 -31.48 61.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 61.8 t -139.27 140.25 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' B' ' 213' ' ' TYR . 62.0 t -134.0 129.6 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.939 -1.1 . . . . 0.0 111.995 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.27 123.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.411 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -107.4 122.16 46.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.539 ' OE2' ' CZ ' ' B' ' 334' ' ' TYR . 18.4 tp10 -83.81 114.21 21.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.605 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -119.34 149.02 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 0.0 109.562 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 57.6 m -167.7 -31.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.45 150.59 51.83 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -35.62 131.12 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.718 2.279 . . . . 0.0 112.514 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.768 ' O ' HD23 ' A' ' 88' ' ' LEU . 15.4 m -166.29 116.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.11 -0.994 . . . . 0.0 109.622 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 87' ' ' SER . 3.5 mt -68.27 -41.23 81.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.102 -0.999 . . . . 0.0 109.568 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.73 -36.32 71.52 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.83 -49.75 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -1.016 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.29 90.3 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.77 ' OH ' HG21 ' A' ' 98' ' ' VAL . 67.0 t80 -60.97 -44.67 97.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.233 -1.157 . . . . 0.0 109.419 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.67 -32.04 72.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.0 mt -67.17 -43.43 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.64 -39.74 97.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -40.87 90.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.267 -1.137 . . . . 0.0 108.739 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -70.25 -39.83 74.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.796 HG21 ' OH ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -52.96 -37.71 26.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -75.23 -50.3 16.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.57 -5.05 17.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.126 -0.984 . . . . 0.0 108.848 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 48.07 29.01 6.27 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.46 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 25.3 mtmm -95.75 152.29 38.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.953 -1.322 . . . . 0.0 107.748 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' B' ' 302' ' ' LYS . 84.0 Cg_exo -34.08 119.01 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.24 1.96 . . . . 0.0 111.788 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.563 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.5 mt -120.07 105.01 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.359 -0.838 . . . . 0.0 111.032 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 60.5 tp -99.85 115.94 30.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 306' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -107.8 139.7 42.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.067 -1.021 . . . . 0.0 108.251 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' B' ' 283' ' ' VAL . 11.8 mt -124.0 144.67 49.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.028 -1.045 . . . . 0.0 112.093 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -143.94 140.14 29.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.48 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 27.7 mtt180 -97.35 140.28 21.94 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 111.557 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.04 -33.66 2.0 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.607 2.205 . . . . 0.0 110.796 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' B' ' 312' ' ' SER . 18.2 pt20 -48.33 -38.96 20.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.481 ' O ' ' C ' ' B' ' 313' ' ' GLY . 7.5 p -91.31 -20.31 22.02 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 37.17 39.62 0.48 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' B' ' 315' ' ' VAL . 45.5 mtt-85 -74.78 13.72 0.6 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.311 -1.111 . . . . 0.0 109.724 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' B' ' 314' ' ' ARG . 55.3 t 49.58 100.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 110.119 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 320' ' ' ILE . 36.6 tp -48.34 143.85 4.42 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.53 141.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.02 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 318' ' ' ALA . . . . . 0.464 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -54.87 -55.12 33.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.693 -0.63 . . . . 0.0 110.79 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.771 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 14.2 mtp -60.13 -40.22 89.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.029 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 45.1 mm -62.53 -41.86 93.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.82 -1.175 . . . . 0.0 109.477 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' ' 325' ' ' ASP . 0.9 OUTLIER -72.77 -45.91 56.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 109.893 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -65.36 -18.78 65.79 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -51.32 -57.6 8.45 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.124 -1.221 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -153.96 -89.03 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.85 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 23.2 t0 94.12 -0.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . 177.76 82.5 0.06 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.758 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.0 OUTLIER 165.81 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.433 -1.039 . . . . 0.0 109.811 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.42 -25.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.761 ' CD1' ' HB3' ' B' ' 324' ' ' ALA . 9.0 t80 -117.25 115.67 25.75 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.67 132.98 41.33 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.173 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 73.0 t -92.41 102.55 13.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 332' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.09 145.15 26.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.08 -1.012 . . . . 0.0 110.441 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.487 ' O ' ' SD ' ' B' ' 342' ' ' MET . 65.7 m-20 -96.41 152.11 18.91 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.539 ' CZ ' ' OE2' ' B' ' 282' ' ' GLU . 5.6 p90 -170.28 174.08 5.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.51 -1.368 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -148.09 150.9 34.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.0 mt-10 -40.43 -27.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.0 110.308 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 337' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -85.5 -5.27 84.93 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.015 -1.053 . . . . 0.0 111.226 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -135.43 4.62 3.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.92 -1.341 . . . . 0.0 110.082 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.1 p -57.97 -48.64 83.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.888 -1.132 . . . . 0.0 108.763 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 24.0 pt-20 -55.23 -33.78 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.0 m -65.77 -39.75 91.35 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 14.0 mmt -54.88 -53.96 48.65 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 32.1 mt -62.39 -31.66 72.36 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.891 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 30.0 t0 -68.95 -46.09 69.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.18 -0.95 . . . . 0.0 111.063 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -70.93 -50.61 32.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.473 -1.392 . . . . 0.0 109.759 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 346' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' B' ' 346' ' ' TYR . 29.6 t80 -56.58 -50.1 72.93 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.436 -0.79 . . . . 0.0 109.994 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' B' ' 351' ' ' LEU . 25.2 m-85 -75.85 -30.76 59.04 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.561 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 348' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 5.3 mm-40 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -87.41 19.56 3.23 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' B' ' 347' ' ' PHE . 2.0 t80 -148.0 -34.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.571 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.561 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 18.7 mt -117.72 40.77 0.33 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.864 -1.147 . . . . 0.0 111.277 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 63.9 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 121.963 1.775 . . . . 0.0 111.164 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.99 155.51 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.059 1.84 . . . . 0.0 111.344 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.3 p -58.84 175.66 0.25 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.024 -1.047 . . . . 0.0 108.583 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 14.6 m -119.0 153.05 35.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.315 -0.866 . . . . 0.0 109.525 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -123.84 126.74 73.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.602 ' HB3' HG13 ' A' ' 79' ' ' VAL . 37.1 t80 -88.83 129.66 35.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 46' ' ' VAL . 16.4 t80 -97.15 131.91 43.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.613 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.851 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -142.14 100.61 3.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.383 -0.823 . . . . 0.0 109.332 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.31 -176.18 14.33 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.533 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 4.5 m -87.53 120.27 28.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -1.125 . . . . 0.0 110.186 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' NE ' ' A' ' 22' ' ' ARG . 3.6 mt . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.556 ' NE ' ' O ' ' A' ' 18' ' ' ILE . 72.0 mtt-85 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 122.726 1.251 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.29 -17.4 28.66 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 40.9 m-20 -63.7 -38.93 92.98 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.68 ' OE1' ' HB3' ' A' ' 49' ' ' ALA . 60.9 mm-40 -68.22 -42.74 79.35 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.89 -51.43 69.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.084 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 -35.42 75.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.686 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.3 m-30 -68.89 -42.12 77.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -63.54 -38.19 90.2 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 108.951 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -71.41 -55.51 7.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.754 -1.217 . . . . 0.0 108.292 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.68 -44.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -63.5 -27.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.5 p -67.4 -39.53 85.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.497 ' NE ' ' CD ' ' A' ' 140' ' ' GLU . 84.8 mtt-85 -69.15 -47.38 65.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.833 -1.167 . . . . 0.0 108.757 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 38' ' ' TYR . 4.7 mt -62.25 -33.86 75.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -64.91 -28.38 69.5 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -71.28 -59.88 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.4 p90 -121.57 151.36 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.89 77.84 1.12 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 39' ' ' GLY . 43.2 mtmt -40.9 118.64 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.451 -1.029 . . . . 0.0 108.57 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 32' ' ' VAL . 32.9 t -82.4 128.04 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 110.118 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.2 mt -105.86 172.43 6.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.782 HG22 ' O ' ' A' ' 43' ' ' THR . 32.4 m 51.81 47.28 25.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 108.887 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' HIS . 75.3 tt0 -50.05 -21.17 1.15 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.635 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -38.42 -47.49 1.26 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.374 -0.829 . . . . 0.0 110.157 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.707 ' O ' ' N ' ' A' ' 48' ' ' ASP . 3.4 p -57.47 162.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.941 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 60.85 -58.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.055 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.977 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.2 16.73 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.715 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -82.07 -39.56 23.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.15 -0.969 . . . . 0.0 108.475 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 58.3 mt-10 -45.92 -15.39 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.246 -0.909 . . . . 0.0 108.656 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.977 HD22 ' O ' ' A' ' 48' ' ' ASP . 3.0 mp -54.64 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 110.042 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.72 ' H ' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -155.55 -44.77 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.661 -0.649 . . . . 0.0 109.991 -178.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -84.06 80.37 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.916 2.411 . . . . 0.0 110.526 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.797 ' N ' HD12 ' A' ' 54' ' ' LEU . 5.1 mp -95.52 157.42 15.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.323 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 42.96 -167.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG3' ' HB2' ' B' ' 318' ' ' ALA . 43.5 mp0 -72.83 -30.86 64.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.579 -0.953 . . . . 0.0 109.696 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' GLU . 72.9 tt0 -47.53 -20.8 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -56.69 91.24 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.48 -3.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.933 . . . . 0.0 109.858 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -49.05 -46.12 33.16 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.65 79.36 0.03 OUTLIER Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -48.23 -46.96 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -60.16 -44.51 94.96 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 68' ' ' GLN . 51.6 t80 -61.43 -47.02 87.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 109.143 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 45' ' ' HIS . 0.7 OUTLIER -54.32 -39.66 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.645 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 2.2 t-80 -75.14 -48.46 23.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.84 -57.44 9.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 110.022 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 96.8 mm-40 -63.13 -40.36 97.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 109.354 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.702 ' OD1' HG23 ' A' ' 43' ' ' THR . 65.2 m-20 -60.5 -40.77 92.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.932 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -74.66 -39.02 62.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.635 -1.291 . . . . 0.0 109.84 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -56.3 -45.77 80.1 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -70.49 -40.13 73.78 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.5 tp -58.32 -33.34 69.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HA ' HD13 ' A' ' 100' ' ' LEU . 31.8 mt-30 -80.29 -28.07 38.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.558 -0.714 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -98.6 5.9 47.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.07 . . . . 0.0 108.989 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.27 132.74 46.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 111.756 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 11' ' ' SER . 70.1 m-20 -85.22 -30.96 23.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 22.3 t -143.32 138.18 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 13' ' ' TYR . 99.5 t -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.219 -0.925 . . . . 0.0 111.641 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.15 114.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.851 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . . . -115.17 131.83 56.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.149 -0.969 . . . . 0.0 110.386 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -91.16 114.72 27.32 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.8 t -85.97 -99.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.947 -1.095 . . . . 0.0 109.977 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.409 ' H ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 m 64.66 -122.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.674 -1.266 . . . . 0.0 109.047 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 15.2 pt20 -48.72 147.3 4.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.064 -1.023 . . . . 0.0 109.128 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.46 124.38 11.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.362 2.041 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.416 ' OG ' HG23 ' A' ' 90' ' ' VAL . 31.6 t -140.61 130.18 24.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.37 -41.39 73.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.55 97.38 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.416 HG23 ' OG ' ' A' ' 87' ' ' SER . 20.7 t -69.9 -47.19 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.356 -1.085 . . . . 0.0 109.078 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.87 -46.8 93.48 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 19.9 t80 -62.28 -45.05 94.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.748 -0.854 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -60.79 -33.54 73.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.221 -0.925 . . . . 0.0 109.098 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 81' ' ' ALA . 77.0 mt -73.42 -41.56 63.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.31 -48.7 62.11 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 100' ' ' LEU . 19.0 tpt180 -59.24 -42.42 91.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.31 -1.112 . . . . 0.0 108.871 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' A' ' 101' ' ' GLY . . . -66.72 -39.48 88.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.048 . . . . 0.0 108.905 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -51.72 -40.8 27.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -47.74 50.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.896 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 101' ' ' GLY . 2.8 pp -124.7 -33.19 3.0 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.932 -1.105 . . . . 0.0 111.298 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.798 ' N ' HD12 ' A' ' 100' ' ' LEU . . . -74.25 10.51 7.88 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 7.85 -74.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.342 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' GLY . 30.9 Cg_endo -65.33 108.43 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.349 1.16 . . . . 0.0 111.261 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 102' ' ' LYS . 3.7 mt -134.55 150.16 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.132 0.968 . . . . 0.0 111.486 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.9 tp -128.02 113.74 16.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.765 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -114.17 150.79 33.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.815 -1.178 . . . . 0.0 109.19 -179.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 2.9 mp -132.46 137.08 47.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 0.0 111.585 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -128.81 140.01 51.9 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -88.93 133.05 36.33 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.001 -1.062 . . . . 0.0 110.992 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 113' ' ' GLY . 87.8 Cg_endo -78.76 -38.81 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.537 2.158 . . . . 0.0 111.277 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.27 -31.52 6.04 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 113' ' ' GLY . 22.0 p -95.23 -20.55 19.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 38.42 42.49 1.33 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.438 HH11 ' HB2' ' A' ' 112' ' ' SER . 1.7 mtt85 -67.48 7.19 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.376 -1.073 . . . . 0.0 109.494 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 113' ' ' GLY . 77.3 t 57.57 99.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.448 -0.783 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.741 ' CD1' HG11 ' A' ' 83' ' ' VAL . 19.4 tp -54.76 151.12 8.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.05 142.07 47.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.116 -0.99 . . . . 0.0 110.9 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' B' ' 256' ' ' GLU . . . -57.34 -42.68 82.4 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 41.8 mmm -62.25 -45.7 92.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.724 0.773 . . . . 0.0 109.361 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' ALA . 28.0 mm -61.1 -43.19 95.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.122 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' GLY . 0.3 OUTLIER -55.61 -45.46 77.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.615 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -51.05 -40.07 42.74 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 103.973 -3.651 . . . . 0.0 103.973 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.612 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -76.07 89.56 3.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.14 40.42 0.07 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.918 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 127' ' ' SER . 97.7 m-20 -54.7 -20.08 7.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 110.059 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 68.8 -14.62 0.74 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 125' ' ' ASP . 22.5 t -102.49 -74.62 0.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.236 . . . . 0.0 108.805 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.77 -49.15 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.765 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 4.5 t80 -103.55 129.05 50.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -140.47 135.65 32.19 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.581 -1.324 . . . . 0.0 111.895 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.2 112.19 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 14.2 m0 -108.09 138.76 43.81 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.979 -1.076 . . . . 0.0 109.946 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' SD ' ' A' ' 142' ' ' MET . 80.9 m-20 -90.04 155.37 19.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.6 -1.313 . . . . 0.0 107.771 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.8 p90 -172.15 -177.28 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.697 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -150.89 148.33 28.3 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' ALA . 62.3 mt-10 -41.7 -34.62 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.745 -1.222 . . . . 0.0 110.438 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.81 6.18 75.49 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.885 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -137.89 -3.61 1.81 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.961 -1.317 . . . . 0.0 109.795 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.2 p -55.7 -46.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 54.5 mt-10 -52.64 -34.56 52.0 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -70.07 -38.78 75.84 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.375 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 13.0 mmt -53.5 -53.38 52.29 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 79.0 mt -60.69 -39.11 87.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.029 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.53 -45.22 93.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 110.941 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -68.64 -51.55 41.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.545 -1.347 . . . . 0.0 108.873 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.45 -45.27 80.9 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.611 -0.68 . . . . 0.0 109.971 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 151' ' ' LEU . 15.5 m-85 -73.4 -33.15 64.84 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -58.09 -29.9 65.82 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.18 26.86 4.45 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.99 -82.4 0.21 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.693 -1.203 . . . . 0.0 113.472 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 147' ' ' PHE . 4.8 mt -55.11 -59.21 11.49 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.131 -0.98 . . . . 0.0 112.195 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 2.6 Cg_endo . . . . . 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 0.0 111.878 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -56.41 155.89 23.68 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.986 1.791 . . . . 0.0 111.279 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 18.6 p -58.92 175.55 0.27 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.047 -1.033 . . . . 0.0 108.506 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 14.6 m -119.09 153.18 35.2 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.41 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 0.0 OUTLIER -123.92 126.97 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.589 ' HB3' HG13 ' B' ' 279' ' ' VAL . 36.4 t80 -89.04 129.42 35.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' B' ' 246' ' ' VAL . 15.9 t80 -96.99 132.34 42.89 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.2 OUTLIER -142.57 101.15 3.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -0.807 . . . . 0.0 109.234 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.62 -176.39 14.41 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.515 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 4.4 m -87.19 120.62 28.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 110.108 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.559 ' O ' ' NE ' ' B' ' 222' ' ' ARG . 3.9 mt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' B' ' 218' ' ' ILE . 73.7 mtt-85 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 122.692 1.234 . . . . 0.0 112.734 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.18 -17.34 26.6 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 44.2 m-20 -64.0 -38.9 92.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.667 ' OE1' ' HB3' ' B' ' 249' ' ' ALA . 61.6 mm-40 -68.13 -42.94 79.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.73 -51.28 70.46 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.989 -1.084 . . . . 0.0 108.173 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.52 -35.98 77.28 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.678 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -68.29 -42.74 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.536 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.471 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -62.95 -38.25 90.32 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.846 -1.159 . . . . 0.0 109.091 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -71.38 -55.41 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.877 -1.14 . . . . 0.0 108.249 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 45.6 mt -53.74 -44.64 59.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.678 HG23 ' O ' ' B' ' 228' ' ' TYR . 55.9 t -63.35 -28.18 44.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 23.9 p -67.21 -39.52 86.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' ARG . . . . . 0.498 ' NE ' ' CD ' ' B' ' 340' ' ' GLU . 85.4 mtt-85 -69.31 -47.33 64.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.912 -1.117 . . . . 0.0 108.815 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 238' ' ' TYR . 4.7 mt -62.26 -33.72 75.16 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -65.1 -28.55 69.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -71.19 -59.87 2.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.4 p90 -121.42 151.7 39.89 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 83.33 77.92 1.09 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' B' ' 239' ' ' GLY . 42.9 mtmt -40.87 118.71 1.02 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.385 -1.068 . . . . 0.0 108.657 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.411 HG11 HG13 ' B' ' 232' ' ' VAL . 30.3 t -82.35 127.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.192 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.441 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 17.1 mt -105.52 172.45 6.79 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.766 HG22 ' O ' ' B' ' 243' ' ' THR . 35.7 m 51.69 48.01 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 108.881 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 245' ' ' HIS . 75.1 tt0 -50.77 -20.83 1.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -38.48 -47.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.255 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.705 ' O ' ' N ' ' B' ' 248' ' ' ASP . 3.4 p -57.58 163.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 108.976 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.705 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 60.42 -58.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.473 -0.767 . . . . 0.0 109.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.976 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -62.15 16.76 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.705 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -81.91 -39.31 23.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 108.594 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -46.45 -14.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.61 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.976 HD22 ' O ' ' B' ' 248' ' ' ASP . 2.9 mp -55.26 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.713 ' H ' ' CD ' ' B' ' 253' ' ' PRO . 1.0 OUTLIER -155.47 -44.81 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.62 -0.675 . . . . 0.0 109.886 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.713 ' CD ' ' H ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -84.06 80.52 2.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.994 2.462 . . . . 0.0 110.668 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 254' ' ' LEU . 5.0 mp -95.84 157.62 15.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.345 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 43.11 -167.76 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 118' ' ' ALA . 41.2 mp0 -73.08 -30.29 63.58 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.523 -0.986 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' B' ' 256' ' ' GLU . 71.2 tt0 -48.21 -20.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -57.22 91.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -55.54 -4.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 260' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -48.39 -46.57 28.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 152.7 79.51 0.03 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -48.24 -46.96 36.14 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -60.2 -44.4 95.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.58 -47.01 87.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.7 OUTLIER -54.24 -39.92 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.625 ' CE1' ' HG ' ' B' ' 270' ' ' LEU . 2.2 t-80 -74.72 -48.43 25.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.07 -57.38 9.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.962 . . . . 0.0 110.091 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.08 -40.28 97.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' B' ' 243' ' ' THR . 62.0 m-20 -60.76 -40.68 93.4 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -74.82 -39.28 61.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.599 -1.313 . . . . 0.0 109.79 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -56.01 -45.69 79.01 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.971 -1.081 . . . . 0.0 108.15 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.441 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -70.43 -40.62 73.69 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.482 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.3 tp -58.06 -33.03 68.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 108.471 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.523 ' HA ' HD13 ' B' ' 300' ' ' LEU . 31.6 mt-30 -80.49 -28.15 37.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -98.47 6.11 47.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.992 -1.068 . . . . 0.0 108.949 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.74 132.88 46.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.33 -0.856 . . . . 0.0 111.765 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 70.1 m-20 -85.36 -31.01 23.2 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 24.4 t -143.1 138.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' B' ' 213' ' ' TYR . 99.0 t -120.95 148.17 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.134 -0.979 . . . . 0.0 111.614 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.24 114.68 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.384 0.612 . . . . 0.0 109.388 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.856 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . . . -115.74 131.54 56.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.49 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.402 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 71.7 tt0 -90.95 114.63 27.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' B' ' 316' ' ' LEU . 1.7 t -85.55 -98.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.965 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' B' ' 283' ' ' VAL . 5.0 m 64.26 -122.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.549 -1.345 . . . . 0.0 109.111 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -49.69 147.23 6.43 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.042 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.24 124.73 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.395 2.064 . . . . 0.0 111.785 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.409 ' OG ' HG23 ' B' ' 290' ' ' VAL . 28.9 t -141.28 130.37 23.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.143 -0.973 . . . . 0.0 109.383 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.59 -41.74 71.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.51 -40.7 96.58 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.409 HG23 ' OG ' ' B' ' 287' ' ' SER . 19.5 t -69.93 -47.39 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -1.082 . . . . 0.0 109.169 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.72 93.59 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 18.2 t80 -62.47 -44.85 95.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.958 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.6 -33.54 72.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.04 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' B' ' 281' ' ' ALA . 76.7 mt -73.77 -41.01 63.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.69 -48.67 60.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.505 ' NE ' HD21 ' B' ' 300' ' ' LEU . 18.5 tpt180 -59.17 -42.54 91.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.333 -1.099 . . . . 0.0 108.779 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.489 ' HA ' ' H ' ' B' ' 301' ' ' GLY . . . -66.7 -39.63 88.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.446 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -51.63 -40.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -71.98 -47.94 48.52 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.92 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.784 HD12 ' N ' ' B' ' 301' ' ' GLY . 2.8 pp -124.37 -33.15 3.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.986 -1.071 . . . . 0.0 111.226 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.784 ' N ' HD12 ' B' ' 300' ' ' LEU . . . -74.16 10.08 8.47 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' B' ' 301' ' ' GLY . 0.0 OUTLIER 7.93 -74.11 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 303' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' B' ' 301' ' ' GLY . 29.0 Cg_endo -65.17 107.89 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.456 1.199 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 302' ' ' LYS . 3.7 mt -134.08 149.87 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.189 0.995 . . . . 0.0 111.534 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 49.1 tp -127.72 114.02 16.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 306' ' ' CYS . . . . . 0.773 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -114.46 150.53 34.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 109.211 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 2.9 mp -132.15 137.0 47.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 111.463 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -128.68 140.0 51.96 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -88.85 133.12 36.34 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.924 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 313' ' ' GLY . 77.0 Cg_endo -78.83 -38.94 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.544 2.163 . . . . 0.0 111.069 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.24 -31.72 6.25 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.463 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.3 p -95.01 -20.34 19.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 38.5 42.41 1.34 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.42 HH11 ' HB2' ' B' ' 312' ' ' SER . 1.8 mtt85 -67.55 7.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.29 -1.124 . . . . 0.0 109.588 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' B' ' 313' ' ' GLY . 79.4 t 57.21 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.496 -0.753 . . . . 0.0 110.648 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.747 ' CD1' HG11 ' B' ' 283' ' ' VAL . 19.4 tp -54.8 151.17 8.78 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.86 141.77 48.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.926 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 318' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -57.3 -43.22 83.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 42.6 mmm -61.76 -45.5 93.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.626 0.727 . . . . 0.0 109.286 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' B' ' 323' ' ' ALA . 28.4 mm -61.19 -43.21 95.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.472 ' O ' ' C ' ' B' ' 322' ' ' GLY . 0.3 OUTLIER -55.62 -45.09 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.825 -1.172 . . . . 0.0 107.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.645 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -51.33 -40.03 44.77 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 103.997 -3.641 . . . . 0.0 103.997 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' B' ' 329' ' ' PHE . . . -76.02 89.5 2.99 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -165.07 40.47 0.07 Allowed 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.812 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' B' ' 327' ' ' SER . 98.4 m-20 -54.61 -20.35 7.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.825 . . . . 0.0 110.029 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 69.06 -14.93 0.76 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 327' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 325' ' ' ASP . 19.8 t -102.55 -74.68 0.62 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -1.231 . . . . 0.0 108.819 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -83.67 -49.41 9.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.773 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 4.4 t80 -103.39 129.06 50.4 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.34 135.66 32.39 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.661 -1.274 . . . . 0.0 111.853 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.34 111.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.569 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 14.1 m0 -107.78 138.87 43.26 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.0 110.108 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.469 ' O ' ' SD ' ' B' ' 342' ' ' MET . 81.4 m-20 -90.38 154.72 19.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.62 -1.3 . . . . 0.0 107.802 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.553 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -171.59 -177.16 1.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.782 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -150.75 148.31 28.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' B' ' 335' ' ' ALA . 62.1 mt-10 -41.6 -34.34 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.767 -1.208 . . . . 0.0 110.51 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.87 5.75 77.66 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.844 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -137.62 -3.6 1.87 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.001 -1.293 . . . . 0.0 109.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.0 p -55.88 -47.0 80.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 108.597 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 55.7 mt-10 -52.84 -34.07 52.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.1 m -70.61 -38.24 73.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.31 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 12.5 mmt -54.07 -52.97 59.23 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 76.8 mt -60.81 -39.16 87.93 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.044 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.4 -45.18 94.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 110.942 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -68.68 -51.79 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.516 -1.365 . . . . 0.0 108.808 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -56.13 -45.98 79.36 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.819 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' B' ' 351' ' ' LEU . 15.8 m-85 -72.82 -33.11 65.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.401 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.1 -29.62 65.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -97.38 26.77 4.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.05 -82.39 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.434 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' B' ' 347' ' ' PHE . 4.7 mt -54.9 -59.23 11.22 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.179 -0.951 . . . . 0.0 112.181 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 2.3 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.362 2.041 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.26 -156.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.35 2.033 . . . . 0.0 111.283 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 25.9 p -108.99 172.77 6.65 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 61.4 m -115.07 158.9 21.49 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.849 -1.157 . . . . 0.0 108.99 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 35' ' ' LEU . 16.6 t -137.41 134.14 46.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 8.3 t80 -115.53 97.29 6.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.623 ' O ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -93.48 126.79 38.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.526 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 1.7 m -101.67 130.1 47.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.955 . . . . 0.0 108.92 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.921 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -126.05 -124.01 2.73 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 58.1 m -155.69 138.08 14.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 109.105 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 120.913 -1.117 . . . . 0.0 109.441 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 122.073 0.94 . . . . 0.0 111.522 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.18 -40.83 96.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 74.8 m-20 -55.53 -33.32 63.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 1.8 mm100 -68.78 -39.18 80.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -52.04 66.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 108.702 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -34.6 76.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.3 m-85 -69.2 -47.85 63.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.085 -1.01 . . . . 0.0 110.251 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.32 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.256 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.7 ttt85 -69.67 -57.22 5.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 108.494 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.5 mt -50.82 -43.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.4 t -61.16 -30.58 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 4.6 m -66.84 -41.18 87.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -67.92 -48.88 64.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.901 -1.125 . . . . 0.0 109.197 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 12' ' ' VAL . 31.6 mt -57.9 -40.27 79.94 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -62.1 -26.07 68.08 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -74.9 -36.97 62.22 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.94 -1.1 . . . . 0.0 108.873 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.6 m-85 -70.4 -48.36 56.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.947 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -153.1 -145.38 4.13 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' H ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.98 131.38 46.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.968 -1.313 . . . . 0.0 108.658 178.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.58 HG11 HG13 ' A' ' 32' ' ' VAL . 18.1 t -90.73 127.47 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.553 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 11.9 mt -87.05 -38.63 16.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.198 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 14' ' ' PHE . 7.9 t -70.77 37.67 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 42' ' ' LEU . 57.7 mt-10 -54.28 -28.57 42.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.81 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.482 ' NE2' ' CG1' ' A' ' 65' ' ' ILE . 18.4 t-80 -52.09 -44.9 64.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.183 -0.948 . . . . 0.0 109.865 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.496 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 41.3 t -50.12 -69.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.32 61.02 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 14.6 t70 -85.34 43.08 0.99 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -118.54 -32.3 4.64 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG2' HE21 ' A' ' 25' ' ' GLN . 12.2 pt-20 -86.1 60.28 6.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.498 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -168.88 22.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER 162.19 160.7 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -37.28 99.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.268 1.979 . . . . 0.0 111.67 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 54' ' ' LEU . 6.8 mp -49.36 -79.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . -175.33 -36.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HG21 ' B' ' 315' ' ' VAL . 0.2 OUTLIER -46.97 -101.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.582 -0.952 . . . . 0.0 110.554 -179.119 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 56' ' ' GLU . 80.8 mm-40 -64.18 -8.9 13.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.025 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 158.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.63 66.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.19 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.01 -171.99 36.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 103.02 -29.86 11.61 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 20.5 p-10 -56.15 -43.16 78.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.5 mt-30 -70.39 -53.2 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -28.84 56.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' GLY . 1.8 mt -70.37 -39.71 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 1.3 t-80 -76.45 -60.59 2.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.489 0.661 . . . . 0.0 109.367 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.562 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 8.4 tp10 -43.04 -54.52 4.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -64.68 -44.6 89.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.945 . . . . 0.0 110.044 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.462 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 73.9 m-20 -60.91 -44.14 97.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.0 111.265 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' OH ' ' A' ' 92' ' ' TYR . 1.1 mm? -65.4 -50.25 66.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.024 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.18 -50.48 71.67 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.489 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.29 -42.46 99.08 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.3 tp -52.03 -37.33 53.16 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -75.36 -28.08 59.41 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.603 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -83.52 -5.96 59.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.869 -1.145 . . . . 0.0 109.258 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.84 125.33 25.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 112.153 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' HB2' ' H ' ' A' ' 11' ' ' SER . 39.0 m-20 -77.81 -33.15 52.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.21 148.18 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.26 138.7 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.966 -1.084 . . . . 0.0 111.002 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 20.5 t -138.45 164.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -159.46 130.42 5.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.579 -1.326 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CG ' ' OH ' ' A' ' 134' ' ' TYR . 53.1 tt0 -93.65 126.03 38.6 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -155.71 114.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.08 -1.012 . . . . 0.0 110.353 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 39.5 m -105.76 -18.54 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.679 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 6.6 tt0 163.81 -37.31 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.383 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 7.0 Cg_exo -71.14 104.1 1.49 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.327 2.018 . . . . 0.0 112.009 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.558 ' HB2' HD21 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -159.51 173.49 16.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 108.574 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.709 ' C ' ' H ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER 167.77 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.48 ' O ' ' SD ' ' B' ' 319' ' ' MET . . . 73.33 -23.21 0.96 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.921 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.1 t -85.14 -46.35 17.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.85 -30.48 56.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.481 ' OH ' HD11 ' A' ' 70' ' ' LEU . 1.3 t80 -68.58 -41.86 79.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.66 -34.59 65.14 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 94' ' ' LEU . 55.6 mt -73.2 -37.83 66.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.71 95.87 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.034 -2.027 . . . . 0.0 108.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -66.14 -40.0 90.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.489 -1.006 . . . . 0.0 108.711 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.43 ' C ' HD11 ' A' ' 104' ' ' ILE . . . -69.32 -40.99 77.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.064 . . . . 0.0 108.549 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -39.86 48.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.44 56.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.007 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.3 mt -71.16 -7.22 45.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.135 -0.978 . . . . 0.0 108.786 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.12 24.86 9.75 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.838 -0.539 . . . . 0.0 112.09 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -79.7 154.45 75.93 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 120.603 -1.528 . . . . 0.0 108.141 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.37 118.58 1.79 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.933 1.755 . . . . 0.0 111.167 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD11 ' C ' ' A' ' 97' ' ' ALA . 11.8 mt -121.13 135.3 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.988 . . . . 0.0 111.223 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.4 m -110.44 156.06 21.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.911 -1.118 . . . . 0.0 108.228 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 83' ' ' VAL . 3.5 mp -136.61 152.63 50.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 111.63 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.87 130.72 15.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -52.89 140.03 41.34 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.052 -1.03 . . . . 0.0 110.522 -177.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 134' ' ' TYR . 31.8 Cg_endo -67.15 -50.25 1.09 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.147 1.898 . . . . 0.0 109.252 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' N ' ' A' ' 113' ' ' GLY . 13.3 pt20 -67.11 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.56 -72.25 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.989 -1.07 . . . . 0.0 109.753 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 111' ' ' GLN . . . 68.34 42.74 81.62 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' VAL . 4.5 mtt180 -85.63 18.42 2.84 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.71 HG21 ' HB2' ' B' ' 256' ' ' GLU . 15.7 t 49.77 99.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.881 0.848 . . . . 0.0 109.448 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 117' ' ' SER . 8.9 tp -45.22 -61.24 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 162.86 144.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.288 -0.883 . . . . 0.0 110.002 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.52 86.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.555 -0.716 . . . . 0.0 110.399 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' B' ' 289' ' ' GLY . 1.7 mtp -74.81 -36.38 62.46 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.388 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.4 mm -72.42 -46.07 57.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 109.37 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.401 ' NE ' ' HB3' ' A' ' 116' ' ' LEU . 63.3 mtt180 -77.54 -34.74 53.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 108.807 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.8 -27.49 73.82 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -43.56 -59.31 2.22 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -133.65 -111.5 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 112.178 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 1.9 m-20 160.23 -2.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.436 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.1 38.93 0.36 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.468 -1.349 . . . . 0.0 111.604 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 58.5 p -116.1 -86.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.727 -1.455 . . . . 0.0 108.838 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.501 ' O ' ' NE2' ' A' ' 130' ' ' GLN . 20.0 tpt180 -94.4 -30.05 14.67 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -117.69 126.0 51.7 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 128' ' ' ARG . 6.9 mp0 -131.91 135.92 47.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.55 -1.344 . . . . 0.0 112.726 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.42 106.89 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 20.8 m0 -104.63 143.02 33.64 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.006 -1.059 . . . . 0.0 110.986 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' O ' ' SD ' ' A' ' 142' ' ' MET . 68.0 m-20 -85.84 154.86 21.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.651 -1.281 . . . . 0.0 108.002 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.458 ' OH ' ' CG ' ' A' ' 82' ' ' GLU . 3.6 p90 -168.7 172.54 7.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 0.0 111.488 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -141.65 146.67 36.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 40.0 mt-10 -39.26 -37.03 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.746 -1.221 . . . . 0.0 110.335 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.17 15.52 33.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 135' ' ' ALA . 74.8 mt-10 -146.29 -4.88 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.258 . . . . 0.0 110.407 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.6 p -54.04 -46.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 120.865 -1.147 . . . . 0.0 108.616 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 22.8 pt-20 -56.54 -34.63 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.8 m -65.67 -39.41 91.3 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.165 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 11.3 mmt -55.82 -51.6 66.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.91 -30.3 71.4 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.347 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 48.6 m-20 -69.27 -44.14 72.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 0.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -71.67 -43.61 65.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.677 -1.264 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -62.97 -48.6 78.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.446 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.923 ' CD1' HD12 ' A' ' 151' ' ' LEU . 19.6 m-85 -73.64 -31.08 63.32 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.393 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -68.25 -27.16 66.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.47 65.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.689 -0.632 . . . . 0.0 109.621 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.813 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -145.88 -63.69 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.042 -1.036 . . . . 0.0 110.653 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 147' ' ' PHE . 1.4 mt -31.01 92.89 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 0.0 110.643 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 150' ' ' TYR . 72.4 Cg_endo . . . . . 0 C--N 1.311 -1.419 0 C-N-CA 123.166 2.577 . . . . 0.0 111.048 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.67 -156.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.217 1.945 . . . . 0.0 111.24 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 26.6 p -109.12 172.98 6.53 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 69.8 m -115.38 159.08 21.55 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.895 -1.128 . . . . 0.0 108.909 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 235' ' ' LEU . 15.8 t -137.63 133.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 8.1 t80 -115.31 97.59 6.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.638 ' O ' HG21 ' B' ' 243' ' ' THR . 0.0 OUTLIER -93.74 126.83 39.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.455 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.417 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 1.8 m -101.49 129.4 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.18 -0.95 . . . . 0.0 108.93 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.919 ' O ' HG21 ' B' ' 290' ' ' VAL . . . -125.42 -124.3 2.79 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' SER . . . . . 0.553 ' O ' ' NH1' ' B' ' 222' ' ' ARG . 58.7 m -155.58 137.8 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.055 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.894 -1.129 . . . . 0.0 109.581 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.553 ' NH1' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.171 0.986 . . . . 0.0 111.418 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.03 -40.64 96.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' B' ' 228' ' ' TYR . 74.7 m-20 -55.31 -33.77 63.58 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 1.9 mm100 -68.45 -38.84 81.48 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.19 66.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 108.646 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -34.31 76.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.788 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.0 m-85 -69.14 -48.42 62.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.059 -1.025 . . . . 0.0 110.217 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.61 75.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' B' ' 233' ' ' SER . 32.0 ttt85 -69.62 -57.31 5.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.089 . . . . 0.0 108.452 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -50.61 -43.39 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 228' ' ' TYR . 67.9 t -61.03 -30.73 48.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 233' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 230' ' ' ARG . 4.4 m -66.65 -41.36 88.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.776 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.91 -48.57 65.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.745 -1.222 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.699 HD22 HG11 ' B' ' 212' ' ' VAL . 32.8 mt -58.2 -40.37 81.4 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -61.99 -25.98 67.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -74.93 -37.2 62.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.913 -1.117 . . . . 0.0 108.92 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' TYR . . . . . 0.486 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.5 m-85 -70.09 -48.55 57.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.614 -0.679 . . . . 0.0 110.072 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.73 -145.53 4.16 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -100.88 131.48 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -1.216 . . . . 0.0 108.575 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.583 HG11 HG13 ' B' ' 232' ' ' VAL . 19.4 t -90.67 127.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.561 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 12.0 mt -87.08 -38.44 16.49 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.181 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.638 HG21 ' O ' ' B' ' 214' ' ' PHE . 8.1 t -71.18 37.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 109.257 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' B' ' 242' ' ' LEU . 59.3 mt-10 -54.29 -28.84 44.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.818 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.498 ' NE2' ' CG1' ' B' ' 265' ' ' ILE . 17.7 t-80 -52.08 -45.24 64.71 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.494 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 41.2 t -49.85 -69.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.295 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -51.87 -41.36 61.82 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 248' ' ' ASP . 14.5 t70 -85.2 43.44 1.01 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -119.0 -32.05 4.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 250' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' B' ' 225' ' ' GLN . 11.7 pt-20 -86.4 60.55 6.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.269 -0.894 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -169.28 22.56 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.514 -0.741 . . . . 0.0 109.945 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER 161.87 160.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -37.03 99.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.382 2.055 . . . . 0.0 111.702 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.77 HD12 ' H ' ' B' ' 254' ' ' LEU . 6.7 mp -49.17 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.05 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . -175.71 -37.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.71 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -46.68 -101.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.568 -0.96 . . . . 0.0 110.578 -178.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 257' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' B' ' 256' ' ' GLU . 80.7 mm-40 -63.94 -8.21 10.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.875 . . . . 0.0 110.058 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -56.84 159.04 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.37 66.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 109.16 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -171.42 -172.33 37.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 261' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 103.14 -29.95 11.39 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 262' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 20.0 p-10 -56.17 -43.02 77.97 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 263' ' ' GLN . . . . . 0.467 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 2.5 mt-30 -70.59 -53.25 16.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.29 -28.51 54.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.498 ' CG1' ' NE2' ' B' ' 245' ' ' HIS . 1.9 mt -71.08 -39.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.56 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 1.2 t-80 -76.32 -60.73 2.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 267' ' ' GLU . . . . . 0.56 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 9.4 tp10 -43.02 -54.86 4.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.723 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -64.63 -43.8 92.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.449 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 75.3 m-20 -61.84 -44.1 97.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.2 -0.937 . . . . 0.0 111.2 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.486 HD11 ' OH ' ' B' ' 292' ' ' TYR . 1.1 mm? -65.32 -50.05 67.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.975 -1.078 . . . . 0.0 110.02 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -62.22 -50.76 70.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.03 -42.76 99.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.362 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.4 tp -51.76 -37.3 50.74 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -75.4 -28.1 59.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -83.42 -5.94 59.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.191 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.91 125.74 26.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -0.851 . . . . 0.0 112.034 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' B' ' 211' ' ' SER . 41.9 m-20 -78.25 -33.14 49.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.91 147.7 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 79.3 t -133.93 138.38 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.883 -1.136 . . . . 0.0 111.015 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 280' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 20.0 t -137.83 164.76 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.448 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -159.95 130.16 5.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.614 -1.304 . . . . 0.0 110.143 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.453 ' CG ' ' OH ' ' B' ' 334' ' ' TYR . 52.0 tt0 -93.56 125.75 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 0.5 OUTLIER -155.3 115.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.987 -1.07 . . . . 0.0 110.349 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 285' ' ' GLN . 38.0 m -106.06 -19.0 13.86 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.68 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 6.6 tt0 164.09 -37.18 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.244 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 7.5 Cg_exo -70.9 103.82 1.41 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.389 2.06 . . . . 0.0 111.937 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -159.81 173.25 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.747 ' C ' ' H ' ' B' ' 290' ' ' VAL . 0.1 OUTLIER 167.9 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 289' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 119' ' ' MET . . . 73.26 -22.81 0.97 Allowed Glycine 0 N--CA 1.481 1.662 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -176.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.919 HG21 ' O ' ' B' ' 216' ' ' GLY . 2.1 t -85.43 -46.41 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -55.65 -30.51 56.34 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.486 ' OH ' HD11 ' B' ' 270' ' ' LEU . 1.3 t80 -68.62 -41.98 78.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.8 -34.55 65.41 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' B' ' 294' ' ' LEU . 54.4 mt -73.15 -37.97 66.4 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.9 -37.79 94.34 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.8 -39.88 87.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.451 -1.029 . . . . 0.0 108.649 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 297' ' ' ALA . . . . . 0.449 ' C ' HD11 ' B' ' 304' ' ' ILE . . . -69.55 -41.08 76.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.96 -1.088 . . . . 0.0 108.524 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -39.79 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.11 57.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.007 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -71.63 -6.97 44.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 108.832 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 301' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . 51.05 25.01 9.49 Favored Glycine 0 N--CA 1.494 2.557 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.052 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 302' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -79.76 154.61 75.83 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 120.631 -1.511 . . . . 0.0 108.254 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.39 118.35 1.71 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.806 1.67 . . . . 0.0 111.098 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.449 HD11 ' C ' ' B' ' 297' ' ' ALA . 11.9 mt -120.82 134.77 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.149 -0.969 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.25 114.78 18.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 85.9 m -110.57 156.18 21.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.76 -1.213 . . . . 0.0 108.105 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' B' ' 283' ' ' VAL . 3.5 mp -136.59 152.43 50.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.0 -1.062 . . . . 0.0 111.626 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -148.68 130.62 15.25 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.263 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 0.0 OUTLIER -52.87 139.8 41.6 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.045 -1.034 . . . . 0.0 110.496 -177.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' B' ' 311' ' ' GLN . 33.3 Cg_endo -67.08 -50.06 1.17 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.067 1.845 . . . . 0.0 109.352 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.788 ' O ' ' N ' ' B' ' 313' ' ' GLY . 13.2 pt20 -67.09 -143.21 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.31 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 109.687 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.788 ' N ' ' O ' ' B' ' 311' ' ' GLN . . . 68.39 42.76 81.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' B' ' 315' ' ' VAL . 4.4 mtt180 -85.43 17.57 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 56' ' ' GLU . 17.9 t 50.41 99.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.969 0.89 . . . . 0.0 109.4 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 317' ' ' SER . 8.5 tp -45.33 -61.42 1.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 317' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.9 OUTLIER 162.97 143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.49 86.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.437 -0.79 . . . . 0.0 110.316 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 89' ' ' GLY . 1.6 mtp -74.3 -36.78 63.76 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.038 -1.039 . . . . 0.0 109.407 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.32 -45.93 58.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 109.439 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -77.46 -34.77 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 108.841 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -69.09 -27.27 74.0 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -43.43 -59.56 2.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -1.122 . . . . 0.0 110.013 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 325' ' ' ASP . . . -133.07 -111.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 112.068 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 325' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' B' ' 324' ' ' ALA . 2.0 m-20 160.01 -2.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.336 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 128.27 38.97 0.35 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 119.611 -1.281 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 57.0 p -115.97 -86.97 0.61 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.773 -1.427 . . . . 0.0 108.678 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.506 ' O ' ' NE2' ' B' ' 330' ' ' GLN . 20.1 tpt180 -94.29 -29.91 14.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 0.7 OUTLIER -117.86 126.25 52.04 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 330' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 328' ' ' ARG . 6.9 mp0 -132.23 136.37 46.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.471 -1.393 . . . . 0.0 112.65 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.72 107.11 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 20.7 m0 -104.48 142.92 33.77 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.071 -1.018 . . . . 0.0 110.939 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.542 ' O ' ' SD ' ' B' ' 342' ' ' MET . 67.0 m-20 -86.05 155.18 20.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.626 -1.296 . . . . 0.0 107.855 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.453 ' OH ' ' CG ' ' B' ' 282' ' ' GLU . 3.9 p90 -168.74 172.63 7.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.388 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -141.74 146.81 36.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' B' ' 335' ' ' ALA . 36.7 mt-10 -39.35 -37.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.83 -1.169 . . . . 0.0 110.286 -178.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.93 15.67 31.14 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 338' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 335' ' ' ALA . 74.1 mt-10 -146.59 -5.15 0.56 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.119 -1.224 . . . . 0.0 110.47 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.8 p -53.8 -46.85 63.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.804 -1.185 . . . . 0.0 108.606 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 23.1 pt-20 -56.29 -34.39 66.42 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 32.2 m -65.78 -39.46 91.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.542 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 11.8 mmt -55.79 -51.56 67.0 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 343' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' B' ' 343' ' ' LEU . 25.0 mt -63.79 -30.48 71.57 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.39 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -69.26 -44.09 72.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.991 -1.068 . . . . 0.0 110.69 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -71.86 -43.35 65.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.532 -1.355 . . . . 0.0 109.38 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -63.02 -48.86 76.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.358 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.926 ' CD1' HD12 ' B' ' 351' ' ' LEU . 19.9 m-85 -73.36 -31.0 63.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.413 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -68.15 -27.48 66.47 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -59.25 -27.56 65.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.766 -0.584 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.822 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.1 OUTLIER -145.73 -63.63 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.0 -1.063 . . . . 0.0 110.591 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.926 HD12 ' CD1' ' B' ' 347' ' ' PHE . 1.4 mt -31.13 92.99 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.633 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 352' ' ' PRO . . . . . 0.53 ' N ' ' O ' ' B' ' 350' ' ' TYR . 77.2 Cg_endo . . . . . 0 C--N 1.311 -1.442 0 C-N-CA 123.105 2.536 . . . . 0.0 110.914 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.51 -161.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.457 2.105 . . . . 0.0 111.704 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 29.1 p -99.8 -173.25 2.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 1.2 m -118.68 143.52 46.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG11 HD22 ' A' ' 35' ' ' LEU . 58.3 t -126.01 136.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CZ ' ' OE1' ' A' ' 44' ' ' GLU . 5.9 t80 -113.41 109.17 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.557 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.23 129.95 44.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.636 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 3.2 m -102.12 151.19 22.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.342 -0.849 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.84 162.66 36.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -86.35 132.94 33.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.226 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' A' ' 46' ' ' VAL . 1.3 mm . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 51.3 mp0 -51.5 -46.2 63.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 5.7 m-20 -65.01 -22.62 67.02 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 18.3 tp60 -63.35 -39.15 93.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.87 -47.88 67.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.86 -32.22 67.44 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.816 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.5 m-30 -67.44 -46.99 71.48 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . . . -60.28 -37.48 80.62 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.644 -1.285 . . . . 0.0 109.046 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -70.79 -56.79 5.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.756 -1.215 . . . . 0.0 108.515 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.508 HG21 ' OE2' ' A' ' 82' ' ' GLU . 5.0 mt -52.9 -43.99 47.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 28' ' ' TYR . 61.6 t -59.44 -29.09 41.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.3 m -71.68 -34.41 69.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -69.46 -53.29 19.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 108.615 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD22 HG11 ' A' ' 12' ' ' VAL . 13.1 mt -56.95 -39.51 74.67 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.96 -22.92 67.15 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -72.89 -44.54 61.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 109.412 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.95 -50.09 9.55 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.564 -0.71 . . . . 0.0 111.784 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.554 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . -142.46 132.48 5.15 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -35.79 145.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -1.052 . . . . 0.0 109.129 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.706 HG21 HG13 ' A' ' 32' ' ' VAL . 50.2 t -79.4 100.56 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 72' ' ' TRP . 0.1 OUTLIER -49.88 94.56 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.952 -177.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 41' ' ' VAL . 6.6 m 28.21 100.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.363 0.602 . . . . 0.0 111.371 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' OE1' ' CZ ' ' A' ' 13' ' ' TYR . 16.3 tp10 -142.9 65.88 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' VAL . 25.0 p80 -50.16 -5.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 39.0 t -40.18 -58.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.66 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -66.93 -40.76 87.7 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 108.641 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 51' ' ' LEU . 7.4 t70 -70.67 25.05 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -101.98 -16.18 16.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.01 -43.96 70.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 109.027 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.973 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.73 136.99 20.94 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 0.0 109.353 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 51' ' ' LEU . 20.8 mm-40 53.98 153.55 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.997 . . . . 0.0 109.082 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.47 88.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.195 1.93 . . . . 0.0 111.736 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.476 HD11 ' NH1' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.15 -163.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.155 -0.966 . . . . 0.0 109.806 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 91.09 151.85 27.22 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.649 ' C ' ' H ' ' A' ' 58' ' ' ALA . 44.4 mt-10 -50.55 178.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -1.176 . . . . 0.0 109.003 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 64.91 -24.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.166 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.649 ' H ' ' C ' ' A' ' 56' ' ' GLU . . . -80.37 141.41 35.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 109.162 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.58 133.38 36.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.154 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.38 -77.08 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.05 83.61 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -52.44 -45.79 66.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -1.043 . . . . 0.0 108.562 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -62.14 -46.36 89.37 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 35.3 t80 -62.56 -41.62 99.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 11.9 mt -56.02 -46.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.753 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.7 t-80 -76.46 -27.11 56.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.7 -0.625 . . . . 0.0 109.852 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -61.86 -56.8 15.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.314 -0.867 . . . . 0.0 109.592 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 23.5 mp0 -76.37 -41.78 46.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.627 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 63.6 m-20 -60.11 -52.82 63.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.149 -0.97 . . . . 0.0 109.797 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.501 HD22 ' NE2' ' A' ' 66' ' ' HIS . 1.2 tp -67.98 -44.71 76.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.591 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -59.33 -49.27 78.46 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.592 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.694 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -76.73 -19.71 57.36 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.084 -1.447 . . . . 0.0 109.485 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.8 tp -64.67 -35.14 80.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -86.66 -19.0 29.89 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.398 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.48 ' OE1' ' CD1' ' A' ' 72' ' ' TRP . 27.1 tt0 -99.26 2.74 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.879 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 129.26 39.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.194 -0.941 . . . . 0.0 111.381 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 11' ' ' SER . 94.6 m-20 -63.5 -35.23 79.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' OH ' ' A' ' 150' ' ' TYR . 42.9 t -138.41 149.78 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.0 t -137.39 142.0 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.499 1.142 . . . . 0.0 112.106 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 105' ' ' LEU . 97.7 t -138.2 165.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -158.04 137.13 11.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.632 -1.293 . . . . 0.0 109.227 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 90' ' ' VAL . 28.4 mt-10 -93.61 126.1 38.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -126.68 130.72 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 85' ' ' GLN . 20.0 m -170.5 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.843 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 31.5 tt0 -100.05 -24.64 0.22 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.706 . . . . 0.0 109.843 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 96.2 Cg_exo -43.3 -142.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.731 2.287 . . . . 0.0 112.163 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.664 ' OG ' ' N ' ' A' ' 88' ' ' LEU . 2.4 t 172.53 -153.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.677 -1.264 . . . . 0.0 109.669 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.664 ' N ' ' OG ' ' A' ' 87' ' ' SER . 20.9 mt -30.59 136.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 110.091 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.37 -38.07 3.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -88.85 -41.86 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.969 . . . . 0.0 108.589 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.66 -33.39 71.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' CD2' ' SD ' ' B' ' 319' ' ' MET . 65.4 t80 -66.65 -52.89 39.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -1.143 . . . . 0.0 109.745 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.562 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 59.0 mt-10 -64.82 -31.27 72.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.314 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 81' ' ' ALA . 25.1 mt -66.9 -44.42 80.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.88 -33.06 86.24 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.587 HH11 ' CG1' ' B' ' 298' ' ' VAL . 17.2 mmm180 -65.27 -44.46 87.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -1.03 . . . . 0.0 109.846 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 -36.71 73.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 108.67 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.568 ' CG1' HH11 ' B' ' 296' ' ' ARG . 0.5 OUTLIER -53.52 -44.52 56.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -74.8 -50.85 15.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.647 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 74' ' ' GLN . 14.2 mt -65.98 -6.45 12.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.53 17.54 66.79 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.905 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 104' ' ' ILE . 64.4 mmtt -83.47 135.43 43.75 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 120.708 -1.466 . . . . 0.0 107.973 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.15 121.73 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.642 1.561 . . . . 0.0 110.966 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 104' ' ' ILE . 1.7 mp -108.8 100.13 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.961 -1.087 . . . . 0.0 111.45 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HB3' HG22 ' A' ' 80' ' ' VAL . 24.6 tp -91.75 114.37 26.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -110.95 154.53 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 109.383 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.8 mt -122.92 149.5 44.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -145.03 119.63 9.76 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' NH1' ' NE2' ' A' ' 111' ' ' GLN . 7.2 mtm180 -79.25 124.61 84.27 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.797 -1.189 . . . . 0.0 111.109 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 113' ' ' GLY . 95.3 Cg_endo -83.42 -30.74 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.594 2.196 . . . . 0.0 110.758 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.469 ' NE2' ' NH1' ' A' ' 109' ' ' ARG . 9.4 pt20 -51.25 -35.24 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 39.6 m -98.7 -11.9 21.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 110' ' ' PRO . . . 39.98 48.07 3.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 5.12 2.43 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -1.15 . . . . 0.0 109.386 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.0 t 53.92 109.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.822 0.82 . . . . 0.0 110.135 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 131' ' ' VAL . 8.7 tp -56.19 149.32 16.31 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.94 150.07 14.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.16 86.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 108.643 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.602 ' SD ' ' CD2' ' B' ' 292' ' ' TYR . 0.0 OUTLIER -60.28 -50.58 73.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' ALA . 32.6 mm -63.94 -36.32 76.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.104 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 18.9 mmt85 -53.58 -43.37 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.75 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -54.63 -43.92 79.04 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.715 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -78.01 90.17 4.18 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' ARG . . . -174.28 46.5 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.591 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.37 -12.39 61.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 67.62 2.61 22.75 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.4 m -105.58 -78.85 0.57 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.993 -1.298 . . . . 0.0 108.87 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -93.19 -31.77 14.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.708 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 8.5 t80 -110.74 130.19 55.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.6 125.74 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.864 -1.148 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.716 HG11 HD22 ' A' ' 116' ' ' LEU . 38.5 t -85.68 106.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 12.3 m0 -102.06 138.02 39.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.0 -1.063 . . . . 0.0 109.558 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' O ' ' CE ' ' A' ' 142' ' ' MET . 91.8 m-20 -91.79 152.67 20.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.705 -1.247 . . . . 0.0 109.012 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.8 p90 -164.29 -179.33 6.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.475 -1.29 . . . . 0.0 111.917 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.53 147.36 25.33 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 135' ' ' ALA . 52.0 mt-10 -42.06 -36.17 1.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.926 -1.109 . . . . 0.0 110.298 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.36 4.44 41.53 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.496 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.96 7.15 0.33 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.552 -1.558 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.8 p -51.25 -43.29 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 108.464 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.7 mt-10 -57.93 -36.34 72.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 m -64.99 -45.53 85.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.455 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 3.9 tpp -51.56 -46.32 63.37 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.84 -33.18 68.26 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.702 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 55.3 m-20 -65.43 -40.42 93.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.95 -1.093 . . . . 0.0 109.837 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -69.91 -49.06 55.8 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.634 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.28 -48.73 80.06 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 109.979 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.829 ' CD1' HD12 ' A' ' 151' ' ' LEU . 8.9 m-85 -66.95 -32.43 73.67 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.904 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.71 -25.14 64.62 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.588 -1.32 . . . . 0.0 107.785 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.39 62.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.53 -0.732 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -146.05 -0.13 0.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.456 -1.402 . . . . 0.0 111.649 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 147' ' ' PHE . 16.6 mt -115.69 82.75 10.58 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.672 -1.267 . . . . 0.0 109.267 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--N 1.31 -1.454 0 C-N-CA 122.646 2.231 . . . . 0.0 112.095 179.77 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.61 -161.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.625 2.217 . . . . 0.0 111.587 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' CYS . . . . . 0.456 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 29.7 p -100.07 -173.19 2.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 1.2 m -118.62 143.76 46.6 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' VAL . . . . . 0.494 HG11 HD22 ' B' ' 235' ' ' LEU . 60.1 t -126.14 136.63 60.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' TYR . . . . . 0.53 ' CZ ' ' OE1' ' B' ' 244' ' ' GLU . 6.0 t80 -113.35 109.12 18.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.13 130.09 44.91 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.658 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 3.2 m -102.28 151.33 22.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -165.95 162.75 36.23 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 15.9 m -86.48 133.0 33.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.168 -1.195 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' B' ' 246' ' ' VAL . 1.3 mm . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 223' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 50.3 mp0 -51.34 -46.08 62.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 6.0 m-20 -65.56 -22.53 66.7 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 17.9 tp60 -63.44 -39.07 93.49 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.29 68.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.95 -32.53 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' TYR . . . . . 0.809 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -67.27 -47.02 71.94 Favored 'General case' 0 C--O 1.198 -1.631 0 O-C-N 121.527 -0.733 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 247' ' ' ALA . . . -60.38 -37.4 80.64 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.723 -1.236 . . . . 0.0 109.044 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -70.65 -56.86 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.773 -1.204 . . . . 0.0 108.505 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.495 HG21 ' OE2' ' B' ' 282' ' ' GLU . 4.9 mt -52.83 -43.93 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 228' ' ' TYR . 60.6 t -59.66 -28.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.0 m -71.93 -34.19 68.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.0 109.383 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.47 -53.54 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.871 -1.143 . . . . 0.0 108.626 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 212' ' ' VAL . 12.9 mt -56.64 -39.61 73.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -62.97 -22.97 67.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -72.91 -44.62 61.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 109.491 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.81 -49.9 9.85 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.513 -0.742 . . . . 0.0 111.873 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . -142.67 132.75 5.24 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' B' ' 239' ' ' GLY . 0.0 OUTLIER -35.96 145.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -1.003 . . . . 0.0 109.027 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 241' ' ' VAL . . . . . 0.716 HG21 HG13 ' B' ' 232' ' ' VAL . 44.7 t -79.31 100.63 4.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' B' ' 272' ' ' TRP . 0.1 OUTLIER -49.84 94.88 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.938 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 243' ' ' THR . . . . . 0.524 ' N ' ' O ' ' B' ' 241' ' ' VAL . 6.6 m 27.81 100.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.421 0.629 . . . . 0.0 111.387 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' B' ' 246' ' ' VAL . 15.7 tp10 -143.2 66.52 1.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' B' ' 246' ' ' VAL . 25.0 p80 -50.64 -5.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.562 -0.711 . . . . 0.0 110.147 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' VAL . . . . . 0.555 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 39.3 t -40.36 -58.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.675 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -67.2 -40.54 86.51 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 108.616 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 248' ' ' ASP . . . . . 0.851 ' O ' HD11 ' B' ' 251' ' ' LEU . 7.0 t70 -71.0 25.58 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -102.47 -15.97 16.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -54.16 -43.89 70.98 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' LEU . . . . . 0.956 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -50.83 136.79 21.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 252' ' ' GLU . . . . . 0.606 ' O ' ' O ' ' B' ' 251' ' ' LEU . 20.6 mm-40 54.17 153.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.98 . . . . 0.0 109.175 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.69 89.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.181 1.921 . . . . 0.0 111.542 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' LEU . . . . . 0.483 HD11 ' NH1' ' B' ' 222' ' ' ARG . 0.3 OUTLIER -61.88 -163.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.75 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 91.37 151.58 27.03 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 256' ' ' GLU . . . . . 0.653 ' C ' ' H ' ' B' ' 258' ' ' ALA . 46.7 mt-10 -50.29 178.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -1.214 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 64.82 -25.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 109.055 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 258' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -80.08 141.73 35.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.29 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.21 132.12 38.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 168.57 -77.5 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 138.81 83.21 0.1 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -52.08 -45.88 64.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -1.072 . . . . 0.0 108.387 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -62.09 -46.52 88.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 264' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 36.0 t80 -62.72 -41.3 99.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.31 -0.869 . . . . 0.0 108.994 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 265' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 12.0 mt -56.28 -45.86 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 266' ' ' HIS . . . . . 0.75 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -76.68 -27.33 55.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.926 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.66 -56.66 17.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.348 -0.845 . . . . 0.0 109.688 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 268' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 23.1 mp0 -76.65 -41.54 45.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 269' ' ' ASP . . . . . 0.472 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 62.1 m-20 -60.01 -52.3 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 270' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' B' ' 274' ' ' GLN . 1.2 tp -68.57 -44.49 74.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.23 -49.37 78.09 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.621 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 272' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' B' ' 242' ' ' LEU . 0.2 OUTLIER -76.6 -19.63 57.64 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.121 -1.432 . . . . 0.0 109.588 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 273' ' ' LEU . . . . . 0.447 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.7 tp -64.81 -34.91 79.49 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 274' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.0 OUTLIER -86.96 -19.1 29.24 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.442 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 275' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' B' ' 275' ' ' GLN . 27.2 tt0 -99.11 2.39 45.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.822 -1.174 . . . . 0.0 108.817 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.02 129.3 39.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.108 -0.995 . . . . 0.0 111.405 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 95.2 m-20 -63.37 -35.38 80.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.463 HG21 ' OH ' ' B' ' 350' ' ' TYR . 42.6 t -138.28 149.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 279' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' B' ' 213' ' ' TYR . 83.2 t -137.48 142.22 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.534 1.159 . . . . 0.0 112.194 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 280' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' B' ' 305' ' ' LEU . 97.2 t -138.34 165.45 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 281' ' ' ALA . . . . . 0.522 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -157.72 137.04 11.85 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.548 -1.345 . . . . 0.0 109.283 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 282' ' ' GLU . . . . . 0.519 ' O ' HG11 ' B' ' 290' ' ' VAL . 28.7 mt-10 -93.32 126.29 38.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 283' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -126.81 130.88 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 284' ' ' THR . . . . . 0.569 HG22 ' N ' ' B' ' 285' ' ' GLN . 20.2 m -170.77 -92.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 285' ' ' GLN . . . . . 0.841 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 31.8 tt0 -100.11 -24.75 0.22 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.452 -0.78 . . . . 0.0 109.838 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 286' ' ' PRO . . . . . 0.841 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 97.6 Cg_exo -43.31 -142.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.688 2.259 . . . . 0.0 112.125 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 287' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' B' ' 288' ' ' LEU . 2.1 t 172.53 -153.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.569 -1.332 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 288' ' ' LEU . . . . . 0.679 ' N ' ' OG ' ' B' ' 287' ' ' SER . 20.2 mt -30.49 136.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 114.97 -37.64 3.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 290' ' ' VAL . . . . . 0.519 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.3 t -89.17 -42.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.583 -0.951 . . . . 0.0 108.588 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.06 71.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 292' ' ' TYR . . . . . 0.602 ' CD2' ' SD ' ' A' ' 119' ' ' MET . 65.7 t80 -66.97 -52.24 45.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -1.161 . . . . 0.0 109.9 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 293' ' ' GLU . . . . . 0.552 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 59.5 mt-10 -65.25 -31.3 72.39 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 294' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 281' ' ' ALA . 24.6 mt -66.98 -44.46 80.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.11 -32.75 85.06 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 296' ' ' ARG . . . . . 0.568 HH11 ' CG1' ' A' ' 98' ' ' VAL . 16.9 mmm180 -65.33 -44.52 87.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.051 . . . . 0.0 109.82 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.84 -36.82 73.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.993 . . . . 0.0 108.647 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 298' ' ' VAL . . . . . 0.587 ' CG1' HH11 ' A' ' 96' ' ' ARG . 0.5 OUTLIER -53.26 -44.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 299' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.02 -50.68 15.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.736 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 300' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' B' ' 274' ' ' GLN . 14.5 mt -66.45 -6.18 13.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.41 17.57 66.56 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.817 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 302' ' ' LYS . . . . . 0.43 ' O ' HG13 ' B' ' 304' ' ' ILE . 65.1 mmtt -83.42 135.69 43.62 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 120.667 -1.49 . . . . 0.0 107.931 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.23 122.16 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.75 1.634 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 304' ' ' ILE . . . . . 0.626 HD12 ' H ' ' B' ' 304' ' ' ILE . 1.7 mp -109.37 99.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.987 . . . . 0.0 111.283 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 305' ' ' LEU . . . . . 0.58 ' HB3' HG22 ' B' ' 280' ' ' VAL . 24.9 tp -91.55 114.37 26.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 306' ' ' CYS . . . . . 0.703 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.3 OUTLIER -110.97 154.34 24.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.901 -1.124 . . . . 0.0 109.566 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 307' ' ' LEU . . . . . 0.558 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 9.2 mt -122.86 149.76 43.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.245 -0.909 . . . . 0.0 111.249 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 308' ' ' PHE . . . . . 0.71 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.4 OUTLIER -145.72 119.69 9.37 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 309' ' ' ARG . . . . . 0.461 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 7.7 mtm180 -79.07 125.21 84.1 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.0 111.131 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 310' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.5 Cg_endo -83.55 -29.98 0.94 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.579 2.186 . . . . 0.0 110.669 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 311' ' ' GLN . . . . . 0.461 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 9.4 pt20 -51.95 -35.16 45.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 312' ' ' SER . . . . . 0.448 ' O ' ' C ' ' B' ' 313' ' ' GLY . 31.1 m -98.8 -11.68 21.59 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 313' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 310' ' ' PRO . . . 39.84 47.93 3.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 314' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' B' ' 315' ' ' VAL . 0.5 OUTLIER -71.14 4.39 2.8 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.168 -1.195 . . . . 0.0 109.373 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' B' ' 314' ' ' ARG . 2.9 t 54.6 109.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.82 0.819 . . . . 0.0 110.101 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 316' ' ' LEU . . . . . 0.713 HD22 HG11 ' B' ' 331' ' ' VAL . 8.7 tp -56.58 149.83 16.71 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 150.03 16.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.629 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.66 85.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 108.606 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 319' ' ' MET . . . . . 0.612 ' SD ' ' CD2' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -60.78 -50.48 73.28 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 108.836 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 320' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' B' ' 323' ' ' ALA . 32.2 mm -64.02 -36.34 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.981 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 321' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' B' ' 324' ' ' ALA . 19.2 mmt85 -53.54 -43.61 68.55 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 322' ' ' GLY . . . . . 0.753 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -54.58 -43.82 78.55 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 104.632 -3.387 . . . . 0.0 104.632 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 323' ' ' ALA . . . . . 0.71 ' O ' ' O ' ' B' ' 320' ' ' ILE . . . -77.92 90.14 4.12 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 324' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 321' ' ' ARG . . . -174.14 46.32 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.622 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.08 -12.29 61.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.413 -0.805 . . . . 0.0 111.212 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 326' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 67.36 2.15 18.62 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.666 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 73.6 m -105.27 -78.91 0.56 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.991 -1.299 . . . . 0.0 108.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -93.16 -32.11 14.53 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.703 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 9.1 t80 -110.23 130.13 55.6 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.52 125.43 13.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.796 -1.19 . . . . 0.0 111.25 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 331' ' ' VAL . . . . . 0.713 HG11 HD22 ' B' ' 316' ' ' LEU . 35.9 t -85.46 106.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 332' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 11.9 m0 -102.02 137.79 39.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.04 -1.038 . . . . 0.0 109.44 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 333' ' ' ASP . . . . . 0.458 ' O ' ' SD ' ' B' ' 342' ' ' MET . 91.8 m-20 -91.54 152.57 20.26 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.801 -1.187 . . . . 0.0 109.084 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 334' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.7 p90 -164.15 -179.22 6.01 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.856 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.91 147.59 25.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 336' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.4 mt-10 -42.21 -36.07 1.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.802 -1.186 . . . . 0.0 110.281 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -75.26 3.79 44.79 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.507 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.52 7.09 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.486 -1.597 . . . . 0.0 110.866 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.9 p -51.11 -43.49 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.908 -1.12 . . . . 0.0 108.467 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 340' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 83.1 mt-10 -57.88 -36.24 72.1 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 72.1 m -64.88 -45.67 85.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 342' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.9 tpp -51.42 -46.81 63.06 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.23 -33.6 70.02 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.789 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 344' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' B' ' 340' ' ' GLU . 55.4 m-20 -65.4 -40.33 93.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.972 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.92 -49.17 54.66 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.923 -1.111 . . . . 0.0 108.462 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.15 -48.61 80.8 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.215 -0.928 . . . . 0.0 110.017 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 347' ' ' PHE . . . . . 0.853 ' CD1' HD12 ' B' ' 351' ' ' LEU . 9.1 m-85 -66.96 -32.18 73.25 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.934 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -68.98 -25.04 64.33 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.54 -1.35 . . . . 0.0 107.83 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.26 62.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 350' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.5 OUTLIER -146.26 -0.34 0.78 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.611 -1.306 . . . . 0.0 111.512 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 351' ' ' LEU . . . . . 0.853 HD12 ' CD1' ' B' ' 347' ' ' PHE . 16.7 mt -115.53 82.58 10.0 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 120.576 -1.328 . . . . 0.0 109.189 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--N 1.312 -1.391 0 C-N-CA 122.752 2.301 . . . . 0.0 112.136 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.99 146.9 40.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.8 154.52 36.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 6' ' ' GLU . 17.7 m -57.98 158.4 6.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.78 38.46 0.5 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 4' ' ' SER . 95.3 mt-10 -114.88 156.94 24.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.496 -1.002 . . . . 0.0 109.207 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.43 176.58 8.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -89.76 135.54 30.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.314 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' ALA . 32.1 Cg_exo -57.62 -150.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.804 1.669 . . . . 0.0 111.213 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -111.03 -175.39 2.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 36.0 m -121.44 152.43 39.1 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 35' ' ' LEU . 10.8 t -131.0 136.09 58.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' CG ' ' A' ' 69' ' ' ASP . 8.1 t80 -113.17 99.26 7.69 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -89.49 116.75 27.89 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.46 -0.896 . . . . 0.0 108.883 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.55 146.76 23.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.443 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.62 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -168.58 75.13 0.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.62 ' C ' ' O ' ' A' ' 16' ' ' GLY . 15.7 m -16.2 127.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.936 -0.743 . . . . 0.0 110.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 19' ' ' ARG . 2.4 mt -94.43 -75.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 110.034 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' NE ' ' OE2' ' A' ' 56' ' ' GLU . 39.7 mmm-85 48.42 72.08 0.31 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 54' ' ' LEU . . . 110.41 -116.71 4.45 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.39 95.57 0.11 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -129.09 -144.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 111.859 -175.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -59.76 -42.95 94.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.7 m-20 -52.06 -34.76 45.01 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.556 HE21 ' HB3' ' A' ' 49' ' ' ALA . 5.9 tp60 -64.09 -44.61 91.82 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.92 60.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.285 -0.885 . . . . 0.0 109.227 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -58.75 -32.45 69.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.0 m-30 -67.86 -46.03 72.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.343 -0.848 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.71 78.27 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.995 -1.065 . . . . 0.0 108.997 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -70.8 -57.22 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.077 . . . . 0.0 108.579 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.5 mt -51.7 -42.57 31.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.1 t -61.72 -31.32 50.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.0 t -67.12 -39.24 86.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 110.026 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 38' ' ' TYR . 53.0 ttt85 -69.56 -48.61 59.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.699 -1.251 . . . . 0.0 109.415 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 12' ' ' VAL . 15.3 mt -60.71 -38.54 85.37 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -63.17 -24.99 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -78.05 -36.66 48.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.056 -1.027 . . . . 0.0 109.419 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.553 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-85 -69.8 -47.05 64.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.426 -0.796 . . . . 0.0 110.416 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.75 2.56 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -99.36 135.68 40.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.85 117.61 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 44' ' ' GLU . 19.3 mt -80.94 -35.81 31.8 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -68.27 37.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.561 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 42' ' ' LEU . 44.3 tp10 -50.27 -34.49 23.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -49.77 -52.85 28.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 48' ' ' ASP . 21.8 t -58.83 163.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.719 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 62.55 -59.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.759 ' O ' HD11 ' A' ' 51' ' ' LEU . 24.0 t70 -65.85 24.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.719 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -103.63 -10.83 18.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.73 -39.78 95.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.028 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.07 161.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.527 -0.733 . . . . 0.0 109.773 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 51' ' ' LEU . 12.8 mt-10 55.97 158.61 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.287 -0.883 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' C ' HD22 ' A' ' 54' ' ' LEU . 23.6 Cg_endo -63.04 131.8 34.13 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.446 2.097 . . . . 0.0 111.593 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 49' ' ' ALA . 3.7 mm? -93.91 171.16 9.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 141.27 37.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' OE2' ' NE ' ' A' ' 19' ' ' ARG . 50.0 mt-10 47.11 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.482 -1.01 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 55' ' ' GLY . 97.1 mt-10 -47.47 -20.6 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' A' ' 56' ' ' GLU . . . -48.66 151.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.91 136.89 6.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.89 -62.57 0.17 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.78 80.6 1.13 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 18.8 p-10 -52.17 -45.22 65.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -1.091 . . . . 0.0 108.307 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 88.4 mt-30 -63.49 -48.59 77.02 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -61.64 -36.0 79.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.094 -1.004 . . . . 0.0 109.015 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 45' ' ' HIS . 2.0 mt -62.71 -52.22 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.657 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 0.1 OUTLIER -67.56 -50.54 58.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.588 0.709 . . . . 0.0 109.423 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 45.7 tp10 -43.09 -58.14 2.59 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -63.9 -39.42 94.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.656 ' CG ' ' OH ' ' A' ' 13' ' ' TYR . 8.5 t0 -58.42 -48.0 82.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.408 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.516 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -64.51 -45.14 88.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' ND2' ' OE1' ' A' ' 75' ' ' GLN . 13.5 t30 -65.44 -52.11 55.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.447 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.12 -45.69 90.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 108.976 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 42.1 tp -50.35 -37.22 35.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HA ' HD11 ' A' ' 100' ' ' LEU . 32.1 mt-30 -73.7 -28.1 61.55 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.435 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.491 ' OE1' ' ND2' ' A' ' 71' ' ' ASN . 38.0 mt-30 -88.1 -0.5 57.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 109.646 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.81 44.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.091 -1.005 . . . . 0.0 112.277 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 11' ' ' SER . 61.5 m-20 -85.61 -31.67 22.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.47 143.96 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 13' ' ' TYR . 86.2 t -138.88 130.81 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.687 -1.258 . . . . 0.0 111.748 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 105' ' ' LEU . 84.0 t -136.65 130.66 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -116.23 137.21 52.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.663 -1.273 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD2' ' A' ' 27' ' ' LEU . 55.1 tt0 -84.71 139.18 32.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.6 -0.687 . . . . 0.0 109.282 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.613 HG13 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -143.62 147.71 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.272 -0.893 . . . . 0.0 109.793 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 14.5 m -173.87 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' ' OD2' ' A' ' 24' ' ' ASP . 24.6 pt20 -97.93 153.61 38.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -37.37 143.71 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.146 1.897 . . . . 0.0 111.676 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB3' HG23 ' A' ' 90' ' ' VAL . 3.5 m -163.5 123.9 2.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 110.104 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' B' ' 287' ' ' SER . 4.0 mt -76.62 -45.19 31.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.316 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.564 ' N ' ' OG ' ' A' ' 17' ' ' SER . . . -60.78 -42.17 99.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.613 HG11 HG13 ' A' ' 83' ' ' VAL . 40.7 t -64.62 -45.21 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.194 -1.18 . . . . 0.0 109.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.79 -46.7 93.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' B' ' 319' ' ' MET . 82.5 t80 -66.25 -47.94 72.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -1.081 . . . . 0.0 109.501 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' SD ' ' B' ' 319' ' ' MET . 10.8 mm-40 -59.76 -37.27 78.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.6 mt -75.22 -41.53 57.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.051 -1.031 . . . . 0.0 109.242 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.04 -50.02 59.65 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -40.05 82.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.392 -1.064 . . . . 0.0 108.612 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -68.33 -37.06 80.18 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.633 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.73 -45.14 48.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.892 -1.13 . . . . 0.0 108.276 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -89.59 -53.04 4.7 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.089 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 100' ' ' LEU . 1.8 tm? -90.06 -29.85 18.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.089 -1.007 . . . . 0.0 109.643 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 97' ' ' ALA . . . -74.19 166.68 54.74 Favored Glycine 0 C--N 1.283 -2.392 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 4.8 mtmm -124.55 -71.09 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 82.9 Cg_endo -79.48 111.43 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.978 1.786 . . . . 0.0 109.293 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 97' ' ' ALA . 16.0 mt -129.59 116.03 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.782 -1.199 . . . . 0.0 111.995 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 80' ' ' VAL . 57.3 tp -110.5 126.26 54.18 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 145.66 39.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.928 -1.108 . . . . 0.0 108.771 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.3 mt -122.47 135.49 54.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.911 . . . . 0.0 111.625 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -133.5 138.01 45.91 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' NE ' ' NE2' ' A' ' 111' ' ' GLN . 4.4 mtm180 -98.98 134.66 21.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 120.703 -1.248 . . . . 0.0 111.338 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.43 -26.1 4.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.553 2.169 . . . . 0.0 111.267 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.447 ' NE2' ' NE ' ' A' ' 109' ' ' ARG . 7.5 pt20 -46.63 -38.66 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' GLY . 31.0 t -102.13 -15.8 16.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.82 51.37 2.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 115' ' ' VAL . 58.8 mtp85 -80.87 18.08 1.07 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.998 -1.295 . . . . 0.0 109.062 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 114' ' ' ARG . 48.7 t 46.99 100.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.671 0.748 . . . . 0.0 110.141 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 83' ' ' VAL . 49.1 tp -47.95 145.77 2.82 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 0.0 109.449 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -45.8 143.13 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.63 -30.31 69.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.458 -0.776 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.408 ' SD ' ' CD ' ' B' ' 293' ' ' GLU . 0.8 OUTLIER -70.76 -51.57 26.28 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.878 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.66 -42.51 96.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.675 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -65.17 -48.84 72.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.544 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.617 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -62.35 -31.25 78.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . . . -62.6 -15.66 52.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.038 -1.272 . . . . 0.0 108.199 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.45 96.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 65.3 m-20 -105.29 -22.52 13.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.893 . . . . 0.0 108.693 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.42 30.37 77.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 89.6 p -134.89 59.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.7 mtt180 98.61 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 123' ' ' ALA . 88.5 t80 -97.49 120.03 37.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.6 mt-30 -145.91 142.02 28.34 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.852 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.83 100.59 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.508 ' CG ' HD11 ' A' ' 105' ' ' LEU . 21.6 m0 -95.43 152.68 18.19 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.237 -0.914 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -97.38 155.54 16.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.094 -1.004 . . . . 0.0 108.877 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 6.3 p90 -170.19 -178.68 2.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.724 -1.235 . . . . 0.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.94 149.72 27.57 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.9 mt-10 -42.47 -29.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.704 -1.247 . . . . 0.0 110.154 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.51 -6.06 88.05 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.56 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.08 11.32 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.587 -1.537 . . . . 0.0 110.581 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.0 p -54.34 -45.35 68.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.924 -1.11 . . . . 0.0 108.448 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.504 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 49.9 mt-10 -57.76 -32.67 67.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.451 -0.781 . . . . 0.0 109.262 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.8 m -68.18 -45.52 73.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.568 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.97 -50.91 60.33 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.55 -34.1 77.15 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.89 -41.53 95.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.413 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -68.87 -48.7 62.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.867 -1.146 . . . . 0.0 108.331 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.39 -48.17 82.9 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 16.7 m-85 -69.74 -32.9 71.7 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.942 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 150' ' ' TYR . 27.1 mm-40 -62.24 -32.42 73.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.14 10.87 5.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.2 t80 -134.6 -105.09 0.23 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.24 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 14.9 mt -34.4 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.8 -0.563 . . . . 0.0 111.208 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 150' ' ' TYR . 87.1 Cg_endo -94.8 -61.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.168 2.578 . . . . 0.0 111.142 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -107.54 -23.48 12.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -57.19 -30.25 64.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 108.949 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 156' ' ' ALA . 12.0 t -57.1 -44.94 83.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.57 ' N ' HG23 ' A' ' 155' ' ' THR . . . -168.48 148.86 4.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -150.56 118.8 6.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.54 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 m -74.02 -31.09 62.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.7 p -96.33 151.28 19.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.517 ' N ' ' ND1' ' A' ' 160' ' ' HIS . 6.4 p-80 -139.04 76.46 33.21 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.855 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 152.6 12.76 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.707 2.272 . . . . 0.0 112.02 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.5 m -55.14 153.18 7.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.372 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.438 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.14 146.64 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.525 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -64.52 154.23 36.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' SER . . . . . 0.506 ' C ' ' H ' ' B' ' 206' ' ' GLU . 18.2 m -57.87 158.34 6.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -70.68 38.01 0.48 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' B' ' 204' ' ' SER . 95.4 mt-10 -114.23 155.61 25.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.522 -0.987 . . . . 0.0 109.181 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.51 176.42 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 109.43 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.56 136.1 30.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.249 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.09 -150.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.961 1.774 . . . . 0.0 111.279 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 28.2 p -111.25 -175.65 2.76 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 33.6 m -121.13 152.81 38.29 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.778 HG11 HD22 ' B' ' 235' ' ' LEU . 10.5 t -131.25 136.17 58.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.659 ' OH ' ' CG ' ' B' ' 269' ' ' ASP . 8.1 t80 -113.29 99.29 7.69 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -89.67 116.52 27.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.975 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.1 m -92.34 146.75 23.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.625 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -168.29 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.625 ' C ' ' O ' ' B' ' 216' ' ' GLY . 14.6 m -15.94 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.883 -0.775 . . . . 0.0 110.78 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.97 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.448 ' NE ' ' OE2' ' B' ' 256' ' ' GLU . 39.8 mmm-85 49.02 71.63 0.36 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.532 ' O ' HD12 ' B' ' 254' ' ' LEU . . . 110.84 -116.65 4.36 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 159.23 95.82 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 106.51 -2.636 . . . . 0.0 106.51 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER -129.21 -144.27 0.27 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -1.138 . . . . 0.0 111.825 -175.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.92 -42.38 93.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.613 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.8 m-20 -52.68 -34.6 52.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.572 HE21 ' HB3' ' B' ' 249' ' ' ALA . 5.9 tp60 -64.16 -44.44 92.09 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.02 59.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.32 -0.862 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.432 ' CD2' ' OE2' ' B' ' 282' ' ' GLU . 0.6 OUTLIER -58.67 -32.92 69.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.699 ' O ' HG23 ' B' ' 232' ' ' VAL . 15.9 m-30 -67.49 -45.79 74.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.835 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.66 78.85 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.905 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -70.84 -57.15 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.901 -1.125 . . . . 0.0 108.619 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.76 -42.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.6 t -62.05 -31.23 50.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 10.5 t -67.07 -39.2 86.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.542 ' NH2' ' OH ' ' B' ' 238' ' ' TYR . 53.8 ttt85 -69.56 -48.71 59.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.644 -1.285 . . . . 0.0 109.323 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.778 HD22 HG11 ' B' ' 212' ' ' VAL . 14.7 mt -60.51 -38.66 85.06 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -63.18 -25.0 68.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.101 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -77.94 -36.43 49.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.026 -1.046 . . . . 0.0 109.402 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.568 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-85 -69.99 -47.1 63.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.505 -0.747 . . . . 0.0 110.469 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.92 2.6 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -99.3 135.75 40.25 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.363 -1.081 . . . . 0.0 109.346 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.86 117.55 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' B' ' 244' ' ' GLU . 19.4 mt -80.93 -35.82 31.85 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.318 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.42 ' H ' HG22 ' B' ' 243' ' ' THR . 0.9 OUTLIER -68.34 36.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.597 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' B' ' 242' ' ' LEU . 45.1 tp10 -49.98 -34.03 19.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.525 ' CD2' HG23 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -49.87 -52.22 34.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.11 -0.994 . . . . 0.0 109.047 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' B' ' 248' ' ' ASP . 21.9 t -59.62 163.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 108.899 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 62.57 -59.89 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.795 ' O ' HD11 ' B' ' 251' ' ' LEU . 24.4 t70 -65.76 24.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.697 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -103.16 -10.68 18.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.627 -0.671 . . . . 0.0 109.194 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -63.68 -39.85 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 1.025 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -55.05 161.69 1.59 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.451 -0.78 . . . . 0.0 109.754 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' B' ' 251' ' ' LEU . 12.3 mt-10 56.14 158.68 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.408 ' C ' HD22 ' B' ' 254' ' ' LEU . 21.8 Cg_endo -63.07 131.64 33.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 111.618 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.639 HD11 ' O ' ' B' ' 249' ' ' ALA . 3.7 mm? -94.0 170.26 9.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.294 -0.879 . . . . 0.0 109.827 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 142.28 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.448 ' OE2' ' NE ' ' B' ' 219' ' ' ARG . 50.4 mt-10 46.9 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 255' ' ' GLY . 96.8 mt-10 -47.21 -21.23 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.171 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -47.92 151.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -46.35 136.23 7.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.57 -62.81 0.16 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.07 80.7 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 18.6 p-10 -52.34 -44.96 65.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -1.125 . . . . 0.0 108.254 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 263' ' ' GLN . . . . . 0.476 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.1 mt-30 -63.71 -48.78 75.71 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -61.6 -35.5 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 109.08 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.525 HG23 ' CD2' ' B' ' 245' ' ' HIS . 1.9 mt -63.21 -52.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.617 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -67.42 -50.09 60.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.493 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.577 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 44.4 tp10 -43.74 -58.19 2.83 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 110.032 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -39.16 93.54 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.0 109.382 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.659 ' CG ' ' OH ' ' B' ' 213' ' ' TYR . 9.0 t0 -58.55 -48.14 81.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -0.867 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -64.5 -45.3 87.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 109.797 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -65.34 -51.92 57.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 109.678 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.444 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.18 -45.7 90.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.938 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 42.3 tp -50.37 -37.23 36.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.405 ' HA ' HD11 ' B' ' 300' ' ' LEU . 32.3 mt-30 -73.74 -28.06 61.5 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.423 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' B' ' 272' ' ' TRP . 38.1 mt-30 -87.93 -0.58 57.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.999 -1.063 . . . . 0.0 109.707 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.99 131.62 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.205 -0.934 . . . . 0.0 112.4 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' B' ' 211' ' ' SER . 64.0 m-20 -85.65 -31.63 22.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 97.1 t -134.51 143.8 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' B' ' 213' ' ' TYR . 88.9 t -138.76 130.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.69 -1.256 . . . . 0.0 111.849 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 280' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' B' ' 305' ' ' LEU . 91.4 t -136.47 130.54 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -116.26 136.84 52.65 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.669 -1.269 . . . . 0.0 110.268 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.432 ' OE2' ' CD2' ' B' ' 227' ' ' LEU . 52.7 tt0 -84.32 139.59 32.19 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.589 -0.694 . . . . 0.0 109.273 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.623 HG13 HG11 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -144.13 147.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 15.2 m -173.47 -68.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.46 ' NE2' ' OD2' ' B' ' 224' ' ' ASP . 24.7 pt20 -98.38 153.86 37.84 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.12 144.04 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.131 1.888 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.508 ' HB3' HG23 ' B' ' 290' ' ' VAL . 3.5 m -163.72 123.7 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.48 ' HG ' ' H ' ' A' ' 87' ' ' SER . 4.0 mt -76.8 -45.16 29.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 217' ' ' SER . . . -60.43 -42.75 99.1 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.623 HG11 HG13 ' B' ' 283' ' ' VAL . 41.2 t -64.07 -45.57 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -1.201 . . . . 0.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.03 93.11 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 119' ' ' MET . 81.7 t80 -66.17 -47.97 72.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 109.557 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.408 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 11.6 mm-40 -59.87 -37.12 78.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.5 mt -75.25 -41.65 56.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.033 -1.042 . . . . 0.0 109.212 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.93 60.2 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -39.66 82.4 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.395 -1.062 . . . . 0.0 108.596 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.484 ' O ' HD11 ' B' ' 304' ' ' ILE . . . -68.45 -37.22 80.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.921 -1.111 . . . . 0.0 108.626 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -52.66 -45.51 48.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.889 -1.132 . . . . 0.0 108.226 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -89.27 -52.76 4.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.236 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.774 ' C ' HD13 ' B' ' 300' ' ' LEU . 1.7 tm? -90.46 -29.84 17.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.026 -1.047 . . . . 0.0 109.593 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' B' ' 297' ' ' ALA . . . -73.51 166.4 54.63 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 108.308 -1.917 . . . . 0.0 108.308 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.508 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 4.8 mtmm -124.54 -71.25 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 84.7 Cg_endo -79.4 110.86 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.884 1.723 . . . . 0.0 109.398 176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.484 HD11 ' O ' ' B' ' 297' ' ' ALA . 16.6 mt -128.98 116.35 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.699 -1.25 . . . . 0.0 112.103 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.659 ' HB3' HG22 ' B' ' 280' ' ' VAL . 57.8 tp -110.88 126.06 54.29 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 145.92 38.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.97 -1.081 . . . . 0.0 108.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.585 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 8.1 mt -122.98 135.6 54.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.229 -0.919 . . . . 0.0 111.643 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -133.45 138.35 46.15 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.45 ' NE ' ' NE2' ' B' ' 311' ' ' GLN . 4.3 mtm180 -99.36 134.82 20.96 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 0.0 111.307 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.33 -26.27 4.23 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.531 2.154 . . . . 0.0 111.31 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.45 ' NE2' ' NE ' ' B' ' 309' ' ' ARG . 7.3 pt20 -46.37 -38.76 9.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 28.7 t -102.04 -15.77 16.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.89 51.14 2.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.3 mtp85 -80.63 17.33 1.15 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.978 -1.307 . . . . 0.0 109.048 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.0 t 47.67 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.688 0.756 . . . . 0.0 110.128 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.557 HD11 HG11 ' B' ' 283' ' ' VAL . 47.8 tp -47.44 145.6 2.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.569 -0.707 . . . . 0.0 109.519 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.4 m -45.7 142.98 2.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.892 . . . . 0.0 110.195 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.37 69.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -0.759 . . . . 0.0 109.607 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.443 ' SD ' ' CD ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -70.33 -52.03 25.7 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.911 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.401 ' CG2' HD21 ' B' ' 316' ' ' LEU . 35.9 mm -62.43 -42.28 95.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.61 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 18.0 tpt85 -65.33 -48.94 71.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.143 -0.973 . . . . 0.0 109.484 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.657 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.41 -31.36 79.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' B' ' 329' ' ' PHE . . . -62.19 -15.76 48.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.036 -1.273 . . . . 0.0 108.111 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -44.24 96.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 66.7 m-20 -105.17 -22.41 13.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 108.696 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 65.51 30.14 76.81 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.637 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.2 p -134.7 59.57 1.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' B' ' 327' ' ' SER . 95.1 mtt180 98.89 -31.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' B' ' 323' ' ' ALA . 88.5 t80 -97.37 119.73 36.44 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.406 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 82.0 mt-30 -145.71 142.11 28.68 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.901 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 30.4 t -107.85 100.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.502 ' CG ' HD11 ' B' ' 305' ' ' LEU . 21.4 m0 -95.34 152.62 18.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.248 -0.908 . . . . 0.0 109.578 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -97.23 155.65 16.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 108.822 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.585 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 6.2 p90 -170.28 -179.12 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.761 -1.212 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.59 149.61 27.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 335' ' ' ALA . 49.5 mt-10 -42.56 -29.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.707 -1.245 . . . . 0.0 110.18 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.33 -6.02 87.75 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.624 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -145.02 11.33 1.36 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.504 . . . . 0.0 110.6 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 5.0 p -54.3 -45.25 68.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.896 -1.128 . . . . 0.0 108.55 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 49.4 mt-10 -57.77 -32.76 67.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.498 -0.751 . . . . 0.0 109.203 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.7 m -68.33 -45.42 72.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.88 -51.21 58.44 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.12 -34.37 77.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.816 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.92 -41.43 95.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -68.75 -48.87 62.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.778 -1.201 . . . . 0.0 108.265 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.27 -48.1 83.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.856 . . . . 0.0 110.139 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.7 m-85 -69.85 -32.87 71.49 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.952 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 350' ' ' TYR . 26.4 mm-40 -62.27 -32.67 73.42 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -81.9 10.82 5.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.3 t80 -134.4 -105.14 0.23 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.236 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' B' ' 350' ' ' TYR . 15.0 mt -34.22 92.17 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 111.182 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' B' ' 350' ' ' TYR . 88.6 Cg_endo -94.9 -61.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 123.103 2.536 . . . . 0.0 111.074 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 353' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' B' ' 352' ' ' PRO . 92.4 mm-40 -107.19 -24.01 12.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -56.66 -30.51 63.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 108.952 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' THR . . . . . 0.596 HG23 ' N ' ' B' ' 356' ' ' ALA . 12.0 t -57.01 -45.36 83.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 356' ' ' ALA . . . . . 0.596 ' N ' HG23 ' B' ' 355' ' ' THR . . . -168.1 148.32 4.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 23.5 t -150.39 118.37 6.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.417 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 50.5 m -73.58 -31.48 63.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 84.7 p -95.66 151.23 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.526 ' N ' ' ND1' ' B' ' 360' ' ' HIS . 5.9 p-80 -138.79 76.76 34.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.897 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.69 152.71 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.554 2.169 . . . . 0.0 111.917 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 20.4 m -55.45 148.64 14.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.543 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.295 0.569 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 141.33 39.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 5' ' ' GLY . . . -66.12 -31.26 72.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.605 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 m 49.54 17.57 0.24 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 3' ' ' ALA . . . -52.89 -39.1 55.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -60.81 135.37 57.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -1.086 . . . . 0.0 109.354 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.0 -55.84 11.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -137.81 153.78 74.12 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.683 . . . . 0.0 109.263 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.8 Cg_exo -55.38 -154.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.386 2.057 . . . . 0.0 111.424 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 32.0 p -111.91 172.74 6.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 18.4 t -114.86 155.44 26.81 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 108.704 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 2.7 t -130.45 126.92 61.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.67 ' HB3' HG13 ' A' ' 79' ' ' VAL . 32.9 t80 -93.99 127.46 39.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 32' ' ' VAL . 17.8 t80 -100.81 130.7 46.87 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.787 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' GLU . 5.5 t -134.0 128.79 35.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.99 -178.96 33.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -76.02 118.7 19.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -1.192 . . . . 0.0 108.634 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER -131.7 97.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -88.57 -87.99 0.15 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.29 36.38 2.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.07 137.33 6.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.696 ' H ' ' CB ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -172.21 -164.08 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.83 -1.394 . . . . 0.0 111.235 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 49.4 mp0 -60.62 -53.28 59.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 108.934 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -55.31 -29.36 58.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.696 ' CB ' ' H ' ' A' ' 22' ' ' ARG . 35.6 tp60 -64.34 -43.06 95.78 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -49.08 68.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 -34.22 67.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.2 m-30 -69.17 -41.32 77.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.983 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.0 84.69 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 109.11 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.56 -56.78 5.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.841 -1.162 . . . . 0.0 108.613 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -54.08 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 28' ' ' TYR . 45.5 t -65.27 -28.73 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.8 m -67.08 -40.47 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.593 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 -69.59 -47.26 64.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.806 -1.183 . . . . 0.0 109.113 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 12' ' ' VAL . 13.8 mt -60.71 -40.62 92.97 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.428 ' HA ' HG23 ' A' ' 41' ' ' VAL . 67.2 ttt-85 -62.57 -25.29 68.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.688 -0.632 . . . . 0.0 109.42 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -78.03 -37.58 46.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.576 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.0 m-85 -67.83 -45.73 73.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 110.534 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -152.63 -152.48 5.98 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -90.08 120.39 31.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -1.167 . . . . 0.0 109.388 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG11 HG13 ' A' ' 32' ' ' VAL . 3.7 t -89.61 115.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 15.9 mt -79.44 172.35 13.92 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.498 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 45' ' ' HIS . 4.7 m 54.23 41.86 31.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.257 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.32 -12.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 108.778 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 65' ' ' ILE . 47.4 t-80 -52.98 -45.57 67.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.387 -0.821 . . . . 0.0 109.614 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 69.2 t -39.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 50' ' ' GLU . . . -50.05 -42.53 49.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 108.903 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.859 ' O ' HD21 ' A' ' 51' ' ' LEU . 26.2 t70 -81.14 24.49 0.52 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -105.95 33.41 3.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.62 -21.33 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.938 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.08 163.62 20.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.499 -0.751 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 51' ' ' LEU . 14.6 mt-10 54.58 157.85 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' LEU . 23.2 Cg_endo -62.98 71.07 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.425 2.083 . . . . 0.0 111.475 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -54.97 -169.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 116.69 129.96 4.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 63.6 mt-10 -50.24 -33.69 20.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.248 . . . . 0.0 108.629 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -69.58 -24.07 63.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -62.09 150.02 39.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.88 11.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.908 . . . . 0.0 109.404 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -52.97 -30.88 38.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.56 76.8 1.18 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 56' ' ' GLU . 3.1 m-20 -52.96 -44.83 67.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.359 -1.083 . . . . 0.0 108.539 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -62.31 -45.5 92.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -55.45 -36.61 66.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 108.612 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.658 HD11 ' CE1' ' A' ' 45' ' ' HIS . 3.2 mt -67.61 -35.62 73.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.0 t-80 -79.4 -62.91 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 66' ' ' HIS . 72.2 mt-10 -43.58 -48.02 7.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.899 -1.126 . . . . 0.0 109.71 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -69.25 -42.75 75.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.115 -0.99 . . . . 0.0 109.371 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.522 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 1.2 m-20 -59.56 -47.06 87.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 110.307 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 1.5 mm? -65.21 -46.58 80.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.322 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 33.0 t-20 -61.86 -54.52 41.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.18 -34.78 75.61 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.208 -0.933 . . . . 0.0 109.236 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 39.5 tp -57.09 -41.56 79.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.122 -0.986 . . . . 0.0 108.754 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -76.9 -22.83 52.79 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.36 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 44.9 mt-30 -84.27 -9.09 58.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.108 . . . . 0.0 108.829 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 132.36 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.354 -0.841 . . . . 0.0 112.082 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 11' ' ' SER . 12.4 m-20 -86.95 -27.66 23.17 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 74.7 t -139.23 137.4 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.67 HG13 ' HB3' ' A' ' 13' ' ' TYR . 63.5 t -126.91 141.49 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.739 -1.226 . . . . 0.0 111.085 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 t -138.86 122.37 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.549 0.69 . . . . 0.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.61 128.76 53.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 110.044 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' HG11 ' A' ' 90' ' ' VAL . 46.5 mt-10 -87.71 125.91 34.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 108.549 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.602 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -115.74 27.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.428 -0.795 . . . . 0.0 109.747 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.5 ' C ' ' CZ ' ' A' ' 114' ' ' ARG . 4.3 m -78.39 23.97 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.903 . . . . 0.0 108.851 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.567 ' N ' ' CZ ' ' A' ' 114' ' ' ARG . 5.0 tp-100 -166.32 118.91 0.82 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.978 . . . . 0.0 109.373 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.67 ' N ' HH21 ' A' ' 114' ' ' ARG . 76.8 Cg_exo -45.44 108.75 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.061 1.841 . . . . 0.0 111.946 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 m -142.36 131.03 22.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.839 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD11 HH22 ' B' ' 314' ' ' ARG . 74.1 mt -68.66 -39.07 80.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -62.38 -45.03 96.78 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 82' ' ' GLU . 18.4 t -64.81 -48.61 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -1.034 . . . . 0.0 108.787 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.73 98.03 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.419 ' HB2' HD11 ' B' ' 320' ' ' ILE . 75.7 t80 -64.78 -49.15 71.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.457 -1.025 . . . . 0.0 109.756 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 6.2 tp10 -59.65 -32.02 70.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 81' ' ' ALA . 62.7 mt -70.78 -43.77 68.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.684 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -45.55 80.74 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -44.69 96.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.967 . . . . 0.0 108.748 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.39 -36.16 82.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.136 -0.978 . . . . 0.0 108.522 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -54.41 -44.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.877 -1.139 . . . . 0.0 108.071 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -86.67 -52.89 5.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.699 -0.626 . . . . 0.0 111.908 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.739 ' C ' HD13 ' A' ' 100' ' ' LEU . 2.2 tm? -92.34 -31.85 15.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.048 -1.033 . . . . 0.0 109.948 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -69.74 174.65 35.62 Favored Glycine 0 C--N 1.281 -2.507 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.754 ' H ' ' CD ' ' A' ' 103' ' ' PRO . 22.1 mttt -136.55 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 102' ' ' LYS . 59.3 Cg_endo -98.84 109.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 123.748 2.965 . . . . 0.0 109.684 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.425 HG21 ' CD2' ' A' ' 129' ' ' PHE . 37.8 mt -127.21 124.35 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.839 -1.163 . . . . 0.0 112.027 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.2 tp -123.52 116.08 22.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.448 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 1.5 m -105.94 147.2 29.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.867 -1.145 . . . . 0.0 108.894 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 mt -120.26 139.12 53.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.193 -0.942 . . . . 0.0 111.068 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -146.02 122.96 11.35 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 16.8 mtt180 -88.07 140.0 30.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.719 -1.238 . . . . 0.0 110.481 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.66 -29.03 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.415 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.31 -32.9 5.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -99.17 -26.36 14.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.496 -0.752 . . . . 0.0 109.114 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.49 49.49 32.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.67 HH21 ' N ' ' A' ' 86' ' ' PRO . 10.4 mtp-105 -75.11 -11.41 60.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.035 -1.274 . . . . 0.0 111.205 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 114' ' ' ARG . 38.8 t 59.46 119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 116' ' ' LEU . 2.4 mt -77.34 158.64 30.03 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.84 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.454 ' OG ' ' CA ' ' B' ' 289' ' ' GLY . 0.3 OUTLIER -54.13 145.15 17.79 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.768 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.63 -19.09 5.37 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 108.696 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.496 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 1.0 OUTLIER -77.9 -45.18 24.86 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.399 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' B' ' 292' ' ' TYR . 42.5 mm -66.71 -48.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.2 -0.938 . . . . 0.0 108.575 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.443 ' CZ ' HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -68.4 -44.68 74.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.247 -0.908 . . . . 0.0 108.81 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -64.15 -28.23 72.61 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -40.68 -64.65 0.5 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.553 -0.969 . . . . 0.0 110.273 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -150.94 -95.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.204 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 15.0 p-10 111.54 5.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.53 70.77 0.02 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.836 ' C ' ' H ' ' A' ' 129' ' ' PHE . 37.5 p -164.15 66.34 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 66.43 -20.3 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.836 ' H ' ' C ' ' A' ' 127' ' ' SER . 9.3 t80 -117.77 118.76 32.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.601 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 31.3 tt0 -137.19 134.28 36.11 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.205 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 121' ' ' ARG . 69.5 t -91.85 105.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.601 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 13.7 m0 -102.14 142.35 33.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.171 -0.955 . . . . 0.0 109.724 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 54.0 m-20 -97.79 157.17 16.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.062 -1.024 . . . . 0.0 108.947 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' OH ' ' NE ' ' A' ' 109' ' ' ARG . 10.0 p90 -165.29 -172.72 2.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.591 -1.318 . . . . 0.0 111.936 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -159.27 148.37 18.34 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.4 mt-10 -42.93 -37.12 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.76 -1.213 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.92 2.86 53.71 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.207 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.97 7.14 0.52 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.58 -1.541 . . . . 0.0 110.601 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.8 p -53.99 -45.36 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.97 -1.081 . . . . 0.0 108.53 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 44.6 mt-10 -57.07 -33.67 67.5 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 83.9 m -68.19 -45.07 74.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.707 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.437 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.4 tpp -51.63 -48.13 63.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.76 -35.06 74.61 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 77.8 m-20 -65.59 -39.66 91.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 110.315 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -69.65 -50.29 45.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.818 -1.176 . . . . 0.0 108.315 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.92 -46.98 87.61 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.958 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 151' ' ' LEU . 12.2 m-85 -68.96 -34.05 74.71 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.136 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.03 -23.9 66.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.34 59.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.675 -0.641 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -156.04 -48.86 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.221 -1.55 . . . . 0.0 112.715 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.721 HD12 ' CD1' ' A' ' 147' ' ' PHE . 4.1 mt -38.32 -57.93 1.67 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.916 -1.115 . . . . 0.0 111.562 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 12.0 Cg_endo -59.67 -26.25 81.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.763 1.642 . . . . 0.0 111.741 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -81.75 -15.01 55.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.252 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -56.1 -31.79 63.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.1 t -65.24 -36.41 84.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.48 72.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.2 m -57.52 152.46 14.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.344 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.0 t -153.58 160.03 42.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.7 m -64.45 150.82 45.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.324 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -67.75 150.98 97.56 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.37 -22.96 51.84 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.55 2.167 . . . . 0.0 111.912 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.5 t -97.71 146.8 25.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.331 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.595 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.244 0.545 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.96 141.11 39.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.899 . . . . 0.0 109.393 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' B' ' 205' ' ' GLY . . . -66.07 -30.63 71.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 32.8 m 48.77 17.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 203' ' ' ALA . . . -52.85 -39.0 55.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -60.54 135.51 57.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -1.113 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -68.05 -55.7 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . -137.93 153.88 73.98 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ALA . 31.7 Cg_exo -55.52 -154.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.276 1.984 . . . . 0.0 111.377 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.6 p -112.21 172.75 6.72 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 19.4 t -114.97 155.35 27.08 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.756 -1.215 . . . . 0.0 108.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 2.6 t -130.49 127.1 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' B' ' 279' ' ' VAL . 33.5 t80 -93.8 127.6 39.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.632 ' CD2' HG22 ' B' ' 232' ' ' VAL . 17.9 t80 -100.86 130.7 46.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.81 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' B' ' 293' ' ' GLU . 5.7 t -134.04 129.08 35.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.532 -0.73 . . . . 0.0 109.415 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -159.36 -178.85 33.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.7 p -76.11 118.06 18.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 0.0 108.757 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.457 HG23 ' OE1' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -131.23 98.05 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.274 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -88.52 -87.85 0.16 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -128.6 36.37 2.46 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.12 136.87 5.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.683 ' H ' ' CB ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -171.96 -164.22 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.813 -1.404 . . . . 0.0 111.319 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 49.0 mp0 -60.5 -53.14 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 108.983 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.48 -29.01 57.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.683 ' CB ' ' H ' ' B' ' 222' ' ' ARG . 36.1 tp60 -64.68 -43.15 94.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.44 -0.787 . . . . 0.0 109.21 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -34.09 67.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.635 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.4 m-30 -69.28 -41.32 76.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.182 -0.949 . . . . 0.0 110.037 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.26 85.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.59 -1.319 . . . . 0.0 109.161 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -70.37 -56.67 6.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.834 -1.166 . . . . 0.0 108.654 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 83.0 mt -54.09 -41.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.7 t -65.16 -28.63 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.761 . . . . 0.0 109.103 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.1 m -67.31 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -69.7 -47.87 61.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.891 -1.131 . . . . 0.0 109.078 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.56 HD22 HG11 ' B' ' 212' ' ' VAL . 13.1 mt -60.1 -40.77 90.79 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.431 ' HA ' HG23 ' B' ' 241' ' ' VAL . 64.7 ttt-85 -62.29 -25.45 67.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.695 -0.628 . . . . 0.0 109.458 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -78.0 -37.69 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.975 . . . . 0.0 109.535 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.573 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.0 m-85 -67.71 -45.51 74.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.591 -0.693 . . . . 0.0 110.541 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.86 -152.53 6.02 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -90.24 120.63 31.56 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.365 -1.079 . . . . 0.0 109.389 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.632 HG11 HG13 ' B' ' 232' ' ' VAL . 3.6 t -89.81 116.21 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.473 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 15.7 mt -79.81 172.15 14.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.082 -1.012 . . . . 0.0 109.491 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.495 ' C ' ' N ' ' B' ' 245' ' ' HIS . 4.5 m 54.38 41.92 31.7 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.36 -0.837 . . . . 0.0 109.322 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -50.64 -12.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 108.766 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.646 ' CE1' HD11 ' B' ' 265' ' ' ILE . 46.7 t-80 -53.59 -45.14 69.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.5 -0.75 . . . . 0.0 109.426 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 249' ' ' ALA . 68.9 t -39.87 -79.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.622 -0.674 . . . . 0.0 109.992 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' B' ' 250' ' ' GLU . . . -49.69 -42.6 46.12 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.237 -0.915 . . . . 0.0 108.908 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.86 ' O ' HD21 ' B' ' 251' ' ' LEU . 24.3 t70 -80.82 24.22 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 246' ' ' VAL . . . -105.73 33.61 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' B' ' 247' ' ' ALA . 0.1 OUTLIER -123.5 -22.12 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.932 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -82.62 163.09 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.459 -0.776 . . . . 0.0 109.564 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' B' ' 251' ' ' LEU . 14.9 mt-10 54.82 157.75 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 109.88 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 254' ' ' LEU . 22.6 Cg_endo -62.74 71.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.441 2.094 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.796 HD23 ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER -55.66 -169.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.902 . . . . 0.0 109.454 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 117.5 129.97 4.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' B' ' 262' ' ' ASP . 61.6 mt-10 -50.1 -33.8 19.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.088 -1.242 . . . . 0.0 108.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -69.52 -24.55 63.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -61.56 150.04 37.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.488 -0.758 . . . . 0.0 109.351 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.73 11.1 0.15 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -52.68 -31.26 37.29 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.68 77.27 1.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' B' ' 256' ' ' GLU . 2.7 m-20 -52.89 -44.94 67.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -1.111 . . . . 0.0 108.589 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -62.04 -46.0 91.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.26 -37.12 66.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.961 . . . . 0.0 108.557 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.646 HD11 ' CE1' ' B' ' 245' ' ' HIS . 3.3 mt -67.26 -35.25 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' B' ' 267' ' ' GLU . 4.1 t-80 -79.69 -63.35 1.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 109.859 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' B' ' 266' ' ' HIS . 72.7 mt-10 -42.94 -48.44 5.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.67 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -69.03 -42.57 76.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.472 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.535 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 1.2 m-20 -59.85 -46.89 87.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' B' ' 270' ' ' LEU . 1.6 mm? -65.17 -46.83 79.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 110.424 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 32.9 t-20 -61.77 -54.52 41.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.138 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.473 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -61.15 -34.99 75.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.151 -0.968 . . . . 0.0 109.077 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 38.2 tp -56.89 -41.08 77.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.0 108.822 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -77.48 -22.53 51.15 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 44.1 mt-30 -84.55 -8.78 58.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.14 . . . . 0.0 108.884 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.88 132.39 45.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.402 -0.811 . . . . 0.0 112.131 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' B' ' 211' ' ' SER . 9.7 m-20 -86.63 -27.88 23.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 63.6 t -139.33 137.94 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' B' ' 213' ' ' TYR . 64.8 t -127.14 141.54 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.852 -1.155 . . . . 0.0 111.131 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 18.3 t -138.71 121.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.514 -0.741 . . . . 0.0 109.306 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.02 128.98 54.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.005 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.508 ' O ' HG11 ' B' ' 290' ' ' VAL . 46.3 mt-10 -88.08 125.52 34.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.59 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -115.28 27.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 109.658 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.492 ' C ' ' CZ ' ' B' ' 314' ' ' ARG . 4.1 m -78.42 24.51 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 108.91 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.574 ' N ' ' CZ ' ' B' ' 314' ' ' ARG . 4.9 tp-100 -166.65 118.5 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.658 ' N ' HH21 ' B' ' 314' ' ' ARG . 74.4 Cg_exo -45.31 109.13 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.011 1.807 . . . . 0.0 111.898 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 29.4 m -142.34 131.23 22.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 70.7 mt -69.21 -38.31 78.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' GLY . . . . . 0.454 ' CA ' ' OG ' ' A' ' 117' ' ' SER . . . -63.08 -44.98 96.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.508 HG11 ' O ' ' B' ' 282' ' ' GLU . 17.4 t -64.74 -48.7 83.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -1.036 . . . . 0.0 108.703 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -62.02 -39.57 97.76 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.414 ' HB2' HD11 ' A' ' 120' ' ' ILE . 74.7 t80 -65.08 -49.13 71.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -1.036 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.525 ' CB ' ' SG ' ' B' ' 215' ' ' CYS . 6.8 tp10 -59.55 -32.08 70.0 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' B' ' 281' ' ' ALA . 61.0 mt -70.72 -43.86 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 108.691 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.27 81.48 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -43.96 97.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.597 -0.943 . . . . 0.0 108.8 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -67.16 -36.14 81.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.137 -0.977 . . . . 0.0 108.429 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.477 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.7 OUTLIER -54.31 -44.53 66.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -86.76 -52.95 5.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.914 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.747 ' C ' HD13 ' B' ' 300' ' ' LEU . 2.2 tm? -92.13 -31.84 15.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 109.93 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -69.75 174.55 35.85 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.758 ' H ' ' CD ' ' B' ' 303' ' ' PRO . 22.6 mttt -136.59 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.758 ' CD ' ' H ' ' B' ' 302' ' ' LYS . 58.7 Cg_endo -98.83 109.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 123.703 2.935 . . . . 0.0 109.704 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' B' ' 329' ' ' PHE . 37.7 mt -127.53 124.39 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.8 -1.188 . . . . 0.0 112.087 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 25.3 tp -123.73 115.97 22.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' CYS . . . . . 0.454 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 1.5 m -105.4 147.36 28.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 108.88 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.494 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.1 mt -120.47 138.97 53.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.088 -1.008 . . . . 0.0 110.997 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' B' ' 333' ' ' ASP . 0.6 OUTLIER -145.89 122.99 11.45 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.572 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 15.7 mtt180 -88.25 140.3 30.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.726 -1.234 . . . . 0.0 110.378 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.78 -28.79 6.05 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.631 2.221 . . . . 0.0 111.623 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -47.56 -32.69 5.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 20.6 t -99.31 -26.28 14.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.064 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 49.33 49.62 31.26 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.658 HH21 ' N ' ' B' ' 286' ' ' PRO . 10.3 mtp-105 -75.1 -11.36 60.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.303 . . . . 0.0 111.218 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' B' ' 314' ' ' ARG . 38.4 t 59.6 119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.54 HD23 ' N ' ' B' ' 316' ' ' LEU . 2.4 mt -77.36 158.29 30.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.646 -1.221 . . . . 0.0 108.822 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 0.4 OUTLIER -53.78 145.27 16.2 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.712 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.74 -19.04 5.46 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.269 -0.895 . . . . 0.0 108.729 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.492 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -77.99 -45.41 23.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.337 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 92' ' ' TYR . 40.1 mm -66.26 -48.61 80.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.615 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.446 ' CZ ' HG11 ' B' ' 331' ' ' VAL . 0.1 OUTLIER -68.55 -44.19 75.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.935 . . . . 0.0 108.748 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -64.11 -29.0 73.69 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -40.14 -65.21 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.555 -0.968 . . . . 0.0 110.314 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -150.78 -95.18 0.06 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.233 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 15.0 p-10 111.47 4.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 161.46 70.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.823 ' C ' ' H ' ' B' ' 329' ' ' PHE . 32.8 p -164.31 66.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 66.33 -20.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.823 ' H ' ' C ' ' B' ' 327' ' ' SER . 8.8 t80 -117.53 118.9 33.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 31.7 tt0 -137.22 134.1 35.87 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.209 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 331' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' B' ' 321' ' ' ARG . 72.8 t -91.67 106.01 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 13.7 m0 -102.14 142.31 33.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.115 -0.991 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' B' ' 308' ' ' PHE . 53.9 m-20 -97.77 157.27 16.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.937 -1.102 . . . . 0.0 108.921 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.572 ' OH ' ' NE ' ' B' ' 309' ' ' ARG . 10.2 p90 -165.0 -171.88 2.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.629 -1.294 . . . . 0.0 111.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.461 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -159.97 148.31 17.11 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.4 mt-10 -42.85 -37.13 1.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.724 -1.235 . . . . 0.0 110.234 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.13 3.35 52.6 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -151.62 7.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.537 -1.566 . . . . 0.0 110.559 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.52 HG13 ' N ' ' B' ' 340' ' ' GLU . 6.2 p -53.97 -45.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 108.556 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.52 ' N ' HG13 ' B' ' 339' ' ' VAL . 42.5 mt-10 -57.14 -34.14 68.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.3 m -67.45 -45.51 75.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.147 -0.971 . . . . 0.0 109.658 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.423 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.4 tpp -51.42 -48.06 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 46.6 mt -69.65 -35.02 74.81 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.72 -39.43 91.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.927 -1.108 . . . . 0.0 110.294 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -70.05 -50.1 44.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.937 -1.102 . . . . 0.0 108.243 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.94 -47.3 86.35 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.017 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.719 ' CD1' HD12 ' B' ' 351' ' ' LEU . 12.5 m-85 -68.76 -33.83 74.57 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.149 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.59 -9.92 58.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.785 -0.572 . . . . 0.0 111.428 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -156.31 -48.88 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.161 -1.587 . . . . 0.0 112.643 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.719 HD12 ' CD1' ' B' ' 347' ' ' PHE . 4.0 mt -38.62 -57.85 1.81 Allowed Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.961 -1.087 . . . . 0.0 111.526 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 12.1 Cg_endo -59.77 -25.8 80.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.826 1.684 . . . . 0.0 111.703 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -82.21 -14.95 54.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.344 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -56.17 -31.79 63.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.439 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 8.1 t -65.02 -36.02 83.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.86 73.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 46.8 m -57.36 152.33 14.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 8.6 t -153.37 160.05 42.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 109.513 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 43.0 m -64.18 151.18 44.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.223 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -68.51 150.76 97.57 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.95 . . . . 0.0 109.387 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.09 -22.04 55.17 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.56 2.173 . . . . 0.0 111.84 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 8.8 t -99.31 152.17 20.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.404 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.7 157.16 36.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.82 154.29 39.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m -55.18 -34.64 64.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.82 51.69 28.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -81.07 140.75 34.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.8 -56.65 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.567 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.52 151.86 91.71 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.52 -152.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.318 2.012 . . . . 0.0 111.444 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.6 p -109.97 -179.69 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 20.5 p -120.03 158.24 27.22 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG11 HD22 ' A' ' 35' ' ' LEU . 2.2 t -136.67 137.1 47.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.849 0.833 . . . . 0.0 109.565 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 6.8 t80 -123.14 101.28 7.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.539 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -94.49 127.71 40.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.341 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 12.0 m -85.36 149.75 25.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -156.44 165.17 32.82 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.499 ' CB ' ' OG ' ' A' ' 87' ' ' SER . 6.1 t -91.8 130.05 37.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -124.38 -1.21 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.629 HH12 ' H ' ' A' ' 55' ' ' GLY . 26.8 mmt180 -119.97 15.64 12.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.354 -0.841 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.22 2.73 6.25 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.28 -179.52 40.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -130.32 -23.07 2.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.44 -1.036 . . . . 0.0 109.326 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -53.83 -39.8 65.89 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.6 m-20 -64.91 -27.02 68.57 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.686 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 8.9 tp60 -64.88 -41.88 95.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.08 63.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -26.98 68.45 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 108.765 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.661 ' O ' HG23 ' A' ' 32' ' ' VAL . 12.6 m-30 -68.49 -46.75 68.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.01 74.75 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.357 -1.337 . . . . 0.0 107.924 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 33' ' ' SER . 57.4 ttt180 -71.97 -58.39 3.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.93 -1.106 . . . . 0.0 108.671 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 32' ' ' VAL . 6.0 tt -52.37 -40.3 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 28' ' ' TYR . 44.5 t -64.31 -29.54 47.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 30' ' ' ARG . 19.4 p -67.78 -39.85 84.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.743 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -71.7 -49.29 40.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.702 -1.249 . . . . 0.0 108.591 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.735 HD22 HG11 ' A' ' 12' ' ' VAL . 10.4 mt -56.63 -39.46 73.7 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -65.8 -23.63 66.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -76.39 -36.77 57.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.988 -1.07 . . . . 0.0 108.988 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.574 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-30 -70.3 -48.53 56.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.5 -140.19 3.02 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -101.02 136.45 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG11 HG13 ' A' ' 32' ' ' VAL . 68.3 t -101.88 122.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 10.6 mt -84.2 -42.85 15.52 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.511 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.727 ' O ' HG23 ' A' ' 43' ' ' THR . 13.7 t -67.54 60.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 109.771 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' LEU . 83.7 mt-10 -82.83 -25.34 32.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.059 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.65 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 12.8 p-80 -53.19 -45.78 68.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.686 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -55.64 -60.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HG13 ' A' ' 46' ' ' VAL . . . -59.41 -31.93 69.72 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.826 -1.171 . . . . 0.0 108.973 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.639 ' C ' HD21 ' A' ' 51' ' ' LEU . 22.0 t70 -87.92 48.25 1.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.466 -0.771 . . . . 0.0 109.104 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB3' HE21 ' A' ' 25' ' ' GLN . . . -135.24 -16.03 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.43 -11.83 59.89 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.028 -1.045 . . . . 0.0 109.165 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.109 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.7 -43.95 72.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.172 -0.955 . . . . 0.0 108.686 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 3.3 tt0 -176.9 -48.47 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.538 -0.727 . . . . 0.0 109.422 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 15.4 Cg_exo -69.9 106.5 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.662 2.241 . . . . 0.0 111.56 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -148.06 110.51 4.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.352 -0.843 . . . . 0.0 109.369 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 130.26 42.05 0.22 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' H ' ' NH1' ' A' ' 19' ' ' ARG . 61.0 mt-10 53.58 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -1.038 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.0 tt0 -42.59 -33.11 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 108.915 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' PRO . . . -106.49 65.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.01 -40.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.66 54.6 0.77 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.41 76.56 1.14 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -51.25 -43.76 61.58 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.2 -44.66 83.85 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -58.34 -34.76 70.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.547 HG12 ' CD2' ' A' ' 45' ' ' HIS . 0.4 OUTLIER -68.17 -32.42 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.421 ' CE1' HD22 ' A' ' 70' ' ' LEU . 23.3 t-80 -78.19 -64.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 68' ' ' GLN . 19.2 pt-20 -50.12 -44.56 52.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 109.572 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 51.5 tt0 -66.48 -48.23 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.39 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD2' ' CE1' ' A' ' 45' ' ' HIS . 84.0 m-20 -70.85 -54.38 11.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.982 . . . . 0.0 110.985 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 66' ' ' HIS . 5.1 tp -56.58 -39.11 72.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 85.7 m-20 -63.68 -52.78 59.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.396 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.29 -41.21 83.9 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.468 -0.893 . . . . 0.0 108.731 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 11.8 tp -50.32 -41.38 51.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.41 -27.23 63.16 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.447 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 34.7 mt-30 -88.98 0.13 56.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.958 -1.089 . . . . 0.0 109.352 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.09 130.89 44.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.897 . . . . 0.0 111.862 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 11' ' ' SER . 38.8 t0 -80.6 -32.97 36.27 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.16 144.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.8 t -136.08 124.81 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 111.501 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 81' ' ' ALA . 24.0 t -117.98 176.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.626 ' H ' HG12 ' A' ' 80' ' ' VAL . . . -164.15 116.03 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.574 -1.329 . . . . 0.0 110.033 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -79.22 142.94 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -147.66 148.38 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.785 -179.416 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 2.7 m -171.82 -42.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -129.47 152.56 79.82 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD23 ' B' ' 288' ' ' LEU . 76.4 Cg_exo -36.36 147.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.604 2.202 . . . . 0.0 112.731 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.584 ' H ' ' CD2' ' B' ' 288' ' ' LEU . 12.9 t -175.34 123.0 0.22 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 110.484 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.685 HD12 HG13 ' B' ' 320' ' ' ILE . 2.2 mm? -71.32 -44.72 64.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.03 -36.69 75.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' A' ' 87' ' ' SER . 11.8 t -75.75 -49.09 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -1.032 . . . . 0.0 109.495 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' CA ' HD13 ' B' ' 288' ' ' LEU . . . -67.6 -37.97 89.87 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.846 -1.169 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -69.45 -52.19 29.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -1.186 . . . . 0.0 109.867 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' OE2' ' SD ' ' B' ' 319' ' ' MET . 95.1 mt-10 -63.22 -30.86 71.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.514 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.8 mt -69.79 -47.46 62.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.971 . . . . 0.0 109.249 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.15 -36.77 93.44 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -62.24 -41.76 98.7 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.556 -0.967 . . . . 0.0 109.366 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.2 -38.52 78.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.897 -1.127 . . . . 0.0 108.956 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.36 -40.65 32.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -82.21 -53.01 6.4 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.71 -9.23 2.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -0.999 . . . . 0.0 110.206 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 102' ' ' LYS . . . 54.5 94.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.979 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 104' ' ' ILE . 41.8 mttm -164.66 150.81 9.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 79' ' ' VAL . 82.4 Cg_exo -38.83 104.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.707 1.605 . . . . 0.0 111.332 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.2 mt -107.09 95.45 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.771 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.63 118.29 35.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 143.09 49.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -132.1 144.11 50.49 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.063 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.79 147.42 50.79 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 134' ' ' TYR . 12.3 mtt180 -99.31 142.32 24.4 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.237 . . . . 0.0 111.472 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' GLY . 89.1 Cg_endo -80.82 -31.24 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.855 2.37 . . . . 0.0 110.944 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -45.62 -38.57 6.76 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 21.8 p -95.69 -20.52 18.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.86 43.43 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' VAL . 61.0 mtt180 -79.37 13.03 2.09 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -1.114 . . . . 0.0 109.387 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 114' ' ' ARG . 75.8 t 49.57 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.408 -0.807 . . . . 0.0 110.157 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.505 HD11 HG11 ' A' ' 83' ' ' VAL . 24.2 tp -45.15 158.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.88 142.99 22.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 111.089 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.515 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -56.99 -50.68 71.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.73 -0.606 . . . . 0.0 110.339 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.51 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 19.5 mtp -65.89 -38.37 88.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.927 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.662 HG13 HD12 ' B' ' 288' ' ' LEU . 5.1 mm -66.34 -44.92 90.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.064 -1.023 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -74.46 -44.41 51.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.025 -1.047 . . . . 0.0 109.055 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.48 -22.33 61.26 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -45.77 -60.91 1.96 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.477 -1.013 . . . . 0.0 109.937 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -156.7 -88.18 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.147 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER 97.24 -1.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -179.92 85.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.777 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 162.08 74.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.475 -1.015 . . . . 0.0 109.595 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 67.04 -23.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.777 ' H ' ' C ' ' A' ' 127' ' ' SER . 12.8 t80 -123.28 118.89 28.6 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.23 138.3 43.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 111.214 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 84.7 t -101.95 99.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 21.0 m0 -93.76 148.68 21.9 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -93.75 147.71 22.79 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.5 p90 -168.02 174.31 7.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.363 -1.461 . . . . 0.0 112.133 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -140.6 147.28 39.14 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 135' ' ' ALA . 50.0 mt-10 -41.99 -30.3 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.932 -1.105 . . . . 0.0 110.581 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.25 1.46 88.78 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.999 -1.063 . . . . 0.0 110.752 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -135.82 -2.76 2.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.958 -1.319 . . . . 0.0 109.975 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 1.4 p -52.15 -45.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.013 -1.054 . . . . 0.0 108.161 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 27.6 mt-10 -52.67 -36.62 57.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -40.8 90.06 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.461 -0.775 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 11.4 mmt -55.67 -54.87 38.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 37.2 mt -59.71 -27.03 66.1 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.46 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 16.5 t70 -69.47 -46.86 65.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 0.0 111.111 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -73.81 -44.08 56.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.477 -1.389 . . . . 0.0 109.805 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 42.3 t80 -60.41 -46.53 89.69 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.764 ' CD1' HD12 ' A' ' 151' ' ' LEU . 11.4 m-85 -74.77 -34.4 62.45 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.349 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -68.93 -23.31 64.15 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.238 -1.538 . . . . 0.0 107.425 178.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.46 -10.46 55.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.623 -0.673 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.607 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -154.91 -47.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.419 -1.426 . . . . 0.0 112.16 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 147' ' ' PHE . 2.3 mt -41.52 -54.34 6.5 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.97 -1.081 . . . . 0.0 111.076 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -44.57 -12.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.986 1.791 . . . . 0.0 112.141 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 151' ' ' LEU . 50.5 tt0 -65.95 -63.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.488 ' HZ2' HD23 ' A' ' 151' ' ' LEU . 14.7 pttm -84.06 -18.0 38.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.149 -0.969 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 86.8 m -87.89 149.15 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 155' ' ' THR . . . 62.49 44.69 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 96.3 p -137.39 170.56 15.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.44 ' O ' ' CE1' ' A' ' 160' ' ' HIS . 12.8 t -69.49 131.9 45.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.6 p -80.67 154.38 27.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.472 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 158' ' ' SER . 20.9 m80 -131.03 74.33 79.93 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.96 153.77 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.86 2.373 . . . . 0.0 112.192 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.6 t -87.55 153.22 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.16 -0.962 . . . . 0.0 109.467 179.933 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.396 0.617 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.79 157.48 36.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.557 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.09 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 15.3 m -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.7 51.58 29.58 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -80.42 141.79 34.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -1.112 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -63.56 -57.41 10.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.91 151.82 93.02 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.444 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.27 -152.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 111.571 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 15.0 p -110.06 -179.75 3.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 17.2 p -120.1 157.73 28.36 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.734 HG11 HD22 ' B' ' 235' ' ' LEU . 2.2 t -136.18 137.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.782 0.801 . . . . 0.0 109.57 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 6.8 t80 -123.04 101.54 7.47 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.2 OUTLIER -94.82 127.41 40.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 109.163 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.433 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 12.4 m -85.13 148.82 25.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.002 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' B' ' 228' ' ' TYR . . . -155.19 164.95 32.14 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.781 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.503 ' CB ' ' OG ' ' B' ' 287' ' ' SER . 6.2 t -92.12 129.52 38.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.644 -0.915 . . . . 0.0 109.388 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -124.16 -0.53 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.655 HH12 ' H ' ' B' ' 255' ' ' GLY . 27.3 mmt180 -120.47 15.52 12.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -129.39 2.83 6.19 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 166.55 -179.97 40.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -130.52 -23.33 2.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.488 -1.007 . . . . 0.0 109.22 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -53.58 -39.84 65.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 75.4 m-20 -64.89 -27.15 68.66 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.7 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 9.2 tp60 -64.84 -41.34 95.79 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.99 63.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.97 -26.89 68.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 108.72 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.648 ' O ' HG23 ' B' ' 232' ' ' VAL . 12.7 m-30 -68.6 -46.72 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.667 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.97 -32.83 74.51 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.368 -1.333 . . . . 0.0 107.939 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' B' ' 233' ' ' SER . 57.6 ttt180 -72.09 -58.5 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.851 -1.155 . . . . 0.0 108.715 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' B' ' 232' ' ' VAL . 5.9 tt -52.15 -40.48 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.6 t -64.28 -29.43 47.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 20.1 p -67.76 -39.81 84.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -71.86 -49.13 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.786 -1.196 . . . . 0.0 108.601 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.734 HD22 HG11 ' B' ' 212' ' ' VAL . 9.9 mt -56.94 -39.37 74.4 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -65.64 -23.7 66.86 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -76.54 -37.17 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.948 -1.095 . . . . 0.0 108.932 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.591 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -69.87 -48.43 58.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.554 -0.716 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -153.32 -140.5 3.08 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -101.08 136.53 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -1.104 . . . . 0.0 109.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.642 HG11 HG13 ' B' ' 232' ' ' VAL . 62.1 t -101.9 122.8 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 10.7 mt -84.08 -42.66 15.86 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.478 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.749 ' O ' HG23 ' B' ' 243' ' ' THR . 13.8 t -67.36 60.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.845 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' B' ' 242' ' ' LEU . 82.7 mt-10 -82.58 -25.98 32.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.119 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.648 ' CG ' ' N ' ' B' ' 246' ' ' VAL . 12.8 p-80 -52.48 -45.69 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.7 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 0.2 OUTLIER -55.97 -60.15 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 109.546 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.471 ' H ' HG13 ' B' ' 246' ' ' VAL . . . -59.28 -31.63 69.28 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.91 -1.119 . . . . 0.0 108.915 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.647 ' C ' HD21 ' B' ' 251' ' ' LEU . 22.4 t70 -88.26 48.01 1.58 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.721 0.772 . . . . 0.0 109.244 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.561 ' HB3' HE21 ' B' ' 225' ' ' GLN . . . -134.89 -16.19 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' B' ' 250' ' ' GLU . 1.0 OUTLIER -77.4 -11.8 59.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.105 -0.997 . . . . 0.0 109.276 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 1.06 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -54.79 -43.13 72.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 108.651 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 3.3 tt0 -177.83 -48.28 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.326 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 16.0 Cg_exo -69.83 106.27 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.617 2.211 . . . . 0.0 111.661 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.463 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.3 OUTLIER -147.99 110.41 4.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.87 . . . . 0.0 109.494 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.655 ' H ' HH12 ' B' ' 219' ' ' ARG . . . 130.34 41.85 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.576 ' H ' ' NH1' ' B' ' 219' ' ' ARG . 64.8 mt-10 53.87 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.474 -1.015 . . . . 0.0 109.812 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.2 tt0 -43.14 -32.29 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 108.942 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' B' ' 253' ' ' PRO . . . -106.96 65.55 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -148.57 -40.51 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.098 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 105.46 53.95 0.76 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.96 76.46 1.11 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -51.02 -43.54 60.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.44 -44.37 84.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.55 -35.35 72.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.539 HG12 ' CD2' ' B' ' 245' ' ' HIS . 0.4 OUTLIER -67.57 -32.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.409 ' CE1' HD22 ' B' ' 270' ' ' LEU . 23.3 t-80 -78.06 -65.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' B' ' 268' ' ' GLN . 19.1 pt-20 -49.58 -44.34 46.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.995 -1.066 . . . . 0.0 109.689 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 268' ' ' GLN . . . . . 0.507 ' N ' ' CG ' ' B' ' 267' ' ' GLU . 51.7 tt0 -66.7 -48.59 68.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.516 ' OD2' ' CE1' ' B' ' 245' ' ' HIS . 85.3 m-20 -70.51 -54.16 13.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' B' ' 266' ' ' HIS . 5.2 tp -56.75 -39.28 73.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.982 . . . . 0.0 109.726 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 84.0 m-20 -63.45 -52.69 60.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -58.67 -41.14 85.44 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 108.728 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.535 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 11.7 tp -50.39 -41.24 51.72 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -71.42 -27.34 63.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.307 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 34.7 mt-30 -89.16 0.56 56.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.913 -1.117 . . . . 0.0 109.32 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.67 130.31 42.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.279 -0.888 . . . . 0.0 111.891 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' B' ' 211' ' ' SER . 40.6 t0 -80.23 -32.74 38.39 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.38 144.0 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' B' ' 213' ' ' TYR . 80.8 t -135.92 124.92 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.98 -1.075 . . . . 0.0 111.353 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 280' ' ' VAL . . . . . 0.621 HG12 ' H ' ' B' ' 281' ' ' ALA . 25.5 t -118.02 176.82 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.621 ' H ' HG12 ' B' ' 280' ' ' VAL . . . -164.01 115.69 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.576 -1.328 . . . . 0.0 110.089 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.93 143.22 36.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 108.67 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -147.88 148.23 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.098 -1.001 . . . . 0.0 109.772 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 2.8 m -171.72 -42.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -130.19 151.92 79.23 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 88' ' ' LEU . 77.0 Cg_exo -35.87 146.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.675 2.25 . . . . 0.0 112.682 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.562 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 14.8 t -175.46 122.46 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 0.0 110.525 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.662 HD12 HG13 ' A' ' 120' ' ' ILE . 2.2 mm? -70.99 -43.94 66.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.333 -0.854 . . . . 0.0 109.655 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.42 -36.56 77.45 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' B' ' 287' ' ' SER . 11.7 t -76.1 -49.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -1.076 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' GLY . . . . . 0.482 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -67.41 -37.98 90.69 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -69.77 -52.11 28.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -1.187 . . . . 0.0 109.926 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.51 ' OE2' ' SD ' ' A' ' 119' ' ' MET . 95.9 mt-10 -63.2 -31.15 72.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.222 -0.923 . . . . 0.0 109.495 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.4 mt -69.65 -47.35 63.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.73 93.33 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -62.42 -41.58 98.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.546 -0.973 . . . . 0.0 109.299 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.64 79.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.956 -1.09 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.409 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.6 OUTLIER -52.24 -40.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -81.88 -53.13 6.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.079 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.86 -9.16 2.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.104 -0.997 . . . . 0.0 110.206 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' B' ' 302' ' ' LYS . . . 54.41 94.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.94 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 41.4 mttm -165.04 150.54 8.51 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' B' ' 279' ' ' VAL . 82.8 Cg_exo -38.63 104.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.75 1.634 . . . . 0.0 111.296 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.2 mt -106.82 95.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.654 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.73 118.53 36.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 142.29 50.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.602 HD12 ' N ' ' B' ' 307' ' ' LEU . 0.4 OUTLIER -131.3 143.62 50.67 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.298 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -128.11 147.49 50.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -99.19 141.82 23.53 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.732 -1.23 . . . . 0.0 111.516 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 313' ' ' GLY . 92.7 Cg_endo -80.27 -31.63 1.61 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.807 2.338 . . . . 0.0 110.954 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 310' ' ' PRO . 20.2 pt20 -45.47 -38.65 6.38 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.0 p -95.66 -20.02 19.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.46 43.09 1.47 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.0 mtt180 -78.98 13.0 1.91 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.346 -1.091 . . . . 0.0 109.424 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 314' ' ' ARG . 79.6 t 49.42 101.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.366 -0.834 . . . . 0.0 110.255 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.525 HD11 HG11 ' B' ' 283' ' ' VAL . 24.0 tp -45.19 158.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.64 142.75 22.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 111.05 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 318' ' ' ALA . . . . . 0.479 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.93 -50.66 71.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.367 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.514 ' SD ' ' OE2' ' A' ' 93' ' ' GLU . 19.3 mtp -65.65 -38.65 89.94 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.964 -1.085 . . . . 0.0 109.859 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.685 HG13 HD12 ' A' ' 88' ' ' LEU . 5.1 mm -66.24 -44.86 91.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -74.26 -44.47 52.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.952 -1.093 . . . . 0.0 108.97 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -61.55 -22.33 61.43 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 320' ' ' ILE . . . -45.49 -61.04 1.85 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.576 -0.956 . . . . 0.0 110.047 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -156.64 -87.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.967 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 0.7 OUTLIER 96.99 -1.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -177.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -179.59 84.95 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.783 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.1 p 162.37 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.406 -1.055 . . . . 0.0 109.737 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 67.11 -23.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.783 ' H ' ' C ' ' B' ' 327' ' ' SER . 11.9 t80 -123.65 118.97 28.48 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.21 138.68 43.85 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.212 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 83.9 t -102.3 100.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 21.1 m0 -94.04 148.58 22.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.85 148.13 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.6 p90 -168.53 174.37 6.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.114 -1.434 . . . . 0.0 112.057 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -140.69 147.28 39.0 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.5 mt-10 -41.86 -30.37 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.605 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.19 1.31 88.93 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.766 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -135.53 -2.72 2.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.95 -1.324 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 1.4 p -52.31 -45.81 44.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 26.5 mt-10 -52.93 -36.34 59.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 24.4 m -66.37 -41.03 90.04 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 11.6 mmt -55.34 -54.99 36.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 39.6 mt -59.61 -27.17 66.07 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' B' ' 348' ' ' GLU . 15.9 t70 -69.33 -46.79 66.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -0.966 . . . . 0.0 111.184 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -73.64 -44.36 57.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.333 -1.48 . . . . 0.0 109.846 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' TYR . . . . . 0.429 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 42.2 t80 -60.18 -46.49 89.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.738 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.765 ' CD1' HD12 ' B' ' 351' ' ' LEU . 11.5 m-85 -74.88 -34.23 62.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.437 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 348' ' ' GLU . 0.7 OUTLIER -69.07 -23.38 64.02 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 117.846 -1.542 . . . . 0.0 107.485 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.4 -10.23 53.75 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.612 -0.68 . . . . 0.0 110.468 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -155.11 -47.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.46 -1.4 . . . . 0.0 112.15 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' B' ' 347' ' ' PHE . 2.2 mt -41.53 -54.33 6.53 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 110.998 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -44.46 -13.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.008 1.805 . . . . 0.0 112.231 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 351' ' ' LEU . 50.5 tt0 -65.85 -63.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.956 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 354' ' ' LYS . . . . . 0.476 ' HZ2' HD23 ' B' ' 351' ' ' LEU . 14.2 pttm -84.25 -17.93 38.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.051 -1.031 . . . . 0.0 109.753 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 355' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' B' ' 356' ' ' ALA . 87.1 m -88.02 149.82 23.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 356' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 355' ' ' THR . . . 62.17 44.16 8.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.87 . . . . 0.0 109.383 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 89.6 p -136.99 171.4 14.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.392 -0.818 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' SER . . . . . 0.424 ' O ' ' CE1' ' B' ' 360' ' ' HIS . 10.8 t -70.25 132.65 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 61.6 p -81.38 155.22 26.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.424 ' CE1' ' O ' ' B' ' 358' ' ' SER . 21.0 m80 -131.77 73.99 78.15 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.756 . . . . 0.0 109.39 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.21 151.88 18.15 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.829 2.352 . . . . 0.0 112.25 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 33.0 t -84.2 144.42 28.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.431 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 tpp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.63 149.26 45.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.33 156.53 7.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.482 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 p -54.52 172.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.64 -176.38 42.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -137.06 157.51 46.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -1.155 . . . . 0.0 109.563 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -133.19 -177.22 4.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.413 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.98 148.59 49.38 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.457 -0.777 . . . . 0.0 109.121 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 -155.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.402 2.068 . . . . 0.0 110.965 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 26.4 p -99.67 178.02 4.97 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.576 ' OG ' HD21 ' A' ' 42' ' ' LEU . 3.0 t -116.08 152.95 32.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.81 132.63 56.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.431 -0.793 . . . . 0.0 109.348 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' CZ ' ' OE2' ' A' ' 44' ' ' GLU . 39.2 t80 -96.34 147.1 24.15 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.673 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.6 t80 -110.45 133.21 53.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.029 . . . . 0.0 111.517 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 102.53 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.29 177.58 19.48 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 122.86 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -1.061 . . . . 0.0 109.73 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.727 ' CD1' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -138.02 95.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 108.654 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -129.75 4.58 5.01 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 110.331 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 145.58 99.23 0.25 Allowed Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.502 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 20' ' ' GLY . . . 19.57 115.59 0.0 OUTLIER Glycine 0 N--CA 1.506 3.317 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.611 ' H ' ' HB2' ' A' ' 25' ' ' GLN . 12.5 ptm180 -150.52 163.97 37.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.853 -1.381 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -55.96 -39.27 71.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 86.9 m-20 -60.03 -33.34 71.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.611 ' HB2' ' H ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -63.24 -46.83 85.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -50.19 69.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.62 -35.49 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 32' ' ' VAL . 18.5 m-30 -67.44 -47.7 69.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.93 75.8 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.681 -1.262 . . . . 0.0 108.803 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 -68.69 -57.15 6.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 108.609 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -50.88 -45.2 28.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 28' ' ' TYR . 94.5 t -59.65 -30.63 45.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -66.02 -40.13 90.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.115 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -63.45 -41.99 98.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.78 -1.2 . . . . 0.0 108.045 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 32' ' ' VAL . 52.9 mt -61.24 -43.1 99.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -56.66 -26.1 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -85.49 -29.42 24.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.161 -0.962 . . . . 0.0 110.046 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.508 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.2 m-85 -84.39 -58.8 2.6 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.182 -0.949 . . . . 0.0 110.511 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -132.61 -164.61 10.99 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 11' ' ' SER . 33.7 mtmt -89.61 124.2 34.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.223 -1.163 . . . . 0.0 109.036 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.45 HG11 ' CG1' ' A' ' 32' ' ' VAL . 39.8 t -80.62 104.05 8.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD21 ' OG ' ' A' ' 11' ' ' SER . 80.9 mt -52.03 142.43 15.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.764 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.561 ' OG1' ' CE3' ' A' ' 72' ' ' TRP . 17.4 p -37.75 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.512 0.672 . . . . 0.0 110.161 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 13' ' ' TYR . 19.5 mm-40 -122.91 110.41 15.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.664 ' O ' ' N ' ' A' ' 49' ' ' ALA . 4.7 p80 -56.44 -15.35 4.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.341 -0.85 . . . . 0.0 109.624 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CD1' ' A' ' 18' ' ' ILE . 60.8 t -41.7 -78.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.335 -0.853 . . . . 0.0 110.651 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.25 10.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.883 -1.136 . . . . 0.0 109.09 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.916 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.7 t70 -96.54 22.71 7.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -109.2 35.88 3.11 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HG3' HD13 ' A' ' 51' ' ' LEU . 1.9 pt-20 -129.57 -20.32 3.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.916 HD21 ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -62.67 -102.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -57.02 164.1 2.55 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.4 36.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.552 2.168 . . . . 0.0 112.996 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 54' ' ' LEU . 6.6 mp 51.3 -155.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.93 -1.106 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . -127.83 -36.58 0.47 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 56' ' ' GLU . 36.4 mp0 -46.58 -20.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -1.061 . . . . 0.0 109.108 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' GLY . 24.5 pt-20 -132.47 3.51 3.9 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 54' ' ' LEU . . . -145.59 -173.79 4.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.05 152.45 21.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.18 -9.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.64 74.93 1.22 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -53.62 -37.0 62.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.348 -1.09 . . . . 0.0 108.336 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.628 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 3.4 mp0 -62.23 -47.15 85.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -53.58 -36.27 61.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 0.0 109.184 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -67.3 -53.1 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.132 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.491 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 4.8 t-80 -63.65 -45.77 88.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 110.785 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -54.43 -54.73 36.8 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.632 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' TRP . 99.5 mt-30 -72.42 -40.34 67.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 110.169 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 23.8 m-20 -64.93 -52.97 53.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.972 . . . . 0.0 111.014 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.93 78.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 111.148 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -65.41 -54.01 34.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.785 -1.197 . . . . 0.0 110.049 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.45 -42.74 99.68 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.814 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 2.0 tt -53.15 -36.87 61.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -75.18 -26.2 58.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.527 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.496 ' CD ' ' CD1' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -97.86 5.7 48.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.797 -1.189 . . . . 0.0 109.064 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -65.08 129.4 39.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.697 0.76 . . . . 0.0 112.536 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 11' ' ' SER . 64.0 t0 -74.94 -36.17 62.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 79' ' ' VAL . 46.0 t -134.25 168.01 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' N ' HG12 ' A' ' 78' ' ' VAL . 60.8 t -150.21 140.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.104 -0.998 . . . . 0.0 111.074 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -132.07 143.23 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -152.74 156.14 38.55 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 110.51 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' OH ' ' A' ' 134' ' ' TYR . 47.1 tt0 -123.25 124.77 43.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -120.22 23.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 109.523 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 109' ' ' ARG . 89.4 m -45.76 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.148 -0.97 . . . . 0.0 108.564 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' PRO . 34.3 tt0 -68.15 133.74 91.59 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLN . 86.2 Cg_exo -37.34 112.71 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.99 1.793 . . . . 0.0 111.769 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.462 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 2.4 p -117.06 130.56 56.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.218 -0.926 . . . . 0.0 110.201 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' B' ' 287' ' ' SER . 0.4 OUTLIER -80.88 -56.36 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 317' ' ' SER . . . -57.87 -40.21 92.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.65 -36.62 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.164 . . . . 0.0 109.437 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.16 95.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.489 ' HB2' HD11 ' B' ' 320' ' ' ILE . 67.5 t80 -66.89 -47.53 71.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.679 -0.895 . . . . 0.0 109.709 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.37 -34.77 75.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.493 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.32 -42.46 75.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 108.478 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.07 -36.44 80.7 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' NH1' ' CG1' ' B' ' 298' ' ' VAL . 20.0 tpt180 -64.97 -45.46 85.61 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -68.8 -37.8 79.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.482 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.8 OUTLIER -51.46 -43.36 30.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -68.72 -44.99 72.72 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.09 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.587 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -129.19 -38.88 1.57 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.096 -1.002 . . . . 0.0 110.386 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -70.65 97.46 0.63 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.39 -69.65 0.55 Allowed Pre-proline 0 C--N 1.288 -2.08 0 O-C-N 121.762 -0.846 . . . . 0.0 111.446 -176.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 24.0 Cg_endo -63.41 111.36 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.88 1.72 . . . . 0.0 111.348 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 101' ' ' GLY . 46.5 mt -135.88 101.94 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.157 -0.965 . . . . 0.0 111.088 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.24 118.21 30.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -111.42 138.24 48.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.991 -1.068 . . . . 0.0 108.352 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mt -118.15 146.28 44.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.15 -0.969 . . . . 0.0 110.926 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.573 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -149.95 142.06 24.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.091 -1.005 . . . . 0.0 108.827 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.605 ' O ' ' N ' ' A' ' 113' ' ' GLY . 10.7 mtm180 -119.59 150.34 49.87 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.291 -0.88 . . . . 0.0 110.924 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 113' ' ' GLY . 46.0 Cg_endo -69.82 -15.64 36.96 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.643 2.229 . . . . 0.0 112.4 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 112' ' ' SER . 1.8 pt20 -67.09 -37.24 83.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -0.971 . . . . 0.0 110.151 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.475 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 31.0 m -142.51 -6.03 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 109' ' ' ARG . . . -111.19 99.69 1.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 106.74 -2.544 . . . . 0.0 106.74 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -98.26 -59.38 1.76 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.664 -0.903 . . . . 0.0 108.608 -177.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG21 ' O ' ' B' ' 256' ' ' GLU . 78.1 t -132.07 109.38 15.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.812 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -54.49 146.55 15.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' B' ' 289' ' ' GLY . 0.6 OUTLIER -43.3 146.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 0.0 109.398 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.0 81.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 77.6 mmm -64.8 -37.59 88.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 292' ' ' TYR . 48.4 mm -65.25 -47.12 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.992 . . . . 0.0 109.31 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -62.99 -40.8 98.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.04 -37.48 95.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.84 -47.38 71.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -0.3 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.415 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 128' ' ' ARG . 54.9 t0 -76.74 -35.24 57.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 108.58 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.8 -22.29 6.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -101.26 -46.26 5.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.066 -1.256 . . . . 0.0 109.869 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 125' ' ' ASP . 34.2 ptt-85 -121.11 -43.3 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.492 -0.755 . . . . 0.0 109.32 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 129' ' ' PHE . 7.0 t80 -97.29 130.03 44.52 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.491 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 16.2 tt0 -155.67 161.68 40.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.712 -1.242 . . . . 0.0 111.376 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.79 105.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.491 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 15.9 m0 -101.79 143.14 32.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 134' ' ' TYR . 61.0 t0 -93.34 155.32 17.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.101 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.596 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 6.3 p90 -169.88 -166.54 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.091 -1.006 . . . . 0.0 110.342 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -169.91 160.51 8.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 136' ' ' GLU . 18.9 mt-10 -59.46 28.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.09 -2.07 3.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -156.13 12.25 0.29 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.013 -1.286 . . . . 0.0 110.102 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 140' ' ' GLU . 7.5 p -52.03 -42.93 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 108.631 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 139' ' ' VAL . 36.7 mt-10 -57.47 -37.09 72.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.107 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.4 m -66.67 -44.28 82.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.9 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.4 tpp -52.44 -49.51 64.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 89.8 mt -71.36 -29.31 64.81 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.428 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 36.4 t0 -67.25 -38.97 86.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 109.881 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -73.35 -50.2 23.29 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.84 -1.163 . . . . 0.0 108.801 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.5 t80 -56.67 -47.12 80.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.339 -0.851 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.7 m-85 -78.41 -30.57 47.81 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.512 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 44.8 mt-10 -58.53 -25.47 62.48 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -71.99 -16.7 62.08 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.768 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -177.85 105.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 0.0 111.114 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.6 OUTLIER 175.82 -54.78 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.326 -0.858 . . . . 0.0 109.642 177.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 20.1 Cg_endo -62.78 -14.06 38.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.093 1.862 . . . . 0.0 111.513 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -69.17 -45.69 69.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 109.806 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.402 ' NZ ' HD23 ' A' ' 151' ' ' LEU . 23.1 mtmm -60.45 -36.26 77.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 31.2 p -61.61 -40.73 95.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.05 60.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 83.0 p -72.97 159.27 33.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 85.0 p -144.63 160.61 40.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 109.398 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -63.28 -32.6 74.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -130.16 79.26 73.14 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.399 -0.813 . . . . 0.0 109.506 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.66 -21.11 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.82 2.347 . . . . 0.0 112.189 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.8 m 47.0 -161.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.513 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.59 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 31.3 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.22 149.84 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -57.86 156.6 8.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 52.0 p -54.35 172.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.324 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 89.59 -176.06 42.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.41 158.34 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.89 -177.21 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.04 148.52 48.94 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.162 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.4 -155.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.487 2.124 . . . . 0.0 110.893 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.46 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 27.9 p -99.52 178.04 4.98 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.585 ' OG ' HD21 ' B' ' 242' ' ' LEU . 3.0 t -116.22 152.83 32.99 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.41 132.64 57.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.562 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CZ ' ' OE2' ' B' ' 244' ' ' GLU . 39.3 t80 -96.35 146.43 24.75 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.681 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.0 t80 -109.89 132.6 54.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.07 -1.019 . . . . 0.0 111.614 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.29 102.51 5.38 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -136.22 177.67 19.39 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.39 123.22 23.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.834 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' B' ' 246' ' ' VAL . 0.0 OUTLIER -138.48 95.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -130.36 4.47 4.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.317 -0.864 . . . . 0.0 110.19 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.733 ' O ' ' O ' ' B' ' 221' ' ' GLY . . . 145.7 99.22 0.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.603 -1.285 . . . . 0.0 110.554 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.733 ' O ' ' O ' ' B' ' 220' ' ' GLY . . . 19.54 115.33 0.0 OUTLIER Glycine 0 N--CA 1.504 3.181 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.617 ' H ' ' HB2' ' B' ' 225' ' ' GLN . 12.4 ptm180 -150.28 163.83 37.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.395 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -55.82 -39.1 70.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 88.2 m-20 -60.45 -33.39 72.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.617 ' HB2' ' H ' ' B' ' 222' ' ' ARG . 0.8 OUTLIER -63.03 -46.93 85.22 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.07 -50.27 69.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.45 -35.58 70.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.756 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.902 ' O ' HG23 ' B' ' 232' ' ' VAL . 18.5 m-30 -67.44 -47.42 70.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.326 -0.859 . . . . 0.0 109.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.28 -37.84 75.82 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.593 -1.317 . . . . 0.0 108.886 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.403 ' HE ' ' NH2' ' B' ' 234' ' ' ARG . 39.2 ttt85 -68.83 -57.03 6.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.849 -1.157 . . . . 0.0 108.648 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.3 mt -50.94 -45.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.902 HG23 ' O ' ' B' ' 228' ' ' TYR . 87.1 t -59.92 -30.33 45.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 7.2 t -66.15 -40.16 90.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.075 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.403 ' NH2' ' HE ' ' B' ' 230' ' ' ARG . 81.4 mtt-85 -63.45 -41.87 98.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.822 -1.174 . . . . 0.0 107.929 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' B' ' 232' ' ' VAL . 52.9 mt -61.23 -42.92 99.44 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -56.95 -26.08 59.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -85.37 -29.55 24.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.969 . . . . 0.0 110.079 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.506 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.2 m-85 -84.34 -58.7 2.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.215 -0.928 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 210' ' ' CYS . . . -132.94 -164.87 11.02 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' B' ' 211' ' ' SER . 33.1 mtmt -89.58 124.14 34.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.191 -1.181 . . . . 0.0 109.015 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.443 HG11 ' CG1' ' B' ' 232' ' ' VAL . 38.6 t -80.49 104.22 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' B' ' 211' ' ' SER . 80.7 mt -52.22 141.98 17.75 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.833 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.568 ' OG1' ' CE3' ' B' ' 272' ' ' TRP . 17.3 p -37.38 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.502 0.668 . . . . 0.0 110.234 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.544 ' OE2' ' CZ ' ' B' ' 213' ' ' TYR . 19.1 mm-40 -122.99 110.68 15.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' B' ' 249' ' ' ALA . 4.9 p80 -56.59 -15.58 4.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' B' ' 218' ' ' ILE . 62.5 t -41.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.239 -0.913 . . . . 0.0 110.695 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -48.72 -33.29 9.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.934 -1.104 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.883 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.5 t70 -96.53 22.96 7.32 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' B' ' 245' ' ' HIS . . . -109.47 35.68 3.22 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.518 ' HG3' HD13 ' B' ' 251' ' ' LEU . 1.9 pt-20 -129.27 -20.09 3.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.89 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -62.72 -103.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' B' ' 254' ' ' LEU . 0.0 OUTLIER -56.1 164.39 1.85 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.85 36.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.525 2.15 . . . . 0.0 112.895 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.645 HD12 ' N ' ' B' ' 254' ' ' LEU . 6.6 mp 51.28 -155.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.018 -1.051 . . . . 0.0 109.548 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . -127.35 -36.53 0.49 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' B' ' 256' ' ' GLU . 36.5 mp0 -46.44 -20.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -1.033 . . . . 0.0 109.211 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 255' ' ' GLY . 24.4 pt-20 -133.2 4.39 3.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 108.925 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 254' ' ' LEU . . . -145.97 -173.49 4.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -90.95 151.5 21.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.15 -9.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.45 74.62 1.21 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -36.91 62.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.36 -1.082 . . . . 0.0 108.321 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' GLN . . . . . 0.636 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 3.4 mp0 -62.5 -47.18 85.1 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -53.6 -36.03 61.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -67.55 -52.87 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.486 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 4.6 t-80 -64.03 -46.26 85.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.454 -0.779 . . . . 0.0 110.654 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -53.74 -55.08 29.4 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.84 -1.162 . . . . 0.0 109.676 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' TRP . 99.5 mt-30 -72.21 -40.36 67.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.503 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 25.5 m-20 -64.79 -52.95 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.03 -1.044 . . . . 0.0 111.174 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.87 78.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 111.138 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.5 -54.01 34.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.671 -1.268 . . . . 0.0 110.147 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -62.42 -42.38 99.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.037 -1.039 . . . . 0.0 108.935 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.473 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 1.9 tt -53.62 -36.49 62.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -75.34 -26.25 58.43 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.372 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.492 ' CD ' ' CD1' ' B' ' 272' ' ' TRP . 0.0 OUTLIER -98.02 5.82 48.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.175 . . . . 0.0 109.095 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -65.17 129.47 39.84 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.759 0.79 . . . . 0.0 112.555 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' B' ' 211' ' ' SER . 64.1 t0 -75.14 -35.86 61.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.59 HG12 ' N ' ' B' ' 279' ' ' VAL . 46.6 t -134.4 167.94 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.59 ' N ' HG12 ' B' ' 278' ' ' VAL . 61.8 t -150.37 140.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.026 . . . . 0.0 111.06 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.06 143.6 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.08 156.16 38.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.046 -1.034 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' B' ' 334' ' ' TYR . 47.4 tt0 -123.15 125.04 44.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' B' ' 316' ' ' LEU . 0.1 OUTLIER -120.5 22.69 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.519 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.441 HG23 ' H ' ' B' ' 309' ' ' ARG . 87.5 m -45.25 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.184 -0.948 . . . . 0.0 108.54 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' B' ' 286' ' ' PRO . 33.4 tt0 -68.0 133.92 91.88 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 285' ' ' GLN . 87.9 Cg_exo -37.36 112.57 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.084 1.856 . . . . 0.0 111.842 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 2.6 p -116.91 130.52 56.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.74 -56.14 4.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 289' ' ' GLY . . . . . 0.556 ' N ' ' OG ' ' A' ' 117' ' ' SER . . . -58.0 -40.27 93.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.61 -36.67 78.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.322 -1.104 . . . . 0.0 109.497 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.2 95.48 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.502 ' HB2' HD11 ' A' ' 120' ' ' ILE . 67.8 t80 -67.05 -47.25 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.623 -0.928 . . . . 0.0 109.84 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.91 -34.77 76.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 294' ' ' LEU . 72.5 mt -69.29 -42.44 75.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.965 . . . . 0.0 108.578 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.24 -36.09 78.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.418 ' NH1' ' CG1' ' A' ' 98' ' ' VAL . 20.0 tpt180 -64.93 -45.59 85.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.272 -1.134 . . . . 0.0 109.517 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -68.67 -37.89 79.95 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.466 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.455 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.8 OUTLIER -51.61 -43.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -68.6 -45.1 72.87 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.177 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.596 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -129.35 -38.21 1.58 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.135 -0.978 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -71.18 97.26 0.66 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.596 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -65.26 -69.77 0.54 Allowed Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.826 -0.808 . . . . 0.0 111.43 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 24.0 Cg_endo -63.44 111.02 1.35 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.878 1.719 . . . . 0.0 111.534 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.439 HD11 ' O ' ' B' ' 301' ' ' GLY . 45.5 mt -135.61 101.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 111.174 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.16 118.54 30.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -111.53 137.95 48.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 108.445 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' LEU . . . . . . . . . . . . . 9.7 mt -118.05 146.09 44.33 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -0.973 . . . . 0.0 110.862 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -149.77 142.19 24.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 108.764 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.598 ' O ' ' N ' ' B' ' 313' ' ' GLY . 10.5 mtm180 -119.47 150.53 49.98 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 110.867 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.18 -15.31 35.49 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.469 ' HG3' ' N ' ' B' ' 312' ' ' SER . 1.9 pt20 -67.34 -37.61 83.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.229 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' B' ' 311' ' ' GLN . 23.2 m -142.16 -5.82 0.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' B' ' 309' ' ' ARG . . . -111.2 100.04 1.18 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.629 ' CD ' ' N ' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -98.41 -59.55 1.73 Allowed 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.695 -0.885 . . . . 0.0 108.614 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 56' ' ' GLU . 77.8 t -131.94 109.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.765 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.632 HD11 ' HB ' ' B' ' 283' ' ' VAL . 0.1 OUTLIER -54.55 146.27 16.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 89' ' ' GLY . 0.6 OUTLIER -43.08 146.17 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.98 -1.075 . . . . 0.0 109.431 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.24 80.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 0.0 110.534 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.63 -37.69 88.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 92' ' ' TYR . 47.5 mm -64.94 -47.23 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.303 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 0.1 OUTLIER -63.13 -40.6 98.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -63.08 -37.47 94.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.594 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.89 -47.83 70.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.594 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 0.32 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.521 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.533 ' OD2' ' NH1' ' B' ' 328' ' ' ARG . 53.7 t0 -76.34 -35.25 58.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.889 -1.132 . . . . 0.0 108.565 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 82.81 -22.26 6.86 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 30.0 t -101.36 -45.92 5.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.984 -1.303 . . . . 0.0 109.874 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.533 ' NH1' ' OD2' ' B' ' 325' ' ' ASP . 34.2 ptt-85 -121.45 -43.44 2.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.529 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 6.9 t80 -97.15 130.1 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.485 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 16.4 tt0 -155.67 161.71 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.513 -1.275 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.75 105.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.485 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 15.7 m0 -101.72 143.1 32.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' B' ' 334' ' ' TYR . 59.7 t0 -93.18 155.36 17.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 109.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.582 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 6.3 p90 -169.7 -166.31 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -170.26 160.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -59.39 28.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -134.97 -2.44 3.08 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -155.87 12.1 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -1.196 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.51 HG13 ' N ' ' B' ' 340' ' ' GLU . 8.1 p -51.9 -42.9 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 108.548 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.51 ' N ' HG13 ' B' ' 339' ' ' VAL . 40.0 mt-10 -57.64 -36.97 72.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.558 -0.714 . . . . 0.0 109.123 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 57.0 m -66.69 -44.16 82.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.867 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -52.74 -49.54 65.23 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 88.8 mt -71.2 -29.34 65.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.491 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 37.6 t0 -67.2 -39.05 86.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.067 -1.02 . . . . 0.0 109.937 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -73.11 -50.36 23.24 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.89 -1.131 . . . . 0.0 108.834 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 346' ' ' TYR . . . . . 0.481 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.8 t80 -56.36 -47.31 79.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' B' ' 351' ' ' LEU . 12.7 m-85 -78.05 -30.76 50.0 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.591 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 45.3 mt-10 -58.5 -25.71 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 349' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -71.62 -17.11 62.29 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.772 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -177.69 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.073 -1.017 . . . . 0.0 111.162 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.7 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 176.14 -55.28 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 20.1 Cg_endo -62.2 -14.21 36.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.861 1.708 . . . . 0.0 111.579 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -68.84 -45.09 72.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.768 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 354' ' ' LYS . . . . . 0.411 ' NZ ' HD23 ' B' ' 351' ' ' LEU . 23.0 mtmm -61.13 -36.08 78.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.121 -0.987 . . . . 0.0 109.619 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 30.4 p -61.76 -40.2 94.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.14 -22.96 60.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.712 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -73.09 159.09 34.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.71 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 85.0 p -144.51 160.84 40.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.377 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 17.0 m -63.63 -31.51 72.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -131.24 79.41 70.5 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.363 -0.836 . . . . 0.0 109.438 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.92 -22.83 4.96 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.784 2.323 . . . . 0.0 112.311 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 68.7 m 47.55 -167.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.524 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.45 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptt? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.4 29.03 4.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.2 158.64 43.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 109.655 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.5 p -147.91 170.23 18.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' GLU . . . 84.81 -99.56 2.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLY . 91.7 mt-10 47.78 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -1.186 . . . . 0.0 109.349 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.84 178.5 6.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.88 153.8 80.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.564 -0.71 . . . . 0.0 109.143 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.13 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.617 2.211 . . . . 0.0 111.772 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 89.8 m -100.31 177.14 5.14 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 2.6 m -119.93 121.21 38.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.026 -1.046 . . . . 0.0 108.581 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 78' ' ' VAL . 5.3 t -94.06 130.94 42.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 69' ' ' ASP . 33.2 t80 -99.85 133.39 44.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 32' ' ' VAL . 26.6 t80 -86.88 116.34 24.89 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.365 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 6.5 t -107.0 108.99 20.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.771 0.796 . . . . 0.0 109.287 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.556 ' C ' HG22 ' A' ' 90' ' ' VAL . . . -174.85 174.3 46.62 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 90' ' ' VAL . 6.7 p -113.44 160.13 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -1.074 . . . . 0.0 108.461 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.408 HG23 ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -84.66 -13.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.605 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 21' ' ' GLY . 17.7 mmm180 -50.18 -85.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 40.87 -82.1 0.0 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.758 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 162.94 36.4 0.02 OUTLIER Glycine 0 N--CA 1.488 2.153 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HE ' ' CD1' ' A' ' 54' ' ' LEU . 38.3 mmt-85 55.88 -46.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.314 -0.521 . . . . 0.0 109.817 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 21' ' ' GLY . 76.9 mm-40 -56.99 -38.86 73.63 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -63.67 -26.68 68.78 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.59 HE21 ' C ' ' A' ' 46' ' ' VAL . 20.2 tp60 -64.77 -42.68 94.92 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.71 84.37 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.96 -37.88 77.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.741 ' O ' HG23 ' A' ' 32' ' ' VAL . 21.1 m-30 -65.94 -41.81 90.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -63.14 -39.31 94.3 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 120.851 -1.156 . . . . 0.0 109.041 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.49 -55.02 9.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.951 -1.093 . . . . 0.0 108.321 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.432 HG21 ' OE2' ' A' ' 82' ' ' GLU . 20.9 mt -53.89 -45.07 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.3 t -60.15 -29.37 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.6 m -67.31 -38.56 85.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.082 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -68.51 -50.19 54.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.127 . . . . 0.0 109.043 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.601 HD22 HG11 ' A' ' 12' ' ' VAL . 25.1 mt -56.77 -40.82 76.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -61.6 -27.05 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.845 -0.535 . . . . 0.0 109.598 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -75.94 -36.81 59.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.959 -1.088 . . . . 0.0 109.542 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.519 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.8 m-85 -71.69 -48.76 45.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.52 -0.737 . . . . 0.0 110.598 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -149.35 -148.83 4.84 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -95.66 125.13 40.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.413 -1.051 . . . . 0.0 109.825 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 32' ' ' VAL . 3.2 t -83.4 101.17 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' A' ' 76' ' ' ALA . 93.8 mt -47.1 149.67 0.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.31 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 m -44.61 140.08 2.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 109.301 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' VAL . 11.0 pt-20 -161.57 134.27 6.06 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.0 t-80 -74.86 25.0 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.241 -0.912 . . . . 0.0 109.188 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.681 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 27.6 t -83.97 -85.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' C ' ' N ' ' A' ' 49' ' ' ALA . . . -68.08 178.87 1.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.814 ' O ' HD11 ' A' ' 51' ' ' LEU . 14.7 t70 48.57 20.09 0.29 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.188 . . . . 0.0 108.193 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -115.01 -9.51 12.37 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -62.85 -32.96 74.3 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 108.798 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.991 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.63 157.1 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.604 -0.685 . . . . 0.0 109.961 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 51' ' ' LEU . 17.9 mt-10 55.02 155.46 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 55.6 Cg_endo -72.19 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.493 2.129 . . . . 0.0 111.938 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD1' ' HE ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -55.55 165.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.895 -1.128 . . . . 0.0 109.628 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 150.46 32.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 22.9 mm-40 59.15 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.926 . . . . 0.0 109.447 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.7 tt0 -52.46 -28.77 21.55 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 53' ' ' PRO . . . -68.07 149.18 49.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.78 142.9 5.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.67 -58.53 0.23 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.75 80.63 0.48 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -53.47 -41.11 65.85 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.33 -1.1 . . . . 0.0 108.494 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.96 -48.89 67.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -60.08 -38.15 82.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.36 -40.22 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.436 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.4 t-80 -78.84 -51.03 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 110.55 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -50.68 -47.93 58.72 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.869 -1.144 . . . . 0.0 110.012 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.82 -49.04 27.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 0.0 110.421 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 68.6 m-20 -62.75 -51.92 65.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 0.0 110.776 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -68.22 -41.28 81.51 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 0.0 111.274 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -61.87 -54.03 47.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.597 -1.314 . . . . 0.0 109.314 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.577 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.07 -38.02 75.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.163 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.0 tp -52.6 -45.76 66.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' A' ' 96' ' ' ARG . 20.2 mt-30 -67.03 -30.32 70.37 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.483 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 3.2 mt-30 -91.24 3.53 54.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.54 -1.35 . . . . 0.0 109.349 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -64.5 141.59 58.72 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.987 0.899 . . . . 0.0 112.612 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' PRO . 65.1 t0 -98.48 -20.51 17.05 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 12' ' ' VAL . 18.4 t -144.55 144.63 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.01 137.96 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.717 -1.239 . . . . 0.0 112.382 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.13 125.41 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -112.54 144.6 41.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.34 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' OE2' HG21 ' A' ' 31' ' ' ILE . 50.2 mt-10 -108.6 121.71 45.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.71 . . . . 0.0 109.169 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 107' ' ' LEU . 1.7 m -146.77 113.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 m -130.04 -13.42 4.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -142.92 156.18 62.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -39.13 108.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.047 1.831 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.64 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 45.1 m -126.29 134.39 51.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.142 -0.974 . . . . 0.0 111.165 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.635 ' HB2' ' H ' ' B' ' 287' ' ' SER . 14.7 tp -105.68 153.11 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.59 -29.99 3.19 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 16' ' ' GLY . 47.4 t -86.01 -49.92 14.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.35 62.45 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.431 ' HB2' HD11 ' B' ' 320' ' ' ILE . 85.8 t80 -70.86 -58.14 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 85.9 mt-10 -52.16 -32.95 38.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 81' ' ' ALA . 37.8 mt -76.29 -41.15 49.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.0 -48.76 81.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 74' ' ' GLN . 45.4 ttm-85 -62.61 -38.26 89.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.341 -1.093 . . . . 0.0 108.89 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.56 -39.93 88.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -54.92 -44.31 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.791 -1.193 . . . . 0.0 108.136 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -76.01 -48.93 19.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.469 ' O ' ' CD ' ' A' ' 102' ' ' LYS . 2.8 pp -116.66 -23.08 8.33 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.831 -1.168 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -53.26 170.3 0.78 Allowed Glycine 0 C--N 1.286 -2.196 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.538 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -131.63 -75.71 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 79.8 Cg_endo -81.79 109.12 1.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.811 1.674 . . . . 0.0 109.552 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.08 126.7 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.691 -1.256 . . . . 0.0 111.579 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 132' ' ' TRP . 24.4 tp -123.0 119.39 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.73 153.05 21.12 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.71 -1.244 . . . . 0.0 108.561 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 14.7 mt -127.9 132.69 49.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.962 -1.086 . . . . 0.0 111.838 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.482 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -138.93 122.35 17.2 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 65.4 mtm180 -86.55 135.66 35.92 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 111.388 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 72.7 Cg_endo -79.32 -23.87 7.06 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.434 2.089 . . . . 0.0 110.58 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' SER . 14.6 pt20 -48.06 -38.2 16.84 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 10.7 t -95.3 -18.59 20.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.1 52.77 4.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 115' ' ' VAL . 3.6 mtp180 -87.57 6.26 35.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.289 . . . . 0.0 109.993 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 114' ' ' ARG . 21.1 t 58.08 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 117' ' ' SER . 30.6 tp -74.08 150.83 40.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.587 ' H ' HD23 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -40.49 140.03 0.71 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.311 -0.868 . . . . 0.0 110.609 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.64 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -61.07 -43.67 98.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 81.0 mmm -63.89 -44.06 94.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.17 -0.956 . . . . 0.0 109.176 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' B' ' 292' ' ' TYR . 45.1 mm -61.74 -41.79 91.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.243 -0.91 . . . . 0.0 108.768 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.81 -45.15 95.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.425 -0.797 . . . . 0.0 109.585 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -66.98 -39.11 93.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.645 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -48.41 -55.91 9.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -1.215 . . . . 0.0 108.217 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -9.87 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.432 0.634 . . . . 0.0 111.148 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -130.89 -28.16 2.01 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 80.24 -5.45 63.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.668 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 p -79.17 39.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 127' ' ' SER . 86.1 mtt-85 106.12 -25.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.903 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -89.71 114.67 26.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.1 mt-30 -137.66 137.76 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.762 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.85 103.98 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.546 ' CD2' HD11 ' A' ' 105' ' ' LEU . 15.0 m0 -104.59 143.09 33.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.074 -1.016 . . . . 0.0 109.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.474 ' O ' ' SD ' ' A' ' 142' ' ' MET . 98.7 m-20 -96.96 159.83 14.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.86 -1.15 . . . . 0.0 108.792 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 8.0 p90 -165.5 -167.06 1.06 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.652 -1.28 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -166.71 146.63 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 135' ' ' ALA . 42.6 mt-10 -41.48 -37.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.127 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.59 4.13 37.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.447 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -155.75 8.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.463 -1.61 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.3 p -53.63 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.913 -1.117 . . . . 0.0 108.539 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 20.8 pt-20 -58.86 -31.94 69.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.483 -0.761 . . . . 0.0 109.09 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.1 m -68.51 -46.01 70.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.0 tpp -51.06 -45.8 61.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.63 -34.97 70.25 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.493 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.54 -40.53 95.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 110.279 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -71.64 -50.54 29.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.894 -1.129 . . . . 0.0 108.629 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -59.61 -46.44 88.97 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.966 ' CD1' HD12 ' A' ' 151' ' ' LEU . 13.6 m-85 -70.16 -32.95 71.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.88 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.505 -1.372 . . . . 0.0 107.551 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.14 -18.05 62.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.571 -0.705 . . . . 0.0 110.661 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.563 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -152.84 3.37 0.33 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.385 -1.447 . . . . 0.0 111.598 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 147' ' ' PHE . 6.1 mt -116.25 83.84 13.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.677 -1.264 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.11 -100.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.594 2.196 . . . . 0.0 111.688 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -72.89 -35.32 67.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -54.49 -22.42 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.294 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 151' ' ' LEU . 58.9 m -47.46 -39.41 15.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.48 143.17 22.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 109.549 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.3 m -139.16 160.42 39.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.45 ' HG ' ' CE1' ' A' ' 160' ' ' HIS . 18.4 t -139.22 157.26 46.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.426 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 m -57.36 -41.76 80.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.45 ' CE1' ' HG ' ' A' ' 158' ' ' SER . 3.7 p-80 -85.56 152.2 56.99 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.79 147.75 85.84 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.508 2.138 . . . . 0.0 112.025 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 81.1 p -58.95 -13.05 5.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.313 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.686 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 51.98 29.11 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.29 158.98 43.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.603 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 53.1 p -148.24 170.36 18.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 206' ' ' GLU . . . 84.82 -99.16 2.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' B' ' 205' ' ' GLY . 90.7 mt-10 47.34 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -1.163 . . . . 0.0 109.372 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.41 178.24 6.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -129.57 154.25 80.83 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.39 -156.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.62 2.213 . . . . 0.0 111.719 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.527 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 92.0 m -100.09 177.08 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 2.4 m -119.97 120.86 37.58 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.625 HG13 HG12 ' B' ' 278' ' ' VAL . 5.8 t -93.86 130.95 42.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' B' ' 269' ' ' ASP . 32.7 t80 -100.01 133.32 44.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.516 ' CD2' HG22 ' B' ' 232' ' ' VAL . 26.9 t80 -86.7 116.82 25.05 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.273 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' B' ' 281' ' ' ALA . 5.6 t -107.76 109.03 20.5 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.728 0.775 . . . . 0.0 109.267 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.553 ' C ' HG22 ' B' ' 290' ' ' VAL . . . -174.75 174.54 46.69 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 290' ' ' VAL . 6.5 p -113.46 160.09 18.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -1.059 . . . . 0.0 108.362 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.415 HG23 ' NE2' ' B' ' 225' ' ' GLN . 0.7 OUTLIER -84.91 -13.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.516 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.69 ' O ' ' N ' ' B' ' 221' ' ' GLY . 17.5 mmm180 -50.15 -85.81 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 219' ' ' ARG . . . 40.61 -82.07 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.755 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 163.19 36.26 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.655 ' HE ' ' CD1' ' B' ' 254' ' ' LEU . 39.2 mmt-85 56.07 -47.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 122.242 -0.563 . . . . 0.0 109.77 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' B' ' 221' ' ' GLY . 75.8 mm-40 -56.75 -38.87 73.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.68 -26.82 68.83 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.568 HE21 ' C ' ' B' ' 246' ' ' VAL . 19.9 tp60 -64.58 -42.69 95.46 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.61 84.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 tp -59.21 -38.03 78.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.745 ' O ' HG23 ' B' ' 232' ' ' VAL . 21.2 m-30 -65.86 -41.53 91.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -63.34 -39.44 94.55 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.828 -1.17 . . . . 0.0 108.992 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.22 -55.13 10.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.078 . . . . 0.0 108.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.435 HG21 ' OE2' ' B' ' 282' ' ' GLU . 20.6 mt -53.78 -45.4 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.8 t -59.91 -29.14 42.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 5.9 m -67.43 -38.33 84.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.81 -50.13 52.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.893 -1.129 . . . . 0.0 108.932 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.605 HD22 HG11 ' B' ' 212' ' ' VAL . 24.9 mt -56.71 -40.75 76.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -61.6 -27.02 68.35 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -76.07 -36.57 58.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.882 -1.136 . . . . 0.0 109.473 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.525 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.8 m-85 -72.14 -48.79 41.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.536 -0.727 . . . . 0.0 110.646 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -149.15 -149.1 4.89 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.7 125.33 40.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 109.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.441 HG11 HG13 ' B' ' 232' ' ' VAL . 3.2 t -83.22 101.27 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' B' ' 276' ' ' ALA . 94.3 mt -47.28 149.59 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.256 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 3.5 m -44.59 140.08 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 109.303 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' B' ' 246' ' ' VAL . 11.2 pt-20 -161.54 134.6 6.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.339 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 34.4 t-80 -74.86 24.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.935 . . . . 0.0 109.222 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.67 ' O ' ' HB3' ' B' ' 249' ' ' ALA . 27.7 t -83.42 -85.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' B' ' 249' ' ' ALA . . . -67.97 178.86 1.64 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.833 ' O ' HD11 ' B' ' 251' ' ' LEU . 15.5 t70 48.89 19.5 0.27 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.75 -1.218 . . . . 0.0 108.226 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -114.27 -9.89 12.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -62.2 -33.23 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.98 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -57.75 157.37 7.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.525 -0.734 . . . . 0.0 109.915 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' B' ' 251' ' ' LEU . 18.3 mt-10 54.7 155.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.619 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' B' ' 258' ' ' ALA . 55.9 Cg_endo -72.09 68.12 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.506 2.138 . . . . 0.0 111.937 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.655 ' CD1' ' HE ' ' B' ' 222' ' ' ARG . 0.2 OUTLIER -55.35 165.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.992 . . . . 0.0 109.643 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 149.83 32.78 0.05 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.64 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 23.8 mm-40 58.9 -74.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.9 tt0 -52.51 -27.94 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' B' ' 253' ' ' PRO . . . -68.88 149.17 49.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.356 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -48.68 141.96 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 167.43 -58.24 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.44 80.64 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -53.49 -40.85 65.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -1.108 . . . . 0.0 108.525 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.22 -48.96 66.28 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 108.775 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.95 -38.34 82.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.29 -39.94 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.3 t-80 -79.16 -51.37 9.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.572 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -50.21 -47.9 54.56 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.87 -1.144 . . . . 0.0 109.879 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -74.11 -48.42 29.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.547 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 69.1 m-20 -63.27 -51.45 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.71 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.472 HD11 ' NE ' ' B' ' 296' ' ' ARG . 0.6 OUTLIER -68.76 -40.96 79.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.887 -1.133 . . . . 0.0 111.277 -178.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.4 t-20 -62.19 -53.77 50.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.654 -1.279 . . . . 0.0 109.305 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.567 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -58.04 -38.18 75.77 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.088 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.455 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.1 tp -52.63 -45.65 66.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.554 ' OE1' ' NH1' ' B' ' 296' ' ' ARG . 20.5 mt-30 -67.12 -30.37 70.36 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 3.2 mt-30 -91.28 3.54 54.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.625 -1.297 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.582 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -64.79 141.07 58.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.0 112.527 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' B' ' 303' ' ' PRO . 65.3 t0 -97.84 -20.43 17.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.625 HG12 HG13 ' B' ' 212' ' ' VAL . 18.7 t -144.65 144.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 22.6 t -143.5 137.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.544 -1.347 . . . . 0.0 112.527 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.86 125.88 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.55 ' CB ' HD21 ' B' ' 294' ' ' LEU . . . -112.97 144.98 41.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.195 -0.94 . . . . 0.0 110.274 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.435 ' OE2' HG21 ' B' ' 231' ' ' ILE . 48.9 mt-10 -108.83 121.65 45.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.535 -0.728 . . . . 0.0 109.179 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 1.7 m -146.74 113.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 18.9 m -130.22 -13.6 3.94 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -142.79 156.26 62.7 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -39.07 108.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.259 1.973 . . . . 0.0 111.691 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.635 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 45.6 m -125.9 134.35 51.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.099 -1.001 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.64 ' HB2' ' H ' ' A' ' 87' ' ' SER . 15.0 tp -105.32 153.51 21.53 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 81.97 -29.74 3.03 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.569 ' H ' ' C ' ' B' ' 288' ' ' LEU . 46.6 t -86.39 -49.54 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.67 -28.55 62.93 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 106.946 -2.461 . . . . 0.0 106.946 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' A' ' 120' ' ' ILE . 86.1 t80 -70.99 -57.95 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.936 -0.743 . . . . 0.0 109.088 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.403 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . 86.5 mt-10 -52.2 -33.2 39.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' B' ' 281' ' ' ALA . 36.7 mt -76.26 -41.13 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.74 -48.63 82.95 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.554 ' NH1' ' OE1' ' B' ' 274' ' ' GLN . 45.4 ttm-85 -62.97 -38.16 90.0 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.371 -1.076 . . . . 0.0 108.987 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.6 -39.68 88.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.486 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -54.92 -44.32 72.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 120.82 -1.175 . . . . 0.0 108.216 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.98 -49.28 18.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.46 ' O ' ' CD ' ' B' ' 302' ' ' LYS . 2.8 pp -116.36 -23.56 8.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.949 -1.094 . . . . 0.0 110.403 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -52.92 170.38 0.64 Allowed Glycine 0 C--N 1.288 -2.128 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.543 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 0.4 OUTLIER -131.46 -75.67 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 66.5 Cg_endo -81.73 109.49 2.02 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.819 1.679 . . . . 0.0 109.623 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 55.4 mt -130.47 126.79 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.688 -1.258 . . . . 0.0 111.514 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 332' ' ' TRP . 24.1 tp -123.06 119.29 29.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.45 153.08 20.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.642 -1.286 . . . . 0.0 108.511 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 14.7 mt -127.69 132.5 49.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.996 -1.065 . . . . 0.0 111.865 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -138.79 122.51 17.54 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 68.3 mtm180 -86.93 135.61 35.12 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.985 -1.072 . . . . 0.0 111.421 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' B' ' 313' ' ' GLY . 72.8 Cg_endo -79.36 -24.29 6.64 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.508 2.139 . . . . 0.0 110.425 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' B' ' 312' ' ' SER . 14.6 pt20 -47.9 -38.28 16.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 9.9 t -95.23 -18.78 20.58 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 40.8 53.1 3.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' B' ' 315' ' ' VAL . 3.6 mtp180 -87.73 6.44 34.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.923 -1.339 . . . . 0.0 109.98 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' B' ' 314' ' ' ARG . 24.1 t 58.25 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.841 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 316' ' ' LEU . 30.0 tp -74.19 151.21 40.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.594 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -40.59 139.84 0.75 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 110.596 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 318' ' ' ALA . . . . . 0.612 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -60.81 -43.61 97.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.468 -0.77 . . . . 0.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 81.0 mmm -64.31 -43.9 93.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 92' ' ' TYR . 45.7 mm -61.57 -41.6 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.102 -0.999 . . . . 0.0 108.756 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.09 -45.03 95.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.435 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -67.01 -39.0 93.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.636 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -48.45 -55.96 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.065 -1.256 . . . . 0.0 108.288 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.636 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -9.99 118.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.344 0.592 . . . . 0.0 111.16 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -131.43 -27.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 79.95 -5.18 63.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 54.7 p -79.34 39.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.66 ' HB2' ' O ' ' B' ' 327' ' ' SER . 84.8 mtt-85 106.22 -25.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.969 -1.469 . . . . 0.0 107.831 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -89.66 114.3 25.9 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.473 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 81.0 mt-30 -137.14 137.85 39.65 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.748 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.94 104.15 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.551 ' CD2' HD11 ' B' ' 305' ' ' LEU . 14.7 m0 -104.88 142.81 34.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.189 -0.945 . . . . 0.0 109.824 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.476 ' O ' ' SD ' ' B' ' 342' ' ' MET . 97.9 m-20 -97.06 159.97 14.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.828 -1.17 . . . . 0.0 108.807 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 8.1 p90 -165.4 -167.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.705 -1.247 . . . . 0.0 111.64 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.467 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -166.39 146.51 6.08 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.7 mt-10 -41.33 -37.24 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.801 -1.187 . . . . 0.0 110.058 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -74.75 4.89 34.01 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.389 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.21 8.79 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.461 -1.611 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.3 p -53.51 -44.75 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.92 -1.113 . . . . 0.0 108.468 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 20.2 pt-20 -58.64 -31.88 68.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.428 -0.795 . . . . 0.0 109.202 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 62.2 m -68.76 -45.91 70.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.0 tpp -51.38 -45.67 62.53 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.6 mt -71.53 -35.19 70.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.2 -40.57 96.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -72.02 -50.1 31.38 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.933 -1.104 . . . . 0.0 108.717 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -59.99 -46.39 89.6 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.1 -1.0 . . . . 0.0 110.153 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' B' ' 351' ' ' LEU . 13.6 m-85 -70.03 -33.03 71.46 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.903 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -67.08 -22.9 65.82 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.493 -1.379 . . . . 0.0 107.589 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.05 -17.82 62.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.512 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.9 OUTLIER -153.02 3.11 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.494 -1.379 . . . . 0.0 111.689 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.977 HD12 ' CD1' ' B' ' 347' ' ' PHE . 6.2 mt -116.05 83.87 12.89 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.662 -1.274 . . . . 0.0 109.69 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.9 -100.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.651 2.234 . . . . 0.0 111.75 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -72.63 -35.78 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -53.82 -22.24 9.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 355' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 351' ' ' LEU . 57.9 m -47.71 -39.27 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.903 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -152.25 143.16 23.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 69.6 m -139.11 160.46 39.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.375 -0.828 . . . . 0.0 109.251 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 358' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' B' ' 360' ' ' HIS . 14.6 t -139.52 157.6 45.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 20.2 m -57.86 -41.47 82.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' B' ' 358' ' ' SER . 3.5 p-80 -86.0 152.11 55.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.43 147.99 87.59 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.517 2.145 . . . . 0.0 112.006 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 59.6 p -60.88 -21.36 63.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.361 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.375 -179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.41 141.25 58.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.26 147.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.6 m -62.46 157.27 20.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.77 -169.01 54.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 7' ' ' GLN . 83.9 tt0 -90.39 128.22 36.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -1.159 . . . . 0.0 109.392 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' GLU . 89.7 mt-30 46.32 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.658 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' HB1' ' HD2' ' A' ' 9' ' ' PRO . . . -155.35 163.75 23.5 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 89.5 Cg_endo -80.71 -154.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 111.406 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.489 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 30.3 p -102.41 -178.19 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 2.7 p -119.88 150.62 40.18 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.8 t -125.41 131.96 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CB ' HG22 ' A' ' 79' ' ' VAL . 26.5 t80 -99.09 94.88 6.75 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' N ' ' OG1' ' A' ' 43' ' ' THR . 63.2 t80 -88.01 128.77 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 111.213 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 m -118.39 157.8 26.49 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.248 -0.907 . . . . 0.0 109.765 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' C ' ' CG2' ' A' ' 90' ' ' VAL . . . -168.93 173.8 43.47 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.4 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 19.2 t -81.6 132.25 35.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -1.124 . . . . 0.0 109.689 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -137.24 133.54 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.153 -0.967 . . . . 0.0 109.968 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' H ' ' H ' ' A' ' 20' ' ' GLY . 6.3 tpp180 -175.89 0.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.982 -1.074 . . . . 0.0 110.571 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 19' ' ' ARG . . . 155.85 82.95 0.04 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.891 ' H ' HD22 ' A' ' 54' ' ' LEU . . . 56.88 -140.55 44.2 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.711 ' CB ' ' O ' ' A' ' 21' ' ' GLY . 65.9 mtt180 118.01 131.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 117.752 0.776 . . . . 0.0 110.93 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -52.55 -26.87 14.47 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 66.1 m-20 -69.71 -36.05 75.59 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -59.8 -43.59 94.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.93 72.49 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.4 -28.95 68.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 12.7 m-30 -69.43 -49.39 55.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.552 -0.717 . . . . 0.0 110.088 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.25 77.12 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.544 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -71.74 -55.45 7.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.864 -1.147 . . . . 0.0 108.393 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 5.5 mt -54.04 -47.36 65.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.552 HG13 HG11 ' A' ' 41' ' ' VAL . 40.4 t -60.85 -28.77 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.72 -0.613 . . . . 0.0 109.363 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -69.31 -37.2 77.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.553 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -70.46 -47.41 60.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.831 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.26 -41.54 97.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -61.02 -26.12 67.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -78.66 -35.15 45.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.573 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -74.68 -51.77 13.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.47 -0.769 . . . . 0.0 109.809 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -142.54 -152.85 5.76 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -98.07 130.9 44.85 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.218 -1.166 . . . . 0.0 109.018 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG11 HG13 ' A' ' 32' ' ' VAL . 2.2 t -89.46 111.22 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.1 mt -79.8 -29.09 40.22 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.569 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 14' ' ' PHE . 12.5 p -82.96 23.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . 85.9 tt0 -44.08 -31.47 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -54.91 -35.96 64.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.875 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 45' ' ' HIS . 56.1 t -50.43 -66.75 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.916 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -62.94 -38.97 93.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -61.58 -0.58 0.44 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -60.57 -40.16 90.67 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.246 -0.909 . . . . 0.0 108.678 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.06 -23.73 1.3 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -66.3 123.15 19.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 109.403 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 51' ' ' LEU . 3.6 mt-10 54.02 162.79 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.798 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ALA . 84.2 Cg_exo -42.71 136.51 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.816 1.677 . . . . 0.0 111.065 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.891 HD22 ' H ' ' A' ' 21' ' ' GLY . 4.3 mp -81.9 -103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 108.694 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.725 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 38.52 112.98 0.0 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.791 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 15.8 mm-40 -37.74 -48.91 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -1.217 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -74.95 -31.58 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 0.0 108.858 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -83.39 46.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.03 -165.0 1.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.12 69.21 0.21 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 75.36 1.08 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 30.3 p-10 -52.44 -38.76 59.98 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.548 ' NE2' ' OE2' ' A' ' 67' ' ' GLU . 46.8 tt0 -63.26 -48.57 77.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -57.15 -36.73 71.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.17 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -64.1 -38.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -77.27 -58.25 3.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 110.45 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 96.2 mt-10 -45.13 -46.14 11.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.894 -1.129 . . . . 0.0 109.853 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.06 -42.47 76.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 109.716 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 86.0 m-20 -66.59 -36.06 81.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.607 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.3 mm? -69.77 -52.05 28.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -57.21 -40.57 77.74 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.539 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -67.22 -44.74 78.77 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.572 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 14.2 tp -51.97 -35.74 47.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.1 -33.2 67.67 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.858 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -84.04 -1.23 54.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.188 -0.945 . . . . 0.0 109.216 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.05 136.65 50.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.062 0.934 . . . . 0.0 112.486 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 47.6 m-20 -99.71 -30.44 12.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 58.1 t -137.1 144.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG22 ' CB ' ' A' ' 13' ' ' TYR . 80.6 t -132.99 140.14 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.787 -1.196 . . . . 0.0 111.205 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.63 121.64 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -113.34 121.91 45.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.814 -1.178 . . . . 0.0 110.28 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 54.8 tt0 -86.1 112.95 21.76 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.794 HG11 HD11 ' A' ' 116' ' ' LEU . 1.8 t -86.65 -99.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 110.383 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 85' ' ' GLN . 6.5 m 59.48 -96.87 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.203 -1.561 . . . . 0.0 109.032 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' H ' ' HB ' ' A' ' 84' ' ' THR . 25.3 tt0 -61.39 133.34 93.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.914 -1.116 . . . . 0.0 108.589 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.465 ' HD3' ' HE ' ' A' ' 114' ' ' ARG . 32.3 Cg_endo -66.62 115.59 3.64 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.975 1.784 . . . . 0.0 111.869 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.405 ' OG ' HG23 ' A' ' 90' ' ' VAL . 12.8 t -138.45 129.73 27.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.849 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' CG1' ' B' ' 283' ' ' VAL . 8.9 mt -69.05 -40.25 78.66 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 108.932 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.19 95.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 16' ' ' GLY . 44.6 t -66.13 -47.29 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.451 -1.029 . . . . 0.0 108.832 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.96 74.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -68.89 -47.61 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.507 -0.996 . . . . 0.0 109.698 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.48 -35.22 78.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.551 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.3 mt -69.09 -46.73 67.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 108.616 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.4 -33.95 87.97 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.496 HH21 ' HB2' ' B' ' 299' ' ' ALA . 0.3 OUTLIER -64.18 -43.99 93.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.49 -1.006 . . . . 0.0 109.706 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -71.14 -29.1 64.8 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.602 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -53.61 -50.42 50.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.305 -1.497 . . . . 0.0 106.994 178.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' N ' HG12 ' A' ' 98' ' ' VAL . . . -85.43 -55.64 3.91 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.452 0.644 . . . . 0.0 110.681 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.643 ' O ' HD23 ' A' ' 100' ' ' LEU . 1.2 tt -61.97 -16.81 54.11 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.503 1.144 . . . . 0.0 108.004 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 102' ' ' LYS . . . 75.81 -163.17 53.35 Favored Glycine 0 C--N 1.281 -2.511 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 7.6 mmtm 96.85 136.24 0.03 OUTLIER Pre-proline 0 C--N 1.285 -2.215 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -36.41 111.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.218 1.945 . . . . 0.0 111.429 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.5 mt -105.36 87.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.248 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.7 tp -91.42 116.7 29.06 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.514 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -108.0 139.81 42.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 108.536 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.5 mt -123.31 138.6 54.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -140.4 138.9 35.12 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -92.06 135.27 27.36 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 0.0 110.906 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.04 -32.86 2.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.514 2.143 . . . . 0.0 111.094 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.02 -33.52 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 113' ' ' GLY . 36.4 p -97.11 -21.41 17.36 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 39.74 44.84 2.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.465 ' HE ' ' HD3' ' A' ' 86' ' ' PRO . 14.8 mtp85 -70.62 8.43 0.85 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.202 -1.175 . . . . 0.0 109.323 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 113' ' ' GLY . 94.5 t 53.92 102.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.428 -0.795 . . . . 0.0 110.419 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.794 HD11 HG11 ' A' ' 83' ' ' VAL . 13.4 tp -57.05 139.52 52.03 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.1 144.63 1.22 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.476 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.798 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -59.83 -37.11 78.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.484 -0.76 . . . . 0.0 109.913 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 119' ' ' MET . 26.7 mmm -68.58 -45.69 71.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.315 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.5 -47.37 89.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.79 -44.21 77.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.401 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.27 -26.53 69.48 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -56.44 -51.96 66.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.261 . . . . 0.0 107.743 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 8.97 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.6 t0 -67.86 -35.4 78.49 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.692 -1.255 . . . . 0.0 107.921 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.887 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.77 176.54 45.73 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 56.05 -26.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.488 1.137 . . . . 0.0 108.79 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.887 ' H ' ' C ' ' A' ' 126' ' ' GLY . 7.2 tpp85 -149.95 -3.63 0.38 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.415 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 6.3 t80 -152.73 112.31 3.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.868 -1.145 . . . . 0.0 108.013 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.548 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 86.8 mt-30 -138.62 132.27 30.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -86.7 103.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.548 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 14.2 m0 -98.11 139.73 33.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.288 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' O ' ' CE ' ' A' ' 142' ' ' MET . 74.2 m-20 -94.18 141.92 28.0 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.954 -1.091 . . . . 0.0 109.046 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 139' ' ' VAL . 3.6 p90 -157.51 -173.63 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.035 -1.04 . . . . 0.0 111.034 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -158.87 157.75 32.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.5 30.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.447 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -135.78 -1.33 3.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.666 ' O ' ' SD ' ' A' ' 142' ' ' MET . 23.2 pt-20 -154.26 10.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.122 -1.222 . . . . 0.0 110.027 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.7 p -50.86 -41.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.045 -1.034 . . . . 0.0 108.865 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.447 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.0 tt0 -61.66 -29.18 69.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 108.771 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' GLU . 16.9 m -71.31 -48.36 51.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 110.367 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -55.76 -47.16 77.49 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.42 -29.83 70.79 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.128 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.479 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 43.2 t0 -69.09 -39.08 79.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 110.0 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -70.54 -51.76 26.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.69 -1.256 . . . . 0.0 108.814 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.7 t80 -57.92 -47.33 83.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.08 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.0 m-85 -74.34 -32.82 62.94 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.123 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 12.2 mm-40 -58.54 -26.48 63.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -70.21 -22.15 62.95 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.82 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -172.75 101.48 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.7 OUTLIER 175.23 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 151' ' ' LEU . 86.9 Cg_endo -83.0 30.22 0.54 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.913 2.409 . . . . 0.0 111.456 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 65.76 32.82 8.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.073 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp 51.3 40.04 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -50.44 169.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.16 -29.85 65.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.832 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.3 t 49.31 -167.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.0 p -136.41 157.83 45.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.278 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 t -126.43 146.8 49.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' SER . 10.1 m-70 -78.63 152.05 77.65 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.045 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -38.76 -25.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.554 2.169 . . . . 0.0 112.22 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' HIS . 73.5 m -71.77 159.56 34.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.853 . . . . 0.0 109.448 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.503 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.11 141.41 58.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -64.23 147.18 52.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.6 m -62.47 156.43 22.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.26 -168.26 54.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' B' ' 207' ' ' GLN . 84.0 tt0 -90.78 127.95 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -1.183 . . . . 0.0 109.431 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' B' ' 206' ' ' GLU . 89.4 mt-30 46.4 -170.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.32 -0.863 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' B' ' 209' ' ' PRO . . . -155.18 163.69 23.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' B' ' 208' ' ' ALA . 90.1 Cg_endo -80.69 -154.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.065 2.51 . . . . 0.0 111.459 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.493 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 30.3 p -102.65 -178.16 3.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 2.8 p -119.77 151.12 39.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 3.6 t -125.86 131.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.667 ' CB ' HG22 ' B' ' 279' ' ' VAL . 26.0 t80 -98.98 94.46 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.506 ' O ' ' CB ' ' B' ' 243' ' ' THR . 62.4 t80 -87.84 129.3 35.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 0.0 111.117 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -119.24 157.99 26.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.402 -0.812 . . . . 0.0 109.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CG2' ' B' ' 290' ' ' VAL . . . -169.12 174.29 43.6 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 17.7 t -81.73 132.12 35.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -1.115 . . . . 0.0 109.8 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.452 ' N ' ' NH1' ' B' ' 222' ' ' ARG . 1.0 OUTLIER -137.04 133.27 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.201 -0.937 . . . . 0.0 110.101 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 6.1 tpp180 -175.35 0.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.905 -1.122 . . . . 0.0 110.623 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.85 82.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.898 ' H ' HD22 ' B' ' 254' ' ' LEU . . . 57.0 -140.91 44.02 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.709 ' CB ' ' O ' ' B' ' 221' ' ' GLY . 65.9 mtt180 118.38 131.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 117.768 0.784 . . . . 0.0 110.981 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -52.75 -26.28 13.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 63.7 m-20 -70.58 -35.79 73.24 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 222' ' ' ARG . 0.4 OUTLIER -59.9 -43.34 94.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.03 71.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.34 -28.81 68.46 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' B' ' 224' ' ' ASP . 12.8 m-30 -69.55 -49.18 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 110.167 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.28 77.36 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.477 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -71.4 -55.41 8.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.138 . . . . 0.0 108.356 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.43 ' CD1' ' OE1' ' B' ' 282' ' ' GLU . 5.8 mt -54.24 -47.51 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.536 HG13 HG11 ' B' ' 241' ' ' VAL . 40.1 t -60.73 -28.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 28.4 p -69.44 -37.31 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.541 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -70.08 -47.61 61.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.131 . . . . 0.0 108.919 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.24 -41.61 97.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.8 -26.27 67.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -78.51 -35.47 46.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.045 -1.034 . . . . 0.0 109.371 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.566 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -74.3 -51.65 14.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -142.45 -152.51 5.7 Favored Glycine 0 N--CA 1.478 1.443 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -98.18 130.97 44.92 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.253 -1.145 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.536 HG11 HG13 ' B' ' 232' ' ' VAL . 2.2 t -89.67 110.79 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.526 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 16.9 mt -79.37 -29.2 42.05 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.673 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' B' ' 214' ' ' PHE . 13.6 p -83.0 24.19 0.78 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.521 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 243' ' ' THR . 85.9 tt0 -44.36 -31.19 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.539 ' CD2' ' OD2' ' B' ' 269' ' ' ASP . 0.1 OUTLIER -54.96 -36.05 64.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.845 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' B' ' 245' ' ' HIS . 55.8 t -50.32 -66.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -63.11 -39.16 93.89 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -61.41 -0.31 0.37 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -60.58 -40.15 90.68 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.167 -0.958 . . . . 0.0 108.735 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -49.29 -23.1 1.25 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.494 -0.754 . . . . 0.0 109.782 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' B' ' 251' ' ' LEU . 0.7 OUTLIER -66.78 123.25 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 251' ' ' LEU . 3.3 mt-10 54.06 163.25 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 108.88 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' B' ' 258' ' ' ALA . 84.5 Cg_exo -43.09 135.84 5.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.781 1.654 . . . . 0.0 111.038 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.898 HD22 ' H ' ' B' ' 221' ' ' GLY . 4.6 mp -81.14 -103.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 108.842 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 38.18 113.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.798 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 14.7 mm-40 -37.86 -48.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.12 -1.223 . . . . 0.0 109.204 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -74.8 -31.91 61.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 108.846 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -83.22 46.97 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -139.89 -164.71 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.24 68.62 0.22 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.03 75.66 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 30.5 p-10 -52.57 -38.4 59.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 263' ' ' GLN . . . . . 0.583 ' NE2' ' OE2' ' B' ' 267' ' ' GLU . 46.4 tt0 -63.49 -48.9 75.74 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -56.66 -36.9 70.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.099 -1.001 . . . . 0.0 109.145 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.5 OUTLIER -64.05 -38.07 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.595 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.5 OUTLIER -77.31 -58.13 3.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.716 . . . . 0.0 110.478 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.595 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 95.9 mt-10 -45.23 -46.26 12.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.778 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.82 -42.61 77.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.746 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' B' ' 245' ' ' HIS . 87.5 m-20 -66.47 -36.37 82.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.969 . . . . 0.0 110.695 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.554 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 1.3 mm? -69.56 -52.23 28.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.92 -1.113 . . . . 0.0 109.636 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -57.01 -40.58 76.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.526 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 1.0 OUTLIER -67.21 -44.64 79.05 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.275 -0.89 . . . . 0.0 109.608 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.573 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.9 tp -52.22 -35.31 49.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -72.34 -33.45 67.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.79 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.81 -1.33 54.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.37 51.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 112.401 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' B' ' 211' ' ' SER . 53.1 m-20 -100.58 -30.43 11.78 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 57.4 t -137.03 144.31 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.667 HG22 ' CB ' ' B' ' 213' ' ' TYR . 77.2 t -133.33 139.78 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.782 -1.199 . . . . 0.0 111.16 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 280' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 43.5 t -142.54 121.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -113.38 122.18 46.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.799 -1.188 . . . . 0.0 110.188 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.43 ' OE1' ' CD1' ' B' ' 231' ' ' ILE . 53.7 tt0 -86.03 112.91 21.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.836 HG11 HD11 ' B' ' 316' ' ' LEU . 1.9 t -86.45 -99.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 6.2 m 59.9 -96.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.217 -1.552 . . . . 0.0 109.036 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -61.64 133.43 93.45 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.871 -1.143 . . . . 0.0 108.582 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.472 ' HD3' ' HE ' ' B' ' 314' ' ' ARG . 33.1 Cg_endo -66.77 115.27 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.938 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.403 ' OG ' HG23 ' B' ' 290' ' ' VAL . 13.1 t -138.22 130.22 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.812 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.476 HD13 ' CG1' ' A' ' 83' ' ' VAL . 8.4 mt -69.39 -40.8 77.17 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.79 94.19 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' B' ' 216' ' ' GLY . 43.5 t -65.57 -47.53 86.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.462 -1.023 . . . . 0.0 108.827 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.26 73.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -68.85 -47.49 65.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.59 -0.947 . . . . 0.0 109.773 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.76 -35.08 78.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 0.0 109.635 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.5 mt -69.02 -46.82 66.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 108.596 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.38 -34.19 88.65 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.47 HH21 ' HB2' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -64.02 -43.89 94.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.458 -1.025 . . . . 0.0 109.685 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -71.39 -28.65 64.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.619 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.591 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -53.91 -50.15 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.591 ' N ' HG12 ' B' ' 298' ' ' VAL . . . -85.61 -55.75 3.84 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.419 0.628 . . . . 0.0 110.564 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.624 ' O ' HD23 ' B' ' 300' ' ' LEU . 1.1 tt -61.81 -17.07 54.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' B' ' 302' ' ' LYS . . . 75.78 -162.75 53.16 Favored Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' B' ' 301' ' ' GLY . 7.5 mmtm 96.63 136.4 0.03 OUTLIER Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 302' ' ' LYS . 80.7 Cg_exo -36.41 110.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.2 1.933 . . . . 0.0 111.591 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.503 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.4 mt -104.65 87.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.91 0.862 . . . . 0.0 111.256 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 305' ' ' LEU . 32.9 tp -91.16 116.94 29.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 306' ' ' CYS . . . . . 0.541 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.4 OUTLIER -108.28 140.29 41.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 0.0 108.585 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.0 mt -123.7 138.77 54.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.0 111.059 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -140.34 138.89 35.23 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -91.69 135.17 27.99 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.29 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.518 2.145 . . . . 0.0 110.934 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -49.78 -33.49 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.452 ' O ' ' C ' ' B' ' 313' ' ' GLY . 38.7 p -97.27 -21.06 17.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 39.6 44.74 2.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.472 ' HE ' ' HD3' ' B' ' 286' ' ' PRO . 14.5 mtp85 -70.31 8.38 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -1.203 . . . . 0.0 109.397 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' B' ' 313' ' ' GLY . 97.3 t 53.85 102.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.297 -0.877 . . . . 0.0 110.356 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 283' ' ' VAL . 13.3 tp -57.39 139.6 52.63 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.13 144.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.469 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 318' ' ' ALA . . . . . 0.791 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -59.74 -36.95 77.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' B' ' 319' ' ' MET . 25.3 mmm -69.0 -45.35 70.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.83 -46.59 91.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -68.44 -44.54 74.71 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.116 -0.99 . . . . 0.0 109.326 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.8 -26.6 68.89 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -56.47 -52.45 64.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.015 -1.285 . . . . 0.0 107.863 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 9.25 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' B' ' 323' ' ' ALA . 23.5 t0 -67.75 -35.48 78.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 107.945 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.878 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.78 176.49 45.68 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 21.1 m 56.25 -26.05 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.463 1.125 . . . . 0.0 108.824 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.878 ' H ' ' C ' ' B' ' 326' ' ' GLY . 7.2 tpp85 -150.34 -3.32 0.36 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.37 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.541 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 6.1 t80 -153.0 112.55 3.87 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.542 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 86.8 mt-30 -138.77 132.85 31.34 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.572 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 43.5 t -87.16 103.69 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.542 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 14.2 m0 -98.4 139.71 33.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -0.932 . . . . 0.0 109.306 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.477 ' O ' ' CE ' ' B' ' 342' ' ' MET . 73.9 m-20 -94.32 142.11 27.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.891 -1.13 . . . . 0.0 109.052 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.485 ' CD2' HG23 ' B' ' 339' ' ' VAL . 3.7 p90 -157.71 -173.28 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 111.078 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.651 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -159.22 157.61 31.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.6 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -135.77 -1.14 3.08 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.648 ' O ' ' SD ' ' B' ' 342' ' ' MET . 23.0 pt-20 -154.29 10.37 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.235 . . . . 0.0 109.995 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' B' ' 342' ' ' MET . 1.9 p -51.03 -41.82 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.023 -1.048 . . . . 0.0 108.856 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 81.2 tt0 -61.37 -28.78 69.48 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.027 -1.045 . . . . 0.0 108.833 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.1 m -71.96 -48.12 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.665 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.76 -47.0 77.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 75.3 mt -62.62 -30.13 71.13 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.07 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 43.4 t0 -68.32 -39.55 81.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -70.47 -51.61 27.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.173 . . . . 0.0 108.955 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 346' ' ' TYR . . . . . 0.63 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.3 t80 -57.88 -47.06 83.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.507 -0.746 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.818 ' CG ' HD12 ' B' ' 351' ' ' LEU . 11.7 m-85 -74.83 -32.46 61.96 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.185 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 12.3 mm-40 -58.94 -26.28 64.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 349' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -70.51 -21.67 62.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.821 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -173.23 101.56 0.12 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.818 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 175.17 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' B' ' 351' ' ' LEU . 90.7 Cg_endo -83.15 30.49 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 111.513 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 65.38 34.12 8.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.505 -0.747 . . . . 0.0 109.02 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp 50.02 40.74 22.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 9.7 t -51.14 169.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.07 65.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 46.8 t 49.4 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 82.9 p -136.8 158.61 44.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.838 . . . . 0.0 109.143 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 25.4 t -127.34 146.36 50.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' B' ' 362' ' ' SER . 10.1 m-70 -78.29 152.32 78.79 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -38.68 -25.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.41 2.073 . . . . 0.0 112.111 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 360' ' ' HIS . 73.1 m -72.5 160.42 32.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.449 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.23 153.63 39.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.55 147.4 30.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.4 t -140.22 145.6 37.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.365 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.32 176.6 37.76 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -103.29 140.75 36.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -1.107 . . . . 0.0 109.57 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -148.89 176.93 9.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 109.585 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -170.61 135.93 1.14 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.452 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' CYS . 61.2 Cg_endo -75.09 155.27 42.48 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.389 2.059 . . . . 0.0 112.141 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 12.2 p -54.01 -175.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.112 -0.992 . . . . 0.0 108.508 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 69.4 m -111.17 152.63 26.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.109 -0.995 . . . . 0.0 108.739 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 35' ' ' LEU . 9.0 t -140.09 136.94 38.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 122.086 0.946 . . . . 0.0 109.273 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 69' ' ' ASP . 7.3 t80 -115.58 111.03 20.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.574 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.14 124.47 42.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 0.0 109.087 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 13.3 m -99.81 143.2 30.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.194 -0.941 . . . . 0.0 109.034 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.68 157.09 27.15 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.556 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 5.3 m -81.0 119.82 24.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.773 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.688 ' CG2' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -109.42 137.68 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.9 . . . . 0.0 108.732 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 47.2 ttt-85 83.12 10.88 0.52 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.56 -13.8 12.41 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.03 103.52 0.17 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.55 -25.67 27.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.063 -1.257 . . . . 0.0 109.635 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -53.03 -39.16 62.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.65 -28.99 68.91 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.91 -41.62 97.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.89 -50.46 70.79 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.23 -32.91 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.5 m-30 -69.41 -46.86 65.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.951 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.89 84.47 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.739 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.692 HH22 HH21 ' A' ' 34' ' ' ARG . 65.9 ttt-85 -69.46 -56.4 7.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.506 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.47 -48.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -58.1 -32.27 43.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 p -63.32 -43.32 98.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 109.7 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.692 HH21 HH22 ' A' ' 30' ' ' ARG . 82.3 mtt-85 -64.4 -40.3 95.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.154 . . . . 0.0 108.06 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 38' ' ' TYR . 85.4 mt -62.9 -43.08 99.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.83 -28.49 61.64 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.81 -59.88 2.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.709 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -125.49 152.38 45.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 176.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.8 64.29 1.62 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' C ' ' O ' ' A' ' 39' ' ' GLY . 10.4 ttpt -34.42 121.79 0.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -1.037 . . . . 0.0 108.657 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.38 108.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.811 -1.181 . . . . 0.0 109.16 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 78.3 mt -72.17 -36.82 69.38 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.775 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.526 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -91.24 93.16 8.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.024 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.23 -23.74 19.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.51 -37.85 85.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 55.9 t -47.32 -73.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.098 -1.001 . . . . 0.0 109.68 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.18 -47.6 71.86 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.039 -1.038 . . . . 0.0 109.14 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.691 ' C ' HD11 ' A' ' 51' ' ' LEU . 26.3 t70 -72.35 45.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -122.79 -16.34 7.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -8.28 17.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.04 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.11 130.08 34.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.224 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 51' ' ' LEU . 5.7 mt-10 55.81 157.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' HH22 ' A' ' 22' ' ' ARG . 8.9 Cg_endo -52.77 112.03 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.286 1.991 . . . . 0.0 111.493 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.66 -3.79 54.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.617 ' N ' HD12 ' A' ' 54' ' ' LEU . . . -46.09 150.37 1.58 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' B' ' 318' ' ' ALA . 43.9 mt-10 -53.56 -35.49 60.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.062 -1.258 . . . . 0.0 109.117 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -66.31 -11.21 49.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . -57.17 176.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -47.03 164.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.26 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -43.31 150.96 0.46 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 154.87 -17.44 0.55 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.85 -44.03 90.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.0 109.219 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.39 -55.45 7.04 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -56.42 -29.31 61.42 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -69.85 -49.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.427 ' CE1' HD22 ' A' ' 70' ' ' LEU . 4.4 t-80 -64.73 -55.34 20.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.629 -0.669 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 91.1 mt-10 -49.1 -54.91 13.98 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.967 -1.083 . . . . 0.0 110.206 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 68' ' ' GLN . 4.2 mp0 -71.77 -50.61 28.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.924 -1.11 . . . . 0.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.482 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.4 m-20 -61.43 -54.61 41.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 111.493 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -72.37 -39.15 68.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.709 -1.244 . . . . 0.0 111.202 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 63.8 t-20 -58.48 -50.26 74.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.011 -1.68 . . . . 0.0 108.217 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.55 -38.77 81.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.2 tp -49.84 -39.79 40.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.54 -31.3 65.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.614 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -85.06 0.31 51.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.919 -1.113 . . . . 0.0 109.344 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.98 121.86 18.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 112.057 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' SER . 76.2 m-20 -68.47 -37.63 80.33 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 79.6 t -131.49 151.23 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.0 t -135.77 143.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 0.0 112.356 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 t -135.08 156.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 15' ' ' CYS . . . -162.99 123.38 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.364 -1.46 . . . . 0.0 110.749 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.09 116.46 22.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 116' ' ' LEU . 2.0 m -101.39 30.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 108.778 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 113' ' ' GLY . 25.9 m -62.13 -108.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.817 -0.552 . . . . 0.0 110.125 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 84' ' ' THR . 17.2 tm0? -41.02 126.57 2.03 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.502 -0.749 . . . . 0.0 110.221 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -45.76 113.44 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.881 1.721 . . . . 0.0 111.645 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.615 ' O ' HD23 ' B' ' 288' ' ' LEU . 8.0 t -142.16 131.88 24.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.0 110.219 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' O ' ' B' ' 287' ' ' SER . 8.3 mt -79.71 -42.46 24.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.76 -37.29 89.78 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 t -74.37 -42.56 50.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -1.22 . . . . 0.0 108.817 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.02 -25.18 67.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -70.82 -56.51 6.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.79 -0.829 . . . . 0.0 109.308 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 96.1 mt-10 -60.18 -33.76 72.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.693 ' C ' HD13 ' A' ' 94' ' ' LEU . 3.2 tm? -70.75 -49.95 41.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.17 57.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 HG11 ' B' ' 298' ' ' VAL . 56.0 ttt85 -56.16 -36.28 68.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -1.076 . . . . 0.0 108.334 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.69 -38.58 87.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -54.4 -43.47 62.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.876 -1.14 . . . . 0.0 108.531 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -74.71 -48.36 26.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.411 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.8 pp -119.5 -28.02 5.42 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.912 -1.117 . . . . 0.0 110.585 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -40.74 162.35 0.01 OUTLIER Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 2.5 mmtp -98.38 -161.57 0.04 OUTLIER Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 71.8 Cg_exo -41.71 115.03 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.354 1.519 . . . . 0.0 110.376 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.3 mt -106.62 138.97 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.088 0.947 . . . . 0.0 112.188 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 132' ' ' TRP . 50.8 tp -126.5 118.1 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER -102.63 157.27 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.924 -1.11 . . . . 0.0 109.411 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 134' ' ' TYR . 5.7 mt -143.12 127.75 18.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -138.78 145.05 39.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.208 -0.933 . . . . 0.0 108.966 178.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.522 ' NH1' ' OH ' ' A' ' 134' ' ' TYR . 24.2 ptt-85 -128.67 148.12 67.14 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.52 29.46 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.58 2.186 . . . . 0.0 112.507 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 50.6 mt-30 -104.79 -44.01 4.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -129.69 -22.62 2.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 108.676 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 114' ' ' ARG . . . -87.03 -52.03 3.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.705 ' O ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 39.59 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 114' ' ' ARG . 96.6 t 61.78 93.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.887 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.5 pt? -70.03 -43.56 71.05 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.788 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER 163.05 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.877 -1.139 . . . . 0.0 110.303 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' B' ' 256' ' ' GLU . . . -63.91 -46.12 86.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.818 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 80.4 mmm -62.22 -46.53 88.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 94' ' ' LEU . 3.8 mm -61.1 -41.86 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -44.57 95.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.921 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.21 -33.96 88.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -56.3 -22.16 28.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.274 -1.133 . . . . 0.0 108.659 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -36.45 109.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.276 0.56 . . . . 0.0 110.084 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' OD2' ' OG ' ' A' ' 127' ' ' SER . 55.0 t0 -105.73 -29.41 10.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.38 77.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 80.0 p -122.24 -78.97 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -1.066 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' N ' ' OG ' ' A' ' 127' ' ' SER . 46.6 ttp180 -97.92 -5.08 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 108.885 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.27 125.34 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.449 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 57.0 mt-30 -138.35 149.94 46.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.051 -1.03 . . . . 0.0 111.215 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.25 107.22 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.437 ' CD2' HD11 ' A' ' 105' ' ' LEU . 20.3 m0 -106.14 145.23 31.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.128 -0.983 . . . . 0.0 109.984 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.531 ' O ' ' CE ' ' A' ' 142' ' ' MET . 57.7 p-10 -100.97 161.07 13.85 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.649 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 8.0 p90 -172.67 -167.88 0.47 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.807 -1.183 . . . . 0.0 110.7 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.963 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -131.34 149.95 52.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.714 ' C ' ' O ' ' A' ' 135' ' ' ALA . 72.2 mt-10 -32.29 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.963 ' O ' ' O ' ' A' ' 135' ' ' ALA . . . -95.54 -176.45 37.14 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.92 -13.11 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.057 -1.261 . . . . 0.0 108.864 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.7 ' H ' ' C ' ' A' ' 137' ' ' GLY . 1.3 p -59.19 -46.88 91.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.541 ' OE1' ' NH2' ' A' ' 34' ' ' ARG . 23.3 pt-20 -53.37 -33.58 54.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.7 m -68.31 -40.84 81.56 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.395 -0.816 . . . . 0.0 108.884 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 8.2 mmt -52.49 -48.04 66.2 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.0 -38.59 91.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.44 -40.46 95.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 110.731 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -70.05 -49.87 46.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.488 -1.382 . . . . 0.0 108.796 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.84 -48.72 80.55 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 151' ' ' LEU . 19.4 m-85 -70.45 -32.95 70.72 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.236 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -61.19 -31.14 70.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.13 12.21 5.44 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -138.1 -104.29 0.18 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.323 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 12.1 mt -33.5 90.69 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.844 -0.535 . . . . 0.0 110.841 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' N ' ' O ' ' A' ' 150' ' ' TYR . 83.6 Cg_endo -95.33 -83.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 123.217 2.612 . . . . 0.0 111.477 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -82.58 -22.93 34.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -53.04 -36.22 60.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 94.1 m -58.6 -40.74 84.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -84.7 -48.7 9.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.7 t -156.73 140.94 16.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.963 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.9 m -74.43 163.93 27.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.359 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -64.82 153.98 38.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 162' ' ' SER . 47.4 m80 -58.47 152.57 43.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -42.82 -19.81 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 160' ' ' HIS . 15.0 t -54.14 -30.94 50.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.615 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.2 37.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.97 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.09 30.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.8 t -139.07 145.24 39.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -70.61 176.49 35.5 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -103.41 140.81 36.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 0.0 109.394 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -149.11 176.86 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -170.7 135.93 1.11 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.49 -0.756 . . . . 0.0 109.498 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' B' ' 210' ' ' CYS . 61.1 Cg_endo -75.09 155.01 42.46 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.46 2.107 . . . . 0.0 112.18 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' B' ' 209' ' ' PRO . 10.2 p -53.85 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.173 -0.955 . . . . 0.0 108.467 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' B' ' 277' ' ' ASP . 62.9 m -111.17 152.82 26.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.157 -0.965 . . . . 0.0 108.714 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.549 HG11 HD22 ' B' ' 235' ' ' LEU . 8.9 t -140.33 136.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 122.04 0.924 . . . . 0.0 109.21 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 269' ' ' ASP . 7.2 t80 -115.51 110.95 19.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.592 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.04 124.2 42.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.036 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.425 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 12.2 m -99.73 142.62 30.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.046 -1.034 . . . . 0.0 109.071 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -144.18 157.17 27.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.552 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 5.7 m -80.78 119.96 24.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -1.037 . . . . 0.0 109.795 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.686 ' CG2' HD22 ' B' ' 254' ' ' LEU . 0.4 OUTLIER -109.41 138.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' B' ' 218' ' ' ILE . 47.3 ttt-85 82.85 10.66 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.661 -0.649 . . . . 0.0 109.487 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -111.87 -13.5 12.43 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 166.21 103.54 0.17 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' B' ' 222' ' ' ARG . 0.0 OUTLIER -54.65 -25.6 27.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -1.213 . . . . 0.0 109.538 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.09 -39.14 63.14 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 79.4 m-20 -66.7 -29.01 68.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -63.93 -41.81 97.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.16 72.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.28 -33.17 69.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.654 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.5 m-30 -69.26 -46.47 67.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 0.0 110.074 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.87 85.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.766 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.725 HH22 HH21 ' B' ' 234' ' ' ARG . 65.8 ttt-85 -69.37 -56.19 8.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 108.535 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.2 mt -52.86 -48.18 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 228' ' ' TYR . 56.1 t -58.2 -32.22 43.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 18.1 p -63.29 -43.58 97.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 109.597 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.725 HH21 HH22 ' B' ' 230' ' ' ARG . 83.6 mtt-85 -64.23 -40.5 96.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.867 -1.145 . . . . 0.0 108.008 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.712 ' O ' ' O ' ' B' ' 238' ' ' TYR . 87.0 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -56.93 -28.3 61.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 108.75 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.04 -59.87 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.712 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.9 OUTLIER -125.32 152.32 44.87 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 176.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 84.03 64.16 1.62 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' B' ' 239' ' ' GLY . 10.6 ttpt -34.2 121.9 0.48 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -1.085 . . . . 0.0 108.584 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.67 109.53 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.793 -1.192 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 78.1 mt -72.6 -37.64 68.07 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.677 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.53 ' OG1' HG23 ' B' ' 246' ' ' VAL . 0.1 OUTLIER -90.47 92.86 9.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.957 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -91.89 -23.7 19.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 109.158 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -61.94 -37.77 85.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 110.128 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.59 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 55.8 t -46.86 -73.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.658 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -53.83 -48.08 70.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.684 ' C ' HD11 ' B' ' 251' ' ' LEU . 26.2 t70 -72.26 45.48 0.13 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -122.82 -16.57 7.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -8.32 15.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.984 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -84.3 130.41 34.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.088 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' B' ' 251' ' ' LEU . 6.0 mt-10 55.55 157.97 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.039 -1.038 . . . . 0.0 108.861 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.446 ' HA ' HH22 ' B' ' 222' ' ' ARG . 8.6 Cg_endo -52.7 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.224 1.95 . . . . 0.0 111.437 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.686 HD22 ' CG2' ' B' ' 218' ' ' ILE . 0.3 OUTLIER -92.87 -3.97 53.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.608 ' N ' HD12 ' B' ' 254' ' ' LEU . . . -45.84 150.2 1.48 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 44.2 mt-10 -53.43 -35.89 60.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -1.205 . . . . 0.0 108.983 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.99 -11.14 45.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.0 108.843 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 255' ' ' GLY . . . -57.51 175.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' B' ' 260' ' ' GLY . . . -46.97 165.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.326 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' B' ' 259' ' ' ALA . . . -43.36 151.5 0.42 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 154.25 -17.53 0.61 Allowed Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.07 -44.24 91.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.116 -1.226 . . . . 0.0 109.265 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -72.32 -55.26 7.42 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 0.9 OUTLIER -56.39 -29.27 61.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' B' ' 261' ' ' GLY . 8.5 mt -69.87 -49.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.429 ' CE1' HD22 ' B' ' 270' ' ' LEU . 3.9 t-80 -65.27 -55.15 19.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.662 -0.649 . . . . 0.0 110.001 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 90.9 mt-10 -49.01 -54.55 15.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 110.224 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 268' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 4.8 mp0 -72.06 -50.8 25.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.923 -1.111 . . . . 0.0 111.038 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.469 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 1.6 m-20 -61.2 -54.79 39.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.457 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.429 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.5 OUTLIER -72.43 -38.79 68.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.766 -1.209 . . . . 0.0 111.323 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 64.7 t-20 -58.74 -50.02 75.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 119.955 -1.715 . . . . 0.0 108.155 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -59.8 -38.9 83.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.4 tp -49.64 -39.47 36.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.402 ' OE1' ' NH2' ' B' ' 296' ' ' ARG . 15.2 mt-30 -72.84 -31.22 64.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.533 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.24 0.2 52.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.97 121.95 18.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.318 -0.864 . . . . 0.0 112.091 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.482 ' H ' ' HB2' ' B' ' 211' ' ' SER . 79.3 m-20 -68.56 -37.65 80.09 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 77.7 t -131.34 151.45 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 86.9 t -136.16 143.6 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 122.564 1.173 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 27.8 t -135.11 156.35 39.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -163.06 122.72 2.2 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.434 -1.416 . . . . 0.0 110.81 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.29 116.23 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.476 HG21 HD12 ' B' ' 316' ' ' LEU . 1.9 m -101.24 29.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 108.778 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.595 HG22 ' N ' ' B' ' 313' ' ' GLY . 25.3 m -61.86 -109.37 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.728 -0.607 . . . . 0.0 110.169 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.409 ' N ' HG22 ' B' ' 284' ' ' THR . 17.4 tm0? -40.63 126.76 1.87 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.407 -0.808 . . . . 0.0 110.181 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -45.61 113.7 0.61 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.933 1.755 . . . . 0.0 111.595 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.627 ' O ' HD23 ' A' ' 88' ' ' LEU . 8.1 t -142.64 131.66 23.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.121 -0.987 . . . . 0.0 110.251 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 87' ' ' SER . 8.3 mt -79.68 -42.6 24.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 109.304 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -58.57 -37.52 89.07 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 8.2 t -74.2 -42.28 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 108.809 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -63.49 -24.98 68.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -70.81 -56.42 6.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.707 -0.878 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.425 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 95.7 mt-10 -60.19 -33.68 72.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.677 ' C ' HD13 ' B' ' 294' ' ' LEU . 3.3 tm? -70.77 -49.73 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.99 -51.5 54.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.41 HH11 HG11 ' A' ' 98' ' ' VAL . 56.1 ttt85 -55.96 -36.4 67.76 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 108.394 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.55 -38.78 87.85 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.463 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.4 OUTLIER -54.19 -43.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 120.862 -1.149 . . . . 0.0 108.565 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -74.55 -48.8 24.71 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 112.387 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.7 pp -119.06 -27.95 5.61 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.974 -1.079 . . . . 0.0 110.747 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' B' ' 300' ' ' LEU . . . -40.8 162.19 0.01 OUTLIER Glycine 0 C--N 1.289 -2.044 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.49 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 2.8 mmtp -98.23 -161.54 0.04 OUTLIER Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 75.9 Cg_exo -41.89 115.41 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 121.458 1.557 . . . . 0.0 110.329 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.85 138.96 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.195 0.998 . . . . 0.0 112.147 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' B' ' 332' ' ' TRP . 50.9 tp -126.47 118.25 24.55 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.8 157.41 16.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.899 -1.126 . . . . 0.0 109.457 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' B' ' 334' ' ' TYR . 5.9 mt -143.02 128.0 18.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -139.33 144.7 38.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.139 -0.976 . . . . 0.0 108.865 178.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' B' ' 334' ' ' TYR . 24.9 ptt-85 -128.65 148.09 66.96 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.464 -0.772 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.42 29.46 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.208 . . . . 0.0 112.566 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.544 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 51.3 mt-30 -104.62 -43.77 5.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 22.6 m -129.73 -23.24 2.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 108.6 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.707 ' O ' ' O ' ' B' ' 314' ' ' ARG . . . -86.44 -51.87 3.37 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.707 ' O ' ' O ' ' B' ' 313' ' ' GLY . 0.1 OUTLIER 39.47 101.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 315' ' ' VAL . . . . . . . . . . . . . 96.6 t 61.97 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.897 HD23 ' H ' ' B' ' 316' ' ' LEU . 1.5 pt? -70.45 -43.84 69.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.739 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.3 OUTLIER 163.35 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.96 -1.088 . . . . 0.0 110.176 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 318' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . . . -64.1 -45.57 88.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.442 -0.786 . . . . 0.0 109.798 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 80.2 mmm -62.52 -46.9 86.3 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.36 -0.838 . . . . 0.0 109.371 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.411 ' CD1' HD12 ' B' ' 294' ' ' LEU . 3.8 mm -60.69 -41.88 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -44.39 96.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.748 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -63.66 -33.58 87.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -56.7 -22.11 32.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -1.15 . . . . 0.0 108.605 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -36.44 109.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.21 0.529 . . . . 0.0 110.043 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -105.94 -29.46 9.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.12 3.7 76.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 68.1 p -121.49 -79.08 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.472 -1.017 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -97.89 -4.93 35.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.855 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.404 ' HE1' HD11 ' B' ' 294' ' ' LEU . 85.6 t80 -137.37 125.24 22.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.13 149.77 46.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.0 111.12 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.04 106.93 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.436 ' CD2' HD11 ' B' ' 305' ' ' LEU . 20.4 m0 -106.21 145.11 31.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.111 -0.993 . . . . 0.0 110.103 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.54 ' O ' ' CE ' ' B' ' 342' ' ' MET . 57.1 p-10 -100.68 160.83 14.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 8.0 p90 -172.41 -167.89 0.49 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.735 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.962 ' O ' ' O ' ' B' ' 337' ' ' GLY . . . -131.47 149.49 52.51 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.76 ' C ' ' O ' ' B' ' 335' ' ' ALA . 71.1 mt-10 -31.94 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.962 ' O ' ' O ' ' B' ' 335' ' ' ALA . . . -95.36 -176.71 37.42 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -13.06 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.93 -1.335 . . . . 0.0 108.908 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.713 ' H ' ' C ' ' B' ' 337' ' ' GLY . 1.3 p -59.12 -46.97 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.55 ' OE1' ' NH2' ' B' ' 234' ' ' ARG . 22.7 pt-20 -53.21 -33.78 54.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 17.9 m -68.16 -40.7 82.27 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.955 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.54 ' CE ' ' O ' ' B' ' 333' ' ' ASP . 7.9 mmt -52.86 -47.91 67.47 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.824 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -64.44 -40.36 95.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.42 -0.8 . . . . 0.0 110.73 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -70.11 -49.71 48.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.422 -1.423 . . . . 0.0 108.756 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.25 -48.65 80.83 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 109.961 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.494 ' HB3' HD12 ' B' ' 351' ' ' LEU . 19.7 m-85 -70.41 -32.51 70.17 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.144 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.59 -30.95 71.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.24 12.25 5.53 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.5 t80 -138.04 -104.44 0.18 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.283 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' B' ' 347' ' ' PHE . 12.0 mt -33.53 90.77 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.915 -0.491 . . . . 0.0 110.815 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' B' ' 350' ' ' TYR . 78.8 Cg_endo -95.46 -83.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 123.27 2.647 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.33 -23.34 35.15 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -52.78 -36.33 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 93.9 m -58.34 -40.87 83.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.586 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -84.72 -48.88 8.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.923 . . . . 0.0 109.473 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 23.5 t -156.38 141.53 17.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 31.5 m -75.16 162.79 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 44.2 t -63.79 153.47 36.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.347 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' B' ' 362' ' ' SER . 49.0 m80 -57.91 152.86 36.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.62 -19.77 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.373 2.049 . . . . 0.0 112.089 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.445 ' N ' ' O ' ' B' ' 360' ' ' HIS . 12.5 t -53.86 -30.57 46.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.216 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.34 179.792 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.74 -35.06 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.49 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.58 -33.77 74.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 p -78.94 154.39 29.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.288 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.38 43.07 2.67 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -96.91 131.02 44.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 109.56 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -143.93 178.06 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.07 151.7 78.34 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.434 -0.791 . . . . 0.0 109.029 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -155.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.533 2.155 . . . . 0.0 111.459 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -102.07 -175.61 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.5 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 11.2 p -120.35 154.39 35.12 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.717 HG11 HD22 ' A' ' 35' ' ' LEU . 7.2 t -133.58 135.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 0.0 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.1 t80 -118.15 95.39 4.87 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -83.2 104.73 13.6 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -95.03 170.43 9.42 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 111.417 -176.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.678 ' HA2' HG22 ' A' ' 90' ' ' VAL . . . 84.3 93.05 0.72 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' CE2' ' A' ' 28' ' ' TYR . 2.7 p -168.39 -177.29 3.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.014 -1.286 . . . . 0.0 109.746 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.75 ' C ' ' H ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER 37.2 -160.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.592 -0.693 . . . . 0.0 109.922 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 1.3 tpm_? 62.43 -16.93 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.75 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . 166.03 108.97 0.21 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.76 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 159.94 -58.71 0.32 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.985 -1.303 . . . . 0.0 110.072 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.3 mmt85 49.43 -73.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.327 -1.102 . . . . 0.0 109.266 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.76 ' N ' ' O ' ' A' ' 21' ' ' GLY . 94.6 mt-10 -54.08 -35.22 61.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 28' ' ' TYR . 4.6 t0 -65.99 -27.75 68.37 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.607 ' OE1' ' N ' ' A' ' 50' ' ' GLU . 5.5 tt0 -57.9 -45.55 86.29 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.46 94.15 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.65 -30.22 71.35 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 32' ' ' VAL . 22.7 m-30 -70.77 -49.77 43.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.48 -0.762 . . . . 0.0 110.089 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.32 72.68 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.426 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -71.43 -58.15 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.918 -1.113 . . . . 0.0 108.291 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.85 -44.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.802 HG13 HG11 ' A' ' 41' ' ' VAL . 55.4 t -61.07 -28.84 44.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -70.82 -35.09 72.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.422 ' HA ' HH11 ' A' ' 37' ' ' ARG . 68.1 mtp85 -73.89 -50.28 20.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 108.694 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.717 HD22 HG11 ' A' ' 12' ' ' VAL . 13.4 mt -59.64 -40.09 86.51 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.95 -23.0 67.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.422 HH11 ' HA ' ' A' ' 34' ' ' ARG . 26.0 mtt85 -77.88 -34.6 51.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.026 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.9 m-30 -73.32 -51.09 18.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 110.082 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.11 -144.99 4.22 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -98.95 135.59 40.15 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.178 -1.189 . . . . 0.0 108.669 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.802 HG11 HG13 ' A' ' 32' ' ' VAL . 12.4 t -100.11 122.19 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 12.2 mt -87.36 -17.05 33.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.295 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.426 HG22 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -86.22 43.23 1.04 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.402 -0.811 . . . . 0.0 109.513 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -66.34 -38.67 88.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.493 ' ND1' ' C ' ' A' ' 45' ' ' HIS . 6.5 t-80 -53.94 -46.97 71.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.877 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG11 ' CZ ' ' A' ' 14' ' ' PHE . 5.3 t -48.34 -49.31 13.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.315 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.3 -40.74 62.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 108.54 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' HD22 ' A' ' 51' ' ' LEU . 2.7 t0 -75.07 50.89 0.49 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.635 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -126.21 -30.69 2.89 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.607 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -55.08 -5.33 0.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.197 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -49.49 -55.99 11.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 1.8 tm-20 -179.67 -44.73 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.418 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' O ' HD22 ' A' ' 54' ' ' LEU . 13.2 Cg_exo -69.31 92.22 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.686 2.257 . . . . 0.0 112.467 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD22 ' O ' ' A' ' 53' ' ' PRO . 4.0 mm? -125.21 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.809 . . . . 0.0 109.549 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 68.19 35.73 83.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' ALA . 69.3 mm-40 47.46 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.531 -0.982 . . . . 0.0 109.197 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 47.92 13.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.04 -1.037 . . . . 0.0 108.65 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' GLU . . . -139.64 96.64 3.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.48 -0.763 . . . . 0.0 109.016 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 65' ' ' ILE . . . -172.72 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.233 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.16 17.12 21.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 62' ' ' ASP . . . 152.23 76.83 0.02 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 23.8 p-10 -48.69 -44.29 37.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.497 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 89.6 mt-30 -57.42 -45.13 84.95 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.63 -41.58 95.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.506 HD12 ' CB ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -58.04 -39.06 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.463 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.8 t-80 -76.14 -51.02 13.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.63 -0.669 . . . . 0.0 110.38 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 97.0 mt-10 -46.68 -53.69 11.17 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.071 -1.018 . . . . 0.0 109.825 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.85 -42.63 66.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 110.91 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.71 -57.44 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.965 -1.084 . . . . 0.0 111.143 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.097 -1.002 . . . . 0.0 110.792 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -60.97 -52.94 62.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.591 -1.318 . . . . 0.0 108.958 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.69 -40.84 89.21 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 108.703 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 7.6 tp -50.07 -37.7 34.85 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' NZ ' ' A' ' 102' ' ' LYS . 51.4 mt-30 -74.44 -29.43 61.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.715 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 15.3 mt-30 -90.2 3.87 52.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.83 -1.169 . . . . 0.0 109.284 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.01 130.08 40.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.899 . . . . 0.0 112.27 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 11' ' ' SER . 85.1 m-20 -78.09 -34.9 49.91 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.25 144.24 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 13' ' ' TYR . 91.9 t -136.08 129.06 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.917 -1.115 . . . . 0.0 111.205 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 70.1 t -129.03 124.85 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.767 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -121.39 156.13 33.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.307 -1.496 . . . . 0.0 110.24 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -99.82 122.66 43.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.32 33.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 109' ' ' ARG . 4.2 m -88.87 -73.54 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.741 -0.6 . . . . 0.0 109.756 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -77.77 120.48 81.5 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.798 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.41 141.84 89.28 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.236 1.957 . . . . 0.0 112.202 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.92 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -179.49 141.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 110.019 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 92' ' ' TYR . 19.7 mt -62.45 -43.21 99.36 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.458 -0.776 . . . . 0.0 109.044 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -54.48 -38.52 63.13 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.92 HG23 ' OG ' ' A' ' 87' ' ' SER . 44.6 t -68.07 -53.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.512 -0.993 . . . . 0.0 108.676 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.37 -28.41 73.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.509 ' OH ' ' HB2' ' B' ' 323' ' ' ALA . 51.3 t80 -70.72 -55.09 9.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -1.092 . . . . 0.0 109.633 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' SD ' ' B' ' 319' ' ' MET . 77.4 mt-10 -62.15 -34.15 75.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.253 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 81' ' ' ALA . 21.1 mt -70.22 -48.55 56.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.253 -0.905 . . . . 0.0 109.195 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.24 96.07 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -61.92 -40.47 95.59 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.519 -0.989 . . . . 0.0 109.299 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.53 -41.21 76.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.09 -1.006 . . . . 0.0 108.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -39.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -77.64 -51.14 11.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.68 -6.18 10.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.973 -1.079 . . . . 0.0 108.722 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.6 26.0 30.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 104' ' ' ILE . 43.9 mttp -84.38 147.54 50.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.906 -1.35 . . . . 0.0 107.644 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -38.53 116.52 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.756 1.637 . . . . 0.0 110.896 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -115.95 98.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.271 -0.893 . . . . 0.0 111.602 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 80' ' ' VAL . 59.1 tp -94.69 120.64 35.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.28 131.22 55.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.885 -1.134 . . . . 0.0 108.838 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 3.5 mt -123.15 130.19 52.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 0.0 111.502 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -131.12 151.07 51.82 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.569 ' H ' HG23 ' A' ' 84' ' ' THR . 49.9 mtm180 -114.23 136.02 22.22 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.115 -0.99 . . . . 0.0 110.219 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -29.97 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.355 2.037 . . . . 0.0 111.286 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' ' 112' ' ' SER . 12.2 pt20 -59.7 -46.36 89.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.354 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 17.2 t -75.85 -22.18 56.49 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' O ' ' NE ' ' A' ' 114' ' ' ARG . . . 55.93 111.0 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.601 ' O ' ' C ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -144.6 -7.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -1.017 . . . . 0.0 110.259 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' A' ' 114' ' ' ARG . 94.7 t 32.85 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.978 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -61.13 172.31 1.07 Allowed 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.81 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 289' ' ' GLY . 29.3 t -64.95 141.36 58.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 111.721 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.18 63.76 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.529 ' SD ' ' CG ' ' B' ' 293' ' ' GLU . 1.7 mtp -63.94 -43.51 95.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.542 -0.724 . . . . 0.0 109.317 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' B' ' 292' ' ' TYR . 4.1 mm -61.87 -45.48 98.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.497 -0.752 . . . . 0.0 109.418 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -64.43 -44.8 90.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -58.55 -32.1 68.27 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -51.7 -57.33 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 108.265 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 10.38 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 123' ' ' ALA . 2.2 m-20 -68.97 -35.36 76.64 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.747 -1.221 . . . . 0.0 107.757 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.817 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.41 174.04 40.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.4 t 60.56 -30.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.668 1.223 . . . . 0.0 108.573 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.817 ' H ' ' C ' ' A' ' 126' ' ' GLY . 8.7 mtm180 -147.33 0.95 0.71 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.539 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' GLY . 11.3 t80 -156.94 112.9 2.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.521 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 90.5 mt-30 -139.29 142.8 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.398 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.51 98.86 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.521 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 18.1 m0 -94.66 147.29 23.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.345 -0.847 . . . . 0.0 109.521 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' O ' ' HE1' ' A' ' 142' ' ' MET . 67.6 m-20 -100.27 150.64 22.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 7.8 p90 -170.95 177.58 3.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.642 -1.286 . . . . 0.0 111.548 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -141.99 146.83 36.03 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.0 mt-10 -39.41 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.748 -1.22 . . . . 0.0 110.474 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -86.32 -2.37 85.42 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.109 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -135.93 0.19 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.813 -1.404 . . . . 0.0 110.231 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -55.21 -47.04 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.851 -1.156 . . . . 0.0 108.476 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 29.6 mt-10 -53.16 -33.17 51.41 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.7 m -69.56 -40.91 76.52 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 109.25 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.467 ' HE1' ' O ' ' A' ' 133' ' ' ASP . 12.9 mmt -53.16 -51.78 60.9 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 48.8 mt -62.05 -32.48 73.0 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.72 -43.91 87.62 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 -71.98 -47.74 49.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.534 -1.354 . . . . 0.0 109.149 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -60.44 -48.96 79.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 21.3 m-85 -71.37 -28.86 64.34 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.159 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.05 -31.14 71.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.07 9.57 10.03 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 2.5 t80 -134.85 -104.49 0.23 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.237 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.531 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 22.6 mt -32.42 90.84 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.91 -0.494 . . . . 0.0 110.925 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . 71.5 Cg_endo -93.31 -72.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.067 2.511 . . . . 0.0 111.248 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.94 -18.88 19.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -59.95 -29.69 68.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.067 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 156' ' ' ALA . 55.2 m -64.52 157.85 25.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.468 ' HB1' ' OG ' ' A' ' 159' ' ' SER . . . -42.85 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 159' ' ' SER . 8.7 t -99.82 147.79 25.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 m 51.18 12.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.468 ' OG ' ' HB1' ' A' ' 156' ' ' ALA . 85.1 p -82.79 161.15 22.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.547 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -129.39 79.21 74.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 109.286 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.86 -23.66 60.34 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.687 2.258 . . . . 0.0 112.142 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 t -98.02 142.39 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.522 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.25 72.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -61.29 -33.94 74.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 7.4 p -78.64 154.12 30.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.13 43.24 2.69 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -96.97 131.38 43.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -1.147 . . . . 0.0 109.524 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -144.12 177.27 8.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -132.31 151.37 78.19 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.55 -0.719 . . . . 0.0 109.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.62 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 111.34 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 32.1 p -102.21 -175.61 2.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.9 p -120.36 154.0 35.68 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.722 HG11 HD22 ' B' ' 235' ' ' LEU . 6.8 t -133.41 135.37 56.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.7 0.762 . . . . 0.0 109.034 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' B' ' 279' ' ' VAL . 7.9 t80 -118.01 95.76 5.05 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.868 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -83.36 104.94 13.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.1 OUTLIER -95.28 170.23 9.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.078 0.942 . . . . 0.0 111.49 -176.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' B' ' 290' ' ' VAL . . . 84.37 93.51 0.71 Allowed Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.574 ' CB ' ' CE2' ' B' ' 228' ' ' TYR . 2.6 p -168.52 -176.85 2.94 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.754 ' C ' ' H ' ' B' ' 220' ' ' GLY . 0.0 OUTLIER 36.89 -160.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 0.0 109.888 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.404 ' HE ' ' HG3' ' B' ' 256' ' ' GLU . 1.2 tpm_? 62.61 -17.08 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.754 ' H ' ' C ' ' B' ' 218' ' ' ILE . . . 166.18 109.04 0.21 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.757 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 159.91 -59.0 0.32 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.1 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' B' ' 225' ' ' GLN . 9.4 mmt85 49.77 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.324 -1.104 . . . . 0.0 109.093 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.757 ' N ' ' O ' ' B' ' 221' ' ' GLY . 95.2 mt-10 -54.05 -34.9 61.25 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' B' ' 228' ' ' TYR . 4.5 t0 -66.26 -27.61 68.08 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.595 ' OE1' ' N ' ' B' ' 250' ' ' GLU . 5.5 tt0 -58.15 -45.21 87.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.64 -43.28 94.18 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.9 tp -64.07 -29.68 70.8 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.677 ' O ' HG23 ' B' ' 232' ' ' VAL . 22.7 m-30 -71.11 -49.62 42.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.39 -0.818 . . . . 0.0 109.98 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.04 72.67 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.478 -1.289 . . . . 0.0 108.44 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -71.71 -57.9 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.882 -1.136 . . . . 0.0 108.283 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.5 mt -53.09 -44.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.822 HG13 HG11 ' B' ' 241' ' ' VAL . 55.7 t -60.99 -28.74 44.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' B' ' 237' ' ' ARG . 7.1 t -70.94 -34.91 71.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.394 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.412 ' HA ' HH11 ' B' ' 237' ' ' ARG . 67.8 mtp85 -73.88 -50.5 19.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 108.752 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.722 HD22 HG11 ' B' ' 212' ' ' VAL . 14.1 mt -59.22 -40.42 85.78 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -64.78 -23.16 67.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' B' ' 233' ' ' SER . 24.1 mtt85 -77.66 -34.98 52.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 108.922 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -73.23 -50.86 20.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 110.041 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -145.22 -145.29 4.26 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -98.59 135.34 40.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.293 -1.122 . . . . 0.0 108.704 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.822 HG11 HG13 ' B' ' 232' ' ' VAL . 12.8 t -100.07 122.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 11.4 mt -87.35 -16.34 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.309 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.419 HG22 ' CG2' ' B' ' 246' ' ' VAL . 0.2 OUTLIER -86.84 43.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.4 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -66.55 -38.22 86.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.89 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.488 ' ND1' ' C ' ' B' ' 245' ' ' HIS . 6.6 t-80 -54.43 -46.92 73.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.971 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.462 HG11 ' CZ ' ' B' ' 214' ' ' PHE . 5.5 t -48.5 -48.38 14.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.97 59.61 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.649 ' O ' HD22 ' B' ' 251' ' ' LEU . 2.7 t0 -74.86 50.68 0.46 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -126.32 -30.08 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.595 ' N ' ' OE1' ' B' ' 225' ' ' GLN . 0.4 OUTLIER -55.71 -4.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.66 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.4 OUTLIER -50.12 -55.3 15.52 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 1.8 tm-20 179.99 -45.28 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.426 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.644 ' O ' HD22 ' B' ' 254' ' ' LEU . 13.0 Cg_exo -69.14 92.35 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.644 HD22 ' O ' ' B' ' 253' ' ' PRO . 4.0 mm? -125.44 178.39 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 68.26 35.93 83.77 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' B' ' 258' ' ' ALA . 69.0 mm-40 47.05 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -1.02 . . . . 0.0 109.277 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 48.15 13.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.583 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -139.29 96.35 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' B' ' 265' ' ' ILE . . . -172.38 -30.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.64 16.39 22.24 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' B' ' 262' ' ' ASP . . . 152.74 76.56 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 23.8 p-10 -48.42 -44.14 34.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 263' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.9 mt-30 -57.49 -45.41 84.92 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -60.13 -42.05 93.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.505 HD12 ' CB ' ' B' ' 259' ' ' ALA . 0.1 OUTLIER -57.75 -38.7 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.49 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.8 t-80 -76.35 -51.21 12.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.246 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 97.1 mt-10 -46.67 -53.42 11.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.794 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.97 -42.79 66.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.68 -57.35 9.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.0 -1.062 . . . . 0.0 111.143 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -39.64 83.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.091 -1.005 . . . . 0.0 110.81 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.6 t-20 -60.95 -52.74 63.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.684 -1.26 . . . . 0.0 108.965 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.515 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -60.0 -40.75 90.28 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.738 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 8.1 tp -50.06 -37.81 35.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.49 ' O ' ' NZ ' ' B' ' 302' ' ' LYS . 52.2 mt-30 -74.25 -29.55 61.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.773 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 14.8 mt-30 -90.11 3.97 51.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.838 -1.164 . . . . 0.0 109.204 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.07 129.95 39.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 112.311 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.508 ' HB2' ' H ' ' B' ' 211' ' ' SER . 85.1 m-20 -77.96 -34.74 50.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.66 144.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' B' ' 213' ' ' TYR . 87.3 t -136.12 129.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.921 -1.112 . . . . 0.0 111.296 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 280' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 69.4 t -128.96 125.15 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.752 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -121.87 156.72 32.7 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.296 -1.503 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -100.19 123.03 43.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.82 33.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.556 HG23 ' H ' ' B' ' 309' ' ' ARG . 4.0 m -88.45 -73.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.766 -0.583 . . . . 0.0 109.804 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -77.43 120.75 82.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.47 141.7 89.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.255 1.97 . . . . 0.0 112.229 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.937 ' OG ' HG23 ' B' ' 290' ' ' VAL . 0.1 OUTLIER -179.34 140.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.102 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 292' ' ' TYR . 20.1 mt -62.24 -42.83 99.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 289' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 117' ' ' SER . . . -54.88 -38.6 65.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.937 HG23 ' OG ' ' B' ' 287' ' ' SER . 44.3 t -68.03 -52.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.933 . . . . 0.0 108.696 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.45 -27.94 73.42 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.515 ' OH ' ' HB2' ' A' ' 123' ' ' ALA . 50.5 t80 -71.1 -55.28 8.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.368 -1.078 . . . . 0.0 109.592 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.529 ' CG ' ' SD ' ' A' ' 119' ' ' MET . 76.7 mt-10 -62.09 -34.05 75.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.137 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' B' ' 281' ' ' ALA . 21.7 mt -70.24 -48.6 56.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.86 95.87 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 16.8 tpt85 -62.27 -40.42 96.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.544 -0.974 . . . . 0.0 109.244 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.499 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -69.46 -41.48 76.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 108.937 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.41 -39.64 22.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -77.53 -51.38 10.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.924 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.49 -6.11 9.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.949 -1.094 . . . . 0.0 108.834 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.44 26.0 28.97 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.518 ' O ' HG13 ' B' ' 304' ' ' ILE . 43.7 mttp -84.29 147.32 49.96 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.849 -1.383 . . . . 0.0 107.667 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 302' ' ' LYS . 83.6 Cg_exo -38.26 116.15 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.805 1.67 . . . . 0.0 110.856 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 302' ' ' LYS . 3.6 mt -115.76 98.54 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 0.0 111.467 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 280' ' ' VAL . 58.0 tp -94.45 120.85 35.31 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 131.6 54.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.77 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.5 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 3.3 mt -123.48 130.62 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 111.429 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -131.36 151.4 51.56 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.556 ' H ' HG23 ' B' ' 284' ' ' THR . 49.6 mtm180 -114.7 135.88 22.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.026 -1.046 . . . . 0.0 110.185 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.06 -29.37 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 111.381 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' B' ' 312' ' ' SER . 12.1 pt20 -60.32 -45.92 91.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.526 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 16.6 t -76.44 -21.84 55.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.559 ' O ' ' NE ' ' B' ' 314' ' ' ARG . . . 55.82 110.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' B' ' 315' ' ' VAL . 0.0 OUTLIER -144.57 -7.72 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.434 -1.039 . . . . 0.0 110.244 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.568 ' C ' ' O ' ' B' ' 314' ' ' ARG . 86.5 t 33.09 90.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.948 ' H ' HD23 ' B' ' 316' ' ' LEU . 0.2 OUTLIER -60.89 172.23 1.02 Allowed 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.77 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 28.8 t -65.02 141.28 58.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.039 -1.038 . . . . 0.0 111.736 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.38 -32.99 63.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.493 ' SD ' ' CG ' ' A' ' 93' ' ' GLU . 1.8 mtp -64.21 -43.67 94.28 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.597 -0.689 . . . . 0.0 109.319 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 92' ' ' TYR . 4.3 mm -61.49 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -64.82 -44.36 90.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.19 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -58.51 -32.06 68.04 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -52.08 -57.43 9.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -1.178 . . . . 0.0 108.326 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.583 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 10.36 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' B' ' 323' ' ' ALA . 2.0 m-20 -69.12 -35.07 76.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.793 -1.192 . . . . 0.0 107.855 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.803 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.32 174.02 40.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 7.1 t 60.58 -30.92 0.06 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.637 1.208 . . . . 0.0 108.718 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.803 ' H ' ' C ' ' B' ' 326' ' ' GLY . 8.5 mtm180 -147.22 1.04 0.73 Allowed 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.518 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' GLY . 12.1 t80 -157.0 112.83 2.91 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.509 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 91.0 mt-30 -139.23 142.42 37.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.423 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.12 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.509 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 18.3 m0 -94.4 147.24 23.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.28 151.09 21.88 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 7.9 p90 -171.36 177.65 3.48 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.659 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -142.13 147.13 36.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 335' ' ' ALA . 41.3 mt-10 -39.27 -25.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.575 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -86.19 -2.36 85.73 Favored Glycine 0 N--CA 1.495 2.599 0 O-C-N 120.999 -1.063 . . . . 0.0 111.208 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -136.27 0.46 2.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.843 -1.386 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 0.9 OUTLIER -55.59 -47.19 79.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.821 -1.174 . . . . 0.0 108.413 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 30.1 mt-10 -52.67 -33.53 47.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.3 m -69.21 -41.01 77.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 12.7 mmt -53.16 -51.64 61.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 47.4 mt -62.07 -32.61 73.17 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.81 -43.84 87.44 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.326 -0.859 . . . . 0.0 110.587 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -71.81 -48.0 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.527 -1.358 . . . . 0.0 109.216 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.15 -49.02 79.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 110.454 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 20.9 m-85 -71.46 -29.0 64.35 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.219 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -65.98 -31.13 71.86 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.09 9.17 10.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.6 t80 -134.47 -104.21 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.201 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' B' ' 350' ' ' TYR . 21.6 mt -32.91 91.08 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.891 -0.506 . . . . 0.0 110.955 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' TYR . 72.2 Cg_endo -93.42 -72.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.239 2.626 . . . . 0.0 111.301 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -97.31 -19.85 18.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -59.38 -29.5 67.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.063 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 355' ' ' THR . . . . . 0.45 HG22 ' N ' ' B' ' 356' ' ' ALA . 54.2 m -64.45 158.14 24.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.143 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 356' ' ' ALA . . . . . 0.45 ' N ' HG22 ' B' ' 355' ' ' THR . . . -43.16 102.84 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 357' ' ' SER . . . . . 0.43 ' C ' ' N ' ' B' ' 359' ' ' SER . 8.4 t -99.24 147.87 24.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.61 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 75.3 m 51.26 12.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' SER . . . . . 0.44 ' OG ' ' HB1' ' B' ' 356' ' ' ALA . 82.7 p -82.74 160.8 22.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.634 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -129.14 79.34 74.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.419 -0.8 . . . . 0.0 109.263 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.62 -23.32 56.56 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.812 2.342 . . . . 0.0 112.151 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 36.8 t -99.39 144.85 28.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.507 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.428 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' SER . . . -151.03 158.66 44.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.505 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.21 16.62 0.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.415 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 2' ' ' ALA . 50.4 m -65.11 153.21 41.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.76 6.44 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -49.32 140.26 10.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.05 178.07 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.726 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -49.88 150.74 3.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.246 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.4 Cg_exo -56.3 -158.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.967 1.778 . . . . 0.0 110.987 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 31.1 p -111.72 174.55 5.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.683 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 m -113.45 157.02 22.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.15 134.03 47.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.464 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 9.5 t80 -111.84 95.5 5.52 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.646 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.05 118.29 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.78 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -125.21 -130.0 3.43 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t 156.57 111.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.405 -1.056 . . . . 0.0 109.42 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.705 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -54.01 -49.21 62.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 108.883 179.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -51.68 110.42 0.46 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.86 -39.7 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 151.88 14.44 0.07 OUTLIER Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.849 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLN . 2.0 tpp85 66.84 -41.3 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.295 . . . . 0.0 109.393 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' GLY . 80.4 mm-40 -52.03 -37.06 52.24 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 25' ' ' GLN . 35.4 p-10 -68.24 -31.55 71.12 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.555 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 5.1 tt0 -60.9 -42.73 98.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.6 68.22 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.01 -27.85 65.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' VAL . 17.3 m-30 -70.93 -53.59 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -58.43 -35.43 72.08 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.425 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.66 -58.49 3.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.07 . . . . 0.0 108.673 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.4 mt -51.59 -42.78 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.879 HG13 HG11 ' A' ' 41' ' ' VAL . 47.2 t -62.45 -30.03 48.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -69.17 -40.69 77.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.174 -0.954 . . . . 0.0 109.71 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' A' ' 139' ' ' VAL . 95.2 mtt180 -70.29 -49.17 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 108.895 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.05 -39.71 82.88 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 41' ' ' VAL . 48.5 ttt85 -63.1 -24.5 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -76.23 -37.84 57.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.958 -1.089 . . . . 0.0 109.247 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.4 m-85 -68.45 -47.91 65.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.515 -0.74 . . . . 0.0 110.674 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -151.82 -150.31 5.32 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.32 115.48 26.83 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.115 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.879 HG11 HG13 ' A' ' 32' ' ' VAL . 2.7 t -78.29 103.06 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 2.0 mt -47.14 126.33 9.03 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.001 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' LEU . 43.1 m -38.57 138.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.815 0.817 . . . . 0.0 111.131 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' VAL . 26.5 mt-10 -149.46 101.93 3.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 49' ' ' ALA . 18.6 t-80 -43.19 -19.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.738 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 44' ' ' GLU . 87.5 t -46.03 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.05 -39.54 66.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.861 -1.15 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.941 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.72 21.07 0.16 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -86.69 -19.41 29.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 108.859 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 57.1 mt-10 -62.11 7.33 0.06 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -88.86 134.87 33.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 51' ' ' LEU . 7.3 mm-40 54.9 159.61 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' C ' HD22 ' A' ' 54' ' ' LEU . 89.0 Cg_exo -38.56 153.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.562 2.175 . . . . 0.0 112.258 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 53' ' ' PRO . 3.9 mm? -112.7 154.69 25.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.379 -0.826 . . . . 0.0 109.726 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 137.48 41.81 0.1 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 49.16 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -1.062 . . . . 0.0 109.256 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 55' ' ' GLY . 50.5 tp10 -48.53 -26.17 2.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.61 44.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.18 179.67 5.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.755 . . . . 0.0 109.474 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.18 62.75 0.51 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.87 79.14 0.87 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -49.31 -38.16 26.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.13 -1.217 . . . . 0.0 107.803 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.512 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 2.8 mp0 -59.86 -41.16 90.87 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -54.4 -38.86 66.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.642 -1.286 . . . . 0.0 108.835 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -46.57 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -71.91 -61.97 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 110.44 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 79.1 mm-40 -43.71 -52.17 6.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.09 -41.95 99.5 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.024 -1.048 . . . . 0.0 109.628 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.458 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 77.9 m-20 -66.52 -40.92 89.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 111.605 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -68.01 -51.85 42.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -178.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -60.14 -46.55 89.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.632 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -64.79 -45.78 84.82 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.027 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 59.0 tp -52.44 -34.17 47.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.975 -1.078 . . . . 0.0 108.45 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -78.04 -32.01 50.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.508 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.632 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 29.3 mt-30 -87.66 -0.68 57.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.875 -1.141 . . . . 0.0 109.23 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -62.83 125.71 24.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 112.122 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 11' ' ' SER . 82.7 m-20 -76.09 -35.44 59.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 79' ' ' VAL . 90.4 t -132.91 155.29 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 78' ' ' VAL . 58.8 t -142.18 139.33 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.812 -1.18 . . . . 0.0 111.931 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.62 158.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -153.53 148.85 27.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.495 -1.378 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.636 ' O ' HG11 ' A' ' 90' ' ' VAL . 7.8 mt-10 -113.08 124.29 52.25 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.519 ' HB ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -122.6 26.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 110.136 -179.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 83' ' ' VAL . 62.8 m -43.49 -69.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.992 -1.067 . . . . 0.0 109.043 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.52 149.05 38.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 108.689 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HA ' HD23 ' B' ' 288' ' ' LEU . 6.3 Cg_endo -51.72 91.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.168 1.912 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.514 ' OG ' HG23 ' A' ' 90' ' ' VAL . 32.8 t -99.36 135.4 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 110.632 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 286' ' ' PRO . 0.2 OUTLIER -76.55 -40.24 50.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 109.07 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.92 93.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.7 t -71.33 -39.29 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.29 . . . . 0.0 109.914 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -47.86 87.77 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -67.81 -44.73 76.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.642 -0.916 . . . . 0.0 109.603 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.94 -30.59 71.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.253 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.2 mt -73.04 -39.5 65.9 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 108.668 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.24 99.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.26 -42.14 99.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.417 -1.049 . . . . 0.0 109.156 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.1 -38.53 82.39 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.161 -0.962 . . . . 0.0 108.814 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -55.76 -42.73 71.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.773 -1.205 . . . . 0.0 108.518 179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -75.02 -50.12 17.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 112.509 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.2 pp -118.34 -24.97 6.69 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.122 -0.986 . . . . 0.0 110.566 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -47.33 166.17 0.12 Allowed Glycine 0 C--N 1.29 -1.972 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 1.5 mptm? -117.68 -85.86 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 51.5 Cg_endo -85.22 102.3 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 121.387 1.531 . . . . 0.0 109.431 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 ' HB1' ' A' ' 97' ' ' ALA . 15.2 mt -102.05 98.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.805 -1.184 . . . . 0.0 111.187 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 tp -94.27 118.9 32.27 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.7 OUTLIER -106.73 154.06 21.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.022 -1.049 . . . . 0.0 108.895 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.519 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 17.4 mt -125.3 137.46 54.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 110.263 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -137.41 117.84 13.77 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.443 ' HB2' HG23 ' A' ' 84' ' ' THR . 0.1 OUTLIER -75.02 123.34 88.86 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 0.0 110.562 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 88.4 Cg_endo -82.7 -31.41 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.326 2.017 . . . . 0.0 110.663 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.461 HE22 ' HB1' ' A' ' 135' ' ' ALA . 2.4 pt20 -49.75 -35.06 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.446 ' HB3' HH11 ' A' ' 114' ' ' ARG . 53.1 m -97.82 -14.65 20.64 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.39 51.57 4.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 115' ' ' VAL . 42.2 mtp85 -83.58 13.3 4.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.049 -1.265 . . . . 0.0 110.279 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' ARG . 54.1 t 54.31 107.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 0.0 110.138 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 131' ' ' VAL . 19.4 tp -46.34 -71.96 0.06 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 164.47 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.21 82.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.981 -1.074 . . . . 0.0 109.789 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' A' ' 119' ' ' MET . 17.9 mmm -66.38 -50.58 63.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 116' ' ' LEU . 35.5 mm -63.68 -41.16 91.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 108.93 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HG2' HD23 ' A' ' 116' ' ' LEU . 18.5 mmt85 -62.42 -44.02 97.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 109.604 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -64.68 -36.12 92.75 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.221 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 129' ' ' PHE . . . -53.75 -23.06 10.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.061 -1.258 . . . . 0.0 107.98 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 121' ' ' ARG . . . -32.48 101.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.234 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 93.1 m-20 -101.33 -30.01 11.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 108.709 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.66 -0.12 57.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.4 p -112.49 -69.39 0.87 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.58 -0.953 . . . . 0.0 108.582 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.16 -39.55 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 123' ' ' ALA . 32.1 t80 -98.37 129.18 45.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.56 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 42.1 tt0 -154.06 163.79 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.05 -1.031 . . . . 0.0 110.435 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 116' ' ' LEU . 23.3 t -125.72 112.33 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.56 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 20.6 m0 -105.02 145.0 31.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 108.944 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 43.4 p30 -89.78 154.23 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.802 -1.186 . . . . 0.0 109.16 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.4 p90 -163.85 -174.49 3.66 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.898 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -152.86 148.11 26.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 135' ' ' ALA . 47.7 mt-10 -36.71 -37.8 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.928 -1.107 . . . . 0.0 110.259 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.46 19.04 38.36 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.446 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.644 ' N ' ' O ' ' A' ' 135' ' ' ALA . 94.5 mt-10 -142.69 -10.39 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.067 -1.255 . . . . 0.0 110.397 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 140' ' ' GLU . 8.0 p -50.89 -45.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.921 -1.112 . . . . 0.0 108.655 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' N ' HG13 ' A' ' 139' ' ' VAL . 23.2 pt-20 -60.38 -36.41 77.98 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.282 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -65.68 -46.26 79.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.486 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -47.85 64.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 38.7 mt -68.51 -31.99 71.65 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.479 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 76.9 m-20 -66.17 -42.74 88.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.536 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -69.86 -50.75 39.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.67 -1.269 . . . . 0.0 108.264 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.681 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 38' ' ' TYR . 13.2 m-85 -71.74 -33.16 68.45 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.764 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.56 28.45 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.01 -78.0 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.836 -1.146 . . . . 0.0 113.065 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 8.3 mt -61.42 -40.2 69.45 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.139 -0.975 . . . . 0.0 112.402 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 47.6 Cg_exo -54.83 -27.34 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.91 1.74 . . . . 0.0 111.733 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.25 -21.4 13.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.278 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -58.98 -37.38 76.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.8 m -56.17 -40.14 73.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -91.08 120.95 32.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.418 ' OG ' ' CB ' ' A' ' 163' ' ' ALA . 9.4 t -176.36 -27.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.8 p -58.48 -28.89 65.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.306 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.8 p -70.71 -28.02 64.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.587 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.34 148.73 56.51 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.12 -24.02 45.18 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.513 2.142 . . . . 0.0 112.273 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.3 t -152.72 147.98 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.367 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.418 ' CB ' ' OG ' ' A' ' 157' ' ' SER . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.323 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.291 0.567 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 204' ' ' SER . . . -151.67 158.22 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . 51.34 16.97 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.84 . . . . 0.0 109.39 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' SER . . . . . 0.4 ' N ' ' C ' ' B' ' 202' ' ' ALA . 50.4 m -65.4 153.16 42.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.87 51.28 6.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -48.95 140.13 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -1.22 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -74.01 178.79 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.862 . . . . 0.0 109.681 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -50.75 151.18 4.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.185 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.48 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.072 1.848 . . . . 0.0 110.947 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.2 p -111.7 174.5 5.84 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 11.2 m -113.63 156.73 23.17 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.84 133.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 9.7 t80 -111.6 95.57 5.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -83.23 118.28 23.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -87.32 123.48 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 109.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' B' ' 217' ' ' SER . . . -126.37 -130.22 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' B' ' 216' ' ' GLY . 1.4 t 156.98 111.86 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -1.045 . . . . 0.0 109.369 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.702 ' H ' HD13 ' B' ' 218' ' ' ILE . 0.0 OUTLIER -54.59 -49.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.721 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -51.66 110.26 0.44 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 170.86 -39.7 0.18 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 152.03 14.47 0.07 OUTLIER Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.494 -1.004 . . . . 0.0 110.977 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 66.74 -41.19 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.928 -1.336 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' B' ' 221' ' ' GLY . 80.1 mm-40 -52.44 -36.63 55.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 225' ' ' GLN . 35.3 p-10 -68.52 -31.52 70.81 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.542 ' N ' ' OD1' ' B' ' 224' ' ' ASP . 5.0 tt0 -60.93 -42.62 98.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.05 -48.45 68.27 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.95 -28.11 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.605 ' O ' HG23 ' B' ' 232' ' ' VAL . 17.3 m-30 -70.49 -53.6 15.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.426 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -58.53 -35.28 72.04 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.68 -58.69 3.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.923 -1.11 . . . . 0.0 108.548 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.54 -42.92 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.874 HG13 HG11 ' B' ' 241' ' ' VAL . 46.7 t -62.37 -29.82 47.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.3 p -69.34 -40.77 77.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.518 ' NH1' ' CG1' ' B' ' 339' ' ' VAL . 95.4 mtt180 -70.15 -49.47 50.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.798 -1.189 . . . . 0.0 108.903 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.69 -39.99 82.3 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 241' ' ' VAL . 49.0 ttt85 -63.02 -24.69 68.03 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -75.96 -38.06 57.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.931 -1.106 . . . . 0.0 109.329 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.4 m-85 -68.29 -48.03 66.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.559 -0.713 . . . . 0.0 110.766 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -151.56 -150.4 5.33 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -89.31 115.44 26.79 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.19 -1.183 . . . . 0.0 109.058 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.874 HG11 HG13 ' B' ' 232' ' ' VAL . 2.7 t -78.18 103.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' B' ' 272' ' ' TRP . 2.2 mt -47.55 126.8 10.44 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.929 -1.109 . . . . 0.0 108.97 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 242' ' ' LEU . 42.1 m -39.16 137.99 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 111.133 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 246' ' ' VAL . 26.8 mt-10 -148.81 101.84 3.23 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 249' ' ' ALA . 18.3 t-80 -43.1 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 109.864 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 244' ' ' GLU . 82.6 t -46.11 -84.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -54.16 -40.01 67.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.823 -1.173 . . . . 0.0 108.927 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.927 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -75.38 20.91 0.14 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -86.22 -19.88 29.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.818 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' B' ' 225' ' ' GLN . 59.1 mt-10 -61.77 7.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 248' ' ' ASP . 0.6 OUTLIER -88.87 134.48 33.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' B' ' 251' ' ' LEU . 7.0 mm-40 54.75 159.19 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.204 -0.935 . . . . 0.0 109.409 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.499 ' C ' HD22 ' B' ' 254' ' ' LEU . 97.7 Cg_exo -37.93 152.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.67 2.247 . . . . 0.0 112.439 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.499 HD22 ' C ' ' B' ' 253' ' ' PRO . 3.9 mm? -112.68 154.1 26.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.652 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 138.28 41.34 0.1 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 49.83 -82.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -1.045 . . . . 0.0 109.104 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' B' ' 255' ' ' GLY . 50.8 tp10 -48.87 -26.72 2.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 108.504 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' B' ' 253' ' ' PRO . . . -80.13 45.02 0.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -129.18 -179.32 5.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.461 -0.774 . . . . 0.0 109.298 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.56 63.14 0.54 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 113.61 78.75 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -49.22 -37.94 24.69 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' GLN . . . . . 0.5 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 2.8 mp0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -54.48 -38.67 66.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.718 -1.239 . . . . 0.0 108.876 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.8 OUTLIER -65.9 -46.84 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.9 OUTLIER -71.97 -62.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.626 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 79.4 mm-40 -43.17 -52.39 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -62.97 -41.71 99.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.474 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 80.9 m-20 -66.67 -40.92 88.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 111.522 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.2 OUTLIER -68.13 -51.68 43.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.021 -1.05 . . . . 0.0 110.2 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -60.4 -46.4 90.11 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.133 -0.979 . . . . 0.0 109.576 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.479 ' CZ3' ' OE1' ' B' ' 275' ' ' GLN . 0.1 OUTLIER -64.85 -46.25 82.68 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.477 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 59.8 tp -52.06 -34.03 41.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.42 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.34 -32.16 48.96 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.479 ' OE1' ' CZ3' ' B' ' 272' ' ' TRP . 91.0 mt-30 -87.25 -0.81 57.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.891 -1.131 . . . . 0.0 109.286 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 276' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' B' ' 213' ' ' TYR . . . -62.79 125.73 24.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.24 -0.913 . . . . 0.0 112.159 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.688 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.9 m-20 -76.04 -35.75 59.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.407 HG12 ' N ' ' B' ' 279' ' ' VAL . 88.8 t -132.65 155.08 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.407 ' N ' HG12 ' B' ' 278' ' ' VAL . 60.1 t -141.96 139.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 111.832 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 24.4 t -137.93 158.25 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.486 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.599 -1.313 . . . . 0.0 110.322 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.639 ' O ' HG11 ' B' ' 290' ' ' VAL . 8.8 mt-10 -113.84 123.58 50.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' B' ' 316' ' ' LEU . 0.0 OUTLIER -122.1 26.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.041 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.445 HG23 ' HB2' ' B' ' 309' ' ' ARG . 66.5 m -43.21 -69.7 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.01 -1.056 . . . . 0.0 109.019 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -91.51 149.22 39.05 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 108.756 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.574 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.9 Cg_endo -52.38 91.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.027 1.818 . . . . 0.0 111.262 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.514 ' OG ' HG23 ' B' ' 290' ' ' VAL . 34.3 t -99.92 135.31 41.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -76.25 -39.67 53.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.533 -0.73 . . . . 0.0 109.206 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.3 -40.3 91.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.639 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.5 t -71.11 -39.41 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.053 -1.263 . . . . 0.0 109.961 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.76 -47.53 89.7 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -68.02 -45.24 74.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 0.0 109.649 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.4 -30.88 70.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.1 mt -72.56 -39.76 67.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 108.732 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -63.58 -41.78 99.03 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.463 -1.022 . . . . 0.0 109.175 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.517 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -68.23 -38.67 82.11 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.143 -0.973 . . . . 0.0 108.792 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -55.87 -42.42 70.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.732 -1.23 . . . . 0.0 108.481 179.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.25 -50.0 17.53 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.2 pp -118.67 -24.93 6.54 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 0.0 110.422 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -47.16 166.45 0.1 Allowed Glycine 0 C--N 1.289 -2.079 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 1.5 mptm? -117.96 -85.87 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 49.6 Cg_endo -85.23 102.32 0.76 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 121.42 1.543 . . . . 0.0 109.378 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.517 HG12 ' HB1' ' B' ' 297' ' ' ALA . 14.8 mt -102.15 98.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.237 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 35.4 tp -93.98 118.4 31.44 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.42 153.79 21.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.009 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 17.0 mt -124.92 138.02 54.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.26 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -137.85 117.85 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.445 ' HB2' HG23 ' B' ' 284' ' ' THR . 0.1 OUTLIER -74.92 123.39 88.93 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.494 -0.754 . . . . 0.0 110.536 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.6 Cg_endo -82.82 -31.7 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.381 2.054 . . . . 0.0 110.763 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.457 HE22 ' HB1' ' B' ' 335' ' ' ALA . 2.3 pt20 -49.65 -34.88 19.54 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.444 ' OG ' ' NH2' ' B' ' 309' ' ' ARG . 49.8 m -97.86 -14.66 20.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 41.35 51.55 4.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' B' ' 315' ' ' VAL . 42.2 mtp85 -83.49 13.32 4.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.988 -1.301 . . . . 0.0 110.221 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.4 t 54.51 106.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 110.054 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.857 HD22 HG11 ' B' ' 331' ' ' VAL . 19.0 tp -46.36 -72.12 0.06 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.64 -0.662 . . . . 0.0 109.305 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 1.0 OUTLIER 164.75 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.08 -43.85 81.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 109.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' B' ' 319' ' ' MET . 17.7 mmm -66.07 -50.79 62.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.278 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.784 HG22 HD21 ' B' ' 316' ' ' LEU . 34.9 mm -63.4 -41.26 92.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 108.905 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.68 ' HG2' HD23 ' B' ' 316' ' ' LEU . 18.8 mmt85 -62.46 -43.62 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.947 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -64.64 -36.67 93.42 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 329' ' ' PHE . . . -53.34 -23.38 9.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.061 -1.258 . . . . 0.0 108.066 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -32.33 101.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.248 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 92.3 m-20 -101.84 -30.04 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 108.705 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.62 0.09 57.69 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 12.9 p -112.99 -69.95 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.981 . . . . 0.0 108.462 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -107.24 -39.77 5.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 323' ' ' ALA . 31.2 t80 -98.57 128.92 45.07 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 43.2 tt0 -153.49 164.29 38.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 331' ' ' VAL . . . . . 0.857 HG11 HD22 ' B' ' 316' ' ' LEU . 25.5 t -126.11 112.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 20.5 m0 -105.15 144.97 31.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.903 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 42.0 p30 -90.03 154.35 19.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 0.0 109.202 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 5.6 p90 -163.73 -174.28 3.61 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.64 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -152.95 148.05 26.66 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.8 mt-10 -36.79 -37.49 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.11 . . . . 0.0 110.198 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -88.68 19.56 36.4 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.473 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 335' ' ' ALA . 94.3 mt-10 -143.25 -10.71 0.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.073 -1.251 . . . . 0.0 110.491 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 340' ' ' GLU . 7.1 p -50.95 -45.19 28.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.003 -1.061 . . . . 0.0 108.548 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.553 ' N ' HG13 ' B' ' 339' ' ' VAL . 22.7 pt-20 -60.3 -36.62 78.32 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.226 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.5 m -65.57 -46.25 80.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.173 -0.954 . . . . 0.0 109.498 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.21 -47.69 65.49 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 37.4 mt -68.52 -32.29 72.14 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.86 -42.74 90.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.005 -1.059 . . . . 0.0 110.457 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -70.01 -50.94 36.53 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.684 -1.26 . . . . 0.0 108.27 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.42 -47.03 79.88 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.462 -0.774 . . . . 0.0 109.755 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' B' ' 238' ' ' TYR . 13.7 m-85 -71.59 -33.01 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.844 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.75 -26.19 65.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -101.4 27.84 5.94 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.8 -78.16 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.78 -1.168 . . . . 0.0 113.101 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 8.3 mt -60.81 -40.76 77.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 112.334 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 48.5 Cg_exo -54.44 -27.42 49.26 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.014 1.809 . . . . 0.0 111.726 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -103.13 -22.22 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -58.21 -37.36 74.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 41.1 m -56.28 -40.04 73.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.16 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.865 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 11.4 t -176.45 -28.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 53.1 p -58.03 -29.74 65.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.339 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 -28.31 65.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.591 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.1 148.77 57.34 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.311 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.35 -24.32 43.4 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.552 2.168 . . . . 0.0 112.276 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 31.3 t -154.17 156.44 37.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 109.732 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.414 179.861 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.62 -172.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.97 -94.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.238 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m -113.85 142.28 46.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.833 . . . . 0.0 109.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.24 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.49 168.95 12.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.341 -1.093 . . . . 0.0 109.64 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 13.6 mt-30 -59.83 -54.47 45.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 7' ' ' GLN . . . 62.97 144.68 0.08 OUTLIER Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.72 -0.613 . . . . 0.0 109.585 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 10' ' ' CYS . 50.1 Cg_endo -71.01 155.54 61.62 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.357 2.038 . . . . 0.0 111.228 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' PRO . 22.6 p -52.61 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.037 -1.04 . . . . 0.0 109.16 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 5.0 p -109.19 149.3 29.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 13.0 t -139.86 131.52 33.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 69' ' ' ASP . 14.2 t80 -100.65 124.91 46.89 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -96.21 122.73 39.38 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.539 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.6 t -133.87 154.97 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 -159.53 21.71 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -96.66 139.09 33.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -1.187 . . . . 0.0 108.724 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.8 mt -136.89 4.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.104 . . . . 0.0 110.822 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.72 ' NH2' ' H ' ' A' ' 89' ' ' GLY . 47.3 mmt-85 -47.94 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.854 -1.154 . . . . 0.0 108.728 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . 75.22 172.86 31.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.05 129.36 26.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' NH2' ' NE2' ' A' ' 85' ' ' GLN . 50.1 mtp85 -135.12 149.89 50.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.289 . . . . 0.0 111.333 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.71 -24.29 14.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 80.0 m-20 -69.84 -32.25 70.55 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' ARG . 11.0 mt-30 -64.78 -40.2 94.87 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.07 -52.47 34.9 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.31 -29.83 64.25 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.614 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m-30 -69.18 -44.46 72.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 110.295 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.11 83.34 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.488 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.599 ' NE ' HH22 ' A' ' 34' ' ' ARG . 60.0 ttt180 -71.26 -56.69 5.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.928 -1.108 . . . . 0.0 108.146 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HH11 ' A' ' 34' ' ' ARG . 12.1 mt -52.85 -45.33 50.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 28' ' ' TYR . 42.1 t -60.66 -27.58 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -68.87 -36.68 78.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.389 -0.819 . . . . 0.0 109.367 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.599 HH22 ' NE ' ' A' ' 30' ' ' ARG . 77.4 mtt85 -68.6 -47.96 65.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.597 -1.314 . . . . 0.0 107.849 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.673 HD22 HG11 ' A' ' 12' ' ' VAL . 3.1 mt -62.3 -28.91 70.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 41' ' ' VAL . 2.0 tpm_? -64.98 -29.14 70.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -70.8 -62.08 1.53 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -123.74 157.01 34.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.274 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 81.59 69.86 1.37 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.8 mtmt -36.37 131.81 0.62 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.333 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.695 ' H ' HH21 ' A' ' 36' ' ' ARG . 23.2 t -96.05 107.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.828 -1.17 . . . . 0.0 108.854 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 24.6 mt -78.79 152.94 31.11 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.204 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 45' ' ' HIS . 19.7 m 51.36 53.22 13.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -54.4 -7.22 0.14 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 43' ' ' THR . 8.5 t-80 -45.34 -31.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.6 -53.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.093 -1.004 . . . . 0.0 109.881 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -65.92 -43.47 88.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 108.714 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.789 ' O ' HD21 ' A' ' 51' ' ' LEU . 38.1 t70 -73.64 37.01 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.823 ' O ' HD21 ' A' ' 54' ' ' LEU . . . -108.97 9.48 26.49 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' HD13 ' A' ' 51' ' ' LEU . 2.3 mt-10 -104.25 3.3 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.588 -0.695 . . . . 0.0 109.719 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.0 163.16 15.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.242 -0.911 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.5 mt-10 54.46 156.69 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.499 -0.751 . . . . 0.0 109.238 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.67 122.42 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.068 1.846 . . . . 0.0 111.878 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.823 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -90.77 -164.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 90.64 130.82 4.63 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 28.3 mm-40 -49.43 -30.9 8.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.997 -1.296 . . . . 0.0 109.132 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.12 -0.68 8.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.054 -1.029 . . . . 0.0 108.993 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -65.16 149.12 50.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.494 -0.753 . . . . 0.0 109.114 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.31 0.37 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.7 -31.26 7.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.2 76.43 1.03 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 56' ' ' GLU . 91.8 m-20 -52.18 -38.14 56.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -67.22 -52.01 46.31 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -58.64 -32.64 69.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 5.3 mt -65.64 -52.26 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' ND1' ' C ' ' A' ' 66' ' ' HIS . 2.6 t-80 -66.23 -53.67 34.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.589 -0.695 . . . . 0.0 109.985 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -47.68 -57.34 5.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.991 -1.068 . . . . 0.0 109.667 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.91 -37.5 81.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -68.19 -56.69 7.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 110.763 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 66' ' ' HIS . 6.5 tp -58.84 -40.61 84.73 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.47 -0.769 . . . . 0.0 110.313 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 90.8 m-20 -65.33 -58.84 4.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.007 -1.058 . . . . 0.0 109.253 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.463 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -57.2 -40.78 78.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -50.72 -41.05 55.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -72.54 -26.18 61.65 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.807 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 19.3 mt-30 -90.76 1.26 57.04 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.965 -1.084 . . . . 0.0 108.826 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.03 122.72 23.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.381 -0.825 . . . . 0.0 111.748 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 11' ' ' SER . 89.7 m-20 -69.95 -35.74 74.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 t -135.16 141.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.65 120.13 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.825 -1.172 . . . . 0.0 111.805 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -116.0 120.16 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.693 0.758 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.28 158.37 35.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 30.0 tt0 -97.07 128.27 43.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -107.64 28.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.756 . . . . 0.0 110.135 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 109' ' ' ARG . 5.2 m -79.67 -77.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.446 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.585 ' NE2' ' NH2' ' A' ' 22' ' ' ARG . 6.3 mm100 -64.33 136.39 96.73 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' B' ' 286' ' ' PRO . 72.9 Cg_endo -77.43 88.09 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 111.716 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -121.77 139.58 53.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.16 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' H ' ' B' ' 287' ' ' SER . 16.1 mt -59.45 -42.1 91.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.182 -0.949 . . . . 0.0 108.677 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.72 ' H ' ' NH2' ' A' ' 19' ' ' ARG . . . -55.6 -30.9 56.99 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 87' ' ' SER . 80.7 t -75.44 -57.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.63 -0.924 . . . . 0.0 108.904 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.29 -36.31 89.34 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 88' ' ' LEU . 75.5 t80 -65.56 -52.54 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.088 . . . . 0.0 109.129 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' OE2' ' OD1' ' A' ' 69' ' ' ASP . 1.8 tp10 -58.75 -34.82 71.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.338 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 94' ' ' LEU . 18.2 mt -74.63 -41.08 61.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.99 . . . . 0.0 108.742 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -34.52 89.47 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.686 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.79 -43.17 80.36 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.626 -0.926 . . . . 0.0 109.176 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.663 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -69.86 -42.0 74.09 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.521 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -37.92 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -49.76 35.41 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -126.53 -34.71 2.43 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.145 -0.972 . . . . 0.0 109.885 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -73.82 102.61 1.34 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.615 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.72 -69.78 0.31 Allowed Pre-proline 0 C--N 1.288 -2.092 0 O-C-N 121.595 -0.944 . . . . 0.0 110.871 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 31.5 Cg_endo -65.64 109.01 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.573 1.515 . . . . 0.0 110.841 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' HD1' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.63 119.38 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 110.777 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 132' ' ' TRP . 46.0 tp -105.26 119.45 39.1 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -107.46 139.48 41.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.012 . . . . 0.0 108.566 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 11.6 mt -126.82 124.19 39.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -124.0 154.5 39.76 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' OE2' ' A' ' 136' ' ' GLU . 50.2 mtm180 -109.82 141.23 23.29 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.835 -1.166 . . . . 0.0 110.95 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.43 -29.32 3.08 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.812 2.341 . . . . 0.0 111.384 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 112' ' ' SER . 19.3 pt20 -46.5 -40.46 12.55 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.444 ' HB3' ' NE ' ' A' ' 114' ' ' ARG . 2.7 m -98.41 -23.1 15.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 50.07 40.57 36.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NE ' ' HB3' ' A' ' 112' ' ' SER . 7.6 mmt180 -51.0 -8.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.862 -1.375 . . . . 0.0 109.364 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 113' ' ' GLY . 23.4 t 64.1 99.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.963 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' HD22 ' A' ' 116' ' ' LEU . 4.1 mm? -37.97 128.25 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.416 ' HB2' HH21 ' B' ' 219' ' ' ARG . 2.3 t -51.3 147.75 5.45 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.104 -0.998 . . . . 0.0 109.094 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.68 78.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.982 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 0.1 OUTLIER -67.03 -42.31 85.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 109.359 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 35.8 mm -66.58 -46.38 86.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.054 -1.029 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 121' ' ' ARG . 0.3 OUTLIER -62.04 -47.77 83.24 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' B' ' 266' ' ' HIS . . . -58.56 -36.68 86.23 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 124' ' ' ALA . . . -50.42 -61.85 1.94 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 123' ' ' ALA . . . 155.34 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.306 1.05 . . . . 0.0 112.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.695 ' HA ' ' H ' ' A' ' 131' ' ' VAL . 55.7 p30 -126.27 26.69 6.39 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -178.08 149.88 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.77 ' C ' ' H ' ' A' ' 129' ' ' PHE . 4.2 t 96.88 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 117.935 0.868 . . . . 0.0 109.044 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 61.68 -19.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.77 ' H ' ' C ' ' A' ' 127' ' ' SER . 82.0 t80 -120.39 121.9 39.57 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.465 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 18.1 mt-30 -139.68 132.35 28.92 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.122 -1.431 . . . . 0.0 111.656 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.695 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 73.3 t -105.32 101.62 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 130' ' ' GLN . 22.8 m0 -98.37 155.66 17.12 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 110.771 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -107.51 147.74 30.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 139' ' ' VAL . 6.6 p90 -164.14 -175.73 4.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.848 -1.158 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.665 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -155.27 158.09 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.538 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 15.3 mt-10 -58.1 23.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.438 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -119.16 -11.46 7.49 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.684 ' O ' ' SD ' ' A' ' 142' ' ' MET . 5.7 pt-20 -153.96 16.2 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.997 -1.296 . . . . 0.0 110.202 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' MET . 3.5 p -51.05 -41.97 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.189 -0.944 . . . . 0.0 109.117 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 81.2 tt0 -61.63 -27.89 68.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.003 -1.061 . . . . 0.0 109.125 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.3 m -73.96 -48.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 110.444 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.684 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -54.41 -48.62 71.4 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 143' ' ' LEU . 92.8 mt -57.69 -38.66 75.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 45.2 t0 -63.08 -37.97 89.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -70.61 -53.38 16.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.62 -1.3 . . . . 0.0 108.773 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.422 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 67.3 t80 -58.16 -48.23 80.91 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 17.9 m-85 -70.48 -31.13 68.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.998 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 38.7 mt-10 -59.69 -29.89 68.4 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 17.62 10.19 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.48 -21.44 0.33 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.833 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 85.2 mt -120.34 39.84 0.37 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.527 -1.358 . . . . 0.0 111.776 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 92.4 Cg_endo -79.38 116.7 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.223 1.949 . . . . 0.0 110.526 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 157' ' ' SER . 61.4 mt-30 67.83 -37.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.0 109.039 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 152' ' ' PRO . 76.4 tttt -59.57 -26.43 65.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.0 . . . . 0.0 108.788 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 m -53.66 -38.4 64.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 157' ' ' SER . . . -171.14 -12.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 0.0 109.568 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 153' ' ' GLN . 99.2 p 48.89 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.542 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.7 m -118.11 154.49 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.378 -0.826 . . . . 0.0 109.411 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.0 p -149.93 176.24 10.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.1 m80 55.67 69.14 2.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.497 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.25 -23.49 9.99 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 0.0 112.153 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.44 ' O ' ' OXT' ' A' ' 163' ' ' ALA . 82.5 p -65.15 162.6 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.44 ' OXT' ' O ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.524 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 49.07 -172.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.583 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -161.29 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.163 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 67.7 m -114.88 141.58 47.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.71 -163.7 29.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -87.56 169.68 11.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.311 -1.111 . . . . 0.0 109.516 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' B' ' 208' ' ' ALA . 13.8 mt-30 -60.92 -53.65 54.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 207' ' ' GLN . . . 62.05 144.45 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.665 -0.647 . . . . 0.0 109.505 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' B' ' 210' ' ' CYS . 45.7 Cg_endo -70.56 155.9 62.35 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.389 2.059 . . . . 0.0 111.185 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' B' ' 209' ' ' PRO . 23.9 p -52.82 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.028 -1.045 . . . . 0.0 109.15 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.487 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 7.3 p -109.21 148.85 30.27 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 12.9 t -139.63 131.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' B' ' 269' ' ' ASP . 13.8 t80 -100.8 124.36 46.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.343 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -95.48 122.89 38.68 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.553 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 21.7 t -133.95 155.02 50.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.252 -0.905 . . . . 0.0 110.082 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -175.73 -159.83 22.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 25.1 p -96.32 138.9 33.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.222 -1.163 . . . . 0.0 108.888 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' B' ' 220' ' ' GLY . 2.7 mt -136.73 5.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.928 -1.108 . . . . 0.0 110.797 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.731 ' NH2' ' H ' ' B' ' 289' ' ' GLY . 49.4 mmt-85 -48.21 98.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.95 -1.094 . . . . 0.0 108.579 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 218' ' ' ILE . . . 74.88 173.17 31.14 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.23 129.16 25.85 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.191 -1.964 . . . . 0.0 108.191 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.589 ' NH2' ' NE2' ' B' ' 285' ' ' GLN . 51.5 mtp85 -135.05 149.95 50.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.236 . . . . 0.0 111.427 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.31 -24.95 13.11 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.5 m-20 -69.48 -32.06 70.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' B' ' 222' ' ' ARG . 9.7 mt-30 -65.02 -39.92 94.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.42 -52.42 32.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.13 -30.0 64.04 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.614 ' O ' HG23 ' B' ' 232' ' ' VAL . 10.0 m-30 -69.09 -44.56 72.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.681 -0.637 . . . . 0.0 110.295 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.07 83.13 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.507 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.585 ' NE ' HH22 ' B' ' 234' ' ' ARG . 60.3 ttt180 -71.32 -56.81 5.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.082 . . . . 0.0 108.115 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.525 ' HA ' HH11 ' B' ' 234' ' ' ARG . 12.1 mt -52.77 -45.35 49.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 228' ' ' TYR . 41.8 t -60.48 -27.72 40.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -68.79 -36.84 78.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.431 -0.793 . . . . 0.0 109.405 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.585 HH22 ' NE ' ' B' ' 230' ' ' ARG . 77.5 mtt85 -68.38 -47.91 66.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.287 . . . . 0.0 107.831 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.657 HD22 HG11 ' B' ' 212' ' ' VAL . 3.0 mt -62.33 -29.08 70.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.718 HH21 ' H ' ' B' ' 241' ' ' VAL . 2.1 tpm_? -64.89 -29.34 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -70.57 -61.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.8 OUTLIER -123.81 156.92 35.25 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 81.73 69.84 1.37 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' B' ' 239' ' ' GLY . 50.6 mtmt -36.58 131.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.347 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.718 ' H ' HH21 ' B' ' 236' ' ' ARG . 24.1 t -96.23 107.71 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.859 -1.15 . . . . 0.0 108.835 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.466 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 24.4 mt -78.67 153.71 30.76 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.494 ' C ' ' H ' ' B' ' 245' ' ' HIS . 22.5 m 50.62 53.25 13.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.71 -7.08 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.078 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' B' ' 245' ' ' HIS . 8.1 t-80 -45.59 -30.97 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.34 -52.91 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.74 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -66.14 -43.56 86.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 108.847 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.8 ' O ' HD21 ' B' ' 251' ' ' LEU . 36.0 t70 -73.58 37.08 0.09 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.816 ' O ' HD21 ' B' ' 254' ' ' LEU . . . -109.16 9.84 26.01 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.412 ' C ' HD13 ' B' ' 251' ' ' LEU . 2.3 mt-10 -104.44 3.11 31.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.946 ' N ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -112.69 163.31 14.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.269 -0.894 . . . . 0.0 109.643 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 47.6 mt-10 54.57 156.78 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.467 -0.771 . . . . 0.0 109.339 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -40.91 121.96 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.034 1.822 . . . . 0.0 111.795 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.816 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.0 OUTLIER -90.4 -164.19 1.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 90.38 130.49 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' B' ' 262' ' ' ASP . 28.4 mm-40 -49.34 -31.47 9.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.066 -1.256 . . . . 0.0 109.275 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.36 -1.15 7.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 0.0 108.782 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -64.38 148.85 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.166 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.52 4.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -47.23 -30.85 5.88 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.0 76.05 1.01 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' B' ' 256' ' ' GLU . 94.7 m-20 -52.01 -38.2 56.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -67.25 -51.85 48.09 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -58.91 -32.53 69.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' B' ' 269' ' ' ASP . 5.0 mt -65.64 -51.86 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.496 ' ND1' ' C ' ' B' ' 266' ' ' HIS . 2.5 t-80 -66.71 -53.61 31.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.59 -57.37 5.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.647 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -67.77 -37.86 82.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.505 ' OD2' ' OH ' ' B' ' 213' ' ' TYR . 0.4 OUTLIER -68.0 -56.83 7.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.08 -1.012 . . . . 0.0 110.785 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' B' ' 266' ' ' HIS . 6.5 tp -58.76 -40.36 83.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 88.8 m-20 -65.43 -58.74 5.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.074 -1.016 . . . . 0.0 109.158 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.12 -41.17 78.53 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 13.0 tp -50.36 -41.31 51.42 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -72.43 -26.18 61.74 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 18.6 mt-30 -90.68 1.03 57.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.012 -1.055 . . . . 0.0 108.725 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.56 122.82 22.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.497 -0.752 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' B' ' 211' ' ' SER . 89.2 m-20 -70.14 -35.76 74.28 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 51.1 t -135.37 141.4 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.61 120.25 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.69 -1.256 . . . . 0.0 111.61 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.79 120.12 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.594 -0.692 . . . . 0.0 109.514 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -126.12 159.2 33.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 109.881 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.448 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 30.5 tt0 -97.87 128.76 44.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.419 HG13 HD11 ' B' ' 294' ' ' LEU . 0.0 OUTLIER -107.95 27.86 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.307 -0.87 . . . . 0.0 110.095 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 309' ' ' ARG . 5.4 m -79.17 -76.99 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.589 ' NE2' ' NH2' ' B' ' 222' ' ' ARG . 6.5 mm100 -64.53 136.26 96.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.494 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' PRO . 73.1 Cg_endo -77.33 87.58 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.341 2.027 . . . . 0.0 111.839 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.619 ' HB3' HG23 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -121.4 139.84 52.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 87' ' ' SER . 15.0 mt -59.31 -41.82 89.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.115 -0.991 . . . . 0.0 108.777 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 289' ' ' GLY . . . . . 0.731 ' H ' ' NH2' ' B' ' 219' ' ' ARG . . . -56.19 -30.92 58.68 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' B' ' 287' ' ' SER . 89.9 t -75.15 -57.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.545 -0.974 . . . . 0.0 108.8 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.12 90.62 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' B' ' 288' ' ' LEU . 74.9 t80 -66.15 -52.76 45.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -1.131 . . . . 0.0 109.222 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.476 ' OE1' ' SD ' ' A' ' 119' ' ' MET . 1.7 tp10 -58.37 -34.91 71.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' B' ' 294' ' ' LEU . 18.1 mt -74.44 -41.4 60.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 108.796 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.3 -34.44 89.25 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.671 ' HE ' ' HA ' ' B' ' 296' ' ' ARG . 0.4 OUTLIER -67.96 -42.68 80.54 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.625 -0.926 . . . . 0.0 109.186 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.659 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -70.24 -41.88 72.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.493 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -37.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -72.13 -49.88 32.42 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.354 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.603 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -126.21 -34.51 2.51 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -74.03 102.44 1.34 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.603 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -72.57 -69.86 0.31 Allowed Pre-proline 0 C--N 1.288 -2.087 0 O-C-N 121.651 -0.911 . . . . 0.0 110.841 -177.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 31.7 Cg_endo -65.64 109.07 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.508 1.472 . . . . 0.0 110.849 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -135.43 119.11 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.087 -1.008 . . . . 0.0 110.754 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' B' ' 332' ' ' TRP . 47.6 tp -105.22 119.4 38.98 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -107.5 140.8 39.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.007 . . . . 0.0 108.622 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 11.8 mt -127.91 124.34 37.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -124.13 154.58 39.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.542 ' NH1' ' OE2' ' B' ' 336' ' ' GLU . 52.1 mtm180 -109.78 140.82 22.59 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 111.006 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.29 -29.62 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.643 2.229 . . . . 0.0 111.428 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.446 ' CG ' ' N ' ' B' ' 312' ' ' SER . 19.4 pt20 -45.96 -40.66 10.62 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 2.6 m -98.12 -23.34 15.77 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 50.5 40.73 39.98 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.445 ' NE ' ' HB3' ' B' ' 312' ' ' SER . 7.7 mmt180 -51.36 -8.33 0.05 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.965 -1.315 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 313' ' ' GLY . 22.6 t 64.11 99.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.537 -0.727 . . . . 0.0 110.039 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.599 ' H ' HD22 ' B' ' 316' ' ' LEU . 4.1 mm? -38.33 128.46 1.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.1 t -51.51 148.18 5.44 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.059 -1.026 . . . . 0.0 109.215 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.74 78.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 109.88 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -67.21 -42.76 83.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' B' ' 323' ' ' ALA . 35.6 mm -66.09 -46.11 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.899 -1.125 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.448 ' HG3' HH11 ' B' ' 321' ' ' ARG . 0.3 OUTLIER -62.42 -47.82 82.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -58.09 -36.64 82.69 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.771 ' O ' ' HB2' ' B' ' 324' ' ' ALA . . . -50.68 -62.18 1.75 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' B' ' 323' ' ' ALA . . . 155.72 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.284 1.04 . . . . 0.0 112.157 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.692 ' HA ' ' H ' ' B' ' 331' ' ' VAL . 56.5 p30 -126.33 27.04 6.29 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -178.3 150.06 9.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.749 ' C ' ' H ' ' B' ' 329' ' ' PHE . 4.1 t 96.51 71.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.632 -0.923 . . . . 0.0 109.089 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 61.71 -19.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.749 ' H ' ' C ' ' B' ' 327' ' ' SER . 81.2 t80 -120.02 121.33 38.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.452 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 16.8 mt-30 -139.3 132.69 30.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.051 -1.46 . . . . 0.0 111.577 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 331' ' ' VAL . . . . . 0.692 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 67.4 t -105.31 101.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.452 ' HE1' ' HB3' ' B' ' 330' ' ' GLN . 23.3 m0 -98.61 155.8 17.12 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.198 -0.939 . . . . 0.0 110.728 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 50.6 p-10 -107.67 147.72 30.33 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.544 ' CD2' HG23 ' B' ' 339' ' ' VAL . 6.5 p90 -164.24 -175.57 4.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.903 -1.123 . . . . 0.0 111.07 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -155.18 158.37 38.82 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' B' ' 309' ' ' ARG . 17.0 mt-10 -58.42 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -118.99 -11.07 7.82 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.675 ' O ' ' SD ' ' B' ' 342' ' ' MET . 5.9 pt-20 -154.63 16.6 0.45 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.929 -1.336 . . . . 0.0 110.168 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' B' ' 342' ' ' MET . 3.6 p -51.32 -42.05 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 0.0 108.975 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 82.3 tt0 -61.44 -27.89 68.87 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.125 -0.984 . . . . 0.0 109.139 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.9 m -74.09 -48.4 29.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.395 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.675 ' SD ' ' O ' ' B' ' 338' ' ' GLU . 0.0 OUTLIER -54.64 -48.61 72.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 343' ' ' LEU . 94.1 mt -57.73 -38.39 75.21 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 45.3 t0 -63.38 -37.94 89.22 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.543 -0.723 . . . . 0.0 110.169 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -70.43 -53.28 17.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.669 -1.269 . . . . 0.0 108.784 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 346' ' ' TYR . . . . . 0.432 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 67.2 t80 -58.31 -47.95 82.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 18.6 m-85 -70.89 -31.11 67.66 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.999 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 38.2 mt-10 -59.48 -29.76 68.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -93.09 17.98 10.02 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -148.91 -21.39 0.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.686 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 85.5 mt -120.48 40.02 0.38 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 111.741 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 93.6 Cg_endo -79.95 117.24 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.191 1.927 . . . . 0.0 110.408 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 353' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' B' ' 357' ' ' SER . 60.3 mt-30 67.62 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.869 . . . . 0.0 109.024 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 354' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' B' ' 352' ' ' PRO . 76.8 tttt -59.75 -25.7 65.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 108.798 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 9.0 m -54.52 -38.03 66.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.746 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 356' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' B' ' 357' ' ' SER . . . -171.5 -12.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 357' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 353' ' ' GLN . 95.7 p 48.28 -175.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.605 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 20.5 m -117.48 154.52 31.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 98.4 p -150.01 176.3 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.544 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 45.6 m80 55.46 69.42 1.96 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.593 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.88 -23.16 8.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.688 2.259 . . . . 0.0 112.031 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' B' ' 363' ' ' ALA . 80.0 p -68.55 167.26 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 363' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 362' ' ' SER . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.415 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.56 -44.29 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.966 . . . . 0.0 109.753 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.89 162.03 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.611 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 p -63.29 -23.44 67.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 109.371 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.67 -170.35 41.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -60.21 140.79 56.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -1.195 . . . . 0.0 109.225 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.21 -167.8 1.94 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -48.32 158.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' ALA . 45.2 Cg_exo -53.0 -155.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.641 2.227 . . . . 0.0 111.699 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.9 p -108.05 178.07 4.62 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.431 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 3.8 m -120.87 131.67 54.53 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.842 -1.161 . . . . 0.0 108.814 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.953 HG11 HD22 ' A' ' 35' ' ' LEU . 4.6 t -102.95 126.18 57.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 79' ' ' VAL . 40.8 t80 -93.19 118.99 31.88 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.582 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.0 t80 -85.58 123.98 31.62 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.434 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 2.7 t -117.34 113.65 22.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -162.07 75.98 0.18 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 16' ' ' GLY . 30.4 t -31.8 106.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.932 . . . . 0.0 110.48 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.13 -170.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.739 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 60.3 ttt85 51.54 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.068 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.97 -22.73 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.964 -2.055 . . . . 0.0 107.964 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 178.89 -29.9 0.06 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.798 ' NH2' ' H ' ' A' ' 55' ' ' GLY . 33.6 mmt180 73.91 -33.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.126 -0.632 . . . . 0.0 109.621 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 21' ' ' GLY . 78.5 tt0 -55.15 -46.8 75.73 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 17.2 m-20 -62.74 -20.5 65.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.669 HE21 ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -67.25 -47.06 71.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.18 85.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.18 -37.15 74.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.4 m-30 -67.33 -41.49 85.18 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.405 -0.809 . . . . 0.0 109.69 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -60.82 -36.54 79.34 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.419 -1.425 . . . . 0.0 108.463 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 140' ' ' GLU . 70.7 ttt-85 -72.56 -57.38 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.1 -40.74 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' TYR . 52.3 t -64.62 -29.35 47.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 10.2 m -67.8 -37.15 81.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.39 -0.819 . . . . 0.0 109.646 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.41 -52.11 24.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.671 -1.268 . . . . 0.0 108.755 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 12' ' ' VAL . 16.6 mt -57.48 -40.21 78.08 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -61.36 -25.32 67.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.73 -31.05 32.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 0.0 109.745 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.564 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 1.8 m-85 -75.18 -52.67 10.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.242 -0.911 . . . . 0.0 110.946 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.34 -147.05 4.46 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -89.81 129.04 36.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.4 -1.059 . . . . 0.0 109.006 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 32' ' ' VAL . 2.8 t -93.77 106.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.886 -1.134 . . . . 0.0 107.974 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 20.5 mt -72.38 -176.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.543 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 1.7 m 55.82 39.67 30.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.783 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 52.3 mp0 -46.3 -25.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -49.06 -38.41 24.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.093 -1.004 . . . . 0.0 108.996 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 47' ' ' ALA . 59.2 t -61.27 170.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 61.82 -71.96 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.86 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.0 t70 -67.82 28.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -106.62 12.91 28.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' CD ' HE21 ' A' ' 25' ' ' GLN . 28.7 mt-10 -108.47 11.4 26.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.336 -0.852 . . . . 0.0 109.744 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.015 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -86.08 -93.76 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.01 . . . . 0.0 110.232 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.477 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 mp0 -42.67 158.73 0.21 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 0.0 110.268 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.0 -22.16 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.647 2.232 . . . . 0.0 112.24 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.6 mm? 59.69 -172.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 109.73 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.798 ' H ' ' NH2' ' A' ' 22' ' ' ARG . . . 99.04 25.67 9.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 62' ' ' ASP . 73.4 mm-40 53.52 -74.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.781 -0.834 . . . . 0.0 109.664 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.679 ' N ' ' O ' ' A' ' 55' ' ' GLY . 86.6 tt0 -44.5 -26.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' LEU . . . -67.87 166.28 15.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.105 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.84 133.67 31.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.242 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.39 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.37 80.88 0.37 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 56' ' ' GLU . 3.0 m-20 -52.5 -44.13 65.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -1.144 . . . . 0.0 108.255 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -62.61 -49.26 75.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -60.48 -34.79 74.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 109.049 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -63.03 -53.95 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' N ' HG22 ' A' ' 65' ' ' ILE . 1.6 t-80 -65.6 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.623 -0.673 . . . . 0.0 109.666 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.1 -64.0 1.03 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -71.55 -38.95 70.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 110.138 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 10.1 m-20 -62.69 -59.25 5.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.093 -1.004 . . . . 0.0 110.351 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -61.05 -36.86 80.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.845 -1.159 . . . . 0.0 109.785 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -66.57 -52.36 46.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.565 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.484 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -43.52 87.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.133 -0.979 . . . . 0.0 108.998 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CE2' ' A' ' 13' ' ' TYR . 4.1 tt -53.47 -43.65 68.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.49 ' CG ' HH21 ' A' ' 96' ' ' ARG . 28.2 mt-30 -65.78 -29.87 70.43 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.68 -0.638 . . . . 0.0 111.258 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -103.49 11.51 36.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.626 -1.296 . . . . 0.0 109.274 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.05 138.83 48.14 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.337 -0.852 . . . . 0.0 111.694 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 11' ' ' SER . 86.4 m-20 -88.16 -25.74 22.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 69.7 t -144.99 136.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 13' ' ' TYR . 93.9 t -133.14 125.17 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.864 -1.147 . . . . 0.0 111.91 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.19 124.69 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.55 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.24 146.54 45.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.072 0.939 . . . . 0.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' HG11 ' A' ' 90' ' ' VAL . 1.3 pp20? -100.23 147.23 25.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.674 HG11 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.06 -89.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.525 HG21 ' HE ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER 64.29 -141.12 0.28 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.063 -1.648 . . . . 0.0 109.748 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 84' ' ' THR . 17.0 pt20 -43.29 148.63 0.62 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.754 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -45.24 128.0 9.45 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.131 1.888 . . . . 0.0 111.615 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.616 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 15.7 t -102.41 -121.1 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB2' ' H ' ' B' ' 287' ' ' SER . 9.9 tp 160.02 -58.66 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.06 58.72 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 82' ' ' GLU . 48.5 t -65.4 -45.25 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.48 -35.4 66.25 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.504 ' OH ' HG21 ' B' ' 298' ' ' VAL . 64.4 t80 -68.32 -56.09 9.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.46 -1.024 . . . . 0.0 109.675 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.521 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 87.0 mt-10 -57.25 -36.64 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.518 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.736 HD22 ' SG ' ' A' ' 106' ' ' CYS . 63.2 mt -60.35 -49.09 78.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.83 65.39 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' A' ' 74' ' ' GLN . 17.1 mmm180 -71.94 -47.26 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -1.179 . . . . 0.0 110.102 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -70.35 -34.49 72.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.376 -1.453 . . . . 0.0 107.766 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG21 ' OH ' ' B' ' 292' ' ' TYR . 1.1 t -57.72 -40.93 78.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -78.49 -55.87 4.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.682 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 0.88 40.17 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.242 -0.911 . . . . 0.0 108.606 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . 72.99 -156.93 52.1 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 18.6 mtmm 95.68 132.75 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.191 0 C-N-CA 123.887 0.875 . . . . 0.0 108.768 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.89 112.96 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.05 1.833 . . . . 0.0 111.196 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 102' ' ' LYS . 1.1 mt -112.32 104.46 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.224 -0.922 . . . . 0.0 110.961 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 132' ' ' TRP . 45.6 tp -99.89 121.21 40.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.736 ' SG ' HD22 ' A' ' 94' ' ' LEU . 75.0 m -109.9 124.72 51.85 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 1.1 mt -121.76 131.19 53.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.512 ' HE2' ' O ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -125.63 153.37 43.87 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HE ' HG21 ' A' ' 84' ' ' THR . 60.7 mtm180 -105.82 145.75 31.51 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.732 -1.23 . . . . 0.0 111.805 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' GLY . 92.7 Cg_endo -83.49 -23.29 3.46 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 123.019 2.48 . . . . 0.0 111.6 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 110' ' ' PRO . 6.9 pt20 -45.66 -42.44 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 m -90.38 -14.33 33.22 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . 46.74 45.65 18.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' O ' ' HE2' ' A' ' 108' ' ' PHE . 32.5 mtp85 -85.32 177.26 7.88 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.998 -1.295 . . . . 0.0 107.588 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 116' ' ' LEU . 87.5 t -114.05 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.8 -1.188 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.674 HD11 HG11 ' A' ' 83' ' ' VAL . 9.9 tp -41.59 137.41 1.6 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.3 m -46.52 145.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.032 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.25 64.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.584 -0.697 . . . . 0.0 109.69 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.405 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 3.3 tpt -72.23 -52.39 16.65 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.26 -43.27 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 108.788 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -59.62 -47.57 85.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -56.89 -33.32 63.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -59.54 -47.17 86.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.232 . . . . 0.0 107.949 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -20.95 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 123' ' ' ALA . 65.9 m-20 -110.24 -16.54 13.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 108.794 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.84 40.53 97.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 86.1 p -144.64 63.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.642 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.1 mtt-85 95.38 -31.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -102.32 121.83 43.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.404 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 20.2 mt-30 -145.25 145.3 31.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.049 -1.032 . . . . 0.0 110.426 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.29 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.435 ' CD1' ' N ' ' A' ' 132' ' ' TRP . 16.0 m0 -97.66 147.76 24.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.522 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 37.8 p-10 -99.44 144.89 28.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.9 p90 -167.18 178.62 5.53 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.379 -1.328 . . . . 0.0 111.505 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.681 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -150.93 155.94 40.16 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 38.6 mt-10 -58.03 27.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.416 -0.802 . . . . 0.0 110.396 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -126.44 -12.63 3.36 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.596 ' O ' ' SD ' ' A' ' 142' ' ' MET . 3.3 pt-20 -145.4 10.04 1.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.145 -1.209 . . . . 0.0 109.554 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 3.7 p -48.98 -43.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 30' ' ' ARG . 93.9 mt-10 -56.1 -33.2 64.88 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.532 HG22 HH11 ' A' ' 145' ' ' ARG . 15.6 m -65.62 -41.1 93.08 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 108.858 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -55.07 -50.95 67.85 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 84.7 mt -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 38.5 m-20 -70.37 -43.86 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.262 -0.899 . . . . 0.0 110.806 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.532 HH11 HG22 ' A' ' 141' ' ' THR . 52.7 mtt85 -70.49 -47.74 59.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.392 . . . . 0.0 108.951 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 36.1 t80 -60.1 -46.51 89.35 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.662 -0.649 . . . . 0.0 110.572 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.837 ' CG ' HD12 ' A' ' 151' ' ' LEU . 14.6 m-85 -80.1 -27.84 39.14 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.842 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 60.5 mt-10 -61.98 -29.27 70.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -68.61 -19.19 64.43 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.785 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -174.65 101.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 111.098 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.837 HD12 ' CG ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER 170.7 -47.63 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.587 -0.696 . . . . 0.0 109.232 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.573 ' O ' HG22 ' A' ' 155' ' ' THR . 69.7 Cg_exo -49.05 -39.6 41.01 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.338 2.025 . . . . 0.0 112.021 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.434 ' C ' ' H ' ' A' ' 155' ' ' THR . 48.5 tt0 -67.57 -34.34 76.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 109.245 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 156' ' ' ALA . 46.0 tttp -66.61 2.92 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 152' ' ' PRO . 9.1 t -68.3 34.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 154' ' ' LYS . . . 61.16 39.26 16.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.2 t -72.89 145.9 46.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.341 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.5 m -66.62 151.09 48.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.174 -0.954 . . . . 0.0 109.512 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -67.01 -13.5 61.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.9 m80 52.17 68.17 3.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.744 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.31 -24.43 42.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.816 2.344 . . . . 0.0 112.057 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -73.22 155.88 39.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.872 . . . . 0.0 109.566 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.457 -179.857 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -73.83 162.23 29.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.698 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 59.7 p -63.4 -23.72 67.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.858 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.88 -169.74 40.68 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -60.73 141.17 57.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -90.37 -167.96 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.815 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . -48.48 158.17 0.64 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.843 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' B' ' 208' ' ' ALA . 43.6 Cg_exo -53.0 -155.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 111.817 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.84 177.82 4.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 3.9 m -120.86 131.33 54.35 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.983 -1.073 . . . . 0.0 108.776 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.997 HG11 HD22 ' B' ' 235' ' ' LEU . 4.9 t -102.52 126.29 56.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.677 ' HB3' HG22 ' B' ' 279' ' ' VAL . 41.0 t80 -93.22 119.05 31.97 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.587 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.3 t80 -85.53 123.47 30.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.532 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.511 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 2.8 t -116.84 113.42 22.47 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.678 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -161.79 75.91 0.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.522 ' C ' ' O ' ' B' ' 216' ' ' GLY . 28.4 t -31.66 106.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.646 -0.914 . . . . 0.0 110.588 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.737 HD13 ' N ' ' B' ' 218' ' ' ILE . 0.0 OUTLIER -60.67 -171.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 108.778 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.76 ' H ' ' NH1' ' B' ' 222' ' ' ARG . 59.7 ttt85 51.8 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.97 . . . . 0.0 109.127 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 177.12 -22.87 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.016 -2.033 . . . . 0.0 108.016 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' B' ' 222' ' ' ARG . . . 179.29 -29.86 0.06 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.806 ' NH2' ' H ' ' B' ' 255' ' ' GLY . 33.6 mmt180 73.93 -33.57 0.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 122.16 -0.612 . . . . 0.0 109.764 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 221' ' ' GLY . 78.0 tt0 -55.25 -46.08 76.08 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 16.4 m-20 -63.33 -20.49 65.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.674 HE21 ' CD ' ' B' ' 250' ' ' GLU . 0.0 OUTLIER -67.32 -46.73 72.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.23 86.43 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.1 -37.14 73.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.743 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.4 m-30 -67.5 -41.18 84.91 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.703 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.15 -36.37 79.6 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.43 -1.419 . . . . 0.0 108.52 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 340' ' ' GLU . 71.3 ttt-85 -72.76 -57.4 4.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 108.6 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.89 -40.87 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.743 HG23 ' O ' ' B' ' 228' ' ' TYR . 51.3 t -64.71 -29.23 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.401 ' N ' ' O ' ' B' ' 230' ' ' ARG . 12.2 m -67.88 -37.01 81.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.38 -0.825 . . . . 0.0 109.493 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.35 -52.29 23.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.719 -1.238 . . . . 0.0 108.757 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.997 HD22 HG11 ' B' ' 212' ' ' VAL . 15.8 mt -57.53 -39.94 77.71 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -61.49 -25.39 67.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.78 -31.33 31.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.141 -0.975 . . . . 0.0 109.777 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.567 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -75.01 -52.6 10.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.21 -0.931 . . . . 0.0 110.926 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -147.21 -147.58 4.57 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -89.42 129.08 35.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 108.961 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.689 HG11 HG13 ' B' ' 232' ' ' VAL . 2.8 t -93.54 106.78 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.494 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 20.4 mt -72.88 -176.78 2.14 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.865 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.563 HG22 HG23 ' B' ' 246' ' ' VAL . 1.9 m 56.25 39.2 30.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.001 -1.062 . . . . 0.0 108.786 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' B' ' 244' ' ' GLU . 52.6 mp0 -45.99 -25.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.731 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -48.95 -38.1 21.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 247' ' ' ALA . 62.0 t -61.23 170.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.687 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 61.74 -71.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.854 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.0 t70 -67.59 28.65 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -106.76 13.46 27.94 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.674 ' CD ' HE21 ' B' ' 225' ' ' GLN . 29.0 mt-10 -108.64 10.52 26.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 1.08 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -85.59 -94.06 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.106 -0.996 . . . . 0.0 110.256 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.481 ' O ' HD23 ' B' ' 254' ' ' LEU . 1.9 mp0 -42.43 158.68 0.21 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.28 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -41.09 -22.11 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.212 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.572 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.6 mm? 59.52 -172.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.829 . . . . 0.0 109.933 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.806 ' H ' ' NH2' ' B' ' 222' ' ' ARG . . . 98.51 25.23 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.441 ' OE1' ' OD1' ' B' ' 262' ' ' ASP . 73.5 mm-40 53.73 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.913 -0.757 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.673 ' N ' ' O ' ' B' ' 255' ' ' GLY . 86.8 tt0 -44.59 -25.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 254' ' ' LEU . . . -69.6 165.11 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.113 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -50.39 134.02 23.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.351 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.82 -81.6 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 126.26 81.34 0.39 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.441 ' OD1' ' OE1' ' B' ' 256' ' ' GLU . 3.1 m-20 -52.87 -43.99 66.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.63 -49.33 75.61 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -60.52 -35.02 74.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.503 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.4 OUTLIER -62.51 -54.07 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.018 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.503 ' N ' HG22 ' B' ' 265' ' ' ILE . 1.7 t-80 -65.51 -33.78 76.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.577 -0.702 . . . . 0.0 109.64 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -55.79 -64.18 0.94 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 109.551 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -71.62 -38.71 70.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 110.217 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.444 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 10.4 m-20 -62.87 -59.22 5.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 110.296 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.479 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.9 OUTLIER -61.12 -36.86 80.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.118 . . . . 0.0 109.734 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -66.35 -52.53 46.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -0.949 . . . . 0.0 109.638 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.494 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.91 -43.79 86.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.497 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 3.9 tt -53.21 -43.82 67.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.481 ' CG ' HH21 ' B' ' 296' ' ' ARG . 28.9 mt-30 -65.41 -30.15 70.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.683 -0.636 . . . . 0.0 111.136 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.54 11.72 35.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.124 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.87 48.04 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.845 . . . . 0.0 111.514 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' B' ' 211' ' ' SER . 87.4 m-20 -88.45 -25.72 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 69.9 t -144.82 136.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' B' ' 213' ' ' TYR . 91.4 t -133.09 125.27 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.89 -1.132 . . . . 0.0 111.914 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.3 124.65 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.39 146.04 46.58 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.1 0.953 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.535 ' O ' HG11 ' B' ' 290' ' ' VAL . 1.2 pp20? -99.8 147.07 25.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.686 HG11 HD11 ' B' ' 316' ' ' LEU . 0.4 OUTLIER -122.96 -90.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.927 -1.108 . . . . 0.0 109.986 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.539 HG21 ' HE ' ' B' ' 309' ' ' ARG . 0.2 OUTLIER 64.36 -140.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 119.902 -1.749 . . . . 0.0 109.776 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.416 ' HA ' ' NE ' ' B' ' 314' ' ' ARG . 17.0 pt20 -43.47 148.56 0.66 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.24 128.12 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.185 1.923 . . . . 0.0 111.622 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.598 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 15.4 t -102.43 -120.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.616 ' HB2' ' H ' ' A' ' 87' ' ' SER . 9.7 tp 159.74 -58.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.51 58.8 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.535 HG11 ' O ' ' B' ' 282' ' ' GLU . 48.9 t -65.89 -45.09 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -56.47 -35.5 66.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.53 ' OH ' HG21 ' A' ' 98' ' ' VAL . 64.7 t80 -68.35 -56.03 9.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.602 -0.94 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.511 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 82.9 mt-10 -57.21 -36.62 71.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' B' ' 306' ' ' CYS . 63.4 mt -60.44 -48.96 79.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.67 -23.67 65.42 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.481 HH21 ' CG ' ' B' ' 274' ' ' GLN . 17.2 mmm180 -71.92 -47.22 54.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -1.158 . . . . 0.0 110.096 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -70.43 -34.43 72.47 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.36 -1.462 . . . . 0.0 107.879 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.504 HG21 ' OH ' ' A' ' 92' ' ' TYR . 1.1 t -57.82 -40.64 76.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -78.75 -56.37 4.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.594 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.1 0.65 39.71 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.929 0.871 . . . . 0.0 108.675 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' B' ' 302' ' ' LYS . . . 72.82 -156.81 52.11 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' B' ' 301' ' ' GLY . 18.2 mtmm 95.5 132.6 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 302' ' ' LYS . 87.7 Cg_exo -38.49 113.42 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.941 1.761 . . . . 0.0 111.209 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 302' ' ' LYS . 1.1 mt -112.83 104.62 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.334 -0.854 . . . . 0.0 110.871 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' B' ' 332' ' ' TRP . 47.1 tp -100.03 121.48 41.45 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 306' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' B' ' 294' ' ' LEU . 73.5 m -110.28 124.42 51.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 1.1 mt -121.31 131.17 54.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.988 -1.07 . . . . 0.0 112.321 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -125.63 153.36 43.9 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.539 ' HE ' HG21 ' B' ' 284' ' ' THR . 60.9 mtm180 -105.92 145.38 30.79 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.713 -1.242 . . . . 0.0 111.663 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' B' ' 313' ' ' GLY . 94.4 Cg_endo -83.39 -22.83 3.72 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.965 2.443 . . . . 0.0 111.68 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 310' ' ' PRO . 6.7 pt20 -46.1 -42.45 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 39.7 m -89.96 -14.72 33.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 310' ' ' PRO . . . 46.8 45.62 18.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.505 ' O ' ' HE2' ' B' ' 308' ' ' PHE . 32.5 mtp85 -85.44 177.28 7.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.97 -1.312 . . . . 0.0 107.563 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 316' ' ' LEU . 83.5 t -114.25 107.96 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.686 HD11 HG11 ' B' ' 283' ' ' VAL . 9.7 tp -41.63 137.41 1.62 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 59.1 m -46.57 145.61 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 110.034 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.87 -22.77 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.45 -53.03 13.3 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 109.69 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 39.7 mm -61.64 -42.86 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.016 -1.052 . . . . 0.0 108.833 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -60.36 -47.56 85.55 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.953 -1.092 . . . . 0.0 108.34 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -56.85 -33.2 63.04 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -59.75 -47.58 85.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.111 -1.229 . . . . 0.0 107.982 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -20.42 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.962 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' B' ' 323' ' ' ALA . 65.5 m-20 -110.67 -16.41 13.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 108.814 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 64.76 39.85 96.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.7 p -143.89 62.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' B' ' 327' ' ' SER . 93.6 mtt-85 95.72 -31.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -102.4 121.53 42.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.403 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 19.5 mt-30 -145.08 145.0 31.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.452 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.23 101.46 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.434 ' CG ' HD11 ' B' ' 305' ' ' LEU . 16.1 m0 -97.84 147.75 24.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 0.0 110.473 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 333' ' ' ASP . 38.7 p-10 -99.49 144.79 28.18 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.0 p90 -166.91 178.81 5.6 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.464 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.671 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -151.12 156.14 40.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -58.2 27.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.424 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -126.83 -12.13 3.37 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.586 ' O ' ' SD ' ' B' ' 342' ' ' MET . 3.4 pt-20 -145.93 10.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.133 -1.216 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 3.6 p -48.95 -43.42 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 230' ' ' ARG . 93.1 mt-10 -56.33 -33.26 65.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 341' ' ' THR . . . . . 0.526 HG22 HH11 ' B' ' 345' ' ' ARG . 14.0 m -65.41 -41.11 93.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.872 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.01 -51.3 66.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.142 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 82.4 mt -60.17 -30.77 69.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.849 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 39.1 m-20 -70.6 -43.62 68.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 110.666 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 345' ' ' ARG . . . . . 0.526 HH11 HG22 ' B' ' 341' ' ' THR . 53.0 mtt85 -70.8 -47.41 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.411 -1.431 . . . . 0.0 108.955 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 346' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 35.8 t80 -60.18 -46.75 88.64 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.69 -0.631 . . . . 0.0 110.506 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.824 ' CG ' HD12 ' B' ' 351' ' ' LEU . 14.9 m-85 -79.99 -27.87 39.55 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.84 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 61.5 mt-10 -61.95 -29.1 70.01 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 349' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -68.96 -18.76 64.12 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.787 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -174.94 102.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.824 HD12 ' CG ' ' B' ' 347' ' ' PHE . 1.0 OUTLIER 170.21 -48.03 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.536 -0.727 . . . . 0.0 109.328 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.583 ' O ' HG22 ' B' ' 355' ' ' THR . 75.0 Cg_exo -48.77 -39.83 38.88 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.395 2.064 . . . . 0.0 112.061 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 353' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' B' ' 355' ' ' THR . 48.2 tt0 -67.52 -34.21 76.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 354' ' ' LYS . . . . . 0.552 ' C ' ' H ' ' B' ' 356' ' ' ALA . 46.3 tttp -66.39 2.85 1.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 355' ' ' THR . . . . . 0.583 HG22 ' O ' ' B' ' 352' ' ' PRO . 8.9 t -68.45 34.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 356' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' B' ' 354' ' ' LYS . . . 60.84 38.57 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 38.6 t -72.31 146.19 47.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 25.8 m -67.09 150.87 48.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.968 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 64.0 m -66.56 -14.33 62.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.095 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 40.0 m80 52.67 68.11 3.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.727 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.42 -22.06 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.768 2.312 . . . . 0.0 112.239 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 26.9 t -77.32 153.85 33.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.377 179.702 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.311 0.576 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.5 -19.48 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.608 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.63 146.31 45.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.161 -0.962 . . . . 0.0 109.454 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.5 p -79.61 170.82 15.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -0.899 . . . . 0.0 109.679 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.93 170.72 35.41 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -74.63 152.02 39.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -1.161 . . . . 0.0 109.388 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' N ' ' OE1' ' A' ' 7' ' ' GLN . 0.8 OUTLIER -63.74 -179.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.571 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.09 153.43 81.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' CYS . 55.3 Cg_endo -72.12 158.69 51.68 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.637 2.225 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' PRO . 32.1 p -52.49 -179.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.132 -0.98 . . . . 0.0 108.734 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 p -112.54 146.36 38.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.096 -1.003 . . . . 0.0 108.522 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.981 HG11 HD22 ' A' ' 35' ' ' LEU . 7.8 t -127.38 127.12 68.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB3' HG13 ' A' ' 79' ' ' VAL . 29.2 t80 -100.85 144.17 30.13 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 32' ' ' VAL . 3.7 t80 -104.27 128.17 52.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 110.279 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 104.34 10.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.95 162.64 22.45 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.41 ' OG ' ' CB ' ' A' ' 87' ' ' SER . 2.5 m -67.39 -55.32 14.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -1.067 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 18' ' ' ILE . 9.5 mt 58.0 -123.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.981 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttp180 52.64 82.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.68 -34.35 5.17 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.67 113.91 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -142.34 -147.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.105 -1.232 . . . . 0.0 110.133 -178.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.07 -39.41 92.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 71.5 m-20 -58.54 -30.21 66.93 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.81 ' OE1' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.86 -49.06 61.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.023 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.03 81.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.3 -34.7 70.84 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.1 m-30 -68.54 -43.88 75.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.56 80.22 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.398 -1.439 . . . . 0.0 108.815 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.653 ' NE ' HH22 ' A' ' 34' ' ' ARG . 61.7 ttt180 -71.58 -59.0 2.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.915 -1.116 . . . . 0.0 108.533 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -51.55 -40.97 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.8 t -66.57 -27.78 41.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 17.4 p -65.53 -41.34 93.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.187 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.653 HH22 ' NE ' ' A' ' 30' ' ' ARG . 73.2 mtt85 -65.57 -41.72 92.59 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.981 HD22 HG11 ' A' ' 12' ' ' VAL . 86.0 mt -59.59 -42.94 93.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -58.88 -24.49 62.31 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 88.5 mtt-85 -70.18 -62.43 1.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.2 p90 -129.15 154.1 47.06 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 87.45 72.27 1.29 Allowed Glycine 0 N--CA 1.477 1.421 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 39' ' ' GLY . 2.6 ttmt -35.76 126.65 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.052 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -84.18 90.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.552 -1.343 . . . . 0.0 107.964 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -52.42 -57.41 9.95 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.229 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -86.69 91.22 8.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.14 -24.15 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.264 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 30.4 t-80 -65.47 -29.54 70.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.764 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.606 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 25.2 t -52.75 -20.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.591 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.614 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -106.64 -65.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.513 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.854 ' O ' ' N ' ' A' ' 50' ' ' GLU . 56.5 m-20 -44.81 -24.22 0.19 Allowed 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.81 ' HB3' ' OE1' ' A' ' 25' ' ' GLN . . . -23.01 -30.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.525 0.678 . . . . 0.0 110.318 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 48' ' ' ASP . 26.9 mt-10 -62.42 -19.55 63.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.94 -1.1 . . . . 0.0 109.352 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -57.85 135.39 56.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.89 -1.131 . . . . 0.0 108.545 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 56.42 152.63 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 109.336 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' A' ' 54' ' ' LEU . 39.5 Cg_endo -69.28 92.47 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.167 1.912 . . . . 0.0 110.836 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.762 HD11 ' O ' ' A' ' 49' ' ' ALA . 20.6 mt -53.77 -155.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.803 0.811 . . . . 0.0 110.696 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . 96.54 26.47 10.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 26.1 mt-10 63.18 -23.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.974 -0.721 . . . . 0.0 109.353 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 55' ' ' GLY . 60.8 tt0 -75.02 -17.73 60.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 108.849 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 60' ' ' GLY . . . -58.88 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.191 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 58' ' ' ALA . . . -36.67 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.631 -0.668 . . . . 0.0 109.612 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 58' ' ' ALA . . . 91.31 -162.72 28.47 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.718 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 92.88 42.54 4.38 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' GLY . 66.5 m-20 -48.08 -45.41 32.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -59.64 -43.49 93.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -61.01 -48.06 83.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.625 -0.672 . . . . 0.0 109.847 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 tt -71.34 -33.88 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.771 ' ND1' ' O ' ' B' ' 319' ' ' MET . 21.8 t60 -78.58 -31.22 47.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 46.1 mm-40 -68.79 -51.93 35.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 108.702 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.17 -39.7 89.96 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.393 -0.817 . . . . 0.0 109.217 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 74.6 m-20 -69.78 -53.22 19.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.37 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 66' ' ' HIS . 6.3 tp -68.42 -38.5 81.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.11 -0.994 . . . . 0.0 110.697 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 49.0 t-20 -64.36 -53.13 53.43 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.167 -0.958 . . . . 0.0 109.402 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.555 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -60.23 -41.64 93.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 108.659 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 4.3 tt -52.69 -37.33 58.76 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -74.91 -29.28 60.92 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.751 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.555 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 32.1 mt-30 -92.56 5.14 51.98 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.42 131.13 35.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.317 -0.865 . . . . 0.0 111.722 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 11' ' ' SER . 81.1 m-20 -74.49 -31.3 62.16 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 61.5 t -139.36 140.11 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 13' ' ' TYR . 61.7 t -134.0 128.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.905 -1.122 . . . . 0.0 111.942 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.82 123.87 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.75 47.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 109.326 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' OE2' ' CZ ' ' A' ' 134' ' ' TYR . 18.5 tp10 -84.44 114.4 21.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.481 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -119.82 148.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.512 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 114' ' ' ARG . 57.8 m -167.44 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -143.69 150.65 51.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.434 ' O ' ' OG ' ' A' ' 87' ' ' SER . 85.1 Cg_exo -35.6 131.69 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.755 2.303 . . . . 0.0 112.425 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.773 ' O ' HD23 ' B' ' 288' ' ' LEU . 15.6 m -166.87 116.22 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.768 HD23 ' O ' ' B' ' 287' ' ' SER . 3.1 mt -68.15 -41.18 81.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.988 -1.07 . . . . 0.0 109.647 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.18 70.62 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.05 -49.49 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -1.017 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.96 -39.95 89.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.796 ' OH ' HG21 ' B' ' 298' ' ' VAL . 66.4 t80 -61.5 -44.56 96.85 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.234 -1.156 . . . . 0.0 109.434 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.86 -31.72 71.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.403 -0.811 . . . . 0.0 109.194 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.27 -43.56 81.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.75 97.66 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -41.02 90.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -1.062 . . . . 0.0 108.887 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -70.09 -39.94 75.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.77 HG21 ' OH ' ' B' ' 292' ' ' TYR . 0.5 OUTLIER -52.75 -37.77 26.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.25 -50.26 16.69 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.129 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.95 -4.83 18.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.061 -1.025 . . . . 0.0 108.877 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.04 29.02 6.22 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 25.0 mtmm -95.72 152.12 38.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.976 -1.308 . . . . 0.0 107.786 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 90.8 Cg_exo -34.21 118.67 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.148 1.899 . . . . 0.0 111.775 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.582 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.6 mt -119.63 104.88 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 0.0 110.98 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.69 115.64 29.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.57 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -107.69 139.58 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 83' ' ' VAL . 11.7 mt -123.84 144.73 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.105 -0.997 . . . . 0.0 112.046 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.88 140.24 29.66 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 27.8 mtt180 -97.39 140.54 22.08 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.592 -1.318 . . . . 0.0 111.518 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.6 Cg_endo -78.29 -34.14 1.67 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 122.652 2.235 . . . . 0.0 110.789 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.473 ' CG ' ' N ' ' A' ' 112' ' ' SER . 18.2 pt20 -47.83 -38.96 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 113' ' ' GLY . 8.1 p -90.95 -21.04 21.53 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 37.91 39.38 0.64 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' VAL . 45.7 mtt-85 -74.79 13.73 0.6 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.389 -1.065 . . . . 0.0 109.711 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' B' ' 219' ' ' ARG . 56.0 t 49.43 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.313 -0.867 . . . . 0.0 110.066 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 120' ' ' ILE . 36.1 tp -48.28 143.55 4.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -40.42 141.62 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 111.053 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.465 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -54.98 -55.03 35.38 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.44 0.638 . . . . 0.0 110.854 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.745 ' O ' ' ND1' ' B' ' 266' ' ' HIS . 14.8 mtp -60.37 -39.78 88.45 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.18 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' B' ' 292' ' ' TYR . 45.2 mm -62.67 -41.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.712 -1.242 . . . . 0.0 109.59 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.533 HH12 ' CG ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -72.86 -45.69 56.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 109.969 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.22 -18.98 65.73 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 -57.54 8.96 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.039 -1.271 . . . . 0.0 109.616 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.777 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -153.69 -89.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.687 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 22.9 t0 94.26 -0.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . 177.4 82.59 0.06 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.807 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 165.44 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.445 -1.033 . . . . 0.0 109.79 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.38 -25.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.807 ' H ' ' C ' ' A' ' 127' ' ' SER . 8.9 t80 -116.95 115.5 25.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.53 132.71 41.26 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.175 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.04 102.75 13.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.29 145.22 26.31 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.169 -0.957 . . . . 0.0 110.378 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' SD ' ' A' ' 142' ' ' MET . 63.7 m-20 -96.54 152.21 18.85 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CZ ' ' OE2' ' A' ' 82' ' ' GLU . 5.5 p90 -170.35 173.86 5.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.606 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -147.79 150.95 35.18 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.5 mt-10 -40.5 -27.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.826 -1.171 . . . . 0.0 110.316 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -85.79 -4.75 84.72 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 120.976 -1.077 . . . . 0.0 111.2 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -135.36 4.37 3.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.784 -1.421 . . . . 0.0 110.112 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.0 p -57.82 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.979 -1.076 . . . . 0.0 108.759 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.524 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.9 pt-20 -55.01 -33.65 62.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 m -66.13 -39.45 89.89 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.069 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 14.3 mmt -55.06 -53.19 59.04 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 30.6 mt -63.34 -31.59 72.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.549 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 28.7 t0 -69.05 -46.05 68.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 111.001 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -70.64 -50.36 37.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.404 -1.435 . . . . 0.0 109.818 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 29.4 t80 -57.12 -50.07 73.94 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 151' ' ' LEU . 27.0 m-85 -75.79 -30.83 59.23 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.586 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 5.5 mm-40 -55.12 -35.3 64.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.98 18.72 3.38 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 147' ' ' PHE . 2.0 t80 -147.27 -34.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 111.723 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.557 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 18.4 mt -117.87 40.99 0.34 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 61.3 Cg_endo -74.13 -32.84 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.922 1.748 . . . . 0.0 111.169 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.27 -26.93 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -58.31 -33.61 69.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.24 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 47.3 m -57.5 -37.59 73.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.93 139.79 30.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 95.9 p -148.49 162.91 38.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.856 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.9 p 55.2 50.3 15.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 160' ' ' HIS . 96.8 p -61.62 -34.72 76.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 159' ' ' SER . 1.0 OUTLIER 56.22 150.68 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.521 -0.737 . . . . 0.0 109.705 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.43 148.37 79.12 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.547 2.164 . . . . 0.0 112.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.9 m -58.74 -31.08 67.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.487 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 55.9 mtt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.06 -18.46 65.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -61.31 145.82 50.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 84.4 p -79.29 169.46 18.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -157.46 170.11 34.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -73.89 151.65 40.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -1.207 . . . . 0.0 109.382 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' B' ' 207' ' ' GLN . 0.8 OUTLIER -63.48 -179.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.421 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.97 153.66 81.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.337 -0.852 . . . . 0.0 109.268 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 210' ' ' CYS . 55.3 Cg_endo -72.3 159.13 50.28 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.595 2.197 . . . . 0.0 111.786 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' B' ' 209' ' ' PRO . 31.0 p -52.77 -179.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.09 -1.007 . . . . 0.0 108.766 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.1 p -112.71 146.26 39.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 1.005 HG11 HD22 ' B' ' 235' ' ' LEU . 7.2 t -127.35 127.41 69.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.579 ' HB3' HG13 ' B' ' 279' ' ' VAL . 29.7 t80 -101.04 144.32 30.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' B' ' 232' ' ' VAL . 3.7 t80 -104.57 127.8 52.39 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 110.392 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 104.78 11.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.5 22.44 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.416 ' HG ' ' CB ' ' B' ' 287' ' ' SER . 2.7 m -66.83 -55.98 12.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 109.205 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 mt 58.62 -123.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.473 -0.767 . . . . 0.0 109.883 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 13.5 ttp180 52.59 82.22 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.261 -0.899 . . . . 0.0 109.172 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 112.97 -34.12 5.25 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 71.63 113.76 0.05 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.615 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER -142.63 -147.81 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.176 -1.19 . . . . 0.0 110.169 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.14 -39.66 93.33 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 70.8 m-20 -58.29 -30.07 66.34 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.798 ' OE1' ' HB3' ' B' ' 249' ' ' ALA . 0.0 OUTLIER -69.13 -48.7 61.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.08 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.95 81.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.8 tp -58.76 -34.35 71.32 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.751 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.3 m-30 -68.61 -43.96 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.55 80.14 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.519 -1.363 . . . . 0.0 108.823 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.647 ' NE ' HH22 ' B' ' 234' ' ' ARG . 57.8 ttt180 -71.5 -58.94 3.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.806 -1.183 . . . . 0.0 108.505 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.46 -41.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.751 HG23 ' O ' ' B' ' 228' ' ' TYR . 70.8 t -66.33 -28.07 42.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 14.5 p -65.44 -41.17 93.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.647 HH22 ' NE ' ' B' ' 230' ' ' ARG . 73.5 mtt85 -65.61 -41.67 92.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 1.005 HD22 HG11 ' B' ' 212' ' ' VAL . 84.9 mt -59.92 -42.86 94.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -58.7 -24.58 61.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 234' ' ' ARG . 87.6 mtt-85 -70.26 -62.94 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.1 p90 -128.49 154.49 46.05 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 86.98 72.39 1.29 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' B' ' 239' ' ' GLY . 2.7 ttmt -35.75 126.53 0.68 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.575 -0.956 . . . . 0.0 109.112 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.99 90.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.543 -1.348 . . . . 0.0 108.088 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 1.1 mt -52.22 -57.43 9.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.223 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.472 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 0.2 OUTLIER -86.85 91.37 8.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.742 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.2 -24.47 51.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.529 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 31.8 t-80 -65.23 -29.64 70.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.614 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 25.3 t -52.65 -20.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.579 ' C ' ' N ' ' B' ' 249' ' ' ALA . . . -106.56 -65.28 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.858 ' O ' ' N ' ' B' ' 250' ' ' GLU . 55.8 m-20 -44.98 -24.13 0.2 Allowed 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.798 ' HB3' ' OE1' ' B' ' 225' ' ' GLN . . . -23.18 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.858 ' N ' ' O ' ' B' ' 248' ' ' ASP . 27.0 mt-10 -63.08 -19.31 64.29 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.901 -1.124 . . . . 0.0 109.35 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -57.78 135.33 56.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.961 -1.087 . . . . 0.0 108.58 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 0.8 OUTLIER 56.38 152.37 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' B' ' 254' ' ' LEU . 39.1 Cg_endo -69.08 92.43 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.194 1.929 . . . . 0.0 110.895 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.772 HD11 ' O ' ' B' ' 249' ' ' ALA . 20.1 mt -53.99 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.848 0.833 . . . . 0.0 110.69 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' B' ' 257' ' ' GLU . . . 96.25 26.94 10.5 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.465 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 26.9 mt-10 62.99 -23.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.931 -0.747 . . . . 0.0 109.401 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.666 ' H ' ' C ' ' B' ' 255' ' ' GLY . 61.0 tt0 -74.5 -17.66 60.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 108.928 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' B' ' 260' ' ' GLY . . . -58.7 -161.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.417 -0.802 . . . . 0.0 109.356 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 258' ' ' ALA . . . -36.68 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.431 0.634 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' B' ' 258' ' ' ALA . . . 91.48 -162.81 28.3 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 120.16 -1.019 . . . . 0.0 110.737 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' B' ' 264' ' ' PHE . . . 93.37 42.44 4.26 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 261' ' ' GLY . 68.4 m-20 -47.98 -45.29 31.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.85 -43.58 94.56 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' B' ' 261' ' ' GLY . 0.7 OUTLIER -60.87 -48.35 82.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.541 -0.724 . . . . 0.0 109.937 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 3.8 tt -71.23 -33.59 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.475 -0.765 . . . . 0.0 109.996 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.745 ' ND1' ' O ' ' A' ' 119' ' ' MET . 22.5 t60 -78.65 -31.14 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 46.0 mm-40 -68.78 -52.71 27.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 108.63 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -65.3 -40.24 93.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.117 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.459 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 67.1 m-20 -69.12 -53.65 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.83 . . . . 0.0 110.564 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' B' ' 266' ' ' HIS . 6.2 tp -68.46 -38.39 81.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.029 -1.044 . . . . 0.0 110.644 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 271' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 50.6 t-20 -64.14 -53.49 48.66 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.353 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -59.92 -41.77 92.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 108.642 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.442 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 4.1 tt -52.78 -36.92 58.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -75.39 -28.99 59.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.726 . . . . 0.0 109.769 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.561 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 32.4 mt-30 -92.45 4.76 52.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.971 -1.08 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.26 131.49 35.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.458 -0.776 . . . . 0.0 111.829 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.2 m-20 -74.91 -31.48 61.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 61.8 t -139.27 140.25 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' B' ' 213' ' ' TYR . 62.0 t -134.0 129.6 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.939 -1.1 . . . . 0.0 111.995 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.27 123.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.411 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -107.4 122.16 46.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.539 ' OE2' ' CZ ' ' B' ' 334' ' ' TYR . 18.4 tp10 -83.81 114.21 21.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.605 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -119.34 149.02 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 0.0 109.562 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 57.6 m -167.7 -31.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.45 150.59 51.83 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -35.62 131.12 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.718 2.279 . . . . 0.0 112.514 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.768 ' O ' HD23 ' A' ' 88' ' ' LEU . 15.4 m -166.29 116.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.11 -0.994 . . . . 0.0 109.622 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 87' ' ' SER . 3.5 mt -68.27 -41.23 81.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.102 -0.999 . . . . 0.0 109.568 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.73 -36.32 71.52 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.83 -49.75 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -1.016 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.29 90.3 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.77 ' OH ' HG21 ' A' ' 98' ' ' VAL . 67.0 t80 -60.97 -44.67 97.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.233 -1.157 . . . . 0.0 109.419 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.67 -32.04 72.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.0 mt -67.17 -43.43 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.64 -39.74 97.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -40.87 90.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.267 -1.137 . . . . 0.0 108.739 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -70.25 -39.83 74.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.796 HG21 ' OH ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -52.96 -37.71 26.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -75.23 -50.3 16.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.57 -5.05 17.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.126 -0.984 . . . . 0.0 108.848 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 48.07 29.01 6.27 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.46 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 25.3 mtmm -95.75 152.29 38.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.953 -1.322 . . . . 0.0 107.748 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' B' ' 302' ' ' LYS . 84.0 Cg_exo -34.08 119.01 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.24 1.96 . . . . 0.0 111.788 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.563 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.5 mt -120.07 105.01 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.359 -0.838 . . . . 0.0 111.032 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 60.5 tp -99.85 115.94 30.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 306' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -107.8 139.7 42.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.067 -1.021 . . . . 0.0 108.251 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' B' ' 283' ' ' VAL . 11.8 mt -124.0 144.67 49.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.028 -1.045 . . . . 0.0 112.093 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -143.94 140.14 29.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.48 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 27.7 mtt180 -97.35 140.28 21.94 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 111.557 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.04 -33.66 2.0 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.607 2.205 . . . . 0.0 110.796 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' B' ' 312' ' ' SER . 18.2 pt20 -48.33 -38.96 20.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.481 ' O ' ' C ' ' B' ' 313' ' ' GLY . 7.5 p -91.31 -20.31 22.02 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 37.17 39.62 0.48 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' B' ' 315' ' ' VAL . 45.5 mtt-85 -74.78 13.72 0.6 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.311 -1.111 . . . . 0.0 109.724 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 55.3 t 49.58 100.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 110.119 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 320' ' ' ILE . 36.6 tp -48.34 143.85 4.42 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.53 141.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.02 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 318' ' ' ALA . . . . . 0.464 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -54.87 -55.12 33.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.693 -0.63 . . . . 0.0 110.79 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.771 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 14.2 mtp -60.13 -40.22 89.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.029 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 45.1 mm -62.53 -41.86 93.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.82 -1.175 . . . . 0.0 109.477 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' ' 325' ' ' ASP . 0.9 OUTLIER -72.77 -45.91 56.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 109.893 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -65.36 -18.78 65.79 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -51.32 -57.6 8.45 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.124 -1.221 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -153.96 -89.03 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.85 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 23.2 t0 94.12 -0.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . 177.76 82.5 0.06 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.758 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.0 OUTLIER 165.81 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.433 -1.039 . . . . 0.0 109.811 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.42 -25.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.761 ' CD1' ' HB3' ' B' ' 324' ' ' ALA . 9.0 t80 -117.25 115.67 25.75 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.67 132.98 41.33 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.173 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 73.0 t -92.41 102.55 13.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 332' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.09 145.15 26.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.08 -1.012 . . . . 0.0 110.441 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.487 ' O ' ' SD ' ' B' ' 342' ' ' MET . 65.7 m-20 -96.41 152.11 18.91 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.539 ' CZ ' ' OE2' ' B' ' 282' ' ' GLU . 5.6 p90 -170.28 174.08 5.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.51 -1.368 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -148.09 150.9 34.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.0 mt-10 -40.43 -27.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.0 110.308 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 337' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -85.5 -5.27 84.93 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.015 -1.053 . . . . 0.0 111.226 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -135.43 4.62 3.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.92 -1.341 . . . . 0.0 110.082 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.1 p -57.97 -48.64 83.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.888 -1.132 . . . . 0.0 108.763 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 24.0 pt-20 -55.23 -33.78 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.0 m -65.77 -39.75 91.35 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 14.0 mmt -54.88 -53.96 48.65 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 32.1 mt -62.39 -31.66 72.36 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.891 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 30.0 t0 -68.95 -46.09 69.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.18 -0.95 . . . . 0.0 111.063 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -70.93 -50.61 32.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.473 -1.392 . . . . 0.0 109.759 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 346' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' B' ' 346' ' ' TYR . 29.6 t80 -56.58 -50.1 72.93 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.436 -0.79 . . . . 0.0 109.994 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' B' ' 351' ' ' LEU . 25.2 m-85 -75.85 -30.76 59.04 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.561 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 348' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 5.3 mm-40 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -87.41 19.56 3.23 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' B' ' 347' ' ' PHE . 2.0 t80 -148.0 -34.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.571 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.561 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 18.7 mt -117.72 40.77 0.33 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.864 -1.147 . . . . 0.0 111.277 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 63.9 Cg_endo -74.26 -32.79 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.963 1.775 . . . . 0.0 111.164 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -129.24 -26.38 2.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -58.85 -33.72 70.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.188 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 47.5 m -57.59 -37.45 73.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -95.18 139.36 31.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 95.4 p -147.94 162.42 39.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.38 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 17.9 p 55.55 50.59 14.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 359' ' ' SER . . . . . 0.524 ' O ' ' O ' ' B' ' 360' ' ' HIS . 88.6 p -61.94 -34.46 76.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' B' ' 359' ' ' SER . 0.9 OUTLIER 56.25 150.57 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.666 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 147.9 77.83 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.553 2.168 . . . . 0.0 112.074 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 15.1 m -59.54 -32.38 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.377 179.875 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 3' ' ' ALA . 56.7 mtt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.64 10.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -59.67 -24.9 64.29 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.379 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p -56.53 -18.6 12.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.11 -158.26 32.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.65 144.89 2.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.383 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -90.76 -172.37 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.94 80.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.395 -0.815 . . . . 0.0 109.415 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.99 155.51 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.059 1.84 . . . . 0.0 111.344 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.3 p -58.84 175.66 0.25 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.024 -1.047 . . . . 0.0 108.583 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 14.6 m -119.0 153.05 35.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.315 -0.866 . . . . 0.0 109.525 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -123.84 126.74 73.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.602 ' HB3' HG13 ' A' ' 79' ' ' VAL . 37.1 t80 -88.83 129.66 35.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 46' ' ' VAL . 16.4 t80 -97.15 131.91 43.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.613 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.851 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -142.14 100.61 3.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.383 -0.823 . . . . 0.0 109.332 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.31 -176.18 14.33 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.533 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 4.5 m -87.53 120.27 28.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -1.125 . . . . 0.0 110.186 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' NE ' ' A' ' 22' ' ' ARG . 3.6 mt -110.2 -108.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 0.2 OUTLIER 75.0 -10.34 1.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.14 -0.975 . . . . 0.0 110.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 173.66 177.47 42.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' GLN . . . -48.08 -86.34 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.556 ' NE ' ' O ' ' A' ' 18' ' ' ILE . 72.0 mtt-85 72.12 142.39 0.06 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.726 1.251 . . . . 0.0 112.605 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.29 -17.4 28.66 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 40.9 m-20 -63.7 -38.93 92.98 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.68 ' OE1' ' HB3' ' A' ' 49' ' ' ALA . 60.9 mm-40 -68.22 -42.74 79.35 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.89 -51.43 69.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.084 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 -35.42 75.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.686 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.3 m-30 -68.89 -42.12 77.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -63.54 -38.19 90.2 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 108.951 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -71.41 -55.51 7.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.754 -1.217 . . . . 0.0 108.292 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.68 -44.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -63.5 -27.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.5 p -67.4 -39.53 85.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' NE ' ' CD ' ' A' ' 140' ' ' GLU . 84.8 mtt-85 -69.15 -47.38 65.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.833 -1.167 . . . . 0.0 108.757 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 38' ' ' TYR . 4.7 mt -62.25 -33.86 75.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -64.91 -28.38 69.5 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -71.28 -59.88 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.4 p90 -121.57 151.36 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.89 77.84 1.12 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 39' ' ' GLY . 43.2 mtmt -40.9 118.64 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.451 -1.029 . . . . 0.0 108.57 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 32' ' ' VAL . 32.9 t -82.4 128.04 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 110.118 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.2 mt -105.86 172.43 6.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.782 HG22 ' O ' ' A' ' 43' ' ' THR . 32.4 m 51.81 47.28 25.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 108.887 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' HIS . 75.3 tt0 -50.05 -21.17 1.15 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.635 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -38.42 -47.49 1.26 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.374 -0.829 . . . . 0.0 110.157 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.707 ' O ' ' N ' ' A' ' 48' ' ' ASP . 3.4 p -57.47 162.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.941 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 60.85 -58.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.055 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.977 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.2 16.73 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.715 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -82.07 -39.56 23.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.15 -0.969 . . . . 0.0 108.475 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 58.3 mt-10 -45.92 -15.39 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.246 -0.909 . . . . 0.0 108.656 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.977 HD22 ' O ' ' A' ' 48' ' ' ASP . 3.0 mp -54.64 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 110.042 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.72 ' H ' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -155.55 -44.77 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.661 -0.649 . . . . 0.0 109.991 -178.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -84.06 80.37 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.916 2.411 . . . . 0.0 110.526 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.797 ' N ' HD12 ' A' ' 54' ' ' LEU . 5.1 mp -95.52 157.42 15.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.323 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 42.96 -167.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG3' ' HB2' ' B' ' 318' ' ' ALA . 43.5 mp0 -72.83 -30.86 64.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.579 -0.953 . . . . 0.0 109.696 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' GLU . 72.9 tt0 -47.53 -20.8 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -56.69 91.24 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.48 -3.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.933 . . . . 0.0 109.858 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -49.05 -46.12 33.16 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.65 79.36 0.03 OUTLIER Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -48.23 -46.96 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -60.16 -44.51 94.96 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 68' ' ' GLN . 51.6 t80 -61.43 -47.02 87.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 109.143 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 45' ' ' HIS . 0.7 OUTLIER -54.32 -39.66 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.645 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 2.2 t-80 -75.14 -48.46 23.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.84 -57.44 9.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 110.022 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 96.8 mm-40 -63.13 -40.36 97.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 109.354 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.702 ' OD1' HG23 ' A' ' 43' ' ' THR . 65.2 m-20 -60.5 -40.77 92.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.932 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -74.66 -39.02 62.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.635 -1.291 . . . . 0.0 109.84 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -56.3 -45.77 80.1 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -70.49 -40.13 73.78 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.5 tp -58.32 -33.34 69.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HA ' HD13 ' A' ' 100' ' ' LEU . 31.8 mt-30 -80.29 -28.07 38.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.558 -0.714 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -98.6 5.9 47.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.07 . . . . 0.0 108.989 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.27 132.74 46.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 111.756 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 11' ' ' SER . 70.1 m-20 -85.22 -30.96 23.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 22.3 t -143.32 138.18 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 13' ' ' TYR . 99.5 t -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.219 -0.925 . . . . 0.0 111.641 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.15 114.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.851 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . . . -115.17 131.83 56.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.149 -0.969 . . . . 0.0 110.386 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -91.16 114.72 27.32 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.8 t -85.97 -99.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.947 -1.095 . . . . 0.0 109.977 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.409 ' H ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 m 64.66 -122.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.674 -1.266 . . . . 0.0 109.047 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 15.2 pt20 -48.72 147.3 4.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.064 -1.023 . . . . 0.0 109.128 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.46 124.38 11.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.362 2.041 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.416 ' OG ' HG23 ' A' ' 90' ' ' VAL . 31.6 t -140.61 130.18 24.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.37 -41.39 73.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.55 97.38 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.416 HG23 ' OG ' ' A' ' 87' ' ' SER . 20.7 t -69.9 -47.19 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.356 -1.085 . . . . 0.0 109.078 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.87 -46.8 93.48 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 19.9 t80 -62.28 -45.05 94.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.748 -0.854 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -60.79 -33.54 73.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.221 -0.925 . . . . 0.0 109.098 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 81' ' ' ALA . 77.0 mt -73.42 -41.56 63.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.31 -48.7 62.11 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 100' ' ' LEU . 19.0 tpt180 -59.24 -42.42 91.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.31 -1.112 . . . . 0.0 108.871 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' A' ' 101' ' ' GLY . . . -66.72 -39.48 88.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.048 . . . . 0.0 108.905 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -51.72 -40.8 27.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -47.74 50.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.896 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 101' ' ' GLY . 2.8 pp -124.7 -33.19 3.0 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.932 -1.105 . . . . 0.0 111.298 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.798 ' N ' HD12 ' A' ' 100' ' ' LEU . . . -74.25 10.51 7.88 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 7.85 -74.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.342 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' GLY . 30.9 Cg_endo -65.33 108.43 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.349 1.16 . . . . 0.0 111.261 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 102' ' ' LYS . 3.7 mt -134.55 150.16 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.132 0.968 . . . . 0.0 111.486 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.9 tp -128.02 113.74 16.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.765 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -114.17 150.79 33.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.815 -1.178 . . . . 0.0 109.19 -179.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 2.9 mp -132.46 137.08 47.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 0.0 111.585 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -128.81 140.01 51.9 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -88.93 133.05 36.33 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.001 -1.062 . . . . 0.0 110.992 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 113' ' ' GLY . 87.8 Cg_endo -78.76 -38.81 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.537 2.158 . . . . 0.0 111.277 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.27 -31.52 6.04 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 113' ' ' GLY . 22.0 p -95.23 -20.55 19.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 38.42 42.49 1.33 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.438 HH11 ' HB2' ' A' ' 112' ' ' SER . 1.7 mtt85 -67.48 7.19 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.376 -1.073 . . . . 0.0 109.494 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 113' ' ' GLY . 77.3 t 57.57 99.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.448 -0.783 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.741 ' CD1' HG11 ' A' ' 83' ' ' VAL . 19.4 tp -54.76 151.12 8.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.05 142.07 47.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.116 -0.99 . . . . 0.0 110.9 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' B' ' 256' ' ' GLU . . . -57.34 -42.68 82.4 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 41.8 mmm -62.25 -45.7 92.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.724 0.773 . . . . 0.0 109.361 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' ALA . 28.0 mm -61.1 -43.19 95.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.122 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' GLY . 0.3 OUTLIER -55.61 -45.46 77.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.615 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -51.05 -40.07 42.74 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 103.973 -3.651 . . . . 0.0 103.973 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.612 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -76.07 89.56 3.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.14 40.42 0.07 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.918 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 127' ' ' SER . 97.7 m-20 -54.7 -20.08 7.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 110.059 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 68.8 -14.62 0.74 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 125' ' ' ASP . 22.5 t -102.49 -74.62 0.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.236 . . . . 0.0 108.805 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.77 -49.15 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.765 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 4.5 t80 -103.55 129.05 50.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -140.47 135.65 32.19 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.581 -1.324 . . . . 0.0 111.895 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.2 112.19 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 14.2 m0 -108.09 138.76 43.81 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.979 -1.076 . . . . 0.0 109.946 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' SD ' ' A' ' 142' ' ' MET . 80.9 m-20 -90.04 155.37 19.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.6 -1.313 . . . . 0.0 107.771 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.8 p90 -172.15 -177.28 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.697 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -150.89 148.33 28.3 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' ALA . 62.3 mt-10 -41.7 -34.62 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.745 -1.222 . . . . 0.0 110.438 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.81 6.18 75.49 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.885 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -137.89 -3.61 1.81 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.961 -1.317 . . . . 0.0 109.795 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.2 p -55.7 -46.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 54.5 mt-10 -52.64 -34.56 52.0 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -70.07 -38.78 75.84 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.375 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 13.0 mmt -53.5 -53.38 52.29 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 79.0 mt -60.69 -39.11 87.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.029 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.53 -45.22 93.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 110.941 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -68.64 -51.55 41.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.545 -1.347 . . . . 0.0 108.873 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.45 -45.27 80.9 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.611 -0.68 . . . . 0.0 109.971 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 151' ' ' LEU . 15.5 m-85 -73.4 -33.15 64.84 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -58.09 -29.9 65.82 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.18 26.86 4.45 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.99 -82.4 0.21 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.693 -1.203 . . . . 0.0 113.472 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 147' ' ' PHE . 4.8 mt -55.11 -59.21 11.49 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.131 -0.98 . . . . 0.0 112.195 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 2.6 Cg_endo -41.1 -17.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 0.0 111.878 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 151' ' ' LEU . 55.6 tt0 -87.42 -61.76 1.65 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -4.83 14.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 19.1 m -49.31 -37.16 23.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -168.95 44.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 51.1 m -67.72 -33.2 74.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.2 p -68.91 162.91 25.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.428 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.5 t -88.85 152.08 21.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 160' ' ' HIS . 11.8 p80 -128.55 76.07 78.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 109.244 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 162' ' ' SER . 53.2 Cg_exo -49.59 -17.87 2.16 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.855 2.37 . . . . 0.0 112.33 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 161' ' ' PRO . 69.1 m 49.68 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.484 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.501 ' O ' ' N ' ' B' ' 203' ' ' ALA . 55.7 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 50.13 10.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' B' ' 201' ' ' MET . . . -59.62 -24.84 64.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.331 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 97.3 p -56.82 -18.39 12.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.3 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.29 -158.77 33.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.69 144.69 3.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -1.15 . . . . 0.0 109.385 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.14 -172.05 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.41 153.31 79.02 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.547 -0.721 . . . . 0.0 109.328 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -56.41 155.89 23.68 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.986 1.791 . . . . 0.0 111.279 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 18.6 p -58.92 175.55 0.27 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.047 -1.033 . . . . 0.0 108.506 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 14.6 m -119.09 153.18 35.2 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.41 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 0.0 OUTLIER -123.92 126.97 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.589 ' HB3' HG13 ' B' ' 279' ' ' VAL . 36.4 t80 -89.04 129.42 35.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' B' ' 246' ' ' VAL . 15.9 t80 -96.99 132.34 42.89 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.2 OUTLIER -142.57 101.15 3.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -0.807 . . . . 0.0 109.234 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.62 -176.39 14.41 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.515 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 4.4 m -87.19 120.62 28.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 110.108 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.559 ' O ' ' NE ' ' B' ' 222' ' ' ARG . 3.9 mt -110.63 -108.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER 74.97 -10.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 221' ' ' GLY . . . 173.43 177.37 42.61 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' B' ' 225' ' ' GLN . . . -47.89 -86.2 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' B' ' 218' ' ' ILE . 73.7 mtt-85 71.96 142.17 0.06 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.692 1.234 . . . . 0.0 112.734 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.18 -17.34 26.6 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 44.2 m-20 -64.0 -38.9 92.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.667 ' OE1' ' HB3' ' B' ' 249' ' ' ALA . 61.6 mm-40 -68.13 -42.94 79.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.73 -51.28 70.46 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.989 -1.084 . . . . 0.0 108.173 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.52 -35.98 77.28 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.678 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -68.29 -42.74 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.536 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.471 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -62.95 -38.25 90.32 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.846 -1.159 . . . . 0.0 109.091 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -71.38 -55.41 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.877 -1.14 . . . . 0.0 108.249 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 45.6 mt -53.74 -44.64 59.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.678 HG23 ' O ' ' B' ' 228' ' ' TYR . 55.9 t -63.35 -28.18 44.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 23.9 p -67.21 -39.52 86.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' ARG . . . . . 0.498 ' NE ' ' CD ' ' B' ' 340' ' ' GLU . 85.4 mtt-85 -69.31 -47.33 64.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.912 -1.117 . . . . 0.0 108.815 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 238' ' ' TYR . 4.7 mt -62.26 -33.72 75.16 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -65.1 -28.55 69.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -71.19 -59.87 2.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.4 p90 -121.42 151.7 39.89 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 83.33 77.92 1.09 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' B' ' 239' ' ' GLY . 42.9 mtmt -40.87 118.71 1.02 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.385 -1.068 . . . . 0.0 108.657 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.411 HG11 HG13 ' B' ' 232' ' ' VAL . 30.3 t -82.35 127.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.192 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.441 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 17.1 mt -105.52 172.45 6.79 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.766 HG22 ' O ' ' B' ' 243' ' ' THR . 35.7 m 51.69 48.01 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 108.881 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 245' ' ' HIS . 75.1 tt0 -50.77 -20.83 1.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -38.48 -47.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.255 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.705 ' O ' ' N ' ' B' ' 248' ' ' ASP . 3.4 p -57.58 163.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 108.976 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.705 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 60.42 -58.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.473 -0.767 . . . . 0.0 109.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.976 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -62.15 16.76 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.705 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -81.91 -39.31 23.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 108.594 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -46.45 -14.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.61 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.976 HD22 ' O ' ' B' ' 248' ' ' ASP . 2.9 mp -55.26 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.713 ' H ' ' CD ' ' B' ' 253' ' ' PRO . 1.0 OUTLIER -155.47 -44.81 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.62 -0.675 . . . . 0.0 109.886 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.713 ' CD ' ' H ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -84.06 80.52 2.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.994 2.462 . . . . 0.0 110.668 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 254' ' ' LEU . 5.0 mp -95.84 157.62 15.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.345 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 43.11 -167.76 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 118' ' ' ALA . 41.2 mp0 -73.08 -30.29 63.58 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.523 -0.986 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' B' ' 256' ' ' GLU . 71.2 tt0 -48.21 -20.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -57.22 91.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -55.54 -4.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -48.39 -46.57 28.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 152.7 79.51 0.03 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -48.24 -46.96 36.14 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -60.2 -44.4 95.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.58 -47.01 87.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.7 OUTLIER -54.24 -39.92 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.625 ' CE1' ' HG ' ' B' ' 270' ' ' LEU . 2.2 t-80 -74.72 -48.43 25.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.07 -57.38 9.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.962 . . . . 0.0 110.091 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.08 -40.28 97.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' B' ' 243' ' ' THR . 62.0 m-20 -60.76 -40.68 93.4 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -74.82 -39.28 61.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.599 -1.313 . . . . 0.0 109.79 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -56.01 -45.69 79.01 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.971 -1.081 . . . . 0.0 108.15 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.441 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -70.43 -40.62 73.69 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.482 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.3 tp -58.06 -33.03 68.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 108.471 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.523 ' HA ' HD13 ' B' ' 300' ' ' LEU . 31.6 mt-30 -80.49 -28.15 37.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -98.47 6.11 47.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.992 -1.068 . . . . 0.0 108.949 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.74 132.88 46.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.33 -0.856 . . . . 0.0 111.765 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 70.1 m-20 -85.36 -31.01 23.2 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 24.4 t -143.1 138.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' B' ' 213' ' ' TYR . 99.0 t -120.95 148.17 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.134 -0.979 . . . . 0.0 111.614 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.24 114.68 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.384 0.612 . . . . 0.0 109.388 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.856 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . . . -115.74 131.54 56.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.49 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.402 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 71.7 tt0 -90.95 114.63 27.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' B' ' 316' ' ' LEU . 1.7 t -85.55 -98.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.965 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' B' ' 283' ' ' VAL . 5.0 m 64.26 -122.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.549 -1.345 . . . . 0.0 109.111 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -49.69 147.23 6.43 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.042 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.24 124.73 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.395 2.064 . . . . 0.0 111.785 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.409 ' OG ' HG23 ' B' ' 290' ' ' VAL . 28.9 t -141.28 130.37 23.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.143 -0.973 . . . . 0.0 109.383 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.59 -41.74 71.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.51 -40.7 96.58 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.409 HG23 ' OG ' ' B' ' 287' ' ' SER . 19.5 t -69.93 -47.39 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -1.082 . . . . 0.0 109.169 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.72 93.59 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 18.2 t80 -62.47 -44.85 95.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.958 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.6 -33.54 72.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.04 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' B' ' 281' ' ' ALA . 76.7 mt -73.77 -41.01 63.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.69 -48.67 60.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.505 ' NE ' HD21 ' B' ' 300' ' ' LEU . 18.5 tpt180 -59.17 -42.54 91.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.333 -1.099 . . . . 0.0 108.779 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.489 ' HA ' ' H ' ' B' ' 301' ' ' GLY . . . -66.7 -39.63 88.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.446 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -51.63 -40.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -71.98 -47.94 48.52 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.92 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.784 HD12 ' N ' ' B' ' 301' ' ' GLY . 2.8 pp -124.37 -33.15 3.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.986 -1.071 . . . . 0.0 111.226 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.784 ' N ' HD12 ' B' ' 300' ' ' LEU . . . -74.16 10.08 8.47 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' B' ' 301' ' ' GLY . 0.0 OUTLIER 7.93 -74.11 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 303' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' B' ' 301' ' ' GLY . 29.0 Cg_endo -65.17 107.89 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.456 1.199 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 302' ' ' LYS . 3.7 mt -134.08 149.87 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.189 0.995 . . . . 0.0 111.534 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 49.1 tp -127.72 114.02 16.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 306' ' ' CYS . . . . . 0.773 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -114.46 150.53 34.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 109.211 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 2.9 mp -132.15 137.0 47.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 111.463 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -128.68 140.0 51.96 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -88.85 133.12 36.34 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.924 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 313' ' ' GLY . 77.0 Cg_endo -78.83 -38.94 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.544 2.163 . . . . 0.0 111.069 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.24 -31.72 6.25 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.463 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.3 p -95.01 -20.34 19.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 38.5 42.41 1.34 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.42 HH11 ' HB2' ' B' ' 312' ' ' SER . 1.8 mtt85 -67.55 7.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.29 -1.124 . . . . 0.0 109.588 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.515 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.4 t 57.21 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.496 -0.753 . . . . 0.0 110.648 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.747 ' CD1' HG11 ' B' ' 283' ' ' VAL . 19.4 tp -54.8 151.17 8.78 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.86 141.77 48.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.926 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 318' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -57.3 -43.22 83.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 42.6 mmm -61.76 -45.5 93.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.626 0.727 . . . . 0.0 109.286 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.594 ' O ' ' O ' ' B' ' 323' ' ' ALA . 28.4 mm -61.19 -43.21 95.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.472 ' O ' ' C ' ' B' ' 322' ' ' GLY . 0.3 OUTLIER -55.62 -45.09 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.825 -1.172 . . . . 0.0 107.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.645 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -51.33 -40.03 44.77 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 103.997 -3.641 . . . . 0.0 103.997 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' B' ' 329' ' ' PHE . . . -76.02 89.5 2.99 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -165.07 40.47 0.07 Allowed 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.812 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' B' ' 327' ' ' SER . 98.4 m-20 -54.61 -20.35 7.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.825 . . . . 0.0 110.029 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 69.06 -14.93 0.76 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 327' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 325' ' ' ASP . 19.8 t -102.55 -74.68 0.62 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -1.231 . . . . 0.0 108.819 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -83.67 -49.41 9.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.773 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 4.4 t80 -103.39 129.06 50.4 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.34 135.66 32.39 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.661 -1.274 . . . . 0.0 111.853 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.34 111.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.569 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 14.1 m0 -107.78 138.87 43.26 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.0 110.108 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.469 ' O ' ' SD ' ' B' ' 342' ' ' MET . 81.4 m-20 -90.38 154.72 19.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.62 -1.3 . . . . 0.0 107.802 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.553 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -171.59 -177.16 1.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.782 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -150.75 148.31 28.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' B' ' 335' ' ' ALA . 62.1 mt-10 -41.6 -34.34 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.767 -1.208 . . . . 0.0 110.51 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.87 5.75 77.66 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.844 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -137.62 -3.6 1.87 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.001 -1.293 . . . . 0.0 109.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.0 p -55.88 -47.0 80.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 108.597 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 55.7 mt-10 -52.84 -34.07 52.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.1 m -70.61 -38.24 73.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.31 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 12.5 mmt -54.07 -52.97 59.23 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 76.8 mt -60.81 -39.16 87.93 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.044 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.4 -45.18 94.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 110.942 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -68.68 -51.79 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.516 -1.365 . . . . 0.0 108.808 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -56.13 -45.98 79.36 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.819 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' B' ' 351' ' ' LEU . 15.8 m-85 -72.82 -33.11 65.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.401 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.1 -29.62 65.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -97.38 26.77 4.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.05 -82.39 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.434 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' B' ' 347' ' ' PHE . 4.7 mt -54.9 -59.23 11.22 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.179 -0.951 . . . . 0.0 112.181 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 2.3 Cg_endo -41.14 -17.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.362 2.041 . . . . 0.0 112.064 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 353' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' B' ' 351' ' ' LEU . 54.1 tt0 -87.88 -62.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.993 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -4.95 11.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 109.77 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 19.0 m -49.29 -38.07 26.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.616 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -167.85 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 54.1 m -67.82 -34.12 76.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.548 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 80.1 p -68.37 163.38 23.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 24.0 t -88.9 151.99 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.928 . . . . 0.0 109.628 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.416 ' O ' ' CG ' ' B' ' 360' ' ' HIS . 12.2 p80 -128.64 76.53 78.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.462 -0.774 . . . . 0.0 109.118 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 361' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 362' ' ' SER . 50.0 Cg_exo -50.7 -16.64 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 0.0 112.253 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.431 ' O ' ' OXT' ' B' ' 363' ' ' ALA . 67.5 m 50.2 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.168 -0.958 . . . . 0.0 109.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 363' ' ' ALA . . . . . 0.431 ' OXT' ' O ' ' B' ' 362' ' ' SER . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.628 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.7 148.97 36.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.63 142.15 48.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.5 t -95.47 147.87 23.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.42 28.92 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -100.31 162.6 12.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.267 -1.137 . . . . 0.0 109.334 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -71.26 177.3 3.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -155.34 154.63 28.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.26 -156.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.35 2.033 . . . . 0.0 111.283 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 25.9 p -108.99 172.77 6.65 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 61.4 m -115.07 158.9 21.49 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.849 -1.157 . . . . 0.0 108.99 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 35' ' ' LEU . 16.6 t -137.41 134.14 46.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 8.3 t80 -115.53 97.29 6.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.623 ' O ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -93.48 126.79 38.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.526 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 1.7 m -101.67 130.1 47.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.955 . . . . 0.0 108.92 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.921 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -126.05 -124.01 2.73 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 58.1 m -155.69 138.08 14.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 109.105 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.22 149.68 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.913 -1.117 . . . . 0.0 109.441 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' NH2' ' OE1' ' B' ' 285' ' ' GLN . 1.7 tpt180 -165.14 1.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.95 7.52 0.03 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.535 ' N ' HD21 ' A' ' 54' ' ' LEU . . . 68.79 94.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -127.79 -151.59 0.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -1.187 . . . . 0.0 111.522 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.18 -40.83 96.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 74.8 m-20 -55.53 -33.32 63.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 1.8 mm100 -68.78 -39.18 80.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -52.04 66.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 108.702 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -34.6 76.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.3 m-85 -69.2 -47.85 63.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.085 -1.01 . . . . 0.0 110.251 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.32 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.256 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.7 ttt85 -69.67 -57.22 5.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 108.494 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.5 mt -50.82 -43.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.4 t -61.16 -30.58 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 4.6 m -66.84 -41.18 87.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -67.92 -48.88 64.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.901 -1.125 . . . . 0.0 109.197 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 12' ' ' VAL . 31.6 mt -57.9 -40.27 79.94 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -62.1 -26.07 68.08 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -74.9 -36.97 62.22 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.94 -1.1 . . . . 0.0 108.873 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' HD1' ' N ' ' A' ' 38' ' ' TYR . 2.6 m-85 -70.4 -48.36 56.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.947 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -153.1 -145.38 4.13 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' H ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.98 131.38 46.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.968 -1.313 . . . . 0.0 108.658 178.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.58 HG11 HG13 ' A' ' 32' ' ' VAL . 18.1 t -90.73 127.47 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.553 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 11.9 mt -87.05 -38.63 16.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.198 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 14' ' ' PHE . 7.9 t -70.77 37.67 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 42' ' ' LEU . 57.7 mt-10 -54.28 -28.57 42.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.81 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.482 ' NE2' ' CG1' ' A' ' 65' ' ' ILE . 18.4 t-80 -52.09 -44.9 64.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.183 -0.948 . . . . 0.0 109.865 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.496 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 41.3 t -50.12 -69.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.32 61.02 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 14.6 t70 -85.34 43.08 0.99 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -118.54 -32.3 4.64 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG2' HE21 ' A' ' 25' ' ' GLN . 12.2 pt-20 -86.1 60.28 6.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.498 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -168.88 22.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER 162.19 160.7 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -37.28 99.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.268 1.979 . . . . 0.0 111.67 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.763 HD12 ' H ' ' A' ' 54' ' ' LEU . 6.8 mp -49.36 -79.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . -175.33 -36.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HG21 ' B' ' 315' ' ' VAL . 0.2 OUTLIER -46.97 -101.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.582 -0.952 . . . . 0.0 110.554 -179.119 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 56' ' ' GLU . 80.8 mm-40 -64.18 -8.9 13.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.025 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 158.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.63 66.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.19 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.01 -171.99 36.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 103.02 -29.86 11.61 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 20.5 p-10 -56.15 -43.16 78.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 2.5 mt-30 -70.39 -53.2 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -28.84 56.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' GLY . 1.8 mt -70.37 -39.71 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 1.3 t-80 -76.45 -60.59 2.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.489 0.661 . . . . 0.0 109.367 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.562 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 8.4 tp10 -43.04 -54.52 4.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -64.68 -44.6 89.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.945 . . . . 0.0 110.044 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.462 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 73.9 m-20 -60.91 -44.14 97.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.0 111.265 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' OH ' ' A' ' 92' ' ' TYR . 1.1 mm? -65.4 -50.25 66.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.024 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.18 -50.48 71.67 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.489 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.29 -42.46 99.08 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.3 tp -52.03 -37.33 53.16 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -75.36 -28.08 59.41 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.603 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -83.52 -5.96 59.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.869 -1.145 . . . . 0.0 109.258 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.84 125.33 25.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 112.153 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' HB2' ' H ' ' A' ' 11' ' ' SER . 39.0 m-20 -77.81 -33.15 52.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.21 148.18 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.26 138.7 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.966 -1.084 . . . . 0.0 111.002 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 20.5 t -138.45 164.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -159.46 130.42 5.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.579 -1.326 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CG ' ' OH ' ' A' ' 134' ' ' TYR . 53.1 tt0 -93.65 126.03 38.6 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -155.71 114.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.08 -1.012 . . . . 0.0 110.353 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 39.5 m -105.76 -18.54 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.679 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 6.6 tt0 163.81 -37.31 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.383 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 7.0 Cg_exo -71.14 104.1 1.49 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.327 2.018 . . . . 0.0 112.009 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.558 ' HB2' HD21 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -159.51 173.49 16.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 108.574 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.709 ' C ' ' H ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER 167.77 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.48 ' O ' ' SD ' ' B' ' 319' ' ' MET . . . 73.33 -23.21 0.96 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.921 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.1 t -85.14 -46.35 17.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.85 -30.48 56.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.481 ' OH ' HD11 ' A' ' 70' ' ' LEU . 1.3 t80 -68.58 -41.86 79.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.66 -34.59 65.14 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 94' ' ' LEU . 55.6 mt -73.2 -37.83 66.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.71 95.87 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.034 -2.027 . . . . 0.0 108.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -66.14 -40.0 90.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.489 -1.006 . . . . 0.0 108.711 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.43 ' C ' HD11 ' A' ' 104' ' ' ILE . . . -69.32 -40.99 77.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.064 . . . . 0.0 108.549 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -39.86 48.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.44 56.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.007 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.3 mt -71.16 -7.22 45.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.135 -0.978 . . . . 0.0 108.786 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.12 24.86 9.75 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.838 -0.539 . . . . 0.0 112.09 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -79.7 154.45 75.93 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 120.603 -1.528 . . . . 0.0 108.141 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.37 118.58 1.79 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.933 1.755 . . . . 0.0 111.167 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD11 ' C ' ' A' ' 97' ' ' ALA . 11.8 mt -121.13 135.3 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.988 . . . . 0.0 111.223 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.4 m -110.44 156.06 21.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.911 -1.118 . . . . 0.0 108.228 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 83' ' ' VAL . 3.5 mp -136.61 152.63 50.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 111.63 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.87 130.72 15.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -52.89 140.03 41.34 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.052 -1.03 . . . . 0.0 110.522 -177.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 134' ' ' TYR . 31.8 Cg_endo -67.15 -50.25 1.09 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.147 1.898 . . . . 0.0 109.252 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' N ' ' A' ' 113' ' ' GLY . 13.3 pt20 -67.11 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.56 -72.25 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.989 -1.07 . . . . 0.0 109.753 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 111' ' ' GLN . . . 68.34 42.74 81.62 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' VAL . 4.5 mtt180 -85.63 18.42 2.84 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.71 HG21 ' HB2' ' B' ' 256' ' ' GLU . 15.7 t 49.77 99.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.881 0.848 . . . . 0.0 109.448 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 117' ' ' SER . 8.9 tp -45.22 -61.24 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 162.86 144.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.288 -0.883 . . . . 0.0 110.002 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.52 86.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.555 -0.716 . . . . 0.0 110.399 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' B' ' 289' ' ' GLY . 1.7 mtp -74.81 -36.38 62.46 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.388 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.4 mm -72.42 -46.07 57.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 109.37 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.401 ' NE ' ' HB3' ' A' ' 116' ' ' LEU . 63.3 mtt180 -77.54 -34.74 53.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 108.807 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.8 -27.49 73.82 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -43.56 -59.31 2.22 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -133.65 -111.5 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 112.178 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 1.9 m-20 160.23 -2.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.436 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.1 38.93 0.36 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.468 -1.349 . . . . 0.0 111.604 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 58.5 p -116.1 -86.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.727 -1.455 . . . . 0.0 108.838 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.501 ' O ' ' NE2' ' A' ' 130' ' ' GLN . 20.0 tpt180 -94.4 -30.05 14.67 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -117.69 126.0 51.7 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 128' ' ' ARG . 6.9 mp0 -131.91 135.92 47.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.55 -1.344 . . . . 0.0 112.726 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.42 106.89 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 20.8 m0 -104.63 143.02 33.64 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.006 -1.059 . . . . 0.0 110.986 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' O ' ' SD ' ' A' ' 142' ' ' MET . 68.0 m-20 -85.84 154.86 21.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.651 -1.281 . . . . 0.0 108.002 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.458 ' OH ' ' CG ' ' A' ' 82' ' ' GLU . 3.6 p90 -168.7 172.54 7.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 0.0 111.488 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -141.65 146.67 36.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 40.0 mt-10 -39.26 -37.03 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.746 -1.221 . . . . 0.0 110.335 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.17 15.52 33.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 135' ' ' ALA . 74.8 mt-10 -146.29 -4.88 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.258 . . . . 0.0 110.407 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.6 p -54.04 -46.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 120.865 -1.147 . . . . 0.0 108.616 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 22.8 pt-20 -56.54 -34.63 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.8 m -65.67 -39.41 91.3 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.165 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 11.3 mmt -55.82 -51.6 66.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.91 -30.3 71.4 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.347 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 48.6 m-20 -69.27 -44.14 72.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 0.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -71.67 -43.61 65.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.677 -1.264 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -62.97 -48.6 78.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.446 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.923 ' CD1' HD12 ' A' ' 151' ' ' LEU . 19.6 m-85 -73.64 -31.08 63.32 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.393 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -68.25 -27.16 66.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.47 65.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.689 -0.632 . . . . 0.0 109.621 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.813 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -145.88 -63.69 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.042 -1.036 . . . . 0.0 110.653 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 147' ' ' PHE . 1.4 mt -31.01 92.89 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 0.0 110.643 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 150' ' ' TYR . 72.4 Cg_endo -92.92 50.95 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.166 2.577 . . . . 0.0 111.048 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 52.44 21.85 1.9 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptp 50.77 25.85 2.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.9 m -68.1 -24.31 65.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.611 -0.681 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.46 155.5 47.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.3 p -148.58 161.06 42.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -62.34 -30.33 71.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.7 p -69.31 168.05 15.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.345 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 54.13 72.43 1.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -54.03 -14.03 5.47 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.827 2.351 . . . . 0.0 112.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.0 t -53.85 -33.01 55.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.383 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -61.03 149.31 37.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -72.86 142.5 47.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.3 t -96.15 148.19 22.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.09 174.44 29.52 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.91 162.06 13.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -1.092 . . . . 0.0 109.428 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.47 177.65 3.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.492 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -155.77 154.94 28.85 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.67 -156.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.217 1.945 . . . . 0.0 111.24 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 26.6 p -109.12 172.98 6.53 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 69.8 m -115.38 159.08 21.55 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.895 -1.128 . . . . 0.0 108.909 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 235' ' ' LEU . 15.8 t -137.63 133.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 8.1 t80 -115.31 97.59 6.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.638 ' O ' HG21 ' B' ' 243' ' ' THR . 0.0 OUTLIER -93.74 126.83 39.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.455 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.417 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 1.8 m -101.49 129.4 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.18 -0.95 . . . . 0.0 108.93 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.919 ' O ' HG21 ' B' ' 290' ' ' VAL . . . -125.42 -124.3 2.79 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' SER . . . . . 0.553 ' O ' ' NH1' ' B' ' 222' ' ' ARG . 58.7 m -155.58 137.8 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.055 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.79 149.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.894 -1.129 . . . . 0.0 109.581 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.47 ' NH2' ' OE1' ' A' ' 85' ' ' GLN . 1.6 tpt180 -164.74 1.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 220' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' B' ' 219' ' ' ARG . . . 169.65 7.3 0.03 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.537 ' N ' HD21 ' B' ' 254' ' ' LEU . . . 68.83 94.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.553 ' NH1' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER -127.69 -151.99 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.272 -1.134 . . . . 0.0 111.418 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.03 -40.64 96.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' B' ' 228' ' ' TYR . 74.7 m-20 -55.31 -33.77 63.58 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 1.9 mm100 -68.45 -38.84 81.48 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.19 66.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 108.646 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -34.31 76.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.788 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.0 m-85 -69.14 -48.42 62.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.059 -1.025 . . . . 0.0 110.217 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.61 75.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' B' ' 233' ' ' SER . 32.0 ttt85 -69.62 -57.31 5.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.089 . . . . 0.0 108.452 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -50.61 -43.39 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 228' ' ' TYR . 67.9 t -61.03 -30.73 48.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 230' ' ' ARG . 4.4 m -66.65 -41.36 88.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.776 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.91 -48.57 65.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.745 -1.222 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.699 HD22 HG11 ' B' ' 212' ' ' VAL . 32.8 mt -58.2 -40.37 81.4 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -61.99 -25.98 67.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -74.93 -37.2 62.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.913 -1.117 . . . . 0.0 108.92 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' TYR . . . . . 0.486 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.5 m-85 -70.09 -48.55 57.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.614 -0.679 . . . . 0.0 110.072 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.73 -145.53 4.16 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -100.88 131.48 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -1.216 . . . . 0.0 108.575 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.583 HG11 HG13 ' B' ' 232' ' ' VAL . 19.4 t -90.67 127.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.561 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 12.0 mt -87.08 -38.44 16.49 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.181 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.638 HG21 ' O ' ' B' ' 214' ' ' PHE . 8.1 t -71.18 37.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 109.257 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' B' ' 242' ' ' LEU . 59.3 mt-10 -54.29 -28.84 44.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.818 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.498 ' NE2' ' CG1' ' B' ' 265' ' ' ILE . 17.7 t-80 -52.08 -45.24 64.71 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.494 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 41.2 t -49.85 -69.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.295 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -51.87 -41.36 61.82 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' B' ' 248' ' ' ASP . 14.5 t70 -85.2 43.44 1.01 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -119.0 -32.05 4.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' B' ' 225' ' ' GLN . 11.7 pt-20 -86.4 60.55 6.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.269 -0.894 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -169.28 22.56 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.514 -0.741 . . . . 0.0 109.945 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER 161.87 160.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -37.03 99.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.382 2.055 . . . . 0.0 111.702 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.77 HD12 ' H ' ' B' ' 254' ' ' LEU . 6.7 mp -49.17 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.05 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . -175.71 -37.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.71 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -46.68 -101.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.568 -0.96 . . . . 0.0 110.578 -178.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 257' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' B' ' 256' ' ' GLU . 80.7 mm-40 -63.94 -8.21 10.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.875 . . . . 0.0 110.058 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -56.84 159.04 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.37 66.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 109.16 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -171.42 -172.33 37.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 103.14 -29.95 11.39 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 20.0 p-10 -56.17 -43.02 77.97 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 263' ' ' GLN . . . . . 0.467 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 2.5 mt-30 -70.59 -53.25 16.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.29 -28.51 54.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.498 ' CG1' ' NE2' ' B' ' 245' ' ' HIS . 1.9 mt -71.08 -39.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.56 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 1.2 t-80 -76.32 -60.73 2.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 267' ' ' GLU . . . . . 0.56 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 9.4 tp10 -43.02 -54.86 4.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.723 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -64.63 -43.8 92.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.449 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 75.3 m-20 -61.84 -44.1 97.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.2 -0.937 . . . . 0.0 111.2 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.486 HD11 ' OH ' ' B' ' 292' ' ' TYR . 1.1 mm? -65.32 -50.05 67.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.975 -1.078 . . . . 0.0 110.02 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -62.22 -50.76 70.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.03 -42.76 99.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.362 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.4 tp -51.76 -37.3 50.74 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -75.4 -28.1 59.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -83.42 -5.94 59.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.191 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.91 125.74 26.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -0.851 . . . . 0.0 112.034 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' B' ' 211' ' ' SER . 41.9 m-20 -78.25 -33.14 49.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.91 147.7 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 79.3 t -133.93 138.38 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.883 -1.136 . . . . 0.0 111.015 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 280' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 20.0 t -137.83 164.76 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.448 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -159.95 130.16 5.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.614 -1.304 . . . . 0.0 110.143 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.453 ' CG ' ' OH ' ' B' ' 334' ' ' TYR . 52.0 tt0 -93.56 125.75 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 0.5 OUTLIER -155.3 115.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.987 -1.07 . . . . 0.0 110.349 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 285' ' ' GLN . 38.0 m -106.06 -19.0 13.86 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.68 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 6.6 tt0 164.09 -37.18 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.244 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 7.5 Cg_exo -70.9 103.82 1.41 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.389 2.06 . . . . 0.0 111.937 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -159.81 173.25 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.747 ' C ' ' H ' ' B' ' 290' ' ' VAL . 0.1 OUTLIER 167.9 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 289' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 119' ' ' MET . . . 73.26 -22.81 0.97 Allowed Glycine 0 N--CA 1.481 1.662 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -176.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.919 HG21 ' O ' ' B' ' 216' ' ' GLY . 2.1 t -85.43 -46.41 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -55.65 -30.51 56.34 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.486 ' OH ' HD11 ' B' ' 270' ' ' LEU . 1.3 t80 -68.62 -41.98 78.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.8 -34.55 65.41 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' B' ' 294' ' ' LEU . 54.4 mt -73.15 -37.97 66.4 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.9 -37.79 94.34 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.8 -39.88 87.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.451 -1.029 . . . . 0.0 108.649 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 297' ' ' ALA . . . . . 0.449 ' C ' HD11 ' B' ' 304' ' ' ILE . . . -69.55 -41.08 76.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.96 -1.088 . . . . 0.0 108.524 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -39.79 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.11 57.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.007 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -71.63 -6.97 44.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 108.832 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 301' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . 51.05 25.01 9.49 Favored Glycine 0 N--CA 1.494 2.557 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.052 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 302' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -79.76 154.61 75.83 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 120.631 -1.511 . . . . 0.0 108.254 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.39 118.35 1.71 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.806 1.67 . . . . 0.0 111.098 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.449 HD11 ' C ' ' B' ' 297' ' ' ALA . 11.9 mt -120.82 134.77 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.149 -0.969 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.25 114.78 18.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 85.9 m -110.57 156.18 21.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.76 -1.213 . . . . 0.0 108.105 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' B' ' 283' ' ' VAL . 3.5 mp -136.59 152.43 50.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.0 -1.062 . . . . 0.0 111.626 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -148.68 130.62 15.25 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 0.0 OUTLIER -52.87 139.8 41.6 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.045 -1.034 . . . . 0.0 110.496 -177.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' B' ' 311' ' ' GLN . 33.3 Cg_endo -67.08 -50.06 1.17 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.067 1.845 . . . . 0.0 109.352 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.788 ' O ' ' N ' ' B' ' 313' ' ' GLY . 13.2 pt20 -67.09 -143.21 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.31 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 109.687 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.788 ' N ' ' O ' ' B' ' 311' ' ' GLN . . . 68.39 42.76 81.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' B' ' 315' ' ' VAL . 4.4 mtt180 -85.43 17.57 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 56' ' ' GLU . 17.9 t 50.41 99.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.969 0.89 . . . . 0.0 109.4 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 317' ' ' SER . 8.5 tp -45.33 -61.42 1.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 317' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.9 OUTLIER 162.97 143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.49 86.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.437 -0.79 . . . . 0.0 110.316 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 89' ' ' GLY . 1.6 mtp -74.3 -36.78 63.76 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.038 -1.039 . . . . 0.0 109.407 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.32 -45.93 58.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 109.439 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -77.46 -34.77 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 108.841 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -69.09 -27.27 74.0 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -43.43 -59.56 2.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -1.122 . . . . 0.0 110.013 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 325' ' ' ASP . . . -133.07 -111.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 112.068 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 325' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' B' ' 324' ' ' ALA . 2.0 m-20 160.01 -2.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.336 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 128.27 38.97 0.35 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 119.611 -1.281 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 57.0 p -115.97 -86.97 0.61 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.773 -1.427 . . . . 0.0 108.678 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.506 ' O ' ' NE2' ' B' ' 330' ' ' GLN . 20.1 tpt180 -94.29 -29.91 14.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' B' ' 329' ' ' PHE . 0.7 OUTLIER -117.86 126.25 52.04 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 330' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 328' ' ' ARG . 6.9 mp0 -132.23 136.37 46.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.471 -1.393 . . . . 0.0 112.65 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.72 107.11 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 20.7 m0 -104.48 142.92 33.77 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.071 -1.018 . . . . 0.0 110.939 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.542 ' O ' ' SD ' ' B' ' 342' ' ' MET . 67.0 m-20 -86.05 155.18 20.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.626 -1.296 . . . . 0.0 107.855 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.453 ' OH ' ' CG ' ' B' ' 282' ' ' GLU . 3.9 p90 -168.74 172.63 7.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.388 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -141.74 146.81 36.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' B' ' 335' ' ' ALA . 36.7 mt-10 -39.35 -37.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.83 -1.169 . . . . 0.0 110.286 -178.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.93 15.67 31.14 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 338' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 335' ' ' ALA . 74.1 mt-10 -146.59 -5.15 0.56 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.119 -1.224 . . . . 0.0 110.47 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.8 p -53.8 -46.85 63.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.804 -1.185 . . . . 0.0 108.606 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 23.1 pt-20 -56.29 -34.39 66.42 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 32.2 m -65.78 -39.46 91.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.542 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 11.8 mmt -55.79 -51.56 67.0 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 343' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' B' ' 343' ' ' LEU . 25.0 mt -63.79 -30.48 71.57 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.39 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -69.26 -44.09 72.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.991 -1.068 . . . . 0.0 110.69 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -71.86 -43.35 65.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.532 -1.355 . . . . 0.0 109.38 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -63.02 -48.86 76.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.358 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.926 ' CD1' HD12 ' B' ' 351' ' ' LEU . 19.9 m-85 -73.36 -31.0 63.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.413 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -68.15 -27.48 66.47 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -59.25 -27.56 65.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.766 -0.584 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.822 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.1 OUTLIER -145.73 -63.63 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.0 -1.063 . . . . 0.0 110.591 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.926 HD12 ' CD1' ' B' ' 347' ' ' PHE . 1.4 mt -31.13 92.99 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.633 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 352' ' ' PRO . . . . . 0.53 ' N ' ' O ' ' B' ' 350' ' ' TYR . 77.2 Cg_endo -92.99 51.2 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.105 2.536 . . . . 0.0 110.914 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 52.04 22.07 1.74 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 50.69 25.85 2.25 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 5.4 m -68.29 -24.18 64.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -131.52 155.02 48.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.853 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 87.5 p -148.18 161.13 42.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 19.2 m -62.21 -30.53 71.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.359 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 86.4 p -69.31 168.13 14.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 360' ' ' HIS . . . . . 0.425 ' CD2' ' N ' ' B' ' 360' ' ' HIS . 20.4 m170 54.07 71.91 1.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -53.58 -15.28 6.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.829 2.353 . . . . 0.0 112.184 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 9.5 t -51.3 -25.89 6.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.554 179.93 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.7 ttp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.78 -26.22 67.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.01 147.91 40.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.9 p -78.53 158.28 28.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.5 -178.44 21.02 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -106.63 140.32 39.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -1.044 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -87.26 177.1 7.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.78 149.36 35.87 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 0.0 109.37 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.51 -161.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.457 2.105 . . . . 0.0 111.704 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 29.1 p -99.8 -173.25 2.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 1.2 m -118.68 143.52 46.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG11 HD22 ' A' ' 35' ' ' LEU . 58.3 t -126.01 136.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CZ ' ' OE1' ' A' ' 44' ' ' GLU . 5.9 t80 -113.41 109.17 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.557 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.23 129.95 44.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.636 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 3.2 m -102.12 151.19 22.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.342 -0.849 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.84 162.66 36.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -86.35 132.94 33.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.226 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' A' ' 46' ' ' VAL . 1.3 mm -99.89 -27.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.704 ' NH1' ' H ' ' A' ' 56' ' ' GLU . 15.0 mmm180 -55.22 -69.85 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 18.81 56.87 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -67.61 -90.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 55.13 -93.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.389 -1.065 . . . . 0.0 108.591 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 51.3 mp0 -51.5 -46.2 63.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 5.7 m-20 -65.01 -22.62 67.02 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 18.3 tp60 -63.35 -39.15 93.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.87 -47.88 67.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.86 -32.22 67.44 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.816 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.5 m-30 -67.44 -46.99 71.48 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . . . -60.28 -37.48 80.62 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.644 -1.285 . . . . 0.0 109.046 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -70.79 -56.79 5.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.756 -1.215 . . . . 0.0 108.515 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.508 HG21 ' OE2' ' A' ' 82' ' ' GLU . 5.0 mt -52.9 -43.99 47.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 28' ' ' TYR . 61.6 t -59.44 -29.09 41.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.3 m -71.68 -34.41 69.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -69.46 -53.29 19.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 108.615 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD22 HG11 ' A' ' 12' ' ' VAL . 13.1 mt -56.95 -39.51 74.67 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.96 -22.92 67.15 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -72.89 -44.54 61.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 109.412 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.95 -50.09 9.55 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.564 -0.71 . . . . 0.0 111.784 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.554 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . -142.46 132.48 5.15 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -35.79 145.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -1.052 . . . . 0.0 109.129 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.706 HG21 HG13 ' A' ' 32' ' ' VAL . 50.2 t -79.4 100.56 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 72' ' ' TRP . 0.1 OUTLIER -49.88 94.56 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.952 -177.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 41' ' ' VAL . 6.6 m 28.21 100.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.363 0.602 . . . . 0.0 111.371 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' OE1' ' CZ ' ' A' ' 13' ' ' TYR . 16.3 tp10 -142.9 65.88 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' VAL . 25.0 p80 -50.16 -5.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 39.0 t -40.18 -58.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.66 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -66.93 -40.76 87.7 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 108.641 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 51' ' ' LEU . 7.4 t70 -70.67 25.05 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -101.98 -16.18 16.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.01 -43.96 70.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 109.027 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.973 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.73 136.99 20.94 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 0.0 109.353 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 51' ' ' LEU . 20.8 mm-40 53.98 153.55 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.997 . . . . 0.0 109.082 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.47 88.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.195 1.93 . . . . 0.0 111.736 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.476 HD11 ' NH1' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.15 -163.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.155 -0.966 . . . . 0.0 109.806 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 91.09 151.85 27.22 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.704 ' H ' ' NH1' ' A' ' 19' ' ' ARG . 44.4 mt-10 -50.55 178.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -1.176 . . . . 0.0 109.003 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 64.91 -24.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.166 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.649 ' H ' ' C ' ' A' ' 56' ' ' GLU . . . -80.37 141.41 35.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 109.162 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.58 133.38 36.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.154 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.38 -77.08 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.05 83.61 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -52.44 -45.79 66.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -1.043 . . . . 0.0 108.562 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -62.14 -46.36 89.37 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 35.3 t80 -62.56 -41.62 99.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 11.9 mt -56.02 -46.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.753 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.7 t-80 -76.46 -27.11 56.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.7 -0.625 . . . . 0.0 109.852 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -61.86 -56.8 15.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.314 -0.867 . . . . 0.0 109.592 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 23.5 mp0 -76.37 -41.78 46.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.627 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 63.6 m-20 -60.11 -52.82 63.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.149 -0.97 . . . . 0.0 109.797 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.501 HD22 ' NE2' ' A' ' 66' ' ' HIS . 1.2 tp -67.98 -44.71 76.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.591 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -59.33 -49.27 78.46 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.592 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.694 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -76.73 -19.71 57.36 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.084 -1.447 . . . . 0.0 109.485 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.8 tp -64.67 -35.14 80.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -86.66 -19.0 29.89 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.398 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.48 ' OE1' ' CD1' ' A' ' 72' ' ' TRP . 27.1 tt0 -99.26 2.74 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.879 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 129.26 39.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.194 -0.941 . . . . 0.0 111.381 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 11' ' ' SER . 94.6 m-20 -63.5 -35.23 79.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' OH ' ' A' ' 150' ' ' TYR . 42.9 t -138.41 149.78 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.0 t -137.39 142.0 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.499 1.142 . . . . 0.0 112.106 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 105' ' ' LEU . 97.7 t -138.2 165.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -158.04 137.13 11.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.632 -1.293 . . . . 0.0 109.227 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 90' ' ' VAL . 28.4 mt-10 -93.61 126.1 38.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -126.68 130.72 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 85' ' ' GLN . 20.0 m -170.5 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.843 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 31.5 tt0 -100.05 -24.64 0.22 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.706 . . . . 0.0 109.843 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 96.2 Cg_exo -43.3 -142.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.731 2.287 . . . . 0.0 112.163 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.664 ' OG ' ' N ' ' A' ' 88' ' ' LEU . 2.4 t 172.53 -153.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.677 -1.264 . . . . 0.0 109.669 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.664 ' N ' ' OG ' ' A' ' 87' ' ' SER . 20.9 mt -30.59 136.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 110.091 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.37 -38.07 3.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -88.85 -41.86 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.969 . . . . 0.0 108.589 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.66 -33.39 71.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' CD2' ' SD ' ' B' ' 319' ' ' MET . 65.4 t80 -66.65 -52.89 39.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -1.143 . . . . 0.0 109.745 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.562 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 59.0 mt-10 -64.82 -31.27 72.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.314 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 81' ' ' ALA . 25.1 mt -66.9 -44.42 80.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.88 -33.06 86.24 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.587 HH11 ' CG1' ' B' ' 298' ' ' VAL . 17.2 mmm180 -65.27 -44.46 87.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -1.03 . . . . 0.0 109.846 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 -36.71 73.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 108.67 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.568 ' CG1' HH11 ' B' ' 296' ' ' ARG . 0.5 OUTLIER -53.52 -44.52 56.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -74.8 -50.85 15.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.647 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 74' ' ' GLN . 14.2 mt -65.98 -6.45 12.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.53 17.54 66.79 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.905 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 104' ' ' ILE . 64.4 mmtt -83.47 135.43 43.75 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 120.708 -1.466 . . . . 0.0 107.973 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.15 121.73 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.642 1.561 . . . . 0.0 110.966 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 104' ' ' ILE . 1.7 mp -108.8 100.13 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.961 -1.087 . . . . 0.0 111.45 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HB3' HG22 ' A' ' 80' ' ' VAL . 24.6 tp -91.75 114.37 26.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -110.95 154.53 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 109.383 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.8 mt -122.92 149.5 44.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -145.03 119.63 9.76 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' NH1' ' NE2' ' A' ' 111' ' ' GLN . 7.2 mtm180 -79.25 124.61 84.27 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.797 -1.189 . . . . 0.0 111.109 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 113' ' ' GLY . 95.3 Cg_endo -83.42 -30.74 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.594 2.196 . . . . 0.0 110.758 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.469 ' NE2' ' NH1' ' A' ' 109' ' ' ARG . 9.4 pt20 -51.25 -35.24 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 39.6 m -98.7 -11.9 21.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 110' ' ' PRO . . . 39.98 48.07 3.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 5.12 2.43 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -1.15 . . . . 0.0 109.386 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.0 t 53.92 109.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.822 0.82 . . . . 0.0 110.135 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 131' ' ' VAL . 8.7 tp -56.19 149.32 16.31 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.94 150.07 14.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.16 86.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 108.643 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.602 ' SD ' ' CD2' ' B' ' 292' ' ' TYR . 0.0 OUTLIER -60.28 -50.58 73.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' ALA . 32.6 mm -63.94 -36.32 76.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.104 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 18.9 mmt85 -53.58 -43.37 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.75 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -54.63 -43.92 79.04 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.715 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -78.01 90.17 4.18 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' ARG . . . -174.28 46.5 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.591 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.37 -12.39 61.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 67.62 2.61 22.75 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.4 m -105.58 -78.85 0.57 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.993 -1.298 . . . . 0.0 108.87 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -93.19 -31.77 14.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.708 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 8.5 t80 -110.74 130.19 55.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.6 125.74 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.864 -1.148 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.716 HG11 HD22 ' A' ' 116' ' ' LEU . 38.5 t -85.68 106.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 12.3 m0 -102.06 138.02 39.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.0 -1.063 . . . . 0.0 109.558 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' O ' ' CE ' ' A' ' 142' ' ' MET . 91.8 m-20 -91.79 152.67 20.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.705 -1.247 . . . . 0.0 109.012 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.8 p90 -164.29 -179.33 6.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.475 -1.29 . . . . 0.0 111.917 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.53 147.36 25.33 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 135' ' ' ALA . 52.0 mt-10 -42.06 -36.17 1.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.926 -1.109 . . . . 0.0 110.298 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.36 4.44 41.53 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.496 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.96 7.15 0.33 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.552 -1.558 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.8 p -51.25 -43.29 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 108.464 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.7 mt-10 -57.93 -36.34 72.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 m -64.99 -45.53 85.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.455 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 3.9 tpp -51.56 -46.32 63.37 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.84 -33.18 68.26 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.702 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 55.3 m-20 -65.43 -40.42 93.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.95 -1.093 . . . . 0.0 109.837 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -69.91 -49.06 55.8 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.634 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.28 -48.73 80.06 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 109.979 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.829 ' CD1' HD12 ' A' ' 151' ' ' LEU . 8.9 m-85 -66.95 -32.43 73.67 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.904 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.71 -25.14 64.62 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.588 -1.32 . . . . 0.0 107.785 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.39 62.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.53 -0.732 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -146.05 -0.13 0.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.456 -1.402 . . . . 0.0 111.649 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 147' ' ' PHE . 16.6 mt -115.69 82.75 10.58 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.672 -1.267 . . . . 0.0 109.267 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.24 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.646 2.231 . . . . 0.0 112.095 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.93 -34.95 64.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -51.82 -27.17 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.147 -0.971 . . . . 0.0 109.299 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 151' ' ' LEU . 36.2 m -53.23 -35.84 60.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.78 114.41 4.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.089 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.1 t -56.67 -26.7 57.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t -64.11 150.9 44.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.42 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -59.93 146.08 43.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.76 150.54 86.42 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.224 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.84 157.9 53.92 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.529 2.153 . . . . 0.0 112.132 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -54.17 -37.62 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.516 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 37.2 ttp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.18 66.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -73.82 148.45 42.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 93.7 p -79.43 158.39 27.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -145.32 -178.88 21.21 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -106.24 139.74 40.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -1.124 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -86.65 176.52 7.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -99.4 149.53 35.93 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.432 -0.792 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.61 -161.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.625 2.217 . . . . 0.0 111.587 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' CYS . . . . . 0.456 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 29.7 p -100.07 -173.19 2.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 1.2 m -118.62 143.76 46.6 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.494 HG11 HD22 ' B' ' 235' ' ' LEU . 60.1 t -126.14 136.63 60.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' TYR . . . . . 0.53 ' CZ ' ' OE1' ' B' ' 244' ' ' GLU . 6.0 t80 -113.35 109.12 18.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.13 130.09 44.91 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.658 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 3.2 m -102.28 151.33 22.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -165.95 162.75 36.23 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 15.9 m -86.48 133.0 33.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.168 -1.195 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' B' ' 246' ' ' VAL . 1.3 mm -99.95 -27.46 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.229 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.726 ' NH1' ' H ' ' B' ' 256' ' ' GLU . 14.9 mmm180 -54.96 -69.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 109.827 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -97.01 18.77 56.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . -67.67 -89.91 0.06 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER 54.98 -93.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -1.054 . . . . 0.0 108.53 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 50.3 mp0 -51.34 -46.08 62.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 6.0 m-20 -65.56 -22.53 66.7 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 17.9 tp60 -63.44 -39.07 93.49 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.29 68.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.95 -32.53 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' TYR . . . . . 0.809 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -67.27 -47.02 71.94 Favored 'General case' 0 C--O 1.198 -1.631 0 O-C-N 121.527 -0.733 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 247' ' ' ALA . . . -60.38 -37.4 80.64 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.723 -1.236 . . . . 0.0 109.044 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -70.65 -56.86 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.773 -1.204 . . . . 0.0 108.505 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.495 HG21 ' OE2' ' B' ' 282' ' ' GLU . 4.9 mt -52.83 -43.93 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 228' ' ' TYR . 60.6 t -59.66 -28.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.0 m -71.93 -34.19 68.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.0 109.383 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.47 -53.54 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.871 -1.143 . . . . 0.0 108.626 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 212' ' ' VAL . 12.9 mt -56.64 -39.61 73.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -62.97 -22.97 67.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -72.91 -44.62 61.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 109.491 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.81 -49.9 9.85 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.513 -0.742 . . . . 0.0 111.873 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . -142.67 132.75 5.24 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' B' ' 239' ' ' GLY . 0.0 OUTLIER -35.96 145.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -1.003 . . . . 0.0 109.027 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 241' ' ' VAL . . . . . 0.716 HG21 HG13 ' B' ' 232' ' ' VAL . 44.7 t -79.31 100.63 4.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' B' ' 272' ' ' TRP . 0.1 OUTLIER -49.84 94.88 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.938 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 243' ' ' THR . . . . . 0.524 ' N ' ' O ' ' B' ' 241' ' ' VAL . 6.6 m 27.81 100.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.421 0.629 . . . . 0.0 111.387 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' B' ' 246' ' ' VAL . 15.7 tp10 -143.2 66.52 1.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' B' ' 246' ' ' VAL . 25.0 p80 -50.64 -5.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.562 -0.711 . . . . 0.0 110.147 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' VAL . . . . . 0.555 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 39.3 t -40.36 -58.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.675 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -67.2 -40.54 86.51 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 108.616 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' ASP . . . . . 0.851 ' O ' HD11 ' B' ' 251' ' ' LEU . 7.0 t70 -71.0 25.58 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -102.47 -15.97 16.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -54.16 -43.89 70.98 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' LEU . . . . . 0.956 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -50.83 136.79 21.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLU . . . . . 0.606 ' O ' ' O ' ' B' ' 251' ' ' LEU . 20.6 mm-40 54.17 153.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.98 . . . . 0.0 109.175 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.69 89.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.181 1.921 . . . . 0.0 111.542 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' LEU . . . . . 0.483 HD11 ' NH1' ' B' ' 222' ' ' ARG . 0.3 OUTLIER -61.88 -163.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.75 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 91.37 151.58 27.03 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.726 ' H ' ' NH1' ' B' ' 219' ' ' ARG . 46.7 mt-10 -50.29 178.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -1.214 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 64.82 -25.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 109.055 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -80.08 141.73 35.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.29 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.21 132.12 38.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 168.57 -77.5 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 138.81 83.21 0.1 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -52.08 -45.88 64.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -1.072 . . . . 0.0 108.387 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -62.09 -46.52 88.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 264' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 36.0 t80 -62.72 -41.3 99.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.31 -0.869 . . . . 0.0 108.994 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 265' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 12.0 mt -56.28 -45.86 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 266' ' ' HIS . . . . . 0.75 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -76.68 -27.33 55.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.926 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.66 -56.66 17.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.348 -0.845 . . . . 0.0 109.688 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 268' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 23.1 mp0 -76.65 -41.54 45.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 269' ' ' ASP . . . . . 0.472 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 62.1 m-20 -60.01 -52.3 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' B' ' 274' ' ' GLN . 1.2 tp -68.57 -44.49 74.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.23 -49.37 78.09 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.621 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' B' ' 242' ' ' LEU . 0.2 OUTLIER -76.6 -19.63 57.64 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.121 -1.432 . . . . 0.0 109.588 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.447 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.7 tp -64.81 -34.91 79.49 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.0 OUTLIER -86.96 -19.1 29.24 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.442 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 275' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' B' ' 275' ' ' GLN . 27.2 tt0 -99.11 2.39 45.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.822 -1.174 . . . . 0.0 108.817 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.02 129.3 39.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.108 -0.995 . . . . 0.0 111.405 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 95.2 m-20 -63.37 -35.38 80.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.463 HG21 ' OH ' ' B' ' 350' ' ' TYR . 42.6 t -138.28 149.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 279' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' B' ' 213' ' ' TYR . 83.2 t -137.48 142.22 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.534 1.159 . . . . 0.0 112.194 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 280' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' B' ' 305' ' ' LEU . 97.2 t -138.34 165.45 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 281' ' ' ALA . . . . . 0.522 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -157.72 137.04 11.85 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.548 -1.345 . . . . 0.0 109.283 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 282' ' ' GLU . . . . . 0.519 ' O ' HG11 ' B' ' 290' ' ' VAL . 28.7 mt-10 -93.32 126.29 38.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 283' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -126.81 130.88 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 284' ' ' THR . . . . . 0.569 HG22 ' N ' ' B' ' 285' ' ' GLN . 20.2 m -170.77 -92.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 285' ' ' GLN . . . . . 0.841 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 31.8 tt0 -100.11 -24.75 0.22 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.452 -0.78 . . . . 0.0 109.838 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 286' ' ' PRO . . . . . 0.841 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 97.6 Cg_exo -43.31 -142.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.688 2.259 . . . . 0.0 112.125 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 287' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' B' ' 288' ' ' LEU . 2.1 t 172.53 -153.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.569 -1.332 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 288' ' ' LEU . . . . . 0.679 ' N ' ' OG ' ' B' ' 287' ' ' SER . 20.2 mt -30.49 136.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 114.97 -37.64 3.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' VAL . . . . . 0.519 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.3 t -89.17 -42.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.583 -0.951 . . . . 0.0 108.588 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.06 71.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' TYR . . . . . 0.602 ' CD2' ' SD ' ' A' ' 119' ' ' MET . 65.7 t80 -66.97 -52.24 45.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -1.161 . . . . 0.0 109.9 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 293' ' ' GLU . . . . . 0.552 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 59.5 mt-10 -65.25 -31.3 72.39 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 294' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 281' ' ' ALA . 24.6 mt -66.98 -44.46 80.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.11 -32.75 85.06 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 296' ' ' ARG . . . . . 0.568 HH11 ' CG1' ' A' ' 98' ' ' VAL . 16.9 mmm180 -65.33 -44.52 87.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.051 . . . . 0.0 109.82 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.84 -36.82 73.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.993 . . . . 0.0 108.647 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 298' ' ' VAL . . . . . 0.587 ' CG1' HH11 ' A' ' 96' ' ' ARG . 0.5 OUTLIER -53.26 -44.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 299' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.02 -50.68 15.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.736 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 300' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' B' ' 274' ' ' GLN . 14.5 mt -66.45 -6.18 13.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.41 17.57 66.56 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.817 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' LYS . . . . . 0.43 ' O ' HG13 ' B' ' 304' ' ' ILE . 65.1 mmtt -83.42 135.69 43.62 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 120.667 -1.49 . . . . 0.0 107.931 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.23 122.16 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.75 1.634 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 304' ' ' ILE . . . . . 0.626 HD12 ' H ' ' B' ' 304' ' ' ILE . 1.7 mp -109.37 99.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.987 . . . . 0.0 111.283 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.58 ' HB3' HG22 ' B' ' 280' ' ' VAL . 24.9 tp -91.55 114.37 26.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 306' ' ' CYS . . . . . 0.703 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.3 OUTLIER -110.97 154.34 24.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.901 -1.124 . . . . 0.0 109.566 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 307' ' ' LEU . . . . . 0.558 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 9.2 mt -122.86 149.76 43.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.245 -0.909 . . . . 0.0 111.249 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 308' ' ' PHE . . . . . 0.71 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.4 OUTLIER -145.72 119.69 9.37 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 309' ' ' ARG . . . . . 0.461 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 7.7 mtm180 -79.07 125.21 84.1 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.0 111.131 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.5 Cg_endo -83.55 -29.98 0.94 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.579 2.186 . . . . 0.0 110.669 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 311' ' ' GLN . . . . . 0.461 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 9.4 pt20 -51.95 -35.16 45.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 312' ' ' SER . . . . . 0.448 ' O ' ' C ' ' B' ' 313' ' ' GLY . 31.1 m -98.8 -11.68 21.59 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 313' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 310' ' ' PRO . . . 39.84 47.93 3.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 314' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' B' ' 315' ' ' VAL . 0.5 OUTLIER -71.14 4.39 2.8 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.168 -1.195 . . . . 0.0 109.373 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' B' ' 314' ' ' ARG . 2.9 t 54.6 109.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.82 0.819 . . . . 0.0 110.101 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 316' ' ' LEU . . . . . 0.713 HD22 HG11 ' B' ' 331' ' ' VAL . 8.7 tp -56.58 149.83 16.71 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 150.03 16.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.629 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.66 85.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 108.606 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.612 ' SD ' ' CD2' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -60.78 -50.48 73.28 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 108.836 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' B' ' 323' ' ' ALA . 32.2 mm -64.02 -36.34 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.981 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 321' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' B' ' 324' ' ' ALA . 19.2 mmt85 -53.54 -43.61 68.55 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 322' ' ' GLY . . . . . 0.753 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -54.58 -43.82 78.55 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 104.632 -3.387 . . . . 0.0 104.632 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 323' ' ' ALA . . . . . 0.71 ' O ' ' O ' ' B' ' 320' ' ' ILE . . . -77.92 90.14 4.12 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 324' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 321' ' ' ARG . . . -174.14 46.32 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.622 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.08 -12.29 61.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.413 -0.805 . . . . 0.0 111.212 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 326' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 67.36 2.15 18.62 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.666 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 73.6 m -105.27 -78.91 0.56 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.991 -1.299 . . . . 0.0 108.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -93.16 -32.11 14.53 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.703 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 9.1 t80 -110.23 130.13 55.6 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.52 125.43 13.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.796 -1.19 . . . . 0.0 111.25 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 331' ' ' VAL . . . . . 0.713 HG11 HD22 ' B' ' 316' ' ' LEU . 35.9 t -85.46 106.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 332' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 11.9 m0 -102.02 137.79 39.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.04 -1.038 . . . . 0.0 109.44 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 333' ' ' ASP . . . . . 0.458 ' O ' ' SD ' ' B' ' 342' ' ' MET . 91.8 m-20 -91.54 152.57 20.26 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.801 -1.187 . . . . 0.0 109.084 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 334' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.7 p90 -164.15 -179.22 6.01 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.856 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.91 147.59 25.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 336' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.4 mt-10 -42.21 -36.07 1.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.802 -1.186 . . . . 0.0 110.281 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -75.26 3.79 44.79 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.507 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.52 7.09 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.486 -1.597 . . . . 0.0 110.866 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.9 p -51.11 -43.49 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.908 -1.12 . . . . 0.0 108.467 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 340' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 83.1 mt-10 -57.88 -36.24 72.1 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 72.1 m -64.88 -45.67 85.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 342' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.9 tpp -51.42 -46.81 63.06 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.23 -33.6 70.02 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.789 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 344' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' B' ' 340' ' ' GLU . 55.4 m-20 -65.4 -40.33 93.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.972 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.92 -49.17 54.66 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.923 -1.111 . . . . 0.0 108.462 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.15 -48.61 80.8 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.215 -0.928 . . . . 0.0 110.017 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 347' ' ' PHE . . . . . 0.853 ' CD1' HD12 ' B' ' 351' ' ' LEU . 9.1 m-85 -66.96 -32.18 73.25 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.934 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -68.98 -25.04 64.33 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.54 -1.35 . . . . 0.0 107.83 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.26 62.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 350' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.5 OUTLIER -146.26 -0.34 0.78 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.611 -1.306 . . . . 0.0 111.512 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.853 HD12 ' CD1' ' B' ' 347' ' ' PHE . 16.7 mt -115.53 82.58 10.0 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 120.576 -1.328 . . . . 0.0 109.189 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.97 -96.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.752 2.301 . . . . 0.0 112.136 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -74.68 -34.37 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -52.31 -26.61 12.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 355' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' B' ' 351' ' ' LEU . 32.9 m -53.4 -36.54 61.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -151.37 114.38 4.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.366 -0.834 . . . . 0.0 109.244 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 30.5 t -56.52 -26.48 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 33.3 t -64.43 151.29 44.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.283 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 46.3 m -60.3 146.72 42.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -75.2 150.35 85.29 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 109.182 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.15 158.05 54.13 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.464 2.109 . . . . 0.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 47.8 m -52.81 -34.03 51.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.385 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.48 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' ALA . 32.1 Cg_exo -57.62 -150.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.804 1.669 . . . . 0.0 111.213 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -111.03 -175.39 2.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 36.0 m -121.44 152.43 39.1 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 35' ' ' LEU . 10.8 t -131.0 136.09 58.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' CG ' ' A' ' 69' ' ' ASP . 8.1 t80 -113.17 99.26 7.69 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -89.49 116.75 27.89 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.46 -0.896 . . . . 0.0 108.883 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.55 146.76 23.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.443 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.62 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -168.58 75.13 0.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.62 ' C ' ' O ' ' A' ' 16' ' ' GLY . 15.7 m -16.2 127.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.936 -0.743 . . . . 0.0 110.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.301 -1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 110.034 -179.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.704 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.855 0.836 . . . . 0.0 111.859 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -59.76 -42.95 94.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.7 m-20 -52.06 -34.76 45.01 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.556 HE21 ' HB3' ' A' ' 49' ' ' ALA . 5.9 tp60 -64.09 -44.61 91.82 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.92 60.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.285 -0.885 . . . . 0.0 109.227 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -58.75 -32.45 69.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.0 m-30 -67.86 -46.03 72.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.343 -0.848 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.71 78.27 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.995 -1.065 . . . . 0.0 108.997 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -70.8 -57.22 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.077 . . . . 0.0 108.579 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.5 mt -51.7 -42.57 31.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.1 t -61.72 -31.32 50.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.0 t -67.12 -39.24 86.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 110.026 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 38' ' ' TYR . 53.0 ttt85 -69.56 -48.61 59.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.699 -1.251 . . . . 0.0 109.415 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 12' ' ' VAL . 15.3 mt -60.71 -38.54 85.37 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -63.17 -24.99 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -78.05 -36.66 48.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.056 -1.027 . . . . 0.0 109.419 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.553 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-85 -69.8 -47.05 64.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.426 -0.796 . . . . 0.0 110.416 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.75 2.56 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -99.36 135.68 40.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.85 117.61 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 44' ' ' GLU . 19.3 mt -80.94 -35.81 31.8 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -68.27 37.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.561 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 42' ' ' LEU . 44.3 tp10 -50.27 -34.49 23.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -49.77 -52.85 28.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 48' ' ' ASP . 21.8 t -58.83 163.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.719 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 62.55 -59.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.759 ' O ' HD11 ' A' ' 51' ' ' LEU . 24.0 t70 -65.85 24.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.719 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -103.63 -10.83 18.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.73 -39.78 95.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.028 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.07 161.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.527 -0.733 . . . . 0.0 109.773 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 51' ' ' LEU . 12.8 mt-10 55.97 158.61 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.287 -0.883 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' C ' HD22 ' A' ' 54' ' ' LEU . 23.6 Cg_endo -63.04 131.8 34.13 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.446 2.097 . . . . 0.0 111.593 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 49' ' ' ALA . 3.7 mm? -93.91 171.16 9.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 141.27 37.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' C ' ' N ' ' A' ' 58' ' ' ALA . 50.0 mt-10 47.11 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.482 -1.01 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 55' ' ' GLY . 97.1 mt-10 -47.47 -20.6 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' A' ' 56' ' ' GLU . . . -48.66 151.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.91 136.89 6.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.89 -62.57 0.17 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.78 80.6 1.13 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 18.8 p-10 -52.17 -45.22 65.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -1.091 . . . . 0.0 108.307 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 88.4 mt-30 -63.49 -48.59 77.02 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -61.64 -36.0 79.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.094 -1.004 . . . . 0.0 109.015 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 45' ' ' HIS . 2.0 mt -62.71 -52.22 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.657 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 0.1 OUTLIER -67.56 -50.54 58.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.588 0.709 . . . . 0.0 109.423 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 45.7 tp10 -43.09 -58.14 2.59 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -63.9 -39.42 94.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.656 ' CG ' ' OH ' ' A' ' 13' ' ' TYR . 8.5 t0 -58.42 -48.0 82.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.408 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.516 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -64.51 -45.14 88.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' NE2' ' A' ' 75' ' ' GLN . 10.1 t-20 -65.44 -52.11 55.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.447 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.12 -45.69 90.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 108.976 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 42.1 tp -50.35 -37.22 35.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HA ' HD11 ' A' ' 100' ' ' LEU . 68.9 mt-30 -73.7 -28.1 61.55 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.435 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.49 ' NE2' ' OD1' ' A' ' 71' ' ' ASN . 41.2 mt-30 -88.1 -0.5 57.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 109.646 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.81 44.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.091 -1.005 . . . . 0.0 112.277 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 11' ' ' SER . 61.5 m-20 -85.61 -31.67 22.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.47 143.96 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 13' ' ' TYR . 86.2 t -138.88 130.81 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.687 -1.258 . . . . 0.0 111.748 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 105' ' ' LEU . 84.0 t -136.65 130.66 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -116.23 137.21 52.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.663 -1.273 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD2' ' A' ' 27' ' ' LEU . 55.1 tt0 -84.71 139.18 32.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.6 -0.687 . . . . 0.0 109.282 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.613 HG13 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -143.62 147.71 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.272 -0.893 . . . . 0.0 109.793 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 14.5 m -173.87 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' ' OD2' ' A' ' 24' ' ' ASP . 24.6 pt20 -97.93 153.61 38.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -37.37 143.71 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.146 1.897 . . . . 0.0 111.676 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB3' HG23 ' A' ' 90' ' ' VAL . 3.5 m -163.5 123.9 2.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 110.104 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' B' ' 287' ' ' SER . 4.0 mt -76.62 -45.19 31.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.316 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.564 ' N ' ' OG ' ' A' ' 17' ' ' SER . . . -60.78 -42.17 99.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.613 HG11 HG13 ' A' ' 83' ' ' VAL . 40.7 t -64.62 -45.21 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.194 -1.18 . . . . 0.0 109.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.79 -46.7 93.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' B' ' 319' ' ' MET . 82.5 t80 -66.25 -47.94 72.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -1.081 . . . . 0.0 109.501 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' SD ' ' B' ' 319' ' ' MET . 10.8 mm-40 -59.76 -37.27 78.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.6 mt -75.22 -41.53 57.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.051 -1.031 . . . . 0.0 109.242 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.04 -50.02 59.65 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -40.05 82.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.392 -1.064 . . . . 0.0 108.612 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.49 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -68.33 -37.06 80.18 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.633 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.73 -45.14 48.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.892 -1.13 . . . . 0.0 108.276 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -89.59 -53.04 4.7 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.089 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 100' ' ' LEU . 1.8 tm? -90.06 -29.85 18.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.089 -1.007 . . . . 0.0 109.643 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -74.19 166.68 54.74 Favored Glycine 0 C--N 1.283 -2.392 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 4.8 mtmm -124.55 -71.09 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 82.9 Cg_endo -79.48 111.43 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.978 1.786 . . . . 0.0 109.293 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 97' ' ' ALA . 16.0 mt -129.59 116.03 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.782 -1.199 . . . . 0.0 111.995 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 80' ' ' VAL . 57.3 tp -110.5 126.26 54.18 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 145.66 39.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.928 -1.108 . . . . 0.0 108.771 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.3 mt -122.47 135.49 54.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.911 . . . . 0.0 111.625 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -133.5 138.01 45.91 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.577 ' NH2' ' NE2' ' A' ' 111' ' ' GLN . 4.4 mtm180 -98.98 134.66 21.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 120.703 -1.248 . . . . 0.0 111.338 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.43 -26.1 4.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.553 2.169 . . . . 0.0 111.267 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.577 ' NE2' ' NH2' ' A' ' 109' ' ' ARG . 20.3 pt20 -46.63 -38.66 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' GLY . 31.0 t -102.13 -15.8 16.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.82 51.37 2.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 115' ' ' VAL . 58.8 mtp85 -80.87 18.08 1.07 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.998 -1.295 . . . . 0.0 109.062 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 114' ' ' ARG . 48.7 t 46.99 100.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.671 0.748 . . . . 0.0 110.141 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 83' ' ' VAL . 49.1 tp -47.95 145.77 2.82 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 0.0 109.449 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -45.8 143.13 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.63 -30.31 69.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.458 -0.776 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.408 ' SD ' ' CD ' ' B' ' 293' ' ' GLU . 0.8 OUTLIER -70.76 -51.57 26.28 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.878 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.66 -42.51 96.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.675 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -65.17 -48.84 72.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.544 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.617 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -62.35 -31.25 78.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . . . -62.6 -15.66 52.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.038 -1.272 . . . . 0.0 108.199 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.45 96.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 65.3 m-20 -105.29 -22.52 13.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.893 . . . . 0.0 108.693 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.42 30.37 77.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 89.6 p -134.89 59.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.7 mtt180 98.61 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 123' ' ' ALA . 88.5 t80 -97.49 120.03 37.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.6 mt-30 -145.91 142.02 28.34 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.852 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.83 100.59 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.508 ' CG ' HD11 ' A' ' 105' ' ' LEU . 21.6 m0 -95.43 152.68 18.19 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.237 -0.914 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -97.38 155.54 16.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.094 -1.004 . . . . 0.0 108.877 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 6.3 p90 -170.19 -178.68 2.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.724 -1.235 . . . . 0.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.94 149.72 27.57 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.9 mt-10 -42.47 -29.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.704 -1.247 . . . . 0.0 110.154 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.51 -6.06 88.05 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.56 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.08 11.32 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.587 -1.537 . . . . 0.0 110.581 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.0 p -54.34 -45.35 68.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.924 -1.11 . . . . 0.0 108.448 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.504 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 49.9 mt-10 -57.76 -32.67 67.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.451 -0.781 . . . . 0.0 109.262 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.8 m -68.18 -45.52 73.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.568 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.97 -50.91 60.33 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.55 -34.1 77.15 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.89 -41.53 95.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.413 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -68.87 -48.7 62.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.867 -1.146 . . . . 0.0 108.331 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.39 -48.17 82.9 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 16.7 m-85 -69.74 -32.9 71.7 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.942 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 150' ' ' TYR . 27.1 mm-40 -62.24 -32.42 73.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.14 10.87 5.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.2 t80 -134.6 -105.09 0.23 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.24 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 14.9 mt -34.4 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.8 -0.563 . . . . 0.0 111.208 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 150' ' ' TYR . 87.1 Cg_endo . . . . . 0 C--N 1.313 -1.315 0 C-N-CA 123.168 2.578 . . . . 0.0 111.142 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.09 -150.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.961 1.774 . . . . 0.0 111.279 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 28.2 p -111.25 -175.65 2.76 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 33.6 m -121.13 152.81 38.29 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.778 HG11 HD22 ' B' ' 235' ' ' LEU . 10.5 t -131.25 136.17 58.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.659 ' OH ' ' CG ' ' B' ' 269' ' ' ASP . 8.1 t80 -113.29 99.29 7.69 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -89.67 116.52 27.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.975 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.1 m -92.34 146.75 23.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.625 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -168.29 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.625 ' C ' ' O ' ' B' ' 216' ' ' GLY . 14.6 m -15.94 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.883 -0.775 . . . . 0.0 110.78 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.303 -1.433 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.894 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.891 0.853 . . . . 0.0 111.825 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.92 -42.38 93.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.613 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.8 m-20 -52.68 -34.6 52.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.572 HE21 ' HB3' ' B' ' 249' ' ' ALA . 5.9 tp60 -64.16 -44.44 92.09 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.02 59.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.32 -0.862 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.432 ' CD2' ' OE2' ' B' ' 282' ' ' GLU . 0.6 OUTLIER -58.67 -32.92 69.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.699 ' O ' HG23 ' B' ' 232' ' ' VAL . 15.9 m-30 -67.49 -45.79 74.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.835 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.66 78.85 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.905 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -70.84 -57.15 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.901 -1.125 . . . . 0.0 108.619 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.76 -42.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.6 t -62.05 -31.23 50.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 10.5 t -67.07 -39.2 86.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.542 ' NH2' ' OH ' ' B' ' 238' ' ' TYR . 53.8 ttt85 -69.56 -48.71 59.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.644 -1.285 . . . . 0.0 109.323 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.778 HD22 HG11 ' B' ' 212' ' ' VAL . 14.7 mt -60.51 -38.66 85.06 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -63.18 -25.0 68.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.101 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -77.94 -36.43 49.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.026 -1.046 . . . . 0.0 109.402 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.568 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-85 -69.99 -47.1 63.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.505 -0.747 . . . . 0.0 110.469 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.92 2.6 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -99.3 135.75 40.25 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.363 -1.081 . . . . 0.0 109.346 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.86 117.55 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' B' ' 244' ' ' GLU . 19.4 mt -80.93 -35.82 31.85 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.318 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.42 ' H ' HG22 ' B' ' 243' ' ' THR . 0.9 OUTLIER -68.34 36.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.597 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' B' ' 242' ' ' LEU . 45.1 tp10 -49.98 -34.03 19.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.525 ' CD2' HG23 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -49.87 -52.22 34.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.11 -0.994 . . . . 0.0 109.047 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' B' ' 248' ' ' ASP . 21.9 t -59.62 163.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 108.899 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 62.57 -59.89 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.795 ' O ' HD11 ' B' ' 251' ' ' LEU . 24.4 t70 -65.76 24.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.697 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -103.16 -10.68 18.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.627 -0.671 . . . . 0.0 109.194 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -63.68 -39.85 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 1.025 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -55.05 161.69 1.59 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.451 -0.78 . . . . 0.0 109.754 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' B' ' 251' ' ' LEU . 12.3 mt-10 56.14 158.68 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.408 ' C ' HD22 ' B' ' 254' ' ' LEU . 21.8 Cg_endo -63.07 131.64 33.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 111.618 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.639 HD11 ' O ' ' B' ' 249' ' ' ALA . 3.7 mm? -94.0 170.26 9.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.294 -0.879 . . . . 0.0 109.827 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 142.28 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.414 ' O ' ' N ' ' B' ' 258' ' ' ALA . 50.4 mt-10 46.9 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 255' ' ' GLY . 96.8 mt-10 -47.21 -21.23 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.171 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -47.92 151.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -46.35 136.23 7.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.57 -62.81 0.16 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.07 80.7 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 18.6 p-10 -52.34 -44.96 65.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -1.125 . . . . 0.0 108.254 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . 0.476 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.1 mt-30 -63.71 -48.78 75.71 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -61.6 -35.5 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 109.08 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.525 HG23 ' CD2' ' B' ' 245' ' ' HIS . 1.9 mt -63.21 -52.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.617 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -67.42 -50.09 60.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.493 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.577 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 44.4 tp10 -43.74 -58.19 2.83 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 110.032 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -39.16 93.54 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.0 109.382 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.659 ' CG ' ' OH ' ' B' ' 213' ' ' TYR . 9.0 t0 -58.55 -48.14 81.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -0.867 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -64.5 -45.3 87.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 109.797 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.475 ' OD1' ' NE2' ' B' ' 275' ' ' GLN . 10.0 t-20 -65.34 -51.92 57.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 109.678 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.444 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.18 -45.7 90.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.938 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 42.3 tp -50.37 -37.23 36.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.405 ' HA ' HD11 ' B' ' 300' ' ' LEU . 68.8 mt-30 -73.74 -28.06 61.5 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.423 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.475 ' NE2' ' OD1' ' B' ' 271' ' ' ASN . 41.1 mt-30 -87.93 -0.58 57.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.999 -1.063 . . . . 0.0 109.707 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.99 131.62 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.205 -0.934 . . . . 0.0 112.4 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' B' ' 211' ' ' SER . 64.0 m-20 -85.65 -31.63 22.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 97.1 t -134.51 143.8 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' B' ' 213' ' ' TYR . 88.9 t -138.76 130.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.69 -1.256 . . . . 0.0 111.849 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' B' ' 305' ' ' LEU . 91.4 t -136.47 130.54 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -116.26 136.84 52.65 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.669 -1.269 . . . . 0.0 110.268 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.432 ' OE2' ' CD2' ' B' ' 227' ' ' LEU . 52.7 tt0 -84.32 139.59 32.19 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.589 -0.694 . . . . 0.0 109.273 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.623 HG13 HG11 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -144.13 147.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 15.2 m -173.47 -68.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.46 ' NE2' ' OD2' ' B' ' 224' ' ' ASP . 24.7 pt20 -98.38 153.86 37.84 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.12 144.04 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.131 1.888 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.508 ' HB3' HG23 ' B' ' 290' ' ' VAL . 3.5 m -163.72 123.7 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.48 ' HG ' ' H ' ' A' ' 87' ' ' SER . 4.0 mt -76.8 -45.16 29.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 217' ' ' SER . . . -60.43 -42.75 99.1 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.623 HG11 HG13 ' B' ' 283' ' ' VAL . 41.2 t -64.07 -45.57 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -1.201 . . . . 0.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.03 93.11 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 119' ' ' MET . 81.7 t80 -66.17 -47.97 72.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 109.557 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.408 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 11.6 mm-40 -59.87 -37.12 78.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.5 mt -75.25 -41.65 56.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.033 -1.042 . . . . 0.0 109.212 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.93 60.2 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -39.66 82.4 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.395 -1.062 . . . . 0.0 108.596 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.484 ' O ' HD11 ' B' ' 304' ' ' ILE . . . -68.45 -37.22 80.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.921 -1.111 . . . . 0.0 108.626 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -52.66 -45.51 48.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.889 -1.132 . . . . 0.0 108.226 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -89.27 -52.76 4.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.236 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.774 HD13 ' C ' ' B' ' 300' ' ' LEU . 1.7 tm? -90.46 -29.84 17.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.026 -1.047 . . . . 0.0 109.593 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' B' ' 297' ' ' ALA . . . -73.51 166.4 54.63 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 108.308 -1.917 . . . . 0.0 108.308 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.508 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 4.8 mtmm -124.54 -71.25 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 84.7 Cg_endo -79.4 110.86 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.884 1.723 . . . . 0.0 109.398 176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.484 HD11 ' O ' ' B' ' 297' ' ' ALA . 16.6 mt -128.98 116.35 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.699 -1.25 . . . . 0.0 112.103 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.659 ' HB3' HG22 ' B' ' 280' ' ' VAL . 57.8 tp -110.88 126.06 54.29 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 145.92 38.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.97 -1.081 . . . . 0.0 108.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.585 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 8.1 mt -122.98 135.6 54.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.229 -0.919 . . . . 0.0 111.643 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -133.45 138.35 46.15 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 311' ' ' GLN . 4.3 mtm180 -99.36 134.82 20.96 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 0.0 111.307 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.33 -26.27 4.23 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.531 2.154 . . . . 0.0 111.31 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 309' ' ' ARG . 20.2 pt20 -46.37 -38.76 9.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 28.7 t -102.04 -15.77 16.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.89 51.14 2.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.3 mtp85 -80.63 17.33 1.15 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.978 -1.307 . . . . 0.0 109.048 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.0 t 47.67 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.688 0.756 . . . . 0.0 110.128 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.557 HD11 HG11 ' B' ' 283' ' ' VAL . 47.8 tp -47.44 145.6 2.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.569 -0.707 . . . . 0.0 109.519 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.4 m -45.7 142.98 2.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.892 . . . . 0.0 110.195 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.37 69.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -0.759 . . . . 0.0 109.607 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.443 ' SD ' ' CD ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -70.33 -52.03 25.7 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.911 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.401 ' CG2' HD21 ' B' ' 316' ' ' LEU . 35.9 mm -62.43 -42.28 95.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.61 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 18.0 tpt85 -65.33 -48.94 71.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.143 -0.973 . . . . 0.0 109.484 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.657 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.41 -31.36 79.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' B' ' 329' ' ' PHE . . . -62.19 -15.76 48.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.036 -1.273 . . . . 0.0 108.111 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -44.24 96.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 66.7 m-20 -105.17 -22.41 13.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 108.696 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 65.51 30.14 76.81 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.637 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.2 p -134.7 59.57 1.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' B' ' 327' ' ' SER . 95.1 mtt180 98.89 -31.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' B' ' 323' ' ' ALA . 88.5 t80 -97.37 119.73 36.44 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.406 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 82.0 mt-30 -145.71 142.11 28.68 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.901 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 30.4 t -107.85 100.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.502 ' CG ' HD11 ' B' ' 305' ' ' LEU . 21.4 m0 -95.34 152.62 18.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.248 -0.908 . . . . 0.0 109.578 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -97.23 155.65 16.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 108.822 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.585 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 6.2 p90 -170.28 -179.12 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.761 -1.212 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.59 149.61 27.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 335' ' ' ALA . 49.5 mt-10 -42.56 -29.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.707 -1.245 . . . . 0.0 110.18 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.33 -6.02 87.75 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.624 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -145.02 11.33 1.36 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.504 . . . . 0.0 110.6 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 5.0 p -54.3 -45.25 68.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.896 -1.128 . . . . 0.0 108.55 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 49.4 mt-10 -57.77 -32.76 67.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.498 -0.751 . . . . 0.0 109.203 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.7 m -68.33 -45.42 72.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.88 -51.21 58.44 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.12 -34.37 77.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.816 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.92 -41.43 95.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -68.75 -48.87 62.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.778 -1.201 . . . . 0.0 108.265 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.27 -48.1 83.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.856 . . . . 0.0 110.139 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.7 m-85 -69.85 -32.87 71.49 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.952 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 350' ' ' TYR . 26.4 mm-40 -62.27 -32.67 73.42 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -81.9 10.82 5.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.3 t80 -134.4 -105.14 0.23 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.236 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' B' ' 350' ' ' TYR . 15.0 mt -34.22 92.17 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 111.182 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' B' ' 350' ' ' TYR . 88.6 Cg_endo . . . . . 0 C--N 1.312 -1.351 0 C-N-CA 123.103 2.536 . . . . 0.0 111.074 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.8 Cg_exo -55.38 -154.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.386 2.057 . . . . 0.0 111.424 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 32.0 p -111.91 172.74 6.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 18.4 t -114.86 155.44 26.81 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 108.704 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 2.7 t -130.45 126.92 61.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.67 ' HB3' HG13 ' A' ' 79' ' ' VAL . 32.9 t80 -93.99 127.46 39.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 32' ' ' VAL . 17.8 t80 -100.81 130.7 46.87 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.787 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' GLU . 5.5 t -134.0 128.79 35.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.99 -178.96 33.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -76.02 118.7 19.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -1.192 . . . . 0.0 108.634 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.883 0.849 . . . . 0.0 111.235 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 49.4 mp0 -60.62 -53.28 59.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 108.934 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -55.31 -29.36 58.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 35.6 tp60 -64.34 -43.06 95.78 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -49.08 68.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 -34.22 67.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.2 m-30 -69.17 -41.32 77.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.983 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.0 84.69 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 109.11 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.56 -56.78 5.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.841 -1.162 . . . . 0.0 108.613 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -54.08 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 28' ' ' TYR . 45.5 t -65.27 -28.73 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.8 m -67.08 -40.47 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.593 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 -69.59 -47.26 64.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.806 -1.183 . . . . 0.0 109.113 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 12' ' ' VAL . 13.8 mt -60.71 -40.62 92.97 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.428 ' HA ' HG23 ' A' ' 41' ' ' VAL . 67.2 ttt-85 -62.57 -25.29 68.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.688 -0.632 . . . . 0.0 109.42 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -78.03 -37.58 46.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.576 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.0 m-85 -67.83 -45.73 73.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 110.534 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -152.63 -152.48 5.98 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -90.08 120.39 31.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -1.167 . . . . 0.0 109.388 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.621 HG11 HG13 ' A' ' 32' ' ' VAL . 3.7 t -89.61 115.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 15.9 mt -79.44 172.35 13.92 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.498 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 45' ' ' HIS . 4.7 m 54.23 41.86 31.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.257 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.32 -12.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 108.778 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 65' ' ' ILE . 47.4 t-80 -52.98 -45.57 67.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.387 -0.821 . . . . 0.0 109.614 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 69.2 t -39.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 50' ' ' GLU . . . -50.05 -42.53 49.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 108.903 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.859 ' O ' HD21 ' A' ' 51' ' ' LEU . 26.2 t70 -81.14 24.49 0.52 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -105.95 33.41 3.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.62 -21.33 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.938 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.08 163.62 20.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.499 -0.751 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 51' ' ' LEU . 14.6 mt-10 54.58 157.85 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' LEU . 23.2 Cg_endo -62.98 71.07 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.425 2.083 . . . . 0.0 111.475 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -54.97 -169.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 116.69 129.96 4.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 63.6 mt-10 -50.24 -33.69 20.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.248 . . . . 0.0 108.629 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -69.58 -24.07 63.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -62.09 150.02 39.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.88 11.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.908 . . . . 0.0 109.404 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -52.97 -30.88 38.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.56 76.8 1.18 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 56' ' ' GLU . 3.1 m-20 -52.96 -44.83 67.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.359 -1.083 . . . . 0.0 108.539 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -62.31 -45.5 92.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -55.45 -36.61 66.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 108.612 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.658 HD11 ' CE1' ' A' ' 45' ' ' HIS . 3.2 mt -67.61 -35.62 73.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.0 t-80 -79.4 -62.91 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 66' ' ' HIS . 72.2 mt-10 -43.58 -48.02 7.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.899 -1.126 . . . . 0.0 109.71 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -69.25 -42.75 75.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.115 -0.99 . . . . 0.0 109.371 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.522 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 1.2 m-20 -59.56 -47.06 87.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 110.307 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.5 mm? -65.21 -46.58 80.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.322 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 33.0 t-20 -61.86 -54.52 41.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.18 -34.78 75.61 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.208 -0.933 . . . . 0.0 109.236 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 39.5 tp -57.09 -41.56 79.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.122 -0.986 . . . . 0.0 108.754 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -76.9 -22.83 52.79 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.36 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 47.7 mt-30 -84.27 -9.09 58.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.108 . . . . 0.0 108.829 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 132.36 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.354 -0.841 . . . . 0.0 112.082 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 11' ' ' SER . 12.4 m-20 -86.95 -27.66 23.17 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 74.7 t -139.23 137.4 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.67 HG13 ' HB3' ' A' ' 13' ' ' TYR . 63.5 t -126.91 141.49 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.739 -1.226 . . . . 0.0 111.085 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 t -138.86 122.37 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.549 0.69 . . . . 0.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.61 128.76 53.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 110.044 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' HG11 ' A' ' 90' ' ' VAL . 46.5 mt-10 -87.71 125.91 34.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 108.549 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.602 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -115.74 27.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.428 -0.795 . . . . 0.0 109.747 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.5 ' C ' ' CZ ' ' A' ' 114' ' ' ARG . 4.3 m -78.39 23.97 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.903 . . . . 0.0 108.851 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.567 ' N ' ' CZ ' ' A' ' 114' ' ' ARG . 5.0 tp-100 -166.32 118.91 0.82 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.978 . . . . 0.0 109.373 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.67 ' N ' HH21 ' A' ' 114' ' ' ARG . 76.8 Cg_exo -45.44 108.75 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.061 1.841 . . . . 0.0 111.946 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 m -142.36 131.03 22.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.839 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.405 HD11 HH22 ' B' ' 314' ' ' ARG . 74.1 mt -68.66 -39.07 80.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -62.38 -45.03 96.78 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 82' ' ' GLU . 18.4 t -64.81 -48.61 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -1.034 . . . . 0.0 108.787 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.73 98.03 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.419 ' HB2' HD11 ' B' ' 320' ' ' ILE . 75.7 t80 -64.78 -49.15 71.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.457 -1.025 . . . . 0.0 109.756 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 6.2 tp10 -59.65 -32.02 70.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 81' ' ' ALA . 62.7 mt -70.78 -43.77 68.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.684 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -45.55 80.74 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -44.69 96.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.967 . . . . 0.0 108.748 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.39 -36.16 82.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.136 -0.978 . . . . 0.0 108.522 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -54.41 -44.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.877 -1.139 . . . . 0.0 108.071 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -86.67 -52.89 5.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.699 -0.626 . . . . 0.0 111.908 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.739 HD13 ' C ' ' A' ' 100' ' ' LEU . 2.2 tm? -92.34 -31.85 15.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.048 -1.033 . . . . 0.0 109.948 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -69.74 174.65 35.62 Favored Glycine 0 C--N 1.281 -2.507 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.754 ' H ' ' CD ' ' A' ' 103' ' ' PRO . 22.1 mttt -136.55 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 102' ' ' LYS . 59.3 Cg_endo -98.84 109.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 123.748 2.965 . . . . 0.0 109.684 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.425 HG21 ' CD2' ' A' ' 129' ' ' PHE . 37.8 mt -127.21 124.35 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.839 -1.163 . . . . 0.0 112.027 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.2 tp -123.52 116.08 22.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.448 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 1.5 m -105.94 147.2 29.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.867 -1.145 . . . . 0.0 108.894 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 mt -120.26 139.12 53.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.193 -0.942 . . . . 0.0 111.068 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -146.02 122.96 11.35 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 16.8 mtt180 -88.07 140.0 30.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.719 -1.238 . . . . 0.0 110.481 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.66 -29.03 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.415 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.31 -32.9 5.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -99.17 -26.36 14.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.496 -0.752 . . . . 0.0 109.114 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.49 49.49 32.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.67 HH21 ' N ' ' A' ' 86' ' ' PRO . 10.4 mtp-105 -75.11 -11.41 60.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.035 -1.274 . . . . 0.0 111.205 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 114' ' ' ARG . 38.8 t 59.46 119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 116' ' ' LEU . 2.4 mt -77.34 158.64 30.03 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.84 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.454 ' OG ' ' CA ' ' B' ' 289' ' ' GLY . 0.3 OUTLIER -54.13 145.15 17.79 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.768 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.63 -19.09 5.37 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 108.696 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.496 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 1.0 OUTLIER -77.9 -45.18 24.86 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.399 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' B' ' 292' ' ' TYR . 42.5 mm -66.71 -48.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.2 -0.938 . . . . 0.0 108.575 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.443 ' CZ ' HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -68.4 -44.68 74.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.247 -0.908 . . . . 0.0 108.81 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -64.15 -28.23 72.61 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -40.68 -64.65 0.5 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.553 -0.969 . . . . 0.0 110.273 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -150.94 -95.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.204 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 15.0 p-10 111.54 5.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.53 70.77 0.02 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.836 ' C ' ' H ' ' A' ' 129' ' ' PHE . 37.5 p -164.15 66.34 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 66.43 -20.3 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.836 ' H ' ' C ' ' A' ' 127' ' ' SER . 9.3 t80 -117.77 118.76 32.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.601 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 31.3 tt0 -137.19 134.28 36.11 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.205 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 121' ' ' ARG . 69.5 t -91.85 105.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.601 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 13.7 m0 -102.14 142.35 33.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.171 -0.955 . . . . 0.0 109.724 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 54.0 m-20 -97.79 157.17 16.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.062 -1.024 . . . . 0.0 108.947 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' OH ' ' NE ' ' A' ' 109' ' ' ARG . 10.0 p90 -165.29 -172.72 2.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.591 -1.318 . . . . 0.0 111.936 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -159.27 148.37 18.34 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.4 mt-10 -42.93 -37.12 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.76 -1.213 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.92 2.86 53.71 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.207 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.97 7.14 0.52 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.58 -1.541 . . . . 0.0 110.601 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.8 p -53.99 -45.36 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.97 -1.081 . . . . 0.0 108.53 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 44.6 mt-10 -57.07 -33.67 67.5 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 83.9 m -68.19 -45.07 74.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.707 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.437 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.4 tpp -51.63 -48.13 63.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.76 -35.06 74.61 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 77.8 m-20 -65.59 -39.66 91.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 110.315 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -69.65 -50.29 45.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.818 -1.176 . . . . 0.0 108.315 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.92 -46.98 87.61 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.958 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 151' ' ' LEU . 12.2 m-85 -68.96 -34.05 74.71 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.136 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.03 -23.9 66.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.34 59.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.675 -0.641 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -156.04 -48.86 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.221 -1.55 . . . . 0.0 112.715 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.721 HD12 ' CD1' ' A' ' 147' ' ' PHE . 4.1 mt -38.32 -57.93 1.67 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.916 -1.115 . . . . 0.0 111.562 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 12.0 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 121.763 1.642 . . . . 0.0 111.741 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ALA . 31.7 Cg_exo -55.52 -154.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.276 1.984 . . . . 0.0 111.377 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.6 p -112.21 172.75 6.72 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 19.4 t -114.97 155.35 27.08 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.756 -1.215 . . . . 0.0 108.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 2.6 t -130.49 127.1 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' B' ' 279' ' ' VAL . 33.5 t80 -93.8 127.6 39.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.632 ' CD2' HG22 ' B' ' 232' ' ' VAL . 17.9 t80 -100.86 130.7 46.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.81 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' B' ' 293' ' ' GLU . 5.7 t -134.04 129.08 35.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.532 -0.73 . . . . 0.0 109.415 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -159.36 -178.85 33.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.7 p -76.11 118.06 18.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 0.0 108.757 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.457 HG23 ' OE1' ' B' ' 225' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.274 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.902 0.858 . . . . 0.0 111.319 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 49.0 mp0 -60.5 -53.14 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 108.983 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.48 -29.01 57.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' B' ' 222' ' ' ARG . 36.1 tp60 -64.68 -43.15 94.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.44 -0.787 . . . . 0.0 109.21 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -34.09 67.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.635 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.4 m-30 -69.28 -41.32 76.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.182 -0.949 . . . . 0.0 110.037 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.26 85.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.59 -1.319 . . . . 0.0 109.161 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -70.37 -56.67 6.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.834 -1.166 . . . . 0.0 108.654 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 83.0 mt -54.09 -41.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.7 t -65.16 -28.63 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.761 . . . . 0.0 109.103 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.1 m -67.31 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -69.7 -47.87 61.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.891 -1.131 . . . . 0.0 109.078 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.56 HD22 HG11 ' B' ' 212' ' ' VAL . 13.1 mt -60.1 -40.77 90.79 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.431 ' HA ' HG23 ' B' ' 241' ' ' VAL . 64.7 ttt-85 -62.29 -25.45 67.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.695 -0.628 . . . . 0.0 109.458 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -78.0 -37.69 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.975 . . . . 0.0 109.535 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.573 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.0 m-85 -67.71 -45.51 74.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.591 -0.693 . . . . 0.0 110.541 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.86 -152.53 6.02 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -90.24 120.63 31.56 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.365 -1.079 . . . . 0.0 109.389 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.632 HG11 HG13 ' B' ' 232' ' ' VAL . 3.6 t -89.81 116.21 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.473 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 15.7 mt -79.81 172.15 14.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.082 -1.012 . . . . 0.0 109.491 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.495 ' C ' ' N ' ' B' ' 245' ' ' HIS . 4.5 m 54.38 41.92 31.7 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.36 -0.837 . . . . 0.0 109.322 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -50.64 -12.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 108.766 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.646 ' CE1' HD11 ' B' ' 265' ' ' ILE . 46.7 t-80 -53.59 -45.14 69.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.5 -0.75 . . . . 0.0 109.426 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 249' ' ' ALA . 68.9 t -39.87 -79.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.622 -0.674 . . . . 0.0 109.992 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' B' ' 250' ' ' GLU . . . -49.69 -42.6 46.12 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.237 -0.915 . . . . 0.0 108.908 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.86 ' O ' HD21 ' B' ' 251' ' ' LEU . 24.3 t70 -80.82 24.22 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 246' ' ' VAL . . . -105.73 33.61 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' B' ' 247' ' ' ALA . 0.1 OUTLIER -123.5 -22.12 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.932 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -82.62 163.09 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.459 -0.776 . . . . 0.0 109.564 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' B' ' 251' ' ' LEU . 14.9 mt-10 54.82 157.75 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 109.88 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 254' ' ' LEU . 22.6 Cg_endo -62.74 71.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.441 2.094 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.796 HD23 ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER -55.66 -169.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.902 . . . . 0.0 109.454 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 117.5 129.97 4.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' B' ' 262' ' ' ASP . 61.6 mt-10 -50.1 -33.8 19.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.088 -1.242 . . . . 0.0 108.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -69.52 -24.55 63.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -61.56 150.04 37.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.488 -0.758 . . . . 0.0 109.351 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.73 11.1 0.15 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -52.68 -31.26 37.29 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.68 77.27 1.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' B' ' 256' ' ' GLU . 2.7 m-20 -52.89 -44.94 67.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -1.111 . . . . 0.0 108.589 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -62.04 -46.0 91.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.26 -37.12 66.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.961 . . . . 0.0 108.557 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.646 HD11 ' CE1' ' B' ' 245' ' ' HIS . 3.3 mt -67.26 -35.25 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' B' ' 267' ' ' GLU . 4.1 t-80 -79.69 -63.35 1.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 109.859 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' B' ' 266' ' ' HIS . 72.7 mt-10 -42.94 -48.44 5.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.67 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -69.03 -42.57 76.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.472 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.535 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 1.2 m-20 -59.85 -46.89 87.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' B' ' 270' ' ' LEU . 1.6 mm? -65.17 -46.83 79.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 110.424 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 32.9 t-20 -61.77 -54.52 41.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.138 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.473 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -61.15 -34.99 75.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.151 -0.968 . . . . 0.0 109.077 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 38.2 tp -56.89 -41.08 77.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.0 108.822 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -77.48 -22.53 51.15 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 47.7 mt-30 -84.55 -8.78 58.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.14 . . . . 0.0 108.884 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.88 132.39 45.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.402 -0.811 . . . . 0.0 112.131 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' B' ' 211' ' ' SER . 9.7 m-20 -86.63 -27.88 23.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 63.6 t -139.33 137.94 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' B' ' 213' ' ' TYR . 64.8 t -127.14 141.54 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.852 -1.155 . . . . 0.0 111.131 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 18.3 t -138.71 121.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.514 -0.741 . . . . 0.0 109.306 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.02 128.98 54.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.005 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.508 ' O ' HG11 ' B' ' 290' ' ' VAL . 46.3 mt-10 -88.08 125.52 34.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.59 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -115.28 27.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 109.658 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.492 ' C ' ' CZ ' ' B' ' 314' ' ' ARG . 4.1 m -78.42 24.51 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 108.91 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.574 ' N ' ' CZ ' ' B' ' 314' ' ' ARG . 4.9 tp-100 -166.65 118.5 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.658 ' N ' HH21 ' B' ' 314' ' ' ARG . 74.4 Cg_exo -45.31 109.13 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.011 1.807 . . . . 0.0 111.898 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 29.4 m -142.34 131.23 22.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 70.7 mt -69.21 -38.31 78.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . 0.454 ' CA ' ' OG ' ' A' ' 117' ' ' SER . . . -63.08 -44.98 96.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.508 HG11 ' O ' ' B' ' 282' ' ' GLU . 17.4 t -64.74 -48.7 83.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -1.036 . . . . 0.0 108.703 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -62.02 -39.57 97.76 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.414 ' HB2' HD11 ' A' ' 120' ' ' ILE . 74.7 t80 -65.08 -49.13 71.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -1.036 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.525 ' CB ' ' SG ' ' B' ' 215' ' ' CYS . 6.8 tp10 -59.55 -32.08 70.0 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' B' ' 281' ' ' ALA . 61.0 mt -70.72 -43.86 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 108.691 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.27 81.48 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -43.96 97.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.597 -0.943 . . . . 0.0 108.8 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -67.16 -36.14 81.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.137 -0.977 . . . . 0.0 108.429 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.477 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.7 OUTLIER -54.31 -44.53 66.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -86.76 -52.95 5.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.914 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.747 HD13 ' C ' ' B' ' 300' ' ' LEU . 2.2 tm? -92.13 -31.84 15.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 109.93 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -69.75 174.55 35.85 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.758 ' H ' ' CD ' ' B' ' 303' ' ' PRO . 22.6 mttt -136.59 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.758 ' CD ' ' H ' ' B' ' 302' ' ' LYS . 58.7 Cg_endo -98.83 109.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 123.703 2.935 . . . . 0.0 109.704 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' B' ' 329' ' ' PHE . 37.7 mt -127.53 124.39 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.8 -1.188 . . . . 0.0 112.087 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 25.3 tp -123.73 115.97 22.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . 0.454 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 1.5 m -105.4 147.36 28.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 108.88 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.494 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.1 mt -120.47 138.97 53.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.088 -1.008 . . . . 0.0 110.997 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' B' ' 333' ' ' ASP . 0.6 OUTLIER -145.89 122.99 11.45 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.572 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 15.7 mtt180 -88.25 140.3 30.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.726 -1.234 . . . . 0.0 110.378 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.78 -28.79 6.05 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.631 2.221 . . . . 0.0 111.623 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -47.56 -32.69 5.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 20.6 t -99.31 -26.28 14.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.064 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 49.33 49.62 31.26 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.658 HH21 ' N ' ' B' ' 286' ' ' PRO . 10.3 mtp-105 -75.1 -11.36 60.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.303 . . . . 0.0 111.218 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' B' ' 314' ' ' ARG . 38.4 t 59.6 119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.54 HD23 ' N ' ' B' ' 316' ' ' LEU . 2.4 mt -77.36 158.29 30.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.646 -1.221 . . . . 0.0 108.822 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 0.4 OUTLIER -53.78 145.27 16.2 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.712 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.74 -19.04 5.46 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.269 -0.895 . . . . 0.0 108.729 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.492 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -77.99 -45.41 23.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.337 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 92' ' ' TYR . 40.1 mm -66.26 -48.61 80.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.615 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.446 ' CZ ' HG11 ' B' ' 331' ' ' VAL . 0.1 OUTLIER -68.55 -44.19 75.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.935 . . . . 0.0 108.748 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -64.11 -29.0 73.69 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -40.14 -65.21 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.555 -0.968 . . . . 0.0 110.314 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -150.78 -95.18 0.06 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.233 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 15.0 p-10 111.47 4.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 161.46 70.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.823 ' C ' ' H ' ' B' ' 329' ' ' PHE . 32.8 p -164.31 66.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 66.33 -20.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.823 ' H ' ' C ' ' B' ' 327' ' ' SER . 8.8 t80 -117.53 118.9 33.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 31.7 tt0 -137.22 134.1 35.87 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.209 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' B' ' 321' ' ' ARG . 72.8 t -91.67 106.01 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 13.7 m0 -102.14 142.31 33.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.115 -0.991 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' B' ' 308' ' ' PHE . 53.9 m-20 -97.77 157.27 16.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.937 -1.102 . . . . 0.0 108.921 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.572 ' OH ' ' NE ' ' B' ' 309' ' ' ARG . 10.2 p90 -165.0 -171.88 2.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.629 -1.294 . . . . 0.0 111.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.461 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -159.97 148.31 17.11 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.4 mt-10 -42.85 -37.13 1.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.724 -1.235 . . . . 0.0 110.234 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.13 3.35 52.6 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -151.62 7.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.537 -1.566 . . . . 0.0 110.559 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.52 HG13 ' N ' ' B' ' 340' ' ' GLU . 6.2 p -53.97 -45.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 108.556 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.52 ' N ' HG13 ' B' ' 339' ' ' VAL . 42.5 mt-10 -57.14 -34.14 68.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.3 m -67.45 -45.51 75.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.147 -0.971 . . . . 0.0 109.658 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.423 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.4 tpp -51.42 -48.06 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 46.6 mt -69.65 -35.02 74.81 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.72 -39.43 91.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.927 -1.108 . . . . 0.0 110.294 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -70.05 -50.1 44.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.937 -1.102 . . . . 0.0 108.243 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.94 -47.3 86.35 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.017 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.719 ' CD1' HD12 ' B' ' 351' ' ' LEU . 12.5 m-85 -68.76 -33.83 74.57 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.149 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.59 -9.92 58.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.785 -0.572 . . . . 0.0 111.428 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -156.31 -48.88 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.161 -1.587 . . . . 0.0 112.643 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.719 HD12 ' CD1' ' B' ' 347' ' ' PHE . 4.0 mt -38.62 -57.85 1.81 Allowed Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.961 -1.087 . . . . 0.0 111.526 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 12.1 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 121.826 1.684 . . . . 0.0 111.703 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.52 -152.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.318 2.012 . . . . 0.0 111.444 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.6 p -109.97 -179.69 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 20.5 p -120.03 158.24 27.22 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG11 HD22 ' A' ' 35' ' ' LEU . 2.2 t -136.67 137.1 47.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.849 0.833 . . . . 0.0 109.565 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 6.8 t80 -123.14 101.28 7.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.539 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -94.49 127.71 40.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.341 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 12.0 m -85.36 149.75 25.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -156.44 165.17 32.82 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.499 ' CB ' ' OG ' ' A' ' 87' ' ' SER . 6.1 t -91.8 130.05 37.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.444 0.64 . . . . 0.0 109.326 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -53.83 -39.8 65.89 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.6 m-20 -64.91 -27.02 68.57 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.686 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 8.9 tp60 -64.88 -41.88 95.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.08 63.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -26.98 68.45 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 108.765 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.661 ' O ' HG23 ' A' ' 32' ' ' VAL . 12.6 m-30 -68.49 -46.75 68.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.01 74.75 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.357 -1.337 . . . . 0.0 107.924 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 33' ' ' SER . 57.4 ttt180 -71.97 -58.39 3.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.93 -1.106 . . . . 0.0 108.671 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 32' ' ' VAL . 6.0 tt -52.37 -40.3 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 28' ' ' TYR . 44.5 t -64.31 -29.54 47.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 30' ' ' ARG . 19.4 p -67.78 -39.85 84.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.743 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -71.7 -49.29 40.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.702 -1.249 . . . . 0.0 108.591 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.735 HD22 HG11 ' A' ' 12' ' ' VAL . 10.4 mt -56.63 -39.46 73.7 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -65.8 -23.63 66.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -76.39 -36.77 57.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.988 -1.07 . . . . 0.0 108.988 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.574 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -70.3 -48.53 56.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.5 -140.19 3.02 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -101.02 136.45 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG11 HG13 ' A' ' 32' ' ' VAL . 68.3 t -101.88 122.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 10.6 mt -84.2 -42.85 15.52 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.511 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 43' ' ' THR . 13.7 t -67.54 60.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 109.771 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' LEU . 83.7 mt-10 -82.83 -25.34 32.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.059 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.65 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 4.7 p80 -53.19 -45.78 68.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.686 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -55.64 -60.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HG13 ' A' ' 46' ' ' VAL . . . -59.41 -31.93 69.72 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.826 -1.171 . . . . 0.0 108.973 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.639 ' C ' HD21 ' A' ' 51' ' ' LEU . 22.0 t70 -87.92 48.25 1.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.466 -0.771 . . . . 0.0 109.104 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB3' HE21 ' A' ' 25' ' ' GLN . . . -135.24 -16.03 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.43 -11.83 59.89 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.028 -1.045 . . . . 0.0 109.165 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.109 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.7 -43.95 72.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.172 -0.955 . . . . 0.0 108.686 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 3.3 tt0 -176.9 -48.47 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.538 -0.727 . . . . 0.0 109.422 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 15.4 Cg_exo -69.9 106.5 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.662 2.241 . . . . 0.0 111.56 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -148.06 110.51 4.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.352 -0.843 . . . . 0.0 109.369 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 130.26 42.05 0.22 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 61.0 mt-10 53.58 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -1.038 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.0 tt0 -42.59 -33.11 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 108.915 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' PRO . . . -106.49 65.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.01 -40.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.66 54.6 0.77 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.41 76.56 1.14 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -51.25 -43.76 61.58 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.2 -44.66 83.85 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -58.34 -34.76 70.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -68.17 -32.42 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.421 ' CE1' HD22 ' A' ' 70' ' ' LEU . 23.3 t-80 -78.19 -64.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 68' ' ' GLN . 19.2 pt-20 -50.12 -44.56 52.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 109.572 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 51.5 tt0 -66.48 -48.23 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.39 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.519 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 84.0 m-20 -70.85 -54.38 11.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.982 . . . . 0.0 110.985 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 66' ' ' HIS . 5.1 tp -56.58 -39.11 72.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 85.7 m-20 -63.68 -52.78 59.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.396 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.29 -41.21 83.9 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.468 -0.893 . . . . 0.0 108.731 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 11.8 tp -50.32 -41.38 51.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.41 -27.23 63.16 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.447 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 35.1 mt-30 -88.98 0.13 56.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.958 -1.089 . . . . 0.0 109.352 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.09 130.89 44.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.897 . . . . 0.0 111.862 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 11' ' ' SER . 38.8 t0 -80.6 -32.97 36.27 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.16 144.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.8 t -136.08 124.81 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 111.501 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 81' ' ' ALA . 24.0 t -117.98 176.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.626 ' H ' HG12 ' A' ' 80' ' ' VAL . . . -164.15 116.03 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.574 -1.329 . . . . 0.0 110.033 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -79.22 142.94 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -147.66 148.38 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.785 -179.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 2.7 m -171.82 -42.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -129.47 152.56 79.82 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD23 ' B' ' 288' ' ' LEU . 76.4 Cg_exo -36.36 147.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.604 2.202 . . . . 0.0 112.731 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.584 ' H ' ' CD2' ' B' ' 288' ' ' LEU . 12.9 t -175.34 123.0 0.22 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 110.484 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.685 HD12 HG13 ' B' ' 320' ' ' ILE . 2.2 mm? -71.32 -44.72 64.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.03 -36.69 75.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' A' ' 87' ' ' SER . 11.8 t -75.75 -49.09 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -1.032 . . . . 0.0 109.495 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' CA ' HD13 ' B' ' 288' ' ' LEU . . . -67.6 -37.97 89.87 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.846 -1.169 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -69.45 -52.19 29.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -1.186 . . . . 0.0 109.867 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' OE2' ' SD ' ' B' ' 319' ' ' MET . 95.1 mt-10 -63.22 -30.86 71.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.514 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.8 mt -69.79 -47.46 62.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.971 . . . . 0.0 109.249 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.15 -36.77 93.44 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -62.24 -41.76 98.7 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.556 -0.967 . . . . 0.0 109.366 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.2 -38.52 78.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.897 -1.127 . . . . 0.0 108.956 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.36 -40.65 32.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -82.21 -53.01 6.4 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.71 -9.23 2.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -0.999 . . . . 0.0 110.206 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 102' ' ' LYS . . . 54.5 94.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.979 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 104' ' ' ILE . 41.8 mttm -164.66 150.81 9.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 79' ' ' VAL . 82.4 Cg_exo -38.83 104.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.707 1.605 . . . . 0.0 111.332 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.2 mt -107.09 95.45 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.771 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.63 118.29 35.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 143.09 49.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -132.1 144.11 50.49 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.063 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.79 147.42 50.79 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 134' ' ' TYR . 12.3 mtt180 -99.31 142.32 24.4 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.237 . . . . 0.0 111.472 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' GLY . 89.1 Cg_endo -80.82 -31.24 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.855 2.37 . . . . 0.0 110.944 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -45.62 -38.57 6.76 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 21.8 p -95.69 -20.52 18.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.86 43.43 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' VAL . 61.0 mtt180 -79.37 13.03 2.09 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -1.114 . . . . 0.0 109.387 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 114' ' ' ARG . 75.8 t 49.57 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.408 -0.807 . . . . 0.0 110.157 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.505 HD11 HG11 ' A' ' 83' ' ' VAL . 24.2 tp -45.15 158.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.88 142.99 22.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 111.089 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.515 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -56.99 -50.68 71.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.73 -0.606 . . . . 0.0 110.339 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.51 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 19.5 mtp -65.89 -38.37 88.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.927 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.662 HG13 HD12 ' B' ' 288' ' ' LEU . 5.1 mm -66.34 -44.92 90.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.064 -1.023 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -74.46 -44.41 51.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.025 -1.047 . . . . 0.0 109.055 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.48 -22.33 61.26 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -45.77 -60.91 1.96 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.477 -1.013 . . . . 0.0 109.937 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -156.7 -88.18 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.147 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER 97.24 -1.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -179.92 85.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.777 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 162.08 74.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.475 -1.015 . . . . 0.0 109.595 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 67.04 -23.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.777 ' H ' ' C ' ' A' ' 127' ' ' SER . 12.8 t80 -123.28 118.89 28.6 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -135.23 138.3 43.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 111.214 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 84.7 t -101.95 99.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 21.0 m0 -93.76 148.68 21.9 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -93.75 147.71 22.79 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.5 p90 -168.02 174.31 7.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.363 -1.461 . . . . 0.0 112.133 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -140.6 147.28 39.14 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 135' ' ' ALA . 50.0 mt-10 -41.99 -30.3 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.932 -1.105 . . . . 0.0 110.581 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.25 1.46 88.78 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.999 -1.063 . . . . 0.0 110.752 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -135.82 -2.76 2.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.958 -1.319 . . . . 0.0 109.975 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 1.4 p -52.15 -45.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.013 -1.054 . . . . 0.0 108.161 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 27.6 mt-10 -52.67 -36.62 57.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -40.8 90.06 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.461 -0.775 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 11.4 mmt -55.67 -54.87 38.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 37.2 mt -59.71 -27.03 66.1 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.46 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 16.5 t70 -69.47 -46.86 65.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 0.0 111.111 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -73.81 -44.08 56.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.477 -1.389 . . . . 0.0 109.805 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 42.3 t80 -60.41 -46.53 89.69 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.764 ' CD1' HD12 ' A' ' 151' ' ' LEU . 11.4 m-85 -74.77 -34.4 62.45 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.349 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -68.93 -23.31 64.15 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.238 -1.538 . . . . 0.0 107.425 178.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.46 -10.46 55.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.623 -0.673 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.607 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -154.91 -47.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.419 -1.426 . . . . 0.0 112.16 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 147' ' ' PHE . 2.3 mt -41.52 -54.34 6.5 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.97 -1.081 . . . . 0.0 111.076 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 121.986 1.791 . . . . 0.0 112.141 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.27 -152.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 111.571 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 15.0 p -110.06 -179.75 3.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 17.2 p -120.1 157.73 28.36 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.734 HG11 HD22 ' B' ' 235' ' ' LEU . 2.2 t -136.18 137.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.782 0.801 . . . . 0.0 109.57 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 6.8 t80 -123.04 101.54 7.47 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.2 OUTLIER -94.82 127.41 40.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 109.163 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.433 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 12.4 m -85.13 148.82 25.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.002 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' B' ' 228' ' ' TYR . . . -155.19 164.95 32.14 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.781 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.503 ' CB ' ' OG ' ' B' ' 287' ' ' SER . 6.2 t -92.12 129.52 38.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.644 -0.915 . . . . 0.0 109.388 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -53.58 -39.84 65.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 75.4 m-20 -64.89 -27.15 68.66 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.7 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 9.2 tp60 -64.84 -41.34 95.79 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.99 63.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.97 -26.89 68.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 108.72 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.648 ' O ' HG23 ' B' ' 232' ' ' VAL . 12.7 m-30 -68.6 -46.72 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.667 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.97 -32.83 74.51 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.368 -1.333 . . . . 0.0 107.939 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' B' ' 233' ' ' SER . 57.6 ttt180 -72.09 -58.5 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.851 -1.155 . . . . 0.0 108.715 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' B' ' 232' ' ' VAL . 5.9 tt -52.15 -40.48 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.6 t -64.28 -29.43 47.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 20.1 p -67.76 -39.81 84.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -71.86 -49.13 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.786 -1.196 . . . . 0.0 108.601 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.734 HD22 HG11 ' B' ' 212' ' ' VAL . 9.9 mt -56.94 -39.37 74.4 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -65.64 -23.7 66.86 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -76.54 -37.17 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.948 -1.095 . . . . 0.0 108.932 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.591 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -69.87 -48.43 58.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.554 -0.716 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -153.32 -140.5 3.08 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -101.08 136.53 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -1.104 . . . . 0.0 109.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.642 HG11 HG13 ' B' ' 232' ' ' VAL . 62.1 t -101.9 122.8 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 10.7 mt -84.08 -42.66 15.86 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.478 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.749 ' O ' HG23 ' B' ' 243' ' ' THR . 13.8 t -67.36 60.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.845 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' B' ' 242' ' ' LEU . 82.7 mt-10 -82.58 -25.98 32.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.119 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.648 ' CG ' ' N ' ' B' ' 246' ' ' VAL . 4.8 p80 -52.48 -45.69 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.7 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 0.2 OUTLIER -55.97 -60.15 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 109.546 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.471 ' H ' HG13 ' B' ' 246' ' ' VAL . . . -59.28 -31.63 69.28 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.91 -1.119 . . . . 0.0 108.915 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.647 ' C ' HD21 ' B' ' 251' ' ' LEU . 22.4 t70 -88.26 48.01 1.58 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.721 0.772 . . . . 0.0 109.244 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.561 ' HB3' HE21 ' B' ' 225' ' ' GLN . . . -134.89 -16.19 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' B' ' 250' ' ' GLU . 1.0 OUTLIER -77.4 -11.8 59.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.105 -0.997 . . . . 0.0 109.276 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 1.06 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -54.79 -43.13 72.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 108.651 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 3.3 tt0 -177.83 -48.28 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.326 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 16.0 Cg_exo -69.83 106.27 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.617 2.211 . . . . 0.0 111.661 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.463 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.3 OUTLIER -147.99 110.41 4.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.87 . . . . 0.0 109.494 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 130.34 41.85 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.515 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 64.8 mt-10 53.87 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.474 -1.015 . . . . 0.0 109.812 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.2 tt0 -43.14 -32.29 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 108.942 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' B' ' 253' ' ' PRO . . . -106.96 65.55 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -148.57 -40.51 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.098 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 105.46 53.95 0.76 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.96 76.46 1.11 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -51.02 -43.54 60.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.44 -44.37 84.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.55 -35.35 72.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.412 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.4 OUTLIER -67.57 -32.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.409 ' CE1' HD22 ' B' ' 270' ' ' LEU . 23.3 t-80 -78.06 -65.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' B' ' 268' ' ' GLN . 19.1 pt-20 -49.58 -44.34 46.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.995 -1.066 . . . . 0.0 109.689 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . 0.507 ' N ' ' CG ' ' B' ' 267' ' ' GLU . 51.7 tt0 -66.7 -48.59 68.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.502 ' CG ' ' CD2' ' B' ' 245' ' ' HIS . 85.3 m-20 -70.51 -54.16 13.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' B' ' 266' ' ' HIS . 5.2 tp -56.75 -39.28 73.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.982 . . . . 0.0 109.726 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 84.0 m-20 -63.45 -52.69 60.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -58.67 -41.14 85.44 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 108.728 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.535 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 11.7 tp -50.39 -41.24 51.72 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -71.42 -27.34 63.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.307 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 35.3 mt-30 -89.16 0.56 56.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.913 -1.117 . . . . 0.0 109.32 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.67 130.31 42.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.279 -0.888 . . . . 0.0 111.891 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' B' ' 211' ' ' SER . 40.6 t0 -80.23 -32.74 38.39 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.38 144.0 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' B' ' 213' ' ' TYR . 80.8 t -135.92 124.92 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.98 -1.075 . . . . 0.0 111.353 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . 0.621 HG12 ' H ' ' B' ' 281' ' ' ALA . 25.5 t -118.02 176.82 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.621 ' H ' HG12 ' B' ' 280' ' ' VAL . . . -164.01 115.69 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.576 -1.328 . . . . 0.0 110.089 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.93 143.22 36.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 108.67 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -147.88 148.23 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.098 -1.001 . . . . 0.0 109.772 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 2.8 m -171.72 -42.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -130.19 151.92 79.23 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 88' ' ' LEU . 77.0 Cg_exo -35.87 146.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.675 2.25 . . . . 0.0 112.682 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.562 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 14.8 t -175.46 122.46 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 0.0 110.525 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.662 HD12 HG13 ' A' ' 120' ' ' ILE . 2.2 mm? -70.99 -43.94 66.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.333 -0.854 . . . . 0.0 109.655 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.42 -36.56 77.45 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' B' ' 287' ' ' SER . 11.7 t -76.1 -49.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -1.076 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . 0.482 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -67.41 -37.98 90.69 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -69.77 -52.11 28.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -1.187 . . . . 0.0 109.926 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.51 ' OE2' ' SD ' ' A' ' 119' ' ' MET . 95.9 mt-10 -63.2 -31.15 72.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.222 -0.923 . . . . 0.0 109.495 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.4 mt -69.65 -47.35 63.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.73 93.33 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -62.42 -41.58 98.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.546 -0.973 . . . . 0.0 109.299 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.64 79.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.956 -1.09 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.409 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.6 OUTLIER -52.24 -40.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -81.88 -53.13 6.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.079 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.86 -9.16 2.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.104 -0.997 . . . . 0.0 110.206 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' B' ' 302' ' ' LYS . . . 54.41 94.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.94 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 41.4 mttm -165.04 150.54 8.51 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' B' ' 279' ' ' VAL . 82.8 Cg_exo -38.63 104.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.75 1.634 . . . . 0.0 111.296 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.2 mt -106.82 95.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.654 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.73 118.53 36.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 142.29 50.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.602 HD12 ' N ' ' B' ' 307' ' ' LEU . 0.4 OUTLIER -131.3 143.62 50.67 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.298 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -128.11 147.49 50.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -99.19 141.82 23.53 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.732 -1.23 . . . . 0.0 111.516 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 313' ' ' GLY . 92.7 Cg_endo -80.27 -31.63 1.61 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.807 2.338 . . . . 0.0 110.954 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 310' ' ' PRO . 20.2 pt20 -45.47 -38.65 6.38 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.0 p -95.66 -20.02 19.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.46 43.09 1.47 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.0 mtt180 -78.98 13.0 1.91 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.346 -1.091 . . . . 0.0 109.424 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 314' ' ' ARG . 79.6 t 49.42 101.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.366 -0.834 . . . . 0.0 110.255 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.525 HD11 HG11 ' B' ' 283' ' ' VAL . 24.0 tp -45.19 158.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.64 142.75 22.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 111.05 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . 0.479 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.93 -50.66 71.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.367 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.514 ' SD ' ' OE2' ' A' ' 93' ' ' GLU . 19.3 mtp -65.65 -38.65 89.94 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.964 -1.085 . . . . 0.0 109.859 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.685 HG13 HD12 ' A' ' 88' ' ' LEU . 5.1 mm -66.24 -44.86 91.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -74.26 -44.47 52.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.952 -1.093 . . . . 0.0 108.97 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -61.55 -22.33 61.43 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 320' ' ' ILE . . . -45.49 -61.04 1.85 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.576 -0.956 . . . . 0.0 110.047 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -156.64 -87.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.967 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 0.7 OUTLIER 96.99 -1.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -177.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -179.59 84.95 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.783 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.1 p 162.37 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.406 -1.055 . . . . 0.0 109.737 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 67.11 -23.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.783 ' H ' ' C ' ' B' ' 327' ' ' SER . 11.9 t80 -123.65 118.97 28.48 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -135.21 138.68 43.85 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.212 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 83.9 t -102.3 100.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 21.1 m0 -94.04 148.58 22.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.85 148.13 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.6 p90 -168.53 174.37 6.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.114 -1.434 . . . . 0.0 112.057 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -140.69 147.28 39.0 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.5 mt-10 -41.86 -30.37 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.605 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.19 1.31 88.93 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.766 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -135.53 -2.72 2.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.95 -1.324 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 1.4 p -52.31 -45.81 44.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 26.5 mt-10 -52.93 -36.34 59.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 24.4 m -66.37 -41.03 90.04 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 11.6 mmt -55.34 -54.99 36.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 39.6 mt -59.61 -27.17 66.07 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' B' ' 348' ' ' GLU . 15.9 t70 -69.33 -46.79 66.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -0.966 . . . . 0.0 111.184 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -73.64 -44.36 57.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.333 -1.48 . . . . 0.0 109.846 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . 0.429 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 42.2 t80 -60.18 -46.49 89.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.738 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.765 ' CD1' HD12 ' B' ' 351' ' ' LEU . 11.5 m-85 -74.88 -34.23 62.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.437 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 348' ' ' GLU . 0.7 OUTLIER -69.07 -23.38 64.02 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 117.846 -1.542 . . . . 0.0 107.485 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.4 -10.23 53.75 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.612 -0.68 . . . . 0.0 110.468 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -155.11 -47.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.46 -1.4 . . . . 0.0 112.15 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' B' ' 347' ' ' PHE . 2.2 mt -41.53 -54.33 6.53 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 110.998 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 C--N 1.308 -1.574 0 C-N-CA 122.008 1.805 . . . . 0.0 112.231 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 -155.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.402 2.068 . . . . 0.0 110.965 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 26.4 p -99.67 178.02 4.97 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.576 ' OG ' HD21 ' A' ' 42' ' ' LEU . 3.0 t -116.08 152.95 32.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.81 132.63 56.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.431 -0.793 . . . . 0.0 109.348 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' CZ ' ' OE2' ' A' ' 44' ' ' GLU . 39.2 t80 -96.34 147.1 24.15 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.673 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.6 t80 -110.45 133.21 53.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.029 . . . . 0.0 111.517 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 102.53 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.29 177.58 19.48 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 122.86 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -1.061 . . . . 0.0 109.73 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.727 ' CD1' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 108.654 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.496 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 12.5 ptm180 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.901 0.858 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -55.96 -39.27 71.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 86.9 m-20 -60.03 -33.34 71.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.496 ' H ' ' HG3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -63.24 -46.83 85.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -50.19 69.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.62 -35.49 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 32' ' ' VAL . 18.5 m-30 -67.44 -47.7 69.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.93 75.8 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.681 -1.262 . . . . 0.0 108.803 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 -68.69 -57.15 6.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 108.609 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -50.88 -45.2 28.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 28' ' ' TYR . 94.5 t -59.65 -30.63 45.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -66.02 -40.13 90.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.115 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -63.45 -41.99 98.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.78 -1.2 . . . . 0.0 108.045 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 32' ' ' VAL . 52.9 mt -61.24 -43.1 99.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -56.66 -26.1 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -85.49 -29.42 24.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.161 -0.962 . . . . 0.0 110.046 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.508 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.2 m-85 -84.39 -58.8 2.6 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.182 -0.949 . . . . 0.0 110.511 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -132.61 -164.61 10.99 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 11' ' ' SER . 33.7 mtmt -89.61 124.2 34.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.223 -1.163 . . . . 0.0 109.036 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.45 HG11 ' CG1' ' A' ' 32' ' ' VAL . 39.8 t -80.62 104.05 8.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD21 ' OG ' ' A' ' 11' ' ' SER . 80.9 mt -52.03 142.43 15.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.764 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.561 ' OG1' ' CE3' ' A' ' 72' ' ' TRP . 17.4 p -37.75 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.512 0.672 . . . . 0.0 110.161 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 13' ' ' TYR . 19.5 mm-40 -122.91 110.41 15.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.664 ' O ' ' N ' ' A' ' 49' ' ' ALA . 4.7 p80 -56.44 -15.35 4.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.341 -0.85 . . . . 0.0 109.624 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CD1' ' A' ' 18' ' ' ILE . 60.8 t -41.7 -78.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.335 -0.853 . . . . 0.0 110.651 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.25 10.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.883 -1.136 . . . . 0.0 109.09 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.916 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.7 t70 -96.54 22.71 7.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -109.2 35.88 3.11 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HG3' HD13 ' A' ' 51' ' ' LEU . 1.9 pt-20 -129.57 -20.32 3.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.916 HD21 ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -62.67 -102.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -57.02 164.1 2.55 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.4 36.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.552 2.168 . . . . 0.0 112.996 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 54' ' ' LEU . 6.6 mp 51.3 -155.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.93 -1.106 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . -127.83 -36.58 0.47 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 36.4 mp0 -46.58 -20.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -1.061 . . . . 0.0 109.108 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' GLY . 24.5 pt-20 -132.47 3.51 3.9 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 54' ' ' LEU . . . -145.59 -173.79 4.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.05 152.45 21.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.18 -9.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.64 74.93 1.22 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -53.62 -37.0 62.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.348 -1.09 . . . . 0.0 108.336 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.628 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 16.4 mp0 -62.23 -47.15 85.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -53.58 -36.27 61.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 0.0 109.184 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -67.3 -53.1 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.491 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 4.8 t-80 -63.65 -45.77 88.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 110.785 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -54.43 -54.73 36.8 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.632 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' TRP . 99.5 mt-30 -72.42 -40.34 67.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 110.169 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 23.8 m-20 -64.93 -52.97 53.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.972 . . . . 0.0 111.014 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.93 78.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 111.148 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -65.41 -54.01 34.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.785 -1.197 . . . . 0.0 110.049 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.45 -42.74 99.68 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.814 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 2.0 tt -53.15 -36.87 61.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -75.18 -26.2 58.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.527 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.496 ' CD ' ' CD1' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -97.86 5.7 48.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.797 -1.189 . . . . 0.0 109.064 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -65.08 129.4 39.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.697 0.76 . . . . 0.0 112.536 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 11' ' ' SER . 64.0 t0 -74.94 -36.17 62.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 79' ' ' VAL . 46.0 t -134.25 168.01 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' N ' HG12 ' A' ' 78' ' ' VAL . 60.8 t -150.21 140.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.104 -0.998 . . . . 0.0 111.074 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -132.07 143.23 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -152.74 156.14 38.55 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 110.51 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' OH ' ' A' ' 134' ' ' TYR . 47.1 tt0 -123.25 124.77 43.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -120.22 23.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 109.523 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 109' ' ' ARG . 89.4 m -45.76 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.148 -0.97 . . . . 0.0 108.564 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' PRO . 34.3 tt0 -68.15 133.74 91.59 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLN . 86.2 Cg_exo -37.34 112.71 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.99 1.793 . . . . 0.0 111.769 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.462 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 2.4 p -117.06 130.56 56.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.218 -0.926 . . . . 0.0 110.201 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' B' ' 287' ' ' SER . 0.4 OUTLIER -80.88 -56.36 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 317' ' ' SER . . . -57.87 -40.21 92.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.65 -36.62 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.164 . . . . 0.0 109.437 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.16 95.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.489 ' HB2' HD11 ' B' ' 320' ' ' ILE . 67.5 t80 -66.89 -47.53 71.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.679 -0.895 . . . . 0.0 109.709 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.37 -34.77 75.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.493 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.32 -42.46 75.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 108.478 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.07 -36.44 80.7 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' NH1' ' CG1' ' B' ' 298' ' ' VAL . 20.0 tpt180 -64.97 -45.46 85.61 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -68.8 -37.8 79.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.482 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.8 OUTLIER -51.46 -43.36 30.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -68.72 -44.99 72.72 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.09 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.587 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -129.19 -38.88 1.57 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.096 -1.002 . . . . 0.0 110.386 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -70.65 97.46 0.63 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.39 -69.65 0.55 Allowed Pre-proline 0 C--N 1.288 -2.08 0 O-C-N 121.762 -0.846 . . . . 0.0 111.446 -176.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 24.0 Cg_endo -63.41 111.36 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.88 1.72 . . . . 0.0 111.348 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 101' ' ' GLY . 46.5 mt -135.88 101.94 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.157 -0.965 . . . . 0.0 111.088 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.24 118.21 30.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -111.42 138.24 48.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.991 -1.068 . . . . 0.0 108.352 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mt -118.15 146.28 44.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.15 -0.969 . . . . 0.0 110.926 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -149.95 142.06 24.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.091 -1.005 . . . . 0.0 108.827 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.645 HH11 ' NE2' ' A' ' 111' ' ' GLN . 10.7 mtm180 -119.59 150.34 49.87 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.291 -0.88 . . . . 0.0 110.924 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 113' ' ' GLY . 46.0 Cg_endo -69.82 -15.64 36.96 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.643 2.229 . . . . 0.0 112.4 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.645 ' NE2' HH11 ' A' ' 109' ' ' ARG . 4.7 pt20 -67.09 -37.24 83.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -0.971 . . . . 0.0 110.151 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.475 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 31.0 m -142.51 -6.03 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 109' ' ' ARG . . . -111.19 99.69 1.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 106.74 -2.544 . . . . 0.0 106.74 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -98.26 -59.38 1.76 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.664 -0.903 . . . . 0.0 108.608 -177.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.503 HG21 ' O ' ' B' ' 256' ' ' GLU . 78.1 t -132.07 109.38 15.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.812 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -54.49 146.55 15.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' B' ' 289' ' ' GLY . 0.6 OUTLIER -43.3 146.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 0.0 109.398 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.0 81.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 77.6 mmm -64.8 -37.59 88.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 292' ' ' TYR . 48.4 mm -65.25 -47.12 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.992 . . . . 0.0 109.31 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -62.99 -40.8 98.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.04 -37.48 95.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.84 -47.38 71.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -0.3 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.415 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 128' ' ' ARG . 54.9 t0 -76.74 -35.24 57.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 108.58 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.8 -22.29 6.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -101.26 -46.26 5.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.066 -1.256 . . . . 0.0 109.869 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 125' ' ' ASP . 34.2 ptt-85 -121.11 -43.3 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.492 -0.755 . . . . 0.0 109.32 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 7.0 t80 -97.29 130.03 44.52 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.701 ' NE2' ' HE1' ' A' ' 132' ' ' TRP . 3.6 tt0 -155.67 161.68 40.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.712 -1.242 . . . . 0.0 111.376 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.79 105.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.701 ' HE1' ' NE2' ' A' ' 130' ' ' GLN . 15.9 m0 -101.79 143.14 32.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 134' ' ' TYR . 61.0 t0 -93.34 155.32 17.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.101 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.596 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 6.3 p90 -169.88 -166.54 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.091 -1.006 . . . . 0.0 110.342 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -169.91 160.51 8.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 136' ' ' GLU . 18.9 mt-10 -59.46 28.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.09 -2.07 3.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -156.13 12.25 0.29 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.013 -1.286 . . . . 0.0 110.102 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 140' ' ' GLU . 7.5 p -52.03 -42.93 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 108.631 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 139' ' ' VAL . 36.7 mt-10 -57.47 -37.09 72.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.107 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.4 m -66.67 -44.28 82.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.9 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.4 tpp -52.44 -49.51 64.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 89.8 mt -71.36 -29.31 64.81 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.428 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 36.4 t0 -67.25 -38.97 86.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 109.881 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -73.35 -50.2 23.29 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.84 -1.163 . . . . 0.0 108.801 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.5 t80 -56.67 -47.12 80.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.339 -0.851 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.7 m-85 -78.41 -30.57 47.81 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.512 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 44.8 mt-10 -58.53 -25.47 62.48 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -71.99 -16.7 62.08 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.768 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -177.85 105.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 0.0 111.114 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.6 OUTLIER 175.82 -54.78 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.326 -0.858 . . . . 0.0 109.642 177.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 20.1 Cg_endo . . . . . 0 C--N 1.309 -1.543 0 C-N-CA 122.093 1.862 . . . . 0.0 111.513 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.4 -155.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.487 2.124 . . . . 0.0 110.893 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.46 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 27.9 p -99.52 178.04 4.98 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.585 ' OG ' HD21 ' B' ' 242' ' ' LEU . 3.0 t -116.22 152.83 32.99 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.41 132.64 57.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.562 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CZ ' ' OE2' ' B' ' 244' ' ' GLU . 39.3 t80 -96.35 146.43 24.75 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.681 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.0 t80 -109.89 132.6 54.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.07 -1.019 . . . . 0.0 111.614 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.29 102.51 5.38 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -136.22 177.67 19.39 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.39 123.22 23.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.834 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' B' ' 246' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.501 ' HG3' ' H ' ' B' ' 225' ' ' GLN . 12.4 ptm180 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.932 0.873 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -55.82 -39.1 70.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 88.2 m-20 -60.45 -33.39 72.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.501 ' H ' ' HG3' ' B' ' 222' ' ' ARG . 0.8 OUTLIER -63.03 -46.93 85.22 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.07 -50.27 69.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.45 -35.58 70.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.756 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.902 ' O ' HG23 ' B' ' 232' ' ' VAL . 18.5 m-30 -67.44 -47.42 70.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.326 -0.859 . . . . 0.0 109.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.28 -37.84 75.82 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.593 -1.317 . . . . 0.0 108.886 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.403 ' HE ' ' NH2' ' B' ' 234' ' ' ARG . 39.2 ttt85 -68.83 -57.03 6.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.849 -1.157 . . . . 0.0 108.648 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.3 mt -50.94 -45.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.902 HG23 ' O ' ' B' ' 228' ' ' TYR . 87.1 t -59.92 -30.33 45.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 7.2 t -66.15 -40.16 90.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.075 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.403 ' NH2' ' HE ' ' B' ' 230' ' ' ARG . 81.4 mtt-85 -63.45 -41.87 98.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.822 -1.174 . . . . 0.0 107.929 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' B' ' 232' ' ' VAL . 52.9 mt -61.23 -42.92 99.44 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -56.95 -26.08 59.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -85.37 -29.55 24.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.969 . . . . 0.0 110.079 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.506 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.2 m-85 -84.34 -58.7 2.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.215 -0.928 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 210' ' ' CYS . . . -132.94 -164.87 11.02 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' B' ' 211' ' ' SER . 33.1 mtmt -89.58 124.14 34.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.191 -1.181 . . . . 0.0 109.015 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.443 HG11 ' CG1' ' B' ' 232' ' ' VAL . 38.6 t -80.49 104.22 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' B' ' 211' ' ' SER . 80.7 mt -52.22 141.98 17.75 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.833 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.568 ' OG1' ' CE3' ' B' ' 272' ' ' TRP . 17.3 p -37.38 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.502 0.668 . . . . 0.0 110.234 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.544 ' OE2' ' CZ ' ' B' ' 213' ' ' TYR . 19.1 mm-40 -122.99 110.68 15.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' B' ' 249' ' ' ALA . 4.9 p80 -56.59 -15.58 4.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' B' ' 218' ' ' ILE . 62.5 t -41.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.239 -0.913 . . . . 0.0 110.695 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -48.72 -33.29 9.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.934 -1.104 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.883 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.5 t70 -96.53 22.96 7.32 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' B' ' 245' ' ' HIS . . . -109.47 35.68 3.22 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.518 ' HG3' HD13 ' B' ' 251' ' ' LEU . 1.9 pt-20 -129.27 -20.09 3.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.89 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -62.72 -103.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' B' ' 254' ' ' LEU . 0.0 OUTLIER -56.1 164.39 1.85 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.85 36.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.525 2.15 . . . . 0.0 112.895 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.645 HD12 ' N ' ' B' ' 254' ' ' LEU . 6.6 mp 51.28 -155.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.018 -1.051 . . . . 0.0 109.548 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . -127.35 -36.53 0.49 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' B' ' 256' ' ' GLU . 36.5 mp0 -46.44 -20.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -1.033 . . . . 0.0 109.211 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 255' ' ' GLY . 24.4 pt-20 -133.2 4.39 3.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 108.925 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 254' ' ' LEU . . . -145.97 -173.49 4.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -90.95 151.5 21.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.15 -9.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.45 74.62 1.21 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -36.91 62.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.36 -1.082 . . . . 0.0 108.321 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . 0.636 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 17.0 mp0 -62.5 -47.18 85.1 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -53.6 -36.03 61.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -67.55 -52.87 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.486 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 4.6 t-80 -64.03 -46.26 85.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.454 -0.779 . . . . 0.0 110.654 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -53.74 -55.08 29.4 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.84 -1.162 . . . . 0.0 109.676 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' TRP . 99.5 mt-30 -72.21 -40.36 67.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.503 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 25.5 m-20 -64.79 -52.95 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.03 -1.044 . . . . 0.0 111.174 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.87 78.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 111.138 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.5 -54.01 34.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.671 -1.268 . . . . 0.0 110.147 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -62.42 -42.38 99.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.037 -1.039 . . . . 0.0 108.935 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.473 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 1.9 tt -53.62 -36.49 62.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -75.34 -26.25 58.43 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.372 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.492 ' CD ' ' CD1' ' B' ' 272' ' ' TRP . 0.0 OUTLIER -98.02 5.82 48.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.175 . . . . 0.0 109.095 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -65.17 129.47 39.84 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.759 0.79 . . . . 0.0 112.555 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' B' ' 211' ' ' SER . 64.1 t0 -75.14 -35.86 61.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.59 HG12 ' N ' ' B' ' 279' ' ' VAL . 46.6 t -134.4 167.94 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.59 ' N ' HG12 ' B' ' 278' ' ' VAL . 61.8 t -150.37 140.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.026 . . . . 0.0 111.06 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.06 143.6 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.08 156.16 38.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.046 -1.034 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' B' ' 334' ' ' TYR . 47.4 tt0 -123.15 125.04 44.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' B' ' 316' ' ' LEU . 0.1 OUTLIER -120.5 22.69 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.519 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.441 HG23 ' H ' ' B' ' 309' ' ' ARG . 87.5 m -45.25 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.184 -0.948 . . . . 0.0 108.54 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' B' ' 286' ' ' PRO . 33.4 tt0 -68.0 133.92 91.88 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 285' ' ' GLN . 87.9 Cg_exo -37.36 112.57 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.084 1.856 . . . . 0.0 111.842 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 2.6 p -116.91 130.52 56.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.74 -56.14 4.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . 0.556 ' N ' ' OG ' ' A' ' 117' ' ' SER . . . -58.0 -40.27 93.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.61 -36.67 78.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.322 -1.104 . . . . 0.0 109.497 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.2 95.48 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.502 ' HB2' HD11 ' A' ' 120' ' ' ILE . 67.8 t80 -67.05 -47.25 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.623 -0.928 . . . . 0.0 109.84 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.91 -34.77 76.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 294' ' ' LEU . 72.5 mt -69.29 -42.44 75.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.965 . . . . 0.0 108.578 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.24 -36.09 78.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.418 ' NH1' ' CG1' ' A' ' 98' ' ' VAL . 20.0 tpt180 -64.93 -45.59 85.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.272 -1.134 . . . . 0.0 109.517 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -68.67 -37.89 79.95 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.466 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.455 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.8 OUTLIER -51.61 -43.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -68.6 -45.1 72.87 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.177 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.596 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -129.35 -38.21 1.58 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.135 -0.978 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -71.18 97.26 0.66 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.596 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -65.26 -69.77 0.54 Allowed Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.826 -0.808 . . . . 0.0 111.43 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 24.0 Cg_endo -63.44 111.02 1.35 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.878 1.719 . . . . 0.0 111.534 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.439 HD11 ' O ' ' B' ' 301' ' ' GLY . 45.5 mt -135.61 101.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 111.174 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.16 118.54 30.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -111.53 137.95 48.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 108.445 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . . . . . . . . . 9.7 mt -118.05 146.09 44.33 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -0.973 . . . . 0.0 110.862 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -149.77 142.19 24.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 108.764 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.647 HH11 ' NE2' ' B' ' 311' ' ' GLN . 10.5 mtm180 -119.47 150.53 49.98 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 110.867 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.18 -15.31 35.49 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.647 ' NE2' HH11 ' B' ' 309' ' ' ARG . 4.6 pt20 -67.34 -37.61 83.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.229 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' B' ' 311' ' ' GLN . 23.2 m -142.16 -5.82 0.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' B' ' 309' ' ' ARG . . . -111.2 100.04 1.18 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -98.41 -59.55 1.73 Allowed 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.695 -0.885 . . . . 0.0 108.614 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 56' ' ' GLU . 77.8 t -131.94 109.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.765 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.632 HD11 ' HB ' ' B' ' 283' ' ' VAL . 0.1 OUTLIER -54.55 146.27 16.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 89' ' ' GLY . 0.6 OUTLIER -43.08 146.17 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.98 -1.075 . . . . 0.0 109.431 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.24 80.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 0.0 110.534 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.63 -37.69 88.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 92' ' ' TYR . 47.5 mm -64.94 -47.23 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.303 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 0.1 OUTLIER -63.13 -40.6 98.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -63.08 -37.47 94.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.594 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.89 -47.83 70.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.594 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 0.32 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.521 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.533 ' OD2' ' NH1' ' B' ' 328' ' ' ARG . 53.7 t0 -76.34 -35.25 58.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.889 -1.132 . . . . 0.0 108.565 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 82.81 -22.26 6.86 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 30.0 t -101.36 -45.92 5.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.984 -1.303 . . . . 0.0 109.874 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.533 ' NH1' ' OD2' ' B' ' 325' ' ' ASP . 34.2 ptt-85 -121.45 -43.44 2.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 329' ' ' PHE . 6.9 t80 -97.15 130.1 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.694 ' NE2' ' HE1' ' B' ' 332' ' ' TRP . 3.6 tt0 -155.67 161.71 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.513 -1.275 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.75 105.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.694 ' HE1' ' NE2' ' B' ' 330' ' ' GLN . 15.7 m0 -101.72 143.1 32.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' B' ' 334' ' ' TYR . 59.7 t0 -93.18 155.36 17.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 109.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.582 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 6.3 p90 -169.7 -166.31 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -170.26 160.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -59.39 28.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -134.97 -2.44 3.08 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -155.87 12.1 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -1.196 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.51 HG13 ' N ' ' B' ' 340' ' ' GLU . 8.1 p -51.9 -42.9 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 108.548 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.51 ' N ' HG13 ' B' ' 339' ' ' VAL . 40.0 mt-10 -57.64 -36.97 72.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.558 -0.714 . . . . 0.0 109.123 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 57.0 m -66.69 -44.16 82.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.867 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -52.74 -49.54 65.23 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 88.8 mt -71.2 -29.34 65.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.491 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 37.6 t0 -67.2 -39.05 86.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.067 -1.02 . . . . 0.0 109.937 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -73.11 -50.36 23.24 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.89 -1.131 . . . . 0.0 108.834 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . 0.481 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.8 t80 -56.36 -47.31 79.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' B' ' 351' ' ' LEU . 12.7 m-85 -78.05 -30.76 50.0 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.591 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 45.3 mt-10 -58.5 -25.71 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -71.62 -17.11 62.29 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.772 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -177.69 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.073 -1.017 . . . . 0.0 111.162 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.7 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 176.14 -55.28 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 20.1 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 121.861 1.708 . . . . 0.0 111.579 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.13 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.617 2.211 . . . . 0.0 111.772 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 89.8 m -100.31 177.14 5.14 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 2.6 m -119.93 121.21 38.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.026 -1.046 . . . . 0.0 108.581 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 78' ' ' VAL . 5.3 t -94.06 130.94 42.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 69' ' ' ASP . 33.2 t80 -99.85 133.39 44.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 32' ' ' VAL . 26.6 t80 -86.88 116.34 24.89 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.365 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 6.5 t -107.0 108.99 20.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.771 0.796 . . . . 0.0 109.287 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.556 ' C ' HG22 ' A' ' 90' ' ' VAL . . . -174.85 174.3 46.62 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 90' ' ' VAL . 6.7 p -113.44 160.13 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -1.074 . . . . 0.0 108.461 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.408 HG23 ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.587 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.605 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HE ' ' CD1' ' A' ' 54' ' ' LEU . 38.3 mmt-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.118 0.485 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -56.99 -38.86 73.63 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -63.67 -26.68 68.78 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.59 HE21 ' C ' ' A' ' 46' ' ' VAL . 20.2 tp60 -64.77 -42.68 94.92 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.71 84.37 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.96 -37.88 77.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.741 ' O ' HG23 ' A' ' 32' ' ' VAL . 21.1 m-30 -65.94 -41.81 90.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -63.14 -39.31 94.3 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 120.851 -1.156 . . . . 0.0 109.041 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.49 -55.02 9.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.951 -1.093 . . . . 0.0 108.321 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.432 HG21 ' OE2' ' A' ' 82' ' ' GLU . 20.9 mt -53.89 -45.07 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.3 t -60.15 -29.37 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.6 m -67.31 -38.56 85.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.082 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -68.51 -50.19 54.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.127 . . . . 0.0 109.043 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.601 HD22 HG11 ' A' ' 12' ' ' VAL . 25.1 mt -56.77 -40.82 76.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -61.6 -27.05 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.845 -0.535 . . . . 0.0 109.598 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -75.94 -36.81 59.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.959 -1.088 . . . . 0.0 109.542 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.519 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.8 m-85 -71.69 -48.76 45.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.52 -0.737 . . . . 0.0 110.598 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -149.35 -148.83 4.84 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -95.66 125.13 40.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.413 -1.051 . . . . 0.0 109.825 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 32' ' ' VAL . 3.2 t -83.4 101.17 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' A' ' 76' ' ' ALA . 93.8 mt -47.1 149.67 0.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.31 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 m -44.61 140.08 2.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 109.301 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' VAL . 11.0 pt-20 -161.57 134.27 6.06 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.0 t-80 -74.86 25.0 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.241 -0.912 . . . . 0.0 109.188 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.681 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 27.6 t -83.97 -85.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' C ' ' N ' ' A' ' 49' ' ' ALA . . . -68.08 178.87 1.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.814 ' O ' HD11 ' A' ' 51' ' ' LEU . 14.7 t70 48.57 20.09 0.29 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.188 . . . . 0.0 108.193 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -115.01 -9.51 12.37 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -62.85 -32.96 74.3 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 108.798 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.991 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.63 157.1 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.604 -0.685 . . . . 0.0 109.961 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 51' ' ' LEU . 17.9 mt-10 55.02 155.46 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 55.6 Cg_endo -72.19 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.493 2.129 . . . . 0.0 111.938 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD1' ' HE ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -55.55 165.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.895 -1.128 . . . . 0.0 109.628 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 150.46 32.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 22.9 mm-40 59.15 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.926 . . . . 0.0 109.447 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.7 tt0 -52.46 -28.77 21.55 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 53' ' ' PRO . . . -68.07 149.18 49.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.78 142.9 5.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.67 -58.53 0.23 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.75 80.63 0.48 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -53.47 -41.11 65.85 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.33 -1.1 . . . . 0.0 108.494 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.96 -48.89 67.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -60.08 -38.15 82.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.36 -40.22 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.436 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.4 t-80 -78.84 -51.03 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 110.55 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -50.68 -47.93 58.72 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.869 -1.144 . . . . 0.0 110.012 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.82 -49.04 27.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 0.0 110.421 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 68.6 m-20 -62.75 -51.92 65.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 0.0 110.776 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -68.22 -41.28 81.51 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 0.0 111.274 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -61.87 -54.03 47.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.597 -1.314 . . . . 0.0 109.314 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.577 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.07 -38.02 75.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.163 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.0 tp -52.6 -45.76 66.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' A' ' 96' ' ' ARG . 20.2 mt-30 -67.03 -30.32 70.37 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.483 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 5.3 mt-30 -91.24 3.53 54.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.54 -1.35 . . . . 0.0 109.349 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -64.5 141.59 58.72 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.987 0.899 . . . . 0.0 112.612 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' PRO . 65.1 t0 -98.48 -20.51 17.05 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 12' ' ' VAL . 18.4 t -144.55 144.63 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.01 137.96 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.717 -1.239 . . . . 0.0 112.382 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.13 125.41 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -112.54 144.6 41.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.34 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.432 ' OE2' HG21 ' A' ' 31' ' ' ILE . 50.2 mt-10 -108.6 121.71 45.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.71 . . . . 0.0 109.169 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 107' ' ' LEU . 1.7 m -146.77 113.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 m -130.04 -13.42 4.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -142.92 156.18 62.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -39.13 108.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.047 1.831 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.64 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 45.1 m -126.29 134.39 51.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.142 -0.974 . . . . 0.0 111.165 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.635 ' HB2' ' H ' ' B' ' 287' ' ' SER . 14.7 tp -105.68 153.11 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.59 -29.99 3.19 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 16' ' ' GLY . 47.4 t -86.01 -49.92 14.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.35 62.45 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.431 ' HB2' HD11 ' B' ' 320' ' ' ILE . 85.8 t80 -70.86 -58.14 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 85.9 mt-10 -52.16 -32.95 38.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 81' ' ' ALA . 37.8 mt -76.29 -41.15 49.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.0 -48.76 81.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 74' ' ' GLN . 45.4 ttm-85 -62.61 -38.26 89.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.341 -1.093 . . . . 0.0 108.89 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.56 -39.93 88.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -54.92 -44.31 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.791 -1.193 . . . . 0.0 108.136 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -76.01 -48.93 19.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.469 ' O ' ' CD ' ' A' ' 102' ' ' LYS . 2.8 pp -116.66 -23.08 8.33 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.831 -1.168 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -53.26 170.3 0.78 Allowed Glycine 0 C--N 1.286 -2.196 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.538 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -131.63 -75.71 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 79.8 Cg_endo -81.79 109.12 1.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.811 1.674 . . . . 0.0 109.552 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.08 126.7 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.691 -1.256 . . . . 0.0 111.579 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 132' ' ' TRP . 24.4 tp -123.0 119.39 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.73 153.05 21.12 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.71 -1.244 . . . . 0.0 108.561 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 14.7 mt -127.9 132.69 49.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.962 -1.086 . . . . 0.0 111.838 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.482 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -138.93 122.35 17.2 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 65.4 mtm180 -86.55 135.66 35.92 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 111.388 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 72.7 Cg_endo -79.32 -23.87 7.06 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.434 2.089 . . . . 0.0 110.58 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' SER . 14.6 pt20 -48.06 -38.2 16.84 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 10.7 t -95.3 -18.59 20.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.1 52.77 4.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 115' ' ' VAL . 3.6 mtp180 -87.57 6.26 35.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.289 . . . . 0.0 109.993 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 114' ' ' ARG . 21.1 t 58.08 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 117' ' ' SER . 30.6 tp -74.08 150.83 40.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.587 ' H ' HD23 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -40.49 140.03 0.71 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.311 -0.868 . . . . 0.0 110.609 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.64 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -61.07 -43.67 98.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 81.0 mmm -63.89 -44.06 94.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.17 -0.956 . . . . 0.0 109.176 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' B' ' 292' ' ' TYR . 45.1 mm -61.74 -41.79 91.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.243 -0.91 . . . . 0.0 108.768 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.81 -45.15 95.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.425 -0.797 . . . . 0.0 109.585 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -66.98 -39.11 93.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.645 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -48.41 -55.91 9.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -1.215 . . . . 0.0 108.217 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -9.87 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.432 0.634 . . . . 0.0 111.148 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -130.89 -28.16 2.01 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 80.24 -5.45 63.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.668 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 p -79.17 39.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 127' ' ' SER . 86.1 mtt-85 106.12 -25.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.903 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -89.71 114.67 26.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.1 mt-30 -137.66 137.76 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.762 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.85 103.98 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.546 ' CD2' HD11 ' A' ' 105' ' ' LEU . 15.0 m0 -104.59 143.09 33.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.074 -1.016 . . . . 0.0 109.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.474 ' O ' ' SD ' ' A' ' 142' ' ' MET . 98.7 m-20 -96.96 159.83 14.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.86 -1.15 . . . . 0.0 108.792 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 8.0 p90 -165.5 -167.06 1.06 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.652 -1.28 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.473 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -166.71 146.63 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 135' ' ' ALA . 42.6 mt-10 -41.48 -37.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.127 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.59 4.13 37.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.447 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -155.75 8.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.463 -1.61 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.3 p -53.63 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.913 -1.117 . . . . 0.0 108.539 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 20.8 pt-20 -58.86 -31.94 69.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.483 -0.761 . . . . 0.0 109.09 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.1 m -68.51 -46.01 70.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.0 tpp -51.06 -45.8 61.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.63 -34.97 70.25 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.493 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.54 -40.53 95.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 110.279 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -71.64 -50.54 29.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.894 -1.129 . . . . 0.0 108.629 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -59.61 -46.44 88.97 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.966 ' CD1' HD12 ' A' ' 151' ' ' LEU . 13.6 m-85 -70.16 -32.95 71.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.88 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.505 -1.372 . . . . 0.0 107.551 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.14 -18.05 62.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.571 -0.705 . . . . 0.0 110.661 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -152.84 3.37 0.33 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.385 -1.447 . . . . 0.0 111.598 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 147' ' ' PHE . 6.1 mt -116.25 83.84 13.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.677 -1.264 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.594 2.196 . . . . 0.0 111.688 179.275 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.39 -156.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.62 2.213 . . . . 0.0 111.719 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.527 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 92.0 m -100.09 177.08 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 2.4 m -119.97 120.86 37.58 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.625 HG13 HG12 ' B' ' 278' ' ' VAL . 5.8 t -93.86 130.95 42.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' B' ' 269' ' ' ASP . 32.7 t80 -100.01 133.32 44.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.516 ' CD2' HG22 ' B' ' 232' ' ' VAL . 26.9 t80 -86.7 116.82 25.05 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.273 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' B' ' 281' ' ' ALA . 5.6 t -107.76 109.03 20.5 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.728 0.775 . . . . 0.0 109.267 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.553 ' C ' HG22 ' B' ' 290' ' ' VAL . . . -174.75 174.54 46.69 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 290' ' ' VAL . 6.5 p -113.46 160.09 18.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -1.059 . . . . 0.0 108.362 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.415 HG23 ' NE2' ' B' ' 225' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.516 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.655 ' HE ' ' CD1' ' B' ' 254' ' ' LEU . 39.2 mmt-85 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -56.75 -38.87 73.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.68 -26.82 68.83 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.568 HE21 ' C ' ' B' ' 246' ' ' VAL . 19.9 tp60 -64.58 -42.69 95.46 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.61 84.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 tp -59.21 -38.03 78.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.745 ' O ' HG23 ' B' ' 232' ' ' VAL . 21.2 m-30 -65.86 -41.53 91.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -63.34 -39.44 94.55 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.828 -1.17 . . . . 0.0 108.992 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.22 -55.13 10.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.078 . . . . 0.0 108.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.435 HG21 ' OE2' ' B' ' 282' ' ' GLU . 20.6 mt -53.78 -45.4 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.8 t -59.91 -29.14 42.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 5.9 m -67.43 -38.33 84.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.81 -50.13 52.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.893 -1.129 . . . . 0.0 108.932 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.605 HD22 HG11 ' B' ' 212' ' ' VAL . 24.9 mt -56.71 -40.75 76.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -61.6 -27.02 68.35 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -76.07 -36.57 58.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.882 -1.136 . . . . 0.0 109.473 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.525 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.8 m-85 -72.14 -48.79 41.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.536 -0.727 . . . . 0.0 110.646 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -149.15 -149.1 4.89 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.7 125.33 40.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 109.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.441 HG11 HG13 ' B' ' 232' ' ' VAL . 3.2 t -83.22 101.27 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' B' ' 276' ' ' ALA . 94.3 mt -47.28 149.59 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.256 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 3.5 m -44.59 140.08 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 109.303 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' B' ' 246' ' ' VAL . 11.2 pt-20 -161.54 134.6 6.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.339 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 34.4 t-80 -74.86 24.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.935 . . . . 0.0 109.222 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.67 ' O ' ' HB3' ' B' ' 249' ' ' ALA . 27.7 t -83.42 -85.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' B' ' 249' ' ' ALA . . . -67.97 178.86 1.64 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.833 ' O ' HD11 ' B' ' 251' ' ' LEU . 15.5 t70 48.89 19.5 0.27 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.75 -1.218 . . . . 0.0 108.226 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -114.27 -9.89 12.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -62.2 -33.23 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.98 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -57.75 157.37 7.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.525 -0.734 . . . . 0.0 109.915 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' B' ' 251' ' ' LEU . 18.3 mt-10 54.7 155.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.619 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' B' ' 258' ' ' ALA . 55.9 Cg_endo -72.09 68.12 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.506 2.138 . . . . 0.0 111.937 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.655 ' CD1' ' HE ' ' B' ' 222' ' ' ARG . 0.2 OUTLIER -55.35 165.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.992 . . . . 0.0 109.643 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 149.83 32.78 0.05 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.64 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 23.8 mm-40 58.9 -74.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.9 tt0 -52.51 -27.94 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' B' ' 253' ' ' PRO . . . -68.88 149.17 49.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.356 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -48.68 141.96 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 167.43 -58.24 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.44 80.64 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -53.49 -40.85 65.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -1.108 . . . . 0.0 108.525 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.22 -48.96 66.28 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 108.775 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.95 -38.34 82.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.29 -39.94 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.3 t-80 -79.16 -51.37 9.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.572 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -50.21 -47.9 54.56 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.87 -1.144 . . . . 0.0 109.879 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -74.11 -48.42 29.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.547 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 69.1 m-20 -63.27 -51.45 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.71 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.472 HD11 ' NE ' ' B' ' 296' ' ' ARG . 0.6 OUTLIER -68.76 -40.96 79.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.887 -1.133 . . . . 0.0 111.277 -178.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.4 t-20 -62.19 -53.77 50.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.654 -1.279 . . . . 0.0 109.305 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.567 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -58.04 -38.18 75.77 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.088 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.455 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.1 tp -52.63 -45.65 66.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.554 ' OE1' ' NH1' ' B' ' 296' ' ' ARG . 20.5 mt-30 -67.12 -30.37 70.36 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 5.3 mt-30 -91.28 3.54 54.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.625 -1.297 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . 0.582 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -64.79 141.07 58.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.0 112.527 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' B' ' 303' ' ' PRO . 65.3 t0 -97.84 -20.43 17.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.625 HG12 HG13 ' B' ' 212' ' ' VAL . 18.7 t -144.65 144.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 22.6 t -143.5 137.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.544 -1.347 . . . . 0.0 112.527 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.86 125.88 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.55 ' CB ' HD21 ' B' ' 294' ' ' LEU . . . -112.97 144.98 41.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.195 -0.94 . . . . 0.0 110.274 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.435 ' OE2' HG21 ' B' ' 231' ' ' ILE . 48.9 mt-10 -108.83 121.65 45.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.535 -0.728 . . . . 0.0 109.179 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 1.7 m -146.74 113.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 18.9 m -130.22 -13.6 3.94 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -142.79 156.26 62.7 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -39.07 108.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.259 1.973 . . . . 0.0 111.691 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.635 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 45.6 m -125.9 134.35 51.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.099 -1.001 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.64 ' HB2' ' H ' ' A' ' 87' ' ' SER . 15.0 tp -105.32 153.51 21.53 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 81.97 -29.74 3.03 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.569 ' H ' ' C ' ' B' ' 288' ' ' LEU . 46.6 t -86.39 -49.54 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.67 -28.55 62.93 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 106.946 -2.461 . . . . 0.0 106.946 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' A' ' 120' ' ' ILE . 86.1 t80 -70.99 -57.95 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.936 -0.743 . . . . 0.0 109.088 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.403 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . 86.5 mt-10 -52.2 -33.2 39.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' B' ' 281' ' ' ALA . 36.7 mt -76.26 -41.13 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.74 -48.63 82.95 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.554 ' NH1' ' OE1' ' B' ' 274' ' ' GLN . 45.4 ttm-85 -62.97 -38.16 90.0 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.371 -1.076 . . . . 0.0 108.987 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.6 -39.68 88.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.486 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -54.92 -44.32 72.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 120.82 -1.175 . . . . 0.0 108.216 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.98 -49.28 18.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.46 ' O ' ' CD ' ' B' ' 302' ' ' LYS . 2.8 pp -116.36 -23.56 8.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.949 -1.094 . . . . 0.0 110.403 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -52.92 170.38 0.64 Allowed Glycine 0 C--N 1.288 -2.128 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.543 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 0.4 OUTLIER -131.46 -75.67 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 66.5 Cg_endo -81.73 109.49 2.02 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.819 1.679 . . . . 0.0 109.623 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 55.4 mt -130.47 126.79 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.688 -1.258 . . . . 0.0 111.514 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 332' ' ' TRP . 24.1 tp -123.06 119.29 29.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.45 153.08 20.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.642 -1.286 . . . . 0.0 108.511 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 14.7 mt -127.69 132.5 49.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.996 -1.065 . . . . 0.0 111.865 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -138.79 122.51 17.54 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 68.3 mtm180 -86.93 135.61 35.12 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.985 -1.072 . . . . 0.0 111.421 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' B' ' 313' ' ' GLY . 72.8 Cg_endo -79.36 -24.29 6.64 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.508 2.139 . . . . 0.0 110.425 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' B' ' 312' ' ' SER . 14.6 pt20 -47.9 -38.28 16.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 9.9 t -95.23 -18.78 20.58 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 40.8 53.1 3.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' B' ' 315' ' ' VAL . 3.6 mtp180 -87.73 6.44 34.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.923 -1.339 . . . . 0.0 109.98 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' B' ' 314' ' ' ARG . 24.1 t 58.25 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.841 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 316' ' ' LEU . 30.0 tp -74.19 151.21 40.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.594 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -40.59 139.84 0.75 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 110.596 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . 0.612 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -60.81 -43.61 97.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.468 -0.77 . . . . 0.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 81.0 mmm -64.31 -43.9 93.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 92' ' ' TYR . 45.7 mm -61.57 -41.6 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.102 -0.999 . . . . 0.0 108.756 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.09 -45.03 95.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.435 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -67.01 -39.0 93.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.636 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -48.45 -55.96 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.065 -1.256 . . . . 0.0 108.288 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.636 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -9.99 118.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.344 0.592 . . . . 0.0 111.16 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -131.43 -27.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 79.95 -5.18 63.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 54.7 p -79.34 39.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.66 ' HB2' ' O ' ' B' ' 327' ' ' SER . 84.8 mtt-85 106.22 -25.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.969 -1.469 . . . . 0.0 107.831 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -89.66 114.3 25.9 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.473 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 81.0 mt-30 -137.14 137.85 39.65 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.748 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.94 104.15 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.551 ' CD2' HD11 ' B' ' 305' ' ' LEU . 14.7 m0 -104.88 142.81 34.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.189 -0.945 . . . . 0.0 109.824 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.476 ' O ' ' SD ' ' B' ' 342' ' ' MET . 97.9 m-20 -97.06 159.97 14.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.828 -1.17 . . . . 0.0 108.807 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 8.1 p90 -165.4 -167.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.705 -1.247 . . . . 0.0 111.64 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.467 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -166.39 146.51 6.08 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.7 mt-10 -41.33 -37.24 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.801 -1.187 . . . . 0.0 110.058 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -74.75 4.89 34.01 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.389 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.21 8.79 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.461 -1.611 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.3 p -53.51 -44.75 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.92 -1.113 . . . . 0.0 108.468 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 20.2 pt-20 -58.64 -31.88 68.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.428 -0.795 . . . . 0.0 109.202 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 62.2 m -68.76 -45.91 70.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.0 tpp -51.38 -45.67 62.53 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.6 mt -71.53 -35.19 70.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.2 -40.57 96.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -72.02 -50.1 31.38 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.933 -1.104 . . . . 0.0 108.717 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -59.99 -46.39 89.6 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.1 -1.0 . . . . 0.0 110.153 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' B' ' 351' ' ' LEU . 13.6 m-85 -70.03 -33.03 71.46 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.903 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -67.08 -22.9 65.82 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.493 -1.379 . . . . 0.0 107.589 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.05 -17.82 62.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.512 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.9 OUTLIER -153.02 3.11 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.494 -1.379 . . . . 0.0 111.689 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.977 HD12 ' CD1' ' B' ' 347' ' ' PHE . 6.2 mt -116.05 83.87 12.89 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.662 -1.274 . . . . 0.0 109.69 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 C--N 1.309 -1.547 0 C-N-CA 122.651 2.234 . . . . 0.0 111.75 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.539 ' HB1' ' HD2' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 89.5 Cg_endo -80.71 -154.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 111.406 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.489 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 30.3 p -102.41 -178.19 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 2.7 p -119.88 150.62 40.18 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.8 t -125.41 131.96 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CB ' HG22 ' A' ' 79' ' ' VAL . 26.5 t80 -99.09 94.88 6.75 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.501 ' N ' ' OG1' ' A' ' 43' ' ' THR . 63.2 t80 -88.01 128.77 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 111.213 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 m -118.39 157.8 26.49 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.248 -0.907 . . . . 0.0 109.765 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' C ' ' CG2' ' A' ' 90' ' ' VAL . . . -168.93 173.8 43.47 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' NE2' ' A' ' 85' ' ' GLN . 19.2 t -81.6 132.25 35.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -1.124 . . . . 0.0 109.689 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.153 -0.967 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.621 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 65.9 mtt180 . . . . . 0 N--CA 1.503 2.197 0 CA-C-O 121.716 0.769 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -52.55 -26.87 14.47 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 66.1 m-20 -69.71 -36.05 75.59 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -59.8 -43.59 94.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.93 72.49 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.4 -28.95 68.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 12.7 m-30 -69.43 -49.39 55.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.552 -0.717 . . . . 0.0 110.088 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.25 77.12 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.544 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -71.74 -55.45 7.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.864 -1.147 . . . . 0.0 108.393 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.409 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 5.5 mt -54.04 -47.36 65.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.552 HG13 HG11 ' A' ' 41' ' ' VAL . 40.4 t -60.85 -28.77 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.72 -0.613 . . . . 0.0 109.363 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -69.31 -37.2 77.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.553 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -70.46 -47.41 60.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.831 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.26 -41.54 97.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -61.02 -26.12 67.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -78.66 -35.15 45.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.573 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.8 m-85 -74.68 -51.77 13.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.47 -0.769 . . . . 0.0 109.809 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -142.54 -152.85 5.76 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -98.07 130.9 44.85 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.218 -1.166 . . . . 0.0 109.018 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG11 HG13 ' A' ' 32' ' ' VAL . 2.2 t -89.46 111.22 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.1 mt -79.8 -29.09 40.22 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.569 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 14' ' ' PHE . 12.5 p -82.96 23.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . 85.9 tt0 -44.08 -31.47 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -54.91 -35.96 64.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.875 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 45' ' ' HIS . 56.1 t -50.43 -66.75 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.916 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -62.94 -38.97 93.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -61.58 -0.58 0.44 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -60.57 -40.16 90.67 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.246 -0.909 . . . . 0.0 108.678 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.06 -23.73 1.3 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -66.3 123.15 19.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 109.403 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 51' ' ' LEU . 3.6 mt-10 54.02 162.79 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.798 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ALA . 84.2 Cg_exo -42.71 136.51 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.816 1.677 . . . . 0.0 111.065 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.806 ' N ' HD12 ' A' ' 54' ' ' LEU . 4.3 mp -81.9 -103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 108.694 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.725 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 38.52 112.98 0.0 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.791 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 15.8 mm-40 -37.74 -48.91 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -1.217 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -74.95 -31.58 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 0.0 108.858 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -83.39 46.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.03 -165.0 1.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.12 69.21 0.21 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 75.36 1.08 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 30.3 p-10 -52.44 -38.76 59.98 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 6.6 tt0 -63.26 -48.57 77.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -57.15 -36.73 71.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.17 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -64.1 -38.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -77.27 -58.25 3.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 110.45 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 96.2 mt-10 -45.13 -46.14 11.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.894 -1.129 . . . . 0.0 109.853 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.06 -42.47 76.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 109.716 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 86.0 m-20 -66.59 -36.06 81.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.607 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.3 mm? -69.77 -52.05 28.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -57.21 -40.57 77.74 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.539 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -67.22 -44.74 78.77 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.572 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 14.2 tp -51.97 -35.74 47.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.1 -33.2 67.67 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.858 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 72' ' ' TRP . 43.0 mt-30 -84.04 -1.23 54.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.188 -0.945 . . . . 0.0 109.216 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.05 136.65 50.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.062 0.934 . . . . 0.0 112.486 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 47.6 m-20 -99.71 -30.44 12.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 58.1 t -137.1 144.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG22 ' CB ' ' A' ' 13' ' ' TYR . 80.6 t -132.99 140.14 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.787 -1.196 . . . . 0.0 111.205 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.63 121.64 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -113.34 121.91 45.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.814 -1.178 . . . . 0.0 110.28 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 54.8 tt0 -86.1 112.95 21.76 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.794 HG11 HD11 ' A' ' 116' ' ' LEU . 1.8 t -86.65 -99.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 110.383 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 85' ' ' GLN . 6.5 m 59.48 -96.87 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.203 -1.561 . . . . 0.0 109.032 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.621 HE22 ' CZ ' ' A' ' 22' ' ' ARG . 28.7 tt0 -61.39 133.34 93.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.914 -1.116 . . . . 0.0 108.589 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.465 ' HD3' ' HE ' ' A' ' 114' ' ' ARG . 32.3 Cg_endo -66.62 115.59 3.64 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.975 1.784 . . . . 0.0 111.869 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.405 ' OG ' HG23 ' A' ' 90' ' ' VAL . 12.8 t -138.45 129.73 27.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.849 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' CG1' ' B' ' 283' ' ' VAL . 8.9 mt -69.05 -40.25 78.66 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 108.932 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.19 95.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 16' ' ' GLY . 44.6 t -66.13 -47.29 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.451 -1.029 . . . . 0.0 108.832 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.96 74.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -68.89 -47.61 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.507 -0.996 . . . . 0.0 109.698 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.48 -35.22 78.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.551 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.3 mt -69.09 -46.73 67.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 108.616 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.4 -33.95 87.97 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.496 HH21 ' HB2' ' B' ' 299' ' ' ALA . 0.3 OUTLIER -64.18 -43.99 93.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.49 -1.006 . . . . 0.0 109.706 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -71.14 -29.1 64.8 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.602 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -53.61 -50.42 50.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.305 -1.497 . . . . 0.0 106.994 178.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' N ' HG12 ' A' ' 98' ' ' VAL . . . -85.43 -55.64 3.91 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.452 0.644 . . . . 0.0 110.681 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 100' ' ' LEU . 1.2 tt -61.97 -16.81 54.11 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.503 1.144 . . . . 0.0 108.004 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 102' ' ' LYS . . . 75.81 -163.17 53.35 Favored Glycine 0 C--N 1.281 -2.511 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 7.6 mmtm 96.85 136.24 0.03 OUTLIER Pre-proline 0 C--N 1.285 -2.215 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -36.41 111.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.218 1.945 . . . . 0.0 111.429 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.499 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.5 mt -105.36 87.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.248 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.7 tp -91.42 116.7 29.06 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.514 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -108.0 139.81 42.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 108.536 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.5 mt -123.31 138.6 54.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -140.4 138.9 35.12 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -92.06 135.27 27.36 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 0.0 110.906 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.04 -32.86 2.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.514 2.143 . . . . 0.0 111.094 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.02 -33.52 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 113' ' ' GLY . 36.4 p -97.11 -21.41 17.36 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 39.74 44.84 2.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.465 ' HE ' ' HD3' ' A' ' 86' ' ' PRO . 14.8 mtp85 -70.62 8.43 0.85 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.202 -1.175 . . . . 0.0 109.323 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 113' ' ' GLY . 94.5 t 53.92 102.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.428 -0.795 . . . . 0.0 110.419 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.794 HD11 HG11 ' A' ' 83' ' ' VAL . 13.4 tp -57.05 139.52 52.03 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.1 144.63 1.22 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.476 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.798 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -59.83 -37.11 78.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.484 -0.76 . . . . 0.0 109.913 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 119' ' ' MET . 26.7 mmm -68.58 -45.69 71.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.315 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.5 -47.37 89.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.79 -44.21 77.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.401 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.27 -26.53 69.48 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -56.44 -51.96 66.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.261 . . . . 0.0 107.743 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 8.97 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.6 t0 -67.86 -35.4 78.49 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.692 -1.255 . . . . 0.0 107.921 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.887 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.77 176.54 45.73 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 56.05 -26.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.488 1.137 . . . . 0.0 108.79 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.887 ' H ' ' C ' ' A' ' 126' ' ' GLY . 7.2 tpp85 -149.95 -3.63 0.38 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.415 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 6.3 t80 -152.73 112.31 3.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.868 -1.145 . . . . 0.0 108.013 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.548 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 86.8 mt-30 -138.62 132.27 30.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -86.7 103.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.548 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 14.2 m0 -98.11 139.73 33.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.288 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' O ' ' CE ' ' A' ' 142' ' ' MET . 74.2 m-20 -94.18 141.92 28.0 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.954 -1.091 . . . . 0.0 109.046 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 139' ' ' VAL . 3.6 p90 -157.51 -173.63 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.035 -1.04 . . . . 0.0 111.034 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -158.87 157.75 32.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.5 30.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.447 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -135.78 -1.33 3.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.666 ' O ' ' SD ' ' A' ' 142' ' ' MET . 23.2 pt-20 -154.26 10.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.122 -1.222 . . . . 0.0 110.027 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.7 p -50.86 -41.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.045 -1.034 . . . . 0.0 108.865 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.447 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.0 tt0 -61.66 -29.18 69.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 108.771 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' GLU . 16.9 m -71.31 -48.36 51.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 110.367 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -55.76 -47.16 77.49 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.42 -29.83 70.79 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.128 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.479 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 43.2 t0 -69.09 -39.08 79.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 110.0 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -70.54 -51.76 26.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.69 -1.256 . . . . 0.0 108.814 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.7 t80 -57.92 -47.33 83.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.08 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.0 m-85 -74.34 -32.82 62.94 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.123 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 12.2 mm-40 -58.54 -26.48 63.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -70.21 -22.15 62.95 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.82 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -172.75 101.48 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.7 OUTLIER 175.23 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 151' ' ' LEU . 86.9 Cg_endo . . . . . 0 C--N 1.31 -1.492 0 C-N-CA 122.913 2.409 . . . . 0.0 111.456 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' B' ' 208' ' ' ALA . 90.1 Cg_endo -80.69 -154.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.065 2.51 . . . . 0.0 111.459 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.493 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 30.3 p -102.65 -178.16 3.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 2.8 p -119.77 151.12 39.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 3.6 t -125.86 131.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.667 ' CB ' HG22 ' B' ' 279' ' ' VAL . 26.0 t80 -98.98 94.46 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.506 ' O ' ' CB ' ' B' ' 243' ' ' THR . 62.4 t80 -87.84 129.3 35.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 0.0 111.117 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -119.24 157.99 26.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.402 -0.812 . . . . 0.0 109.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CG2' ' B' ' 290' ' ' VAL . . . -169.12 174.29 43.6 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.52 ' OG ' ' NE2' ' B' ' 285' ' ' GLN . 17.7 t -81.73 132.12 35.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -1.115 . . . . 0.0 109.8 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.452 ' N ' ' NH1' ' B' ' 222' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.201 -0.937 . . . . 0.0 110.101 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.617 ' CZ ' HE22 ' B' ' 285' ' ' GLN . 65.9 mtt180 . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 121.666 0.746 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -52.75 -26.28 13.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 63.7 m-20 -70.58 -35.79 73.24 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 222' ' ' ARG . 0.4 OUTLIER -59.9 -43.34 94.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.03 71.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.34 -28.81 68.46 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' B' ' 224' ' ' ASP . 12.8 m-30 -69.55 -49.18 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 110.167 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.28 77.36 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.477 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -71.4 -55.41 8.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.138 . . . . 0.0 108.356 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.43 ' CD1' ' OE1' ' B' ' 282' ' ' GLU . 5.8 mt -54.24 -47.51 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.536 HG13 HG11 ' B' ' 241' ' ' VAL . 40.1 t -60.73 -28.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 28.4 p -69.44 -37.31 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.541 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -70.08 -47.61 61.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.131 . . . . 0.0 108.919 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.24 -41.61 97.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.8 -26.27 67.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -78.51 -35.47 46.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.045 -1.034 . . . . 0.0 109.371 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.566 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -74.3 -51.65 14.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -142.45 -152.51 5.7 Favored Glycine 0 N--CA 1.478 1.443 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -98.18 130.97 44.92 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.253 -1.145 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.536 HG11 HG13 ' B' ' 232' ' ' VAL . 2.2 t -89.67 110.79 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.526 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 16.9 mt -79.37 -29.2 42.05 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.673 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' B' ' 214' ' ' PHE . 13.6 p -83.0 24.19 0.78 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.521 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 243' ' ' THR . 85.9 tt0 -44.36 -31.19 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.539 ' CD2' ' OD2' ' B' ' 269' ' ' ASP . 0.1 OUTLIER -54.96 -36.05 64.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.845 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' B' ' 245' ' ' HIS . 55.8 t -50.32 -66.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -63.11 -39.16 93.89 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -61.41 -0.31 0.37 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -60.58 -40.15 90.68 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.167 -0.958 . . . . 0.0 108.735 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -49.29 -23.1 1.25 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.494 -0.754 . . . . 0.0 109.782 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.614 ' N ' ' CD1' ' B' ' 251' ' ' LEU . 0.7 OUTLIER -66.78 123.25 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 251' ' ' LEU . 3.3 mt-10 54.06 163.25 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 108.88 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' B' ' 258' ' ' ALA . 84.5 Cg_exo -43.09 135.84 5.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.781 1.654 . . . . 0.0 111.038 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.798 HD12 ' N ' ' B' ' 254' ' ' LEU . 4.6 mp -81.14 -103.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 108.842 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 38.18 113.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.798 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 14.7 mm-40 -37.86 -48.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.12 -1.223 . . . . 0.0 109.204 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -74.8 -31.91 61.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 108.846 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -83.22 46.97 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -139.89 -164.71 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.24 68.62 0.22 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.03 75.66 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 30.5 p-10 -52.57 -38.4 59.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 6.7 tt0 -63.49 -48.9 75.74 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -56.66 -36.9 70.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.099 -1.001 . . . . 0.0 109.145 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.5 OUTLIER -64.05 -38.07 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.595 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.5 OUTLIER -77.31 -58.13 3.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.716 . . . . 0.0 110.478 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.595 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 95.9 mt-10 -45.23 -46.26 12.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.778 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.82 -42.61 77.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.746 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' B' ' 245' ' ' HIS . 87.5 m-20 -66.47 -36.37 82.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.969 . . . . 0.0 110.695 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.554 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 1.3 mm? -69.56 -52.23 28.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.92 -1.113 . . . . 0.0 109.636 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -57.01 -40.58 76.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.526 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 1.0 OUTLIER -67.21 -44.64 79.05 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.275 -0.89 . . . . 0.0 109.608 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.573 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.9 tp -52.22 -35.31 49.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -72.34 -33.45 67.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.79 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' B' ' 272' ' ' TRP . 43.1 mt-30 -83.81 -1.33 54.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.37 51.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 112.401 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' B' ' 211' ' ' SER . 53.1 m-20 -100.58 -30.43 11.78 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 57.4 t -137.03 144.31 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.667 HG22 ' CB ' ' B' ' 213' ' ' TYR . 77.2 t -133.33 139.78 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.782 -1.199 . . . . 0.0 111.16 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 43.5 t -142.54 121.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -113.38 122.18 46.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.799 -1.188 . . . . 0.0 110.188 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.43 ' OE1' ' CD1' ' B' ' 231' ' ' ILE . 53.7 tt0 -86.03 112.91 21.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.836 HG11 HD11 ' B' ' 316' ' ' LEU . 1.9 t -86.45 -99.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 6.2 m 59.9 -96.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.217 -1.552 . . . . 0.0 109.036 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.617 HE22 ' CZ ' ' B' ' 222' ' ' ARG . 28.9 tt0 -61.64 133.43 93.45 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.871 -1.143 . . . . 0.0 108.582 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.472 ' HD3' ' HE ' ' B' ' 314' ' ' ARG . 33.1 Cg_endo -66.77 115.27 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.938 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.403 ' OG ' HG23 ' B' ' 290' ' ' VAL . 13.1 t -138.22 130.22 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.812 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.476 HD13 ' CG1' ' A' ' 83' ' ' VAL . 8.4 mt -69.39 -40.8 77.17 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.79 94.19 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' B' ' 216' ' ' GLY . 43.5 t -65.57 -47.53 86.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.462 -1.023 . . . . 0.0 108.827 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.26 73.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -68.85 -47.49 65.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.59 -0.947 . . . . 0.0 109.773 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.76 -35.08 78.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 0.0 109.635 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.5 mt -69.02 -46.82 66.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 108.596 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.38 -34.19 88.65 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.47 HH21 ' HB2' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -64.02 -43.89 94.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.458 -1.025 . . . . 0.0 109.685 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -71.39 -28.65 64.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.619 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.591 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -53.91 -50.15 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.591 ' N ' HG12 ' B' ' 298' ' ' VAL . . . -85.61 -55.75 3.84 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.419 0.628 . . . . 0.0 110.564 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.624 ' O ' HD23 ' B' ' 300' ' ' LEU . 1.1 tt -61.81 -17.07 54.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' B' ' 302' ' ' LYS . . . 75.78 -162.75 53.16 Favored Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' B' ' 301' ' ' GLY . 7.5 mmtm 96.63 136.4 0.03 OUTLIER Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 302' ' ' LYS . 80.7 Cg_exo -36.41 110.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.2 1.933 . . . . 0.0 111.591 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.503 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.4 mt -104.65 87.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.91 0.862 . . . . 0.0 111.256 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 305' ' ' LEU . 32.9 tp -91.16 116.94 29.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . 0.541 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.4 OUTLIER -108.28 140.29 41.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 0.0 108.585 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.0 mt -123.7 138.77 54.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.0 111.059 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -140.34 138.89 35.23 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -91.69 135.17 27.99 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.29 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.518 2.145 . . . . 0.0 110.934 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -49.78 -33.49 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.452 ' O ' ' C ' ' B' ' 313' ' ' GLY . 38.7 p -97.27 -21.06 17.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 39.6 44.74 2.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.472 ' HE ' ' HD3' ' B' ' 286' ' ' PRO . 14.5 mtp85 -70.31 8.38 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -1.203 . . . . 0.0 109.397 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' B' ' 313' ' ' GLY . 97.3 t 53.85 102.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.297 -0.877 . . . . 0.0 110.356 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 283' ' ' VAL . 13.3 tp -57.39 139.6 52.63 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.13 144.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.469 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . 0.791 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -59.74 -36.95 77.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' B' ' 319' ' ' MET . 25.3 mmm -69.0 -45.35 70.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.83 -46.59 91.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -68.44 -44.54 74.71 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.116 -0.99 . . . . 0.0 109.326 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.8 -26.6 68.89 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -56.47 -52.45 64.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.015 -1.285 . . . . 0.0 107.863 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 9.25 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' B' ' 323' ' ' ALA . 23.5 t0 -67.75 -35.48 78.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 107.945 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.878 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.78 176.49 45.68 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 21.1 m 56.25 -26.05 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.463 1.125 . . . . 0.0 108.824 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.878 ' H ' ' C ' ' B' ' 326' ' ' GLY . 7.2 tpp85 -150.34 -3.32 0.36 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.37 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.541 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 6.1 t80 -153.0 112.55 3.87 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.542 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 86.8 mt-30 -138.77 132.85 31.34 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.572 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 43.5 t -87.16 103.69 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.542 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 14.2 m0 -98.4 139.71 33.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -0.932 . . . . 0.0 109.306 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.477 ' O ' ' CE ' ' B' ' 342' ' ' MET . 73.9 m-20 -94.32 142.11 27.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.891 -1.13 . . . . 0.0 109.052 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.485 ' CD2' HG23 ' B' ' 339' ' ' VAL . 3.7 p90 -157.71 -173.28 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 111.078 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.651 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -159.22 157.61 31.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.6 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -135.77 -1.14 3.08 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.648 ' O ' ' SD ' ' B' ' 342' ' ' MET . 23.0 pt-20 -154.29 10.37 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.235 . . . . 0.0 109.995 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' B' ' 342' ' ' MET . 1.9 p -51.03 -41.82 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.023 -1.048 . . . . 0.0 108.856 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 81.2 tt0 -61.37 -28.78 69.48 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.027 -1.045 . . . . 0.0 108.833 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.1 m -71.96 -48.12 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.665 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.76 -47.0 77.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 75.3 mt -62.62 -30.13 71.13 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.07 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 43.4 t0 -68.32 -39.55 81.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -70.47 -51.61 27.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.173 . . . . 0.0 108.955 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . 0.63 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.3 t80 -57.88 -47.06 83.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.507 -0.746 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.818 ' CG ' HD12 ' B' ' 351' ' ' LEU . 11.7 m-85 -74.83 -32.46 61.96 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.185 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 12.3 mm-40 -58.94 -26.28 64.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -70.51 -21.67 62.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.821 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -173.23 101.56 0.12 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.818 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 175.17 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' B' ' 351' ' ' LEU . 90.7 Cg_endo . . . . . 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 111.513 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' CYS . 61.2 Cg_endo -75.09 155.27 42.48 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.389 2.059 . . . . 0.0 112.141 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 12.2 p -54.01 -175.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.112 -0.992 . . . . 0.0 108.508 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.47 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 69.4 m -111.17 152.63 26.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.109 -0.995 . . . . 0.0 108.739 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 35' ' ' LEU . 9.0 t -140.09 136.94 38.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 122.086 0.946 . . . . 0.0 109.273 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 69' ' ' ASP . 7.3 t80 -115.58 111.03 20.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.574 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.14 124.47 42.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 0.0 109.087 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.416 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 13.3 m -99.81 143.2 30.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.194 -0.941 . . . . 0.0 109.034 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.68 157.09 27.15 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.556 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 5.3 m -81.0 119.82 24.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.773 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.688 ' CG2' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.9 . . . . 0.0 108.732 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.196 0.522 . . . . 0.0 109.635 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -53.03 -39.16 62.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.65 -28.99 68.91 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.91 -41.62 97.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.89 -50.46 70.79 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.23 -32.91 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.5 m-30 -69.41 -46.86 65.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.951 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.89 84.47 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.739 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.692 HH22 HH21 ' A' ' 34' ' ' ARG . 65.9 ttt-85 -69.46 -56.4 7.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.506 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.47 -48.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -58.1 -32.27 43.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 p -63.32 -43.32 98.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 109.7 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.692 HH21 HH22 ' A' ' 30' ' ' ARG . 82.3 mtt-85 -64.4 -40.3 95.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.154 . . . . 0.0 108.06 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 38' ' ' TYR . 85.4 mt -62.9 -43.08 99.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.83 -28.49 61.64 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.81 -59.88 2.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.709 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -125.49 152.38 45.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 176.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.8 64.29 1.62 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' C ' ' O ' ' A' ' 39' ' ' GLY . 10.4 ttpt -34.42 121.79 0.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -1.037 . . . . 0.0 108.657 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.38 108.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.811 -1.181 . . . . 0.0 109.16 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 78.3 mt -72.17 -36.82 69.38 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.775 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.526 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -91.24 93.16 8.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.024 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.23 -23.74 19.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.51 -37.85 85.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 55.9 t -47.32 -73.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.098 -1.001 . . . . 0.0 109.68 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.18 -47.6 71.86 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.039 -1.038 . . . . 0.0 109.14 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.691 ' C ' HD11 ' A' ' 51' ' ' LEU . 26.3 t70 -72.35 45.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -122.79 -16.34 7.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -8.28 17.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.04 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.11 130.08 34.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.224 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 51' ' ' LEU . 5.7 mt-10 55.81 157.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' HH22 ' A' ' 22' ' ' ARG . 8.9 Cg_endo -52.77 112.03 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.286 1.991 . . . . 0.0 111.493 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.66 -3.79 54.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.617 ' N ' HD12 ' A' ' 54' ' ' LEU . . . -46.09 150.37 1.58 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' B' ' 318' ' ' ALA . 43.9 mt-10 -53.56 -35.49 60.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.062 -1.258 . . . . 0.0 109.117 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -66.31 -11.21 49.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . -57.17 176.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -47.03 164.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.26 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -43.31 150.96 0.46 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 154.87 -17.44 0.55 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.85 -44.03 90.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.0 109.219 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.39 -55.45 7.04 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -56.42 -29.31 61.42 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -69.85 -49.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.427 ' CE1' HD22 ' A' ' 70' ' ' LEU . 4.4 t-80 -64.73 -55.34 20.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.629 -0.669 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 91.1 mt-10 -49.1 -54.91 13.98 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.967 -1.083 . . . . 0.0 110.206 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 68' ' ' GLN . 4.2 mp0 -71.77 -50.61 28.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.924 -1.11 . . . . 0.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.482 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.4 m-20 -61.43 -54.61 41.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 111.493 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -72.37 -39.15 68.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.709 -1.244 . . . . 0.0 111.202 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 63.8 t-20 -58.48 -50.26 74.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.011 -1.68 . . . . 0.0 108.217 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.55 -38.77 81.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.2 tp -49.84 -39.79 40.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.54 -31.3 65.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.614 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -85.06 0.31 51.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.919 -1.113 . . . . 0.0 109.344 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.98 121.86 18.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 112.057 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' SER . 76.2 m-20 -68.47 -37.63 80.33 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 79.6 t -131.49 151.23 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.0 t -135.77 143.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 0.0 112.356 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 t -135.08 156.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 15' ' ' CYS . . . -162.99 123.38 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.364 -1.46 . . . . 0.0 110.749 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.09 116.46 22.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 116' ' ' LEU . 2.0 m -101.39 30.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 108.778 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 113' ' ' GLY . 25.9 m -62.13 -108.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.817 -0.552 . . . . 0.0 110.125 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 84' ' ' THR . 1.2 tm0? -41.02 126.57 2.03 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.502 -0.749 . . . . 0.0 110.221 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 78.2 Cg_exo -45.76 113.44 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.881 1.721 . . . . 0.0 111.645 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.615 ' O ' HD23 ' B' ' 288' ' ' LEU . 8.0 t -142.16 131.88 24.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.0 110.219 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' O ' ' B' ' 287' ' ' SER . 8.3 mt -79.71 -42.46 24.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.76 -37.29 89.78 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 t -74.37 -42.56 50.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -1.22 . . . . 0.0 108.817 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.02 -25.18 67.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -70.82 -56.51 6.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.79 -0.829 . . . . 0.0 109.308 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.416 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 96.1 mt-10 -60.18 -33.76 72.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.693 HD13 ' C ' ' A' ' 94' ' ' LEU . 3.2 tm? -70.75 -49.95 41.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.17 57.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 HG11 ' B' ' 298' ' ' VAL . 56.0 ttt85 -56.16 -36.28 68.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -1.076 . . . . 0.0 108.334 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.69 -38.58 87.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -54.4 -43.47 62.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.876 -1.14 . . . . 0.0 108.531 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -74.71 -48.36 26.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.411 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.8 pp -119.5 -28.02 5.42 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.912 -1.117 . . . . 0.0 110.585 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -40.74 162.35 0.01 OUTLIER Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.497 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 2.5 mmtp -98.38 -161.57 0.04 OUTLIER Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 71.8 Cg_exo -41.71 115.03 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.354 1.519 . . . . 0.0 110.376 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.3 mt -106.62 138.97 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.088 0.947 . . . . 0.0 112.188 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 132' ' ' TRP . 50.8 tp -126.5 118.1 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER -102.63 157.27 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.924 -1.11 . . . . 0.0 109.411 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 134' ' ' TYR . 5.7 mt -143.12 127.75 18.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -138.78 145.05 39.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.208 -0.933 . . . . 0.0 108.966 178.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.522 ' NH1' ' OH ' ' A' ' 134' ' ' TYR . 24.2 ptt-85 -128.67 148.12 67.14 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.52 29.46 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.58 2.186 . . . . 0.0 112.507 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 50.6 mt-30 -104.79 -44.01 4.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -129.69 -22.62 2.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 108.676 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 114' ' ' ARG . . . -87.03 -52.03 3.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.705 ' O ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 39.59 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 114' ' ' ARG . 96.6 t 61.78 93.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.887 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.5 pt? -70.03 -43.56 71.05 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.788 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER 163.05 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.877 -1.139 . . . . 0.0 110.303 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' B' ' 256' ' ' GLU . . . -63.91 -46.12 86.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.818 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 80.4 mmm -62.22 -46.53 88.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 94' ' ' LEU . 3.8 mm -61.1 -41.86 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -44.57 95.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.921 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.21 -33.96 88.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -56.3 -22.16 28.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.274 -1.133 . . . . 0.0 108.659 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -36.45 109.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.276 0.56 . . . . 0.0 110.084 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' OD2' ' OG ' ' A' ' 127' ' ' SER . 55.0 t0 -105.73 -29.41 10.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.38 77.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 80.0 p -122.24 -78.97 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -1.066 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' N ' ' OG ' ' A' ' 127' ' ' SER . 46.6 ttp180 -97.92 -5.08 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 108.885 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.27 125.34 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.449 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 57.0 mt-30 -138.35 149.94 46.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.051 -1.03 . . . . 0.0 111.215 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.25 107.22 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.437 ' CD2' HD11 ' A' ' 105' ' ' LEU . 20.3 m0 -106.14 145.23 31.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.128 -0.983 . . . . 0.0 109.984 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.531 ' O ' ' CE ' ' A' ' 142' ' ' MET . 57.7 p-10 -100.97 161.07 13.85 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.649 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 8.0 p90 -172.67 -167.88 0.47 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.807 -1.183 . . . . 0.0 110.7 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.963 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -131.34 149.95 52.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.714 ' C ' ' O ' ' A' ' 135' ' ' ALA . 72.2 mt-10 -32.29 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.963 ' O ' ' O ' ' A' ' 135' ' ' ALA . . . -95.54 -176.45 37.14 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.92 -13.11 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.057 -1.261 . . . . 0.0 108.864 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.7 ' H ' ' C ' ' A' ' 137' ' ' GLY . 1.3 p -59.19 -46.88 91.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.541 ' OE1' ' NH2' ' A' ' 34' ' ' ARG . 23.3 pt-20 -53.37 -33.58 54.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.7 m -68.31 -40.84 81.56 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.395 -0.816 . . . . 0.0 108.884 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 8.2 mmt -52.49 -48.04 66.2 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.0 -38.59 91.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.44 -40.46 95.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 110.731 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -70.05 -49.87 46.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.488 -1.382 . . . . 0.0 108.796 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.84 -48.72 80.55 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 151' ' ' LEU . 19.4 m-85 -70.45 -32.95 70.72 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.236 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -61.19 -31.14 70.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.13 12.21 5.44 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -138.1 -104.29 0.18 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.323 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.492 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 12.1 mt -33.5 90.69 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.844 -0.535 . . . . 0.0 110.841 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' N ' ' O ' ' A' ' 150' ' ' TYR . 83.6 Cg_endo . . . . . 0 C--N 1.313 -1.292 0 C-N-CA 123.217 2.612 . . . . 0.0 111.477 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' B' ' 210' ' ' CYS . 61.1 Cg_endo -75.09 155.01 42.46 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.46 2.107 . . . . 0.0 112.18 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' B' ' 209' ' ' PRO . 10.2 p -53.85 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.173 -0.955 . . . . 0.0 108.467 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' B' ' 277' ' ' ASP . 62.9 m -111.17 152.82 26.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.157 -0.965 . . . . 0.0 108.714 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.549 HG11 HD22 ' B' ' 235' ' ' LEU . 8.9 t -140.33 136.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 122.04 0.924 . . . . 0.0 109.21 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 269' ' ' ASP . 7.2 t80 -115.51 110.95 19.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.592 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.04 124.2 42.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.036 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.425 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 12.2 m -99.73 142.62 30.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.046 -1.034 . . . . 0.0 109.071 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -144.18 157.17 27.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.552 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 5.7 m -80.78 119.96 24.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -1.037 . . . . 0.0 109.795 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.686 ' CG2' HD22 ' B' ' 254' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.258 0.551 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.09 -39.14 63.14 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 79.4 m-20 -66.7 -29.01 68.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -63.93 -41.81 97.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.16 72.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.28 -33.17 69.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.654 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.5 m-30 -69.26 -46.47 67.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 0.0 110.074 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.87 85.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.766 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.725 HH22 HH21 ' B' ' 234' ' ' ARG . 65.8 ttt-85 -69.37 -56.19 8.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 108.535 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.2 mt -52.86 -48.18 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 228' ' ' TYR . 56.1 t -58.2 -32.22 43.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 18.1 p -63.29 -43.58 97.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 109.597 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.725 HH21 HH22 ' B' ' 230' ' ' ARG . 83.6 mtt-85 -64.23 -40.5 96.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.867 -1.145 . . . . 0.0 108.008 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.712 ' O ' ' O ' ' B' ' 238' ' ' TYR . 87.0 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -56.93 -28.3 61.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 108.75 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.04 -59.87 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.712 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.9 OUTLIER -125.32 152.32 44.87 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 176.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 84.03 64.16 1.62 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' B' ' 239' ' ' GLY . 10.6 ttpt -34.2 121.9 0.48 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -1.085 . . . . 0.0 108.584 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.67 109.53 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.793 -1.192 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 78.1 mt -72.6 -37.64 68.07 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.677 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.53 ' OG1' HG23 ' B' ' 246' ' ' VAL . 0.1 OUTLIER -90.47 92.86 9.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.957 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -91.89 -23.7 19.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 109.158 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -61.94 -37.77 85.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 110.128 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.59 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 55.8 t -46.86 -73.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.658 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -53.83 -48.08 70.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.684 ' C ' HD11 ' B' ' 251' ' ' LEU . 26.2 t70 -72.26 45.48 0.13 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -122.82 -16.57 7.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -8.32 15.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.984 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -84.3 130.41 34.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.088 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' B' ' 251' ' ' LEU . 6.0 mt-10 55.55 157.97 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.039 -1.038 . . . . 0.0 108.861 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.446 ' HA ' HH22 ' B' ' 222' ' ' ARG . 8.6 Cg_endo -52.7 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.224 1.95 . . . . 0.0 111.437 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.686 HD22 ' CG2' ' B' ' 218' ' ' ILE . 0.3 OUTLIER -92.87 -3.97 53.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.608 ' N ' HD12 ' B' ' 254' ' ' LEU . . . -45.84 150.2 1.48 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 44.2 mt-10 -53.43 -35.89 60.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -1.205 . . . . 0.0 108.983 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.99 -11.14 45.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.0 108.843 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 255' ' ' GLY . . . -57.51 175.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' B' ' 260' ' ' GLY . . . -46.97 165.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.326 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' B' ' 259' ' ' ALA . . . -43.36 151.5 0.42 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 154.25 -17.53 0.61 Allowed Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.07 -44.24 91.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.116 -1.226 . . . . 0.0 109.265 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -72.32 -55.26 7.42 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 0.9 OUTLIER -56.39 -29.27 61.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' B' ' 261' ' ' GLY . 8.5 mt -69.87 -49.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.429 ' CE1' HD22 ' B' ' 270' ' ' LEU . 3.9 t-80 -65.27 -55.15 19.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.662 -0.649 . . . . 0.0 110.001 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 90.9 mt-10 -49.01 -54.55 15.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 110.224 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 4.8 mp0 -72.06 -50.8 25.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.923 -1.111 . . . . 0.0 111.038 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.469 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 1.6 m-20 -61.2 -54.79 39.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.457 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.429 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.5 OUTLIER -72.43 -38.79 68.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.766 -1.209 . . . . 0.0 111.323 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 64.7 t-20 -58.74 -50.02 75.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 119.955 -1.715 . . . . 0.0 108.155 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -59.8 -38.9 83.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.4 tp -49.64 -39.47 36.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.402 ' OE1' ' NH2' ' B' ' 296' ' ' ARG . 15.2 mt-30 -72.84 -31.22 64.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.533 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -85.24 0.2 52.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.97 121.95 18.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.318 -0.864 . . . . 0.0 112.091 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.482 ' H ' ' HB2' ' B' ' 211' ' ' SER . 79.3 m-20 -68.56 -37.65 80.09 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 77.7 t -131.34 151.45 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 86.9 t -136.16 143.6 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 122.564 1.173 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 27.8 t -135.11 156.35 39.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -163.06 122.72 2.2 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.434 -1.416 . . . . 0.0 110.81 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.29 116.23 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.476 HG21 HD12 ' B' ' 316' ' ' LEU . 1.9 m -101.24 29.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 108.778 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.595 HG22 ' N ' ' B' ' 313' ' ' GLY . 25.3 m -61.86 -109.37 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.728 -0.607 . . . . 0.0 110.169 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' B' ' 286' ' ' PRO . 1.2 tm0? -40.63 126.76 1.87 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.407 -0.808 . . . . 0.0 110.181 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.41 ' O ' ' NE2' ' B' ' 285' ' ' GLN . 76.6 Cg_exo -45.61 113.7 0.61 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.933 1.755 . . . . 0.0 111.595 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.627 ' O ' HD23 ' A' ' 88' ' ' LEU . 8.1 t -142.64 131.66 23.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.121 -0.987 . . . . 0.0 110.251 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 87' ' ' SER . 8.3 mt -79.68 -42.6 24.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 109.304 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -58.57 -37.52 89.07 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 8.2 t -74.2 -42.28 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 108.809 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -63.49 -24.98 68.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -70.81 -56.42 6.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.707 -0.878 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.425 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 95.7 mt-10 -60.19 -33.68 72.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.677 HD13 ' C ' ' B' ' 294' ' ' LEU . 3.3 tm? -70.77 -49.73 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.99 -51.5 54.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.41 HH11 HG11 ' A' ' 98' ' ' VAL . 56.1 ttt85 -55.96 -36.4 67.76 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 108.394 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.55 -38.78 87.85 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.463 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.4 OUTLIER -54.19 -43.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 120.862 -1.149 . . . . 0.0 108.565 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -74.55 -48.8 24.71 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 112.387 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.7 pp -119.06 -27.95 5.61 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.974 -1.079 . . . . 0.0 110.747 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' B' ' 300' ' ' LEU . . . -40.8 162.19 0.01 OUTLIER Glycine 0 C--N 1.289 -2.044 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.49 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 2.8 mmtp -98.23 -161.54 0.04 OUTLIER Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 75.9 Cg_exo -41.89 115.41 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 121.458 1.557 . . . . 0.0 110.329 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.85 138.96 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.195 0.998 . . . . 0.0 112.147 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' B' ' 332' ' ' TRP . 50.9 tp -126.47 118.25 24.55 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.8 157.41 16.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.899 -1.126 . . . . 0.0 109.457 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' B' ' 334' ' ' TYR . 5.9 mt -143.02 128.0 18.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -139.33 144.7 38.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.139 -0.976 . . . . 0.0 108.865 178.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' B' ' 334' ' ' TYR . 24.9 ptt-85 -128.65 148.09 66.96 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.464 -0.772 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.42 29.46 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.208 . . . . 0.0 112.566 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.544 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 51.3 mt-30 -104.62 -43.77 5.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 22.6 m -129.73 -23.24 2.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 108.6 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.707 ' O ' ' O ' ' B' ' 314' ' ' ARG . . . -86.44 -51.87 3.37 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.707 ' O ' ' O ' ' B' ' 313' ' ' GLY . 0.1 OUTLIER 39.47 101.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . . . . . . . . . 96.6 t 61.97 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.897 ' H ' HD23 ' B' ' 316' ' ' LEU . 1.5 pt? -70.45 -43.84 69.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.739 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.3 OUTLIER 163.35 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.96 -1.088 . . . . 0.0 110.176 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . . . -64.1 -45.57 88.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.442 -0.786 . . . . 0.0 109.798 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 80.2 mmm -62.52 -46.9 86.3 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.36 -0.838 . . . . 0.0 109.371 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.411 ' CD1' HD12 ' B' ' 294' ' ' LEU . 3.8 mm -60.69 -41.88 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -44.39 96.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.748 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -63.66 -33.58 87.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -56.7 -22.11 32.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -1.15 . . . . 0.0 108.605 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -36.44 109.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.21 0.529 . . . . 0.0 110.043 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -105.94 -29.46 9.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.12 3.7 76.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 68.1 p -121.49 -79.08 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.472 -1.017 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -97.89 -4.93 35.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.855 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.404 ' HE1' HD11 ' B' ' 294' ' ' LEU . 85.6 t80 -137.37 125.24 22.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.13 149.77 46.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.0 111.12 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.04 106.93 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.436 ' CD2' HD11 ' B' ' 305' ' ' LEU . 20.4 m0 -106.21 145.11 31.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.111 -0.993 . . . . 0.0 110.103 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.54 ' O ' ' CE ' ' B' ' 342' ' ' MET . 57.1 p-10 -100.68 160.83 14.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 8.0 p90 -172.41 -167.89 0.49 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.735 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.962 ' O ' ' O ' ' B' ' 337' ' ' GLY . . . -131.47 149.49 52.51 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.76 ' C ' ' O ' ' B' ' 335' ' ' ALA . 71.1 mt-10 -31.94 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.962 ' O ' ' O ' ' B' ' 335' ' ' ALA . . . -95.36 -176.71 37.42 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -13.06 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.93 -1.335 . . . . 0.0 108.908 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.713 ' H ' ' C ' ' B' ' 337' ' ' GLY . 1.3 p -59.12 -46.97 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.55 ' OE1' ' NH2' ' B' ' 234' ' ' ARG . 22.7 pt-20 -53.21 -33.78 54.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 17.9 m -68.16 -40.7 82.27 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.955 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.54 ' CE ' ' O ' ' B' ' 333' ' ' ASP . 7.9 mmt -52.86 -47.91 67.47 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.824 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -64.44 -40.36 95.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.42 -0.8 . . . . 0.0 110.73 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -70.11 -49.71 48.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.422 -1.423 . . . . 0.0 108.756 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.25 -48.65 80.83 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 109.961 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.494 ' HB3' HD12 ' B' ' 351' ' ' LEU . 19.7 m-85 -70.41 -32.51 70.17 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.144 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.59 -30.95 71.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.24 12.25 5.53 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.5 t80 -138.04 -104.44 0.18 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.283 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' B' ' 347' ' ' PHE . 12.0 mt -33.53 90.77 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.915 -0.491 . . . . 0.0 110.815 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' B' ' 350' ' ' TYR . 78.8 Cg_endo . . . . . 0 C--N 1.315 -1.225 0 C-N-CA 123.27 2.647 . . . . 0.0 111.339 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -155.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.533 2.155 . . . . 0.0 111.459 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -102.07 -175.61 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.5 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 11.2 p -120.35 154.39 35.12 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.717 HG11 HD22 ' A' ' 35' ' ' LEU . 7.2 t -133.58 135.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 0.0 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.1 t80 -118.15 95.39 4.87 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -83.2 104.73 13.6 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -95.03 170.43 9.42 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 111.417 -176.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.678 ' HA2' HG22 ' A' ' 90' ' ' VAL . . . 84.3 93.05 0.72 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' CE2' ' A' ' 28' ' ' TYR . 2.7 p -168.39 -177.29 3.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.014 -1.286 . . . . 0.0 109.746 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.592 -0.693 . . . . 0.0 109.922 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.3 mmt85 . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.08 -35.22 61.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 28' ' ' TYR . 4.6 t0 -65.99 -27.75 68.37 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.931 HE22 HD21 ' A' ' 54' ' ' LEU . 35.3 tt0 -57.9 -45.55 86.29 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.46 94.15 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.65 -30.22 71.35 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 32' ' ' VAL . 22.7 m-30 -70.77 -49.77 43.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.48 -0.762 . . . . 0.0 110.089 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.32 72.68 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.426 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -71.43 -58.15 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.918 -1.113 . . . . 0.0 108.291 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.85 -44.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.802 HG13 HG11 ' A' ' 41' ' ' VAL . 55.4 t -61.07 -28.84 44.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -70.82 -35.09 72.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.422 ' HA ' HH11 ' A' ' 37' ' ' ARG . 68.1 mtp85 -73.89 -50.28 20.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 108.694 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.717 HD22 HG11 ' A' ' 12' ' ' VAL . 13.4 mt -59.64 -40.09 86.51 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.95 -23.0 67.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.422 HH11 ' HA ' ' A' ' 34' ' ' ARG . 26.0 mtt85 -77.88 -34.6 51.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.026 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -73.32 -51.09 18.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 110.082 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.11 -144.99 4.22 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -98.95 135.59 40.15 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.178 -1.189 . . . . 0.0 108.669 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.802 HG11 HG13 ' A' ' 32' ' ' VAL . 12.4 t -100.11 122.19 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 12.2 mt -87.36 -17.05 33.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.295 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.426 HG22 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -86.22 43.23 1.04 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.402 -0.811 . . . . 0.0 109.513 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -66.34 -38.67 88.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.493 ' C ' ' ND1' ' A' ' 45' ' ' HIS . 6.5 t-80 -53.94 -46.97 71.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.877 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG11 ' CZ ' ' A' ' 14' ' ' PHE . 5.3 t -48.34 -49.31 13.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.315 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.3 -40.74 62.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 108.54 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' HD22 ' A' ' 51' ' ' LEU . 2.7 t0 -75.07 50.89 0.49 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.686 ' HB3' HE21 ' A' ' 25' ' ' GLN . . . -126.21 -30.69 2.89 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.746 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -55.08 -5.33 0.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.676 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -49.49 -55.99 11.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 1.8 tm-20 -179.67 -44.73 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.418 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' O ' HD22 ' A' ' 54' ' ' LEU . 13.2 Cg_exo -69.31 92.22 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.686 2.257 . . . . 0.0 112.467 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.931 HD21 HE22 ' A' ' 25' ' ' GLN . 4.0 mm? -125.21 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.809 . . . . 0.0 109.549 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 68.19 35.73 83.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' ALA . 69.3 mm-40 47.46 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.531 -0.982 . . . . 0.0 109.197 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 47.92 13.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.04 -1.037 . . . . 0.0 108.65 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' GLU . . . -139.64 96.64 3.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.48 -0.763 . . . . 0.0 109.016 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 65' ' ' ILE . . . -172.72 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.233 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.16 17.12 21.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 62' ' ' ASP . . . 152.23 76.83 0.02 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 23.8 p-10 -48.69 -44.29 37.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.497 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 89.6 mt-30 -57.42 -45.13 84.95 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.63 -41.58 95.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.506 HD12 ' CB ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -58.04 -39.06 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.463 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.8 t-80 -76.14 -51.02 13.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.63 -0.669 . . . . 0.0 110.38 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 97.0 mt-10 -46.68 -53.69 11.17 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.071 -1.018 . . . . 0.0 109.825 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.85 -42.63 66.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 110.91 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.71 -57.44 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.965 -1.084 . . . . 0.0 111.143 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.097 -1.002 . . . . 0.0 110.792 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -60.97 -52.94 62.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.591 -1.318 . . . . 0.0 108.958 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.69 -40.84 89.21 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 108.703 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 7.6 tp -50.07 -37.7 34.85 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' NZ ' ' A' ' 102' ' ' LYS . 51.4 mt-30 -74.44 -29.43 61.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.715 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 18.0 mt-30 -90.2 3.87 52.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.83 -1.169 . . . . 0.0 109.284 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.01 130.08 40.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.899 . . . . 0.0 112.27 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 11' ' ' SER . 85.1 m-20 -78.09 -34.9 49.91 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.25 144.24 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 13' ' ' TYR . 91.9 t -136.08 129.06 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.917 -1.115 . . . . 0.0 111.205 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 70.1 t -129.03 124.85 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.767 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -121.39 156.13 33.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.307 -1.496 . . . . 0.0 110.24 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -99.82 122.66 43.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.32 33.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 109' ' ' ARG . 4.2 m -88.87 -73.54 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.741 -0.6 . . . . 0.0 109.756 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.77 120.48 81.5 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.798 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.41 141.84 89.28 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.236 1.957 . . . . 0.0 112.202 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.92 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -179.49 141.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 110.019 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 92' ' ' TYR . 19.7 mt -62.45 -43.21 99.36 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.458 -0.776 . . . . 0.0 109.044 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -54.48 -38.52 63.13 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.92 HG23 ' OG ' ' A' ' 87' ' ' SER . 44.6 t -68.07 -53.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.512 -0.993 . . . . 0.0 108.676 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.37 -28.41 73.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.509 ' OH ' ' HB2' ' B' ' 323' ' ' ALA . 51.3 t80 -70.72 -55.09 9.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -1.092 . . . . 0.0 109.633 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' SD ' ' B' ' 319' ' ' MET . 77.4 mt-10 -62.15 -34.15 75.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.253 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 81' ' ' ALA . 21.1 mt -70.22 -48.55 56.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.253 -0.905 . . . . 0.0 109.195 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.24 96.07 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -61.92 -40.47 95.59 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.519 -0.989 . . . . 0.0 109.299 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.53 -41.21 76.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.09 -1.006 . . . . 0.0 108.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -39.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -77.64 -51.14 11.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.68 -6.18 10.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.973 -1.079 . . . . 0.0 108.722 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.6 26.0 30.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 104' ' ' ILE . 43.9 mttp -84.38 147.54 50.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.906 -1.35 . . . . 0.0 107.644 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -38.53 116.52 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.756 1.637 . . . . 0.0 110.896 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -115.95 98.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.271 -0.893 . . . . 0.0 111.602 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 80' ' ' VAL . 59.1 tp -94.69 120.64 35.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.28 131.22 55.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.885 -1.134 . . . . 0.0 108.838 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 3.5 mt -123.15 130.19 52.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 0.0 111.502 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -131.12 151.07 51.82 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.569 ' H ' HG23 ' A' ' 84' ' ' THR . 49.9 mtm180 -114.23 136.02 22.22 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.115 -0.99 . . . . 0.0 110.219 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -29.97 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.355 2.037 . . . . 0.0 111.286 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' ' 112' ' ' SER . 12.2 pt20 -59.7 -46.36 89.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.354 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 17.2 t -75.85 -22.18 56.49 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' O ' ' NE ' ' A' ' 114' ' ' ARG . . . 55.93 111.0 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.601 ' O ' ' C ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -144.6 -7.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -1.017 . . . . 0.0 110.259 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' A' ' 114' ' ' ARG . 94.7 t 32.85 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.978 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -61.13 172.31 1.07 Allowed 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.81 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 289' ' ' GLY . 29.3 t -64.95 141.36 58.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 111.721 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.18 63.76 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.529 ' SD ' ' CG ' ' B' ' 293' ' ' GLU . 1.7 mtp -63.94 -43.51 95.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.542 -0.724 . . . . 0.0 109.317 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' B' ' 292' ' ' TYR . 4.1 mm -61.87 -45.48 98.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.497 -0.752 . . . . 0.0 109.418 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -64.43 -44.8 90.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -58.55 -32.1 68.27 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -51.7 -57.33 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 108.265 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 10.38 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 123' ' ' ALA . 2.2 m-20 -68.97 -35.36 76.64 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.747 -1.221 . . . . 0.0 107.757 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.817 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.41 174.04 40.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.4 t 60.56 -30.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.668 1.223 . . . . 0.0 108.573 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.817 ' H ' ' C ' ' A' ' 126' ' ' GLY . 8.7 mtm180 -147.33 0.95 0.71 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.539 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' GLY . 11.3 t80 -156.94 112.9 2.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.521 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 90.5 mt-30 -139.29 142.8 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.398 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.51 98.86 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.521 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 18.1 m0 -94.66 147.29 23.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.345 -0.847 . . . . 0.0 109.521 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' O ' ' HE1' ' A' ' 142' ' ' MET . 67.6 m-20 -100.27 150.64 22.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 7.8 p90 -170.95 177.58 3.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.642 -1.286 . . . . 0.0 111.548 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -141.99 146.83 36.03 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.0 mt-10 -39.41 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.748 -1.22 . . . . 0.0 110.474 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -86.32 -2.37 85.42 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.109 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -135.93 0.19 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.813 -1.404 . . . . 0.0 110.231 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -55.21 -47.04 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.851 -1.156 . . . . 0.0 108.476 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 29.6 mt-10 -53.16 -33.17 51.41 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.7 m -69.56 -40.91 76.52 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 109.25 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.467 ' HE1' ' O ' ' A' ' 133' ' ' ASP . 12.9 mmt -53.16 -51.78 60.9 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 48.8 mt -62.05 -32.48 73.0 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.72 -43.91 87.62 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 -71.98 -47.74 49.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.534 -1.354 . . . . 0.0 109.149 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -60.44 -48.96 79.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 21.3 m-85 -71.37 -28.86 64.34 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.159 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.05 -31.14 71.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.07 9.57 10.03 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 2.5 t80 -134.85 -104.49 0.23 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.237 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.531 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 22.6 mt -32.42 90.84 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.91 -0.494 . . . . 0.0 110.925 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . 71.5 Cg_endo . . . . . 0 C--N 1.313 -1.335 0 C-N-CA 123.067 2.511 . . . . 0.0 111.248 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.62 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 111.34 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 32.1 p -102.21 -175.61 2.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.9 p -120.36 154.0 35.68 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.722 HG11 HD22 ' B' ' 235' ' ' LEU . 6.8 t -133.41 135.37 56.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.7 0.762 . . . . 0.0 109.034 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' B' ' 279' ' ' VAL . 7.9 t80 -118.01 95.76 5.05 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.868 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -83.36 104.94 13.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.1 OUTLIER -95.28 170.23 9.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.078 0.942 . . . . 0.0 111.49 -176.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' B' ' 290' ' ' VAL . . . 84.37 93.51 0.71 Allowed Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.574 ' CB ' ' CE2' ' B' ' 228' ' ' TYR . 2.6 p -168.52 -176.85 2.94 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 0.0 109.888 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' B' ' 225' ' ' GLN . 9.4 mmt85 . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.05 -34.9 61.25 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' B' ' 228' ' ' TYR . 4.5 t0 -66.26 -27.61 68.08 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.938 HE22 HD21 ' B' ' 254' ' ' LEU . 35.5 tt0 -58.15 -45.21 87.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.64 -43.28 94.18 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.9 tp -64.07 -29.68 70.8 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.677 ' O ' HG23 ' B' ' 232' ' ' VAL . 22.7 m-30 -71.11 -49.62 42.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.39 -0.818 . . . . 0.0 109.98 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.04 72.67 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.478 -1.289 . . . . 0.0 108.44 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -71.71 -57.9 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.882 -1.136 . . . . 0.0 108.283 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.5 mt -53.09 -44.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.822 HG13 HG11 ' B' ' 241' ' ' VAL . 55.7 t -60.99 -28.74 44.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' B' ' 237' ' ' ARG . 7.1 t -70.94 -34.91 71.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.394 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.412 ' HA ' HH11 ' B' ' 237' ' ' ARG . 67.8 mtp85 -73.88 -50.5 19.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 108.752 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.722 HD22 HG11 ' B' ' 212' ' ' VAL . 14.1 mt -59.22 -40.42 85.78 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -64.78 -23.16 67.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' B' ' 233' ' ' SER . 24.1 mtt85 -77.66 -34.98 52.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 108.922 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -73.23 -50.86 20.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 110.041 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -145.22 -145.29 4.26 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -98.59 135.34 40.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.293 -1.122 . . . . 0.0 108.704 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.822 HG11 HG13 ' B' ' 232' ' ' VAL . 12.8 t -100.07 122.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 11.4 mt -87.35 -16.34 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.309 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.419 HG22 ' CG2' ' B' ' 246' ' ' VAL . 0.2 OUTLIER -86.84 43.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.4 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -66.55 -38.22 86.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.89 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.488 ' ND1' ' C ' ' B' ' 245' ' ' HIS . 6.6 t-80 -54.43 -46.92 73.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.971 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.462 HG11 ' CZ ' ' B' ' 214' ' ' PHE . 5.5 t -48.5 -48.38 14.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.97 59.61 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.649 ' O ' HD22 ' B' ' 251' ' ' LEU . 2.7 t0 -74.86 50.68 0.46 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.679 ' HB3' HE21 ' B' ' 225' ' ' GLN . . . -126.32 -30.08 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.736 ' N ' ' NE2' ' B' ' 225' ' ' GLN . 0.4 OUTLIER -55.71 -4.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.66 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.4 OUTLIER -50.12 -55.3 15.52 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 1.8 tm-20 179.99 -45.28 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.426 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.644 ' O ' HD22 ' B' ' 254' ' ' LEU . 13.0 Cg_exo -69.14 92.35 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.938 HD21 HE22 ' B' ' 225' ' ' GLN . 4.0 mm? -125.44 178.39 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 68.26 35.93 83.77 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' B' ' 258' ' ' ALA . 69.0 mm-40 47.05 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -1.02 . . . . 0.0 109.277 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 48.15 13.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.583 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -139.29 96.35 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' B' ' 265' ' ' ILE . . . -172.38 -30.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.64 16.39 22.24 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' B' ' 262' ' ' ASP . . . 152.74 76.56 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 23.8 p-10 -48.42 -44.14 34.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.9 mt-30 -57.49 -45.41 84.92 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -60.13 -42.05 93.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.505 HD12 ' CB ' ' B' ' 259' ' ' ALA . 0.1 OUTLIER -57.75 -38.7 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.49 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.8 t-80 -76.35 -51.21 12.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.246 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 97.1 mt-10 -46.67 -53.42 11.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.794 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.97 -42.79 66.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.68 -57.35 9.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.0 -1.062 . . . . 0.0 111.143 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -39.64 83.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.091 -1.005 . . . . 0.0 110.81 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.6 t-20 -60.95 -52.74 63.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.684 -1.26 . . . . 0.0 108.965 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.515 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -60.0 -40.75 90.28 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.738 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 8.1 tp -50.06 -37.81 35.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.49 ' O ' ' NZ ' ' B' ' 302' ' ' LYS . 52.2 mt-30 -74.25 -29.55 61.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.773 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 17.7 mt-30 -90.11 3.97 51.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.838 -1.164 . . . . 0.0 109.204 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.07 129.95 39.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 112.311 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.508 ' HB2' ' H ' ' B' ' 211' ' ' SER . 85.1 m-20 -77.96 -34.74 50.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.66 144.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' B' ' 213' ' ' TYR . 87.3 t -136.12 129.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.921 -1.112 . . . . 0.0 111.296 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 69.4 t -128.96 125.15 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.752 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -121.87 156.72 32.7 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.296 -1.503 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -100.19 123.03 43.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.82 33.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.556 HG23 ' H ' ' B' ' 309' ' ' ARG . 4.0 m -88.45 -73.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.766 -0.583 . . . . 0.0 109.804 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.43 120.75 82.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.47 141.7 89.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.255 1.97 . . . . 0.0 112.229 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.937 ' OG ' HG23 ' B' ' 290' ' ' VAL . 0.1 OUTLIER -179.34 140.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.102 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 292' ' ' TYR . 20.1 mt -62.24 -42.83 99.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 117' ' ' SER . . . -54.88 -38.6 65.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.937 HG23 ' OG ' ' B' ' 287' ' ' SER . 44.3 t -68.03 -52.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.933 . . . . 0.0 108.696 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.45 -27.94 73.42 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.515 ' OH ' ' HB2' ' A' ' 123' ' ' ALA . 50.5 t80 -71.1 -55.28 8.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.368 -1.078 . . . . 0.0 109.592 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.529 ' CG ' ' SD ' ' A' ' 119' ' ' MET . 76.7 mt-10 -62.09 -34.05 75.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.137 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' B' ' 281' ' ' ALA . 21.7 mt -70.24 -48.6 56.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.86 95.87 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 16.8 tpt85 -62.27 -40.42 96.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.544 -0.974 . . . . 0.0 109.244 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.499 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -69.46 -41.48 76.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 108.937 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.41 -39.64 22.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -77.53 -51.38 10.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.924 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.49 -6.11 9.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.949 -1.094 . . . . 0.0 108.834 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.44 26.0 28.97 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.518 ' O ' HG13 ' B' ' 304' ' ' ILE . 43.7 mttp -84.29 147.32 49.96 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.849 -1.383 . . . . 0.0 107.667 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 302' ' ' LYS . 83.6 Cg_exo -38.26 116.15 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.805 1.67 . . . . 0.0 110.856 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 302' ' ' LYS . 3.6 mt -115.76 98.54 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 0.0 111.467 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 280' ' ' VAL . 58.0 tp -94.45 120.85 35.31 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 131.6 54.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.77 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.5 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 3.3 mt -123.48 130.62 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 111.429 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -131.36 151.4 51.56 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.556 ' H ' HG23 ' B' ' 284' ' ' THR . 49.6 mtm180 -114.7 135.88 22.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.026 -1.046 . . . . 0.0 110.185 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.06 -29.37 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 111.381 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' B' ' 312' ' ' SER . 12.1 pt20 -60.32 -45.92 91.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.526 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 16.6 t -76.44 -21.84 55.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.559 ' O ' ' NE ' ' B' ' 314' ' ' ARG . . . 55.82 110.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' B' ' 315' ' ' VAL . 0.0 OUTLIER -144.57 -7.72 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.434 -1.039 . . . . 0.0 110.244 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.568 ' C ' ' O ' ' B' ' 314' ' ' ARG . 86.5 t 33.09 90.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.948 ' H ' HD23 ' B' ' 316' ' ' LEU . 0.2 OUTLIER -60.89 172.23 1.02 Allowed 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.77 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 28.8 t -65.02 141.28 58.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.039 -1.038 . . . . 0.0 111.736 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.38 -32.99 63.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.493 ' SD ' ' CG ' ' A' ' 93' ' ' GLU . 1.8 mtp -64.21 -43.67 94.28 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.597 -0.689 . . . . 0.0 109.319 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 92' ' ' TYR . 4.3 mm -61.49 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -64.82 -44.36 90.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.19 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -58.51 -32.06 68.04 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -52.08 -57.43 9.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -1.178 . . . . 0.0 108.326 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.583 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 10.36 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' B' ' 323' ' ' ALA . 2.0 m-20 -69.12 -35.07 76.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.793 -1.192 . . . . 0.0 107.855 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.803 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.32 174.02 40.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 7.1 t 60.58 -30.92 0.06 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.637 1.208 . . . . 0.0 108.718 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.803 ' H ' ' C ' ' B' ' 326' ' ' GLY . 8.5 mtm180 -147.22 1.04 0.73 Allowed 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.518 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' GLY . 12.1 t80 -157.0 112.83 2.91 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.509 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 91.0 mt-30 -139.23 142.42 37.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.423 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.12 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.509 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 18.3 m0 -94.4 147.24 23.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.28 151.09 21.88 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 7.9 p90 -171.36 177.65 3.48 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.659 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -142.13 147.13 36.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 335' ' ' ALA . 41.3 mt-10 -39.27 -25.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.575 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -86.19 -2.36 85.73 Favored Glycine 0 N--CA 1.495 2.599 0 O-C-N 120.999 -1.063 . . . . 0.0 111.208 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -136.27 0.46 2.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.843 -1.386 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 0.9 OUTLIER -55.59 -47.19 79.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.821 -1.174 . . . . 0.0 108.413 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 30.1 mt-10 -52.67 -33.53 47.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.3 m -69.21 -41.01 77.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 12.7 mmt -53.16 -51.64 61.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 47.4 mt -62.07 -32.61 73.17 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.81 -43.84 87.44 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.326 -0.859 . . . . 0.0 110.587 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -71.81 -48.0 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.527 -1.358 . . . . 0.0 109.216 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.15 -49.02 79.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 110.454 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 20.9 m-85 -71.46 -29.0 64.35 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.219 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -65.98 -31.13 71.86 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.09 9.17 10.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.6 t80 -134.47 -104.21 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.201 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' B' ' 350' ' ' TYR . 21.6 mt -32.91 91.08 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.891 -0.506 . . . . 0.0 110.955 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' TYR . 72.2 Cg_endo . . . . . 0 C--N 1.312 -1.348 0 C-N-CA 123.239 2.626 . . . . 0.0 111.301 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.4 Cg_exo -56.3 -158.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.967 1.778 . . . . 0.0 110.987 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 31.1 p -111.72 174.55 5.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.683 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 m -113.45 157.02 22.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.15 134.03 47.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.464 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 9.5 t80 -111.84 95.5 5.52 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.646 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.05 118.29 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.78 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -125.21 -130.0 3.43 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t 156.57 111.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.405 -1.056 . . . . 0.0 109.42 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.705 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 108.883 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLN . 2.0 tpp85 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -52.03 -37.06 52.24 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 25' ' ' GLN . 35.4 p-10 -68.24 -31.55 71.12 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.723 HE21 ' N ' ' A' ' 50' ' ' GLU . 31.5 tt0 -60.9 -42.73 98.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.6 68.22 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.01 -27.85 65.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' VAL . 17.3 m-30 -70.93 -53.59 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -58.43 -35.43 72.08 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.425 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.66 -58.49 3.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.07 . . . . 0.0 108.673 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.4 mt -51.59 -42.78 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.879 HG13 HG11 ' A' ' 41' ' ' VAL . 47.2 t -62.45 -30.03 48.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -69.17 -40.69 77.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.174 -0.954 . . . . 0.0 109.71 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' A' ' 139' ' ' VAL . 95.2 mtt180 -70.29 -49.17 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 108.895 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.05 -39.71 82.88 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 41' ' ' VAL . 48.5 ttt85 -63.1 -24.5 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -76.23 -37.84 57.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.958 -1.089 . . . . 0.0 109.247 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.4 m-85 -68.45 -47.91 65.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.515 -0.74 . . . . 0.0 110.674 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -151.82 -150.31 5.32 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.32 115.48 26.83 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.115 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.879 HG11 HG13 ' A' ' 32' ' ' VAL . 2.7 t -78.29 103.06 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 2.0 mt -47.14 126.33 9.03 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.001 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' LEU . 43.1 m -38.57 138.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.815 0.817 . . . . 0.0 111.131 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' VAL . 26.5 mt-10 -149.46 101.93 3.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 49' ' ' ALA . 18.6 t-80 -43.19 -19.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.738 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 44' ' ' GLU . 87.5 t -46.03 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.05 -39.54 66.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.861 -1.15 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.941 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.72 21.07 0.16 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -86.69 -19.41 29.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 108.859 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.723 ' N ' HE21 ' A' ' 25' ' ' GLN . 57.1 mt-10 -62.11 7.33 0.06 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -88.86 134.87 33.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 51' ' ' LEU . 7.3 mm-40 54.9 159.61 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' C ' HD22 ' A' ' 54' ' ' LEU . 89.0 Cg_exo -38.56 153.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.562 2.175 . . . . 0.0 112.258 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 53' ' ' PRO . 3.9 mm? -112.7 154.69 25.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.379 -0.826 . . . . 0.0 109.726 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 137.48 41.81 0.1 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 49.16 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -1.062 . . . . 0.0 109.256 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 55' ' ' GLY . 50.5 tp10 -48.53 -26.17 2.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.61 44.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.18 179.67 5.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.755 . . . . 0.0 109.474 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.18 62.75 0.51 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.87 79.14 0.87 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -49.31 -38.16 26.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.13 -1.217 . . . . 0.0 107.803 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 9.5 mp0 -59.86 -41.16 90.87 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -54.4 -38.86 66.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.642 -1.286 . . . . 0.0 108.835 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -46.57 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -71.91 -61.97 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 110.44 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 79.1 mm-40 -43.71 -52.17 6.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.09 -41.95 99.5 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.024 -1.048 . . . . 0.0 109.628 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.458 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 77.9 m-20 -66.52 -40.92 89.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 111.605 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -68.01 -51.85 42.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -178.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -60.14 -46.55 89.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.632 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -64.79 -45.78 84.82 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.027 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 59.0 tp -52.44 -34.17 47.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.975 -1.078 . . . . 0.0 108.45 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -78.04 -32.01 50.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.508 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.632 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 29.3 mt-30 -87.66 -0.68 57.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.875 -1.141 . . . . 0.0 109.23 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -62.83 125.71 24.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 112.122 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 11' ' ' SER . 82.7 m-20 -76.09 -35.44 59.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 79' ' ' VAL . 90.4 t -132.91 155.29 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 78' ' ' VAL . 58.8 t -142.18 139.33 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.812 -1.18 . . . . 0.0 111.931 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.62 158.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -153.53 148.85 27.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.495 -1.378 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.636 ' O ' HG11 ' A' ' 90' ' ' VAL . 7.8 mt-10 -113.08 124.29 52.25 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.519 ' HB ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -122.6 26.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 110.136 -179.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 83' ' ' VAL . 62.8 m -43.49 -69.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.992 -1.067 . . . . 0.0 109.043 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.52 149.05 38.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 108.689 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HA ' HD23 ' B' ' 288' ' ' LEU . 6.3 Cg_endo -51.72 91.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.168 1.912 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.514 ' OG ' HG23 ' A' ' 90' ' ' VAL . 32.8 t -99.36 135.4 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 110.632 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 286' ' ' PRO . 0.2 OUTLIER -76.55 -40.24 50.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 109.07 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.92 93.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.7 t -71.33 -39.29 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.29 . . . . 0.0 109.914 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -47.86 87.77 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -67.81 -44.73 76.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.642 -0.916 . . . . 0.0 109.603 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.94 -30.59 71.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.253 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.2 mt -73.04 -39.5 65.9 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 108.668 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.24 99.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.26 -42.14 99.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.417 -1.049 . . . . 0.0 109.156 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.1 -38.53 82.39 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.161 -0.962 . . . . 0.0 108.814 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -55.76 -42.73 71.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.773 -1.205 . . . . 0.0 108.518 179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -75.02 -50.12 17.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 112.509 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.2 pp -118.34 -24.97 6.69 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.122 -0.986 . . . . 0.0 110.566 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -47.33 166.17 0.12 Allowed Glycine 0 C--N 1.29 -1.972 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 1.5 mptm? -117.68 -85.86 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 51.5 Cg_endo -85.22 102.3 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 121.387 1.531 . . . . 0.0 109.431 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 ' HB1' ' A' ' 97' ' ' ALA . 15.2 mt -102.05 98.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.805 -1.184 . . . . 0.0 111.187 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 tp -94.27 118.9 32.27 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.7 OUTLIER -106.73 154.06 21.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.022 -1.049 . . . . 0.0 108.895 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.519 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 17.4 mt -125.3 137.46 54.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 110.263 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -137.41 117.84 13.77 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 0.1 OUTLIER -75.02 123.34 88.86 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 0.0 110.562 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 88.4 Cg_endo -82.7 -31.41 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.326 2.017 . . . . 0.0 110.663 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 13.7 pt20 -49.75 -35.06 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.446 ' HB3' HH11 ' A' ' 114' ' ' ARG . 53.1 m -97.82 -14.65 20.64 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.39 51.57 4.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 115' ' ' VAL . 42.2 mtp85 -83.58 13.3 4.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.049 -1.265 . . . . 0.0 110.279 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' ARG . 54.1 t 54.31 107.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 0.0 110.138 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 131' ' ' VAL . 19.4 tp -46.34 -71.96 0.06 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 164.47 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.21 82.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.981 -1.074 . . . . 0.0 109.789 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 119' ' ' MET . 17.9 mmm -66.38 -50.58 63.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 116' ' ' LEU . 35.5 mm -63.68 -41.16 91.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 108.93 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HG2' HD23 ' A' ' 116' ' ' LEU . 18.5 mmt85 -62.42 -44.02 97.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 109.604 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -64.68 -36.12 92.75 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.221 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 129' ' ' PHE . . . -53.75 -23.06 10.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.061 -1.258 . . . . 0.0 107.98 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 121' ' ' ARG . . . -32.48 101.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.234 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 93.1 m-20 -101.33 -30.01 11.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 108.709 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.66 -0.12 57.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.4 p -112.49 -69.39 0.87 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.58 -0.953 . . . . 0.0 108.582 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.16 -39.55 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 123' ' ' ALA . 32.1 t80 -98.37 129.18 45.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.56 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 42.1 tt0 -154.06 163.79 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.05 -1.031 . . . . 0.0 110.435 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 116' ' ' LEU . 23.3 t -125.72 112.33 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.56 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 20.6 m0 -105.02 145.0 31.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 108.944 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 43.4 p30 -89.78 154.23 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.802 -1.186 . . . . 0.0 109.16 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.4 p90 -163.85 -174.49 3.66 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.898 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -152.86 148.11 26.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 135' ' ' ALA . 47.7 mt-10 -36.71 -37.8 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.928 -1.107 . . . . 0.0 110.259 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.46 19.04 38.36 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.446 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.644 ' N ' ' O ' ' A' ' 135' ' ' ALA . 94.5 mt-10 -142.69 -10.39 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.067 -1.255 . . . . 0.0 110.397 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 140' ' ' GLU . 8.0 p -50.89 -45.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.921 -1.112 . . . . 0.0 108.655 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' N ' HG13 ' A' ' 139' ' ' VAL . 23.2 pt-20 -60.38 -36.41 77.98 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.282 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -65.68 -46.26 79.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.486 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -47.85 64.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 38.7 mt -68.51 -31.99 71.65 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.479 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 76.9 m-20 -66.17 -42.74 88.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.536 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -69.86 -50.75 39.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.67 -1.269 . . . . 0.0 108.264 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.681 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 38' ' ' TYR . 13.2 m-85 -71.74 -33.16 68.45 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.764 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.56 28.45 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.01 -78.0 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.836 -1.146 . . . . 0.0 113.065 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 8.3 mt -61.42 -40.2 69.45 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.139 -0.975 . . . . 0.0 112.402 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 47.6 Cg_exo . . . . . 0 C--N 1.302 -1.899 0 C-N-CA 121.91 1.74 . . . . 0.0 111.733 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.48 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.072 1.848 . . . . 0.0 110.947 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.2 p -111.7 174.5 5.84 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 11.2 m -113.63 156.73 23.17 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.84 133.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 9.7 t80 -111.6 95.57 5.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -83.23 118.28 23.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -87.32 123.48 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 109.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' B' ' 217' ' ' SER . . . -126.37 -130.22 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' B' ' 216' ' ' GLY . 1.4 t 156.98 111.86 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -1.045 . . . . 0.0 109.369 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.702 ' H ' HD13 ' B' ' 218' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.721 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.44 -36.63 55.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 225' ' ' GLN . 35.3 p-10 -68.52 -31.52 70.81 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.74 HE21 ' N ' ' B' ' 250' ' ' GLU . 30.8 tt0 -60.93 -42.62 98.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.05 -48.45 68.27 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.95 -28.11 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.605 ' O ' HG23 ' B' ' 232' ' ' VAL . 17.3 m-30 -70.49 -53.6 15.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.426 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -58.53 -35.28 72.04 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.68 -58.69 3.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.923 -1.11 . . . . 0.0 108.548 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.54 -42.92 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.874 HG13 HG11 ' B' ' 241' ' ' VAL . 46.7 t -62.37 -29.82 47.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.3 p -69.34 -40.77 77.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.518 ' NH1' ' CG1' ' B' ' 339' ' ' VAL . 95.4 mtt180 -70.15 -49.47 50.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.798 -1.189 . . . . 0.0 108.903 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.69 -39.99 82.3 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 241' ' ' VAL . 49.0 ttt85 -63.02 -24.69 68.03 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -75.96 -38.06 57.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.931 -1.106 . . . . 0.0 109.329 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.4 m-85 -68.29 -48.03 66.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.559 -0.713 . . . . 0.0 110.766 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -151.56 -150.4 5.33 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -89.31 115.44 26.79 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.19 -1.183 . . . . 0.0 109.058 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.874 HG11 HG13 ' B' ' 232' ' ' VAL . 2.7 t -78.18 103.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' B' ' 272' ' ' TRP . 2.2 mt -47.55 126.8 10.44 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.929 -1.109 . . . . 0.0 108.97 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 242' ' ' LEU . 42.1 m -39.16 137.99 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 111.133 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 246' ' ' VAL . 26.8 mt-10 -148.81 101.84 3.23 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 249' ' ' ALA . 18.3 t-80 -43.1 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 109.864 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 244' ' ' GLU . 82.6 t -46.11 -84.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -54.16 -40.01 67.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.823 -1.173 . . . . 0.0 108.927 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.927 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -75.38 20.91 0.14 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -86.22 -19.88 29.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.818 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.74 ' N ' HE21 ' B' ' 225' ' ' GLN . 59.1 mt-10 -61.77 7.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 248' ' ' ASP . 0.6 OUTLIER -88.87 134.48 33.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' B' ' 251' ' ' LEU . 7.0 mm-40 54.75 159.19 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.204 -0.935 . . . . 0.0 109.409 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.499 ' C ' HD22 ' B' ' 254' ' ' LEU . 97.7 Cg_exo -37.93 152.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.67 2.247 . . . . 0.0 112.439 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.499 HD22 ' C ' ' B' ' 253' ' ' PRO . 3.9 mm? -112.68 154.1 26.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.652 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 138.28 41.34 0.1 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 49.83 -82.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -1.045 . . . . 0.0 109.104 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' B' ' 255' ' ' GLY . 50.8 tp10 -48.87 -26.72 2.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 108.504 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' B' ' 253' ' ' PRO . . . -80.13 45.02 0.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -129.18 -179.32 5.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.461 -0.774 . . . . 0.0 109.298 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.56 63.14 0.54 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 113.61 78.75 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -49.22 -37.94 24.69 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . 0.5 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 10.2 mp0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -54.48 -38.67 66.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.718 -1.239 . . . . 0.0 108.876 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.8 OUTLIER -65.9 -46.84 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.9 OUTLIER -71.97 -62.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.626 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 79.4 mm-40 -43.17 -52.39 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -62.97 -41.71 99.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.474 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 80.9 m-20 -66.67 -40.92 88.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 111.522 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.2 OUTLIER -68.13 -51.68 43.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.021 -1.05 . . . . 0.0 110.2 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -60.4 -46.4 90.11 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.133 -0.979 . . . . 0.0 109.576 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.633 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.1 OUTLIER -64.85 -46.25 82.68 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.477 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 59.8 tp -52.06 -34.03 41.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.42 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.34 -32.16 48.96 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.633 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 29.2 mt-30 -87.25 -0.81 57.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.891 -1.131 . . . . 0.0 109.286 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' B' ' 213' ' ' TYR . . . -62.79 125.73 24.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.24 -0.913 . . . . 0.0 112.159 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.688 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.9 m-20 -76.04 -35.75 59.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.407 HG12 ' N ' ' B' ' 279' ' ' VAL . 88.8 t -132.65 155.08 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.407 ' N ' HG12 ' B' ' 278' ' ' VAL . 60.1 t -141.96 139.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 111.832 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 24.4 t -137.93 158.25 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.486 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.599 -1.313 . . . . 0.0 110.322 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.639 ' O ' HG11 ' B' ' 290' ' ' VAL . 8.8 mt-10 -113.84 123.58 50.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' B' ' 316' ' ' LEU . 0.0 OUTLIER -122.1 26.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.041 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.445 HG23 ' HB2' ' B' ' 309' ' ' ARG . 66.5 m -43.21 -69.7 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.01 -1.056 . . . . 0.0 109.019 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -91.51 149.22 39.05 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 108.756 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.574 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.9 Cg_endo -52.38 91.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.027 1.818 . . . . 0.0 111.262 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.514 ' OG ' HG23 ' B' ' 290' ' ' VAL . 34.3 t -99.92 135.31 41.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -76.25 -39.67 53.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.533 -0.73 . . . . 0.0 109.206 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.3 -40.3 91.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.639 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.5 t -71.11 -39.41 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.053 -1.263 . . . . 0.0 109.961 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.76 -47.53 89.7 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -68.02 -45.24 74.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 0.0 109.649 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.4 -30.88 70.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.1 mt -72.56 -39.76 67.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 108.732 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -63.58 -41.78 99.03 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.463 -1.022 . . . . 0.0 109.175 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.517 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -68.23 -38.67 82.11 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.143 -0.973 . . . . 0.0 108.792 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -55.87 -42.42 70.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.732 -1.23 . . . . 0.0 108.481 179.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.25 -50.0 17.53 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.2 pp -118.67 -24.93 6.54 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 0.0 110.422 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -47.16 166.45 0.1 Allowed Glycine 0 C--N 1.289 -2.079 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 1.5 mptm? -117.96 -85.87 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 49.6 Cg_endo -85.23 102.32 0.76 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 121.42 1.543 . . . . 0.0 109.378 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.517 HG12 ' HB1' ' B' ' 297' ' ' ALA . 14.8 mt -102.15 98.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.237 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 35.4 tp -93.98 118.4 31.44 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.42 153.79 21.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.009 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 17.0 mt -124.92 138.02 54.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.26 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -137.85 117.85 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.578 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 0.1 OUTLIER -74.92 123.39 88.93 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.494 -0.754 . . . . 0.0 110.536 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.6 Cg_endo -82.82 -31.7 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.381 2.054 . . . . 0.0 110.763 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.578 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 13.3 pt20 -49.65 -34.88 19.54 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.444 ' OG ' ' NH2' ' B' ' 309' ' ' ARG . 49.8 m -97.86 -14.66 20.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 41.35 51.55 4.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' B' ' 315' ' ' VAL . 42.2 mtp85 -83.49 13.32 4.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.988 -1.301 . . . . 0.0 110.221 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.4 t 54.51 106.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 110.054 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.857 HD22 HG11 ' B' ' 331' ' ' VAL . 19.0 tp -46.36 -72.12 0.06 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.64 -0.662 . . . . 0.0 109.305 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 1.0 OUTLIER 164.75 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.08 -43.85 81.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 109.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' B' ' 319' ' ' MET . 17.7 mmm -66.07 -50.79 62.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.278 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.784 HG22 HD21 ' B' ' 316' ' ' LEU . 34.9 mm -63.4 -41.26 92.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 108.905 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.68 ' HG2' HD23 ' B' ' 316' ' ' LEU . 18.8 mmt85 -62.46 -43.62 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.947 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -64.64 -36.67 93.42 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 329' ' ' PHE . . . -53.34 -23.38 9.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.061 -1.258 . . . . 0.0 108.066 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -32.33 101.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.248 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 92.3 m-20 -101.84 -30.04 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 108.705 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.62 0.09 57.69 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 12.9 p -112.99 -69.95 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.981 . . . . 0.0 108.462 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -107.24 -39.77 5.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 323' ' ' ALA . 31.2 t80 -98.57 128.92 45.07 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 43.2 tt0 -153.49 164.29 38.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . 0.857 HG11 HD22 ' B' ' 316' ' ' LEU . 25.5 t -126.11 112.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 20.5 m0 -105.15 144.97 31.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.903 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' B' ' 333' ' ' ASP . 42.0 p30 -90.03 154.35 19.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 0.0 109.202 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 5.6 p90 -163.73 -174.28 3.61 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.64 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -152.95 148.05 26.66 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.8 mt-10 -36.79 -37.49 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.11 . . . . 0.0 110.198 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -88.68 19.56 36.4 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.473 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 335' ' ' ALA . 94.3 mt-10 -143.25 -10.71 0.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.073 -1.251 . . . . 0.0 110.491 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 340' ' ' GLU . 7.1 p -50.95 -45.19 28.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.003 -1.061 . . . . 0.0 108.548 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.553 ' N ' HG13 ' B' ' 339' ' ' VAL . 22.7 pt-20 -60.3 -36.62 78.32 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.226 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.5 m -65.57 -46.25 80.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.173 -0.954 . . . . 0.0 109.498 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.21 -47.69 65.49 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 37.4 mt -68.52 -32.29 72.14 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.86 -42.74 90.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.005 -1.059 . . . . 0.0 110.457 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -70.01 -50.94 36.53 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.684 -1.26 . . . . 0.0 108.27 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.42 -47.03 79.88 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.462 -0.774 . . . . 0.0 109.755 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' B' ' 238' ' ' TYR . 13.7 m-85 -71.59 -33.01 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.844 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.75 -26.19 65.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -101.4 27.84 5.94 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.8 -78.16 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.78 -1.168 . . . . 0.0 113.101 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 8.3 mt -60.81 -40.76 77.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 112.334 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 48.5 Cg_exo . . . . . 0 C--N 1.302 -1.881 0 C-N-CA 122.014 1.809 . . . . 0.0 111.726 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 10' ' ' CYS . 50.1 Cg_endo -71.01 155.54 61.62 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.357 2.038 . . . . 0.0 111.228 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' PRO . 22.6 p -52.61 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.037 -1.04 . . . . 0.0 109.16 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 5.0 p -109.19 149.3 29.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 13.0 t -139.86 131.52 33.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 69' ' ' ASP . 14.2 t80 -100.65 124.91 46.89 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -96.21 122.73 39.38 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.539 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.6 t -133.87 154.97 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 -159.53 21.71 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -96.66 139.09 33.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -1.187 . . . . 0.0 108.724 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.104 . . . . 0.0 110.822 -179.258 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.585 ' NH2' ' NE2' ' A' ' 85' ' ' GLN . 50.1 mtp85 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 122.001 0.905 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.71 -24.29 14.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 80.0 m-20 -69.84 -32.25 70.55 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.611 ' NE2' ' O ' ' A' ' 49' ' ' ALA . 5.9 mt-30 -64.78 -40.2 94.87 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.07 -52.47 34.9 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.31 -29.83 64.25 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.614 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m-30 -69.18 -44.46 72.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 110.295 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.11 83.34 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.488 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.599 ' NE ' HH22 ' A' ' 34' ' ' ARG . 60.0 ttt180 -71.26 -56.69 5.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.928 -1.108 . . . . 0.0 108.146 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HH11 ' A' ' 34' ' ' ARG . 12.1 mt -52.85 -45.33 50.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 28' ' ' TYR . 42.1 t -60.66 -27.58 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -68.87 -36.68 78.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.389 -0.819 . . . . 0.0 109.367 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.599 HH22 ' NE ' ' A' ' 30' ' ' ARG . 77.4 mtt85 -68.6 -47.96 65.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.597 -1.314 . . . . 0.0 107.849 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.673 HD22 HG11 ' A' ' 12' ' ' VAL . 3.1 mt -62.3 -28.91 70.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 41' ' ' VAL . 2.0 tpm_? -64.98 -29.14 70.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -70.8 -62.08 1.53 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -123.74 157.01 34.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.576 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 81.59 69.86 1.37 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.8 mtmt -36.37 131.81 0.62 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.333 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.695 ' H ' HH21 ' A' ' 36' ' ' ARG . 23.2 t -96.05 107.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.828 -1.17 . . . . 0.0 108.854 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 24.6 mt -78.79 152.94 31.11 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.204 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 45' ' ' HIS . 19.7 m 51.36 53.22 13.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -54.4 -7.22 0.14 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 43' ' ' THR . 8.5 t-80 -45.34 -31.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.6 -53.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.093 -1.004 . . . . 0.0 109.881 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -65.92 -43.47 88.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 108.714 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.789 ' O ' HD21 ' A' ' 51' ' ' LEU . 38.1 t70 -73.64 37.01 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.823 ' O ' HD21 ' A' ' 54' ' ' LEU . . . -108.97 9.48 26.49 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' HD13 ' A' ' 51' ' ' LEU . 2.3 mt-10 -104.25 3.3 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.588 -0.695 . . . . 0.0 109.719 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.0 163.16 15.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.242 -0.911 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.562 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.5 mt-10 54.46 156.69 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.499 -0.751 . . . . 0.0 109.238 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.67 122.42 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.068 1.846 . . . . 0.0 111.878 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.823 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -90.77 -164.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 90.64 130.82 4.63 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 28.3 mm-40 -49.43 -30.9 8.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.997 -1.296 . . . . 0.0 109.132 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.12 -0.68 8.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.054 -1.029 . . . . 0.0 108.993 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -65.16 149.12 50.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.494 -0.753 . . . . 0.0 109.114 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.31 0.37 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.7 -31.26 7.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.2 76.43 1.03 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 56' ' ' GLU . 91.8 m-20 -52.18 -38.14 56.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -67.22 -52.01 46.31 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -58.64 -32.64 69.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 5.3 mt -65.64 -52.26 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' ND1' ' C ' ' A' ' 66' ' ' HIS . 2.6 t-80 -66.23 -53.67 34.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.589 -0.695 . . . . 0.0 109.985 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -47.68 -57.34 5.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.991 -1.068 . . . . 0.0 109.667 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.91 -37.5 81.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -68.19 -56.69 7.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 110.763 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 66' ' ' HIS . 6.5 tp -58.84 -40.61 84.73 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.47 -0.769 . . . . 0.0 110.313 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 90.8 m-20 -65.33 -58.84 4.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.007 -1.058 . . . . 0.0 109.253 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.463 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -57.2 -40.78 78.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -50.72 -41.05 55.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -72.54 -26.18 61.65 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.807 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 19.3 mt-30 -90.76 1.26 57.04 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.965 -1.084 . . . . 0.0 108.826 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.03 122.72 23.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.381 -0.825 . . . . 0.0 111.748 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 11' ' ' SER . 89.7 m-20 -69.95 -35.74 74.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 t -135.16 141.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.65 120.13 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.825 -1.172 . . . . 0.0 111.805 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -116.0 120.16 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.693 0.758 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.28 158.37 35.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.444 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 30.0 tt0 -97.07 128.27 43.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -107.64 28.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.756 . . . . 0.0 110.135 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 109' ' ' ARG . 5.2 m -79.67 -77.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.446 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.585 ' NE2' ' NH2' ' A' ' 22' ' ' ARG . 6.3 mm100 -64.33 136.39 96.73 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' B' ' 286' ' ' PRO . 72.9 Cg_endo -77.43 88.09 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 111.716 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -121.77 139.58 53.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.16 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' H ' ' B' ' 287' ' ' SER . 16.1 mt -59.45 -42.1 91.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.182 -0.949 . . . . 0.0 108.677 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.6 -30.9 56.99 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 87' ' ' SER . 80.7 t -75.44 -57.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.63 -0.924 . . . . 0.0 108.904 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.29 -36.31 89.34 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 88' ' ' LEU . 75.5 t80 -65.56 -52.54 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.088 . . . . 0.0 109.129 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' OE2' ' OD1' ' A' ' 69' ' ' ASP . 1.8 tp10 -58.75 -34.82 71.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.338 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 94' ' ' LEU . 18.2 mt -74.63 -41.08 61.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.99 . . . . 0.0 108.742 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -34.52 89.47 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.686 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.79 -43.17 80.36 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.626 -0.926 . . . . 0.0 109.176 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.663 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -69.86 -42.0 74.09 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.521 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -37.92 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -49.76 35.41 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -126.53 -34.71 2.43 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.145 -0.972 . . . . 0.0 109.885 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -73.82 102.61 1.34 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.615 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.72 -69.78 0.31 Allowed Pre-proline 0 C--N 1.288 -2.092 0 O-C-N 121.595 -0.944 . . . . 0.0 110.871 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 31.5 Cg_endo -65.64 109.01 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.573 1.515 . . . . 0.0 110.841 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' HD1' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.63 119.38 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 110.777 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 132' ' ' TRP . 46.0 tp -105.26 119.45 39.1 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -107.46 139.48 41.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.012 . . . . 0.0 108.566 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 11.6 mt -126.82 124.19 39.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -124.0 154.5 39.76 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' OE2' ' A' ' 136' ' ' GLU . 50.2 mtm180 -109.82 141.23 23.29 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.835 -1.166 . . . . 0.0 110.95 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.43 -29.32 3.08 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.812 2.341 . . . . 0.0 111.384 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 112' ' ' SER . 19.3 pt20 -46.5 -40.46 12.55 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.444 ' HB3' ' NE ' ' A' ' 114' ' ' ARG . 2.7 m -98.41 -23.1 15.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 50.07 40.57 36.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NE ' ' HB3' ' A' ' 112' ' ' SER . 7.6 mmt180 -51.0 -8.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.862 -1.375 . . . . 0.0 109.364 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 113' ' ' GLY . 23.4 t 64.1 99.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.963 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' HD22 ' A' ' 116' ' ' LEU . 4.1 mm? -37.97 128.25 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.3 t -51.3 147.75 5.45 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.104 -0.998 . . . . 0.0 109.094 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.68 78.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.982 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 0.1 OUTLIER -67.03 -42.31 85.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 109.359 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 35.8 mm -66.58 -46.38 86.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.054 -1.029 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 121' ' ' ARG . 0.3 OUTLIER -62.04 -47.77 83.24 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' B' ' 266' ' ' HIS . . . -58.56 -36.68 86.23 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 124' ' ' ALA . . . -50.42 -61.85 1.94 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 123' ' ' ALA . . . 155.34 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.306 1.05 . . . . 0.0 112.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.695 ' HA ' ' H ' ' A' ' 131' ' ' VAL . 55.7 p30 -126.27 26.69 6.39 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -178.08 149.88 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.77 ' C ' ' H ' ' A' ' 129' ' ' PHE . 4.2 t 96.88 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 117.935 0.868 . . . . 0.0 109.044 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 61.68 -19.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.77 ' H ' ' C ' ' A' ' 127' ' ' SER . 82.0 t80 -120.39 121.9 39.57 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.465 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 18.1 mt-30 -139.68 132.35 28.92 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.122 -1.431 . . . . 0.0 111.656 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.695 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 73.3 t -105.32 101.62 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 130' ' ' GLN . 22.8 m0 -98.37 155.66 17.12 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 110.771 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -107.51 147.74 30.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 139' ' ' VAL . 6.6 p90 -164.14 -175.73 4.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.848 -1.158 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.665 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -155.27 158.09 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.538 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 15.3 mt-10 -58.1 23.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.438 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -119.16 -11.46 7.49 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.684 ' O ' ' SD ' ' A' ' 142' ' ' MET . 5.7 pt-20 -153.96 16.2 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.997 -1.296 . . . . 0.0 110.202 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' MET . 3.5 p -51.05 -41.97 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.189 -0.944 . . . . 0.0 109.117 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 81.2 tt0 -61.63 -27.89 68.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.003 -1.061 . . . . 0.0 109.125 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.3 m -73.96 -48.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 110.444 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.684 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -54.41 -48.62 71.4 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 143' ' ' LEU . 92.8 mt -57.69 -38.66 75.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 45.2 t0 -63.08 -37.97 89.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -70.61 -53.38 16.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.62 -1.3 . . . . 0.0 108.773 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.422 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 67.3 t80 -58.16 -48.23 80.91 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 17.9 m-85 -70.48 -31.13 68.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.998 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 38.7 mt-10 -59.69 -29.89 68.4 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 17.62 10.19 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.48 -21.44 0.33 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.833 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 85.2 mt -120.34 39.84 0.37 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.527 -1.358 . . . . 0.0 111.776 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 92.4 Cg_endo . . . . . 0 C--N 1.309 -1.539 0 C-N-CA 122.223 1.949 . . . . 0.0 110.526 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' B' ' 210' ' ' CYS . 45.7 Cg_endo -70.56 155.9 62.35 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.389 2.059 . . . . 0.0 111.185 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' B' ' 209' ' ' PRO . 23.9 p -52.82 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.028 -1.045 . . . . 0.0 109.15 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.487 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 7.3 p -109.21 148.85 30.27 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 12.9 t -139.63 131.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' B' ' 269' ' ' ASP . 13.8 t80 -100.8 124.36 46.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.343 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -95.48 122.89 38.68 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.553 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 21.7 t -133.95 155.02 50.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.252 -0.905 . . . . 0.0 110.082 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -175.73 -159.83 22.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 25.1 p -96.32 138.9 33.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.222 -1.163 . . . . 0.0 108.888 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 120.928 -1.108 . . . . 0.0 110.797 -179.204 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.589 ' NH2' ' NE2' ' B' ' 285' ' ' GLN . 51.5 mtp85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.991 0.901 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.31 -24.95 13.11 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.5 m-20 -69.48 -32.06 70.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.591 ' NE2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-30 -65.02 -39.92 94.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.42 -52.42 32.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.13 -30.0 64.04 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.614 ' O ' HG23 ' B' ' 232' ' ' VAL . 10.0 m-30 -69.09 -44.56 72.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.681 -0.637 . . . . 0.0 110.295 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.07 83.13 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.507 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.585 ' NE ' HH22 ' B' ' 234' ' ' ARG . 60.3 ttt180 -71.32 -56.81 5.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.082 . . . . 0.0 108.115 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.525 ' HA ' HH11 ' B' ' 234' ' ' ARG . 12.1 mt -52.77 -45.35 49.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 228' ' ' TYR . 41.8 t -60.48 -27.72 40.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -68.79 -36.84 78.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.431 -0.793 . . . . 0.0 109.405 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.585 HH22 ' NE ' ' B' ' 230' ' ' ARG . 77.5 mtt85 -68.38 -47.91 66.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.287 . . . . 0.0 107.831 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.657 HD22 HG11 ' B' ' 212' ' ' VAL . 3.0 mt -62.33 -29.08 70.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.718 HH21 ' H ' ' B' ' 241' ' ' VAL . 2.1 tpm_? -64.89 -29.34 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -70.57 -61.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.8 OUTLIER -123.81 156.92 35.25 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 81.73 69.84 1.37 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' B' ' 239' ' ' GLY . 50.6 mtmt -36.58 131.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.347 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.718 ' H ' HH21 ' B' ' 236' ' ' ARG . 24.1 t -96.23 107.71 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.859 -1.15 . . . . 0.0 108.835 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.466 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 24.4 mt -78.67 153.71 30.76 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.494 ' C ' ' H ' ' B' ' 245' ' ' HIS . 22.5 m 50.62 53.25 13.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.71 -7.08 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.078 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' B' ' 245' ' ' HIS . 8.1 t-80 -45.59 -30.97 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.34 -52.91 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.74 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -66.14 -43.56 86.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 108.847 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.8 ' O ' HD21 ' B' ' 251' ' ' LEU . 36.0 t70 -73.58 37.08 0.09 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.816 ' O ' HD21 ' B' ' 254' ' ' LEU . . . -109.16 9.84 26.01 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.412 ' C ' HD13 ' B' ' 251' ' ' LEU . 2.3 mt-10 -104.44 3.11 31.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.946 HD13 ' N ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -112.69 163.31 14.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.269 -0.894 . . . . 0.0 109.643 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 47.6 mt-10 54.57 156.78 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.467 -0.771 . . . . 0.0 109.339 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -40.91 121.96 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.034 1.822 . . . . 0.0 111.795 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.816 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.0 OUTLIER -90.4 -164.19 1.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 90.38 130.49 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' B' ' 262' ' ' ASP . 28.4 mm-40 -49.34 -31.47 9.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.066 -1.256 . . . . 0.0 109.275 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.36 -1.15 7.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 0.0 108.782 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -64.38 148.85 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.166 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.52 4.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -47.23 -30.85 5.88 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.0 76.05 1.01 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' B' ' 256' ' ' GLU . 94.7 m-20 -52.01 -38.2 56.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -67.25 -51.85 48.09 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -58.91 -32.53 69.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' B' ' 269' ' ' ASP . 5.0 mt -65.64 -51.86 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.496 ' C ' ' ND1' ' B' ' 266' ' ' HIS . 2.5 t-80 -66.71 -53.61 31.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.59 -57.37 5.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.647 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -67.77 -37.86 82.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.505 ' OD2' ' OH ' ' B' ' 213' ' ' TYR . 0.4 OUTLIER -68.0 -56.83 7.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.08 -1.012 . . . . 0.0 110.785 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' B' ' 266' ' ' HIS . 6.5 tp -58.76 -40.36 83.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 88.8 m-20 -65.43 -58.74 5.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.074 -1.016 . . . . 0.0 109.158 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.12 -41.17 78.53 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 13.0 tp -50.36 -41.31 51.42 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -72.43 -26.18 61.74 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 18.6 mt-30 -90.68 1.03 57.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.012 -1.055 . . . . 0.0 108.725 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.56 122.82 22.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.497 -0.752 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' B' ' 211' ' ' SER . 89.2 m-20 -70.14 -35.76 74.28 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 51.1 t -135.37 141.4 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.61 120.25 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.69 -1.256 . . . . 0.0 111.61 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.79 120.12 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.594 -0.692 . . . . 0.0 109.514 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -126.12 159.2 33.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 109.881 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.448 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 30.5 tt0 -97.87 128.76 44.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.419 HG13 HD11 ' B' ' 294' ' ' LEU . 0.0 OUTLIER -107.95 27.86 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.307 -0.87 . . . . 0.0 110.095 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 309' ' ' ARG . 5.4 m -79.17 -76.99 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.589 ' NE2' ' NH2' ' B' ' 222' ' ' ARG . 6.5 mm100 -64.53 136.26 96.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.494 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' PRO . 73.1 Cg_endo -77.33 87.58 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.341 2.027 . . . . 0.0 111.839 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.619 ' HB3' HG23 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -121.4 139.84 52.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 87' ' ' SER . 15.0 mt -59.31 -41.82 89.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.115 -0.991 . . . . 0.0 108.777 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.19 -30.92 58.68 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' B' ' 287' ' ' SER . 89.9 t -75.15 -57.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.545 -0.974 . . . . 0.0 108.8 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.12 90.62 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' B' ' 288' ' ' LEU . 74.9 t80 -66.15 -52.76 45.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -1.131 . . . . 0.0 109.222 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.476 ' OE1' ' SD ' ' A' ' 119' ' ' MET . 1.7 tp10 -58.37 -34.91 71.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' B' ' 294' ' ' LEU . 18.1 mt -74.44 -41.4 60.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 108.796 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.3 -34.44 89.25 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.671 ' HA ' ' HE ' ' B' ' 296' ' ' ARG . 0.4 OUTLIER -67.96 -42.68 80.54 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.625 -0.926 . . . . 0.0 109.186 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.659 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -70.24 -41.88 72.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.493 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -37.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -72.13 -49.88 32.42 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.354 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.603 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -126.21 -34.51 2.51 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -74.03 102.44 1.34 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.603 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -72.57 -69.86 0.31 Allowed Pre-proline 0 C--N 1.288 -2.087 0 O-C-N 121.651 -0.911 . . . . 0.0 110.841 -177.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 31.7 Cg_endo -65.64 109.07 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.508 1.472 . . . . 0.0 110.849 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -135.43 119.11 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.087 -1.008 . . . . 0.0 110.754 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' B' ' 332' ' ' TRP . 47.6 tp -105.22 119.4 38.98 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -107.5 140.8 39.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.007 . . . . 0.0 108.622 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 11.8 mt -127.91 124.34 37.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -124.13 154.58 39.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.542 ' NH1' ' OE2' ' B' ' 336' ' ' GLU . 52.1 mtm180 -109.78 140.82 22.59 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 111.006 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.29 -29.62 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.643 2.229 . . . . 0.0 111.428 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.446 ' CG ' ' N ' ' B' ' 312' ' ' SER . 19.4 pt20 -45.96 -40.66 10.62 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 2.6 m -98.12 -23.34 15.77 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 50.5 40.73 39.98 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.445 ' NE ' ' HB3' ' B' ' 312' ' ' SER . 7.7 mmt180 -51.36 -8.33 0.05 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.965 -1.315 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 313' ' ' GLY . 22.6 t 64.11 99.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.537 -0.727 . . . . 0.0 110.039 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.599 ' H ' HD22 ' B' ' 316' ' ' LEU . 4.1 mm? -38.33 128.46 1.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.1 t -51.51 148.18 5.44 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.059 -1.026 . . . . 0.0 109.215 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.74 78.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 109.88 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -67.21 -42.76 83.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' B' ' 323' ' ' ALA . 35.6 mm -66.09 -46.11 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.899 -1.125 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' B' ' 321' ' ' ARG . 0.3 OUTLIER -62.42 -47.82 82.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -58.09 -36.64 82.69 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.771 ' O ' ' HB2' ' B' ' 324' ' ' ALA . . . -50.68 -62.18 1.75 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' B' ' 323' ' ' ALA . . . 155.72 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.284 1.04 . . . . 0.0 112.157 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.692 ' HA ' ' H ' ' B' ' 331' ' ' VAL . 56.5 p30 -126.33 27.04 6.29 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -178.3 150.06 9.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.749 ' C ' ' H ' ' B' ' 329' ' ' PHE . 4.1 t 96.51 71.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.632 -0.923 . . . . 0.0 109.089 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 61.71 -19.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.749 ' H ' ' C ' ' B' ' 327' ' ' SER . 81.2 t80 -120.02 121.33 38.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.452 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 16.8 mt-30 -139.3 132.69 30.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.051 -1.46 . . . . 0.0 111.577 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . 0.692 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 67.4 t -105.31 101.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.452 ' HE1' ' HB3' ' B' ' 330' ' ' GLN . 23.3 m0 -98.61 155.8 17.12 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.198 -0.939 . . . . 0.0 110.728 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 333' ' ' ASP . 50.6 p-10 -107.67 147.72 30.33 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.544 ' CD2' HG23 ' B' ' 339' ' ' VAL . 6.5 p90 -164.24 -175.57 4.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.903 -1.123 . . . . 0.0 111.07 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -155.18 158.37 38.82 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' B' ' 309' ' ' ARG . 17.0 mt-10 -58.42 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -118.99 -11.07 7.82 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.675 ' O ' ' SD ' ' B' ' 342' ' ' MET . 5.9 pt-20 -154.63 16.6 0.45 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.929 -1.336 . . . . 0.0 110.168 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' B' ' 342' ' ' MET . 3.6 p -51.32 -42.05 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 0.0 108.975 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 82.3 tt0 -61.44 -27.89 68.87 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.125 -0.984 . . . . 0.0 109.139 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.9 m -74.09 -48.4 29.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.395 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.675 ' SD ' ' O ' ' B' ' 338' ' ' GLU . 0.0 OUTLIER -54.64 -48.61 72.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 343' ' ' LEU . 94.1 mt -57.73 -38.39 75.21 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 45.3 t0 -63.38 -37.94 89.22 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.543 -0.723 . . . . 0.0 110.169 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -70.43 -53.28 17.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.669 -1.269 . . . . 0.0 108.784 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . 0.432 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 67.2 t80 -58.31 -47.95 82.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 18.6 m-85 -70.89 -31.11 67.66 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.999 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 38.2 mt-10 -59.48 -29.76 68.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -93.09 17.98 10.02 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -148.91 -21.39 0.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.686 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 85.5 mt -120.48 40.02 0.38 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 111.741 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 93.6 Cg_endo . . . . . 0 C--N 1.31 -1.486 0 C-N-CA 122.191 1.927 . . . . 0.0 110.408 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' ALA . 45.2 Cg_exo -53.0 -155.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.641 2.227 . . . . 0.0 111.699 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.9 p -108.05 178.07 4.62 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.431 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 3.8 m -120.87 131.67 54.53 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.842 -1.161 . . . . 0.0 108.814 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.953 HG11 HD22 ' A' ' 35' ' ' LEU . 4.6 t -102.95 126.18 57.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 79' ' ' VAL . 40.8 t80 -93.19 118.99 31.88 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.582 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.0 t80 -85.58 123.98 31.62 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.434 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 2.7 t -117.34 113.65 22.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -162.07 75.98 0.18 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 16' ' ' GLY . 30.4 t -31.8 106.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.932 . . . . 0.0 110.48 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.798 ' NH2' ' H ' ' A' ' 55' ' ' GLY . 33.6 mmt180 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.185 0.517 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -55.15 -46.8 75.73 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 17.2 m-20 -62.74 -20.5 65.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.861 HE22 ' H ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -67.25 -47.06 71.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.18 85.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.18 -37.15 74.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.4 m-30 -67.33 -41.49 85.18 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.405 -0.809 . . . . 0.0 109.69 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -60.82 -36.54 79.34 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.419 -1.425 . . . . 0.0 108.463 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 140' ' ' GLU . 70.7 ttt-85 -72.56 -57.38 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.1 -40.74 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' TYR . 52.3 t -64.62 -29.35 47.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 10.2 m -67.8 -37.15 81.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.39 -0.819 . . . . 0.0 109.646 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.41 -52.11 24.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.671 -1.268 . . . . 0.0 108.755 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 12' ' ' VAL . 16.6 mt -57.48 -40.21 78.08 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -61.36 -25.32 67.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.73 -31.05 32.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 0.0 109.745 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.564 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.8 m-85 -75.18 -52.67 10.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.242 -0.911 . . . . 0.0 110.946 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.34 -147.05 4.46 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -89.81 129.04 36.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.4 -1.059 . . . . 0.0 109.006 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 32' ' ' VAL . 2.8 t -93.77 106.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.886 -1.134 . . . . 0.0 107.974 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 20.5 mt -72.38 -176.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.543 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 1.7 m 55.82 39.67 30.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.783 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 52.3 mp0 -46.3 -25.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -49.06 -38.41 24.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.093 -1.004 . . . . 0.0 108.996 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 47' ' ' ALA . 59.2 t -61.27 170.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.861 ' H ' HE22 ' A' ' 25' ' ' GLN . . . 61.82 -71.96 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.86 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.0 t70 -67.82 28.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -106.62 12.91 28.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -108.47 11.4 26.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.336 -0.852 . . . . 0.0 109.744 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.015 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -86.08 -93.76 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.01 . . . . 0.0 110.232 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.477 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 mp0 -42.67 158.73 0.21 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 0.0 110.268 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.0 -22.16 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.647 2.232 . . . . 0.0 112.24 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.6 mm? 59.69 -172.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 109.73 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.798 ' H ' ' NH2' ' A' ' 22' ' ' ARG . . . 99.04 25.67 9.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 62' ' ' ASP . 73.4 mm-40 53.52 -74.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.781 -0.834 . . . . 0.0 109.664 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.679 ' N ' ' O ' ' A' ' 55' ' ' GLY . 86.6 tt0 -44.5 -26.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' LEU . . . -67.87 166.28 15.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.105 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.84 133.67 31.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.242 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.39 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.37 80.88 0.37 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 56' ' ' GLU . 3.0 m-20 -52.5 -44.13 65.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -1.144 . . . . 0.0 108.255 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -62.61 -49.26 75.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -60.48 -34.79 74.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 109.049 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -63.03 -53.95 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.511 ' N ' HG22 ' A' ' 65' ' ' ILE . 1.6 t-80 -65.6 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.623 -0.673 . . . . 0.0 109.666 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.1 -64.0 1.03 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -71.55 -38.95 70.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 110.138 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 10.1 m-20 -62.69 -59.25 5.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.093 -1.004 . . . . 0.0 110.351 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -61.05 -36.86 80.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.845 -1.159 . . . . 0.0 109.785 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -66.57 -52.36 46.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.565 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.484 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -43.52 87.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.133 -0.979 . . . . 0.0 108.998 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CE2' ' A' ' 13' ' ' TYR . 4.1 tt -53.47 -43.65 68.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.49 ' CG ' HH21 ' A' ' 96' ' ' ARG . 28.2 mt-30 -65.78 -29.87 70.43 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.68 -0.638 . . . . 0.0 111.258 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -103.49 11.51 36.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.626 -1.296 . . . . 0.0 109.274 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.05 138.83 48.14 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.337 -0.852 . . . . 0.0 111.694 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 11' ' ' SER . 86.4 m-20 -88.16 -25.74 22.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 69.7 t -144.99 136.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 13' ' ' TYR . 93.9 t -133.14 125.17 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.864 -1.147 . . . . 0.0 111.91 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.19 124.69 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.55 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.24 146.54 45.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.072 0.939 . . . . 0.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' HG11 ' A' ' 90' ' ' VAL . 1.3 pp20? -100.23 147.23 25.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.674 HG11 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.06 -89.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.525 HG21 ' HE ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER 64.29 -141.12 0.28 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.063 -1.648 . . . . 0.0 109.748 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 84' ' ' THR . 2.0 pt20 -43.29 148.63 0.62 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.754 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -45.24 128.0 9.45 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.131 1.888 . . . . 0.0 111.615 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.616 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 15.7 t -102.41 -121.1 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB2' ' H ' ' B' ' 287' ' ' SER . 9.9 tp 160.02 -58.66 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.06 58.72 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 82' ' ' GLU . 48.5 t -65.4 -45.25 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.48 -35.4 66.25 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.504 ' OH ' HG21 ' B' ' 298' ' ' VAL . 64.4 t80 -68.32 -56.09 9.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.46 -1.024 . . . . 0.0 109.675 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.521 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 87.0 mt-10 -57.25 -36.64 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.518 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.736 HD22 ' SG ' ' A' ' 106' ' ' CYS . 63.2 mt -60.35 -49.09 78.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.83 65.39 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' A' ' 74' ' ' GLN . 17.1 mmm180 -71.94 -47.26 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -1.179 . . . . 0.0 110.102 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -70.35 -34.49 72.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.376 -1.453 . . . . 0.0 107.766 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.53 HG21 ' OH ' ' B' ' 292' ' ' TYR . 1.1 t -57.72 -40.93 78.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -78.49 -55.87 4.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.682 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 0.88 40.17 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.242 -0.911 . . . . 0.0 108.606 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . 72.99 -156.93 52.1 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 18.6 mtmm 95.68 132.75 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.191 0 C-N-CA 123.887 0.875 . . . . 0.0 108.768 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.89 112.96 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.05 1.833 . . . . 0.0 111.196 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 102' ' ' LYS . 1.1 mt -112.32 104.46 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.224 -0.922 . . . . 0.0 110.961 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 132' ' ' TRP . 45.6 tp -99.89 121.21 40.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.736 ' SG ' HD22 ' A' ' 94' ' ' LEU . 75.0 m -109.9 124.72 51.85 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 1.1 mt -121.76 131.19 53.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.512 ' HE2' ' O ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -125.63 153.37 43.87 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HE ' HG21 ' A' ' 84' ' ' THR . 60.7 mtm180 -105.82 145.75 31.51 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.732 -1.23 . . . . 0.0 111.805 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' GLY . 92.7 Cg_endo -83.49 -23.29 3.46 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 123.019 2.48 . . . . 0.0 111.6 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.456 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 18.7 pt20 -45.66 -42.44 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 m -90.38 -14.33 33.22 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . 46.74 45.65 18.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' O ' ' HE2' ' A' ' 108' ' ' PHE . 32.5 mtp85 -85.32 177.26 7.88 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.998 -1.295 . . . . 0.0 107.588 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 116' ' ' LEU . 87.5 t -114.05 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.8 -1.188 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.674 HD11 HG11 ' A' ' 83' ' ' VAL . 9.9 tp -41.59 137.41 1.6 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.3 m -46.52 145.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.032 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.25 64.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.584 -0.697 . . . . 0.0 109.69 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.405 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 3.3 tpt -72.23 -52.39 16.65 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.26 -43.27 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 108.788 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -59.62 -47.57 85.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -56.89 -33.32 63.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -59.54 -47.17 86.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.232 . . . . 0.0 107.949 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -20.95 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 123' ' ' ALA . 65.9 m-20 -110.24 -16.54 13.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 108.794 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.84 40.53 97.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 86.1 p -144.64 63.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.642 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.1 mtt-85 95.38 -31.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -102.32 121.83 43.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.404 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 20.2 mt-30 -145.25 145.3 31.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.049 -1.032 . . . . 0.0 110.426 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.29 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.435 ' N ' ' CD1' ' A' ' 132' ' ' TRP . 16.0 m0 -97.66 147.76 24.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.522 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 37.8 p-10 -99.44 144.89 28.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.9 p90 -167.18 178.62 5.53 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.379 -1.328 . . . . 0.0 111.505 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.681 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -150.93 155.94 40.16 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 38.6 mt-10 -58.03 27.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.416 -0.802 . . . . 0.0 110.396 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -126.44 -12.63 3.36 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.596 ' O ' ' SD ' ' A' ' 142' ' ' MET . 3.3 pt-20 -145.4 10.04 1.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.145 -1.209 . . . . 0.0 109.554 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 3.7 p -48.98 -43.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 30' ' ' ARG . 93.9 mt-10 -56.1 -33.2 64.88 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.532 HG22 HH11 ' A' ' 145' ' ' ARG . 15.6 m -65.62 -41.1 93.08 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 108.858 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -55.07 -50.95 67.85 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 84.7 mt -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 38.5 m-20 -70.37 -43.86 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.262 -0.899 . . . . 0.0 110.806 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.532 HH11 HG22 ' A' ' 141' ' ' THR . 52.7 mtt85 -70.49 -47.74 59.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.392 . . . . 0.0 108.951 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 36.1 t80 -60.1 -46.51 89.35 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.662 -0.649 . . . . 0.0 110.572 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.837 ' CG ' HD12 ' A' ' 151' ' ' LEU . 14.6 m-85 -80.1 -27.84 39.14 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.842 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 60.5 mt-10 -61.98 -29.27 70.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -68.61 -19.19 64.43 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.785 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -174.65 101.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 111.098 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.837 HD12 ' CG ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER 170.7 -47.63 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.587 -0.696 . . . . 0.0 109.232 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 69.7 Cg_exo . . . . . 0 C--N 1.309 -1.521 0 C-N-CA 122.338 2.025 . . . . 0.0 112.021 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' B' ' 208' ' ' ALA . 43.6 Cg_exo -53.0 -155.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 111.817 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.84 177.82 4.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 3.9 m -120.86 131.33 54.35 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.983 -1.073 . . . . 0.0 108.776 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.997 HG11 HD22 ' B' ' 235' ' ' LEU . 4.9 t -102.52 126.29 56.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.677 ' HB3' HG22 ' B' ' 279' ' ' VAL . 41.0 t80 -93.22 119.05 31.97 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.587 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.3 t80 -85.53 123.47 30.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.532 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.511 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 2.8 t -116.84 113.42 22.47 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.678 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -161.79 75.91 0.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.522 ' C ' ' O ' ' B' ' 216' ' ' GLY . 28.4 t -31.66 106.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.646 -0.914 . . . . 0.0 110.588 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.737 ' N ' HD13 ' B' ' 218' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 108.778 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.806 ' NH2' ' H ' ' B' ' 255' ' ' GLY . 33.6 mmt180 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.238 0.542 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -55.25 -46.08 76.08 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 16.4 m-20 -63.33 -20.49 65.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.821 ' NE2' ' H ' ' B' ' 247' ' ' ALA . 0.7 OUTLIER -67.32 -46.73 72.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.23 86.43 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.1 -37.14 73.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.743 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.4 m-30 -67.5 -41.18 84.91 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.703 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.15 -36.37 79.6 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.43 -1.419 . . . . 0.0 108.52 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 340' ' ' GLU . 71.3 ttt-85 -72.76 -57.4 4.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 108.6 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.89 -40.87 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.743 HG23 ' O ' ' B' ' 228' ' ' TYR . 51.3 t -64.71 -29.23 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . 0.401 ' N ' ' O ' ' B' ' 230' ' ' ARG . 12.2 m -67.88 -37.01 81.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.38 -0.825 . . . . 0.0 109.493 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.35 -52.29 23.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.719 -1.238 . . . . 0.0 108.757 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.997 HD22 HG11 ' B' ' 212' ' ' VAL . 15.8 mt -57.53 -39.94 77.71 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -61.49 -25.39 67.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.78 -31.33 31.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.141 -0.975 . . . . 0.0 109.777 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.567 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -75.01 -52.6 10.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.21 -0.931 . . . . 0.0 110.926 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -147.21 -147.58 4.57 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -89.42 129.08 35.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 108.961 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.689 HG11 HG13 ' B' ' 232' ' ' VAL . 2.8 t -93.54 106.78 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.494 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 20.4 mt -72.88 -176.78 2.14 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.865 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.563 HG22 HG23 ' B' ' 246' ' ' VAL . 1.9 m 56.25 39.2 30.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.001 -1.062 . . . . 0.0 108.786 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.594 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 52.6 mp0 -45.99 -25.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.731 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -48.95 -38.1 21.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 247' ' ' ALA . 62.0 t -61.23 170.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.821 ' H ' ' NE2' ' B' ' 225' ' ' GLN . . . 61.74 -71.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.854 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.0 t70 -67.59 28.65 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -106.76 13.46 27.94 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -108.64 10.52 26.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 1.08 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -85.59 -94.06 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.106 -0.996 . . . . 0.0 110.256 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.481 ' O ' HD23 ' B' ' 254' ' ' LEU . 1.9 mp0 -42.43 158.68 0.21 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.28 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -41.09 -22.11 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.212 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.572 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.6 mm? 59.52 -172.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.829 . . . . 0.0 109.933 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.806 ' H ' ' NH2' ' B' ' 222' ' ' ARG . . . 98.51 25.23 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.441 ' OE1' ' OD1' ' B' ' 262' ' ' ASP . 73.5 mm-40 53.73 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.913 -0.757 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.673 ' N ' ' O ' ' B' ' 255' ' ' GLY . 86.8 tt0 -44.59 -25.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 254' ' ' LEU . . . -69.6 165.11 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.113 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -50.39 134.02 23.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.351 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.82 -81.6 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 126.26 81.34 0.39 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.441 ' OD1' ' OE1' ' B' ' 256' ' ' GLU . 3.1 m-20 -52.87 -43.99 66.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.63 -49.33 75.61 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -60.52 -35.02 74.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.503 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.4 OUTLIER -62.51 -54.07 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.503 ' N ' HG22 ' B' ' 265' ' ' ILE . 1.7 t-80 -65.51 -33.78 76.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.577 -0.702 . . . . 0.0 109.64 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -55.79 -64.18 0.94 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 109.551 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -71.62 -38.71 70.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 110.217 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.444 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 10.4 m-20 -62.87 -59.22 5.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 110.296 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.479 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.9 OUTLIER -61.12 -36.86 80.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.118 . . . . 0.0 109.734 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -66.35 -52.53 46.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -0.949 . . . . 0.0 109.638 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.494 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.91 -43.79 86.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.497 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 3.9 tt -53.21 -43.82 67.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.481 ' CG ' HH21 ' B' ' 296' ' ' ARG . 28.9 mt-30 -65.41 -30.15 70.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.683 -0.636 . . . . 0.0 111.136 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.54 11.72 35.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.124 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.87 48.04 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.845 . . . . 0.0 111.514 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' B' ' 211' ' ' SER . 87.4 m-20 -88.45 -25.72 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 69.9 t -144.82 136.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' B' ' 213' ' ' TYR . 91.4 t -133.09 125.27 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.89 -1.132 . . . . 0.0 111.914 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.3 124.65 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.39 146.04 46.58 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.1 0.953 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.535 ' O ' HG11 ' B' ' 290' ' ' VAL . 1.2 pp20? -99.8 147.07 25.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.686 HG11 HD11 ' B' ' 316' ' ' LEU . 0.4 OUTLIER -122.96 -90.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.927 -1.108 . . . . 0.0 109.986 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.539 HG21 ' HE ' ' B' ' 309' ' ' ARG . 0.2 OUTLIER 64.36 -140.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 119.902 -1.749 . . . . 0.0 109.776 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.416 ' HA ' ' NE ' ' B' ' 314' ' ' ARG . 2.0 pt20 -43.47 148.56 0.66 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.24 128.12 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.185 1.923 . . . . 0.0 111.622 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.598 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 15.4 t -102.43 -120.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.616 ' HB2' ' H ' ' A' ' 87' ' ' SER . 9.7 tp 159.74 -58.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.51 58.8 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.535 HG11 ' O ' ' B' ' 282' ' ' GLU . 48.9 t -65.89 -45.09 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -56.47 -35.5 66.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.53 ' OH ' HG21 ' A' ' 98' ' ' VAL . 64.7 t80 -68.35 -56.03 9.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.602 -0.94 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.511 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 82.9 mt-10 -57.21 -36.62 71.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' B' ' 306' ' ' CYS . 63.4 mt -60.44 -48.96 79.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.67 -23.67 65.42 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.481 HH21 ' CG ' ' B' ' 274' ' ' GLN . 17.2 mmm180 -71.92 -47.22 54.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -1.158 . . . . 0.0 110.096 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -70.43 -34.43 72.47 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.36 -1.462 . . . . 0.0 107.879 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.504 HG21 ' OH ' ' A' ' 92' ' ' TYR . 1.1 t -57.82 -40.64 76.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -78.75 -56.37 4.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.594 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.1 0.65 39.71 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.929 0.871 . . . . 0.0 108.675 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' B' ' 302' ' ' LYS . . . 72.82 -156.81 52.11 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' B' ' 301' ' ' GLY . 18.2 mtmm 95.5 132.6 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 302' ' ' LYS . 87.7 Cg_exo -38.49 113.42 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.941 1.761 . . . . 0.0 111.209 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 302' ' ' LYS . 1.1 mt -112.83 104.62 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.334 -0.854 . . . . 0.0 110.871 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' B' ' 332' ' ' TRP . 47.1 tp -100.03 121.48 41.45 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' B' ' 294' ' ' LEU . 73.5 m -110.28 124.42 51.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 1.1 mt -121.31 131.17 54.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.988 -1.07 . . . . 0.0 112.321 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -125.63 153.36 43.9 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.539 ' HE ' HG21 ' B' ' 284' ' ' THR . 60.9 mtm180 -105.92 145.38 30.79 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.713 -1.242 . . . . 0.0 111.663 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' B' ' 313' ' ' GLY . 94.4 Cg_endo -83.39 -22.83 3.72 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.965 2.443 . . . . 0.0 111.68 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.481 ' NE2' ' CZ ' ' B' ' 309' ' ' ARG . 18.3 pt20 -46.1 -42.45 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 39.7 m -89.96 -14.72 33.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 310' ' ' PRO . . . 46.8 45.62 18.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.505 ' O ' ' HE2' ' B' ' 308' ' ' PHE . 32.5 mtp85 -85.44 177.28 7.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.97 -1.312 . . . . 0.0 107.563 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 316' ' ' LEU . 83.5 t -114.25 107.96 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.686 HD11 HG11 ' B' ' 283' ' ' VAL . 9.7 tp -41.63 137.41 1.62 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 59.1 m -46.57 145.61 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 110.034 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.87 -22.77 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.45 -53.03 13.3 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 109.69 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 39.7 mm -61.64 -42.86 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.016 -1.052 . . . . 0.0 108.833 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -60.36 -47.56 85.55 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.953 -1.092 . . . . 0.0 108.34 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -56.85 -33.2 63.04 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -59.75 -47.58 85.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.111 -1.229 . . . . 0.0 107.982 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -20.42 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.962 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' B' ' 323' ' ' ALA . 65.5 m-20 -110.67 -16.41 13.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 108.814 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 64.76 39.85 96.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.7 p -143.89 62.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' B' ' 327' ' ' SER . 93.6 mtt-85 95.72 -31.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -102.4 121.53 42.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.403 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 19.5 mt-30 -145.08 145.0 31.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.452 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.23 101.46 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.434 ' CG ' HD11 ' B' ' 305' ' ' LEU . 16.1 m0 -97.84 147.75 24.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 0.0 110.473 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' B' ' 333' ' ' ASP . 38.7 p-10 -99.49 144.79 28.18 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.0 p90 -166.91 178.81 5.6 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.464 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.671 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -151.12 156.14 40.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -58.2 27.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.424 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -126.83 -12.13 3.37 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.586 ' O ' ' SD ' ' B' ' 342' ' ' MET . 3.4 pt-20 -145.93 10.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.133 -1.216 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 3.6 p -48.95 -43.42 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 230' ' ' ARG . 93.1 mt-10 -56.33 -33.26 65.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . 0.526 HG22 HH11 ' B' ' 345' ' ' ARG . 14.0 m -65.41 -41.11 93.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.872 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.01 -51.3 66.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 82.4 mt -60.17 -30.77 69.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.849 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 39.1 m-20 -70.6 -43.62 68.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 110.666 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . 0.526 HH11 HG22 ' B' ' 341' ' ' THR . 53.0 mtt85 -70.8 -47.41 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.411 -1.431 . . . . 0.0 108.955 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 35.8 t80 -60.18 -46.75 88.64 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.69 -0.631 . . . . 0.0 110.506 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.824 ' CG ' HD12 ' B' ' 351' ' ' LEU . 14.9 m-85 -79.99 -27.87 39.55 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.84 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 61.5 mt-10 -61.95 -29.1 70.01 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -68.96 -18.76 64.12 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.787 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -174.94 102.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.824 HD12 ' CG ' ' B' ' 347' ' ' PHE . 1.0 OUTLIER 170.21 -48.03 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.536 -0.727 . . . . 0.0 109.328 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 75.0 Cg_exo . . . . . 0 C--N 1.309 -1.533 0 C-N-CA 122.395 2.064 . . . . 0.0 112.061 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' CYS . 55.3 Cg_endo -72.12 158.69 51.68 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.637 2.225 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' PRO . 32.1 p -52.49 -179.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.132 -0.98 . . . . 0.0 108.734 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 p -112.54 146.36 38.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.096 -1.003 . . . . 0.0 108.522 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.981 HG11 HD22 ' A' ' 35' ' ' LEU . 7.8 t -127.38 127.12 68.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB3' HG13 ' A' ' 79' ' ' VAL . 29.2 t80 -100.85 144.17 30.13 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 32' ' ' VAL . 3.7 t80 -104.27 128.17 52.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 110.279 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 104.34 10.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.95 162.64 22.45 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.41 ' OG ' ' CB ' ' A' ' 87' ' ' SER . 2.5 m -67.39 -55.32 14.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -1.067 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 18' ' ' ILE . 9.5 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.981 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.612 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.591 0.71 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.07 -39.41 92.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 71.5 m-20 -58.54 -30.21 66.93 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.96 ' NE2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.86 -49.06 61.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.03 81.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.3 -34.7 70.84 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.1 m-30 -68.54 -43.88 75.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.56 80.22 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.398 -1.439 . . . . 0.0 108.815 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.653 ' NE ' HH22 ' A' ' 34' ' ' ARG . 61.7 ttt180 -71.58 -59.0 2.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.915 -1.116 . . . . 0.0 108.533 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -51.55 -40.97 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.8 t -66.57 -27.78 41.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 17.4 p -65.53 -41.34 93.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.187 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.653 HH22 ' NE ' ' A' ' 30' ' ' ARG . 73.2 mtt85 -65.57 -41.72 92.59 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.981 HD22 HG11 ' A' ' 12' ' ' VAL . 86.0 mt -59.59 -42.94 93.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -58.88 -24.49 62.31 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 88.5 mtt-85 -70.18 -62.43 1.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.2 p90 -129.15 154.1 47.06 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 87.45 72.27 1.29 Allowed Glycine 0 N--CA 1.477 1.421 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 39' ' ' GLY . 2.6 ttmt -35.76 126.65 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.052 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -84.18 90.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.552 -1.343 . . . . 0.0 107.964 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -52.42 -57.41 9.95 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.229 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -86.69 91.22 8.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.14 -24.15 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.264 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 30.4 t-80 -65.47 -29.54 70.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.764 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 14' ' ' PHE . 25.2 t -52.75 -20.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.591 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.614 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -106.64 -65.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.513 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.854 ' O ' ' N ' ' A' ' 50' ' ' GLU . 56.5 m-20 -44.81 -24.22 0.19 Allowed 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.96 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . . . -23.01 -30.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.525 0.678 . . . . 0.0 110.318 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 48' ' ' ASP . 26.9 mt-10 -62.42 -19.55 63.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.94 -1.1 . . . . 0.0 109.352 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -57.85 135.39 56.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.89 -1.131 . . . . 0.0 108.545 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 56.42 152.63 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 109.336 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' A' ' 54' ' ' LEU . 39.5 Cg_endo -69.28 92.47 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.167 1.912 . . . . 0.0 110.836 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.762 HD11 ' O ' ' A' ' 49' ' ' ALA . 20.6 mt -53.77 -155.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.803 0.811 . . . . 0.0 110.696 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . 96.54 26.47 10.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 26.1 mt-10 63.18 -23.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.974 -0.721 . . . . 0.0 109.353 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 55' ' ' GLY . 60.8 tt0 -75.02 -17.73 60.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 108.849 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 60' ' ' GLY . . . -58.88 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.191 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 58' ' ' ALA . . . -36.67 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.631 -0.668 . . . . 0.0 109.612 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 58' ' ' ALA . . . 91.31 -162.72 28.47 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.718 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 92.88 42.54 4.38 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' GLY . 66.5 m-20 -48.08 -45.41 32.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -59.64 -43.49 93.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -61.01 -48.06 83.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.625 -0.672 . . . . 0.0 109.847 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 tt -71.34 -33.88 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.771 ' ND1' ' O ' ' B' ' 319' ' ' MET . 21.8 t60 -78.58 -31.22 47.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 46.1 mm-40 -68.79 -51.93 35.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 108.702 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.17 -39.7 89.96 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.393 -0.817 . . . . 0.0 109.217 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 74.6 m-20 -69.78 -53.22 19.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.37 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 66' ' ' HIS . 6.3 tp -68.42 -38.5 81.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.11 -0.994 . . . . 0.0 110.697 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 49.0 t-20 -64.36 -53.13 53.43 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.167 -0.958 . . . . 0.0 109.402 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.555 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -60.23 -41.64 93.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 108.659 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 4.3 tt -52.69 -37.33 58.76 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -74.91 -29.28 60.92 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.751 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.555 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 32.1 mt-30 -92.56 5.14 51.98 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.42 131.13 35.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.317 -0.865 . . . . 0.0 111.722 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 11' ' ' SER . 81.1 m-20 -74.49 -31.3 62.16 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 61.5 t -139.36 140.11 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 13' ' ' TYR . 61.7 t -134.0 128.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.905 -1.122 . . . . 0.0 111.942 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.82 123.87 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.75 47.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 109.326 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' OE2' ' CZ ' ' A' ' 134' ' ' TYR . 18.5 tp10 -84.44 114.4 21.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.481 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -119.82 148.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.512 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 114' ' ' ARG . 57.8 m -167.44 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -143.69 150.65 51.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.434 ' O ' ' OG ' ' A' ' 87' ' ' SER . 85.1 Cg_exo -35.6 131.69 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.755 2.303 . . . . 0.0 112.425 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.773 ' O ' HD23 ' B' ' 288' ' ' LEU . 15.6 m -166.87 116.22 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.768 HD23 ' O ' ' B' ' 287' ' ' SER . 3.1 mt -68.15 -41.18 81.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.988 -1.07 . . . . 0.0 109.647 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.18 70.62 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.05 -49.49 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -1.017 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.96 -39.95 89.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.796 ' OH ' HG21 ' B' ' 298' ' ' VAL . 66.4 t80 -61.5 -44.56 96.85 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.234 -1.156 . . . . 0.0 109.434 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.86 -31.72 71.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.403 -0.811 . . . . 0.0 109.194 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.27 -43.56 81.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.75 97.66 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -41.02 90.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -1.062 . . . . 0.0 108.887 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -70.09 -39.94 75.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.77 HG21 ' OH ' ' B' ' 292' ' ' TYR . 0.5 OUTLIER -52.75 -37.77 26.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.25 -50.26 16.69 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.129 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.95 -4.83 18.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.061 -1.025 . . . . 0.0 108.877 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.04 29.02 6.22 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 25.0 mtmm -95.72 152.12 38.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.976 -1.308 . . . . 0.0 107.786 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 90.8 Cg_exo -34.21 118.67 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.148 1.899 . . . . 0.0 111.775 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.582 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.6 mt -119.63 104.88 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 0.0 110.98 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.69 115.64 29.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.57 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -107.69 139.58 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 83' ' ' VAL . 11.7 mt -123.84 144.73 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.105 -0.997 . . . . 0.0 112.046 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.88 140.24 29.66 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.45 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 27.8 mtt180 -97.39 140.54 22.08 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.592 -1.318 . . . . 0.0 111.518 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.6 Cg_endo -78.29 -34.14 1.67 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 122.652 2.235 . . . . 0.0 110.789 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.473 ' CG ' ' N ' ' A' ' 112' ' ' SER . 18.2 pt20 -47.83 -38.96 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 113' ' ' GLY . 8.1 p -90.95 -21.04 21.53 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 37.91 39.38 0.64 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' VAL . 45.7 mtt-85 -74.79 13.73 0.6 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.389 -1.065 . . . . 0.0 109.711 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 114' ' ' ARG . 56.0 t 49.43 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.313 -0.867 . . . . 0.0 110.066 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 120' ' ' ILE . 36.1 tp -48.28 143.55 4.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -40.42 141.62 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 111.053 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.465 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -54.98 -55.03 35.38 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.44 0.638 . . . . 0.0 110.854 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.745 ' O ' ' ND1' ' B' ' 266' ' ' HIS . 14.8 mtp -60.37 -39.78 88.45 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.18 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' B' ' 292' ' ' TYR . 45.2 mm -62.67 -41.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.712 -1.242 . . . . 0.0 109.59 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.533 HH12 ' CG ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -72.86 -45.69 56.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 109.969 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.22 -18.98 65.73 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 -57.54 8.96 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.039 -1.271 . . . . 0.0 109.616 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.777 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -153.69 -89.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.687 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.616 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 22.9 t0 94.26 -0.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . 177.4 82.59 0.06 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.807 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 165.44 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.445 -1.033 . . . . 0.0 109.79 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.38 -25.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.807 ' H ' ' C ' ' A' ' 127' ' ' SER . 8.9 t80 -116.95 115.5 25.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.53 132.71 41.26 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.175 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.04 102.75 13.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.29 145.22 26.31 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.169 -0.957 . . . . 0.0 110.378 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' SD ' ' A' ' 142' ' ' MET . 63.7 m-20 -96.54 152.21 18.85 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CZ ' ' OE2' ' A' ' 82' ' ' GLU . 5.5 p90 -170.35 173.86 5.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.606 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -147.79 150.95 35.18 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.5 mt-10 -40.5 -27.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.826 -1.171 . . . . 0.0 110.316 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -85.79 -4.75 84.72 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 120.976 -1.077 . . . . 0.0 111.2 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -135.36 4.37 3.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.784 -1.421 . . . . 0.0 110.112 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.0 p -57.82 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.979 -1.076 . . . . 0.0 108.759 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.524 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.9 pt-20 -55.01 -33.65 62.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 m -66.13 -39.45 89.89 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.069 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 14.3 mmt -55.06 -53.19 59.04 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 30.6 mt -63.34 -31.59 72.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.549 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 28.7 t0 -69.05 -46.05 68.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 111.001 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -70.64 -50.36 37.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.404 -1.435 . . . . 0.0 109.818 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 29.4 t80 -57.12 -50.07 73.94 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 151' ' ' LEU . 27.0 m-85 -75.79 -30.83 59.23 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.586 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 5.5 mm-40 -55.12 -35.3 64.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.98 18.72 3.38 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 147' ' ' PHE . 2.0 t80 -147.27 -34.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 111.723 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.557 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 18.4 mt -117.87 40.99 0.34 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 61.3 Cg_endo . . . . . 0 C--N 1.311 -1.427 0 C-N-CA 121.922 1.748 . . . . 0.0 111.169 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 210' ' ' CYS . 55.3 Cg_endo -72.3 159.13 50.28 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.595 2.197 . . . . 0.0 111.786 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' B' ' 209' ' ' PRO . 31.0 p -52.77 -179.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.09 -1.007 . . . . 0.0 108.766 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.1 p -112.71 146.26 39.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 1.005 HG11 HD22 ' B' ' 235' ' ' LEU . 7.2 t -127.35 127.41 69.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.579 ' HB3' HG13 ' B' ' 279' ' ' VAL . 29.7 t80 -101.04 144.32 30.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' B' ' 232' ' ' VAL . 3.7 t80 -104.57 127.8 52.39 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 110.392 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 104.78 11.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.5 22.44 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.416 ' HG ' ' CB ' ' B' ' 287' ' ' SER . 2.7 m -66.83 -55.98 12.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 109.205 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.473 -0.767 . . . . 0.0 109.883 179.675 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.615 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.14 -39.66 93.33 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 70.8 m-20 -58.29 -30.07 66.34 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.942 ' NE2' ' HB3' ' B' ' 249' ' ' ALA . 0.0 OUTLIER -69.13 -48.7 61.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.95 81.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.8 tp -58.76 -34.35 71.32 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.751 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.3 m-30 -68.61 -43.96 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.55 80.14 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.519 -1.363 . . . . 0.0 108.823 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.647 ' NE ' HH22 ' B' ' 234' ' ' ARG . 57.8 ttt180 -71.5 -58.94 3.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.806 -1.183 . . . . 0.0 108.505 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.46 -41.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.751 HG23 ' O ' ' B' ' 228' ' ' TYR . 70.8 t -66.33 -28.07 42.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 14.5 p -65.44 -41.17 93.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.647 HH22 ' NE ' ' B' ' 230' ' ' ARG . 73.5 mtt85 -65.61 -41.67 92.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 1.005 HD22 HG11 ' B' ' 212' ' ' VAL . 84.9 mt -59.92 -42.86 94.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -58.7 -24.58 61.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 234' ' ' ARG . 87.6 mtt-85 -70.26 -62.94 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.1 p90 -128.49 154.49 46.05 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 86.98 72.39 1.29 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' B' ' 239' ' ' GLY . 2.7 ttmt -35.75 126.53 0.68 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.575 -0.956 . . . . 0.0 109.112 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.99 90.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.543 -1.348 . . . . 0.0 108.088 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 1.1 mt -52.22 -57.43 9.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.223 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.472 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 0.2 OUTLIER -86.85 91.37 8.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.742 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.2 -24.47 51.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.529 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 31.8 t-80 -65.23 -29.64 70.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' B' ' 214' ' ' PHE . 25.3 t -52.65 -20.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.579 ' C ' ' N ' ' B' ' 249' ' ' ALA . . . -106.56 -65.28 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.858 ' O ' ' N ' ' B' ' 250' ' ' GLU . 55.8 m-20 -44.98 -24.13 0.2 Allowed 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.942 ' HB3' ' NE2' ' B' ' 225' ' ' GLN . . . -23.18 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.858 ' N ' ' O ' ' B' ' 248' ' ' ASP . 27.0 mt-10 -63.08 -19.31 64.29 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.901 -1.124 . . . . 0.0 109.35 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -57.78 135.33 56.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.961 -1.087 . . . . 0.0 108.58 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 0.8 OUTLIER 56.38 152.37 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' B' ' 254' ' ' LEU . 39.1 Cg_endo -69.08 92.43 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.194 1.929 . . . . 0.0 110.895 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.772 HD11 ' O ' ' B' ' 249' ' ' ALA . 20.1 mt -53.99 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.848 0.833 . . . . 0.0 110.69 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' B' ' 257' ' ' GLU . . . 96.25 26.94 10.5 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.465 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 26.9 mt-10 62.99 -23.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.931 -0.747 . . . . 0.0 109.401 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.666 ' H ' ' C ' ' B' ' 255' ' ' GLY . 61.0 tt0 -74.5 -17.66 60.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 108.928 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' B' ' 260' ' ' GLY . . . -58.7 -161.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.417 -0.802 . . . . 0.0 109.356 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 258' ' ' ALA . . . -36.68 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.431 0.634 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' B' ' 258' ' ' ALA . . . 91.48 -162.81 28.3 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 120.16 -1.019 . . . . 0.0 110.737 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' B' ' 264' ' ' PHE . . . 93.37 42.44 4.26 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 261' ' ' GLY . 68.4 m-20 -47.98 -45.29 31.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.85 -43.58 94.56 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' B' ' 261' ' ' GLY . 0.7 OUTLIER -60.87 -48.35 82.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.541 -0.724 . . . . 0.0 109.937 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 3.8 tt -71.23 -33.59 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.475 -0.765 . . . . 0.0 109.996 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.745 ' ND1' ' O ' ' A' ' 119' ' ' MET . 22.5 t60 -78.65 -31.14 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 46.0 mm-40 -68.78 -52.71 27.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 108.63 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -65.3 -40.24 93.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.117 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.459 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 67.1 m-20 -69.12 -53.65 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.83 . . . . 0.0 110.564 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' B' ' 266' ' ' HIS . 6.2 tp -68.46 -38.39 81.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.029 -1.044 . . . . 0.0 110.644 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 50.6 t-20 -64.14 -53.49 48.66 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.353 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -59.92 -41.77 92.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 108.642 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.442 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 4.1 tt -52.78 -36.92 58.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -75.39 -28.99 59.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.726 . . . . 0.0 109.769 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.561 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 32.4 mt-30 -92.45 4.76 52.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.971 -1.08 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.26 131.49 35.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.458 -0.776 . . . . 0.0 111.829 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.2 m-20 -74.91 -31.48 61.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 61.8 t -139.27 140.25 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' B' ' 213' ' ' TYR . 62.0 t -134.0 129.6 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.939 -1.1 . . . . 0.0 111.995 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.27 123.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.411 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -107.4 122.16 46.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.539 ' OE2' ' CZ ' ' B' ' 334' ' ' TYR . 18.4 tp10 -83.81 114.21 21.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.605 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -119.34 149.02 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 0.0 109.562 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 57.6 m -167.7 -31.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.45 150.59 51.83 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -35.62 131.12 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.718 2.279 . . . . 0.0 112.514 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.768 ' O ' HD23 ' A' ' 88' ' ' LEU . 15.4 m -166.29 116.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.11 -0.994 . . . . 0.0 109.622 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 87' ' ' SER . 3.5 mt -68.27 -41.23 81.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.102 -0.999 . . . . 0.0 109.568 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.73 -36.32 71.52 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.83 -49.75 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -1.016 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.29 90.3 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.77 ' OH ' HG21 ' A' ' 98' ' ' VAL . 67.0 t80 -60.97 -44.67 97.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.233 -1.157 . . . . 0.0 109.419 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.67 -32.04 72.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.0 mt -67.17 -43.43 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.64 -39.74 97.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -40.87 90.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.267 -1.137 . . . . 0.0 108.739 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -70.25 -39.83 74.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.796 HG21 ' OH ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -52.96 -37.71 26.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -75.23 -50.3 16.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.57 -5.05 17.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.126 -0.984 . . . . 0.0 108.848 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 48.07 29.01 6.27 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.46 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 25.3 mtmm -95.75 152.29 38.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.953 -1.322 . . . . 0.0 107.748 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' B' ' 302' ' ' LYS . 84.0 Cg_exo -34.08 119.01 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.24 1.96 . . . . 0.0 111.788 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.563 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.5 mt -120.07 105.01 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.359 -0.838 . . . . 0.0 111.032 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 60.5 tp -99.85 115.94 30.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -107.8 139.7 42.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.067 -1.021 . . . . 0.0 108.251 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' B' ' 283' ' ' VAL . 11.8 mt -124.0 144.67 49.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.028 -1.045 . . . . 0.0 112.093 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -143.94 140.14 29.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.48 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 27.7 mtt180 -97.35 140.28 21.94 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 111.557 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.04 -33.66 2.0 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.607 2.205 . . . . 0.0 110.796 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' B' ' 312' ' ' SER . 18.2 pt20 -48.33 -38.96 20.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.481 ' O ' ' C ' ' B' ' 313' ' ' GLY . 7.5 p -91.31 -20.31 22.02 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 37.17 39.62 0.48 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' B' ' 315' ' ' VAL . 45.5 mtt-85 -74.78 13.72 0.6 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.311 -1.111 . . . . 0.0 109.724 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' B' ' 314' ' ' ARG . 55.3 t 49.58 100.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 110.119 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 320' ' ' ILE . 36.6 tp -48.34 143.85 4.42 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.53 141.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.02 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . 0.464 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -54.87 -55.12 33.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.693 -0.63 . . . . 0.0 110.79 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.771 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 14.2 mtp -60.13 -40.22 89.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.029 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 45.1 mm -62.53 -41.86 93.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.82 -1.175 . . . . 0.0 109.477 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' ' 325' ' ' ASP . 0.9 OUTLIER -72.77 -45.91 56.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 109.893 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -65.36 -18.78 65.79 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -51.32 -57.6 8.45 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.124 -1.221 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -153.96 -89.03 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.85 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 23.2 t0 94.12 -0.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . 177.76 82.5 0.06 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.758 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.0 OUTLIER 165.81 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.433 -1.039 . . . . 0.0 109.811 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.42 -25.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.761 ' CD1' ' HB3' ' B' ' 324' ' ' ALA . 9.0 t80 -117.25 115.67 25.75 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.67 132.98 41.33 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.173 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 73.0 t -92.41 102.55 13.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.09 145.15 26.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.08 -1.012 . . . . 0.0 110.441 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.487 ' O ' ' SD ' ' B' ' 342' ' ' MET . 65.7 m-20 -96.41 152.11 18.91 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.539 ' CZ ' ' OE2' ' B' ' 282' ' ' GLU . 5.6 p90 -170.28 174.08 5.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.51 -1.368 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -148.09 150.9 34.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.0 mt-10 -40.43 -27.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.0 110.308 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -85.5 -5.27 84.93 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.015 -1.053 . . . . 0.0 111.226 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -135.43 4.62 3.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.92 -1.341 . . . . 0.0 110.082 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.1 p -57.97 -48.64 83.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.888 -1.132 . . . . 0.0 108.763 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 24.0 pt-20 -55.23 -33.78 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.0 m -65.77 -39.75 91.35 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 14.0 mmt -54.88 -53.96 48.65 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 32.1 mt -62.39 -31.66 72.36 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.891 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 30.0 t0 -68.95 -46.09 69.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.18 -0.95 . . . . 0.0 111.063 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -70.93 -50.61 32.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.473 -1.392 . . . . 0.0 109.759 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' B' ' 346' ' ' TYR . 29.6 t80 -56.58 -50.1 72.93 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.436 -0.79 . . . . 0.0 109.994 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' B' ' 351' ' ' LEU . 25.2 m-85 -75.85 -30.76 59.04 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.561 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 5.3 mm-40 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -87.41 19.56 3.23 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' B' ' 347' ' ' PHE . 2.0 t80 -148.0 -34.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.571 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.561 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 18.7 mt -117.72 40.77 0.33 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.864 -1.147 . . . . 0.0 111.277 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 63.9 Cg_endo . . . . . 0 C--N 1.31 -1.47 0 C-N-CA 121.963 1.775 . . . . 0.0 111.164 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.99 155.51 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.059 1.84 . . . . 0.0 111.344 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.3 p -58.84 175.66 0.25 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.024 -1.047 . . . . 0.0 108.583 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 14.6 m -119.0 153.05 35.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.315 -0.866 . . . . 0.0 109.525 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -123.84 126.74 73.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.602 ' HB3' HG13 ' A' ' 79' ' ' VAL . 37.1 t80 -88.83 129.66 35.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 46' ' ' VAL . 16.4 t80 -97.15 131.91 43.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.613 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.851 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -142.14 100.61 3.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.383 -0.823 . . . . 0.0 109.332 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.31 -176.18 14.33 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.533 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 4.5 m -87.53 120.27 28.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -1.125 . . . . 0.0 110.186 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' NE ' ' A' ' 22' ' ' ARG . 3.6 mt . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.556 ' NE ' ' O ' ' A' ' 18' ' ' ILE . 72.0 mtt-85 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 122.726 1.251 . . . . 0.0 112.605 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.29 -17.4 28.66 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 40.9 m-20 -63.7 -38.93 92.98 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.832 ' NE2' ' HB3' ' A' ' 49' ' ' ALA . 20.1 mm100 -68.22 -42.74 79.35 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.89 -51.43 69.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.084 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 -35.42 75.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.686 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.3 m-30 -68.89 -42.12 77.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -63.54 -38.19 90.2 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 108.951 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -71.41 -55.51 7.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.754 -1.217 . . . . 0.0 108.292 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.68 -44.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -63.5 -27.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.5 p -67.4 -39.53 85.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.497 ' NE ' ' CD ' ' A' ' 140' ' ' GLU . 84.8 mtt-85 -69.15 -47.38 65.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.833 -1.167 . . . . 0.0 108.757 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 38' ' ' TYR . 4.7 mt -62.25 -33.86 75.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -64.91 -28.38 69.5 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -71.28 -59.88 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.4 p90 -121.57 151.36 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.89 77.84 1.12 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 39' ' ' GLY . 43.2 mtmt -40.9 118.64 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.451 -1.029 . . . . 0.0 108.57 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 32' ' ' VAL . 32.9 t -82.4 128.04 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 110.118 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.2 mt -105.86 172.43 6.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.782 HG22 ' O ' ' A' ' 43' ' ' THR . 32.4 m 51.81 47.28 25.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 108.887 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' HIS . 75.3 tt0 -50.05 -21.17 1.15 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.635 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -38.42 -47.49 1.26 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.374 -0.829 . . . . 0.0 110.157 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.707 ' O ' ' N ' ' A' ' 48' ' ' ASP . 3.4 p -57.47 162.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.941 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 60.85 -58.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.055 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.977 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.2 16.73 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.832 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . . . -82.07 -39.56 23.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.15 -0.969 . . . . 0.0 108.475 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 58.3 mt-10 -45.92 -15.39 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.246 -0.909 . . . . 0.0 108.656 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.977 HD22 ' O ' ' A' ' 48' ' ' ASP . 3.0 mp -54.64 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 110.042 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.72 ' H ' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -155.55 -44.77 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.661 -0.649 . . . . 0.0 109.991 -178.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -84.06 80.37 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.916 2.411 . . . . 0.0 110.526 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.797 ' N ' HD12 ' A' ' 54' ' ' LEU . 5.1 mp -95.52 157.42 15.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.323 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 42.96 -167.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG3' ' HB2' ' B' ' 318' ' ' ALA . 43.5 mp0 -72.83 -30.86 64.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.579 -0.953 . . . . 0.0 109.696 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' GLU . 72.9 tt0 -47.53 -20.8 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -56.69 91.24 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.48 -3.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.933 . . . . 0.0 109.858 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -49.05 -46.12 33.16 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.65 79.36 0.03 OUTLIER Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -48.23 -46.96 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -60.16 -44.51 94.96 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 68' ' ' GLN . 51.6 t80 -61.43 -47.02 87.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 109.143 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 45' ' ' HIS . 0.7 OUTLIER -54.32 -39.66 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.645 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 2.2 t-80 -75.14 -48.46 23.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.84 -57.44 9.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 110.022 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 96.8 mm-40 -63.13 -40.36 97.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 109.354 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.702 ' OD1' HG23 ' A' ' 43' ' ' THR . 65.2 m-20 -60.5 -40.77 92.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.932 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -74.66 -39.02 62.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.635 -1.291 . . . . 0.0 109.84 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -56.3 -45.77 80.1 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -70.49 -40.13 73.78 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.5 tp -58.32 -33.34 69.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HA ' HD13 ' A' ' 100' ' ' LEU . 55.9 mt-30 -80.29 -28.07 38.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.558 -0.714 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.6 5.9 47.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.07 . . . . 0.0 108.989 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.27 132.74 46.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 111.756 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 11' ' ' SER . 70.1 m-20 -85.22 -30.96 23.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 22.3 t -143.32 138.18 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 13' ' ' TYR . 99.5 t -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.219 -0.925 . . . . 0.0 111.641 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.15 114.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.851 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . . . -115.17 131.83 56.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.149 -0.969 . . . . 0.0 110.386 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -91.16 114.72 27.32 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.8 t -85.97 -99.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.947 -1.095 . . . . 0.0 109.977 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.409 ' H ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 m 64.66 -122.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.674 -1.266 . . . . 0.0 109.047 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 15.2 pt20 -48.72 147.3 4.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.064 -1.023 . . . . 0.0 109.128 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.46 124.38 11.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.362 2.041 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.416 ' OG ' HG23 ' A' ' 90' ' ' VAL . 31.6 t -140.61 130.18 24.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.37 -41.39 73.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.55 97.38 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.416 HG23 ' OG ' ' A' ' 87' ' ' SER . 20.7 t -69.9 -47.19 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.356 -1.085 . . . . 0.0 109.078 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.87 -46.8 93.48 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 19.9 t80 -62.28 -45.05 94.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.748 -0.854 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -60.79 -33.54 73.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.221 -0.925 . . . . 0.0 109.098 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 81' ' ' ALA . 77.0 mt -73.42 -41.56 63.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.31 -48.7 62.11 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 100' ' ' LEU . 19.0 tpt180 -59.24 -42.42 91.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.31 -1.112 . . . . 0.0 108.871 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' A' ' 101' ' ' GLY . . . -66.72 -39.48 88.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.048 . . . . 0.0 108.905 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -51.72 -40.8 27.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -47.74 50.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.896 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 101' ' ' GLY . 2.8 pp -124.7 -33.19 3.0 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.932 -1.105 . . . . 0.0 111.298 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.798 ' N ' HD12 ' A' ' 100' ' ' LEU . . . -74.25 10.51 7.88 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 7.85 -74.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.342 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' GLY . 30.9 Cg_endo -65.33 108.43 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.349 1.16 . . . . 0.0 111.261 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 102' ' ' LYS . 3.7 mt -134.55 150.16 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.132 0.968 . . . . 0.0 111.486 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.9 tp -128.02 113.74 16.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.765 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -114.17 150.79 33.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.815 -1.178 . . . . 0.0 109.19 -179.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 2.9 mp -132.46 137.08 47.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 0.0 111.585 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -128.81 140.01 51.9 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -88.93 133.05 36.33 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.001 -1.062 . . . . 0.0 110.992 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 113' ' ' GLY . 87.8 Cg_endo -78.76 -38.81 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.537 2.158 . . . . 0.0 111.277 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.27 -31.52 6.04 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 113' ' ' GLY . 22.0 p -95.23 -20.55 19.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 38.42 42.49 1.33 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.438 HH11 ' HB2' ' A' ' 112' ' ' SER . 1.7 mtt85 -67.48 7.19 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.376 -1.073 . . . . 0.0 109.494 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 113' ' ' GLY . 77.3 t 57.57 99.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.448 -0.783 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.741 ' CD1' HG11 ' A' ' 83' ' ' VAL . 19.4 tp -54.76 151.12 8.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.05 142.07 47.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.116 -0.99 . . . . 0.0 110.9 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' B' ' 256' ' ' GLU . . . -57.34 -42.68 82.4 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 41.8 mmm -62.25 -45.7 92.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.724 0.773 . . . . 0.0 109.361 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' ALA . 28.0 mm -61.1 -43.19 95.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.122 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' GLY . 0.3 OUTLIER -55.61 -45.46 77.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.615 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -51.05 -40.07 42.74 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 103.973 -3.651 . . . . 0.0 103.973 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.612 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -76.07 89.56 3.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.14 40.42 0.07 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.918 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 127' ' ' SER . 97.7 m-20 -54.7 -20.08 7.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 110.059 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 68.8 -14.62 0.74 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 125' ' ' ASP . 22.5 t -102.49 -74.62 0.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.236 . . . . 0.0 108.805 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.77 -49.15 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.765 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 4.5 t80 -103.55 129.05 50.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.777 HE21 ' HE1' ' A' ' 132' ' ' TRP . 2.6 mt-30 -140.47 135.65 32.19 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.581 -1.324 . . . . 0.0 111.895 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.2 112.19 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.777 ' HE1' HE21 ' A' ' 130' ' ' GLN . 14.2 m0 -108.09 138.76 43.81 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.979 -1.076 . . . . 0.0 109.946 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' SD ' ' A' ' 142' ' ' MET . 80.9 m-20 -90.04 155.37 19.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.6 -1.313 . . . . 0.0 107.771 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.8 p90 -172.15 -177.28 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.697 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -150.89 148.33 28.3 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' ALA . 62.3 mt-10 -41.7 -34.62 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.745 -1.222 . . . . 0.0 110.438 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.81 6.18 75.49 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.885 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -137.89 -3.61 1.81 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.961 -1.317 . . . . 0.0 109.795 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.2 p -55.7 -46.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 54.5 mt-10 -52.64 -34.56 52.0 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -70.07 -38.78 75.84 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.375 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 13.0 mmt -53.5 -53.38 52.29 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 79.0 mt -60.69 -39.11 87.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.029 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.53 -45.22 93.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 110.941 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -68.64 -51.55 41.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.545 -1.347 . . . . 0.0 108.873 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.45 -45.27 80.9 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.611 -0.68 . . . . 0.0 109.971 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 151' ' ' LEU . 15.5 m-85 -73.4 -33.15 64.84 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -58.09 -29.9 65.82 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.18 26.86 4.45 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.99 -82.4 0.21 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.693 -1.203 . . . . 0.0 113.472 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 147' ' ' PHE . 4.8 mt -55.11 -59.21 11.49 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.131 -0.98 . . . . 0.0 112.195 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 2.6 Cg_endo . . . . . 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 0.0 111.878 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -56.41 155.89 23.68 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.986 1.791 . . . . 0.0 111.279 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 18.6 p -58.92 175.55 0.27 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.047 -1.033 . . . . 0.0 108.506 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 14.6 m -119.09 153.18 35.2 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.41 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 0.0 OUTLIER -123.92 126.97 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.589 ' HB3' HG13 ' B' ' 279' ' ' VAL . 36.4 t80 -89.04 129.42 35.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' B' ' 246' ' ' VAL . 15.9 t80 -96.99 132.34 42.89 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.2 OUTLIER -142.57 101.15 3.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -0.807 . . . . 0.0 109.234 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.62 -176.39 14.41 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.515 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 4.4 m -87.19 120.62 28.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 110.108 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.559 ' O ' ' NE ' ' B' ' 222' ' ' ARG . 3.9 mt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' B' ' 218' ' ' ILE . 73.7 mtt-85 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 122.692 1.234 . . . . 0.0 112.734 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.18 -17.34 26.6 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 44.2 m-20 -64.0 -38.9 92.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.83 ' NE2' ' HB3' ' B' ' 249' ' ' ALA . 20.3 mm100 -68.13 -42.94 79.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.73 -51.28 70.46 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.989 -1.084 . . . . 0.0 108.173 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.52 -35.98 77.28 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.678 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -68.29 -42.74 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.536 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.471 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -62.95 -38.25 90.32 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.846 -1.159 . . . . 0.0 109.091 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -71.38 -55.41 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.877 -1.14 . . . . 0.0 108.249 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 45.6 mt -53.74 -44.64 59.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.678 HG23 ' O ' ' B' ' 228' ' ' TYR . 55.9 t -63.35 -28.18 44.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 23.9 p -67.21 -39.52 86.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . 0.498 ' NE ' ' CD ' ' B' ' 340' ' ' GLU . 85.4 mtt-85 -69.31 -47.33 64.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.912 -1.117 . . . . 0.0 108.815 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 238' ' ' TYR . 4.7 mt -62.26 -33.72 75.16 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -65.1 -28.55 69.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -71.19 -59.87 2.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.4 p90 -121.42 151.7 39.89 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 83.33 77.92 1.09 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' B' ' 239' ' ' GLY . 42.9 mtmt -40.87 118.71 1.02 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.385 -1.068 . . . . 0.0 108.657 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.411 HG11 HG13 ' B' ' 232' ' ' VAL . 30.3 t -82.35 127.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.192 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.441 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 17.1 mt -105.52 172.45 6.79 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.766 ' O ' HG22 ' B' ' 243' ' ' THR . 35.7 m 51.69 48.01 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 108.881 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 245' ' ' HIS . 75.1 tt0 -50.77 -20.83 1.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -38.48 -47.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.255 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.705 ' O ' ' N ' ' B' ' 248' ' ' ASP . 3.4 p -57.58 163.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 108.976 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.705 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 60.42 -58.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.473 -0.767 . . . . 0.0 109.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.976 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -62.15 16.76 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.83 ' HB3' ' NE2' ' B' ' 225' ' ' GLN . . . -81.91 -39.31 23.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 108.594 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -46.45 -14.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.61 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.976 HD22 ' O ' ' B' ' 248' ' ' ASP . 2.9 mp -55.26 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.713 ' H ' ' CD ' ' B' ' 253' ' ' PRO . 1.0 OUTLIER -155.47 -44.81 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.62 -0.675 . . . . 0.0 109.886 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.713 ' CD ' ' H ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -84.06 80.52 2.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.994 2.462 . . . . 0.0 110.668 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 254' ' ' LEU . 5.0 mp -95.84 157.62 15.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.345 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 43.11 -167.76 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 118' ' ' ALA . 41.2 mp0 -73.08 -30.29 63.58 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.523 -0.986 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' B' ' 256' ' ' GLU . 71.2 tt0 -48.21 -20.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -57.22 91.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -55.54 -4.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -48.39 -46.57 28.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 152.7 79.51 0.03 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -48.24 -46.96 36.14 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -60.2 -44.4 95.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.58 -47.01 87.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.7 OUTLIER -54.24 -39.92 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.625 ' CE1' ' HG ' ' B' ' 270' ' ' LEU . 2.2 t-80 -74.72 -48.43 25.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.07 -57.38 9.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.962 . . . . 0.0 110.091 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.08 -40.28 97.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' B' ' 243' ' ' THR . 62.0 m-20 -60.76 -40.68 93.4 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -74.82 -39.28 61.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.599 -1.313 . . . . 0.0 109.79 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -56.01 -45.69 79.01 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.971 -1.081 . . . . 0.0 108.15 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.441 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -70.43 -40.62 73.69 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.482 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.3 tp -58.06 -33.03 68.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 108.471 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.523 ' HA ' HD13 ' B' ' 300' ' ' LEU . 55.5 mt-30 -80.49 -28.15 37.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.47 6.11 47.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.992 -1.068 . . . . 0.0 108.949 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.74 132.88 46.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.33 -0.856 . . . . 0.0 111.765 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 70.1 m-20 -85.36 -31.01 23.2 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 24.4 t -143.1 138.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' B' ' 213' ' ' TYR . 99.0 t -120.95 148.17 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.134 -0.979 . . . . 0.0 111.614 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.24 114.68 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.384 0.612 . . . . 0.0 109.388 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.856 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . . . -115.74 131.54 56.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.49 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.402 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 71.7 tt0 -90.95 114.63 27.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' B' ' 316' ' ' LEU . 1.7 t -85.55 -98.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.965 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' B' ' 283' ' ' VAL . 5.0 m 64.26 -122.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.549 -1.345 . . . . 0.0 109.111 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -49.69 147.23 6.43 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.042 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.24 124.73 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.395 2.064 . . . . 0.0 111.785 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.409 ' OG ' HG23 ' B' ' 290' ' ' VAL . 28.9 t -141.28 130.37 23.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.143 -0.973 . . . . 0.0 109.383 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.59 -41.74 71.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.51 -40.7 96.58 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.409 HG23 ' OG ' ' B' ' 287' ' ' SER . 19.5 t -69.93 -47.39 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -1.082 . . . . 0.0 109.169 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.72 93.59 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 18.2 t80 -62.47 -44.85 95.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.958 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.6 -33.54 72.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.04 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' B' ' 281' ' ' ALA . 76.7 mt -73.77 -41.01 63.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.69 -48.67 60.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.505 ' NE ' HD21 ' B' ' 300' ' ' LEU . 18.5 tpt180 -59.17 -42.54 91.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.333 -1.099 . . . . 0.0 108.779 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.489 ' HA ' ' H ' ' B' ' 301' ' ' GLY . . . -66.7 -39.63 88.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.446 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -51.63 -40.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -71.98 -47.94 48.52 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.92 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.784 HD12 ' N ' ' B' ' 301' ' ' GLY . 2.8 pp -124.37 -33.15 3.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.986 -1.071 . . . . 0.0 111.226 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.784 ' N ' HD12 ' B' ' 300' ' ' LEU . . . -74.16 10.08 8.47 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' B' ' 301' ' ' GLY . 0.0 OUTLIER 7.93 -74.11 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' B' ' 301' ' ' GLY . 29.0 Cg_endo -65.17 107.89 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.456 1.199 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 302' ' ' LYS . 3.7 mt -134.08 149.87 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.189 0.995 . . . . 0.0 111.534 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 49.1 tp -127.72 114.02 16.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . 0.773 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -114.46 150.53 34.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 109.211 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 2.9 mp -132.15 137.0 47.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 111.463 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -128.68 140.0 51.96 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -88.85 133.12 36.34 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.924 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 313' ' ' GLY . 77.0 Cg_endo -78.83 -38.94 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.544 2.163 . . . . 0.0 111.069 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.24 -31.72 6.25 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.463 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.3 p -95.01 -20.34 19.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 38.5 42.41 1.34 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.42 HH11 ' HB2' ' B' ' 312' ' ' SER . 1.8 mtt85 -67.55 7.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.29 -1.124 . . . . 0.0 109.588 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' B' ' 313' ' ' GLY . 79.4 t 57.21 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.496 -0.753 . . . . 0.0 110.648 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.747 ' CD1' HG11 ' B' ' 283' ' ' VAL . 19.4 tp -54.8 151.17 8.78 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.86 141.77 48.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.926 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -57.3 -43.22 83.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 42.6 mmm -61.76 -45.5 93.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.626 0.727 . . . . 0.0 109.286 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' B' ' 323' ' ' ALA . 28.4 mm -61.19 -43.21 95.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.472 ' O ' ' C ' ' B' ' 322' ' ' GLY . 0.3 OUTLIER -55.62 -45.09 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.825 -1.172 . . . . 0.0 107.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.645 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -51.33 -40.03 44.77 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 103.997 -3.641 . . . . 0.0 103.997 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' B' ' 329' ' ' PHE . . . -76.02 89.5 2.99 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -165.07 40.47 0.07 Allowed 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.812 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' B' ' 327' ' ' SER . 98.4 m-20 -54.61 -20.35 7.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.825 . . . . 0.0 110.029 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 69.06 -14.93 0.76 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 325' ' ' ASP . 19.8 t -102.55 -74.68 0.62 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -1.231 . . . . 0.0 108.819 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -83.67 -49.41 9.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.773 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 4.4 t80 -103.39 129.06 50.4 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.795 HE21 ' HE1' ' B' ' 332' ' ' TRP . 2.7 mt-30 -140.34 135.66 32.39 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.661 -1.274 . . . . 0.0 111.853 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.34 111.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.795 ' HE1' HE21 ' B' ' 330' ' ' GLN . 14.1 m0 -107.78 138.87 43.26 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.0 110.108 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.469 ' O ' ' SD ' ' B' ' 342' ' ' MET . 81.4 m-20 -90.38 154.72 19.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.62 -1.3 . . . . 0.0 107.802 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.553 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -171.59 -177.16 1.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.782 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -150.75 148.31 28.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' B' ' 335' ' ' ALA . 62.1 mt-10 -41.6 -34.34 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.767 -1.208 . . . . 0.0 110.51 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.87 5.75 77.66 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.844 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -137.62 -3.6 1.87 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.001 -1.293 . . . . 0.0 109.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.0 p -55.88 -47.0 80.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 108.597 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 55.7 mt-10 -52.84 -34.07 52.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.1 m -70.61 -38.24 73.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.31 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 12.5 mmt -54.07 -52.97 59.23 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 76.8 mt -60.81 -39.16 87.93 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.044 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.4 -45.18 94.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 110.942 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -68.68 -51.79 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.516 -1.365 . . . . 0.0 108.808 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -56.13 -45.98 79.36 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.819 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' B' ' 351' ' ' LEU . 15.8 m-85 -72.82 -33.11 65.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.401 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.1 -29.62 65.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -97.38 26.77 4.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.05 -82.39 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.434 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' B' ' 347' ' ' PHE . 4.7 mt -54.9 -59.23 11.22 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.179 -0.951 . . . . 0.0 112.181 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 2.3 Cg_endo . . . . . 0 C--N 1.308 -1.568 0 C-N-CA 122.362 2.041 . . . . 0.0 112.064 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.26 -156.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.35 2.033 . . . . 0.0 111.283 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 25.9 p -108.99 172.77 6.65 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 61.4 m -115.07 158.9 21.49 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.849 -1.157 . . . . 0.0 108.99 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 35' ' ' LEU . 16.6 t -137.41 134.14 46.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 8.3 t80 -115.53 97.29 6.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.623 ' O ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -93.48 126.79 38.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.526 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 1.7 m -101.67 130.1 47.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.955 . . . . 0.0 108.92 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.921 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -126.05 -124.01 2.73 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 58.1 m -155.69 138.08 14.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 109.105 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 120.913 -1.117 . . . . 0.0 109.441 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 122.073 0.94 . . . . 0.0 111.522 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.18 -40.83 96.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 74.8 m-20 -55.53 -33.32 63.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 1.8 mm100 -68.78 -39.18 80.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -52.04 66.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 108.702 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -34.6 76.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.3 m-85 -69.2 -47.85 63.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.085 -1.01 . . . . 0.0 110.251 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.32 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.256 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.7 ttt85 -69.67 -57.22 5.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 108.494 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.5 mt -50.82 -43.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.4 t -61.16 -30.58 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 4.6 m -66.84 -41.18 87.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -67.92 -48.88 64.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.901 -1.125 . . . . 0.0 109.197 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 12' ' ' VAL . 31.6 mt -57.9 -40.27 79.94 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -62.1 -26.07 68.08 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -74.9 -36.97 62.22 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.94 -1.1 . . . . 0.0 108.873 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.6 m-85 -70.4 -48.36 56.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.947 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -153.1 -145.38 4.13 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.98 131.38 46.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.968 -1.313 . . . . 0.0 108.658 178.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.58 HG11 HG13 ' A' ' 32' ' ' VAL . 18.1 t -90.73 127.47 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.553 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 11.9 mt -87.05 -38.63 16.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.198 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 14' ' ' PHE . 7.9 t -70.77 37.67 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 42' ' ' LEU . 57.7 mt-10 -54.28 -28.57 42.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.81 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.482 ' NE2' ' CG1' ' A' ' 65' ' ' ILE . 18.4 t-80 -52.09 -44.9 64.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.183 -0.948 . . . . 0.0 109.865 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.496 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 41.3 t -50.12 -69.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.32 61.02 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 14.6 t70 -85.34 43.08 0.99 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -118.54 -32.3 4.64 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG2' HE21 ' A' ' 25' ' ' GLN . 12.2 pt-20 -86.1 60.28 6.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.498 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -168.88 22.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER 162.19 160.7 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -37.28 99.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.268 1.979 . . . . 0.0 111.67 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.763 ' H ' HD12 ' A' ' 54' ' ' LEU . 6.8 mp -49.36 -79.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . -175.33 -36.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HG21 ' B' ' 315' ' ' VAL . 0.2 OUTLIER -46.97 -101.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.582 -0.952 . . . . 0.0 110.554 -179.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 56' ' ' GLU . 80.8 mm-40 -64.18 -8.9 13.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.025 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 158.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.63 66.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.19 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.01 -171.99 36.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 103.02 -29.86 11.61 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 20.5 p-10 -56.15 -43.16 78.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.2 mt-30 -70.39 -53.2 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -28.84 56.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' GLY . 1.8 mt -70.37 -39.71 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 1.3 t-80 -76.45 -60.59 2.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.489 0.661 . . . . 0.0 109.367 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.562 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 8.4 tp10 -43.04 -54.52 4.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -64.68 -44.6 89.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.945 . . . . 0.0 110.044 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.462 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 73.9 m-20 -60.91 -44.14 97.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.0 111.265 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' OH ' ' A' ' 92' ' ' TYR . 1.1 mm? -65.4 -50.25 66.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.024 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.18 -50.48 71.67 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.489 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.553 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.29 -42.46 99.08 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.3 tp -52.03 -37.33 53.16 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.36 -28.08 59.41 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.603 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -83.52 -5.96 59.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.869 -1.145 . . . . 0.0 109.258 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.84 125.33 25.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 112.153 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' HB2' ' H ' ' A' ' 11' ' ' SER . 39.0 m-20 -77.81 -33.15 52.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.21 148.18 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.26 138.7 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.966 -1.084 . . . . 0.0 111.002 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 20.5 t -138.45 164.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -159.46 130.42 5.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.579 -1.326 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CG ' ' OH ' ' A' ' 134' ' ' TYR . 53.1 tt0 -93.65 126.03 38.6 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -155.71 114.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.08 -1.012 . . . . 0.0 110.353 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 39.5 m -105.76 -18.54 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.679 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 6.6 tt0 163.81 -37.31 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.383 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 7.0 Cg_exo -71.14 104.1 1.49 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.327 2.018 . . . . 0.0 112.009 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.558 ' HB2' HD21 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -159.51 173.49 16.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 108.574 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.709 ' C ' ' H ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER 167.77 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.48 ' O ' ' SD ' ' B' ' 319' ' ' MET . . . 73.33 -23.21 0.96 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.921 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.1 t -85.14 -46.35 17.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.85 -30.48 56.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.481 ' OH ' HD11 ' A' ' 70' ' ' LEU . 1.3 t80 -68.58 -41.86 79.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.66 -34.59 65.14 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 94' ' ' LEU . 55.6 mt -73.2 -37.83 66.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.71 95.87 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.034 -2.027 . . . . 0.0 108.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -66.14 -40.0 90.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.489 -1.006 . . . . 0.0 108.711 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.43 ' C ' HD11 ' A' ' 104' ' ' ILE . . . -69.32 -40.99 77.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.064 . . . . 0.0 108.549 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -39.86 48.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.44 56.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.007 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.3 mt -71.16 -7.22 45.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.135 -0.978 . . . . 0.0 108.786 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.12 24.86 9.75 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.838 -0.539 . . . . 0.0 112.09 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -79.7 154.45 75.93 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 120.603 -1.528 . . . . 0.0 108.141 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.37 118.58 1.79 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.933 1.755 . . . . 0.0 111.167 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.43 HD11 ' C ' ' A' ' 97' ' ' ALA . 11.8 mt -121.13 135.3 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.988 . . . . 0.0 111.223 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.4 m -110.44 156.06 21.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.911 -1.118 . . . . 0.0 108.228 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 83' ' ' VAL . 3.5 mp -136.61 152.63 50.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 111.63 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.87 130.72 15.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -52.89 140.03 41.34 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.052 -1.03 . . . . 0.0 110.522 -177.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 134' ' ' TYR . 31.8 Cg_endo -67.15 -50.25 1.09 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.147 1.898 . . . . 0.0 109.252 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' N ' ' A' ' 113' ' ' GLY . 13.3 pt20 -67.11 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.56 -72.25 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.989 -1.07 . . . . 0.0 109.753 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 111' ' ' GLN . . . 68.34 42.74 81.62 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' VAL . 4.5 mtt180 -85.63 18.42 2.84 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.71 HG21 ' HB2' ' B' ' 256' ' ' GLU . 15.7 t 49.77 99.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.881 0.848 . . . . 0.0 109.448 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 117' ' ' SER . 8.9 tp -45.22 -61.24 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 162.86 144.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.288 -0.883 . . . . 0.0 110.002 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.52 86.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.555 -0.716 . . . . 0.0 110.399 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' B' ' 289' ' ' GLY . 1.7 mtp -74.81 -36.38 62.46 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.388 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.4 mm -72.42 -46.07 57.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 109.37 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.401 ' NE ' ' HB3' ' A' ' 116' ' ' LEU . 63.3 mtt180 -77.54 -34.74 53.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 108.807 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.418 ' HA2' HE21 ' B' ' 263' ' ' GLN . . . -68.8 -27.49 73.82 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -43.56 -59.31 2.22 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -133.65 -111.5 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 112.178 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 1.9 m-20 160.23 -2.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.436 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.1 38.93 0.36 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.468 -1.349 . . . . 0.0 111.604 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 58.5 p -116.1 -86.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.727 -1.455 . . . . 0.0 108.838 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.501 ' O ' ' NE2' ' A' ' 130' ' ' GLN . 20.0 tpt180 -94.4 -30.05 14.67 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -117.69 126.0 51.7 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 128' ' ' ARG . 6.9 mp0 -131.91 135.92 47.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.55 -1.344 . . . . 0.0 112.726 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.42 106.89 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 20.8 m0 -104.63 143.02 33.64 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.006 -1.059 . . . . 0.0 110.986 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.548 ' O ' ' SD ' ' A' ' 142' ' ' MET . 68.0 m-20 -85.84 154.86 21.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.651 -1.281 . . . . 0.0 108.002 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.458 ' OH ' ' CG ' ' A' ' 82' ' ' GLU . 3.6 p90 -168.7 172.54 7.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 0.0 111.488 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -141.65 146.67 36.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 40.0 mt-10 -39.26 -37.03 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.746 -1.221 . . . . 0.0 110.335 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.17 15.52 33.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 135' ' ' ALA . 74.8 mt-10 -146.29 -4.88 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.258 . . . . 0.0 110.407 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.6 p -54.04 -46.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 120.865 -1.147 . . . . 0.0 108.616 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 22.8 pt-20 -56.54 -34.63 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.8 m -65.67 -39.41 91.3 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.165 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 11.3 mmt -55.82 -51.6 66.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.91 -30.3 71.4 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.347 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 48.6 m-20 -69.27 -44.14 72.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 0.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -71.67 -43.61 65.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.677 -1.264 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -62.97 -48.6 78.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.446 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.923 ' CD1' HD12 ' A' ' 151' ' ' LEU . 19.6 m-85 -73.64 -31.08 63.32 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.393 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -68.25 -27.16 66.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.47 65.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.689 -0.632 . . . . 0.0 109.621 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.813 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -145.88 -63.69 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.042 -1.036 . . . . 0.0 110.653 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 147' ' ' PHE . 1.4 mt -31.01 92.89 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 0.0 110.643 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 150' ' ' TYR . 72.4 Cg_endo . . . . . 0 C--N 1.311 -1.419 0 C-N-CA 123.166 2.577 . . . . 0.0 111.048 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.67 -156.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.217 1.945 . . . . 0.0 111.24 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 26.6 p -109.12 172.98 6.53 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 69.8 m -115.38 159.08 21.55 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.895 -1.128 . . . . 0.0 108.909 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 235' ' ' LEU . 15.8 t -137.63 133.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 8.1 t80 -115.31 97.59 6.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.638 ' O ' HG21 ' B' ' 243' ' ' THR . 0.0 OUTLIER -93.74 126.83 39.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.455 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.417 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 1.8 m -101.49 129.4 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.18 -0.95 . . . . 0.0 108.93 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.919 ' O ' HG21 ' B' ' 290' ' ' VAL . . . -125.42 -124.3 2.79 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . 0.553 ' O ' ' NH1' ' B' ' 222' ' ' ARG . 58.7 m -155.58 137.8 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.055 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 O-C-N 120.894 -1.129 . . . . 0.0 109.581 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.553 ' NH1' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 122.171 0.986 . . . . 0.0 111.418 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.03 -40.64 96.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' B' ' 228' ' ' TYR . 74.7 m-20 -55.31 -33.77 63.58 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 1.9 mm100 -68.45 -38.84 81.48 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.19 66.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 108.646 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -34.31 76.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.788 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.0 m-85 -69.14 -48.42 62.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.059 -1.025 . . . . 0.0 110.217 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.61 75.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' B' ' 233' ' ' SER . 32.0 ttt85 -69.62 -57.31 5.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.089 . . . . 0.0 108.452 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -50.61 -43.39 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 228' ' ' TYR . 67.9 t -61.03 -30.73 48.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 230' ' ' ARG . 4.4 m -66.65 -41.36 88.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.776 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.91 -48.57 65.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.745 -1.222 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.699 HD22 HG11 ' B' ' 212' ' ' VAL . 32.8 mt -58.2 -40.37 81.4 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -61.99 -25.98 67.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -74.93 -37.2 62.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.913 -1.117 . . . . 0.0 108.92 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . 0.486 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.5 m-85 -70.09 -48.55 57.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.614 -0.679 . . . . 0.0 110.072 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.73 -145.53 4.16 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -100.88 131.48 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -1.216 . . . . 0.0 108.575 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.583 HG11 HG13 ' B' ' 232' ' ' VAL . 19.4 t -90.67 127.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.561 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 12.0 mt -87.08 -38.44 16.49 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.181 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.638 HG21 ' O ' ' B' ' 214' ' ' PHE . 8.1 t -71.18 37.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 109.257 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' B' ' 242' ' ' LEU . 59.3 mt-10 -54.29 -28.84 44.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.818 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.498 ' NE2' ' CG1' ' B' ' 265' ' ' ILE . 17.7 t-80 -52.08 -45.24 64.71 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.494 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 41.2 t -49.85 -69.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.295 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -51.87 -41.36 61.82 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 248' ' ' ASP . 14.5 t70 -85.2 43.44 1.01 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -119.0 -32.05 4.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' B' ' 225' ' ' GLN . 11.7 pt-20 -86.4 60.55 6.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.269 -0.894 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -169.28 22.56 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.514 -0.741 . . . . 0.0 109.945 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER 161.87 160.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -37.03 99.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.382 2.055 . . . . 0.0 111.702 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.77 HD12 ' H ' ' B' ' 254' ' ' LEU . 6.7 mp -49.17 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.05 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . -175.71 -37.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.71 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -46.68 -101.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.568 -0.96 . . . . 0.0 110.578 -178.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' B' ' 256' ' ' GLU . 80.7 mm-40 -63.94 -8.21 10.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.875 . . . . 0.0 110.058 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -56.84 159.04 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.37 66.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 109.16 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -171.42 -172.33 37.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 103.14 -29.95 11.39 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 20.0 p-10 -56.17 -43.02 77.97 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . 0.467 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 1.2 mt-30 -70.59 -53.25 16.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.29 -28.51 54.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.498 ' CG1' ' NE2' ' B' ' 245' ' ' HIS . 1.9 mt -71.08 -39.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.56 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 1.2 t-80 -76.32 -60.73 2.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . 0.56 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 9.4 tp10 -43.02 -54.86 4.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.723 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -64.63 -43.8 92.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.449 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 75.3 m-20 -61.84 -44.1 97.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.2 -0.937 . . . . 0.0 111.2 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.486 HD11 ' OH ' ' B' ' 292' ' ' TYR . 1.1 mm? -65.32 -50.05 67.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.975 -1.078 . . . . 0.0 110.02 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -62.22 -50.76 70.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.03 -42.76 99.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.362 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.4 tp -51.76 -37.3 50.74 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.4 -28.1 59.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.42 -5.94 59.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.191 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.91 125.74 26.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -0.851 . . . . 0.0 112.034 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' B' ' 211' ' ' SER . 41.9 m-20 -78.25 -33.14 49.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.91 147.7 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 79.3 t -133.93 138.38 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.883 -1.136 . . . . 0.0 111.015 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 20.0 t -137.83 164.76 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.448 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -159.95 130.16 5.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.614 -1.304 . . . . 0.0 110.143 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.453 ' CG ' ' OH ' ' B' ' 334' ' ' TYR . 52.0 tt0 -93.56 125.75 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 0.5 OUTLIER -155.3 115.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.987 -1.07 . . . . 0.0 110.349 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 285' ' ' GLN . 38.0 m -106.06 -19.0 13.86 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.68 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 6.6 tt0 164.09 -37.18 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.244 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 7.5 Cg_exo -70.9 103.82 1.41 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.389 2.06 . . . . 0.0 111.937 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -159.81 173.25 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.747 ' C ' ' H ' ' B' ' 290' ' ' VAL . 0.1 OUTLIER 167.9 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 119' ' ' MET . . . 73.26 -22.81 0.97 Allowed Glycine 0 N--CA 1.481 1.662 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -176.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.919 HG21 ' O ' ' B' ' 216' ' ' GLY . 2.1 t -85.43 -46.41 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -55.65 -30.51 56.34 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.486 ' OH ' HD11 ' B' ' 270' ' ' LEU . 1.3 t80 -68.62 -41.98 78.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.8 -34.55 65.41 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' B' ' 294' ' ' LEU . 54.4 mt -73.15 -37.97 66.4 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.9 -37.79 94.34 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.8 -39.88 87.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.451 -1.029 . . . . 0.0 108.649 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . 0.449 ' C ' HD11 ' B' ' 304' ' ' ILE . . . -69.55 -41.08 76.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.96 -1.088 . . . . 0.0 108.524 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -39.79 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.11 57.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.007 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -71.63 -6.97 44.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 108.832 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . 51.05 25.01 9.49 Favored Glycine 0 N--CA 1.494 2.557 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.052 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -79.76 154.61 75.83 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 120.631 -1.511 . . . . 0.0 108.254 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.39 118.35 1.71 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.806 1.67 . . . . 0.0 111.098 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.449 HD11 ' C ' ' B' ' 297' ' ' ALA . 11.9 mt -120.82 134.77 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.149 -0.969 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.25 114.78 18.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 85.9 m -110.57 156.18 21.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.76 -1.213 . . . . 0.0 108.105 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' B' ' 283' ' ' VAL . 3.5 mp -136.59 152.43 50.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.0 -1.062 . . . . 0.0 111.626 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -148.68 130.62 15.25 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 0.0 OUTLIER -52.87 139.8 41.6 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.045 -1.034 . . . . 0.0 110.496 -177.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' B' ' 311' ' ' GLN . 33.3 Cg_endo -67.08 -50.06 1.17 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.067 1.845 . . . . 0.0 109.352 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.788 ' O ' ' N ' ' B' ' 313' ' ' GLY . 13.2 pt20 -67.09 -143.21 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.31 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 109.687 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.788 ' N ' ' O ' ' B' ' 311' ' ' GLN . . . 68.39 42.76 81.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' B' ' 315' ' ' VAL . 4.4 mtt180 -85.43 17.57 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 56' ' ' GLU . 17.9 t 50.41 99.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.969 0.89 . . . . 0.0 109.4 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 317' ' ' SER . 8.5 tp -45.33 -61.42 1.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.9 OUTLIER 162.97 143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.49 86.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.437 -0.79 . . . . 0.0 110.316 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 89' ' ' GLY . 1.6 mtp -74.3 -36.78 63.76 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.038 -1.039 . . . . 0.0 109.407 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.32 -45.93 58.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 109.439 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -77.46 -34.77 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 108.841 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -69.09 -27.27 74.0 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -43.43 -59.56 2.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -1.122 . . . . 0.0 110.013 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 325' ' ' ASP . . . -133.07 -111.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 112.068 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' B' ' 324' ' ' ALA . 2.0 m-20 160.01 -2.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.336 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 128.27 38.97 0.35 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 119.611 -1.281 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 57.0 p -115.97 -86.97 0.61 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.773 -1.427 . . . . 0.0 108.678 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.506 ' O ' ' NE2' ' B' ' 330' ' ' GLN . 20.1 tpt180 -94.29 -29.91 14.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' B' ' 329' ' ' PHE . 0.7 OUTLIER -117.86 126.25 52.04 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 328' ' ' ARG . 6.9 mp0 -132.23 136.37 46.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.471 -1.393 . . . . 0.0 112.65 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.72 107.11 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 20.7 m0 -104.48 142.92 33.77 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.071 -1.018 . . . . 0.0 110.939 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.542 ' O ' ' SD ' ' B' ' 342' ' ' MET . 67.0 m-20 -86.05 155.18 20.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.626 -1.296 . . . . 0.0 107.855 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.453 ' OH ' ' CG ' ' B' ' 282' ' ' GLU . 3.9 p90 -168.74 172.63 7.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.388 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -141.74 146.81 36.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' B' ' 335' ' ' ALA . 36.7 mt-10 -39.35 -37.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.83 -1.169 . . . . 0.0 110.286 -178.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.93 15.67 31.14 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 335' ' ' ALA . 74.1 mt-10 -146.59 -5.15 0.56 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.119 -1.224 . . . . 0.0 110.47 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.8 p -53.8 -46.85 63.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.804 -1.185 . . . . 0.0 108.606 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 23.1 pt-20 -56.29 -34.39 66.42 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 32.2 m -65.78 -39.46 91.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.542 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 11.8 mmt -55.79 -51.56 67.0 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' B' ' 343' ' ' LEU . 25.0 mt -63.79 -30.48 71.57 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.39 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -69.26 -44.09 72.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.991 -1.068 . . . . 0.0 110.69 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -71.86 -43.35 65.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.532 -1.355 . . . . 0.0 109.38 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -63.02 -48.86 76.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.358 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.926 ' CD1' HD12 ' B' ' 351' ' ' LEU . 19.9 m-85 -73.36 -31.0 63.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.413 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -68.15 -27.48 66.47 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -59.25 -27.56 65.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.766 -0.584 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.822 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.1 OUTLIER -145.73 -63.63 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.0 -1.063 . . . . 0.0 110.591 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.926 HD12 ' CD1' ' B' ' 347' ' ' PHE . 1.4 mt -31.13 92.99 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.633 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . 0.53 ' N ' ' O ' ' B' ' 350' ' ' TYR . 77.2 Cg_endo . . . . . 0 C--N 1.311 -1.442 0 C-N-CA 123.105 2.536 . . . . 0.0 110.914 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.51 -161.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.457 2.105 . . . . 0.0 111.704 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 29.1 p -99.8 -173.25 2.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 1.2 m -118.68 143.52 46.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG11 HD22 ' A' ' 35' ' ' LEU . 58.3 t -126.01 136.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CZ ' ' OE1' ' A' ' 44' ' ' GLU . 5.9 t80 -113.41 109.17 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.557 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.23 129.95 44.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.636 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 3.2 m -102.12 151.19 22.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.342 -0.849 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.84 162.66 36.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -86.35 132.94 33.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.226 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' A' ' 46' ' ' VAL . 1.3 mm . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 51.3 mp0 -51.5 -46.2 63.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 5.7 m-20 -65.01 -22.62 67.02 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 18.3 tp60 -63.35 -39.15 93.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.87 -47.88 67.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.86 -32.22 67.44 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.816 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.5 m-30 -67.44 -46.99 71.48 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . . . -60.28 -37.48 80.62 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.644 -1.285 . . . . 0.0 109.046 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -70.79 -56.79 5.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.756 -1.215 . . . . 0.0 108.515 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.508 HG21 ' OE2' ' A' ' 82' ' ' GLU . 5.0 mt -52.9 -43.99 47.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 28' ' ' TYR . 61.6 t -59.44 -29.09 41.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.3 m -71.68 -34.41 69.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -69.46 -53.29 19.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 108.615 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD22 HG11 ' A' ' 12' ' ' VAL . 13.1 mt -56.95 -39.51 74.67 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.96 -22.92 67.15 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -72.89 -44.54 61.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 109.412 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.95 -50.09 9.55 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.564 -0.71 . . . . 0.0 111.784 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.554 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . -142.46 132.48 5.15 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -35.79 145.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -1.052 . . . . 0.0 109.129 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.706 HG21 HG13 ' A' ' 32' ' ' VAL . 50.2 t -79.4 100.56 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 72' ' ' TRP . 0.1 OUTLIER -49.88 94.56 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.952 -177.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 41' ' ' VAL . 6.6 m 28.21 100.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.363 0.602 . . . . 0.0 111.371 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' OE1' ' CZ ' ' A' ' 13' ' ' TYR . 16.3 tp10 -142.9 65.88 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' VAL . 25.0 p80 -50.16 -5.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 39.0 t -40.18 -58.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.66 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -66.93 -40.76 87.7 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 108.641 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 51' ' ' LEU . 7.4 t70 -70.67 25.05 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -101.98 -16.18 16.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.01 -43.96 70.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 109.027 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.973 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.73 136.99 20.94 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 0.0 109.353 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 51' ' ' LEU . 20.8 mm-40 53.98 153.55 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.997 . . . . 0.0 109.082 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.47 88.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.195 1.93 . . . . 0.0 111.736 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.476 HD11 ' NH1' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.15 -163.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.155 -0.966 . . . . 0.0 109.806 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 91.09 151.85 27.22 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.649 ' C ' ' H ' ' A' ' 58' ' ' ALA . 44.4 mt-10 -50.55 178.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -1.176 . . . . 0.0 109.003 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 64.91 -24.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.166 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.649 ' H ' ' C ' ' A' ' 56' ' ' GLU . . . -80.37 141.41 35.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 109.162 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.58 133.38 36.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.154 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.38 -77.08 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.05 83.61 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -52.44 -45.79 66.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -1.043 . . . . 0.0 108.562 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -62.14 -46.36 89.37 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 35.3 t80 -62.56 -41.62 99.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 11.9 mt -56.02 -46.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.753 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.7 t-80 -76.46 -27.11 56.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.7 -0.625 . . . . 0.0 109.852 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -61.86 -56.8 15.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.314 -0.867 . . . . 0.0 109.592 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 23.5 mp0 -76.37 -41.78 46.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.627 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 63.6 m-20 -60.11 -52.82 63.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.149 -0.97 . . . . 0.0 109.797 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.501 HD22 ' NE2' ' A' ' 66' ' ' HIS . 1.2 tp -67.98 -44.71 76.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.591 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -59.33 -49.27 78.46 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.592 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.694 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -76.73 -19.71 57.36 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.084 -1.447 . . . . 0.0 109.485 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.8 tp -64.67 -35.14 80.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -86.66 -19.0 29.89 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.398 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.63 ' NE2' ' CD1' ' A' ' 72' ' ' TRP . 4.0 tt0 -99.26 2.74 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.879 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 129.26 39.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.194 -0.941 . . . . 0.0 111.381 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 11' ' ' SER . 94.6 m-20 -63.5 -35.23 79.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' OH ' ' A' ' 150' ' ' TYR . 42.9 t -138.41 149.78 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.0 t -137.39 142.0 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.499 1.142 . . . . 0.0 112.106 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 105' ' ' LEU . 97.7 t -138.2 165.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -158.04 137.13 11.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.632 -1.293 . . . . 0.0 109.227 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 90' ' ' VAL . 28.4 mt-10 -93.61 126.1 38.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -126.68 130.72 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 85' ' ' GLN . 20.0 m -170.5 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.843 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 31.5 tt0 -100.05 -24.64 0.22 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.706 . . . . 0.0 109.843 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 96.2 Cg_exo -43.3 -142.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.731 2.287 . . . . 0.0 112.163 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.664 ' OG ' ' N ' ' A' ' 88' ' ' LEU . 2.4 t 172.53 -153.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.677 -1.264 . . . . 0.0 109.669 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.664 ' N ' ' OG ' ' A' ' 87' ' ' SER . 20.9 mt -30.59 136.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 110.091 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.37 -38.07 3.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -88.85 -41.86 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.969 . . . . 0.0 108.589 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.66 -33.39 71.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' CD2' ' SD ' ' B' ' 319' ' ' MET . 65.4 t80 -66.65 -52.89 39.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -1.143 . . . . 0.0 109.745 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.562 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 59.0 mt-10 -64.82 -31.27 72.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.314 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 81' ' ' ALA . 25.1 mt -66.9 -44.42 80.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.88 -33.06 86.24 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.587 HH11 ' CG1' ' B' ' 298' ' ' VAL . 17.2 mmm180 -65.27 -44.46 87.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -1.03 . . . . 0.0 109.846 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 -36.71 73.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 108.67 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.568 ' CG1' HH11 ' B' ' 296' ' ' ARG . 0.5 OUTLIER -53.52 -44.52 56.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -74.8 -50.85 15.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.647 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 74' ' ' GLN . 14.2 mt -65.98 -6.45 12.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.53 17.54 66.79 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.905 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 104' ' ' ILE . 64.4 mmtt -83.47 135.43 43.75 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 120.708 -1.466 . . . . 0.0 107.973 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.15 121.73 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.642 1.561 . . . . 0.0 110.966 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -108.8 100.13 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.961 -1.087 . . . . 0.0 111.45 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HB3' HG22 ' A' ' 80' ' ' VAL . 24.6 tp -91.75 114.37 26.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -110.95 154.53 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 109.383 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.8 mt -122.92 149.5 44.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -145.03 119.63 9.76 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' NH1' ' NE2' ' A' ' 111' ' ' GLN . 7.2 mtm180 -79.25 124.61 84.27 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.797 -1.189 . . . . 0.0 111.109 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 113' ' ' GLY . 95.3 Cg_endo -83.42 -30.74 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.594 2.196 . . . . 0.0 110.758 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.469 ' NE2' ' NH1' ' A' ' 109' ' ' ARG . 9.4 pt20 -51.25 -35.24 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 39.6 m -98.7 -11.9 21.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 110' ' ' PRO . . . 39.98 48.07 3.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 5.12 2.43 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -1.15 . . . . 0.0 109.386 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.0 t 53.92 109.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.822 0.82 . . . . 0.0 110.135 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 131' ' ' VAL . 8.7 tp -56.19 149.32 16.31 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.94 150.07 14.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.16 86.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 108.643 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.602 ' SD ' ' CD2' ' B' ' 292' ' ' TYR . 0.0 OUTLIER -60.28 -50.58 73.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' ALA . 32.6 mm -63.94 -36.32 76.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.104 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 18.9 mmt85 -53.58 -43.37 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.75 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -54.63 -43.92 79.04 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.715 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -78.01 90.17 4.18 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' ARG . . . -174.28 46.5 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.591 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.37 -12.39 61.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 67.62 2.61 22.75 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.4 m -105.58 -78.85 0.57 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.993 -1.298 . . . . 0.0 108.87 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -93.19 -31.77 14.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.708 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 8.5 t80 -110.74 130.19 55.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.6 125.74 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.864 -1.148 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.716 HG11 HD22 ' A' ' 116' ' ' LEU . 38.5 t -85.68 106.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 12.3 m0 -102.06 138.02 39.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.0 -1.063 . . . . 0.0 109.558 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' O ' ' CE ' ' A' ' 142' ' ' MET . 91.8 m-20 -91.79 152.67 20.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.705 -1.247 . . . . 0.0 109.012 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.8 p90 -164.29 -179.33 6.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.475 -1.29 . . . . 0.0 111.917 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.53 147.36 25.33 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 135' ' ' ALA . 52.0 mt-10 -42.06 -36.17 1.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.926 -1.109 . . . . 0.0 110.298 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.36 4.44 41.53 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.496 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.96 7.15 0.33 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.552 -1.558 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.8 p -51.25 -43.29 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 108.464 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.7 mt-10 -57.93 -36.34 72.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 m -64.99 -45.53 85.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.455 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 3.9 tpp -51.56 -46.32 63.37 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.84 -33.18 68.26 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.702 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 55.3 m-20 -65.43 -40.42 93.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.95 -1.093 . . . . 0.0 109.837 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -69.91 -49.06 55.8 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.634 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.28 -48.73 80.06 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 109.979 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.829 ' CD1' HD12 ' A' ' 151' ' ' LEU . 8.9 m-85 -66.95 -32.43 73.67 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.904 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.71 -25.14 64.62 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.588 -1.32 . . . . 0.0 107.785 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.39 62.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.53 -0.732 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -146.05 -0.13 0.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.456 -1.402 . . . . 0.0 111.649 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 147' ' ' PHE . 16.6 mt -115.69 82.75 10.58 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.672 -1.267 . . . . 0.0 109.267 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 C--N 1.31 -1.454 0 C-N-CA 122.646 2.231 . . . . 0.0 112.095 179.77 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.61 -161.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.625 2.217 . . . . 0.0 111.587 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' CYS . . . . . 0.456 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 29.7 p -100.07 -173.19 2.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 1.2 m -118.62 143.76 46.6 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . 0.494 HG11 HD22 ' B' ' 235' ' ' LEU . 60.1 t -126.14 136.63 60.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' TYR . . . . . 0.53 ' CZ ' ' OE1' ' B' ' 244' ' ' GLU . 6.0 t80 -113.35 109.12 18.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.13 130.09 44.91 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.658 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 3.2 m -102.28 151.33 22.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -165.95 162.75 36.23 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 15.9 m -86.48 133.0 33.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.168 -1.195 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' B' ' 246' ' ' VAL . 1.3 mm . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.229 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 50.3 mp0 -51.34 -46.08 62.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 6.0 m-20 -65.56 -22.53 66.7 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 17.9 tp60 -63.44 -39.07 93.49 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.29 68.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.95 -32.53 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' TYR . . . . . 0.809 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -67.27 -47.02 71.94 Favored 'General case' 0 C--O 1.198 -1.631 0 O-C-N 121.527 -0.733 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 247' ' ' ALA . . . -60.38 -37.4 80.64 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.723 -1.236 . . . . 0.0 109.044 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -70.65 -56.86 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.773 -1.204 . . . . 0.0 108.505 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.495 HG21 ' OE2' ' B' ' 282' ' ' GLU . 4.9 mt -52.83 -43.93 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 228' ' ' TYR . 60.6 t -59.66 -28.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.0 m -71.93 -34.19 68.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.0 109.383 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.47 -53.54 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.871 -1.143 . . . . 0.0 108.626 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 212' ' ' VAL . 12.9 mt -56.64 -39.61 73.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -62.97 -22.97 67.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -72.91 -44.62 61.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 109.491 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.81 -49.9 9.85 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.513 -0.742 . . . . 0.0 111.873 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . -142.67 132.75 5.24 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' B' ' 239' ' ' GLY . 0.0 OUTLIER -35.96 145.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -1.003 . . . . 0.0 109.027 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' VAL . . . . . 0.716 HG21 HG13 ' B' ' 232' ' ' VAL . 44.7 t -79.31 100.63 4.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' B' ' 272' ' ' TRP . 0.1 OUTLIER -49.84 94.88 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.938 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' THR . . . . . 0.524 ' N ' ' O ' ' B' ' 241' ' ' VAL . 6.6 m 27.81 100.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.421 0.629 . . . . 0.0 111.387 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' B' ' 246' ' ' VAL . 15.7 tp10 -143.2 66.52 1.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' B' ' 246' ' ' VAL . 25.0 p80 -50.64 -5.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.562 -0.711 . . . . 0.0 110.147 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' VAL . . . . . 0.555 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 39.3 t -40.36 -58.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.675 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -67.2 -40.54 86.51 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 108.616 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' ASP . . . . . 0.851 ' O ' HD11 ' B' ' 251' ' ' LEU . 7.0 t70 -71.0 25.58 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -102.47 -15.97 16.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -54.16 -43.89 70.98 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' LEU . . . . . 0.956 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -50.83 136.79 21.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' GLU . . . . . 0.606 ' O ' ' O ' ' B' ' 251' ' ' LEU . 20.6 mm-40 54.17 153.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.98 . . . . 0.0 109.175 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.69 89.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.181 1.921 . . . . 0.0 111.542 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' LEU . . . . . 0.483 HD11 ' NH1' ' B' ' 222' ' ' ARG . 0.3 OUTLIER -61.88 -163.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.75 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 91.37 151.58 27.03 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' GLU . . . . . 0.653 ' C ' ' H ' ' B' ' 258' ' ' ALA . 46.7 mt-10 -50.29 178.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -1.214 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 64.82 -25.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 109.055 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -80.08 141.73 35.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.29 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.21 132.12 38.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 168.57 -77.5 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 138.81 83.21 0.1 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -52.08 -45.88 64.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -1.072 . . . . 0.0 108.387 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -62.09 -46.52 88.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 36.0 t80 -62.72 -41.3 99.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.31 -0.869 . . . . 0.0 108.994 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 12.0 mt -56.28 -45.86 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' HIS . . . . . 0.75 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -76.68 -27.33 55.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.926 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.66 -56.66 17.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.348 -0.845 . . . . 0.0 109.688 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 23.1 mp0 -76.65 -41.54 45.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' ASP . . . . . 0.472 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 62.1 m-20 -60.01 -52.3 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' B' ' 274' ' ' GLN . 1.2 tp -68.57 -44.49 74.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.23 -49.37 78.09 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.621 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' B' ' 242' ' ' LEU . 0.2 OUTLIER -76.6 -19.63 57.64 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.121 -1.432 . . . . 0.0 109.588 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 273' ' ' LEU . . . . . 0.447 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.7 tp -64.81 -34.91 79.49 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 274' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.2 OUTLIER -86.96 -19.1 29.24 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.442 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 275' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' B' ' 272' ' ' TRP . 4.1 tt0 -99.11 2.39 45.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.822 -1.174 . . . . 0.0 108.817 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.02 129.3 39.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.108 -0.995 . . . . 0.0 111.405 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 95.2 m-20 -63.37 -35.38 80.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.463 HG21 ' OH ' ' B' ' 350' ' ' TYR . 42.6 t -138.28 149.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 279' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' B' ' 213' ' ' TYR . 83.2 t -137.48 142.22 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.534 1.159 . . . . 0.0 112.194 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 280' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' B' ' 305' ' ' LEU . 97.2 t -138.34 165.45 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 281' ' ' ALA . . . . . 0.522 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -157.72 137.04 11.85 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.548 -1.345 . . . . 0.0 109.283 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 282' ' ' GLU . . . . . 0.519 ' O ' HG11 ' B' ' 290' ' ' VAL . 28.7 mt-10 -93.32 126.29 38.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 283' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -126.81 130.88 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 284' ' ' THR . . . . . 0.569 HG22 ' N ' ' B' ' 285' ' ' GLN . 20.2 m -170.77 -92.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 285' ' ' GLN . . . . . 0.841 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 31.8 tt0 -100.11 -24.75 0.22 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.452 -0.78 . . . . 0.0 109.838 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 286' ' ' PRO . . . . . 0.841 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 97.6 Cg_exo -43.31 -142.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.688 2.259 . . . . 0.0 112.125 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 287' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' B' ' 288' ' ' LEU . 2.1 t 172.53 -153.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.569 -1.332 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 288' ' ' LEU . . . . . 0.679 ' N ' ' OG ' ' B' ' 287' ' ' SER . 20.2 mt -30.49 136.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 114.97 -37.64 3.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 290' ' ' VAL . . . . . 0.519 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.3 t -89.17 -42.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.583 -0.951 . . . . 0.0 108.588 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.06 71.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 292' ' ' TYR . . . . . 0.602 ' CD2' ' SD ' ' A' ' 119' ' ' MET . 65.7 t80 -66.97 -52.24 45.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -1.161 . . . . 0.0 109.9 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 293' ' ' GLU . . . . . 0.552 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 59.5 mt-10 -65.25 -31.3 72.39 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 294' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 281' ' ' ALA . 24.6 mt -66.98 -44.46 80.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.11 -32.75 85.06 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 296' ' ' ARG . . . . . 0.568 HH11 ' CG1' ' A' ' 98' ' ' VAL . 16.9 mmm180 -65.33 -44.52 87.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.051 . . . . 0.0 109.82 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.84 -36.82 73.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.993 . . . . 0.0 108.647 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 298' ' ' VAL . . . . . 0.587 ' CG1' HH11 ' A' ' 96' ' ' ARG . 0.5 OUTLIER -53.26 -44.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 299' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.02 -50.68 15.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.736 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 300' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' B' ' 274' ' ' GLN . 14.5 mt -66.45 -6.18 13.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.41 17.57 66.56 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.817 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 302' ' ' LYS . . . . . 0.43 ' O ' HG13 ' B' ' 304' ' ' ILE . 65.1 mmtt -83.42 135.69 43.62 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 120.667 -1.49 . . . . 0.0 107.931 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.23 122.16 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.75 1.634 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 304' ' ' ILE . . . . . 0.626 HD12 ' H ' ' B' ' 304' ' ' ILE . 1.7 mp -109.37 99.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.987 . . . . 0.0 111.283 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 305' ' ' LEU . . . . . 0.58 ' HB3' HG22 ' B' ' 280' ' ' VAL . 24.9 tp -91.55 114.37 26.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 306' ' ' CYS . . . . . 0.703 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.3 OUTLIER -110.97 154.34 24.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.901 -1.124 . . . . 0.0 109.566 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 307' ' ' LEU . . . . . 0.558 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 9.2 mt -122.86 149.76 43.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.245 -0.909 . . . . 0.0 111.249 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 308' ' ' PHE . . . . . 0.71 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.4 OUTLIER -145.72 119.69 9.37 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 309' ' ' ARG . . . . . 0.461 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 7.7 mtm180 -79.07 125.21 84.1 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.0 111.131 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 310' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.5 Cg_endo -83.55 -29.98 0.94 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.579 2.186 . . . . 0.0 110.669 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 311' ' ' GLN . . . . . 0.461 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 9.4 pt20 -51.95 -35.16 45.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 312' ' ' SER . . . . . 0.448 ' O ' ' C ' ' B' ' 313' ' ' GLY . 31.1 m -98.8 -11.68 21.59 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 310' ' ' PRO . . . 39.84 47.93 3.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 314' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' B' ' 315' ' ' VAL . 0.5 OUTLIER -71.14 4.39 2.8 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.168 -1.195 . . . . 0.0 109.373 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' B' ' 314' ' ' ARG . 2.9 t 54.6 109.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.82 0.819 . . . . 0.0 110.101 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 316' ' ' LEU . . . . . 0.713 HD22 HG11 ' B' ' 331' ' ' VAL . 8.7 tp -56.58 149.83 16.71 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 150.03 16.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.629 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.66 85.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 108.606 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 319' ' ' MET . . . . . 0.612 ' SD ' ' CD2' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -60.78 -50.48 73.28 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 108.836 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 320' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' B' ' 323' ' ' ALA . 32.2 mm -64.02 -36.34 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.981 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 321' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' B' ' 324' ' ' ALA . 19.2 mmt85 -53.54 -43.61 68.55 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 322' ' ' GLY . . . . . 0.753 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -54.58 -43.82 78.55 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 104.632 -3.387 . . . . 0.0 104.632 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 323' ' ' ALA . . . . . 0.71 ' O ' ' O ' ' B' ' 320' ' ' ILE . . . -77.92 90.14 4.12 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 324' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 321' ' ' ARG . . . -174.14 46.32 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.622 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.08 -12.29 61.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.413 -0.805 . . . . 0.0 111.212 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 326' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 67.36 2.15 18.62 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.666 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 73.6 m -105.27 -78.91 0.56 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.991 -1.299 . . . . 0.0 108.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -93.16 -32.11 14.53 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.703 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 9.1 t80 -110.23 130.13 55.6 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.52 125.43 13.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.796 -1.19 . . . . 0.0 111.25 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 331' ' ' VAL . . . . . 0.713 HG11 HD22 ' B' ' 316' ' ' LEU . 35.9 t -85.46 106.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 332' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 11.9 m0 -102.02 137.79 39.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.04 -1.038 . . . . 0.0 109.44 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 333' ' ' ASP . . . . . 0.458 ' O ' ' SD ' ' B' ' 342' ' ' MET . 91.8 m-20 -91.54 152.57 20.26 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.801 -1.187 . . . . 0.0 109.084 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 334' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.7 p90 -164.15 -179.22 6.01 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.856 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.91 147.59 25.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 336' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.4 mt-10 -42.21 -36.07 1.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.802 -1.186 . . . . 0.0 110.281 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -75.26 3.79 44.79 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.507 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.52 7.09 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.486 -1.597 . . . . 0.0 110.866 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.9 p -51.11 -43.49 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.908 -1.12 . . . . 0.0 108.467 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 340' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 83.1 mt-10 -57.88 -36.24 72.1 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 72.1 m -64.88 -45.67 85.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 342' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.9 tpp -51.42 -46.81 63.06 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.23 -33.6 70.02 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.789 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 344' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' B' ' 340' ' ' GLU . 55.4 m-20 -65.4 -40.33 93.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.972 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.92 -49.17 54.66 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.923 -1.111 . . . . 0.0 108.462 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.15 -48.61 80.8 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.215 -0.928 . . . . 0.0 110.017 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 347' ' ' PHE . . . . . 0.853 ' CD1' HD12 ' B' ' 351' ' ' LEU . 9.1 m-85 -66.96 -32.18 73.25 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.934 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -68.98 -25.04 64.33 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.54 -1.35 . . . . 0.0 107.83 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.26 62.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 350' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.5 OUTLIER -146.26 -0.34 0.78 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.611 -1.306 . . . . 0.0 111.512 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 351' ' ' LEU . . . . . 0.853 HD12 ' CD1' ' B' ' 347' ' ' PHE . 16.7 mt -115.53 82.58 10.0 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 120.576 -1.328 . . . . 0.0 109.189 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--N 1.312 -1.391 0 C-N-CA 122.752 2.301 . . . . 0.0 112.136 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.6 mtp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.99 146.9 40.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.528 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.8 154.52 36.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.374 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 6' ' ' GLU . 17.7 m -57.98 158.4 6.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.9 . . . . 0.0 109.414 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.78 38.46 0.5 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 4' ' ' SER . 95.3 mt-10 -114.88 156.94 24.04 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.496 -1.002 . . . . 0.0 109.207 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.43 176.58 8.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -89.76 135.54 30.44 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.314 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 8' ' ' ALA . 32.1 Cg_exo -57.62 -150.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.804 1.669 . . . . 0.0 111.213 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -111.03 -175.39 2.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.496 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 36.0 m -121.44 152.43 39.1 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.796 HG11 HD22 ' A' ' 35' ' ' LEU . 10.8 t -131.0 136.09 58.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.656 ' OH ' ' CG ' ' A' ' 69' ' ' ASP . 8.1 t80 -113.17 99.26 7.69 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -89.49 116.75 27.89 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.46 -0.896 . . . . 0.0 108.883 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.3 m -92.55 146.76 23.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.908 -1.12 . . . . 0.0 109.443 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.62 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -168.58 75.13 0.12 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.62 ' C ' ' O ' ' A' ' 16' ' ' GLY . 15.7 m -16.2 127.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.936 -0.743 . . . . 0.0 110.766 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 19' ' ' ARG . 2.4 mt -94.43 -75.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 110.034 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' NE ' ' OE2' ' A' ' 56' ' ' GLU . 39.7 mmm-85 48.42 72.08 0.31 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.529 ' O ' HD12 ' A' ' 54' ' ' LEU . . . 110.41 -116.71 4.45 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.39 95.57 0.11 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.704 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -129.09 -144.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -1.127 . . . . 0.0 111.859 -175.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -59.76 -42.95 94.4 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.7 m-20 -52.06 -34.76 45.01 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.556 HE21 ' HB3' ' A' ' 49' ' ' ALA . 5.9 tp60 -64.09 -44.61 91.82 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 -49.92 60.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.285 -0.885 . . . . 0.0 109.227 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -58.75 -32.45 69.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 32' ' ' VAL . 16.0 m-30 -67.86 -46.03 72.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.343 -0.848 . . . . 0.0 109.742 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.2 -36.71 78.27 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 120.995 -1.065 . . . . 0.0 108.997 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -70.8 -57.22 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.976 -1.077 . . . . 0.0 108.579 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.5 mt -51.7 -42.57 31.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.1 t -61.72 -31.32 50.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.0 t -67.12 -39.24 86.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 110.026 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 38' ' ' TYR . 53.0 ttt85 -69.56 -48.61 59.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.699 -1.251 . . . . 0.0 109.415 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.796 HD22 HG11 ' A' ' 12' ' ' VAL . 15.3 mt -60.71 -38.54 85.37 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.9 mtp85 -63.17 -24.99 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -78.05 -36.66 48.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.056 -1.027 . . . . 0.0 109.419 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.553 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-85 -69.8 -47.05 64.26 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.426 -0.796 . . . . 0.0 110.416 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.75 2.56 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -99.36 135.68 40.42 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.364 -1.08 . . . . 0.0 109.29 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.85 117.61 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 44' ' ' GLU . 19.3 mt -80.94 -35.81 31.8 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.262 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -68.27 37.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.08 -1.012 . . . . 0.0 109.561 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 42' ' ' LEU . 44.3 tp10 -50.27 -34.49 23.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.415 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -49.77 -52.85 28.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.223 -0.923 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 48' ' ' ASP . 21.8 t -58.83 163.65 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.719 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 62.55 -59.92 0.13 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.759 ' O ' HD11 ' A' ' 51' ' ' LEU . 24.0 t70 -65.85 24.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.719 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -103.63 -10.83 18.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -63.73 -39.78 95.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.028 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -55.07 161.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.527 -0.733 . . . . 0.0 109.773 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 51' ' ' LEU . 12.8 mt-10 55.97 158.61 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.287 -0.883 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' C ' HD22 ' A' ' 54' ' ' LEU . 23.6 Cg_endo -63.04 131.8 34.13 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.446 2.097 . . . . 0.0 111.593 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.644 HD11 ' O ' ' A' ' 49' ' ' ALA . 3.7 mm? -93.91 171.16 9.03 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.855 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 141.27 37.97 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' OE2' ' NE ' ' A' ' 19' ' ' ARG . 50.0 mt-10 47.11 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.482 -1.01 . . . . 0.0 109.56 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 55' ' ' GLY . 97.1 mt-10 -47.47 -20.6 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' A' ' 56' ' ' GLU . . . -48.66 151.11 1.22 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 108.995 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -45.91 136.89 6.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.494 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.89 -62.57 0.17 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.78 80.6 1.13 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 18.8 p-10 -52.17 -45.22 65.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -1.091 . . . . 0.0 108.307 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.492 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 88.4 mt-30 -63.49 -48.59 77.02 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -61.64 -36.0 79.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.094 -1.004 . . . . 0.0 109.015 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.514 HG23 ' CD2' ' A' ' 45' ' ' HIS . 2.0 mt -62.71 -52.22 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.657 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 0.1 OUTLIER -67.56 -50.54 58.01 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.588 0.709 . . . . 0.0 109.423 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 45.7 tp10 -43.09 -58.14 2.59 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.039 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -63.9 -39.42 94.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.656 ' CG ' ' OH ' ' A' ' 13' ' ' TYR . 8.5 t0 -58.42 -48.0 82.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.421 -0.799 . . . . 0.0 110.408 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.516 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -64.51 -45.14 88.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.155 -0.966 . . . . 0.0 109.881 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' NE2' ' A' ' 75' ' ' GLN . 10.1 t-20 -65.44 -52.11 55.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.24 -0.913 . . . . 0.0 109.702 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.447 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.12 -45.69 90.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.093 -1.004 . . . . 0.0 108.976 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 42.1 tp -50.35 -37.22 35.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.407 ' HA ' HD11 ' A' ' 100' ' ' LEU . 68.9 mt-30 -73.7 -28.1 61.55 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.435 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.49 ' NE2' ' OD1' ' A' ' 71' ' ' ASN . 41.2 mt-30 -88.1 -0.5 57.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.97 -1.081 . . . . 0.0 109.646 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.81 44.87 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.091 -1.005 . . . . 0.0 112.277 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 11' ' ' SER . 61.5 m-20 -85.61 -31.67 22.48 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.5 t -134.47 143.96 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 13' ' ' TYR . 86.2 t -138.88 130.81 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.687 -1.258 . . . . 0.0 111.748 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 105' ' ' LEU . 84.0 t -136.65 130.66 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.503 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -116.23 137.21 52.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.663 -1.273 . . . . 0.0 110.291 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' OE2' ' CD2' ' A' ' 27' ' ' LEU . 55.1 tt0 -84.71 139.18 32.19 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.6 -0.687 . . . . 0.0 109.282 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.613 HG13 HG11 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -143.62 147.71 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.272 -0.893 . . . . 0.0 109.793 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 14.5 m -173.87 -69.0 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' NE2' ' OD2' ' A' ' 24' ' ' ASP . 24.6 pt20 -97.93 153.61 38.12 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -37.37 143.71 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.146 1.897 . . . . 0.0 111.676 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB3' HG23 ' A' ' 90' ' ' VAL . 3.5 m -163.5 123.9 2.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.055 -1.028 . . . . 0.0 110.104 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.47 ' HG ' ' H ' ' B' ' 287' ' ' SER . 4.0 mt -76.62 -45.19 31.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.186 -0.946 . . . . 0.0 109.316 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.564 ' N ' ' OG ' ' A' ' 17' ' ' SER . . . -60.78 -42.17 99.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.613 HG11 HG13 ' A' ' 83' ' ' VAL . 40.7 t -64.62 -45.21 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.194 -1.18 . . . . 0.0 109.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.79 -46.7 93.65 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' B' ' 319' ' ' MET . 82.5 t80 -66.25 -47.94 72.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -1.081 . . . . 0.0 109.501 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.443 ' CD ' ' SD ' ' B' ' 319' ' ' MET . 10.8 mm-40 -59.76 -37.27 78.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.903 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.6 mt -75.22 -41.53 57.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.051 -1.031 . . . . 0.0 109.242 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.04 -50.02 59.65 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.71 -40.05 82.58 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.392 -1.064 . . . . 0.0 108.612 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.49 ' O ' HD11 ' A' ' 104' ' ' ILE . . . -68.33 -37.06 80.18 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.633 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.73 -45.14 48.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.892 -1.13 . . . . 0.0 108.276 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -89.59 -53.04 4.7 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.089 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 100' ' ' LEU . 1.8 tm? -90.06 -29.85 18.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.089 -1.007 . . . . 0.0 109.643 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -74.19 166.68 54.74 Favored Glycine 0 C--N 1.283 -2.392 0 N-CA-C 108.391 -1.884 . . . . 0.0 108.391 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.496 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 4.8 mtmm -124.55 -71.09 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 82.9 Cg_endo -79.48 111.43 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.978 1.786 . . . . 0.0 109.293 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.49 HD11 ' O ' ' A' ' 97' ' ' ALA . 16.0 mt -129.59 116.03 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.782 -1.199 . . . . 0.0 111.995 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 80' ' ' VAL . 57.3 tp -110.5 126.26 54.18 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.78 145.66 39.0 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.928 -1.108 . . . . 0.0 108.771 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.3 mt -122.47 135.49 54.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.911 . . . . 0.0 111.625 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -133.5 138.01 45.91 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.577 ' NH2' ' NE2' ' A' ' 111' ' ' GLN . 4.4 mtm180 -98.98 134.66 21.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 120.703 -1.248 . . . . 0.0 111.338 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.43 -26.1 4.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.553 2.169 . . . . 0.0 111.267 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.577 ' NE2' ' NH2' ' A' ' 109' ' ' ARG . 20.3 pt20 -46.63 -38.66 9.97 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 113' ' ' GLY . 31.0 t -102.13 -15.8 16.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.82 51.37 2.56 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 115' ' ' VAL . 58.8 mtp85 -80.87 18.08 1.07 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.998 -1.295 . . . . 0.0 109.062 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 114' ' ' ARG . 48.7 t 46.99 100.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.671 0.748 . . . . 0.0 110.141 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.544 HD11 HG11 ' A' ' 83' ' ' VAL . 49.1 tp -47.95 145.77 2.82 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 0.0 109.449 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.9 m -45.8 143.13 2.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.63 -30.31 69.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.458 -0.776 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.408 ' SD ' ' CD ' ' B' ' 293' ' ' GLU . 0.8 OUTLIER -70.76 -51.57 26.28 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.878 -178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.66 -42.51 96.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.675 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.3 tpt85 -65.17 -48.84 72.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.13 -0.981 . . . . 0.0 109.544 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.617 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -62.35 -31.25 78.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.539 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . . . -62.6 -15.66 52.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.038 -1.272 . . . . 0.0 108.199 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.45 96.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.479 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 65.3 m-20 -105.29 -22.52 13.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.27 -0.893 . . . . 0.0 108.693 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.42 30.37 77.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 89.6 p -134.89 59.82 1.72 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.7 mtt180 98.61 -31.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 123' ' ' ALA . 88.5 t80 -97.49 120.03 37.12 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.41 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.6 mt-30 -145.91 142.02 28.34 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.852 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.83 100.59 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.508 ' CG ' HD11 ' A' ' 105' ' ' LEU . 21.6 m0 -95.43 152.68 18.19 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.237 -0.914 . . . . 0.0 109.626 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -97.38 155.54 16.86 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.094 -1.004 . . . . 0.0 108.877 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 6.3 p90 -170.19 -178.68 2.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.724 -1.235 . . . . 0.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.94 149.72 27.57 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.9 mt-10 -42.47 -29.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.704 -1.247 . . . . 0.0 110.154 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.51 -6.06 88.05 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.56 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.08 11.32 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.587 -1.537 . . . . 0.0 110.581 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.0 p -54.34 -45.35 68.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.924 -1.11 . . . . 0.0 108.448 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.504 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 49.9 mt-10 -57.76 -32.67 67.72 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.451 -0.781 . . . . 0.0 109.262 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.8 m -68.18 -45.52 73.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.568 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.97 -50.91 60.33 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 18.6 mt -66.55 -34.1 77.15 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.768 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -64.89 -41.53 95.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.413 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 39.1 mtt-85 -68.87 -48.7 62.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.867 -1.146 . . . . 0.0 108.331 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.39 -48.17 82.9 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.331 -0.855 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.464 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 16.7 m-85 -69.74 -32.9 71.7 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.942 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 150' ' ' TYR . 27.1 mm-40 -62.24 -32.42 73.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.14 10.87 5.94 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.2 t80 -134.6 -105.09 0.23 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.24 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.484 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 14.9 mt -34.4 92.13 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.8 -0.563 . . . . 0.0 111.208 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.493 ' N ' ' O ' ' A' ' 150' ' ' TYR . 87.1 Cg_endo -94.8 -61.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 123.168 2.578 . . . . 0.0 111.142 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -107.54 -23.48 12.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -57.19 -30.25 64.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 108.949 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.57 HG23 ' N ' ' A' ' 156' ' ' ALA . 12.0 t -57.1 -44.94 83.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.443 -0.786 . . . . 0.0 109.548 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.57 ' N ' HG23 ' A' ' 155' ' ' THR . . . -168.48 148.86 4.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.26 -0.9 . . . . 0.0 109.524 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -150.56 118.8 6.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 109.54 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.0 m -74.02 -31.09 62.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.7 p -96.33 151.28 19.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.304 -0.873 . . . . 0.0 109.279 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.517 ' N ' ' ND1' ' A' ' 160' ' ' HIS . 6.4 p-80 -139.04 76.46 33.21 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.855 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.72 152.6 12.76 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.707 2.272 . . . . 0.0 112.02 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.5 m -55.14 153.18 7.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.189 -0.945 . . . . 0.0 109.372 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.438 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.14 146.64 38.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.525 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -64.52 154.23 36.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . 0.506 ' C ' ' H ' ' B' ' 206' ' ' GLU . 18.2 m -57.87 158.34 6.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.927 . . . . 0.0 109.468 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -70.68 38.01 0.48 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' B' ' 204' ' ' SER . 95.4 mt-10 -114.23 155.61 25.81 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.522 -0.987 . . . . 0.0 109.181 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -76.51 176.42 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.158 -0.964 . . . . 0.0 109.43 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -89.56 136.1 30.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.249 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.09 -150.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.961 1.774 . . . . 0.0 111.279 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 28.2 p -111.25 -175.65 2.76 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 33.6 m -121.13 152.81 38.29 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.778 HG11 HD22 ' B' ' 235' ' ' LEU . 10.5 t -131.25 136.17 58.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.659 ' OH ' ' CG ' ' B' ' 269' ' ' ASP . 8.1 t80 -113.29 99.29 7.69 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -89.67 116.52 27.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.975 -179.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.1 m -92.34 146.75 23.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.991 -1.068 . . . . 0.0 109.423 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.625 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -168.29 74.95 0.12 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.625 ' C ' ' O ' ' B' ' 216' ' ' GLY . 14.6 m -15.94 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.883 -0.775 . . . . 0.0 110.78 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 2.5 mt -93.97 -75.81 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.448 ' NE ' ' OE2' ' B' ' 256' ' ' GLU . 39.8 mmm-85 49.02 71.63 0.36 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.532 ' O ' HD12 ' B' ' 254' ' ' LEU . . . 110.84 -116.65 4.36 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 159.23 95.82 0.11 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 106.51 -2.636 . . . . 0.0 106.51 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.704 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER -129.21 -144.27 0.27 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -1.138 . . . . 0.0 111.825 -175.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.92 -42.38 93.81 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.613 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.8 m-20 -52.68 -34.6 52.7 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.572 HE21 ' HB3' ' B' ' 249' ' ' ALA . 5.9 tp60 -64.16 -44.44 92.09 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.02 59.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.32 -0.862 . . . . 0.0 109.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.432 ' CD2' ' OE2' ' B' ' 282' ' ' GLU . 0.6 OUTLIER -58.67 -32.92 69.56 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.699 ' O ' HG23 ' B' ' 232' ' ' VAL . 15.9 m-30 -67.49 -45.79 74.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.835 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.66 78.85 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.905 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -70.84 -57.15 4.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.901 -1.125 . . . . 0.0 108.619 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.76 -42.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.699 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.6 t -62.05 -31.23 50.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 10.5 t -67.07 -39.2 86.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.335 -0.853 . . . . 0.0 110.05 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.542 ' NH2' ' OH ' ' B' ' 238' ' ' TYR . 53.8 ttt85 -69.56 -48.71 59.41 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.644 -1.285 . . . . 0.0 109.323 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.778 HD22 HG11 ' B' ' 212' ' ' VAL . 14.7 mt -60.51 -38.66 85.06 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 56.6 mtp85 -63.18 -25.0 68.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.101 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -77.94 -36.43 49.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.026 -1.046 . . . . 0.0 109.402 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.568 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-85 -69.99 -47.1 63.56 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.505 -0.747 . . . . 0.0 110.469 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -157.63 -138.92 2.6 Favored Glycine 0 N--CA 1.48 1.567 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -99.3 135.75 40.25 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.363 -1.081 . . . . 0.0 109.346 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 3.7 t -97.86 117.55 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' B' ' 244' ' ' GLU . 19.4 mt -80.93 -35.82 31.85 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.318 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.42 ' H ' HG22 ' B' ' 243' ' ' THR . 0.9 OUTLIER -68.34 36.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 0.0 109.597 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' B' ' 242' ' ' LEU . 45.1 tp10 -49.98 -34.03 19.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.525 ' CD2' HG23 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -49.87 -52.22 34.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.11 -0.994 . . . . 0.0 109.047 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' B' ' 248' ' ' ASP . 21.9 t -59.62 163.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.383 -0.823 . . . . 0.0 108.899 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 62.57 -59.89 0.13 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.795 ' O ' HD11 ' B' ' 251' ' ' LEU . 24.4 t70 -65.76 24.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.697 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -103.16 -10.68 18.61 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.627 -0.671 . . . . 0.0 109.194 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -63.68 -39.85 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 1.025 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -55.05 161.69 1.59 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.451 -0.78 . . . . 0.0 109.754 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.483 ' O ' ' O ' ' B' ' 251' ' ' LEU . 12.3 mt-10 56.14 158.68 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.408 ' C ' HD22 ' B' ' 254' ' ' LEU . 21.8 Cg_endo -63.07 131.64 33.41 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.45 2.1 . . . . 0.0 111.618 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.639 HD11 ' O ' ' B' ' 249' ' ' ALA . 3.7 mm? -94.0 170.26 9.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.294 -0.879 . . . . 0.0 109.827 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.617 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 142.28 38.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.448 ' OE2' ' NE ' ' B' ' 219' ' ' ARG . 50.4 mt-10 46.9 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -1.007 . . . . 0.0 109.444 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 255' ' ' GLY . 96.8 mt-10 -47.21 -21.23 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.171 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -47.92 151.27 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -46.35 136.23 7.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 109.407 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.57 -62.81 0.16 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.07 80.7 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 18.6 p-10 -52.34 -44.96 65.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -1.125 . . . . 0.0 108.254 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . 0.476 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.1 mt-30 -63.71 -48.78 75.71 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -61.6 -35.5 78.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.071 -1.018 . . . . 0.0 109.08 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.525 HG23 ' CD2' ' B' ' 245' ' ' HIS . 1.9 mt -63.21 -52.21 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.617 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -67.42 -50.09 60.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.522 -0.736 . . . . 0.0 109.493 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.577 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 44.4 tp10 -43.74 -58.19 2.83 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.41 -0.806 . . . . 0.0 110.032 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.9 -39.16 93.54 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.072 -1.018 . . . . 0.0 109.382 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.659 ' CG ' ' OH ' ' B' ' 213' ' ' TYR . 9.0 t0 -58.55 -48.14 81.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.313 -0.867 . . . . 0.0 110.483 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -64.5 -45.3 87.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 109.797 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.475 ' OD1' ' NE2' ' B' ' 275' ' ' GLN . 10.0 t-20 -65.34 -51.92 57.31 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 109.678 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.444 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.18 -45.7 90.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.082 -1.011 . . . . 0.0 108.938 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 42.3 tp -50.37 -37.23 36.11 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.405 ' HA ' HD11 ' B' ' 300' ' ' LEU . 68.8 mt-30 -73.74 -28.06 61.5 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.423 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.475 ' NE2' ' OD1' ' B' ' 271' ' ' ASN . 41.1 mt-30 -87.93 -0.58 57.17 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.999 -1.063 . . . . 0.0 109.707 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.99 131.62 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.205 -0.934 . . . . 0.0 112.4 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' B' ' 211' ' ' SER . 64.0 m-20 -85.65 -31.63 22.44 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 97.1 t -134.51 143.8 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' B' ' 213' ' ' TYR . 88.9 t -138.76 130.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.69 -1.256 . . . . 0.0 111.849 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' B' ' 305' ' ' LEU . 91.4 t -136.47 130.54 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -116.26 136.84 52.65 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.669 -1.269 . . . . 0.0 110.268 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.432 ' OE2' ' CD2' ' B' ' 227' ' ' LEU . 52.7 tt0 -84.32 139.59 32.19 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.589 -0.694 . . . . 0.0 109.273 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.623 HG13 HG11 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -144.13 147.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.299 -0.875 . . . . 0.0 109.716 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 15.2 m -173.47 -68.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.46 ' NE2' ' OD2' ' B' ' 224' ' ' ASP . 24.7 pt20 -98.38 153.86 37.84 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -37.12 144.04 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.131 1.888 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.508 ' HB3' HG23 ' B' ' 290' ' ' VAL . 3.5 m -163.72 123.7 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.93 -1.106 . . . . 0.0 110.061 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.48 ' HG ' ' H ' ' A' ' 87' ' ' SER . 4.0 mt -76.8 -45.16 29.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 217' ' ' SER . . . -60.43 -42.75 99.1 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.623 HG11 HG13 ' B' ' 283' ' ' VAL . 41.2 t -64.07 -45.57 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -1.201 . . . . 0.0 109.08 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.29 -47.03 93.11 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 119' ' ' MET . 81.7 t80 -66.17 -47.97 72.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -1.082 . . . . 0.0 109.557 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.408 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 11.6 mm-40 -59.87 -37.12 78.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.5 mt -75.25 -41.65 56.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.033 -1.042 . . . . 0.0 109.212 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -49.93 60.2 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -39.66 82.4 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.395 -1.062 . . . . 0.0 108.596 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.484 ' O ' HD11 ' B' ' 304' ' ' ILE . . . -68.45 -37.22 80.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.921 -1.111 . . . . 0.0 108.626 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.49 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -52.66 -45.51 48.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 120.889 -1.132 . . . . 0.0 108.226 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.511 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -89.27 -52.76 4.88 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.236 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.774 HD13 ' C ' ' B' ' 300' ' ' LEU . 1.7 tm? -90.46 -29.84 17.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.026 -1.047 . . . . 0.0 109.593 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' B' ' 297' ' ' ALA . . . -73.51 166.4 54.63 Favored Glycine 0 C--N 1.283 -2.38 0 N-CA-C 108.308 -1.917 . . . . 0.0 108.308 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.508 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 4.8 mtmm -124.54 -71.25 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 84.7 Cg_endo -79.4 110.86 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.884 1.723 . . . . 0.0 109.398 176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.484 HD11 ' O ' ' B' ' 297' ' ' ALA . 16.6 mt -128.98 116.35 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.699 -1.25 . . . . 0.0 112.103 -177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.659 ' HB3' HG22 ' B' ' 280' ' ' VAL . 57.8 tp -110.88 126.06 54.29 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 145.92 38.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.97 -1.081 . . . . 0.0 108.768 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.585 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 8.1 mt -122.98 135.6 54.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.229 -0.919 . . . . 0.0 111.643 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -133.45 138.35 46.15 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.587 ' NH2' ' NE2' ' B' ' 311' ' ' GLN . 4.3 mtm180 -99.36 134.82 20.96 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 0.0 111.307 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.33 -26.27 4.23 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.531 2.154 . . . . 0.0 111.31 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.587 ' NE2' ' NH2' ' B' ' 309' ' ' ARG . 20.2 pt20 -46.37 -38.76 9.31 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 28.7 t -102.04 -15.77 16.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.89 51.14 2.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.477 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.3 mtp85 -80.63 17.33 1.15 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.978 -1.307 . . . . 0.0 109.048 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.0 t 47.67 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.688 0.756 . . . . 0.0 110.128 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.557 HD11 HG11 ' B' ' 283' ' ' VAL . 47.8 tp -47.44 145.6 2.43 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.569 -0.707 . . . . 0.0 109.519 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.4 m -45.7 142.98 2.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.892 . . . . 0.0 110.195 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.37 69.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.485 -0.759 . . . . 0.0 109.607 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.443 ' SD ' ' CD ' ' A' ' 93' ' ' GLU . 0.8 OUTLIER -70.33 -52.03 25.7 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.911 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.401 ' CG2' HD21 ' B' ' 316' ' ' LEU . 35.9 mm -62.43 -42.28 95.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.61 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 18.0 tpt85 -65.33 -48.94 71.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.143 -0.973 . . . . 0.0 109.484 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.657 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.41 -31.36 79.19 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.542 ' HB3' ' CE2' ' B' ' 329' ' ' PHE . . . -62.19 -15.76 48.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.036 -1.273 . . . . 0.0 108.111 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -44.24 96.2 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.508 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 66.7 m-20 -105.17 -22.41 13.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 108.696 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 65.51 30.14 76.81 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.637 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.2 p -134.7 59.57 1.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' B' ' 327' ' ' SER . 95.1 mtt180 98.89 -31.78 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' B' ' 323' ' ' ALA . 88.5 t80 -97.37 119.73 36.44 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.406 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 82.0 mt-30 -145.71 142.11 28.68 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.901 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 30.4 t -107.85 100.71 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.502 ' CG ' HD11 ' B' ' 305' ' ' LEU . 21.4 m0 -95.34 152.62 18.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.248 -0.908 . . . . 0.0 109.578 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -97.23 155.65 16.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.013 . . . . 0.0 108.822 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.585 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 6.2 p90 -170.28 -179.12 2.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.761 -1.212 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.59 149.61 27.8 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 335' ' ' ALA . 49.5 mt-10 -42.56 -29.73 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.707 -1.245 . . . . 0.0 110.18 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.33 -6.02 87.75 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.624 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -145.02 11.33 1.36 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.504 . . . . 0.0 110.6 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 5.0 p -54.3 -45.25 68.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.896 -1.128 . . . . 0.0 108.55 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 49.4 mt-10 -57.77 -32.76 67.8 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.498 -0.751 . . . . 0.0 109.203 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.7 m -68.33 -45.42 72.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -51.88 -51.21 58.44 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.12 -34.37 77.91 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.816 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -64.92 -41.43 95.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.424 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -68.75 -48.87 62.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.778 -1.201 . . . . 0.0 108.265 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.27 -48.1 83.19 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.856 . . . . 0.0 110.139 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 15.7 m-85 -69.85 -32.87 71.49 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.952 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' B' ' 350' ' ' TYR . 26.4 mm-40 -62.27 -32.67 73.42 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -81.9 10.82 5.74 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.3 t80 -134.4 -105.14 0.23 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.236 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' B' ' 350' ' ' TYR . 15.0 mt -34.22 92.17 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.822 -0.549 . . . . 0.0 111.182 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.491 ' N ' ' O ' ' B' ' 350' ' ' TYR . 88.6 Cg_endo -94.9 -61.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 123.103 2.536 . . . . 0.0 111.074 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' B' ' 352' ' ' PRO . 92.4 mm-40 -107.19 -24.01 12.07 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -56.66 -30.51 63.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 108.952 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . 0.596 HG23 ' N ' ' B' ' 356' ' ' ALA . 12.0 t -57.01 -45.36 83.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.715 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . 0.596 ' N ' HG23 ' B' ' 355' ' ' THR . . . -168.1 148.32 4.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 23.5 t -150.39 118.37 6.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 109.417 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 50.5 m -73.58 -31.48 63.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.928 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 84.7 p -95.66 151.23 19.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.306 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.526 ' N ' ' ND1' ' B' ' 360' ' ' HIS . 5.9 p-80 -138.79 76.76 34.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.264 -0.897 . . . . 0.0 109.512 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.69 152.71 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.554 2.169 . . . . 0.0 111.917 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 20.4 m -55.45 148.64 14.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.543 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.295 0.569 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 141.33 39.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 5' ' ' GLY . . . -66.12 -31.26 72.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.605 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 m 49.54 17.57 0.24 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 3' ' ' ALA . . . -52.89 -39.1 55.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -60.81 135.37 57.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -1.086 . . . . 0.0 109.354 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -68.0 -55.84 11.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -137.81 153.78 74.12 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.606 -0.683 . . . . 0.0 109.263 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.8 Cg_exo -55.38 -154.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.386 2.057 . . . . 0.0 111.424 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 32.0 p -111.91 172.74 6.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 18.4 t -114.86 155.44 26.81 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.824 -1.172 . . . . 0.0 108.704 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 2.7 t -130.45 126.92 61.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.67 ' HB3' HG13 ' A' ' 79' ' ' VAL . 32.9 t80 -93.99 127.46 39.79 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.63 ' CD2' HG22 ' A' ' 32' ' ' VAL . 17.8 t80 -100.81 130.7 46.87 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.787 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' GLU . 5.5 t -134.0 128.79 35.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.459 -0.776 . . . . 0.0 109.4 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.99 -178.96 33.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 p -76.02 118.7 19.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -1.192 . . . . 0.0 108.634 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER -131.7 97.82 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 -88.57 -87.99 0.15 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.29 36.38 2.49 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.07 137.33 6.15 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.696 ' H ' ' CB ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -172.21 -164.08 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.83 -1.394 . . . . 0.0 111.235 -179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 49.4 mp0 -60.62 -53.28 59.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.128 -0.982 . . . . 0.0 108.934 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -55.31 -29.36 58.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.696 ' CB ' ' H ' ' A' ' 22' ' ' ARG . 35.6 tp60 -64.34 -43.06 95.78 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -49.08 68.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 -34.22 67.97 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.2 m-30 -69.17 -41.32 77.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.983 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.0 84.69 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.601 -1.312 . . . . 0.0 109.11 -179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -70.56 -56.78 5.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.841 -1.162 . . . . 0.0 108.613 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -54.08 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 28' ' ' TYR . 45.5 t -65.27 -28.73 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.8 m -67.08 -40.47 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.593 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.8 mtp-105 -69.59 -47.26 64.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.806 -1.183 . . . . 0.0 109.113 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD22 HG11 ' A' ' 12' ' ' VAL . 13.8 mt -60.71 -40.62 92.97 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.428 ' HA ' HG23 ' A' ' 41' ' ' VAL . 67.2 ttt-85 -62.57 -25.29 68.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.688 -0.632 . . . . 0.0 109.42 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -78.03 -37.58 46.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.139 -0.976 . . . . 0.0 109.632 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.576 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.0 m-85 -67.83 -45.73 73.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 110.534 -178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -152.63 -152.48 5.98 Favored Glycine 0 N--CA 1.479 1.516 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -90.08 120.39 31.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -1.167 . . . . 0.0 109.388 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.621 HG11 HG13 ' A' ' 32' ' ' VAL . 3.7 t -89.61 115.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.453 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 15.9 mt -79.44 172.35 13.92 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.498 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 45' ' ' HIS . 4.7 m 54.23 41.86 31.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.46 -0.775 . . . . 0.0 109.257 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.32 -12.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 108.778 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.658 ' CE1' HD11 ' A' ' 65' ' ' ILE . 47.4 t-80 -52.98 -45.57 67.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.387 -0.821 . . . . 0.0 109.614 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 69.2 t -39.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.621 -0.674 . . . . 0.0 110.012 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' CG ' ' A' ' 50' ' ' GLU . . . -50.05 -42.53 49.92 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 108.903 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.859 ' O ' HD21 ' A' ' 51' ' ' LEU . 26.2 t70 -81.14 24.49 0.52 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -105.95 33.41 3.8 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' CG ' ' O ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -123.62 -21.33 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.938 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -83.08 163.62 20.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.499 -0.751 . . . . 0.0 109.442 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 51' ' ' LEU . 14.6 mt-10 54.58 157.85 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.868 . . . . 0.0 109.851 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 54' ' ' LEU . 23.2 Cg_endo -62.98 71.07 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.425 2.083 . . . . 0.0 111.475 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -54.97 -169.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 116.69 129.96 4.41 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 63.6 mt-10 -50.24 -33.69 20.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.078 -1.248 . . . . 0.0 108.629 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -69.58 -24.07 63.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -62.09 150.02 39.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.88 11.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.908 . . . . 0.0 109.404 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -52.97 -30.88 38.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.56 76.8 1.18 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 56' ' ' GLU . 3.1 m-20 -52.96 -44.83 67.43 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.359 -1.083 . . . . 0.0 108.539 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -62.31 -45.5 92.96 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -55.45 -36.61 66.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.055 -1.028 . . . . 0.0 108.612 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.658 HD11 ' CE1' ' A' ' 45' ' ' HIS . 3.2 mt -67.61 -35.62 73.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 70' ' ' LEU . 4.0 t-80 -79.4 -62.91 1.54 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 66' ' ' HIS . 72.2 mt-10 -43.58 -48.02 7.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.899 -1.126 . . . . 0.0 109.71 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -69.25 -42.75 75.2 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.115 -0.99 . . . . 0.0 109.371 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.522 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 1.2 m-20 -59.56 -47.06 87.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 110.307 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 1.5 mm? -65.21 -46.58 80.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.92 . . . . 0.0 110.322 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 33.0 t-20 -61.86 -54.52 41.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.141 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.18 -34.78 75.61 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.208 -0.933 . . . . 0.0 109.236 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 39.5 tp -57.09 -41.56 79.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.122 -0.986 . . . . 0.0 108.754 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -76.9 -22.83 52.79 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.36 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 47.7 mt-30 -84.27 -9.09 58.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.926 -1.108 . . . . 0.0 108.829 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 132.36 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.354 -0.841 . . . . 0.0 112.082 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 11' ' ' SER . 12.4 m-20 -86.95 -27.66 23.17 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 74.7 t -139.23 137.4 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.67 HG13 ' HB3' ' A' ' 13' ' ' TYR . 63.5 t -126.91 141.49 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.739 -1.226 . . . . 0.0 111.085 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.0 t -138.86 122.37 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-O 121.549 0.69 . . . . 0.0 109.386 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.61 128.76 53.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 110.044 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' HG11 ' A' ' 90' ' ' VAL . 46.5 mt-10 -87.71 125.91 34.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 108.549 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.602 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -115.74 27.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.428 -0.795 . . . . 0.0 109.747 -179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.5 ' C ' ' CZ ' ' A' ' 114' ' ' ARG . 4.3 m -78.39 23.97 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.256 -0.903 . . . . 0.0 108.851 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.567 ' N ' ' CZ ' ' A' ' 114' ' ' ARG . 5.0 tp-100 -166.32 118.91 0.82 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.978 . . . . 0.0 109.373 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.67 ' N ' HH21 ' A' ' 114' ' ' ARG . 76.8 Cg_exo -45.44 108.75 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.061 1.841 . . . . 0.0 111.946 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.9 m -142.36 131.03 22.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 109.839 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.405 HD11 HH22 ' B' ' 314' ' ' ARG . 74.1 mt -68.66 -39.07 80.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.544 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -62.38 -45.03 96.78 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.161 -1.575 . . . . 0.0 109.161 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 82' ' ' GLU . 18.4 t -64.81 -48.61 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -1.034 . . . . 0.0 108.787 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.73 98.03 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.419 ' HB2' HD11 ' B' ' 320' ' ' ILE . 75.7 t80 -64.78 -49.15 71.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.457 -1.025 . . . . 0.0 109.756 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' CB ' ' SG ' ' A' ' 15' ' ' CYS . 6.2 tp10 -59.65 -32.02 70.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 81' ' ' ALA . 62.7 mt -70.78 -43.77 68.06 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.133 -0.979 . . . . 0.0 108.684 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.12 -45.55 80.74 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -44.69 96.45 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.555 -0.967 . . . . 0.0 108.748 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.39 -36.16 82.14 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.136 -0.978 . . . . 0.0 108.522 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.7 OUTLIER -54.41 -44.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.877 -1.139 . . . . 0.0 108.071 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -86.67 -52.89 5.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.699 -0.626 . . . . 0.0 111.908 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.739 HD13 ' C ' ' A' ' 100' ' ' LEU . 2.2 tm? -92.34 -31.85 15.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.048 -1.033 . . . . 0.0 109.948 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -69.74 174.65 35.62 Favored Glycine 0 C--N 1.281 -2.507 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.754 ' H ' ' CD ' ' A' ' 103' ' ' PRO . 22.1 mttt -136.55 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 102' ' ' LYS . 59.3 Cg_endo -98.84 109.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 123.748 2.965 . . . . 0.0 109.684 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.425 HG21 ' CD2' ' A' ' 129' ' ' PHE . 37.8 mt -127.21 124.35 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.839 -1.163 . . . . 0.0 112.027 -177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.2 tp -123.52 116.08 22.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.448 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 1.5 m -105.94 147.2 29.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.867 -1.145 . . . . 0.0 108.894 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.1 mt -120.26 139.12 53.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.193 -0.942 . . . . 0.0 111.068 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -146.02 122.96 11.35 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.583 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 16.8 mtt180 -88.07 140.0 30.76 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.719 -1.238 . . . . 0.0 110.481 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.66 -29.03 6.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.536 2.157 . . . . 0.0 111.415 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.31 -32.9 5.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 18.2 t -99.17 -26.36 14.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.496 -0.752 . . . . 0.0 109.114 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.49 49.49 32.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.67 HH21 ' N ' ' A' ' 86' ' ' PRO . 10.4 mtp-105 -75.11 -11.41 60.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.035 -1.274 . . . . 0.0 111.205 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 114' ' ' ARG . 38.8 t 59.46 119.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 116' ' ' LEU . 2.4 mt -77.34 158.64 30.03 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.84 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.454 ' OG ' ' CA ' ' B' ' 289' ' ' GLY . 0.3 OUTLIER -54.13 145.15 17.79 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.768 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.63 -19.09 5.37 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 108.696 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.496 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 1.0 OUTLIER -77.9 -45.18 24.86 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.399 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' B' ' 292' ' ' TYR . 42.5 mm -66.71 -48.45 80.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.2 -0.938 . . . . 0.0 108.575 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.443 ' CZ ' HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -68.4 -44.68 74.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.247 -0.908 . . . . 0.0 108.81 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -64.15 -28.23 72.61 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -40.68 -64.65 0.5 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.553 -0.969 . . . . 0.0 110.273 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.622 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -150.94 -95.46 0.06 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.204 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.622 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 15.0 p-10 111.54 5.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.53 70.77 0.02 OUTLIER Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.836 ' C ' ' H ' ' A' ' 129' ' ' PHE . 37.5 p -164.15 66.34 0.16 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 66.43 -20.3 0.1 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.836 ' H ' ' C ' ' A' ' 127' ' ' SER . 9.3 t80 -117.77 118.76 32.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.601 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 31.3 tt0 -137.19 134.28 36.11 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.205 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 121' ' ' ARG . 69.5 t -91.85 105.89 17.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.601 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 13.7 m0 -102.14 142.35 33.54 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.171 -0.955 . . . . 0.0 109.724 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 54.0 m-20 -97.79 157.17 16.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.062 -1.024 . . . . 0.0 108.947 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' OH ' ' NE ' ' A' ' 109' ' ' ARG . 10.0 p90 -165.29 -172.72 2.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.591 -1.318 . . . . 0.0 111.936 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -159.27 148.37 18.34 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 135' ' ' ALA . 45.4 mt-10 -42.93 -37.12 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.76 -1.213 . . . . 0.0 110.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.92 2.86 53.71 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.207 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.97 7.14 0.52 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.58 -1.541 . . . . 0.0 110.601 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 5.8 p -53.99 -45.36 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.97 -1.081 . . . . 0.0 108.53 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 44.6 mt-10 -57.07 -33.67 67.5 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.537 -0.727 . . . . 0.0 109.101 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 83.9 m -68.19 -45.07 74.4 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.707 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.437 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.4 tpp -51.63 -48.13 63.44 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 42.8 mt -69.76 -35.06 74.61 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.286 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 77.8 m-20 -65.59 -39.66 91.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 0.0 110.315 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -69.65 -50.29 45.53 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.818 -1.176 . . . . 0.0 108.315 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.92 -46.98 87.61 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.958 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 151' ' ' LEU . 12.2 m-85 -68.96 -34.05 74.71 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.136 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.03 -23.9 66.64 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.34 59.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.675 -0.641 . . . . 0.0 111.371 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.616 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -156.04 -48.86 0.08 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.221 -1.55 . . . . 0.0 112.715 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.721 HD12 ' CD1' ' A' ' 147' ' ' PHE . 4.1 mt -38.32 -57.93 1.67 Allowed Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 120.916 -1.115 . . . . 0.0 111.562 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 12.0 Cg_endo -59.67 -26.25 81.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.763 1.642 . . . . 0.0 111.741 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -81.75 -15.01 55.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.868 . . . . 0.0 109.252 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -56.1 -31.79 63.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -0.822 . . . . 0.0 109.495 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.1 t -65.24 -36.41 84.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.42 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.25 -31.48 72.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.578 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.2 m -57.52 152.46 14.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.344 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.0 t -153.58 160.03 42.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.7 m -64.45 150.82 45.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.324 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 23.4 m80 -67.75 150.98 97.56 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.969 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.37 -22.96 51.84 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.55 2.167 . . . . 0.0 111.912 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.5 t -97.71 146.8 25.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.331 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.595 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.244 0.545 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.96 141.11 39.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.899 . . . . 0.0 109.393 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' B' ' 205' ' ' GLY . . . -66.07 -30.63 71.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 32.8 m 48.77 17.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 203' ' ' ALA . . . -52.85 -39.0 55.3 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -60.54 135.51 57.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.309 -1.113 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -68.05 -55.7 11.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . -137.93 153.88 73.98 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.607 -0.683 . . . . 0.0 109.35 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ALA . 31.7 Cg_exo -55.52 -154.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.276 1.984 . . . . 0.0 111.377 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.537 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.6 p -112.21 172.75 6.72 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 19.4 t -114.97 155.35 27.08 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 120.756 -1.215 . . . . 0.0 108.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 2.6 t -130.49 127.1 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.663 ' HB3' HG13 ' B' ' 279' ' ' VAL . 33.5 t80 -93.8 127.6 39.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.632 ' CD2' HG22 ' B' ' 232' ' ' VAL . 17.9 t80 -100.86 130.7 46.91 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.81 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.525 ' SG ' ' CB ' ' B' ' 293' ' ' GLU . 5.7 t -134.04 129.08 35.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.532 -0.73 . . . . 0.0 109.415 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -159.36 -178.85 33.74 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 14.7 p -76.11 118.06 18.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 0.0 108.757 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.457 HG23 ' OE1' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -131.23 98.05 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.274 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.3 tpp85 -88.52 -87.85 0.16 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -128.6 36.37 2.46 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 89.12 136.87 5.98 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.683 ' H ' ' CB ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -171.96 -164.22 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.813 -1.404 . . . . 0.0 111.319 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 49.0 mp0 -60.5 -53.14 61.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 0.0 108.983 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.48 -29.01 57.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.683 ' CB ' ' H ' ' B' ' 222' ' ' ARG . 36.1 tp60 -64.68 -43.15 94.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.24 68.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.44 -0.787 . . . . 0.0 109.21 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.92 -34.09 67.62 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.635 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.4 m-30 -69.28 -41.32 76.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.182 -0.949 . . . . 0.0 110.037 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.26 85.67 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.59 -1.319 . . . . 0.0 109.161 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -70.37 -56.67 6.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.834 -1.166 . . . . 0.0 108.654 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 83.0 mt -54.09 -41.25 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.635 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.7 t -65.16 -28.63 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.483 -0.761 . . . . 0.0 109.103 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 19.1 m -67.31 -40.13 85.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.842 . . . . 0.0 109.526 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.6 mtp-105 -69.7 -47.87 61.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.891 -1.131 . . . . 0.0 109.078 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.56 HD22 HG11 ' B' ' 212' ' ' VAL . 13.1 mt -60.1 -40.77 90.79 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.431 ' HA ' HG23 ' B' ' 241' ' ' VAL . 64.7 ttt-85 -62.29 -25.45 67.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.695 -0.628 . . . . 0.0 109.458 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -78.0 -37.69 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.975 . . . . 0.0 109.535 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.573 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.0 m-85 -67.71 -45.51 74.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.591 -0.693 . . . . 0.0 110.541 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.86 -152.53 6.02 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -90.24 120.63 31.56 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.365 -1.079 . . . . 0.0 109.389 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.632 HG11 HG13 ' B' ' 232' ' ' VAL . 3.6 t -89.81 116.21 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.473 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 15.7 mt -79.81 172.15 14.16 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.082 -1.012 . . . . 0.0 109.491 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.495 ' C ' ' N ' ' B' ' 245' ' ' HIS . 4.5 m 54.38 41.92 31.7 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.36 -0.837 . . . . 0.0 109.322 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -50.64 -12.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 108.766 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.646 ' CE1' HD11 ' B' ' 265' ' ' ILE . 46.7 t-80 -53.59 -45.14 69.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.5 -0.75 . . . . 0.0 109.426 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 249' ' ' ALA . 68.9 t -39.87 -79.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.622 -0.674 . . . . 0.0 109.992 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' B' ' 250' ' ' GLU . . . -49.69 -42.6 46.12 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.237 -0.915 . . . . 0.0 108.908 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.86 ' O ' HD21 ' B' ' 251' ' ' LEU . 24.3 t70 -80.82 24.22 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' B' ' 246' ' ' VAL . . . -105.73 33.61 3.68 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.441 ' CG ' ' O ' ' B' ' 247' ' ' ALA . 0.1 OUTLIER -123.5 -22.12 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.932 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -82.62 163.09 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.459 -0.776 . . . . 0.0 109.564 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' B' ' 251' ' ' LEU . 14.9 mt-10 54.82 157.75 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.306 -0.871 . . . . 0.0 109.88 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 254' ' ' LEU . 22.6 Cg_endo -62.74 71.41 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.441 2.094 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.796 HD23 ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER -55.66 -169.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.902 . . . . 0.0 109.454 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 117.5 129.97 4.27 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.477 ' O ' ' OD1' ' B' ' 262' ' ' ASP . 61.6 mt-10 -50.1 -33.8 19.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.088 -1.242 . . . . 0.0 108.609 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -69.52 -24.55 63.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -61.56 150.04 37.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.488 -0.758 . . . . 0.0 109.351 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.73 11.1 0.15 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -52.68 -31.26 37.29 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.68 77.27 1.21 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' B' ' 256' ' ' GLU . 2.7 m-20 -52.89 -44.94 67.27 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.311 -1.111 . . . . 0.0 108.589 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -62.04 -46.0 91.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.26 -37.12 66.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.163 -0.961 . . . . 0.0 108.557 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.646 HD11 ' CE1' ' B' ' 245' ' ' HIS . 3.3 mt -67.26 -35.25 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' B' ' 267' ' ' GLU . 4.1 t-80 -79.69 -63.35 1.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.275 -0.891 . . . . 0.0 109.859 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' B' ' 266' ' ' HIS . 72.7 mt-10 -42.94 -48.44 5.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.67 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -69.03 -42.57 76.19 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.472 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.535 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 1.2 m-20 -59.85 -46.89 87.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' B' ' 270' ' ' LEU . 1.6 mm? -65.17 -46.83 79.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.172 -0.955 . . . . 0.0 110.424 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 32.9 t-20 -61.77 -54.52 41.33 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.138 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.473 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -61.15 -34.99 75.89 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.151 -0.968 . . . . 0.0 109.077 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 38.2 tp -56.89 -41.08 77.42 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.095 -1.003 . . . . 0.0 108.822 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.3 OUTLIER -77.48 -22.53 51.15 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.31 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 47.7 mt-30 -84.55 -8.78 58.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.877 -1.14 . . . . 0.0 108.884 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.88 132.39 45.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.402 -0.811 . . . . 0.0 112.131 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' B' ' 211' ' ' SER . 9.7 m-20 -86.63 -27.88 23.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 63.6 t -139.33 137.94 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' B' ' 213' ' ' TYR . 64.8 t -127.14 141.54 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.852 -1.155 . . . . 0.0 111.131 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 18.3 t -138.71 121.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.514 -0.741 . . . . 0.0 109.306 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.569 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.02 128.98 54.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.005 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.508 ' O ' HG11 ' B' ' 290' ' ' VAL . 46.3 mt-10 -88.08 125.52 34.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 108.502 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.59 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -115.28 27.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.794 . . . . 0.0 109.658 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.492 ' C ' ' CZ ' ' B' ' 314' ' ' ARG . 4.1 m -78.42 24.51 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 108.91 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.574 ' N ' ' CZ ' ' B' ' 314' ' ' ARG . 4.9 tp-100 -166.65 118.5 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.658 ' N ' HH21 ' B' ' 314' ' ' ARG . 74.4 Cg_exo -45.31 109.13 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.011 1.807 . . . . 0.0 111.898 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . . . . . . . . . 29.4 m -142.34 131.23 22.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.154 -0.966 . . . . 0.0 109.843 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 70.7 mt -69.21 -38.31 78.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.477 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . 0.454 ' CA ' ' OG ' ' A' ' 117' ' ' SER . . . -63.08 -44.98 96.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.508 HG11 ' O ' ' B' ' 282' ' ' GLU . 17.4 t -64.74 -48.7 83.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.439 -1.036 . . . . 0.0 108.703 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -62.02 -39.57 97.76 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.414 ' HB2' HD11 ' A' ' 120' ' ' ILE . 74.7 t80 -65.08 -49.13 71.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.438 -1.036 . . . . 0.0 109.728 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.525 ' CB ' ' SG ' ' B' ' 215' ' ' CYS . 6.8 tp10 -59.55 -32.08 70.0 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.569 HD21 ' HB3' ' B' ' 281' ' ' ALA . 61.0 mt -70.72 -43.86 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.165 -0.959 . . . . 0.0 108.691 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.3 -45.27 81.48 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -43.96 97.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.597 -0.943 . . . . 0.0 108.8 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -67.16 -36.14 81.19 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.137 -0.977 . . . . 0.0 108.429 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.477 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.7 OUTLIER -54.31 -44.53 66.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.538 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -86.76 -52.95 5.2 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.146 -0.621 . . . . 0.0 111.914 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.747 HD13 ' C ' ' B' ' 300' ' ' LEU . 2.2 tm? -92.13 -31.84 15.35 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.98 -1.075 . . . . 0.0 109.93 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -69.75 174.55 35.85 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.758 ' H ' ' CD ' ' B' ' 303' ' ' PRO . 22.6 mttt -136.59 -47.06 0.02 OUTLIER Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.758 ' CD ' ' H ' ' B' ' 302' ' ' LYS . 58.7 Cg_endo -98.83 109.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 123.703 2.935 . . . . 0.0 109.704 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' B' ' 329' ' ' PHE . 37.7 mt -127.53 124.39 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.8 -1.188 . . . . 0.0 112.087 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 25.3 tp -123.73 115.97 22.27 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . 0.454 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 1.5 m -105.4 147.36 28.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.762 -1.211 . . . . 0.0 108.88 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.494 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.1 mt -120.47 138.97 53.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.088 -1.008 . . . . 0.0 110.997 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' B' ' 333' ' ' ASP . 0.6 OUTLIER -145.89 122.99 11.45 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.572 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 15.7 mtt180 -88.25 140.3 30.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.726 -1.234 . . . . 0.0 110.378 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.78 -28.79 6.05 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.631 2.221 . . . . 0.0 111.623 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -47.56 -32.69 5.65 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 20.6 t -99.31 -26.28 14.21 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.464 -0.773 . . . . 0.0 109.064 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 49.33 49.62 31.26 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.658 HH21 ' N ' ' B' ' 286' ' ' PRO . 10.3 mtp-105 -75.1 -11.36 60.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.985 -1.303 . . . . 0.0 111.218 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.507 ' O ' ' O ' ' B' ' 314' ' ' ARG . 38.4 t 59.6 119.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.54 HD23 ' N ' ' B' ' 316' ' ' LEU . 2.4 mt -77.36 158.29 30.2 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.646 -1.221 . . . . 0.0 108.822 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.462 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 0.4 OUTLIER -53.78 145.27 16.2 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.326 -0.949 . . . . 0.0 108.712 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.74 -19.04 5.46 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.269 -0.895 . . . . 0.0 108.729 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.492 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 1.0 OUTLIER -77.99 -45.41 23.9 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.337 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 92' ' ' TYR . 40.1 mm -66.26 -48.61 80.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.615 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.446 ' CZ ' HG11 ' B' ' 331' ' ' VAL . 0.1 OUTLIER -68.55 -44.19 75.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.935 . . . . 0.0 108.748 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -64.11 -29.0 73.69 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -40.14 -65.21 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.555 -0.968 . . . . 0.0 110.314 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.63 ' O ' ' CB ' ' B' ' 325' ' ' ASP . . . -150.78 -95.18 0.06 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.233 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.63 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 15.0 p-10 111.47 4.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 161.46 70.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.823 ' C ' ' H ' ' B' ' 329' ' ' PHE . 32.8 p -164.31 66.69 0.15 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 66.33 -20.68 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.823 ' H ' ' C ' ' B' ' 327' ' ' SER . 8.8 t80 -117.53 118.9 33.42 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 31.7 tt0 -137.22 134.1 35.87 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.537 -1.265 . . . . 0.0 111.209 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' B' ' 321' ' ' ARG . 72.8 t -91.67 106.01 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 13.7 m0 -102.14 142.31 33.59 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.115 -0.991 . . . . 0.0 109.649 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' B' ' 308' ' ' PHE . 53.9 m-20 -97.77 157.27 16.16 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.937 -1.102 . . . . 0.0 108.921 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.572 ' OH ' ' NE ' ' B' ' 309' ' ' ARG . 10.2 p90 -165.0 -171.88 2.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.629 -1.294 . . . . 0.0 111.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.461 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -159.97 148.31 17.11 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.4 mt-10 -42.85 -37.13 1.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.724 -1.235 . . . . 0.0 110.234 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -76.13 3.35 52.6 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -151.62 7.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.537 -1.566 . . . . 0.0 110.559 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.52 HG13 ' N ' ' B' ' 340' ' ' GLU . 6.2 p -53.97 -45.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.028 -1.045 . . . . 0.0 108.556 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.52 ' N ' HG13 ' B' ' 339' ' ' VAL . 42.5 mt-10 -57.14 -34.14 68.09 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.57 -0.706 . . . . 0.0 109.105 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.3 m -67.45 -45.51 75.79 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.147 -0.971 . . . . 0.0 109.658 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.423 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.4 tpp -51.42 -48.06 62.78 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 46.6 mt -69.65 -35.02 74.81 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.226 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -65.72 -39.43 91.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.927 -1.108 . . . . 0.0 110.294 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 26.9 mtt180 -70.05 -50.1 44.57 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.937 -1.102 . . . . 0.0 108.243 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -59.94 -47.3 86.35 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.017 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.719 ' CD1' HD12 ' B' ' 351' ' ' LEU . 12.5 m-85 -68.76 -33.83 74.57 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.149 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.59 -9.92 58.97 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.785 -0.572 . . . . 0.0 111.428 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -156.31 -48.88 0.08 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.161 -1.587 . . . . 0.0 112.643 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.719 HD12 ' CD1' ' B' ' 347' ' ' PHE . 4.0 mt -38.62 -57.85 1.81 Allowed Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 120.961 -1.087 . . . . 0.0 111.526 -177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 12.1 Cg_endo -59.77 -25.8 80.31 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.826 1.684 . . . . 0.0 111.703 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -82.21 -14.95 54.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.344 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -56.17 -31.79 63.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.194 -0.942 . . . . 0.0 109.439 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 8.1 t -65.02 -36.02 83.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 109.409 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.52 -31.86 73.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 46.8 m -57.36 152.33 14.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.945 . . . . 0.0 109.492 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 8.6 t -153.37 160.05 42.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 109.513 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 43.0 m -64.18 151.18 44.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.258 -0.901 . . . . 0.0 109.223 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -68.51 150.76 97.57 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.181 -0.95 . . . . 0.0 109.387 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.09 -22.04 55.17 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.56 2.173 . . . . 0.0 111.84 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 8.8 t -99.31 152.17 20.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.421 -0.799 . . . . 0.0 109.245 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.404 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.7 157.16 36.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.82 154.29 39.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m -55.18 -34.64 64.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.763 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.82 51.69 28.35 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -81.07 140.75 34.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.317 -1.108 . . . . 0.0 109.585 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.8 -56.65 15.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.336 -0.852 . . . . 0.0 109.567 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.52 151.86 91.71 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.397 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.52 -152.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.318 2.012 . . . . 0.0 111.444 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.6 p -109.97 -179.69 3.87 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 20.5 p -120.03 158.24 27.22 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG11 HD22 ' A' ' 35' ' ' LEU . 2.2 t -136.67 137.1 47.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.849 0.833 . . . . 0.0 109.565 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 6.8 t80 -123.14 101.28 7.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.539 ' O ' ' CG ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -94.49 127.71 40.59 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.341 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 12.0 m -85.36 149.75 25.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.028 -1.045 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' CZ ' ' A' ' 28' ' ' TYR . . . -156.44 165.17 32.82 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.788 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.499 ' CB ' ' OG ' ' A' ' 87' ' ' SER . 6.1 t -91.8 130.05 37.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.929 . . . . 0.0 109.444 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -124.38 -1.21 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.363 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.629 HH12 ' H ' ' A' ' 55' ' ' GLY . 26.8 mmt180 -119.97 15.64 12.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.354 -0.841 . . . . 0.0 109.275 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.22 2.73 6.25 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.28 -179.52 40.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -130.32 -23.07 2.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.44 -1.036 . . . . 0.0 109.326 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -53.83 -39.8 65.89 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 75.6 m-20 -64.91 -27.02 68.57 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.686 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 8.9 tp60 -64.88 -41.88 95.26 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.96 -51.08 63.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -26.98 68.45 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.238 -0.914 . . . . 0.0 108.765 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.661 ' O ' HG23 ' A' ' 32' ' ' VAL . 12.6 m-30 -68.49 -46.75 68.85 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.01 74.75 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 118.357 -1.337 . . . . 0.0 107.924 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 33' ' ' SER . 57.4 ttt180 -71.97 -58.39 3.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.93 -1.106 . . . . 0.0 108.671 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 32' ' ' VAL . 6.0 tt -52.37 -40.3 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 28' ' ' TYR . 44.5 t -64.31 -29.54 47.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 30' ' ' ARG . 19.4 p -67.78 -39.85 84.04 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.743 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 64.6 mtp85 -71.7 -49.29 40.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.702 -1.249 . . . . 0.0 108.591 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.735 HD22 HG11 ' A' ' 12' ' ' VAL . 10.4 mt -56.63 -39.46 73.7 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -65.8 -23.63 66.74 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -76.39 -36.77 57.92 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.988 -1.07 . . . . 0.0 108.988 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.574 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -70.3 -48.53 56.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -153.5 -140.19 3.02 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -101.02 136.45 40.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -1.175 . . . . 0.0 109.487 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG11 HG13 ' A' ' 32' ' ' VAL . 68.3 t -101.88 122.75 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 10.6 mt -84.2 -42.85 15.52 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.801 -1.16 . . . . 0.0 110.511 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 43' ' ' THR . 13.7 t -67.54 60.58 0.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.132 -0.98 . . . . 0.0 109.771 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' LEU . 83.7 mt-10 -82.83 -25.34 32.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.059 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.65 ' CG ' ' N ' ' A' ' 46' ' ' VAL . 4.7 p80 -53.19 -45.78 68.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.607 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.686 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -55.64 -60.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.328 -0.857 . . . . 0.0 109.62 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' H ' HG13 ' A' ' 46' ' ' VAL . . . -59.41 -31.93 69.72 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.826 -1.171 . . . . 0.0 108.973 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.639 ' C ' HD21 ' A' ' 51' ' ' LEU . 22.0 t70 -87.92 48.25 1.62 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.466 -0.771 . . . . 0.0 109.104 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' HB3' HE21 ' A' ' 25' ' ' GLN . . . -135.24 -16.03 1.9 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -77.43 -11.83 59.89 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.028 -1.045 . . . . 0.0 109.165 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.109 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -54.7 -43.95 72.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.172 -0.955 . . . . 0.0 108.686 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 3.3 tt0 -176.9 -48.47 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.538 -0.727 . . . . 0.0 109.422 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 52' ' ' GLU . 15.4 Cg_exo -69.9 106.5 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.662 2.241 . . . . 0.0 111.56 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -148.06 110.51 4.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.352 -0.843 . . . . 0.0 109.369 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.63 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 130.26 42.05 0.22 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.573 ' H ' ' NH1' ' A' ' 19' ' ' ARG . 61.0 mt-10 53.58 -78.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -1.038 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.63 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.0 tt0 -42.59 -33.11 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.236 -0.915 . . . . 0.0 108.915 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' PRO . . . -106.49 65.39 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.01 -40.0 0.17 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.17 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.66 54.6 0.77 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.41 76.56 1.14 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -51.25 -43.76 61.58 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -57.2 -44.66 83.85 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -58.34 -34.76 70.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -68.17 -32.42 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.421 ' CE1' HD22 ' A' ' 70' ' ' LEU . 23.3 t-80 -78.19 -64.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 0.0 110.379 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 68' ' ' GLN . 19.2 pt-20 -50.12 -44.56 52.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 109.572 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 51.5 tt0 -66.48 -48.23 70.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 110.39 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.519 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 84.0 m-20 -70.85 -54.38 11.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.982 . . . . 0.0 110.985 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.421 HD22 ' CE1' ' A' ' 66' ' ' HIS . 5.1 tp -56.58 -39.11 72.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 85.7 m-20 -63.68 -52.78 59.15 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.396 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -58.29 -41.21 83.9 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.468 -0.893 . . . . 0.0 108.731 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 11.8 tp -50.32 -41.38 51.03 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.41 -27.23 63.16 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.447 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 35.1 mt-30 -88.98 0.13 56.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.958 -1.089 . . . . 0.0 109.352 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.09 130.89 44.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.897 . . . . 0.0 111.862 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' HB3' ' H ' ' A' ' 11' ' ' SER . 38.8 t0 -80.6 -32.97 36.27 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.2 t -133.16 144.16 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.8 t -136.08 124.81 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 111.501 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 81' ' ' ALA . 24.0 t -117.98 176.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.626 ' H ' HG12 ' A' ' 80' ' ' VAL . . . -164.15 116.03 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.574 -1.329 . . . . 0.0 110.033 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -79.22 142.94 35.81 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -147.66 148.38 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.111 -0.993 . . . . 0.0 109.785 -179.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 83' ' ' VAL . 2.7 m -171.82 -42.54 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -129.47 152.56 79.82 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.514 ' HA ' HD23 ' B' ' 288' ' ' LEU . 76.4 Cg_exo -36.36 147.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.604 2.202 . . . . 0.0 112.731 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.584 ' H ' ' CD2' ' B' ' 288' ' ' LEU . 12.9 t -175.34 123.0 0.22 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.393 -0.817 . . . . 0.0 110.484 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.685 HD12 HG13 ' B' ' 320' ' ' ILE . 2.2 mm? -71.32 -44.72 64.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.03 -36.69 75.27 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' A' ' 87' ' ' SER . 11.8 t -75.75 -49.09 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.446 -1.032 . . . . 0.0 109.495 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' CA ' HD13 ' B' ' 288' ' ' LEU . . . -67.6 -37.97 89.87 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.846 -1.169 . . . . 0.0 110.257 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -69.45 -52.19 29.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.183 -1.186 . . . . 0.0 109.867 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' OE2' ' SD ' ' B' ' 319' ' ' MET . 95.1 mt-10 -63.22 -30.86 71.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.514 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.8 mt -69.79 -47.46 62.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.147 -0.971 . . . . 0.0 109.249 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.15 -36.77 93.44 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.0 tpt85 -62.24 -41.76 98.7 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.556 -0.967 . . . . 0.0 109.366 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.2 -38.52 78.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.897 -1.127 . . . . 0.0 108.956 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -52.36 -40.65 32.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -82.21 -53.01 6.4 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -59.71 -9.23 2.55 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -0.999 . . . . 0.0 110.206 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 102' ' ' LYS . . . 54.5 94.42 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 C-N-CA 119.344 -1.408 . . . . 0.0 109.979 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 104' ' ' ILE . 41.8 mttm -164.66 150.81 9.18 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 79' ' ' VAL . 82.4 Cg_exo -38.83 104.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.707 1.605 . . . . 0.0 111.332 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.2 mt -107.09 95.45 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 110.771 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.63 118.29 35.85 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.83 143.09 49.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -132.1 144.11 50.49 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.063 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.79 147.42 50.79 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 134' ' ' TYR . 12.3 mtt180 -99.31 142.32 24.4 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.237 . . . . 0.0 111.472 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 113' ' ' GLY . 89.1 Cg_endo -80.82 -31.24 1.48 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.855 2.37 . . . . 0.0 110.944 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -45.62 -38.57 6.76 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 21.8 p -95.69 -20.52 18.85 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 38.86 43.43 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 115' ' ' VAL . 61.0 mtt180 -79.37 13.03 2.09 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.307 -1.114 . . . . 0.0 109.387 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 114' ' ' ARG . 75.8 t 49.57 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.408 -0.807 . . . . 0.0 110.157 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.505 HD11 HG11 ' A' ' 83' ' ' VAL . 24.2 tp -45.15 158.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.88 142.99 22.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.165 -0.959 . . . . 0.0 111.089 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.515 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -56.99 -50.68 71.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.73 -0.606 . . . . 0.0 110.339 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.51 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 19.5 mtp -65.89 -38.37 88.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.927 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.662 HG13 HD12 ' B' ' 288' ' ' LEU . 5.1 mm -66.34 -44.92 90.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.064 -1.023 . . . . 0.0 109.565 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -74.46 -44.41 51.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.025 -1.047 . . . . 0.0 109.055 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.48 -22.33 61.26 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 120' ' ' ILE . . . -45.77 -60.91 1.96 Allowed 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.477 -1.013 . . . . 0.0 109.937 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.674 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -156.7 -88.18 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.856 -1.138 . . . . 0.0 112.147 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.593 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER 97.24 -1.55 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -179.92 85.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.777 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 162.08 74.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.475 -1.015 . . . . 0.0 109.595 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 67.04 -23.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.777 ' H ' ' C ' ' A' ' 127' ' ' SER . 12.8 t80 -123.28 118.89 28.6 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -135.23 138.3 43.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 0.0 111.214 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 84.7 t -101.95 99.87 9.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 21.0 m0 -93.76 148.68 21.9 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.27 -0.894 . . . . 0.0 110.167 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -93.75 147.71 22.79 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.424 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.5 p90 -168.02 174.31 7.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.363 -1.461 . . . . 0.0 112.133 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -140.6 147.28 39.14 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 135' ' ' ALA . 50.0 mt-10 -41.99 -30.3 0.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.932 -1.105 . . . . 0.0 110.581 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.25 1.46 88.78 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 120.999 -1.063 . . . . 0.0 110.752 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -135.82 -2.76 2.34 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.958 -1.319 . . . . 0.0 109.975 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 1.4 p -52.15 -45.87 43.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.013 -1.054 . . . . 0.0 108.161 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.495 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 27.6 mt-10 -52.67 -36.62 57.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -66.35 -40.8 90.06 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.461 -0.775 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 11.4 mmt -55.67 -54.87 38.94 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 37.2 mt -59.71 -27.03 66.1 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.46 ' O ' ' CD ' ' A' ' 148' ' ' GLU . 16.5 t70 -69.47 -46.86 65.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 0.0 111.111 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -73.81 -44.08 56.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.477 -1.389 . . . . 0.0 109.805 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 42.3 t80 -60.41 -46.53 89.69 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 110.715 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.764 ' CD1' HD12 ' A' ' 151' ' ' LEU . 11.4 m-85 -74.77 -34.4 62.45 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.349 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -68.93 -23.31 64.15 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.238 -1.538 . . . . 0.0 107.425 178.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.46 -10.46 55.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.623 -0.673 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.607 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -154.91 -47.1 0.08 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.419 -1.426 . . . . 0.0 112.16 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.764 HD12 ' CD1' ' A' ' 147' ' ' PHE . 2.3 mt -41.52 -54.34 6.5 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 120.97 -1.081 . . . . 0.0 111.076 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -44.57 -12.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.986 1.791 . . . . 0.0 112.141 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 151' ' ' LEU . 50.5 tt0 -65.95 -63.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.488 ' HZ2' HD23 ' A' ' 151' ' ' LEU . 14.7 pttm -84.06 -18.0 38.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.149 -0.969 . . . . 0.0 109.729 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.446 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 86.8 m -87.89 149.15 24.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.101 -1.0 . . . . 0.0 109.396 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 155' ' ' THR . . . 62.49 44.69 6.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 96.3 p -137.39 170.56 15.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.398 -0.814 . . . . 0.0 109.415 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 12.8 t -69.49 131.9 45.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.353 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.6 p -80.67 154.38 27.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.472 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.403 ' CD2' ' O ' ' A' ' 158' ' ' SER . 20.3 m-70 -131.03 74.33 79.93 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.338 -0.851 . . . . 0.0 109.315 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -80.96 153.77 19.41 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.86 2.373 . . . . 0.0 112.192 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.6 t -87.55 153.22 21.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.16 -0.962 . . . . 0.0 109.467 179.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.396 0.617 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.79 157.48 36.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.557 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -66.23 154.09 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 15.3 m -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.636 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.7 51.58 29.58 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -80.42 141.79 34.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.31 -1.112 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -63.56 -57.41 10.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.91 151.82 93.02 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.424 -0.797 . . . . 0.0 109.444 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.27 -152.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.392 2.061 . . . . 0.0 111.571 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 15.0 p -110.06 -179.75 3.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 17.2 p -120.1 157.73 28.36 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.734 HG11 HD22 ' B' ' 235' ' ' LEU . 2.2 t -136.18 137.09 48.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.782 0.801 . . . . 0.0 109.57 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.535 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 6.8 t80 -123.04 101.54 7.47 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' B' ' 214' ' ' PHE . 0.2 OUTLIER -94.82 127.41 40.81 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.167 -0.958 . . . . 0.0 109.163 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.433 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 12.4 m -85.13 148.82 25.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.002 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' B' ' 228' ' ' TYR . . . -155.19 164.95 32.14 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.781 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.503 ' CB ' ' OG ' ' B' ' 287' ' ' SER . 6.2 t -92.12 129.52 38.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.644 -0.915 . . . . 0.0 109.388 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.402 HD11 ' HB ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -124.16 -0.53 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 109.407 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.655 HH12 ' H ' ' B' ' 255' ' ' GLY . 27.3 mmt180 -120.47 15.52 12.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.275 -0.891 . . . . 0.0 109.36 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -129.39 2.83 6.19 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 166.55 -179.97 40.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -130.52 -23.33 2.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.488 -1.007 . . . . 0.0 109.22 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -53.58 -39.84 65.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.545 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 75.4 m-20 -64.89 -27.15 68.66 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.7 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 9.2 tp60 -64.84 -41.34 95.79 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.47 -50.99 63.27 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.97 -26.89 68.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.327 -0.858 . . . . 0.0 108.72 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.648 ' O ' HG23 ' B' ' 232' ' ' VAL . 12.7 m-30 -68.6 -46.72 68.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.667 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.97 -32.83 74.51 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.368 -1.333 . . . . 0.0 107.939 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' B' ' 233' ' ' SER . 57.6 ttt180 -72.09 -58.5 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.851 -1.155 . . . . 0.0 108.715 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' B' ' 232' ' ' VAL . 5.9 tt -52.15 -40.48 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 228' ' ' TYR . 44.6 t -64.28 -29.43 47.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 20.1 p -67.76 -39.81 84.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.435 -0.79 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -71.86 -49.13 40.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.786 -1.196 . . . . 0.0 108.601 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.734 HD22 HG11 ' B' ' 212' ' ' VAL . 9.9 mt -56.94 -39.37 74.4 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -65.64 -23.7 66.86 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -76.54 -37.17 57.07 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.948 -1.095 . . . . 0.0 108.932 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.591 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -69.87 -48.43 58.79 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.554 -0.716 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -153.32 -140.5 3.08 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -101.08 136.53 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -1.104 . . . . 0.0 109.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.642 HG11 HG13 ' B' ' 232' ' ' VAL . 62.1 t -101.9 122.8 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.525 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 10.7 mt -84.08 -42.66 15.86 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.478 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.749 ' O ' HG23 ' B' ' 243' ' ' THR . 13.8 t -67.36 60.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.845 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' B' ' 242' ' ' LEU . 82.7 mt-10 -82.58 -25.98 32.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.119 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.648 ' CG ' ' N ' ' B' ' 246' ' ' VAL . 4.8 p80 -52.48 -45.69 66.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.399 -0.813 . . . . 0.0 109.737 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.7 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 0.2 OUTLIER -55.97 -60.15 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 109.546 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.471 ' H ' HG13 ' B' ' 246' ' ' VAL . . . -59.28 -31.63 69.28 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.91 -1.119 . . . . 0.0 108.915 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.647 ' C ' HD21 ' B' ' 251' ' ' LEU . 22.4 t70 -88.26 48.01 1.58 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.721 0.772 . . . . 0.0 109.244 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.561 ' HB3' HE21 ' B' ' 225' ' ' GLN . . . -134.89 -16.19 1.98 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' B' ' 250' ' ' GLU . 1.0 OUTLIER -77.4 -11.8 59.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.105 -0.997 . . . . 0.0 109.276 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 1.06 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -54.79 -43.13 72.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.158 -0.964 . . . . 0.0 108.651 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.506 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 3.3 tt0 -177.83 -48.28 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.535 -0.728 . . . . 0.0 109.326 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' B' ' 252' ' ' GLU . 16.0 Cg_exo -69.83 106.27 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.617 2.211 . . . . 0.0 111.661 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.463 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.3 OUTLIER -147.99 110.41 4.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.87 . . . . 0.0 109.494 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.655 ' H ' HH12 ' B' ' 219' ' ' ARG . . . 130.34 41.85 0.22 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.576 ' H ' ' NH1' ' B' ' 219' ' ' ARG . 64.8 mt-10 53.87 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.474 -1.015 . . . . 0.0 109.812 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.2 tt0 -43.14 -32.29 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.388 -0.82 . . . . 0.0 108.942 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' B' ' 253' ' ' PRO . . . -106.96 65.55 0.66 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -148.57 -40.51 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 109.098 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 105.46 53.95 0.76 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.96 76.46 1.11 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -51.02 -43.54 60.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -57.44 -44.37 84.64 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.55 -35.35 72.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.412 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.4 OUTLIER -67.57 -32.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.409 ' CE1' HD22 ' B' ' 270' ' ' LEU . 23.3 t-80 -78.06 -65.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' B' ' 268' ' ' GLN . 19.1 pt-20 -49.58 -44.34 46.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.995 -1.066 . . . . 0.0 109.689 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . 0.507 ' N ' ' CG ' ' B' ' 267' ' ' GLU . 51.7 tt0 -66.7 -48.59 68.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.861 . . . . 0.0 110.35 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.502 ' CG ' ' CD2' ' B' ' 245' ' ' HIS . 85.3 m-20 -70.51 -54.16 13.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 111.045 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' B' ' 266' ' ' HIS . 5.2 tp -56.75 -39.28 73.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.982 . . . . 0.0 109.726 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 84.0 m-20 -63.45 -52.69 60.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.525 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -58.67 -41.14 85.44 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 108.728 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.535 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 11.7 tp -50.39 -41.24 51.72 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -71.42 -27.34 63.23 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.307 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 35.3 mt-30 -89.16 0.56 56.64 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.913 -1.117 . . . . 0.0 109.32 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.67 130.31 42.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.279 -0.888 . . . . 0.0 111.891 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' B' ' 211' ' ' SER . 40.6 t0 -80.23 -32.74 38.39 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.38 144.0 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' B' ' 213' ' ' TYR . 80.8 t -135.92 124.92 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.98 -1.075 . . . . 0.0 111.353 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . 0.621 HG12 ' H ' ' B' ' 281' ' ' ALA . 25.5 t -118.02 176.82 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.621 ' H ' HG12 ' B' ' 280' ' ' VAL . . . -164.01 115.69 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.576 -1.328 . . . . 0.0 110.089 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -78.93 143.22 36.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 108.67 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -147.88 148.23 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.098 -1.001 . . . . 0.0 109.772 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' B' ' 283' ' ' VAL . 2.8 m -171.72 -42.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -130.19 151.92 79.23 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 88' ' ' LEU . 77.0 Cg_exo -35.87 146.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.675 2.25 . . . . 0.0 112.682 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.562 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 14.8 t -175.46 122.46 0.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 0.0 110.525 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.662 HD12 HG13 ' A' ' 120' ' ' ILE . 2.2 mm? -70.99 -43.94 66.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.333 -0.854 . . . . 0.0 109.655 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.42 -36.56 77.45 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.451 HG23 ' OG ' ' B' ' 287' ' ' SER . 11.7 t -76.1 -49.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.371 -1.076 . . . . 0.0 109.338 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . 0.482 ' HA3' HD13 ' A' ' 88' ' ' LEU . . . -67.41 -37.98 90.69 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -69.77 -52.11 28.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -1.187 . . . . 0.0 109.926 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.51 ' OE2' ' SD ' ' A' ' 119' ' ' MET . 95.9 mt-10 -63.2 -31.15 72.23 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.222 -0.923 . . . . 0.0 109.495 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.4 mt -69.65 -47.35 63.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.303 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.07 -36.73 93.33 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -62.42 -41.58 98.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.546 -0.973 . . . . 0.0 109.299 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.64 79.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.956 -1.09 . . . . 0.0 108.976 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.409 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.6 OUTLIER -52.24 -40.9 32.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -81.88 -53.13 6.42 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.079 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.86 -9.16 2.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.104 -0.997 . . . . 0.0 110.206 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' B' ' 302' ' ' LYS . . . 54.41 94.84 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.401 -1.38 . . . . 0.0 109.94 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.525 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 41.4 mttm -165.04 150.54 8.51 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' B' ' 279' ' ' VAL . 82.8 Cg_exo -38.63 104.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.75 1.634 . . . . 0.0 111.296 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' B' ' 302' ' ' LYS . 3.2 mt -106.82 95.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.234 -0.916 . . . . 0.0 110.654 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 54.5 tp -99.73 118.53 36.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 142.29 50.12 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.602 HD12 ' N ' ' B' ' 307' ' ' LEU . 0.4 OUTLIER -131.3 143.62 50.67 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.298 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.626 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -128.11 147.49 50.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -99.19 141.82 23.53 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.732 -1.23 . . . . 0.0 111.516 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' B' ' 313' ' ' GLY . 92.7 Cg_endo -80.27 -31.63 1.61 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.807 2.338 . . . . 0.0 110.954 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 310' ' ' PRO . 20.2 pt20 -45.47 -38.65 6.38 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.0 p -95.66 -20.02 19.26 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 38.46 43.09 1.47 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 315' ' ' VAL . 59.0 mtt180 -78.98 13.0 1.91 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.346 -1.091 . . . . 0.0 109.424 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 314' ' ' ARG . 79.6 t 49.42 101.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 121.366 -0.834 . . . . 0.0 110.255 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.525 HD11 HG11 ' B' ' 283' ' ' VAL . 24.0 tp -45.19 158.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.64 142.75 22.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 111.05 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . 0.479 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.93 -50.66 71.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.591 -0.693 . . . . 0.0 110.367 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.514 ' SD ' ' OE2' ' A' ' 93' ' ' GLU . 19.3 mtp -65.65 -38.65 89.94 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.964 -1.085 . . . . 0.0 109.859 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.685 HG13 HD12 ' A' ' 88' ' ' LEU . 5.1 mm -66.24 -44.86 91.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.541 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -74.26 -44.47 52.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.952 -1.093 . . . . 0.0 108.97 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -61.55 -22.33 61.43 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 320' ' ' ILE . . . -45.49 -61.04 1.85 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.576 -0.956 . . . . 0.0 110.047 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -156.64 -87.94 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.967 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 0.7 OUTLIER 96.99 -1.9 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -177.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -179.59 84.95 0.06 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.783 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.1 p 162.37 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.406 -1.055 . . . . 0.0 109.737 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 67.11 -23.19 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.783 ' H ' ' C ' ' B' ' 327' ' ' SER . 11.9 t80 -123.65 118.97 28.48 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -135.21 138.68 43.85 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.212 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 83.9 t -102.3 100.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 21.1 m0 -94.04 148.58 22.03 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.251 -0.906 . . . . 0.0 110.075 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.85 148.13 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.6 p90 -168.53 174.37 6.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.114 -1.434 . . . . 0.0 112.057 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -140.69 147.28 39.0 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.5 mt-10 -41.86 -30.37 0.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.605 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -84.19 1.31 88.93 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.766 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -135.53 -2.72 2.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.95 -1.324 . . . . 0.0 110.008 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 1.4 p -52.31 -45.81 44.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 26.5 mt-10 -52.93 -36.34 59.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 24.4 m -66.37 -41.03 90.04 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.587 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 11.6 mmt -55.34 -54.99 36.64 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 39.6 mt -59.61 -27.17 66.07 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' B' ' 348' ' ' GLU . 15.9 t70 -69.33 -46.79 66.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -0.966 . . . . 0.0 111.184 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -73.64 -44.36 57.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.333 -1.48 . . . . 0.0 109.846 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . 0.429 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 42.2 t80 -60.18 -46.49 89.54 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.387 -0.82 . . . . 0.0 110.738 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.765 ' CD1' HD12 ' B' ' 351' ' ' LEU . 11.5 m-85 -74.88 -34.23 62.2 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.437 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' B' ' 348' ' ' GLU . 0.7 OUTLIER -69.07 -23.38 64.02 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 117.846 -1.542 . . . . 0.0 107.485 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -68.4 -10.23 53.75 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.612 -0.68 . . . . 0.0 110.468 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.604 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.2 OUTLIER -155.11 -47.25 0.08 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.46 -1.4 . . . . 0.0 112.15 -179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' B' ' 347' ' ' PHE . 2.2 mt -41.53 -54.33 6.53 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 110.998 -177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -44.46 -13.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.008 1.805 . . . . 0.0 112.231 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' B' ' 351' ' ' LEU . 50.5 tt0 -65.85 -63.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.956 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . 0.476 ' HZ2' HD23 ' B' ' 351' ' ' LEU . 14.2 pttm -84.25 -17.93 38.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.051 -1.031 . . . . 0.0 109.753 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' B' ' 356' ' ' ALA . 87.1 m -88.02 149.82 23.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 109.509 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 355' ' ' THR . . . 62.17 44.16 8.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.87 . . . . 0.0 109.383 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 89.6 p -136.99 171.4 14.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.392 -0.818 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 10.8 t -70.25 132.65 46.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 61.6 p -81.38 155.22 26.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.526 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -131.77 73.99 78.15 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.491 -0.756 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.21 151.88 18.15 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.829 2.352 . . . . 0.0 112.25 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 33.0 t -84.2 144.42 28.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.431 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 tpp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.63 149.26 45.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.187 -0.946 . . . . 0.0 109.472 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.33 156.53 7.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.482 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.0 p -54.52 172.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.241 -0.912 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.64 -176.38 42.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -137.06 157.51 46.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -1.155 . . . . 0.0 109.563 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -133.19 -177.22 4.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.413 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.98 148.59 49.38 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.457 -0.777 . . . . 0.0 109.121 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.41 -155.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.402 2.068 . . . . 0.0 110.965 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 26.4 p -99.67 178.02 4.97 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.576 ' OG ' HD21 ' A' ' 42' ' ' LEU . 3.0 t -116.08 152.95 32.6 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.9 t -133.81 132.63 56.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.431 -0.793 . . . . 0.0 109.348 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' CZ ' ' OE2' ' A' ' 44' ' ' GLU . 39.2 t80 -96.34 147.1 24.15 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.673 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.6 t80 -110.45 133.21 53.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.029 . . . . 0.0 111.517 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.84 102.53 5.28 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.29 177.58 19.48 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.24 122.86 22.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.396 -1.061 . . . . 0.0 109.73 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.727 ' CD1' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -138.02 95.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.246 -0.909 . . . . 0.0 108.654 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -129.75 4.58 5.01 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.247 -0.908 . . . . 0.0 110.331 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 145.58 99.23 0.25 Allowed Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.502 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' A' ' 20' ' ' GLY . . . 19.57 115.59 0.0 OUTLIER Glycine 0 N--CA 1.506 3.317 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.611 ' H ' ' HB2' ' A' ' 25' ' ' GLN . 12.5 ptm180 -150.52 163.97 37.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.853 -1.381 . . . . 0.0 110.97 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -55.96 -39.27 71.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 86.9 m-20 -60.03 -33.34 71.88 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.611 ' HB2' ' H ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -63.24 -46.83 85.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -50.19 69.38 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp -57.62 -35.49 70.55 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.885 ' O ' HG23 ' A' ' 32' ' ' VAL . 18.5 m-30 -67.44 -47.7 69.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 109.982 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.93 75.8 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.681 -1.262 . . . . 0.0 108.803 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 -68.69 -57.15 6.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.786 -1.196 . . . . 0.0 108.609 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 84.9 mt -50.88 -45.2 28.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 28' ' ' TYR . 94.5 t -59.65 -30.63 45.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -66.02 -40.13 90.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 109.115 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -63.45 -41.99 98.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.78 -1.2 . . . . 0.0 108.045 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 32' ' ' VAL . 52.9 mt -61.24 -43.1 99.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -56.66 -26.1 55.45 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -85.49 -29.42 24.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.161 -0.962 . . . . 0.0 110.046 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.508 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.2 m-85 -84.39 -58.8 2.6 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.182 -0.949 . . . . 0.0 110.511 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -132.61 -164.61 10.99 Favored Glycine 0 N--CA 1.481 1.641 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' H ' ' HA ' ' A' ' 11' ' ' SER . 33.7 mtmt -89.61 124.2 34.35 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.223 -1.163 . . . . 0.0 109.036 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.45 HG11 ' CG1' ' A' ' 32' ' ' VAL . 39.8 t -80.62 104.05 8.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD21 ' OG ' ' A' ' 11' ' ' SER . 80.9 mt -52.03 142.43 15.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.764 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.561 ' OG1' ' CE3' ' A' ' 72' ' ' TRP . 17.4 p -37.75 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.512 0.672 . . . . 0.0 110.161 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' OE2' ' CZ ' ' A' ' 13' ' ' TYR . 19.5 mm-40 -122.91 110.41 15.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.664 ' O ' ' N ' ' A' ' 49' ' ' ALA . 4.7 p80 -56.44 -15.35 4.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.341 -0.85 . . . . 0.0 109.624 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CD1' ' A' ' 18' ' ' ILE . 60.8 t -41.7 -78.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.335 -0.853 . . . . 0.0 110.651 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -49.03 -33.25 10.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.883 -1.136 . . . . 0.0 109.09 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.916 ' O ' HD21 ' A' ' 51' ' ' LEU . 20.7 t70 -96.54 22.71 7.65 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 45' ' ' HIS . . . -109.2 35.88 3.11 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HG3' HD13 ' A' ' 51' ' ' LEU . 1.9 pt-20 -129.57 -20.32 3.27 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.446 -0.784 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.916 HD21 ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -62.67 -102.34 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -57.02 164.1 2.55 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.4 36.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.552 2.168 . . . . 0.0 112.996 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 54' ' ' LEU . 6.6 mp 51.3 -155.27 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.93 -1.106 . . . . 0.0 109.577 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . -127.83 -36.58 0.47 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.581 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 36.4 mp0 -46.58 -20.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -1.061 . . . . 0.0 109.108 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' GLY . 24.5 pt-20 -132.47 3.51 3.9 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 54' ' ' LEU . . . -145.59 -173.79 4.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.158 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.05 152.45 21.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.122 -0.986 . . . . 0.0 109.559 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.18 -9.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.64 74.93 1.22 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -53.62 -37.0 62.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.348 -1.09 . . . . 0.0 108.336 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.628 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 16.4 mp0 -62.23 -47.15 85.69 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -53.58 -36.27 61.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.13 -0.981 . . . . 0.0 109.184 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -67.3 -53.1 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.491 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 4.8 t-80 -63.65 -45.77 88.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 110.785 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -54.43 -54.73 36.8 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.833 -1.167 . . . . 0.0 109.632 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' TRP . 99.5 mt-30 -72.42 -40.34 67.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 0.0 110.169 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 23.8 m-20 -64.93 -52.97 53.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.972 . . . . 0.0 111.014 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.93 78.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 111.148 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -65.41 -54.01 34.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.785 -1.197 . . . . 0.0 110.049 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -62.45 -42.74 99.68 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.814 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 2.0 tt -53.15 -36.87 61.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -75.18 -26.2 58.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.527 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.496 ' CD ' ' CD1' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -97.86 5.7 48.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.797 -1.189 . . . . 0.0 109.064 179.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -65.08 129.4 39.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.697 0.76 . . . . 0.0 112.536 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 11' ' ' SER . 64.0 t0 -74.94 -36.17 62.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG12 ' N ' ' A' ' 79' ' ' VAL . 46.0 t -134.25 168.01 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' N ' HG12 ' A' ' 78' ' ' VAL . 60.8 t -150.21 140.2 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.104 -0.998 . . . . 0.0 111.074 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -132.07 143.23 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -152.74 156.14 38.55 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.079 -1.013 . . . . 0.0 110.51 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' OE1' ' OH ' ' A' ' 134' ' ' TYR . 47.1 tt0 -123.25 124.77 43.75 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -120.22 23.21 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 109.523 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 109' ' ' ARG . 89.4 m -45.76 -87.19 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.148 -0.97 . . . . 0.0 108.564 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 86' ' ' PRO . 34.3 tt0 -68.15 133.74 91.59 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLN . 86.2 Cg_exo -37.34 112.71 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.99 1.793 . . . . 0.0 111.769 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.462 ' H ' ' HG ' ' B' ' 288' ' ' LEU . 2.4 p -117.06 130.56 56.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.218 -0.926 . . . . 0.0 110.201 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' B' ' 287' ' ' SER . 0.4 OUTLIER -80.88 -56.36 4.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.43 -0.794 . . . . 0.0 110.095 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.566 ' N ' ' OG ' ' B' ' 317' ' ' SER . . . -57.87 -40.21 92.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.65 -36.62 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -1.164 . . . . 0.0 109.437 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.25 -43.16 95.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.489 ' HB2' HD11 ' B' ' 320' ' ' ILE . 67.5 t80 -66.89 -47.53 71.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.679 -0.895 . . . . 0.0 109.709 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.37 -34.77 75.86 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.493 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.9 mt -69.32 -42.46 75.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 108.478 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -69.07 -36.44 80.7 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' NH1' ' CG1' ' B' ' 298' ' ' VAL . 20.0 tpt180 -64.97 -45.46 85.61 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.322 -1.105 . . . . 0.0 109.563 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -68.8 -37.8 79.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.444 -1.303 . . . . 0.0 108.482 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.8 OUTLIER -51.46 -43.36 30.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -68.72 -44.99 72.72 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.09 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.587 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -129.19 -38.88 1.57 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.096 -1.002 . . . . 0.0 110.386 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -70.65 97.46 0.63 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 106.751 -2.54 . . . . 0.0 106.751 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.587 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -65.39 -69.65 0.55 Allowed Pre-proline 0 C--N 1.288 -2.08 0 O-C-N 121.762 -0.846 . . . . 0.0 111.446 -176.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 24.0 Cg_endo -63.41 111.36 1.44 Allowed 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.88 1.72 . . . . 0.0 111.348 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 101' ' ' GLY . 46.5 mt -135.88 101.94 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.157 -0.965 . . . . 0.0 111.088 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.24 118.21 30.28 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -111.42 138.24 48.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.991 -1.068 . . . . 0.0 108.352 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.6 mt -118.15 146.28 44.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.15 -0.969 . . . . 0.0 110.926 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -149.95 142.06 24.02 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.091 -1.005 . . . . 0.0 108.827 178.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.645 HH11 ' NE2' ' A' ' 111' ' ' GLN . 10.7 mtm180 -119.59 150.34 49.87 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.291 -0.88 . . . . 0.0 110.924 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 113' ' ' GLY . 46.0 Cg_endo -69.82 -15.64 36.96 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.643 2.229 . . . . 0.0 112.4 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.645 ' NE2' HH11 ' A' ' 109' ' ' ARG . 4.7 pt20 -67.09 -37.24 83.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.147 -0.971 . . . . 0.0 110.151 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.475 ' N ' ' HG3' ' A' ' 111' ' ' GLN . 31.0 m -142.51 -6.03 0.92 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 109' ' ' ARG . . . -111.19 99.69 1.15 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 106.74 -2.544 . . . . 0.0 106.74 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -98.26 -59.38 1.76 Allowed 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.664 -0.903 . . . . 0.0 108.608 -177.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.503 HG21 ' O ' ' B' ' 256' ' ' GLU . 78.1 t -132.07 109.38 15.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.812 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.635 HD11 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -54.49 146.55 15.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' B' ' 289' ' ' GLY . 0.6 OUTLIER -43.3 146.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 0.0 109.398 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.83 -41.0 81.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 110.49 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 77.6 mmm -64.8 -37.59 88.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 0.0 109.796 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.502 HD11 ' HB2' ' B' ' 292' ' ' TYR . 48.4 mm -65.25 -47.12 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.992 . . . . 0.0 109.31 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -62.99 -40.8 98.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.04 -37.48 95.02 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -53.84 -47.38 71.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -0.3 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.415 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 128' ' ' ARG . 54.9 t0 -76.74 -35.24 57.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 108.58 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.8 -22.29 6.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -101.26 -46.26 5.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.066 -1.256 . . . . 0.0 109.869 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 125' ' ' ASP . 34.2 ptt-85 -121.11 -43.3 2.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.492 -0.755 . . . . 0.0 109.32 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 7.0 t80 -97.29 130.03 44.52 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.701 ' NE2' ' HE1' ' A' ' 132' ' ' TRP . 3.6 tt0 -155.67 161.68 40.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.712 -1.242 . . . . 0.0 111.376 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.79 105.78 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.701 ' HE1' ' NE2' ' A' ' 130' ' ' GLN . 15.9 m0 -101.79 143.14 32.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 134' ' ' TYR . 61.0 t0 -93.34 155.32 17.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.101 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.596 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 6.3 p90 -169.88 -166.54 0.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.091 -1.006 . . . . 0.0 110.342 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -169.91 160.51 8.46 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 136' ' ' GLU . 18.9 mt-10 -59.46 28.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.322 -0.861 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -135.09 -2.07 3.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -156.13 12.25 0.29 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.013 -1.286 . . . . 0.0 110.102 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 140' ' ' GLU . 7.5 p -52.03 -42.93 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.011 . . . . 0.0 108.631 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 139' ' ' VAL . 36.7 mt-10 -57.47 -37.09 72.32 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.539 -0.725 . . . . 0.0 109.107 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.4 m -66.67 -44.28 82.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.9 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.4 tpp -52.44 -49.51 64.44 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 89.8 mt -71.36 -29.31 64.81 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.428 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 36.4 t0 -67.25 -38.97 86.05 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 109.881 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -73.35 -50.2 23.29 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.84 -1.163 . . . . 0.0 108.801 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.485 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.5 t80 -56.67 -47.12 80.53 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.339 -0.851 . . . . 0.0 110.235 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.694 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.7 m-85 -78.41 -30.57 47.81 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.512 -178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 44.8 mt-10 -58.53 -25.47 62.48 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -71.99 -16.7 62.08 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.768 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -177.85 105.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 0.0 111.114 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.694 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.6 OUTLIER 175.82 -54.78 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.326 -0.858 . . . . 0.0 109.642 177.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 20.1 Cg_endo -62.78 -14.06 38.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.093 1.862 . . . . 0.0 111.513 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -69.17 -45.69 69.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.394 -0.816 . . . . 0.0 109.806 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.402 ' NZ ' HD23 ' A' ' 151' ' ' LEU . 23.1 mtmm -60.45 -36.26 77.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 109.502 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 31.2 p -61.61 -40.73 95.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.05 60.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.132 -0.98 . . . . 0.0 109.77 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 83.0 p -72.97 159.27 33.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 85.0 p -144.63 160.61 40.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 109.398 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -63.28 -32.6 74.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.429 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -130.16 79.26 73.14 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.399 -0.813 . . . . 0.0 109.506 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.66 -21.11 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.82 2.347 . . . . 0.0 112.189 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.8 m 47.0 -161.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.513 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.59 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 31.3 tpp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.22 149.84 45.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -57.86 156.6 8.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 52.0 p -54.35 172.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.324 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 89.59 -176.06 42.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -137.41 158.34 44.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -133.89 -177.21 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.466 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.04 148.52 48.94 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.488 -0.757 . . . . 0.0 109.162 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.4 -155.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.487 2.124 . . . . 0.0 110.893 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.46 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 27.9 p -99.52 178.04 4.98 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.585 ' OG ' HD21 ' B' ' 242' ' ' LEU . 3.0 t -116.22 152.83 32.99 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.41 132.64 57.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.562 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.544 ' CZ ' ' OE2' ' B' ' 244' ' ' GLU . 39.3 t80 -96.35 146.43 24.75 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.681 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.0 t80 -109.89 132.6 54.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.07 -1.019 . . . . 0.0 111.614 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.29 102.51 5.38 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -136.22 177.67 19.39 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.39 123.22 23.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -1.123 . . . . 0.0 109.834 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' B' ' 246' ' ' VAL . 0.0 OUTLIER -138.48 95.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -130.36 4.47 4.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.317 -0.864 . . . . 0.0 110.19 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.733 ' O ' ' O ' ' B' ' 221' ' ' GLY . . . 145.7 99.22 0.25 Allowed Glycine 0 N--CA 1.494 2.562 0 C-N-CA 119.603 -1.285 . . . . 0.0 110.554 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.733 ' O ' ' O ' ' B' ' 220' ' ' GLY . . . 19.54 115.33 0.0 OUTLIER Glycine 0 N--CA 1.504 3.181 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.617 ' H ' ' HB2' ' B' ' 225' ' ' GLN . 12.4 ptm180 -150.28 163.83 37.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.828 -1.395 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -55.82 -39.1 70.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 88.2 m-20 -60.45 -33.39 72.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.617 ' HB2' ' H ' ' B' ' 222' ' ' ARG . 0.8 OUTLIER -63.03 -46.93 85.22 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.07 -50.27 69.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -0.826 . . . . 0.0 108.798 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.45 -35.58 70.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 108.756 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.902 ' O ' HG23 ' B' ' 232' ' ' VAL . 18.5 m-30 -67.44 -47.42 70.23 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.326 -0.859 . . . . 0.0 109.93 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.28 -37.84 75.82 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.593 -1.317 . . . . 0.0 108.886 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.403 ' HE ' ' NH2' ' B' ' 234' ' ' ARG . 39.2 ttt85 -68.83 -57.03 6.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.849 -1.157 . . . . 0.0 108.648 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 84.3 mt -50.94 -45.18 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.902 HG23 ' O ' ' B' ' 228' ' ' TYR . 87.1 t -59.92 -30.33 45.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 7.2 t -66.15 -40.16 90.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 109.075 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.403 ' NH2' ' HE ' ' B' ' 230' ' ' ARG . 81.4 mtt-85 -63.45 -41.87 98.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.822 -1.174 . . . . 0.0 107.929 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' B' ' 232' ' ' VAL . 52.9 mt -61.23 -42.92 99.44 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 42.6 mtp180 -56.95 -26.08 59.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -85.37 -29.55 24.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.969 . . . . 0.0 110.079 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.506 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.2 m-85 -84.34 -58.7 2.64 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.215 -0.928 . . . . 0.0 110.453 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 210' ' ' CYS . . . -132.94 -164.87 11.02 Favored Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.456 -1.857 . . . . 0.0 108.456 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' B' ' 211' ' ' SER . 33.1 mtmt -89.58 124.14 34.28 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.191 -1.181 . . . . 0.0 109.015 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.443 HG11 ' CG1' ' B' ' 232' ' ' VAL . 38.6 t -80.49 104.22 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.585 HD21 ' OG ' ' B' ' 211' ' ' SER . 80.7 mt -52.22 141.98 17.75 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.833 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.568 ' OG1' ' CE3' ' B' ' 272' ' ' TRP . 17.3 p -37.38 99.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.502 0.668 . . . . 0.0 110.234 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.544 ' OE2' ' CZ ' ' B' ' 213' ' ' TYR . 19.1 mm-40 -122.99 110.68 15.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' B' ' 249' ' ' ALA . 4.9 p80 -56.59 -15.58 4.63 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.541 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' B' ' 218' ' ' ILE . 62.5 t -41.54 -78.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.239 -0.913 . . . . 0.0 110.695 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -48.72 -33.29 9.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.934 -1.104 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.883 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.5 t70 -96.53 22.96 7.32 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' B' ' 245' ' ' HIS . . . -109.47 35.68 3.22 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.518 ' HG3' HD13 ' B' ' 251' ' ' LEU . 1.9 pt-20 -129.27 -20.09 3.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.89 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -62.72 -103.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' B' ' 254' ' ' LEU . 0.0 OUTLIER -56.1 164.39 1.85 Allowed Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.85 36.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.525 2.15 . . . . 0.0 112.895 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.645 HD12 ' N ' ' B' ' 254' ' ' LEU . 6.6 mp 51.28 -155.51 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.018 -1.051 . . . . 0.0 109.548 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . -127.35 -36.53 0.49 Allowed Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' B' ' 256' ' ' GLU . 36.5 mp0 -46.44 -20.09 0.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -1.033 . . . . 0.0 109.211 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' B' ' 255' ' ' GLY . 24.4 pt-20 -133.2 4.39 3.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 108.925 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' B' ' 254' ' ' LEU . . . -145.97 -173.49 4.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.144 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -90.95 151.5 21.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 171.15 -9.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.45 74.62 1.21 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -53.45 -36.91 62.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.36 -1.082 . . . . 0.0 108.321 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . 0.636 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 17.0 mp0 -62.5 -47.18 85.1 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -53.6 -36.03 61.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -67.55 -52.87 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.486 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 4.6 t-80 -64.03 -46.26 85.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.454 -0.779 . . . . 0.0 110.654 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -53.74 -55.08 29.4 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.84 -1.162 . . . . 0.0 109.676 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' TRP . 99.5 mt-30 -72.21 -40.36 67.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.109 -0.995 . . . . 0.0 110.251 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.503 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 25.5 m-20 -64.79 -52.95 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.03 -1.044 . . . . 0.0 111.174 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.11 -40.87 78.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 111.138 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.5 -54.01 34.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.671 -1.268 . . . . 0.0 110.147 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.576 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -62.42 -42.38 99.4 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.037 -1.039 . . . . 0.0 108.935 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.473 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 1.9 tt -53.62 -36.49 62.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -75.34 -26.25 58.43 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.372 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.492 ' CD ' ' CD1' ' B' ' 272' ' ' TRP . 0.0 OUTLIER -98.02 5.82 48.33 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.175 . . . . 0.0 109.095 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -65.17 129.47 39.84 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.759 0.79 . . . . 0.0 112.555 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' B' ' 211' ' ' SER . 64.1 t0 -75.14 -35.86 61.62 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.59 HG12 ' N ' ' B' ' 279' ' ' VAL . 46.6 t -134.4 167.94 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.59 ' N ' HG12 ' B' ' 278' ' ' VAL . 61.8 t -150.37 140.21 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.059 -1.026 . . . . 0.0 111.06 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.06 143.6 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -153.08 156.16 38.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.046 -1.034 . . . . 0.0 110.588 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.55 ' OE1' ' OH ' ' B' ' 334' ' ' TYR . 47.4 tt0 -123.15 125.04 44.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' B' ' 316' ' ' LEU . 0.1 OUTLIER -120.5 22.69 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.519 -179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.441 HG23 ' H ' ' B' ' 309' ' ' ARG . 87.5 m -45.25 -87.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.184 -0.948 . . . . 0.0 108.54 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' B' ' 286' ' ' PRO . 33.4 tt0 -68.0 133.92 91.88 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.403 ' C ' ' O ' ' B' ' 285' ' ' GLN . 87.9 Cg_exo -37.36 112.57 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.084 1.856 . . . . 0.0 111.842 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 2.6 p -116.91 130.52 56.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.74 -56.14 4.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.191 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . 0.556 ' N ' ' OG ' ' A' ' 117' ' ' SER . . . -58.0 -40.27 93.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.61 -36.67 78.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.322 -1.104 . . . . 0.0 109.497 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.18 -43.2 95.48 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.502 ' HB2' HD11 ' A' ' 120' ' ' ILE . 67.8 t80 -67.05 -47.25 71.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.623 -0.928 . . . . 0.0 109.84 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -61.91 -34.77 76.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.308 -0.87 . . . . 0.0 109.296 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 294' ' ' LEU . 72.5 mt -69.29 -42.44 75.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.157 -0.965 . . . . 0.0 108.578 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.24 -36.09 78.48 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.418 ' NH1' ' CG1' ' A' ' 98' ' ' VAL . 20.0 tpt180 -64.93 -45.59 85.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.272 -1.134 . . . . 0.0 109.517 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.602 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -68.67 -37.89 79.95 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.466 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.455 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.8 OUTLIER -51.61 -43.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.466 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -68.6 -45.1 72.87 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.177 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.596 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -129.35 -38.21 1.58 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.135 -0.978 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -71.18 97.26 0.66 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 106.67 -2.572 . . . . 0.0 106.67 178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.596 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -65.26 -69.77 0.54 Allowed Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.826 -0.808 . . . . 0.0 111.43 -176.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 24.0 Cg_endo -63.44 111.02 1.35 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.878 1.719 . . . . 0.0 111.534 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.439 HD11 ' O ' ' B' ' 301' ' ' GLY . 45.5 mt -135.61 101.96 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 111.174 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 63.8 tp -91.16 118.54 30.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -111.53 137.95 48.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.0 108.445 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . . . . . . . . . 9.7 mt -118.05 146.09 44.33 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -0.973 . . . . 0.0 110.862 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -149.77 142.19 24.31 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.206 -0.934 . . . . 0.0 108.764 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.647 HH11 ' NE2' ' B' ' 311' ' ' GLN . 10.5 mtm180 -119.47 150.53 49.98 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.26 -0.9 . . . . 0.0 110.867 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.18 -15.31 35.49 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.647 ' NE2' HH11 ' B' ' 309' ' ' ARG . 4.6 pt20 -67.34 -37.61 83.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.229 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' B' ' 311' ' ' GLN . 23.2 m -142.16 -5.82 0.97 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' B' ' 309' ' ' ARG . . . -111.2 100.04 1.18 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 106.727 -2.549 . . . . 0.0 106.727 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.629 ' N ' ' CD ' ' B' ' 314' ' ' ARG . 0.0 OUTLIER -98.41 -59.55 1.73 Allowed 'General case' 0 C--N 1.289 -2.024 0 O-C-N 121.695 -0.885 . . . . 0.0 108.614 -177.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 56' ' ' GLU . 77.8 t -131.94 109.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.765 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.632 HD11 ' HB ' ' B' ' 283' ' ' VAL . 0.1 OUTLIER -54.55 146.27 16.77 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 89' ' ' GLY . 0.6 OUTLIER -43.08 146.17 0.44 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.98 -1.075 . . . . 0.0 109.431 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.24 80.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 0.0 110.534 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 76.6 mmm -64.63 -37.69 88.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.972 -1.08 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 92' ' ' TYR . 47.5 mm -64.94 -47.23 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.303 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 324' ' ' ALA . 0.1 OUTLIER -63.13 -40.6 98.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 -179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.491 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -63.08 -37.47 94.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.594 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -53.89 -47.83 70.7 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.594 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 0.32 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.521 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.533 ' OD2' ' NH1' ' B' ' 328' ' ' ARG . 53.7 t0 -76.34 -35.25 58.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.889 -1.132 . . . . 0.0 108.565 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 82.81 -22.26 6.86 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 30.0 t -101.36 -45.92 5.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.984 -1.303 . . . . 0.0 109.874 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.533 ' NH1' ' OD2' ' B' ' 325' ' ' ASP . 34.2 ptt-85 -121.45 -43.44 2.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 329' ' ' PHE . 6.9 t80 -97.15 130.1 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.694 ' NE2' ' HE1' ' B' ' 332' ' ' TRP . 3.6 tt0 -155.67 161.71 40.72 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.513 -1.275 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.3 t -116.75 105.68 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.694 ' HE1' ' NE2' ' B' ' 330' ' ' GLN . 15.7 m0 -101.72 143.1 32.08 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.327 -0.858 . . . . 0.0 109.677 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' B' ' 334' ' ' TYR . 59.7 t0 -93.18 155.36 17.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 109.147 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.582 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 6.3 p90 -169.7 -166.31 0.57 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -170.26 160.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -59.39 28.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.045 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -134.97 -2.44 3.08 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -155.87 12.1 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.167 -1.196 . . . . 0.0 110.082 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.51 HG13 ' N ' ' B' ' 340' ' ' GLU . 8.1 p -51.9 -42.9 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.021 -1.049 . . . . 0.0 108.548 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.51 ' N ' HG13 ' B' ' 339' ' ' VAL . 40.0 mt-10 -57.64 -36.97 72.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.558 -0.714 . . . . 0.0 109.123 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 57.0 m -66.69 -44.16 82.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.312 -0.867 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 2.5 tpp -52.74 -49.54 65.23 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 88.8 mt -71.2 -29.34 65.04 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.491 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 37.6 t0 -67.2 -39.05 86.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.067 -1.02 . . . . 0.0 109.937 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -73.11 -50.36 23.24 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.89 -1.131 . . . . 0.0 108.834 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . 0.481 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.8 t80 -56.36 -47.31 79.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.7 ' CG ' HD12 ' B' ' 351' ' ' LEU . 12.7 m-85 -78.05 -30.76 50.0 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.591 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 45.3 mt-10 -58.5 -25.71 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -71.62 -17.11 62.29 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.772 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -177.69 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.073 -1.017 . . . . 0.0 111.162 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.7 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 176.14 -55.28 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.587 177.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 20.1 Cg_endo -62.2 -14.21 36.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.861 1.708 . . . . 0.0 111.579 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -68.84 -45.09 72.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.346 -0.846 . . . . 0.0 109.768 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . 0.411 ' NZ ' HD23 ' B' ' 351' ' ' LEU . 23.0 mtmm -61.13 -36.08 78.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.121 -0.987 . . . . 0.0 109.619 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 30.4 p -61.76 -40.2 94.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.14 -22.96 60.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 109.712 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -73.09 159.09 34.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.153 -0.967 . . . . 0.0 109.71 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 85.0 p -144.51 160.84 40.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.377 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 17.0 m -63.63 -31.51 72.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -131.24 79.41 70.5 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.363 -0.836 . . . . 0.0 109.438 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -81.92 -22.83 4.96 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.784 2.323 . . . . 0.0 112.311 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 68.7 m 47.55 -167.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.524 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.45 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptt? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.4 29.03 4.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.591 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.2 158.64 43.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 109.655 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.5 p -147.91 170.23 18.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.174 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 6' ' ' GLU . . . 84.81 -99.56 2.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLY . 91.7 mt-10 47.78 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -1.186 . . . . 0.0 109.349 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.84 178.5 6.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.924 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -129.88 153.8 80.99 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.564 -0.71 . . . . 0.0 109.143 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.13 -156.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.617 2.211 . . . . 0.0 111.772 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 89.8 m -100.31 177.14 5.14 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 77' ' ' ASP . 2.6 m -119.93 121.21 38.5 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.026 -1.046 . . . . 0.0 108.581 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.611 HG13 HG12 ' A' ' 78' ' ' VAL . 5.3 t -94.06 130.94 42.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CE2' ' O ' ' A' ' 69' ' ' ASP . 33.2 t80 -99.85 133.39 44.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.525 ' CD2' HG22 ' A' ' 32' ' ' VAL . 26.6 t80 -86.88 116.34 24.89 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.365 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 81' ' ' ALA . 6.5 t -107.0 108.99 20.76 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.771 0.796 . . . . 0.0 109.287 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.556 ' C ' HG22 ' A' ' 90' ' ' VAL . . . -174.85 174.3 46.62 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.522 ' N ' HG22 ' A' ' 90' ' ' VAL . 6.7 p -113.44 160.13 18.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -1.074 . . . . 0.0 108.461 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.408 HG23 ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -84.66 -13.43 11.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.605 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 21' ' ' GLY . 17.7 mmm180 -50.18 -85.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 40.87 -82.1 0.0 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.758 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 162.94 36.4 0.02 OUTLIER Glycine 0 N--CA 1.488 2.153 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HE ' ' CD1' ' A' ' 54' ' ' LEU . 38.3 mmt-85 55.88 -46.87 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 122.314 -0.521 . . . . 0.0 109.817 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.758 ' N ' ' O ' ' A' ' 21' ' ' GLY . 76.9 mm-40 -56.99 -38.86 73.63 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -63.67 -26.68 68.78 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.59 HE21 ' C ' ' A' ' 46' ' ' VAL . 20.2 tp60 -64.77 -42.68 94.92 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.71 84.37 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.96 -37.88 77.79 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.741 ' O ' HG23 ' A' ' 32' ' ' VAL . 21.1 m-30 -65.94 -41.81 90.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -63.14 -39.31 94.3 Favored 'General case' 0 C--N 1.291 -1.974 0 O-C-N 120.851 -1.156 . . . . 0.0 109.041 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.49 -55.02 9.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.951 -1.093 . . . . 0.0 108.321 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.432 HG21 ' OE2' ' A' ' 82' ' ' GLU . 20.9 mt -53.89 -45.07 62.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 28' ' ' TYR . 49.3 t -60.15 -29.37 43.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.6 m -67.31 -38.56 85.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.082 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -68.51 -50.19 54.04 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.127 . . . . 0.0 109.043 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.601 HD22 HG11 ' A' ' 12' ' ' VAL . 25.1 mt -56.77 -40.82 76.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -61.6 -27.05 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.845 -0.535 . . . . 0.0 109.598 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -75.94 -36.81 59.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.959 -1.088 . . . . 0.0 109.542 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.519 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.8 m-85 -71.69 -48.76 45.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.52 -0.737 . . . . 0.0 110.598 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -149.35 -148.83 4.84 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -95.66 125.13 40.04 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.413 -1.051 . . . . 0.0 109.825 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.444 HG11 HG13 ' A' ' 32' ' ' VAL . 3.2 t -83.4 101.17 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' A' ' 76' ' ' ALA . 93.8 mt -47.1 149.67 0.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.31 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 m -44.61 140.08 2.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 109.301 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 46' ' ' VAL . 11.0 pt-20 -161.57 134.27 6.06 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 35.0 t-80 -74.86 25.0 0.09 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.241 -0.912 . . . . 0.0 109.188 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.681 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 27.6 t -83.97 -85.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' C ' ' N ' ' A' ' 49' ' ' ALA . . . -68.08 178.87 1.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.814 ' O ' HD11 ' A' ' 51' ' ' LEU . 14.7 t70 48.57 20.09 0.29 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.798 -1.188 . . . . 0.0 108.193 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -115.01 -9.51 12.37 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -62.85 -32.96 74.3 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.324 -0.86 . . . . 0.0 108.798 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.991 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -57.63 157.1 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.604 -0.685 . . . . 0.0 109.961 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 51' ' ' LEU . 17.9 mt-10 55.02 155.46 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 58' ' ' ALA . 55.6 Cg_endo -72.19 68.5 3.32 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.493 2.129 . . . . 0.0 111.938 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' CD1' ' HE ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -55.55 165.15 0.87 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.895 -1.128 . . . . 0.0 109.628 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 150.46 32.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 22.9 mm-40 59.15 -73.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.626 -0.926 . . . . 0.0 109.447 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' N ' ' O ' ' A' ' 55' ' ' GLY . 78.7 tt0 -52.46 -28.77 21.55 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.28 -0.887 . . . . 0.0 109.148 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 53' ' ' PRO . . . -68.07 149.18 49.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.78 142.9 5.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.447 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.67 -58.53 0.23 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.75 80.63 0.48 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -53.47 -41.11 65.85 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.33 -1.1 . . . . 0.0 108.494 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.96 -48.89 67.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -60.08 -38.15 82.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -63.36 -40.22 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.436 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.4 t-80 -78.84 -51.03 10.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.352 -0.842 . . . . 0.0 110.55 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -50.68 -47.93 58.72 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.869 -1.144 . . . . 0.0 110.012 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.82 -49.04 27.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 0.0 110.421 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 68.6 m-20 -62.75 -51.92 65.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 0.0 110.776 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.46 HD11 ' NE ' ' A' ' 96' ' ' ARG . 0.6 OUTLIER -68.22 -41.28 81.51 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 0.0 111.274 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -61.87 -54.03 47.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.597 -1.314 . . . . 0.0 109.314 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.577 ' CD1' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.07 -38.02 75.56 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.163 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.0 tp -52.6 -45.76 66.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' A' ' 96' ' ' ARG . 20.2 mt-30 -67.03 -30.32 70.37 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.483 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 5.3 mt-30 -91.24 3.53 54.61 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.54 -1.35 . . . . 0.0 109.349 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HA ' HD11 ' A' ' 42' ' ' LEU . . . -64.5 141.59 58.72 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.987 0.899 . . . . 0.0 112.612 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' PRO . 65.1 t0 -98.48 -20.51 17.05 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.611 HG12 HG13 ' A' ' 12' ' ' VAL . 18.4 t -144.55 144.63 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.01 137.96 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 120.717 -1.239 . . . . 0.0 112.382 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.13 125.41 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -112.54 144.6 41.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.298 -0.876 . . . . 0.0 110.34 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' OE2' HG21 ' A' ' 31' ' ' ILE . 50.2 mt-10 -108.6 121.71 45.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.563 -0.71 . . . . 0.0 109.169 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 107' ' ' LEU . 1.7 m -146.77 113.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.7 m -130.04 -13.42 4.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -142.92 156.18 62.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -39.13 108.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.047 1.831 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.64 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 45.1 m -126.29 134.39 51.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.142 -0.974 . . . . 0.0 111.165 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.635 ' HB2' ' H ' ' B' ' 287' ' ' SER . 14.7 tp -105.68 153.11 22.28 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.59 -29.99 3.19 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 105.983 -2.847 . . . . 0.0 105.983 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 16' ' ' GLY . 47.4 t -86.01 -49.92 14.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.35 62.45 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.431 ' HB2' HD11 ' B' ' 320' ' ' ILE . 85.8 t80 -70.86 -58.14 3.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 85.9 mt-10 -52.16 -32.95 38.22 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 81' ' ' ALA . 37.8 mt -76.29 -41.15 49.68 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.0 -48.76 81.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 74' ' ' GLN . 45.4 ttm-85 -62.61 -38.26 89.51 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.341 -1.093 . . . . 0.0 108.89 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.56 -39.93 88.75 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -54.92 -44.31 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 120.791 -1.193 . . . . 0.0 108.136 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -76.01 -48.93 19.1 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.469 ' O ' ' CD ' ' A' ' 102' ' ' LYS . 2.8 pp -116.66 -23.08 8.33 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 120.831 -1.168 . . . . 0.0 110.326 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 97' ' ' ALA . . . -53.26 170.3 0.78 Allowed Glycine 0 C--N 1.286 -2.196 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.538 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -131.63 -75.71 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 79.8 Cg_endo -81.79 109.12 1.96 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.811 1.674 . . . . 0.0 109.552 176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 55.0 mt -130.08 126.7 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.691 -1.256 . . . . 0.0 111.579 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 132' ' ' TRP . 24.4 tp -123.0 119.39 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.73 153.05 21.12 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.71 -1.244 . . . . 0.0 108.561 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 14.7 mt -127.9 132.69 49.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.962 -1.086 . . . . 0.0 111.838 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.482 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -138.93 122.35 17.2 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 65.4 mtm180 -86.55 135.66 35.92 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.848 -1.157 . . . . 0.0 111.388 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 72.7 Cg_endo -79.32 -23.87 7.06 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.434 2.089 . . . . 0.0 110.58 178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 112' ' ' SER . 14.6 pt20 -48.06 -38.2 16.84 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 10.7 t -95.3 -18.59 20.69 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.1 52.77 4.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 115' ' ' VAL . 3.6 mtp180 -87.57 6.26 35.3 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.289 . . . . 0.0 109.993 -178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.491 ' O ' ' O ' ' A' ' 114' ' ' ARG . 21.1 t 58.08 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 117' ' ' SER . 30.6 tp -74.08 150.83 40.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.587 ' H ' HD23 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -40.49 140.03 0.71 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.311 -0.868 . . . . 0.0 110.609 -178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.64 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -61.07 -43.67 98.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 81.0 mmm -63.89 -44.06 94.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.17 -0.956 . . . . 0.0 109.176 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' B' ' 292' ' ' TYR . 45.1 mm -61.74 -41.79 91.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.243 -0.91 . . . . 0.0 108.768 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -61.81 -45.15 95.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.425 -0.797 . . . . 0.0 109.585 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -66.98 -39.11 93.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.645 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -48.41 -55.91 9.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -1.215 . . . . 0.0 108.217 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -9.87 118.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.432 0.634 . . . . 0.0 111.148 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -130.89 -28.16 2.01 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 80.24 -5.45 63.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.668 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 55.9 p -79.17 39.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 127' ' ' SER . 86.1 mtt-85 106.12 -25.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.005 -1.452 . . . . 0.0 107.903 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -89.71 114.67 26.37 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.457 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 80.1 mt-30 -137.66 137.76 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.762 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.85 103.98 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.546 ' CD2' HD11 ' A' ' 105' ' ' LEU . 15.0 m0 -104.59 143.09 33.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.074 -1.016 . . . . 0.0 109.825 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.474 ' O ' ' SD ' ' A' ' 142' ' ' MET . 98.7 m-20 -96.96 159.83 14.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.86 -1.15 . . . . 0.0 108.792 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 8.0 p90 -165.5 -167.06 1.06 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.652 -1.28 . . . . 0.0 111.73 -179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.473 ' N ' ' CD2' ' A' ' 134' ' ' TYR . . . -166.71 146.63 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 135' ' ' ALA . 42.6 mt-10 -41.48 -37.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.896 -1.127 . . . . 0.0 109.971 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.59 4.13 37.65 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.447 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -155.75 8.99 0.26 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.463 -1.61 . . . . 0.0 110.797 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.3 p -53.63 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.913 -1.117 . . . . 0.0 108.539 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 20.8 pt-20 -58.86 -31.94 69.0 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.483 -0.761 . . . . 0.0 109.09 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 57.1 m -68.51 -46.01 70.75 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 3.0 tpp -51.06 -45.8 61.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 26.4 mt -71.63 -34.97 70.25 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.493 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -64.54 -40.53 95.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 110.279 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -71.64 -50.54 29.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.894 -1.129 . . . . 0.0 108.629 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -59.61 -46.44 88.97 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.22 -0.925 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.966 ' CD1' HD12 ' A' ' 151' ' ' LEU . 13.6 m-85 -70.16 -32.95 71.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.88 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.505 -1.372 . . . . 0.0 107.551 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.14 -18.05 62.53 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.571 -0.705 . . . . 0.0 110.661 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.563 ' O ' ' CD1' ' A' ' 150' ' ' TYR . 1.0 OUTLIER -152.84 3.37 0.33 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.385 -1.447 . . . . 0.0 111.598 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.966 HD12 ' CD1' ' A' ' 147' ' ' PHE . 6.1 mt -116.25 83.84 13.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 120.677 -1.264 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -85.11 -100.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.594 2.196 . . . . 0.0 111.688 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -72.89 -35.32 67.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -54.49 -22.42 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.294 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 151' ' ' LEU . 58.9 m -47.46 -39.41 15.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -0.819 . . . . 0.0 109.534 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.48 143.17 22.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 109.549 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.3 m -139.16 160.42 39.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.45 ' HG ' ' CE1' ' A' ' 160' ' ' HIS . 18.4 t -139.22 157.26 46.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 109.426 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.2 m -57.36 -41.76 80.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.45 ' CE1' ' HG ' ' A' ' 158' ' ' SER . 3.7 p-80 -85.56 152.2 56.99 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.79 147.75 85.84 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.508 2.138 . . . . 0.0 112.025 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 81.1 p -58.95 -13.05 5.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.313 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.686 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.316 0.579 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 51.98 29.11 5.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.29 158.98 43.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -0.921 . . . . 0.0 109.603 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 53.1 p -148.24 170.36 18.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' B' ' 206' ' ' GLU . . . 84.82 -99.16 2.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' B' ' 205' ' ' GLY . 90.7 mt-10 47.34 93.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -1.163 . . . . 0.0 109.372 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -87.41 178.24 6.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -129.57 154.25 80.83 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.39 -156.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.62 2.213 . . . . 0.0 111.719 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.527 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 92.0 m -100.09 177.08 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' B' ' 277' ' ' ASP . 2.4 m -119.97 120.86 37.58 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.956 -1.09 . . . . 0.0 108.611 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.625 HG13 HG12 ' B' ' 278' ' ' VAL . 5.8 t -93.86 130.95 42.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' B' ' 269' ' ' ASP . 32.7 t80 -100.01 133.32 44.56 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.516 ' CD2' HG22 ' B' ' 232' ' ' VAL . 26.9 t80 -86.7 116.82 25.05 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.273 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' B' ' 281' ' ' ALA . 5.6 t -107.76 109.03 20.5 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.728 0.775 . . . . 0.0 109.267 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.553 ' C ' HG22 ' B' ' 290' ' ' VAL . . . -174.75 174.54 46.69 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 290' ' ' VAL . 6.5 p -113.46 160.09 18.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -1.059 . . . . 0.0 108.362 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.415 HG23 ' NE2' ' B' ' 225' ' ' GLN . 0.7 OUTLIER -84.91 -13.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.516 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.69 ' O ' ' N ' ' B' ' 221' ' ' GLY . 17.5 mmm180 -50.15 -85.81 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 219' ' ' ARG . . . 40.61 -82.07 0.0 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.755 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 163.19 36.26 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.655 ' HE ' ' CD1' ' B' ' 254' ' ' LEU . 39.2 mmt-85 56.07 -47.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 122.242 -0.563 . . . . 0.0 109.77 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.755 ' N ' ' O ' ' B' ' 221' ' ' GLY . 75.8 mm-40 -56.75 -38.87 73.04 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.68 -26.82 68.83 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.568 HE21 ' C ' ' B' ' 246' ' ' VAL . 19.9 tp60 -64.58 -42.69 95.46 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.21 -47.61 84.7 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 tp -59.21 -38.03 78.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.745 ' O ' HG23 ' B' ' 232' ' ' VAL . 21.2 m-30 -65.86 -41.53 91.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.8 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' B' ' 233' ' ' SER . . . -63.34 -39.44 94.55 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 120.828 -1.17 . . . . 0.0 108.992 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -70.22 -55.13 10.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.976 -1.078 . . . . 0.0 108.349 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.435 HG21 ' OE2' ' B' ' 282' ' ' GLU . 20.6 mt -53.78 -45.4 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.745 HG23 ' O ' ' B' ' 228' ' ' TYR . 49.8 t -59.91 -29.14 42.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 229' ' ' ALA . 5.9 m -67.43 -38.33 84.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.158 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.81 -50.13 52.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.893 -1.129 . . . . 0.0 108.932 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.605 HD22 HG11 ' B' ' 212' ' ' VAL . 24.9 mt -56.71 -40.75 76.23 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -61.6 -27.02 68.35 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -76.07 -36.57 58.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.882 -1.136 . . . . 0.0 109.473 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.525 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.8 m-85 -72.14 -48.79 41.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.536 -0.727 . . . . 0.0 110.646 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -149.15 -149.1 4.89 Favored Glycine 0 N--CA 1.477 1.419 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.7 125.33 40.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.29 -1.124 . . . . 0.0 109.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.441 HG11 HG13 ' B' ' 232' ' ' VAL . 3.2 t -83.22 101.27 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' B' ' 276' ' ' ALA . 94.3 mt -47.28 149.59 1.01 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.256 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . . . . . . . . . 3.5 m -44.59 140.08 2.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.615 -0.678 . . . . 0.0 109.303 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' B' ' 246' ' ' VAL . 11.2 pt-20 -161.54 134.6 6.26 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.339 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 34.4 t-80 -74.86 24.35 0.09 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.205 -0.935 . . . . 0.0 109.222 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.67 ' O ' ' HB3' ' B' ' 249' ' ' ALA . 27.7 t -83.42 -85.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' B' ' 249' ' ' ALA . . . -67.97 178.86 1.64 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.833 ' O ' HD11 ' B' ' 251' ' ' LEU . 15.5 t70 48.89 19.5 0.27 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.75 -1.218 . . . . 0.0 108.226 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -114.27 -9.89 12.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -62.2 -33.23 74.15 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.98 ' H ' HD13 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -57.75 157.37 7.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.525 -0.734 . . . . 0.0 109.915 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.557 ' O ' ' O ' ' B' ' 251' ' ' LEU . 18.3 mt-10 54.7 155.47 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.379 -0.825 . . . . 0.0 109.619 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' B' ' 258' ' ' ALA . 55.9 Cg_endo -72.09 68.12 3.27 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.506 2.138 . . . . 0.0 111.937 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.655 ' CD1' ' HE ' ' B' ' 222' ' ' ARG . 0.2 OUTLIER -55.35 165.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -0.992 . . . . 0.0 109.643 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 149.83 32.78 0.05 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.64 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 23.8 mm-40 58.9 -74.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.583 -0.951 . . . . 0.0 109.501 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' B' ' 255' ' ' GLY . 78.9 tt0 -52.51 -27.94 18.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.358 -0.839 . . . . 0.0 109.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' B' ' 253' ' ' PRO . . . -68.88 149.17 49.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.356 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -48.68 141.96 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.943 . . . . 0.0 109.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 167.43 -58.24 0.22 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 123.44 80.64 0.5 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -53.49 -40.85 65.68 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.316 -1.108 . . . . 0.0 108.525 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -67.22 -48.96 66.28 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 108.775 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -59.95 -38.34 82.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.29 -39.94 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.448 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.3 t-80 -79.16 -51.37 9.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.0 110.572 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -50.21 -47.9 54.56 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.87 -1.144 . . . . 0.0 109.879 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -74.11 -48.42 29.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.547 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 69.1 m-20 -63.27 -51.45 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.054 -1.028 . . . . 0.0 110.71 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.472 HD11 ' NE ' ' B' ' 296' ' ' ARG . 0.6 OUTLIER -68.76 -40.96 79.5 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.887 -1.133 . . . . 0.0 111.277 -178.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.4 t-20 -62.19 -53.77 50.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.654 -1.279 . . . . 0.0 109.305 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.567 ' CD1' HD22 ' B' ' 242' ' ' LEU . 0.0 OUTLIER -58.04 -38.18 75.77 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.088 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.455 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.1 tp -52.63 -45.65 66.72 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.554 ' OE1' ' NH1' ' B' ' 296' ' ' ARG . 20.5 mt-30 -67.12 -30.37 70.36 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.652 -0.655 . . . . 0.0 110.451 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 5.3 mt-30 -91.28 3.54 54.6 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.625 -1.297 . . . . 0.0 109.34 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.582 ' HA ' HD11 ' B' ' 242' ' ' LEU . . . -64.79 141.07 58.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.0 112.527 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' B' ' 303' ' ' PRO . 65.3 t0 -97.84 -20.43 17.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.625 HG12 HG13 ' B' ' 212' ' ' VAL . 18.7 t -144.65 144.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 22.6 t -143.5 137.94 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.544 -1.347 . . . . 0.0 112.527 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 55.1 t -133.86 125.88 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.55 ' CB ' HD21 ' B' ' 294' ' ' LEU . . . -112.97 144.98 41.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.195 -0.94 . . . . 0.0 110.274 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.435 ' OE2' HG21 ' B' ' 231' ' ' ILE . 48.9 mt-10 -108.83 121.65 45.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.535 -0.728 . . . . 0.0 109.179 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 1.7 m -146.74 113.59 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 18.9 m -130.22 -13.6 3.94 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -142.79 156.26 62.7 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -39.07 108.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.259 1.973 . . . . 0.0 111.691 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.635 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 45.6 m -125.9 134.35 51.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.099 -1.001 . . . . 0.0 111.242 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.64 ' HB2' ' H ' ' A' ' 87' ' ' SER . 15.0 tp -105.32 153.51 21.53 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 81.97 -29.74 3.03 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.569 ' H ' ' C ' ' B' ' 288' ' ' LEU . 46.6 t -86.39 -49.54 14.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -58.67 -28.55 62.93 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 106.946 -2.461 . . . . 0.0 106.946 176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' A' ' 120' ' ' ILE . 86.1 t80 -70.99 -57.95 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.936 -0.743 . . . . 0.0 109.088 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.403 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . 86.5 mt-10 -52.2 -33.2 39.91 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.55 HD21 ' CB ' ' B' ' 281' ' ' ALA . 36.7 mt -76.26 -41.13 50.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.74 -48.63 82.95 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.554 ' NH1' ' OE1' ' B' ' 274' ' ' GLN . 45.4 ttm-85 -62.97 -38.16 90.0 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.371 -1.076 . . . . 0.0 108.987 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.6 -39.68 88.5 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.486 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -54.92 -44.32 72.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 120.82 -1.175 . . . . 0.0 108.216 179.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.569 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -75.98 -49.28 18.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.46 ' O ' ' CD ' ' B' ' 302' ' ' LYS . 2.8 pp -116.36 -23.56 8.28 Favored 'General case' 0 N--CA 1.507 2.413 0 O-C-N 120.949 -1.094 . . . . 0.0 110.403 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -52.92 170.38 0.64 Allowed Glycine 0 C--N 1.288 -2.128 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 177.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.543 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 0.4 OUTLIER -131.46 -75.67 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.023 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.543 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 66.5 Cg_endo -81.73 109.49 2.02 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.819 1.679 . . . . 0.0 109.623 176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 55.4 mt -130.47 126.79 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.688 -1.258 . . . . 0.0 111.514 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' B' ' 332' ' ' TRP . 24.1 tp -123.06 119.29 29.88 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 1.4 m -103.45 153.08 20.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.642 -1.286 . . . . 0.0 108.511 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 14.7 mt -127.69 132.5 49.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.996 -1.065 . . . . 0.0 111.865 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -138.79 122.51 17.54 Favored 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 68.3 mtm180 -86.93 135.61 35.12 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.985 -1.072 . . . . 0.0 111.421 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' B' ' 313' ' ' GLY . 72.8 Cg_endo -79.36 -24.29 6.64 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.508 2.139 . . . . 0.0 110.425 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' B' ' 312' ' ' SER . 14.6 pt20 -47.9 -38.28 16.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.445 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 9.9 t -95.23 -18.78 20.58 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 40.8 53.1 3.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' B' ' 315' ' ' VAL . 3.6 mtp180 -87.73 6.44 34.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.923 -1.339 . . . . 0.0 109.98 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.493 ' O ' ' O ' ' B' ' 314' ' ' ARG . 24.1 t 58.25 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.841 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 316' ' ' LEU . 30.0 tp -74.19 151.21 40.05 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.594 ' H ' HD23 ' A' ' 88' ' ' LEU . 0.4 OUTLIER -40.59 139.84 0.75 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.265 -0.897 . . . . 0.0 110.596 -178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . 0.612 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -60.81 -43.61 97.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.468 -0.77 . . . . 0.0 109.411 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 81.0 mmm -64.31 -43.9 93.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 92' ' ' TYR . 45.7 mm -61.57 -41.6 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.102 -0.999 . . . . 0.0 108.756 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -62.09 -45.03 95.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.34 -0.85 . . . . 0.0 109.435 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -67.01 -39.0 93.1 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.636 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -48.45 -55.96 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.065 -1.256 . . . . 0.0 108.288 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.636 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -9.99 118.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.344 0.592 . . . . 0.0 111.16 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -131.43 -27.99 1.91 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 79.95 -5.18 63.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.66 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 54.7 p -79.34 39.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.66 ' HB2' ' O ' ' B' ' 327' ' ' SER . 84.8 mtt-85 106.22 -25.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 113.969 -1.469 . . . . 0.0 107.831 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -89.66 114.3 25.9 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.473 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 81.0 mt-30 -137.14 137.85 39.65 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.748 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.94 104.15 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.551 ' CD2' HD11 ' B' ' 305' ' ' LEU . 14.7 m0 -104.88 142.81 34.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.189 -0.945 . . . . 0.0 109.824 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.476 ' O ' ' SD ' ' B' ' 342' ' ' MET . 97.9 m-20 -97.06 159.97 14.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.828 -1.17 . . . . 0.0 108.807 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 8.1 p90 -165.4 -167.26 1.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.705 -1.247 . . . . 0.0 111.64 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.467 ' N ' ' CD2' ' B' ' 334' ' ' TYR . . . -166.39 146.51 6.08 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.7 mt-10 -41.33 -37.24 0.95 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.801 -1.187 . . . . 0.0 110.058 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -74.75 4.89 34.01 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.389 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.21 8.79 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.461 -1.611 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.3 p -53.51 -44.75 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.92 -1.113 . . . . 0.0 108.468 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 20.2 pt-20 -58.64 -31.88 68.54 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.428 -0.795 . . . . 0.0 109.202 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 62.2 m -68.76 -45.91 70.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 109.335 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.0 tpp -51.38 -45.67 62.53 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 25.6 mt -71.53 -35.19 70.59 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.548 -0.72 . . . . 0.0 109.506 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -64.2 -40.57 96.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -72.02 -50.1 31.38 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.933 -1.104 . . . . 0.0 108.717 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -59.99 -46.39 89.6 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.1 -1.0 . . . . 0.0 110.153 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.977 ' CD1' HD12 ' B' ' 351' ' ' LEU . 13.6 m-85 -70.03 -33.03 71.46 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.903 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -67.08 -22.9 65.82 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 120.493 -1.379 . . . . 0.0 107.589 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -71.05 -17.82 62.59 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.512 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.574 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.9 OUTLIER -153.02 3.11 0.31 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.494 -1.379 . . . . 0.0 111.689 -179.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.977 HD12 ' CD1' ' B' ' 347' ' ' PHE . 6.2 mt -116.05 83.87 12.89 Favored Pre-proline 0 N--CA 1.503 2.195 0 O-C-N 120.662 -1.274 . . . . 0.0 109.69 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.9 -100.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.651 2.234 . . . . 0.0 111.75 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -72.63 -35.78 67.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.854 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -53.82 -22.24 9.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.431 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 351' ' ' LEU . 57.9 m -47.71 -39.27 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.903 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -152.25 143.16 23.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.587 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 69.6 m -139.11 160.46 39.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.375 -0.828 . . . . 0.0 109.251 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' B' ' 360' ' ' HIS . 14.6 t -139.52 157.6 45.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 20.2 m -57.86 -41.47 82.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.547 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' B' ' 358' ' ' SER . 3.5 p-80 -86.0 152.11 55.66 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.179 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.43 147.99 87.59 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.517 2.145 . . . . 0.0 112.006 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 59.6 p -60.88 -21.36 63.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.361 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.375 -179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.41 141.25 58.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.26 147.36 52.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.6 m -62.46 157.27 20.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.494 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.77 -169.01 54.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 7' ' ' GLN . 83.9 tt0 -90.39 128.22 36.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -1.159 . . . . 0.0 109.392 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' GLU . 89.7 mt-30 46.32 -170.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 109.658 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' HB1' ' HD2' ' A' ' 9' ' ' PRO . . . -155.35 163.75 23.5 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HD2' ' HB1' ' A' ' 8' ' ' ALA . 89.5 Cg_endo -80.71 -154.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.002 2.468 . . . . 0.0 111.406 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.489 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 30.3 p -102.41 -178.19 3.62 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 2.7 p -119.88 150.62 40.18 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 3.8 t -125.41 131.96 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.65 ' CB ' HG22 ' A' ' 79' ' ' VAL . 26.5 t80 -99.09 94.88 6.75 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.501 ' N ' ' OG1' ' A' ' 43' ' ' THR . 63.2 t80 -88.01 128.77 35.4 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 111.213 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.1 m -118.39 157.8 26.49 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.248 -0.907 . . . . 0.0 109.765 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' C ' ' CG2' ' A' ' 90' ' ' VAL . . . -168.93 173.8 43.47 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.511 ' OG ' ' NE2' ' A' ' 85' ' ' GLN . 19.2 t -81.6 132.25 35.3 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.289 -1.124 . . . . 0.0 109.689 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 1.0 OUTLIER -137.24 133.54 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.153 -0.967 . . . . 0.0 109.968 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 6.3 tpp180 -175.89 0.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.982 -1.074 . . . . 0.0 110.571 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 19' ' ' ARG . . . 155.85 82.95 0.04 OUTLIER Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.891 ' H ' HD22 ' A' ' 54' ' ' LEU . . . 56.88 -140.55 44.2 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.711 ' CB ' ' O ' ' A' ' 21' ' ' GLY . 65.9 mtt180 118.01 131.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 CA-C-N 117.752 0.776 . . . . 0.0 110.93 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -52.55 -26.87 14.47 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 66.1 m-20 -69.71 -36.05 75.59 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -59.8 -43.59 94.39 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.93 72.49 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.4 -28.95 68.64 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 24' ' ' ASP . 12.7 m-30 -69.43 -49.39 55.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.552 -0.717 . . . . 0.0 110.088 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -34.25 77.12 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.544 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -71.74 -55.45 7.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.864 -1.147 . . . . 0.0 108.393 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 5.5 mt -54.04 -47.36 65.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.552 HG13 HG11 ' A' ' 41' ' ' VAL . 40.4 t -60.85 -28.77 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.72 -0.613 . . . . 0.0 109.363 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -69.31 -37.2 77.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.553 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -70.46 -47.41 60.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.882 -1.136 . . . . 0.0 108.831 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.2 mt -61.26 -41.54 97.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -61.02 -26.12 67.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -78.66 -35.15 45.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.001 . . . . 0.0 109.36 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.573 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.8 m-85 -74.68 -51.77 13.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.47 -0.769 . . . . 0.0 109.809 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -142.54 -152.85 5.76 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -98.07 130.9 44.85 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.218 -1.166 . . . . 0.0 109.018 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG11 HG13 ' A' ' 32' ' ' VAL . 2.2 t -89.46 111.22 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.1 mt -79.8 -29.09 40.22 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.311 -0.956 . . . . 0.0 109.569 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' A' ' 14' ' ' PHE . 12.5 p -82.96 23.92 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.259 -0.901 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . 85.9 tt0 -44.08 -31.47 0.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.532 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.526 ' CD2' ' OD2' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -54.91 -35.96 64.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 109.875 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' A' ' 45' ' ' HIS . 56.1 t -50.43 -66.75 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.916 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -62.94 -38.97 93.15 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 109.479 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -61.58 -0.58 0.44 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -60.57 -40.16 90.67 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.246 -0.909 . . . . 0.0 108.678 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -49.06 -23.73 1.3 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.802 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -66.3 123.15 19.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.363 -0.835 . . . . 0.0 109.403 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' A' ' 51' ' ' LEU . 3.6 mt-10 54.02 162.79 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.798 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ALA . 84.2 Cg_exo -42.71 136.51 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.816 1.677 . . . . 0.0 111.065 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.891 HD22 ' H ' ' A' ' 21' ' ' GLY . 4.3 mp -81.9 -103.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.053 -1.03 . . . . 0.0 108.694 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.725 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 38.52 112.98 0.0 OUTLIER Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.791 ' OE1' ' HB2' ' B' ' 318' ' ' ALA . 15.8 mm-40 -37.74 -48.91 1.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -1.217 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -74.95 -31.58 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.312 -0.867 . . . . 0.0 108.858 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -83.39 46.99 1.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 109.317 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.03 -165.0 1.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.341 -0.849 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.12 69.21 0.21 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 75.36 1.08 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 30.3 p-10 -52.44 -38.76 59.98 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.526 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 6.6 tt0 -63.26 -48.57 77.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -57.15 -36.73 71.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.17 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.5 OUTLIER -64.1 -38.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.603 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -77.27 -58.25 3.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 110.45 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 96.2 mt-10 -45.13 -46.14 11.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.894 -1.129 . . . . 0.0 109.853 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.06 -42.47 76.2 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 109.716 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' OD2' ' CD2' ' A' ' 45' ' ' HIS . 86.0 m-20 -66.59 -36.06 81.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.166 -0.959 . . . . 0.0 110.607 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.555 ' HG ' ' NE2' ' A' ' 66' ' ' HIS . 1.3 mm? -69.77 -52.05 28.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -57.21 -40.57 77.74 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.539 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -67.22 -44.74 78.77 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.572 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 14.2 tp -51.97 -35.74 47.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.1 -33.2 67.67 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.858 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 72' ' ' TRP . 43.0 mt-30 -84.04 -1.23 54.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.188 -0.945 . . . . 0.0 109.216 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.05 136.65 50.55 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.062 0.934 . . . . 0.0 112.486 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 47.6 m-20 -99.71 -30.44 12.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 58.1 t -137.1 144.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG22 ' CB ' ' A' ' 13' ' ' TYR . 80.6 t -132.99 140.14 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.787 -1.196 . . . . 0.0 111.205 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.1 t -142.63 121.64 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -113.34 121.91 45.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.814 -1.178 . . . . 0.0 110.28 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 54.8 tt0 -86.1 112.95 21.76 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.794 HG11 HD11 ' A' ' 116' ' ' LEU . 1.8 t -86.65 -99.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 110.383 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 85' ' ' GLN . 6.5 m 59.48 -96.87 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.203 -1.561 . . . . 0.0 109.032 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.621 HE22 ' CZ ' ' A' ' 22' ' ' ARG . 28.7 tt0 -61.39 133.34 93.06 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.914 -1.116 . . . . 0.0 108.589 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.465 ' HD3' ' HE ' ' A' ' 114' ' ' ARG . 32.3 Cg_endo -66.62 115.59 3.64 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.975 1.784 . . . . 0.0 111.869 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.405 ' OG ' HG23 ' A' ' 90' ' ' VAL . 12.8 t -138.45 129.73 27.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.849 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD13 ' CG1' ' B' ' 283' ' ' VAL . 8.9 mt -69.05 -40.25 78.66 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.314 -0.866 . . . . 0.0 108.932 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.33 -43.19 95.78 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 16' ' ' GLY . 44.6 t -66.13 -47.29 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.451 -1.029 . . . . 0.0 108.832 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.18 -31.96 74.85 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -68.89 -47.61 65.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.507 -0.996 . . . . 0.0 109.698 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.48 -35.22 78.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.551 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 81' ' ' ALA . 17.3 mt -69.09 -46.73 67.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 108.616 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.4 -33.95 87.97 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.496 HH21 ' HB2' ' B' ' 299' ' ' ALA . 0.3 OUTLIER -64.18 -43.99 93.43 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.49 -1.006 . . . . 0.0 109.706 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -71.14 -29.1 64.8 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.42 -1.312 . . . . 0.0 107.602 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -53.61 -50.42 50.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.305 -1.497 . . . . 0.0 106.994 178.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' N ' HG12 ' A' ' 98' ' ' VAL . . . -85.43 -55.64 3.91 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.452 0.644 . . . . 0.0 110.681 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 100' ' ' LEU . 1.2 tt -61.97 -16.81 54.11 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 122.503 1.144 . . . . 0.0 108.004 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 102' ' ' LYS . . . 75.81 -163.17 53.35 Favored Glycine 0 C--N 1.281 -2.511 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 7.6 mmtm 96.85 136.24 0.03 OUTLIER Pre-proline 0 C--N 1.285 -2.215 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -36.41 111.13 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.218 1.945 . . . . 0.0 111.429 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.499 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.5 mt -105.36 87.6 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.865 0.841 . . . . 0.0 111.248 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.7 tp -91.42 116.7 29.06 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.514 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -108.0 139.81 42.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 108.536 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 13.5 mt -123.31 138.6 54.58 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 111.075 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -140.4 138.9 35.12 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 178.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -92.06 135.27 27.36 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 0.0 110.906 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.04 -32.86 2.32 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 122.514 2.143 . . . . 0.0 111.094 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.02 -33.52 18.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 113' ' ' GLY . 36.4 p -97.11 -21.41 17.36 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 39.74 44.84 2.67 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.465 ' HE ' ' HD3' ' A' ' 86' ' ' PRO . 14.8 mtp85 -70.62 8.43 0.85 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.202 -1.175 . . . . 0.0 109.323 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.462 ' H ' ' C ' ' A' ' 113' ' ' GLY . 94.5 t 53.92 102.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.428 -0.795 . . . . 0.0 110.419 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.794 HD11 HG11 ' A' ' 83' ' ' VAL . 13.4 tp -57.05 139.52 52.03 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.1 144.63 1.22 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.476 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.798 ' HB2' ' OE1' ' B' ' 256' ' ' GLU . . . -59.83 -37.11 78.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.484 -0.76 . . . . 0.0 109.913 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.44 ' N ' ' SD ' ' A' ' 119' ' ' MET . 26.7 mmm -68.58 -45.69 71.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.315 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.3 mm -64.5 -47.37 89.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -67.79 -44.21 77.91 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.178 -0.952 . . . . 0.0 109.401 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.544 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -63.27 -26.53 69.48 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -56.44 -51.96 66.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.057 -1.261 . . . . 0.0 107.743 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 8.97 58.09 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 123' ' ' ALA . 22.6 t0 -67.86 -35.4 78.49 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.692 -1.255 . . . . 0.0 107.921 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.887 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.77 176.54 45.73 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 20.0 m 56.05 -26.17 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.488 1.137 . . . . 0.0 108.79 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.887 ' H ' ' C ' ' A' ' 126' ' ' GLY . 7.2 tpp85 -149.95 -3.63 0.38 Allowed 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.415 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.514 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 6.3 t80 -152.73 112.31 3.9 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.868 -1.145 . . . . 0.0 108.013 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.548 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 86.8 mt-30 -138.62 132.27 30.72 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.2 t -86.7 103.48 13.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.548 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 14.2 m0 -98.11 139.73 33.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 109.288 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' O ' ' CE ' ' A' ' 142' ' ' MET . 74.2 m-20 -94.18 141.92 28.0 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.954 -1.091 . . . . 0.0 109.046 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 139' ' ' VAL . 3.6 p90 -157.51 -173.63 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.035 -1.04 . . . . 0.0 111.034 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -158.87 157.75 32.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.5 30.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.447 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -135.78 -1.33 3.03 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.666 ' O ' ' SD ' ' A' ' 142' ' ' MET . 23.2 pt-20 -154.26 10.41 0.38 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.122 -1.222 . . . . 0.0 110.027 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 142' ' ' MET . 1.7 p -50.86 -41.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.045 -1.034 . . . . 0.0 108.865 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.447 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.0 tt0 -61.66 -29.18 69.91 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.012 -1.055 . . . . 0.0 108.771 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' GLU . 16.9 m -71.31 -48.36 51.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 110.367 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -55.76 -47.16 77.49 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 76.6 mt -62.42 -29.83 70.79 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.128 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.479 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 43.2 t0 -69.09 -39.08 79.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.369 -0.832 . . . . 0.0 110.0 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -70.54 -51.76 26.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.69 -1.256 . . . . 0.0 108.814 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 66.7 t80 -57.92 -47.33 83.17 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.515 -0.74 . . . . 0.0 110.08 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.809 ' CG ' HD12 ' A' ' 151' ' ' LEU . 12.0 m-85 -74.34 -32.82 62.94 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.123 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.479 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 12.2 mm-40 -58.54 -26.48 63.59 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -70.21 -22.15 62.95 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.82 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -172.75 101.48 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 111.03 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.809 HD12 ' CG ' ' A' ' 147' ' ' PHE . 0.7 OUTLIER 175.23 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.227 -0.921 . . . . 0.0 109.485 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 151' ' ' LEU . 86.9 Cg_endo -83.0 30.22 0.54 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.913 2.409 . . . . 0.0 111.456 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 65.76 32.82 8.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.528 -0.733 . . . . 0.0 109.073 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp 51.3 40.04 25.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.079 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -50.44 169.85 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 109.594 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.16 -29.85 65.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.832 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.3 t 49.31 -167.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 109.367 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 73.0 p -136.41 157.83 45.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.357 -0.839 . . . . 0.0 109.278 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 t -126.43 146.8 49.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.325 -0.859 . . . . 0.0 109.645 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' SER . 10.1 m-70 -78.63 152.05 77.65 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.045 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -38.76 -25.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.554 2.169 . . . . 0.0 112.22 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' HIS . 73.5 m -71.77 159.56 34.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.853 . . . . 0.0 109.448 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.503 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.11 141.41 58.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -64.23 147.18 52.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.346 -0.846 . . . . 0.0 109.511 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.6 m -62.47 156.43 22.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.26 -168.26 54.51 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' B' ' 207' ' ' GLN . 84.0 tt0 -90.78 127.95 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -1.183 . . . . 0.0 109.431 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . 0.408 ' O ' ' O ' ' B' ' 206' ' ' GLU . 89.4 mt-30 46.4 -170.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.32 -0.863 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' B' ' 209' ' ' PRO . . . -155.18 163.69 23.67 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' B' ' 208' ' ' ALA . 90.1 Cg_endo -80.69 -154.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.065 2.51 . . . . 0.0 111.459 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.493 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 30.3 p -102.65 -178.16 3.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 2.8 p -119.77 151.12 39.29 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 3.6 t -125.86 131.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.667 ' CB ' HG22 ' B' ' 279' ' ' VAL . 26.0 t80 -98.98 94.46 6.56 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.506 ' O ' ' CB ' ' B' ' 243' ' ' THR . 62.4 t80 -87.84 129.3 35.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 0.0 111.117 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -119.24 157.99 26.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.402 -0.812 . . . . 0.0 109.606 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CG2' ' B' ' 290' ' ' VAL . . . -169.12 174.29 43.6 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.52 ' OG ' ' NE2' ' B' ' 285' ' ' GLN . 17.7 t -81.73 132.12 35.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.304 -1.115 . . . . 0.0 109.8 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.452 ' N ' ' NH1' ' B' ' 222' ' ' ARG . 1.0 OUTLIER -137.04 133.27 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.201 -0.937 . . . . 0.0 110.101 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 6.1 tpp180 -175.35 0.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.905 -1.122 . . . . 0.0 110.623 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 155.85 82.77 0.04 OUTLIER Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.898 ' H ' HD22 ' B' ' 254' ' ' LEU . . . 57.0 -140.91 44.02 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.709 ' CB ' ' O ' ' B' ' 221' ' ' GLY . 65.9 mtt180 118.38 131.99 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 117.768 0.784 . . . . 0.0 110.981 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -52.75 -26.28 13.69 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.495 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 63.7 m-20 -70.58 -35.79 73.24 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' B' ' 222' ' ' ARG . 0.4 OUTLIER -59.9 -43.34 94.89 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.5 -47.03 71.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.34 -28.81 68.46 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' B' ' 224' ' ' ASP . 12.8 m-30 -69.55 -49.18 56.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.507 -0.746 . . . . 0.0 110.167 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.34 -34.28 77.36 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.468 -1.293 . . . . 0.0 108.477 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -71.4 -55.41 8.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.138 . . . . 0.0 108.356 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.43 ' CD1' ' OE1' ' B' ' 282' ' ' GLU . 5.8 mt -54.24 -47.51 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.536 HG13 HG11 ' B' ' 241' ' ' VAL . 40.1 t -60.73 -28.77 43.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 28.4 p -69.44 -37.31 77.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.541 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -70.08 -47.61 61.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.131 . . . . 0.0 108.919 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 25.1 mt -61.24 -41.61 97.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.8 -26.27 67.18 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -78.51 -35.47 46.32 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.045 -1.034 . . . . 0.0 109.371 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.566 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -74.3 -51.65 14.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.435 -0.791 . . . . 0.0 109.902 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -142.45 -152.51 5.7 Favored Glycine 0 N--CA 1.478 1.443 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -98.18 130.97 44.92 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.253 -1.145 . . . . 0.0 108.911 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.536 HG11 HG13 ' B' ' 232' ' ' VAL . 2.2 t -89.67 110.79 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.526 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 16.9 mt -79.37 -29.2 42.05 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.673 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' B' ' 214' ' ' PHE . 13.6 p -83.0 24.19 0.78 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.0 109.521 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 243' ' ' THR . 85.9 tt0 -44.36 -31.19 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.825 . . . . 0.0 109.41 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.539 ' CD2' ' OD2' ' B' ' 269' ' ' ASP . 0.1 OUTLIER -54.96 -36.05 64.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.845 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' B' ' 245' ' ' HIS . 55.8 t -50.32 -66.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -63.11 -39.16 93.89 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -61.41 -0.31 0.37 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -60.58 -40.15 90.68 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.167 -0.958 . . . . 0.0 108.735 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -49.29 -23.1 1.25 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.494 -0.754 . . . . 0.0 109.782 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.614 ' N ' ' CD1' ' B' ' 251' ' ' LEU . 0.7 OUTLIER -66.78 123.25 19.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.322 -0.861 . . . . 0.0 109.314 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 251' ' ' LEU . 3.3 mt-10 54.06 163.25 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 108.88 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' B' ' 258' ' ' ALA . 84.5 Cg_exo -43.09 135.84 5.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.781 1.654 . . . . 0.0 111.038 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.898 HD22 ' H ' ' B' ' 221' ' ' GLY . 4.6 mp -81.14 -103.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 108.842 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.735 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 38.18 113.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.798 ' OE1' ' HB2' ' A' ' 118' ' ' ALA . 14.7 mm-40 -37.86 -48.99 1.18 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.12 -1.223 . . . . 0.0 109.204 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -74.8 -31.91 61.85 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.239 -0.913 . . . . 0.0 108.846 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -83.22 46.97 1.18 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -139.89 -164.71 1.75 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.354 -0.841 . . . . 0.0 109.698 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.24 68.62 0.22 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.03 75.66 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 30.5 p-10 -52.57 -38.4 59.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . 0.512 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 6.7 tt0 -63.49 -48.9 75.74 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -56.66 -36.9 70.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.099 -1.001 . . . . 0.0 109.145 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.451 ' O ' ' CG ' ' B' ' 269' ' ' ASP . 0.5 OUTLIER -64.05 -38.07 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.595 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.5 OUTLIER -77.31 -58.13 3.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.716 . . . . 0.0 110.478 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.595 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 95.9 mt-10 -45.23 -46.26 12.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.778 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -68.82 -42.61 77.02 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.746 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' B' ' 245' ' ' HIS . 87.5 m-20 -66.47 -36.37 82.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.15 -0.969 . . . . 0.0 110.695 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.554 ' HG ' ' NE2' ' B' ' 266' ' ' HIS . 1.3 mm? -69.56 -52.23 28.1 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.92 -1.113 . . . . 0.0 109.636 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -57.01 -40.58 76.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.526 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 1.0 OUTLIER -67.21 -44.64 79.05 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.275 -0.89 . . . . 0.0 109.608 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.573 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.9 tp -52.22 -35.31 49.14 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -72.34 -33.45 67.31 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.79 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' B' ' 272' ' ' TRP . 43.1 mt-30 -83.81 -1.33 54.1 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.8 137.37 51.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.205 -0.934 . . . . 0.0 112.401 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' B' ' 211' ' ' SER . 53.1 m-20 -100.58 -30.43 11.78 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 57.4 t -137.03 144.31 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.667 HG22 ' CB ' ' B' ' 213' ' ' TYR . 77.2 t -133.33 139.78 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.782 -1.199 . . . . 0.0 111.16 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 43.5 t -142.54 121.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -113.38 122.18 46.6 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.799 -1.188 . . . . 0.0 110.188 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.43 ' OE1' ' CD1' ' B' ' 231' ' ' ILE . 53.7 tt0 -86.03 112.91 21.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.836 HG11 HD11 ' B' ' 316' ' ' LEU . 1.9 t -86.45 -99.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 110.216 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 6.2 m 59.9 -96.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.217 -1.552 . . . . 0.0 109.036 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.617 HE22 ' CZ ' ' B' ' 222' ' ' ARG . 28.9 tt0 -61.64 133.43 93.45 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.871 -1.143 . . . . 0.0 108.582 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.472 ' HD3' ' HE ' ' B' ' 314' ' ' ARG . 33.1 Cg_endo -66.77 115.27 3.49 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.938 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.403 ' OG ' HG23 ' B' ' 290' ' ' VAL . 13.1 t -138.22 130.22 28.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.812 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.476 HD13 ' CG1' ' A' ' 83' ' ' VAL . 8.4 mt -69.39 -40.8 77.17 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.79 94.19 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.421 ' CG2' ' C ' ' B' ' 216' ' ' GLY . 43.5 t -65.57 -47.53 86.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.462 -1.023 . . . . 0.0 108.827 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.68 -32.26 73.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -68.85 -47.49 65.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.59 -0.947 . . . . 0.0 109.773 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.76 -35.08 78.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 0.0 109.635 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 281' ' ' ALA . 17.5 mt -69.02 -46.82 66.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 108.596 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.38 -34.19 88.65 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.47 HH21 ' HB2' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -64.02 -43.89 94.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.458 -1.025 . . . . 0.0 109.685 -179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -71.39 -28.65 64.17 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.619 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.591 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -53.91 -50.15 54.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.591 ' N ' HG12 ' B' ' 298' ' ' VAL . . . -85.61 -55.75 3.84 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.419 0.628 . . . . 0.0 110.564 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.624 ' O ' HD23 ' B' ' 300' ' ' LEU . 1.1 tt -61.81 -17.07 54.85 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' B' ' 302' ' ' LYS . . . 75.78 -162.75 53.16 Favored Glycine 0 C--N 1.281 -2.497 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' B' ' 301' ' ' GLY . 7.5 mmtm 96.63 136.4 0.03 OUTLIER Pre-proline 0 C--N 1.283 -2.294 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 302' ' ' LYS . 80.7 Cg_exo -36.41 110.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.2 1.933 . . . . 0.0 111.591 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.503 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.4 mt -104.65 87.11 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.91 0.862 . . . . 0.0 111.256 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 305' ' ' LEU . 32.9 tp -91.16 116.94 29.21 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . 0.541 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.4 OUTLIER -108.28 140.29 41.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 0.0 108.585 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 13.0 mt -123.7 138.77 54.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.168 -0.958 . . . . 0.0 111.059 -178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -140.34 138.89 35.23 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -91.69 135.17 27.99 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.913 -1.117 . . . . 0.0 110.863 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.29 2.12 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.518 2.145 . . . . 0.0 110.934 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -49.78 -33.49 16.6 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.452 ' O ' ' C ' ' B' ' 313' ' ' GLY . 38.7 p -97.27 -21.06 17.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 39.6 44.74 2.53 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.472 ' HE ' ' HD3' ' B' ' 286' ' ' PRO . 14.5 mtp85 -70.31 8.38 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -1.203 . . . . 0.0 109.397 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' B' ' 313' ' ' GLY . 97.3 t 53.85 102.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.297 -0.877 . . . . 0.0 110.356 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 283' ' ' VAL . 13.3 tp -57.39 139.6 52.63 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.13 144.78 1.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.469 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . 0.791 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . . . -59.74 -36.95 77.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.587 -0.696 . . . . 0.0 109.942 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' B' ' 319' ' ' MET . 25.3 mmm -69.0 -45.35 70.8 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.83 -46.59 91.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.224 -0.922 . . . . 0.0 109.206 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -68.44 -44.54 74.71 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.116 -0.99 . . . . 0.0 109.326 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.526 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -62.8 -26.6 68.89 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.576 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -56.47 -52.45 64.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.015 -1.285 . . . . 0.0 107.863 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.57 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 9.25 58.05 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' B' ' 323' ' ' ALA . 23.5 t0 -67.75 -35.48 78.81 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 107.945 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.878 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.78 176.49 45.68 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 21.1 m 56.25 -26.05 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.463 1.125 . . . . 0.0 108.824 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.878 ' H ' ' C ' ' B' ' 326' ' ' GLY . 7.2 tpp85 -150.34 -3.32 0.36 Allowed 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.37 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.541 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 6.1 t80 -153.0 112.55 3.87 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.542 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 86.8 mt-30 -138.77 132.85 31.34 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.888 -1.125 . . . . 0.0 110.572 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 43.5 t -87.16 103.69 13.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.542 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 14.2 m0 -98.4 139.71 33.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.209 -0.932 . . . . 0.0 109.306 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.477 ' O ' ' CE ' ' B' ' 342' ' ' MET . 73.9 m-20 -94.32 142.11 27.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.891 -1.13 . . . . 0.0 109.052 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.485 ' CD2' HG23 ' B' ' 339' ' ' VAL . 3.7 p90 -157.71 -173.28 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 111.078 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.651 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -159.22 157.61 31.03 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.6 30.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -135.77 -1.14 3.08 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.648 ' O ' ' SD ' ' B' ' 342' ' ' MET . 23.0 pt-20 -154.29 10.37 0.38 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.235 . . . . 0.0 109.995 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' B' ' 342' ' ' MET . 1.9 p -51.03 -41.82 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.023 -1.048 . . . . 0.0 108.856 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.461 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 81.2 tt0 -61.37 -28.78 69.48 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.027 -1.045 . . . . 0.0 108.833 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.1 m -71.96 -48.12 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.412 -0.805 . . . . 0.0 110.468 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.665 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.76 -47.0 77.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 75.3 mt -62.62 -30.13 71.13 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.07 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 43.4 t0 -68.32 -39.55 81.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 109.995 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -70.47 -51.61 27.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.822 -1.173 . . . . 0.0 108.955 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . 0.63 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 65.3 t80 -57.88 -47.06 83.87 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.507 -0.746 . . . . 0.0 110.07 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.818 ' CG ' HD12 ' B' ' 351' ' ' LEU . 11.7 m-85 -74.83 -32.46 61.96 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.185 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 12.3 mm-40 -58.94 -26.28 64.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 105.245 -2.131 . . . . 0.0 105.245 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -70.51 -21.67 62.72 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.821 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -173.23 101.56 0.12 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.063 -1.023 . . . . 0.0 111.099 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.818 HD12 ' CG ' ' B' ' 347' ' ' PHE . 0.7 OUTLIER 175.17 57.54 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 177.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' B' ' 351' ' ' LEU . 90.7 Cg_endo -83.15 30.49 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 111.513 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 65.38 34.12 8.42 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.505 -0.747 . . . . 0.0 109.02 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp 50.02 40.74 22.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.158 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 9.7 t -51.14 169.7 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.07 65.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.844 . . . . 0.0 109.49 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 46.8 t 49.4 -166.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 82.9 p -136.8 158.61 44.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.838 . . . . 0.0 109.143 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 25.4 t -127.34 146.36 50.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.469 ' O ' ' N ' ' B' ' 362' ' ' SER . 10.1 m-70 -78.29 152.32 78.79 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -38.68 -25.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.41 2.073 . . . . 0.0 112.111 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 360' ' ' HIS . 73.1 m -72.5 160.42 32.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.449 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.23 153.63 39.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.55 147.4 30.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.4 t -140.22 145.6 37.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.365 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.32 176.6 37.76 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -103.29 140.75 36.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -1.107 . . . . 0.0 109.57 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -148.89 176.93 9.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.347 -0.846 . . . . 0.0 109.585 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -170.61 135.93 1.14 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.401 -0.812 . . . . 0.0 109.452 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' CYS . 61.2 Cg_endo -75.09 155.27 42.48 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.389 2.059 . . . . 0.0 112.141 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 9' ' ' PRO . 12.2 p -54.01 -175.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.112 -0.992 . . . . 0.0 108.508 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 69.4 m -111.17 152.63 26.82 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.109 -0.995 . . . . 0.0 108.739 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 HD22 ' A' ' 35' ' ' LEU . 9.0 t -140.09 136.94 38.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 122.086 0.946 . . . . 0.0 109.273 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.482 ' OH ' ' O ' ' A' ' 69' ' ' ASP . 7.3 t80 -115.58 111.03 20.06 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.574 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.14 124.47 42.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.324 -0.86 . . . . 0.0 109.087 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.416 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 13.3 m -99.81 143.2 30.31 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.194 -0.941 . . . . 0.0 109.034 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -144.68 157.09 27.15 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.556 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 5.3 m -81.0 119.82 24.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -1.051 . . . . 0.0 109.773 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.688 ' CG2' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -109.42 137.68 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.259 -0.9 . . . . 0.0 108.732 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 18' ' ' ILE . 47.2 ttt-85 83.12 10.88 0.52 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.56 -13.8 12.41 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 166.03 103.52 0.17 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -54.55 -25.67 27.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.063 -1.257 . . . . 0.0 109.635 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -53.03 -39.16 62.97 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -66.65 -28.99 68.91 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.597 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.91 -41.62 97.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.89 -50.46 70.79 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.23 -32.91 68.77 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.5 m-30 -69.41 -46.86 65.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.951 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.89 84.47 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.739 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.692 HH22 HH21 ' A' ' 34' ' ' ARG . 65.9 ttt-85 -69.46 -56.4 7.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.506 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.47 -48.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -58.1 -32.27 43.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 p -63.32 -43.32 98.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 109.7 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.692 HH21 HH22 ' A' ' 30' ' ' ARG . 82.3 mtt-85 -64.4 -40.3 95.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.154 . . . . 0.0 108.06 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 38' ' ' TYR . 85.4 mt -62.9 -43.08 99.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.83 -28.49 61.64 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -68.81 -59.88 2.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.709 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -125.49 152.38 45.04 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 176.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.8 64.29 1.62 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' C ' ' O ' ' A' ' 39' ' ' GLY . 10.4 ttpt -34.42 121.79 0.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.438 -1.037 . . . . 0.0 108.657 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.5 t -83.38 108.86 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.811 -1.181 . . . . 0.0 109.16 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 78.3 mt -72.17 -36.82 69.38 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.775 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.526 ' OG1' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -91.24 93.16 8.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.066 -1.021 . . . . 0.0 110.024 -179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.23 -23.74 19.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.51 -37.85 85.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.353 -0.842 . . . . 0.0 110.089 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.597 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 55.9 t -47.32 -73.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.098 -1.001 . . . . 0.0 109.68 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.18 -47.6 71.86 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.039 -1.038 . . . . 0.0 109.14 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.691 ' C ' HD11 ' A' ' 51' ' ' LEU . 26.3 t70 -72.35 45.26 0.13 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -122.79 -16.34 7.17 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.3 -8.28 17.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.858 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.04 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.11 130.08 34.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.224 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.544 ' O ' ' O ' ' A' ' 51' ' ' LEU . 5.7 mt-10 55.81 157.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.183 -0.948 . . . . 0.0 108.806 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' HH22 ' A' ' 22' ' ' ARG . 8.9 Cg_endo -52.77 112.03 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.286 1.991 . . . . 0.0 111.493 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -92.66 -3.79 54.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 110.233 -179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.617 ' N ' HD12 ' A' ' 54' ' ' LEU . . . -46.09 150.37 1.58 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' B' ' 318' ' ' ALA . 43.9 mt-10 -53.56 -35.49 60.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.062 -1.258 . . . . 0.0 109.117 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -66.31 -11.21 49.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . -57.17 176.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.287 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -47.03 164.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.26 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -43.31 150.96 0.46 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 154.87 -17.44 0.55 Allowed Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.85 -44.03 90.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.0 109.219 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -72.39 -55.45 7.04 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 0.8 OUTLIER -56.42 -29.31 61.42 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' GLY . 9.2 mt -69.85 -49.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.427 ' CE1' HD22 ' A' ' 70' ' ' LEU . 4.4 t-80 -64.73 -55.34 20.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.629 -0.669 . . . . 0.0 110.012 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 91.1 mt-10 -49.1 -54.91 13.98 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.967 -1.083 . . . . 0.0 110.206 -179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' N ' ' CD ' ' A' ' 68' ' ' GLN . 4.2 mp0 -71.77 -50.61 28.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.924 -1.11 . . . . 0.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.482 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.4 m-20 -61.43 -54.61 41.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 111.493 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.427 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -72.37 -39.15 68.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.709 -1.244 . . . . 0.0 111.202 -178.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 63.8 t-20 -58.48 -50.26 74.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.011 -1.68 . . . . 0.0 108.217 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.55 -38.77 81.97 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.2 tp -49.84 -39.79 40.09 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.54 -31.3 65.18 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.614 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -85.06 0.31 51.99 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.919 -1.113 . . . . 0.0 109.344 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.98 121.86 18.22 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.0 112.057 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' SER . 76.2 m-20 -68.47 -37.63 80.33 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 79.6 t -131.49 151.23 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.0 t -135.77 143.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.848 -1.157 . . . . 0.0 112.356 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 t -135.08 156.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 15' ' ' CYS . . . -162.99 123.38 2.32 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.364 -1.46 . . . . 0.0 110.749 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -83.09 116.46 22.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 116' ' ' LEU . 2.0 m -101.39 30.07 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 0.0 108.778 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 113' ' ' GLY . 25.9 m -62.13 -108.83 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.817 -0.552 . . . . 0.0 110.125 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 84' ' ' THR . 1.2 tm0? -41.02 126.57 2.03 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.502 -0.749 . . . . 0.0 110.221 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 78.2 Cg_exo -45.76 113.44 0.57 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.881 1.721 . . . . 0.0 111.645 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.615 ' O ' HD23 ' B' ' 288' ' ' LEU . 8.0 t -142.16 131.88 24.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.0 110.219 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.627 HD23 ' O ' ' B' ' 287' ' ' SER . 8.3 mt -79.71 -42.46 24.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.76 -37.29 89.78 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 t -74.37 -42.56 50.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -1.22 . . . . 0.0 108.817 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.02 -25.18 67.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -70.82 -56.51 6.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.79 -0.829 . . . . 0.0 109.308 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.416 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 96.1 mt-10 -60.18 -33.76 72.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.693 HD13 ' C ' ' A' ' 94' ' ' LEU . 3.2 tm? -70.75 -49.95 41.32 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.84 -51.17 57.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 HG11 ' B' ' 298' ' ' VAL . 56.0 ttt85 -56.16 -36.28 68.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.371 -1.076 . . . . 0.0 108.334 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -66.69 -38.58 87.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -54.4 -43.47 62.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 120.876 -1.14 . . . . 0.0 108.531 179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' B' ' 299' ' ' ALA . . . -74.71 -48.36 26.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.411 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.481 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.8 pp -119.5 -28.02 5.42 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.912 -1.117 . . . . 0.0 110.585 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -40.74 162.35 0.01 OUTLIER Glycine 0 C--N 1.29 -1.974 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.497 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 2.5 mmtp -98.38 -161.57 0.04 OUTLIER Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 71.8 Cg_exo -41.71 115.03 0.39 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 CA-C-N 121.354 1.519 . . . . 0.0 110.376 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 102' ' ' LYS . 3.3 mt -106.62 138.97 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 122.088 0.947 . . . . 0.0 112.188 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.437 HD11 ' CD2' ' A' ' 132' ' ' TRP . 50.8 tp -126.5 118.1 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER -102.63 157.27 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.924 -1.11 . . . . 0.0 109.411 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 134' ' ' TYR . 5.7 mt -143.12 127.75 18.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.894 . . . . 0.0 110.534 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -138.78 145.05 39.69 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.208 -0.933 . . . . 0.0 108.966 178.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.522 ' NH1' ' OH ' ' A' ' 134' ' ' TYR . 24.2 ptt-85 -128.67 148.12 67.14 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.52 29.46 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.58 2.186 . . . . 0.0 112.507 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 50.6 mt-30 -104.79 -44.01 4.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -0.946 . . . . 0.0 110.06 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m -129.69 -22.62 2.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 108.676 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.705 ' O ' ' O ' ' A' ' 114' ' ' ARG . . . -87.03 -52.03 3.21 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.705 ' O ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER 39.59 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 114' ' ' ARG . 96.6 t 61.78 93.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.887 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.5 pt? -70.03 -43.56 71.05 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.788 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER 163.05 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.877 -1.139 . . . . 0.0 110.303 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' HB2' ' HG2' ' B' ' 256' ' ' GLU . . . -63.91 -46.12 86.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.818 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 80.4 mmm -62.22 -46.53 88.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.246 -0.909 . . . . 0.0 109.505 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.425 ' CD1' HD12 ' A' ' 94' ' ' LEU . 3.8 mm -61.1 -41.86 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -44.57 95.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.528 -0.732 . . . . 0.0 109.921 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.21 -33.96 88.66 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -56.3 -22.16 28.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.274 -1.133 . . . . 0.0 108.659 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -36.45 109.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.276 0.56 . . . . 0.0 110.084 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' OD2' ' OG ' ' A' ' 127' ' ' SER . 55.0 t0 -105.73 -29.41 10.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.38 77.02 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 80.0 p -122.24 -78.97 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -1.066 . . . . 0.0 109.15 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' N ' ' OG ' ' A' ' 127' ' ' SER . 46.6 ttp180 -97.92 -5.08 35.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.0 108.885 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -137.27 125.34 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.449 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 57.0 mt-30 -138.35 149.94 46.1 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.051 -1.03 . . . . 0.0 111.215 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -118.25 107.22 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.437 ' CD2' HD11 ' A' ' 105' ' ' LEU . 20.3 m0 -106.14 145.23 31.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.128 -0.983 . . . . 0.0 109.984 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.531 ' O ' ' CE ' ' A' ' 142' ' ' MET . 57.7 p-10 -100.97 161.07 13.85 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.649 ' CD2' ' N ' ' A' ' 135' ' ' ALA . 8.0 p90 -172.67 -167.88 0.47 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.807 -1.183 . . . . 0.0 110.7 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.963 ' O ' ' O ' ' A' ' 137' ' ' GLY . . . -131.34 149.95 52.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.714 ' C ' ' O ' ' A' ' 135' ' ' ALA . 72.2 mt-10 -32.29 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.963 ' O ' ' O ' ' A' ' 135' ' ' ALA . . . -95.54 -176.45 37.14 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.92 -13.11 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.057 -1.261 . . . . 0.0 108.864 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.7 ' H ' ' C ' ' A' ' 137' ' ' GLY . 1.3 p -59.19 -46.88 91.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.541 ' OE1' ' NH2' ' A' ' 34' ' ' ARG . 23.3 pt-20 -53.37 -33.58 54.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.7 m -68.31 -40.84 81.56 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.395 -0.816 . . . . 0.0 108.884 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.531 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 8.2 mmt -52.49 -48.04 66.2 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.0 -38.59 91.62 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -64.44 -40.46 95.79 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.4 -0.813 . . . . 0.0 110.731 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -70.05 -49.87 46.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.488 -1.382 . . . . 0.0 108.796 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.84 -48.72 80.55 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.49 ' HB3' HD12 ' A' ' 151' ' ' LEU . 19.4 m-85 -70.45 -32.95 70.72 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.236 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -61.19 -31.14 70.9 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.13 12.21 5.44 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 152' ' ' PRO . 2.5 t80 -138.1 -104.29 0.18 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.323 -177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.492 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 12.1 mt -33.5 90.69 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.844 -0.535 . . . . 0.0 110.841 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' N ' ' O ' ' A' ' 150' ' ' TYR . 83.6 Cg_endo -95.33 -83.82 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 123.217 2.612 . . . . 0.0 111.477 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -82.58 -22.93 34.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -53.04 -36.22 60.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.297 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 94.1 m -58.6 -40.74 84.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -84.7 -48.7 9.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.503 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.7 t -156.73 140.94 16.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -0.963 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.9 m -74.43 163.93 27.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.359 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -64.82 153.98 38.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.44 ' O ' ' N ' ' A' ' 162' ' ' SER . 47.4 m80 -58.47 152.57 43.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.284 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -42.82 -19.81 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.351 2.034 . . . . 0.0 112.094 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 160' ' ' HIS . 15.0 t -54.14 -30.94 50.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.305 -0.872 . . . . 0.0 109.481 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.615 179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.2 37.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.97 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.09 30.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.8 t -139.07 145.24 39.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -70.61 176.49 35.5 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -103.41 140.81 36.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 0.0 109.394 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -149.11 176.86 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -170.7 135.93 1.11 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.49 -0.756 . . . . 0.0 109.498 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.42 ' O ' ' O ' ' B' ' 210' ' ' CYS . 61.1 Cg_endo -75.09 155.01 42.46 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.46 2.107 . . . . 0.0 112.18 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' B' ' 209' ' ' PRO . 10.2 p -53.85 -175.2 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.173 -0.955 . . . . 0.0 108.467 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' B' ' 277' ' ' ASP . 62.9 m -111.17 152.82 26.6 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.157 -0.965 . . . . 0.0 108.714 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.549 HG11 HD22 ' B' ' 235' ' ' LEU . 8.9 t -140.33 136.86 37.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 122.04 0.924 . . . . 0.0 109.21 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 269' ' ' ASP . 7.2 t80 -115.51 110.95 19.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.592 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.04 124.2 42.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.036 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.425 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 12.2 m -99.73 142.62 30.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.046 -1.034 . . . . 0.0 109.071 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -144.18 157.17 27.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.552 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 5.7 m -80.78 119.96 24.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.437 -1.037 . . . . 0.0 109.795 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.686 ' CG2' HD22 ' B' ' 254' ' ' LEU . 0.4 OUTLIER -109.41 138.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' B' ' 218' ' ' ILE . 47.3 ttt-85 82.85 10.66 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.661 -0.649 . . . . 0.0 109.487 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -111.87 -13.5 12.43 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 166.21 103.54 0.17 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' B' ' 222' ' ' ARG . 0.0 OUTLIER -54.65 -25.6 27.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -1.213 . . . . 0.0 109.538 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -53.09 -39.14 63.14 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 79.4 m-20 -66.7 -29.01 68.9 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 0.3 OUTLIER -63.93 -41.81 97.52 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.16 72.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.28 -33.17 69.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.654 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.5 m-30 -69.26 -46.47 67.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.461 -0.774 . . . . 0.0 110.074 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.87 85.38 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.766 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.725 HH22 HH21 ' B' ' 234' ' ' ARG . 65.8 ttt-85 -69.37 -56.19 8.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 108.535 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.2 mt -52.86 -48.18 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.654 HG23 ' O ' ' B' ' 228' ' ' TYR . 56.1 t -58.2 -32.22 43.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 18.1 p -63.29 -43.58 97.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.337 -0.852 . . . . 0.0 109.597 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.725 HH21 HH22 ' B' ' 230' ' ' ARG . 83.6 mtt-85 -64.23 -40.5 96.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.867 -1.145 . . . . 0.0 108.008 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.712 ' O ' ' O ' ' B' ' 238' ' ' TYR . 87.0 mt -62.65 -42.96 99.89 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -56.93 -28.3 61.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 108.75 178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -69.04 -59.87 2.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.712 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.9 OUTLIER -125.32 152.32 44.87 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 176.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.58 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 84.03 64.16 1.62 Allowed Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' B' ' 239' ' ' GLY . 10.6 ttpt -34.2 121.9 0.48 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -1.085 . . . . 0.0 108.584 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.67 109.53 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.793 -1.192 . . . . 0.0 109.102 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 78.1 mt -72.6 -37.64 68.07 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.677 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.53 ' OG1' HG23 ' B' ' 246' ' ' VAL . 0.1 OUTLIER -90.47 92.86 9.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 109.957 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -91.89 -23.7 19.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.32 -0.862 . . . . 0.0 109.158 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -61.94 -37.77 85.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 110.128 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.59 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 55.8 t -46.86 -73.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 0.0 109.658 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -53.83 -48.08 70.29 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.117 -0.989 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.684 ' C ' HD11 ' B' ' 251' ' ' LEU . 26.2 t70 -72.26 45.48 0.13 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -122.82 -16.57 7.09 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -8.32 15.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.184 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.984 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -84.3 130.41 34.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.088 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' B' ' 251' ' ' LEU . 6.0 mt-10 55.55 157.97 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.039 -1.038 . . . . 0.0 108.861 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.446 ' HA ' HH22 ' B' ' 222' ' ' ARG . 8.6 Cg_endo -52.7 112.37 0.88 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.224 1.95 . . . . 0.0 111.437 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.686 HD22 ' CG2' ' B' ' 218' ' ' ILE . 0.3 OUTLIER -92.87 -3.97 53.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.608 ' N ' HD12 ' B' ' 254' ' ' LEU . . . -45.84 150.2 1.48 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 118' ' ' ALA . 44.2 mt-10 -53.43 -35.89 60.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -1.205 . . . . 0.0 108.983 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -65.99 -11.14 45.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.0 108.843 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 255' ' ' GLY . . . -57.51 175.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 109.177 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' B' ' 260' ' ' GLY . . . -46.97 165.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.229 -0.92 . . . . 0.0 109.326 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' B' ' 259' ' ' ALA . . . -43.36 151.5 0.42 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 154.25 -17.53 0.61 Allowed Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -59.07 -44.24 91.85 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.116 -1.226 . . . . 0.0 109.265 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -72.32 -55.26 7.42 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 0.9 OUTLIER -56.39 -29.27 61.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' B' ' 261' ' ' GLY . 8.5 mt -69.87 -49.23 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.429 ' CE1' HD22 ' B' ' 270' ' ' LEU . 3.9 t-80 -65.27 -55.15 19.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.662 -0.649 . . . . 0.0 110.001 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 90.9 mt-10 -49.01 -54.55 15.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.106 -0.996 . . . . 0.0 110.224 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 4.8 mp0 -72.06 -50.8 25.33 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.923 -1.111 . . . . 0.0 111.038 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.469 ' O ' ' OH ' ' B' ' 213' ' ' TYR . 1.6 m-20 -61.2 -54.79 39.85 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.167 -0.958 . . . . 0.0 111.457 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.429 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.5 OUTLIER -72.43 -38.79 68.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.766 -1.209 . . . . 0.0 111.323 -178.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 64.7 t-20 -58.74 -50.02 75.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 119.955 -1.715 . . . . 0.0 108.155 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.408 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -59.8 -38.9 83.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.436 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.4 tp -49.64 -39.47 36.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.402 ' OE1' ' NH2' ' B' ' 296' ' ' ARG . 15.2 mt-30 -72.84 -31.22 64.62 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.533 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -85.24 0.2 52.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.945 -1.097 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.97 121.95 18.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.318 -0.864 . . . . 0.0 112.091 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.482 ' H ' ' HB2' ' B' ' 211' ' ' SER . 79.3 m-20 -68.56 -37.65 80.09 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 77.7 t -131.34 151.45 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 86.9 t -136.16 143.6 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-O 122.564 1.173 . . . . 0.0 112.226 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 27.8 t -135.11 156.35 39.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -163.06 122.72 2.2 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.434 -1.416 . . . . 0.0 110.81 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -82.29 116.23 21.71 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.476 HG21 HD12 ' B' ' 316' ' ' LEU . 1.9 m -101.24 29.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.036 -1.04 . . . . 0.0 108.778 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.595 HG22 ' N ' ' B' ' 313' ' ' GLY . 25.3 m -61.86 -109.37 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.728 -0.607 . . . . 0.0 110.169 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.41 ' NE2' ' O ' ' B' ' 286' ' ' PRO . 1.2 tm0? -40.63 126.76 1.87 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.407 -0.808 . . . . 0.0 110.181 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.41 ' O ' ' NE2' ' B' ' 285' ' ' GLN . 76.6 Cg_exo -45.61 113.7 0.61 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.933 1.755 . . . . 0.0 111.595 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.627 ' O ' HD23 ' A' ' 88' ' ' LEU . 8.1 t -142.64 131.66 23.08 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.121 -0.987 . . . . 0.0 110.251 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 87' ' ' SER . 8.3 mt -79.68 -42.6 24.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.365 -0.834 . . . . 0.0 109.304 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -58.57 -37.52 89.07 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 8.2 t -74.2 -42.28 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -1.156 . . . . 0.0 108.809 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -63.49 -24.98 68.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -70.81 -56.42 6.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.707 -0.878 . . . . 0.0 109.248 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.425 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 95.7 mt-10 -60.19 -33.68 72.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.677 HD13 ' C ' ' B' ' 294' ' ' LEU . 3.3 tm? -70.77 -49.73 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.99 -51.5 54.98 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.41 HH11 HG11 ' A' ' 98' ' ' VAL . 56.1 ttt85 -55.96 -36.4 67.76 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.357 -1.084 . . . . 0.0 108.394 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -66.55 -38.78 87.85 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.463 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.4 OUTLIER -54.19 -43.46 60.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 O-C-N 120.862 -1.149 . . . . 0.0 108.565 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 99' ' ' ALA . . . -74.55 -48.8 24.71 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 112.387 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.7 pp -119.06 -27.95 5.61 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.974 -1.079 . . . . 0.0 110.747 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' B' ' 300' ' ' LEU . . . -40.8 162.19 0.01 OUTLIER Glycine 0 C--N 1.289 -2.044 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.49 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 2.8 mmtp -98.23 -161.54 0.04 OUTLIER Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 75.9 Cg_exo -41.89 115.41 0.45 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 121.458 1.557 . . . . 0.0 110.329 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . . . . . . . . . 3.4 mt -106.85 138.96 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.195 0.998 . . . . 0.0 112.147 -176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' B' ' 332' ' ' TRP . 50.9 tp -126.47 118.25 24.55 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.8 157.41 16.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.899 -1.126 . . . . 0.0 109.457 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' B' ' 334' ' ' TYR . 5.9 mt -143.02 128.0 18.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.455 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.41 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -139.33 144.7 38.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.139 -0.976 . . . . 0.0 108.865 178.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.54 ' NH1' ' OH ' ' B' ' 334' ' ' TYR . 24.9 ptt-85 -128.65 148.09 66.96 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.464 -0.772 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.42 29.46 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.613 2.208 . . . . 0.0 112.566 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.544 ' O ' ' NH1' ' B' ' 314' ' ' ARG . 51.3 mt-30 -104.62 -43.77 5.05 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.199 -0.938 . . . . 0.0 109.976 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 22.6 m -129.73 -23.24 2.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.182 -0.949 . . . . 0.0 108.6 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.707 ' O ' ' O ' ' B' ' 314' ' ' ARG . . . -86.44 -51.87 3.37 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.707 ' O ' ' O ' ' B' ' 313' ' ' GLY . 0.1 OUTLIER 39.47 101.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . . . . . . . . . 96.6 t 61.97 93.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.897 ' H ' HD23 ' B' ' 316' ' ' LEU . 1.5 pt? -70.45 -43.84 69.02 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.739 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.3 OUTLIER 163.35 134.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.96 -1.088 . . . . 0.0 110.176 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . . . -64.1 -45.57 88.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.442 -0.786 . . . . 0.0 109.798 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 80.2 mmm -62.52 -46.9 86.3 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.36 -0.838 . . . . 0.0 109.371 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.411 ' CD1' HD12 ' B' ' 294' ' ' LEU . 3.8 mm -60.69 -41.88 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -44.39 96.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.748 . . . . 0.0 109.931 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -63.66 -33.58 87.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -56.7 -22.11 32.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -1.15 . . . . 0.0 108.605 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -36.44 109.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.21 0.529 . . . . 0.0 110.043 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -105.94 -29.46 9.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 76.12 3.7 76.35 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 68.1 p -121.49 -79.08 0.6 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.472 -1.017 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -97.89 -4.93 35.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.855 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.404 ' HE1' HD11 ' B' ' 294' ' ' LEU . 85.6 t80 -137.37 125.24 22.61 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.13 149.77 46.22 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.0 111.12 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.04 106.93 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.436 ' CD2' HD11 ' B' ' 305' ' ' LEU . 20.4 m0 -106.21 145.11 31.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.111 -0.993 . . . . 0.0 110.103 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.54 ' O ' ' CE ' ' B' ' 342' ' ' MET . 57.1 p-10 -100.68 160.83 14.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.983 -1.073 . . . . 0.0 108.186 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.641 ' CD2' ' N ' ' B' ' 335' ' ' ALA . 8.0 p90 -172.41 -167.89 0.49 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.744 -1.182 . . . . 0.0 110.735 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.962 ' O ' ' O ' ' B' ' 337' ' ' GLY . . . -131.47 149.49 52.51 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.76 ' C ' ' O ' ' B' ' 335' ' ' ALA . 71.1 mt-10 -31.94 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.962 ' O ' ' O ' ' B' ' 335' ' ' ALA . . . -95.36 -176.71 37.42 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 107.592 -2.203 . . . . 0.0 107.592 175.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.97 -13.06 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.93 -1.335 . . . . 0.0 108.908 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.713 ' H ' ' C ' ' B' ' 337' ' ' GLY . 1.3 p -59.12 -46.97 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.55 ' OE1' ' NH2' ' B' ' 234' ' ' ARG . 22.7 pt-20 -53.21 -33.78 54.26 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 17.9 m -68.16 -40.7 82.27 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.955 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.54 ' CE ' ' O ' ' B' ' 333' ' ' ASP . 7.9 mmt -52.86 -47.91 67.47 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.599 -0.841 . . . . 0.0 108.824 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -64.44 -40.36 95.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.42 -0.8 . . . . 0.0 110.73 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -70.11 -49.71 48.09 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.422 -1.423 . . . . 0.0 108.756 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.25 -48.65 80.83 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 109.961 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.494 ' HB3' HD12 ' B' ' 351' ' ' LEU . 19.7 m-85 -70.41 -32.51 70.17 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.144 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -61.59 -30.95 71.01 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.24 12.25 5.53 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.5 t80 -138.04 -104.44 0.18 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.283 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' B' ' 347' ' ' PHE . 12.0 mt -33.53 90.77 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.915 -0.491 . . . . 0.0 110.815 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.526 ' N ' ' O ' ' B' ' 350' ' ' TYR . 78.8 Cg_endo -95.46 -83.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 123.27 2.647 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.33 -23.34 35.15 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -52.78 -36.33 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 93.9 m -58.34 -40.87 83.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.586 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -84.72 -48.88 8.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.923 . . . . 0.0 109.473 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 23.5 t -156.38 141.53 17.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.554 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 31.5 m -75.16 162.79 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 44.2 t -63.79 153.47 36.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.347 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' B' ' 362' ' ' SER . 49.0 m80 -57.91 152.86 36.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.394 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.62 -19.77 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.373 2.049 . . . . 0.0 112.089 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.445 ' N ' ' O ' ' B' ' 360' ' ' HIS . 12.5 t -53.86 -30.57 46.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.216 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.03 -0.985 . . . . 0.0 109.34 179.792 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.74 -35.06 72.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -0.857 . . . . 0.0 109.49 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.58 -33.77 74.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.91 . . . . 0.0 109.226 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 p -78.94 154.39 29.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.288 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.38 43.07 2.67 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -96.91 131.02 44.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -1.128 . . . . 0.0 109.56 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -143.93 178.06 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.561 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.07 151.7 78.34 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.434 -0.791 . . . . 0.0 109.029 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.02 -155.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.533 2.155 . . . . 0.0 111.459 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -102.07 -175.61 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.5 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 11.2 p -120.35 154.39 35.12 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.717 HG11 HD22 ' A' ' 35' ' ' LEU . 7.2 t -133.58 135.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.659 0.742 . . . . 0.0 109.006 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' HB3' HG22 ' A' ' 79' ' ' VAL . 8.1 t80 -118.15 95.39 4.87 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -83.2 104.73 13.6 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -95.03 170.43 9.42 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.061 0.934 . . . . 0.0 111.417 -176.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.678 ' HA2' HG22 ' A' ' 90' ' ' VAL . . . 84.3 93.05 0.72 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' CE2' ' A' ' 28' ' ' TYR . 2.7 p -168.39 -177.29 3.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.014 -1.286 . . . . 0.0 109.746 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.75 ' C ' ' H ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER 37.2 -160.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.592 -0.693 . . . . 0.0 109.922 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 1.3 tpm_? 62.43 -16.93 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.75 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . 166.03 108.97 0.21 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.76 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 159.94 -58.71 0.32 Allowed Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.985 -1.303 . . . . 0.0 110.072 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 25' ' ' GLN . 9.3 mmt85 49.43 -73.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.327 -1.102 . . . . 0.0 109.266 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.76 ' N ' ' O ' ' A' ' 21' ' ' GLY . 94.6 mt-10 -54.08 -35.22 61.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 28' ' ' TYR . 4.6 t0 -65.99 -27.75 68.37 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.931 HE22 HD21 ' A' ' 54' ' ' LEU . 35.3 tt0 -57.9 -45.55 86.29 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.46 94.15 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tp -63.65 -30.22 71.35 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.679 ' O ' HG23 ' A' ' 32' ' ' VAL . 22.7 m-30 -70.77 -49.77 43.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.48 -0.762 . . . . 0.0 110.089 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.87 -32.32 72.68 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.426 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -71.43 -58.15 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.918 -1.113 . . . . 0.0 108.291 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.7 mt -52.85 -44.76 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.802 HG13 HG11 ' A' ' 41' ' ' VAL . 55.4 t -61.07 -28.84 44.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.3 t -70.82 -35.09 72.34 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.412 -0.805 . . . . 0.0 109.388 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.422 ' HA ' HH11 ' A' ' 37' ' ' ARG . 68.1 mtp85 -73.89 -50.28 20.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.815 -1.178 . . . . 0.0 108.694 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.717 HD22 HG11 ' A' ' 12' ' ' VAL . 13.4 mt -59.64 -40.09 86.51 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -64.95 -23.0 67.09 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.422 HH11 ' HA ' ' A' ' 34' ' ' ARG . 26.0 mtt85 -77.88 -34.6 51.53 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.058 -1.026 . . . . 0.0 108.974 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.9 m-30 -73.32 -51.09 18.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.503 -0.748 . . . . 0.0 110.082 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -145.11 -144.99 4.22 Favored Glycine 0 N--CA 1.478 1.457 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -98.95 135.59 40.15 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.178 -1.189 . . . . 0.0 108.669 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.802 HG11 HG13 ' A' ' 32' ' ' VAL . 12.4 t -100.11 122.19 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 12.2 mt -87.36 -17.05 33.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.295 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.426 HG22 ' CG2' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -86.22 43.23 1.04 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.402 -0.811 . . . . 0.0 109.513 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -66.34 -38.67 88.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 109.923 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.493 ' C ' ' ND1' ' A' ' 45' ' ' HIS . 6.5 t-80 -53.94 -46.97 71.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 0.0 109.877 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG11 ' CZ ' ' A' ' 14' ' ' PHE . 5.3 t -48.34 -49.31 13.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.315 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.3 -40.74 62.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.144 -0.973 . . . . 0.0 108.54 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' O ' HD22 ' A' ' 51' ' ' LEU . 2.7 t0 -75.07 50.89 0.49 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.686 ' HB3' HE21 ' A' ' 25' ' ' GLN . . . -126.21 -30.69 2.89 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.746 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -55.08 -5.33 0.1 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.676 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -49.49 -55.99 11.36 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 1.8 tm-20 -179.67 -44.73 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.418 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' O ' HD22 ' A' ' 54' ' ' LEU . 13.2 Cg_exo -69.31 92.22 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.686 2.257 . . . . 0.0 112.467 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.931 HD21 HE22 ' A' ' 25' ' ' GLN . 4.0 mm? -125.21 178.93 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.406 -0.809 . . . . 0.0 109.549 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 68.19 35.73 83.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' ALA . 69.3 mm-40 47.46 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.531 -0.982 . . . . 0.0 109.197 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 47.92 13.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.04 -1.037 . . . . 0.0 108.65 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 56' ' ' GLU . . . -139.64 96.64 3.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.48 -0.763 . . . . 0.0 109.016 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' A' ' 65' ' ' ILE . . . -172.72 -30.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.371 -0.83 . . . . 0.0 109.233 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.16 17.12 21.29 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 62' ' ' ASP . . . 152.23 76.83 0.02 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 23.8 p-10 -48.69 -44.29 37.78 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.497 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 89.6 mt-30 -57.42 -45.13 84.95 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -60.63 -41.58 95.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.506 HD12 ' CB ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -58.04 -39.06 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.463 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.8 t-80 -76.14 -51.02 13.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.63 -0.669 . . . . 0.0 110.38 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 97.0 mt-10 -46.68 -53.69 11.17 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.071 -1.018 . . . . 0.0 109.825 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.85 -42.63 66.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.156 -0.965 . . . . 0.0 110.91 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -64.71 -57.44 8.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.965 -1.084 . . . . 0.0 111.143 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.66 -39.6 84.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.097 -1.002 . . . . 0.0 110.792 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 28.5 t-20 -60.97 -52.94 62.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.591 -1.318 . . . . 0.0 108.958 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -59.69 -40.84 89.21 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 108.703 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 7.6 tp -50.07 -37.7 34.85 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' NZ ' ' A' ' 102' ' ' LYS . 51.4 mt-30 -74.44 -29.43 61.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.715 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 18.0 mt-30 -90.2 3.87 52.22 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.83 -1.169 . . . . 0.0 109.284 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.01 130.08 40.08 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.899 . . . . 0.0 112.27 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 11' ' ' SER . 85.1 m-20 -78.09 -34.9 49.91 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.0 t -133.25 144.24 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 13' ' ' TYR . 91.9 t -136.08 129.06 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.917 -1.115 . . . . 0.0 111.205 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.874 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 70.1 t -129.03 124.85 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.904 -1.146 . . . . 0.0 107.904 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.767 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -121.39 156.13 33.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.307 -1.496 . . . . 0.0 110.24 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -99.82 122.66 43.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.32 33.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 109' ' ' ARG . 4.2 m -88.87 -73.54 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.741 -0.6 . . . . 0.0 109.756 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.77 120.48 81.5 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 109.798 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.41 141.84 89.28 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.236 1.957 . . . . 0.0 112.202 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.92 ' OG ' HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -179.49 141.22 0.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 110.019 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 92' ' ' TYR . 19.7 mt -62.45 -43.21 99.36 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.458 -0.776 . . . . 0.0 109.044 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' B' ' 317' ' ' SER . . . -54.48 -38.52 63.13 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.458 -1.857 . . . . 0.0 108.458 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.92 HG23 ' OG ' ' A' ' 87' ' ' SER . 44.6 t -68.07 -53.07 32.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.512 -0.993 . . . . 0.0 108.676 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.37 -28.41 73.7 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.509 ' OH ' ' HB2' ' B' ' 323' ' ' ALA . 51.3 t80 -70.72 -55.09 9.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -1.092 . . . . 0.0 109.633 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CG ' ' SD ' ' B' ' 319' ' ' MET . 77.4 mt-10 -62.15 -34.15 75.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.356 -0.84 . . . . 0.0 109.253 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 81' ' ' ALA . 21.1 mt -70.22 -48.55 56.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.253 -0.905 . . . . 0.0 109.195 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.56 -40.24 96.07 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -61.92 -40.47 95.59 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.519 -0.989 . . . . 0.0 109.299 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -69.53 -41.21 76.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.09 -1.006 . . . . 0.0 108.982 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.78 -39.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -77.64 -51.14 11.11 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 45.7 mt -65.68 -6.18 10.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.973 -1.079 . . . . 0.0 108.722 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.6 26.0 30.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.521 ' O ' HG13 ' A' ' 104' ' ' ILE . 43.9 mttp -84.38 147.54 50.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.906 -1.35 . . . . 0.0 107.644 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -38.53 116.52 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.756 1.637 . . . . 0.0 110.896 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 102' ' ' LYS . 3.6 mt -115.95 98.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.271 -0.893 . . . . 0.0 111.602 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HB3' HG22 ' A' ' 80' ' ' VAL . 59.1 tp -94.69 120.64 35.24 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.28 131.22 55.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.885 -1.134 . . . . 0.0 108.838 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 3.5 mt -123.15 130.19 52.43 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.253 -0.904 . . . . 0.0 111.502 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -131.12 151.07 51.82 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.569 ' H ' HG23 ' A' ' 84' ' ' THR . 49.9 mtm180 -114.23 136.02 22.22 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.115 -0.99 . . . . 0.0 110.219 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -29.97 3.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.355 2.037 . . . . 0.0 111.286 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.524 ' CG ' ' N ' ' A' ' 112' ' ' SER . 12.2 pt20 -59.7 -46.36 89.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.503 -0.748 . . . . 0.0 109.354 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 111' ' ' GLN . 17.2 t -75.85 -22.18 56.49 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' O ' ' NE ' ' A' ' 114' ' ' ARG . . . 55.93 111.0 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.601 ' O ' ' C ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -144.6 -7.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -1.017 . . . . 0.0 110.259 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' A' ' 114' ' ' ARG . 94.7 t 32.85 90.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.978 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -61.13 172.31 1.07 Allowed 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.81 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 289' ' ' GLY . 29.3 t -64.95 141.36 58.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 111.721 -177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.62 -33.18 63.76 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.529 ' SD ' ' CG ' ' B' ' 293' ' ' GLU . 1.7 mtp -63.94 -43.51 95.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.542 -0.724 . . . . 0.0 109.317 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' B' ' 292' ' ' TYR . 4.1 mm -61.87 -45.48 98.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.497 -0.752 . . . . 0.0 109.418 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -64.43 -44.8 90.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.351 -0.843 . . . . 0.0 109.339 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.49 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -58.55 -32.1 68.27 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 125' ' ' ASP . . . -51.7 -57.33 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -1.187 . . . . 0.0 108.265 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . 10.38 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 123' ' ' ALA . 2.2 m-20 -68.97 -35.36 76.64 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.747 -1.221 . . . . 0.0 107.757 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.817 ' C ' ' H ' ' A' ' 128' ' ' ARG . . . 77.41 174.04 40.61 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.4 t 60.56 -30.76 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.668 1.223 . . . . 0.0 108.573 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.817 ' H ' ' C ' ' A' ' 126' ' ' GLY . 8.7 mtm180 -147.33 0.95 0.71 Allowed 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.539 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' N ' ' A' ' 126' ' ' GLY . 11.3 t80 -156.94 112.9 2.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.521 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 90.5 mt-30 -139.29 142.8 37.7 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.398 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.51 98.86 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.521 ' HE1' ' CB ' ' A' ' 130' ' ' GLN . 18.1 m0 -94.66 147.29 23.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.345 -0.847 . . . . 0.0 109.521 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' O ' ' HE1' ' A' ' 142' ' ' MET . 67.6 m-20 -100.27 150.64 22.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 7.8 p90 -170.95 177.58 3.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.642 -1.286 . . . . 0.0 111.548 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -141.99 146.83 36.03 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.0 mt-10 -39.41 -25.56 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.748 -1.22 . . . . 0.0 110.474 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -86.32 -2.37 85.42 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.109 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -135.93 0.19 2.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.813 -1.404 . . . . 0.0 110.231 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -55.21 -47.04 78.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.851 -1.156 . . . . 0.0 108.476 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 29.6 mt-10 -53.16 -33.17 51.41 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.7 m -69.56 -40.91 76.52 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.507 -0.746 . . . . 0.0 109.25 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.467 ' HE1' ' O ' ' A' ' 133' ' ' ASP . 12.9 mmt -53.16 -51.78 60.9 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 48.8 mt -62.05 -32.48 73.0 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -65.72 -43.91 87.62 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 -71.98 -47.74 49.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.534 -1.354 . . . . 0.0 109.149 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -60.44 -48.96 79.49 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 21.3 m-85 -71.37 -28.86 64.34 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.159 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -66.05 -31.14 71.85 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.07 9.57 10.03 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.531 ' HB3' ' H ' ' A' ' 151' ' ' LEU . 2.5 t80 -134.85 -104.49 0.23 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.237 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.531 ' H ' ' HB3' ' A' ' 150' ' ' TYR . 22.6 mt -32.42 90.84 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.91 -0.494 . . . . 0.0 110.925 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.516 ' N ' ' O ' ' A' ' 150' ' ' TYR . 71.5 Cg_endo -93.31 -72.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.067 2.511 . . . . 0.0 111.248 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -96.94 -18.88 19.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -59.95 -29.69 68.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 109.067 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 156' ' ' ALA . 55.2 m -64.52 157.85 25.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.165 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.468 ' HB1' ' OG ' ' A' ' 159' ' ' SER . . . -42.85 103.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.217 -0.927 . . . . 0.0 109.649 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 159' ' ' SER . 8.7 t -99.82 147.79 25.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 m 51.18 12.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.468 ' OG ' ' HB1' ' A' ' 156' ' ' ALA . 85.1 p -82.79 161.15 22.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.547 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -129.39 79.21 74.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 109.286 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.86 -23.66 60.34 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.687 2.258 . . . . 0.0 112.142 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 40.3 t -98.02 142.39 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -0.859 . . . . 0.0 109.532 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.522 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.25 72.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -61.29 -33.94 74.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -0.96 . . . . 0.0 109.217 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 7.4 p -78.64 154.12 30.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.31 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -92.13 43.24 2.69 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -96.97 131.38 43.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -1.147 . . . . 0.0 109.524 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -144.12 177.27 8.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -132.31 151.37 78.19 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.55 -0.719 . . . . 0.0 109.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.62 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 111.34 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 32.1 p -102.21 -175.61 2.88 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.9 p -120.36 154.0 35.68 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.722 HG11 HD22 ' B' ' 235' ' ' LEU . 6.8 t -133.41 135.37 56.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.7 0.762 . . . . 0.0 109.034 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' B' ' 279' ' ' VAL . 7.9 t80 -118.01 95.76 5.05 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.868 ' HA ' ' O ' ' B' ' 280' ' ' VAL . 0.0 OUTLIER -83.36 104.94 13.9 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.1 OUTLIER -95.28 170.23 9.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.078 0.942 . . . . 0.0 111.49 -176.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.682 ' HA2' HG22 ' B' ' 290' ' ' VAL . . . 84.37 93.51 0.71 Allowed Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.574 ' CB ' ' CE2' ' B' ' 228' ' ' TYR . 2.6 p -168.52 -176.85 2.94 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.175 -1.191 . . . . 0.0 109.614 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.754 ' C ' ' H ' ' B' ' 220' ' ' GLY . 0.0 OUTLIER 36.89 -160.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.777 -0.577 . . . . 0.0 109.888 -179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.404 ' HE ' ' HG3' ' B' ' 256' ' ' GLU . 1.2 tpm_? 62.61 -17.08 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.754 ' H ' ' C ' ' B' ' 218' ' ' ILE . . . 166.18 109.04 0.21 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.757 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 159.91 -59.0 0.32 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.559 -1.305 . . . . 0.0 110.1 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' B' ' 225' ' ' GLN . 9.4 mmt85 49.77 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.324 -1.104 . . . . 0.0 109.093 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.757 ' N ' ' O ' ' B' ' 221' ' ' GLY . 95.2 mt-10 -54.05 -34.9 61.25 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.548 ' OD1' ' CE1' ' B' ' 228' ' ' TYR . 4.5 t0 -66.26 -27.61 68.08 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.938 HE22 HD21 ' B' ' 254' ' ' LEU . 35.5 tt0 -58.15 -45.21 87.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.64 -43.28 94.18 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 2.9 tp -64.07 -29.68 70.8 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.677 ' O ' HG23 ' B' ' 232' ' ' VAL . 22.7 m-30 -71.11 -49.62 42.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.39 -0.818 . . . . 0.0 109.98 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.25 -32.04 72.67 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 118.478 -1.289 . . . . 0.0 108.44 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -71.71 -57.9 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.882 -1.136 . . . . 0.0 108.283 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 9.5 mt -53.09 -44.89 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.822 HG13 HG11 ' B' ' 241' ' ' VAL . 55.7 t -60.99 -28.74 44.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' B' ' 237' ' ' ARG . 7.1 t -70.94 -34.91 71.95 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.394 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.412 ' HA ' HH11 ' B' ' 237' ' ' ARG . 67.8 mtp85 -73.88 -50.5 19.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.735 -1.228 . . . . 0.0 108.752 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.722 HD22 HG11 ' B' ' 212' ' ' VAL . 14.1 mt -59.22 -40.42 85.78 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -64.78 -23.16 67.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' B' ' 233' ' ' SER . 24.1 mtt85 -77.66 -34.98 52.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 108.922 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.9 m-30 -73.23 -50.86 20.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 110.041 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -145.22 -145.29 4.26 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -98.59 135.34 40.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.293 -1.122 . . . . 0.0 108.704 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.822 HG11 HG13 ' B' ' 232' ' ' VAL . 12.8 t -100.07 122.02 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 11.4 mt -87.35 -16.34 35.3 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.082 -1.047 . . . . 0.0 109.309 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.419 HG22 ' CG2' ' B' ' 246' ' ' VAL . 0.2 OUTLIER -86.84 43.52 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.424 -0.797 . . . . 0.0 109.4 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -66.55 -38.22 86.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 109.89 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.488 ' ND1' ' C ' ' B' ' 245' ' ' HIS . 6.6 t-80 -54.43 -46.92 73.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.971 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.462 HG11 ' CZ ' ' B' ' 214' ' ' PHE . 5.5 t -48.5 -48.38 14.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -75.1 -40.97 59.61 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.649 ' O ' HD22 ' B' ' 251' ' ' LEU . 2.7 t0 -74.86 50.68 0.46 Allowed 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.679 ' HB3' HE21 ' B' ' 225' ' ' GLN . . . -126.32 -30.08 2.92 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.736 ' N ' ' NE2' ' B' ' 225' ' ' GLN . 0.4 OUTLIER -55.71 -4.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.66 HD13 ' H ' ' B' ' 251' ' ' LEU . 0.4 OUTLIER -50.12 -55.3 15.52 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' B' ' 253' ' ' PRO . 1.8 tm-20 179.99 -45.28 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.426 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.644 ' O ' HD22 ' B' ' 254' ' ' LEU . 13.0 Cg_exo -69.14 92.35 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.938 HD21 HE22 ' B' ' 225' ' ' GLN . 4.0 mm? -125.44 178.39 5.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 68.26 35.93 83.77 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' B' ' 258' ' ' ALA . 69.0 mm-40 47.05 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -1.02 . . . . 0.0 109.277 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 48.15 13.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 108.583 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' B' ' 256' ' ' GLU . . . -139.29 96.35 3.09 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . 0.505 ' CB ' HD12 ' B' ' 265' ' ' ILE . . . -172.38 -30.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 102.64 16.39 22.24 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' B' ' 262' ' ' ASP . . . 152.74 76.56 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 23.8 p-10 -48.42 -44.14 34.83 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . 0.494 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 89.9 mt-30 -57.49 -45.41 84.92 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -60.13 -42.05 93.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.505 HD12 ' CB ' ' B' ' 259' ' ' ALA . 0.1 OUTLIER -57.75 -38.7 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.49 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.8 t-80 -76.35 -51.21 12.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 110.246 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 97.1 mt-10 -46.67 -53.42 11.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.102 -0.999 . . . . 0.0 109.794 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -71.97 -42.79 66.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 110.862 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -64.68 -57.35 9.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.0 -1.062 . . . . 0.0 111.143 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -39.64 83.94 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.091 -1.005 . . . . 0.0 110.81 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 28.6 t-20 -60.95 -52.74 63.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.684 -1.26 . . . . 0.0 108.965 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.515 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.2 OUTLIER -60.0 -40.75 90.28 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.211 -0.996 . . . . 0.0 108.738 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 8.1 tp -50.06 -37.81 35.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.49 ' O ' ' NZ ' ' B' ' 302' ' ' LYS . 52.2 mt-30 -74.25 -29.55 61.74 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.773 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 17.7 mt-30 -90.11 3.97 51.76 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.838 -1.164 . . . . 0.0 109.204 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.07 129.95 39.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 112.311 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.508 ' HB2' ' H ' ' B' ' 211' ' ' SER . 85.1 m-20 -77.96 -34.74 50.92 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.66 144.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' B' ' 213' ' ' TYR . 87.3 t -136.12 129.04 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.921 -1.112 . . . . 0.0 111.296 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . 0.868 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 69.4 t -128.96 125.15 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.752 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -121.87 156.72 32.7 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.296 -1.503 . . . . 0.0 110.3 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -100.19 123.03 43.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.727 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.82 33.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.556 HG23 ' H ' ' B' ' 309' ' ' ARG . 4.0 m -88.45 -73.87 0.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.766 -0.583 . . . . 0.0 109.804 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -77.43 120.75 82.75 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.772 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.47 141.7 89.89 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.255 1.97 . . . . 0.0 112.229 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.937 ' OG ' HG23 ' B' ' 290' ' ' VAL . 0.1 OUTLIER -179.34 140.92 0.16 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.102 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 292' ' ' TYR . 20.1 mt -62.24 -42.83 99.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 117' ' ' SER . . . -54.88 -38.6 65.31 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.937 HG23 ' OG ' ' B' ' 287' ' ' SER . 44.3 t -68.03 -52.99 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.614 -0.933 . . . . 0.0 108.696 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.45 -27.94 73.42 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.515 ' OH ' ' HB2' ' A' ' 123' ' ' ALA . 50.5 t80 -71.1 -55.28 8.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.368 -1.078 . . . . 0.0 109.592 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.529 ' CG ' ' SD ' ' A' ' 119' ' ' MET . 76.7 mt-10 -62.09 -34.05 75.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.137 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.752 HD21 ' HB3' ' B' ' 281' ' ' ALA . 21.7 mt -70.24 -48.6 56.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.089 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -59.76 -39.86 95.87 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 16.8 tpt85 -62.27 -40.42 96.18 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.544 -0.974 . . . . 0.0 109.244 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.499 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -69.46 -41.48 76.18 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.127 -0.983 . . . . 0.0 108.937 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.41 -39.64 22.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -77.53 -51.38 10.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.924 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.49 -6.11 9.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.949 -1.094 . . . . 0.0 108.834 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 53.44 26.0 28.97 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.518 ' O ' HG13 ' B' ' 304' ' ' ILE . 43.7 mttp -84.29 147.32 49.96 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.849 -1.383 . . . . 0.0 107.667 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 302' ' ' LYS . 83.6 Cg_exo -38.26 116.15 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.805 1.67 . . . . 0.0 110.856 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 302' ' ' LYS . 3.6 mt -115.76 98.54 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.246 -0.909 . . . . 0.0 111.467 -177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 280' ' ' VAL . 58.0 tp -94.45 120.85 35.31 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 131.6 54.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.77 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.5 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 3.3 mt -123.48 130.62 52.95 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.233 -0.917 . . . . 0.0 111.429 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.551 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -131.36 151.4 51.56 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.556 ' H ' HG23 ' B' ' 284' ' ' THR . 49.6 mtm180 -114.7 135.88 22.4 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.026 -1.046 . . . . 0.0 110.185 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.06 -29.37 4.23 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 111.381 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' B' ' 312' ' ' SER . 12.1 pt20 -60.32 -45.92 91.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.457 -0.777 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.526 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 16.6 t -76.44 -21.84 55.41 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.559 ' O ' ' NE ' ' B' ' 314' ' ' ARG . . . 55.82 110.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.568 ' O ' ' C ' ' B' ' 315' ' ' VAL . 0.0 OUTLIER -144.57 -7.72 0.67 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.434 -1.039 . . . . 0.0 110.244 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.568 ' C ' ' O ' ' B' ' 314' ' ' ARG . 86.5 t 33.09 90.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.948 ' H ' HD23 ' B' ' 316' ' ' LEU . 0.2 OUTLIER -60.89 172.23 1.02 Allowed 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.77 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 89' ' ' GLY . 28.8 t -65.02 141.28 58.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.039 -1.038 . . . . 0.0 111.736 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.38 -32.99 63.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.493 ' SD ' ' CG ' ' A' ' 93' ' ' GLU . 1.8 mtp -64.21 -43.67 94.28 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.597 -0.689 . . . . 0.0 109.319 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 92' ' ' TYR . 4.3 mm -61.49 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 109.328 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -64.82 -44.36 90.11 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.19 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -58.51 -32.06 68.04 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' B' ' 325' ' ' ASP . . . -52.08 -57.43 9.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -1.178 . . . . 0.0 108.326 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.583 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . 10.36 56.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' B' ' 323' ' ' ALA . 2.0 m-20 -69.12 -35.07 76.02 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.793 -1.192 . . . . 0.0 107.855 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.803 ' C ' ' H ' ' B' ' 328' ' ' ARG . . . 77.32 174.02 40.35 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 7.1 t 60.58 -30.92 0.06 Allowed 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.637 1.208 . . . . 0.0 108.718 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.803 ' H ' ' C ' ' B' ' 326' ' ' GLY . 8.5 mtm180 -147.22 1.04 0.73 Allowed 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.518 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' GLY . 12.1 t80 -157.0 112.83 2.91 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.509 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 91.0 mt-30 -139.23 142.42 37.84 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.423 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.12 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.509 ' HE1' ' CB ' ' B' ' 330' ' ' GLN . 18.3 m0 -94.4 147.24 23.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.28 151.09 21.88 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 7.9 p90 -171.36 177.65 3.48 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.456 -1.298 . . . . 0.0 111.659 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -142.13 147.13 36.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 335' ' ' ALA . 41.3 mt-10 -39.27 -25.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.852 -1.155 . . . . 0.0 110.575 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -86.19 -2.36 85.73 Favored Glycine 0 N--CA 1.495 2.599 0 O-C-N 120.999 -1.063 . . . . 0.0 111.208 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -136.27 0.46 2.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.843 -1.386 . . . . 0.0 110.243 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 0.9 OUTLIER -55.59 -47.19 79.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.821 -1.174 . . . . 0.0 108.413 -179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 30.1 mt-10 -52.67 -33.53 47.73 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 16.3 m -69.21 -41.01 77.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.502 -0.749 . . . . 0.0 109.205 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 12.7 mmt -53.16 -51.64 61.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 47.4 mt -62.07 -32.61 73.17 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -65.81 -43.84 87.44 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.326 -0.859 . . . . 0.0 110.587 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -71.81 -48.0 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.527 -1.358 . . . . 0.0 109.216 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.15 -49.02 79.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.418 -0.801 . . . . 0.0 110.454 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.456 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 20.9 m-85 -71.46 -29.0 64.35 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.219 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -65.98 -31.13 71.86 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -83.09 9.17 10.96 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' PRO . 2.6 t80 -134.47 -104.21 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.201 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' B' ' 350' ' ' TYR . 21.6 mt -32.91 91.08 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.891 -0.506 . . . . 0.0 110.955 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' TYR . 72.2 Cg_endo -93.42 -72.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.239 2.626 . . . . 0.0 111.301 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -97.31 -19.85 18.25 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -59.38 -29.5 67.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.063 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . 0.45 HG22 ' N ' ' B' ' 356' ' ' ALA . 54.2 m -64.45 158.14 24.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.143 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . 0.45 ' N ' HG22 ' B' ' 355' ' ' THR . . . -43.16 102.84 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 109.624 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . 0.43 ' C ' ' N ' ' B' ' 359' ' ' SER . 8.4 t -99.24 147.87 24.71 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.61 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 75.3 m 51.26 12.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.454 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . 0.44 ' OG ' ' HB1' ' B' ' 356' ' ' ALA . 82.7 p -82.74 160.8 22.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.634 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -129.14 79.34 74.6 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.419 -0.8 . . . . 0.0 109.263 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.62 -23.32 56.56 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.812 2.342 . . . . 0.0 112.151 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 36.8 t -99.39 144.85 28.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 109.507 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.428 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' SER . . . -151.03 158.66 44.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 109.505 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.21 16.62 0.4 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.415 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 2' ' ' ALA . 50.4 m -65.11 153.21 41.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.76 6.44 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -49.32 140.26 10.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -1.158 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.05 178.07 5.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.726 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -49.88 150.74 3.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.246 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' ALA . 31.4 Cg_exo -56.3 -158.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.967 1.778 . . . . 0.0 110.987 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 31.1 p -111.72 174.55 5.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.683 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 m -113.45 157.02 22.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.15 134.03 47.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.464 ' CD2' ' HA ' ' A' ' 73' ' ' LEU . 9.5 t80 -111.84 95.5 5.52 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.646 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.05 118.29 23.43 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.99 -1.069 . . . . 0.0 109.78 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -125.21 -130.0 3.43 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t 156.57 111.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.405 -1.056 . . . . 0.0 109.42 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.705 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -54.01 -49.21 62.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.152 -0.968 . . . . 0.0 108.883 179.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -51.68 110.42 0.46 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.86 -39.7 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . 151.88 14.44 0.07 OUTLIER Glycine 0 N--CA 1.497 2.731 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.849 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLN . 2.0 tpp85 66.84 -41.3 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.295 . . . . 0.0 109.393 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' GLY . 80.4 mm-40 -52.03 -37.06 52.24 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 25' ' ' GLN . 35.4 p-10 -68.24 -31.55 71.12 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.723 HE21 ' N ' ' A' ' 50' ' ' GLU . 31.5 tt0 -60.9 -42.73 98.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.9 -48.6 68.22 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.01 -27.85 65.83 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.601 ' O ' HG23 ' A' ' 32' ' ' VAL . 17.3 m-30 -70.93 -53.59 14.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -58.43 -35.43 72.08 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.425 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.66 -58.49 3.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.989 -1.07 . . . . 0.0 108.673 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.4 mt -51.59 -42.78 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.879 HG13 HG11 ' A' ' 41' ' ' VAL . 47.2 t -62.45 -30.03 48.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -69.17 -40.69 77.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.174 -0.954 . . . . 0.0 109.71 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.522 ' NH1' ' CG1' ' A' ' 139' ' ' VAL . 95.2 mtt180 -70.29 -49.17 52.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.916 -1.115 . . . . 0.0 108.895 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.8 mt -59.05 -39.71 82.88 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 41' ' ' VAL . 48.5 ttt85 -63.1 -24.5 67.93 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -76.23 -37.84 57.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.958 -1.089 . . . . 0.0 109.247 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CD2' ' CD2' ' A' ' 147' ' ' PHE . 2.4 m-85 -68.45 -47.91 65.93 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.515 -0.74 . . . . 0.0 110.674 -177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -151.82 -150.31 5.32 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -89.32 115.48 26.83 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.246 -1.15 . . . . 0.0 109.115 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.879 HG11 HG13 ' A' ' 32' ' ' VAL . 2.7 t -78.29 103.06 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 72' ' ' TRP . 2.0 mt -47.14 126.33 9.03 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.001 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' LEU . 43.1 m -38.57 138.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.815 0.817 . . . . 0.0 111.131 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' VAL . 26.5 mt-10 -149.46 101.93 3.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' O ' ' N ' ' A' ' 49' ' ' ALA . 18.6 t-80 -43.19 -19.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.352 -0.842 . . . . 0.0 109.738 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 44' ' ' GLU . 87.5 t -46.03 -84.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -54.05 -39.54 66.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.861 -1.15 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.941 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -75.72 21.07 0.16 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 51' ' ' LEU . . . -86.69 -19.41 29.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.16 -0.963 . . . . 0.0 108.859 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.723 ' N ' HE21 ' A' ' 25' ' ' GLN . 57.1 mt-10 -62.11 7.33 0.06 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -88.86 134.87 33.8 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.523 ' O ' ' O ' ' A' ' 51' ' ' LEU . 7.3 mm-40 54.9 159.61 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.202 -0.936 . . . . 0.0 109.405 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' C ' HD22 ' A' ' 54' ' ' LEU . 89.0 Cg_exo -38.56 153.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.562 2.175 . . . . 0.0 112.258 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 53' ' ' PRO . 3.9 mm? -112.7 154.69 25.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.379 -0.826 . . . . 0.0 109.726 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 57' ' ' GLU . . . 137.48 41.81 0.1 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 49.16 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -1.062 . . . . 0.0 109.256 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 55' ' ' GLY . 50.5 tp10 -48.53 -26.17 2.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.61 44.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.18 179.67 5.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.493 -0.755 . . . . 0.0 109.474 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.18 62.75 0.51 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.87 79.14 0.87 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -49.31 -38.16 26.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.13 -1.217 . . . . 0.0 107.803 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 9.5 mp0 -59.86 -41.16 90.87 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -54.4 -38.86 66.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.642 -1.286 . . . . 0.0 108.835 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -46.57 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -71.91 -61.97 1.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 110.44 -179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 79.1 mm-40 -43.71 -52.17 6.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.09 -41.95 99.5 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.024 -1.048 . . . . 0.0 109.628 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.458 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 77.9 m-20 -66.52 -40.92 89.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 111.605 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -68.01 -51.85 42.35 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.914 -1.116 . . . . 0.0 110.159 -178.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -60.14 -46.55 89.27 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.226 -0.922 . . . . 0.0 109.672 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.632 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -64.79 -45.78 84.82 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.027 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 59.0 tp -52.44 -34.17 47.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.975 -1.078 . . . . 0.0 108.45 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -78.04 -32.01 50.72 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.508 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.632 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 29.3 mt-30 -87.66 -0.68 57.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.875 -1.141 . . . . 0.0 109.23 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 13' ' ' TYR . . . -62.83 125.71 24.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 112.122 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.683 ' HB2' ' H ' ' A' ' 11' ' ' SER . 82.7 m-20 -76.09 -35.44 59.35 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 79' ' ' VAL . 90.4 t -132.91 155.29 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' N ' HG12 ' A' ' 78' ' ' VAL . 58.8 t -142.18 139.33 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.812 -1.18 . . . . 0.0 111.931 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.62 158.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -153.53 148.85 27.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.495 -1.378 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.636 ' O ' HG11 ' A' ' 90' ' ' VAL . 7.8 mt-10 -113.08 124.29 52.25 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.519 ' HB ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -122.6 26.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.254 -0.904 . . . . 0.0 110.136 -179.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 83' ' ' VAL . 62.8 m -43.49 -69.8 0.13 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.992 -1.067 . . . . 0.0 109.043 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.52 149.05 38.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 108.689 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HA ' HD23 ' B' ' 288' ' ' LEU . 6.3 Cg_endo -51.72 91.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.168 1.912 . . . . 0.0 111.313 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.514 ' OG ' HG23 ' A' ' 90' ' ' VAL . 32.8 t -99.36 135.4 40.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 110.632 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.574 HD23 ' HA ' ' B' ' 286' ' ' PRO . 0.2 OUTLIER -76.55 -40.24 50.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.446 -0.784 . . . . 0.0 109.07 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.98 -39.92 93.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.7 t -71.33 -39.29 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.29 . . . . 0.0 109.914 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -47.86 87.77 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -67.81 -44.73 76.6 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.642 -0.916 . . . . 0.0 109.603 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.94 -30.59 71.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.253 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 81' ' ' ALA . 20.2 mt -73.04 -39.5 65.9 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.182 -0.949 . . . . 0.0 108.668 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.24 99.08 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.26 -42.14 99.07 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.417 -1.049 . . . . 0.0 109.156 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -68.1 -38.53 82.39 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.161 -0.962 . . . . 0.0 108.814 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -55.76 -42.73 71.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.773 -1.205 . . . . 0.0 108.518 179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -75.02 -50.12 17.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.789 -0.569 . . . . 0.0 112.509 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 101' ' ' GLY . 2.2 pp -118.34 -24.97 6.69 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.122 -0.986 . . . . 0.0 110.566 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 100' ' ' LEU . . . -47.33 166.17 0.12 Allowed Glycine 0 C--N 1.29 -1.972 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' A' ' 103' ' ' PRO . 1.5 mptm? -117.68 -85.86 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.046 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 51.5 Cg_endo -85.22 102.3 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 121.387 1.531 . . . . 0.0 109.431 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG12 ' HB1' ' A' ' 97' ' ' ALA . 15.2 mt -102.05 98.98 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.805 -1.184 . . . . 0.0 111.187 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.9 tp -94.27 118.9 32.27 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 130' ' ' GLN . 0.7 OUTLIER -106.73 154.06 21.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.022 -1.049 . . . . 0.0 108.895 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.519 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 17.4 mt -125.3 137.46 54.07 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.291 -0.881 . . . . 0.0 110.263 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -137.41 117.84 13.77 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 0.1 OUTLIER -75.02 123.34 88.86 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.41 -0.806 . . . . 0.0 110.562 -178.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 113' ' ' GLY . 88.4 Cg_endo -82.7 -31.41 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.326 2.017 . . . . 0.0 110.663 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 13.7 pt20 -49.75 -35.06 20.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.446 ' HB3' HH11 ' A' ' 114' ' ' ARG . 53.1 m -97.82 -14.65 20.64 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 41.39 51.57 4.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 115' ' ' VAL . 42.2 mtp85 -83.58 13.3 4.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.049 -1.265 . . . . 0.0 110.279 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 114' ' ' ARG . 54.1 t 54.31 107.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.016 -1.053 . . . . 0.0 110.138 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 131' ' ' VAL . 19.4 tp -46.34 -71.96 0.06 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 164.47 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.21 82.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.981 -1.074 . . . . 0.0 109.789 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 119' ' ' MET . 17.9 mmm -66.38 -50.58 63.01 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 116' ' ' LEU . 35.5 mm -63.68 -41.16 91.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.216 -0.927 . . . . 0.0 108.93 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.693 ' HG2' HD23 ' A' ' 116' ' ' LEU . 18.5 mmt85 -62.42 -44.02 97.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 109.604 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.54 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -64.68 -36.12 92.75 Favored Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.221 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 129' ' ' PHE . . . -53.75 -23.06 10.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.061 -1.258 . . . . 0.0 107.98 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 121' ' ' ARG . . . -32.48 101.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.234 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ALA . 93.1 m-20 -101.33 -30.01 11.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 108.709 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.66 -0.12 57.29 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.4 p -112.49 -69.39 0.87 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.58 -0.953 . . . . 0.0 108.582 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -108.16 -39.55 5.45 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 123' ' ' ALA . 32.1 t80 -98.37 129.18 45.03 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.56 ' CD ' ' HE1' ' A' ' 132' ' ' TRP . 42.1 tt0 -154.06 163.79 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.05 -1.031 . . . . 0.0 110.435 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 116' ' ' LEU . 23.3 t -125.72 112.33 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.56 ' HE1' ' CD ' ' A' ' 130' ' ' GLN . 20.6 m0 -105.02 145.0 31.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.266 -0.896 . . . . 0.0 108.944 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 43.4 p30 -89.78 154.23 20.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.802 -1.186 . . . . 0.0 109.16 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 5.4 p90 -163.85 -174.49 3.66 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.627 -1.229 . . . . 0.0 111.898 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -152.86 148.11 26.79 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 135' ' ' ALA . 47.7 mt-10 -36.71 -37.8 0.15 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.928 -1.107 . . . . 0.0 110.259 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.46 19.04 38.36 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.446 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.644 ' N ' ' O ' ' A' ' 135' ' ' ALA . 94.5 mt-10 -142.69 -10.39 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.067 -1.255 . . . . 0.0 110.397 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.539 HG13 ' N ' ' A' ' 140' ' ' GLU . 8.0 p -50.89 -45.44 28.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.921 -1.112 . . . . 0.0 108.655 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' N ' HG13 ' A' ' 139' ' ' VAL . 23.2 pt-20 -60.38 -36.41 77.98 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.282 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -65.68 -46.26 79.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.486 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.92 -47.85 64.46 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 38.7 mt -68.51 -31.99 71.65 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.479 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 76.9 m-20 -66.17 -42.74 88.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.536 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -69.86 -50.75 39.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.67 -1.269 . . . . 0.0 108.264 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.681 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 38' ' ' TYR . 13.2 m-85 -71.74 -33.16 68.45 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.282 -0.967 . . . . 0.0 109.764 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.56 28.45 5.54 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.01 -78.0 0.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.836 -1.146 . . . . 0.0 113.065 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.558 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 8.3 mt -61.42 -40.2 69.45 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.139 -0.975 . . . . 0.0 112.402 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 47.6 Cg_exo -54.83 -27.34 52.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.91 1.74 . . . . 0.0 111.733 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -103.25 -21.4 13.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 109.278 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -58.98 -37.38 76.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.311 -0.868 . . . . 0.0 109.664 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.8 m -56.17 -40.14 73.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -91.08 120.95 32.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.408 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.418 ' OG ' ' CB ' ' A' ' 163' ' ' ALA . 9.4 t -176.36 -27.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.434 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 52.8 p -58.48 -28.89 65.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.306 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.8 p -70.71 -28.02 64.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.587 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -83.34 148.73 56.51 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.383 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.12 -24.02 45.18 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.513 2.142 . . . . 0.0 112.273 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.3 t -152.72 147.98 26.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 109.367 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.418 ' CB ' ' OG ' ' A' ' 157' ' ' SER . . . . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.914 -1.041 . . . . 0.0 109.323 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.291 0.567 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 204' ' ' SER . . . -151.67 158.22 43.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . 51.34 16.97 0.46 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.357 -0.84 . . . . 0.0 109.39 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . 0.4 ' N ' ' C ' ' B' ' 202' ' ' ALA . 50.4 m -65.4 153.16 42.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.87 51.28 6.41 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -48.95 140.13 9.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -1.22 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -74.01 178.79 4.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.322 -0.862 . . . . 0.0 109.681 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -50.75 151.18 4.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.355 -0.84 . . . . 0.0 109.185 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -56.48 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.072 1.848 . . . . 0.0 110.947 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.438 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 31.2 p -111.7 174.5 5.84 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.688 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 11.2 m -113.63 156.73 23.17 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.84 133.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 9.7 t80 -111.6 95.57 5.58 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -83.23 118.28 23.52 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 m -87.32 123.48 32.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.083 -1.011 . . . . 0.0 109.735 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' B' ' 217' ' ' SER . . . -126.37 -130.22 3.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' B' ' 216' ' ' GLY . 1.4 t 156.98 111.86 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -1.045 . . . . 0.0 109.369 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.702 ' H ' HD13 ' B' ' 218' ' ' ILE . 0.0 OUTLIER -54.59 -49.04 70.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 108.721 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 -51.66 110.26 0.44 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 170.86 -39.7 0.18 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . 152.03 14.47 0.07 OUTLIER Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.494 -1.004 . . . . 0.0 110.977 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 1.9 tpp85 66.74 -41.19 0.39 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.928 -1.336 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' B' ' 221' ' ' GLY . 80.1 mm-40 -52.44 -36.63 55.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 225' ' ' GLN . 35.3 p-10 -68.52 -31.52 70.81 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.74 HE21 ' N ' ' B' ' 250' ' ' GLU . 30.8 tt0 -60.93 -42.62 98.52 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.05 -48.45 68.27 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.95 -28.11 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.605 ' O ' HG23 ' B' ' 232' ' ' VAL . 17.3 m-30 -70.49 -53.6 15.6 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.23 -0.919 . . . . 0.0 110.089 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.426 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -58.53 -35.28 72.04 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.607 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -69.68 -58.69 3.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.923 -1.11 . . . . 0.0 108.548 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.54 -42.92 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.874 HG13 HG11 ' B' ' 241' ' ' VAL . 46.7 t -62.37 -29.82 47.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.3 p -69.34 -40.77 77.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.736 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.518 ' NH1' ' CG1' ' B' ' 339' ' ' VAL . 95.4 mtt180 -70.15 -49.47 50.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.798 -1.189 . . . . 0.0 108.903 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.69 -39.99 82.3 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.422 ' N ' HG23 ' B' ' 241' ' ' VAL . 49.0 ttt85 -63.02 -24.69 68.03 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -75.96 -38.06 57.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.931 -1.106 . . . . 0.0 109.329 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' B' ' 347' ' ' PHE . 2.4 m-85 -68.29 -48.03 66.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.559 -0.713 . . . . 0.0 110.766 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -151.56 -150.4 5.33 Favored Glycine 0 N--CA 1.476 1.342 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -89.31 115.44 26.79 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.19 -1.183 . . . . 0.0 109.058 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.874 HG11 HG13 ' B' ' 232' ' ' VAL . 2.7 t -78.18 103.44 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' B' ' 272' ' ' TRP . 2.2 mt -47.55 126.8 10.44 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.929 -1.109 . . . . 0.0 108.97 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.406 ' C ' ' O ' ' B' ' 242' ' ' LEU . 42.1 m -39.16 137.99 0.66 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.801 0.81 . . . . 0.0 111.133 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 246' ' ' VAL . 26.8 mt-10 -148.81 101.84 3.23 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 249' ' ' ALA . 18.3 t-80 -43.1 -19.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.829 . . . . 0.0 109.864 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' B' ' 244' ' ' GLU . 82.6 t -46.11 -84.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.876 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -54.16 -40.01 67.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.823 -1.173 . . . . 0.0 108.927 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.927 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -75.38 20.91 0.14 Allowed 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' B' ' 251' ' ' LEU . . . -86.22 -19.88 29.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.818 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.74 ' N ' HE21 ' B' ' 225' ' ' GLN . 59.1 mt-10 -61.77 7.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 248' ' ' ASP . 0.6 OUTLIER -88.87 134.48 33.93 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' B' ' 251' ' ' LEU . 7.0 mm-40 54.75 159.19 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.204 -0.935 . . . . 0.0 109.409 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.499 ' C ' HD22 ' B' ' 254' ' ' LEU . 97.7 Cg_exo -37.93 152.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.67 2.247 . . . . 0.0 112.439 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.499 HD22 ' C ' ' B' ' 253' ' ' PRO . 3.9 mm? -112.68 154.1 26.64 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.335 -0.853 . . . . 0.0 109.82 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.652 ' O ' ' N ' ' B' ' 257' ' ' GLU . . . 138.28 41.34 0.1 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 49.83 -82.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -1.045 . . . . 0.0 109.104 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.652 ' N ' ' O ' ' B' ' 255' ' ' GLY . 50.8 tp10 -48.87 -26.72 2.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 108.504 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' B' ' 253' ' ' PRO . . . -80.13 45.02 0.7 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -129.18 -179.32 5.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.461 -0.774 . . . . 0.0 109.298 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.56 63.14 0.54 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 113.61 78.75 0.86 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -49.22 -37.94 24.69 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . 0.5 ' H ' ' CD ' ' B' ' 263' ' ' GLN . 10.2 mp0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -54.48 -38.67 66.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.718 -1.239 . . . . 0.0 108.876 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.8 OUTLIER -65.9 -46.84 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.626 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 0.9 OUTLIER -71.97 -62.31 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.626 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 79.4 mm-40 -43.17 -52.39 5.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.029 -1.044 . . . . 0.0 110.158 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -62.97 -41.71 99.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.474 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 80.9 m-20 -66.67 -40.92 88.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.411 -0.806 . . . . 0.0 111.522 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.591 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.2 OUTLIER -68.13 -51.68 43.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.021 -1.05 . . . . 0.0 110.2 -178.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -60.4 -46.4 90.11 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.133 -0.979 . . . . 0.0 109.576 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.633 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.1 OUTLIER -64.85 -46.25 82.68 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.247 -0.908 . . . . 0.0 108.955 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.477 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 59.8 tp -52.06 -34.03 41.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.42 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -78.34 -32.16 48.96 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.433 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.633 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 29.2 mt-30 -87.25 -0.81 57.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.891 -1.131 . . . . 0.0 109.286 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . 0.43 ' HB2' ' HB2' ' B' ' 213' ' ' TYR . . . -62.79 125.73 24.94 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.24 -0.913 . . . . 0.0 112.159 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.688 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.9 m-20 -76.04 -35.75 59.35 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.407 HG12 ' N ' ' B' ' 279' ' ' VAL . 88.8 t -132.65 155.08 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.407 ' N ' HG12 ' B' ' 278' ' ' VAL . 60.1 t -141.96 139.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.817 -1.177 . . . . 0.0 111.832 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 24.4 t -137.93 158.25 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.486 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.599 -1.313 . . . . 0.0 110.322 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.639 ' O ' HG11 ' B' ' 290' ' ' VAL . 8.8 mt-10 -113.84 123.58 50.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.511 ' HB ' HD12 ' B' ' 316' ' ' LEU . 0.0 OUTLIER -122.1 26.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.161 -0.962 . . . . 0.0 110.041 -179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.445 HG23 ' HB2' ' B' ' 309' ' ' ARG . 66.5 m -43.21 -69.7 0.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.01 -1.056 . . . . 0.0 109.019 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -91.51 149.22 39.05 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 108.756 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.574 ' HA ' HD23 ' A' ' 88' ' ' LEU . 6.9 Cg_endo -52.38 91.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.027 1.818 . . . . 0.0 111.262 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.514 ' OG ' HG23 ' B' ' 290' ' ' VAL . 34.3 t -99.92 135.31 41.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.428 -0.795 . . . . 0.0 110.542 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.564 HD23 ' HA ' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -76.25 -39.67 53.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.533 -0.73 . . . . 0.0 109.206 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.3 -40.3 91.99 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.639 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.5 t -71.11 -39.41 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.053 -1.263 . . . . 0.0 109.961 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -61.76 -47.53 89.7 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -68.02 -45.24 74.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.548 -0.972 . . . . 0.0 109.649 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -61.4 -30.88 70.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.1 mt -72.56 -39.76 67.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 108.732 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -63.58 -41.78 99.03 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.463 -1.022 . . . . 0.0 109.175 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.517 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -68.23 -38.67 82.11 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.143 -0.973 . . . . 0.0 108.792 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.452 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -55.87 -42.42 70.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.732 -1.23 . . . . 0.0 108.481 179.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.588 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.25 -50.0 17.53 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' B' ' 301' ' ' GLY . 2.2 pp -118.67 -24.93 6.54 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.919 -1.113 . . . . 0.0 110.422 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . -47.16 166.45 0.1 Allowed Glycine 0 C--N 1.289 -2.079 0 N-CA-C 107.869 -2.093 . . . . 0.0 107.869 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.567 ' CB ' ' CD ' ' B' ' 303' ' ' PRO . 1.5 mptm? -117.96 -85.87 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 49.6 Cg_endo -85.23 102.32 0.76 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 CA-C-N 121.42 1.543 . . . . 0.0 109.378 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.517 HG12 ' HB1' ' B' ' 297' ' ' ALA . 14.8 mt -102.15 98.61 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.942 -1.099 . . . . 0.0 111.237 -177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 35.4 tp -93.98 118.4 31.44 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.42 153.79 21.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 109.009 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 17.0 mt -124.92 138.02 54.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.26 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -137.85 117.85 13.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.578 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 0.1 OUTLIER -74.92 123.39 88.93 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.494 -0.754 . . . . 0.0 110.536 -178.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.6 Cg_endo -82.82 -31.7 0.7 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.381 2.054 . . . . 0.0 110.763 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.578 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 13.3 pt20 -49.65 -34.88 19.54 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.444 ' OG ' ' NH2' ' B' ' 309' ' ' ARG . 49.8 m -97.86 -14.66 20.58 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 41.35 51.55 4.47 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' B' ' 315' ' ' VAL . 42.2 mtp85 -83.49 13.32 4.58 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.988 -1.301 . . . . 0.0 110.221 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 314' ' ' ARG . 52.4 t 54.51 106.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 110.054 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.857 HD22 HG11 ' B' ' 331' ' ' VAL . 19.0 tp -46.36 -72.12 0.06 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.64 -0.662 . . . . 0.0 109.305 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 1.0 OUTLIER 164.75 148.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.08 -43.85 81.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.085 -1.01 . . . . 0.0 109.674 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' B' ' 319' ' ' MET . 17.7 mmm -66.07 -50.79 62.88 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.278 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.784 HG22 HD21 ' B' ' 316' ' ' LEU . 34.9 mm -63.4 -41.26 92.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 108.905 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.68 ' HG2' HD23 ' B' ' 316' ' ' LEU . 18.8 mmt85 -62.46 -43.62 98.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.184 -0.947 . . . . 0.0 109.578 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -64.64 -36.67 93.42 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' B' ' 329' ' ' PHE . . . -53.34 -23.38 9.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.061 -1.258 . . . . 0.0 108.066 179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' B' ' 321' ' ' ARG . . . -32.33 101.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.248 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 323' ' ' ALA . 92.3 m-20 -101.84 -30.04 11.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.155 -0.965 . . . . 0.0 108.705 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 74.62 0.09 57.69 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 12.9 p -112.99 -69.95 0.83 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.532 -0.981 . . . . 0.0 108.462 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -107.24 -39.77 5.59 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' B' ' 323' ' ' ALA . 31.2 t80 -98.57 128.92 45.07 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.583 ' CD ' ' HE1' ' B' ' 332' ' ' TRP . 43.2 tt0 -153.49 164.29 38.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . 0.857 HG11 HD22 ' B' ' 316' ' ' LEU . 25.5 t -126.11 112.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.583 ' HE1' ' CD ' ' B' ' 330' ' ' GLN . 20.5 m0 -105.15 144.97 31.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.329 -0.857 . . . . 0.0 108.903 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' B' ' 333' ' ' ASP . 42.0 p30 -90.03 154.35 19.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 0.0 109.202 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 5.6 p90 -163.73 -174.28 3.61 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.64 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -152.95 148.05 26.66 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.514 ' C ' ' O ' ' B' ' 335' ' ' ALA . 46.8 mt-10 -36.79 -37.49 0.14 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.925 -1.11 . . . . 0.0 110.198 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -88.68 19.56 36.4 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.473 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' B' ' 335' ' ' ALA . 94.3 mt-10 -143.25 -10.71 0.74 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.073 -1.251 . . . . 0.0 110.491 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.553 HG13 ' N ' ' B' ' 340' ' ' GLU . 7.1 p -50.95 -45.19 28.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.003 -1.061 . . . . 0.0 108.548 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.553 ' N ' HG13 ' B' ' 339' ' ' VAL . 22.7 pt-20 -60.3 -36.62 78.32 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.431 -0.793 . . . . 0.0 109.226 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 99.5 m -65.57 -46.25 80.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.173 -0.954 . . . . 0.0 109.498 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -52.21 -47.69 65.49 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 37.4 mt -68.52 -32.29 72.14 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.237 -0.585 . . . . 0.0 109.45 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.86 -42.74 90.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.005 -1.059 . . . . 0.0 110.457 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -70.01 -50.94 36.53 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 120.684 -1.26 . . . . 0.0 108.27 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -56.42 -47.03 79.88 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.462 -0.774 . . . . 0.0 109.755 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.53 ' CD2' ' CD2' ' B' ' 238' ' ' TYR . 13.7 m-85 -71.59 -33.01 68.67 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.844 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -59.75 -26.19 65.48 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -101.4 27.84 5.94 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.8 -78.16 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.78 -1.168 . . . . 0.0 113.101 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.562 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 8.3 mt -60.81 -40.76 77.8 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 112.334 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 48.5 Cg_exo -54.44 -27.42 49.26 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.014 1.809 . . . . 0.0 111.726 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -103.13 -22.22 13.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -58.21 -37.36 74.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.579 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 41.1 m -56.28 -40.04 73.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.543 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.16 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -0.865 . . . . 0.0 109.312 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 11.4 t -176.45 -28.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 53.1 p -58.03 -29.74 65.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.339 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 88.1 p -69.85 -28.31 65.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.591 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.1 148.77 57.34 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.311 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.35 -24.32 43.4 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.552 2.168 . . . . 0.0 112.276 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 31.3 t -154.17 156.44 37.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.099 -1.0 . . . . 0.0 109.732 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.414 179.861 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.62 -172.19 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.97 -94.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.238 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 m -113.85 142.28 46.29 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.366 -0.833 . . . . 0.0 109.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.24 28.89 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -88.49 168.95 12.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.341 -1.093 . . . . 0.0 109.64 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 44.7 mt-30 -59.83 -54.47 45.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.137 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 7' ' ' GLN . . . 62.97 144.68 0.08 OUTLIER Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.72 -0.613 . . . . 0.0 109.585 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 10' ' ' CYS . 50.1 Cg_endo -71.01 155.54 61.62 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.357 2.038 . . . . 0.0 111.228 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' PRO . 22.6 p -52.61 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.037 -1.04 . . . . 0.0 109.16 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.491 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 5.0 p -109.19 149.3 29.57 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 13.0 t -139.86 131.52 33.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' OH ' ' OD2' ' A' ' 69' ' ' ASP . 14.2 t80 -100.65 124.91 46.89 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -96.21 122.73 39.38 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.539 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.6 t -133.87 154.97 50.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.144 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.64 -159.53 21.71 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.6 p -96.66 139.09 33.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.182 -1.187 . . . . 0.0 108.724 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 20' ' ' GLY . 2.8 mt -136.89 4.92 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.934 -1.104 . . . . 0.0 110.822 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.72 ' NH2' ' H ' ' A' ' 89' ' ' GLY . 47.3 mmt-85 -47.94 98.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.854 -1.154 . . . . 0.0 108.728 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . 75.22 172.86 31.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.05 129.36 26.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.585 ' NH2' ' NE2' ' A' ' 85' ' ' GLN . 50.1 mtp85 -135.12 149.89 50.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.289 . . . . 0.0 111.333 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -53.71 -24.29 14.22 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.578 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 80.0 m-20 -69.84 -32.25 70.55 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.611 ' NE2' ' O ' ' A' ' 49' ' ' ALA . 5.9 mt-30 -64.78 -40.2 94.87 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.07 -52.47 34.9 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.31 -29.83 64.25 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.614 ' O ' HG23 ' A' ' 32' ' ' VAL . 9.9 m-30 -69.18 -44.46 72.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.623 -0.673 . . . . 0.0 110.295 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.11 83.34 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.488 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.599 ' NE ' HH22 ' A' ' 34' ' ' ARG . 60.0 ttt180 -71.26 -56.69 5.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.928 -1.108 . . . . 0.0 108.146 177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' HA ' HH11 ' A' ' 34' ' ' ARG . 12.1 mt -52.85 -45.33 50.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 28' ' ' TYR . 42.1 t -60.66 -27.58 40.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -68.87 -36.68 78.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.389 -0.819 . . . . 0.0 109.367 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.599 HH22 ' NE ' ' A' ' 30' ' ' ARG . 77.4 mtt85 -68.6 -47.96 65.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.597 -1.314 . . . . 0.0 107.849 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.673 HD22 HG11 ' A' ' 12' ' ' VAL . 3.1 mt -62.3 -28.91 70.06 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.695 HH21 ' H ' ' A' ' 41' ' ' VAL . 2.0 tpm_? -64.98 -29.14 70.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -70.8 -62.08 1.53 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -123.74 157.01 34.95 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.274 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.576 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 81.59 69.86 1.37 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 39' ' ' GLY . 50.8 mtmt -36.37 131.81 0.62 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.333 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.695 ' H ' HH21 ' A' ' 36' ' ' ARG . 23.2 t -96.05 107.74 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.828 -1.17 . . . . 0.0 108.854 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 24.6 mt -78.79 152.94 31.11 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.204 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 45' ' ' HIS . 19.7 m 51.36 53.22 13.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.314 -0.866 . . . . 0.0 109.62 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -54.4 -7.22 0.14 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.119 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 43' ' ' THR . 8.5 t-80 -45.34 -31.02 1.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 110.245 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.6 -53.08 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.093 -1.004 . . . . 0.0 109.881 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -65.92 -43.47 88.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 108.714 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.789 ' O ' HD21 ' A' ' 51' ' ' LEU . 38.1 t70 -73.64 37.01 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.823 ' O ' HD21 ' A' ' 54' ' ' LEU . . . -108.97 9.48 26.49 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' HD13 ' A' ' 51' ' ' LEU . 2.3 mt-10 -104.25 3.3 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.588 -0.695 . . . . 0.0 109.719 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -113.0 163.16 15.02 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.242 -0.911 . . . . 0.0 109.643 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.562 ' O ' ' O ' ' A' ' 51' ' ' LEU . 46.5 mt-10 54.46 156.69 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.499 -0.751 . . . . 0.0 109.238 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -40.67 122.42 1.39 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.068 1.846 . . . . 0.0 111.878 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.823 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -90.77 -164.45 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' ALA . . . 90.64 130.82 4.63 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' A' ' 62' ' ' ASP . 28.3 mm-40 -49.43 -30.9 8.7 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.997 -1.296 . . . . 0.0 109.132 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -70.12 -0.68 8.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.054 -1.029 . . . . 0.0 108.993 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 55' ' ' GLY . . . -65.16 149.12 50.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.494 -0.753 . . . . 0.0 109.114 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.31 0.37 3.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 109.619 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -47.7 -31.26 7.26 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.2 76.43 1.03 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 56' ' ' GLU . 91.8 m-20 -52.18 -38.14 56.89 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -67.22 -52.01 46.31 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -58.64 -32.64 69.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 5.3 mt -65.64 -52.26 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' ND1' ' C ' ' A' ' 66' ' ' HIS . 2.6 t-80 -66.23 -53.67 34.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.589 -0.695 . . . . 0.0 109.985 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -47.68 -57.34 5.64 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.991 -1.068 . . . . 0.0 109.667 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -67.91 -37.5 81.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.481 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' OD2' ' OH ' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -68.19 -56.69 7.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.122 -0.986 . . . . 0.0 110.763 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 66' ' ' HIS . 6.5 tp -58.84 -40.61 84.73 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.47 -0.769 . . . . 0.0 110.313 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 90.8 m-20 -65.33 -58.84 4.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.007 -1.058 . . . . 0.0 109.253 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.463 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -57.2 -40.78 78.1 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -50.72 -41.05 55.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -72.54 -26.18 61.65 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.807 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' ASN . 19.3 mt-30 -90.76 1.26 57.04 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.965 -1.084 . . . . 0.0 108.826 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.03 122.72 23.09 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.381 -0.825 . . . . 0.0 111.748 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB2' ' H ' ' A' ' 11' ' ' SER . 89.7 m-20 -69.95 -35.74 74.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 t -135.16 141.52 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 56.0 t -126.65 120.13 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.825 -1.172 . . . . 0.0 111.805 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.3 t -116.0 120.16 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.693 0.758 . . . . 0.0 109.533 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.28 158.37 35.93 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' OE2' ' OH ' ' A' ' 134' ' ' TYR . 30.0 tt0 -97.07 128.27 43.84 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG13 HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -107.64 28.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.49 -0.756 . . . . 0.0 110.135 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 109' ' ' ARG . 5.2 m -79.67 -77.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.446 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.585 ' NE2' ' NH2' ' A' ' 22' ' ' ARG . 6.3 mm100 -64.33 136.39 96.73 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' B' ' 286' ' ' PRO . 72.9 Cg_endo -77.43 88.09 1.45 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.33 2.02 . . . . 0.0 111.716 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.634 ' HB3' HG23 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -121.77 139.58 53.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 110.16 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' H ' ' B' ' 287' ' ' SER . 16.1 mt -59.45 -42.1 91.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.182 -0.949 . . . . 0.0 108.677 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.72 ' H ' ' NH2' ' A' ' 19' ' ' ARG . . . -55.6 -30.9 56.99 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 87' ' ' SER . 80.7 t -75.44 -57.33 6.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.63 -0.924 . . . . 0.0 108.904 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.29 -36.31 89.34 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 88' ' ' LEU . 75.5 t80 -65.56 -52.54 51.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.351 -1.088 . . . . 0.0 109.129 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' OE2' ' OD1' ' A' ' 69' ' ' ASP . 1.8 tp10 -58.75 -34.82 71.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 0.0 109.338 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 94' ' ' LEU . 18.2 mt -74.63 -41.08 61.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.99 . . . . 0.0 108.742 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -34.52 89.47 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.686 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER -67.79 -43.17 80.36 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.626 -0.926 . . . . 0.0 109.176 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.663 ' O ' ' O ' ' A' ' 101' ' ' GLY . . . -69.86 -42.0 74.09 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.521 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -37.92 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -49.76 35.41 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.361 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' O ' ' CE ' ' A' ' 102' ' ' LYS . 1.8 pp -126.53 -34.71 2.43 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.145 -0.972 . . . . 0.0 109.885 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 97' ' ' ALA . . . -73.82 102.61 1.34 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 106.823 -2.511 . . . . 0.0 106.823 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.615 ' CE ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -72.72 -69.78 0.31 Allowed Pre-proline 0 C--N 1.288 -2.092 0 O-C-N 121.595 -0.944 . . . . 0.0 110.871 -177.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 102' ' ' LYS . 31.5 Cg_endo -65.64 109.01 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.573 1.515 . . . . 0.0 110.841 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.487 HD12 ' HD1' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -135.63 119.38 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 110.777 -178.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 132' ' ' TRP . 46.0 tp -105.26 119.45 39.1 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -107.46 139.48 41.9 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.012 . . . . 0.0 108.566 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 11.6 mt -126.82 124.19 39.08 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.183 -0.948 . . . . 0.0 111.125 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' C ' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -124.0 154.5 39.76 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' OE2' ' A' ' 136' ' ' GLU . 50.2 mtm180 -109.82 141.23 23.29 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.835 -1.166 . . . . 0.0 110.95 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.43 -29.32 3.08 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.812 2.341 . . . . 0.0 111.384 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.442 ' CG ' ' N ' ' A' ' 112' ' ' SER . 19.3 pt20 -46.5 -40.46 12.55 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.444 ' HB3' ' NE ' ' A' ' 114' ' ' ARG . 2.7 m -98.41 -23.1 15.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 50.07 40.57 36.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NE ' ' HB3' ' A' ' 112' ' ' SER . 7.6 mmt180 -51.0 -8.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.862 -1.375 . . . . 0.0 109.364 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 113' ' ' GLY . 23.4 t 64.1 99.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.963 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' HD22 ' A' ' 116' ' ' LEU . 4.1 mm? -37.97 128.25 1.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.416 ' HB2' HH21 ' B' ' 219' ' ' ARG . 2.3 t -51.3 147.75 5.45 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.104 -0.998 . . . . 0.0 109.094 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.68 78.28 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.248 -0.908 . . . . 0.0 109.982 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.476 ' SD ' ' OE1' ' B' ' 293' ' ' GLU . 0.1 OUTLIER -67.03 -42.31 85.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.908 -1.12 . . . . 0.0 109.359 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 35.8 mm -66.58 -46.38 86.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.054 -1.029 . . . . 0.0 108.705 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 121' ' ' ARG . 0.3 OUTLIER -62.04 -47.77 83.24 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' B' ' 266' ' ' HIS . . . -58.56 -36.68 86.23 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.781 ' O ' ' HB2' ' A' ' 124' ' ' ALA . . . -50.42 -61.85 1.94 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 123' ' ' ALA . . . 155.34 155.51 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 122.306 1.05 . . . . 0.0 112.151 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.695 ' HA ' ' H ' ' A' ' 131' ' ' VAL . 55.7 p30 -126.27 26.69 6.39 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . -178.08 149.88 9.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.314 -1.915 . . . . 0.0 108.314 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.77 ' C ' ' H ' ' A' ' 129' ' ' PHE . 4.2 t 96.88 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 117.935 0.868 . . . . 0.0 109.044 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 61.68 -19.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.77 ' H ' ' C ' ' A' ' 127' ' ' SER . 82.0 t80 -120.39 121.9 39.57 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.465 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . 18.1 mt-30 -139.68 132.35 28.92 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.122 -1.431 . . . . 0.0 111.656 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.695 ' H ' ' HA ' ' A' ' 125' ' ' ASP . 73.3 t -105.32 101.62 12.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 130' ' ' GLN . 22.8 m0 -98.37 155.66 17.12 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.292 -0.88 . . . . 0.0 110.771 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -107.51 147.74 30.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 139' ' ' VAL . 6.6 p90 -164.14 -175.73 4.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.848 -1.158 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.665 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -155.27 158.09 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.538 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 15.3 mt-10 -58.1 23.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.135 -0.978 . . . . 0.0 110.438 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.665 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -119.16 -11.46 7.49 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.684 ' O ' ' SD ' ' A' ' 142' ' ' MET . 5.7 pt-20 -153.96 16.2 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.997 -1.296 . . . . 0.0 110.202 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 142' ' ' MET . 3.5 p -51.05 -41.97 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.189 -0.944 . . . . 0.0 109.117 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 81.2 tt0 -61.63 -27.89 68.98 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.003 -1.061 . . . . 0.0 109.125 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.3 m -73.96 -48.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.157 -0.965 . . . . 0.0 110.444 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.684 ' SD ' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -54.41 -48.62 71.4 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 143' ' ' LEU . 92.8 mt -57.69 -38.66 75.57 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 45.2 t0 -63.08 -37.97 89.32 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 35.5 mtt-85 -70.61 -53.38 16.13 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.62 -1.3 . . . . 0.0 108.773 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.422 ' HB2' ' CH2' ' A' ' 132' ' ' TRP . 67.3 t80 -58.16 -48.23 80.91 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.384 -0.822 . . . . 0.0 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 151' ' ' LEU . 17.9 m-85 -70.48 -31.13 68.13 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.998 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 38.7 mt-10 -59.69 -29.89 68.4 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.8 17.62 10.19 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.48 -21.44 0.33 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.656 -1.218 . . . . 0.0 112.833 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.591 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 85.2 mt -120.34 39.84 0.37 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.527 -1.358 . . . . 0.0 111.776 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 92.4 Cg_endo -79.38 116.7 3.63 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.223 1.949 . . . . 0.0 110.526 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 157' ' ' SER . 61.4 mt-30 67.83 -37.01 0.32 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 0.0 109.039 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 152' ' ' PRO . 76.4 tttt -59.57 -26.43 65.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.0 . . . . 0.0 108.788 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.9 m -53.66 -38.4 64.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -0.827 . . . . 0.0 109.66 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' A' ' 157' ' ' SER . . . -171.14 -12.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 0.0 109.568 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 153' ' ' GLN . 99.2 p 48.89 -175.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.542 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.7 m -118.11 154.49 32.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.378 -0.826 . . . . 0.0 109.411 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 88.0 p -149.93 176.24 10.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 109.626 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 47.1 m80 55.67 69.14 2.03 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 0.0 109.497 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.25 -23.49 9.99 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.739 2.293 . . . . 0.0 112.153 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.44 ' O ' ' OXT' ' A' ' 163' ' ' ALA . 82.5 p -65.15 162.6 16.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.567 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.44 ' OXT' ' O ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.524 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 49.07 -172.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.357 -0.84 . . . . 0.0 109.583 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -161.29 -93.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.282 -0.886 . . . . 0.0 109.163 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 67.7 m -114.88 141.58 47.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.71 -163.7 29.44 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -87.56 169.68 11.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.311 -1.111 . . . . 0.0 109.516 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' B' ' 208' ' ' ALA . 45.4 mt-30 -60.92 -53.65 54.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 0.0 109.089 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 207' ' ' GLN . . . 62.05 144.45 0.07 OUTLIER Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.665 -0.647 . . . . 0.0 109.505 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' B' ' 210' ' ' CYS . 45.7 Cg_endo -70.56 155.9 62.35 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.389 2.059 . . . . 0.0 111.185 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.43 ' O ' ' O ' ' B' ' 209' ' ' PRO . 23.9 p -52.82 -175.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.028 -1.045 . . . . 0.0 109.15 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.487 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 7.3 p -109.21 148.85 30.27 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 12.9 t -139.63 131.67 34.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.505 ' OH ' ' OD2' ' B' ' 269' ' ' ASP . 13.8 t80 -100.8 124.36 46.33 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.343 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -95.48 122.89 38.68 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.418 -0.801 . . . . 0.0 109.553 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 21.7 t -133.95 155.02 50.68 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.252 -0.905 . . . . 0.0 110.082 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -175.73 -159.83 22.28 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 25.1 p -96.32 138.9 33.24 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.222 -1.163 . . . . 0.0 108.888 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' B' ' 220' ' ' GLY . 2.7 mt -136.73 5.41 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.928 -1.108 . . . . 0.0 110.797 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.731 ' NH2' ' H ' ' B' ' 289' ' ' GLY . 49.4 mmt-85 -48.21 98.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.95 -1.094 . . . . 0.0 108.579 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 218' ' ' ILE . . . 74.88 173.17 31.14 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -68.23 129.16 25.85 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.191 -1.964 . . . . 0.0 108.191 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.589 ' NH2' ' NE2' ' B' ' 285' ' ' GLN . 51.5 mtp85 -135.05 149.95 50.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.236 . . . . 0.0 111.427 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.31 -24.95 13.11 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 80.5 m-20 -69.48 -32.06 70.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.591 ' NE2' ' O ' ' B' ' 249' ' ' ALA . 5.5 mt-30 -65.02 -39.92 94.09 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.42 -52.42 32.97 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 tp -57.13 -30.0 64.04 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.614 ' O ' HG23 ' B' ' 232' ' ' VAL . 10.0 m-30 -69.09 -44.56 72.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.681 -0.637 . . . . 0.0 110.295 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.78 -36.07 83.13 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.507 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.585 ' NE ' HH22 ' B' ' 234' ' ' ARG . 60.3 ttt180 -71.32 -56.81 5.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.97 -1.082 . . . . 0.0 108.115 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.525 ' HA ' HH11 ' B' ' 234' ' ' ARG . 12.1 mt -52.77 -45.35 49.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 228' ' ' TYR . 41.8 t -60.48 -27.72 40.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -68.79 -36.84 78.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.431 -0.793 . . . . 0.0 109.405 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.585 HH22 ' NE ' ' B' ' 230' ' ' ARG . 77.5 mtt85 -68.38 -47.91 66.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.287 . . . . 0.0 107.831 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.657 HD22 HG11 ' B' ' 212' ' ' VAL . 3.0 mt -62.33 -29.08 70.19 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.718 HH21 ' H ' ' B' ' 241' ' ' VAL . 2.1 tpm_? -64.89 -29.34 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -70.57 -61.94 1.58 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' B' ' 235' ' ' LEU . 0.8 OUTLIER -123.81 156.92 35.25 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 177.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.562 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 81.73 69.84 1.37 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.162 -2.375 . . . . 0.0 107.162 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.562 ' C ' ' O ' ' B' ' 239' ' ' GLY . 50.6 mtmt -36.58 131.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.347 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.718 ' H ' HH21 ' B' ' 236' ' ' ARG . 24.1 t -96.23 107.71 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.859 -1.15 . . . . 0.0 108.835 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.466 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 24.4 mt -78.67 153.71 30.76 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.494 ' C ' ' H ' ' B' ' 245' ' ' HIS . 22.5 m 50.62 53.25 13.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.71 -7.08 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.078 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' B' ' 245' ' ' HIS . 8.1 t-80 -45.59 -30.97 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.862 . . . . 0.0 110.155 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . . . . . . . . . 61.5 t -54.34 -52.91 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.74 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -66.14 -43.56 86.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 108.847 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.8 ' O ' HD21 ' B' ' 251' ' ' LEU . 36.0 t70 -73.58 37.08 0.09 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.816 ' O ' HD21 ' B' ' 254' ' ' LEU . . . -109.16 9.84 26.01 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.412 ' C ' HD13 ' B' ' 251' ' ' LEU . 2.3 mt-10 -104.44 3.11 31.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.946 HD13 ' N ' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -112.69 163.31 14.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.269 -0.894 . . . . 0.0 109.643 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 47.6 mt-10 54.57 156.78 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.467 -0.771 . . . . 0.0 109.339 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -40.91 121.96 1.39 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.034 1.822 . . . . 0.0 111.795 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.816 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.0 OUTLIER -90.4 -164.19 1.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' B' ' 258' ' ' ALA . . . 90.38 130.49 4.41 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.462 ' O ' ' OD2' ' B' ' 262' ' ' ASP . 28.4 mm-40 -49.34 -31.47 9.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.066 -1.256 . . . . 0.0 109.275 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -69.36 -1.15 7.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 0.0 108.782 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' B' ' 255' ' ' GLY . . . -64.38 148.85 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.452 -0.78 . . . . 0.0 109.166 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -68.08 -0.52 4.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 109.554 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -47.23 -30.85 5.88 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.0 76.05 1.01 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' B' ' 256' ' ' GLU . 94.7 m-20 -52.01 -38.2 56.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -67.25 -51.85 48.09 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -58.91 -32.53 69.62 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' B' ' 269' ' ' ASP . 5.0 mt -65.64 -51.86 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.496 ' C ' ' ND1' ' B' ' 266' ' ' HIS . 2.5 t-80 -66.71 -53.61 31.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.965 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.59 -57.37 5.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.647 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -67.77 -37.86 82.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.505 ' OD2' ' OH ' ' B' ' 213' ' ' TYR . 0.4 OUTLIER -68.0 -56.83 7.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.08 -1.012 . . . . 0.0 110.785 -178.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' B' ' 266' ' ' HIS . 6.5 tp -58.76 -40.36 83.68 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' B' ' 275' ' ' GLN . 88.8 m-20 -65.43 -58.74 5.1 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.074 -1.016 . . . . 0.0 109.158 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.466 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.12 -41.17 78.53 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 13.0 tp -50.36 -41.31 51.42 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -72.43 -26.18 61.74 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.802 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' B' ' 271' ' ' ASN . 18.6 mt-30 -90.68 1.03 57.19 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.012 -1.055 . . . . 0.0 108.725 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.56 122.82 22.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.497 -0.752 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' B' ' 211' ' ' SER . 89.2 m-20 -70.14 -35.76 74.28 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 51.1 t -135.37 141.4 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.61 120.25 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.69 -1.256 . . . . 0.0 111.61 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.79 120.12 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.594 -0.692 . . . . 0.0 109.514 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -126.12 159.2 33.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.921 . . . . 0.0 109.881 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.448 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 30.5 tt0 -97.87 128.76 44.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.419 HG13 HD11 ' B' ' 294' ' ' LEU . 0.0 OUTLIER -107.95 27.86 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.307 -0.87 . . . . 0.0 110.095 -179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.425 HG23 ' H ' ' B' ' 309' ' ' ARG . 5.4 m -79.17 -76.99 0.18 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.126 -0.984 . . . . 0.0 108.424 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.589 ' NE2' ' NH2' ' B' ' 222' ' ' ARG . 6.5 mm100 -64.53 136.26 96.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 109.494 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 86' ' ' PRO . 73.1 Cg_endo -77.33 87.58 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.341 2.027 . . . . 0.0 111.839 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.619 ' HB3' HG23 ' B' ' 290' ' ' VAL . 0.2 OUTLIER -121.4 139.84 52.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.262 -0.899 . . . . 0.0 110.141 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.468 HD21 ' H ' ' A' ' 87' ' ' SER . 15.0 mt -59.31 -41.82 89.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.115 -0.991 . . . . 0.0 108.777 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . 0.731 ' H ' ' NH2' ' B' ' 219' ' ' ARG . . . -56.19 -30.92 58.68 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' B' ' 287' ' ' SER . 89.9 t -75.15 -57.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.545 -0.974 . . . . 0.0 108.8 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -66.86 -36.12 90.62 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' B' ' 288' ' ' LEU . 74.9 t80 -66.15 -52.76 45.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -1.131 . . . . 0.0 109.222 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.476 ' OE1' ' SD ' ' A' ' 119' ' ' MET . 1.7 tp10 -58.37 -34.91 71.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.417 -0.802 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.492 ' HA ' HD23 ' B' ' 294' ' ' LEU . 18.1 mt -74.44 -41.4 60.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 108.796 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.3 -34.44 89.25 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.671 ' HA ' ' HE ' ' B' ' 296' ' ' ARG . 0.4 OUTLIER -67.96 -42.68 80.54 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.625 -0.926 . . . . 0.0 109.186 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.659 ' O ' ' O ' ' B' ' 301' ' ' GLY . . . -70.24 -41.88 72.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.493 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.76 -37.79 21.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.497 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -72.13 -49.88 32.42 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.354 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.603 ' O ' ' CE ' ' B' ' 302' ' ' LYS . 1.8 pp -126.21 -34.51 2.51 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' O ' ' B' ' 297' ' ' ALA . . . -74.03 102.44 1.34 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.603 ' CE ' ' O ' ' B' ' 300' ' ' LEU . 0.0 OUTLIER -72.57 -69.86 0.31 Allowed Pre-proline 0 C--N 1.288 -2.087 0 O-C-N 121.651 -0.911 . . . . 0.0 110.841 -177.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' B' ' 302' ' ' LYS . 31.7 Cg_endo -65.64 109.07 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.508 1.472 . . . . 0.0 110.849 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -135.43 119.11 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.087 -1.008 . . . . 0.0 110.754 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.417 HD11 ' CD2' ' B' ' 332' ' ' TRP . 47.6 tp -105.22 119.4 38.98 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -107.5 140.8 39.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.088 -1.007 . . . . 0.0 108.622 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 11.8 mt -127.91 124.34 37.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -124.13 154.58 39.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.542 ' NH1' ' OE2' ' B' ' 336' ' ' GLU . 52.1 mtm180 -109.78 140.82 22.59 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 111.006 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.29 -29.62 3.01 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.643 2.229 . . . . 0.0 111.428 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.446 ' CG ' ' N ' ' B' ' 312' ' ' SER . 19.4 pt20 -45.96 -40.66 10.62 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' B' ' 311' ' ' GLN . 2.6 m -98.12 -23.34 15.77 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 50.5 40.73 39.98 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.445 ' NE ' ' HB3' ' B' ' 312' ' ' SER . 7.7 mmt180 -51.36 -8.33 0.05 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.965 -1.315 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' B' ' 313' ' ' GLY . 22.6 t 64.11 99.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.537 -0.727 . . . . 0.0 110.039 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.599 ' H ' HD22 ' B' ' 316' ' ' LEU . 4.1 mm? -38.33 128.46 1.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 2.1 t -51.51 148.18 5.44 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.059 -1.026 . . . . 0.0 109.215 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.42 -36.74 78.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 109.88 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.43 ' SD ' ' OE1' ' A' ' 93' ' ' GLU . 0.1 OUTLIER -67.21 -42.76 83.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 109.282 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' B' ' 323' ' ' ALA . 35.6 mm -66.09 -46.11 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.899 -1.125 . . . . 0.0 108.898 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' B' ' 321' ' ' ARG . 0.3 OUTLIER -62.42 -47.82 82.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -58.09 -36.64 82.69 Favored Glycine 0 N--CA 1.482 1.724 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.771 ' O ' ' HB2' ' B' ' 324' ' ' ALA . . . -50.68 -62.18 1.75 Allowed 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' B' ' 323' ' ' ALA . . . 155.72 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 122.284 1.04 . . . . 0.0 112.157 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.692 ' HA ' ' H ' ' B' ' 331' ' ' VAL . 56.5 p30 -126.33 27.04 6.29 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . -178.3 150.06 9.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.749 ' C ' ' H ' ' B' ' 329' ' ' PHE . 4.1 t 96.51 71.77 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.632 -0.923 . . . . 0.0 109.089 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 61.71 -19.47 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.749 ' H ' ' C ' ' B' ' 327' ' ' SER . 81.2 t80 -120.02 121.33 38.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.452 ' HB3' ' HE1' ' B' ' 332' ' ' TRP . 16.8 mt-30 -139.3 132.69 30.11 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.051 -1.46 . . . . 0.0 111.577 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . 0.692 ' H ' ' HA ' ' B' ' 325' ' ' ASP . 67.4 t -105.31 101.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.452 ' HE1' ' HB3' ' B' ' 330' ' ' GLN . 23.3 m0 -98.61 155.8 17.12 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.198 -0.939 . . . . 0.0 110.728 -177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 333' ' ' ASP . 50.6 p-10 -107.67 147.72 30.33 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.544 ' CD2' HG23 ' B' ' 339' ' ' VAL . 6.5 p90 -164.24 -175.57 4.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.903 -1.123 . . . . 0.0 111.07 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' B' ' 337' ' ' GLY . . . -155.18 158.37 38.82 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.542 ' OE2' ' NH1' ' B' ' 309' ' ' ARG . 17.0 mt-10 -58.42 23.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 0.0 110.468 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.674 ' H ' ' C ' ' B' ' 335' ' ' ALA . . . -118.99 -11.07 7.82 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.675 ' O ' ' SD ' ' B' ' 342' ' ' MET . 5.9 pt-20 -154.63 16.6 0.45 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.929 -1.336 . . . . 0.0 110.168 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' B' ' 342' ' ' MET . 3.6 p -51.32 -42.05 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 0.0 108.975 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.469 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 82.3 tt0 -61.44 -27.89 68.87 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.125 -0.984 . . . . 0.0 109.139 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.9 m -74.09 -48.4 29.9 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.152 -0.967 . . . . 0.0 110.395 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.675 ' SD ' ' O ' ' B' ' 338' ' ' GLU . 0.0 OUTLIER -54.64 -48.61 72.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 343' ' ' LEU . 94.1 mt -57.73 -38.39 75.21 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 45.3 t0 -63.38 -37.94 89.22 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.543 -0.723 . . . . 0.0 110.169 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -70.43 -53.28 17.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.669 -1.269 . . . . 0.0 108.784 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . 0.432 ' HB2' ' CH2' ' B' ' 332' ' ' TRP . 67.2 t80 -58.31 -47.95 82.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.523 -0.735 . . . . 0.0 109.69 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' B' ' 351' ' ' LEU . 18.6 m-85 -70.89 -31.11 67.66 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.999 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 38.2 mt-10 -59.48 -29.76 68.06 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -93.09 17.98 10.02 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -148.91 -21.39 0.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.552 -1.259 . . . . 0.0 112.686 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 85.5 mt -120.48 40.02 0.38 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.623 -1.298 . . . . 0.0 111.741 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 93.6 Cg_endo -79.95 117.24 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.191 1.927 . . . . 0.0 110.408 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' B' ' 357' ' ' SER . 60.3 mt-30 67.62 -37.22 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.869 . . . . 0.0 109.024 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' B' ' 352' ' ' PRO . 76.8 tttt -59.75 -25.7 65.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 108.798 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 9.0 m -54.52 -38.03 66.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.38 -0.825 . . . . 0.0 109.746 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' B' ' 357' ' ' SER . . . -171.5 -12.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 353' ' ' GLN . 95.7 p 48.28 -175.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.3 -0.875 . . . . 0.0 109.605 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 20.5 m -117.48 154.52 31.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.318 -0.864 . . . . 0.0 109.391 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 98.4 p -150.01 176.3 10.91 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.544 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 45.6 m80 55.46 69.42 1.96 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.593 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.88 -23.16 8.33 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.688 2.259 . . . . 0.0 112.031 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' B' ' 363' ' ' ALA . 80.0 p -68.55 167.26 15.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.377 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 362' ' ' SER . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.415 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.56 -44.29 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.966 . . . . 0.0 109.753 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.89 162.03 29.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.611 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 p -63.29 -23.44 67.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.254 -0.904 . . . . 0.0 109.371 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.67 -170.35 41.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -60.21 140.79 56.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -1.195 . . . . 0.0 109.225 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.21 -167.8 1.94 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 9' ' ' PRO . . . -48.32 158.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 8' ' ' ALA . 45.2 Cg_exo -53.0 -155.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.641 2.227 . . . . 0.0 111.699 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.9 p -108.05 178.07 4.62 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.431 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 3.8 m -120.87 131.67 54.53 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.842 -1.161 . . . . 0.0 108.814 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.953 HG11 HD22 ' A' ' 35' ' ' LEU . 4.6 t -102.95 126.18 57.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 79' ' ' VAL . 40.8 t80 -93.19 118.99 31.88 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.582 ' CD2' HG22 ' A' ' 32' ' ' VAL . 24.0 t80 -85.58 123.98 31.62 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.434 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 2.7 t -117.34 113.65 22.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 17' ' ' SER . . . -162.07 75.98 0.18 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 16' ' ' GLY . 30.4 t -31.8 106.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.616 -0.932 . . . . 0.0 110.48 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -61.13 -170.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.739 ' H ' ' NH1' ' A' ' 22' ' ' ARG . 60.3 ttt85 51.54 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.068 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.97 -22.73 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.964 -2.055 . . . . 0.0 107.964 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . 178.89 -29.9 0.06 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.798 ' NH2' ' H ' ' A' ' 55' ' ' GLY . 33.6 mmt180 73.91 -33.56 0.26 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.126 -0.632 . . . . 0.0 109.621 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 21' ' ' GLY . 78.5 tt0 -55.15 -46.8 75.73 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' TYR . 17.2 m-20 -62.74 -20.5 65.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.861 HE22 ' H ' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -67.25 -47.06 71.89 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.05 -46.18 85.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.18 -37.15 74.18 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.4 m-30 -67.33 -41.49 85.18 Favored 'General case' 0 C--O 1.198 -1.644 0 O-C-N 121.405 -0.809 . . . . 0.0 109.69 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 33' ' ' SER . . . -60.82 -36.54 79.34 Favored 'General case' 0 C--N 1.292 -1.924 0 O-C-N 120.419 -1.425 . . . . 0.0 108.463 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.515 ' NH2' ' OE2' ' A' ' 140' ' ' GLU . 70.7 ttt-85 -72.56 -57.38 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.957 -1.089 . . . . 0.0 108.506 178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.1 -40.74 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' TYR . 52.3 t -64.62 -29.35 47.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 10.2 m -67.8 -37.15 81.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.39 -0.819 . . . . 0.0 109.646 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.41 -52.11 24.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.671 -1.268 . . . . 0.0 108.755 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.953 HD22 HG11 ' A' ' 12' ' ' VAL . 16.6 mt -57.48 -40.21 78.08 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -61.36 -25.32 67.08 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.73 -31.05 32.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.948 -1.095 . . . . 0.0 109.745 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.564 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 1.8 m-85 -75.18 -52.67 10.37 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.242 -0.911 . . . . 0.0 110.946 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.34 -147.05 4.46 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -89.81 129.04 36.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.4 -1.059 . . . . 0.0 109.006 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 32' ' ' VAL . 2.8 t -93.77 106.74 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.886 -1.134 . . . . 0.0 107.974 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 20.5 mt -72.38 -176.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 108.838 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.543 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 1.7 m 55.82 39.67 30.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.783 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 52.3 mp0 -46.3 -25.06 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -49.06 -38.41 24.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.093 -1.004 . . . . 0.0 108.996 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG12 ' N ' ' A' ' 47' ' ' ALA . 59.2 t -61.27 170.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.861 ' H ' HE22 ' A' ' 25' ' ' GLN . . . 61.82 -71.96 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.86 ' O ' HD21 ' A' ' 51' ' ' LEU . 21.0 t70 -67.82 28.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -106.62 12.91 28.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -108.47 11.4 26.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.336 -0.852 . . . . 0.0 109.744 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.015 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -86.08 -93.76 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.085 -1.01 . . . . 0.0 110.232 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.477 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.0 mp0 -42.67 158.73 0.21 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.206 -0.934 . . . . 0.0 110.268 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.0 -22.16 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.647 2.232 . . . . 0.0 112.24 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.574 HD21 ' O ' ' A' ' 49' ' ' ALA . 1.6 mm? 59.69 -172.71 0.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.337 -0.852 . . . . 0.0 109.73 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.798 ' H ' ' NH2' ' A' ' 22' ' ' ARG . . . 99.04 25.67 9.43 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 62' ' ' ASP . 73.4 mm-40 53.52 -74.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.781 -0.834 . . . . 0.0 109.664 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.679 ' N ' ' O ' ' A' ' 55' ' ' GLY . 86.6 tt0 -44.5 -26.46 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.459 -0.775 . . . . 0.0 109.299 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 54' ' ' LEU . . . -67.87 166.28 15.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.105 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.84 133.67 31.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.242 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 173.39 -81.59 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.37 80.88 0.37 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD1' ' OE1' ' A' ' 56' ' ' GLU . 3.0 m-20 -52.5 -44.13 65.48 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.256 -1.144 . . . . 0.0 108.255 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -62.61 -49.26 75.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -60.48 -34.79 74.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 109.049 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -63.03 -53.95 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' N ' HG22 ' A' ' 65' ' ' ILE . 1.6 t-80 -65.6 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.623 -0.673 . . . . 0.0 109.666 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.1 -64.0 1.03 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -71.55 -38.95 70.96 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.277 -0.89 . . . . 0.0 110.138 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 10.1 m-20 -62.69 -59.25 5.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.093 -1.004 . . . . 0.0 110.351 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.47 HD22 ' CE1' ' A' ' 66' ' ' HIS . 0.9 OUTLIER -61.05 -36.86 80.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.845 -1.159 . . . . 0.0 109.785 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -66.57 -52.36 46.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 109.565 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.484 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -58.12 -43.52 87.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.133 -0.979 . . . . 0.0 108.998 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' N ' ' CE2' ' A' ' 13' ' ' TYR . 4.1 tt -53.47 -43.65 68.33 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.49 ' CG ' HH21 ' A' ' 96' ' ' ARG . 28.2 mt-30 -65.78 -29.87 70.43 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.68 -0.638 . . . . 0.0 111.258 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -103.49 11.51 36.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.626 -1.296 . . . . 0.0 109.274 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -72.05 138.83 48.14 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.337 -0.852 . . . . 0.0 111.694 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 11' ' ' SER . 86.4 m-20 -88.16 -25.74 22.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 69.7 t -144.99 136.35 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 13' ' ' TYR . 93.9 t -133.14 125.17 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.864 -1.147 . . . . 0.0 111.91 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -119.19 124.69 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.55 ' HB3' HD21 ' A' ' 94' ' ' LEU . . . -120.24 146.54 45.96 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.072 0.939 . . . . 0.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' HG11 ' A' ' 90' ' ' VAL . 1.3 pp20? -100.23 147.23 25.96 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.674 HG11 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -123.06 -89.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.97 -1.081 . . . . 0.0 109.915 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.525 HG21 ' HE ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER 64.29 -141.12 0.28 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.063 -1.648 . . . . 0.0 109.748 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 84' ' ' THR . 2.0 pt20 -43.29 148.63 0.62 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.754 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -45.24 128.0 9.45 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.131 1.888 . . . . 0.0 111.615 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.616 ' H ' ' HB2' ' B' ' 288' ' ' LEU . 15.7 t -102.41 -121.1 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' HB2' ' H ' ' B' ' 287' ' ' SER . 9.9 tp 160.02 -58.66 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.63 -36.06 58.72 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 106.824 -2.51 . . . . 0.0 106.824 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 82' ' ' GLU . 48.5 t -65.4 -45.25 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.48 -35.4 66.25 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.504 ' OH ' HG21 ' B' ' 298' ' ' VAL . 64.4 t80 -68.32 -56.09 9.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.46 -1.024 . . . . 0.0 109.675 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.521 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 87.0 mt-10 -57.25 -36.64 71.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.518 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.736 HD22 ' SG ' ' A' ' 106' ' ' CYS . 63.2 mt -60.35 -49.09 78.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.57 -23.83 65.39 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' A' ' 74' ' ' GLN . 17.1 mmm180 -71.94 -47.26 53.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -1.179 . . . . 0.0 110.102 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 101' ' ' GLY . . . -70.35 -34.49 72.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.376 -1.453 . . . . 0.0 107.766 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG21 ' OH ' ' B' ' 292' ' ' TYR . 1.1 t -57.72 -40.93 78.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -78.49 -55.87 4.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.682 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.44 0.88 40.17 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.242 -0.911 . . . . 0.0 108.606 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 102' ' ' LYS . . . 72.99 -156.93 52.1 Favored Glycine 0 C--N 1.283 -2.387 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 101' ' ' GLY . 18.6 mtmm 95.68 132.75 0.03 OUTLIER Pre-proline 0 C--N 1.286 -2.191 0 C-N-CA 123.887 0.875 . . . . 0.0 108.768 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -38.89 112.96 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.05 1.833 . . . . 0.0 111.196 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 102' ' ' LYS . 1.1 mt -112.32 104.46 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.224 -0.922 . . . . 0.0 110.961 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 132' ' ' TRP . 45.6 tp -99.89 121.21 40.97 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.736 ' SG ' HD22 ' A' ' 94' ' ' LEU . 75.0 m -109.9 124.72 51.85 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 1.1 mt -121.76 131.19 53.94 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.024 -1.048 . . . . 0.0 112.334 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.512 ' HE2' ' O ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -125.63 153.37 43.87 Favored 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HE ' HG21 ' A' ' 84' ' ' THR . 60.7 mtm180 -105.82 145.75 31.51 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 120.732 -1.23 . . . . 0.0 111.805 -177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 113' ' ' GLY . 92.7 Cg_endo -83.49 -23.29 3.46 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 123.019 2.48 . . . . 0.0 111.6 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.456 ' NE2' ' CZ ' ' A' ' 109' ' ' ARG . 18.7 pt20 -45.66 -42.44 11.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.0 m -90.38 -14.33 33.22 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . 46.74 45.65 18.39 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' O ' ' HE2' ' A' ' 108' ' ' PHE . 32.5 mtp85 -85.32 177.26 7.88 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.998 -1.295 . . . . 0.0 107.588 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 116' ' ' LEU . 87.5 t -114.05 107.68 23.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 O-C-N 120.8 -1.188 . . . . 0.0 109.604 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.674 HD11 HG11 ' A' ' 83' ' ' VAL . 9.9 tp -41.59 137.41 1.6 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.3 m -46.52 145.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.032 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.6 -23.25 64.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.584 -0.697 . . . . 0.0 109.69 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.405 ' SD ' ' OE2' ' B' ' 293' ' ' GLU . 3.3 tpt -72.23 -52.39 16.65 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.26 -43.27 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.033 -1.042 . . . . 0.0 108.788 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -59.62 -47.57 85.05 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.32 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -56.89 -33.32 63.39 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.549 ' O ' ' C ' ' A' ' 124' ' ' ALA . . . -59.54 -47.17 86.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.232 . . . . 0.0 107.949 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 123' ' ' ALA . . . -20.95 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.819 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.461 ' CG ' ' O ' ' A' ' 123' ' ' ALA . 65.9 m-20 -110.24 -16.54 13.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 108.794 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.84 40.53 97.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.98 -2.048 . . . . 0.0 107.98 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 86.1 p -144.64 63.13 1.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.642 ' HB2' ' O ' ' A' ' 127' ' ' SER . 94.1 mtt-85 95.38 -31.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -102.32 121.83 43.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.404 ' CB ' ' HE1' ' A' ' 132' ' ' TRP . 20.2 mt-30 -145.25 145.3 31.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.049 -1.032 . . . . 0.0 110.426 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.29 101.26 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.435 ' N ' ' CD1' ' A' ' 132' ' ' TRP . 16.0 m0 -97.66 147.76 24.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.401 -0.812 . . . . 0.0 110.522 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 37.8 p-10 -99.44 144.89 28.03 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.545 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.9 p90 -167.18 178.62 5.53 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.379 -1.328 . . . . 0.0 111.505 -178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.681 ' C ' ' H ' ' A' ' 137' ' ' GLY . . . -150.93 155.94 40.16 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' OE2' ' NH1' ' A' ' 109' ' ' ARG . 38.6 mt-10 -58.03 27.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.416 -0.802 . . . . 0.0 110.396 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 135' ' ' ALA . . . -126.44 -12.63 3.36 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.596 ' O ' ' SD ' ' A' ' 142' ' ' MET . 3.3 pt-20 -145.4 10.04 1.25 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.145 -1.209 . . . . 0.0 109.554 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 3.7 p -48.98 -43.69 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.515 ' OE2' ' NH2' ' A' ' 30' ' ' ARG . 93.9 mt-10 -56.1 -33.2 64.88 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.532 HG22 HH11 ' A' ' 145' ' ' ARG . 15.6 m -65.62 -41.1 93.08 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 108.858 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.672 ' SD ' ' N ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -55.07 -50.95 67.85 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 84.7 mt -60.55 -30.75 69.96 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.762 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 38.5 m-20 -70.37 -43.86 69.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.262 -0.899 . . . . 0.0 110.806 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.532 HH11 HG22 ' A' ' 141' ' ' THR . 52.7 mtt85 -70.49 -47.74 59.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.392 . . . . 0.0 108.951 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 36.1 t80 -60.1 -46.51 89.35 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.662 -0.649 . . . . 0.0 110.572 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.837 ' CG ' HD12 ' A' ' 151' ' ' LEU . 14.6 m-85 -80.1 -27.84 39.14 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.019 -1.072 . . . . 0.0 110.842 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 60.5 mt-10 -61.98 -29.27 70.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 146' ' ' TYR . . . -68.61 -19.19 64.43 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.785 ' O ' ' CG ' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -174.65 101.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.069 -1.02 . . . . 0.0 111.098 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.837 HD12 ' CG ' ' A' ' 147' ' ' PHE . 1.0 OUTLIER 170.7 -47.63 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.587 -0.696 . . . . 0.0 109.232 177.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.573 ' O ' HG22 ' A' ' 155' ' ' THR . 69.7 Cg_exo -49.05 -39.6 41.01 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.338 2.025 . . . . 0.0 112.021 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.434 ' C ' ' H ' ' A' ' 155' ' ' THR . 48.5 tt0 -67.57 -34.34 76.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.354 -0.841 . . . . 0.0 109.245 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 156' ' ' ALA . 46.0 tttp -66.61 2.92 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 152' ' ' PRO . 9.1 t -68.3 34.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.546 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' A' ' 154' ' ' LYS . . . 61.16 39.26 16.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.2 t -72.89 145.9 46.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.341 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 160' ' ' HIS . 20.5 m -66.62 151.09 48.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.174 -0.954 . . . . 0.0 109.512 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.1 m -67.01 -13.5 61.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 109.081 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 158' ' ' SER . 93.1 m-70 52.17 68.17 3.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.744 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -55.31 -24.43 42.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.816 2.344 . . . . 0.0 112.057 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -73.22 155.88 39.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.872 . . . . 0.0 109.566 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.457 -179.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -159.84 -44.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.673 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -73.83 162.23 29.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.698 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 59.7 p -63.4 -23.72 67.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.858 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.88 -169.74 40.68 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -60.73 141.17 57.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -1.178 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -90.37 -167.96 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.815 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' B' ' 209' ' ' PRO . . . -48.48 158.17 0.64 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.843 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' B' ' 208' ' ' ALA . 43.6 Cg_exo -53.0 -155.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.591 2.194 . . . . 0.0 111.817 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 31.8 p -107.84 177.82 4.7 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 3.9 m -120.86 131.33 54.35 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 120.983 -1.073 . . . . 0.0 108.776 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.997 HG11 HD22 ' B' ' 235' ' ' LEU . 4.9 t -102.52 126.29 56.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.677 ' HB3' HG22 ' B' ' 279' ' ' VAL . 41.0 t80 -93.22 119.05 31.97 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.587 ' CD2' HG22 ' B' ' 232' ' ' VAL . 24.3 t80 -85.53 123.47 30.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.808 -1.157 . . . . 0.0 109.532 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.511 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 2.8 t -116.84 113.42 22.47 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.678 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.522 ' O ' ' C ' ' B' ' 217' ' ' SER . . . -161.79 75.91 0.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.522 ' C ' ' O ' ' B' ' 216' ' ' GLY . 28.4 t -31.66 106.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.646 -0.914 . . . . 0.0 110.588 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.737 ' N ' HD13 ' B' ' 218' ' ' ILE . 0.0 OUTLIER -60.67 -171.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 108.778 179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.76 ' H ' ' NH1' ' B' ' 222' ' ' ARG . 59.7 ttt85 51.8 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.149 -0.97 . . . . 0.0 109.127 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 177.12 -22.87 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.016 -2.033 . . . . 0.0 108.016 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' B' ' 222' ' ' ARG . . . 179.29 -29.86 0.06 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.806 ' NH2' ' H ' ' B' ' 255' ' ' GLY . 33.6 mmt180 73.93 -33.57 0.26 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 122.16 -0.612 . . . . 0.0 109.764 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 221' ' ' GLY . 78.0 tt0 -55.25 -46.08 76.08 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' B' ' 228' ' ' TYR . 16.4 m-20 -63.33 -20.49 65.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.821 ' NE2' ' H ' ' B' ' 247' ' ' ALA . 0.7 OUTLIER -67.32 -46.73 72.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.23 86.43 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.1 -37.14 73.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.743 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.4 m-30 -67.5 -41.18 84.91 Favored 'General case' 0 C--O 1.199 -1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.703 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.15 -36.37 79.6 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.43 -1.419 . . . . 0.0 108.52 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 340' ' ' GLU . 71.3 ttt-85 -72.76 -57.4 4.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 108.6 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.89 -40.87 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.743 HG23 ' O ' ' B' ' 228' ' ' TYR . 51.3 t -64.71 -29.23 46.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.401 ' N ' ' O ' ' B' ' 230' ' ' ARG . 12.2 m -67.88 -37.01 81.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.38 -0.825 . . . . 0.0 109.493 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -70.35 -52.29 23.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.719 -1.238 . . . . 0.0 108.757 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.997 HD22 HG11 ' B' ' 212' ' ' VAL . 15.8 mt -57.53 -39.94 77.71 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -61.49 -25.39 67.23 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 79.7 mtt-85 -81.78 -31.33 31.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.141 -0.975 . . . . 0.0 109.777 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.567 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 1.8 m-85 -75.01 -52.6 10.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.21 -0.931 . . . . 0.0 110.926 -177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . . . . . . . . . . . -147.21 -147.58 4.57 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -89.42 129.08 35.98 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.312 -1.111 . . . . 0.0 108.961 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.689 HG11 HG13 ' B' ' 232' ' ' VAL . 2.8 t -93.54 106.78 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.494 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 20.4 mt -72.88 -176.78 2.14 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.519 -0.872 . . . . 0.0 108.865 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.563 HG22 HG23 ' B' ' 246' ' ' VAL . 1.9 m 56.25 39.2 30.29 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.001 -1.062 . . . . 0.0 108.786 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.594 ' H ' ' CD ' ' B' ' 244' ' ' GLU . 52.6 mp0 -45.99 -25.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.391 -0.818 . . . . 0.0 109.731 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -48.95 -38.1 21.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.615 HG12 ' N ' ' B' ' 247' ' ' ALA . 62.0 t -61.23 170.84 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.821 ' H ' ' NE2' ' B' ' 225' ' ' GLN . . . 61.74 -71.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.854 ' O ' HD21 ' B' ' 251' ' ' LEU . 20.0 t70 -67.59 28.65 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -106.76 13.46 27.94 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -108.64 10.52 26.95 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 1.08 ' H ' HD22 ' B' ' 251' ' ' LEU . 0.0 OUTLIER -85.59 -94.06 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.106 -0.996 . . . . 0.0 110.256 -179.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.481 ' O ' HD23 ' B' ' 254' ' ' LEU . 1.9 mp0 -42.43 158.68 0.21 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.28 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -41.09 -22.11 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.748 2.299 . . . . 0.0 112.212 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.572 HD21 ' O ' ' B' ' 249' ' ' ALA . 1.6 mm? 59.52 -172.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.829 . . . . 0.0 109.933 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.806 ' H ' ' NH2' ' B' ' 222' ' ' ARG . . . 98.51 25.23 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.441 ' OE1' ' OD1' ' B' ' 262' ' ' ASP . 73.5 mm-40 53.73 -73.72 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.913 -0.757 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.673 ' N ' ' O ' ' B' ' 255' ' ' GLY . 86.8 tt0 -44.59 -25.37 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 254' ' ' LEU . . . -69.6 165.11 21.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.113 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -50.39 134.02 23.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.351 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 172.82 -81.6 0.08 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 126.26 81.34 0.39 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.441 ' OD1' ' OE1' ' B' ' 256' ' ' GLU . 3.1 m-20 -52.87 -43.99 66.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.63 -49.33 75.61 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -60.52 -35.02 74.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.503 HG22 ' N ' ' B' ' 266' ' ' HIS . 0.4 OUTLIER -62.51 -54.07 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.503 ' N ' HG22 ' B' ' 265' ' ' ILE . 1.7 t-80 -65.51 -33.78 76.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.577 -0.702 . . . . 0.0 109.64 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -55.79 -64.18 0.94 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 109.551 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -71.62 -38.71 70.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.859 . . . . 0.0 110.217 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.444 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 10.4 m-20 -62.87 -59.22 5.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.022 -1.049 . . . . 0.0 110.296 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.479 HD22 ' CE1' ' B' ' 266' ' ' HIS . 0.9 OUTLIER -61.12 -36.86 80.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.912 -1.118 . . . . 0.0 109.734 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -66.35 -52.53 46.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.181 -0.949 . . . . 0.0 109.638 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.494 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.0 OUTLIER -57.91 -43.79 86.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.135 -0.978 . . . . 0.0 109.025 -179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.497 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 3.9 tt -53.21 -43.82 67.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.481 ' CG ' HH21 ' B' ' 296' ' ' ARG . 28.9 mt-30 -65.41 -30.15 70.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.683 -0.636 . . . . 0.0 111.136 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.54 11.72 35.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.124 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.87 48.04 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.347 -0.845 . . . . 0.0 111.514 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' B' ' 211' ' ' SER . 87.4 m-20 -88.45 -25.72 22.48 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 69.9 t -144.82 136.11 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' B' ' 213' ' ' TYR . 91.4 t -133.09 125.27 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.89 -1.132 . . . . 0.0 111.914 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.3 124.65 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.551 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -120.39 146.04 46.58 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.1 0.953 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.535 ' O ' HG11 ' B' ' 290' ' ' VAL . 1.2 pp20? -99.8 147.07 25.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.686 HG11 HD11 ' B' ' 316' ' ' LEU . 0.4 OUTLIER -122.96 -90.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.927 -1.108 . . . . 0.0 109.986 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.539 HG21 ' HE ' ' B' ' 309' ' ' ARG . 0.2 OUTLIER 64.36 -140.97 0.27 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 119.902 -1.749 . . . . 0.0 109.776 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.416 ' HA ' ' NE ' ' B' ' 314' ' ' ARG . 2.0 pt20 -43.47 148.56 0.66 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -45.24 128.12 9.53 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.185 1.923 . . . . 0.0 111.622 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.598 ' H ' ' HB2' ' A' ' 88' ' ' LEU . 15.4 t -102.43 -120.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.616 ' HB2' ' H ' ' A' ' 87' ' ' SER . 9.7 tp 159.74 -58.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.71 -35.51 58.8 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.535 HG11 ' O ' ' B' ' 282' ' ' GLU . 48.9 t -65.89 -45.09 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -56.47 -35.5 66.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.53 ' OH ' HG21 ' A' ' 98' ' ' VAL . 64.7 t80 -68.35 -56.03 9.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.602 -0.94 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.511 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 82.9 mt-10 -57.21 -36.62 71.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.731 HD22 ' SG ' ' B' ' 306' ' ' CYS . 63.4 mt -60.44 -48.96 79.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -62.67 -23.67 65.42 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.481 HH21 ' CG ' ' B' ' 274' ' ' GLN . 17.2 mmm180 -71.92 -47.22 54.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -1.158 . . . . 0.0 110.096 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' B' ' 301' ' ' GLY . . . -70.43 -34.43 72.47 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.36 -1.462 . . . . 0.0 107.879 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.504 HG21 ' OH ' ' A' ' 92' ' ' TYR . 1.1 t -57.82 -40.64 76.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.682 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -78.75 -56.37 4.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.594 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.1 0.65 39.71 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.929 0.871 . . . . 0.0 108.675 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.659 ' O ' ' HB2' ' B' ' 302' ' ' LYS . . . 72.82 -156.81 52.11 Favored Glycine 0 C--N 1.282 -2.418 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' B' ' 301' ' ' GLY . 18.2 mtmm 95.5 132.6 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 302' ' ' LYS . 87.7 Cg_exo -38.49 113.42 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.941 1.761 . . . . 0.0 111.209 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 302' ' ' LYS . 1.1 mt -112.83 104.62 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.334 -0.854 . . . . 0.0 110.871 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' B' ' 332' ' ' TRP . 47.1 tp -100.03 121.48 41.45 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' B' ' 294' ' ' LEU . 73.5 m -110.28 124.42 51.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.54 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 1.1 mt -121.31 131.17 54.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.988 -1.07 . . . . 0.0 112.321 -177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -125.63 153.36 43.9 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.539 ' HE ' HG21 ' B' ' 284' ' ' THR . 60.9 mtm180 -105.92 145.38 30.79 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 120.713 -1.242 . . . . 0.0 111.663 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' B' ' 313' ' ' GLY . 94.4 Cg_endo -83.39 -22.83 3.72 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 C-N-CA 122.965 2.443 . . . . 0.0 111.68 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.481 ' NE2' ' CZ ' ' B' ' 309' ' ' ARG . 18.3 pt20 -46.1 -42.45 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 39.7 m -89.96 -14.72 33.48 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 310' ' ' PRO . . . 46.8 45.62 18.68 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.505 ' O ' ' HE2' ' B' ' 308' ' ' PHE . 32.5 mtp85 -85.44 177.28 7.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.97 -1.312 . . . . 0.0 107.563 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' B' ' 316' ' ' LEU . 83.5 t -114.25 107.96 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.722 -1.191 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.686 HD11 HG11 ' B' ' 283' ' ' VAL . 9.7 tp -41.63 137.41 1.62 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 59.1 m -46.57 145.61 1.78 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 110.034 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.87 -22.77 64.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 3.3 tpt -72.45 -53.03 13.3 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.298 -0.877 . . . . 0.0 109.69 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 39.7 mm -61.64 -42.86 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.016 -1.052 . . . . 0.0 108.833 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -60.36 -47.56 85.55 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.953 -1.092 . . . . 0.0 108.34 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -56.85 -33.2 63.04 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.551 ' O ' ' C ' ' B' ' 324' ' ' ALA . . . -59.75 -47.58 85.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.111 -1.229 . . . . 0.0 107.982 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.551 ' C ' ' O ' ' B' ' 323' ' ' ALA . . . -20.42 92.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.962 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' B' ' 323' ' ' ALA . 65.5 m-20 -110.67 -16.41 13.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.297 -0.877 . . . . 0.0 108.814 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 64.76 39.85 96.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' B' ' 328' ' ' ARG . 86.7 p -143.89 62.8 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' B' ' 327' ' ' SER . 93.6 mtt-85 95.72 -31.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -102.4 121.53 42.49 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.403 ' CB ' ' HE1' ' B' ' 332' ' ' TRP . 19.5 mt-30 -145.08 145.0 31.25 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.452 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.23 101.46 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.434 ' CG ' HD11 ' B' ' 305' ' ' LEU . 16.1 m0 -97.84 147.75 24.11 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.783 . . . . 0.0 110.473 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' B' ' 333' ' ' ASP . 38.7 p-10 -99.49 144.79 28.18 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.0 p90 -166.91 178.81 5.6 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.395 -1.322 . . . . 0.0 111.464 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.671 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -151.12 156.14 40.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -58.2 27.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.353 -0.842 . . . . 0.0 110.424 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -126.83 -12.13 3.37 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.586 ' O ' ' SD ' ' B' ' 342' ' ' MET . 3.4 pt-20 -145.93 10.04 1.17 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.133 -1.216 . . . . 0.0 109.412 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 3.6 p -48.95 -43.42 14.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 230' ' ' ARG . 93.1 mt-10 -56.33 -33.26 65.44 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . 0.526 HG22 HH11 ' B' ' 345' ' ' ARG . 14.0 m -65.41 -41.11 93.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.664 -0.814 . . . . 0.0 108.872 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.683 ' SD ' ' N ' ' B' ' 342' ' ' MET . 0.0 OUTLIER -55.01 -51.3 66.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 82.4 mt -60.17 -30.77 69.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.849 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 39.1 m-20 -70.6 -43.62 68.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.381 -0.824 . . . . 0.0 110.666 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . 0.526 HH11 HG22 ' B' ' 341' ' ' THR . 53.0 mtt85 -70.8 -47.41 59.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.411 -1.431 . . . . 0.0 108.955 -179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' B' ' 349' ' ' ALA . 35.8 t80 -60.18 -46.75 88.64 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.69 -0.631 . . . . 0.0 110.506 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.824 ' CG ' HD12 ' B' ' 351' ' ' LEU . 14.9 m-85 -79.99 -27.87 39.55 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.991 -1.083 . . . . 0.0 110.84 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 61.5 mt-10 -61.95 -29.1 70.01 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 346' ' ' TYR . . . -68.96 -18.76 64.12 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.787 ' O ' ' CG ' ' B' ' 350' ' ' TYR . 0.0 OUTLIER -174.94 102.32 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 110.988 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.824 HD12 ' CG ' ' B' ' 347' ' ' PHE . 1.0 OUTLIER 170.21 -48.03 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.536 -0.727 . . . . 0.0 109.328 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.583 ' O ' HG22 ' B' ' 355' ' ' THR . 75.0 Cg_exo -48.77 -39.83 38.88 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.395 2.064 . . . . 0.0 112.061 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' B' ' 355' ' ' THR . 48.2 tt0 -67.52 -34.21 76.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . 0.552 ' C ' ' H ' ' B' ' 356' ' ' ALA . 46.3 tttp -66.39 2.85 1.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.372 -0.83 . . . . 0.0 109.471 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . 0.583 HG22 ' O ' ' B' ' 352' ' ' PRO . 8.9 t -68.45 34.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.93 . . . . 0.0 109.501 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' B' ' 354' ' ' LYS . . . 60.84 38.57 17.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 38.6 t -72.31 146.19 47.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.221 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . 0.483 ' O ' ' CD2' ' B' ' 360' ' ' HIS . 25.8 m -67.09 150.87 48.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.968 . . . . 0.0 109.589 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 64.0 m -66.56 -14.33 62.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.095 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' B' ' 358' ' ' SER . 93.0 m-70 52.67 68.11 3.34 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.727 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -55.42 -22.06 32.58 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.768 2.312 . . . . 0.0 112.239 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 26.9 t -77.32 153.85 33.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.377 179.702 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 mtt . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.311 0.576 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.5 -19.48 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.608 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.63 146.31 45.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.161 -0.962 . . . . 0.0 109.454 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.5 p -79.61 170.82 15.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -0.899 . . . . 0.0 109.679 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.93 170.72 35.41 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -74.63 152.02 39.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -1.161 . . . . 0.0 109.388 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' OE1' ' N ' ' A' ' 7' ' ' GLN . 0.8 OUTLIER -63.74 -179.18 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.571 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.09 153.43 81.34 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' CYS . 55.3 Cg_endo -72.12 158.69 51.68 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.637 2.225 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 9' ' ' PRO . 32.1 p -52.49 -179.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.132 -0.98 . . . . 0.0 108.734 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.438 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 10.3 p -112.54 146.36 38.65 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.096 -1.003 . . . . 0.0 108.522 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.981 HG11 HD22 ' A' ' 35' ' ' LEU . 7.8 t -127.38 127.12 68.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' HB3' HG13 ' A' ' 79' ' ' VAL . 29.2 t80 -100.85 144.17 30.13 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 32' ' ' VAL . 3.7 t80 -104.27 128.17 52.0 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 110.279 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 104.34 10.57 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.95 162.64 22.45 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.41 ' OG ' ' CB ' ' A' ' 87' ' ' SER . 2.5 m -67.39 -55.32 14.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.385 -1.067 . . . . 0.0 109.415 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 18' ' ' ILE . 9.5 mt 58.0 -123.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.393 -0.817 . . . . 0.0 109.981 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttp180 52.64 82.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.68 -34.35 5.17 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.67 113.91 0.05 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.612 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -142.34 -147.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.105 -1.232 . . . . 0.0 110.133 -178.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.07 -39.41 92.31 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 71.5 m-20 -58.54 -30.21 66.93 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.96 ' NE2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -68.86 -49.06 61.52 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.91 -48.03 81.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -58.3 -34.7 70.84 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 32' ' ' VAL . 20.1 m-30 -68.54 -43.88 75.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.83 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.2 -36.56 80.22 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.398 -1.439 . . . . 0.0 108.815 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.653 ' NE ' HH22 ' A' ' 34' ' ' ARG . 61.7 ttt180 -71.58 -59.0 2.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.915 -1.116 . . . . 0.0 108.533 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.6 mt -51.55 -40.97 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.8 t -66.57 -27.78 41.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 17.4 p -65.53 -41.34 93.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.187 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.653 HH22 ' NE ' ' A' ' 30' ' ' ARG . 73.2 mtt85 -65.57 -41.72 92.59 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.981 HD22 HG11 ' A' ' 12' ' ' VAL . 86.0 mt -59.59 -42.94 93.7 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -58.88 -24.49 62.31 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 88.5 mtt-85 -70.18 -62.43 1.39 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.593 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.2 p90 -129.15 154.1 47.06 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 87.45 72.27 1.29 Allowed Glycine 0 N--CA 1.477 1.421 0 N-CA-C 107.047 -2.421 . . . . 0.0 107.047 -177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 39' ' ' GLY . 2.6 ttmt -35.76 126.65 0.68 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.979 . . . . 0.0 109.052 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.5 t -84.18 90.31 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.552 -1.343 . . . . 0.0 107.964 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -52.42 -57.41 9.95 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.229 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' CE2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -86.69 91.22 8.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.689 -179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.14 -24.15 51.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.264 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.517 ' O ' ' HB2' ' A' ' 49' ' ' ALA . 30.4 t-80 -65.47 -29.54 70.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 109.764 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 14' ' ' PHE . 25.2 t -52.75 -20.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.591 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.614 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -106.64 -65.41 1.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.186 -0.946 . . . . 0.0 109.513 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.854 ' O ' ' N ' ' A' ' 50' ' ' GLU . 56.5 m-20 -44.81 -24.22 0.19 Allowed 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.96 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . . . -23.01 -30.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.525 0.678 . . . . 0.0 110.318 177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.854 ' N ' ' O ' ' A' ' 48' ' ' ASP . 26.9 mt-10 -62.42 -19.55 63.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 120.94 -1.1 . . . . 0.0 109.352 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -57.85 135.39 56.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.89 -1.131 . . . . 0.0 108.545 179.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' O ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER 56.42 152.63 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 109.336 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' A' ' 54' ' ' LEU . 39.5 Cg_endo -69.28 92.47 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.167 1.912 . . . . 0.0 110.836 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.762 HD11 ' O ' ' A' ' 49' ' ' ALA . 20.6 mt -53.77 -155.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.803 0.811 . . . . 0.0 110.696 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . 96.54 26.47 10.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' B' ' 318' ' ' ALA . 26.1 mt-10 63.18 -23.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.974 -0.721 . . . . 0.0 109.353 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 55' ' ' GLY . 60.8 tt0 -75.02 -17.73 60.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 108.849 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 60' ' ' GLY . . . -58.88 -161.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.191 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' A' ' 58' ' ' ALA . . . -36.67 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.631 -0.668 . . . . 0.0 109.612 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 58' ' ' ALA . . . 91.31 -162.72 28.47 Favored Glycine 0 N--CA 1.488 2.165 0 C-N-CA 120.015 -1.088 . . . . 0.0 110.718 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' PHE . . . 92.88 42.54 4.38 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' GLY . 66.5 m-20 -48.08 -45.41 32.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -59.64 -43.49 93.86 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.468 ' N ' ' O ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -61.01 -48.06 83.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.625 -0.672 . . . . 0.0 109.847 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.7 tt -71.34 -33.88 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.771 ' ND1' ' O ' ' B' ' 319' ' ' MET . 21.8 t60 -78.58 -31.22 47.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.016 -1.052 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 71' ' ' ASN . 46.1 mm-40 -68.79 -51.93 35.69 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 108.702 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.17 -39.7 89.96 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.393 -0.817 . . . . 0.0 109.217 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 74.6 m-20 -69.78 -53.22 19.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.325 -0.859 . . . . 0.0 110.37 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.471 HD22 ' HE2' ' A' ' 66' ' ' HIS . 6.3 tp -68.42 -38.5 81.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.11 -0.994 . . . . 0.0 110.697 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 67' ' ' GLU . 49.0 t-20 -64.36 -53.13 53.43 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.167 -0.958 . . . . 0.0 109.402 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.555 ' CZ3' ' NE2' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -60.23 -41.64 93.56 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.105 -0.997 . . . . 0.0 108.659 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 4.3 tt -52.69 -37.33 58.76 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -74.91 -29.28 60.92 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.751 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.555 ' NE2' ' CZ3' ' A' ' 72' ' ' TRP . 32.1 mt-30 -92.56 5.14 51.98 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.022 -1.049 . . . . 0.0 109.368 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.42 131.13 35.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.317 -0.865 . . . . 0.0 111.722 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 11' ' ' SER . 81.1 m-20 -74.49 -31.3 62.16 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 61.5 t -139.36 140.11 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' A' ' 13' ' ' TYR . 61.7 t -134.0 128.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.905 -1.122 . . . . 0.0 111.942 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.82 123.87 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.4 122.75 47.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.162 -0.961 . . . . 0.0 109.326 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' OE2' ' CZ ' ' A' ' 134' ' ' TYR . 18.5 tp10 -84.44 114.4 21.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.428 -0.795 . . . . 0.0 109.481 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -119.82 148.88 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.512 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.401 ' O ' ' CD ' ' A' ' 114' ' ' ARG . 57.8 m -167.44 -30.76 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -143.69 150.65 51.19 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.434 ' O ' ' OG ' ' A' ' 87' ' ' SER . 85.1 Cg_exo -35.6 131.69 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.755 2.303 . . . . 0.0 112.425 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.773 ' O ' HD23 ' B' ' 288' ' ' LEU . 15.6 m -166.87 116.22 0.87 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.768 HD23 ' O ' ' B' ' 287' ' ' SER . 3.1 mt -68.15 -41.18 81.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.988 -1.07 . . . . 0.0 109.647 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.18 70.62 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.4 t -79.05 -49.49 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.47 -1.017 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.96 -39.95 89.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.796 ' OH ' HG21 ' B' ' 298' ' ' VAL . 66.4 t80 -61.5 -44.56 96.85 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.234 -1.156 . . . . 0.0 109.434 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.86 -31.72 71.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.403 -0.811 . . . . 0.0 109.194 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -67.27 -43.56 81.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.75 97.66 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -41.02 90.65 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -1.062 . . . . 0.0 108.887 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 104' ' ' ILE . . . -70.09 -39.94 75.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.183 -0.948 . . . . 0.0 108.965 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.77 HG21 ' OH ' ' B' ' 292' ' ' TYR . 0.5 OUTLIER -52.75 -37.77 26.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.25 -50.26 16.69 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.129 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.95 -4.83 18.16 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.061 -1.025 . . . . 0.0 108.877 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.04 29.02 6.22 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 25.0 mtmm -95.72 152.12 38.9 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.976 -1.308 . . . . 0.0 107.786 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 90.8 Cg_exo -34.21 118.67 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.148 1.899 . . . . 0.0 111.775 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.582 HG12 ' HB1' ' A' ' 97' ' ' ALA . 3.6 mt -119.63 104.88 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.358 -0.839 . . . . 0.0 110.98 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.69 115.64 29.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.57 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -107.69 139.58 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 83' ' ' VAL . 11.7 mt -123.84 144.73 49.56 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.105 -0.997 . . . . 0.0 112.046 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.88 140.24 29.66 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.45 ' NE ' ' OH ' ' A' ' 134' ' ' TYR . 27.8 mtt180 -97.39 140.54 22.08 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 120.592 -1.318 . . . . 0.0 111.518 -177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 113' ' ' GLY . 72.6 Cg_endo -78.29 -34.14 1.67 Allowed 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 122.652 2.235 . . . . 0.0 110.789 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.473 ' CG ' ' N ' ' A' ' 112' ' ' SER . 18.2 pt20 -47.83 -38.96 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 113' ' ' GLY . 8.1 p -90.95 -21.04 21.53 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' A' ' 112' ' ' SER . . . 37.91 39.38 0.64 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 115' ' ' VAL . 45.7 mtt-85 -74.79 13.73 0.6 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.389 -1.065 . . . . 0.0 109.711 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.543 ' O ' ' NH1' ' B' ' 219' ' ' ARG . 56.0 t 49.43 100.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.313 -0.867 . . . . 0.0 110.066 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 120' ' ' ILE . 36.1 tp -48.28 143.55 4.57 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -40.42 141.62 0.5 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 111.053 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.465 ' N ' ' OE2' ' B' ' 256' ' ' GLU . . . -54.98 -55.03 35.38 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.44 0.638 . . . . 0.0 110.854 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.745 ' O ' ' ND1' ' B' ' 266' ' ' HIS . 14.8 mtp -60.37 -39.78 88.45 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.18 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.472 ' CD1' ' CD1' ' B' ' 292' ' ' TYR . 45.2 mm -62.67 -41.96 94.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.712 -1.242 . . . . 0.0 109.59 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.533 HH12 ' CG ' ' A' ' 125' ' ' ASP . 0.7 OUTLIER -72.86 -45.69 56.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.063 -1.023 . . . . 0.0 109.969 -179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -65.22 -18.98 65.73 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 -57.54 8.96 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.039 -1.271 . . . . 0.0 109.616 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.777 ' HB3' ' CD1' ' A' ' 129' ' ' PHE . . . -153.69 -89.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.952 -1.099 . . . . 0.0 111.687 -177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.616 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 22.9 t0 94.26 -0.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 127' ' ' SER . . . 177.4 82.59 0.06 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.807 ' C ' ' H ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER 165.44 72.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.445 -1.033 . . . . 0.0 109.79 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.38 -25.72 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.807 ' H ' ' C ' ' A' ' 127' ' ' SER . 8.9 t80 -116.95 115.5 25.57 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.53 132.71 41.26 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.175 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 71.4 t -92.04 102.75 13.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.29 145.22 26.31 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.169 -0.957 . . . . 0.0 110.378 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' SD ' ' A' ' 142' ' ' MET . 63.7 m-20 -96.54 152.21 18.85 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CZ ' ' OE2' ' A' ' 82' ' ' GLU . 5.5 p90 -170.35 173.86 5.5 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.383 -1.327 . . . . 0.0 111.606 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 137' ' ' GLY . . . -147.79 150.95 35.18 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 135' ' ' ALA . 41.5 mt-10 -40.5 -27.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.826 -1.171 . . . . 0.0 110.316 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 135' ' ' ALA . . . -85.79 -4.75 84.72 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 120.976 -1.077 . . . . 0.0 111.2 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -135.36 4.37 3.15 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.784 -1.421 . . . . 0.0 110.112 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.0 p -57.82 -48.86 82.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.979 -1.076 . . . . 0.0 108.759 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.524 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 23.9 pt-20 -55.01 -33.65 62.78 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 m -66.13 -39.45 89.89 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.069 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 14.3 mmt -55.06 -53.19 59.04 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 30.6 mt -63.34 -31.59 72.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.549 ' O ' ' CG ' ' A' ' 148' ' ' GLU . 28.7 t0 -69.05 -46.05 68.85 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 111.001 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -70.64 -50.36 37.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.404 -1.435 . . . . 0.0 109.818 -178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 29.4 t80 -57.12 -50.07 73.94 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' A' ' 151' ' ' LEU . 27.0 m-85 -75.79 -30.83 59.23 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.586 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 144' ' ' ASP . 5.5 mm-40 -55.12 -35.3 64.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.98 18.72 3.38 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 147' ' ' PHE . 2.0 t80 -147.27 -34.85 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 111.723 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.557 ' N ' ' CD ' ' A' ' 152' ' ' PRO . 18.4 mt -117.87 40.99 0.34 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 120.893 -1.129 . . . . 0.0 111.148 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 151' ' ' LEU . 61.3 Cg_endo -74.13 -32.84 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.922 1.748 . . . . 0.0 111.169 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -129.27 -26.93 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -58.31 -33.61 69.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.415 -0.803 . . . . 0.0 109.24 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 47.3 m -57.5 -37.59 73.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.571 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.93 139.79 30.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.93 . . . . 0.0 109.608 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 95.9 p -148.49 162.91 38.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.331 -0.856 . . . . 0.0 109.414 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.9 p 55.2 50.3 15.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 160' ' ' HIS . 96.8 p -61.62 -34.72 76.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.422 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 159' ' ' SER . 1.0 OUTLIER 56.22 150.68 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.521 -0.737 . . . . 0.0 109.705 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.43 148.37 79.12 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.547 2.164 . . . . 0.0 112.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.9 m -58.74 -31.08 67.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.487 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 55.9 mtt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.06 -18.46 65.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.588 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -61.31 145.82 50.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 109.403 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 84.4 p -79.29 169.46 18.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.606 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -157.46 170.11 34.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -73.89 151.65 40.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -1.207 . . . . 0.0 109.382 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' B' ' 207' ' ' GLN . 0.8 OUTLIER -63.48 -179.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.421 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.97 153.66 81.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.337 -0.852 . . . . 0.0 109.268 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' B' ' 210' ' ' CYS . 55.3 Cg_endo -72.3 159.13 50.28 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.595 2.197 . . . . 0.0 111.786 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.402 ' O ' ' O ' ' B' ' 209' ' ' PRO . 31.0 p -52.77 -179.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.09 -1.007 . . . . 0.0 108.766 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 10.1 p -112.71 146.26 39.03 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 1.005 HG11 HD22 ' B' ' 235' ' ' LEU . 7.2 t -127.35 127.41 69.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.579 ' HB3' HG13 ' B' ' 279' ' ' VAL . 29.7 t80 -101.04 144.32 30.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' B' ' 232' ' ' VAL . 3.7 t80 -104.57 127.8 52.39 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.382 -0.824 . . . . 0.0 110.392 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 104.78 11.08 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.5 22.44 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.416 ' HG ' ' CB ' ' B' ' 287' ' ' SER . 2.7 m -66.83 -55.98 12.42 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 109.205 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 9.6 mt 58.62 -123.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.473 -0.767 . . . . 0.0 109.883 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 13.5 ttp180 52.59 82.22 0.07 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.261 -0.899 . . . . 0.0 109.172 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . 112.97 -34.12 5.25 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 71.63 113.76 0.05 OUTLIER Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.615 ' N ' ' CD ' ' B' ' 222' ' ' ARG . 0.0 OUTLIER -142.63 -147.81 0.22 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.176 -1.19 . . . . 0.0 110.169 -178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -62.14 -39.66 93.33 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 70.8 m-20 -58.29 -30.07 66.34 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.942 ' NE2' ' HB3' ' B' ' 249' ' ' ALA . 0.0 OUTLIER -69.13 -48.7 61.73 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.08 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.95 81.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.8 tp -58.76 -34.35 71.32 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.751 ' O ' HG23 ' B' ' 232' ' ' VAL . 20.3 m-30 -68.61 -43.96 75.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.17 -36.55 80.14 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.519 -1.363 . . . . 0.0 108.823 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.647 ' NE ' HH22 ' B' ' 234' ' ' ARG . 57.8 ttt180 -71.5 -58.94 3.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.806 -1.183 . . . . 0.0 108.505 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.46 -41.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.751 HG23 ' O ' ' B' ' 228' ' ' TYR . 70.8 t -66.33 -28.07 42.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.435 ' N ' ' O ' ' B' ' 230' ' ' ARG . 14.5 p -65.44 -41.17 93.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.315 -0.866 . . . . 0.0 109.229 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.647 HH22 ' NE ' ' B' ' 230' ' ' ARG . 73.5 mtt85 -65.61 -41.67 92.47 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 1.005 HD22 HG11 ' B' ' 212' ' ' VAL . 84.9 mt -59.92 -42.86 94.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 25.5 mtt180 -58.7 -24.58 61.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 234' ' ' ARG . 87.6 mtt-85 -70.26 -62.94 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.585 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.1 p90 -128.49 154.49 46.05 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 86.98 72.39 1.29 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 107.127 -2.389 . . . . 0.0 107.127 -177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.524 ' C ' ' O ' ' B' ' 239' ' ' GLY . 2.7 ttmt -35.75 126.53 0.68 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.575 -0.956 . . . . 0.0 109.112 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . . . . . . . . . 75.2 t -83.99 90.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 120.543 -1.348 . . . . 0.0 108.088 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' B' ' 242' ' ' LEU . 1.1 mt -52.22 -57.43 9.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.223 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.472 ' OG1' ' CE2' ' B' ' 213' ' ' TYR . 0.2 OUTLIER -86.85 91.37 8.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 0.0 109.742 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.2 -24.47 51.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.529 ' O ' ' HB2' ' B' ' 249' ' ' ALA . 31.8 t-80 -65.23 -29.64 70.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.743 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' B' ' 214' ' ' PHE . 25.3 t -52.65 -20.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.607 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.579 ' C ' ' N ' ' B' ' 249' ' ' ALA . . . -106.56 -65.28 1.09 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.858 ' O ' ' N ' ' B' ' 250' ' ' GLU . 55.8 m-20 -44.98 -24.13 0.2 Allowed 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.942 ' HB3' ' NE2' ' B' ' 225' ' ' GLN . . . -23.18 -29.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.51 0.671 . . . . 0.0 110.399 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.858 ' N ' ' O ' ' B' ' 248' ' ' ASP . 27.0 mt-10 -63.08 -19.31 64.29 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.901 -1.124 . . . . 0.0 109.35 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' B' ' 248' ' ' ASP . 0.0 OUTLIER -57.78 135.33 56.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.961 -1.087 . . . . 0.0 108.58 179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.553 ' O ' ' O ' ' B' ' 251' ' ' LEU . 0.8 OUTLIER 56.38 152.37 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.334 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.552 ' O ' ' O ' ' B' ' 254' ' ' LEU . 39.1 Cg_endo -69.08 92.43 0.45 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.194 1.929 . . . . 0.0 110.895 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.772 HD11 ' O ' ' B' ' 249' ' ' ALA . 20.1 mt -53.99 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.848 0.833 . . . . 0.0 110.69 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.666 ' C ' ' H ' ' B' ' 257' ' ' GLU . . . 96.25 26.94 10.5 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.951 -2.06 . . . . 0.0 107.951 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.465 ' OE2' ' N ' ' A' ' 118' ' ' ALA . 26.9 mt-10 62.99 -23.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.931 -0.747 . . . . 0.0 109.401 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.666 ' H ' ' C ' ' B' ' 255' ' ' GLY . 61.0 tt0 -74.5 -17.66 60.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.188 -0.945 . . . . 0.0 108.928 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' B' ' 260' ' ' GLY . . . -58.7 -161.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.417 -0.802 . . . . 0.0 109.356 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . 0.491 ' C ' ' O ' ' B' ' 258' ' ' ALA . . . -36.68 -28.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.431 0.634 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' B' ' 258' ' ' ALA . . . 91.48 -162.81 28.3 Favored Glycine 0 N--CA 1.489 2.233 0 C-N-CA 120.16 -1.019 . . . . 0.0 110.737 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' B' ' 264' ' ' PHE . . . 93.37 42.44 4.26 Favored Glycine 0 C--N 1.298 -1.575 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 261' ' ' GLY . 68.4 m-20 -47.98 -45.29 31.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -59.85 -43.58 94.56 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' B' ' 261' ' ' GLY . 0.7 OUTLIER -60.87 -48.35 82.22 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.541 -0.724 . . . . 0.0 109.937 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . . . . . . . . . 3.8 tt -71.23 -33.59 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.475 -0.765 . . . . 0.0 109.996 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.745 ' ND1' ' O ' ' A' ' 119' ' ' MET . 22.5 t60 -78.65 -31.14 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' B' ' 271' ' ' ASN . 46.0 mm-40 -68.78 -52.71 27.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 108.63 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -65.3 -40.24 93.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.307 -0.871 . . . . 0.0 109.117 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.459 ' O ' ' CE2' ' B' ' 213' ' ' TYR . 67.1 m-20 -69.12 -53.65 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.371 -0.83 . . . . 0.0 110.564 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' B' ' 266' ' ' HIS . 6.2 tp -68.46 -38.39 81.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.029 -1.044 . . . . 0.0 110.644 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . 0.41 ' CB ' ' O ' ' B' ' 267' ' ' GLU . 50.6 t-20 -64.14 -53.49 48.66 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.353 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CZ3' ' NE2' ' B' ' 275' ' ' GLN . 0.2 OUTLIER -59.92 -41.77 92.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.104 -0.998 . . . . 0.0 108.642 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.442 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 4.1 tt -52.78 -36.92 58.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -75.39 -28.99 59.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.539 -0.726 . . . . 0.0 109.769 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.561 ' NE2' ' CZ3' ' B' ' 272' ' ' TRP . 32.4 mt-30 -92.45 4.76 52.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.971 -1.08 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.26 131.49 35.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.458 -0.776 . . . . 0.0 111.829 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' B' ' 211' ' ' SER . 83.2 m-20 -74.91 -31.48 61.56 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 61.8 t -139.27 140.25 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' B' ' 213' ' ' TYR . 62.0 t -134.0 129.6 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.939 -1.1 . . . . 0.0 111.995 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 33.3 t -119.27 123.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.411 ' HB3' HD21 ' B' ' 294' ' ' LEU . . . -107.4 122.16 46.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.539 ' OE2' ' CZ ' ' B' ' 334' ' ' TYR . 18.4 tp10 -83.81 114.21 21.47 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.605 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.1 OUTLIER -119.34 149.02 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 0.0 109.562 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . . . . . . . . . 57.6 m -167.7 -31.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -143.45 150.59 51.83 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -35.62 131.12 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.718 2.279 . . . . 0.0 112.514 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.768 ' O ' HD23 ' A' ' 88' ' ' LEU . 15.4 m -166.29 116.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.11 -0.994 . . . . 0.0 109.622 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.773 HD23 ' O ' ' A' ' 87' ' ' SER . 3.5 mt -68.27 -41.23 81.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.102 -0.999 . . . . 0.0 109.568 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.73 -36.32 71.52 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . . . . . . . . . 5.5 t -78.83 -49.75 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.473 -1.016 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.29 90.3 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.77 ' OH ' HG21 ' A' ' 98' ' ' VAL . 67.0 t80 -60.97 -44.67 97.01 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.233 -1.157 . . . . 0.0 109.419 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.67 -32.04 72.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.181 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 281' ' ' ALA . 20.0 mt -67.17 -43.43 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -61.64 -39.74 97.8 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -40.87 90.08 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.267 -1.137 . . . . 0.0 108.739 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' B' ' 304' ' ' ILE . . . -70.25 -39.83 74.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.796 HG21 ' OH ' ' A' ' 92' ' ' TYR . 0.5 OUTLIER -52.96 -37.71 26.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 177.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -75.23 -50.3 16.61 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.073 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.57 -5.05 17.6 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.126 -0.984 . . . . 0.0 108.848 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 48.07 29.01 6.27 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.46 ' O ' ' CG1' ' B' ' 304' ' ' ILE . 25.3 mtmm -95.75 152.29 38.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.953 -1.322 . . . . 0.0 107.748 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.437 ' C ' ' O ' ' B' ' 302' ' ' LYS . 84.0 Cg_exo -34.08 119.01 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.24 1.96 . . . . 0.0 111.788 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.563 HG12 ' HB1' ' B' ' 297' ' ' ALA . 3.5 mt -120.07 105.01 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.359 -0.838 . . . . 0.0 111.032 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 60.5 tp -99.85 115.94 30.76 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . 0.615 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -107.8 139.7 42.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.067 -1.021 . . . . 0.0 108.251 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' B' ' 283' ' ' VAL . 11.8 mt -124.0 144.67 49.68 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.028 -1.045 . . . . 0.0 112.093 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.0 OUTLIER -143.94 140.14 29.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.48 ' NE ' ' OH ' ' B' ' 334' ' ' TYR . 27.7 mtt180 -97.35 140.28 21.94 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.617 -1.302 . . . . 0.0 111.557 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.04 -33.66 2.0 Allowed 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.607 2.205 . . . . 0.0 110.796 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.47 ' CG ' ' N ' ' B' ' 312' ' ' SER . 18.2 pt20 -48.33 -38.96 20.46 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.481 ' O ' ' C ' ' B' ' 313' ' ' GLY . 7.5 p -91.31 -20.31 22.02 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' B' ' 312' ' ' SER . . . 37.17 39.62 0.48 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' B' ' 315' ' ' VAL . 45.5 mtt-85 -74.78 13.72 0.6 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.311 -1.111 . . . . 0.0 109.724 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.544 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 55.3 t 49.58 100.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 110.119 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 320' ' ' ILE . 36.6 tp -48.34 143.85 4.42 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 316' ' ' LEU . 0.4 OUTLIER -40.53 141.34 0.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.353 -0.842 . . . . 0.0 111.02 -178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . 0.464 ' N ' ' OE2' ' A' ' 56' ' ' GLU . . . -54.87 -55.12 33.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.693 -0.63 . . . . 0.0 110.79 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.771 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 14.2 mtp -60.13 -40.22 89.0 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.029 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 45.1 mm -62.53 -41.86 93.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 120.82 -1.175 . . . . 0.0 109.477 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.518 HH12 ' CG ' ' B' ' 325' ' ' ASP . 0.9 OUTLIER -72.77 -45.91 56.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.924 -1.11 . . . . 0.0 109.893 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . . . . . . . . . . . -65.36 -18.78 65.79 Favored Glycine 0 N--CA 1.482 1.728 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . . . . . . . . . . . -51.32 -57.6 8.45 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.124 -1.221 . . . . 0.0 109.534 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' B' ' 329' ' ' PHE . . . -153.96 -89.03 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.039 -1.064 . . . . 0.0 111.85 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.625 ' CB ' ' O ' ' B' ' 324' ' ' ALA . 23.2 t0 94.12 -0.89 0.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' B' ' 327' ' ' SER . . . 177.76 82.5 0.06 OUTLIER Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.758 ' C ' ' H ' ' B' ' 329' ' ' PHE . 1.0 OUTLIER 165.81 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.433 -1.039 . . . . 0.0 109.811 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 67.42 -25.47 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.761 ' CD1' ' HB3' ' B' ' 324' ' ' ALA . 9.0 t80 -117.25 115.67 25.75 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -133.67 132.98 41.33 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.173 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 73.0 t -92.41 102.55 13.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -97.09 145.15 26.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.08 -1.012 . . . . 0.0 110.441 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.487 ' O ' ' SD ' ' B' ' 342' ' ' MET . 65.7 m-20 -96.41 152.11 18.91 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.539 ' CZ ' ' OE2' ' B' ' 282' ' ' GLU . 5.6 p90 -170.28 174.08 5.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.51 -1.368 . . . . 0.0 111.745 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 337' ' ' GLY . . . -148.09 150.9 34.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 335' ' ' ALA . 42.0 mt-10 -40.43 -27.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.0 110.308 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 335' ' ' ALA . . . -85.5 -5.27 84.93 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.015 -1.053 . . . . 0.0 111.226 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -135.43 4.62 3.15 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.92 -1.341 . . . . 0.0 110.082 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.1 p -57.97 -48.64 83.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.888 -1.132 . . . . 0.0 108.763 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 24.0 pt-20 -55.23 -33.78 63.4 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 21.0 m -65.77 -39.75 91.35 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 14.0 mmt -54.88 -53.96 48.65 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 32.1 mt -62.39 -31.66 72.36 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.891 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' B' ' 348' ' ' GLU . 30.0 t0 -68.95 -46.09 69.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.18 -0.95 . . . . 0.0 111.063 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -70.93 -50.61 32.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.473 -1.392 . . . . 0.0 109.759 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . 0.403 ' CD1' ' C ' ' B' ' 346' ' ' TYR . 29.6 t80 -56.58 -50.1 72.93 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.436 -0.79 . . . . 0.0 109.994 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' B' ' 351' ' ' LEU . 25.2 m-85 -75.85 -30.76 59.04 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.561 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . 0.551 ' CG ' ' O ' ' B' ' 344' ' ' ASP . 5.3 mm-40 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -87.41 19.56 3.23 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.476 ' N ' ' O ' ' B' ' 347' ' ' PHE . 2.0 t80 -148.0 -34.93 0.22 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.571 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.561 ' N ' ' CD ' ' B' ' 352' ' ' PRO . 18.7 mt -117.72 40.77 0.33 Allowed Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 120.864 -1.147 . . . . 0.0 111.277 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 351' ' ' LEU . 63.9 Cg_endo -74.26 -32.79 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.963 1.775 . . . . 0.0 111.164 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -129.24 -26.38 2.58 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -58.85 -33.72 70.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.405 -0.809 . . . . 0.0 109.188 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 47.5 m -57.59 -37.45 73.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.515 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -95.18 139.36 31.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.0 109.507 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 95.4 p -147.94 162.42 39.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.38 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 17.9 p 55.55 50.59 14.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.471 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . 0.524 ' O ' ' O ' ' B' ' 360' ' ' HIS . 88.6 p -61.94 -34.46 76.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.926 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.524 ' O ' ' O ' ' B' ' 359' ' ' SER . 0.9 OUTLIER 56.25 150.57 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.709 . . . . 0.0 109.666 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.5 147.9 77.83 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.553 2.168 . . . . 0.0 112.074 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 15.1 m -59.54 -32.38 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.137 -0.977 . . . . 0.0 109.258 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.377 179.875 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 3' ' ' ALA . 56.7 mtt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.64 10.41 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 1' ' ' MET . . . -59.67 -24.9 64.29 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.303 -0.873 . . . . 0.0 109.379 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.3 p -56.53 -18.6 12.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.255 -0.903 . . . . 0.0 109.239 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.11 -158.26 32.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.65 144.89 2.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.383 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -90.76 -172.37 3.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.96 152.94 80.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.395 -0.815 . . . . 0.0 109.415 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -55.99 155.51 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.059 1.84 . . . . 0.0 111.344 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.3 p -58.84 175.66 0.25 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.024 -1.047 . . . . 0.0 108.583 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 14.6 m -119.0 153.05 35.29 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.315 -0.866 . . . . 0.0 109.525 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -123.84 126.74 73.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.602 ' HB3' HG13 ' A' ' 79' ' ' VAL . 37.1 t80 -88.83 129.66 35.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CE1' HG21 ' A' ' 46' ' ' VAL . 16.4 t80 -97.15 131.91 43.45 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 110.613 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.851 ' SG ' ' HB2' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -142.14 100.61 3.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.383 -0.823 . . . . 0.0 109.332 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.31 -176.18 14.33 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.533 ' N ' ' OH ' ' A' ' 28' ' ' TYR . 4.5 m -87.53 120.27 28.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -1.125 . . . . 0.0 110.186 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' NE ' ' A' ' 22' ' ' ARG . 3.6 mt -110.2 -108.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' B' ' 315' ' ' VAL . 0.2 OUTLIER 75.0 -10.34 1.23 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.14 -0.975 . . . . 0.0 110.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 21' ' ' GLY . . . 173.66 177.47 42.89 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' A' ' 25' ' ' GLN . . . -48.08 -86.34 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.556 ' NE ' ' O ' ' A' ' 18' ' ' ILE . 72.0 mtt-85 72.12 142.39 0.06 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 122.726 1.251 . . . . 0.0 112.605 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.29 -17.4 28.66 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 40.9 m-20 -63.7 -38.93 92.98 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.832 ' NE2' ' HB3' ' A' ' 49' ' ' ALA . 20.1 mm100 -68.22 -42.74 79.35 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.89 -51.43 69.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.084 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 -35.42 75.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.686 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.3 m-30 -68.89 -42.12 77.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.667 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.453 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -63.54 -38.19 90.2 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 120.83 -1.169 . . . . 0.0 108.951 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -71.41 -55.51 7.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.754 -1.217 . . . . 0.0 108.292 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mt -53.68 -44.75 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 28' ' ' TYR . 55.7 t -63.5 -27.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.5 p -67.4 -39.53 85.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' NE ' ' CD ' ' A' ' 140' ' ' GLU . 84.8 mtt-85 -69.15 -47.38 65.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.833 -1.167 . . . . 0.0 108.757 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 38' ' ' TYR . 4.7 mt -62.25 -33.86 75.41 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -64.91 -28.38 69.5 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -71.28 -59.88 2.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' O ' ' O ' ' A' ' 35' ' ' LEU . 1.4 p90 -121.57 151.36 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . 83.89 77.84 1.12 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 39' ' ' GLY . 43.2 mtmt -40.9 118.64 1.01 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.451 -1.029 . . . . 0.0 108.57 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG11 HG13 ' A' ' 32' ' ' VAL . 32.9 t -82.4 128.04 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.92 . . . . 0.0 110.118 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 17.2 mt -105.86 172.43 6.81 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.782 HG22 ' O ' ' A' ' 43' ' ' THR . 32.4 m 51.81 47.28 25.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.019 -1.051 . . . . 0.0 108.887 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 45' ' ' HIS . 75.3 tt0 -50.05 -21.17 1.15 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.635 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.601 ' CE1' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -38.42 -47.49 1.26 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.374 -0.829 . . . . 0.0 110.157 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.707 ' O ' ' N ' ' A' ' 48' ' ' ASP . 3.4 p -57.47 162.55 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 108.941 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . 60.85 -58.34 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.055 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.977 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.2 16.73 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.832 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . . . -82.07 -39.56 23.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.15 -0.969 . . . . 0.0 108.475 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 49' ' ' ALA . 58.3 mt-10 -45.92 -15.39 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.246 -0.909 . . . . 0.0 108.656 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.977 HD22 ' O ' ' A' ' 48' ' ' ASP . 3.0 mp -54.64 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.555 0.693 . . . . 0.0 110.042 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.72 ' H ' ' CD ' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -155.55 -44.77 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.661 -0.649 . . . . 0.0 109.991 -178.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -84.06 80.37 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.916 2.411 . . . . 0.0 110.526 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.797 ' N ' HD12 ' A' ' 54' ' ' LEU . 5.1 mp -95.52 157.42 15.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 110.323 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 54' ' ' LEU . . . 42.96 -167.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG3' ' HB2' ' B' ' 318' ' ' ALA . 43.5 mp0 -72.83 -30.86 64.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.579 -0.953 . . . . 0.0 109.696 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 56' ' ' GLU . 72.9 tt0 -47.53 -20.8 0.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 60' ' ' GLY . . . -56.69 91.24 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.48 -3.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.933 . . . . 0.0 109.858 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 58' ' ' ALA . . . -49.05 -46.12 33.16 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.65 79.36 0.03 OUTLIER Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -48.23 -46.96 36.02 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -60.16 -44.51 94.96 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CZ ' ' HG3' ' A' ' 68' ' ' GLN . 51.6 t80 -61.43 -47.02 87.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.821 . . . . 0.0 109.143 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.601 HD11 ' CE1' ' A' ' 45' ' ' HIS . 0.7 OUTLIER -54.32 -39.66 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.645 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 2.2 t-80 -75.14 -48.46 23.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.84 -57.44 9.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 110.022 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.401 ' HG3' ' CZ ' ' A' ' 64' ' ' PHE . 96.8 mm-40 -63.13 -40.36 97.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.171 -0.955 . . . . 0.0 109.354 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.702 ' OD1' HG23 ' A' ' 43' ' ' THR . 65.2 m-20 -60.5 -40.77 92.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.191 -0.943 . . . . 0.0 109.932 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' A' ' 66' ' ' HIS . 0.6 OUTLIER -74.66 -39.02 62.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.635 -1.291 . . . . 0.0 109.84 -179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -56.3 -45.77 80.1 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.1 OUTLIER -70.49 -40.13 73.78 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 12.5 tp -58.32 -33.34 69.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.528 ' HA ' HD13 ' A' ' 100' ' ' LEU . 55.9 mt-30 -80.29 -28.07 38.38 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.558 -0.714 . . . . 0.0 110.34 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.6 5.9 47.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.988 -1.07 . . . . 0.0 108.989 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.27 132.74 46.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 111.756 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 11' ' ' SER . 70.1 m-20 -85.22 -30.96 23.43 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 22.3 t -143.32 138.18 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 13' ' ' TYR . 99.5 t -120.81 148.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.219 -0.925 . . . . 0.0 111.641 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.1 t -141.15 114.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.851 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . . . -115.17 131.83 56.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.149 -0.969 . . . . 0.0 110.386 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -91.16 114.72 27.32 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.8 t -85.97 -99.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.947 -1.095 . . . . 0.0 109.977 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.409 ' H ' ' HB ' ' A' ' 83' ' ' VAL . 5.1 m 64.66 -122.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.674 -1.266 . . . . 0.0 109.047 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 15.2 pt20 -48.72 147.3 4.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.064 -1.023 . . . . 0.0 109.128 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.46 124.38 11.97 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.362 2.041 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.416 ' OG ' HG23 ' A' ' 90' ' ' VAL . 31.6 t -140.61 130.18 24.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -70.37 -41.39 73.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 0.0 109.341 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.16 -40.55 97.38 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.416 HG23 ' OG ' ' A' ' 87' ' ' SER . 20.7 t -69.9 -47.19 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.356 -1.085 . . . . 0.0 109.078 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.87 -46.8 93.48 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 92' ' ' TYR . 19.9 t80 -62.28 -45.05 94.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.748 -0.854 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -60.79 -33.54 73.14 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.221 -0.925 . . . . 0.0 109.098 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 81' ' ' ALA . 77.0 mt -73.42 -41.56 63.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.075 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.31 -48.7 62.11 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 100' ' ' LEU . 19.0 tpt180 -59.24 -42.42 91.03 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.31 -1.112 . . . . 0.0 108.871 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HA ' ' H ' ' A' ' 101' ' ' GLY . . . -66.72 -39.48 88.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.022 -1.048 . . . . 0.0 108.905 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -51.72 -40.8 27.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -71.85 -47.74 50.86 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.896 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 101' ' ' GLY . 2.8 pp -124.7 -33.19 3.0 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.932 -1.105 . . . . 0.0 111.298 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.798 ' N ' HD12 ' A' ' 100' ' ' LEU . . . -74.25 10.51 7.88 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.549 ' C ' ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 7.85 -74.17 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.342 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' O ' ' A' ' 101' ' ' GLY . 30.9 Cg_endo -65.33 108.43 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.349 1.16 . . . . 0.0 111.261 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.528 HD12 ' O ' ' A' ' 102' ' ' LYS . 3.7 mt -134.55 150.16 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 122.132 0.968 . . . . 0.0 111.486 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.9 tp -128.02 113.74 16.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.765 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -114.17 150.79 33.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.815 -1.178 . . . . 0.0 109.19 -179.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 132' ' ' TRP . 2.9 mp -132.46 137.08 47.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 0.0 111.585 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -128.81 140.01 51.9 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -88.93 133.05 36.33 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.001 -1.062 . . . . 0.0 110.992 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 113' ' ' GLY . 87.8 Cg_endo -78.76 -38.81 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.537 2.158 . . . . 0.0 111.277 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -48.27 -31.52 6.04 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.466 ' O ' ' C ' ' A' ' 113' ' ' GLY . 22.0 p -95.23 -20.55 19.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 115' ' ' VAL . . . 38.42 42.49 1.33 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.438 HH11 ' HB2' ' A' ' 112' ' ' SER . 1.7 mtt85 -67.48 7.19 0.49 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.376 -1.073 . . . . 0.0 109.494 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' A' ' 113' ' ' GLY . 77.3 t 57.57 99.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.448 -0.783 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.741 ' CD1' HG11 ' A' ' 83' ' ' VAL . 19.4 tp -54.76 151.12 8.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.05 142.07 47.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.116 -0.99 . . . . 0.0 110.9 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' B' ' 256' ' ' GLU . . . -57.34 -42.68 82.4 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 41.8 mmm -62.25 -45.7 92.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.724 0.773 . . . . 0.0 109.361 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' ALA . 28.0 mm -61.1 -43.19 95.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 109.122 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 122' ' ' GLY . 0.3 OUTLIER -55.61 -45.46 77.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.615 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -51.05 -40.07 42.74 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 103.973 -3.651 . . . . 0.0 103.973 176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.612 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -76.07 89.56 3.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -165.14 40.42 0.07 Allowed 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.192 -1.367 . . . . 0.0 108.918 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 127' ' ' SER . 97.7 m-20 -54.7 -20.08 7.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.478 -0.764 . . . . 0.0 110.059 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 68.8 -14.62 0.74 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 125' ' ' ASP . 22.5 t -102.49 -74.62 0.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.099 -1.236 . . . . 0.0 108.805 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.77 -49.15 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.765 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 4.5 t80 -103.55 129.05 50.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.777 HE21 ' HE1' ' A' ' 132' ' ' TRP . 2.6 mt-30 -140.47 135.65 32.19 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.581 -1.324 . . . . 0.0 111.895 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.2 112.19 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.777 ' HE1' HE21 ' A' ' 130' ' ' GLN . 14.2 m0 -108.09 138.76 43.81 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 120.979 -1.076 . . . . 0.0 109.946 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' SD ' ' A' ' 142' ' ' MET . 80.9 m-20 -90.04 155.37 19.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.6 -1.313 . . . . 0.0 107.771 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.555 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 3.8 p90 -172.15 -177.28 1.82 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.697 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -150.89 148.33 28.3 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 135' ' ' ALA . 62.3 mt-10 -41.7 -34.62 0.64 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.745 -1.222 . . . . 0.0 110.438 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.81 6.18 75.49 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.885 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -137.89 -3.61 1.81 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.961 -1.317 . . . . 0.0 109.795 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.2 p -55.7 -46.8 79.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.004 -1.06 . . . . 0.0 108.656 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 54.5 mt-10 -52.64 -34.56 52.0 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -70.07 -38.78 75.84 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.375 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 13.0 mmt -53.5 -53.38 52.29 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' PHE . 79.0 mt -60.69 -39.11 87.27 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.029 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.53 -45.22 93.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.344 -0.847 . . . . 0.0 110.941 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -68.64 -51.55 41.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.545 -1.347 . . . . 0.0 108.873 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -56.45 -45.27 80.9 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.611 -0.68 . . . . 0.0 109.971 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' A' ' 151' ' ' LEU . 15.5 m-85 -73.4 -33.15 64.84 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.354 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -58.09 -29.9 65.82 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.18 26.86 4.45 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.99 -82.4 0.21 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.693 -1.203 . . . . 0.0 113.472 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 147' ' ' PHE . 4.8 mt -55.11 -59.21 11.49 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.131 -0.98 . . . . 0.0 112.195 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 151' ' ' LEU . 2.6 Cg_endo -41.1 -17.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 0.0 111.878 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 151' ' ' LEU . 6.8 tt0 -87.42 -61.76 1.65 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 110.084 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -4.83 14.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 0.0 109.792 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 19.1 m -49.31 -37.16 23.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -168.95 44.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.837 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 51.1 m -67.72 -33.2 74.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 0.0 109.396 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.2 p -68.91 162.91 25.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.428 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.5 t -88.85 152.08 21.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.627 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 160' ' ' HIS . 11.8 p80 -128.55 76.07 78.88 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.407 -0.808 . . . . 0.0 109.244 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 162' ' ' SER . 53.2 Cg_exo -49.59 -17.87 2.16 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.855 2.37 . . . . 0.0 112.33 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 161' ' ' PRO . 69.1 m 49.68 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.484 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.501 ' O ' ' N ' ' B' ' 203' ' ' ALA . 55.7 mtt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . 50.13 10.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.428 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' B' ' 201' ' ' MET . . . -59.62 -24.84 64.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.152 -0.968 . . . . 0.0 109.331 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 97.3 p -56.82 -18.39 12.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.361 -0.837 . . . . 0.0 109.3 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.29 -158.77 33.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.69 144.69 3.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -1.15 . . . . 0.0 109.385 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.14 -172.05 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 109.733 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.41 153.31 79.02 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.547 -0.721 . . . . 0.0 109.328 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -56.41 155.89 23.68 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.986 1.791 . . . . 0.0 111.279 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . . . . . . . . . 18.6 p -58.92 175.55 0.27 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.047 -1.033 . . . . 0.0 108.506 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 14.6 m -119.09 153.18 35.2 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.41 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' B' ' 278' ' ' VAL . 0.0 OUTLIER -123.92 126.97 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.589 ' HB3' HG13 ' B' ' 279' ' ' VAL . 36.4 t80 -89.04 129.42 35.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.545 ' CE1' HG21 ' B' ' 246' ' ' VAL . 15.9 t80 -96.99 132.34 42.89 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.572 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' B' ' 281' ' ' ALA . 0.2 OUTLIER -142.57 101.15 3.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.408 -0.807 . . . . 0.0 109.234 178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.62 -176.39 14.41 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.515 ' N ' ' OH ' ' B' ' 228' ' ' TYR . 4.4 m -87.19 120.62 28.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 110.108 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.559 ' O ' ' NE ' ' B' ' 222' ' ' ARG . 3.9 mt -110.63 -108.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER 74.97 -10.2 1.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -0.946 . . . . 0.0 110.153 179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' B' ' 221' ' ' GLY . . . 173.43 177.37 42.61 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' B' ' 225' ' ' GLN . . . -47.89 -86.2 0.01 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 107.939 -2.064 . . . . 0.0 107.939 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' B' ' 218' ' ' ILE . 73.7 mtt-85 71.96 142.17 0.06 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.692 1.234 . . . . 0.0 112.734 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.18 -17.34 26.6 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 44.2 m-20 -64.0 -38.9 92.75 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.83 ' NE2' ' HB3' ' B' ' 249' ' ' ALA . 20.3 mm100 -68.13 -42.94 79.45 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.73 -51.28 70.46 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 118.989 -1.084 . . . . 0.0 108.173 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.9 tp -60.52 -35.98 77.28 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.678 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -68.29 -42.74 79.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.536 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.471 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -62.95 -38.25 90.32 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.846 -1.159 . . . . 0.0 109.091 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -71.38 -55.41 8.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.877 -1.14 . . . . 0.0 108.249 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 45.6 mt -53.74 -44.64 59.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.678 HG23 ' O ' ' B' ' 228' ' ' TYR . 55.9 t -63.35 -28.18 44.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 23.9 p -67.21 -39.52 86.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . 0.498 ' NE ' ' CD ' ' B' ' 340' ' ' GLU . 85.4 mtt-85 -69.31 -47.33 64.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.912 -1.117 . . . . 0.0 108.815 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' B' ' 238' ' ' TYR . 4.7 mt -62.26 -33.72 75.16 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -65.1 -28.55 69.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -71.19 -59.87 2.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.608 ' O ' ' O ' ' B' ' 235' ' ' LEU . 1.4 p90 -121.42 151.7 39.89 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 176.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.481 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . 83.33 77.92 1.09 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' B' ' 239' ' ' GLY . 42.9 mtmt -40.87 118.71 1.02 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.385 -1.068 . . . . 0.0 108.657 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.411 HG11 HG13 ' B' ' 232' ' ' VAL . 30.3 t -82.35 127.69 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.145 -0.972 . . . . 0.0 110.192 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.441 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 17.1 mt -105.52 172.45 6.79 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.766 ' O ' HG22 ' B' ' 243' ' ' THR . 35.7 m 51.69 48.01 23.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 108.881 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 245' ' ' HIS . 75.1 tt0 -50.77 -20.83 1.38 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' B' ' 265' ' ' ILE . 0.1 OUTLIER -38.48 -47.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 110.255 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.705 ' O ' ' N ' ' B' ' 248' ' ' ASP . 3.4 p -57.58 163.06 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.159 -0.963 . . . . 0.0 108.976 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.705 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . 60.42 -58.43 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.473 -0.767 . . . . 0.0 109.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.976 ' O ' HD22 ' B' ' 251' ' ' LEU . 0.1 OUTLIER -62.15 16.76 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.83 ' HB3' ' NE2' ' B' ' 225' ' ' GLN . . . -81.91 -39.31 23.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 108.594 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -46.45 -14.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.892 . . . . 0.0 108.61 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.976 HD22 ' O ' ' B' ' 248' ' ' ASP . 2.9 mp -55.26 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.574 0.702 . . . . 0.0 110.034 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.713 ' H ' ' CD ' ' B' ' 253' ' ' PRO . 1.0 OUTLIER -155.47 -44.81 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.62 -0.675 . . . . 0.0 109.886 -178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.713 ' CD ' ' H ' ' B' ' 252' ' ' GLU . 1.0 OUTLIER -84.06 80.52 2.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.994 2.462 . . . . 0.0 110.668 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 254' ' ' LEU . 5.0 mp -95.84 157.62 15.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.331 -0.856 . . . . 0.0 110.345 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' B' ' 254' ' ' LEU . . . 43.11 -167.76 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 118' ' ' ALA . 41.2 mp0 -73.08 -30.29 63.58 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.523 -0.986 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' B' ' 256' ' ' GLU . 71.2 tt0 -48.21 -20.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 260' ' ' GLY . . . -57.22 91.66 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -55.54 -4.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.74 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' B' ' 258' ' ' ALA . . . -48.39 -46.57 28.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 152.7 79.51 0.03 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -48.24 -46.96 36.14 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -60.2 -44.4 95.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.58 -47.01 87.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' B' ' 245' ' ' HIS . 0.7 OUTLIER -54.24 -39.92 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.625 ' CE1' ' HG ' ' B' ' 270' ' ' LEU . 2.2 t-80 -74.72 -48.43 25.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.397 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.07 -57.38 9.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.16 -0.962 . . . . 0.0 110.091 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.08 -40.28 97.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.695 ' OD1' HG23 ' B' ' 243' ' ' THR . 62.0 m-20 -60.76 -40.68 93.4 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.197 -0.94 . . . . 0.0 109.958 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.625 ' HG ' ' CE1' ' B' ' 266' ' ' HIS . 0.6 OUTLIER -74.82 -39.28 61.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.599 -1.313 . . . . 0.0 109.79 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -56.01 -45.69 79.01 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.971 -1.081 . . . . 0.0 108.15 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.441 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.1 OUTLIER -70.43 -40.62 73.69 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.482 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 12.3 tp -58.06 -33.03 68.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 108.471 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.523 ' HA ' HD13 ' B' ' 300' ' ' LEU . 55.5 mt-30 -80.49 -28.15 37.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.47 6.11 47.47 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.992 -1.068 . . . . 0.0 108.949 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.74 132.88 46.03 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.33 -0.856 . . . . 0.0 111.765 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 70.1 m-20 -85.36 -31.01 23.2 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' B' ' 212' ' ' VAL . 24.4 t -143.1 138.25 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' B' ' 213' ' ' TYR . 99.0 t -120.95 148.17 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.134 -0.979 . . . . 0.0 111.614 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.24 114.68 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.384 0.612 . . . . 0.0 109.388 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.856 ' HB2' ' SG ' ' B' ' 215' ' ' CYS . . . -115.74 131.54 56.91 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.49 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.402 ' OE2' ' OH ' ' B' ' 334' ' ' TYR . 71.7 tt0 -90.95 114.63 27.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' B' ' 316' ' ' LEU . 1.7 t -85.55 -98.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.081 -1.012 . . . . 0.0 109.965 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' B' ' 283' ' ' VAL . 5.0 m 64.26 -122.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.549 -1.345 . . . . 0.0 109.111 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -49.69 147.23 6.43 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.065 -1.022 . . . . 0.0 109.042 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.24 124.73 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.395 2.064 . . . . 0.0 111.785 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.409 ' OG ' HG23 ' B' ' 290' ' ' VAL . 28.9 t -141.28 130.37 23.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.143 -0.973 . . . . 0.0 109.383 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.59 -41.74 71.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . -59.51 -40.7 96.58 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.409 HG23 ' OG ' ' B' ' 287' ' ' SER . 19.5 t -69.93 -47.39 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -1.082 . . . . 0.0 109.169 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -59.81 -46.72 93.59 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 292' ' ' TYR . 18.2 t80 -62.47 -44.85 95.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.572 -0.958 . . . . 0.0 109.435 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.6 -33.54 72.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.27 -0.894 . . . . 0.0 109.04 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' B' ' 281' ' ' ALA . 76.7 mt -73.77 -41.01 63.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.69 -48.67 60.54 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.505 ' NE ' HD21 ' B' ' 300' ' ' LEU . 18.5 tpt180 -59.17 -42.54 91.01 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.333 -1.099 . . . . 0.0 108.779 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.489 ' HA ' ' H ' ' B' ' 301' ' ' GLY . . . -66.7 -39.63 88.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.446 HG12 ' N ' ' B' ' 299' ' ' ALA . 0.5 OUTLIER -51.63 -40.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.498 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -71.98 -47.94 48.52 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.92 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.784 HD12 ' N ' ' B' ' 301' ' ' GLY . 2.8 pp -124.37 -33.15 3.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.986 -1.071 . . . . 0.0 111.226 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.784 ' N ' HD12 ' B' ' 300' ' ' LEU . . . -74.16 10.08 8.47 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' B' ' 301' ' ' GLY . 0.0 OUTLIER 7.93 -74.11 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.363 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' B' ' 301' ' ' GLY . 29.0 Cg_endo -65.17 107.89 1.04 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.456 1.199 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.547 HD12 ' O ' ' B' ' 302' ' ' LYS . 3.7 mt -134.08 149.87 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 122.189 0.995 . . . . 0.0 111.534 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 49.1 tp -127.72 114.02 16.77 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . 0.773 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.0 OUTLIER -114.46 150.53 34.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 109.211 -179.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' B' ' 332' ' ' TRP . 2.9 mp -132.15 137.0 47.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.103 -0.998 . . . . 0.0 111.463 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -128.68 140.0 51.96 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . . . . . . . . . 36.4 mtm180 -88.85 133.12 36.34 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.979 -1.076 . . . . 0.0 110.924 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' B' ' 313' ' ' GLY . 77.0 Cg_endo -78.83 -38.94 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 122.544 2.163 . . . . 0.0 111.069 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.24 -31.72 6.25 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.463 ' O ' ' C ' ' B' ' 313' ' ' GLY . 22.3 p -95.01 -20.34 19.43 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' B' ' 315' ' ' VAL . . . 38.5 42.41 1.34 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.42 HH11 ' HB2' ' B' ' 312' ' ' SER . 1.8 mtt85 -67.55 7.24 0.5 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.29 -1.124 . . . . 0.0 109.588 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.515 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.4 t 57.21 100.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.496 -0.753 . . . . 0.0 110.648 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.747 ' CD1' HG11 ' B' ' 283' ' ' VAL . 19.4 tp -54.8 151.17 8.78 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.86 141.77 48.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.191 -0.943 . . . . 0.0 110.926 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . . . -57.3 -43.22 83.0 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 42.6 mmm -61.76 -45.5 93.66 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.626 0.727 . . . . 0.0 109.286 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' B' ' 323' ' ' ALA . 28.4 mm -61.19 -43.21 95.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.472 ' O ' ' C ' ' B' ' 322' ' ' GLY . 0.3 OUTLIER -55.62 -45.09 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.825 -1.172 . . . . 0.0 107.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.645 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -51.33 -40.03 44.77 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 103.997 -3.641 . . . . 0.0 103.997 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.596 ' O ' ' CE1' ' B' ' 329' ' ' PHE . . . -76.02 89.5 2.99 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -165.07 40.47 0.07 Allowed 'General case' 0 C--N 1.274 -2.692 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.812 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' B' ' 327' ' ' SER . 98.4 m-20 -54.61 -20.35 7.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.381 -0.825 . . . . 0.0 110.029 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 69.06 -14.93 0.76 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 325' ' ' ASP . 19.8 t -102.55 -74.68 0.62 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.107 -1.231 . . . . 0.0 108.819 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -83.67 -49.41 9.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.773 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 4.4 t80 -103.39 129.06 50.4 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.795 HE21 ' HE1' ' B' ' 332' ' ' TRP . 2.7 mt-30 -140.34 135.66 32.39 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.661 -1.274 . . . . 0.0 111.853 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 39.6 t -93.34 111.88 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.795 ' HE1' HE21 ' B' ' 330' ' ' GLN . 14.1 m0 -107.78 138.87 43.26 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.926 -1.109 . . . . 0.0 110.108 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.469 ' O ' ' SD ' ' B' ' 342' ' ' MET . 81.4 m-20 -90.38 154.72 19.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.62 -1.3 . . . . 0.0 107.802 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.553 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 3.7 p90 -171.59 -177.16 1.96 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.295 -1.362 . . . . 0.0 111.782 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -150.75 148.31 28.38 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' B' ' 335' ' ' ALA . 62.1 mt-10 -41.6 -34.34 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.767 -1.208 . . . . 0.0 110.51 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -83.87 5.75 77.66 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.844 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -137.62 -3.6 1.87 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.001 -1.293 . . . . 0.0 109.821 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.0 p -55.88 -47.0 80.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.11 -0.994 . . . . 0.0 108.597 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 55.7 mt-10 -52.84 -34.07 52.39 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 91.1 m -70.61 -38.24 73.95 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.496 -0.881 . . . . 0.0 109.31 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 12.5 mmt -54.07 -52.97 59.23 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' B' ' 347' ' ' PHE . 76.8 mt -60.81 -39.16 87.93 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.044 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -62.4 -45.18 94.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 110.942 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -68.68 -51.79 37.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.516 -1.365 . . . . 0.0 108.808 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -56.13 -45.98 79.36 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.819 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.591 ' CD1' HD11 ' B' ' 351' ' ' LEU . 15.8 m-85 -72.82 -33.11 65.99 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.401 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.1 -29.62 65.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -97.38 26.77 4.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.05 -82.39 0.2 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.708 -1.197 . . . . 0.0 113.434 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' B' ' 347' ' ' PHE . 4.7 mt -54.9 -59.23 11.22 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.179 -0.951 . . . . 0.0 112.181 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 351' ' ' LEU . 2.3 Cg_endo -41.14 -17.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.362 2.041 . . . . 0.0 112.064 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' B' ' 351' ' ' LEU . 6.7 tt0 -87.88 -62.18 1.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.993 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -4.95 11.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 109.77 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 19.0 m -49.29 -38.07 26.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.11 -0.994 . . . . 0.0 109.616 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -167.85 45.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 54.1 m -67.82 -34.12 76.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.548 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 80.1 p -68.37 163.38 23.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 24.0 t -88.9 151.99 22.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.216 -0.928 . . . . 0.0 109.628 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.416 ' O ' ' CG ' ' B' ' 360' ' ' HIS . 12.2 p80 -128.64 76.53 78.58 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.462 -0.774 . . . . 0.0 109.118 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' B' ' 362' ' ' SER . 50.0 Cg_exo -50.7 -16.64 2.44 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.807 2.338 . . . . 0.0 112.253 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.431 ' O ' ' OXT' ' B' ' 363' ' ' ALA . 67.5 m 50.2 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.168 -0.958 . . . . 0.0 109.348 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . 0.431 ' OXT' ' O ' ' B' ' 362' ' ' SER . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.628 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ptt? . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.7 148.97 36.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.396 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.63 142.15 48.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.896 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.5 t -95.47 147.87 23.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.36 174.42 28.92 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -100.31 162.6 12.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.267 -1.137 . . . . 0.0 109.334 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -71.26 177.3 3.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.484 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -155.34 154.63 28.79 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.381 -0.824 . . . . 0.0 109.383 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -58.26 -156.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.35 2.033 . . . . 0.0 111.283 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 25.9 p -108.99 172.77 6.65 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.495 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 61.4 m -115.07 158.9 21.49 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.849 -1.157 . . . . 0.0 108.99 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG11 HD22 ' A' ' 35' ' ' LEU . 16.6 t -137.41 134.14 46.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.567 -0.708 . . . . 0.0 109.163 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 69' ' ' ASP . 8.3 t80 -115.53 97.29 6.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.623 ' O ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -93.48 126.79 38.82 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.328 -0.857 . . . . 0.0 109.526 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 81' ' ' ALA . 1.7 m -101.67 130.1 47.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.955 . . . . 0.0 108.92 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.921 ' O ' HG21 ' A' ' 90' ' ' VAL . . . -126.05 -124.01 2.73 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 58.1 m -155.69 138.08 14.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -1.173 . . . . 0.0 109.105 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.22 149.68 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.913 -1.117 . . . . 0.0 109.441 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' NH2' ' OE1' ' B' ' 285' ' ' GLN . 1.7 tpt180 -165.14 1.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.95 7.52 0.03 OUTLIER Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.535 ' N ' HD21 ' A' ' 54' ' ' LEU . . . 68.79 94.06 0.05 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' NH1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -127.79 -151.59 0.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -1.187 . . . . 0.0 111.522 -177.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.18 -40.83 96.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' TYR . 74.8 m-20 -55.53 -33.32 63.69 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.496 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 1.8 mm100 -68.78 -39.18 80.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.5 -52.04 66.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 108.702 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -34.6 76.89 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 32' ' ' VAL . 14.3 m-85 -69.2 -47.85 63.71 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.085 -1.01 . . . . 0.0 110.251 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.51 -35.32 75.67 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.256 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 33' ' ' SER . 32.7 ttt85 -69.67 -57.22 5.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 108.494 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.5 mt -50.82 -43.35 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 28' ' ' TYR . 68.4 t -61.16 -30.58 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 30' ' ' ARG . 4.6 m -66.84 -41.18 87.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 109.729 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -67.92 -48.88 64.73 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.901 -1.125 . . . . 0.0 109.197 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.69 HD22 HG11 ' A' ' 12' ' ' VAL . 31.6 mt -57.9 -40.27 79.94 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -62.1 -26.07 68.08 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.5 mtt-85 -74.9 -36.97 62.22 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.94 -1.1 . . . . 0.0 108.873 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' ' HD1' ' A' ' 38' ' ' TYR . 2.6 m-85 -70.4 -48.36 56.49 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.6 -0.688 . . . . 0.0 109.947 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 10' ' ' CYS . . . -153.1 -145.38 4.13 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -100.98 131.38 46.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.968 -1.313 . . . . 0.0 108.658 178.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.58 HG11 HG13 ' A' ' 32' ' ' VAL . 18.1 t -90.73 127.47 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.553 ' HB3' ' CG ' ' A' ' 72' ' ' TRP . 11.9 mt -87.05 -38.63 16.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.198 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 14' ' ' PHE . 7.9 t -70.77 37.67 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.269 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 42' ' ' LEU . 57.7 mt-10 -54.28 -28.57 42.79 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.81 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.482 ' NE2' ' CG1' ' A' ' 65' ' ' ILE . 18.4 t-80 -52.09 -44.9 64.61 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.183 -0.948 . . . . 0.0 109.865 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.496 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 41.3 t -50.12 -69.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.234 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.55 -41.32 61.02 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 14.6 t70 -85.34 43.08 0.99 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 46' ' ' VAL . . . -118.54 -32.3 4.64 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG2' HE21 ' A' ' 25' ' ' GLN . 12.2 pt-20 -86.1 60.28 6.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 109.498 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -168.88 22.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.389 -0.819 . . . . 0.0 109.905 -179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER 162.19 160.7 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -37.28 99.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.268 1.979 . . . . 0.0 111.67 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.763 ' H ' HD12 ' A' ' 54' ' ' LEU . 6.8 mp -49.36 -79.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.975 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . -175.33 -36.13 0.04 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HB2' HG21 ' B' ' 315' ' ' VAL . 0.2 OUTLIER -46.97 -101.36 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.582 -0.952 . . . . 0.0 110.554 -179.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.509 ' H ' ' CG ' ' A' ' 56' ' ' GLU . 80.8 mm-40 -64.18 -8.9 13.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 110.025 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.08 158.83 3.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.63 66.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.19 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -171.01 -171.99 36.81 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' ILE . . . 103.02 -29.86 11.61 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 20.5 p-10 -56.15 -43.16 78.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 1.2 mt-30 -70.39 -53.2 17.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -28.84 56.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 61' ' ' GLY . 1.8 mt -70.37 -39.71 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 67' ' ' GLU . 1.3 t-80 -76.45 -60.59 2.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.489 0.661 . . . . 0.0 109.367 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.562 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 8.4 tp10 -43.04 -54.52 4.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -64.68 -44.6 89.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.945 . . . . 0.0 110.044 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.462 ' CB ' ' OH ' ' A' ' 13' ' ' TYR . 73.9 m-20 -60.91 -44.14 97.58 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.0 111.265 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD11 ' OH ' ' A' ' 92' ' ' TYR . 1.1 mm? -65.4 -50.25 66.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.087 . . . . 0.0 110.024 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.18 -50.48 71.67 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.489 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.553 ' CG ' ' HB3' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.29 -42.46 99.08 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.3 tp -52.03 -37.33 53.16 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.36 -28.08 59.41 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.603 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -83.52 -5.96 59.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.869 -1.145 . . . . 0.0 109.258 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.84 125.33 25.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.832 . . . . 0.0 112.153 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' HB2' ' H ' ' A' ' 11' ' ' SER . 39.0 m-20 -77.81 -33.15 52.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.21 148.18 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.8 t -134.26 138.7 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.966 -1.084 . . . . 0.0 111.002 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 14' ' ' PHE . 20.5 t -138.45 164.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -159.46 130.42 5.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.579 -1.326 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' CG ' ' OH ' ' A' ' 134' ' ' TYR . 53.1 tt0 -93.65 126.03 38.6 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.504 ' O ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -155.71 114.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.08 -1.012 . . . . 0.0 110.353 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 85' ' ' GLN . 39.5 m -105.76 -18.54 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.679 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 6.6 tt0 163.81 -37.31 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.383 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 7.0 Cg_exo -71.14 104.1 1.49 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 122.327 2.018 . . . . 0.0 112.009 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.558 ' HB2' HD21 ' B' ' 288' ' ' LEU . 0.3 OUTLIER -159.51 173.49 16.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.209 -0.932 . . . . 0.0 108.574 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.709 ' C ' ' H ' ' A' ' 90' ' ' VAL . 0.1 OUTLIER 167.77 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.48 ' O ' ' SD ' ' B' ' 319' ' ' MET . . . 73.33 -23.21 0.96 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.921 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.1 t -85.14 -46.35 17.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.85 -30.48 56.9 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.481 ' OH ' HD11 ' A' ' 70' ' ' LEU . 1.3 t80 -68.58 -41.86 79.06 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.66 -34.59 65.14 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 94' ' ' LEU . 55.6 mt -73.2 -37.83 66.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.92 -38.71 95.87 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.034 -2.027 . . . . 0.0 108.034 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -66.14 -40.0 90.29 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.489 -1.006 . . . . 0.0 108.711 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.43 ' C ' HD11 ' A' ' 104' ' ' ILE . . . -69.32 -40.99 77.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.064 . . . . 0.0 108.549 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -39.86 48.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.26 -48.44 56.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.007 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.3 mt -71.16 -7.22 45.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.135 -0.978 . . . . 0.0 108.786 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.12 24.86 9.75 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 121.838 -0.539 . . . . 0.0 112.09 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -79.7 154.45 75.93 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 120.603 -1.528 . . . . 0.0 108.141 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -44.37 118.58 1.79 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.933 1.755 . . . . 0.0 111.167 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.43 HD11 ' C ' ' A' ' 97' ' ' ALA . 11.8 mt -121.13 135.3 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.12 -0.988 . . . . 0.0 111.223 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.54 114.75 17.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 177.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.4 m -110.44 156.06 21.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.911 -1.118 . . . . 0.0 108.228 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.504 ' O ' ' O ' ' A' ' 83' ' ' VAL . 3.5 mp -136.61 152.63 50.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.962 -1.086 . . . . 0.0 111.63 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -148.87 130.72 15.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 134' ' ' TYR . 0.0 OUTLIER -52.89 140.03 41.34 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.052 -1.03 . . . . 0.0 110.522 -177.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' A' ' 134' ' ' TYR . 31.8 Cg_endo -67.15 -50.25 1.09 Allowed 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 122.147 1.898 . . . . 0.0 109.252 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.794 ' O ' ' N ' ' A' ' 113' ' ' GLY . 13.3 pt20 -67.11 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.56 -72.25 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.989 -1.07 . . . . 0.0 109.753 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.794 ' N ' ' O ' ' A' ' 111' ' ' GLN . . . 68.34 42.74 81.62 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 107.779 -2.128 . . . . 0.0 107.779 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 115' ' ' VAL . 4.5 mtt180 -85.63 18.42 2.84 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.71 HG21 ' HB2' ' B' ' 256' ' ' GLU . 15.7 t 49.77 99.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.881 0.848 . . . . 0.0 109.448 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' O ' ' CB ' ' A' ' 117' ' ' SER . 8.9 tp -45.22 -61.24 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER 162.86 144.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.288 -0.883 . . . . 0.0 110.002 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.94 -38.52 86.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.555 -0.716 . . . . 0.0 110.399 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' B' ' 289' ' ' GLY . 1.7 mtp -74.81 -36.38 62.46 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.081 -1.047 . . . . 0.0 109.388 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.4 mm -72.42 -46.07 57.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.328 -0.858 . . . . 0.0 109.37 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.401 ' NE ' ' HB3' ' A' ' 116' ' ' LEU . 63.3 mtt180 -77.54 -34.74 53.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.108 -0.995 . . . . 0.0 108.807 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.418 ' HA2' HE21 ' B' ' 263' ' ' GLN . . . -68.8 -27.49 73.82 Favored Glycine 0 N--CA 1.482 1.723 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 122' ' ' GLY . . . -43.56 -59.31 2.22 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.26 -1.141 . . . . 0.0 110.122 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' O ' ' CB ' ' A' ' 125' ' ' ASP . . . -133.65 -111.5 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 112.178 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 1.9 m-20 160.23 -2.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.436 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.1 38.93 0.36 Allowed Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.468 -1.349 . . . . 0.0 111.604 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 128' ' ' ARG . 58.5 p -116.1 -86.62 0.61 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.727 -1.455 . . . . 0.0 108.838 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.501 ' O ' ' NE2' ' A' ' 130' ' ' GLN . 20.0 tpt180 -94.4 -30.05 14.67 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -117.69 126.0 51.7 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 128' ' ' ARG . 6.9 mp0 -131.91 135.92 47.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.55 -1.344 . . . . 0.0 112.726 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.42 106.89 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 20.8 m0 -104.63 143.02 33.64 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.006 -1.059 . . . . 0.0 110.986 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.548 ' O ' ' SD ' ' A' ' 142' ' ' MET . 68.0 m-20 -85.84 154.86 21.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.651 -1.281 . . . . 0.0 108.002 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.458 ' OH ' ' CG ' ' A' ' 82' ' ' GLU . 3.6 p90 -168.7 172.54 7.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 0.0 111.488 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 138' ' ' GLU . . . -141.65 146.67 36.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 135' ' ' ALA . 40.0 mt-10 -39.26 -37.03 0.38 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.746 -1.221 . . . . 0.0 110.335 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.17 15.52 33.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.607 ' N ' ' O ' ' A' ' 135' ' ' ALA . 74.8 mt-10 -146.29 -4.88 0.6 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.061 -1.258 . . . . 0.0 110.407 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 2.6 p -54.04 -46.51 65.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 120.865 -1.147 . . . . 0.0 108.616 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 22.8 pt-20 -56.54 -34.63 67.24 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.8 m -65.67 -39.41 91.3 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.165 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 133' ' ' ASP . 11.3 mmt -55.82 -51.6 66.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.3 mt -63.91 -30.3 71.4 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.347 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 48.6 m-20 -69.27 -44.14 72.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 0.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -71.67 -43.61 65.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.677 -1.264 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -62.97 -48.6 78.17 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.553 -0.717 . . . . 0.0 110.446 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.923 ' CD1' HD12 ' A' ' 151' ' ' LEU . 19.6 m-85 -73.64 -31.08 63.32 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.251 -0.906 . . . . 0.0 110.393 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -68.25 -27.16 66.1 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -59.35 -27.47 65.96 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.689 -0.632 . . . . 0.0 109.621 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.813 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -145.88 -63.69 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.042 -1.036 . . . . 0.0 110.653 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 147' ' ' PHE . 1.4 mt -31.01 92.89 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 0.0 110.643 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.514 ' N ' ' O ' ' A' ' 150' ' ' TYR . 72.4 Cg_endo -92.92 50.95 0.43 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 123.166 2.577 . . . . 0.0 111.048 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 52.44 21.85 1.9 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tptp 50.77 25.85 2.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.9 m -68.1 -24.31 65.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.611 -0.681 . . . . 0.0 109.509 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.46 155.5 47.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.361 -0.837 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 94.3 p -148.58 161.06 42.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 109.487 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.2 m -62.34 -30.33 71.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 84.7 p -69.31 168.05 15.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.345 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.411 ' N ' ' CD2' ' A' ' 160' ' ' HIS . 19.7 m170 54.13 72.43 1.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -54.03 -14.03 5.47 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.827 2.351 . . . . 0.0 112.116 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.0 t -53.85 -33.01 55.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.489 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.064 -0.97 . . . . 0.0 109.383 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -61.03 149.31 37.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 109.399 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -72.86 142.5 47.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 44.3 t -96.15 148.19 22.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -150.09 174.44 29.52 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -99.91 162.06 13.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -1.092 . . . . 0.0 109.428 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -70.47 177.65 3.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.492 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -155.77 154.94 28.85 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.398 -0.814 . . . . 0.0 109.401 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -58.67 -156.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.217 1.945 . . . . 0.0 111.24 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.519 ' O ' ' HA3' ' B' ' 239' ' ' GLY . 26.6 p -109.12 172.98 6.53 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 69.8 m -115.38 159.08 21.55 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.895 -1.128 . . . . 0.0 108.909 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 235' ' ' LEU . 15.8 t -137.63 133.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' B' ' 273' ' ' LEU . 8.1 t80 -115.31 97.59 6.27 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.638 ' O ' HG21 ' B' ' 243' ' ' THR . 0.0 OUTLIER -93.74 126.83 39.14 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 109.455 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.417 ' H ' ' HA ' ' B' ' 281' ' ' ALA . 1.8 m -101.49 129.4 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.18 -0.95 . . . . 0.0 108.93 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.919 ' O ' HG21 ' B' ' 290' ' ' VAL . . . -125.42 -124.3 2.79 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . 0.553 ' O ' ' NH1' ' B' ' 222' ' ' ARG . 58.7 m -155.58 137.8 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -1.144 . . . . 0.0 109.055 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.79 149.52 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.894 -1.129 . . . . 0.0 109.581 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.47 ' NH2' ' OE1' ' A' ' 85' ' ' GLN . 1.6 tpt180 -164.74 1.74 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' B' ' 219' ' ' ARG . . . 169.65 7.3 0.03 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.537 ' N ' HD21 ' B' ' 254' ' ' LEU . . . 68.83 94.23 0.05 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.553 ' NH1' ' O ' ' B' ' 217' ' ' SER . 0.0 OUTLIER -127.69 -151.99 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.272 -1.134 . . . . 0.0 111.418 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.03 -40.64 96.76 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' B' ' 228' ' ' TYR . 74.7 m-20 -55.31 -33.77 63.58 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 1.9 mm100 -68.45 -38.84 81.48 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.19 66.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 108.646 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.42 -34.31 76.5 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.788 ' O ' HG23 ' B' ' 232' ' ' VAL . 14.0 m-85 -69.14 -48.42 62.42 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.059 -1.025 . . . . 0.0 110.217 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.61 75.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.483 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' B' ' 233' ' ' SER . 32.0 ttt85 -69.62 -57.31 5.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.089 . . . . 0.0 108.452 178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 20.6 mt -50.61 -43.39 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.788 HG23 ' O ' ' B' ' 228' ' ' TYR . 67.9 t -61.03 -30.73 48.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 230' ' ' ARG . 4.4 m -66.65 -41.36 88.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.776 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.91 -48.57 65.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.745 -1.222 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.699 HD22 HG11 ' B' ' 212' ' ' VAL . 32.8 mt -58.2 -40.37 81.4 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -61.99 -25.98 67.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 71.2 mtt-85 -74.93 -37.2 62.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.913 -1.117 . . . . 0.0 108.92 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . 0.486 ' HD1' ' N ' ' B' ' 238' ' ' TYR . 2.5 m-85 -70.09 -48.55 57.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.614 -0.679 . . . . 0.0 110.072 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' B' ' 210' ' ' CYS . . . -152.73 -145.53 4.16 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' B' ' 240' ' ' LYS . 0.0 OUTLIER -100.88 131.48 46.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -1.216 . . . . 0.0 108.575 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.583 HG11 HG13 ' B' ' 232' ' ' VAL . 19.4 t -90.67 127.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.561 ' HB3' ' CG ' ' B' ' 272' ' ' TRP . 12.0 mt -87.08 -38.44 16.49 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.181 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.638 HG21 ' O ' ' B' ' 214' ' ' PHE . 8.1 t -71.18 37.87 0.05 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 109.257 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' B' ' 242' ' ' LEU . 59.3 mt-10 -54.29 -28.84 44.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.392 -0.818 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.498 ' NE2' ' CG1' ' B' ' 265' ' ' ILE . 17.7 t-80 -52.08 -45.24 64.71 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.084 -1.01 . . . . 0.0 109.808 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.494 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 41.2 t -49.85 -69.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.295 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -51.87 -41.36 61.82 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 248' ' ' ASP . 14.5 t70 -85.2 43.44 1.01 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 246' ' ' VAL . . . -119.0 -32.05 4.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . 0.472 ' HG2' HE21 ' B' ' 225' ' ' GLN . 11.7 pt-20 -86.4 60.55 6.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.269 -0.894 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' B' ' 251' ' ' LEU . 0.1 OUTLIER -169.28 22.56 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.514 -0.741 . . . . 0.0 109.945 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' B' ' 251' ' ' LEU . 1.0 OUTLIER 161.87 160.3 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -37.03 99.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.382 2.055 . . . . 0.0 111.702 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.77 HD12 ' H ' ' B' ' 254' ' ' LEU . 6.7 mp -49.17 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 110.05 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . -175.71 -37.03 0.05 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.71 ' HB2' HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -46.68 -101.43 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.568 -0.96 . . . . 0.0 110.578 -178.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' B' ' 256' ' ' GLU . 80.7 mm-40 -63.94 -8.21 10.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.875 . . . . 0.0 110.058 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . . . . . . . . . . . -56.84 159.04 4.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -66.77 -21.37 66.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 109.16 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . -171.42 -172.33 37.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' B' ' 265' ' ' ILE . . . 103.14 -29.95 11.39 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' B' ' 263' ' ' GLN . 20.0 p-10 -56.17 -43.02 77.97 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . 0.467 ' N ' ' OD1' ' B' ' 262' ' ' ASP . 1.2 mt-30 -70.59 -53.25 16.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.29 -28.51 54.0 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.498 ' CG1' ' NE2' ' B' ' 245' ' ' HIS . 1.9 mt -71.08 -39.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.56 ' ND1' ' N ' ' B' ' 267' ' ' GLU . 1.2 t-80 -76.32 -60.73 2.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . 0.56 ' N ' ' ND1' ' B' ' 266' ' ' HIS . 9.4 tp10 -43.02 -54.86 4.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.723 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -64.63 -43.8 92.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.214 -0.929 . . . . 0.0 110.122 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.449 ' CB ' ' OH ' ' B' ' 213' ' ' TYR . 75.3 m-20 -61.84 -44.1 97.52 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.2 -0.937 . . . . 0.0 111.2 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.486 HD11 ' OH ' ' B' ' 292' ' ' TYR . 1.1 mm? -65.32 -50.05 67.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.975 -1.078 . . . . 0.0 110.02 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -62.22 -50.76 70.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.561 ' CG ' ' HB3' ' B' ' 242' ' ' LEU . 0.5 OUTLIER -63.03 -42.76 99.86 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.362 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.452 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.4 tp -51.76 -37.3 50.74 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -75.4 -28.1 59.32 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.558 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.42 -5.94 59.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.789 -1.194 . . . . 0.0 109.191 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.91 125.74 26.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.338 -0.851 . . . . 0.0 112.034 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' B' ' 211' ' ' SER . 41.9 m-20 -78.25 -33.14 49.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.91 147.7 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . . . . . . . . . 79.3 t -133.93 138.38 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.883 -1.136 . . . . 0.0 111.015 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 214' ' ' PHE . 20.0 t -137.83 164.76 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.448 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -159.95 130.16 5.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.614 -1.304 . . . . 0.0 110.143 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.453 ' CG ' ' OH ' ' B' ' 334' ' ' TYR . 52.0 tt0 -93.56 125.75 38.34 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' B' ' 307' ' ' LEU . 0.5 OUTLIER -155.3 115.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.987 -1.07 . . . . 0.0 110.349 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 285' ' ' GLN . 38.0 m -106.06 -19.0 13.86 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.68 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 6.6 tt0 164.09 -37.18 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.244 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 7.5 Cg_exo -70.9 103.82 1.41 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.389 2.06 . . . . 0.0 111.937 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.556 ' HB2' HD21 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -159.81 173.25 16.27 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.747 ' C ' ' H ' ' B' ' 290' ' ' VAL . 0.1 OUTLIER 167.9 122.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 119' ' ' MET . . . 73.26 -22.81 0.97 Allowed Glycine 0 N--CA 1.481 1.662 0 N-CA-C 105.709 -2.957 . . . . 0.0 105.709 -176.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.919 HG21 ' O ' ' B' ' 216' ' ' GLY . 2.1 t -85.43 -46.41 17.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -55.65 -30.51 56.34 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.486 ' OH ' HD11 ' B' ' 270' ' ' LEU . 1.3 t80 -68.62 -41.98 78.74 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -55.8 -34.55 65.41 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' B' ' 294' ' ' LEU . 54.4 mt -73.15 -37.97 66.4 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -60.9 -37.79 94.34 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -66.8 -39.88 87.9 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.451 -1.029 . . . . 0.0 108.649 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . 0.449 ' C ' HD11 ' B' ' 304' ' ' ILE . . . -69.55 -41.08 76.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.96 -1.088 . . . . 0.0 108.524 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -39.79 45.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.11 57.05 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.007 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . . . . . . . . . 17.5 mt -71.63 -6.97 44.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.094 -1.004 . . . . 0.0 108.832 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 297' ' ' ALA . . . 51.05 25.01 9.49 Favored Glycine 0 N--CA 1.494 2.557 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.052 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -79.76 154.61 75.83 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 120.631 -1.511 . . . . 0.0 108.254 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -44.39 118.35 1.71 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.806 1.67 . . . . 0.0 111.098 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.449 HD11 ' C ' ' B' ' 297' ' ' ALA . 11.9 mt -120.82 134.77 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.149 -0.969 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 31.9 tp -127.25 114.78 18.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . . . . . . . . . 85.9 m -110.57 156.18 21.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.76 -1.213 . . . . 0.0 108.105 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' B' ' 283' ' ' VAL . 3.5 mp -136.59 152.43 50.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.0 -1.062 . . . . 0.0 111.626 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' B' ' 308' ' ' PHE . 0.0 OUTLIER -148.68 130.62 15.25 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 178.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' B' ' 334' ' ' TYR . 0.0 OUTLIER -52.87 139.8 41.6 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.045 -1.034 . . . . 0.0 110.496 -177.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' B' ' 311' ' ' GLN . 33.3 Cg_endo -67.08 -50.06 1.17 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.067 1.845 . . . . 0.0 109.352 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.788 ' O ' ' N ' ' B' ' 313' ' ' GLY . 13.2 pt20 -67.09 -143.21 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 52.31 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.964 -1.085 . . . . 0.0 109.687 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.788 ' N ' ' O ' ' B' ' 311' ' ' GLN . . . 68.39 42.76 81.17 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' B' ' 315' ' ' VAL . 4.4 mtt180 -85.43 17.57 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 56' ' ' GLU . 17.9 t 50.41 99.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.969 0.89 . . . . 0.0 109.4 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 317' ' ' SER . 8.5 tp -45.33 -61.42 1.67 Allowed 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' B' ' 316' ' ' LEU . 0.9 OUTLIER 162.97 143.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 109.78 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.49 86.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.437 -0.79 . . . . 0.0 110.316 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 89' ' ' GLY . 1.6 mtp -74.3 -36.78 63.76 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.038 -1.039 . . . . 0.0 109.407 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.32 -45.93 58.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.333 -0.854 . . . . 0.0 109.439 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -77.46 -34.77 54.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.996 -1.065 . . . . 0.0 108.841 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 323' ' ' ALA . . . -69.09 -27.27 74.0 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 322' ' ' GLY . . . -43.43 -59.56 2.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.293 -1.122 . . . . 0.0 110.013 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 325' ' ' ASP . . . -133.07 -111.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 112.068 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' B' ' 324' ' ' ALA . 2.0 m-20 160.01 -2.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.336 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . . . . . . . . . . . 128.27 38.97 0.35 Allowed Glycine 0 N--CA 1.499 2.859 0 C-N-CA 119.611 -1.281 . . . . 0.0 111.663 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 57.0 p -115.97 -86.97 0.61 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.773 -1.427 . . . . 0.0 108.678 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.506 ' O ' ' NE2' ' B' ' 330' ' ' GLN . 20.1 tpt180 -94.29 -29.91 14.81 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' B' ' 329' ' ' PHE . 0.7 OUTLIER -117.86 126.25 52.04 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 178.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 328' ' ' ARG . 6.9 mp0 -132.23 136.37 46.95 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.471 -1.393 . . . . 0.0 112.65 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.72 107.11 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 20.7 m0 -104.48 142.92 33.77 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.071 -1.018 . . . . 0.0 110.939 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.542 ' O ' ' SD ' ' B' ' 342' ' ' MET . 67.0 m-20 -86.05 155.18 20.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.626 -1.296 . . . . 0.0 107.855 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.453 ' OH ' ' CG ' ' B' ' 282' ' ' GLU . 3.9 p90 -168.74 172.63 7.76 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.407 -1.317 . . . . 0.0 111.388 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' B' ' 338' ' ' GLU . . . -141.74 146.81 36.45 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' B' ' 335' ' ' ALA . 36.7 mt-10 -39.35 -37.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.83 -1.169 . . . . 0.0 110.286 -178.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -82.93 15.67 31.14 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' B' ' 335' ' ' ALA . 74.1 mt-10 -146.59 -5.15 0.56 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.119 -1.224 . . . . 0.0 110.47 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 2.8 p -53.8 -46.85 63.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 120.804 -1.185 . . . . 0.0 108.606 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.518 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 23.1 pt-20 -56.29 -34.39 66.42 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 32.2 m -65.78 -39.46 91.02 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.301 -0.874 . . . . 0.0 109.097 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.542 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 11.8 mmt -55.79 -51.56 67.0 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' B' ' 343' ' ' LEU . 25.0 mt -63.79 -30.48 71.57 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.39 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -69.26 -44.09 72.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.991 -1.068 . . . . 0.0 110.69 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -71.86 -43.35 65.61 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.532 -1.355 . . . . 0.0 109.38 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -63.02 -48.86 76.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.358 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.926 ' CD1' HD12 ' B' ' 351' ' ' LEU . 19.9 m-85 -73.36 -31.0 63.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.413 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -68.15 -27.48 66.47 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -59.25 -27.56 65.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.766 -0.584 . . . . 0.0 109.655 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.822 ' CG ' ' N ' ' B' ' 351' ' ' LEU . 0.1 OUTLIER -145.73 -63.63 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.0 -1.063 . . . . 0.0 110.591 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.926 HD12 ' CD1' ' B' ' 347' ' ' PHE . 1.4 mt -31.13 92.99 0.05 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.633 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . 0.53 ' N ' ' O ' ' B' ' 350' ' ' TYR . 77.2 Cg_endo -92.99 51.2 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.105 2.536 . . . . 0.0 110.914 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 52.04 22.07 1.74 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 1.7 tptp 50.69 25.85 2.25 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 5.4 m -68.29 -24.18 64.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.587 -0.696 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -131.52 155.02 48.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.853 . . . . 0.0 109.437 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 87.5 p -148.18 161.13 42.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 19.2 m -62.21 -30.53 71.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 109.359 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 86.4 p -69.31 168.13 14.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . 0.425 ' CD2' ' N ' ' B' ' 360' ' ' HIS . 20.4 m170 54.07 71.91 1.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.239 -0.913 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -53.58 -15.28 6.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.829 2.353 . . . . 0.0 112.184 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 9.5 t -51.3 -25.89 6.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 109.368 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.554 179.93 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.7 ttp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.78 -26.22 67.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.01 147.91 40.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.9 p -78.53 158.28 28.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.5 -178.44 21.02 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -106.63 140.32 39.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.425 -1.044 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -87.26 177.1 7.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.78 149.36 35.87 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 0.0 109.37 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.51 -161.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.457 2.105 . . . . 0.0 111.704 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' CA ' ' A' ' 39' ' ' GLY . 29.1 p -99.8 -173.25 2.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.229 -0.919 . . . . 0.0 109.238 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' H ' ' HB2' ' A' ' 77' ' ' ASP . 1.2 m -118.68 143.52 46.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG11 HD22 ' A' ' 35' ' ' LEU . 58.3 t -126.01 136.75 59.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.544 ' CZ ' ' OE1' ' A' ' 44' ' ' GLU . 5.9 t80 -113.41 109.17 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.557 ' CD2' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -98.23 129.95 44.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.636 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' OE1' ' A' ' 93' ' ' GLU . 3.2 m -102.12 151.19 22.47 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.342 -0.849 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.84 162.66 36.11 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -86.35 132.94 33.84 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.117 -1.226 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.542 ' CD1' HG13 ' A' ' 46' ' ' VAL . 1.3 mm -99.89 -27.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.704 ' NH1' ' H ' ' A' ' 56' ' ' GLU . 15.0 mmm180 -55.22 -69.85 0.12 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.858 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.87 18.81 56.87 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' GLU . . . -67.61 -90.14 0.06 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER 55.13 -93.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.389 -1.065 . . . . 0.0 108.591 -179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 51.3 mp0 -51.5 -46.2 63.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 28' ' ' TYR . 5.7 m-20 -65.01 -22.62 67.02 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.562 ' NE2' ' O ' ' A' ' 46' ' ' VAL . 18.3 tp60 -63.35 -39.15 93.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.87 -47.88 67.64 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -57.86 -32.22 67.44 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.816 ' O ' HG23 ' A' ' 32' ' ' VAL . 19.5 m-30 -67.44 -46.99 71.48 Favored 'General case' 0 C--O 1.199 -1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 109.683 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . . . -60.28 -37.48 80.62 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.644 -1.285 . . . . 0.0 109.046 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -70.79 -56.79 5.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.756 -1.215 . . . . 0.0 108.515 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.508 HG21 ' OE2' ' A' ' 82' ' ' GLU . 5.0 mt -52.9 -43.99 47.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 28' ' ' TYR . 61.6 t -59.44 -29.09 41.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.3 m -71.68 -34.41 69.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -69.46 -53.29 19.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 108.615 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD22 HG11 ' A' ' 12' ' ' VAL . 13.1 mt -56.95 -39.51 74.67 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -62.96 -22.92 67.15 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt85 -72.89 -44.54 61.16 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.365 -0.834 . . . . 0.0 109.412 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.95 -50.09 9.55 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.564 -0.71 . . . . 0.0 111.784 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.554 ' O ' ' C ' ' A' ' 40' ' ' LYS . . . -142.46 132.48 5.15 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' C ' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -35.79 145.6 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.411 -1.052 . . . . 0.0 109.129 -179.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.706 HG21 HG13 ' A' ' 32' ' ' VAL . 50.2 t -79.4 100.56 4.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.694 HD11 ' CD1' ' A' ' 72' ' ' TRP . 0.1 OUTLIER -49.88 94.56 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.546 -1.262 . . . . 0.0 109.952 -177.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 41' ' ' VAL . 6.6 m 28.21 100.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.363 0.602 . . . . 0.0 111.371 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' OE1' ' CZ ' ' A' ' 13' ' ' TYR . 16.3 tp10 -142.9 65.88 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.475 ' O ' ' C ' ' A' ' 46' ' ' VAL . 25.0 p80 -50.16 -5.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 110.231 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.562 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 39.0 t -40.18 -58.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.66 ' C ' ' H ' ' A' ' 49' ' ' ALA . . . -66.93 -40.76 87.7 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.171 -0.956 . . . . 0.0 108.641 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.865 ' O ' HD11 ' A' ' 51' ' ' LEU . 7.4 t70 -70.67 25.05 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.66 ' H ' ' C ' ' A' ' 47' ' ' ALA . . . -101.98 -16.18 16.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.01 -43.96 70.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 109.027 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.973 ' H ' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -50.73 136.99 20.94 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 0.0 109.353 -179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.609 ' O ' ' O ' ' A' ' 51' ' ' LEU . 20.8 mm-40 53.98 153.55 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.104 -0.997 . . . . 0.0 109.082 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.47 88.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.195 1.93 . . . . 0.0 111.736 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.476 HD11 ' NH1' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -61.15 -163.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.155 -0.966 . . . . 0.0 109.806 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 56' ' ' GLU . . . 91.09 151.85 27.22 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.704 ' H ' ' NH1' ' A' ' 19' ' ' ARG . 44.4 mt-10 -50.55 178.77 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.202 -1.176 . . . . 0.0 109.003 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 64.91 -24.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.166 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.649 ' H ' ' C ' ' A' ' 56' ' ' GLU . . . -80.37 141.41 35.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.333 -0.855 . . . . 0.0 109.162 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.58 133.38 36.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.154 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.38 -77.08 0.12 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.05 83.61 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -52.44 -45.79 66.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -1.043 . . . . 0.0 108.562 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.6 mt-30 -62.14 -46.36 89.37 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CD1' ' OE1' ' A' ' 68' ' ' GLN . 35.3 t80 -62.56 -41.62 99.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 11.9 mt -56.02 -46.13 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.753 ' CG ' ' HA3' ' B' ' 322' ' ' GLY . 1.7 t-80 -76.46 -27.11 56.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.7 -0.625 . . . . 0.0 109.852 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -61.86 -56.8 15.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.314 -0.867 . . . . 0.0 109.592 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.554 ' OE1' ' CD1' ' A' ' 64' ' ' PHE . 23.5 mp0 -76.37 -41.78 46.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.627 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 63.6 m-20 -60.11 -52.82 63.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.149 -0.97 . . . . 0.0 109.797 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.501 HD22 ' NE2' ' A' ' 66' ' ' HIS . 1.2 tp -67.98 -44.71 76.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 110.591 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -59.33 -49.27 78.46 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.592 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.694 ' CD1' HD11 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -76.73 -19.71 57.36 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 118.084 -1.447 . . . . 0.0 109.485 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HA ' ' CD2' ' A' ' 13' ' ' TYR . 13.8 tp -64.67 -35.14 80.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.495 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -86.66 -19.0 29.89 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.033 -1.067 . . . . 0.0 109.398 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.63 ' NE2' ' CD1' ' A' ' 72' ' ' TRP . 4.0 tt0 -99.26 2.74 45.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.879 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.26 129.26 39.31 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.194 -0.941 . . . . 0.0 111.381 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 11' ' ' SER . 94.6 m-20 -63.5 -35.23 79.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' OH ' ' A' ' 150' ' ' TYR . 42.9 t -138.41 149.78 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 13' ' ' TYR . 82.0 t -137.39 142.0 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.499 1.142 . . . . 0.0 112.106 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 105' ' ' LEU . 97.7 t -138.2 165.73 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.542 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -158.04 137.13 11.58 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.632 -1.293 . . . . 0.0 109.227 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 90' ' ' VAL . 28.4 mt-10 -93.61 126.1 38.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -126.68 130.72 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 85' ' ' GLN . 20.0 m -170.5 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.843 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 31.5 tt0 -100.05 -24.64 0.22 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.571 -0.706 . . . . 0.0 109.843 178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.843 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 96.2 Cg_exo -43.3 -142.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.731 2.287 . . . . 0.0 112.163 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.664 ' OG ' ' N ' ' A' ' 88' ' ' LEU . 2.4 t 172.53 -153.76 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.677 -1.264 . . . . 0.0 109.669 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.664 ' N ' ' OG ' ' A' ' 87' ' ' SER . 20.9 mt -30.59 136.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.382 -0.824 . . . . 0.0 110.091 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 115.37 -38.07 3.24 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -88.85 -41.86 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.553 -0.969 . . . . 0.0 108.589 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.66 -33.39 71.49 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' CD2' ' SD ' ' B' ' 319' ' ' MET . 65.4 t80 -66.65 -52.89 39.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -1.143 . . . . 0.0 109.745 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.562 ' OE1' ' SG ' ' A' ' 15' ' ' CYS . 59.0 mt-10 -64.82 -31.27 72.42 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.275 -0.891 . . . . 0.0 109.314 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 81' ' ' ALA . 25.1 mt -66.9 -44.42 80.84 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.88 -33.06 86.24 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.587 HH11 ' CG1' ' B' ' 298' ' ' VAL . 17.2 mmm180 -65.27 -44.46 87.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -1.03 . . . . 0.0 109.846 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.77 -36.71 73.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 108.67 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.568 ' CG1' HH11 ' B' ' 296' ' ' ARG . 0.5 OUTLIER -53.52 -44.52 56.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' B' ' 299' ' ' ALA . . . -74.8 -50.85 15.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.647 -179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 74' ' ' GLN . 14.2 mt -65.98 -6.45 12.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 109.51 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.53 17.54 66.79 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.905 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' O ' HG13 ' A' ' 104' ' ' ILE . 64.4 mmtt -83.47 135.43 43.75 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 120.708 -1.466 . . . . 0.0 107.973 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -40.15 121.73 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.642 1.561 . . . . 0.0 110.966 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 104' ' ' ILE . 1.7 mp -108.8 100.13 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.961 -1.087 . . . . 0.0 111.45 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' HB3' HG22 ' A' ' 80' ' ' VAL . 24.6 tp -91.75 114.37 26.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.708 ' SG ' ' CZ ' ' A' ' 129' ' ' PHE . 0.4 OUTLIER -110.95 154.53 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 0.0 109.383 -178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.567 ' HB3' ' CD1' ' A' ' 134' ' ' TYR . 8.8 mt -122.92 149.5 44.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 111.163 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.5 OUTLIER -145.03 119.63 9.76 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' NH1' ' NE2' ' A' ' 111' ' ' GLN . 7.2 mtm180 -79.25 124.61 84.27 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.797 -1.189 . . . . 0.0 111.109 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 113' ' ' GLY . 95.3 Cg_endo -83.42 -30.74 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.594 2.196 . . . . 0.0 110.758 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.469 ' NE2' ' NH1' ' A' ' 109' ' ' ARG . 9.4 pt20 -51.25 -35.24 36.15 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 113' ' ' GLY . 39.6 m -98.7 -11.9 21.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 110' ' ' PRO . . . 39.98 48.07 3.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 115' ' ' VAL . 0.4 OUTLIER -71.36 5.12 2.43 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -1.15 . . . . 0.0 109.386 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.0 t 53.92 109.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.822 0.82 . . . . 0.0 110.135 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.716 HD22 HG11 ' A' ' 131' ' ' VAL . 8.7 tp -56.19 149.32 16.31 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.94 150.07 14.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 109.766 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.16 86.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 108.643 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.602 ' SD ' ' CD2' ' B' ' 292' ' ' TYR . 0.0 OUTLIER -60.28 -50.58 73.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.715 ' O ' ' O ' ' A' ' 123' ' ' ALA . 32.6 mm -63.94 -36.32 76.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.104 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 18.9 mmt85 -53.58 -43.37 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.75 ' HA3' ' CG ' ' B' ' 266' ' ' HIS . . . -54.63 -43.92 79.04 Favored Glycine 0 N--CA 1.48 1.578 0 N-CA-C 104.7 -3.36 . . . . 0.0 104.7 176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.715 ' O ' ' O ' ' A' ' 120' ' ' ILE . . . -78.01 90.17 4.18 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' ARG . . . -174.28 46.5 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.222 -1.353 . . . . 0.0 108.591 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.37 -12.39 61.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.352 -0.842 . . . . 0.0 111.14 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 129' ' ' PHE . . . 67.62 2.61 22.75 Favored Glycine 0 N--CA 1.495 2.576 0 O-C-N 120.881 -1.137 . . . . 0.0 110.75 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.4 m -105.58 -78.85 0.57 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.993 -1.298 . . . . 0.0 108.87 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -93.19 -31.77 14.64 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.708 ' CZ ' ' SG ' ' A' ' 106' ' ' CYS . 8.5 t80 -110.74 130.19 55.64 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.6 125.74 13.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.864 -1.148 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.716 HG11 HD22 ' A' ' 116' ' ' LEU . 38.5 t -85.68 106.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 12.3 m0 -102.06 138.02 39.57 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.0 -1.063 . . . . 0.0 109.558 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' O ' ' CE ' ' A' ' 142' ' ' MET . 91.8 m-20 -91.79 152.67 20.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.705 -1.247 . . . . 0.0 109.012 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' ' 107' ' ' LEU . 4.8 p90 -164.29 -179.33 6.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.475 -1.29 . . . . 0.0 111.917 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 136' ' ' GLU . . . -153.53 147.36 25.33 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 135' ' ' ALA . 52.0 mt-10 -42.06 -36.17 1.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.926 -1.109 . . . . 0.0 110.298 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -75.36 4.44 41.53 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 120.163 -1.017 . . . . 0.0 111.496 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.96 7.15 0.33 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.552 -1.558 . . . . 0.0 110.742 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 140' ' ' GLU . 4.8 p -51.25 -43.29 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 108.464 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 139' ' ' VAL . 83.7 mt-10 -57.93 -36.34 72.34 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.9 m -64.99 -45.53 85.24 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.455 ' CE ' ' O ' ' A' ' 133' ' ' ASP . 3.9 tpp -51.56 -46.32 63.37 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 mt -71.84 -33.18 68.26 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.702 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 140' ' ' GLU . 55.3 m-20 -65.43 -40.42 93.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.95 -1.093 . . . . 0.0 109.837 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -69.91 -49.06 55.8 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.634 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.28 -48.73 80.06 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 109.979 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.829 ' CD1' HD12 ' A' ' 151' ' ' LEU . 8.9 m-85 -66.95 -32.43 73.67 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.904 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -68.71 -25.14 64.62 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.588 -1.32 . . . . 0.0 107.785 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.73 -20.39 62.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.53 -0.732 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -146.05 -0.13 0.81 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.456 -1.402 . . . . 0.0 111.649 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.829 HD12 ' CD1' ' A' ' 147' ' ' PHE . 16.6 mt -115.69 82.75 10.58 Favored Pre-proline 0 N--CA 1.504 2.228 0 O-C-N 120.672 -1.267 . . . . 0.0 109.267 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.24 -96.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.646 2.231 . . . . 0.0 112.095 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -73.93 -34.95 64.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.676 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -51.82 -27.17 11.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.147 -0.971 . . . . 0.0 109.299 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 151' ' ' LEU . 36.2 m -53.23 -35.84 60.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.177 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.78 114.41 4.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.831 . . . . 0.0 109.089 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.1 t -56.67 -26.7 57.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.9 t -64.11 150.9 44.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.187 -0.946 . . . . 0.0 109.42 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -59.93 146.08 43.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.418 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.76 150.54 86.42 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.174 -0.954 . . . . 0.0 109.224 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.84 157.9 53.92 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.529 2.153 . . . . 0.0 112.132 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -54.17 -37.62 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.516 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 37.2 ttp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.18 66.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ALA . . . . . . . . . . . . . . . -73.82 148.45 42.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.491 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' SER . . . . . . . . . . . . . 93.7 p -79.43 158.39 27.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.419 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' GLY . . . . . . . . . . . . . . . -145.32 -178.88 21.21 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -106.24 139.74 40.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.289 -1.124 . . . . 0.0 109.378 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -86.65 176.52 7.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -99.4 149.53 35.93 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.432 -0.792 . . . . 0.0 109.361 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.61 -161.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.625 2.217 . . . . 0.0 111.587 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' CYS . . . . . 0.456 ' O ' ' CA ' ' B' ' 239' ' ' GLY . 29.7 p -100.07 -173.19 2.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . 0.428 ' H ' ' HB2' ' B' ' 277' ' ' ASP . 1.2 m -118.62 143.76 46.6 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.494 HG11 HD22 ' B' ' 235' ' ' LEU . 60.1 t -126.14 136.63 60.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' TYR . . . . . 0.53 ' CZ ' ' OE1' ' B' ' 244' ' ' GLU . 6.0 t80 -113.35 109.12 18.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' B' ' 232' ' ' VAL . 0.0 OUTLIER -98.13 130.09 44.91 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.658 -179.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' B' ' 293' ' ' GLU . 3.2 m -102.28 151.33 22.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.329 -0.857 . . . . 0.0 109.888 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . -165.95 162.75 36.23 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' SER . . . . . . . . . . . . . 15.9 m -86.48 133.0 33.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.168 -1.195 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.553 ' CD1' HG13 ' B' ' 246' ' ' VAL . 1.3 mm -99.95 -27.46 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.322 -0.861 . . . . 0.0 109.229 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.726 ' NH1' ' H ' ' B' ' 256' ' ' GLU . 14.9 mmm180 -54.96 -69.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 109.827 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -97.01 18.77 56.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' B' ' 223' ' ' GLU . . . -67.67 -89.91 0.06 OUTLIER Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' B' ' 225' ' ' GLN . 0.0 OUTLIER 54.98 -93.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.407 -1.054 . . . . 0.0 108.53 -179.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' B' ' 223' ' ' GLU . 50.3 mp0 -51.34 -46.08 62.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ASP . . . . . 0.466 ' O ' ' CG ' ' B' ' 228' ' ' TYR . 6.0 m-20 -65.56 -22.53 66.7 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.555 ' NE2' ' O ' ' B' ' 246' ' ' VAL . 17.9 tp60 -63.44 -39.07 93.49 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.29 68.11 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.95 -32.53 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' TYR . . . . . 0.809 ' O ' HG23 ' B' ' 232' ' ' VAL . 19.5 m-30 -67.27 -47.02 71.94 Favored 'General case' 0 C--O 1.198 -1.631 0 O-C-N 121.527 -0.733 . . . . 0.0 109.796 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.435 ' HB2' ' HB1' ' B' ' 247' ' ' ALA . . . -60.38 -37.4 80.64 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 120.723 -1.236 . . . . 0.0 109.044 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -70.65 -56.86 5.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.773 -1.204 . . . . 0.0 108.505 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.495 HG21 ' OE2' ' B' ' 282' ' ' GLU . 4.9 mt -52.83 -43.93 47.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' VAL . . . . . 0.809 HG23 ' O ' ' B' ' 228' ' ' TYR . 60.6 t -59.66 -28.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 26.0 m -71.93 -34.19 68.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.211 -0.931 . . . . 0.0 109.383 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -69.47 -53.54 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.871 -1.143 . . . . 0.0 108.626 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . 0.494 HD22 HG11 ' B' ' 212' ' ' VAL . 12.9 mt -56.64 -39.61 73.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -62.97 -22.97 67.19 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' ARG . . . . . . . . . . . . . 6.5 ttt85 -72.91 -44.62 61.01 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.374 -0.829 . . . . 0.0 109.491 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.81 -49.9 9.85 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.513 -0.742 . . . . 0.0 111.873 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' B' ' 240' ' ' LYS . . . -142.67 132.75 5.24 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' B' ' 239' ' ' GLY . 0.0 OUTLIER -35.96 145.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -1.003 . . . . 0.0 109.027 -179.285 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' VAL . . . . . 0.716 HG21 HG13 ' B' ' 232' ' ' VAL . 44.7 t -79.31 100.63 4.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' LEU . . . . . 0.695 HD11 ' CD1' ' B' ' 272' ' ' TRP . 0.1 OUTLIER -49.84 94.88 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 118.558 -1.257 . . . . 0.0 109.938 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' THR . . . . . 0.524 ' N ' ' O ' ' B' ' 241' ' ' VAL . 6.6 m 27.81 100.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.421 0.629 . . . . 0.0 111.387 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' B' ' 246' ' ' VAL . 15.7 tp10 -143.2 66.52 1.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' HIS . . . . . 0.449 ' O ' ' C ' ' B' ' 246' ' ' VAL . 25.0 p80 -50.64 -5.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.562 -0.711 . . . . 0.0 110.147 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' VAL . . . . . 0.555 ' O ' ' NE2' ' B' ' 225' ' ' GLN . 39.3 t -40.36 -58.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.675 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.633 ' C ' ' H ' ' B' ' 249' ' ' ALA . . . -67.2 -40.54 86.51 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 108.616 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' ASP . . . . . 0.851 ' O ' HD11 ' B' ' 251' ' ' LEU . 7.0 t70 -71.0 25.58 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.633 ' H ' ' C ' ' B' ' 247' ' ' ALA . . . -102.47 -15.97 16.31 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -54.16 -43.89 70.98 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.368 -0.833 . . . . 0.0 109.011 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' LEU . . . . . 0.956 ' H ' ' CD1' ' B' ' 251' ' ' LEU . 0.0 OUTLIER -50.83 136.79 21.74 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.582 -0.699 . . . . 0.0 109.39 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLU . . . . . 0.606 ' O ' ' O ' ' B' ' 251' ' ' LEU . 20.6 mm-40 54.17 153.56 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.98 . . . . 0.0 109.175 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.69 89.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.181 1.921 . . . . 0.0 111.542 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . 0.483 HD11 ' NH1' ' B' ' 222' ' ' ARG . 0.3 OUTLIER -61.88 -163.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 109.75 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' B' ' 256' ' ' GLU . . . 91.37 151.58 27.03 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.726 ' H ' ' NH1' ' B' ' 219' ' ' ARG . 46.7 mt-10 -50.29 178.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -1.214 . . . . 0.0 109.157 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 64.82 -25.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 0.0 109.055 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ALA . . . . . 0.653 ' H ' ' C ' ' B' ' 256' ' ' GLU . . . -80.08 141.73 35.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.889 . . . . 0.0 109.29 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . . . . . . . . . . . -53.21 132.12 38.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.148 -0.97 . . . . 0.0 109.335 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 168.57 -77.5 0.11 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . 138.81 83.21 0.1 OUTLIER Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -52.08 -45.88 64.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.378 -1.072 . . . . 0.0 108.387 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -62.09 -46.52 88.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' B' ' 268' ' ' GLN . 36.0 t80 -62.72 -41.3 99.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.31 -0.869 . . . . 0.0 108.994 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' B' ' 269' ' ' ASP . 12.0 mt -56.28 -45.86 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' HIS . . . . . 0.75 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 1.7 t-80 -76.68 -27.33 55.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 109.926 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.66 -56.66 17.33 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.348 -0.845 . . . . 0.0 109.688 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' B' ' 264' ' ' PHE . 23.1 mp0 -76.65 -41.54 45.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' ASP . . . . . 0.472 ' HB3' ' OH ' ' B' ' 213' ' ' TYR . 62.1 m-20 -60.01 -52.3 65.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.829 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' B' ' 274' ' ' GLN . 1.2 tp -68.57 -44.49 74.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 110.559 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -59.23 -49.37 78.09 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.621 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' TRP . . . . . 0.695 ' CD1' HD11 ' B' ' 242' ' ' LEU . 0.2 OUTLIER -76.6 -19.63 57.64 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.121 -1.432 . . . . 0.0 109.588 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.447 ' HA ' ' CD2' ' B' ' 213' ' ' TYR . 13.7 tp -64.81 -34.91 79.49 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' B' ' 270' ' ' LEU . 0.2 OUTLIER -86.96 -19.1 29.24 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.442 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' B' ' 272' ' ' TRP . 4.1 tt0 -99.11 2.39 45.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.822 -1.174 . . . . 0.0 108.817 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.02 129.3 39.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.108 -0.995 . . . . 0.0 111.405 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' B' ' 211' ' ' SER . 95.2 m-20 -63.37 -35.38 80.22 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.463 HG21 ' OH ' ' B' ' 350' ' ' TYR . 42.6 t -138.28 149.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' B' ' 213' ' ' TYR . 83.2 t -137.48 142.22 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 122.534 1.159 . . . . 0.0 112.194 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' B' ' 305' ' ' LEU . 97.2 t -138.34 165.45 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . 0.522 ' N ' HG12 ' B' ' 280' ' ' VAL . . . -157.72 137.04 11.85 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.548 -1.345 . . . . 0.0 109.283 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' GLU . . . . . 0.519 ' O ' HG11 ' B' ' 290' ' ' VAL . 28.7 mt-10 -93.32 126.29 38.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 0.0 110.388 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' VAL . . . . . 0.71 ' O ' ' HA ' ' B' ' 308' ' ' PHE . 0.2 OUTLIER -126.81 130.88 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' THR . . . . . 0.569 HG22 ' N ' ' B' ' 285' ' ' GLN . 20.2 m -170.77 -92.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' GLN . . . . . 0.841 ' N ' ' CD ' ' B' ' 286' ' ' PRO . 31.8 tt0 -100.11 -24.75 0.22 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.452 -0.78 . . . . 0.0 109.838 178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' PRO . . . . . 0.841 ' CD ' ' N ' ' B' ' 285' ' ' GLN . 97.6 Cg_exo -43.31 -142.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.688 2.259 . . . . 0.0 112.125 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' SER . . . . . 0.679 ' OG ' ' N ' ' B' ' 288' ' ' LEU . 2.1 t 172.53 -153.9 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.569 -1.332 . . . . 0.0 109.626 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' LEU . . . . . 0.679 ' N ' ' OG ' ' B' ' 287' ' ' SER . 20.2 mt -30.49 136.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' GLY . . . . . . . . . . . . . . . 114.97 -37.64 3.43 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' VAL . . . . . 0.519 HG11 ' O ' ' B' ' 282' ' ' GLU . 4.3 t -89.17 -42.11 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.583 -0.951 . . . . 0.0 108.588 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' GLY . . . . . . . . . . . . . . . -69.46 -33.06 71.93 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' TYR . . . . . 0.602 ' CD2' ' SD ' ' A' ' 119' ' ' MET . 65.7 t80 -66.97 -52.24 45.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -1.161 . . . . 0.0 109.9 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' GLU . . . . . 0.552 ' OE1' ' SG ' ' B' ' 215' ' ' CYS . 59.5 mt-10 -65.25 -31.3 72.39 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 281' ' ' ALA . 24.6 mt -66.98 -44.46 80.39 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.11 -32.75 85.06 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 296' ' ' ARG . . . . . 0.568 HH11 ' CG1' ' A' ' 98' ' ' VAL . 16.9 mmm180 -65.33 -44.52 87.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.051 . . . . 0.0 109.82 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 297' ' ' ALA . . . . . . . . . . . . . . . -70.84 -36.82 73.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.112 -0.993 . . . . 0.0 108.647 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 298' ' ' VAL . . . . . 0.587 ' CG1' HH11 ' A' ' 96' ' ' ARG . 0.5 OUTLIER -53.26 -44.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' ALA . . . . . 0.63 ' HB1' ' HB1' ' A' ' 99' ' ' ALA . . . -75.02 -50.68 15.72 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.736 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 300' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' B' ' 274' ' ' GLN . 14.5 mt -66.45 -6.18 13.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . 66.41 17.57 66.56 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.817 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' LYS . . . . . 0.43 ' O ' HG13 ' B' ' 304' ' ' ILE . 65.1 mmtt -83.42 135.69 43.62 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 120.667 -1.49 . . . . 0.0 107.931 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -40.23 122.16 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.75 1.634 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' ILE . . . . . 0.626 HD12 ' H ' ' B' ' 304' ' ' ILE . 1.7 mp -109.37 99.98 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.12 -0.987 . . . . 0.0 111.283 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.58 ' HB3' HG22 ' B' ' 280' ' ' VAL . 24.9 tp -91.55 114.37 26.88 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' CYS . . . . . 0.703 ' SG ' ' CZ ' ' B' ' 329' ' ' PHE . 0.3 OUTLIER -110.97 154.34 24.26 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.901 -1.124 . . . . 0.0 109.566 -178.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' LEU . . . . . 0.558 ' HB3' ' CD1' ' B' ' 334' ' ' TYR . 9.2 mt -122.86 149.76 43.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.245 -0.909 . . . . 0.0 111.249 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' PHE . . . . . 0.71 ' HA ' ' O ' ' B' ' 283' ' ' VAL . 0.4 OUTLIER -145.72 119.69 9.37 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' ARG . . . . . 0.461 ' NH1' ' NE2' ' B' ' 311' ' ' GLN . 7.7 mtm180 -79.07 125.21 84.1 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.881 -1.137 . . . . 0.0 111.131 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' B' ' 313' ' ' GLY . 92.5 Cg_endo -83.55 -29.98 0.94 Allowed 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.579 2.186 . . . . 0.0 110.669 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' GLN . . . . . 0.461 ' NE2' ' NH1' ' B' ' 309' ' ' ARG . 9.4 pt20 -51.95 -35.16 45.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' SER . . . . . 0.448 ' O ' ' C ' ' B' ' 313' ' ' GLY . 31.1 m -98.8 -11.68 21.59 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' B' ' 310' ' ' PRO . . . 39.84 47.93 3.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' B' ' 315' ' ' VAL . 0.5 OUTLIER -71.14 4.39 2.8 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.168 -1.195 . . . . 0.0 109.373 -178.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' B' ' 314' ' ' ARG . 2.9 t 54.6 109.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.82 0.819 . . . . 0.0 110.101 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 316' ' ' LEU . . . . . 0.713 HD22 HG11 ' B' ' 331' ' ' VAL . 8.7 tp -56.58 149.83 16.71 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 317' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.54 150.03 16.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.021 -1.049 . . . . 0.0 109.629 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 318' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.66 85.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 108.606 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.612 ' SD ' ' CD2' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -60.78 -50.48 73.28 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.808 0.813 . . . . 0.0 108.836 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.71 ' O ' ' O ' ' B' ' 323' ' ' ALA . 32.2 mm -64.02 -36.34 76.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.981 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 321' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' B' ' 324' ' ' ALA . 19.2 mmt85 -53.54 -43.61 68.55 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 322' ' ' GLY . . . . . 0.753 ' HA3' ' CG ' ' A' ' 66' ' ' HIS . . . -54.58 -43.82 78.55 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 104.632 -3.387 . . . . 0.0 104.632 176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 323' ' ' ALA . . . . . 0.71 ' O ' ' O ' ' B' ' 320' ' ' ILE . . . -77.92 90.14 4.12 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' B' ' 321' ' ' ARG . . . -174.14 46.32 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.622 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 325' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -70.08 -12.29 61.5 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.413 -0.805 . . . . 0.0 111.212 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 326' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' B' ' 329' ' ' PHE . . . 67.36 2.15 18.62 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.666 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 73.6 m -105.27 -78.91 0.56 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.991 -1.299 . . . . 0.0 108.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -93.16 -32.11 14.53 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.703 ' CZ ' ' SG ' ' B' ' 306' ' ' CYS . 9.1 t80 -110.23 130.13 55.6 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 330' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -145.52 125.43 13.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.796 -1.19 . . . . 0.0 111.25 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . 0.713 HG11 HD22 ' B' ' 316' ' ' LEU . 35.9 t -85.46 106.5 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 332' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' B' ' 307' ' ' LEU . 11.9 m0 -102.02 137.79 39.83 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.04 -1.038 . . . . 0.0 109.44 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . 0.458 ' O ' ' SD ' ' B' ' 342' ' ' MET . 91.8 m-20 -91.54 152.57 20.26 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.801 -1.187 . . . . 0.0 109.084 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 334' ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' B' ' 307' ' ' LEU . 4.7 p90 -164.15 -179.22 6.01 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.613 -1.235 . . . . 0.0 111.856 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 335' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' B' ' 336' ' ' GLU . . . -153.91 147.59 25.25 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 336' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 335' ' ' ALA . 51.4 mt-10 -42.21 -36.07 1.12 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.802 -1.186 . . . . 0.0 110.281 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 337' ' ' GLY . . . . . . . . . . . . . . . -75.26 3.79 44.79 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.507 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 338' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.52 7.09 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.486 -1.597 . . . . 0.0 110.866 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' B' ' 340' ' ' GLU . 4.9 p -51.11 -43.49 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.908 -1.12 . . . . 0.0 108.467 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 340' ' ' GLU . . . . . 0.488 ' N ' ' CG1' ' B' ' 339' ' ' VAL . 83.1 mt-10 -57.88 -36.24 72.1 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 341' ' ' THR . . . . . . . . . . . . . 72.1 m -64.88 -45.67 85.04 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . 0.458 ' SD ' ' O ' ' B' ' 333' ' ' ASP . 3.9 tpp -51.42 -46.81 63.06 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 343' ' ' LEU . . . . . . . . . . . . . 52.9 mt -71.23 -33.6 70.02 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.789 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 344' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' B' ' 340' ' ' GLU . 55.4 m-20 -65.4 -40.33 93.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.972 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 345' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -69.92 -49.17 54.66 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.923 -1.111 . . . . 0.0 108.462 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.15 -48.61 80.8 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.215 -0.928 . . . . 0.0 110.017 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 347' ' ' PHE . . . . . 0.853 ' CD1' HD12 ' B' ' 351' ' ' LEU . 9.1 m-85 -66.96 -32.18 73.25 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.934 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 348' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -68.98 -25.04 64.33 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.54 -1.35 . . . . 0.0 107.83 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 349' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.26 62.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.569 -0.707 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 350' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 350' ' ' TYR . 0.5 OUTLIER -146.26 -0.34 0.78 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.611 -1.306 . . . . 0.0 111.512 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.853 HD12 ' CD1' ' B' ' 347' ' ' PHE . 16.7 mt -115.53 82.58 10.0 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 120.576 -1.328 . . . . 0.0 109.189 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 352' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.97 -96.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.752 2.301 . . . . 0.0 112.136 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 353' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -74.68 -34.37 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 354' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -52.31 -26.61 12.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.274 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' B' ' 351' ' ' LEU . 32.9 m -53.4 -36.54 61.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -151.37 114.38 4.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.366 -0.834 . . . . 0.0 109.244 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 357' ' ' SER . . . . . . . . . . . . . 30.5 t -56.52 -26.48 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.624 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 358' ' ' SER . . . . . . . . . . . . . 33.3 t -64.43 151.29 44.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.283 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 359' ' ' SER . . . . . . . . . . . . . 46.3 m -60.3 146.72 42.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.264 -0.897 . . . . 0.0 109.43 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 360' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -75.2 150.35 85.29 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 0.0 109.182 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 361' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.15 158.05 54.13 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.464 2.109 . . . . 0.0 112.077 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . . . . . . . . . 47.8 m -52.81 -34.03 51.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 109.385 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 363' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.48 179.833 . . . . . . . . 0 0 . 1 stop_ save_